Citrus Sinensis ID: 002189
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 955 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.963 | 0.972 | 0.561 | 0.0 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.893 | 0.889 | 0.354 | 1e-137 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.864 | 0.866 | 0.354 | 1e-136 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.841 | 0.858 | 0.351 | 1e-124 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.840 | 0.800 | 0.306 | 3e-90 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.839 | 0.774 | 0.319 | 9e-88 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.828 | 0.794 | 0.313 | 6e-86 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.304 | 0.446 | 0.474 | 1e-75 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.809 | 0.708 | 0.293 | 2e-74 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.308 | 0.415 | 0.455 | 2e-73 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 966 bits (2498), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/944 (56%), Positives = 681/944 (72%), Gaps = 24/944 (2%)
Query: 15 QFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTN-SRVTSITLSG 73
Q + A T+ +DF L+ALK++ W+ +WK++DPCG W GI C N +RV SI+L+
Sbjct: 19 QIYSVYAFTDGSDFTALQALKNE-WDTLSKSWKSSDPCGTEWVGITCNNDNRVVSISLTN 77
Query: 74 MGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 133
LKG+L +I+ L+EL TLDL+ N +L GPLP IGNL+KL+ L L+GC+F+GPIPDSI
Sbjct: 78 RNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPDSI 137
Query: 134 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-PGLDMLVR 192
G+L++L LSLN N FSG +P S+G LS LYW D+ DN+LEG++PVSDG S PGLDML++
Sbjct: 138 GNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDMLLQ 197
Query: 193 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 252
HFHFG N+LSG IPEKLF +M L+HVLFD N TG +P +LGLV++L V+R DRN L
Sbjct: 198 TGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRNRL 257
Query: 253 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 312
SG +PS+LNNLT++ +L+LS+NK TG++PNLT L+ L LD+SNN S VPSW +
Sbjct: 258 SGDIPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFLN 317
Query: 313 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRI 371
SL+TL +E+ L G +P LFS LQTV +K N +N TLDLGT+YS+ L V+L++N I
Sbjct: 318 SLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLDFVDLRDNFI 377
Query: 372 SAYTERGGAPAVNLTLIDNPICQELGTA-KGYCQLSQPISPYSTKQKNCLPAPCNANQSS 430
+ Y P VN+ L DN +CQ+ GYC QP S +ST K C C +
Sbjct: 378 TGYKSPANNP-VNVMLADNQVCQDPANQLSGYCNAVQPNSTFSTLTK-C-GNHCGKGKEP 434
Query: 431 SPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKN 490
+ C C YP TG RS SFS N + + +S+ T F++ K P+DS+++ N +N
Sbjct: 435 NQGCHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNG-KYPVDSVAMRNISEN 493
Query: 491 NFEY-LELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESG 549
+Y L +++ FPSG++ FN+T + S+ + Q Y PPP FGP F D Y+ F++
Sbjct: 494 PTDYHLLINLLIFPSGRDRFNQTEMDSINSAFTIQDYKPPPRFGPYIFVADQYKTFSDLE 553
Query: 550 GSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAHWDMNKSSGS 608
S K+ S+ VIIG V+LLLL LAG+YA QK+RA++A +Q NPFA WD K+
Sbjct: 554 DS-KTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNPFAKWDAGKNEMD 612
Query: 609 IPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG 668
PQL G + F+FEE+ K TNNFSDANDVG GGYG+VYKGTLPNGQ+IAIKRAQQGSMQG
Sbjct: 613 APQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGA 672
Query: 669 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 728
EFK EIELLSRVHHKN+V LLGFCFD+ EQML+YE++PNGSL D LSGKNG++LDW RR
Sbjct: 673 FEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRR 732
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
LKIALG+ +GL+YLHELA+PPIIHRD+KS+NILLDE L AKVADFGLSK + D EK H+T
Sbjct: 733 LKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVT 792
Query: 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848
TQVKGTMGYLDPEYYMT QLTEKSDVY FGV+MLELLTG+ PI+RG Y+V+E++ MDK
Sbjct: 793 TQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKS 852
Query: 849 KELYNLYELIDPT-IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907
+ LY+L EL+D T I S LKGFEKYVD+AL+CV+ G +RPTMSEVV+++E+IL+ G
Sbjct: 853 RNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESILRLVG 912
Query: 908 LNPNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSK 951
LNPNA+ SA+YE+AS PY + + Y+G FPT K
Sbjct: 913 LNPNAD----SATYEEASG----DPYGRDS---FEYTGVFPTPK 945
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1264), Expect = e-137, Method: Compositional matrix adjust.
Identities = 342/966 (35%), Positives = 517/966 (53%), Gaps = 113/966 (11%)
Query: 1 MGVKRKVFLLS-VYLQFLIIAAVTNDNDFVIL----KALKDDIWENEPPNWKNNDPCGDN 55
MGV + ++S L L +T+ D L + LKD + N +WK DPC N
Sbjct: 5 MGVVGIILVVSSCCLSLLDAQEITHPTDVSALQYVHRKLKDPL--NHLQDWKKTDPCASN 62
Query: 56 WEGIGCTNS------RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTI 109
W G+ C V + L M L GQL+ ++ L+ L L+ N DL G +P +
Sbjct: 63 WTGVICIPDPSDGFLHVKELRLLNMNLTGQLAPELGLLSNLTILNFMWN-DLTGQIPPEL 121
Query: 110 GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT 169
GNL L L+L G +G +P +GSL L++L ++ N SG++P S+ NL L
Sbjct: 122 GNLTHLIFLLLSGNQLTGSLPQELGSLSNLLILQIDYNEISGKLPTSLANLKKL------ 175
Query: 170 DNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT 229
KHFH N ++G IP + VL H L D+N LT
Sbjct: 176 ------------------------KHFHMNNNSITGQIPPEYSTLTNVL-HFLMDNNKLT 210
Query: 230 GELPATLGLVKSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSV 288
G LP L + SL +++ D ++ G +PS+ ++ ++ L L N L G +P+L+ V
Sbjct: 211 GNLPPELAQMPSLRILQLDGSNFDGTEIPSSYGSIPNLVKLSLRNCNLEGPIPDLSKSLV 270
Query: 289 LSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 348
L YLD+S+N + FS+ ++TT+ + N L G IP++ +P LQ + ++ N L
Sbjct: 271 LYYLDISSNKLTGEIPKNKFSA--NITTINLYNNLLSGSIPSNFSGLPRLQRLQVQNNNL 328
Query: 349 NGTLDLG-----TSYSENLLVNLQNNRISAYTERGGAPAVNLT--LIDNPICQELGTAK- 400
+G + + E L+++L+NN S + P N+T L NP+C + K
Sbjct: 329 SGEIPVIWENRILKAEEKLILDLRNNMFSNVSSVLLNPPSNVTVKLYGNPVCANVNAGKL 388
Query: 401 -GYCQLS-----------QPISPYSTKQKNCLPAPCNANQS----SSPNCQCAYPYTGTL 444
C +S + IS K+++C P + N S C CA P L
Sbjct: 389 ADLCGISTLEVESPATSSETISTGDCKRQSC---PVSENYDYVIGSPVACFCAAPLGIDL 445
Query: 445 VFRSLSFSDLGNTTYYEILEQSVTTSFQ-STYKLPIDSISLSNPHKNNFEYLELSIQFFP 503
RS SFSD +L+ + + + Y++ ID+ + + + L ++++ FP
Sbjct: 446 RLRSPSFSDFRPYKVSYMLDVASPKNLGINPYQISIDTFAWQSGPR-----LFMNMKIFP 500
Query: 504 SGQE---SFNRTGVSSVGFVLSNQIYSPPPLFGP---MFFNGDPYQ----YFAESGGSHK 553
E FN T V + + + GP + N Y+ F + G
Sbjct: 501 EYSELNSKFNSTEVQRIVDFFATFTLNTDDSLGPYEIISINTGAYKDVTIIFPKKSGMSI 560
Query: 554 STSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKAN--EQNPFAHWDMNKSSGSIPQ 611
S+G+IIGA A V+ L L+ + +KR+ + + +++P MN S
Sbjct: 561 GVSVGIIIGAIAFFLVLSSLALVFFIKRSKRKRKTREVDMEQEHPLPKPPMNMES----- 615
Query: 612 LKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEF 671
+KG ++F E+ T++FSD + +G GGYGKVYKG LP G ++A+KRA+QGS+QG +EF
Sbjct: 616 VKG---YNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQGSLQGQKEF 672
Query: 672 KMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 731
EIELLSR+HH+NLVSLLG+C +GEQML+YE++PNGSL D+LS + L RL+I
Sbjct: 673 FTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQPLSLALRLRI 732
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS----DSEKDHI 787
ALG+ARG+ YLH A+PPIIHRDIK SNILLD ++N KVADFG+SK ++ ++DH+
Sbjct: 733 ALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLIALDGGGVQRDHV 792
Query: 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK 847
TT VKGT GY+DPEYY++ +LTEKSDVYS G++ LE+LTG RPI G+ IVRE+ D
Sbjct: 793 TTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGRNIVREVNEACDA 852
Query: 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907
+ +ID ++G + + +++++LA++C Q++ + RP M E+V+++ENI G
Sbjct: 853 GM----MMSVIDRSMG-QYSEECVKRFMELAIRCCQDNPEARPWMLEIVRELENIY---G 904
Query: 908 LNPNAE 913
L P E
Sbjct: 905 LIPKEE 910
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 486 bits (1251), Expect = e-136, Method: Compositional matrix adjust.
Identities = 337/950 (35%), Positives = 509/950 (53%), Gaps = 124/950 (13%)
Query: 22 VTNDNDFVILKALKDDIWENEP----PNWKNNDPCGDNWEGIGCTNS-------RVTSIT 70
+TN + L+ +K+ + N+P NWK+ DPC NW G+ C NS V+ +
Sbjct: 32 ITNPVEVRALRVIKESL--NDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYLHVSELQ 89
Query: 71 LSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIP 130
L M L G LS ++ L+ L L NK + G +P IGN+K L L+L G +G +P
Sbjct: 90 LFSMNLSGNLSPELGRLSRLTILSFMWNK-ITGSIPKEIGNIKSLELLLLNGNLLNGNLP 148
Query: 131 DSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190
+ +G L L + ++ N SG +P S NL+
Sbjct: 149 EELGFLPNLDRIQIDENRISGPLPKSFANLN----------------------------- 179
Query: 191 VRAKHFHFGKNQLSGSIPEKLFR-PDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 249
+ KHFH N +SG IP +L P +V H+L D+NNL+G LP L + L +++ D
Sbjct: 180 -KTKHFHMNNNSISGQIPPELGSLPSIV--HILLDNNNLSGYLPPELSNMPRLLILQLDN 236
Query: 250 NSLSGP-VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 308
N G +P + N++ + + L N L G +P+L+ + L YLD+S N + S +P+
Sbjct: 237 NHFDGTTIPQSYGNMSKLLKMSLRNCSLQGPVPDLSSIPNLGYLDLSQNQLNGS-IPAGK 295
Query: 309 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL------DLGTSYSENL 362
S S+TT+ + N +L G IP + +P LQ + + N L+G++ + + +E++
Sbjct: 296 LS-DSITTIDLSNNSLTGTIPTNFSGLPRLQKLSLANNALSGSIPSRIWQERELNSTESI 354
Query: 363 LVNLQNNRISAYTERGG-APAVNLTLIDNPICQELGTAKGYCQ--LSQPISPYSTKQKNC 419
+V+L+NN S + R P V + L NP+C + G C + I+ ST
Sbjct: 355 IVDLRNNGFSNISGRSDLRPNVTVWLQGNPLCSD-GNLLRLCGPITEEDINQGSTNSNTT 413
Query: 420 LPAPCNANQSSSP----NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQ-ST 474
+ + C SP C CA P +S FSD Y EQ +T+ +
Sbjct: 414 ICSDCPPPYEFSPEPLRRCFCAAPLLVGYRLKSPGFSDF--VPYRSEFEQYITSGLSLNL 471
Query: 475 YKLPIDSISLSNPHKNNFEYLELSIQFFPS-GQES-----FNRTGVSSVGFVLSNQIYSP 528
Y+L +DS + L + ++FFP G + FNR+ V + + +
Sbjct: 472 YQLRLDSFQWQKGPR-----LRMYLKFFPVFGSNANNSFIFNRSEVRRIRGMFTGWNIRD 526
Query: 529 PPLFGP---MFFN-----GDPYQYFAESGGSHKSTSIGVIIGAAAAG----CVVLLLLL- 575
LFGP M F D + + SG S+ + + G+++G+ AA ++ L+++
Sbjct: 527 EDLFGPYELMNFTLLDVYRDVFPSASPSGLSNGAVA-GIVLGSVAAAVTLTAIIALIIMR 585
Query: 576 --LAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDA 633
+ G A +++R+ KA+ + ++G + F++ E+ T+NF+ +
Sbjct: 586 KRMRGYSAVARRKRSSKASLK-----------------IEGVKSFTYAELALATDNFNSS 628
Query: 634 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
+G GGYGKVYKGTL +G ++AIKRAQ+GS+QG +EF EIELLSR+HH+NLVSLLGFC
Sbjct: 629 TQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLGFC 688
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
+ GEQML+YE++ NG+L D++S K LD+ RL+IALG+A+G+ YLH ANPPI HR
Sbjct: 689 DEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIFHR 748
Query: 754 DIKSSNILLDERLNAKVADFGLSK-----SMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
DIK+SNILLD R AKVADFGLS+ M H++T VKGT GYLDPEY++T QL
Sbjct: 749 DIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTHQL 808
Query: 809 TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868
T+KSDVYS GV++LEL TG +PI GK IVREI + L + + + S
Sbjct: 809 TDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYESGSILSTVDKRMS-----SVPD 863
Query: 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSS 918
+ EK+ LAL+C +E D RP+M+EVV+++E I + L P + A ++
Sbjct: 864 ECLEKFATLALRCCREETDARPSMAEVVRELEIIWE---LMPESHVAKTA 910
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 445 bits (1145), Expect = e-124, Method: Compositional matrix adjust.
Identities = 315/896 (35%), Positives = 455/896 (50%), Gaps = 92/896 (10%)
Query: 45 NWKNNDPCGDNWEGIGCTNS-------RVTSITLSGMGLKGQLSGDITGLTELHTLDLSN 97
NW DPC NW GI C V + L + L G+L+ ++ L L LD+
Sbjct: 53 NWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSGELAPEVGQLLYLEILDVMW 112
Query: 98 NKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI 157
N + +G IP IG + L LL LN N F+G +PP +
Sbjct: 113 N-------------------------NLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPEL 147
Query: 158 GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFR-PDM 216
GNL NL L + +N + G +P S GN L KH H N +SG IP +L + P
Sbjct: 148 GNLQNLNRLQVDENNITGSVPFSFGN------LRSIKHLHLNNNTISGEIPVELSKLPK- 200
Query: 217 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNK 275
L+H++ D+NNLTG LP L + SL +++ D N+ G +P + + + L L N
Sbjct: 201 -LVHMILDNNNLTGTLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCG 259
Query: 276 LTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSI 335
L G++P+L+ + LSYLD+S N + S S ++TT+ + +L G IP +
Sbjct: 260 LQGSIPDLSRIENLSYLDLSWNHLTGTIPESKLS--DNMTTIELSYNHLTGSIPQSFSDL 317
Query: 336 PHLQTVVMKTNELNGTLDL----GTSYSENLL--VNLQNNRISAYTERGGAPAVNLTLID 389
LQ + ++ N L+G++ S+ N L +L NN A V L L
Sbjct: 318 NSLQLLSLENNSLSGSVPTEIWQDKSFENNKLQVYDLNNNFSDATGNLRTPDNVTLYLRG 377
Query: 390 NPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCN------ANQSSSPN-CQCAYPYTG 442
NPIC+ Q + I + PC+ N SP C C P +
Sbjct: 378 NPICKSTSIPM-VTQFFEYICGEKKQTSTNSNTPCSNVSCPFENVKVSPGICLCTAPLSI 436
Query: 443 TLVFRSLSFSDLGNTTYYEI-LEQSVTTSFQ-STYKLPIDSISLSNPHKNNFEYLELSIQ 500
+S SF T Y E + +T+S Q T++L ID + N + YL+L
Sbjct: 437 DYRLKSPSFFFF--TPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRM-YLKL--- 490
Query: 501 FFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQ-----YFAESGGSHKST 555
P G+ +FN++ V + + ++ FGP P Q A++ G
Sbjct: 491 -VPKGRITFNKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLLAQTSGIRTIV 549
Query: 556 SIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGA 615
+ ++ G+ A V L + Y +KRR +++ ++KG
Sbjct: 550 WMMIVAGSVVAATV----LSVTATLLYVRKRRENSHTLTKKRVFRTISR------EIKGV 599
Query: 616 RCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEI 675
+ FSF E+ TN F + +G G YGKVYKG L N +AIKR ++ S+Q +EF EI
Sbjct: 600 KKFSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEI 659
Query: 676 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA 735
+LLSR+HH+NLVSL+G+ D GEQML+YE++PNG++ D LS L + R +ALG+
Sbjct: 660 DLLSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGS 719
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-----SMSDSEKDHITTQ 790
A+G+ YLH ANPP+IHRDIK+SNILLD +L+AKVADFGLS+ D E H++T
Sbjct: 720 AKGILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTV 779
Query: 791 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850
V+GT GYLDPEY+MTQQLT +SDVYSFGV++LELLTG P G +I+RE+RT E
Sbjct: 780 VRGTPGYLDPEYFMTQQLTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTA----NE 835
Query: 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906
+ + D +G + K +K +LAL C ++ + RP MS+VVK++E I Q
Sbjct: 836 CGTVLSVADSRMGQCSPDK-VKKLAELALWCCEDRPETRPPMSKVVKELEGICQSV 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (855), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 303/988 (30%), Positives = 445/988 (45%), Gaps = 185/988 (18%)
Query: 56 WEGIGCTNSR--VTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLK 113
W G+ C SR VTS+ LSG+ L G LS D++ L L L L+ N + GP+P I +L
Sbjct: 59 WIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENL-ISGPIPPEISSLS 117
Query: 114 KLSNLMLVGCSFSGPIPDSIGS-------------------------LQELVLLSLNSNG 148
L +L L F+G PD I S L +L L L N
Sbjct: 118 GLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNY 177
Query: 149 FSGRVPPSIGNLSNLYWLDLTDNKLEGEIP-------------------VSDGNSPGLDM 189
F+G++PPS G+ + +L ++ N+L G+IP DG P +
Sbjct: 178 FAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGN 237
Query: 190 LVRAKHFHFGKNQLSGSIPE---KLFRPDMVLIHV-LFD------------------SNN 227
L F L+G IP KL + D + + V +F SNN
Sbjct: 238 LSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNN 297
Query: 228 L-TGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGL 286
+ TGE+PA+ +K+L ++ RN L G +P + +L + L L N TG++P G
Sbjct: 298 MFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGE 357
Query: 287 S-VLSYLDMSNNSFDAS-----------------------EVPSWFSSMQSLTTLMMENT 322
+ L+ +D+S+N + +P +SLT + M
Sbjct: 358 NGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGEN 417
Query: 323 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYT--ERGG 379
L G IP LF +P L V ++ N L+G L + S NL ++L NN++S G
Sbjct: 418 FLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGN 477
Query: 380 APAVNLTLIDN-----PICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNC 434
V L+D PI E+G + QLS+ ++ P C
Sbjct: 478 FTGVQKLLLDGNKFQGPIPSEVGKLQ---QLSKIDFSHNLFSGRIAP--------EISRC 526
Query: 435 QCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSI-----SLSNPHK 489
+ L F LS ++L EI + + + SI S+ +
Sbjct: 527 KL-------LTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTS 579
Query: 490 NNFEYLELSIQFFPSGQES-FNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAES 548
+F Y LS +GQ S FN T L N P L GP P +
Sbjct: 580 LDFSYNNLSGLVPGTGQFSYFNYTSF------LGN-----PDLCGPYL---GPCKDGVAK 625
Query: 549 GGSHKSTSIGVIIGA-------AAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWD 601
GG H+S S G + + C + V A + R +KA+E
Sbjct: 626 GG-HQSHSKGPLSASMKLLLVLGLLVCSIAF-----AVVAIIKARSLKKASES------- 672
Query: 602 MNKSSGSIPQLKGARCFSFEEVKKYTNNFSDA----NDVGSGGYGKVYKGTLPNGQLIAI 657
+ R +F+ + ++ D+ N +G GG G VYKG +PNG L+A+
Sbjct: 673 -----------RAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAV 721
Query: 658 KRAQQGSMQGGQE--FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL 715
KR S + F EI+ L R+ H+++V LLGFC + +L+YE++PNGSLG+ L
Sbjct: 722 KRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL 781
Query: 716 SGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775
GK G L W R KIAL AA+GL YLH +P I+HRD+KS+NILLD A VADFGL
Sbjct: 782 HGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGL 841
Query: 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER-- 833
+K + DS + + G+ GY+ PEY T ++ EKSDVYSFGV++LEL+TGR+P+
Sbjct: 842 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFG 901
Query: 834 -GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM 892
G IV+ +R + D K+ ++ +++DP + S + +A+ CV+E +RPTM
Sbjct: 902 DGVDIVQWVRKMTDSNKD--SVLKVLDPRLS-SIPIHEVTHVFYVAMLCVEEQAVERPTM 958
Query: 893 SEVVKDIENI--LQQAGLNPNAESASSS 918
EVV+ + I L + P ESA S
Sbjct: 959 REVVQILTEIPKLPPSKDQPMTESAPES 986
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 9e-88, Method: Compositional matrix adjust.
Identities = 280/876 (31%), Positives = 415/876 (47%), Gaps = 74/876 (8%)
Query: 55 NWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKK 114
N +G+ + + + + L GQL + + EL L LS N L G L + NL
Sbjct: 199 NLDGLYNCSKSIQQLHIDSNRLTGQLPDYLYSIRELEQLSLSGNY-LSGELSKNLSNLSG 257
Query: 115 LSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174
L +L++ FS IPD G+L +L L ++SN FSGR PPS+ S L LDL +N L
Sbjct: 258 LKSLLISENRFSDVIPDVFGNLTQLEHLDVSSNKFSGRFPPSLSQCSKLRVLDLRNNSLS 317
Query: 175 GEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA 234
G I ++ L +L A SN+ +G LP
Sbjct: 318 GSINLNFTGFTDLCVLDLA-------------------------------SNHFSGPLPD 346
Query: 235 TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNN---KLTGAMPNLTGLSVLSY 291
+LG ++++ +N G +P NL S+ L LSNN + M L LS
Sbjct: 347 SLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQHCRNLST 406
Query: 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 351
L +S N F E+P+ + +L L + N L+GQIP+ L + L+ + + N GT
Sbjct: 407 LILSKN-FIGEEIPNNVTGFDNLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWNHFYGT 465
Query: 352 LDLGTSYSENLL-VNLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPIS 410
+ E+L ++ NN ++ GA V +T + N I + GTA S I
Sbjct: 466 IPHWIGKMESLFYIDFSNNTLT------GAIPVAITELKNLI-RLNGTASQMTD-SSGIP 517
Query: 411 PYSTKQKNCLPAPCNANQSSSPNCQ--------CAYPYTGTLVFRSLSFSDLGNTTYYEI 462
Y + K+ P N P+ P G L + L DL +
Sbjct: 518 LYVKRNKSSNGLPYNQVSRFPPSIYLNNNRLNGTILPEIGRL--KELHMLDLSRNNFTGT 575
Query: 463 LEQSVT---------TSFQSTY-KLPIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRT 512
+ S++ S+ Y +P+ SL+ + + Y L+ PSG + ++
Sbjct: 576 IPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSVAYNRLT-GAIPSGGQFYSFP 634
Query: 513 GVSSVGFV-LSNQIYSPPPLFGPMFFNGDPYQYFAESGGSHKSTSIGVIIGAAAAGCVVL 571
S G + L I SP + N +GG +SI V+ + A G +L
Sbjct: 635 HSSFEGNLGLCRAIDSPCDVLMSNMLNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLL 694
Query: 572 LLLLLAGVYAYHQKRRAEKANEQN-PFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNF 630
L ++L + R +E+ + S + G + S EE+ K TNNF
Sbjct: 695 LSVILLRISRKDVDDRINDVDEETISGVSKALGPSKIVLFHSCGCKDLSVEELLKSTNNF 754
Query: 631 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
S AN +G GG+G VYK P+G A+KR Q +EF+ E+E LSR HKNLVSL
Sbjct: 755 SQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQ 814
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANP 748
G+C +++LIY F+ NGSL L + + L W RLKIA GAARGL+YLH++ P
Sbjct: 815 GYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEP 874
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
+IHRD+KSSNILLDE+ A +ADFGL++ + + H+TT + GT+GY+ PEY +
Sbjct: 875 NVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDT-HVTTDLVGTLGYIPPEYSQSLIA 933
Query: 809 TEKSDVYSFGVLMLELLTGRRPIE--RGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
T + DVYSFGV++LEL+TGRRP+E +GK + V K E ELID TI +
Sbjct: 934 TCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRDLVSRVFQMKAEKRE-AELIDTTIRENV 992
Query: 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
+ + +++A KC+ RP + EVV +E++
Sbjct: 993 NERTVLEMLEIACKCIDHEPRRRPLIEEVVTWLEDL 1028
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 283/902 (31%), Positives = 436/902 (48%), Gaps = 111/902 (12%)
Query: 76 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 135
L G + + ++ L L+LS N +P GNL L + L C G IPDS+G
Sbjct: 168 LDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQ 227
Query: 136 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 195
L +LV L L N G +PPS+G L+N+ ++L +N L GEIP GN L +L +
Sbjct: 228 LSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASM- 286
Query: 196 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 255
NQL+G IP++L R + +++ NNL GELPA++ L +L +R N L+G
Sbjct: 287 -----NQLTGKIPDELCRVPLESLNLY--ENNLEGELPASIALSPNLYEIRIFGNRLTGG 339
Query: 256 VPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 314
+P +L + + L +S N+ +G +P +L L L + +NSF + +P + +SL
Sbjct: 340 LPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLIIHNSF-SGVIPESLADCRSL 398
Query: 315 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISA 373
T + + G +P + +PH+ + + N +G + + NL L+ L NN +
Sbjct: 399 TRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFT- 457
Query: 374 YTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPN 433
G P +E+G+ QLS A N S P+
Sbjct: 458 ----GSLP------------EEIGSLDNLNQLS---------------ASGNKFSGSLPD 486
Query: 434 CQCAYPYTGTLVFRSLSFS---DLGNTTYYEILEQSVTTSFQSTYKLP--IDSISLSNPH 488
+ GTL FS G ++ ++ E ++ + + T K+P I S+S+ N
Sbjct: 487 SLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADN-EFTGKIPDEIGSLSVLN-- 543
Query: 489 KNNFEYLELSIQFF----PSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMF---FNGDP 541
YL+LS F P +S ++ LS + PP L M+ F G+P
Sbjct: 544 -----YLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDL--PPSLAKDMYKNSFIGNP 596
Query: 542 YQYFAESG--GSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAH 599
G GS + + V+ ++LLAGV ++ K R K +
Sbjct: 597 GLCGDIKGLCGSENEAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSK 656
Query: 600 WDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKR 659
W + S +L FS E+ + + + N +G+G GKVYK L NG+ +A+KR
Sbjct: 657 WTLM----SFHKLG----FSEHEILE---SLDEDNVIGAGASGKVYKVVLTNGETVAVKR 705
Query: 660 AQQGSMQ-------------GGQE--FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704
GS++ G Q+ F+ E+E L ++ HKN+V L C R ++L+YE
Sbjct: 706 LWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYE 765
Query: 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE 764
++PNGSLGD L G L W R KI L AA GLSYLH + PPI+HRDIKS+NIL+D
Sbjct: 766 YMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDG 825
Query: 765 RLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 823
A+VADFG++K++ + K + V G+ GY+ PEY T ++ EKSD+YSFGV++LE
Sbjct: 826 DYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 885
Query: 824 LLTGRRPI--ERG-KYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALK 880
++T +RP+ E G K +V+ + + +D+K + +IDP + S + K +++ L
Sbjct: 886 IVTRKRPVDPELGEKDLVKWVCSTLDQK----GIEHVIDPKLD-SCFKEEISKILNVGLL 940
Query: 881 CVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFD 940
C +RP+M VVK +LQ+ G S D G PY NE+ D
Sbjct: 941 CTSPLPINRPSMRRVVK----MLQEIG----GGDEDSLHKIRDDKDGKL-TPYYNEDTSD 991
Query: 941 YG 942
G
Sbjct: 992 QG 993
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 141/297 (47%), Positives = 205/297 (69%), Gaps = 6/297 (2%)
Query: 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL 677
F++EE+ + TN FS+AN +G GG+G V+KG LP+G+ +A+K+ + GS QG +EF+ E+E+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 678 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR 737
+SRVHH++LVSL+G+C +++L+YEFVPN +L L GK ++W RLKIALG+A+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
GLSYLHE NP IIHRDIK+SNIL+D + AKVADFGL+K SD+ H++T+V GT GY
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMGTFGY 446
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVRE-----IRTVMDKKKELY 852
L PEY + +LTEKSDV+SFGV++LEL+TGRRP++ V + R ++++ E
Sbjct: 447 LAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEG 506
Query: 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 909
+ L D +G + + V A CV+ S RP MS++V+ +E + + LN
Sbjct: 507 DFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLN 563
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (719), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 262/894 (29%), Positives = 420/894 (46%), Gaps = 121/894 (13%)
Query: 76 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 135
L+G+L +I L L L+ L G LP +IGNLK++ + + SGPIPD IG
Sbjct: 202 LRGELPWEIGNCENLVMLGLAETS-LSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGY 260
Query: 136 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-------D 188
EL L L N SG +P +IG L L L L N L G+IP GN P L +
Sbjct: 261 CTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSEN 320
Query: 189 MLVRAKHFHFGK-----------NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 237
+L FGK NQ+SG+IPE+L L H+ D+N +TGE+P+ +
Sbjct: 321 LLTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTK-LTHLEIDNNLITGEIPSLMS 379
Query: 238 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP---------------- 281
++SL + +N L+G +P +L+ + + LS N L+G++P
Sbjct: 380 NLRSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLS 439
Query: 282 -NLTGL--------SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADL 332
+L+G + L L ++ N A +PS ++++L + + L G IP +
Sbjct: 440 NDLSGFIPPDIGNCTNLYRLRLNGNRL-AGSIPSEIGNLKNLNFVDISENRLVGSIPPAI 498
Query: 333 FSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPAVNLT---LI 388
L+ + + TN L+G+L LGT+ ++L ++ +N +S+ G LT L
Sbjct: 499 SGCESLEFLDLHTNSLSGSL-LGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLA 557
Query: 389 DNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNA--NQSSSPNCQCAYPYTGTLVF 446
N + E+ C+ Q ++ +P + + S N C + G +
Sbjct: 558 KNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNR-FVGEIPS 616
Query: 447 RSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFF---P 503
R FSDL N ++ +T + L + +SL N N+F + FF P
Sbjct: 617 R---FSDLKNLGVLDVSHNQLTGNLNVLTDLQ-NLVSL-NISYNDFSGDLPNTPFFRRLP 671
Query: 504 SGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGGSHKSTSIGVIIGA 563
+ NR G +SN I + P DP + S+ + + I
Sbjct: 672 LSDLASNR------GLYISNAISTRP----------DPT--------TRNSSVVRLTILI 707
Query: 564 AAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEV 623
VL+L+ VY + R A K W++ L FS +++
Sbjct: 708 LVVVTAVLVLM---AVYTLVRARAAGKQLLGEEIDSWEVT--------LYQKLDFSIDDI 756
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH 683
K N + AN +G+G G VY+ T+P+G+ +A+K+ G F EI+ L + H
Sbjct: 757 VK---NLTSANVIGTGSSGVVYRITIPSGESLAVKKMWSKEESGA--FNSEIKTLGSIRH 811
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--SGKNGIRLDWIRRLKIALGAARGLSY 741
+N+V LLG+C +R ++L Y+++PNGSL L +GK G +DW R + LG A L+Y
Sbjct: 812 RNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGC-VDWEARYDVVLGVAHALAY 870
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS-------DSEKDHITTQVKGT 794
LH P IIH D+K+ N+LL +ADFGL++++S D K + G+
Sbjct: 871 LHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLAKPTNRPPMAGS 930
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER----GKYIVREIRTVMDKKKE 850
GY+ PE+ Q++TEKSDVYS+GV++LE+LTG+ P++ G ++V+ +R + +KK+
Sbjct: 931 YGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVKWVRDHLAEKKD 990
Query: 851 LYNLYELIDPTIGLST--TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
L+DP + T + + + +A CV ++RP M +VV + I
Sbjct: 991 ---PSRLLDPRLDGRTDSIMHEMLQTLAVAFLCVSNKANERPLMKDVVAMLTEI 1041
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (710), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 139/305 (45%), Positives = 208/305 (68%), Gaps = 10/305 (3%)
Query: 606 SGSIPQL----KGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQ 661
SGS P G F++EE+ T FS N +G GG+G VYKG L +G+L+A+K+ +
Sbjct: 325 SGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLK 384
Query: 662 QGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI 721
GS QG +EFK E+E++SRVHH++LVSL+G+C E++LIYE+VPN +L L GK
Sbjct: 385 VGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRP 444
Query: 722 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781
L+W RR++IA+G+A+GL+YLHE +P IIHRDIKS+NILLD+ A+VADFGL+K ++D
Sbjct: 445 VLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK-LND 503
Query: 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER-----GKY 836
S + H++T+V GT GYL PEY + +LT++SDV+SFGV++LEL+TGR+P+++ +
Sbjct: 504 STQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEES 563
Query: 837 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVV 896
+V R ++ K E + EL+D + + ++ A CV+ SG RP M +VV
Sbjct: 564 LVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVV 623
Query: 897 KDIEN 901
+ +++
Sbjct: 624 RALDS 628
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 955 | ||||||
| 255556695 | 960 | Serine/threonine-protein kinase PBS1, pu | 0.988 | 0.983 | 0.705 | 0.0 | |
| 225465318 | 954 | PREDICTED: probable leucine-rich repeat | 0.986 | 0.987 | 0.662 | 0.0 | |
| 297739430 | 2030 | unnamed protein product [Vitis vinifera] | 0.972 | 0.457 | 0.666 | 0.0 | |
| 356520135 | 959 | PREDICTED: probable leucine-rich repeat | 0.971 | 0.967 | 0.641 | 0.0 | |
| 356532392 | 908 | PREDICTED: probable leucine-rich repeat | 0.908 | 0.955 | 0.641 | 0.0 | |
| 356558021 | 914 | PREDICTED: probable leucine-rich repeat | 0.939 | 0.981 | 0.630 | 0.0 | |
| 357448317 | 986 | Somatic embryogenesis receptor-like kina | 0.958 | 0.927 | 0.587 | 0.0 | |
| 225465316 | 944 | PREDICTED: probable leucine-rich repeat | 0.973 | 0.985 | 0.608 | 0.0 | |
| 30695748 | 953 | leucine-rich repeat protein kinase-like | 0.984 | 0.986 | 0.594 | 0.0 | |
| 449439783 | 966 | PREDICTED: probable leucine-rich repeat | 0.970 | 0.959 | 0.571 | 0.0 |
| >gi|255556695|ref|XP_002519381.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223541448|gb|EEF42998.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1360 bits (3519), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 672/952 (70%), Positives = 804/952 (84%), Gaps = 8/952 (0%)
Query: 7 VFLLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRV 66
+FLL V LQ IAAVTN D L ALKD IW+N PP+WK DPCGD WEGI CTN RV
Sbjct: 14 LFLLFVSLQICNIAAVTNTADSSALNALKD-IWQNTPPSWKGADPCGDKWEGIECTNLRV 72
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
TSITLS +G+ GQLSGDI+ L EL LDLS NK L G LP +IGNLKKL+NL+LVGC FS
Sbjct: 73 TSITLSSIGITGQLSGDISNLQELQILDLSYNKGLEGTLPESIGNLKKLTNLILVGCGFS 132
Query: 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG 186
GPIP+SIGSLQ+LV LSLNSNGFSG +PPSIGNL+ LYWLDL DNKLEG IPVS G +PG
Sbjct: 133 GPIPNSIGSLQQLVFLSLNSNGFSGGIPPSIGNLAKLYWLDLADNKLEGRIPVSTGTTPG 192
Query: 187 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 246
L+MLV KHFHFGKN+L G+IP +LFR DM L+HVLF+SNN TG +P+TLGLV+SLE+VR
Sbjct: 193 LNMLVNTKHFHFGKNRLGGTIPPELFRSDMTLLHVLFESNNFTGSIPSTLGLVQSLEIVR 252
Query: 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
FDRNSL+GPVPSNLNNLT V++L+LSNN+LTG+ PNLTG++ LSYLDMSNNSFDAS+ PS
Sbjct: 253 FDRNSLTGPVPSNLNNLTGVSELFLSNNQLTGSFPNLTGMNSLSYLDMSNNSFDASDFPS 312
Query: 307 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNL 366
W S++QSLTTLMMENT L+GQIPA+ FS+ HL TVV++ N+LNGTLD+GT++ + LL+++
Sbjct: 313 WMSTLQSLTTLMMENTQLQGQIPAEFFSLSHLTTVVLRDNKLNGTLDVGTTHGDQLLIDM 372
Query: 367 QNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNA 426
+NN IS YT+ G L++NPICQE G + YC + SPY T NC P CN+
Sbjct: 373 RNNEISGYTQHGTGQTPVTILLNNPICQETGVKEAYCSVPPSDSPYVTPPNNCEPVQCNS 432
Query: 427 NQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSN 486
NQSSSPNC CAYPY G LVFR+ SFSDL NTT + LEQ++ SF+S ++P+DS+SLSN
Sbjct: 433 NQSSSPNCNCAYPYKGLLVFRAPSFSDLENTTLFISLEQALMNSFRSN-EVPVDSVSLSN 491
Query: 487 PHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFA 546
P K++ +YL+ ++ FP+G++ F+R +S +GFVLSNQ + PP +FGP +F DPY++FA
Sbjct: 492 PRKDSSDYLDFDLEVFPTGKDHFSRIDISGLGFVLSNQTFKPPKVFGPFYFIADPYKFFA 551
Query: 547 -ESGGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAHWDMNK 604
ES S+ S++ G+IIGAAA G V++LLLLLAG+YAY QK+RA++A EQ NPFAHWD +K
Sbjct: 552 GESTESNNSSNTGIIIGAAAGGVVLVLLLLLAGLYAYRQKKRAQRAKEQNNPFAHWDSSK 611
Query: 605 SSGS-IPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG 663
S G+ +PQLKGARCFSFEE+KKYTNNFSDAND+GSGGYGKVY+G LPNGQL+AIKRAQQG
Sbjct: 612 SHGADVPQLKGARCFSFEELKKYTNNFSDANDIGSGGYGKVYRGILPNGQLVAIKRAQQG 671
Query: 664 SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL 723
S+QGG EFK EIELLSRVHHKNLVSLLGFCF+RGEQML+YEFV NGSL DSLSGK+GIRL
Sbjct: 672 SLQGGLEFKTEIELLSRVHHKNLVSLLGFCFERGEQMLVYEFVANGSLSDSLSGKSGIRL 731
Query: 724 DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783
DW+RRLK+ALG+ARGL+Y+HELANPPIIHRD+KS+NILLDERLNAKVADFGLSK MSDSE
Sbjct: 732 DWVRRLKVALGSARGLAYMHELANPPIIHRDVKSTNILLDERLNAKVADFGLSKPMSDSE 791
Query: 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843
K H+TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGV+MLELLTG+RPIERGKYIVRE++
Sbjct: 792 KGHVTTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELLTGKRPIERGKYIVREVKL 851
Query: 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
MD+ K+LYNL+EL+DP IGL TTLKG +K+VDLA+KCVQE G DRPTM +VVK+IENIL
Sbjct: 852 AMDRTKDLYNLHELLDPGIGLETTLKGLDKFVDLAMKCVQELGADRPTMGDVVKEIENIL 911
Query: 904 QQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 955
+ AG+NPNAESAS+SASYE+ASKG+ HHPY N++ F+ YSG FP SKI+PQ
Sbjct: 912 KLAGVNPNAESASTSASYEEASKGSPHHPY-NKDAFE--YSGAFPPSKIDPQ 960
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465318|ref|XP_002269453.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1254 bits (3244), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/954 (66%), Positives = 765/954 (80%), Gaps = 12/954 (1%)
Query: 7 VFLLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRV 66
V LL V++Q A TN +D L ALKD +WEN PP+W DPCG +WEGIGC N RV
Sbjct: 8 VSLLIVFIQISATWARTNTDDATALVALKD-LWENYPPSWVGFDPCGSSWEGIGCYNQRV 66
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
SI L+ MGLKG LSGD+ L+EL LDLS NK+L G +P +IG+LKKL+NL+LVGCSFS
Sbjct: 67 ISIILTSMGLKGGLSGDLDQLSELQILDLSYNKNLTGNIPASIGSLKKLTNLILVGCSFS 126
Query: 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG 186
GPIPD+IGSL ELV LSLNSN FSG +PPSIGNLS LYWLDL DN+L G IP+S+G++PG
Sbjct: 127 GPIPDTIGSLTELVFLSLNSNSFSGGIPPSIGNLSKLYWLDLADNQLTGTIPISNGSTPG 186
Query: 187 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 246
LD L KHFHFGKN+LSGSIP KLF +M+LIH+L +SN LTG +P+TLGL+K+LEVVR
Sbjct: 187 LDKLTHTKHFHFGKNRLSGSIPPKLFSSNMILIHLLLESNRLTGSIPSTLGLLKTLEVVR 246
Query: 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
D NSLSGPVPSNLNNLT V DL+LSNNKLTG +P+LTG++ L+Y+DMSNNSFD S VPS
Sbjct: 247 LDGNSLSGPVPSNLNNLTEVKDLFLSNNKLTGTVPDLTGMNSLNYMDMSNNSFDVSNVPS 306
Query: 307 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVN 365
W S++QSLTTL MENTNLKG IPA LFS+P LQTV ++ N +NGTLD G YS L LV+
Sbjct: 307 WLSTLQSLTTLTMENTNLKGAIPASLFSLPQLQTVSLRNNIINGTLDFGAGYSSQLQLVD 366
Query: 366 LQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCN 425
LQ N I A+TER G V + L++NPIC E + YC SQP YST NC+P+ C+
Sbjct: 367 LQKNYIVAFTERAGH-DVEIILVENPICLEGPKNEKYCMTSQPDFSYSTPPNNCVPSVCS 425
Query: 426 ANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLS 485
++Q SPNC CAYPY GTLVFR+ SFS+LGN++YY LEQ + SFQS +LP+DS+ L+
Sbjct: 426 SDQIPSPNCICAYPYMGTLVFRAPSFSNLGNSSYYISLEQRLMQSFQSQ-QLPVDSVFLA 484
Query: 486 NPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYF 545
+ K++ YL++S++ FP G++ FNRTG+S VGF LSNQ + PP FGP +FNG+ YQYF
Sbjct: 485 DLMKDSNNYLQVSLKVFPHGRDRFNRTGISMVGFALSNQTFKPPSTFGPFYFNGEQYQYF 544
Query: 546 AESGGS---HKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAHWD 601
E S +KS++ G+IIGAA G +++LLLL AGVYA+ QKRRAE+A EQ NPFA+WD
Sbjct: 545 EEVSLSLEPNKSSNTGIIIGAAVGGSLLVLLLLFAGVYAFRQKRRAERATEQSNPFANWD 604
Query: 602 MNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQ 661
+K SG IPQLKGAR F+FEE+KK TNNFSD NDVGSGGYGKVY+ TLP GQ++AIKRA+
Sbjct: 605 ESKGSGGIPQLKGARRFTFEEIKKCTNNFSDVNDVGSGGYGKVYRATLPTGQMVAIKRAK 664
Query: 662 QGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI 721
Q SMQGG EFK EIELLSRVHHKN+VSL+GFCF GEQ+LIYE+VPNGSL +SLSG++GI
Sbjct: 665 QESMQGGLEFKTEIELLSRVHHKNVVSLIGFCFQLGEQILIYEYVPNGSLKESLSGRSGI 724
Query: 722 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781
RLDW RRLK+ALG+ARGL+YLHELA+PPIIHRDIKS+NILLDE LNAKV DFGL K ++D
Sbjct: 725 RLDWRRRLKVALGSARGLAYLHELADPPIIHRDIKSNNILLDEHLNAKVGDFGLCKLLAD 784
Query: 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREI 841
SEK H+TTQVKGTMGY+DPEYYM+QQLTEKSDVYSFGVLMLEL++ R+PIERGKYIV+E+
Sbjct: 785 SEKGHVTTQVKGTMGYMDPEYYMSQQLTEKSDVYSFGVLMLELISARKPIERGKYIVKEV 844
Query: 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
+ MDK K+LYNL L+DPT+G TTL GF K+VDLAL+CV+ESG DRPTM EVVK+IEN
Sbjct: 845 KIAMDKTKDLYNLQGLLDPTLG--TTLGGFNKFVDLALRCVEESGADRPTMGEVVKEIEN 902
Query: 902 ILQQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 955
I+Q AGLNP ES+S+SASYE++S G HPY + FD S G+P S +EP+
Sbjct: 903 IMQLAGLNPITESSSASASYEESSTGTSSHPYGSNSAFD--SSAGYPPSTVEPK 954
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739430|emb|CBI29612.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1244 bits (3219), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 626/939 (66%), Positives = 756/939 (80%), Gaps = 10/939 (1%)
Query: 7 VFLLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRV 66
V LL V++Q A TN +D L ALKD +WEN PP+W DPCG +WEGIGC N RV
Sbjct: 8 VSLLIVFIQISATWARTNTDDATALVALKD-LWENYPPSWVGFDPCGSSWEGIGCYNQRV 66
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
SI L+ MGLKG LSGD+ L+EL LDLS NK+L G +P +IG+LKKL+NL+LVGCSFS
Sbjct: 67 ISIILTSMGLKGGLSGDLDQLSELQILDLSYNKNLTGNIPASIGSLKKLTNLILVGCSFS 126
Query: 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG 186
GPIPD+IGSL ELV LSLNSN FSG +PPSIGNLS LYWLDL DN+L G IP+S+G++PG
Sbjct: 127 GPIPDTIGSLTELVFLSLNSNSFSGGIPPSIGNLSKLYWLDLADNQLTGTIPISNGSTPG 186
Query: 187 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 246
LD L KHFHFGKN+LSGSIP KLF +M+LIH+L +SN LTG +P+TLGL+K+LEVVR
Sbjct: 187 LDKLTHTKHFHFGKNRLSGSIPPKLFSSNMILIHLLLESNRLTGSIPSTLGLLKTLEVVR 246
Query: 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
D NSLSGPVPSNLNNLT V DL+LSNNKLTG +P+LTG++ L+Y+DMSNNSFD S VPS
Sbjct: 247 LDGNSLSGPVPSNLNNLTEVKDLFLSNNKLTGTVPDLTGMNSLNYMDMSNNSFDVSNVPS 306
Query: 307 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVN 365
W S++QSLTTL MENTNLKG IPA LFS+P LQTV ++ N +NGTLD G YS L LV+
Sbjct: 307 WLSTLQSLTTLTMENTNLKGAIPASLFSLPQLQTVSLRNNIINGTLDFGAGYSSQLQLVD 366
Query: 366 LQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCN 425
LQ N I A+TER G V + L++NPIC E + YC SQP YST NC+P+ C+
Sbjct: 367 LQKNYIVAFTERAGH-DVEIILVENPICLEGPKNEKYCMTSQPDFSYSTPPNNCVPSVCS 425
Query: 426 ANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLS 485
++Q SPNC CAYPY GTLVFR+ SFS+LGN++YY LEQ + SFQS +LP+DS+ L+
Sbjct: 426 SDQIPSPNCICAYPYMGTLVFRAPSFSNLGNSSYYISLEQRLMQSFQSQ-QLPVDSVFLA 484
Query: 486 NPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYF 545
+ K++ YL++S++ FP G++ FNRTG+S VGF LSNQ + PP FGP +FNG+ YQYF
Sbjct: 485 DLMKDSNNYLQVSLKVFPHGRDRFNRTGISMVGFALSNQTFKPPSTFGPFYFNGEQYQYF 544
Query: 546 AESGGS---HKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAHWD 601
E S +KS++ G+IIGAA G +++LLLL AGVYA+ QKRRAE+A EQ NPFA+WD
Sbjct: 545 EEVSLSLEPNKSSNTGIIIGAAVGGSLLVLLLLFAGVYAFRQKRRAERATEQSNPFANWD 604
Query: 602 MNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQ 661
+K SG IPQLKGAR F+FEE+KK TNNFSD NDVGSGGYGKVY+ TLP GQ++AIKRA+
Sbjct: 605 ESKGSGGIPQLKGARRFTFEEIKKCTNNFSDVNDVGSGGYGKVYRATLPTGQMVAIKRAK 664
Query: 662 QGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI 721
Q SMQGG EFK EIELLSRVHHKN+VSL+GFCF GEQ+LIYE+VPNGSL +SLSG++GI
Sbjct: 665 QESMQGGLEFKTEIELLSRVHHKNVVSLIGFCFQLGEQILIYEYVPNGSLKESLSGRSGI 724
Query: 722 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781
RLDW RRLK+ALG+ARGL+YLHELA+PPIIHRDIKS+NILLDE LNAKV DFGL K ++D
Sbjct: 725 RLDWRRRLKVALGSARGLAYLHELADPPIIHRDIKSNNILLDEHLNAKVGDFGLCKLLAD 784
Query: 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREI 841
SEK H+TTQVKGTMGY+DPEYYM+QQLTEKSDVYSFGVLMLEL++ R+PIERGKYIV+E+
Sbjct: 785 SEKGHVTTQVKGTMGYMDPEYYMSQQLTEKSDVYSFGVLMLELISARKPIERGKYIVKEV 844
Query: 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
+ MDK K+LYNL L+DPT+G TTL GF K+VDLAL+CV+ESG DRPTM EVVK+IEN
Sbjct: 845 KIAMDKTKDLYNLQGLLDPTLG--TTLGGFNKFVDLALRCVEESGADRPTMGEVVKEIEN 902
Query: 902 ILQQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFD 940
I+Q AGLNP ES+S+SASYE++S G HPY + FD
Sbjct: 903 IMQLAGLNPITESSSASASYEESSTGTSSHPYGSNSAFD 941
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520135|ref|XP_003528720.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1197 bits (3096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/942 (64%), Positives = 732/942 (77%), Gaps = 14/942 (1%)
Query: 23 TNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSG 82
T D D +L + WEN PPNW +DPC D+W GI C NS +TSITLS GL GQLSG
Sbjct: 23 TADGDLTTFLSLIN-TWENTPPNWVGSDPC-DDWVGIKCKNSHITSITLSSTGLAGQLSG 80
Query: 83 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142
DI L+EL TLDLS NKDL GPLP +IG LKKL+ L+LVGCSF GPIPDSIG++QEL+ L
Sbjct: 81 DIGSLSELETLDLSYNKDLTGPLPESIGELKKLATLILVGCSFKGPIPDSIGNMQELLFL 140
Query: 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 202
SLNSN FSG +P SIGNLS LYWLDL DN+L+G IPVS G+ GLD L AKHFH GKN
Sbjct: 141 SLNSNSFSGPIPHSIGNLSKLYWLDLADNQLQGNIPVSSGDISGLDKLHHAKHFHLGKNN 200
Query: 203 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262
LSGSIP +LF +M LIHVL +SN LT ++P TLGLV+SLEVVR D NSL+GPVP N+NN
Sbjct: 201 LSGSIPPQLFSSEMALIHVLLESNQLTDKIPPTLGLVQSLEVVRLDGNSLNGPVPPNINN 260
Query: 263 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322
LT V DLYLSNNKL+G++PNLTG++ LSYLDMSNNSF + P WFS+++SLTTL ME T
Sbjct: 261 LTHVQDLYLSNNKLSGSLPNLTGMNALSYLDMSNNSFKPLDFPGWFSTLKSLTTLKMERT 320
Query: 323 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAP 381
L+GQ+P LF++ +LQ VV+K N++NGTLD+G+SYS L LV+ + N I ++ ++ P
Sbjct: 321 QLQGQVPTSLFTLINLQIVVLKDNKINGTLDIGSSYSNQLRLVDFETNSIDSFEQKDEVP 380
Query: 382 AVNLTLI--DNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYP 439
V + +I DNPICQE G + YC SQP YST NC P C++ Q SPNC CAYP
Sbjct: 381 NVKIKIILKDNPICQENGELESYCSSSQPNVSYSTPLNNCQPGTCSSEQILSPNCICAYP 440
Query: 440 YTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSI 499
Y+GTL FRS F D N TYY +LE+ + SF+S + LP+DS+ LS+P K++ +YLELS+
Sbjct: 441 YSGTLTFRSPPFLDFDNKTYYSMLEEGLMNSFKSHF-LPVDSVLLSHPSKDSTQYLELSL 499
Query: 500 QFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESG--GSHKSTSI 557
Q FPSGQ FNRTG S+GF+LSNQ + PP +FGP +F GD Y++F SG S KS++I
Sbjct: 500 QVFPSGQNHFNRTGAFSIGFLLSNQTFKPPKVFGPFYFVGDKYEHFENSGLTESSKSSNI 559
Query: 558 GVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKA-NEQNPFAHWDMNKSSGSIPQLKGAR 616
G+IIGAA G V+L+LLLLAG+YA+ QK+RAEKA + NPF WD S +PQL AR
Sbjct: 560 GIIIGAAVGGLVLLVLLLLAGLYAFRQKKRAEKAIGQSNPFRRWDTASSKSEVPQLTEAR 619
Query: 617 CFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE 676
FSFEE+KKYT NFS N +GSGG+GKVYKG LPNGQ+IAIKRAQ+ SMQG EFK EIE
Sbjct: 620 MFSFEELKKYTKNFSQVNGIGSGGFGKVYKGNLPNGQVIAIKRAQKESMQGKLEFKAEIE 679
Query: 677 LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA 736
LLSRVHHKNLVSL+GFCF+ EQML+YE+V NGSL D+LSGK+GIRLDWIRRLKIALG A
Sbjct: 680 LLSRVHHKNLVSLVGFCFEHEEQMLVYEYVQNGSLKDALSGKSGIRLDWIRRLKIALGTA 739
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
RGL+YLHEL NPPIIHRDIKS+NILLD+RLNAKV+DFGLSKSM DSEKDH+TTQVKGTMG
Sbjct: 740 RGLAYLHELVNPPIIHRDIKSNNILLDDRLNAKVSDFGLSKSMVDSEKDHVTTQVKGTMG 799
Query: 797 YLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856
YLDPEYYM+QQLTEKSDVYSFGVLMLEL++ RRP+ERGKYIV+E+R +DK K Y L E
Sbjct: 800 YLDPEYYMSQQLTEKSDVYSFGVLMLELISARRPLERGKYIVKEVRNALDKTKGSYGLDE 859
Query: 857 LIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAE 913
+IDP IGL++ TL GF+K+VD+ + CV+ESG DRP MS+VV++IENIL+ AG NP E
Sbjct: 860 IIDPAIGLASTTLTLSGFDKFVDMTMTCVKESGSDRPKMSDVVREIENILKSAGANPTEE 919
Query: 914 SASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 955
S S S+SYE+ S+G+ HPY + + FD S G P K++P+
Sbjct: 920 SPSISSSYEEVSRGSSSHPYNSNDTFD--LSAGLPYPKVDPK 959
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532392|ref|XP_003534757.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1142 bits (2953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 561/875 (64%), Positives = 696/875 (79%), Gaps = 7/875 (0%)
Query: 39 WENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNN 98
W+N PPNW DPCG W+GI CTNSR+TSI+L+ M L GQL+ DI L+EL LDLS N
Sbjct: 12 WQNTPPNWDGTDPCGAGWDGIECTNSRITSISLASMDLSGQLTSDIGSLSELLILDLSYN 71
Query: 99 KDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG 158
K L GPLP IGNL+KL NL+++ C F+GPIP +IG+L+ LV LSLNSNGF+G +P +IG
Sbjct: 72 KKLTGPLPNDIGNLRKLRNLLVINCGFTGPIPVTIGNLERLVFLSLNSNGFTGPIPAAIG 131
Query: 159 NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVL 218
NLSN+YWLDL +N+LEG IP+S+G +PGLDM+ KHFHFGKN+LSG+IP +LF P+M L
Sbjct: 132 NLSNIYWLDLAENQLEGPIPISNGTTPGLDMMHHTKHFHFGKNKLSGNIPSQLFSPEMSL 191
Query: 219 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG 278
IHVLF+SN TG +P+TLGLVK+LEVVRFD N LSGPVP N+NNLTSV +L+LSNN+L+G
Sbjct: 192 IHVLFESNRFTGSIPSTLGLVKTLEVVRFDDNVLSGPVPLNINNLTSVRELFLSNNRLSG 251
Query: 279 AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHL 338
+ PNLTG++ LSYLDMSNNSFD S+ P W ++ +LTT+MMENT L+G+IP LFS+ L
Sbjct: 252 SPPNLTGMNSLSYLDMSNNSFDQSDFPPWLPTLPALTTIMMENTKLQGRIPVSLFSLQQL 311
Query: 339 QTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPAVNLTLIDNPICQELG 397
QTVV+K N+LNGTLD+GTS S NL L++LQ N I + + V + L++NPICQE G
Sbjct: 312 QTVVLKNNQLNGTLDIGTSISNNLDLLDLQINFIEDFDPQIDVSKVEIILVNNPICQETG 371
Query: 398 TAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNT 457
+ YC +++ YST NC+P PC+ +Q+ SP C+CAYPY GTLV R+ SFSDL N
Sbjct: 372 VPQTYCSITKSNDSYSTPPDNCVPVPCSLDQTLSPECKCAYPYEGTLVLRAPSFSDLENK 431
Query: 458 TYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSV 517
T + LE S+ SFQ +K P+DSISLSNP KN ++YLEL+++ FP GQ+ FNRTG+S +
Sbjct: 432 TIFVTLESSLMESFQ-LHKKPVDSISLSNPRKNIYQYLELTLKIFPLGQDRFNRTGISDI 490
Query: 518 GFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGG----SHKSTSIGVIIGAAAAGCVVLLL 573
GF+LSNQ Y PPP+FGP +F D Y+ + ++ G + KS++ G+I GA G +L+L
Sbjct: 491 GFLLSNQTYKPPPMFGPYYFIADEYENYVDNSGPVTSNRKSSNTGIIAGAGGGGAALLVL 550
Query: 574 LLLAGVYAYHQKRRAEKAN-EQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSD 632
+LLA VYA QK++ +K+ NPF WD + S+ SIPQLKGAR FSFEE++ T NFS
Sbjct: 551 VLLACVYAISQKKKTKKSTGNNNPFEQWDPHDSNSSIPQLKGARRFSFEEIQNCTKNFSQ 610
Query: 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
N++GSGGYGKVY+GTLPNGQLIA+KRAQ+ SMQGG EFK EIELLSRVHHKNLVSL+GF
Sbjct: 611 VNNIGSGGYGKVYRGTLPNGQLIAVKRAQKESMQGGLEFKTEIELLSRVHHKNLVSLVGF 670
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
CFD+GEQMLIYE+V NG+L D+LSGK+GIRLDWIRRLKIALGAARGL YLHELANPPIIH
Sbjct: 671 CFDQGEQMLIYEYVANGTLKDTLSGKSGIRLDWIRRLKIALGAARGLDYLHELANPPIIH 730
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
RDIKS+NILLDERL AKV+DFGLSK + + K +ITTQVKGTMGYLDPEYYMTQQLTEKS
Sbjct: 731 RDIKSTNILLDERLIAKVSDFGLSKPLGEGAKGYITTQVKGTMGYLDPEYYMTQQLTEKS 790
Query: 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
DVYSFGVL+LEL+T RRPIERGKYIV+ ++ +DK K Y L E++DPTI L T L GFE
Sbjct: 791 DVYSFGVLLLELITARRPIERGKYIVKVVKGAIDKTKGFYGLEEILDPTIDLGTALSGFE 850
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907
K+VD+A++CV+ES DRPTM+ VVK+IEN+LQ AG
Sbjct: 851 KFVDIAMQCVEESSFDRPTMNYVVKEIENMLQLAG 885
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558021|ref|XP_003547307.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1124 bits (2906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/905 (63%), Positives = 719/905 (79%), Gaps = 8/905 (0%)
Query: 39 WENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNN 98
W+N PPNW +DPCG W+GI CTNSR+TSI+L+ L GQL+ DI L+EL LDLS N
Sbjct: 8 WQNTPPNWVGSDPCGAGWDGIECTNSRITSISLASTDLSGQLTSDIGSLSELLILDLSYN 67
Query: 99 KDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG 158
K L GPLP+ IGNL+KL NL+L+ C F+GPIP +IG+L+ LV LSLNSNGF+G +P +IG
Sbjct: 68 KKLTGPLPSNIGNLRKLRNLLLINCGFTGPIPVTIGNLERLVFLSLNSNGFTGTIPAAIG 127
Query: 159 NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVL 218
NLSN+YWLDL +N+LEG IP+S+G +PGLDM+ KHFHFGKN+LSG+IP +LF P+M L
Sbjct: 128 NLSNVYWLDLAENQLEGPIPISNGTTPGLDMMHHTKHFHFGKNKLSGNIPSQLFSPEMSL 187
Query: 219 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG 278
IHVLF+SN TG +P+TLGLVK+LEVVRFD+N LS P+P N+NNLTSV +L+LSNN+L+G
Sbjct: 188 IHVLFESNRFTGGIPSTLGLVKTLEVVRFDKNFLSEPLPLNINNLTSVRELFLSNNRLSG 247
Query: 279 AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHL 338
++PNLTG++ LSYLDMSNNSFD S+ P W ++ +LTT+MME+T L+G+IP LFS+ L
Sbjct: 248 SLPNLTGMNSLSYLDMSNNSFDQSDFPPWLPTLPALTTIMMEDTKLQGRIPVSLFSLQQL 307
Query: 339 QTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPAVNLTLIDNPICQELG 397
QTVV+K N+LNGTLD+GTS S L L++LQ N I + + V + L++NP CQE G
Sbjct: 308 QTVVLKKNQLNGTLDIGTSISNQLDLLDLQINFIEDFDPQIDVSKVEIILVNNPYCQESG 367
Query: 398 TAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNT 457
+ YC +++ YST NC+P PC+ +Q+ SP C+CAYPYTGTL R+ SFSDL N
Sbjct: 368 VPQPYCTITKSNDSYSTPPDNCVPVPCSLDQTLSPKCKCAYPYTGTLFLRAPSFSDLENE 427
Query: 458 TYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSV 517
T + LE S+ SFQ K P++S+SLSNP KN ++YLEL+++ FP GQ FNRTGVS +
Sbjct: 428 TVFVTLEYSLMESFQLHMK-PVNSVSLSNPRKNIYQYLELTLKIFPFGQGRFNRTGVSGI 486
Query: 518 GFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGG----SHKSTSIGVIIGAAAAGCVVLLL 573
GF+LSNQ Y PP +FGP +F D Y+++ ++ G S KS++ G+I GAA G +L+L
Sbjct: 487 GFLLSNQTYKPPAMFGPYYFIADEYEHYVDNSGLVPSSSKSSNTGIIAGAAGGGAALLVL 546
Query: 574 LLLAGVYAYHQKRRAEKAN-EQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSD 632
++LA VYA +K++++K+ NPF WD + S+ SIPQLKGAR FSFEE++ T NFS
Sbjct: 547 VVLACVYAISRKKKSKKSTGNSNPFEQWDPHDSNSSIPQLKGARRFSFEEIQNCTKNFSQ 606
Query: 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
N++GSGGYGKVY+GTLPNGQLIA+KRAQ+ SMQGG EFK EIELLSRVHHKNLVSL+GF
Sbjct: 607 VNNIGSGGYGKVYRGTLPNGQLIAVKRAQKESMQGGLEFKTEIELLSRVHHKNLVSLVGF 666
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
CF++GEQMLIYE+V NG+L D+LSGK+GIRLDWIRRLKIALGAARGL YLHELANPPIIH
Sbjct: 667 CFEQGEQMLIYEYVANGTLKDTLSGKSGIRLDWIRRLKIALGAARGLDYLHELANPPIIH 726
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
RDIKS+NILLDERLNAKV+DFGLSK + + K +ITTQVKGTMGYLDPEYYMTQQLTEKS
Sbjct: 727 RDIKSTNILLDERLNAKVSDFGLSKPLGEGAKGYITTQVKGTMGYLDPEYYMTQQLTEKS 786
Query: 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
DVYSFGVLMLEL+T RRPIERGKYIV+ ++ +DK K Y L E++DPTI L T L GFE
Sbjct: 787 DVYSFGVLMLELVTARRPIERGKYIVKVVKDAIDKTKGFYGLEEILDPTIELGTALSGFE 846
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPN-AESASSSASYEDASKGNFHH 931
K+VDLA++CV+ES DRPTM+ VVK+IEN+LQ AG +P + SAS+S+SY +A+KG+ H
Sbjct: 847 KFVDLAMQCVEESSSDRPTMNYVVKEIENMLQLAGSSPILSASASTSSSYNNATKGSSLH 906
Query: 932 PYCNE 936
PY NE
Sbjct: 907 PYNNE 911
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357448317|ref|XP_003594434.1| Somatic embryogenesis receptor-like kinase [Medicago truncatula] gi|355483482|gb|AES64685.1| Somatic embryogenesis receptor-like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1107 bits (2862), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 565/961 (58%), Positives = 718/961 (74%), Gaps = 46/961 (4%)
Query: 18 IIAAVTNDNDFVILKALKDDIWENEPPNWKNN-DPCGDNWEGIGCTNSRVTSITLSGMGL 76
++ T+++D++ L LK + W+N PP+W+++ DPCGD+WEGI C+NSRV +I+LS M L
Sbjct: 19 VVVTKTSNDDYLALSTLKYE-WKNVPPSWEDSEDPCGDHWEGIECSNSRVITISLSSMDL 77
Query: 77 KGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSL 136
GQLS +I L+EL L LS NKDL GPLP IGNLKKL+NL L+ C F+GPIPD+IG+L
Sbjct: 78 SGQLSSEIGSLSELQILVLSYNKDLTGPLPAEIGNLKKLTNLQLINCGFTGPIPDTIGNL 137
Query: 137 QELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 196
Q LV LSLNSN FSGR+PPSIGNLSN+ WLDL +N+LEG IPVS+G +PGLDML + KH
Sbjct: 138 QRLVFLSLNSNRFSGRIPPSIGNLSNINWLDLAENQLEGPIPVSNGTTPGLDMLHKTKHL 197
Query: 197 --------------------------------HFGKNQLSGSIPEKLFRPDMVLIHVLFD 224
HFGKN+LSG+IP +LF DM LIHVLF+
Sbjct: 198 YVMLTFFSFDNIYSNLLHINQTLHNKFPFFYSHFGKNKLSGNIPPQLFSSDMSLIHVLFE 257
Query: 225 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLT 284
SN TG +P+TLG V+ LEVVR D N LSGP+P N+NNLT+V +L +S N+L+G +P+LT
Sbjct: 258 SNQFTGTIPSTLGFVQKLEVVRLDNNILSGPLPININNLTNVRELLVSKNRLSGPLPDLT 317
Query: 285 GLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMK 344
G++VLSYLD+SNNSFD S+ P W S++QSL T+MME+T L+G IP LFS+ L TV++K
Sbjct: 318 GMNVLSYLDVSNNSFDRSDFPLWLSTLQSLKTIMMEDTQLQGPIPVSLFSLVQLHTVMLK 377
Query: 345 TNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYC 403
N LNGTLD+GT+ S+ L ++NLQ N I + + V + L++NP+CQE G + YC
Sbjct: 378 NNNLNGTLDIGTAISDQLGVLNLQTNFIEDFDPQIDVSKVEIILVNNPVCQETGVKRTYC 437
Query: 404 QLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEIL 463
+++ Y+T NC+P CN NQ SP C+CAYPYTGTL R+ SFSD+ N T + +L
Sbjct: 438 SIAKNNDTYTTPLNNCVPVECNKNQILSPKCKCAYPYTGTLTLRAPSFSDVRNKTVFAML 497
Query: 464 EQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSN 523
E ++ SF+ ++ P+DS+SLSNP KN ++YL+LS++ FPSGQ+SFNRTG+S +GF+LSN
Sbjct: 498 EFTLMESFR-LHEKPVDSVSLSNPRKNAYQYLDLSLEIFPSGQDSFNRTGISGIGFMLSN 556
Query: 524 QIYSPPP-LFGPMFFNGDPYQYFAESG------GSHKSTSIGVIIGAAAAGCVVLLLLLL 576
Q Y PP FGP +F D Y+++ S KS+ IG+I GAAA GCV++LLLLL
Sbjct: 557 QTYKPPAETFGPYYFIADKYEHYLNDSVIEGPVKSSKSSHIGIIAGAAAGGCVLVLLLLL 616
Query: 577 AGVYAYHQ-KRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDAND 635
A VY + Q + A + N F W ++S+ SIPQLKGAR F+FEE++ YT F++A+
Sbjct: 617 AVVYGFRQKNKAKRAAKKSNLFEQWGPDESNSSIPQLKGARRFTFEEIQNYTKKFAEASY 676
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
VGSGGYGKVY+G L NGQLIA+KRAQ+ S+QGG EFK EIELLSRVHHKNLVSL+GFCF+
Sbjct: 677 VGSGGYGKVYRGALLNGQLIAVKRAQKESIQGGLEFKTEIELLSRVHHKNLVSLIGFCFE 736
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
+GEQ+L+YE+V NG+L D+LSGK+GIRLDWIRRLKIALGA+RGL YLHE ANPPIIHRD+
Sbjct: 737 QGEQILVYEYVVNGTLTDALSGKSGIRLDWIRRLKIALGASRGLDYLHEHANPPIIHRDV 796
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 815
KS+NILLDERLNAKV+DFGLSK + D K +ITTQVKGTMGYLDPEYYMTQQLTEKSDVY
Sbjct: 797 KSTNILLDERLNAKVSDFGLSKPLGDGAKGYITTQVKGTMGYLDPEYYMTQQLTEKSDVY 856
Query: 816 SFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYV 875
SFGVLMLEL+T RRPIERGKYIV+ I+ MDK KELY L E+IDP I +L FEK++
Sbjct: 857 SFGVLMLELITARRPIERGKYIVKVIKNAMDKTKELYGLKEIIDPVIDFKASLSSFEKFI 916
Query: 876 DLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHHPYCN 935
DLA+KCV++S RP+M+ K+IEN+L G NPNAESA SS+SY ++ GN HPY N
Sbjct: 917 DLAMKCVEDSSSSRPSMNYAFKEIENMLMLTGTNPNAESAPSSSSYNES--GNSMHPYEN 974
Query: 936 E 936
E
Sbjct: 975 E 975
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465316|ref|XP_002269419.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1089 bits (2816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 582/956 (60%), Positives = 732/956 (76%), Gaps = 26/956 (2%)
Query: 7 VFLLSVYLQF-LIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSR 65
V LL V++QF A TN +D LK+L +N P W DPC + WEGIGC+N R
Sbjct: 8 VSLLIVFIQFNSATWASTNTDDATALKSL----LKNLPFTWVGADPCVNGWEGIGCSNGR 63
Query: 66 VTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSF 125
V SITL+ M LKG+LS D GL+EL LDLS NK L G +P +IG+LK L+NL+L+GCSF
Sbjct: 64 VISITLASMDLKGELSEDFQGLSELKILDLSYNKGLTGNIPASIGSLKSLTNLILMGCSF 123
Query: 126 SGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSP 185
SG IPD+IGSL LV+LSLNSN FSG +PPSIGNL NL WLD+T+N++ G IP+S+G +P
Sbjct: 124 SGQIPDTIGSLTNLVVLSLNSNSFSGVIPPSIGNLYNLNWLDITENQITGTIPISNGGTP 183
Query: 186 GLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVV 245
GLDML + KHFHFGKN+LSG IP +LF M +IH+L D+N+LTG +P TLGL +LE++
Sbjct: 184 GLDMLTQMKHFHFGKNRLSGPIPPQLFSSKMTMIHLLLDNNHLTGSIPPTLGLATTLEII 243
Query: 246 RFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP 305
R DRN LSGPVPSNLNNLTS+ +L LSNN LTG +PNLTG++ LSYLDMS N+F+ S+ P
Sbjct: 244 RLDRNLLSGPVPSNLNNLTSLTELLLSNNNLTGTVPNLTGMNHLSYLDMSQNNFEVSDFP 303
Query: 306 SWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LV 364
SWFS++ SLTTL ME T L G IP LFS+P LQTV ++ N++ GTL+ G++Y+ +L LV
Sbjct: 304 SWFSTLLSLTTLTMEFTKLTGDIPVALFSLPQLQTVKLRNNQITGTLEFGSAYNSHLRLV 363
Query: 365 NLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKN-CLPAP 423
+LQ N IS + + G + L+ NP+CQ+ G K YC +QP S YST+ K+ C+
Sbjct: 364 DLQKNYISEF-KPGLEYEFKIILVGNPMCQDEGNEK-YCTPAQPNSSYSTQPKHSCIIPF 421
Query: 424 CNANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSIS 483
C+++ PNC CAYPY GTLVFR+ SFS+ G+++ Y+ +EQ + F+S +LP+D++S
Sbjct: 422 CSSDLILGPNCSCAYPYIGTLVFRAPSFSNSGDSSDYKSIEQFLMQLFRS-LQLPVDTVS 480
Query: 484 LSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQ 543
LSN + +YL+++++ FP GQ+ FNRTG+ VGF LSNQ + F DPYQ
Sbjct: 481 LSNSTMVD-DYLKVNLKVFPQGQDRFNRTGIFLVGFALSNQTSA-------FSFIADPYQ 532
Query: 544 YFAE---SGGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQ-NPFAH 599
+F E G+ KS++ G+I+GA G + LLLL AGVYA+ QKRRAE+A +Q NPFA
Sbjct: 533 HFEEVPSPPGAKKSSNTGIIVGATTGGSFLALLLLFAGVYAFSQKRRAERATKQSNPFAK 592
Query: 600 WDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKR 659
WD K SG IPQLKGAR F+FEE+KK TNNFS+AN+VGSGGYGKVY+G LP GQ++AIKR
Sbjct: 593 WDQRKGSGGIPQLKGARQFTFEEIKKCTNNFSEANNVGSGGYGKVYRGILPTGQMVAIKR 652
Query: 660 AQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN 719
A+Q SMQGG EFK E+ELLSRVHHKN+V L+GFCF+ GEQML+YEFVPNGSL +SLSGK+
Sbjct: 653 AKQESMQGGLEFKTELELLSRVHHKNVVGLVGFCFEHGEQMLVYEFVPNGSLKESLSGKS 712
Query: 720 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779
GIRLDW +RLK+AL +ARGL+YLHELA PPIIHRDIKS+NILLDERLNAKVADFGL K +
Sbjct: 713 GIRLDWRKRLKVALCSARGLAYLHELAEPPIIHRDIKSNNILLDERLNAKVADFGLCKLL 772
Query: 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 839
+DSEK H+TTQVKGTMGYLDPEYYM+QQLTEKSDVYSFGVLMLEL++ R+PIERGKYIV+
Sbjct: 773 ADSEKGHVTTQVKGTMGYLDPEYYMSQQLTEKSDVYSFGVLMLELISARKPIERGKYIVK 832
Query: 840 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899
E++ MDK K+LYNL L+DPT+G TTL GF K+VDLAL+CV+ESG DRP M EVVK+I
Sbjct: 833 EVKIEMDKTKDLYNLQGLLDPTLG--TTLGGFNKFVDLALRCVEESGADRPRMGEVVKEI 890
Query: 900 ENILQQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 955
ENI+Q AGLNP ES+S+SASYE++S G HPY N FD S G+ S ++P+
Sbjct: 891 ENIMQLAGLNPIIESSSASASYEESSTGTSSHPYGNNSAFD--NSVGYSPSTVQPK 944
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30695748|ref|NP_199787.2| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|26449348|dbj|BAC41801.1| putative receptor protein kinase [Arabidopsis thaliana] gi|30102752|gb|AAP21294.1| At5g49760 [Arabidopsis thaliana] gi|224589713|gb|ACN59388.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332008471|gb|AED95854.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1068 bits (2762), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 567/954 (59%), Positives = 708/954 (74%), Gaps = 14/954 (1%)
Query: 7 VFLLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRV 66
+ L+ + Q ++A+TN D L ALK + W P W+ +DPCG NW GI C N RV
Sbjct: 9 LLLILFFFQICSVSALTNGLDASALNALKSE-WTTPPDGWEGSDPCGTNWVGITCQNDRV 67
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
SI+L + L+G+L DI+ L+EL LDLS N L GPLP IGNL KL NL+LVGCSFS
Sbjct: 68 VSISLGNLDLEGKLPADISFLSELRILDLSYNPKLSGPLPPNIGNLGKLRNLILVGCSFS 127
Query: 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-P 185
G IP+SIG+L+EL+ LSLN N FSG +PPSIG LS LYW D+ DN++EGE+PVS+G S P
Sbjct: 128 GQIPESIGTLKELIYLSLNLNKFSGTIPPSIGLLSKLYWFDIADNQIEGELPVSNGTSAP 187
Query: 186 GLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVV 245
GLDML++ KHFHFGKN+LSG+IP++LF +M LIHVLFD N TGE+P TL LVK+L V+
Sbjct: 188 GLDMLLQTKHFHFGKNKLSGNIPKELFSSNMSLIHVLFDGNQFTGEIPETLSLVKTLTVL 247
Query: 246 RFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP 305
R DRN L G +PS LNNLT++N+LYL+NN+ TG +PNLT L+ L LD+SNN+ D S +P
Sbjct: 248 RLDRNKLIGDIPSYLNNLTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNTLDFSPIP 307
Query: 306 SWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LV 364
SW SS+ SL+TL ME L G IP FS P LQTV++K N + +LD GT S L V
Sbjct: 308 SWISSLPSLSTLRMEGIQLNGPIPISFFSPPQLQTVILKRNSIVESLDFGTDVSSQLEFV 367
Query: 365 NLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPC 424
+LQ N I+ Y + + L +NP+C E G YC Q + +ST NC +PC
Sbjct: 368 DLQYNEITDYKPSANK-VLQVILANNPVCLEAGNGPSYCSAIQHNTSFSTLPTNC--SPC 424
Query: 425 NANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISL 484
+SP C+CAYP+ GTL FRS SFS L N+T + IL++++ F+ + P+DS+ +
Sbjct: 425 EPGMEASPTCRCAYPFMGTLYFRSPSFSGLFNSTNFSILQKAIADFFKK-FNYPVDSVGV 483
Query: 485 SNPHKNNFEY-LELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQ 543
N +N ++ L + + FP G+ESFN+TG+S VGF SNQ Y PPP+FGP F D Y+
Sbjct: 484 RNIRENPTDHQLLIDLLVFPLGRESFNQTGMSLVGFAFSNQTYKPPPIFGPYIFKADLYK 543
Query: 544 YFAESGGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQN-PFAHWDM 602
F++ S KS++ ++IGA V+LLLL +AG+YA QK+RAE+A QN PFA WD
Sbjct: 544 QFSDVEVSSKSSNKSILIGAVVGVVVLLLLLTIAGIYALRQKKRAERATGQNNPFAKWDT 603
Query: 603 NKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQ 662
+KSS PQL GA+ F+FEE+KK T+NFS+ANDVG GGYGKVY+G LPNGQLIAIKRAQQ
Sbjct: 604 SKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQ 663
Query: 663 GSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR 722
GS+QGG EFK EIELLSRVHHKN+V LLGFCFDR EQML+YE++ NGSL DSLSGK+GIR
Sbjct: 664 GSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIR 723
Query: 723 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782
LDW RRLKIALG+ +GL+YLHELA+PPIIHRDIKS+NILLDE L AKVADFGLSK + D
Sbjct: 724 LDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDP 783
Query: 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 842
EK H+TTQVKGTMGYLDPEYYMT QLTEKSDVY FGV++LELLTGR PIERGKY+VRE++
Sbjct: 784 EKTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVK 843
Query: 843 TVMDKKKELYNLYELIDPTIGLST-TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
T M+K + LY+L EL+D TI S+ LKGFEKYVDLAL+CV+E G +RP+M EVVK+IEN
Sbjct: 844 TKMNKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIEN 903
Query: 902 ILQQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 955
I+Q AGLNPN++SA+SS +YEDA KG+ PY +E + YSG FP SK+EPQ
Sbjct: 904 IMQLAGLNPNSDSATSSRTYEDAIKGS-GDPYGSES---FQYSGNFPASKLEPQ 953
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439783|ref|XP_004137665.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Cucumis sativus] gi|449497159|ref|XP_004160329.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1064 bits (2751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 546/955 (57%), Positives = 703/955 (73%), Gaps = 28/955 (2%)
Query: 20 AAVTNDNDFVILKALKDDIWENEPPNWKNN-DPCGDNWEGIGCTNSRVTSITLSGMGLKG 78
+ T+ D L++L+++ W+N PP+W + DPCG WEG+ C NSRVT++ LS MGLKG
Sbjct: 21 GSFTDPRDSAALESLRNE-WQNTPPSWGASIDPCGTPWEGVACINSRVTALRLSTMGLKG 79
Query: 79 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 138
+L GDI GLTEL +LDLS NKDL G + +G+L+ LS L+L GC FSG IP+ +G+L
Sbjct: 80 KLGGDIGGLTELKSLDLSFNKDLTGSISPALGDLQNLSILILAGCGFSGSIPEQLGNLSN 139
Query: 139 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 198
L L+LNSN F+G +PPS+G LSNLYWLDL DN+L G +PVS +PGLD+L++AKHFHF
Sbjct: 140 LSFLALNSNNFTGTIPPSLGKLSNLYWLDLADNQLTGSLPVSTSETPGLDLLLKAKHFHF 199
Query: 199 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS 258
KNQLSGSI KLFR +MVLIH+LFD N +G +P TLGLVK+LEV+R DRNSL+G VPS
Sbjct: 200 NKNQLSGSISPKLFRSEMVLIHILFDGNKFSGNIPPTLGLVKTLEVLRLDRNSLAGTVPS 259
Query: 259 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 318
NLNNLT++N+L L+NNKLTG +PNLT +S L+Y+D+SNNSFD+SE P WFS++QSLTTL+
Sbjct: 260 NLNNLTNINELNLANNKLTGPLPNLTQMSSLNYVDLSNNSFDSSEAPEWFSNLQSLTTLI 319
Query: 319 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTER 377
+E +++G +P +FS+P +Q V +K N + T D+G SE L LV+LQNN IS +T
Sbjct: 320 IEFGSMRGSVPQGVFSLPQIQQVKLKKNAFSDTFDMGDKVSEQLQLVDLQNNNISHFT-L 378
Query: 378 GGAPAVNLTLIDNPICQELGTAK--GYCQLS-QPISPYSTKQKNCLPAPCNANQSSSP-N 433
G L LI NP+C T YCQ+ QP+ PYST +CL C+ ++ SP +
Sbjct: 379 GSRYTKTLMLIGNPVCSTDVTLSNTNYCQVQDQPVKPYSTSLASCLSKSCSPDEKLSPQS 438
Query: 434 CQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFE 493
C+C YP+ GTL FR+ SF DL N T + LE S+ L S+S+ NP N +
Sbjct: 439 CECTYPFEGTLYFRAPSFRDLSNVTLFHSLEFSLWKKLD----LTPGSVSIQNPFFNVDD 494
Query: 494 YLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGGSHK 553
YL++ + FPS + FNR+ + +GF LSNQ Y PP FGP +F PY + + G+
Sbjct: 495 YLQMQLALFPSDGKYFNRSEIQRIGFYLSNQTYKPPHEFGPFYFIASPYGFADTTKGT-- 552
Query: 554 STSIGVIIGAAAAGCVVLLL-LLLAGVYAYHQKRRAEKA-NEQNPFAHWD-MNKSSGSIP 610
S S GVIIG A GC L+L L+ G+YA QK+RAEKA PFA W SG P
Sbjct: 553 SISPGVIIG-VAIGCAFLVLGLIGVGIYAIWQKKRAEKAIGLSRPFASWAPSGNDSGGAP 611
Query: 611 QLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE 670
QLKGAR FS++E+KK TNNFS +N+VGSGGYGKVY+G L +GQ +AIKRAQQGSMQGG E
Sbjct: 612 QLKGARWFSYDELKKCTNNFSMSNEVGSGGYGKVYRGMLVDGQAVAIKRAQQGSMQGGLE 671
Query: 671 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK 730
FK EIELLSRVHHKNL+ L+GFCF++GEQML+YEF+PNG+L DSLSGK+GI LDW RRL+
Sbjct: 672 FKTEIELLSRVHHKNLLGLVGFCFEQGEQMLVYEFMPNGTLRDSLSGKSGINLDWKRRLR 731
Query: 731 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ 790
IALG+ARGL+YLHELANPPIIHRD+KS+NILLDE LNAKVADFGLSK +SD+EK H++TQ
Sbjct: 732 IALGSARGLAYLHELANPPIIHRDVKSTNILLDEHLNAKVADFGLSKLVSDNEKGHVSTQ 791
Query: 791 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK-KK 849
VKGT+GYLDPEYYMTQQLTEKSDVYSFGV+MLELLTG+ PIE+GKY+VRE+R +M+K ++
Sbjct: 792 VKGTLGYLDPEYYMTQQLTEKSDVYSFGVVMLELLTGKLPIEKGKYVVREVRMLMNKSEE 851
Query: 850 ELYNLYELIDPTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908
E Y L +++D TI +TT+ G ++++LA++CV+ES DRPTMSE+VK IE+ILQ G+
Sbjct: 852 EYYGLKQIMDVTILNNTTTIIGLGRFLELAMRCVEESAGDRPTMSEMVKAIESILQNDGI 911
Query: 909 NPNAESASSSASYEDASKGNFHHPYCN-------EEGFDYGYSGGFP-TSKIEPQ 955
N N SASSSA+ AS+ HPY + + + YSGG+ ++K+EP+
Sbjct: 912 NTNTTSASSSATDFGASRNAPRHPYNDPIPKKDAHDSNSFDYSGGYTLSTKVEPK 966
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 955 | ||||||
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.984 | 0.986 | 0.562 | 9e-283 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.969 | 0.978 | 0.528 | 1.8e-259 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.974 | 0.958 | 0.516 | 1.2e-253 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.370 | 0.413 | 0.622 | 5.6e-226 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.877 | 0.881 | 0.350 | 1.4e-117 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.851 | 0.867 | 0.345 | 1.5e-108 | |
| TAIR|locus:2157047 | 493 | AT5G49750 [Arabidopsis thalian | 0.431 | 0.835 | 0.497 | 2.1e-107 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.251 | 0.236 | 0.422 | 1e-86 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.262 | 0.250 | 0.440 | 1.8e-86 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.287 | 0.212 | 0.422 | 3.3e-86 |
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2717 (961.5 bits), Expect = 9.0e-283, P = 9.0e-283
Identities = 537/954 (56%), Positives = 668/954 (70%)
Query: 7 VFLLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRV 66
+ L+ + Q ++A+TN D L ALK + W P W+ +DPCG NW GI C N RV
Sbjct: 9 LLLILFFFQICSVSALTNGLDASALNALKSE-WTTPPDGWEGSDPCGTNWVGITCQNDRV 67
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
SI+L + L+G+L DI+ L+EL LDLS N L GPLP IGNL KL NL+LVGCSFS
Sbjct: 68 VSISLGNLDLEGKLPADISFLSELRILDLSYNPKLSGPLPPNIGNLGKLRNLILVGCSFS 127
Query: 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-P 185
G IP+SIG+L+EL+ LSLN N FSG +PPSIG LS LYW D+ DN++EGE+PVS+G S P
Sbjct: 128 GQIPESIGTLKELIYLSLNLNKFSGTIPPSIGLLSKLYWFDIADNQIEGELPVSNGTSAP 187
Query: 186 GLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVV 245
GLDML++ KHFHFGKN+LSG+IP++LF +M LIHVLFD N TGE+P TL LVK+L V+
Sbjct: 188 GLDMLLQTKHFHFGKNKLSGNIPKELFSSNMSLIHVLFDGNQFTGEIPETLSLVKTLTVL 247
Query: 246 RFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP 305
R DRN L G +PS LNNLT++N+LYL+NN+ TG +PNLT L+ L LD+SNN+ D S +P
Sbjct: 248 RLDRNKLIGDIPSYLNNLTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNTLDFSPIP 307
Query: 306 SWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LV 364
SW SS+ SL+TL ME L G IP FS P LQTV++K N + +LD GT S L V
Sbjct: 308 SWISSLPSLSTLRMEGIQLNGPIPISFFSPPQLQTVILKRNSIVESLDFGTDVSSQLEFV 367
Query: 365 NLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPC 424
+LQ N I+ Y + + L +NP+C E G YC Q + +ST NC +PC
Sbjct: 368 DLQYNEITDYKPSANK-VLQVILANNPVCLEAGNGPSYCSAIQHNTSFSTLPTNC--SPC 424
Query: 425 NANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISL 484
+SP C+CAYP+ GTL FRS SFS L N+T + IL++++ F+ + P+DS+ +
Sbjct: 425 EPGMEASPTCRCAYPFMGTLYFRSPSFSGLFNSTNFSILQKAIADFFKK-FNYPVDSVGV 483
Query: 485 SNPHKNNFEY-LELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQ 543
N +N ++ L + + FP G+ESFN+TG+S VGF SNQ Y PPP+FGP F D Y+
Sbjct: 484 RNIRENPTDHQLLIDLLVFPLGRESFNQTGMSLVGFAFSNQTYKPPPIFGPYIFKADLYK 543
Query: 544 YFAESGGSHKSTSXXXXXXXXXXXXXXXXXXXXXXXXXYHQKRRAEKANEQN-PFAHWDM 602
F++ S KS++ QK+RAE+A QN PFA WD
Sbjct: 544 QFSDVEVSSKSSNKSILIGAVVGVVVLLLLLTIAGIYALRQKKRAERATGQNNPFAKWDT 603
Query: 603 NKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQ 662
+KSS PQL GA+ F+FEE+KK T+NFS+AND LPNGQLIAIKRAQQ
Sbjct: 604 SKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQ 663
Query: 663 GSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR 722
GS+QGG EFK EIELLSRVHHKN+V LLGFCFDR EQML+YE++ NGSL DSLSGK+GIR
Sbjct: 664 GSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIR 723
Query: 723 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782
LDW RRLKIALG+ +GL+YLHELA+PPIIHRDIKS+NILLDE L AKVADFGLSK + D
Sbjct: 724 LDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDP 783
Query: 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 842
EK H+TTQVKGTMGYLDPEYYMT QLTEKSDVY FGV++LELLTGR PIERGKY+VRE++
Sbjct: 784 EKTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVK 843
Query: 843 TVMDKKKELYNLYELIDPTIGLST-TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
T M+K + LY+L EL+D TI S+ LKGFEKYVDLAL+CV+E G +RP+M EVVK+IEN
Sbjct: 844 TKMNKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIEN 903
Query: 902 ILQQAGLNPNXXXXXXXXXXXXXXKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 955
I+Q AGLNPN KG+ PY +E + YSG FP SK+EPQ
Sbjct: 904 IMQLAGLNPNSDSATSSRTYEDAIKGS-GDPYGSES---FQYSGNFPASKLEPQ 953
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2497 (884.0 bits), Expect = 1.8e-259, P = 1.8e-259
Identities = 502/950 (52%), Positives = 650/950 (68%)
Query: 9 LLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTN-SRVT 67
L+ ++ Q + A T+ +DF L+ALK++ W+ +WK++DPCG W GI C N +RV
Sbjct: 13 LILLFFQIYSVYAFTDGSDFTALQALKNE-WDTLSKSWKSSDPCGTEWVGITCNNDNRVV 71
Query: 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG 127
SI+L+ LKG+L +I+ L+EL TLDL+ N +L GPLP IGNL+KL+ L L+GC+F+G
Sbjct: 72 SISLTNRNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNG 131
Query: 128 PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-PG 186
PIPDSIG+L++L LSLN N FSG +P S+G LS LYW D+ DN+LEG++PVSDG S PG
Sbjct: 132 PIPDSIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPG 191
Query: 187 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 246
LDML++ HFHFG N+LSG IPEKLF +M L+HVLFD N TG +P +LGLV++L V+R
Sbjct: 192 LDMLLQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLR 251
Query: 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
DRN LSG +PS+LNNLT++ +L+LS+NK TG++PNLT L+ L LD+SNN S VPS
Sbjct: 252 LDRNRLSGDIPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPS 311
Query: 307 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVN 365
W + SL+TL +E+ L G +P LFS LQTV +K N +N TLDLGT+YS+ L V+
Sbjct: 312 WIPFLNSLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLDFVD 371
Query: 366 LQNNRISAYTERGGAPAVNLTLIDNPICQE-LGTAKGYCQLSQPISPYSTKQKNCLPAPC 424
L++N I+ Y P VN+ L DN +CQ+ GYC QP S +ST K C C
Sbjct: 372 LRDNFITGYKSPANNP-VNVMLADNQVCQDPANQLSGYCNAVQPNSTFSTLTK-C-GNHC 428
Query: 425 NANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISL 484
+ + C C YP TG RS SFS N + + +S+ T F++ K P+DS+++
Sbjct: 429 GKGKEPNQGCHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNG-KYPVDSVAM 487
Query: 485 SNPHKNNFEY-LELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQ 543
N +N +Y L +++ FPSG++ FN+T + S+ + Q Y PPP FGP F D Y+
Sbjct: 488 RNISENPTDYHLLINLLIFPSGRDRFNQTEMDSINSAFTIQDYKPPPRFGPYIFVADQYK 547
Query: 544 YFAESGGSHKSTSXXXXXXXXXXXXXXXXXXXXXXXXXYHQKRRAEKANEQ-NPFAHWDM 602
F++ S K+ S QK+RA++A +Q NPFA WD
Sbjct: 548 TFSDLEDS-KTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNPFAKWDA 606
Query: 603 NKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQ 662
K+ PQL G + F+FEE+ K TNNFSDAND TLPNGQ+IAIKRAQQ
Sbjct: 607 GKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQ 666
Query: 663 GSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR 722
GSMQG EFK EIELLSRVHHKN+V LLGFCFD+ EQML+YE++PNGSL D LSGKNG++
Sbjct: 667 GSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVK 726
Query: 723 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782
LDW RRLKIALG+ +GL+YLHELA+PPIIHRD+KS+NILLDE L AKVADFGLSK + D
Sbjct: 727 LDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDP 786
Query: 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 842
EK H+TTQVKGTMGYLDPEYYMT QLTEKSDVY FGV+MLELLTG+ PI+RG Y+V+E++
Sbjct: 787 EKAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVK 846
Query: 843 TVMDKKKELYNLYELIDPTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
MDK + LY+L EL+D TI S LKGFEKYVD+AL+CV+ G +RPTMSEVV+++E+
Sbjct: 847 KKMDKSRNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELES 906
Query: 902 ILQQAGLNPNXXXXXXXXXXXXXXKGNFHHPYCNEEGFDYGYSGGFPTSK 951
IL+ GLNPN G+ PY + F+Y +G FPT K
Sbjct: 907 ILRLVGLNPNADSATYEEAS-----GD---PY-GRDSFEY--TGVFPTPK 945
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2442 (864.7 bits), Expect = 1.2e-253, P = 1.2e-253
Identities = 494/956 (51%), Positives = 650/956 (67%)
Query: 16 FLIIAAVTNDNDFVILKALKDDIWENEPPNWK-NNDPCGDNWEGIGCTNSRVTSITLSGM 74
F +I++VT+ D L++L D W+N PP+W ++DPCG WEG+ C NSR+T++ LS M
Sbjct: 25 FSMISSVTDPRDAAALRSLMDQ-WDNTPPSWGGSDDPCGTPWEGVSCNNSRITALGLSTM 83
Query: 75 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 134
GLKG+LSGDI L EL +LDLS N+ L G L + +G+L+KL+ L+L GC F+G IP+ +G
Sbjct: 84 GLKGRLSGDIGELAELRSLDLSFNRGLTGSLTSRLGDLQKLNILILAGCGFTGTIPNELG 143
Query: 135 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 194
L++L L+LNSN F+G++P S+GNL+ +YWLDL DN+L G IP+S G+SPGLD+L++AK
Sbjct: 144 YLKDLSFLALNSNNFTGKIPASLGNLTKVYWLDLADNQLTGPIPISSGSSPGLDLLLKAK 203
Query: 195 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 254
HFHF KNQLSG+IP KLF +M+LIHVLFD N TG +P+TLGL+++LEV+R DRN+L+G
Sbjct: 204 HFHFNKNQLSGTIPPKLFSSEMILIHVLFDGNRFTGSIPSTLGLIQTLEVLRLDRNTLTG 263
Query: 255 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 314
VP NL+NLT++ +L L++NKL G++P+L+ + ++Y+D+SNNSFD SE P WFS++ SL
Sbjct: 264 KVPENLSNLTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPSESPLWFSTLPSL 323
Query: 315 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISA 373
TTL+ME +L+G +P LF P LQ V +K N NGTL LG + L LV+LQ+N IS+
Sbjct: 324 TTLVMEYGSLQGPLPNKLFGFPQLQQVRLKKNAFNGTLSLGDTVGPELQLVDLQDNDISS 383
Query: 374 YTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISP--YSTKQKNCLPAPCNANQSSS 431
T G L L NP+C + YCQ+ Q YST NC C +Q S
Sbjct: 384 VTLSSGYTNT-LILEGNPVCTTALSNTNYCQIQQQQVKRIYSTSLANCGGKSCPLDQKVS 442
Query: 432 P-NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKN 490
P +C+CAYPY GTL FR F DL N Y LE S+ T P S+SL NP N
Sbjct: 443 PQSCECAYPYEGTLYFRGPMFRDLSNVNTYHSLEMSLWVKLGLT---P-GSVSLQNPFFN 498
Query: 491 NFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAESGG 550
N +YL++ + FP + FNRT V +GF LSNQ Y PPPLFGP +F PY + A+ G
Sbjct: 499 NDDYLQIQLALFPPMGKYFNRTEVQRIGFDLSNQTYKPPPLFGPYYFIASPYTFPADGNG 558
Query: 551 SHKSTSXXXXXXXXXXXXXXXXXXXXXXXXXYHQKRRAEKA-NEQNPFAHW-DMNKSSGS 608
H +S + QKRRAE+A PF W K SG
Sbjct: 559 -HSLSSRMVTGIITGCSALVLCLVALGIYAMW-QKRRAEQAIGLSRPFVSWASSGKDSGG 616
Query: 609 IPQLKGARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQGSMQGG 668
PQLKGAR FS+EE+KK TNNFS +++ L +G ++AIKRAQQGS QGG
Sbjct: 617 APQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGG 676
Query: 669 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 728
EFK EIELLSRVHHKNLV L+GFCF++GEQ+L+YE++ NGSL DSL+G++GI LDW RR
Sbjct: 677 LEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGITLDWKRR 736
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
L++ALG+ARGL+YLHELA+PPIIHRD+KS+NILLDE L AKVADFGLSK +SD K H++
Sbjct: 737 LRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVS 796
Query: 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848
TQVKGT+GYLDPEYY TQ+LTEKSDVYSFGV+M+EL+T ++PIE+GKYIVREI+ VM+K
Sbjct: 797 TQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVMNKS 856
Query: 849 KE-LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907
+ Y L + +D ++ TL +Y++LALKCV E+ D+RPTMSEVVK+IE I+Q +G
Sbjct: 857 DDDFYGLRDKMDRSLRDVGTLPELGRYMELALKCVDETADERPTMSEVVKEIEIIIQNSG 916
Query: 908 LNPNXXXXXXXXXXXXXXKGNFHHPYCNEEGFD------YGYSGGF--PTSKIEPQ 955
+ + K + +E D + YSGG+ PT KIEP+
Sbjct: 917 ASSSSSASASSSATDFGEKLLYGGTLKKKEARDGDGGGAFDYSGGYSVPT-KIEPK 971
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 5.6e-226, Sum P(2) = 5.6e-226
Identities = 224/360 (62%), Positives = 271/360 (75%)
Query: 598 AHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAI 657
A WD N++S PQL G + F+FEE++K NNFS AND LP+GQLIAI
Sbjct: 502 AKWDANQNSVDAPQLMGTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAI 561
Query: 658 KRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG 717
KRAQ GS+QG EFK EIELLSRVHHKN+V LLGFCFDRGEQML+YE++PNGSL DSLSG
Sbjct: 562 KRAQPGSLQGALEFKTEIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSG 621
Query: 718 KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777
K+GIRLDW RRL+IALG+ +GL+YLHELA+PPIIHRD+KSSN+LLDE L AKVADFGLS+
Sbjct: 622 KSGIRLDWTRRLRIALGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQ 681
Query: 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 837
+ D+EK ++T QVKGTMGYLDPEYYMT QLTEKSDVY FGV+MLELLTG+ PIE GKY+
Sbjct: 682 LVEDAEKANVTAQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYV 741
Query: 838 VREIRTVMDKKKELYNLYELIDPTIGLSTT--LKGFEKYVDLALKCVQESGDDRPTMSEV 895
V+E++ M+K K LY+L + +D TI ++ LKGFEKYVD+AL+CV G RP+M+EV
Sbjct: 742 VKEMKMKMNKSKNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEV 801
Query: 896 VKDIENILQQAGLNPNXXXXXXXXXXXXXXKGNFHHPYCNEEGFDYGYSGGFPTSKIEPQ 955
VK+IENI+Q AGLNPN K + Y N + YS FPT+ +EPQ
Sbjct: 802 VKEIENIMQYAGLNPNVESYASSRTYDEASKES-GDLYGNNS---FEYSASFPTTNLEPQ 857
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1158 (412.7 bits), Expect = 1.4e-117, P = 1.4e-117
Identities = 321/917 (35%), Positives = 473/917 (51%)
Query: 23 TNDNDFVILKALKDDIWENEP--PNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQL 80
T+ ++ L+++K + + + NW DPC NW G+ C N +G
Sbjct: 28 THPSEVTALRSVKRSLLDPKDYLRNWNRGDPCRSNWTGVICFNE---------IG----- 73
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 140
+ D + EL L N +L G L + L L L + + SG IP+ IG + LV
Sbjct: 74 TDDYLHVREL----LLMNMNLSGTLSPELQKLAHLEILDFMWNNISGSIPNEIGQISSLV 129
Query: 141 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200
LL LN N SG +P +G LSNL + +N + G IP S N L + KH HF
Sbjct: 130 LLLLNGNKLSGTLPSELGYLSNLNRFQIDENNITGPIPKSFSN------LKKVKHLHFNN 183
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP-VPSN 259
N L+G IP +L + HVL D+N L+G LP L + +L++++ D N+ SG +P++
Sbjct: 184 NSLTGQIPVELSNLTNIF-HVLLDNNKLSGNLPPQLSALPNLQILQLDNNNFSGSDIPAS 242
Query: 260 LNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM 319
N +++ L L N L GA+P+ + + L YLD+S N S FS + +TT+ +
Sbjct: 243 YGNFSNILKLSLRNCSLKGALPDFSKIRHLKYLDLSWNELTGPIPSSNFS--KDVTTINL 300
Query: 320 ENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL--DLGTSYS----ENLLVNLQNNRISA 373
N L G IP +P LQ +++K N L+G++ L + S LL++L+NN +S
Sbjct: 301 SNNILNGSIPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKNISFPKKARLLLDLRNNSLSR 360
Query: 374 YTERGGAPAVNLTL-ID-NPICQE--LGTAKGYCQLS--QPIS-PYSTKQK--NCLPAPC 424
+ P N+TL +D N IC + A +C+ + IS P ++ +C P C
Sbjct: 361 -VQGDLTPPQNVTLRLDGNLICTNGSISNANLFCESKGKEWISLPNNSTNSALDCPPLAC 419
Query: 425 NANQ-----SSSP-NCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQ-STYKL 477
+SP C CA P +S SFS Y + + VT Q Y+L
Sbjct: 420 PTPDFYEYSPASPLRCFCAAPLRIGYRLKSPSFSYF--PPYIDQFGEYVTDFLQMEPYQL 477
Query: 478 PIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPM-- 535
IDS + YL+L + + +FN + V + + ++ + LFGP
Sbjct: 478 WIDSYQWEKGPRLRM-YLKLFPKVNETYTRTFNESEVLRIRGIFASWRFPGSDLFGPYEL 536
Query: 536 --FFNGDPYQYFAESGGSHKSTSXXXXXXXXXXXXXXXXXXXXXXXXXYHQKRRAEKANE 593
F PY Y K S RR K
Sbjct: 537 LNFTLQGPYSY-VNFNSERKGVSWRRLAAITAGAVVTAVAISAVVAALL--LRRYSKHER 593
Query: 594 QNPFAHWDMNKSSGSIPQLK-GARCFSFEEVKKYTNNFSDANDXXXXXXXXXXXXTLPNG 652
+ +SS L G R FSF+E+ + T++FS + L +
Sbjct: 594 EI-----SRRRSSSKASLLNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDN 648
Query: 653 QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712
+ AIKRA +GS+QG +EF EIELLSR+HH+NLVSL+G+C + EQML+YEF+ NG+L
Sbjct: 649 TVAAIKRADEGSLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLR 708
Query: 713 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 772
D LS K L + R+++ALGAA+G+ YLH ANPP+ HRDIK+SNILLD NAKVAD
Sbjct: 709 DWLSAKGKESLSFGMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVAD 768
Query: 773 FGLSK--SMSDSEKD---HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 827
FGLS+ + + E+D H++T V+GT GYLDPEY++T +LT+KSDVYS GV+ LELLTG
Sbjct: 769 FGLSRLAPVLEDEEDVPKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTG 828
Query: 828 RRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGD 887
I GK IVRE++T +++++ + LID + +++ EK+ LAL+C +S +
Sbjct: 829 MHAISHGKNIVREVKTA--EQRDM--MVSLIDKRME-PWSMESVEKFAALALRCSHDSPE 883
Query: 888 DRPTMSEVVKDIENILQ 904
RP M+EVVK++E++LQ
Sbjct: 884 MRPGMAEVVKELESLLQ 900
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1073 (382.8 bits), Expect = 1.5e-108, P = 1.5e-108
Identities = 302/873 (34%), Positives = 436/873 (49%)
Query: 55 NW-EGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLK 113
NW +G C NS T I G + G + EL + L+ L G L +G L
Sbjct: 53 NWAKGDPC-NSNWTGIICFG---RSHNDGHFH-VRELQLMRLN----LSGELAPEVGQLL 103
Query: 114 KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 173
L L ++ + +G IP IG + L LL LN N F+G +PP +GNL NL L + +N +
Sbjct: 104 YLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNLNRLQVDENNI 163
Query: 174 EGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP 233
G +P S GN L KH H N +SG IP +L + L+H++ D+NNLTG LP
Sbjct: 164 TGSVPFSFGN------LRSIKHLHLNNNTISGEIPVELSKLPK-LVHMILDNNNLTGTLP 216
Query: 234 ATLGLVKSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYL 292
L + SL +++ D N+ G +P + + + L L N L G++P+L+ + LSYL
Sbjct: 217 LELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENLSYL 276
Query: 293 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352
D+S N + S S ++TT+ + +L G IP + LQ + ++ N L+G++
Sbjct: 277 DLSWNHLTGTIPESKLSD--NMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGSV 334
Query: 353 DL----GTSYSENLL-VNLQNNRISAYTERGGAPA-VNLTLIDNPICQELGTAKGYCQLS 406
S+ N L V NN S T P V L L NPIC+ Q
Sbjct: 335 PTEIWQDKSFENNKLQVYDLNNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPM-VTQFF 393
Query: 407 QPISPYSTKQKNCLPAPCN------ANQSSSPN-CQCAYPYTGTLVFRSLSFSDLGNTTY 459
+ I + PC+ N SP C C P + +S SF T Y
Sbjct: 394 EYICGEKKQTSTNSNTPCSNVSCPFENVKVSPGICLCTAPLSIDYRLKSPSFFFF--TPY 451
Query: 460 YEI-LEQSVTTSFQ-STYKLPIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSV 517
E + +T+S Q T++L ID + N + YL+L P G+ +FN++ V +
Sbjct: 452 IERQFREYITSSLQLETHQLAIDRLVDENRLRPRM-YLKL----VPKGRITFNKSEVIRI 506
Query: 518 GFVLSNQIYSPPPLFGPMFFNGDPYQY-FAESGGSHKSTSXXXXXXXXXXXXXXXXXXXX 576
+ ++ FGP P Q +A+
Sbjct: 507 RDRFMSWSFNKTDFFGPYELLDFPLQGPYADLLAQTSGIRTIVWMMIVAGSVVAATVLSV 566
Query: 577 XXXXXYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDX 636
Y +KRR +++ ++KG + FSF E+ TN F +
Sbjct: 567 TATLLYVRKRRENSHTLTKKRVFRTISR------EIKGVKKFSFVELSDATNGFDSSTLI 620
Query: 637 XXXXXXXXXXXTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
L N +AIKR ++ S+Q +EF EI+LLSR+HH+NLVSL+G+ D
Sbjct: 621 GRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGYSSDI 680
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
GEQML+YE++PNG++ D LS L + R +ALG+A+G+ YLH ANPP+IHRDIK
Sbjct: 681 GEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIK 740
Query: 757 SSNILLDERLNAKVADFGLSK-----SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 811
+SNILLD +L+AKVADFGLS+ D E H++T V+GT GYLDPEY+MTQQLT +
Sbjct: 741 TSNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTVVRGTPGYLDPEYFMTQQLTVR 800
Query: 812 SDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871
SDVYSFGV++LELLTG P G +I+RE+RT E + + D +G + K
Sbjct: 801 SDVYSFGVVLLELLTGMHPFFEGTHIIREVRTA----NECGTVLSVADSRMGQCSPDK-V 855
Query: 872 EKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+K +LAL C ++ + RP MS+VVK++E I Q
Sbjct: 856 KKLAELALWCCEDRPETRPPMSKVVKELEGICQ 888
|
|
| TAIR|locus:2157047 AT5G49750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1062 (378.9 bits), Expect = 2.1e-107, P = 2.1e-107
Identities = 207/416 (49%), Positives = 286/416 (68%)
Query: 3 VKRKVFLLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCT 62
++ + L+ + Q ++A+TN D L+ +K++ W P W+ +DPCG NW GI CT
Sbjct: 62 IRTCMLLILFFFQKCYVSALTNVFDASALRGMKNE-WTRSPKGWEGSDPCGTNWVGITCT 120
Query: 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVG 122
N RV SI+L L+G LS I L+EL LDLS N L GPLP+ IG+LKKL NL+LVG
Sbjct: 121 NDRVVSISLVNHNLEGTLSEYILALSELEILDLSFNIGLTGPLPSNIGDLKKLKNLILVG 180
Query: 123 CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 182
C SG IPDSIGSL++++ LSLN N FSG +P SIG LS L W D+ +N++EGE+P+S+G
Sbjct: 181 CGLSGQIPDSIGSLEQIINLSLNLNKFSGTIPASIGRLSKLDWFDIAENQIEGELPISNG 240
Query: 183 -NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKS 241
+SPGLDML + +HFHFGKN+LSG IPEKLF +M LIHVLF++N TG++P +L LV +
Sbjct: 241 TSSPGLDMLTQTQHFHFGKNKLSGHIPEKLFNSNMSLIHVLFNNNQFTGKIPESLSLVTT 300
Query: 242 LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDA 301
L V+R D N LSG +P +LNNLTS+N L+L NNK TG++PNL L+ L +D+SNN+ +
Sbjct: 301 LLVLRLDTNRLSGDIPPSLNNLTSLNQLHLCNNKFTGSLPNLASLTDLDEIDVSNNTLEF 360
Query: 302 SEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSEN 361
S VPSW S+++LT++ ME L G +P FS+ LQ+V +K N +NGTLD GT+YS+
Sbjct: 361 SLVPSWIVSLRNLTSIRMEGIQLIGPVPISFFSLIRLQSVNLKRNWINGTLDFGTNYSKQ 420
Query: 362 L-LVNLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQ 416
L LV+L+ N I+ Y + + + L +NP+C E+G +C + S +ST Q
Sbjct: 421 LELVSLRYNNITGYKQAANEH-IKVILANNPVCGEVGNKPSFCSAIKHSSSFSTLQ 475
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 1.0e-86, Sum P(2) = 1.0e-86
Identities = 107/253 (42%), Positives = 164/253 (64%)
Query: 654 LIAIKRAQQGS--MQGGQ--EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709
++A+K+ + + ++ G +F E+ LL ++ H+N+V LLGF ++ M++YEF+ NG
Sbjct: 724 VLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNG 783
Query: 710 SLGDSLSGKNGI-RL--DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 766
+LGD++ GKN RL DW+ R IALG A GL+YLH +PP+IHRDIKS+NILLD L
Sbjct: 784 NLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANL 843
Query: 767 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 826
+A++ADFGL++ M+ K + V G+ GY+ PEY T ++ EK D+YS+GV++LELLT
Sbjct: 844 DARIADFGLARMMA--RKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLT 901
Query: 827 GRRPIER--GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYV-DLALKCVQ 883
GRRP+E G+ V + V K ++ +L E +DP +G ++ V +AL C
Sbjct: 902 GRRPLEPEFGES-VDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTT 960
Query: 884 ESGDDRPTMSEVV 896
+ DRP+M +V+
Sbjct: 961 KLPKDRPSMRDVI 973
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 1.8e-86, Sum P(2) = 1.8e-86
Identities = 114/259 (44%), Positives = 164/259 (63%)
Query: 649 LPNGQLIAIKRAQQGSMQGGQE--FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706
+PNG L+A+KR S + F EI+ L R+ H+++V LLGFC + +L+YE++
Sbjct: 713 MPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 772
Query: 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 766
PNGSLG+ L GK G L W R KIAL AA+GL YLH +P I+HRD+KS+NILLD
Sbjct: 773 PNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNF 832
Query: 767 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 826
A VADFGL+K + DS + + G+ GY+ PEY T ++ EKSDVYSFGV++LEL+T
Sbjct: 833 EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVT 892
Query: 827 GRRPIER---GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQ 883
GR+P+ G IV+ +R + D K+ ++ +++DP + S + +A+ CV+
Sbjct: 893 GRKPVGEFGDGVDIVQWVRKMTDSNKD--SVLKVLDPRLS-SIPIHEVTHVFYVAMLCVE 949
Query: 884 ESGDDRPTMSEVVKDIENI 902
E +RPTM EVV+ + I
Sbjct: 950 EQAVERPTMREVVQILTEI 968
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 522 (188.8 bits), Expect = 3.3e-86, Sum P(2) = 3.3e-86
Identities = 122/289 (42%), Positives = 173/289 (59%)
Query: 621 EEVKKYTNNFSDANDXXXXXXXXXXXXTLPNGQLIAIKRAQQG-SMQGGQEFKMEIELLS 679
+++ K T NFS + LP G+ +AIKR G QG +EF E+E +
Sbjct: 993 DDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMETIG 1052
Query: 680 RVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGK-NGIR-LDWIRRLKIALGAAR 737
+V H NLV LLG+C E+ LIYE++ NGSL L + + + L W RLKI LG+AR
Sbjct: 1053 KVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLKICLGSAR 1112
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
GL++LH P IIHRD+KSSNILLDE +V+DFGL++ +S E H++T + GT GY
Sbjct: 1113 GLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACET-HVSTDIAGTFGY 1171
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP-----IERGKYIVREIRTVMDKKKELY 852
+ PEY +T + T K DVYSFGV+MLELLTGR P ++ G +V +R ++ + K+
Sbjct: 1172 IPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVGWVRWMIARGKQ-- 1229
Query: 853 NLYELIDPTIGLSTTLKG-FEKYVDLALKCVQESGDDRPTMSEVVKDIE 900
N EL DP + +S+ + + + +A C + RPTM EVVK ++
Sbjct: 1230 N--ELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGLK 1276
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00035380001 | SubName- Full=Chromosome undetermined scaffold_77, whole genome shotgun sequence; (946 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 955 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-50 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 2e-53
Identities = 87/271 (32%), Positives = 130/271 (47%), Gaps = 28/271 (10%)
Query: 637 GSGGYGKVYKGTL-----PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLL 690
G G +G+VYKGTL +A+K ++ + Q +EF E ++ ++ H N+V LL
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G C + M++ E++P G L D L L L AL ARG+ YL
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NF 124
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
IHRD+ + N L+ E L K++DFGLS+ + D + K + ++ PE + T
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-VKGGKLPIRWMAPESLKEGKFTS 183
Query: 811 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLY-ELIDPTIGLSTTL 868
KSDV+SFGVL+ E+ T G P Y V++ K+ Y L P
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEYLKKGYRLPKPPNCP-------- 230
Query: 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899
+ L L+C E +DRPT SE+V+ +
Sbjct: 231 ---PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 7e-53
Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 35/274 (12%)
Query: 637 GSGGYGKVYKGTL-----PNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 690
G G +G+VYKG L +A+K ++ + + +EF E ++ ++ H N+V LL
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G C + ++ E++ G L L KN +L L AL ARG+ YL
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---NF 123
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG---YLDPEYYMTQQ 807
IHRD+ + N L+ E L K++DFGLS+ + D + + +G ++ PE +
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDD----YYRKRGGKLPIRWMAPESLKEGK 179
Query: 808 LTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLY-ELIDPTIGLS 865
T KSDV+SFGVL+ E+ T G +P Y V++ K Y L P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEYLKNGYRLPQPPNCP----- 229
Query: 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899
+ DL L+C E +DRPT SE+V+ +
Sbjct: 230 ------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 79/265 (29%), Positives = 125/265 (47%), Gaps = 22/265 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 693
+G G +GKVY G+L+AIK ++ ++ +E EI++L ++ H N+V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
D + L+ E+ G L D L + + D R L YLH I+HR
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR--FYLRQILSALEYLHSK---GIVHR 121
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
D+K NILLDE + K+ADFGL++ + EK +TT V GT Y+ PE + + + D
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFV-GTPEYMAPEVLLGKGYGKAVD 178
Query: 814 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 873
++S GV++ ELLTG+ P ++ + + K P +S K
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK------PPFPPPEWDISPEAK---- 228
Query: 874 YVDLALKCVQESGDDRPTMSEVVKD 898
DL K + + + R T E ++
Sbjct: 229 --DLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 8e-50
Identities = 79/286 (27%), Positives = 127/286 (44%), Gaps = 47/286 (16%)
Query: 636 VGSGGYGKVYKGTL----PNGQLIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLL 690
+G G +G+VYKG L +A+K ++ + + + +F E ++ ++ H N+V LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 691 GFCFDRGEQMLIYEFVPNGSL-------GDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
G C + L+ E++ G L L L A+ A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
+HRD+ + N L+ E L K++DFGLS+ + D + T K + ++ PE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 804 MTQQLTEKSDVYSFGVLMLELLT-GRRPIE--RGKYIVREIR--TVMDK----KKELYNL 854
T KSDV+SFGVL+ E+ T G P + ++ +R + K ELY
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY-- 237
Query: 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900
+L L C Q +DRPT SE+V+ +E
Sbjct: 238 ---------------------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 1e-49
Identities = 139/410 (33%), Positives = 215/410 (52%), Gaps = 29/410 (7%)
Query: 8 FLLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEP----PNWK-NNDPCGDNWEGIGCT 62
+L+ + + ++ + + +L + K I N+P NW + D C W+GI C
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSI--NDPLKYLSNWNSSADVC--LWQGITCN 66
Query: 63 N-SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNL-KKLSNLML 120
N SRV SI LSG + G++S I L + T++LSNN+ L GP+P I L L L
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ-LSGPIPDDIFTTSSSLRYLNL 125
Query: 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVS 180
+F+G IP GS+ L L L++N SG +P IG+ S+L LDL N L G+IP S
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 181 DGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFR-PDMVLIHVLFDSNNLTGELPATLGLV 239
N L+ L A NQL G IP +L + + I++ + NNL+GE+P +G +
Sbjct: 184 LTNLTSLEFLTLA------SNQLVGQIPRELGQMKSLKWIYLGY--NNLSGEIPYEIGGL 235
Query: 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNS 298
SL + N+L+GP+PS+L NL ++ L+L NKL+G +P + L L LD+S+NS
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295
Query: 299 FDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSY 358
+ E+P +Q+L L + + N G+IP L S+P LQ + + +N+ +G +
Sbjct: 296 L-SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354
Query: 359 SENLLV-NLQNNRISAYTERGGAPAVNLT---LIDNPICQELGTAKGYCQ 404
NL V +L N ++ G + NL L N + E+ + G C+
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 71/193 (36%), Positives = 103/193 (53%), Gaps = 10/193 (5%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGFC 693
+G GG+G VY G+ +AIK ++ +E EIE+L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
D L+ E+ GSL D L +N +L L+I L GL YLH IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 754 DIKSSNILLDER-LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ-LTEK 811
D+K NILLD K+ADFGLSK ++ + + + GT Y+ PE + + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 812 SDVYSFGVLMLEL 824
SD++S GV++ EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 5e-49
Identities = 87/285 (30%), Positives = 136/285 (47%), Gaps = 56/285 (19%)
Query: 637 GSGGYGKVYKGTL-----PNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 690
G G +G+VYKGTL +A+K ++G+ + +EF E ++ ++ H N+V LL
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G C ++ E++P G L D L K+G +L L++AL A+G+ YL
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLESK---NF 123
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD-----PEYYMT 805
+HRD+ + N L+ E L K++DFGLS+ + + + K G L PE
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRKRGGGKLPIKWMAPESLKD 178
Query: 806 QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NL 854
+ T KSDV+SFGVL+ E+ T G +P Y V++ ++ Y L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLELLEDGYRLPRPENCPDEL 233
Query: 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899
YEL+ L+C +DRPT SE+V+D+
Sbjct: 234 YELM--------------------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 5e-46
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+G G +G VY G+L+A+K S + + + EI +LS + H N+V G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 693 CFDRGEQML-IY-EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR----GLSYLHELA 746
D + L I+ E+V GSL L + IR+ R GL+YLH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY------TRQILEGLAYLHSNG 121
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
I+HRDIK +NIL+D K+ADFG +K + D E T V+GT ++ PE +
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP 830
+ +D++S G ++E+ TG+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-45
Identities = 90/272 (33%), Positives = 126/272 (46%), Gaps = 30/272 (11%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+GSG +G VYK G+++A+K + + + Q + EI +L R+ H N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
D+ L+ E+ G L D LS G L KIAL RGL YLH IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNG---IIH 121
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL-TEK 811
RD+K NILLDE K+ADFGL+K + + T GT Y+ PE + K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 812 SDVYSFGVLMLELLTGRRP-----IERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
DV+S GV++ ELLTG+ P I ++R I + E S
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI---LGPPLEFD-----EPKWSSGSE 231
Query: 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
K DL KC+ + RPT E+++
Sbjct: 232 EAK------DLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 79/268 (29%), Positives = 122/268 (45%), Gaps = 25/268 (9%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
F +G GG+G+VYK G+ +AIK + S + ++ EI++L + H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD--WIRRLKIALGAARGLSYLHELA 746
G + E ++ EF GSL D L N L I + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ-TLTESQIA--YVCKELLKGLEYLHSNG 118
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
IIHRDIK++NILL K+ DFGLS +SD++ + GT ++ PE +
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGK 172
Query: 807 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
K+D++S G+ +EL G+ P + + + L N + S
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEK-------WSD 225
Query: 867 TLKGFEKYVDLALKCVQESGDDRPTMSE 894
K F K KC+Q++ + RPT +
Sbjct: 226 EFKDFLK------KCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-35
Identities = 112/322 (34%), Positives = 157/322 (48%), Gaps = 34/322 (10%)
Query: 76 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 135
L G + + L L L L NK L GP+P +I +L+KL +L L S SG IP+ +
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNK-LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 136 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 195
LQ L +L L SN F+G++P ++ +L L L L NK GEIP + G L +L
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL----- 361
Query: 196 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 255
N L+G IPE L + +LF SN+L GE+P +LG +SL VR NS SG
Sbjct: 362 -DLSTNNLTGEIPEGLCSSGNLFKLILF-SNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419
Query: 256 VPSNLNNLTSVNDLYLSNNKLTG-------AMPNLTGLSV-----------------LSY 291
+PS L V L +SNN L G MP+L LS+ L
Sbjct: 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLEN 479
Query: 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 351
LD+S N F + VP S+ L L + L G+IP +L S L ++ + N+L+G
Sbjct: 480 LDLSRNQFSGA-VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 352 LDLGTSYSENL-LVNLQNNRIS 372
+ S L ++L N++S
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLS 560
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 7e-35
Identities = 109/341 (31%), Positives = 168/341 (49%), Gaps = 36/341 (10%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNK-----------------------D 100
S + + L G L G++ +T LT L L L++N+ +
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223
Query: 101 LRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNL 160
L G +P IG L L++L LV + +GPIP S+G+L+ L L L N SG +PPSI +L
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 161 SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIH 220
L LDL+DN L GEIP L++L H N +G IP L + +
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEIL------HLFSNNFTGKIPVALTSLPRLQVL 337
Query: 221 VLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM 280
L+ SN +GE+P LG +L V+ N+L+G +P L + ++ L L +N L G +
Sbjct: 338 QLW-SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396
Query: 281 P-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQ 339
P +L L + + +NSF + E+PS F+ + + L + N NL+G+I + + +P LQ
Sbjct: 397 PKSLGACRSLRRVRLQDNSF-SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455
Query: 340 TVVMKTNELNGTL--DLGTSYSENLLVNLQNNRISAYTERG 378
+ + N+ G L G+ ENL +L N+ S R
Sbjct: 456 MLSLARNKFFGGLPDSFGSKRLENL--DLSRNQFSGAVPRK 494
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 629 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKN 685
N+ + +G G +G VYKG L G +AIK+ ++ EI+LL + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--SGKNGIRL--DWIRRLKIALGAARGLSY 741
+V +G +I E+ NGSL + G L ++ ++ +GL+Y
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAY 114
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
LHE +IHRDIK++NIL + K+ADFG++ ++D KD V GT ++ PE
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPE 169
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ SD++S G ++ELLTG P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 33/289 (11%)
Query: 634 NDVGSGGYGKVYKGTLPN-----GQLIAIKRAQQGSMQGGQ---EFKMEIELLSRVHHKN 685
+G G +GKV G+ +A+K Q +F+ EIE+L + H+N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN--HSGEEQHRSDFEREIEILRTLDHEN 67
Query: 686 LVSLLGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
+V G C G + LI E++P+GSL D L ++ +++ R L + +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT--MGYLDPE 801
IHRD+ + NIL++ K++DFGL+K + + KD+ + G + + PE
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPED-KDYYYVKEPGESPIFWYAPE 182
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRP-------IERGKYIVREIRTVMDKKKELYNL 854
T + + SDV+SFGV + EL T P R I + V L
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR-------L 235
Query: 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
EL+ L ++ DL C + DRP+ ++++ ++ +
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKNLVSLLGF 692
+G G +GKVY +G+L +K +M + + E+++L +++H N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIR--------LDWIRRLKIALGAARGLSYLHE 744
++G+ ++ E+ G L + + LDW +++ L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA----LKYLHS 121
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
I+HRDIK NI L K+ DFG+SK +S + D T V GT YL PE
Sbjct: 122 -RK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVV-GTPYYLSPELCQ 176
Query: 805 TQQLTEKSDVYSFGVLMLELLTGRRP 830
+ KSD++S G ++ EL T + P
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G G +G V G GQ +A+K + S Q F E +++ + H NLV LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
++ E++ GSL D L + + ++L AL G+ YL E +HRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDL 128
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTEKSD 813
+ N+L+ E L AKV+DFGL+K ++ + + + VK T PE ++ + KSD
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTA----PEALREKKFSTKSD 181
Query: 814 VYSFGVLMLELLT-GRRPIER 833
V+SFG+L+ E+ + GR P R
Sbjct: 182 VWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 81/276 (29%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRV-HHKNLVSLLG 691
+G G +G+VY +L+A+K + +E F EI++L+ + H N+V L
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
F D G L+ E+V GSL D L L L I L YLH I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GI 122
Query: 751 IHRDIKSSNILLDERLN-AKVADFGLSKSMSD----SEKDHITTQVKGTMGYLDPEYYM- 804
IHRDIK NILLD K+ DFGL+K + D S + + GT GY+ PE +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 805 --TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862
+ SD++S G+ + ELLTG P E G+ + EL + +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILELP--TPSLASPL 239
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
S + DL K + + +R + S +
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 637 GSGGYGKVYKGTL-PNGQLIAIKRAQ-QGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
G G G VYK P G++ A+K+ G + ++ E++ L +V G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
GE ++ E++ GSL D L I + IA +GL YLH + IIHRD
Sbjct: 70 KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA--YIARQILKGLDYLHTKRH--IIHRD 125
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 814
IK SN+L++ + K+ADFG+SK + ++ T GT+ Y+ PE + + +D+
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESYSYAADI 183
Query: 815 YSFGVLMLELLTGRRP 830
+S G+ +LE G+ P
Sbjct: 184 WSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 26/274 (9%)
Query: 634 NDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+ +G G YG+VY+G +A+K ++ +M+ +EF E ++ + H NLV LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
C +I EF+ G+L D L N ++ + L +A + + YL E N IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKN--FIH 127
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTE 810
RD+ + N L+ E KVADFGLS+ M+ D T K + + PE + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 811 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869
KSDV++FGVL+ E+ T G P +L +YEL++ +
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPY---------------PGIDLSQVYELLEKGYRMERPEG 229
Query: 870 GFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
K +L C Q + DRP+ +E+ + E +
Sbjct: 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 74/266 (27%), Positives = 134/266 (50%), Gaps = 22/266 (8%)
Query: 635 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
++GSG +G V+ G + +AIK ++G+M ++F E +++ ++ H LV L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
+R L++EF+ +G L D L + G + L + L G++YL +IHRD
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 814
+ + N L+ E KV+DFG+++ + D + +T K + + PE + + + KSDV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 815 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 873
+SFGVLM E+ + G+ P E R+ + + + + L P + +
Sbjct: 185 WSFGVLMWEVFSEGKTPYEN--------RSNSEVVETINAGFRLYKPRLASQSVY----- 231
Query: 874 YVDLALKCVQESGDDRPTMSEVVKDI 899
+L C +E +DRP+ S ++ +
Sbjct: 232 --ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+G G +GKVY L G+L+A+K R Q + +E E+++L + H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 693 CFDRGEQMLIY-EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
R E++ I+ E+ G+L + L + IR + L GL+YLH I+
Sbjct: 68 EVHR-EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSHG---IV 121
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG---YLDPEYYMTQQL 808
HRDIK +NI LD K+ DFG + + ++ + +V+ G Y+ PE +
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 809 TEK---SDVYSFGVLMLELLTGRRP 830
+D++S G ++LE+ TG+RP
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 65/198 (32%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
G+G +G+V+ GT +A+K + G+M + F E +++ ++ H LV L C +
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
++ E++ GSL D L G +L + + +A A G++YL IHRD+
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLA 130
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
+ NIL+ E L K+ADFGL++ + D E ++ +K T PE + T KSD
Sbjct: 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA----PEAANYGRFTIKSD 186
Query: 814 VYSFGVLMLELLT-GRRP 830
V+SFG+L+ E++T GR P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHH 683
++ ++G+G G V K P G+++A+K + + K E+++L + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNS 58
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYL 742
+V G ++ G+ + E++ GSL L + I + KIA+ +GL+YL
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG--KIAVAVLKGLTYL 116
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPE 801
HE IIHRD+K SNIL++ R K+ DFG+S + +S K + GT Y+ PE
Sbjct: 117 HEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPE 169
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRPI 831
+ KSD++S G+ ++EL TGR P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 79/280 (28%), Positives = 134/280 (47%), Gaps = 21/280 (7%)
Query: 636 VGSGGYGKV----YKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
+G G +G V Y N G+++A+K+ Q + + ++F+ EIE+L + H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 691 GFCFDRG--EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
G C+ G L+ E++P GSL D L K+ RLD + L A +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR-- 128
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT--MGYLDPEYYMTQ 806
+HRD+ + NIL++ K+ DFGL+K + +K++ + G + + PE
Sbjct: 129 -YVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWYAPESLTES 186
Query: 807 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE----LYNLYELIDPTI 862
+ + SDV+SFGV++ EL T ++ E +M K+ +Y+L EL+
Sbjct: 187 KFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
L + + +C RP+ SE+ +E I
Sbjct: 244 RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-28
Identities = 86/278 (30%), Positives = 132/278 (47%), Gaps = 35/278 (12%)
Query: 76 LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 135
G++ ++ L LDLS N +L G +P + + L L+L S G IP S+G+
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTN-NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 136 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 195
+ L + L N FSG +P L +Y+LD+++N L+G I + P L ML A+
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR- 461
Query: 196 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 255
N G LP + G K LE + RN SG
Sbjct: 462 ------------------------------NKFFGGLPDSFG-SKRLENLDLSRNQFSGA 490
Query: 256 VPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 314
VP L +L+ + L LS NKL+G +P+ L+ L LD+S+N + ++P+ FS M L
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL-SGQIPASFSEMPVL 549
Query: 315 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352
+ L + L G+IP +L ++ L V + N L+G+L
Sbjct: 550 SQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 69/205 (33%), Positives = 110/205 (53%), Gaps = 8/205 (3%)
Query: 630 FSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
F+ +GSG +G+V++G N +AIK + + Q+F+ E++ L R+ HK+L+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 690 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
C GE + +I E + GSL L G L + +A A G++YL E
Sbjct: 68 FAVC-SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---Q 123
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
IHRD+ + NIL+ E L KVADFGL++ + + ++++ K + PE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTF 181
Query: 809 TEKSDVYSFGVLMLELLT-GRRPIE 832
+ KSDV+SFG+L+ E+ T G+ P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 78/282 (27%), Positives = 138/282 (48%), Gaps = 36/282 (12%)
Query: 634 NDVGSGGYGKVYKGT--LPNGQLI--AIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVS 688
++G G +G V KG + +G+ + A+K +Q + G +EF E +++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 689 LLGFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L+G C +GE ML+ E P G L L + I + ++ L A A G++YL E +
Sbjct: 61 LIGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMGMAYL-ESKH 115
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSM-SDSEKDHITTQVKGTMGYLDPE--YYM 804
+HRD+ + N+LL R AK++DFG+S+++ + S+ TT + + + PE Y
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 805 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
+ KSDV+S+GV + E + G +P Y E++ + L + L P
Sbjct: 174 K--FSSKSDVWSYGVTLWEAFSYGAKP-----Y--GEMKGA-EVIAMLESGERLPRP--- 220
Query: 864 LSTTLKGFEKYV-DLALKCVQESGDDRPTMSEVVKDIENILQ 904
+ + + + L C + +DRPT SE+ +
Sbjct: 221 -----EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 83/284 (29%), Positives = 140/284 (49%), Gaps = 31/284 (10%)
Query: 632 DANDV------GSGGYGKVYKGTL--PNGQ--LIAIKRAQQGSMQGGQ-EFKMEIELLSR 680
D + V G G +G+V +G L P + +AIK + GS + +F E ++ +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQ 61
Query: 681 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 740
H N++ L G M+I E++ NGSL L +G + + + + G A G+
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMK 120
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
YL E+ +HRD+ + NIL++ L KV+DFGLS+ + DSE + T K + + P
Sbjct: 121 YLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
E ++ T SDV+SFG++M E+++ G RP Y + V+ ++ Y L +D
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERP-----YWDMSNQDVIKAVEDGYRLPPPMD 232
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
L L L C Q+ ++RPT S++V ++ ++
Sbjct: 233 CPSALY----------QLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 30/270 (11%)
Query: 635 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
++GSG +G V+ G +AIK ++G+M +F E +++ ++ H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGI-RLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
+ ++ E++ NG L + L + G +W+ L + + YL IHR
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FIHR 124
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT---MGYLDPEYYMTQQLTE 810
D+ + N L+ E KV+DFGL++ + D + T +GT + + PE + + +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 811 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869
KSDV+SFGVLM E+ + G+ P ER V++ Y LY L
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYER-----FSNSEVVESVSAGYRLYR---------PKLA 226
Query: 870 GFEKYVDLALKCVQESGDDRPTMSEVVKDI 899
E Y + C E +DRP +++ +
Sbjct: 227 PTEVY-TIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIK--RAQQGSMQGGQEF-KMEIELLSRVHHKNLVS 688
+G G +GKV K T G+L A+K + ++ + E E +LSR++H +V
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRL--KIALGAARGLSYLHEL 745
L + F E++ L+ E+ P G L LS + + R +I L L YLH L
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLHSL 112
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
II+RD+K NILLD + K+ DFGL+K +S E T GT YL PE +
Sbjct: 113 G---IIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLG 167
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRP 830
+ + D +S GVL+ E+LTG+ P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 83/281 (29%), Positives = 135/281 (48%), Gaps = 55/281 (19%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRA-----QQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
GSG +G VYKG +P G+ + I A ++ S + +E E +++ V H ++V LL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 691 GFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA----------ARGL 739
G C Q LI + +P G L LD++R K +G+ A+G+
Sbjct: 76 GICL--SSQVQLITQLMPLGCL-----------LDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
SYL E ++HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++
Sbjct: 123 SYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 858
E + + T KSDV+S+GV + EL+T G +P E G EI +++K + L
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP-AVEIPDLLEKGERLPQ----- 232
Query: 859 DP---TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVV 896
P TI + L +KC + RPT E++
Sbjct: 233 -PPICTIDVYMVL----------VKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 21/257 (8%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G+G +G+V++G N +A+K + G+M ++F E +++ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
++ E + GSL + L G G L + + +A A G++YL E N IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQN--YIHRDL 129
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 815
+ N+L+ E KVADFGL++ + + + K + + PE + + + KSDV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 816 SFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 874
SFG+L+ E++T GR P E+ +D+ Y + P G L
Sbjct: 189 SFGILLTEIVTYGRMPYP--GMTNAEVLQQVDQG------YRMPCPP-GCPKEL------ 233
Query: 875 VDLALKCVQESGDDRPT 891
D+ L C +E DDRPT
Sbjct: 234 YDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 70/239 (29%), Positives = 121/239 (50%), Gaps = 13/239 (5%)
Query: 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKN 685
+F N +G G +G V+K + ++ A+K+ M + E E +L+++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
++ D+G+ ++ E+ NG L L + G L + + + GL++LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+ I+HRDIKS N+ LD N K+ D G++K +SD+ + + GT YL PE
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPELCED 175
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRPIE---RGKYIVREIRTVMDKKKELYN--LYELID 859
+ EKSDV++ GV++ E TG+ P + +G I++ IR V ++Y+ L +LID
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID 234
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 85/286 (29%), Positives = 132/286 (46%), Gaps = 46/286 (16%)
Query: 636 VGSGGYGKVYKGTL--PNGQLI--AIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLVSLL 690
+G G +G VY GTL +GQ I A+K + ++ ++F E ++ H N++SLL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 691 GFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR----------LKIALGAARGL 739
G C G +++ ++ +G L ++IR + L A+G+
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDL-----------RNFIRSETHNPTVKDLIGFGLQVAKGM 111
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE--KDHITTQVKGTMGY 797
YL A+ +HRD+ + N +LDE KVADFGL++ + D E H T K + +
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857
+ E TQ+ T KSDV+SFGVL+ EL+T RG ++ + D L L
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVDS-FDITVYLLQGRRL 221
Query: 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
+ P ++ L C + RPT SE+V IE I
Sbjct: 222 LQPEYCPDPLY-------EVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQE----------FKMEIELLSRVHHK 684
+G G YG+VY + G+++A+K+ + + G+ + EIE L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 685 NLVSLLGFCFDRGEQML-IY-EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
N+V LGF + E+ L I+ E+VP GS+G L +R + GL+YL
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--LEGLAYL 124
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H + I+HRD+K+ N+L+D K++DFG+SK D + ++G++ ++ PE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 803 YMTQQ--LTEKSDVYSFGVLMLELLTGRRP 830
+ + K D++S G ++LE+ GRRP
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 76/265 (28%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGFC 693
+G G YG VYK GQ++AIK ++ QE EI +L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIK---VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
F + ++ E+ GS+ D + N L I +GL YLH + IHR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
DIK+ NILL+E AK+ADFG+S ++D+ V GT ++ PE K+D
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 814 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 873
++S G+ +E+ G+ P + +R I M K P LS K +
Sbjct: 182 IWSLGITAIEMAEGKPPY-SDIHPMRAI--FMIPNK----------PPPTLSDPEKWSPE 228
Query: 874 YVDLALKCVQESGDDRPTMSEVVKD 898
+ D KC+ + ++RP+ ++++
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQE-----FKMEIELLSRVHHKNLVSL 689
+G G YG+VYK G+L+A+K+ M+ +E EI+LL ++ H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 690 LGFCFD--RGEQMLIYEFVPNGSLGDSLSG---KNGIRLDWIRRLK-IALGAARGLSYLH 743
+G +++E++ + D L+G ++ ++K GL YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH----D-LTGLLDSPEVKFT-ESQIKCYMKQLLEGLQYLH 117
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
I+HRDIK SNIL++ K+ADFGL++ + T +V T+ Y PE
Sbjct: 118 SNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173
Query: 804 M-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
+ + + D++S G ++ EL G +PI +G
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLG-KPIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 37/222 (16%)
Query: 636 VGSGGYGKVYKGTLPNGQ------LIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVS 688
+G G +GKV+ G + + L+A+K ++ + ++ F+ E ELL+ H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSL--SGKNGIRLDWIRR----------LKIALGAA 736
G C + ++++E++ +G L L G + L L+IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT---QVKG 793
G+ Y LA+ +HRD+ + N L+ L K+ DFG+S +D TT +V G
Sbjct: 133 SGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMS-------RDVYTTDYYRVGG 182
Query: 794 T----MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
+ ++ PE M ++ T +SDV+SFGV++ E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 81/259 (31%), Positives = 130/259 (50%), Gaps = 26/259 (10%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G+G +G+V+ G +AIK +QGSM + F E L+ ++ H LV L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
+ +I E++ NGSL D L GI+L + + +A A G++++ E N IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERKN--YIHRDL 128
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTEKSD 813
+++NIL+ E L K+ADFGL++ + D+E T + K + + PE T KSD
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 814 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
V+SFG+L+ E++T GR P T + + L Y + P E
Sbjct: 186 VWSFGILLTEIVTYGRIPYPG--------MTNPEVIQNLERGYRMPRPD-------NCPE 230
Query: 873 KYVDLALKCVQESGDDRPT 891
+ +L C +E ++RPT
Sbjct: 231 ELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 79/269 (29%), Positives = 135/269 (50%), Gaps = 26/269 (9%)
Query: 635 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
++G+G +G V G +AIK ++GSM EF E +++ ++ H+ LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
+ ++ E++ NG L + L ++G R + L++ G++YL + IHRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV--KGTMGYLDPEYYMTQQLTEKS 812
+ + N L+D++ KV+DFGLS+ + D D T+ V K + + PE + + + KS
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 813 DVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871
DV++FGVLM E+ + G+ P ER + E + + LY P +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYER--FNNSETVEKVSQGLRLYR------PHL-------AS 227
Query: 872 EKYVDLALKCVQESGDDRPTMSEVVKDIE 900
EK + C E ++RPT +++ IE
Sbjct: 228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 85/278 (30%), Positives = 131/278 (47%), Gaps = 47/278 (16%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKR-----AQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
+GSG +G VY+G L +G A+K Q + ++ + EI LLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 690 LGFCFDRGEQMLIY-EFVPNGSLGDSLSGKNG------IRLDWIRRLKIALGAARGLSYL 742
LG + + + I+ E VP GSL L K G IRL + R++ GL YL
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRL-YTRQI------LLGLEYL 118
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H + +HRDIK +NIL+D K+ADFG++K + KG+ ++ PE
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQ---VVEFSFAKSFKGSPYWMAPEV 172
Query: 803 YM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861
+D++S G +LE+ TG+ P + + + + + KEL P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG--RSKEL--------PP 222
Query: 862 I--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
I LS K D LKC+Q RPT +E+++
Sbjct: 223 IPDHLSDEAK------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 68/218 (31%), Positives = 118/218 (54%), Gaps = 25/218 (11%)
Query: 635 DVGSGGYGKVYKGTL--PNG----QLIAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLV 687
++G G +GKVYKG L PN +AIK ++ + QEF+ E EL+S + H N+V
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSL------------SGKNGIR--LDWIRRLKIAL 733
LLG C +++E++ +G L + L SG ++ LD L IA+
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
A G+ Y L++ +HRD+ + N L+ E L K++DFGLS+ + ++ + ++
Sbjct: 132 QIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
+ ++ PE + + T +SD++SFGV++ E+ + G +P
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 66/197 (33%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G G +G VYKG L +A+K + ++F E E+L + H N+V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
+ ++ E VP GSL L K RL + L+++L AA G+ YL E N IHRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYL-ESKN--CIHRD 118
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT----MGYLDPEYYMTQQLTE 810
+ + N L+ E K++DFG MS E+ I T G + + PE + T
Sbjct: 119 LAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 811 KSDVYSFGVLMLELLTG 827
+SDV+S+G+L+ E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 75/276 (27%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 635 DVGSGGYGKVYKGTL--PNGQLI--AIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSL 689
+G G +G V +G G++I A+K + + +F E ++ + H+NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL-KIALGAARGLSYLHELANP 748
G M++ E P GSL D L K+ + I L A+ A G+ YL
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLES---K 116
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQ 806
IHRD+ + NILL K+ DFGL +++ +DH + +K + PE T+
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ-NEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 807 QLTEKSDVYSFGVLMLELLT-GRRPIE--RGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
+ SDV+ FGV + E+ T G P G I+++I DK+ E L P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGER-----LERPE-- 224
Query: 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899
+ ++ L+C + DRPT + + + +
Sbjct: 225 -----ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 31/238 (13%)
Query: 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHK 684
+F +G G +GKV ++ A+K + + + E +L ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 685 NLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR------ 737
LV+L + F E M L+ + + G L R +++K + +
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDL----------RYHLSQKVKFSEEQVKFWICEI 109
Query: 738 --GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 795
L YLH IIHRDIK NILLDE+ + + DF ++ ++ TT GT
Sbjct: 110 VLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTP 163
Query: 796 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE-RGKYIVREIRTVMDKKKELY 852
GY+ PE Q + D +S GV E L G+RP + I +IR + LY
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY 221
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 78/258 (30%), Positives = 133/258 (51%), Gaps = 24/258 (9%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G G +G+V+ GT +AIK + G+M + F E +++ ++ H+ LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
++ E++ GSL D L G+ G L + + +A A G++Y+ + +HRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-VKGTMGYLDPEYYMTQQLTEKSDV 814
+++NIL+ E L KVADFGL++ + D+E + Q K + + PE + + T KSDV
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 815 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 873
+SFG+L+ EL T GR P Y R V+D+ + Y + + E
Sbjct: 187 WSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYR----------MPCPPECPES 231
Query: 874 YVDLALKCVQESGDDRPT 891
DL +C ++ ++RPT
Sbjct: 232 LHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 79/278 (28%), Positives = 135/278 (48%), Gaps = 38/278 (13%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQE---------FKMEIELLSRVHHKN 685
+GSG +G VY G +G+L+A+K+ + S+ + EI LL + H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR-LKIALGAARGLSYLHE 744
+V LG D + E+VP GS+ L+ +R ++ L +GL+YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYLH- 123
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSK-----SMSDSEKDHITTQVKGTMGYLD 799
N IIHRDIK +NIL+D + K++DFG+SK S+S ++G++ ++
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA-RPSLQGSVFWMA 180
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
PE T K+D++S G L++E+LTG+ P + + ++ + E
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD-----------CTQLQAIFKIGENAS 229
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
P I + + + +D K + + RPT +E++K
Sbjct: 230 PEIPSNIS----SEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 77/275 (28%), Positives = 137/275 (49%), Gaps = 26/275 (9%)
Query: 636 VGSGGYGKVYKG--TLPNGQLI--AIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLL 690
+G+G +G+V G LP + I AIK + G + + +F E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G M++ E++ NGSL D+ K+ + I+ + + G A G+ YL ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---Y 127
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPEYYMTQQLT 809
+HRD+ + NIL++ L KV+DFGLS+ + D E + T K + + PE ++ T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 810 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868
SDV+S+G++M E+++ G RP Y + V+ +E Y L +D L
Sbjct: 188 SASDVWSYGIVMWEVMSYGERP-----YWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ-- 240
Query: 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
L L C Q+ ++RP ++V ++ ++
Sbjct: 241 --------LMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 84/295 (28%), Positives = 136/295 (46%), Gaps = 51/295 (17%)
Query: 636 VGSGGYGKVYKGTLPNGQL---IAIKRAQQ-GSMQGGQEFKMEIELLSRV-HHKNLVSLL 690
+G G +G+V K + L AIKR ++ S ++F E+E+L ++ HH N+++LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 691 GFCFDRGEQMLIYEFVPNGSLGD--------------SLSGKNGIRLDWIRRLKIALGAA 736
G C RG L E+ P+G+L D +++ L + L A A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
RG+ YL + IHRD+ + NIL+ E AK+ADFGLS+ VK TMG
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--------VYVKKTMG 183
Query: 797 YLDPEYYMTQQL-----TEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 850
L + + L T SDV+S+GVL+ E+++ G P
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---------------CGMT 228
Query: 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
LYE + L L ++ DL +C +E +RP+ ++++ + +L++
Sbjct: 229 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 635 DVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
++G G +GKVYK G A K Q S + ++F +EI++LS H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 694 FDRGEQMLIYEFVPNGSLGD-SLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
F + ++ EF G+L L + G+ IR + L++LH + +IH
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIR--YVCRQMLEALNFLH---SHKVIH 126
Query: 753 RDIKSSNILLDERLNAKVADFGLS-KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE- 810
RD+K+ NILL + K+ADFG+S K+ S +K T + GT ++ PE + +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFI-GTPYWMAPEVVACETFKDN 183
Query: 811 ----KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
K+D++S G+ ++EL P ++ + L + + PT L
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP-----------HHELNPMRVLLKILKSEPPT--LDQ 230
Query: 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
K + D C+ + DDRPT +E++K
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 75/275 (27%), Positives = 133/275 (48%), Gaps = 26/275 (9%)
Query: 636 VGSGGYGKVYKGTLP----NGQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLL 690
+G+G +G+V++G L +AIK + G + + Q+F E ++ + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G M+I E++ NG+L L +G + + + G A G+ YL ++
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMN---Y 128
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPEYYMTQQLT 809
+HRD+ + NIL++ L KV+DFGLS+ + D E + T+ K + + PE ++ T
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 810 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868
SDV+SFG++M E+++ G RP Y VM + + L +D +
Sbjct: 189 SASDVWSFGIVMWEVMSFGERP-----YWDMSNHEVMKAINDGFRLPAPMDCPSAVY--- 240
Query: 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
L L+C Q+ RP ++V ++ +L
Sbjct: 241 -------QLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 636 VGSGGYGKVYKGTLPN-------GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLV 687
+GSG +G+VY+GT + +A+K ++G+ Q +EF E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR-----LDWIRRLKIALGAARGLSYL 742
LLG C Q +I E + G L L R L L I L A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 743 HELANPPIIHRDIKSSNILLDE-----RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
++ IHRD+ + N L+ E K+ DFGL++ + S+ + + +
Sbjct: 123 EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
+ PE + + T +SDV+SFGVLM E+LT G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 80/284 (28%), Positives = 112/284 (39%), Gaps = 45/284 (15%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLI----AIKRAQQGSMQGGQEFKMEIELLSRVHH 683
+ + +G G G V K L N +I I +Q ++ E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKS 58
Query: 684 KNLVSLLGFCFDRGEQML--IYEFVPNGSLGDSLSG---KNGIRLDWIRRLKIALGAARG 738
+V G D + E+ GSL DS+ K G R+ KIA +G
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
LSYLH IIHRDIK SNILL + K+ DFG+S + +S T GT Y+
Sbjct: 118 LSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYM 170
Query: 799 DPEYYMTQQLTEKSDVYSFGVLMLELLTGR-----------RPIERGKYIVREIRTVMDK 847
PE + + SDV+S G+ +LE+ R PIE YIV +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230
Query: 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 891
+ I S K F K C+++ RPT
Sbjct: 231 EPGN---------GIKWSEEFKDFIKQ------CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 83/287 (28%), Positives = 124/287 (43%), Gaps = 36/287 (12%)
Query: 625 KYTNNFSDAND---VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSR 680
+Y + + + +G G YG VY L IAIK + + Q EI L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 681 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--- 737
+ H+N+V LG + G + E VP GSL L K G D I +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD--NEQTIIFYTKQILE 119
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEKDHITTQVKGTMG 796
GL YLH+ I+HRDIK N+L++ K++DFG SK ++ + T GT+
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQ 174
Query: 797 YLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRP-IERGKYIVREIRTVMDKKKELYN 853
Y+ PE +D++S G ++E+ TG+ P IE G+ + M K
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK------ 228
Query: 854 LYELIDPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
I P I LS K F L+C + D R + ++++D
Sbjct: 229 ----IHPEIPESLSAEAKNF------ILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 76/267 (28%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 635 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
++GSG +G V+ G +AIK +G+M ++F E +++ ++ H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
+ ++ EF+ NG L + L + G + D + L + G+ YL E + IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYL-ERNS--FIHR 124
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
D+ + N L+ KV+DFG+++ + D E ++ K + + PE + + + KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 814 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
V+SFGVLM E+ T G+ P E K E+ ++ + LY P + T +
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE--KKSNYEVVEMISRGFRLYR------PKLASMTVYE--- 232
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKDI 899
+ C E + RPT +E+++ I
Sbjct: 233 ----VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 77/258 (29%), Positives = 133/258 (51%), Gaps = 24/258 (9%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G+G +G+V+ GT +A+K + G+M + F E +++ ++ H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
++ E++ GSL D L G L + +A A G++Y+ + IHRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 128
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-VKGTMGYLDPEYYMTQQLTEKSDV 814
+S+NIL+ + L K+ADFGL++ + D+E + Q K + + PE + + T KSDV
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 815 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 873
+SFG+L+ EL+T GR P Y R V+++ + Y + D I L
Sbjct: 187 WSFGILLTELVTKGRVP-----YPGMNNREVLEQVERGYRMPCPQDCPISLH-------- 233
Query: 874 YVDLALKCVQESGDDRPT 891
+L L+C ++ ++RPT
Sbjct: 234 --ELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 82/296 (27%), Positives = 141/296 (47%), Gaps = 40/296 (13%)
Query: 617 CFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQG-SMQGGQEF 671
C EEV +G+G +G+V +G L +AIK + G + + ++F
Sbjct: 5 CVKIEEV------------IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDF 52
Query: 672 KMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 731
E ++ + H N++ L G M+I EF+ NG+L DS +N + I+ + +
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGM 111
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
G A G+ YL E+ +HRD+ + NIL++ L KV+DFGLS+ + D D T
Sbjct: 112 LRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 792 KG---TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847
G + + PE ++ T SDV+S+G++M E+++ G RP Y + V++
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQDVINA 223
Query: 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
++ Y L P + T L L L C Q+ + RP ++V ++ ++
Sbjct: 224 IEQDYRL----PPPMDCPTALH------QLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 27/272 (9%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLGFC 693
+G G VY LPN + +AIKR Q + E++ +S+ +H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL---GAARGLSYLHELANPPI 750
E L+ ++ GSL D + K+ + IA +GL YLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDS--EKDHITTQVKGTMGYLDPEYYMTQQ- 807
IHRDIK+ NILL E + K+ADFG+S S++D + GT ++ PE M Q
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182
Query: 808 -LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
K+D++SFG+ +EL TG P KY ++ L + P++
Sbjct: 183 GYDFKADIWSFGITAIELATGAAPYS--KYPPMKV---------LMLTLQNDPPSLETGA 231
Query: 867 TLKGFEK-YVDLALKCVQESGDDRPTMSEVVK 897
K + K + + C+Q+ RPT E++K
Sbjct: 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 69/213 (32%), Positives = 115/213 (53%), Gaps = 15/213 (7%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G G +G V +G GQ +A+K + Q F E +++++HHKNLV LLG
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
G ++ E + G+L + L + + I+ L+ +L A G+ YL + ++HRD+
Sbjct: 71 NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 815
+ NIL+ E AKV+DFGL++ S D+ VK T PE ++ + KSDV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTA----PEALKHKKFSSKSDVW 181
Query: 816 SFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847
S+GVL+ E+ + GR P K ++E++ ++K
Sbjct: 182 SYGVLLWEVFSYGRAPYP--KMSLKEVKECVEK 212
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 5e-23
Identities = 78/268 (29%), Positives = 137/268 (51%), Gaps = 24/268 (8%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G G +G+V+ GT +AIK + G+M + F E +++ ++ H LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
++ EF+ GSL D L +G L + + +A A G++Y+ + IHRD+
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDL 128
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-VKGTMGYLDPEYYMTQQLTEKSDV 814
+++NIL+ + L K+ADFGL++ + D+E + Q K + + PE + + T KSDV
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 815 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 873
+SFG+L+ EL+T GR P + RE+ +++ Y + P G +L
Sbjct: 187 WSFGILLTELVTKGRVPYP--GMVNREVLEQVERG------YRMPCPQ-GCPESLH---- 233
Query: 874 YVDLALKCVQESGDDRPTMSEVVKDIEN 901
+L C ++ D+RPT + +E+
Sbjct: 234 --ELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 8e-23
Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 25/207 (12%)
Query: 635 DVGSGGYGKV----YKGTLPN-GQLIAIKRAQQGSMQGGQ---EFKMEIELLSRVHHKNL 686
D+G G +GKV Y N G+ +A+K + S GG + K EIE+L ++H+N+
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENI 68
Query: 687 VSLLGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
V G C + G LI EF+P+GSL + L +N +++ ++LK A+ +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE-----KDHITTQVKGTMGYLD 799
+ +HRD+ + N+L++ K+ DFGL+K++ + KD + + V +
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYA 180
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLT 826
PE + + SDV+SFGV + ELLT
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 74/257 (28%), Positives = 123/257 (47%), Gaps = 21/257 (8%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G+G +G+V+ G N +A+K + G+M Q F E L+ + H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
+I E++ GSL D L G ++ + + + A G++Y+ E N IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI-ERKN--YIHRDL 129
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 815
+++N+L+ E L K+ADFGL++ + D+E K + + PE T KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 816 SFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 874
SFG+L+ E++T G+ P Y VM + Y + + + L +K
Sbjct: 189 SFGILLYEIVTYGKIP-----YPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK----- 238
Query: 875 VDLALKCVQESGDDRPT 891
C +E ++RPT
Sbjct: 239 -----TCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 28/274 (10%)
Query: 634 NDVGSGGYGKVYKGTLPNGQLIAIKRA------QQGSMQGGQEFKMEIELLSRVHHKNLV 687
+G G YG VY G GQLIA+K+ + + ++ + E++LL + H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
LG C D + EFVP GS+ L+ + G + + K G++YLH N
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFC-KYTKQILDGVAYLH---N 120
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMS----DSEKDHITTQVKGTMGYLDPEYY 803
++HRDIK +N++L K+ DFG ++ ++ ++ + GT ++ PE
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
KSD++S G + E+ TG+ P+ MD+ ++ +
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLAS-----------MDRLAAMFYIGAHRGLMPR 229
Query: 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
L + +D C+ +RP+ ++++
Sbjct: 230 LPDSFSA--AAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF- 694
+G G +G V G G +A+K + + Q F E +++++ H NLV LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
++G ++ E++ GSL D L + L LK +L + YL AN +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANN-FVHRD 127
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 814
+ + N+L+ E AKV+DFGL+K S S +D VK T PE ++ + KSDV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTA----PEALREKKFSTKSDV 182
Query: 815 YSFGVLMLELLT-GRRPIER 833
+SFG+L+ E+ + GR P R
Sbjct: 183 WSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 637 GSGGYGKVYK-GTLPNGQLIAIKRAQQGSM-QGGQEFKM-EIELLSRVHHKNLVSLLGFC 693
G G YG VYK L + Q A+K GSM Q +E + EI +L+ V+H N++S
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 694 FDRGEQMLIYEFVPNGSLGDSLS----GKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
D + ++ E+ P G L ++S + I I R+ I L RGL LHE
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL--LRGLQALHEQK--- 123
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
I+HRD+KS+NILL K+ D G+SK + K+ TQ+ GT Y+ PE + + +
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYMAPEVWKGRPYS 179
Query: 810 EKSDVYSFGVLMLELLTGRRPIE 832
KSD++S G L+ E+ T P E
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 75/204 (36%), Positives = 111/204 (54%), Gaps = 15/204 (7%)
Query: 636 VGSGGYGKVY---KGTLPN-GQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSL 689
+G G +GKV+ K T P+ GQL A+K ++ +++ KME ++L+ V+H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 690 LGFCFD-RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
+ F G+ LI +F+ G L LS + + ++ L A L +LH L
Sbjct: 64 -HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--ALALDHLHSLG-- 118
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
II+RD+K NILLDE + K+ DFGLSK D EK GT+ Y+ PE +
Sbjct: 119 -IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGH 175
Query: 809 TEKSDVYSFGVLMLELLTGRRPIE 832
T+ +D +SFGVLM E+LTG P +
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 74/288 (25%), Positives = 134/288 (46%), Gaps = 58/288 (20%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG------QEFKMEIELLSRVHHKNLVS 688
+G+G + Y+ + G L+A+K+ + + EI L++R++H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSG----KNGIRLDWIRRLKIALGAARGLSYLHE 744
+LG + L E++ GS+ LS K + +++ +L RGLSYLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLHE 121
Query: 745 LANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSD--SEKDHITTQVKGTMGYLD 799
IIHRD+K +N+L+D +RL ++ADFG + ++ + Q+ GT+ ++
Sbjct: 122 ---NQIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI- 858
PE +Q DV+S G +++E+ T + P ++ N LI
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW---------------NAEKHSNHLALIF 221
Query: 859 -------DPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
P+I LS L+ D+ L+C++ +DRP E++K
Sbjct: 222 KIASATTAPSIPEHLSPGLR------DVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 63/218 (28%), Positives = 115/218 (52%), Gaps = 25/218 (11%)
Query: 635 DVGSGGYGKVYKGTL-----PNGQLIAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLVS 688
++G +GK+YKG L + QL+AIK + + Q EF+ E L++ +HH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSL------------SGKNGI---RLDWIRRLKIAL 733
LLG +++E++ G L + L S ++G LD L IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
A G+ YL ++ +H+D+ + NIL+ E+L+ K++D GLS+ + ++ + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
+ ++ PE M + + SD++SFGV++ E+ + G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-22
Identities = 85/292 (29%), Positives = 136/292 (46%), Gaps = 39/292 (13%)
Query: 615 ARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKR---AQQGSMQGGQE 670
A FS ++ +K F+D ++G G +G VY + +++AIK+ + + S + Q+
Sbjct: 5 AELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 671 FKMEIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLS-GKNGIRLDWIRR 728
E+ L ++ H N + G C+ R L+ E+ GS D L K ++ I
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA- 118
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
I GA +GL+YLH IHRDIK+ NILL E K+ADFG S S+ +
Sbjct: 119 -AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFV- 172
Query: 789 TQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 845
GT ++ PE + Q K DV+S G+ +EL + P+ M
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------M 217
Query: 846 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ LY++ + PT+ + F +VD C+Q+ DRP+ E++K
Sbjct: 218 NAMSALYHIAQNDSPTLSSNDWSDYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 36/230 (15%)
Query: 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRA------QQGSMQGGQEFKMEIELLSR 680
++F +G G + V + AIK ++ ++ K+E E+L+R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK---YVKIEKEVLTR 57
Query: 681 V-HHKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARG 738
+ H ++ L + F D + E+ PNG L + + R A
Sbjct: 58 LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLA 114
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK------ 792
L YLH IIHRD+K NILLD+ ++ K+ DFG +K + +
Sbjct: 115 LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 793 ------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
GT Y+ PE + + SD+++ G ++ ++LTG+ P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 13/207 (6%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+G G +G V K +G+++ K G+M +E + E+ +L + H N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 692 FCFDRGEQML-IY-EFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYLH--EL 745
DR Q L I E+ G L + K ++ +I L H
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
++HRD+K +NI LD N K+ DFGL+K + + T V GT Y+ PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRPIE 832
EKSD++S G L+ EL P
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-------EIELLSRVHHKNLV 687
VG G YG V K G+++AIK+ + ++ + E+++L ++ H+N+V
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKK-----FKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
+L +G L++E+V L + G+ D +R L + ++Y H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCHSHN- 120
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
IIHRDIK NIL+ E K+ DFG ++++ +T V T Y PE +
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDT 177
Query: 808 LTEKS-DVYSFGVLMLELLTGR 828
K DV++ G +M ELL G
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 60/216 (27%), Positives = 116/216 (53%), Gaps = 23/216 (10%)
Query: 635 DVGSGGYGKVY----KGTLPNGQ--LIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
++G G +GKV+ LP L+A+K ++ S Q+F+ E ELL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLG--------DS--LSGKNGI---RLDWIRRLKIALGA 735
G C + ++++E++ +G L D+ L+G + +L + L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 795
A G+ YL L +HRD+ + N L+ + L K+ DFG+S+ + ++ + + +
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 796 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
++ PE + ++ T +SD++SFGV++ E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 635 DVGSGGYGKV--YKGTLPN---GQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVS 688
+G G +GKV Y N G+++A+K ++ Q +K EI +L ++H+N+V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 689 LLGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 746
G C ++G + LI E+VP GSL D L K+ + L + L A G++YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQL--LLFAQQICEGMAYLH--- 124
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-ITTQVKGTMGYLDPEYYMT 805
+ IHRD+ + N+LLD K+ DFGL+K++ + + + + + + E
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 806 QQLTEKSDVYSFGVLMLELLT 826
+ + SDV+SFGV + ELLT
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHH 683
+ + +G G G+VYK T G+ +AIK R ++ + + EI ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDCKH 74
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
N+V E ++ E++ GSL D ++ +N +R++ + + +GL YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
+ +IHRDIKS NILL + + K+ADFG + ++ EK + V GT ++ PE
Sbjct: 134 ---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVV-GTPYWMAPEVI 188
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ K D++S G++ +E+ G P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 59/219 (26%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 635 DVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
++G G +GKV+ N L+A+K + ++ ++F+ E ELL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 689 LLGFCFDRGEQMLIYEFVPNGSL----------------GDSLSGKNGIRLDWIRRLKIA 732
G C D ++++E++ +G L G K + L + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIA 129
Query: 733 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792
A G+ YL A+ +HRD+ + N L+ L K+ DFG+S+ + ++ +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
+ ++ PE M ++ T +SDV+SFGV++ E+ T G++P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 71/215 (33%), Positives = 106/215 (49%), Gaps = 35/215 (16%)
Query: 636 VGSGGYGKVYKGTLPNGQL---IAIKRAQQ-GSMQGGQEFKMEIELLSRV-HHKNLVSLL 690
+G G +G+V K + L AIKR ++ S ++F E+E+L ++ HH N+++LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD--WIRR------------LKIALGAA 736
G C RG L E+ P+G+L D L + D + L A A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
RG+ YL + IHRD+ + NIL+ E AK+ADFGLS+ VK TMG
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE--------VYVKKTMG 171
Query: 797 YLDPEYYMTQQL-----TEKSDVYSFGVLMLELLT 826
L + + L T SDV+S+GVL+ E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 635 DVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
++G G +GKV+ N L+A+K + S ++F E ELL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSL-----------SGKNGIRLDWIRRLKIALGAAR 737
G C + ++++E++ +G L L G L + L IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
G+ YL A+ +HRD+ + N L+ E L K+ DFG+S+ + ++ + + +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
+ PE M ++ T +SDV+S GV++ E+ T G++P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-21
Identities = 74/298 (24%), Positives = 133/298 (44%), Gaps = 48/298 (16%)
Query: 636 VGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVS 688
+G G +GKV K T +A+K ++ + ++ E LL +V+H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLS-----GKNGIRLDWIRR--------------- 728
L G C G +LI E+ GSL L G + + D R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 729 --LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786
+ A +RG+ YL E+ ++HRD+ + N+L+ E K++DFGLS+ + + +
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVM 845
++ + + ++ E T +SDV+SFGVL+ E++T G P I E
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---IAPE----- 236
Query: 846 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
L+ L+ + E+ +L L C ++ D RPT +++ K++E ++
Sbjct: 237 -------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 4e-21
Identities = 85/301 (28%), Positives = 139/301 (46%), Gaps = 35/301 (11%)
Query: 606 SGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVY-KGTLPNGQLIAIKRAQQGS 664
+GS+ + A F E+ +K F+D ++G G +G VY + +++AIK+
Sbjct: 6 AGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG 62
Query: 665 MQGGQEFK---MEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI 721
Q ++++ E++ L R+ H N + G L+ E+ GS D L
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK- 120
Query: 722 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781
L + I GA +GL+YLH + +IHRDIK+ NILL E K+ADFG S S++
Sbjct: 121 PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFG-SASIAS 176
Query: 782 SEKDHITTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838
+ GT ++ PE + Q K DV+S G+ +EL + P+
Sbjct: 177 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----- 226
Query: 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
M+ LY++ + PT+ + F +VD C+Q+ DRPT E++K
Sbjct: 227 ------MNAMSALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDRPTSEELLKH 277
Query: 899 I 899
+
Sbjct: 278 M 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 4e-21
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHHKNLVSLL 690
+G G YG VYK G+++A+K+ + + + G EI LL + H N+V LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG--IPSTALREISLLKELKHPNIVKLL 64
Query: 691 GFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
+ L++E+ D G + + I+ + L RGL+Y H
Sbjct: 65 DVIHTERKLYLVFEYCDMDLKKYLDKRPGP--LSPNLIKSIMYQL--LRGLAYCHSHR-- 118
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
I+HRD+K NIL++ K+ADFGL+++ T +V T+ Y PE + +
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTYTHEVV-TLWYRAPEILLGSKH 175
Query: 809 TEKS-DVYSFGVLMLELLTGRRPIERGK 835
+ D++S G + E++TG +P+ G
Sbjct: 176 YSTAVDIWSVGCIFAEMITG-KPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 80/289 (27%), Positives = 138/289 (47%), Gaps = 42/289 (14%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKM-------EIELLSRVHHKNLV 687
VG G YG V K GQ++AIK+ + ++ KM EI +L ++ H+NLV
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
+L+ + L++EFV + L D NG LD R K RG+ + H +
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---S 118
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
IIHRDIK NIL+ + K+ DFG +++++ + + T T Y PE +
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDT 176
Query: 808 LTEKS-DVYSFGVLMLELLTGR------RPIERGKYIVREIRTVMDKKKELYNLYEL--- 857
++ D+++ G L+ E+LTG I++ +I++ + ++ + +E++ L
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 858 -----IDPTIGLSTTLKGFEKY----VDLALKCVQESGDDRPTMSEVVK 897
+ L K F K +DLA +C++ DDRP+ S+++
Sbjct: 237 MRLPEVKEIEPLE---KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 35/215 (16%)
Query: 636 VGSGGYGKVYKGTLP---NGQLIAIKRAQQ-GSMQGGQEFKMEIELLSRV-HHKNLVSLL 690
+G G +G+V + + AIK ++ S ++F E+E+L ++ HH N+++LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI--------------RRLKIALGAA 736
G C +RG + E+ P G+L D L + D + L+ A A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
G+ YL E IHRD+ + N+L+ E L +K+ADFGLS+ VK TMG
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEE--------VYVKKTMG 178
Query: 797 YLDPEYYMTQQL-----TEKSDVYSFGVLMLELLT 826
L + + L T KSDV+SFGVL+ E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-21
Identities = 78/222 (35%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 69 ITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGP 128
+ L G+L + T L ++ LD+SNN L+G + + ++ L L L F G
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNN-LQGRINSRKWDMPSLQMLSLARNKFFGG 467
Query: 129 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP---VSDGNSP 185
+PDS GS + L L L+ N FSG VP +G+LS L L L++NKL GEIP S
Sbjct: 468 LPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
Query: 186 GLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVV 245
LD+ NQLSG IP F VL + N L+GE+P LG V+SL V
Sbjct: 527 SLDL---------SHNQLSGQIPAS-FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576
Query: 246 RFDRNSLSGPVPSN----LNNLTSV--NDLYLSNNKLTGAMP 281
N L G +PS N ++V N + +G P
Sbjct: 577 NISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
|
Length = 968 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM--EIELLSRVHHKNLVSLLGF 692
+G G +G V+K G+ +A+K+ ++GG + EI+ L H +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 693 CFDRGEQM-LIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
F G L+ E++P L + L + + ++ L +G++Y+H I
Sbjct: 68 -FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHANG---I 120
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE-YYMTQQLT 809
+HRD+K +N+L+ K+ADFGL++ S+ E + QV T Y PE Y ++
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYD 179
Query: 810 EKSDVYSFGVLMLELLTGR 828
D+++ G + ELL G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 81/276 (29%), Positives = 133/276 (48%), Gaps = 36/276 (13%)
Query: 635 DVGSGGYGKVYKGT-LPNGQLIAIKR--AQQGSMQGGQEFK---MEIELLSR-VHHKNLV 687
++G G YG V K +P G ++A+KR A S QE K M++++ R V V
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS----QEQKRLLMDLDISMRSVDCPYTV 63
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGK---NGIRLDWIRRLKIALGAARGLSYLHE 744
+ G F G+ + E V + SL D K G+ + KIA+ + L YLH
Sbjct: 64 TFYGALFREGDVWICME-VMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG--YLDPEY 802
+IHRD+K SN+L++ K+ DFG+S + DS I K M ++PE
Sbjct: 122 --KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862
+ KSDV+S G+ M+EL TGR P + K ++++ V++ +P+
Sbjct: 180 NQ-KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE------------EPSP 226
Query: 863 GLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVK 897
L + F ++ D KC++++ +RP E+++
Sbjct: 227 QLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G+G +G+V+ T +A+K + GSM + F E ++ + H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV-T 71
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
+ +I EF+ GSL D L G + + + + A G++++ + IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 128
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-VKGTMGYLDPEYYMTQQLTEKSDV 814
+++NIL+ L K+ADFGL++ + D+E + + K + + PE T KSDV
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 815 YSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 873
+SFG+L++E++T GR P G IR + + + E+
Sbjct: 187 WSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGYR--------------MPRPENCPEE 231
Query: 874 YVDLALKCVQESGDDRPT---MSEVVKD 898
++ ++C + ++RPT + V+ D
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 76/287 (26%), Positives = 130/287 (45%), Gaps = 46/287 (16%)
Query: 636 VGSGGYGKVYKGTL------PNGQLIAIK-RAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
+G G +G+VY+G +A+K + S Q +F ME ++S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR-----------LKIALGAAR 737
L+G F+R + ++ E + G L K+ +R + R L A A+
Sbjct: 74 LIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFGLSKSMSDSEKDHITTQVKGT 794
G YL E IHRDI + N LL + AK+ADFG+++ + + +
Sbjct: 128 GCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYN 853
+ ++ PE ++ T K+DV+SFGVL+ E+ + G P Y R + VM E
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-----YPGRTNQEVM----EFVT 235
Query: 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900
+DP G + + C Q + +DRP + +++ I+
Sbjct: 236 GGGRLDPPKGCPGPVYR------IMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 77/278 (27%), Positives = 137/278 (49%), Gaps = 47/278 (16%)
Query: 636 VGSGGYGKVYKGT-LPNGQLI----AIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSL 689
+GSG +G VYKG +P G+ + AIK ++ S + +E E +++ V + ++ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA----------ARGL 739
LG C Q LI + +P G L LD++R K +G+ A+G+
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCL-----------LDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
+YL E ++HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++
Sbjct: 123 NYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 858
E + + T +SDV+S+GV + EL+T G +P + EI ++++K + L
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEISSILEKGERL------- 230
Query: 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVV 896
P + T + Y+ + +KC D RP E++
Sbjct: 231 -PQPPICT----IDVYM-IMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 75/284 (26%), Positives = 137/284 (48%), Gaps = 47/284 (16%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRA-----QQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
+GSG +G VYKG +P+G+ + I A + S + +E E +++ V + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA----------ARGL 739
LG C Q L+ + +P G L LD++R K +G+ A+G+
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL-----------LDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
SYL E+ ++HRD+ + N+L+ + K+ DFGL++ + E ++ K + ++
Sbjct: 123 SYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 858
E + ++ T +SDV+S+GV + EL+T G +P + REI +++K + L
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD--GIPAREIPDLLEKGERL------- 230
Query: 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
P + T + Y+ + +KC + RP E+V + +
Sbjct: 231 -PQPPICTI----DVYM-IMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 42/215 (19%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+GSG YG VYK + G+L+AIK ++ G +F++ EI +L H N+V+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIK---VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL---GAARGLSYLHELANP 748
R + ++ E+ GSL D G + L+IA +GL+YLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP----LSELQIAYVCRETLKGLAYLHETG-- 121
Query: 749 PIIHRDIKSSNILLDERLNAKVADFG----LSKSMSDSEKDHITT---------QVKGTM 795
IHRDIK +NILL E + K+ADFG L+ +++ K I T V+
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKG 179
Query: 796 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
GY K D+++ G+ +EL + P
Sbjct: 180 GY-----------DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 5/159 (3%)
Query: 674 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
EI +LS + H N+++ D ++ E+ G+L D + + G + L
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
+SY+H+ I+HRDIK+ NI L + K+ DFG+SK + SE T V G
Sbjct: 109 QIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVV-G 163
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 832
T Y+ PE + KSD+++ G ++ ELLT +R +
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+G G YG VYK G+++AIK+ + G K EI+LL ++H N++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP-KTALREIKLLKELNHPNIIKLLD 65
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+G+ L++EF+ + L + + G+ I+ L +GL++ H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL--LQGLAFCHS-HG--I 119
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLT 809
+HRD+K N+L++ K+ADFGL++S S T V T Y PE + + +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 810 EKSDVYSFGVLMLELLTGRRPIERGK 835
D++S G + ELL+ RRP+ GK
Sbjct: 178 TPVDIWSVGCIFAELLS-RRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 636 VGSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVS 688
+G G +G+V+ L+ +K Q+ + Q EF+ E+++ ++ HKN+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSL----SGKNGIR---LDWIRRLKIALGAARGLSY 741
LLG C + +I E+ G L L S ++ L +++ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
L+N +HRD+ + N L+ + KV+ LSK + +SE + + +L PE
Sbjct: 133 ---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL-RNALIPLRWLAPE 188
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLT 826
+ KSDV+SFGVLM E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 68/213 (31%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 693
+G G YGKVYK GQL+AIK +E K E +L + +H N+ + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 694 F-------DRGEQMLIYEFVPNGSLGD----SLSGKNGIRLDWIRRLKIALGAARGLSYL 742
F + + L+ E GS+ D ++ +WI I RGL+YL
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYL 129
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE- 801
HE +IHRDIK NILL + K+ DFG+S + DS T + GT ++ PE
Sbjct: 130 HE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS-AQLDSTLGRRNTFI-GTPYWMAPEV 184
Query: 802 ----YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+SDV+S G+ +EL G+ P
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGFCF 694
+G G +G+V+KGTL + +A+K ++ Q + +F E +L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
R ++ E VP G L K L + +K AL AA G++YL E N IHRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYL-ESKN--CIHRD 118
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSD---SEKDHITTQVKGTMGYLDPEYYMTQQLTEK 811
+ + N L+ E K++DFG+S+ D S +K T PE + + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTA----PEALNYGRYSSE 174
Query: 812 SDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 870
SDV+S+G+L+ E + G P T ++++ Y + P K
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPG--------MTNQQAREQVEKGYRMSCPQ-------KC 219
Query: 871 FEKYVDLALKCVQESGDDRPTMSEVVKDI 899
+ + +C ++RP SE+ K++
Sbjct: 220 PDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 37/214 (17%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE---FKM--EIELLSRVHHKNLVSL 689
+G G Y VYK G+++AIK+ + G + ++ F EI+LL + H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 690 LG-FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA----------RG 738
L F L++EF+ D L I+ I L A RG
Sbjct: 68 LDVFGHKSNIN-LVFEFME----TD-LEK-------VIKDKSIVLTPADIKSYMLMTLRG 114
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
L YLH I+HRD+K +N+L+ K+ADFGL++S +T QV T Y
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQVV-TRWYR 169
Query: 799 DPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPI 831
PE + D++S G + ELL R P
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 79/282 (28%), Positives = 126/282 (44%), Gaps = 48/282 (17%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRA------------QQGSMQGGQEFKMEIE 676
F+ +G G +G+VYK Q++AIK QQ EI+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-----------EIQ 51
Query: 677 LLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA 735
LS+ + G F +G ++ +I E+ GS D L K G +LD I
Sbjct: 52 FLSQCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLL--KPG-KLDETYIAFILREV 107
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 795
GL YLHE IHRDIK++NILL E + K+ADFG+S ++ + T GT
Sbjct: 108 LLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTP 162
Query: 796 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855
++ PE EK+D++S G+ +EL G P + + + L+ +
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP-----------LSDLHPMRVLFLIP 211
Query: 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ P++ + K F+ +V L C+ + +RP+ E++K
Sbjct: 212 KNNPPSLEGNKFSKPFKDFVSL---CLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 75/281 (26%), Positives = 137/281 (48%), Gaps = 41/281 (14%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRA-----QQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
+GSG +G VYKG +P G+ + I A + + EF E +++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 690 LGFCFDRGEQMLIYEFVPNGSL-------GDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
LG C Q L+ + +P+G L D++ + + L+W ++ A+G+ YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQ--LLLNWCVQI------AKGMMYL 125
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
E ++HRD+ + N+L+ + K+ DFGL++ + EK++ K + ++ E
Sbjct: 126 EERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 803 YMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861
++ T +SDV+S+GV + EL+T G +P + REI +++K + L P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--GIPTREIPDLLEKGERL--------PQ 232
Query: 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
+ T + Y+ + +KC D RP E+ + +
Sbjct: 233 PPICT----IDVYM-VMVKCWMIDADSRPKFKELAAEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 67/199 (33%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 635 DVGSGGYGKVYK-GTLPNGQLIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGF 692
D+G+G G V K +P G ++A K G+ + + E++++ +VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPII 751
+ + EF+ GSL D + K G I ++ + KIA+ GL+YL+ + I+
Sbjct: 72 FLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILG--KIAVAVVEGLTYLYNVHR--IM 126
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 811
HRDIK SNIL++ R K+ DFG+S + +S D T V GT Y+ PE + T K
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---TFV-GTSTYMSPERIQGGKYTVK 182
Query: 812 SDVYSFGVLMLELLTGRRP 830
SDV+S G+ ++EL G+ P
Sbjct: 183 SDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 628 NNFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGG-----QEFKMEIELLSRV 681
N+ +G G +G+VY + G+ +A+K+ + EI+LL +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 682 HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 741
H+ +V G D + E++P GS+ D L G + + R K G+ Y
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK-AYGALTETVTR-KYTRQILEGVEY 119
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT--TQVKGTMGYLD 799
LH + I+HRDIK +NIL D N K+ DFG SK + + T V GT ++
Sbjct: 120 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICSSGTGMKSVTGTPYWMS 175
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
PE + K+DV+S G ++E+LT + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-19
Identities = 85/346 (24%), Positives = 148/346 (42%), Gaps = 39/346 (11%)
Query: 569 VVLLLLLLAGVYAYHQKRR--AEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKY 626
L+L L + R E +N W++ K ++ + ++
Sbjct: 637 GAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQ-----FFDSKVSKSITINDILSS 691
Query: 627 TNNFSDANDVGSGGYGKVYKGTLPNG--QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK 684
+ N + G G YKG Q + + S+ EI + ++ H
Sbjct: 692 LK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHP 743
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
N+V L+G C LI+E++ +L + L L W RR KIA+G A+ L +LH
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHC 798
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
+P ++ ++ I++D + + L + K I++ Y+ PE
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRE 851
Query: 805 TQQLTEKSDVYSFGVLMLELLTGRRP--IERGKY--IVREIRTVMDKKKELYNLYELIDP 860
T+ +TEKSD+Y FG++++ELLTG+ P E G + IV R +L IDP
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD----CHLDMWIDP 907
Query: 861 TIGLSTTLKGFE--KYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+I ++ E + ++LAL C RP ++V+K +E+ +
Sbjct: 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 72/215 (33%), Positives = 105/215 (48%), Gaps = 30/215 (13%)
Query: 634 NDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM------EIELLSRVHHKNL 686
N +GSG G VYK P G+L A+K + G E + EIE+L V+H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALK-----VIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 687 VSLLGFCFDR-GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
V FD GE ++ EF+ GSL + D R++ G++YLH
Sbjct: 135 VKCHDM-FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI------LSGIAYLHRR 187
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
I+HRDIK SN+L++ N K+ADFG+S+ ++ + D + V GT+ Y+ PE T
Sbjct: 188 H---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSV-GTIAYMSPERINT 242
Query: 806 QQLTEK-----SDVYSFGVLMLELLTGRRPIERGK 835
D++S GV +LE GR P G+
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 72/225 (32%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM--EIELLSRV---HH 683
+ + ++G G YG VYK L G+ +A+K+ + + G EI LL ++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 684 KNLVSLLGFC----FDRGEQM-LIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAA 736
N+V LL C DR ++ L++E V + L LS K G+ + I+ L L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQL--L 117
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
RG+ +LH I+HRD+K NIL+ K+ADFGL++ S +T+ V T+
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVV-TLW 171
Query: 797 YLDPE-----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 836
Y PE Y T D++S G + EL RRP+ RG
Sbjct: 172 YRAPEVLLQSSYAT-----PVDMWSVGCIFAELFR-RRPLFRGTS 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 42/232 (18%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPN---GQ---LIAIKRAQQG-SMQGGQEFKMEIELLSR 680
NN D+G G +G+V++ P + ++A+K ++ S +F+ E L++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 681 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------------SGKNG 720
H N+V LLG C L++E++ G L + L G N
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 721 IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM- 779
+ L +L IA A G++YL E +HRD+ + N L+ E + K+ADFGLS+++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 780 -SD----SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 826
+D SE D I + ++ PE + T +SDV+++GV++ E+ +
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQ--QGSMQGGQE---FKMEIELLSRVHHKNLVSL 689
+G G +G+VY + G+ +A K+ Q S + +E + EI+LL + H+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 690 LGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
G DR E+ L E++P GS+ D L + R+ + G+SYLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI--LEGMSYLH---S 124
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKS-----MSDSEKDHITTQVKGTMGYLDPEY 802
I+HRDIK +NIL D N K+ DFG SK MS + +T GT ++ PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GTPYWMSPEV 180
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ K+DV+S G ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 37/277 (13%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 693
VG+G YG+VYKG + GQL AIK + +E K EI +L + HH+N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 694 FDRG-----EQM-LIYEFVPNGSLGDSLSGKNG--IRLDWIRRLKIALGAARGLSYLHEL 745
+ +Q+ L+ EF GS+ D + G ++ +WI I RGLS+LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ- 129
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+IHRDIK N+LL E K+ DFG+S + + T GT ++ PE
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIAC 185
Query: 806 QQLTE-----KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860
+ + KSD++S G+ +E+ G P+ M + L+ + P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPL-----------CDMHPMRALFLIPRNPAP 234
Query: 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ K F+ +++ C+ ++ RPT +++K
Sbjct: 235 RLKSKKWSKKFQSFIE---SCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 636 VGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRV-HHKN 685
+G G +G+V K +A+K + + + ++ E+E++ + HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKN 77
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW--------IRRLK------I 731
+++LLG C G ++ E+ +G+L D L + L
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
A ARG+ +L A+ IHRD+ + N+L+ E K+ADFGL++ + + TT
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 850
+ + ++ PE + T +SDV+SFGVL+ E+ T G P Y + + KE
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-----YPGIPVEELFKLLKE 249
Query: 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
Y + + + L L C E RPT ++V+D++ +L
Sbjct: 250 GYRM----EKPQNCTQELYH------LMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-19
Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 693
VG+G YG+VYKG + GQL AIK + +E K+EI +L + HH+N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 694 FDRG-----EQM-LIYEFVPNGSLGDSLSGKNG--IRLDWIRRLKIALGAARGLSYLHEL 745
+ +Q+ L+ EF GS+ D + G ++ DWI I RGL++LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA- 139
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+IHRDIK N+LL E K+ DFG+S + + T GT ++ PE
Sbjct: 140 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIAC 195
Query: 806 QQLTE-----KSDVYSFGVLMLELLTGRRPI 831
+ + +SD++S G+ +E+ G P+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 64/282 (22%), Positives = 121/282 (42%), Gaps = 34/282 (12%)
Query: 636 VGSGGYGKVYKGTLPN------GQLIAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLVS 688
+G G +G VY+G +AIK + SM+ EF E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGK--------NGIRLDWIRRLKIALGAARGLS 740
LLG +++ E + G L L + + +++A A G++
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
YL +HRD+ + N ++ E L K+ DFG+++ + +++ + + ++ P
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
E T KSDV+SFGV++ E+ T +P + G ++ V+D +D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSNEEVLKFVIDGG--------HLD 241
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
+K ++L C Q + RPT E+V +++
Sbjct: 242 LPENCP------DKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIKRAQQG--SMQGGQEFKM-EIELLSRVHHKNLVSLLG 691
+G GG+G+V + G++ A K+ + + G++ + E ++L +V + +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ F+ + + L+ + G L + R + A GL +LH+ I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
++RD+K N+LLD+ N +++D GL+ + +K GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 811 KSDVYSFGVLMLELLTGRRPI-ERGKYIVRE 840
D ++ G + E++ GR P +R + + +E
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 636 VGSGGYGKVYKGT--LPNGQLI--AIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLL 690
+G G +G VY+G P + I A+K + + ++F E ++ + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G + ++ E P G L L N LD + + + L+YL
Sbjct: 74 GVITEN-PVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
+HRDI + N+L+ K+ DFGLS+ + D + K + ++ PE ++ T
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-GKLPIKWMAPESINFRRFTS 187
Query: 811 KSDVYSFGVLMLELLT-GRRP 830
SDV+ FGV M E+L G +P
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-19
Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 25/197 (12%)
Query: 652 GQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVSLLGFCFDRGEQ-----MLIY 703
G +AIK + + + + F+ E L +R++H N+V+LL D GE ++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL----DSGEAPPGLLFAVF 58
Query: 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL- 762
E+VP +L + L+ L ++ L L+ H N I+HRD+K NI++
Sbjct: 59 EYVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVS 113
Query: 763 --DERLNAKVADFGLSKSMSDSEKDHI-----TTQVKGTMGYLDPEYYMTQQLTEKSDVY 815
R +AKV DFG+ + + TT+V GT Y PE + +T SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 816 SFGVLMLELLTGRRPIE 832
++G++ LE LTG+R ++
Sbjct: 174 AWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 78/284 (27%), Positives = 125/284 (44%), Gaps = 33/284 (11%)
Query: 636 VGSGGYGKVYKGTL--PNG--QLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
+G G +G V +G L +G +A+K + + +EF E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 690 LGFCFDRGEQ------MLIYEFVPNGSLGDSL----SGKNGIRLDWIRRLKIALGAARGL 739
+G CF+ M+I F+ +G L L G +L LK + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
YL +N IHRD+ + N +L E + VADFGLSK + + K + ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
E + T KSDV++FGV M E+ T RG+ + + E+Y+ L
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT------RGQTPYPGV-----ENHEIYDY--LRH 230
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
L ++ DL C + DRPT +++ + +ENIL
Sbjct: 231 GN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 50/228 (21%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHH 683
N+ + ++GSG G+VYK G ++A+K+ ++ + +E K M+++++ + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHD 72
Query: 684 -KNLVS----------------LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI 726
+V L+ C D+ + I +P LG
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCLDKLLK-RIQGPIPEDILG-------------- 117
Query: 727 RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786
K+ + + L YL E +IHRD+K SNILLD N K+ DFG+S + DS K
Sbjct: 118 ---KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAK 171
Query: 787 ITTQVKGTMGYLDPEYYMTQQLTEK----SDVYSFGVLMLELLTGRRP 830
T+ G Y+ PE K +DV+S G+ ++EL TG+ P
Sbjct: 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 73/276 (26%), Positives = 134/276 (48%), Gaps = 39/276 (14%)
Query: 635 DVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
++G G +GKVYK G L A K + S + +++ +EIE+L+ +H +V LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK---IALGAARGLSYLHELANPPI 750
+ G+ ++ EF P G++ + I L+ R L I + + L L L + I
Sbjct: 79 YWDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK----GTMGYLDPEYYMTQ 806
IHRD+K+ N+LL + K+ADFG+S K+ T Q + GT ++ PE M +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSA------KNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 807 QLTE-----KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861
+ + K+D++S G+ ++E+ IE + + +R ++ K +P
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQ----IEPPHHELNPMRVLLKIAKS--------EPP 233
Query: 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
LS K ++ D + + + RP+ +++++
Sbjct: 234 -TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 32/275 (11%)
Query: 630 FSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKN 685
F +++G G +G VY T + +++A+K+ Q ++++ E++ L ++ H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+ G L+ E+ GS D L L + I GA +GL+YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH 140
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+IHRDIK+ NILL E K+ADFG S S S + GT ++ PE +
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFG-SASKSSPANSFV-----GTPYWMAPEVILA 191
Query: 806 Q---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862
Q K DV+S G+ +EL + P+ M+ LY++ + PT+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------MNAMSALYHIAQNDSPTL 240
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ F +VD C+Q+ +RP +E+++
Sbjct: 241 QSNEWTDSFRGFVDY---CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 21/224 (9%)
Query: 615 ARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLI----AIKRAQ-QGSMQGG 668
AR E++K +GSG +G V+KG +P G I AIK Q + Q
Sbjct: 1 ARILKETELRK-------LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 669 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIR 727
QE + + + H +V LLG C G + L+ + P GSL D + LD R
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQR 110
Query: 728 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787
L + A+G+ YL E ++HR++ + NILL ++ADFG++ + +K +
Sbjct: 111 LLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167
Query: 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
++ K + ++ E + + T +SDV+S+GV + E+++ G P
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 41/241 (17%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHH 683
+ D ++G G +G V K G ++A+KR + S +E K M+++++ R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR--STVDEKEQKRLLMDLDVVMRSSD 61
Query: 684 -KNLVSLLGFCFDRG------EQMLI-----YEFV---PNGSLGDSLSGKNGIRLDWIRR 728
+V G F G E M I Y++V + + + GK
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK---------- 111
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
IA+ + L+YL E IIHRD+K SNILLD N K+ DFG+S + DS
Sbjct: 112 --IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--- 164
Query: 789 TQVKGTMGYLDPEYYMTQQLTE---KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 845
T+ G Y+ PE +SDV+S G+ + E+ TG+ P + + ++ V+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224
Query: 846 D 846
Sbjct: 225 K 225
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 639 GGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVSLLG 691
G +G VY + T G AIK ++ M + K E ++ V+ L
Sbjct: 7 GAFGSVYLAKKRST---GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ F + + L+ E++ G + G+ DW + + G+ LH+ I
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRG---I 118
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
IHRDIK N+L+D+ + K+ DFGLS++ +++K GT YL PE + +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDK 172
Query: 811 KSDVYSFGVLMLELLTGRRPIE 832
SD +S G ++ E L G P
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 4e-18
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 630 FSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKN 685
FSD ++G G +G VY + N +++AIK+ Q ++++ E+ L ++ H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+ G L+ E+ GS D L L + + GA +GL+YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH-- 132
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+ +IHRD+K+ NILL E K+ DFG + M+ + GT ++ PE +
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILA 185
Query: 806 Q---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862
Q K DV+S G+ +EL + P+ M+ LY++ + P +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------MNAMSALYHIAQNESPAL 234
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ F +VD C+Q+ DRPT ++K
Sbjct: 235 QSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 636 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQE--FKMEIELLSRVHHKNLVSLLG 691
+G GG+G+V + + A+K ++ + + GQ+ E E+L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
D+ ++ E+ G L L G+ ++ R IA YLH II
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIA-CVVLAFEYLHNRG---II 115
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 811
+RD+K N+LLD K+ DFG +K + +K T GT Y+ PE + +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILNKGYDFS 172
Query: 812 SDVYSFGVLMLELLTGRRP 830
D +S G+L+ ELLTGR P
Sbjct: 173 VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 636 VGSGGYGKVY--KGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLG 691
+G G +GK+Y K + + IK M + + K E+ LL+++ H N+V+
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
+ G ++ E+ G L ++ + G+ + L + + GL ++H+ I+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---IL 123
Query: 752 HRDIKSSNILLDER-LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
HRDIKS NI L + + AK+ DFG+++ ++DS + + GT YL PE +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNN 181
Query: 811 KSDVYSFGVLMLELLTGRRPIE 832
K+D++S G ++ EL T + P E
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 70/224 (31%), Positives = 116/224 (51%), Gaps = 25/224 (11%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELL 678
K+ + F +G G YG+VYK G+L+A+K+ + + + G F + EI++L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG--FPITAIREIKIL 60
Query: 679 SRVHHKNLVSL----------LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 728
+++H+N+V+L L F D+G L++E++ + +G SG D I+
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
L GL+Y H +HRDIK SNILL+ + K+ADFGL++ + E T
Sbjct: 121 FMKQL--LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 789 TQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPI 831
+V T+ Y PE + ++ DV+S G ++ EL T ++PI
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQ--QGSMQGGQE---FKMEIELLSRVHHKNLVSL 689
+G G +G+VY G+ +A+K+ Q S + +E + EI+LL + H+ +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 690 LGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
G D E+ L E +P GS+ D L + + R+ + G+SYLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI--LEGVSYLH---S 124
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD-SEKDHITTQVKGTMGYLDPEYYMTQ 806
I+HRDIK +NIL D N K+ DFG SK + V GT ++ PE +
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP 830
K+D++S G ++E+LT + P
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 70/251 (27%), Positives = 118/251 (47%), Gaps = 44/251 (17%)
Query: 674 EIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW---IRRL 729
E+E++ + HKN+++LLG C G +I E+ G+L + L + +++ I R+
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 730 -----------KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778
ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRR----PIE 832
+++ + TT + + ++ PE + T +SDV+SFGVLM E+ T G P+E
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
Query: 833 RGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM 892
+++E MDK N E Y+ + C RPT
Sbjct: 247 ELFKLLKEGHR-MDKPANCTN------------------ELYM-MMRDCWHAIPSHRPTF 286
Query: 893 SEVVKDIENIL 903
++V+D++ IL
Sbjct: 287 KQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 35/275 (12%)
Query: 630 FSDANDVGSGGYGKVYKGTLPNGQ-LIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 687
F+ +G G +G+V+KG Q ++AIK + ++ + EI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
G + +I E++ GS D L LK L +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 122
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK-----GTMGYLDPEY 802
IHRDIK++N+LL E+ + K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862
K+D++S G+ +EL G P + M + L+ + + PT+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP-----------NSDMHPMRVLFLIPKNNPPTL 221
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ K F++++D C+ + RPT E++K
Sbjct: 222 TGEFS-KPFKEFID---ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 8/158 (5%)
Query: 674 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
E+++L + +V G + GE + E + GSL D + K G R+ KI++
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAG-RIPENILGKISI 106
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
RGL+YL E I+HRD+K SNIL++ R K+ DFG+S + DS + G
Sbjct: 107 AVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 160
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI 831
T Y+ PE T +SD++S G+ ++E+ GR PI
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRA--QQGSMQGGQE---FKMEIELLSRVHHKNLVSL 689
+G G +G+VY G+ +A+K+ S + +E + EI+LL + H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 690 LGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
G D E+ L E++P GS+ D L + + RR + +G+SYLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVSYLH---S 124
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKS-----MSDSEKDHITTQVKGTMGYLDPEY 802
I+HRDIK +NIL D N K+ DFG SK MS + +T GT ++ PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWMSPEV 180
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ K+DV+S ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 629 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFK--MEIELLSRVHHKN 685
F N +G G YG VY+ +G+++A+K+ + + + G EI LL + H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 686 LVSLLGFCFDRGEQM----LIYEFVPN--GSLGDSLSGKNGIRLDWIRRLK-IALGAARG 738
+V L G+ + L+ E+ SL D++ ++K + L RG
Sbjct: 68 IVELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSES-----QVKCLMLQLLRG 120
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
L YLHE IIHRD+K SN+LL ++ K+ADFGL+++ K V T+ Y
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 799 DPE--YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
PE T T D+++ G ++ ELL +P+ GK
Sbjct: 176 APELLLGCTTY-TTAIDMWAVGCILAELLAH-KPLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 635 DVGSGGYGKVYKGT--LPNGQL-IAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLL 690
++GSG +G V KG + Q+ +AIK + + + ++ M E E++ ++ + +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL---GAARGLSYLHELAN 747
G C + ML+ E G L LSGK D I + + G+ YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG--- 113
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSM-SDSEKDHITTQVKGTMGYLDPEYYMTQ 806
+HRD+ + N+LL + AK++DFGLSK++ +D + K + + PE +
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 807 QLTEKSDVYSFGVLMLELLT-GRRPIERGK 835
+ + +SDV+S+G+ M E + G++P ++ K
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 636 VGSGGYGKVYKGTLPNGQ-LIAIKR--AQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
VG G +G V+ Q L+ IK+ +Q + + E ++L + H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
+ M++ E+ P G+L + + + LD L + L ++H I+H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILH 124
Query: 753 RDIKSSNILLDERLN-AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 811
RD+K+ NILLD+ K+ DFG+SK +S K V GT Y+ PE + +K
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQK 181
Query: 812 SDVYSFGVLMLELLTGRRPIE 832
SD+++ G ++ EL + +R E
Sbjct: 182 SDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 27/203 (13%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
+G G G VYK L +++A+K +++ ++ E+E+L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL------KIALGAARGLSYLHELAN 747
F + EF+ GSL D R++ +IA+ +GL+YL L
Sbjct: 69 FVENRISICTEFMDGGSL------------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK- 115
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
I+HRD+K SN+L++ R K+ DFG+S + +S I GT Y+ PE +Q
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQ 169
Query: 808 LTEKSDVYSFGVLMLELLTGRRP 830
SDV+S G+ +EL GR P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVS 688
+ G YG+V+ K T G + AIK ++ M + E ++LS+ +V
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRL--KIALGAARGLSYLHEL 745
L + F + + L+ E++P G L L + D R +I L L YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYLHSN 112
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSK--------SMSDSEKDHITTQVKGTMGY 797
IIHRD+K NIL+D + K+ DFGLSK +++D EK+ ++ GT Y
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE--DKRIVGTPDY 167
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ PE + Q ++ D +S G ++ E L G P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 636 VGSGGYGKV----YKGTLPNGQLIAIKRAQQGSMQGGQEFKM--------EIELLSRVHH 683
+G+G +G+V +K +G+ A+K + + K+ E +L + H
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKI-----LSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR--RLKIALGAARGLSY 741
LV+L G D L+ E+VP G L L R ++ L L Y
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEY 116
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
LH L I++RD+K N+LLD K+ DFG +K + T + GT YL PE
Sbjct: 117 LHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPE 168
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+++ + D ++ G+L+ E+L G P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 10/206 (4%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN 685
++F +++G+G G V K LI ++ ++ + E+++L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+V G + GE + E + GSL L I + + ++ IA+ RGL+YL E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLRE- 121
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
I+HRD+K SNIL++ R K+ DFG+S + DS + GT Y+ PE
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 176
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRPI 831
+ +SD++S G+ ++EL GR PI
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 53/239 (22%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM---------EIELLSRVHHKN 685
+GSG YG V +G+ +AIK+ F + E+++L H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDS---------------LSGKNGIRLDWIRRLK 730
++++ P G+ + + + IR
Sbjct: 66 IIAIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFL 113
Query: 731 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT-- 788
L RGL Y+H AN +IHRD+K SN+L++E ++ DFG+++ +S S +H
Sbjct: 114 YQL--LRGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 789 TQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
T+ T Y PE ++ + T D++S G + E+L GRR + GK V +++ ++
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILS 226
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-16
Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 29/158 (18%)
Query: 48 NNDPCGDN---WEGIGCTNSRVTSI-TLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRG 103
N DPC W G C + G+GL +N+ LRG
Sbjct: 393 NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGL--------------------DNQGLRG 432
Query: 104 PLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNL 163
+P I L+ L ++ L G S G IP S+GS+ L +L L+ N F+G +P S+G L++L
Sbjct: 433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492
Query: 164 YWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 201
L+L N L G +P + G + F+F N
Sbjct: 493 RILNLNGNSLSGRVPAALGGRL-----LHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 31/211 (14%)
Query: 636 VGSGGYGKVYK-----GTLPNGQLIAIKRAQQGSMQGGQE----FKMEIELLSRVHHKNL 686
+G GGYGKV++ G G++ A+K ++ ++ Q+ K E +L V H +
Sbjct: 4 LGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 687 VSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLD-----WIRRLKIALGAARGLS 740
V L+ + F G ++ LI E++ G L L + GI ++ ++ + +AL
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLSEISLALE------ 114
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLD 799
+LH+ II+RD+K NILLD + + K+ DFGL K S+ + H GT+ Y+
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMA 168
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
PE M + D +S G LM ++LTG P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-16
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN 685
++F +++G+G G V+K + LI ++ ++ + E+++L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+V G + GE + E + GSL L I + ++ IA+ +GL+YL E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 121
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
I+HRD+K SNIL++ R K+ DFG+S + DS + GT Y+ PE
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 176
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRPI 831
+ +SD++S G+ ++E+ GR PI
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 34/284 (11%)
Query: 636 VGSGGYGKVYKGTLPNGQLI---AIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLL 690
+G G +G V +G L I A+K + + ++F E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 691 GFCFDRGEQ------MLIYEFVPNGSLGD----SLSGKNGIRLDWIRRLKIALGAARGLS 740
G C E ++I F+ +G L S G L +K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
YL ++ IHRD+ + N +L+E +N VADFGLSK + + + K + ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
E + T KSDV+SFGV M E+ T G+ P Y E + D ++ L + D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP-----YPGVENSEIYDYLRQGNRLKQPPD 238
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
GL L C + DRP+ + ++E L
Sbjct: 239 CLDGL----------YSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 64/212 (30%), Positives = 112/212 (52%), Gaps = 21/212 (9%)
Query: 628 NNFSDANDVGSGGYGKVYKGT---LPNGQL---IAIKRAQQGSMQGGQEFKM-EIELLSR 680
NN S +G+G +GKV + T L +A+K + + +E M E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 681 V-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 739
+ +H+N+V+LLG C G ++I E+ G L + L K L L + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHITTQVKGT---- 794
++L A+ IHRD+ + N+LL K+ DFGL++ M+DS +++ VKG
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS--NYV---VKGNARLP 206
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 826
+ ++ PE T +SDV+S+G+L+ E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 37/282 (13%)
Query: 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVH 682
NF +G G + VYK L +G+++A+K+ Q M + Q+ EI+LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRL-KIALGAARGLS 740
H N++ L + E ++ E G L + K RL R + K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
++H I+HRDIK +N+ + K+ D GL + S S+ + V GT Y+ P
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV-GTPYYMSP 175
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID- 859
E KSD++S G L+ E+ + P DK LY+L + I+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------------GDKMN-LYSLCKKIEK 222
Query: 860 ------PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895
P S L+ DL +C+ + RP +S V
Sbjct: 223 CDYPPLPADHYSEELR------DLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-16
Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 18/168 (10%)
Query: 674 EIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW---IRRL 729
E+EL+ + HKN+++LLG C G +I E+ G+L + L + D+ I ++
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 730 -----------KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778
A ARG+ YL + IHRD+ + N+L+ E K+ADFGL++
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 826
+ D + T+ + + ++ PE + T +SDV+SFG+LM E+ T
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 46/252 (18%)
Query: 674 EIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR---- 728
E+E++ + HKN+++LLG C G +I E+ G+L + L + +++
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 729 ----------LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778
+ A ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT------GRRPIE 832
+ + TT + + ++ PE + T +SDV+SFGVL+ E+ T P+E
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 833 RGKYIVREIRTVMDKKKELYN-LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 891
+++E MDK N LY ++ C RPT
Sbjct: 250 ELFKLLKEGHR-MDKPSNCTNELYMMMR--------------------DCWHAVPSQRPT 288
Query: 892 MSEVVKDIENIL 903
++V+D++ IL
Sbjct: 289 FKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 73/226 (32%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELL 678
E + T+ + +G G YGKVYK T +G L A+K S +E + E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNIL 72
Query: 679 SRV-HHKNLVSLLGFCFDR-----GEQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLK 730
+ +H N+V G + G+ L+ E GS+ + + G G RLD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 731 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ 790
I GA GL +LH N IIHRD+K +NILL K+ DFG+S ++ S + T
Sbjct: 133 ILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTS 188
Query: 791 VKGTMGYLDPEYYMTQQLTEKS-----DVYSFGVLMLELLTGRRPI 831
V GT ++ PE +Q + S DV+S G+ +EL G P+
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 45/285 (15%)
Query: 634 NDVGSGGYGKVYKGTLPNGQLIA---IKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSL 689
+++G+G +GKV G G A +K + + Q F E++ ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRL--KIALGAARGLSYLHELA 746
LG C + +L+ EF P G L + L S + + + + ++A A GL +LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT--MGYLDPEYY- 803
IH D+ N L L+ K+ D+GL ++ +D+ T+ + +L PE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGL--ALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 804 ------MTQQLTEKSDVYSFGVLMLELLT-GRRP------IERGKYIVREIRTVMDKKKE 850
+ + T+KS+++S GV M EL T +P + K +VRE + K
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK--- 232
Query: 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895
P + L + +++ ++ C + + RPT EV
Sbjct: 233 ---------PQLDLKYS----DRWYEVMQFCWLDP-ETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 636 VGSGGYGKVYKGTL-PNGQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
+G G +G+V+ G L + +A+K ++ +F E +L + H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
+ ++ E V G L + G RL +++ AA G+ YL + IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIHR 118
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT----MGYLDPEYYMTQQLT 809
D+ + N L+ E+ K++DFG MS E+D + G + + PE + +
Sbjct: 119 DLAARNCLVTEKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 810 EKSDVYSFGVLMLE 823
+SDV+SFG+L+ E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-15
Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 629 NFSDANDVGSGGYGKVY---KGTLPN-GQLIAIKRAQQGSM----QGGQEFKMEIELLSR 680
NF +G+G YGKV+ K T + G+L A+K Q+ ++ + + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 681 VHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRL--KIALGAAR 737
V + L + F ++ LI ++V G + L ++ D +R +I L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA--- 117
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
L +LH+L I++RDIK NILLD + + DFGLSK EK+ T GT+ Y
Sbjct: 118 -LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEY 172
Query: 798 LDPEYYMTQQLTEKS-DVYSFGVLMLELLTGRRP 830
+ PE + K+ D +S G+L+ ELLTG P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 64/246 (26%), Positives = 116/246 (47%), Gaps = 34/246 (13%)
Query: 674 EIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI------ 726
E+E++ + HKN+++LLG C G ++ E+ G+L + L + +D+
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 727 --------RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778
+ A ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYI 837
+ + + TT + + ++ PE + T +SDV+SFGVL+ E+ T G P Y
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-----YP 238
Query: 838 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ + KE + + + + T L ++ +C RPT ++V+
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMR----------ECWHAVPSQRPTFKQLVE 288
Query: 898 DIENIL 903
D++ +L
Sbjct: 289 DLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 618 FSF-EEVKKYTNNFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-- 673
F F +EV KY +G G +G+V+K Q++A+K+ + + G F +
Sbjct: 5 FPFCDEVSKY----EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FPITA 58
Query: 674 --EIELLSRVHHKNLVSLLGFCF--------DRGEQMLIYEFVPNGSLGDSLSGKN-GIR 722
EI++L + H+N+V+L+ C +G L++EF + L LS KN
Sbjct: 59 LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFT 117
Query: 723 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782
L I+++ L GL Y+H I+HRD+K++NIL+ + K+ADFGL+++ S S
Sbjct: 118 LSEIKKVMKML--LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 783 EKDH---ITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERG 834
+ T +V T+ Y PE + + D++ G +M E+ T R PI +G
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQG 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 629 NFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSM---QGGQEFKM-EIELLSR 680
NF +G+G YGKV+ G G+L A+K ++ ++ E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 681 VHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 739
V + L + F ++ LI ++V G L L + +R + A L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA--L 118
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
+LH+L II+RDIK NILLD + + DFGLSK E++ GT+ Y+
Sbjct: 119 DHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMA 174
Query: 800 PEYYMTQQLTEKS--DVYSFGVLMLELLTGRRP 830
PE D +S GVL ELLTG P
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 67/209 (32%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 637 GSGGYGKV----YKGTLPNGQLIAIKRAQQGSMQGGQEF------KMEIELLSRVHHKNL 686
G G +GKV YK T G+L AIK ++G + E K E + H L
Sbjct: 8 GRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 687 VSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR---GLSYL 742
V+L CF + + + E+ G L I D + AA GL YL
Sbjct: 65 VNLFA-CFQTEDHVCFVMEYAAGGDL------MMHIHTDVFSEPRAVFYAACVVLGLQYL 117
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHITTQVKGTMGYLDPE 801
HE I++RD+K N+LLD K+ADFGL K M ++ T+ GT +L PE
Sbjct: 118 HE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAPE 171
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
T D + GVL+ E+L G P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 64/253 (25%), Positives = 115/253 (45%), Gaps = 20/253 (7%)
Query: 654 LIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712
L+A+K + + + +F EI+++SR+ + N++ LLG C +I E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 713 DSLSGK---------NGI-RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762
LS + N I + L +A+ A G+ YL L +HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLV 162
Query: 763 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLML 822
K+ADFG+S+++ + I + + ++ E + + T SDV++FGV +
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 823 ELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCV 882
E+ T + Y + V++ E + I LS T L ++C
Sbjct: 223 EMFT---LCKEQPYSLLSDEQVIENTGEFFRNQ---GRQIYLSQTPLCPSPVFKLMMRCW 276
Query: 883 QESGDDRPTMSEV 895
DRPT +++
Sbjct: 277 SRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHH---KNLVSLL 690
+G G YG VY+G +P G+++A+K + + + E+ LLS++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 691 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWI----RRLKIALGAARGLSYLHEL 745
G + +G ++ +I E+ GS+ +L I +I R + +AL Y+H++
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL------KYIHKV 120
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+IHRDIK++NIL+ N K+ DFG++ ++ + T GT ++ PE
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITE 175
Query: 806 -QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864
+ K+D++S G+ + E+ TG P R + + K G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYS-DVDAFRAMMLIPKSKPPRLEDN-------GY 227
Query: 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
S L+ F C+ E +R + E++K
Sbjct: 228 SKLLREFVAA------CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 639 GGYGKVYKGTL-----PNGQLIAIKR-AQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G +G+++ G L + + +K S E LL + H+N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 693 C-FDRGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
C D ++Y ++ G+L L N L + + +A+ A G+SYLH+
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+IH+DI + N ++DE L K+ D LS+ + + + + ++ E +
Sbjct: 137 G---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 806 QQLTEKSDVYSFGVLMLELLT 826
++ + SDV+SFGVL+ EL+T
Sbjct: 194 KEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 49/232 (21%)
Query: 629 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNL 686
+ + + +G G YG V T P G +AIK+ Q Q EI++L R H+N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 687 VSLLGF-CFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRLDWIRRLK----------- 730
+ +L E ++ E + D + +K
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMET---------------DLYKLIKTQHLSNDHIQY 110
Query: 731 ----IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786
I G L Y+H AN ++HRD+K SN+LL+ + K+ DFGL++ +D E DH
Sbjct: 111 FLYQILRG----LKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDH 162
Query: 787 --ITTQVKGTMGYLDPEYYMTQQLTEKS-DVYSFGVLMLELLTGRRPIERGK 835
T+ T Y PE + + K+ D++S G ++ E+L+ RP+ GK
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 636 VGSGGYGKVYKGTLP----NGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
+G G +G V + L + Q +A+K +A S +EF E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 690 LGFCFDRGEQ------MLIYEFVPNGSLGD----SLSGKNGIRLDWIRRLKIALGAARGL 739
+G + M+I F+ +G L S G+ L ++ + A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
YL ++ IHRD+ + N +L+E + VADFGLSK + + K + +L
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
E T SDV++FGV M E++T G+ P
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 62/266 (23%), Positives = 112/266 (42%), Gaps = 33/266 (12%)
Query: 644 VYKGTLPNGQLIAI---KRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700
+YKG N + + I K+ +G + EI+ L R+ N++ + GF D + +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 701 ----LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
LI E+ G L + L L + +L +A+ +GL L++ N P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDV 814
S + L+ E K+ GL K +S ++ M Y + + T K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNF-----MVYFSYKMLNDIFSEYTIKDDI 205
Query: 815 YSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 874
YS GV++ E+ TG+ P E KE+Y+L +I+ L L +
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTT------------KEIYDL--IINKNNSLKLPLDCPLEI 251
Query: 875 VDLALKCVQESGDDRPTMSEVVKDIE 900
+ C RP + E++ ++
Sbjct: 252 KCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 71/238 (29%), Positives = 111/238 (46%), Gaps = 30/238 (12%)
Query: 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQ---GSMQGGQEFKMEI 675
F V + TN + D VG G +G V GQ +AIK+ + + + ++ E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-EL 60
Query: 676 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK----- 730
+LL + H+N++SL E IY FV L G + RL R L+
Sbjct: 61 KLLKHLRHENIISLSDIFISPLED--IY-FV------TELLGTDLHRLLTSRPLEKQFIQ 111
Query: 731 -IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 789
RGL Y+H ++HRD+K SNIL++E + K+ DFGL++ +D T
Sbjct: 112 YFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMT 163
Query: 790 QVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
T Y PE +T Q+ + D++S G + E+L G +P+ GK V + + D
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQFSIITD 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 58/223 (26%), Positives = 112/223 (50%), Gaps = 16/223 (7%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQ--GGQEFKM-EIELLSRVHHKNLVSLLG 691
+G GG+G+V + N G++ A K+ + ++ G++ + E E+L +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ F+ + L+ + G L + L+ R + + G+ +LH + I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---I 116
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
++RD+K N+LLD++ N +++D GL+ + D + TQ GT GY+ PE + +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSY 173
Query: 811 KSDVYSFGVLMLELLTGRRPIERGKYIVRE----IRTVMDKKK 849
D ++ G + E++ GR P + K V + RT+ D+ K
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 39/277 (14%)
Query: 630 FSDANDVGSGGYGKVYKGTLPNGQ-LIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 687
F+ +G G +G+V+KG Q ++AIK + ++ + EI +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
G + +I E++ GS D L LD + I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 122
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK-----GTMGYLDPEY 802
IHRDIK++N+LL E K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862
K+D++S G+ +EL G P + + K L+ + + PT+
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPP-----------HSELHPMKVLFLIPKNNPPTL 221
Query: 863 --GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
S LK F + C+ + RPT E++K
Sbjct: 222 EGNYSKPLKEFVE------ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSM-QGGQE--FKMEIELLSRVHHKNLVS 688
+G G +G+V+ K T GQ+ A+K ++ M + Q + E ++L+ +V
Sbjct: 9 IGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 689 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L + F D L+ E++P G L + L K+ + R L A L +H+L
Sbjct: 66 LY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA--LDSVHKLG- 121
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD---------------------- 785
IHRDIK NIL+D + K+ADFGL K M+ ++
Sbjct: 122 --FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 786 -----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
GT Y+ PE + D +S GV++ E+L G P
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 636 VGSGGYGK-VYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGF 692
+G G +GK + + +G+ IK M +E + E+ +LS + H N+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIR------LDWIRRLKIALGAARGLSYLHELA 746
+ G ++ ++ G L ++ + G+ LDW ++ +AL ++H+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHDRK 121
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
I+HRDIKS NI L + K+ DFG+++ ++ + + + GT YL PE +
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENR 176
Query: 807 QLTEKSDVYSFGVLMLELLTGRRPIERG 834
KSD+++ G ++ E+ T + E G
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 31/243 (12%)
Query: 635 DVGSGGYGKVYKG---TLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 689
++GSG +G V KG + + +A+K + + E E ++ ++ + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 690 LGFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
+G C E ML+ E G L L + I L + G+ YL E
Sbjct: 62 IGIC--EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL--VHQVSMGMKYLEE---T 114
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-ITTQVKGTMGYLDPEYYMTQQ 807
+HRD+ + N+LL + AK++DFGLSK++ E + T K + + PE +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 808 LTEKSDVYSFGVLMLELLT-GRRP------------IERGKYIVREIRTVMDKKKELYNL 854
+ KSDV+SFGVLM E + G++P IE G+ + E+Y+L
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE----RMECPQRCPPEMYDL 230
Query: 855 YEL 857
+L
Sbjct: 231 MKL 233
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 630 FSDANDVGSGGYGKVYKGTLPNG-QLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 687
F+ +G G +G+VYKG +++AIK + ++ + EI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
G + +I E++ GS D L K G L+ I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL--KPG-PLEETYIATILREILKGLDYLHSERK 122
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK-----GTMGYLDPEY 802
IHRDIK++N+LL E+ + K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
K+D++S G+ +EL G P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 635 DVGSGGYGKVYKG-TLPNG-QLIAIKRAQQGSMQGGQEFKM--EIELLSRVH---HKNLV 687
++G G YGKV+K L NG + +A+KR + + + G E+ +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 688 SLLGFCF----DRGEQM-LIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLS 740
L C DR ++ L++E V + L L + G+ + I+ + L RGL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLD 124
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
+LH + ++HRD+K NIL+ K+ADFGL++ S T V T+ Y P
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAP 178
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
E + D++S G + E+ R+P+ RG V ++ ++D
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILD 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRV 681
KKYT +G G G VY + GQ +AIK+ Q +E + EI ++
Sbjct: 19 KKYTR----FEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMREN 73
Query: 682 HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 741
H N+V+ L E ++ E++ GSL D ++ + +IA L
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQA 127
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
L L + +IHRDIKS NILL + K+ DFG ++ E+ +T V GT ++ PE
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-GTPYWMAPE 185
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ K D++S G++ +E++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 72/279 (25%), Positives = 130/279 (46%), Gaps = 45/279 (16%)
Query: 635 DVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
++G G +GKVYK G L A K S + +++ +EI++L+ H N+V LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK------IALGAARGLSYLHELAN 747
+ ++ EF G++ + + L+ R L + L+YLHE
Sbjct: 72 YYENNLWILIEFCAGGAV-------DAVMLELERPLTEPQIRVVCKQTLEALNYLHE--- 121
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK----GTMGYLDPEYY 803
IIHRD+K+ NIL + K+ADFG+S K+ T Q + GT ++ PE
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 804 MTQQLTE-----KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858
M + + K+DV+S G+ ++E+ IE + + +R ++ K
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQ----IEPPHHELNPMRVLLKIAKS-------- 223
Query: 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+P L+ + ++ D KC++++ D R T +++++
Sbjct: 224 EPPT-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 43/121 (35%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
+H + + +IHRDIKS+NILL K+ DFG SK + + D + GT Y+ PE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861
+ + ++K+D++S GVL+ ELLT +RP + + VM K L Y+ + P+
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-----ENMEEVM--HKTLAGRYDPLPPS 268
Query: 862 I 862
I
Sbjct: 269 I 269
|
Length = 496 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 29/231 (12%)
Query: 612 LKGARCFSFEEVKKYT-NNFSDANDVGSGGYGKV----YKGTLPNGQLIAIK---RAQQG 663
+K A F+ + + ++F +G+G +G+V +KGT G+ AIK + +
Sbjct: 1 MKAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREIL 57
Query: 664 SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--SGK--N 719
M+ Q E +L + H +V+++ D + EFV G L L +G+ N
Sbjct: 58 KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN 117
Query: 720 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779
+ + L +A YLH II+RD+K N+LLD + + KV DFG +K +
Sbjct: 118 DVAKFYHAELVLAF------EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168
Query: 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
D T + GT YL PE ++ + D ++ GVL+ E + G P
Sbjct: 169 PDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 60/263 (22%), Positives = 117/263 (44%), Gaps = 41/263 (15%)
Query: 654 LIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712
L+A+K ++ + + + +F EI+++SR+ N++ LL C +I E++ NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 713 DSLS---------GKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763
LS + + + + + +A A G+ YL L +HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164
Query: 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 823
+ K+ADFG+S+++ + I + + ++ E + + T SDV++FGV + E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 824 LLT-----------GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
+LT + IE R D+ +++Y + P +
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGEFFR------DQGRQVYLPKPALCP-----------D 267
Query: 873 KYVDLALKCVQESGDDRPTMSEV 895
L L C + + +RP+ E+
Sbjct: 268 SLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 28/260 (10%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 682
++Y ++F +G G G V T + G+ +A+K+ Q + E+ ++ H
Sbjct: 21 REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
H+N+V + E ++ EF+ G+L D ++ R++ + + L R LSYL
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYL 134
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H N +IHRDIKS +ILL K++DFG +S + GT ++ PE
Sbjct: 135 H---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPEV 189
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPI--ERGKYIVREIRTVMDKK-KELYNLYELID 859
+ D++S G++++E++ G P E +R IR + + K+ +
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHK------ 243
Query: 860 PTIGLSTTLKGFEKYVDLAL 879
+S+ L+GF +DL L
Sbjct: 244 ----VSSVLRGF---LDLML 256
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 35/209 (16%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM--------EIELLSRV-HHKN 685
+G G +G VY G+L+AIK+ M+ ++F E++ L ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKK-----MK--KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+V L + E ++E++ G+L + + G I +GL+++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE---- 801
HRD+K N+L+ K+ADFGL++ + + T V T Y PE
Sbjct: 119 G---FFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYV-STRWYRAPEILLR 172
Query: 802 --YYMTQQLTEKSDVYSFGVLMLELLTGR 828
Y + D+++ G +M EL T R
Sbjct: 173 STSY-----SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 636 VGSGGYGKV----YKGTLPNGQLIAIKR------AQQGSMQGGQEFKMEIELLSRVHHKN 685
+G G +GKV KGT +L A+K Q ++ K + L + H
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPF 57
Query: 686 LVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
L L CF +++ + E+V G L + R D R A GL +LHE
Sbjct: 58 LTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE 114
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYY 803
II+RD+K N+LLD + K+ADFG+ K + T+ GT Y+ PE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEIL 168
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRPIE 832
Q D ++ GVL+ E+L G+ P E
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 688
VG GGYG+V+ K T G+++A+KR ++ + E + E ++L+ + LV
Sbjct: 9 VGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
LL + F E + L E+VP G L+ + D R + A + LHEL
Sbjct: 66 LL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALHELG- 121
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
IHRD+K N L+D + K+ DFGLSK + V G+ Y+ PE +
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKG 174
Query: 808 LTEKSDVYSFGVLMLELLTGRRP 830
D +S G ++ E L G P
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 629 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHK 684
+F +GSG YG VYK + G+L AIK + ++ G++F + EI ++ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGD--SLSGKNGIRLDWIRRLKIALGAARGLSYL 742
N+V+ G R + + EF GSL D ++G + +IA + L L
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP-------LSESQIAYVSRETLQGL 119
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS---EKDHITTQVKGTMGYLD 799
+ L + +HRDIK +NILL + + K+ADFG+S ++ + K I GT ++
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMA 174
Query: 800 PEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPI 831
PE ++ + D+++ G+ +EL + P+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 629 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQ-QGSMQGGQEFKM-EIELLSRVHHKN 685
NF +G G YG VYK G+++A+K+ + +G + EI LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLG---DSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
+V LL + L++EF+ + L D+ +GI L I+ L +GL++
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPLIKSYLFQL--LQGLAFC 116
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE- 801
H + ++HRD+K N+L++ K+ADFGL+++ + + V T+ Y PE
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 171
Query: 802 -----YYMTQQLTEKSDVYSFGVLMLELLTGR 828
YY T D++S G + E++T R
Sbjct: 172 LLGCKYYST-----AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-14
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 21/190 (11%)
Query: 654 LIAIKRAQQGSMQGGQ-EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712
L+A+K + + + + +F E+++LSR+ N++ LLG C D +I E++ NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 713 DSLSGKN-----------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
LS + + + L +AL A G+ YL L +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 815
+ N L+ E L K+ADFG+S+++ + I + + ++ E + + T SDV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 816 SFGVLMLELL 825
+FGV + E+L
Sbjct: 225 AFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 636 VGSGGYGKVYKG---TLPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHHKNLVS 688
+G G YG+VYK +G+ AIK+ + Q EI LL + H+N+VS
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-TGISQSACREIALLRELKHENVVS 66
Query: 689 LLGFCFDRGEQM--LIYEFVPNGSLGDSL------SGKNGIRLD--WIRRLKIALGAARG 738
L+ + ++ L++++ + D + + ++ L + G
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQI--LNG 120
Query: 739 LSYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLS-------KSMSDSEKDHI 787
+ YLH +N ++HRD+K +NIL+ ER K+ D GL+ K ++D +
Sbjct: 121 VHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP--- 174
Query: 788 TTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
V T+ Y PE + + T+ D+++ G + ELLT PI +G+
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 71/231 (30%), Positives = 112/231 (48%), Gaps = 43/231 (18%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 691
VGSG YG+V G+ +AIK R Q ++ + ++ E+ LL + H+N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 692 FCFDRGEQM-------LIYEFVPNGSLGDSLSGKNGI----RL--DWIRRLKIALGAARG 738
F + L+ + G L N I +L D I+ L + RG
Sbjct: 82 -VFTPASSLEDFQDVYLVTHLM-----GADL---NNIVKCQKLSDDHIQFLVYQI--LRG 130
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
L Y+H A IIHRD+K SNI ++E K+ DFGL++ +D E +T V T Y
Sbjct: 131 LKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDE---MTGYV-ATRWYR 182
Query: 799 DPE---YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
PE +M + D++S G +M ELLTG + + G + +++ +M+
Sbjct: 183 APEIMLNWM--HYNQTVDIWSVGCIMAELLTG-KTLFPGSDHIDQLKRIMN 230
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 13/211 (6%)
Query: 629 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNL 686
NF +G G Y VYKG G+++A+K + +G + EI L+ + H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 687 VSLLGFCFDRGEQMLIYEFVPNG--SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
V L + ML++E++ D+ + + + ++ L +G+++ HE
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHE 118
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
++HRD+K N+L+++R K+ADFGL+++ V T+ Y P+ +
Sbjct: 119 ---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL 173
Query: 805 TQQLTEKS-DVYSFGVLMLELLTGRRPIERG 834
+ S D++S G +M E++TG RP+ G
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG-RPLFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 629 NFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN 685
+++ +G G YG VYKG GQ++A+K+ + S + G EI LL + H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+V L LI+EF+ S+ K LD + + + + A SYL+++
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-------SMDLKK--YLDSLPKGQ-YMDAELVKSYLYQI 110
Query: 746 ANP-------PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
++HRD+K N+L+D + K+ADFGL+++ + + T T+ Y
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYR 168
Query: 799 DPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERG 834
PE + + + + D++S G + E+ T ++P+ G
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 39/214 (18%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
VGSG YG VYK L G+L A+K + ++ G +F + EI ++ H N+V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 692 FCFDRGEQMLIYEFVPNGSLGD--SLSGKNGIRLDWIRRLKIAL---GAARGLSYLHELA 746
R + + E+ GSL D ++G + L+IA +GL+YLH
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSKG 126
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
+HRDIK +NILL + + K+ADFG++ IT + ++ Y+M
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAK--------ITATIAKRKSFIGTPYWMAP 175
Query: 807 QLT--EKS-------DVYSFGVLMLELLTGRRPI 831
++ EK+ D+++ G+ +EL + P+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 40/291 (13%)
Query: 628 NNFSDAND-------VGSGGYGKVYK-GTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLS 679
++F D +D +G G YGKV+K NG A+K +E + E +L
Sbjct: 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILK 69
Query: 680 RVH-HKNLVSLLGFCFDR----GEQM-LIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKI 731
+ H N+V G + + G+Q+ L+ E GS+ D + G K G R++ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
A GL +LH IHRD+K +NILL K+ DFG+S ++ + T+
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 185
Query: 792 KGTMGYLDPEYYMTQQ-----LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
GT ++ PE +Q + DV+S G+ +EL G P+ +
Sbjct: 186 -GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD-----------LH 233
Query: 847 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ L+ + PT+ ++ D KC+ + + RPT+S++++
Sbjct: 234 PMRALFKIPRNPPPTLHQPELWSN--EFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 682
+ Y +NF +G G G V T+ +G+L+A+K+ Q + E+ ++
Sbjct: 19 RTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
H+N+V + E ++ EF+ G+L D ++ R++ + + L + LS L
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVL 132
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H +IHRDIKS +ILL K++DFG +S + GT ++ PE
Sbjct: 133 HAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPEL 187
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ D++S G++++E++ G P
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 634 NDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
+++G G YG VYK P G +A+K R + + Q ME+++L + +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ-IIMELDILHKAVSPYIVDFY 65
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSG----KNGIRLDWIRRLKIALGAARGLSYLHELA 746
G F G + E++ GSL D L GI D +RR I +GL +L E
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEH 122
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPEYY-- 803
N IIHRD+K +N+L++ K+ DFG+S ++ S K +I G Y+ PE
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKS 175
Query: 804 --MTQQLTE--KSDVYSFGVLMLELLTGRRP 830
Q T +SDV+S G+ +LE+ GR P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 54/220 (24%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 635 DVGSGGYGKVYKGTL------PNGQLIAIKRAQ---QGSMQGGQEFKMEIELLSRVHHKN 685
++G +GKVYKG L Q +AIK + +G ++ +EFK E + SR+ H N
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPN 69
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKI 731
+V LLG +I+ + + L + L ++ L+ + I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
A G+ + L++ ++H+D+ + N+L+ ++LN K++D GL + + ++ +
Sbjct: 130 VTQIAAGMEF---LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
+ ++ PE M + + SD++S+GV++ E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 635 DVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKM--EIELLSRVH---HKNLVS 688
++G G YG VYK P+ G +A+K + + + G E+ LL R+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 689 LLGFC----FDRGEQM-LIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSY 741
L+ C DR ++ L++E V + L L G+ + I+ L RGL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDF 123
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
LH AN I+HRD+K NIL+ K+ADFGL++ S T V T+ Y PE
Sbjct: 124 LH--ANC-IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPE 177
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRPI 831
+ D++S G + E+ R+P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 2e-13
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 682
KKYT +G G G V+ + GQ +AIK+ + EI ++ +
Sbjct: 19 KKYTR----YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
+ N+V+ L E ++ E++ GSL D ++ +D + + + L +L
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFL 131
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H AN +IHRDIKS N+LL + K+ DFG ++ E+ +T V GT ++ PE
Sbjct: 132 H--ANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-GTPYWMAPEV 186
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ K D++S G++ +E++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-13
Identities = 43/105 (40%), Positives = 64/105 (60%), Gaps = 9/105 (8%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM--SDSEKDHITTQVKGT 794
RGL YLH AN +IHRD+K SNIL++ + K+ DFGL++ + + EK +T V T
Sbjct: 114 RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169
Query: 795 MGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGK-YI 837
Y PE ++ + T+ D++S G + ELLT R+P+ G+ YI
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYI 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIKRAQ-QGSMQGGQEFKM-EIELLSRVHHKNLVSLLGF 692
+G G YG V+K +++A+KR + +G + EI LL + HKN+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 693 CFDRGEQMLIYEFVPNG--SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ L++E+ DS +G I + ++ L +GL++ H +
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGD--IDPEIVKSFMFQL--LKGLAFCHS---HNV 120
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
+HRD+K N+L+++ K+ADFGL+++ + + V T+ Y P+ +L
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 178
Query: 811 KS-DVYSFGVLMLELLTGRRPIERGK 835
S D++S G + EL RP+ G
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGN 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKM-EIELLSRVHHKNLVSLLG 691
+G G +GKV+ L Q AIK ++ M E M E +LS ++ L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 692 FCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
F E + + E++ G L + + + D R A GL +LH I
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---I 117
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
++RD+K NILLD + K+ADFG+ K +M K T GT Y+ PE + Q+
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPEILLGQKYN 174
Query: 810 EKSDVYSFGVLMLELLTGRRP 830
D +SFGVL+ E+L G+ P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLG 691
VG+G +G+V+ + A+K ++ Q E +L V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSL--SGK--NGIRLDWIRRLKIALGAARGLSYLHELAN 747
D+ ++ E+VP G L L SG+ N L + + AL YLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL------EYLHSKE- 121
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
I++RD+K NILLD+ + K+ DFG +K + D T + GT YL PE ++
Sbjct: 122 --IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKG 174
Query: 808 LTEKSDVYSFGVLMLELLTGRRP 830
+ D ++ G+L+ E+L G P
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGF 692
+G G YG VYK G+++A+K+ + + G EI LL ++H N+V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 693 CFDRGEQMLIYEF-----------VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 741
+ L++EF P L L +L +G++Y
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL------------LQGIAY 114
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
H + ++HRD+K N+L+D K+ADFGL+++ + + T +V T+ Y PE
Sbjct: 115 CH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPE 169
Query: 802 YYM-TQQLTEKSDVYSFGVLMLELLTGRRPI 831
+ ++Q + D++S G + E++ RRP+
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKM-EIELLSRVHHKNLVSLLG 691
+G G +GKV L +G+L A+K ++ + E M E +LS + ++ L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 692 FCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
CF +++ + EFV G L + + R D R A L +LH+ I
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKG---I 117
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYYMTQQLT 809
I+RD+K N+LLD + K+ADFG+ K + + TT GT Y+ PE
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 810 EKSDVYSFGVLMLELLTGRRPIE 832
D ++ GVL+ E+L G P E
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-13
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 22/170 (12%)
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
L E+ + ++HRD+KS+NI L K+ DFG SK SDS + + GT YL PE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP- 860
+ ++ ++K+D++S GV++ ELLT RP + REI ++ LY Y DP
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIM-----QQVLYGKY---DPF 291
Query: 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVKDIENILQQ 905
+S+ +K L + ++ RPT +E +K + N+ Q
Sbjct: 292 PCPVSSGMKA------LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 37/225 (16%)
Query: 637 GSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHHKNLVSLLG 691
G G +G+VYK + G+++A+K+ + + G F + EI++L ++ H N+V L+
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FPITALREIKILKKLKHPNVVPLID 74
Query: 692 FCFDRGEQML-----IYEFVP------NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 740
+R ++ +Y P +G L + ++L + L G++
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-----PSVKLTESQIKCYMLQLLEGIN 129
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS---------EKDHITTQV 791
YLHE I+HRDIK++NIL+D + K+ADFGL++ T +
Sbjct: 130 YLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 792 KGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
T Y PE + ++ T D++ G + E+ T RRPI +GK
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 629 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
+ +G G G V T G+ +A+K+ Q + E+ ++ H N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
+ E ++ EF+ G+L D ++ R++ + + L + LS+LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---A 133
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK---GTMGYLDPEYYM 804
+IHRDIKS +ILL K++DFG +S + K GT ++ PE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMAPEVIS 188
Query: 805 TQQLTEKSDVYSFGVLMLELLTGRRP 830
+ D++S G++++E++ G P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 691
+G G +GKV + T L I++A S E +L++V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
F F E++ L+ F+ G L L + G R D R L LH+ +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQ-REG-RFDLSRARFYTAELLCALENLHKFN---V 114
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
I+RD+K NILLD + + + DFGL K +M D +K T GT YL PE + T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPELLLGHGYT 171
Query: 810 EKSDVYSFGVLMLELLTGRRP 830
+ D ++ GVL+ E+LTG P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 636 VGSGGYGKVYKG--TLPNGQ--LIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLL 690
+G+G +G++ +G LP+ + +AI + G + F E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G M++ E++ NG+L DS K+ +L + + + G A G+ YL E+
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---Y 128
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
+H+ + + +L++ L K++ F + SE + T K + + PE +
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187
Query: 811 KSDVYSFGVLMLELLT-GRRP 830
SDV+SFG++M E+++ G RP
Sbjct: 188 ASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 62/221 (28%), Positives = 112/221 (50%), Gaps = 30/221 (13%)
Query: 629 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHH 683
+ N + G YG VY+ G+++A+K+ + + G F + EI +L ++ H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG--FPITSLREINILLKLQH 63
Query: 684 KNLVSL----LGFCFDRGEQMLIY---EFVPNGSLGDSLS-GKNGIRLDWIRRLKIALGA 735
N+V++ +G D+ IY E+V + L + K ++ L + L
Sbjct: 64 PNIVTVKEVVVGSNLDK-----IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQL-- 115
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 795
G+++LH+ I+HRD+K+SN+LL+ R K+ DFGL++ K + TQ+ T+
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTL 170
Query: 796 GYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
Y PE + ++ + D++S G + ELLT ++P+ GK
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 629 NFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSM----QGGQEFKMEIELLSR 680
NF +G+G YGKV+ +G+L A+K ++ ++ + + + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 681 VHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA-ARG 738
+ + L + F ++ LI +++ G L LS + + + ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE---QEVQIYSGEIVLA 117
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
L +LH+L II+RDIK NILLD + + DFGLSK + E + GT+ Y+
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIEYM 173
Query: 799 DPEYYMTQQLTEKS--DVYSFGVLMLELLTGRRP 830
P+ D +S GVLM ELLTG P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 56/211 (26%), Positives = 109/211 (51%), Gaps = 13/211 (6%)
Query: 636 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+G GG+G+V + G++ A K+ ++ ++ + M E ++L +V+ + +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ ++ + + L+ + G L + + R + A GL LH+ I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERI 123
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
++RD+K NILLD+ + +++D GL+ + + + I +V GT+GY+ PE ++ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTF 180
Query: 811 KSDVYSFGVLMLELLTGRRPI-ERGKYIVRE 840
D ++ G L+ E++ G+ P +R K I RE
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 37/280 (13%)
Query: 629 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHK 684
NF +G G + +VY+ T L + + +A+K+ Q M + Q+ EI+LL +++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRL-KIALGAARGLSYL 742
N++ L + E ++ E G L + K RL R + K + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H + ++HRDIK +N+ + K+ D GL + S K + GT Y+ PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID--- 859
KSD++S G L+ E+ + P K L++L + I+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-------------YGDKMNLFSLCQKIEQCD 224
Query: 860 ----PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895
PT S EK +L C+ D RP + V
Sbjct: 225 YPPLPTEHYS------EKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLGFC 693
+G G Y V+KG + L+A+K + +G + E+ LL + H N+V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL-GAARGLSYLHELANPPIIH 752
L++E++ + L L N L + +KI + RGLSY H+ I+H
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLD--NCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILH 126
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEK 811
RD+K N+L++E+ K+ADFGL+++ S K + V T+ Y P+ + + + +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYSTP 184
Query: 812 SDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 844
D++ G ++ E+ TG RP+ G + E+ +
Sbjct: 185 IDMWGVGCILYEMATG-RPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 682
KKYT +G G G VY + GQ +AIK+ + EI ++
Sbjct: 19 KKYTR----FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
+ N+V+ L E ++ E++ GSL D ++ +D + + + L +L
Sbjct: 75 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFL 131
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H + +IHRDIKS NILL + K+ DFG ++ E+ +T V GT ++ PE
Sbjct: 132 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-GTPYWMAPEV 186
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ K D++S G++ +E++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKM-EIELLSRVHHKNLVSLLG 691
+G G +GKV L G+ A+K ++ + E M E +L+ ++ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 692 FCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
F E + + EF+ G L + K R D R A GL +LH + I
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLH---SKGI 117
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
I+RD+K N++LD + K+ADFG+ K + D+ + GT Y+ PE + T
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 811 KSDVYSFGVLMLELLTGRRP 830
D +SFGVL+ E+L G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 628 NNFSDANDVGSGGYGKVYKG-TLPNGQLIAIK--RAQQGSMQGGQEFKM--EIELLSRVH 682
+++ +G G Y VYKG + NG+L+A+K R Q+ + G F E LL +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLK 61
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
H N+V L + L++E+V G+ + ++ L RGLSY+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYI 119
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H+ I+HRD+K N+L+ + K+ADFGL++ + S H + T+ Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 803 YM-TQQLTEKSDVYSFGVLMLELLTG 827
+ + + + D++ G + +E++ G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 682
KKYT +G G G VY + GQ +AI++ + EI ++
Sbjct: 20 KKYTR----FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
+ N+V+ L E ++ E++ GSL D ++ +D + + + L +L
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFL 132
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H + +IHRDIKS NILL + K+ DFG ++ + + + GT ++ PE
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 187
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ K D++S G++ +E++ G P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 636 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLG 691
+G GG+G+V + G+L A K+ + + +G + +E +L++VH + +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 692 FCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+ F + + + NG GD ++ +N R GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNG--GDLRYHIYNVDEENP-GFPEPRACFYTAQIISGLEHLHQ- 115
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
II+RD+K N+LLD N +++D GL+ + D + T GT G++ PE
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRPIER 833
++ D ++ GV + E++ R P
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 61/240 (25%), Positives = 104/240 (43%), Gaps = 41/240 (17%)
Query: 619 SFEEVKKYT--NNFSDANDVGSGGYGKVYKG-TLPNGQLIAIKR------------AQQG 663
SF ++Y +G G YGKV K G+++AIK+ +Q
Sbjct: 3 SFSISERYIQKGAH-----LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQL 57
Query: 664 SMQGGQEFKM--EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI 721
G F E+++++ + H+N++ L+ + L+ + + L + K I
Sbjct: 58 VGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--I 114
Query: 722 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS--- 778
RL + I L GL+ LH +HRD+ +NI ++ + K+ADFGL++
Sbjct: 115 RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGY 171
Query: 779 --MSDSEKDHITTQVKG-------TMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGR 828
SD+ T Q + T+ Y PE M ++ D++S G + ELLTG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 54/209 (25%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 636 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+G GG+G+V + G++ A K+ ++ ++ + M E +L +V+ + +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ ++ + + L+ + G L + D R + A GL L I
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERI 123
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
++RD+K NILLD+R + +++D GL+ + + E + +V GT+GY+ PE ++ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTF 180
Query: 811 KSDVYSFGVLMLELLTGRRPIERGKYIVR 839
D + G L+ E++ G+ P + K V+
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVK 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
GL +LH+ II+RD+K N+LLD+ + K+ADFG+ K + E + GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDY 162
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ PE Q+ E D +SFGVL+ E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 42/110 (38%), Positives = 64/110 (58%), Gaps = 7/110 (6%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
RGL Y+H AN ++HRD+K SN+LL+ + K+ DFGL++ + SEK T+ T
Sbjct: 119 RGLKYIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 797 YLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 845
Y PE + + T DV+S G + ELL GR+P+ GK V +++ +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLIT 222
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 25/227 (11%)
Query: 630 FSDANDVGSGGYGKV-YKGTLPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKN 685
+ D VGSG YG V G +AIK R Q + + ++ E+ LL + H+N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75
Query: 686 LVSLLG-FCFDRG-----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 739
++ LL F D + L+ F+ LG + + +L R + +GL
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGL 131
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
Y+H IIHRD+K N+ ++E K+ DFGL++ +DSE T T Y
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSE----MTGYVVTRWYRA 183
Query: 800 PEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 845
PE + T+ D++S G +M E+LTG +P+ +G + ++ +M
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLMEIM 229
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 636 VGSGGYGKVYKGTL----PNGQLIAIKRA--QQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
VG G YG+V +L +G+ IK+ + S + + + E +LLS++ H N+V+
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 690 LGFCFDRGEQMLIY---EFVPNGSLGDSLSGKNGIRL------DWIRRLKIALGAARGLS 740
GE L+Y F G L L + G L +W ++ +AL
Sbjct: 65 RESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------Q 116
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
YLHE I+HRD+K+ N+ L KV D G+++ + +++ D +T + GT Y+ P
Sbjct: 117 YLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLI-GTPYYMSP 171
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLT 826
E + + KSDV++ G + E+ T
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 636 VGSGGYGKVYKGTLPNG--QLIAIKRAQQGSMQGGQEFK----------MEIELL-SRVH 682
+GSG +G VYK N L+A+K + G++ + E+ ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD---SLSGKNGIRLDWIRRLKIALGAARGL 739
H N+V + ++ + + LG+ SL K R R I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ-RFTEERIWNIFVQMVLAL 126
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
YLH+ I+HRD+ +NI+L E + DFGL+K K T V GT+ Y
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSC 181
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLT 826
PE + EK+DV++FG ++ ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 634 NDVGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLG 691
+ +G G Y VYKG + L+A+K + +G + E+ LL + H N+V+L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
L++E++ + L L N I + ++ L RGL+Y H +
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL--LRGLNYCHR---RKV 125
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLT 809
+HRD+K N+L++ER K+ADFGL+++ S K + V T+ Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYS 183
Query: 810 EKSDVYSFGVLMLELLTGRRPIERGKYIVREI 841
+ D++ G + E+ TG RP+ G + ++
Sbjct: 184 TQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 38/287 (13%)
Query: 636 VGSGGYGKVYK-GTLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+G G YG V+K GQ++AIK+ + S K+ EI +L ++ H NLV+L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
F R ++ L++E+ + L + G+ I+ KI + +++ H+
Sbjct: 68 -VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK--KIIWQTLQAVNFCHKHN---C 121
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLT 809
IHRD+K NIL+ ++ K+ DFG ++ ++ D+ T T Y PE + Q
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQYG 179
Query: 810 EKSDVYSFGVLMLELLTGRRPIERGK------YIVREIRTVMD---------KKKELYNL 854
DV++ G + ELLTG +P+ GK Y++R +T+ D + +
Sbjct: 180 PPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIR--KTLGDLIPRHQQIFSTNQFFKG 236
Query: 855 YELIDPTIGLSTTLKGFEKYVDLAL----KCVQESGDDRPTMSEVVK 897
+ +P K F AL C+Q +R + E+++
Sbjct: 237 LSIPEPETREPLESK-FPNISSPALSFLKGCLQMDPTERLSCEELLE 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
RGL YLH A I+HRDIK N+L++ K+ DFGL++ E H+T +V T
Sbjct: 114 RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 797 YLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGR 828
Y PE M ++ T D++S G + ELL R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/225 (25%), Positives = 112/225 (49%), Gaps = 14/225 (6%)
Query: 636 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+G GG+G+V + G++ A KR ++ ++ + M E ++L +V+ + +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ ++ + + L+ + G L + + R L A GL LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENT 123
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
++RD+K NILLD+ + +++D GL+ + E + I +V GT+GY+ PE Q+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKI--PEGESIRGRV-GTVGYMAPEVLNNQRYTL 180
Query: 811 KSDVYSFGVLMLELLTGRRPIERGKYIVR--EIRTVMDKKKELYN 853
D + G L+ E++ G+ P K V+ E+ + + +E+Y+
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 49/169 (28%), Positives = 71/169 (42%), Gaps = 21/169 (12%)
Query: 674 EIELLSRVH-----HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 728
IE + VH + N + L +LI +++ +G L D L K +L
Sbjct: 56 AIEPM--VHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEV 111
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSM-SDSEKDH 786
KI L+ LH IIH DIK N+L D + + D+GL K + + S D
Sbjct: 112 KKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD- 167
Query: 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
GT+ Y PE D ++ GVL ELLTG+ P + +
Sbjct: 168 ------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-11
Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 29/209 (13%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKR---AQQGSMQGGQEFKMEIELLSRV-HHKNLVSLL 690
+G G YG V+K +++A+K+ A + + + F+ EI L + H N+V LL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 691 GFCFDRGEQM----LIYEFVPNGSLGDS-LSG--KNGIRLDWIRRLKIALGAARGLSYLH 743
+ E L++E++ ++ L + I D + + I + L Y+H
Sbjct: 74 NVI--KAENDKDIYLVFEYM------ETDLHAVIRANILED-VHKRYIMYQLLKALKYIH 124
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS---MSDSEKDHITTQVKGTMGYLDP 800
N +IHRD+K SNILL+ K+ADFGL++S + ++ ++ + T T Y P
Sbjct: 125 S-GN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 801 EYYM-TQQLTEKSDVYSFGVLMLELLTGR 828
E + + + T+ D++S G ++ E+L G+
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 669 QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG------IR 722
++ + E LL+++ H N+V+ G ++ E+ G L + + G
Sbjct: 43 EDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI 102
Query: 723 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782
L W ++ + G+ ++HE ++HRDIKS NI L + K+ DFG ++ ++ S
Sbjct: 103 LQWFVQMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-S 152
Query: 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 836
+ T V GT Y+ PE + KSD++S G ++ EL T + P + +
Sbjct: 153 PGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/230 (26%), Positives = 108/230 (46%), Gaps = 24/230 (10%)
Query: 635 DVGSGGYGKVYKGTL-------PNGQLIAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNL 686
++G G +G VY+G P + +AIK + SM+ EF E ++ + ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 687 VSLLGFCFDRGEQMLIYEFVPNG-------SLGDSLSGKNGIRLDWIRRL-KIALGAARG 738
V LLG ++I E + G SL + ++++ ++A A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG-- 796
++YL+ AN +HRD+ + N ++ E K+ DFG+++ + E D+ KG +
Sbjct: 132 MAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVR 186
Query: 797 YLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
++ PE T SDV+SFGV++ E+ T +G + +R VM+
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 630 FSDANDVGSGGYGKVYKG-TLPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKN 685
+ + + VGSG YG V G +A+K R Q + + ++ E+ LL + H+N
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 77
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDS-----LSGKNGIRLDWIRRLK---------I 731
++ LL F P SL + ++ G L+ I + + +
Sbjct: 78 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
RGL Y+H + IIHRD+K SN+ ++E K+ DFGL++ D ++ T+
Sbjct: 126 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 181
Query: 792 KGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGR 828
Y PE + + D++S G +M ELLTGR
Sbjct: 182 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN-LVSLLG 691
+G G YGKVYK G+L+A+K+ + + G EI LL + +V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 692 FCFDRGEQ-------MLIYEFVPNG--SLGDSLSGKNGIRLD--WIRRLKIALGAARGLS 740
+ E+ L++E++ + DS G L I+ L +G++
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LKGVA 124
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
+ H+ ++HRD+K N+L+D++ K+AD GL ++ S K + V T+ Y
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYRA 179
Query: 800 PEYYM-TQQLTEKSDVYSFGVLMLELLTG 827
PE + + + D++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 629 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHK 684
NF +G G + +VY+ T L +G +A+K+ Q + + + EI+LL +++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRL-KIALGAARGLSYL 742
N++ + E ++ E G L + K RL + + K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H + ++HRDIK +N+ + K+ D GL + S K + GT Y+ PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID--- 859
KSD++S G L+ E+ + P K LY+L + I+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-------------YGDKMNLYSLCKKIEQCD 224
Query: 860 -PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895
P + + + V++ C+ + RP ++ V
Sbjct: 225 YPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 13/213 (6%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLGFC 693
+G G Y V+KG + L+A+K + +G + E+ LL + H N+V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL-GAARGLSYLHELANPPIIH 752
L++E++ + L + I + +KI L RGL+Y H ++H
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMS--MHNVKIFLYQILRGLAYCHRRK---VLH 127
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEK 811
RD+K N+L++ER K+ADFGL+++ S K + V T+ Y P+ + + + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQ 185
Query: 812 SDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 844
D++ G + E+ +G RP+ G + E+ +
Sbjct: 186 IDMWGVGCIFFEMASG-RPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 14/222 (6%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFK----MEIELLSRVH 682
N F VG G YG V K +++AIK+ + + +E K E+++L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742
+N+V L RG+ L++E+V L NG+ + +R L A +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-----I 113
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H I+HRDIK N+L+ K+ DFG ++++S+ + T V T Y PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPEL 172
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 844
+ + D++S G ++ EL G +P+ G+ + ++ T+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIE----LLSRVHHKNLVSLL 690
+G G +GKV +G+ A+K Q+ ++ +E K + LL V H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 691 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
+ F +++ + ++V G L L + R A A L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN--- 116
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
II+RD+K NILLD + + + DFGL K + K T+ GT YL PE Q
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYD 174
Query: 810 EKSDVYSFGVLMLELLTGRRP 830
D + G ++ E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK--MEIELLSRVHHKNLVSL 689
+G G +G VY K + +L +K G + + + E +LLS++ H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSLS--GKNGIRL------DWIRRLKIALGAARGLSY 741
+R +I E+ L L G L +W +L + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
+H+ I+HRD+K+ NI L L K+ DFG+S+ + S + T GT Y+ PE
Sbjct: 122 MHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPE 175
Query: 802 YYMTQQLTEKSDVYSFGVLMLEL 824
Q KSD++S G ++ E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 80/344 (23%), Positives = 139/344 (40%), Gaps = 96/344 (27%)
Query: 636 VGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRV-HHKNLV 687
+G G +GKV + + + + +A+K ++G+ + M E+++L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 688 SLLGFCFDR-GEQMLIYE-----------------FVPN------GSLGDSLSGKNGIRL 723
+LLG C G M+I E F P GK RL
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ-RL 133
Query: 724 D------------WI--RRLKIA-----------------------LGAARGLSYLHELA 746
D +I + L ARG+ +L A
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---A 190
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT-QVKGTMGYLDPEYYMT 805
+ IHRD+ + NILL E K+ DFGL++ + + D++ + + ++ PE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMAPESIFD 249
Query: 806 QQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRTVMDKKKELYNLYELIDPT 861
+ T +SDV+SFGVL+ E+ + G P ++ + R ++ + Y E+
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEI---- 305
Query: 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+ L C + +DRPT SE+V+ + ++LQ+
Sbjct: 306 -------------YSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 77/348 (22%), Positives = 132/348 (37%), Gaps = 100/348 (28%)
Query: 636 VGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRV-HHKNLV 687
+G G +G+V + + +A+K ++G+ M E+++L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 688 SLLGFCFDRGEQMLIY------------------EFVP----NGSLGDSLSGKNGIRLDW 725
+LLG C G +++ EFVP + SG I D
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 726 IRRLK--------------------------------------------IALGAARGLSY 741
RRL + A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT-QVKGTMGYLDP 800
L A+ IHRD+ + NILL E K+ DFGL++ + + D++ + + ++ P
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMAP 250
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRTVMDKKKELYNLYE 856
E + T +SDV+SFGVL+ E+ + G P ++ + R ++ + Y E
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 310
Query: 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+ L C RPT SE+V+ + N+LQ
Sbjct: 311 MYQTM-----------------LDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 654 LIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712
L+A+K + + ++F E+++LSR+ N+ LLG C +I E++ NG L
Sbjct: 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 713 ---------DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763
S N L + L +A A G+ YL L +HRD+ + N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVG 164
Query: 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 823
+ K+ADFG+S+++ S+ + + + ++ E + + T KSDV++FGV + E
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 824 LLT-GRRP 830
+LT R
Sbjct: 225 ILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 651 NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 710
+G+ +A+K Q + E+ ++ H+N+V + E ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 711 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770
L D +S RL+ + + + L YLH +IHRDIKS +ILL K+
Sbjct: 105 LTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158
Query: 771 ADFGLSKSMS-DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRR 829
+DFG +S D K + GT ++ PE + D++S G++++E++ G
Sbjct: 159 SDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 830 P 830
P
Sbjct: 216 P 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKNLVSLLGFC 693
+G G Y VYKG + NGQL+A+K + +G + E LL + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
+ ++E++ + G+ +R L RGL+Y+H I+HR
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL--LRGLAYIH---GQHILHR 127
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKS 812
D+K N+L+ K+ADFGL+++ S + + + V T+ Y P+ + +
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSAL 185
Query: 813 DVYSFGVLMLELLTGR 828
D++ G + +E+L G+
Sbjct: 186 DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 18/235 (7%)
Query: 628 NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH 683
+F + VG G +G+V K T + +K++ + + F+ E ++LS +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIA-LGAARGLSYL 742
+ L D+ L+ E+ P G L L+ + + + +A L A + +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA--IHSV 118
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H++ +HRDIK N+L+D + K+ADFG + + + K + GT Y+ PE
Sbjct: 119 HQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEV 174
Query: 803 YMTQQLTEKS------DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851
T K D +S GV+ E++ GR P G + +M+ ++ L
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 637 GSGGYGKVYKG-TLPNGQLIAIK--RAQQGSMQGGQEFKM--EIELLSRVHHKNLVSLLG 691
G G Y VYKG + GQL+A+K R + + G F E LL + H N+V+L
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEH---EEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSG-KNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ L++E++ + L + G+ + +R L RGL+Y H+ +
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL--LRGLAYCHQRR---V 124
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
+HRD+K N+L+ ER K+ADFGL+++ S K + V T+ Y P+ + TE
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGS--TE 180
Query: 811 KS---DVYSFGVLMLELLTGR 828
S D++ G + E+ TGR
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 688
+G G +GKV KGT ++ AIK ++ + + E +L+ ++
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 689 LLGFCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L CF +++ + E+V G L + + + D R A L +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
+I+RD+K NILLD + K+ADFG+ K TT GT Y+ PE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIE 832
D ++ GVLM E++ G+ P E
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 7/98 (7%)
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGT 794
A GL +LH II+RD+K N++LD + K+ADFG+ K ++ D +TT+ GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 832
Y+ PE Q + D ++FGVL+ E+L G+ P E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIK--RAQQGSMQGGQEFKM-EIELLSRVHHKN--LVSL 689
+G GG+G+VY + G++ A+K ++ M+ G+ + E +LS V + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 690 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
+ + F +++ I + + G L LS ++G+ + R A GL ++H N
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRF-YATEIILGLEHMH---NR 116
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
+++RD+K +NILLDE + +++D GL+ S +K H + GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVLQKGTA 172
Query: 809 TEKS-DVYSFGVLMLELLTGRRPIERGK 835
+ S D +S G ++ +LL G P + K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 13/211 (6%)
Query: 636 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+G GG+G+V + G++ A K+ ++ ++ + M E ++L +V+ + +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ ++ + + L+ + G L + D R + A GL LH I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERI 123
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
++RD+K NILLD+ + +++D GL+ + + E I +V GT+GY+ PE ++ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTF 180
Query: 811 KSDVYSFGVLMLELLTGRRPI-ERGKYIVRE 840
D + G L+ E++ G+ P +R + + RE
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGT 794
A GL +LH + II+RD+K N++LD + K+ADFG+ K ++ T GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFCGT 164
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 832
Y+ PE Q + D ++FGVL+ E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 36/234 (15%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQ-GSMQGGQEFKM-----------EIELLSRVHH 683
+G G +G+V QL+ K +Q+ +M+ +F+M E ++++ +
Sbjct: 51 IGRGAFGEV--------QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 684 KNLVSLLGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 741
+V L FC + ++ L + E++P G L + +S + + W + + A L
Sbjct: 103 PWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLA--LDA 157
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
+H + +IHRD+K N+LLD+ + K+ADFG M ++ T V GT Y+ PE
Sbjct: 158 IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPE 213
Query: 802 YYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851
+Q + D +S GV + E+L G P +V +MD K L
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF-YADSLVGTYSKIMDHKNSL 266
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 39/109 (35%), Positives = 64/109 (58%), Gaps = 9/109 (8%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD---HITTQVKG 793
GL Y+H AN ++HRD+K N+L++ K+ DFGL++ S++ + +T V
Sbjct: 116 CGLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 794 TMGYLDPEYYMTQQLTEKS-DVYSFGVLMLELLTGRRPIERGKYIVREI 841
T Y PE ++ Q K+ DV+S G ++ ELL GR+P+ +GK V ++
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQL 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 691
VGSG YG V Q +A+K R Q + + ++ E+ LL + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 692 FCFDRGEQMLIYEFVPNGSLGD--------SLSGKNGIRLDWIRRLK------IALGAAR 737
F P S+ + +L G + + ++L + R
Sbjct: 82 V------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
GL Y+H IIHRD+K SN+ ++E ++ DFGL++ D ++ T+ Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 798 LDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
PE + + D++S G +M ELL G+ YI +++ +M+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIME 230
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 20/159 (12%)
Query: 701 LIYEFVPNGSLGDSLSGKNGIRLDWIR----RLKIALGAARGLSYLHELANPPIIHRDIK 756
++ E++P G L +L I W R + +AL A + + IHRD+K
Sbjct: 120 MVMEYMPGGDLV-NLMSNYDIPEKWARFYTAEVVLALDAIHSMGF---------IHRDVK 169
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ----QLTEKS 812
N+LLD+ + K+ADFG M + T V GT Y+ PE +Q +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228
Query: 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851
D +S GV + E+L G P V +MD K L
Sbjct: 229 DWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMDHKNSL 266
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIE----LLSRVHHKNLVSLL 690
+G G +GKV +G+ A+K Q+ + +E K + LL V H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 691 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
+ F E++ + +FV G L L + R + +A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASA--LGYLHSIN--- 116
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSK---SMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
I++RD+K NILLD + + + DFGL K + SD+ TT GT YL PE Q
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-----TTTFCGTPEYLAPEVIRKQ 171
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP 830
D + G ++ E+L G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-10
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 201
L L++ G G +P I L +L ++L+ N + G IP S G+ L++L N
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL------DLSYN 476
Query: 202 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 237
+GSIPE L + + I + + N+L+G +PA LG
Sbjct: 477 SFNGSIPESLGQLTSLRI-LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 61/243 (25%)
Query: 636 VGSGGYGKV----YKGTLPNGQLIAIKRAQQGSM-QGGQ--EFKMEIELLSRVHHKNLVS 688
+G G +G+V K T G + A+K+ ++ M + Q + E ++L+ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 689 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLD----WIRRLKIALGAARGLSYLH 743
L + F D LI E++P G + L K+ + +I +A+ + L Y
Sbjct: 66 LY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY-- 122
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLS---KSMSDSEKDHITTQVK-------- 792
IHRDIK N+LLD + + K++DFGL K +E I +
Sbjct: 123 -------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 793 -------------------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 827
GT Y+ PE ++ ++ D +S GV+M E+L G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
Query: 828 RRP 830
P
Sbjct: 236 YPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 688
+G G +GKV KGT +L AIK ++ + + + +E +L+ ++
Sbjct: 8 LGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR---GLSYLHE 744
L CF +++ + E+V G L + ++ + + AA GL +LH
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYY 803
II+RD+K N++LD + K+ADFG+ K + D +TT+ GT Y+ PE
Sbjct: 120 RG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEII 173
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRPIE 832
Q + D +++GVL+ E+L G+ P +
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 43/233 (18%)
Query: 618 FSFEEVKKYT----NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQ 669
F EEV K ++ VGSG YG V G+ +AIK R Q + +
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 670 EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD-------------SLS 716
++ E+ LL + H+N++ LL D F S + L
Sbjct: 61 AYR-ELTLLKHMQHENVIGLL----DV--------FTSAVSGDEFQDFYLVMPYMQTDLQ 107
Query: 717 GKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776
G L + + GL Y+H IIHRD+K N+ ++E K+ DFGL+
Sbjct: 108 KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGR 828
+ +D+E T T Y PE + + D++S G +M E+LTG+
Sbjct: 165 RH-ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 688
+G G +GKV K T G+ A+K ++ + E E +L H L +
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L + F +++ + E+ G L LS + D R + +A L YLH
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHSCD- 115
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
+++RD+K N++LD+ + K+ DFGL K +SD GT YL PE
Sbjct: 116 --VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDN 170
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP 830
D + GV+M E++ GR P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (150), Expect = 1e-09
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 49/245 (20%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG------SMQGGQE-----FKMEIE 676
N + +G+G +G+V+ L+ KR Q+ S +G +E +E+
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 677 LLSRVHHKNLVSLLGFCFDRGEQML--IYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIA 732
++ + HKN+V + ++ Q L + EF G L ++ K +++ + I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 733 LGAARGLSYLHELANPP----IIHRDIKSSNILL-----------------DERLNAKVA 771
L+Y H L + P ++HRD+K NI L + R AK+
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVLMLELLTGRR 829
DFGLSK++ H GT Y PE + T+ +KSD+++ G ++ EL +G+
Sbjct: 185 DFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 830 PIERG 834
P +
Sbjct: 242 PFHKA 246
|
Length = 1021 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHKNLVSLLG 691
+G G Y KV L N Q+ A+K ++ + ++ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
CF ++ L+ E+V G L + + + + R + A L++LHE I
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLHERG---I 117
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
I+RD+K N+LLD + K+ D+G+ K T+ GT Y+ PE ++
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 811 KSDVYSFGVLMLELLTGRRPIE 832
D ++ GVLM E++ GR P +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIK--RAQQGSMQGGQEFKM-EIELLSRVHHKN--LVSL 689
+G GG+G+VY + G++ A+K ++ M+ G+ + E +LS V + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 690 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
+ + F +++ I + + G L LS ++G+ + R A GL ++H N
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRF-YAAEIILGLEHMH---NR 116
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
+++RD+K +NILLDE + +++D GL+ S +K H + GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVLQKGVA 172
Query: 809 TEKS-DVYSFGVLMLELLTGRRPIERGK 835
+ S D +S G ++ +LL G P + K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 628 NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSM----QGGQEFKMEIELLS 679
+F + +G YG VY K T Q A+K+ + ++ Q Q F +E ++L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVF-VERDILT 56
Query: 680 RVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARG 738
+ +VS+ F+ + ++ E+V G L + +D + R+ A
Sbjct: 57 FAENPFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFA-ETVLA 113
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-------------SMSDSEKD 785
L YLH N I+HRD+K N+L+ + K+ DFGLSK + ++
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ QV GT Y+ PE + Q + D ++ G+++ E L G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+G G YG VYK + IA+K R +Q EI LL + H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIA----LGAARGLSYLHELANP 748
L++E+ L L D+ + ++ RG++Y H +
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SH 121
Query: 749 PIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQ 806
++HRD+K N+L+D R NA K+ADFGL+++ + V T+ Y PE + ++
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGSR 179
Query: 807 QLTEKSDVYSFGVLMLELLTGR 828
+ D++S G + E++ +
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 14/201 (6%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIE----LLSRVHHKNLVSLL 690
+G G +GKV +G A+K Q+ ++ +E + LL + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 691 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
+ F E++ + ++V G L L + R + +A G YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG--YLHSLN--- 116
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
II+RD+K NILLD + + + DFGL K E + T+ GT YL PE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 810 EKSDVYSFGVLMLELLTGRRP 830
D + G ++ E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 26/175 (14%)
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT- 794
ARG+ +L A+ IHRD+ + NILL E K+ DFGL++ + + D++ KG+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVR---KGSA 236
Query: 795 ---MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 850
+ ++ PE + T +SDV+SFGVL+ E+ + G P Y +I ++
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-----YPGVQINEEFCQR-- 289
Query: 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
L D T + E Y + L C Q +RPT S +V+ + ++LQ+
Sbjct: 290 ------LKDGTRMRAPENATPEIY-RIMLACWQGDPKERPTFSALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 64/254 (25%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 637 GSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVSL 689
G G G+V+ KGT G+L A+K + M + K E E+L+ + H L +L
Sbjct: 10 GKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 690 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLS 740
F + L+ ++ P G L L + G + L AR L
Sbjct: 67 YA-SFQTETYLCLVMDYCPGGELFRLLQRQPG------KCLSEE--VARFYAAEVLLALE 117
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM---------------SDSEKD 785
YLH L I++RD+K NILL E + ++DF LSK S +
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 786 HITTQVK------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER 833
I ++ GT Y+ PE D ++ G+L+ E+L G P +
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF-K 233
Query: 834 GKYIVREIRTVMDK 847
G ++ K
Sbjct: 234 GSNRDETFSNILKK 247
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 28/240 (11%)
Query: 599 HWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQL--IA 656
K S S + K +E+ F+ +G+G +G+V T N +A
Sbjct: 8 QLHKKKDSDSTKEPKRKNKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVA 60
Query: 657 IKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 713
IKR ++ + ++ E ++L+ ++H V+L G D L+ EFV G
Sbjct: 61 IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120
Query: 714 SLSGKNGIRLDWIRRLKIALG---AARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770
L +N +R +G AA+ + L + I++RD+K N+LLD+ K+
Sbjct: 121 FLR-RN-------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKM 172
Query: 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
DFG +K + D T + GT Y+ PE + + +D ++ G+ + E+L G P
Sbjct: 173 TDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 61/247 (24%), Positives = 104/247 (42%), Gaps = 56/247 (22%)
Query: 628 NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSR 680
++F +G G +G+V K T G + A+K ++ M ++ + E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDT---GHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 681 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD----WIRRLKIALGAA 736
+V + D+ LI EF+P G + L K+ + + +I +A+ A
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA- 116
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM----------------- 779
+H+L IHRDIK N+LLD + + K++DFGL +
Sbjct: 117 -----IHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 780 SDSEKDHITTQVK----------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 823
SD ++ ++ K GT Y+ PE +M + D +S GV+M E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 824 LLTGRRP 830
+L G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-09
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 40/212 (18%)
Query: 636 VGSGGYGKV---YKGTLPNGQLIAIKRAQ---QGSMQGGQEFKMEIELLSRVHHKNLVSL 689
+GSG G V Y GQ +AIK+ Q + ++ E+ L+ V+HKN++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGL 80
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGD-------------SLSGKNGIRLDWIRRLKIALGAA 736
L F P SL + +L + LD R +
Sbjct: 81 LNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQML 128
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
G+ +LH + IIHRD+K SNI++ K+ DFGL+++ S + T T
Sbjct: 129 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRY 182
Query: 797 YLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 828
Y PE + E D++S G +M E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
L +LH+ I++RD+K NILLD + + DFGLSK ++ + T GT YL
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 799 DPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRP 830
PE + ++ T+ D +S GVL+ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 70/278 (25%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 635 DVGSGGYGKVYKGTLPNG----QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
++G+G +GKV G + +G Q++ + S+Q +F E + + H NL+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL---DWIRRLKIALGAARGLSYLHELAN 747
G C + +L+ EF P G L L L D ++A A GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT--QVKGTMGYLDPEY--- 802
IH D+ N LL L K+ D+GLS + ++D+ T Q+ + ++ PE
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSH--NKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 803 ----YMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYEL 857
+ T++S+V+S GV + EL G +P ++ T ++++L +L
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH--LSDEQVLTYTVREQQL----KL 230
Query: 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895
P + L + +++ ++ C + + RP+ EV
Sbjct: 231 PKPRLKLPLS----DRWYEVMQFCWLQP-EQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 22/236 (9%)
Query: 619 SFEEVKKYTNNFSDANDVGSGGYGKV---YKGTLP-NGQLIAIKRAQQGSMQGGQEFKME 674
+F +K+Y N +GSG G V Y L N + + R Q + ++ E
Sbjct: 12 TFTVLKRYQN----LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-E 66
Query: 675 IELLSRVHHKNLVSLLG-FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
+ L+ V+HKN++SLL F + + ++ + +L + LD R +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
G+ +LH IIHRD+K SNI++ K+ DFGL+++ S + T
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVV 180
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLE------LLTGRRPIERGKYIVREIRT 843
T Y PE + E D++S G +M E L GR I++ ++ ++ T
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 12/202 (5%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE----FKMEIELLSRVHHKNLVSLLG 691
+G G Y KV L + I + + + E + E + + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 692 FCFDRGEQML-IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
CF ++ + E+V G L + + + + R + A L+YLHE I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG---I 117
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
I+RD+K N+LLD + K+ D+G+ K T+ GT Y+ PE +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 811 KSDVYSFGVLMLELLTGRRPIE 832
D ++ GVLM E++ GR P +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-09
Identities = 66/256 (25%), Positives = 100/256 (39%), Gaps = 62/256 (24%)
Query: 628 NNFSDANDVGSGGYGKV-YKGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHH 683
+F +G G +G+V G++ A+K + M + K E ++L+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDW----IRRLKIALGAARGL 739
+VSL D LI EF+P G L L I+ D + R +A +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-----IKYDTFSEDVTRFYMA-ECVLAI 114
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK---------------------- 777
+H+L IHRDIK NIL+D + K++DFGLS
Sbjct: 115 EAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 778 -------------SMSDSEKDHITTQVK----------GTMGYLDPEYYMTQQLTEKSDV 814
+++ S KD I T K GT Y+ PE ++ Q ++ D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231
Query: 815 YSFGVLMLELLTGRRP 830
+S G +M E L G P
Sbjct: 232 WSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 9e-09
Identities = 71/224 (31%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 80 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 139
L ++ L L L S L + NL L +L L I + L L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSL--DGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNL 118
Query: 140 VLLSLNSNGFSGRVPPSIGNL-SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 198
L L++N + +PP IG L SNL LDL+DNK+E +P N P L L
Sbjct: 119 TSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD------L 170
Query: 199 GKNQLS-----GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 253
N LS S L D+ S N +LP + L+ +LE + NS+
Sbjct: 171 SFNDLSDLPKLLSNLSNLNNLDL--------SGNKISDLPPEIELLSALEELDLSNNSII 222
Query: 254 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 297
+ S+L+NL +++ L LSNNKL ++ LS L LD+SNN
Sbjct: 223 -ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIE----LLSRVHHKNLVSLL 690
+G G +GKV + A+K Q+ ++ +E K + LL V H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 691 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
F F +++ + +++ G L L + R + +A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--LGYLHSLN--- 116
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
I++RD+K NILLD + + + DFGL K + E + T+ GT YL PE Q
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 810 EKSDVYSFGVLMLELLTGRRP 830
D + G ++ E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 635 DVGSGGYGKVYKGTL---PNGQLIAIKRAQ-QGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
++G+G +GKV + + +K + S + EF + + + H N++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR-------LKIALGAARGLSYLH 743
G C + +L++E+ G L LS + W RR ++A A G++++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK--GTMGYLDPE 801
+ +H D+ N L L KV D+G+ S ++D+I T+ + +L PE
Sbjct: 117 KHN---FLHSDLALRNCFLTSDLTVKVGDYGI--GPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 802 Y-------YMTQQLTEKSDVYSFGVLMLELL 825
+T + T+ S+V++ GV + EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 56/246 (22%)
Query: 629 NFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRV 681
+F +G G +G+V K T G + A+K ++ M ++ + E ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDT---GHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 682 HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD----WIRRLKIALGAAR 737
+V + D+ LI EF+P G + L K+ + + +I +A+ +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS-- 116
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM-----------------S 780
+H+L IHRDIK N+LLD + + K++DFGL + S
Sbjct: 117 ----IHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 781 DSEKDHITTQVK----------------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLEL 824
D ++ ++ K GT Y+ PE +M + D +S GV+M E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 825 LTGRRP 830
L G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
L++LHE II+RD+K N+LLD + K+ D+G+ K T+ GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYI 163
Query: 799 DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 832
PE + D ++ GVLM E++ GR P +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
+ LT L +LDL NN +P IG LK + + + +P + +L L L
Sbjct: 112 LLELTNLTSLDLDNNNITD--IPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLD 169
Query: 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 203
L+ N S +P + NLSNL LDL+ NK+ ++P L+ L N +
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELD------LSNNSI 221
Query: 204 SGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNL 263
+ L + L SNN +LP ++G + +LE + N +S S+L +L
Sbjct: 222 I-ELLSSLSNLKNLSG--LELSNNKLEDLPESIGNLSNLETLDLSNNQISSI--SSLGSL 276
Query: 264 TSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNS 298
T++ +L LS N L+ A+P + L +L L ++
Sbjct: 277 TNLRELDLSGNSLSNALPLIALLLLLLELLLNLLL 311
|
Length = 394 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 637 GSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---------GGQEFKMEIELLSRVHHKNL 686
G G + +YKG L L + Q+ S+ F L+S++ HK+L
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
V L G C M + E+V G L L KN + L W +L +A A L YL +
Sbjct: 64 VKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK 120
Query: 746 ANPPIIHRDIKSSNILLDE-------RLNAKVADFGLSKSMSDSEK--DHITTQVKGTMG 796
++H ++ NIL+ K++D G+ ++ E+ + I
Sbjct: 121 K---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-------- 169
Query: 797 YLDPEYYMTQQ--LTEKSDVYSFGVLMLEL 824
++ PE Q LT +D +SFG +LE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 9/105 (8%)
Query: 727 RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786
RRL L A L+YLH IIHRD+K+ NI LDE NA + DFG + +
Sbjct: 192 RRL---LEA---LAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI 831
GT+ PE K+D++S G+++ E+ +
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 21/192 (10%)
Query: 638 SGGYGKVYKGTLPNGQ--LIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
G G+V+ T P GQ + +K Q+G+ +E LL V+H +++ +
Sbjct: 76 PGSEGRVFVATKP-GQPDPVVLKIGQKGTTL------IEAMLLQNVNHPSVIRMKDTLVS 128
Query: 696 RGEQMLIYEFVP--NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
++ +P + L L+ ++ L + L I GL YLH IIHR
Sbjct: 129 GAITCMV---LPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---IIHR 181
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
D+K+ NI +++ + D G ++ + + GT+ PE + K+D
Sbjct: 182 DVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGTVETNAPEVLARDKYNSKAD 238
Query: 814 VYSFGVLMLELL 825
++S G+++ E+L
Sbjct: 239 IWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 7/113 (6%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTM 795
R L Y+H AN + HRD+K NIL + K+ DFGL++ + +D+ T T
Sbjct: 114 RALKYIHT-AN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 796 GYLDPEY--YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
Y PE + T D++S G + E+LTG +P+ GK +V ++ + D
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITD 222
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 636 VGSGGYGKV-YKGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVSLLG 691
+G G +GKV +G+ A+K ++ + E E +L H L SL
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61
Query: 692 FCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ F +++ + E+V G L LS + D R + +A L YLH + I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLH---SGKI 116
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYYMTQQLT 809
++RD+K N++LD+ + K+ DFGL K + D T + GT YL PE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 810 EKSDVYSFGVLMLELLTGRRP 830
D + GV+M E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 44/228 (19%)
Query: 619 SFEEVKKYTNNFSDANDVGSGGYGKV---YKGTLPNGQLIAIK---RAQQGSMQGGQEFK 672
+F +K+Y +GSG G V + L G +A+K R Q + ++
Sbjct: 16 TFTVLKRY----QQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR 69
Query: 673 MEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD-------------SLSGKN 719
E+ LL V+HKN++SLL F P SL + +L
Sbjct: 70 -ELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVI 116
Query: 720 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779
+ LD R + G+ +LH IIHRD+K SNI++ K+ DFGL+++
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173
Query: 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 827
+ + T T Y PE + E D++S G +M EL+ G
Sbjct: 174 C---TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 45/211 (21%)
Query: 637 GSGGYGKVYKG-TLPNGQLIAIKRAQQ--GSMQGGQEFKMEIELLSRV-HHKNLVSLLGF 692
G G + +V K + G+ AIK ++ S++ + EI+ L R+ H N++ L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEV 66
Query: 693 CFDR--GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL----- 745
FDR G L++E + + +L + I+ K L R SY+++L
Sbjct: 67 LFDRKTGRLALVFELM-DMNL-----------YELIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 746 ---ANPPIIHRDIKSSNILL-DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
N I HRDIK NIL+ D+ L K+ADFG + + T+ T Y PE
Sbjct: 115 HMHRNG-IFHRDIKPENILIKDDIL--KLADFGSCRGIYSK---PPYTEYISTRWYRAPE 168
Query: 802 ------YYMTQQLTEKSDVYSFGVLMLELLT 826
YY K D+++ G + E+L+
Sbjct: 169 CLLTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 51/211 (24%), Positives = 78/211 (36%), Gaps = 29/211 (13%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRA--QQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+ K P L+A+K+ S + + + EI ++ H N++ + F
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TSF 68
Query: 695 -DRGEQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIAL---GAARGLSYLHELANP 748
E ++ + GS D L G+ L IA L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIHSKG-- 121
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-----ITTQVKGTMGYLDPEYY 803
IHR +K+S+ILL ++ S SM K + +L PE
Sbjct: 122 -FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE-- 178
Query: 804 MTQQ----LTEKSDVYSFGVLMLELLTGRRP 830
+ QQ EKSD+YS G+ EL G P
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 33/114 (28%), Positives = 65/114 (57%), Gaps = 9/114 (7%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDH--ITTQVKG 793
RGL Y+H AN ++HRD+K +N+ ++ E L K+ DFGL++ + D H ++
Sbjct: 125 RGLKYIHS-AN--VLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLV 180
Query: 794 TMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
T Y P ++ T+ D+++ G + E+LTG +P+ G + + +++ +++
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 51/209 (24%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 635 DVGSGGYGKVYKGT---LPNGQL---IAIKRAQQ-GSMQGGQEFKMEIELLSRVHHKNLV 687
++G G +G VY+G + G+ +A+K + S++ EF E ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGA--ARGL 739
LLG +++ E + +G L L + N R + I + A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GY 797
+YL+ +HRD+ + N ++ K+ DFG+++ + E D+ KG + +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGKGLLPVRW 187
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLT 826
+ PE T SD++SFGV++ E+ +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 619 SFEEVKKYTNNFSDANDVGSGGYGKV---YKGTLPNGQLIAIK---RAQQGSMQGGQEFK 672
+F +K+Y N +GSG G V Y L +AIK R Q + ++
Sbjct: 19 TFTVLKRYQN----LKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR 72
Query: 673 MEIELLSRVHHKNLVSLLG-FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 731
E+ L+ V+HKN++ LL F + + ++ + +L + LD R +
Sbjct: 73 -ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
G+ +LH IIHRD+K SNI++ K+ DFGL+++ S + T
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPY 185
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 828
T Y PE + E D++S G +M E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMG 796
L YLH N +++RD+K N++LD+ + K+ DFGL K + KD T + GT
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPE 161
Query: 797 YLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
YL PE D + GV+M E++ GR P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNI 760
++ E++P G L + +S + + W R + A L +H + IHRD+K N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLA--LDAIHSMG---FIHRDVKPDNM 173
Query: 761 LLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYS 816
LLD+ + K+ADFG M+ T V GT Y+ PE +Q + D +S
Sbjct: 174 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 817 FGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851
GV + E+L G P +V +M+ K L
Sbjct: 233 VGVFLYEMLVGDTPF-YADSLVGTYSKIMNHKNSL 266
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 38/114 (33%), Positives = 63/114 (55%), Gaps = 14/114 (12%)
Query: 723 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSD 781
LD L+ + A+G+ +L A+ IHRD+ + N+LL + AK+ DFGL++ M+D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 782 SEKDHITTQVKGT----MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP 830
S VKG + ++ PE T +SDV+S+G+L+ E+ + G+ P
Sbjct: 266 S-----NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 719 NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778
+ + LD L + A+G+S+L A+ IHRD+ + NILL K+ DFGL++
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD 263
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYI 837
+ + + + + ++ PE T +SDV+S+G+L+ E+ + G P
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG---- 319
Query: 838 VREIRTVMDKKKELYNL----YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 893
M + Y + Y ++ P S E Y D+ C RPT
Sbjct: 320 -------MPVDSKFYKMIKEGYRMLSPECAPS------EMY-DIMKSCWDADPLKRPTFK 365
Query: 894 EVVKDIENIL 903
++V+ IE L
Sbjct: 366 QIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 87/303 (28%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEI-------------------- 675
+G G + K++KG R + G G+ K E+
Sbjct: 3 LGQGTFTKIFKG----------IRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAA 50
Query: 676 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLS-GKNGIRLDWIRRLKIALG 734
++S++ HK+LV G C E +++ E+V GSL L KN I + W L
Sbjct: 51 SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW------KLE 104
Query: 735 AARGLSY-LHELANPPIIHRDIKSSNILLDERLNA--------KVADFGLSKSMSDSEKD 785
A+ L++ LH L + + H ++ + N+LL + K++D G+S ++ K+
Sbjct: 105 VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV--LPKE 162
Query: 786 HITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTG-RRPIERGKYIVREIRT 843
+ ++ ++ PE Q L+ +D +SFG + E+ +G +P+ +
Sbjct: 163 ILLERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL-----------S 207
Query: 844 VMDKKKELYNLYE----LIDPTIGLSTTLKGFEKYVDLAL---KCVQESGDDRPTMSEVV 896
+D +K+L YE L P K+ +LA +C+ D RP+ ++
Sbjct: 208 ALDSQKKL-QFYEDRHQLPAP------------KWTELANLINQCMDYEPDFRPSFRAII 254
Query: 897 KDI 899
+D+
Sbjct: 255 RDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK---MEIELLSRVHHKNLVS 688
+G G +GKV K T G+ A+K ++ + E E +L H L +
Sbjct: 3 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L + F +++ + E+ G L LS + + R + +A L YLH +
Sbjct: 60 L-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH---S 113
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
+++RDIK N++LD+ + K+ DFGL K T GT YL PE
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDND 171
Query: 808 LTEKSDVYSFGVLMLELLTGRRP 830
D + GV+M E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 36/178 (20%)
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS-MSDSEKDHITTQVKGT 794
A G+ +L A+ +HRD+ + N+L+ E K+ DFGL++ M DS ++I+ KG+
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS--NYIS---KGS 300
Query: 795 ----MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 849
+ ++ PE T SDV+SFG+L+ E+ T G P + +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE-----------LPMNE 349
Query: 850 ELYNL----YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
+ YN Y + P ++ ++ KC +E + RP S++V + ++L
Sbjct: 350 QFYNAIKRGYRMAKPA-------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 24/60 (40%), Positives = 37/60 (61%)
Query: 226 NNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTG 285
N++ G +P +LG + SLEV+ NS +G +P +L LTS+ L L+ N L+G +P G
Sbjct: 452 NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
N+V L + L+ + G L +S I + ++R AA + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW-----AAEMVVALDA 100
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-EKDHITTQVKGTMGYLDPEYY 803
L I+ RD+ +NILLD+R + ++ F + DS + + + Y PE
Sbjct: 101 LHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVG 154
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGR 828
+ TE D +S G ++ ELLTG+
Sbjct: 155 GISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-07
Identities = 30/114 (26%), Positives = 50/114 (43%), Gaps = 19/114 (16%)
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK----- 792
+ Y+H ++HRD+K NILL + D+G + E+D + V
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 793 -----------GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
GT Y+ PE + +E +D+Y+ GV++ ++LT P R K
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
|
Length = 932 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 50/202 (24%)
Query: 672 KMEIELLSRVHHKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK 730
K E ++L+ ++ +V L + F D+ + +++P G + SL + GI + + R
Sbjct: 49 KAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMM-SLLIRLGIFEEDLARFY 106
Query: 731 IA-LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL---------SK--- 777
IA L A + +H++ IHRDIK NIL+D + K+ DFGL SK
Sbjct: 107 IAELTCA--IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 778 --------SMSDSE------------------KDHITTQVK---GTMGYLDPEYYMTQQL 808
SM SE + H GT Y+ PE +
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
Query: 809 TEKSDVYSFGVLMLELLTGRRP 830
T+ D +S GV++ E+L G+ P
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 31/196 (15%)
Query: 677 LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGA 735
L+S+V H +L + G C E +++ EFV +G L L + G + + W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNA-------KVADFGLS-KSMSDSEK-DH 786
A LSYL + ++H ++ + NILL A K++D G+S ++S E+ +
Sbjct: 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183
Query: 787 ITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLEL-------LTGRRPIERGKYIV 838
I ++ PE L+ +D +SFG +LE+ L R P E+ ++
Sbjct: 184 IP--------WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235
Query: 839 REIRTVMDKKKELYNL 854
++ R KEL L
Sbjct: 236 KKHRLPEPSCKELATL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 53/227 (23%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 634 NDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
N +G+G +G VY+ + + +AIK+ +Q Q E+ ++ ++H N++ L +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 693 ----CFDRGEQML----IYEFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYL 742
CF + E+ + + EF+P ++ + +N L + R L+Y+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 743 HELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
H + I HRD+K N+L+D + K+ DFG +K++ ++ ++ Y+
Sbjct: 187 H---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---------SVSYICSR 234
Query: 802 YYMTQQL-------TEKSDVYSFGVLMLELLTGRRPIERGKYIVREI 841
+Y +L T D++S G ++ E++ G PI G+ V ++
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
+H + +HRDIK N+LLD + ++ADFG M+ + V GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPE 173
Query: 802 YYMTQQ-----LTEKSDVYSFGVLMLELLTGRRP 830
+ + D +S GV M E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 27/231 (11%)
Query: 636 VGSGGYGKVYKGTLPNG-QLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVSLLG 691
+G G +G+V L N ++ A+K + M E F+ E ++L ++ + +L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD------WIRRLKIALGAARGLSYLHEL 745
D L+ ++ G L LS K RL ++ + IA+ + L Y
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLS-KFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+HRDIK NIL+D + ++ADFG + + + V GT Y+ PE
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 177
Query: 806 QQ-----LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851
+ + D +S GV M E+L G P + +V +M+ K+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762
Y+ + + + LS L + L ARG+ +L A+ +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 763 DERLNAKVADFGLSKS-MSDS---EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 818
+ K+ DFGL++ M DS K VK ++ PE T SDV+S+G
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYG 326
Query: 819 VLMLELLT 826
+L+ E+ +
Sbjct: 327 ILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 636 VGSGGYGKVYKGTLPNGQL---IAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSL- 689
VG G YG VYK +G+ A+K+ + SM +E I LL + H N++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 64
Query: 690 ----------LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 739
+ FD E L + + + S + K ++L + G+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRA---SKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 740 SYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQ-VKGT 794
YLH AN ++HRD+K +NIL+ ER K+AD G ++ + K V T
Sbjct: 122 HYLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 795 MGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPI 831
Y PE + + T+ D+++ G + ELLT PI
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-05
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 245 VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP----NLTGLSVLSYLDMSNNSFD 300
+ D L G +P++++ L + + LS N + G +P ++T L V LD+S NSF+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV---LDLSYNSFN 479
Query: 301 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADL 332
S +P + SL L + +L G++PA L
Sbjct: 480 GS-IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 64/239 (26%), Positives = 97/239 (40%), Gaps = 18/239 (7%)
Query: 62 TNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLV 121
S + + LS ++ L + L L LDLS N LP + NL L+NL L
Sbjct: 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD--LPKLLSNLSNLNNLDLS 194
Query: 122 GCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 181
G S +P I L L L L++N + S+ NL NL L+L++NKLE ++P S
Sbjct: 195 GNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI 251
Query: 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPAT-LGLVK 240
GN L+ L NQ+S SI L + N+L+ LP L L+
Sbjct: 252 GNLSNLETL------DLSNNQIS-SISS--LGSLTNLRELDLSGNSLSNALPLIALLLLL 302
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVND--LYLSNNKLTGAMPNLTGLSVLSYLDMSNN 297
++ + + N L + S+ + + +L L L +N
Sbjct: 303 LELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESN 361
|
Length = 394 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 54/250 (21%)
Query: 630 FSDANDVGSGGYGKV-YKGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHKN 685
F +G G +G+V + L A+K ++ + + K E ++L+ ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+V L D+ + +++P G + SL + + + + R IA + +H++
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMM-SLLIRMEVFPEVLARFYIA-ELTLAIESVHKM 120
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGL--------------------SKSMSDSE-- 783
IHRDIK NIL+D + K+ DFGL SM S+
Sbjct: 121 G---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 784 --------------------KDH---ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVL 820
K H + + GT Y+ PE + + T+ D +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 821 MLELLTGRRP 830
+ E+L G+ P
Sbjct: 238 LFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 10/87 (11%)
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
+HRDIK N+LLD+ + ++ADFG + V GT Y+ PE + Q + +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPE--ILQAMED 180
Query: 811 -------KSDVYSFGVLMLELLTGRRP 830
+ D +S GV M E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 636 VGSGGYGKVYKGTLPNGQ---LIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSL- 689
VG G YG VYK +G+ A+K+ + SM +E I LL + H N+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIALQ 64
Query: 690 ----------LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 739
+ FD E L + + + S + K ++L + G+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRA---SKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 740 SYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQ-VKGT 794
YLH AN ++HRD+K +NIL+ ER K+AD G ++ + K V T
Sbjct: 122 HYLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 795 MGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPI 831
Y PE + + T+ D+++ G + ELLT PI
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-05
Identities = 28/93 (30%), Positives = 53/93 (56%), Gaps = 1/93 (1%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
S + + LS L G++ +++ +L +LDLS+N+ L G +P + + LS L L
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ-LSGQIPASFSEMPVLSQLDLSQN 557
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPS 156
SG IP ++G+++ LV ++++ N G +P +
Sbjct: 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 58/259 (22%), Positives = 107/259 (41%), Gaps = 41/259 (15%)
Query: 622 EVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV 681
++ T V S GK P + + KR + GS Q + EI L R+
Sbjct: 168 ALRASTEEAEARRGVNSTNQGK------PKCERLIAKRVKAGSRAAIQ-LENEILALGRL 220
Query: 682 HHKNLVSL--------LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
+H+N++ + + + +Y F+ + + K+ L R + L
Sbjct: 221 NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQTRAIMKQL 276
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
A + Y+H + +IHRDIK NI L+ + DFG + + E++ G
Sbjct: 277 LCA--VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVG 330
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT---------GRRPIERGKYIVREIRTV 844
T+ PE E +D++S G+++L++L+ G +P GK +++ I ++
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP---GKQLLKIIDSL 387
Query: 845 MDKKKEL----YNLYELID 859
+E L++ ID
Sbjct: 388 SVCDEEFPDPPCKLFDYID 406
|
Length = 501 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 38/137 (27%), Positives = 56/137 (40%), Gaps = 31/137 (22%)
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI------------------RRLKIALGA 735
F +G Q L+++F + +LGD+L GK G + R + + G
Sbjct: 255 FTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGV 314
Query: 736 AR----GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
R GL LH + I+HRDIK N+L+ K+ DFG + M
Sbjct: 315 MRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG------INF 365
Query: 792 KGTMGYLDPEYYMTQQL 808
G LDP Y ++L
Sbjct: 366 NPLYGMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-05
Identities = 26/84 (30%), Positives = 47/84 (55%), Gaps = 2/84 (2%)
Query: 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL 283
D+ L G +P + ++ L+ + NS+ G +P +L ++TS+ L LS N G++P
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 284 TG-LSVLSYLDMSNNSFDASEVPS 306
G L+ L L+++ NS + VP+
Sbjct: 486 LGQLTSLRILNLNGNSL-SGRVPA 508
|
Length = 623 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 4/100 (4%)
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
L I R + YLH IIHRDIK+ NI ++ + + DFG + D +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 828
GT+ PE D++S G+++ E+ T
Sbjct: 242 GWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSF 299
+L+ + N L+ L ++ L LS N LT P +GL L LD+S N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 52/205 (25%)
Query: 672 KMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 731
K E ++L+ ++ +V L D+ + +++P G + SL + GI + + R I
Sbjct: 49 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM-SLLIRMGIFPEDLARFYI 107
Query: 732 A-LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL--------------- 775
A L A + +H++ IHRDIK NIL+D + K+ DFGL
Sbjct: 108 AELTCA--VESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 776 -----------SKSMSDSEKDHITTQVK-------------------GTMGYLDPEYYMT 805
S D ++K GT Y+ PE +
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRP 830
T+ D +S GV++ E+L G+ P
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 63/286 (22%), Positives = 122/286 (42%), Gaps = 56/286 (19%)
Query: 629 NFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK 684
N+ D ++ Y K K L P+ + I++ + SM + +V HK
Sbjct: 17 NYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASM------------MRQVSHK 64
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
++V L G C E +++ EFV G L D + L + K+A A LSYL +
Sbjct: 65 HIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASALSYLED 123
Query: 745 LANPPIIHRDIKSSNILL-DERLNA------KVADFGLSKSMSDSEK--DHITTQVKGTM 795
++H ++ + NILL E ++ K++D G+ ++ ++ + I
Sbjct: 124 ---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP------- 173
Query: 796 GYLDPEYYM-TQQLTEKSDVYSFGVLMLEL-LTGRRPIERGKYIVREIRTVMDKKKELYN 853
++ PE ++ L+ +D +SFG + E+ G P++ +T+ +K++
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD--------KTLAEKERFYEG 224
Query: 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899
L+ P+ ++ DL C+ + RP +++DI
Sbjct: 225 QCMLVTPSC---------KELADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 40/112 (35%), Positives = 57/112 (50%), Gaps = 16/112 (14%)
Query: 731 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS---DSEKDHI 787
I GA RGL+YLH+ IHR+IK+S+IL+ + V+ GLS S + +K +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 788 TTQV----KGTMGYLDPEYYMTQQL---TEKSDVYSFGVLMLELLTGRRPIE 832
+ +L PE + Q L KSD+YS G+ EL TGR P +
Sbjct: 161 VYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 10/133 (7%)
Query: 720 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779
G RL + ++ A + LS + + IIHRDIK+ N+L++ + + DFG +
Sbjct: 251 GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310
Query: 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE-------LLTGRRPIE 832
S + GT+ PE T D++S G+++ E L + R E
Sbjct: 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370
Query: 833 RGKY---IVREIR 842
R Y I+R IR
Sbjct: 371 RRPYDAQILRIIR 383
|
Length = 461 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-04
Identities = 74/274 (27%), Positives = 108/274 (39%), Gaps = 58/274 (21%)
Query: 79 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 138
+L I L +L LD+S ++L LPT I NLK L L L GCS PD ++
Sbjct: 672 ELPSSIQYLNKLEDLDMSRCENLEI-LPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISW 729
Query: 139 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 198
L L F PS L NL L L + K E +P + ML
Sbjct: 730 LDLDETAIEEF-----PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTML-------- 776
Query: 199 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT-GELPATLGLVKSLEVVRFD--RNSLSGP 255
L R LF S+ + ELP+++ + LE + + N + P
Sbjct: 777 ---------SPSLTR--------LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819
Query: 256 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVL-SYLDMSNNSFD-------ASEVPSW 307
NL +L S+ +L+G S L ++ D+S N D EVP W
Sbjct: 820 TGINLESLESL---------------DLSGCSRLRTFPDISTNISDLNLSRTGIEEVPWW 864
Query: 308 FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTV 341
+L+ L M N ++ ++ + HL+TV
Sbjct: 865 IEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETV 898
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 735 AARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777
A L YLH IIHRD+K N+L+ + K+ DFGLSK
Sbjct: 113 VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 24/198 (12%)
Query: 650 PNGQLIAIKRAQQGSMQGGQEFKMEIEL-LSRV-HHKNLVSLLGFCFDRGEQMLIYEFVP 707
P G+ + ++R + ++ EL +S++ +H N+V E ++ F+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 708 NGSLGDSLSGKNGIRLDWIRRLKIA---LGAARGLSYLHELANPPIIHRDIKSSNILLDE 764
GS D + +D + L IA G + L Y+H + +HR +K+S+IL+
Sbjct: 83 YGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILIS- 135
Query: 765 RLNAKVADFGLSKSMS--------DSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDV 814
++ KV GL ++S D VK + +L PE Q KSD+
Sbjct: 136 -VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK-VLPWLSPEVLQQNLQGYDAKSDI 193
Query: 815 YSFGVLMLELLTGRRPIE 832
YS G+ EL G P +
Sbjct: 194 YSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 266 VNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNL 324
++ L L N L G +PN ++ L L +++S NS +P S+ SL L + +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-NIPPSLGSITSLEVLDLSYNSF 478
Query: 325 KGQIPADLFSIPHLQTVVMKTNELNGTL 352
G IP L + L+ + + N L+G +
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 955 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.84 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.65 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.23 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.21 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.96 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.81 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.68 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.64 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.31 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.26 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-82 Score=805.75 Aligned_cols=837 Identities=27% Similarity=0.412 Sum_probs=486.8
Q ss_pred HHHHHHHHHHHHhhcCCHHHHHHHHHHHhhcCCC--CCCCCCCCCCCCCCCccEEeCC-CCEeEEEecCCcCccccCcCc
Q 002189 8 FLLSVYLQFLIIAAVTNDNDFVILKALKDDIWEN--EPPNWKNNDPCGDNWEGIGCTN-SRVTSITLSGMGLKGQLSGDI 84 (955)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~L~~~k~~~~~~--~~~~w~~~~~C~~~w~gv~C~~-~~v~~L~L~~~~l~~~~~~~l 84 (955)
+++++++++.+..+...++|.++|++||+++.+. ...+|+..++|| .|.||+|+. ++|+.|+|+++++++.++..|
T Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~ 89 (968)
T PLN00113 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNNSSRVVSIDLSGKNISGKISSAI 89 (968)
T ss_pred hHHHHHHHHHHHccCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCCCCcEEEEEecCCCccccCChHH
Confidence 4445555555556666789999999999998432 246898766664 799999974 799999999999999999999
Q ss_pred CCCCcccEEecCCCCCCccCCCCCcc-cccccccccccccccCCCCC----------------------CccccCCCCcE
Q 002189 85 TGLTELHTLDLSNNKDLRGPLPTTIG-NLKKLSNLMLVGCSFSGPIP----------------------DSIGSLQELVL 141 (955)
Q Consensus 85 ~~l~~L~~L~Ls~N~~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p----------------------~~~~~l~~L~~ 141 (955)
..+++|+.|+|++|+ +.+.+|..+. ++++|++|+|++|++++.+| ..++++++|++
T Consensus 90 ~~l~~L~~L~Ls~n~-~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 168 (968)
T PLN00113 90 FRLPYIQTINLSNNQ-LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV 168 (968)
T ss_pred hCCCCCCEEECCCCc-cCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCE
Confidence 999999999999997 8887887654 77777777777776665444 44444445555
Q ss_pred EEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeee
Q 002189 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHV 221 (955)
Q Consensus 142 L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L 221 (955)
|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++ .+.+|+.|+|++|++++.+|..+ ..+.+|++|
T Consensus 169 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~------~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L 241 (968)
T PLN00113 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG------QMKSLKWIYLGYNNLSGEIPYEI-GGLTSLNHL 241 (968)
T ss_pred EECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHc------CcCCccEEECcCCccCCcCChhH-hcCCCCCEE
Confidence 55555554444444455555555555555555444444333 23456666777777766666543 345567777
Q ss_pred eccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCC
Q 002189 222 LFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 222 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~ 300 (955)
+|++|++++.+|..++.+++|++|+|++|.+++.+|..+.++++|+.|+|++|.+++..| .+..+++|++|++++|.++
T Consensus 242 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~ 321 (968)
T PLN00113 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFT 321 (968)
T ss_pred ECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccC
Confidence 777777777777777777777777777777776677777777777777777777766555 3556666666666666665
Q ss_pred CCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc------------------------
Q 002189 301 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT------------------------ 356 (955)
Q Consensus 301 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~------------------------ 356 (955)
+ ..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+
T Consensus 322 ~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~ 400 (968)
T PLN00113 322 G-KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400 (968)
T ss_pred C-cCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHH
Confidence 4 455556666666666666666666666666666666666666666655444322
Q ss_pred -chhhhhhhcccCCccccccCCCCCCCcceeEecCcch-------------hcccCc-cccccccCCCCCCCCCCCCCCc
Q 002189 357 -SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPIC-------------QELGTA-KGYCQLSQPISPYSTKQKNCLP 421 (955)
Q Consensus 357 -~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~~c-------------~~~~~~-~~~c~~~~~~~~~~~~~~~~~~ 421 (955)
.+.+|+.|+|++|++++..+..+..+.+|+.++...+ .++..+ .+.|.+.+.+|.... ......
T Consensus 401 ~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~ 479 (968)
T PLN00113 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLEN 479 (968)
T ss_pred hCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceE
Confidence 1233444555555555444444444433333332211 111111 233333333322211 112222
Q ss_pred cccCCCCCCCCCCeeeEeeeeEEEEeccc-------------------cccCCCCchhhhhhHhhhhhhccccCCCcceE
Q 002189 422 APCNANQSSSPNCQCAYPYTGTLVFRSLS-------------------FSDLGNTTYYEILEQSVTTSFQSTYKLPIDSI 482 (955)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (955)
.....|.........-.. ...+.....+ ..++.+..+-. .....|.....+ ..+
T Consensus 480 L~ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L--~~L 552 (968)
T PLN00113 480 LDLSRNQFSGAVPRKLGS-LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG----QIPASFSEMPVL--SQL 552 (968)
T ss_pred EECcCCccCCccChhhhh-hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccc----cCChhHhCcccC--CEE
Confidence 333333322111100000 0000000000 00110000000 000011100000 000
Q ss_pred EecC-----ccc------CCcccceeeecc----ccCCcccceeeeeeeeeEEeeccccCCCCCCCCccccCCCCccccc
Q 002189 483 SLSN-----PHK------NNFEYLELSIQF----FPSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFNGDPYQYFAE 547 (955)
Q Consensus 483 ~~~~-----~~~------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~p~~~~~~~~~~~~~ 547 (955)
..+. ... .+...++++.-. +|.. ..|.... . .....++..+.+ ....+ ...
T Consensus 553 ~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~--~-~~~~~n~~lc~~---------~~~~~-~~~ 618 (968)
T PLN00113 553 DLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAIN--A-SAVAGNIDLCGG---------DTTSG-LPP 618 (968)
T ss_pred ECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccC--h-hhhcCCccccCC---------ccccC-CCC
Confidence 0000 000 000000100000 0000 0000000 0 000000000000 00000 000
Q ss_pred CCCCCcccceeEEehhhHHHHHHHHHHHHHHHHhhhhcchhhhhccCCCCcccccCCCCCCCCCCCCCcccCHHHHHHHh
Q 002189 548 SGGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYT 627 (955)
Q Consensus 548 ~~~~~~~~~~~~ii~~~~~~~v~ll~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~ 627 (955)
.....++...+++|++++++++ ++++++++++++++|++.+..........|..... .....+.++++++ .
T Consensus 619 c~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~---~ 689 (968)
T PLN00113 619 CKRVRKTPSWWFYITCTLGAFL-VLALVAFGFVFIRGRNNLELKRVENEDGTWELQFF-----DSKVSKSITINDI---L 689 (968)
T ss_pred CccccccceeeeehhHHHHHHH-HHHHHHHHHHHHHhhhccccccccccccccccccc-----ccccchhhhHHHH---H
Confidence 0011122233444444444333 33333333333333322111111111111111100 0011123444444 3
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
..|...++||+|+||+||+|+. .+|..||||+++..... ..+|++.+++++|||||+++|+|.+++..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4678889999999999999986 57899999998754322 234688999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++ .++|.++.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+......
T Consensus 766 ~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 766 EGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 9999999996 38999999999999999999997656679999999999999999988875 6665433211
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCC----chHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG----KYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~----~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
....||++|||||++.+..++.++|||||||++|||+||+.|++.. ....+|.+...... .....+||.+
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 909 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC----HLDMWIDPSI 909 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc----chhheeCccc
Confidence 1235889999999999999999999999999999999999998532 23444443322221 1233455554
Q ss_pred CC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 863 GL--STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 863 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.. ....+++.++.+++.+||+.||++||+|+||++.|+++.+.
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 32 23456677889999999999999999999999999988654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=472.36 Aligned_cols=285 Identities=53% Similarity=0.911 Sum_probs=249.3
Q ss_pred CCcccCHHHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEE
Q 002189 614 GARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693 (955)
Q Consensus 614 ~~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 693 (955)
..+.|++.|++.+|++|+..+.||+|+||.||+|.+.+|+.||||++........++|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46789999999999999999999999999999999999999999988765443145699999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEee
Q 002189 694 FDRG-EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 772 (955)
Q Consensus 694 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 772 (955)
.+.+ +.+||||||++|+|.++|+.....+++|.+|++||.++|+||+|||+...++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 599999999999999999986543889999999999999999999999988999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCC-----chHHHHHHHHHhh
Q 002189 773 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG-----KYIVREIRTVMDK 847 (955)
Q Consensus 773 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~-----~~~~~~~~~~~~~ 847 (955)
||+|+....... ...+...||.+|+|||++..+..+.|+|||||||+++|++||++|.+.. ..+.+|....+..
T Consensus 221 FGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976543111 1111117999999999999999999999999999999999999988732 3467777666655
Q ss_pred hhhhhhhhhccCCcCC-CCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 848 KKELYNLYELIDPTIG-LSTTL-KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
. .+.+++||.+. ..+.. +++.++..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 300 ~----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 G----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred c----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 5 47899999986 55554 68889999999999999999999999999986654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=415.21 Aligned_cols=258 Identities=36% Similarity=0.553 Sum_probs=216.1
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch--hHHHHHHHHHHHhccCCCcceEEEEEEeCC-eEEEEEEecCCC
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRG-EQMLIYEFVPNG 709 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~~~~g 709 (955)
.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+|+|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 34599999999999999754459999998654332 458999999999999999999999999987 799999999999
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecccccccCCCCCccee
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~ 788 (955)
+|.++++......+++..+++++.|||+||.|||+.+. ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccc
Confidence 99999987545689999999999999999999999764 99999999999999997 99999999998765422 223
Q ss_pred eeeecCCCCCCHHHhh--hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 789 TQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~--~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... ......+..... .|.+..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~---------Rp~~p~-- 269 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGL---------RPPIPK-- 269 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCC---------CCCCCc--
Confidence 3467999999999999 56999999999999999999999999987665 343333332221 222222
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 908 (955)
.+...+..++.+||+.||..||++.+++..|+.+......
T Consensus 270 --~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 270 --ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred --cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 2557889999999999999999999999999999876543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=424.55 Aligned_cols=411 Identities=23% Similarity=0.392 Sum_probs=286.9
Q ss_pred CcceEEecCcccCCcccceeeeccccCCcccceeeeeeeeeE--EeeccccCCCCCCCCccccCCCCccc-------c-c
Q 002189 478 PIDSISLSNPHKNNFEYLELSIQFFPSGQESFNRTGVSSVGF--VLSNQIYSPPPLFGPMFFNGDPYQYF-------A-E 547 (955)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~p~~~~~p~~~~~~~~~~~-------~-~ 547 (955)
-.-.++|+.+.+.|+..+++++.++++.+.+.+.+-+.+.+. +...........|...+......+.+ - .
T Consensus 457 ~sitlsW~~p~~png~ildYEvky~ek~~~e~~~~~~~t~~~~~ti~gL~p~t~YvfqVRarT~aG~G~~S~~~~fqT~~ 536 (996)
T KOG0196|consen 457 DSITLSWSEPDQPNGVILDYEVKYYEKDEDERSYSTLKTKTTTATITGLKPGTVYVFQVRARTAAGYGPYSGKHEFQTLP 536 (996)
T ss_pred CceEEecCCCCCCCCcceeEEEEEeeccccccceeEEecccceEEeeccCCCcEEEEEEEEecccCCCCCCCceeeeecC
Confidence 455788999999999999999999999877766665554432 22222111112222222111111100 0 0
Q ss_pred C-CCCCcccceeEEehhhHHHHHHHHHHHHHHHHhhhhcchhhhhccCCCCcccccCCCCC-CCCCC-CCCcccCHHHHH
Q 002189 548 S-GGSHKSTSIGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRAEKANEQNPFAHWDMNKSSG-SIPQL-KGARCFSFEEVK 624 (955)
Q Consensus 548 ~-~~~~~~~~~~~ii~~~~~~~v~ll~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~el~ 624 (955)
+ ...-.+..+.+|+|+++++++++++.+++.+.+.++|++..............+....+ ..|.. .-...++|+|--
T Consensus 537 ~~~~~~~~~~l~~i~g~~~~~v~~lll~~vv~~~~~~~r~~~~~~~~~~~~t~~~~~~~~~~~~pG~k~YiDP~TYEDPn 616 (996)
T KOG0196|consen 537 SESSSQSGEQLPLIIGSILAGVVFLLLAAVVVVAIVCSRKRCGYSRAEQEYTEKLQHYSNGEQLPGTKTYIDPHTYEDPN 616 (996)
T ss_pred cccccccccchhhHHHHHHHHHHHHHHHHHHHHhheeecccccchhcccCCChhHhhhhcCCCCCCceeecCCccccCcc
Confidence 0 11112233567777777777766655555555444433111100000000000000111 01100 012223444433
Q ss_pred HHhc---------CCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEE
Q 002189 625 KYTN---------NFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLL 690 (955)
Q Consensus 625 ~~~~---------~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~ 690 (955)
++-. ...+.++||.|.||+||+|+++ ....||||.+|..... .+.+|..|+.||.+++||||++|.
T Consensus 617 qAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 617 QAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred HHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 2222 2345679999999999999975 2357999999976554 356899999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEE
Q 002189 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 691 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
|+.......+||+|||+||+|+.+|+.+.+ .+++.+...+..+||.||.||.+.+ +|||||.++|||++.+..+||
T Consensus 697 GVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKV 772 (996)
T KOG0196|consen 697 GVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKV 772 (996)
T ss_pred EEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEe
Confidence 999999999999999999999999998765 5999999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCC-CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhh
Q 002189 771 ADFGLSKSMSDSE-KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 771 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 848 (955)
+|||++|.+.++. ....+....-+++|.|||.+..+++|.+|||||||+++||.++ |.+||.+..+. +.+..+
T Consensus 773 sDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-dVIkaI---- 847 (996)
T KOG0196|consen 773 SDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAI---- 847 (996)
T ss_pred ccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-HHHHHH----
Confidence 9999999875443 2222333445679999999999999999999999999999988 99998754432 222222
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
....+...+++++..|.+||+.||++|-.+||++.|++..|.+++.+..
T Consensus 848 ----------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 848 ----------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ----------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 2233444566788999999999999999999999999999999987643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=410.74 Aligned_cols=253 Identities=31% Similarity=0.518 Sum_probs=217.2
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcc
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 712 (955)
.+.||+|.||+||.|.++....||+|.++..... .++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 4669999999999999987779999999876444 467999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeee
Q 002189 713 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792 (955)
Q Consensus 713 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 792 (955)
++|+...+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||...+.. ........
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~k 365 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGK 365 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCCCC
Confidence 9999877778999999999999999999999988 9999999999999999999999999999554433 33444456
Q ss_pred cCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 793 gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
-++.|.|||.+..+.++.|||||||||+||||+| |+.|+... +..+.+.. ++...+...+..++
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-sn~ev~~~--------------le~GyRlp~P~~CP 430 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-SNEEVLEL--------------LERGYRLPRPEGCP 430 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-CHHHHHHH--------------HhccCcCCCCCCCC
Confidence 6789999999999999999999999999999999 88887543 22232222 22223334455677
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
..++++|..||+.+|++|||++.+...++++...
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 8999999999999999999999999988888643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=388.73 Aligned_cols=252 Identities=30% Similarity=0.472 Sum_probs=213.0
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC-CcchhHHHHHHHHHHHhccCCCcceEEEEEEe
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 695 (955)
++..|++. .+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||++||+|+.
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45555544 577999999999999975 6899999999543 33446789999999999999999999999999
Q ss_pred CC-eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 696 RG-EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 696 ~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
++ +..|+||||++|||++.+...+ ++++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++|||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccc
Confidence 99 5999999999999999987654 68899999999999999999996 66 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCC----chHHHHHHHHHhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG----KYIVREIRTVMDKKK 849 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~----~~~~~~~~~~~~~~~ 849 (955)
|.++.+.+. ....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+... ..+.+.+..++.+
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-- 297 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-- 297 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC--
Confidence 999987543 455688999999999999999999999999999999999999999753 2333333333222
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..|+++.. .+..++.+++..|+++||.+||+++|++++
T Consensus 298 --------ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 --------PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --------CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 23444332 455789999999999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=427.16 Aligned_cols=261 Identities=28% Similarity=0.491 Sum_probs=224.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
.+....+.||+|+||+||+|+.. +.+.||||.+++.... .+++|++|++++..++|||||+|+|.|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44556678999999999999853 3568999999987666 6789999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCC--------CCC----CCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 701 LIYEFVPNGSLGDSLSGKN--------GIR----LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
||+|||..|||.++|+... +.+ ++..+.+.||.|||.||+||-+++ +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999997532 223 899999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 847 (955)
||+|||++|.....+++.......-+++|||||.++.++||.+||||||||+|||+++ |+.||.+-.+. +.+.. +..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-EVIe~-i~~ 720 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-EVIEC-IRA 720 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-HHHHH-HHc
Confidence 9999999999888887766656677899999999999999999999999999999999 99998754332 22221 122
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
++ ....+..++.++++||..||+..|.+||+++||-..|+...+..
T Consensus 721 g~-------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 721 GQ-------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred CC-------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 11 23455667899999999999999999999999999999886543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.64 Aligned_cols=198 Identities=31% Similarity=0.516 Sum_probs=178.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.+|...+.||+|+||+||+|+++ ++..||||.+... .....+....|+++|+.++|||||++++++..++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777788999999999999975 6899999998765 33345667899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC------CceEEeecccccc
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER------LNAKVADFGLSKS 778 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~------~~~kl~DFGla~~ 778 (955)
||.+|+|.++++..+ .+++.....++.|+|.||++||+.+ ||||||||.||||+.. -.+||+|||+||.
T Consensus 90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999876 6899999999999999999999999 9999999999999865 4689999999999
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcC
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER 833 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~ 833 (955)
+.+.. .....+|++-|||||+++.++|+.|+|+||+|+++|||++|+.||+.
T Consensus 165 L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 165 LQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 87543 34457899999999999999999999999999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=363.69 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=209.3
Q ss_pred cCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEE-EEEeCCe-EEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLG-FCFDRGE-QMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV 702 (955)
.+|.+.++||+|.||+|||++ ..+|..||.|.++-+.. ...++...|+.+|++++|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 346667889999999999997 56899999999885433 34567889999999999999999998 4444444 8999
Q ss_pred EEecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 703 YEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELAN-PPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
|||+..|+|...++. .++..+++..++++..|+++||.++|+.-. ..|+||||||.||+|+.+|.+|++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998864 335679999999999999999999998432 23889999999999999999999999999988
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
.... ......+|||.||+||.+.+..|+.||||||+||++|||+.-++||.+. +....-.++. +.. -
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~-qgd---------~ 245 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIE-QGD---------Y 245 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHH-cCC---------C
Confidence 6433 3445688999999999999999999999999999999999999999765 3333222221 111 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
|.+ .......++..++..|+..||+.||+...++..+..-
T Consensus 246 ~~~---p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 246 PPL---PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCC---cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 111 1234557899999999999999999977777665553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=375.44 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=204.3
Q ss_pred HhcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcc-------hhHHHHHHHHHHHhccCCCcceEEEEEEeCC
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQ-------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 697 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 697 (955)
..+.|...+.||+|+||.|-+|. ..+|+.||||++.+.... ....+++|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567778999999999999997 458999999999753221 2234679999999999999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC---CceEEeecc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFG 774 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFG 774 (955)
..|||||||++|+|.+.+-.++ .+.+..-.-++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999887665 4555566778999999999999999 9999999999999766 789999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhhhCC---CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 851 (955)
+|+..+.. ..+.+.+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.+..........+......
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~- 400 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA- 400 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc-
Confidence 99987633 4566789999999999998653 3348899999999999999999997443322222222221110
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ......+..++..++|.+||..||++||++.|++++
T Consensus 401 --f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 401 --F--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --c--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0 111233445788999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=384.47 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=210.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
..|...+.||+|||+.||+++. ..|+.||+|++.+... ...+.+.+|+++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4578889999999999999996 7899999999976422 33467889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
|+|++|+|.++++.. .++++..+..++.||+.||.|||+++ |||||||..|+++++++++||+|||||..+...+
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999988744 48999999999999999999999999 9999999999999999999999999999886443
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
. .....+||+-|+|||++.....+..+||||+|||+|-|+.|++||+.. +..+....+... +..-|.
T Consensus 173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-~vkety~~Ik~~--------~Y~~P~-- 239 (592)
T KOG0575|consen 173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-TVKETYNKIKLN--------EYSMPS-- 239 (592)
T ss_pred c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-hHHHHHHHHHhc--------Cccccc--
Confidence 2 234589999999999999999999999999999999999999999643 222222222211 111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+||.++|++||.+|||+++|+.+
T Consensus 240 -----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 -----HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222567799999999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=410.65 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=220.9
Q ss_pred CCCccCeeeccCceEEEEEEeC--CCc----EEEEEEcccC-CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP--NGQ----LIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~--~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.....+.||+|+||.||+|.+. +|. .||||.+++. +.++..+|.+|..+|++++|||||+++|.|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3445678999999999999864 343 4899998865 44556789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 702 IYEFVPNGSLGDSLSGKN-----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
++|||++|+|..+|+... ...++....+.++.|||+|+.||++.+ +|||||.++|+||++...+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998652 346889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
|++...+++.......-+.+|||||++..+.++.|+|||||||++||++| |..||....+. +.+..+..+.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~~gg------- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVLEGG------- 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHHhCC-------
Confidence 97776666555444456789999999999999999999999999999999 88888654432 2222232222
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
+.+.+..+++.++++|.+||+.+|++||++..+++.+..+.+...
T Consensus 922 -------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 -------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 234455678899999999999999999999999999999987653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.45 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=204.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
+.|+.+.++|+|+||+|||++.+ +|+.||||++.... ..-.+-..+|+++|++++|+|+|.++++|..+...+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35667788999999999999975 69999999997532 2233557899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
||+..-|.+.=+... .++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+|+||||+||.+....
T Consensus 82 ~~dhTvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred ecchHHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 998755544333222 4788889999999999999999998 9999999999999999999999999999987422
Q ss_pred cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-------hh---
Q 002189 785 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-------YN--- 853 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------~~--- 853 (955)
...+.++.|.+|+|||.+.+ .+|...+||||.||++.||++|.+-| .+.+.++++..+...-..+ +.
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~-PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW-PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC-CCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 23456789999999999987 68999999999999999999999655 5555555554443322111 10
Q ss_pred -hhhccCCcCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 -LYELIDPTIG-----LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 -~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+..+.-|... .....+...-+.+++..|++.||++|++.+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111 11111223457899999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.37 Aligned_cols=263 Identities=26% Similarity=0.422 Sum_probs=209.0
Q ss_pred cCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 702 (955)
+.|..+++||+|+||.||||+ ..+|+.||+|+++..... ...-..+||.+|++|.||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345556779999999999998 568999999998865433 235567899999999999999999999887 689999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
+|||++ +|.-++.. .+..++..++..++.|++.||+|||+.+ |+|||||.+|||||.+|.+||+|||||+.+...
T Consensus 197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999976 77776654 3567999999999999999999999999 999999999999999999999999999988655
Q ss_pred CCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-hhhhhh-----
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-ELYNLY----- 855 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~----- 855 (955)
... ..+..+-|.+|+|||.+.+. .|+.++|+||.|||+.||++|++.+ .+.+.++++..++.--. .-...+
T Consensus 272 ~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~-~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL-QGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc-CCccHHHHHHHHHHHhCCCChhccccccC
Confidence 543 35567889999999999965 7999999999999999999998555 66677777766664211 000011
Q ss_pred ---hccCCcCCCCCCHH-----HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 856 ---ELIDPTIGLSTTLK-----GFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 856 ---~~~d~~l~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
..+.|......... .....++|+..+|..||++|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11122211111111 1255789999999999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=369.02 Aligned_cols=263 Identities=24% Similarity=0.416 Sum_probs=222.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch-hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.+.....++||+|.||+|..++...+.+||||+++..+... +++|.+|+++|.+++|||||+++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 45566788999999999999999888999999999876554 48999999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
|++|+|.+++..+......-....+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||++|-+..++..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999998775434566777889999999999999988 999999999999999999999999999988888888
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh--CCCCCcCCch--HHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRPIERGKY--IVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt--g~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.+....+-+++|||+|.+.-++++.++|||+||+++||+++ .+.||....+ .++.......... +.
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~----------~~ 763 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG----------RQ 763 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC----------cc
Confidence 88888889999999999999999999999999999999876 7788864322 2222211111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.....+..++..+++++.+||..|-.+||+++++...|.+.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12233445678899999999999999999999999887754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=358.28 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=206.9
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|+..++||+|+||+||.++. ++++.+|+|++++.... +.+...+|..+|.+++||.||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 35688999999999999999985 46899999999875433 345678899999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
+||+.||.|..+|+.++ .+++.....++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-..
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999998765 6888888899999999999999999 999999999999999999999999999854332
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
+ ..+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||... +...+...+..... ...|.
T Consensus 179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-~~~~~~~~I~~~k~-------~~~p~- 247 (357)
T KOG0598|consen 179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-DVKKMYDKILKGKL-------PLPPG- 247 (357)
T ss_pred C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-cHHHHHHHHhcCcC-------CCCCc-
Confidence 2 2344589999999999999999999999999999999999999999643 33344444433320 00111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRP----TMSEVVK 897 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 897 (955)
....+..+++.+.+..||++|. ++.++-+
T Consensus 248 ------~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 248 ------YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ------cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1125678999999999999995 5666554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=366.26 Aligned_cols=264 Identities=23% Similarity=0.364 Sum_probs=213.2
Q ss_pred HhcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcch-hHHHHHHHHHHHhcc-CCCcceEEEEEEeCC-eEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVH-HKNLVSLLGFCFDRG-EQML 701 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~l 701 (955)
..++|...++||.|+||.||+|+ ..+|+.||||++++.-... +-.=.+|++.|+++. |||||++.+++.+.+ ..|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34577888999999999999998 4578999999998643332 223468999999998 999999999999988 9999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||| ..+|.+.++.+ +..+++..+..|+.||.+||+|+|.+| +.|||+||+|||+..+..+||+|||+||....
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99999 56999999877 678999999999999999999999999 99999999999999988999999999998764
Q ss_pred CCCcceeeeeecCCCCCCHHHhh-hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh--------hhh
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--------ELY 852 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~--------~~~ 852 (955)
.. ..+.++.|.+|+|||++. .+-|+.+.||||+|||++|+.+-+ |...|.+..+++.++.+-.. +.+
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr-PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR-PLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc-ccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 33 345678999999999987 568999999999999999999876 55577777777776664111 011
Q ss_pred hhhhccC---CcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLYELID---PTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~~~~d---~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+...+. |.... .-......++.+++.+|+..||++|||++|++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111 11100 0111245788999999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=333.24 Aligned_cols=262 Identities=25% Similarity=0.375 Sum_probs=213.0
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch--hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...++||+|.||.||+|+. .+|+.||||+++.....+ .....+|++.|+.++|+||+.+++++...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 566778899999999999984 579999999998764443 24578999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
|+ .+|+..++.. ...++..++..++.++.+|++|||+.. |+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 83 m~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 95 5898888765 457899999999999999999999999 999999999999999999999999999998765542
Q ss_pred ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----hhhhhhhc--
Q 002189 786 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----ELYNLYEL-- 857 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-- 857 (955)
.+..+-|.+|+|||.+.+ +.|+..+||||.||++.||+-|. |+..|++..+++..++..-. ++.++...
T Consensus 158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 333478999999999986 47999999999999999999866 77777777777777665221 11111111
Q ss_pred ------cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 ------IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.+......-..+..++.+++.+|+..||.+|++++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111223344677999999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.71 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=210.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 701 (955)
-.+|...+.||+|+|++||+|+. ..++.+|||++.+.-. ...+-+.+|-++|.+| .||.|++|+..|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 45678888999999999999984 5689999999875422 2224467899999999 79999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+||+++|+|.++|++.+ .+++.....++.+|+.||+|||++| ||||||||+|||||+||++||+|||.|+.+.+
T Consensus 152 vLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999998776 6888888899999999999999999 99999999999999999999999999998865
Q ss_pred CCCc---------ce--eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 782 SEKD---------HI--TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 782 ~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
.... .. ...++||..|++||++..+..+..+|+|+|||+||.|+.|.+||...... -..++++.-
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqkI~~l--- 302 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQKIQAL--- 302 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHHHHHh---
Confidence 3321 11 14589999999999999999999999999999999999999999765433 222222221
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...++...++.+.+|+.+.|..||.+|++.+||.++
T Consensus 303 ------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 112223334778899999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=369.13 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=214.4
Q ss_pred cCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
..|....+||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|..+++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 356667889999999999997 4578999999998766666677889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+.+... .+++.++..|+.++++||+|||..+ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999988754 5899999999999999999999999 99999999999999999999999999988865543
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....+||++|||||+.....|.+|+||||||++++||+.|++||-....+ ..+..+...+ .|++ ..
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-rAlyLIa~ng----------~P~l--k~ 491 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIATNG----------TPKL--KN 491 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-HHHHHHhhcC----------CCCc--CC
Confidence 345678999999999999999999999999999999999999999764433 3333333222 2222 23
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......|.+++.+||+.|+++|++++|++++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 34445788999999999999999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=358.32 Aligned_cols=255 Identities=31% Similarity=0.469 Sum_probs=204.3
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC--eEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG--EQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~ 705 (955)
++...+.||+|+||+||++... +|+..|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4566788999999999999865 48999999887653333567899999999999999999999855554 58999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccccccCC-CC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSD-SE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~-~~ 783 (955)
+++|+|.+++...++ .+++..+..+..||++||+|||+++ ||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999998776 7999999999999999999999999 999999999999999 79999999999987653 11
Q ss_pred CcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.........||+.|||||++..+ ....++||||+||++.||+||++||..-.....++..+.... .-|.+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~---------~~P~i 244 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED---------SLPEI 244 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------CCCCC
Confidence 12223457899999999999964 344599999999999999999999965311122221111111 11222
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+ .....+..+++.+|++.||.+|||+++++++.-
T Consensus 245 p----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 245 P----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred C----cccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1 123367889999999999999999999998744
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=368.19 Aligned_cols=261 Identities=28% Similarity=0.467 Sum_probs=210.1
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch--hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.+.+...+.||+|.||+||+|+|. ..||||+++...... .+.|+.|+.++++-||.||+=|.|||..... .||+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 334456788999999999999985 469999998765543 4789999999999999999999999988877 99999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
||++-+|+.++|..+ ..++..+.+.||.|||+||.|||..+ |||||||..||++.+++.|||+|||++..-.....
T Consensus 468 wCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999999764 57899999999999999999999998 99999999999999999999999999965433222
Q ss_pred cceeeeeecCCCCCCHHHhhhC---CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
........|...|||||+++.+ .|++.+||||||+|+|||+||..||. .+.- +++--.+..+. .-|.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~-dqIifmVGrG~--------l~pd 613 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR-DQIIFMVGRGY--------LMPD 613 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh-hheEEEecccc--------cCcc
Confidence 2223345688899999999844 68999999999999999999999997 3222 22111111110 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
+ ......+..++.+|+..||..++++||.+.+|+..|+.++..
T Consensus 614 ~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 614 L-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred c-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1 112234556888999999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=369.77 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=206.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCC-
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG- 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~- 697 (955)
.++|...++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|++++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45688889999999999999974 2356899999875432 2345788999999999 8999999999987654
Q ss_pred eEEEEEEecCCCCcccccCCCC----------------------------------------------------------
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN---------------------------------------------------------- 719 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 719 (955)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999988876421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCC
Q 002189 720 --GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797 (955)
Q Consensus 720 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 797 (955)
..++++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788899999999999999999988 999999999999999999999999999865433221222234467889
Q ss_pred CCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHH
Q 002189 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVD 876 (955)
Q Consensus 798 ~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 876 (955)
+|||++.+..++.++|||||||++|||++ |..||.......... ....... .+.. .......+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~---------~~~~----~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC-QRLKDGT---------RMRA----PENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH-HHHhcCC---------CCCC----CCCCCHHHHH
Confidence 99999999999999999999999999997 999986533221111 1111110 0111 1123367889
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 877 LALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 877 li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
++.+||+.||++||++.|+++.|+++++.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=349.31 Aligned_cols=262 Identities=25% Similarity=0.376 Sum_probs=210.9
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch-hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+.|...++||.|.-++||+|+. +.++.||||++.-+.... .+.+++|+..|..++||||++.+..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 4678889999999999999984 578999999998654433 47899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
|.+||+.+.++..-...+++..+..|..++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+.+.+..
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 99999999987655556899999999999999999999999 999999999999999999999999998766544321
Q ss_pred c-ee-eeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 786 H-IT-TQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 786 ~-~~-~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
. .. ..++||+.|||||++++ ..|+.|+||||||++..|+.+|..||..-......+.+....... ..-..
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~------~~t~~ 256 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT------LLTSG 256 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC------ccccc
Confidence 1 11 45689999999999764 469999999999999999999999997544332222222111100 00001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+..+........+.+++..|+++||.+|||+++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1222233344678999999999999999999999964
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.46 Aligned_cols=259 Identities=30% Similarity=0.480 Sum_probs=211.3
Q ss_pred CCCccCeeeccCceEEEEEEeC--CC--cE-EEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP--NG--QL-IAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~--~g--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
+....++||+|+||+||+|++. ++ .. ||||..+... ....++|.+|+++|++++|||||+++|++..+...+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 3445588999999999999864 33 23 8999988522 334578999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+|||+|+||+|.++|+..++ .++..+++.++.++|+||+|||+.+ +|||||.++|+|++.++.+||+|||+++.-.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999987654 6999999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
..........-+.+|+|||.+..+.+++++|||||||++||+++ |..||.+.... +....+.....
T Consensus 314 --~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-~v~~kI~~~~~---------- 380 (474)
T KOG0194|consen 314 --QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-EVKAKIVKNGY---------- 380 (474)
T ss_pred --ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-HHHHHHHhcCc----------
Confidence 11111112346789999999999999999999999999999999 88898654432 33333322221
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
+...+...+..+..++.+||..+|++||+|.++.+.++.+.....
T Consensus 381 ---r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 ---RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111222445778889999999999999999999999999986654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.65 Aligned_cols=259 Identities=29% Similarity=0.456 Sum_probs=202.2
Q ss_pred CccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHh--ccCCCcceEEEEEEeCC----eEEEEEE
Q 002189 631 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSR--VHHKNLVSLLGFCFDRG----EQMLIYE 704 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~e 704 (955)
...+.||+|+||.||||++. ++.||||++.. ++.+.|+.|-++... ++|+||++|+++-...+ +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34567999999999999986 49999999964 345678888777774 48999999999876655 8999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc------cCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL------ANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
|.+.|+|.++|..+ .++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||+|..
T Consensus 289 fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999866 699999999999999999999963 367899999999999999999999999999988
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCC-CC-----ChhhhHHHHHHHHHHHhCCCCCcCC---------------chH
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQ-LT-----EKSDVYSFGVLMLELLTGRRPIERG---------------KYI 837 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDvwS~Gv~l~elltg~~P~~~~---------------~~~ 837 (955)
+.........-..+||.+|||||++.+.. +. .+.||||+|.|+|||++....++.+ ...
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 87655444444578999999999998643 22 3689999999999999965443210 111
Q ss_pred HHHHHHHHhhhhhhhhhhhccCCcCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 838 VREIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
.+.++..+- .+...|.++.. ..-..+..+.+.+..||..||+.|.|+.=|-+.+.++..
T Consensus 446 ~e~mq~~VV--------~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 446 LEEMQELVV--------RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHH--------hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 122222221 12223333221 111456778899999999999999999999888887753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=361.04 Aligned_cols=242 Identities=28% Similarity=0.470 Sum_probs=204.6
Q ss_pred CccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 631 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
..++-||+|+.|.||+|++. ++.||||+++.- -..+++-|++|+|+||+.|.|+|.....++||||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34566999999999999986 589999988632 1347899999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeee
Q 002189 711 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ 790 (955)
Q Consensus 711 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 790 (955)
|...|+... .++......|..+||.||.|||.+. |||||||.-||||+.+..+||+|||.++...+. .....
T Consensus 199 L~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 199 LYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 999998654 6788888999999999999999988 999999999999999999999999999887544 23456
Q ss_pred eecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHH
Q 002189 791 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 870 (955)
Q Consensus 791 ~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (955)
++||..|||||++.....+.|+||||||||||||+||..||.+-... .. ++.+-.-.+....+..+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AI----------IwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AI----------IWGVGSNSLHLPVPSTC 336 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----ee----------EEeccCCcccccCcccC
Confidence 89999999999999999999999999999999999999999642211 00 11111222333445567
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 871 FEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 871 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
++-|.-|+++||.-.|..||++++++.+|+-+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 78899999999999999999999999998744
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.10 Aligned_cols=259 Identities=21% Similarity=0.339 Sum_probs=207.8
Q ss_pred CcccCHHHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch---hHHHHHHHHHHHhccCCCcceEEE
Q 002189 615 ARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLG 691 (955)
Q Consensus 615 ~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~ 691 (955)
.+.++.+++. ......||+|++|.||+|++ +|+.||||+++...... .+.|.+|+++|++++|||||+++|
T Consensus 12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 4455666652 23336799999999999998 68999999997643332 366889999999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCC
Q 002189 692 FCFD----RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERL 766 (955)
Q Consensus 692 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~ 766 (955)
++.+ ....++||||+++|+|.++++... .+++.....++.+++.||+|||+. + ++||||||+||++++++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENY 160 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCC
Confidence 9977 346789999999999999997654 688999999999999999999974 6 78999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHH
Q 002189 767 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 844 (955)
Q Consensus 767 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~ 844 (955)
.+||+|||+++.+..... ...|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+
T Consensus 161 ~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-~~~~~~~i 234 (283)
T PHA02988 161 KLKIICHGLEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLI 234 (283)
T ss_pred cEEEcccchHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-HHHHHHHH
Confidence 999999999987643221 2458899999999976 689999999999999999999999997543 22222222
Q ss_pred HhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 845 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
..... .+.. +......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 235 ~~~~~---------~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 235 INKNN---------SLKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HhcCC---------CCCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 21111 1111 1234567899999999999999999999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=355.42 Aligned_cols=247 Identities=26% Similarity=0.443 Sum_probs=210.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|...+.||+|+||.||||+.+ +.+.||+|.+.+.... +.+.+.+|++++++++|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777888999999999999854 6899999998764332 34668899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+.+ +|..++...+ .+++..+..++.+++.||.|||+.+ |+|||+||.|||++.++.+|+||||+||.+.. .
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9966 9999998765 6899999999999999999999998 99999999999999999999999999998764 3
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
..+.+...||+-|||||...++.|+..+|+||+||++||+++|++||.. ..+...++.+.. ||..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~------------d~v~-- 218 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILK------------DPVK-- 218 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhc------------CCCC--
Confidence 4566788999999999999999999999999999999999999999953 222233332221 1111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
++......+..++...+.+||.+|.+..+++.+
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122445788999999999999999999999865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=347.93 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=208.9
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.|...+.||+|.||.||||.. ..++.||+|++...... +.+++++|+.++..++++||.++||.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 456668899999999999985 46899999999865443 3477999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
.+|++.+.++... .+++.....++.++..|+.|||.++ .+|||||+.|||+..+|.+|++|||++..+.....
T Consensus 94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 9999999998654 4477777788999999999999998 99999999999999999999999999988764433
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
....++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+..... .+-++.+.+...|.+..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------mrvlflIpk~~PP~L~~-- 233 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------MRVLFLIPKSAPPRLDG-- 233 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------ceEEEeccCCCCCcccc--
Confidence 23568899999999999988999999999999999999999999864221 12222233444555544
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+.+++..|+.+||+.||++++++++
T Consensus 234 --~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 --DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 333668899999999999999999999974
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.79 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=222.7
Q ss_pred cCCCccCeeeccCceEEEEEEeCC-CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+....++||-|.||.||.|.|+. .-.||||.++.+.+ ..++|..|..+|+.++|||+|+++|+|..+...|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 445667899999999999999864 46899999987654 4578999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
.+|+|.+||+..++..++..-.+.++.||+.||+||...+ +|||||.++|+|+.++..+||+||||+|.+.... +.
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc-ee
Confidence 9999999999888878888889999999999999999888 9999999999999999999999999999986543 33
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.+....-++.|.|||.+....++.|+|||+|||+||||.| |..||.+ .+.. + +++++....+.+
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlS-q-------------VY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLS-Q-------------VYGLLEKGYRMD 486 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHH-H-------------HHHHHhcccccc
Confidence 4444556789999999999999999999999999999999 8888743 2221 1 333444445556
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.+..|+.++++||+.||+..|.+||+++|+-+.++.+++.
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 6777889999999999999999999999999998887643
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=348.62 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=202.5
Q ss_pred cCCCccCeeeccCceEEEEEEeCC-----------------CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN-----------------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSL 689 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l 689 (955)
++|...++||+|+||.||+|.+.+ +..||+|.++..... ...+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999997532 347999998764333 34579999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCcccccCCCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeec
Q 002189 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKN-----------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752 (955)
Q Consensus 690 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 752 (955)
++++.+.+..++||||+++|+|.+++.... ...++|...++++.|++.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999998775321 124788899999999999999999998 999
Q ss_pred cCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh--CCCC
Q 002189 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRP 830 (955)
Q Consensus 753 rDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt--g~~P 830 (955)
|||||+||++++++.+||+|||+++...............++..|||||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987654433222333456789999999998999999999999999999987 5567
Q ss_pred CcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 831 IERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
|..... .+........... . ...........++..+.+++.+||+.||.+||+++||.+.|+
T Consensus 242 ~~~~~~-~~~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD-EQVIENAGEFFRD------Q-GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH-HHHHHHHHHHhhh------c-cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 754322 1111111110000 0 000000111233467899999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.50 Aligned_cols=261 Identities=24% Similarity=0.315 Sum_probs=205.3
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchh--HHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEEEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIYE 704 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 704 (955)
|+.++.|++|+||.||+|+. ++++.||+|+++....... -.-.+|+.+|.+++|||||.+..+.... +..|||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 55678899999999999985 4789999999986543322 2357899999999999999999988764 57899999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
||++ +|...+...+ +++...+...++.|+++|++|||+.. |+|||||++|+|++..|.+||+|||+||.++.+-+
T Consensus 158 ~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9976 7887777554 57889999999999999999999999 99999999999999999999999999999976643
Q ss_pred cceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-hhhhhhccC---
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLYELID--- 859 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d--- 859 (955)
..+..+-|.+|+|||.+.+. .|+..+|+||+|||+.||+++++ ...|+...+++..++..... ...++.-++
T Consensus 233 --~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP-lf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 233 --PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP-LFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred --cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC-CCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 34567889999999999864 69999999999999999999885 44666666777666653210 000010000
Q ss_pred -------CcC-----CCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 -------PTI-----GLSTTLK-GFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 -------~~l-----~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.. ...+... ..+.-++|+..++..||.+|.|++|.+++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000 0001101 12556899999999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=361.55 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=204.0
Q ss_pred cCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
++|+..+.||+|+||+||+|++ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4577789999999999999973 235689999997543 23346788999999999 899999999999999999
Q ss_pred EEEEEecCCCCcccccCCCC------------------------------------------------------------
Q 002189 700 MLIYEFVPNGSLGDSLSGKN------------------------------------------------------------ 719 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 719 (955)
++||||+++|+|.++++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999988875321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 720 -------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 720 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
...+++..+.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 125788999999999999999999988 9999999999999999999999999998765433222
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......++..|+|||++.+..++.++|||||||++|||++ |..||.......... ....... ....|
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~-~~~~~~~------~~~~~----- 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY-KMIKEGY------RMLSP----- 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH-HHHHhCc------cCCCC-----
Confidence 2222345678999999999999999999999999999998 888886433222111 1111110 00011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.....++.+++.+||+.||++||+++|+++.|++.
T Consensus 340 --~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 --ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11235788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=345.39 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=203.7
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchh---HHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|..+.+||+|+||+||.|+- .+|..+|+|++++..+... +.++.|-.+|....+|+||+++..|.+.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46899999999999999999985 4699999999998655443 4577899999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC-
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD- 781 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~- 781 (955)
|||++||++..+|...+ .|++.....++.+++.|++-+|..| +|||||||+|+|||..|++||+||||+.-+..
T Consensus 220 MEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999998765 6777788889999999999999999 99999999999999999999999999853321
Q ss_pred ---------------------CCCc----ce-------------------eeeeecCCCCCCHHHhhhCCCCChhhhHHH
Q 002189 782 ---------------------SEKD----HI-------------------TTQVKGTMGYLDPEYYMTQQLTEKSDVYSF 817 (955)
Q Consensus 782 ---------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~ 817 (955)
.+.. .. ....+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 00 012579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHH
Q 002189 818 GVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP---TMSE 894 (955)
Q Consensus 818 Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~e 894 (955)
|||+|||+.|.+||...... +..+.++..... ..-| .......+..|||.+|+. ||++|. .++|
T Consensus 375 G~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~------l~fP-----~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRET------LKFP-----EEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhh------ccCC-----CcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 99999999999999654433 333333322211 0111 111222678899999999 999996 4667
Q ss_pred HHHH
Q 002189 895 VVKD 898 (955)
Q Consensus 895 vl~~ 898 (955)
|-++
T Consensus 442 IK~H 445 (550)
T KOG0605|consen 442 IKKH 445 (550)
T ss_pred HhcC
Confidence 7654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.57 Aligned_cols=249 Identities=34% Similarity=0.577 Sum_probs=197.4
Q ss_pred cCeeeccCceEEEEEEeC-----CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 633 ANDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+.||.|.||.||+|.+. .+..|+||.++..... ..++|.+|++.+++++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 2578999999764333 3678999999999999999999999999888899999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++......+++..++.|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||+++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999998775567999999999999999999999988 9999999999999999999999999998774333322
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......+...|+|||.+....++.++||||||+++|||++ |+.|+... ...+..... ..... . .
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~~~~-------~------~ 225 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQGQR-------L------P 225 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HTTEE-------T------T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-ccccc-------c------e
Confidence 2333457789999999999999999999999999999999 67888654 323333322 21110 0 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
........+.+++.+||..||++||+++++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112346788999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=360.58 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=204.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
++|...+.||+|+||.||+|+.. ++..||||+++..... ..+.+.+|+++++.+ +|+|||+++++|.+.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46788899999999999999742 3458999999754332 345688999999999 899999999999999999
Q ss_pred EEEEEecCCCCcccccCCCC------------------------------------------------------------
Q 002189 700 MLIYEFVPNGSLGDSLSGKN------------------------------------------------------------ 719 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 719 (955)
++||||+++|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999988775321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeee
Q 002189 720 --------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 720 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
..++++.+..+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 124788899999999999999999988 999999999999999999999999999876443222222223
Q ss_pred ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHH
Q 002189 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 870 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (955)
.++..|||||++.+..++.++|||||||++|||++ |+.||........ ........ ..+.. ....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~---------~~~~~----~~~~ 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRG---------YQMSR----PDFA 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcc---------cCccC----CCCC
Confidence 45678999999999999999999999999999997 9999864322111 11111111 01111 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 871 FEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 871 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
..++.+++.+||+.||++||++.++++.|++++
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 367889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=320.36 Aligned_cols=236 Identities=28% Similarity=0.381 Sum_probs=201.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchh---HHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+...-.. +...+|..+|+.+.||.++++.+.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35777889999999999999864 688999999987544433 34567999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|-|..++++.+ +++......+|.+|+.||+|||+.+ |++||+||+|||||++|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999998765 6889999999999999999999999 999999999999999999999999999987532
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
+-..+||+.|+|||.+....+..++|.|||||++|||+.|.+||..... .....++....-
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v-------------- 258 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKV-------------- 258 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcc--------------
Confidence 4468999999999999999999999999999999999999999976554 233333332211
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCC
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDR 889 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~R 889 (955)
.++.....++.+|+.+.++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1122223577899999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=351.10 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=206.2
Q ss_pred HhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC----Cc-chhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG----SM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGE 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 698 (955)
..+.|...+.||+|+||+|+.|.. .+|+.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 356788899999999999999975 47899999977653 11 23456778999999999 9999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-CceEEeeccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSK 777 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~ 777 (955)
.++||||+.+|+|.+++...+ ++.+.....++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999998743 6888999999999999999999999 9999999999999999 999999999999
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCC-CC-ChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQ-LT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .......+.....
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-~~~l~~ki~~~~~------ 240 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-VPNLYRKIRKGEF------ 240 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-HHHHHHHHhcCCc------
Confidence 873 1123345578999999999999877 86 68999999999999999999997632 2222222211111
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+...+. ..++.+++.+|+..||.+|+++.|++++
T Consensus 241 -~~p~~~~-------S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 241 -KIPSYLL-------SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred -cCCCCcC-------CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 0111110 3678899999999999999999999943
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=344.46 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=202.1
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
|+..+.||+|+||+||+|.. .+|+.||||.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999985 5789999999865322 2234578899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999988876544456899999999999999999999988 9999999999999999999999999998754322
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH--HHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV--REIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... +.+..... .+ .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~------------~~--~ 221 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK------------ED--Q 221 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh------------cc--c
Confidence 1233568999999999999999999999999999999999999997543211 11111110 00 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
..........+.+|+.+||+.||.+||+ +++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1112223467889999999999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.62 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=216.9
Q ss_pred cCCCccCeeeccCceEEEEEEeCC---C--cEEEEEEcccC-CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN---G--QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~---g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
+.....++||+|-||.||+|.+.+ | -.||||..+.+ ...+.+.|..|..+|++++|||||+++|.|.+ ...||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556789999999999998643 3 35899998874 44456789999999999999999999999965 57899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|||.++-|-|..+|+.++ ..++......++.||..+|+|||+.. +|||||.++|||+...--+|++|||++|.+.+
T Consensus 468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999998664 46888899999999999999999988 99999999999999999999999999999887
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
......+ ...-++.|||||.+..++++.++|||.|||.+||++. |..||.+-++.. +...+..
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI~~iEn 607 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VIGHIEN 607 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------eEEEecC
Confidence 6654433 4567889999999999999999999999999999988 999997543310 2222222
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.-+...+..++..++.++.+||..||.+||.+.|+...|..+++..
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 3334456678889999999999999999999999999999998744
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=336.20 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=204.3
Q ss_pred HHHHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--------------hhHHHHHHHHHHHhccCCC
Q 002189 621 EEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--------------GGQEFKMEIELLSRVHHKN 685 (955)
Q Consensus 621 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~n 685 (955)
.+-.+..++|...+.||+|.||.|-+|+. .+++.||||++.+.... ..+...+|+.+|++++|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 34455678899999999999999999985 47899999998642111 1246889999999999999
Q ss_pred cceEEEEEEeC--CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 686 LVSLLGFCFDR--GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 686 iv~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
||+|+++..+. +..|||+|||..|.+...-... ..++..+.+++..++..||+|||.++ ||||||||+|+||+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 99999998764 6789999999988875443222 13899999999999999999999999 99999999999999
Q ss_pred CCCceEEeecccccccCCC---CCcceeeeeecCCCCCCHHHhhhCC----CCChhhhHHHHHHHHHHHhCCCCCcCCch
Q 002189 764 ERLNAKVADFGLSKSMSDS---EKDHITTQVKGTMGYLDPEYYMTQQ----LTEKSDVYSFGVLMLELLTGRRPIERGKY 836 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwS~Gv~l~elltg~~P~~~~~~ 836 (955)
++|++||+|||.+...... +....-...+||+.|||||...++. .+.+.||||+||+||.|+.|+.||.+. .
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-~ 323 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-F 323 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-h
Confidence 9999999999998765322 1111122367999999999998743 356899999999999999999999643 2
Q ss_pred HHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 837 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
..+...++. ...+......+..+++.+||+++|.+||++|.+..+|..+.+
T Consensus 324 ~~~l~~KIv-------------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 324 ELELFDKIV-------------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHHHh-------------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 223222222 222222222244578899999999999999999999987755
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.78 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=210.9
Q ss_pred cCeeeccCceEEEEEEeC--CCc--EEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 633 ANDVGSGGYGKVYKGTLP--NGQ--LIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
.++||+|.||.|++|.|. .|+ .||||.++..... ...+|.+|+.+|-+|+|||+++|||.+.+ ....||||+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 467999999999999985 344 5899999976655 56889999999999999999999999987 67889999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
.|+|.+.|++.....+-......++.|||.||+||.+.+ +|||||.++|+|+-....+||+||||.|-++..+..+.
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 999999999855567888888999999999999999988 99999999999999999999999999998876554333
Q ss_pred e-eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 788 T-TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 788 ~-~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
. ....-.+.|.|||.+..+.++.++|||+|||+||||+| |+.||-+-.- .+ +.+.+|......
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-~q--------------IL~~iD~~erLp 335 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-IQ--------------ILKNIDAGERLP 335 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-HH--------------HHHhccccccCC
Confidence 2 23456778999999999999999999999999999999 8889854322 11 233344444455
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
....+.+++++++++||..+|.+||++..+.+++-
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 66678899999999999999999999999986543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=332.53 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=211.0
Q ss_pred HHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhc--cCCCcceEEEEEEeCC--
Q 002189 622 EVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV--HHKNLVSLLGFCFDRG-- 697 (955)
Q Consensus 622 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~-- 697 (955)
..+....+....+.||+|.||+||+|+|+ |+.||||++.. .+++.+.+|.++.+.. +|+||+.|++.-..++
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 34455667888899999999999999996 79999999964 3456788888888865 9999999999865443
Q ss_pred --eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-----ccCCCeeccCCCCccEEEcCCCceEE
Q 002189 698 --EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-----LANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 698 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
.+|||++|.++|||.|+|... .++....++++..+|.||++||. +|+|.|.|||||+.|||+..++.+.|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 679999999999999999864 69999999999999999999994 67899999999999999999999999
Q ss_pred eecccccccCCCCC--cceeeeeecCCCCCCHHHhhhCC----C--CChhhhHHHHHHHHHHHhC----------CCCCc
Q 002189 771 ADFGLSKSMSDSEK--DHITTQVKGTMGYLDPEYYMTQQ----L--TEKSDVYSFGVLMLELLTG----------RRPIE 832 (955)
Q Consensus 771 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~ksDvwS~Gv~l~elltg----------~~P~~ 832 (955)
+|+|||-....... .......+||.+|||||++.... + -..+||||||.|+||+... +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 99999976654321 11234568999999999997542 2 2369999999999999862 34554
Q ss_pred C---CchHHHHHHHHHhhhhhhhhhhhccCCcCC-CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 833 R---GKYIVREIRTVMDKKKELYNLYELIDPTIG-LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 833 ~---~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
+ .+...+.+++++-. +.+.|.++ .....+.+..+.++|+.||..+|..|-|+-.+-+.|.++.+
T Consensus 438 d~Vp~DPs~eeMrkVVCv--------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCV--------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCCHHHHhcceee--------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1 22223333333322 22334432 33455678889999999999999999999999999888864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.39 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=207.5
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcc--cCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe-----CCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQ--QGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-----RGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~ 698 (955)
...|...+.||+|+||.|++|.. .+|+.||||++. -......++-.+|+++|+.++|+||+.+++.+.- -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34556678899999999999985 478999999987 3344556788899999999999999999998865 356
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.|+|+|+| ..+|...++.+. .++......++.|+++||.|+|+.+ |+||||||+|++++.+...||+|||+||.
T Consensus 101 vYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 89999999 679999887654 5888899999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhh-hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh--------
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-------- 849 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-------- 849 (955)
..........+..+.|.+|.|||.+. ...|+.+.||||.|||+.||++|++-| .|.+..+++..+++--.
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF-pG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF-PGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC-CCCchHHHHHHHHHhcCCCCHHHHH
Confidence 86543334456788999999999987 568999999999999999999998655 55555555544433110
Q ss_pred -----hhhhhhhccCCcCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -----ELYNLYELIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -----~~~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..........+.....+ -.......++|+.+|+..||.+|+|++|.+++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00001111111111110 01223667899999999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.73 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=204.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.+|+..+.||+|+||.||+|.+. .+..||+|.++.... ...+.|.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778899999999999999753 357899999886533 2345788999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999887543 36899999999999999999999988 999999999999999999999999987654222
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. .......++..|+|||++.+..++.++|||||||++||+++ |..||..... .+.+..+ .... .+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~~~~~-~~~~---------~~~ 228 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAV-EDGF---------RLP 228 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHH-HCCC---------CCC
Confidence 11 11112335678999999999999999999999999999875 9999864332 1222211 1110 001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.....+..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 229 ----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 ----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122446788999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=355.36 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=215.3
Q ss_pred CccCeeeccCceEEEEEEe-CCCc----EEEEEEcccC-CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 631 SDANDVGSGGYGKVYKGTL-PNGQ----LIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
...++||+|+||+||||.| .+|+ +||+|++... ..+..+++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999986 4443 6899988754 3445678999999999999999999999998776 789999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
||+.|+|.++++.++ ..+.....+.|..|||+||.|||++. +|||||.++|||+.+-..+||.|||+++.+...+.
T Consensus 778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998654 46788889999999999999999887 99999999999999999999999999999987776
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
........-.+.|||-|.+..+.++.++|||||||++||++| |..|+++.. .+.+...++.+. +
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~ge-------------R 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEKGE-------------R 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhccc-------------c
Confidence 666666667889999999999999999999999999999999 999986532 233333333322 2
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
...+.-+..+++.++.+||..|++.||+++++...+.++.+.
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 334445667899999999999999999999999998888643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.47 Aligned_cols=256 Identities=28% Similarity=0.502 Sum_probs=206.4
Q ss_pred cCCCccCeeeccCceEEEEEEeCC------CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|+..+.||+|+||.||+|.... ...||+|.++.... ....+|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788899999999999998532 25799999875433 23456899999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC
Q 002189 701 LIYEFVPNGSLGDSLSGKNG--------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 766 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 766 (955)
++|||+++|+|.+++..... ..+++...+.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998864321 45788999999999999999999988 99999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHH
Q 002189 767 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVM 845 (955)
Q Consensus 767 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~ 845 (955)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||..... .+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~~i- 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIEMI- 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH-
Confidence 999999999987654433233334457889999999998999999999999999999998 9999864322 1211111
Q ss_pred hhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 846 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
.... ........+.++.+++.+||+.||++||+++||++.|+.
T Consensus 240 ~~~~-------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQ-------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC-------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1110 011122345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.96 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=201.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch---hHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG---GQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 701 (955)
.++|...++||+|+||+|++|..+ +++.+|||++++...-. .+..+.|.+++... +||.++.++.++..+++.|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467899999999999999999975 67899999999875543 34567788888877 59999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+.||++..+.+.. .+++.+...++..|+.||+|||+++ ||+||||.+|||||.+|.+||+|||+++.--.
T Consensus 447 vmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999966555533 6999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
....+++++||+.|||||++.+..|+..+|.|||||+||||+.|+.||.+. +..+....++.. |+.
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-dEee~FdsI~~d-----------~~~ 586 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-DEEEVFDSIVND-----------EVR 586 (694)
T ss_pred --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcC-----------CCC
Confidence 224567799999999999999999999999999999999999999999643 333333222211 122
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTM 892 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 892 (955)
. +.-...+.++++.+++.++|++|..+
T Consensus 587 y----P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 Y----PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C----CCcccHHHHHHHHHHhccCcccccCC
Confidence 1 22234678899999999999999765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.01 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=208.0
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|+..++||+|+||.||+|...+++.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46788899999999999999988888999999875432 35678999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.++++......+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence 999999987655557899999999999999999999988 99999999999999999999999999987643221 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||++..+.++.++|||||||++|||+| |..||..... .+..... ... .... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~-~~~---------~~~~----~ 225 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-SDVMSAL-QRG---------YRMP----R 225 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-HHHHHHH-HcC---------CCCC----C
Confidence 222346778999999998899999999999999999998 8999864322 1111111 111 0000 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
......++.+++.+||..+|++||+++++.+.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11234678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=346.83 Aligned_cols=242 Identities=21% Similarity=0.268 Sum_probs=197.7
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 634 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
+.||+|+||.||+|+. .+|+.||||+++... ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 478999999987532 223356778999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceee
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 789 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 789 (955)
+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~ 153 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence 9998887543 6889999999999999999999998 9999999999999999999999999987543221 1233
Q ss_pred eeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHH
Q 002189 790 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869 (955)
Q Consensus 790 ~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 869 (955)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... +... +..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~~-----------~~~~----p~~ 217 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILME-----------EIRF----PRT 217 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HHHHHHHcC-----------CCCC----CCC
Confidence 467999999999999999999999999999999999999999654321 111111111 0111 112
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 870 GFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 870 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
...++.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 336788999999999999999 79999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=353.57 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=205.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 698 (955)
.++|...++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+++++++. |||||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457788899999999999999852 134799999975433 23457899999999996 9999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCC-----------------------------------------------------------
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN----------------------------------------------------------- 719 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 719 (955)
.+|||||+++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999988775321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC
Q 002189 720 -----------------------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE 764 (955)
Q Consensus 720 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~ 764 (955)
...+++..+..++.|+++||+|||+.+ |+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999988 999999999999999
Q ss_pred CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHH
Q 002189 765 RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRT 843 (955)
Q Consensus 765 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~ 843 (955)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHH
Confidence 99999999999987643322222233457788999999999999999999999999999997 8899864322111 111
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
..... ..+ .........+.+++.+||+.||++||++.+|.+.|++++
T Consensus 352 ~~~~~---------~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 KIKSG---------YRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHhcC---------CCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11110 001 111233467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.60 Aligned_cols=258 Identities=26% Similarity=0.471 Sum_probs=205.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc----EEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.+|+..+.||+|+||+||+|++. +|+ .||||+++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 343 48999987543 23456789999999999999999999999764 5679
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+||+++|+|.++++... ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999987543 35889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||...... + ......... . . +
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~-~~~~~~~~~------~-~-~ 231 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-ISSILEKGE------R-L-P 231 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-H-HHHHHhCCC------C-C-C
Confidence 333222222335678999999999999999999999999999998 99998643221 1 112221111 0 0 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
....+..++.+++.+||+.+|++||++.+++..+..+.+.
T Consensus 232 -----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 232 -----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0112335788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.00 Aligned_cols=251 Identities=28% Similarity=0.480 Sum_probs=203.9
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||.||+|++.++..+|+|.++.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 34777889999999999999988888999999875433 34678899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.++++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 999999887543 25899999999999999999999988 99999999999999999999999999986543221 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+..+..... ...|.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~i~~~~~-------~~~~~----- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGFR-------LYRPK----- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCC-------CCCCC-----
Confidence 122345678999999998899999999999999999999 8889864432 222222211110 01111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
.....+.+++.+||+.+|++||+++|+++.|
T Consensus 225 --~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 --LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=346.28 Aligned_cols=248 Identities=28% Similarity=0.360 Sum_probs=209.4
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
-|...+.||.|+-|.|-.|++ .+|+.+|||++.+.... ....+.+|+-+|+-+.||||++++++|+++.++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 355667899999999999985 57999999999765221 23568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|-|.+++-.++ ++.+.+..+++.||+.|+.|||..+ |+|||+||+|+|||..+++||+|||+|..-.++
T Consensus 93 yv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred ecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 999999999998766 6888899999999999999999999 999999999999999999999999999865433
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCC-ChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
..-.+.+|.+.|.|||++++..|. .++||||+|||||.|+||+.||+ ++++...+.++..+..+ +
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-DdNir~LLlKV~~G~f~------M------ 231 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-DDNIRVLLLKVQRGVFE------M------ 231 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-CccHHHHHHHHHcCccc------C------
Confidence 234457899999999999999986 68999999999999999999997 44554444444433221 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+.....++.+|+.+|+..||.+|.|++||+++-.
T Consensus 232 ---Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 232 ---PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ---CCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 1122367889999999999999999999999743
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=360.03 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=203.8
Q ss_pred CCccCeeeccCceEEEEEEeC-C-CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-N-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++|||||++++++..++..||||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 778899999999999999753 4 67889998765554445678889999999999999999999999999999999999
Q ss_pred CCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 708 NGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 708 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+|+|.++++.. ...++++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999877532 2346889999999999999999999988 999999999999999999999999999876543322
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.......||++|+|||++.+..++.++|||||||++|||++|+.||..... .+.+....... .++
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~~~~~~~~~~~---------~~~----- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-REIMQQVLYGK---------YDP----- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC---------CCC-----
Confidence 233456799999999999999999999999999999999999999964332 22222221110 111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
........+.+++.+||+.||++||++++++.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01122357889999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=341.19 Aligned_cols=245 Identities=25% Similarity=0.326 Sum_probs=201.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999865 68999999986432 123456889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999987544 6888999999999999999999998 9999999999999999999999999998764321
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~-----------~~- 217 (291)
T cd05612 156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGIYEKILAGKL-----------EF- 217 (291)
T ss_pred -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCc-----------CC-
Confidence 234689999999999998999999999999999999999999965432 222222211110 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
.......+.+++.+||+.||.+||+ ++|++++
T Consensus 218 ---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 ---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1112356789999999999999995 8888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.73 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=212.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
..+|...++||+|+||+||+|...+++.+|+|.++........++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45678889999999999999998889999999998766555678999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++...+..+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-- 159 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-- 159 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc--
Confidence 9999999998766667899999999999999999999988 99999999999999999999999999987643321
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......++..|+|||.+..+.++.++||||||+++|||++ |+.||.... ..+......... . ..
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~----------~----~~ 224 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGY----------R----MP 224 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHhCC----------c----CC
Confidence 1223346778999999998899999999999999999998 888885433 222222111110 0 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
........+.+++.+||+.||++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=333.08 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=207.2
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
+|...+.||+|+||.||+|... +++.||+|+++... ...+++.+|++++++++|+||+++++++..++..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4677889999999999999864 58899999987543 335678999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....... ..
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~ 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-ec
Confidence 999999987655557899999999999999999999988 99999999999999999999999999987654322 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||++.+..++.++|||||||++|||++ |..|+.... ..+........ ..+ ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~~~~~~~~~----------~~~----~~ 226 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKG----------YRM----ER 226 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHCC----------CCC----CC
Confidence 112234668999999999999999999999999999998 888886432 22221111110 111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
....+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=347.05 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=204.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999975 58999999987532 223456888999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999987543 6888999999999999999999998 99999999999999999999999999986543
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... .+....+.... ..+.....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~-------~~~~~~~~ 222 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-NETWENLKYWK-------ETLQRPVY 222 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-HHHHHHHHhcc-------ccccCCCC
Confidence 12335699999999999999999999999999999999999999964332 22222111111 00110000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.........++.+++.+||..+|.+||+++|++++
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00011234678899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=345.73 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=204.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeC-Ce
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDR-GE 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 698 (955)
++|...+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|++++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46788899999999999999642 2578999998754322 235678899999999 799999999988754 56
Q ss_pred EEEEEEecCCCCcccccCCCC-----------------------------------------------------------
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN----------------------------------------------------------- 719 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 719 (955)
.++||||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999988775321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCC
Q 002189 720 GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799 (955)
Q Consensus 720 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 799 (955)
..+++|..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 126899999999999999999999988 99999999999999999999999999987643332222223456778999
Q ss_pred HHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHH
Q 002189 800 PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLA 878 (955)
Q Consensus 800 PE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 878 (955)
||++.+..++.++|||||||++|||++ |..||...... +.......... .+. .......++.+++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~---------~~~----~~~~~~~~~~~l~ 309 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGT---------RMR----APEYATPEIYSIM 309 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccC---------CCC----CCccCCHHHHHHH
Confidence 999999999999999999999999998 99998642211 11111111110 000 1112336789999
Q ss_pred HHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 879 LKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 879 ~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
.+||+.+|++||++.|++++|+++++
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=332.60 Aligned_cols=255 Identities=28% Similarity=0.483 Sum_probs=207.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.++|+..+.||+|+||.||+|...+++.||+|.++.... ..+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 356888899999999999999987788999999876443 3567899999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++.......+++..+..++.+++.|+.|||+.+ ++||||||+||++++++.+||+|||+++....... .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence 9999999997655557899999999999999999999988 99999999999999999999999999987653221 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.......+..|+|||++.+..++.++||||||+++|||+| |+.||..... ......+ .... . ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~-~~~~---------~----~~ 224 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQV-DQGY---------R----MP 224 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHH-HcCC---------C----CC
Confidence 1111223457999999998899999999999999999999 8888864322 1111111 1100 0 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
........+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111234678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=346.11 Aligned_cols=245 Identities=25% Similarity=0.346 Sum_probs=201.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999875 68999999987532 223456889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999887654 5788888899999999999999998 9999999999999999999999999998764322
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+.... ....
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~-----------~~~p 235 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-RIYEKILAGR-----------LKFP 235 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCC-----------cCCC
Confidence 2356999999999999999999999999999999999999999654322 2222111110 0011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
......+.+++.+||+.||.+||+ ++|++++
T Consensus 236 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 ----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112256789999999999999986 6888765
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=331.90 Aligned_cols=256 Identities=30% Similarity=0.500 Sum_probs=206.8
Q ss_pred cCCCccCeeeccCceEEEEEEeCC----CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||+||+|++.. ...||||+++..... ...+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468888999999999999998742 458999998754333 345789999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++++|.+++..... .+++..++.++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999876432 6899999999999999999999988 999999999999999999999999999877532
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||...... +..... .... ..+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~-~~~~--------~~~- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKAV-EDGY--------RLP- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-HHHHHH-HcCC--------CCC-
Confidence 22222222345678999999999999999999999999999998 99998643321 111111 1100 001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.....+..+.+++.+||+.+|++||+++|++++|+++
T Consensus 229 ----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1122346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=337.56 Aligned_cols=260 Identities=25% Similarity=0.460 Sum_probs=209.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.+|...+.||+|+||.||+|+.. ++..+++|+++.......+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34677789999999999999742 346799999887665556789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc
Q 002189 702 IYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN 767 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~ 767 (955)
||||+++++|.+++.... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999886432 234899999999999999999999998 999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHh
Q 002189 768 AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMD 846 (955)
Q Consensus 768 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~ 846 (955)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |..||...... +..... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~-~ 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIECI-T 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH-h
Confidence 99999999986644332222233456788999999999999999999999999999999 99998644321 111111 1
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 847 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
... . +. .....+..+.+++.+||+.||++||++++|++.|+++...
T Consensus 240 ~~~--------~-~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QGR--------V-LE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCC--------C-CC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 110 0 00 1112346788999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=336.49 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=203.8
Q ss_pred cCCCccCeeeccCceEEEEEEe-----CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.+|+..+.||+|+||+||+|.. .++..||+|.++.... ....++.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567788999999999999984 2467899999975433 233678899999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC
Q 002189 702 IYEFVPNGSLGDSLSGKN---------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 766 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 766 (955)
||||+++|+|.+++.... ...+++.+.+.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999874221 235788999999999999999999988 99999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHH
Q 002189 767 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVM 845 (955)
Q Consensus 767 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~ 845 (955)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~-~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEV-IEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHH-HHHH
Confidence 999999999987654332222333456778999999998889999999999999999999 8888854322 111 1111
Q ss_pred hhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 846 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
.... .+ ........++.+++.+||+.||++||++.++.+.|..
T Consensus 240 ~~~~---------~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQ---------LL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC---------cC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 00 1111234678899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=336.81 Aligned_cols=264 Identities=21% Similarity=0.273 Sum_probs=201.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 688999999875422 234568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|++++.+..+.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99988776544322 35888999999999999999999988 99999999999999999999999999987643322
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----hh------h
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LY------N 853 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~------~ 853 (955)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+...... .. .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccch
Confidence 122345689999999999998999999999999999999999999975433221 1111110000 00 0
Q ss_pred hhhccCCcCCCCC------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGLST------TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+...... .......+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000001000000 01123568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=336.23 Aligned_cols=255 Identities=24% Similarity=0.472 Sum_probs=205.6
Q ss_pred cCCCccCeeeccCceEEEEEEeCC------CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|...+.||+|+||.||+|+..+ ++.||||.++..... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998633 478999998765444 3468999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 701 LIYEFVPNGSLGDSLSGKN------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
+||||+++|+|.++++..+ ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999886432 235789999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 847 (955)
||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...... +...... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~~~~~-~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVIECIT-Q 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH-c
Confidence 9999999986543322122223446788999999999999999999999999999999 99998643321 2221111 1
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
.. .. . ........+.+++.+||+.||++||++.|+++.|+
T Consensus 240 ~~--------~~-~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GR--------LL-Q----RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CC--------cC-C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 00 0 11123467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=336.13 Aligned_cols=260 Identities=25% Similarity=0.461 Sum_probs=208.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.+|...+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999742 345789999876555555679999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEE
Q 002189 702 IYEFVPNGSLGDSLSGKN-----------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
||||+++++|.+++...+ ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999998886432 235899999999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhh
Q 002189 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... .+....+... .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-~~~~~~i~~~-~ 239 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG-R 239 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC-C
Confidence 99999986643322122223345778999999998999999999999999999999 8888864332 1111111111 0
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. +.. .......+.+++.+||+.||.+||+++|+.+.|+++.+.
T Consensus 240 --------~-~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 240 --------V-LQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --------c-CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0 011 112235789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=342.16 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=204.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|+..+.||+|+||+||+++.. +|..||+|.++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888999999999999999865 688999999875432 234678999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999987544 5888999999999999999999742 29999999999999999999999999997654322
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----hh--------
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----EL-------- 851 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-----~~-------- 851 (955)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... + +........ ..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-E-LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-H-HHHHhcccccccccCCccccCccc
Confidence 22356899999999999999999999999999999999999999643321 1 111111000 00
Q ss_pred --------------------hhhhhcc-CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 852 --------------------YNLYELI-DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 852 --------------------~~~~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
....+.+ ..............++.+++.+||+.||++|||++|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000 00000000112346789999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=334.71 Aligned_cols=267 Identities=27% Similarity=0.410 Sum_probs=204.2
Q ss_pred CccCeeeccCceEEEEEEe-----CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEEE
Q 002189 631 SDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLI 702 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 702 (955)
...+.||+|+||+||++.+ .+++.||+|.++.... ...+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988653 3578999999876432 2346788999999999999999999998764 357899
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++... .+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999998654 4899999999999999999999988 999999999999999999999999999876533
Q ss_pred CCcc-eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 783 EKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 783 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.... ......++..|+|||.+.+..++.++||||||+++|||+||..|+......................+.+.++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2211 112234566799999999889999999999999999999999998643321111110000000001111112211
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.........+.++.+++.+||+.+|++||+++++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111122334578999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=307.48 Aligned_cols=250 Identities=28% Similarity=0.396 Sum_probs=210.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|.||.||.|+.+ ++-.||+|++.+... +-..++.+|+++-..|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56888999999999999999864 678999999875422 23467899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||.++|.+...|+.....+++......++.|+|.|+.|+|..+ ||||||||+|+|++.++..|++|||.+..-..
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-- 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 176 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence 9999999999999777778999999999999999999999988 99999999999999999999999999865432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......+||..|.|||...+...+..+|+|++|++.||++.|.+||.... ..+..+.+.. .+..+|
T Consensus 177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k--------~~~~~p--- 242 (281)
T KOG0580|consen 177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK--------VDLKFP--- 242 (281)
T ss_pred --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH--------ccccCC---
Confidence 23456889999999999999999999999999999999999999997543 2222222111 111222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
........++|.+|+..+|.+|.+..|++++-+
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 222356789999999999999999999998744
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.98 Aligned_cols=242 Identities=23% Similarity=0.277 Sum_probs=197.2
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 634 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
+.||+|+||.||+++. .+|+.||||+++... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999987532 223456788999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceee
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 789 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 789 (955)
+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 153 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK 153 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence 9988886543 6889999999999999999999998 9999999999999999999999999987543221 1223
Q ss_pred eeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHH
Q 002189 790 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869 (955)
Q Consensus 790 ~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 869 (955)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... +..+ +..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~~~~~-----------~~~~----p~~ 217 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILME-----------DIKF----PRT 217 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-HHHHHhccC-----------CccC----CCC
Confidence 457999999999999999999999999999999999999999654321 111111110 0111 112
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 870 GFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 870 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
...++.+++.+||+.||.+|| +++|++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 236788999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.03 Aligned_cols=242 Identities=23% Similarity=0.272 Sum_probs=196.7
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 634 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 468999999987532 223346778999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceee
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 789 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 789 (955)
+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence 9988886543 6899999999999999999999998 9999999999999999999999999987543222 1123
Q ss_pred eeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHH
Q 002189 790 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869 (955)
Q Consensus 790 ~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 869 (955)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ... +..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~~-----------~~~----p~~ 217 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEE-----------IRF----PRT 217 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC-----------CCC----CCC
Confidence 356999999999999999999999999999999999999999654322 1111111110 011 112
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 870 GFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 870 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
....+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 236788999999999999998 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.81 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=200.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...++||+|+||+||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999864 689999999875432 2335678999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++ |+|.+++...+ ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 97 58888876443 35788899999999999999999988 99999999999999999999999999976543221
Q ss_pred ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----h-------hhh
Q 002189 786 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----E-------LYN 853 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----~-------~~~ 853 (955)
......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||..... .+.+..+..... + ...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-KEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhccccchh
Confidence 1233468999999999875 5689999999999999999999999964332 222222211100 0 000
Q ss_pred hhhccCCcCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.....|...... ......++.+++.+|++.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0111111110000 01123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.47 Aligned_cols=258 Identities=27% Similarity=0.384 Sum_probs=199.0
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCe-----EEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE-----QMLI 702 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~lV 702 (955)
.|...+++|.|+||.||+|... +++.||||+...+... -.+|+++|+.++|||||+++.+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3566789999999999999964 5799999998654332 2469999999999999999999876432 3589
Q ss_pred EEecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-CceEEeeccccccc
Q 002189 703 YEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSKSM 779 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~~~ 779 (955)
|||||. +|.+.++.. .+..++...+.-+..|+.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 888877631 2346777777889999999999999988 9999999999999976 89999999999988
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----hhhh
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----ELYN 853 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-----~~~~ 853 (955)
..++.. .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-| .|++..+++..++.-.. ++..
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF-pG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF-PGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc-CCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 766543 346789999999999864 7999999999999999999998555 55666666655554111 1111
Q ss_pred hh----hccCCcCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LY----ELIDPTIGLS-----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~----~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+. +.-.|.+... .......+.++++.++++.+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00 1111222111 222344778999999999999999999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.04 Aligned_cols=265 Identities=24% Similarity=0.348 Sum_probs=201.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+.. +++.||||+++.... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999865 689999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 67777775432 35788889999999999999999998 9999999999999999999999999987543222
Q ss_pred cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----hhhhhh--
Q 002189 785 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLYE-- 856 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~-- 856 (955)
.......||+.|+|||++.+ ..++.++||||+||++|||++|..||....+..+.+......... ......
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12233568999999999875 458899999999999999999999997655544443333221100 000000
Q ss_pred ccCCc-CCC--CCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 LIDPT-IGL--STT-------LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~~d~~-l~~--~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..++. ... ... ......+.+++.+|++.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00110 000 000 0112467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=343.96 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=200.9
Q ss_pred cCCCccCeeeccCceEEEEEEeCC--CcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN--GQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||+||+|++.+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 458888999999999999998543 3689999986432 22345688899999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999987654 6889999999999999999999998 999999999999999999999999999875432
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.....||+.|||||++.+..++.++|||||||++|||++|..||...... .....+.... ..+++
T Consensus 185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~~-------~~~p~-- 249 (340)
T PTZ00426 185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEGI-------IYFPK-- 249 (340)
T ss_pred -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcCC-------CCCCC--
Confidence 12356999999999999988999999999999999999999999754332 1111111110 00111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
.....+.+++.+|++.||.+|+ +++|++++
T Consensus 250 ------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 ------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1225678999999999999995 89998875
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.02 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=205.2
Q ss_pred CCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
+|+..+.||+|+||+||+|... ....+|+|.+..... ...+++.+|+.+++.++||||+++++++..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999752 235789998875433 234678899999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCC----------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCcc
Q 002189 702 IYEFVPNGSLGDSLSGK----------------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSN 759 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N 759 (955)
|+||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999999886532 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHH
Q 002189 760 ILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIV 838 (955)
Q Consensus 760 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~ 838 (955)
|++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-PE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-HH
Confidence 9999999999999999986543322111222346778999999998899999999999999999999 998885432 21
Q ss_pred HHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
+. ....... ..+ .........+.+++.+||+.+|++||+++|+++.|++++.+
T Consensus 237 ~~-~~~~~~~---------~~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 RL-FNLLKTG---------YRM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HH-HHHHhCC---------CCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11 1111110 011 11122346788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=329.14 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=203.4
Q ss_pred CCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+|...+.||+|+||+||+|++.++..+|||.++.... ..+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 4677889999999999999987777899999875433 346799999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.++....... ...
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 999998875433 6899999999999999999999988 99999999999999999999999999886643321 111
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
....++..|+|||++.+..++.++|||||||++|||++ |..||...... +.......... +. ..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~~----------~~----~~ 223 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQGLR----------LY----RP 223 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHhcCCC----------CC----CC
Confidence 22345678999999998889999999999999999999 99998643321 11111111110 00 01
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112367899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.71 Aligned_cols=244 Identities=30% Similarity=0.475 Sum_probs=203.5
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
|..++.||.|+||.||-|+. .+.+.||||++.-.. ...+.++..|+++|++++|||+|.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 45567799999999999984 578999999987433 33457899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
| -||-.|.+.-.+ .++.+..+..|+.+++.||+|||+++ .||||||+.|||+++.|.||++|||.|..+.+..
T Consensus 108 C-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-- 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-- 180 (948)
T ss_pred H-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence 9 667777765432 37888899999999999999999999 9999999999999999999999999998875433
Q ss_pred ceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 786 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.++||++|||||++. .+.|+-|+||||+|++-.|+...++|+...+... .++-+.+.-.|.+
T Consensus 181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-----------ALYHIAQNesPtL 245 (948)
T KOG0577|consen 181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----------ALYHIAQNESPTL 245 (948)
T ss_pred ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-----------HHHHHHhcCCCCC
Confidence 478999999999986 6789999999999999999999999987543221 1111233334555
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ..+....|..++..|+++-|.+|||.++++++
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 3 44566788999999999999999999998853
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.76 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=198.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC--CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhc---cCCCcceEEEEEEe-----
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP--NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRV---HHKNLVSLLGFCFD----- 695 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 695 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++..... ....+.+|+++++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 4688999988753222 234566787777766 69999999999863
Q ss_pred CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 696 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
....++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346899999996 68988887655556899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh--hh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL--YN 853 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~ 853 (955)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|++||...... +.+..+....... ..
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence 98664331 223456899999999999889999999999999999999999999754432 2333332211000 00
Q ss_pred hh-------hccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LY-------ELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~-------~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+. ..+.+.... .........+.+++.+|++.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 000000000 0001123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=337.02 Aligned_cols=259 Identities=26% Similarity=0.471 Sum_probs=207.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 698 (955)
.++|+..+.||+|+||.||+|... +...+|+|+++.... ....++.+|++++.++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456788899999999999999863 236899999875432 2335688999999999 79999999999999999
Q ss_pred EEEEEEecCCCCcccccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC
Q 002189 699 QMLIYEFVPNGSLGDSLSGK--------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE 764 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~ 764 (955)
.++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 99999999999999988532 2346899999999999999999999988 999999999999999
Q ss_pred CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHH
Q 002189 765 RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRT 843 (955)
Q Consensus 765 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~ 843 (955)
++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~- 245 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-EELFK- 245 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-HHHHH-
Confidence 99999999999987654332222222345678999999999999999999999999999998 8888864332 11111
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
...... . ..........+.+++.+||..||++|||++|+++.|+.++
T Consensus 246 ~~~~~~---------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGY---------R----MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCC---------c----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111110 0 0112233467889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=339.31 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=195.0
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
||+|+||+||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 58899999987532 22345678899999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeee
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 99887543 6889999999999999999999988 9999999999999999999999999997543222 223345
Q ss_pred ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ... .....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-~~~~~~~~~~~-----------~~~----~~~~~ 217 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-NEMYRKILQEP-----------LRF----PDGFD 217 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-HHHHHHHHcCC-----------CCC----CCcCC
Confidence 799999999999999999999999999999999999999965432 22222221110 011 11223
Q ss_pred HHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRPT---MSEVVKD 898 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs---~~evl~~ 898 (955)
..+.+++.+||+.||.+||+ +.|++.+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 57889999999999999974 6777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.09 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=206.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
++|...+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888899999999999999741 345899999876433 2345789999999999 799999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||+++|+|.++++......+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.+|++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999987654445899999999999999999999988 999999999999999999999999999866
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..........
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~--------- 261 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGY--------- 261 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCC---------
Confidence 43322112222346778999999999999999999999999999998 999986433211 1111111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.+ ........++.+++.+||..+|++||++.|+++.|+++
T Consensus 262 ~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RM----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 01112236789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.16 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=202.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc----EEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...+.||+|+||+||+|++. +++ .+++|.+..... ....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35677889999999999999863 444 478888764322 22356778888999999999999999875 455788
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999987543 36899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........++..|+|||++.++.++.++|||||||++|||++ |..||..... ........... ....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~------~~~~~ 233 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGE------RLAQP 233 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC------cCCCC
Confidence 333222334557789999999998999999999999999999998 9999864322 11122222111 00111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. .+...+.+++.+||..||++||++.|+++.|..+.+.
T Consensus 234 ~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 234 Q-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred C-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1 1235678899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.29 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=205.7
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...++||+|+||+||+|+..+...||+|+++.... ..+++.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 45888899999999999999987777899999986433 3467899999999999999999999874 456799999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.++++......+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence 999999997654456899999999999999999999988 99999999999999999999999999986643322 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||+..+..++.++||||||+++|||+| |..||...... +...... .. .. ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~~~~-~~---------~~----~~~ 224 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE-RG---------YR----MPC 224 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHHHHHh-cC---------CC----CCC
Confidence 223346778999999998899999999999999999999 77788643321 1111111 00 00 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
....+..+.+++.+|++.||++||+++++++.|+..+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 2234467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.56 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=203.5
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 698 (955)
.+++|+..+.||+|+||+||+|... .+..||||+++.... ....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567889999999999999999753 256799999865332 334578899999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEE
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
.++||||+++|+|.++++... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999886432 124678899999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhh
Q 002189 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
+|||+++...............++..|||||++.++.++.++|||||||++|||++ |..||.... ..+....+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-NEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCc
Confidence 99999986543322111122345778999999999999999999999999999999 678875432 2222221111100
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+. .....+..+.+++.+||+.||++||++.|+++.|+
T Consensus 240 ----------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 ----------LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ----------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 11123467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.76 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=197.1
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC-----eEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQM 700 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 700 (955)
+|...++||+|+||.||+|+.. +|+.||||+++.. .......+.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999854 6899999998743 2233456889999999999999999999886432 479
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||++ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 68888886543 5899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCC-cceeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh--------
Q 002189 781 DSEK-DHITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-------- 849 (955)
Q Consensus 781 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-------- 849 (955)
.... ........||..|+|||++.+ ..++.++|||||||++|||+||+.||...... .....+.....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLLGTPSPETIS 233 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHHH
Confidence 2221 111234569999999999875 67899999999999999999999999643321 11111110000
Q ss_pred -----hhhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -----ELYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -----~~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+.+..... ........+.+++.+||+.||++||+++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000011100000 001123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.93 Aligned_cols=261 Identities=25% Similarity=0.448 Sum_probs=207.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC--------CCcEEEEEEcccCC-cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 697 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 697 (955)
++|...+.||+|+||.||+|+.. ++..+|+|.++... .....++.+|+++++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46888899999999999999752 23579999998643 23345688899999999 7999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999999986532 135889999999999999999999988 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 842 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~ 842 (955)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||... ...+...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~~~~~~ 253 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFK 253 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CHHHHHH
Confidence 999999999999976543222111222234578999999999999999999999999999998 78887532 2222111
Q ss_pred HHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 843 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
...... ..........++.+++.+||+.+|++||++.|+++.|+++++..
T Consensus 254 -~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 254 -LLKEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred -HHHcCC-------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111110 00111223467889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.20 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=209.5
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhH---HHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQ---EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.+|.+.+.||+|.||.|-+|.. ..|+.||||.+++....+.+ .+.+|+++|..++||||++++.+|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3566677899999999999974 67999999999887665544 4789999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||..+|.|.+|+...+ .+++.....++.||..|+.|+|.++ ++|||||.+|||+|+++++||+|||++..+....
T Consensus 133 EYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999998665 7999999999999999999999988 9999999999999999999999999998875443
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCC-ChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.-..++|++-|.+||.+.+..|. +.+|-||+||+||-++.|..||++. +....++++-... ...|..
T Consensus 208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk~lvrQIs~Ga--------YrEP~~ 275 (668)
T KOG0611|consen 208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHKRLVRQISRGA--------YREPET 275 (668)
T ss_pred ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-hHHHHHHHhhccc--------ccCCCC
Confidence 34568999999999999998885 6899999999999999999999653 3333333332211 112222
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+....-||.+|+..+|++|.|..+|..+++
T Consensus 276 --------PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 276 --------PSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --------CchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 234567999999999999999999998865
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=346.08 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=204.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcch-hHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 699 (955)
++|...+.||+|+||.||+|++. .++.||||+++...... .+.+.+|++++.++. |||||+++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 34667789999999999999853 24689999998643322 346889999999997 99999999999999999
Q ss_pred EEEEEecCCCCcccccCCCC------------------------------------------------------------
Q 002189 700 MLIYEFVPNGSLGDSLSGKN------------------------------------------------------------ 719 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 719 (955)
++||||+++|+|.++++..+
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999998886431
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 720 ------------------------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 720 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
...+++.....++.|+++||+|||+.+ ++||||||+||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 123678888999999999999999987 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 842 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~ 842 (955)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-EQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-HHHH
Confidence 999999999999986533221111223457789999999998889999999999999999998 88898643321 1111
Q ss_pred HHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 843 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
....... .+. .+.....++.+++.+||..+|.+||+++||++.|++++
T Consensus 353 ~~~~~~~---------~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NAIKRGY---------RMA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCC---------CCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111110 011 11123467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.81 Aligned_cols=261 Identities=21% Similarity=0.369 Sum_probs=209.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC-----CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEe-CCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN-----GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 699 (955)
.++|...+.||+|+||.||+|...+ +..||+|+++.... ...+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4567888999999999999998755 68899999875432 334668899999999999999999999876 4678
Q ss_pred EEEEEecCCCCcccccCCCCC------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 700 MLIYEFVPNGSLGDSLSGKNG------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
++++||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999998865321 46899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
|+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||..... .+... ......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~-~~~~~~--- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAA-YLKDGY--- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHH-HHHcCC---
Confidence 99987654332222223346778999999998899999999999999999999 9999864322 22111 111110
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.. ......+..+.+++.+||+.||++||++.|+++.|+.+.++
T Consensus 237 ------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 ------RL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ------CC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00 11122346789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.23 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=204.6
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|+..++||+|+||.||+|...++..||+|.++.... ..+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46778899999999999999988888999999876443 3467999999999999999999999875 456899999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.++++......+++.++..++.+++.||+|||+.+ ++||||||+||++++++.++|+|||++..+..... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc-cc
Confidence 999999987655556899999999999999999999988 99999999999999999999999999987643321 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||++.+..++.++||||||+++|||++ |..||.... ..+........ ..+. .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~----------~~~~----~ 224 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQVERG----------YRMP----C 224 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcC----------CCCC----C
Confidence 122345678999999998899999999999999999999 888885432 22222111110 0111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
.......+.+++.+|+..+|++|||+.++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12234678999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.54 Aligned_cols=250 Identities=27% Similarity=0.457 Sum_probs=201.9
Q ss_pred CCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+|+..+.||+|+||.||+|++.++..+|+|.+..... ...++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677888999999999999987778899999875433 345788999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
++|.++++.... .+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++...+... ...
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~ 158 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS 158 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence 999999875432 6899999999999999999999988 99999999999999999999999999986543221 111
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... +...... . ...+. ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~-~---------~~~~~----~~ 223 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVS-A---------GYRLY----RP 223 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHHH-c---------CCcCC----CC
Confidence 11234567999999999999999999999999999999 78888643322 1111111 1 01111 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
...+.++.+++.+||..+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.68 Aligned_cols=242 Identities=28% Similarity=0.385 Sum_probs=195.8
Q ss_pred CeeeccCceEEEEEEe----CCCcEEEEEEcccCC----cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 634 NDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGS----MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+.||+|+||.||+++. .+++.||||+++... ......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 357899999987532 12234678899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.+++...+ .+.+.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999886543 5778888889999999999999998 99999999999999999999999999875432221
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ..+++
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~~~~~-------~~~~~----- 221 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKILKGK-------LNLPP----- 221 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCC-------CCCCC-----
Confidence 223356999999999999888999999999999999999999999754322 2222221110 00111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
....++.+++.+||+.||++|| ++++++++
T Consensus 222 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 222 ---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1235788999999999999999 88888874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=337.05 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=202.3
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|+..++||+|+||+||+|+.. ++..+|+|.++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999999999999865 688999998875422 234568999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
|+++|+|.+++...+ .+++.....++.++++||+|||+. + ++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999987543 578888999999999999999974 5 9999999999999999999999999997653321
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh------------
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL------------ 851 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------ 851 (955)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCcccCCccccccCcccC
Confidence 22346899999999999889999999999999999999999999643221 111110000000
Q ss_pred -------------------hhhhhc-cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 -------------------YNLYEL-IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 -------------------~~~~~~-~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.+. ...............++.+++.+||+.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000 00000000001123568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.76 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=201.8
Q ss_pred CCccCeeeccCceEEEEEEeC-C---CcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCe-----
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-N---GQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE----- 698 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 698 (955)
|...+.||+|+||.||+|... + +..||||+++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456788999999999999864 2 36799999875432 234578999999999999999999999877554
Q ss_pred -EEEEEEecCCCCcccccCCC----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 699 -QMLIYEFVPNGSLGDSLSGK----NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 699 -~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
.++|+||+++|+|..++... ....+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999887432 2346899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
|+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||..... .+........ .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~~~~-~--- 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHG-N--- 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC-C---
Confidence 99987654432222222345678999999988899999999999999999999 8888864332 1222111111 0
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.+. .......++.+++.+||+.||++||++.|+++.|+++
T Consensus 233 ------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 ------RLK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------CCC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 1123346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=347.15 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=198.0
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.|...+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999985 4688999999875322 223568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999987544 5788888899999999999999988 99999999999999999999999999864321000
Q ss_pred ---------------------------------------------cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHH
Q 002189 785 ---------------------------------------------DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGV 819 (955)
Q Consensus 785 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv 819 (955)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012356999999999999889999999999999
Q ss_pred HHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHH--hhccCCCCCCCHHHHHH
Q 002189 820 LMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALK--CVQESGDDRPTMSEVVK 897 (955)
Q Consensus 820 ~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~ 897 (955)
++|||+||+.||......... ..+..... ............++.+++.+ |+..+|..||+++|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~-~~i~~~~~-----------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQ-LKVINWEN-----------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHH-HHHHcccc-----------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999999754432211 11111000 00011111223567788888 55666667999999997
Q ss_pred H
Q 002189 898 D 898 (955)
Q Consensus 898 ~ 898 (955)
+
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.80 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=203.0
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCC-cceEEEEEEeCC------
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKN-LVSLLGFCFDRG------ 697 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------ 697 (955)
..|...++||+|+||+||+|+. .+|+.||+|+++-.... ......+|+.++++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455567799999999999984 57899999998754332 2245688999999999999 999999999877
Q ss_pred eEEEEEEecCCCCcccccCCCCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNG--IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
..++|+||+ .-+|..++..... ..++...+..++.|+++||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 5588888876542 35677888999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----- 849 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----- 849 (955)
|+...-+.. ..+..++|..|+|||++.+. .|+...||||+||+++||++++.-| .+....++...++.-..
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF-pG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF-PGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC-CCCcHHHHHHHHHHHcCCCCcc
Confidence 997653332 24557799999999999976 7999999999999999999977555 55555666655554221
Q ss_pred hhhhhhhccC--CcCCCCC-C---HH-H---HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ELYNLYELID--PTIGLST-T---LK-G---FEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~~~~~~~~~d--~~l~~~~-~---~~-~---~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+..+....+ +...... . .. . .....+++.+|++.+|.+|.|++.++++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000111111 1110000 0 00 1 1367899999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.95 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=213.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCe-EEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE-QMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~ 703 (955)
++|...+++|+|+||.++.++.+ ++..+++|.+...... .++....|+.++.+++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778899999999999998754 6789999998765433 33467889999999999999999999999998 89999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
+|++||++.+.+...++..+++.+...++.|++.|+.|||+.. |+|||||+.||+++.+..|||+|||+|+.+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998887788999999999999999999999887 9999999999999999999999999999987654
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.......||+.||.||.+.+..|..|+||||+||++|||++-+++|...+ ....+.++.... ++|
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-m~~Li~ki~~~~---------~~P--- 225 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-MSELILKINRGL---------YSP--- 225 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-hHHHHHHHhhcc---------CCC---
Confidence 23456789999999999999999999999999999999999999996443 333333332221 121
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+..+..++..++..|++.+|..||++.+++.+
T Consensus 226 --lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 --LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122334678899999999999999999999976
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=308.53 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=211.7
Q ss_pred hcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeC-----CeEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GEQM 700 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~ 700 (955)
.++|.+.+.||+|||.-||.++ ..+++.+|+|++.-...++.+...+|++..++++||||+++++++..+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4578889999999999999998 568899999999876666778899999999999999999999887543 3589
Q ss_pred EEEEecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 701 LIYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
|+++|...|+|.+.+... ++..+++.+.++|+.++.+||++||+.. ++++||||||.|||+++.+.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999988653 3457999999999999999999999976 6799999999999999999999999999876
Q ss_pred cCCCCCcc-------eeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhh
Q 002189 779 MSDSEKDH-------ITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 779 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 848 (955)
..-.-... .......|..|+|||.+. +...++++|||||||++|+|+.|..||+.. .+.+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~~~G 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI----------YQQG 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------hhcC
Confidence 53211000 011245788999999986 456789999999999999999999999521 1111
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.-+ ...+..+.+.........+.+.+++.+|++.||.+||++.+++..+..+.
T Consensus 249 gSl--aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 GSL--ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CeE--EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 100 11222333333334446688999999999999999999999999887653
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.02 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=206.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.++|...++||+|+||.||+|...+++.||+|.+..... ..+++.+|+.++++++|+||+++++++ ..+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 456888899999999999999988899999999886543 346789999999999999999999986 456789999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++....+..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence 9999999987666667899999999999999999999988 99999999999999999999999999976643221 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......++..|+|||++....++.++||||||+++|||++ |+.||..... .+..... ... ..+..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~-~~~---------~~~~~--- 224 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQNL-ERG---------YRMPR--- 224 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHH-HcC---------CCCCC---
Confidence 1223346778999999998899999999999999999999 9999864432 1211111 111 01111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
......++.+++.+||..+|++||+++++++.|+.
T Consensus 225 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 -PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11233678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=356.74 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=205.2
Q ss_pred HHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCC----
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG---- 697 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 697 (955)
...++|...+.||+|+||+||+|+. .+|+.||||++..... .....+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3356889999999999999999985 5789999999875432 33456888999999999999999988775433
Q ss_pred ----eEEEEEEecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 698 ----EQMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 698 ----~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
..++||||+++|+|.++++... ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999886432 346889999999999999999999988 9999999999999999999999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh
Q 002189 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851 (955)
Q Consensus 772 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 851 (955)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+.......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-~~~~~~~~~~~~--- 261 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGR--- 261 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHhcCC---
Confidence 9999987654333233345679999999999999999999999999999999999999996432 222222221111
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.++ + ......++.+++.+||+.||.+||++.+++++
T Consensus 262 ------~~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 ------YDP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------CCC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 1 11233678899999999999999999999864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=336.52 Aligned_cols=242 Identities=21% Similarity=0.264 Sum_probs=195.8
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 634 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
+.||+|+||+||+++. .+|+.||+|+++... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999987532 223356778999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
+|.+++.... .+++..+..++.|++.||+|||+ .+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence 9988886543 68999999999999999999997 67 9999999999999999999999999987543221 122
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .... +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~~~~~i~~~-----------~~~~----p~ 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILME-----------EIRF----PR 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-HHHHHHhcC-----------CCCC----CC
Confidence 3356999999999999999999999999999999999999999654321 111111110 0011 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
....++.+++.+||+.||++|+ ++++++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1235788999999999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=344.08 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=198.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+|...+.||+|+||.||+|.. .+++.||+|+... +.+.+|++++++++|||||++++++..+...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5789999999999999999985 4689999997542 35678999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
. ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 166 ~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~ 238 (391)
T PHA03212 166 K-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238 (391)
T ss_pred C-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence 4 78888776543 5889999999999999999999988 99999999999999999999999999975432221 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch------HHHHHHHHHhhhh-----------
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY------IVREIRTVMDKKK----------- 849 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~------~~~~~~~~~~~~~----------- 849 (955)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ....+..+.....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22345799999999999999999999999999999999999988753221 1111211111100
Q ss_pred -hhhhhh----hc--cCCcCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -ELYNLY----EL--IDPTIGL--STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -~~~~~~----~~--~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+ .. ..+.... ........++.+++.+||+.||.+|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00 0010000 0011234578899999999999999999999974
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.74 Aligned_cols=255 Identities=24% Similarity=0.454 Sum_probs=204.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.+|+..++||+|+||+||+|+.. ++..+|+|.++.......+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999642 356899999886655556789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCC-------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 702 IYEFVPNGSLGDSLSGKNG-------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
||||+++|+|.++++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998865321 35889999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 847 (955)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |.+||...... +........
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~ 240 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-EAIECITQG 240 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-HHHHHHHcC
Confidence 9999999976543322122223345788999999999999999999999999999998 88888643321 111111111
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
. .+. .....+..+.+++.+||+.||.+||+++||++.|+
T Consensus 241 -~---------~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 -R---------ELE----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -c---------cCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 000 11123467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=324.72 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=207.0
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||.||+|+. .+++.||||.++... ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688889999999999999985 478999999876422 223356889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 704 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 704 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||+++|+|.+++... ....+++.....++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999998877532 2345788999999999999999999988 99999999999999999999999999887643
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||................ ...+.
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~ 227 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ---------CDYPP 227 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---------CCCCC
Confidence 221 1123458889999999998889999999999999999999999986543221111111111 01111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
. ........+.+++.+||+.+|++||++++|++.++++
T Consensus 228 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 1123346789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=326.81 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=197.7
Q ss_pred CccCeeeccCceEEEEEEeCC-Cc--EEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeC------CeE
Q 002189 631 SDANDVGSGGYGKVYKGTLPN-GQ--LIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------GEQ 699 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~ 699 (955)
...+.||+|+||.||+|++.+ ++ .||+|.++... ....+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999998754 33 68999887542 23346788999999999999999999988542 246
Q ss_pred EEEEEecCCCCcccccCC----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 700 MLIYEFVPNGSLGDSLSG----KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
++||||+++|+|.+++.. .....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999887632 12345899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNL 854 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 854 (955)
++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~-~~~~~~----- 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYD-YLRQGN----- 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH-HHHcCC-----
Confidence 987654332111222346778999999999999999999999999999999 7888854322 12111 111111
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
. +. ........+.+++.+||+.||++||++.|+++.|+++
T Consensus 232 --~--~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 --R--LK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --C--CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00 1112346688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.75 Aligned_cols=268 Identities=27% Similarity=0.456 Sum_probs=203.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-----CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 700 (955)
.+|...+.||+|+||+||+|... +++.||+|+++.......+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999742 5789999998876555567899999999999999999999987543 4688
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986542 35899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCcce-eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----hhhhhh
Q 002189 781 DSEKDHI-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----ELYNLY 855 (955)
Q Consensus 781 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----~~~~~~ 855 (955)
....... .....++..|+|||++.+..++.++|||||||++|||++|..|+...... ... ...... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMR-MMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhh-hcccccccccchHHHH
Confidence 4322111 11122345699999999889999999999999999999988775422111 000 000000 000001
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
+.+..............++.+++.+||+.+|++|||++|+++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111111222346789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=342.16 Aligned_cols=246 Identities=28% Similarity=0.392 Sum_probs=191.8
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
|...++||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999864 689999999865432 234678899999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.+.. ..++.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 99986543 3456777889999999999999998 99999999999999999999999999987643221 1
Q ss_pred eeeeecCCCCCCHHHhhh-----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 788 TTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||..... .++..... ... ....+..
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~-~~~------~~~~~~~ 296 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMC-AIC------MSQPPEA 296 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHH-HHh------ccCCCCC
Confidence 233569999999998743 2345689999999999999999999963221 11111110 000 0001111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+++.+||+.||++||+++|++++
T Consensus 297 ----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 ----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11233678999999999999999999999985
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=346.10 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=201.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999864 68999999987532 122356788999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999987544 6899999999999999999999998 9999999999999999999999999987543211
Q ss_pred Ccc------------------------------------eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhC
Q 002189 784 KDH------------------------------------ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 827 (955)
Q Consensus 784 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg 827 (955)
... ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000 01124699999999999999999999999999999999999
Q ss_pred CCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002189 828 RRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MSEVVKD 898 (955)
Q Consensus 828 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 898 (955)
..||..... .+....+..... .+...........+.+++.+|+. +|.+|++ ++|++++
T Consensus 236 ~~Pf~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNP-QETYRKIINWKE-----------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCH-HHHHHHHHcCCC-----------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999975432 222222221111 01111111223567889999996 9999987 9999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.64 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=197.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||+|+||+||+|+.. +++.||||+++.... .....+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 689999999875322 22346788999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999987543 6899999999999999999999998 9999999999999999999999999997653211
Q ss_pred Cc---------------------------------ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCC
Q 002189 784 KD---------------------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830 (955)
Q Consensus 784 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P 830 (955)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001235799999999999999999999999999999999999999
Q ss_pred CcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 002189 831 IERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQ--ESGDDRPTMSEVVKD 898 (955)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~ 898 (955)
|..... .+....+...... -.+++.. ....++.+++.+++. .++..||+++|++++
T Consensus 236 f~~~~~-~~~~~~i~~~~~~-----~~~p~~~------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETP-QETYKKVMNWKET-----LIFPPEV------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCH-HHHHHHHHcCcCc-----ccCCCcC------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 965432 2222222211110 0011111 122456677777543 334456999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.98 Aligned_cols=248 Identities=24% Similarity=0.417 Sum_probs=196.8
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
+.||+|+||+||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999864 789999998765432 2346789999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeee
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
.++++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986542 35889999999999999999999988 999999999999999999999999998765432111111111
Q ss_pred ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHH
Q 002189 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 870 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (955)
.++..|+|||.+.++.++.++||||||+++|||++ |..||...... . ........ ..+ ......
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-~-~~~~~~~~---------~~~----~~~~~~ 221 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-Q-TREAIEQG---------VRL----PCPELC 221 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-H-HHHHHHcC---------CCC----CCcccC
Confidence 23457999999999999999999999999999998 88888543221 1 11111110 011 111223
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 871 FEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 871 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
...+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.42 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=201.8
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.|+..++||+|+||+||++... +++.||||++...... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677899999999999999864 6899999998753222 23457789999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999998886544456899999999999999999999988 99999999999999999999999999987543221
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ....+..... . .. .
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~------~-~~----~ 222 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVK------E-DQ----E 222 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHHhh------h-cc----c
Confidence 223468999999999998899999999999999999999999997543211 1111111000 0 00 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
.........+.+++.+||+.||++|| ++++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11122346788999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.25 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=202.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
+++|...+.||+|+||.||+|.+. .+..||+|.+..... .....|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456888899999999999999864 356899998875432 2345689999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC---ceEEe
Q 002189 700 MLIYEFVPNGSLGDSLSGKN-----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL---NAKVA 771 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~ 771 (955)
++||||+++++|.+++.... ...+++..+++++.||++||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999886543 235899999999999999999999988 99999999999998764 59999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhh
Q 002189 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 772 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||..... .+....+... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~~~~~~~~-~- 238 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG-G- 238 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcC-C-
Confidence 9999987643222111112234568999999999999999999999999999997 8889864332 1221111111 0
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
.+ ......+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 239 --------~~----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 --------RL----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------cC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 111223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=332.11 Aligned_cols=261 Identities=25% Similarity=0.452 Sum_probs=207.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeC--------CCcEEEEEEcccCC-cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeC
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR 696 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 696 (955)
.++|...+.||+|+||.||+|+.. ++..||+|.++... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 346778899999999999999741 24579999987543 23346789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 762 (955)
+..++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999886532 235788999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHH
Q 002189 763 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREI 841 (955)
Q Consensus 763 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~ 841 (955)
++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+... ...+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHH
Confidence 9999999999999987654332222223346678999999998899999999999999999998 77777432 222222
Q ss_pred HHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
...... . ...........+.+++.+||+.+|++||++.|+++.|++++.-
T Consensus 250 ~~~~~~-~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 250 KLLKEG-H-------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHcC-C-------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 221111 0 0011123346788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=329.97 Aligned_cols=263 Identities=26% Similarity=0.402 Sum_probs=205.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC-----------------CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcce
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN-----------------GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVS 688 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~ 688 (955)
.++|+..+.||+|+||.||+|...+ +..||+|++..... ...+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999997542 24589999876433 33567899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCcccccCCCC---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCcc
Q 002189 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN---------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSN 759 (955)
Q Consensus 689 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N 759 (955)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999886533 126899999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh--CCCCCcCCchH
Q 002189 760 ILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRPIERGKYI 837 (955)
Q Consensus 760 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt--g~~P~~~~~~~ 837 (955)
|++++++.++|+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986654433233334456789999999998899999999999999999998 67777543321
Q ss_pred HHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 838 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+.......... ..+...........+.++.+++.+||+.||.+||++.|+++.|+
T Consensus 241 -~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 -QVIENAGHFFR-------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -HHHHHHHhccc-------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111100 00111111112223468999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=344.98 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=205.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999865 68999999987532 133456889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999998765 36889999999999999999999988 9999999999999999999999999998765432
Q ss_pred ---------------------------CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch
Q 002189 784 ---------------------------KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 836 (955)
Q Consensus 784 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~ 836 (955)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112345699999999999999999999999999999999999999975542
Q ss_pred HHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 002189 837 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-MSEVVKD 898 (955)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 898 (955)
. .....+..... ............++.+++.+|+. ||.+||+ ++|++++
T Consensus 236 ~-~~~~~i~~~~~-----------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 Q-ETYNKIINWKE-----------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H-HHHHHHhccCC-----------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2 22222221100 00001111134678899999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=329.26 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=202.2
Q ss_pred CCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
+|...+.||+|+||+||+|... +++.||+|+++..... ..+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556678999999999999853 2578999999754332 23568899999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc
Q 002189 702 IYEFVPNGSLGDSLSGK--------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN 767 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~ 767 (955)
++||+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999998887421 1235788899999999999999999988 999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHh
Q 002189 768 AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMD 846 (955)
Q Consensus 768 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~ 846 (955)
+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||..... .+....+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHc
Confidence 99999999987654332222233456789999999998899999999999999999998 7778754322 222222211
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 847 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
... .......+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 242 ~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 RQV--------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCc--------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 110 01112344678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=318.03 Aligned_cols=248 Identities=26% Similarity=0.441 Sum_probs=209.2
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
|.++.+||+|+||.||||.++ .|+.||||++... .+.+++..|+.+|++.+.|++|++||.|......|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556778999999999999865 6999999998753 4567899999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+..+.++.+ +.++++..+..+..+.++||+|||... -||||||+.|||++.+|.+|++|||.|..+.+.- ...
T Consensus 113 GSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKR 186 (502)
T KOG0574|consen 113 GSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKR 186 (502)
T ss_pred CcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--Hhh
Confidence 9999988754 358999999999999999999999988 8999999999999999999999999998765321 223
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
..+.||+.|||||++..-.|+.++||||+|+...||..|++||.+-... +.++.+.. .|..-...+.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------RAIFMIPT--~PPPTF~KPE 253 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------RAIFMIPT--KPPPTFKKPE 253 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------ceeEeccC--CCCCCCCChH
Confidence 4578999999999999999999999999999999999999999642211 11111111 2333344566
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....++.+++++|+.+.|++|-|+.+++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 677899999999999999999999998864
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.26 Aligned_cols=241 Identities=26% Similarity=0.370 Sum_probs=191.4
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57899999987532 12234456677777654 799999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99998886543 5888899999999999999999988 9999999999999999999999999997643322 223
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+... .+... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~-----------~~~~~----~ 217 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILND-----------RPHFP----R 217 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-----------CCCCC----C
Confidence 345799999999999999999999999999999999999999965432 2222211110 11111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMS-EVVK 897 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 897 (955)
....++.+++.+||+.||.+||++. ++++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1235678999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=351.43 Aligned_cols=259 Identities=26% Similarity=0.384 Sum_probs=212.1
Q ss_pred CCCccCeeeccCceEEEEEEeCCC-cEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEE-EEe------CCeE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPNG-QLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGF-CFD------RGEQ 699 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~------~~~~ 699 (955)
+.++.++|.+|||+.||.|+...+ ..||+|++-..+....+.+.+|+++|++|+ |+|||.+++. ... .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 456678999999999999997665 999999988777777788999999999997 9999999993 222 1367
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
+|.||||.+|+|-+++..+....|++.++++|+.|+++|+++||... +||||||||-+||||+.++..||||||-|...
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 89999999999999998665556999999999999999999999875 88999999999999999999999999998643
Q ss_pred CCCCCccee-------eeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh
Q 002189 780 SDSEKDHIT-------TQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 780 ~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
......... -....|+-|+|||.+. +..+++|+|||||||+||-|+....||+.....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------ 264 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------ 264 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------------
Confidence 322110000 0235789999999985 567899999999999999999999999754321
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.+++..........+...+.+||..||+.||++||++-+|+..+-++....
T Consensus 265 ------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 223333333333466789999999999999999999999999988886543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=338.62 Aligned_cols=261 Identities=27% Similarity=0.438 Sum_probs=202.9
Q ss_pred cCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeC-Ce
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDR-GE 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 698 (955)
++|...+.||+|+||+||+|.. .+++.||||+++..... ....+.+|++++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688899999999999999973 34689999999754332 335688999999999 689999999988764 46
Q ss_pred EEEEEEecCCCCcccccCCCC-----------------------------------------------------------
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN----------------------------------------------------------- 719 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 719 (955)
.++||||+++|+|.++++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999998875321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeec
Q 002189 720 ------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793 (955)
Q Consensus 720 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 793 (955)
...+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123688889999999999999999988 99999999999999999999999999986543222111222345
Q ss_pred CCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHH
Q 002189 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872 (955)
Q Consensus 794 t~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 872 (955)
+..|+|||.+.+..++.++||||||+++|||++ |..||........ ......... .+... .....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~---------~~~~~----~~~~~ 309 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGT---------RMRAP----DYTTP 309 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccC---------CCCCC----CCCCH
Confidence 678999999999999999999999999999997 8889864322211 111111110 00111 01225
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 873 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 873 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
++.+++.+||+.||++||++.|++++|+.+++.
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.29 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=201.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|...+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457888999999999999999864 68899999986422 22334578899999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++... .++......++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999988653 4777888889999999999999988 999999999999999999999999999876432
Q ss_pred CCcceeeeeecCCCCCCHHHhhhC----CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~--------- 264 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMDHKN--------- 264 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HHHHHHHHcCCC---------
Confidence 21 112345699999999998753 478999999999999999999999975432 222222221111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 898 (955)
.+..........++.+++.+|++.+|.+ |++++|++++
T Consensus 265 --~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 --SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111111123467889999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=337.97 Aligned_cols=250 Identities=28% Similarity=0.341 Sum_probs=198.6
Q ss_pred CCCccCeeeccCceEEEEEEe----CCCcEEEEEEcccCC----cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGS----MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
+|+..+.||+|+||+||+++. .+++.||+|+++... ....+.+.+|+++++++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999975 357899999986432 12235678899999999 499999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999886543 5889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhhhhh
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYE 856 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~ 856 (955)
..... .......||..|+|||++.+. .++.++|||||||++|||+||+.||.... .....+.....
T Consensus 156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------- 224 (332)
T cd05614 156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL---------- 224 (332)
T ss_pred cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh----------
Confidence 43322 122345799999999999865 47889999999999999999999996321 11111111110
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 857 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
..++... ......+.+++.+||+.||++|| ++++++++
T Consensus 225 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 225 KCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1122221 12235678999999999999999 77888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=330.31 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=204.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc--EEEEEEcccCC-cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ--LIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 702 (955)
++|+..+.||+|+||.||+|... ++. .+++|.++... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788899999999999999864 333 47888887432 23346789999999999 799999999999999999999
Q ss_pred EEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 703 YEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
+||+++|+|.++++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999886432 124889999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 847 (955)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||..... .+........
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~~~~~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 234 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhcC
Confidence 999999986432110 1111223567999999998899999999999999999998 9999864332 1211111110
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
..+. ........+.+++.+||+.+|.+||+++++++.|+.+.+...
T Consensus 235 ----------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 235 ----------YRME----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred ----------CCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111 111234678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=344.76 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=198.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688889999999999999985 478999999886432 122356888999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999887543 5788888899999999999999998 9999999999999999999999999996432110
Q ss_pred Cc---------------------------------------------ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHH
Q 002189 784 KD---------------------------------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 818 (955)
Q Consensus 784 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~G 818 (955)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHH
Q 002189 819 VLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDR---PTMSEV 895 (955)
Q Consensus 819 v~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev 895 (955)
|++|||++|..||..... .+....+..... .+..........++.+++.+|+. +|.+| +++.|+
T Consensus 236 vil~elltG~~Pf~~~~~-~~~~~~i~~~~~-----------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 236 AIMFECLIGWPPFCSENS-HETYRKIINWRE-----------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhhcCCCCCCCCCH-HHHHHHHHccCC-----------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999965432 222222211100 00001111123567899999997 66665 699999
Q ss_pred HHH
Q 002189 896 VKD 898 (955)
Q Consensus 896 l~~ 898 (955)
+++
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=324.01 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=208.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||.||+|+. .+++.+|||.+..... ...+++.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999985 5789999998765322 23457889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 704 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 704 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||+++++|.+++... ....+++..++.++.++++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999987632 2346899999999999999999999988 99999999999999999999999999876643
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||.............. .....+.
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~ 227 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---------EQCDYPP 227 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh---------hcCCCCC
Confidence 221 12234688999999999988999999999999999999999999864332111111111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.. .......+.+++.+||+.||++||||.+|++.++++.
T Consensus 228 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11 1124467889999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=336.22 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=193.6
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 67899999987542 22335577899988877 799999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence 99988876543 6889999999999999999999998 9999999999999999999999999987543221 122
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCC-------chHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG-------KYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... .....++....... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------CCC
Confidence 3457999999999999999999999999999999999999999521 01111111111110 001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPT------MSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 898 (955)
+ +.....++.+++.+||+.||++||+ +.+++++
T Consensus 224 ~----p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 I----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C----CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1 1122366789999999999999998 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=325.81 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=195.5
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
||+|+||+||+++.. +|+.||+|++..... ...+.+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 689999999864322 1234566799999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeee
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 98887655557899999999999999999999988 9999999999999999999999999998664322 22335
Q ss_pred ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
.|+..|+|||++.+..++.++||||+||++|||++|+.||.......... .+.... ....+. .. .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~-~~~~~~-----~~~~~~--~~---~~~~~ 223 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-ELKRRT-----LEDEVK--FE---HQNFT 223 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH-HHHHHh-----hccccc--cc---cccCC
Confidence 68999999999998889999999999999999999999996432211110 111100 000011 00 01233
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.++.+++.+||+.||++||+++|+++.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhh
Confidence 568899999999999999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=334.31 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=194.9
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHH---HhccCCCcceEEEEEEeCCeEEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELL---SRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 68999999987532 12234566676655 566799999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|..+++.. .+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998887643 5899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .......|++.|||||.+.+..++.++|||||||++|||++|+.||..... .+....+.... +..
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~-----------~~~ 220 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFDSIVNDE-----------VRY 220 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-----------CCC
Confidence 1 122346799999999999999999999999999999999999999965432 22222221111 011
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
+......+.+++.+||+.||.+|| ++++++++
T Consensus 221 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 221 ----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 112236678999999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=329.04 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=201.0
Q ss_pred cCCCccCeeeccCceEEEEEEeCC---------------CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN---------------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLG 691 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~ 691 (955)
++|...+.||+|+||.||+++..+ ...||+|+++..... ....|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987532 235899998764322 3457899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCcccccCCCC----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEE
Q 002189 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKN----------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNIL 761 (955)
Q Consensus 692 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIl 761 (955)
++...+..++||||+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999885432 124788999999999999999999988 999999999999
Q ss_pred EcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh--CCCCCcCCchHHH
Q 002189 762 LDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRPIERGKYIVR 839 (955)
Q Consensus 762 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt--g~~P~~~~~~~~~ 839 (955)
+++++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||..... .+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-HH
Confidence 99999999999999986644332222233445778999999998999999999999999999998 5567653221 11
Q ss_pred HHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 840 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
.+......... .............+..+.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111110000 0000000011123367899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=320.99 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=205.9
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|+||.||+|... +++.|++|.+... .....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999864 6899999988643 233456788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++++|.++++......+++..++.++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999999987654557899999999999999999999988 99999999999999999999999999987654322
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......|++.|+|||+..+..++.++|+||||+++|||++|+.||..... .......... .. +...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~---------~~-~~~~-- 222 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALILKIIRG---------VF-PPVS-- 222 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC---------CC-CCCc--
Confidence 22335688999999999999999999999999999999999999965442 1212111111 01 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+.+++.+||+.+|++||++.+++++
T Consensus 223 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 --QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1233678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=326.87 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=195.2
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
||+|+||+||+++.. +|+.||+|++...... ..+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 7899999998653222 224577899999999999999999999999999999999999999
Q ss_pred ccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceee
Q 002189 712 GDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 789 (955)
Q Consensus 712 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 789 (955)
.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8776432 2346899999999999999999999988 99999999999999999999999999986644322 123
Q ss_pred eeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHH
Q 002189 790 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869 (955)
Q Consensus 790 ~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 869 (955)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .... ....... .....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~---------~~~~~~~--~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQ---------RILNDSV--TYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHH---------hhcccCC--CCccc
Confidence 3568999999999999999999999999999999999999997433211110 0000 0011111 11223
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 870 GFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 870 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
....+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 446788999999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.61 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=203.5
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||.||+|...++..+|+|++..... ..+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 45777889999999999999987777899998875433 3467889999999999999999999875 456889999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.++++......+++..+..++.+++.||+|||+.+ ++||||||+||++++++.++|+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 999999997655556899999999999999999999988 99999999999999999999999999986643321 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||+..+..++.++||||||+++|||+| |..||...... +...... .. ..+. .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~-~~---------~~~~----~ 224 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVE-RG---------YRMP----C 224 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cC---------CCCC----C
Confidence 122346778999999998999999999999999999999 88888653322 1111111 10 0111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
....+..+.+++.+||+.||++||+++++++.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11234678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=326.20 Aligned_cols=258 Identities=26% Similarity=0.469 Sum_probs=203.4
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCc----EEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQ----LIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...++||+|+||+||+|++ .+|+ .||+|+++.... ...+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4677889999999999999985 3444 489999875433 334678899999999999999999999875 45779
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
++||+++|+|.++++... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999987543 36899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........++..|+|||...+..++.++|||||||++|||++ |..||..... ........... .+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~---------~~ 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGE---------RL 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC---------cC
Confidence 322111222345678999999999999999999999999999998 8889864322 11111111111 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. .......++.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 231 ~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 P----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred C----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0 1112346788999999999999999999999998877533
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=334.57 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=195.4
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57899999987532 22334577888998876 799999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 99998886543 6889999999999999999999998 9999999999999999999999999987543222 122
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ...| .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~~~--------~~~p-------~ 217 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILHDD--------VLYP-------V 217 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHcCC--------CCCC-------C
Confidence 345699999999999999999999999999999999999999975432 22222221110 0011 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRP-------TMSEVVKD 898 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 898 (955)
....++.+++.+|++.||++|| ++++++++
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1235788999999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=341.38 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=200.7
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC---CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
..++|+..+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3567899999999999999999965 5889999998642 12233567889999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999988643 4788888999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhC----CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
... .......||+.|||||++.+. .++.++||||+||++|||++|+.||..... ......+.....
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~~i~~~~~-------- 264 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYSKIMDHKN-------- 264 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCc--------
Confidence 221 122345799999999999754 378899999999999999999999975432 222222221111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 898 (955)
.+...........+.+++.+|+..++.+ |++++|++++
T Consensus 265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111111123356778999999865544 8999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.46 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=208.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999976 78999999886422 223467899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 704 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 704 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||+++|+|.+++... ....+++.++..++.++++||+|||+.+ ++||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887542 2346899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch-HHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY-IVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.||..... ..+....... . ..+
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~---------~~~ 226 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-C---------DYP 226 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-C---------CCC
Confidence 221 12235688999999999988999999999999999999999999864432 1111111110 0 011
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
... .......+.+++.+||..+|++||++.++++.++++
T Consensus 227 ~~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 PLP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 111 113346788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.14 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=203.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc--EEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ--LIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 702 (955)
++|+..+.||+|+||+||+|++. ++. .+|+|+++.... ...+.+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46778899999999999999864 454 468887765332 3346788999999999 899999999999999999999
Q ss_pred EEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 703 YEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
|||+++|+|.++++... ...+++.+++.++.|+++|++|||+.+ ++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999886432 235789999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 847 (955)
||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... .+...... .
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~-~ 238 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLP-Q 238 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHHHHh-c
Confidence 99999998643211 11111234668999999988889999999999999999998 9999864322 11111110 0
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
...+ .........+.+++.+||+.+|++||+++++++.++++++.+.
T Consensus 239 ---------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 239 ---------GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ---------CCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0000 1111233578899999999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=321.34 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=196.4
Q ss_pred eeeccCceEEEEEEe---CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 635 DVGSGGYGKVYKGTL---PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
.||+|+||+||+|.+ .++..+|+|+++.... ...+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3578999999875432 23467899999999999999999999875 45678999999999
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce-e
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI-T 788 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~ 788 (955)
+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......... .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999986543 6889999999999999999999988 99999999999999999999999999987654332111 1
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
....++..|+|||.+....++.++|||||||++|||++ |..||..... .+.... ..... .+. .+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~-i~~~~---------~~~----~~ 220 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQM-IESGE---------RME----CP 220 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH-HHCCC---------CCC----CC
Confidence 12234578999999988889999999999999999998 9999864322 122211 11111 011 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.....++.+++.+||+.||++||++++|++.|++.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=334.59 Aligned_cols=242 Identities=26% Similarity=0.350 Sum_probs=194.5
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999987532 22335677888888877 699999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT 153 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence 99998886543 6889999999999999999999988 9999999999999999999999999987543221 123
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ...| .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-~~~~~~i~~~~--------~~~~-------~ 217 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDE--------VVYP-------T 217 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCC--------CCCC-------C
Confidence 345799999999999999999999999999999999999999965432 22222221110 0011 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTM------SEVVKD 898 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 898 (955)
....++.+++.+|++.||.+||++ ++++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 123578899999999999999998 666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=335.72 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=194.6
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 688999999975422 2234578899999998 699999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++...+ .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccc
Confidence 99988876543 6899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc-------hHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK-------YIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...++........ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----------QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------CCC
Confidence 34579999999999999999999999999999999999999996211 1111111111110 011
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPT------MSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 898 (955)
+ +.....++.+++.+|++.||.+||+ ++|++++
T Consensus 224 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 I----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1 1122356889999999999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=340.79 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=197.9
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
+|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999854 689999999864321 223568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC-
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE- 783 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~- 783 (955)
|+++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999987654 5788888889999999999999998 9999999999999999999999999975331000
Q ss_pred ----------------------------------------CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHH
Q 002189 784 ----------------------------------------KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 823 (955)
Q Consensus 784 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~e 823 (955)
.........||+.|||||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0001123469999999999999999999999999999999
Q ss_pred HHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 002189 824 LLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP---TMSEVVKD 898 (955)
Q Consensus 824 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 898 (955)
|++|+.||...... +....+.... ..............+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPA-ETQLKVINWE-----------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHH-HHHHHHhccC-----------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999754432 1111111100 00011111122356778888876 5999999 89999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.31 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=193.4
Q ss_pred CeeeccCceEEEEEEeCC---CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 634 NDVGSGGYGKVYKGTLPN---GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
+.||+|+||.||+|.+.+ +..+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45799998875432 33457889999999999999999999999999999999999999
Q ss_pred CcccccCCCC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 710 SLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 710 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
+|.++++... ....++..+..++.|+++|++|||+.+ ++||||||+||++++++.+|++|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999886432 235677888899999999999999988 9999999999999999999999999997654332212
Q ss_pred eeeeeecCCCCCCHHHhhhC-------CCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 787 ITTQVKGTMGYLDPEYYMTQ-------QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~-------~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
......++..|+|||++... .++.++||||||+++|||++ |+.||........... ..... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~-----~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TVREQ-----QLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-Hhhcc-----cCCCC
Confidence 22234578889999998642 35789999999999999996 9999965433221111 11110 11112
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+|... ......+.+++.+|| .+|++||+++||++.|+
T Consensus 232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22221 112356788999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=324.46 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=202.4
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+|...+.||+|+||.||+|+. .+++.||+|+++.......+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999986 578899999987654444567889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.++++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 9999999886543 6889999999999999999999988 99999999999999999999999999986643221
Q ss_pred eeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 787 ITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+.......... .... .....+...
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~--------~~~~~~~~~ 232 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSK--------SNFQPPKLK 232 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeec--------CCCCCCCCc
Confidence 122356889999999985 3457889999999999999999999986432211100 0000 000011111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
........+.+++.+||..+|++||+++++++++
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1112346788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=343.90 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=196.5
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.|...++||+|+||+||+|+. .+++.||+|++..... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999986 4688999999875322 223568889999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC-
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE- 783 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~- 783 (955)
|+++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999887543 5788888899999999999999998 9999999999999999999999999975331000
Q ss_pred --------------------------------------------CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHH
Q 002189 784 --------------------------------------------KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGV 819 (955)
Q Consensus 784 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv 819 (955)
.........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHH
Q 002189 820 LMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MSEVV 896 (955)
Q Consensus 820 ~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 896 (955)
++|||++|+.||....... ....+.... .............++.+++.+|+ .+|.+|++ +.|++
T Consensus 237 il~elltG~~Pf~~~~~~~-~~~~i~~~~-----------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLE-TQMKVINWQ-----------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHHhCCCCCCCCCHHH-HHHHHHccC-----------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 9999999999997543322 111111110 00111111122356678888875 59999987 88887
Q ss_pred HH
Q 002189 897 KD 898 (955)
Q Consensus 897 ~~ 898 (955)
++
T Consensus 304 ~h 305 (382)
T cd05625 304 AH 305 (382)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=323.35 Aligned_cols=256 Identities=27% Similarity=0.507 Sum_probs=204.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CC---cEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NG---QLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|+..+.||+|+||.||+|+.. ++ ..+|+|+++... ....+++..|++++++++|+||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999864 33 379999987543 23346788999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999986543 36899999999999999999999988 999999999999999999999999999866433
Q ss_pred CCccee-eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 783 EKDHIT-TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 783 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...... .....+..|+|||++..+.++.++|||||||++|||++ |..||..... .+....+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~~~------------- 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDG------------- 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhcC-------------
Confidence 221111 11223457999999998899999999999999999998 9999864332 1222221110
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
............+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111122346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=340.14 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=203.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||+|+++.... ...+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999864 689999999875422 23456889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... ..+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999987542 36889999999999999999999998 9999999999999999999999999998765433
Q ss_pred CcceeeeeecCCCCCCHHHhh------hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 784 KDHITTQVKGTMGYLDPEYYM------TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+..... .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~~~-------~ 227 (330)
T cd05601 157 M-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNFQR-------F 227 (330)
T ss_pred c-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcCCC-------c
Confidence 2 2223356899999999987 456789999999999999999999999755432 22222221111 0
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
............+.+++.+|++ +|.+||++++++++
T Consensus 228 ----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 ----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0011111233678899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.43 Aligned_cols=262 Identities=23% Similarity=0.411 Sum_probs=202.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-----------------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-----------------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSL 689 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 689 (955)
++|+..+.||+|+||+||+++.. ++..||+|+++.... ...+++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998532 234789999875433 234679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCcccccCCCC---------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccE
Q 002189 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKN---------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNI 760 (955)
Q Consensus 690 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI 760 (955)
++++...+..++||||+++|+|.+++.... ...+++.+...++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999886532 124778899999999999999999998 99999999999
Q ss_pred EEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh--CCCCCcCCchHH
Q 002189 761 LLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT--GRRPIERGKYIV 838 (955)
Q Consensus 761 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt--g~~P~~~~~~~~ 838 (955)
++++++.++|+|||+++.+.............++..|+|||+...+.++.++|||||||++|||++ |..||..... .
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-E 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-H
Confidence 999999999999999986644332222223345678999999988899999999999999999998 6778754322 1
Q ss_pred HHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+.+.......... ......+ ....++..+.+++.+||+.||++||+++||++.|+
T Consensus 241 ~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQ--GRQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhc--cccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2211111100000 0000001 11223467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=325.56 Aligned_cols=254 Identities=30% Similarity=0.444 Sum_probs=201.9
Q ss_pred HHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeC------
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR------ 696 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------ 696 (955)
.+++.|+..+.||+|+||+||+|... +++.||+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 34667888889999999999999864 68899999987543 3346788999999998 699999999998763
Q ss_pred CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
...++||||+++|+|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 45799999999999999988655557899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 851 (955)
+...... .......|+..|+|||++. +..++.++|||||||++|||++|+.||........... ..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-~~------ 229 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IP------ 229 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-Hh------
Confidence 8654322 1223456899999999986 34588899999999999999999999964432221111 00
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+... .......+.+++.+||..+|.+||+++|++++
T Consensus 230 ----~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 ----RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ----cCCCCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00011111 11233578899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=332.32 Aligned_cols=262 Identities=24% Similarity=0.447 Sum_probs=207.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC--------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 697 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 697 (955)
.+|...+.||+|+||.||+|+.. .+..||+|.++.... ...+++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35788899999999999999742 123689998875432 2346789999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999886431 235889999999999999999999988 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 842 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~ 842 (955)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||... ...+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHH
Confidence 999999999999987654322222222334567999999999999999999999999999998 78887543 2222222
Q ss_pred HHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 843 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
.+.... . .........++.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus 248 ~~~~~~----------~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 248 LLKEGH----------R----MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHcCC----------C----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 211110 0 01111234678899999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.49 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=192.5
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999987532 12234566788888764 899999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++.... .+++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 99999887543 5888999999999999999999988 9999999999999999999999999987542222 122
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.. ..+... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i~~-----------~~~~~~----~ 217 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIRM-----------DNPCYP----R 217 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-----------CCCCCC----c
Confidence 345799999999999999999999999999999999999999965432 121111110 011111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMS-EVVK 897 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 897 (955)
....++.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1235678999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.28 Aligned_cols=237 Identities=27% Similarity=0.350 Sum_probs=189.0
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHH-HHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIE-LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +|+.||||++..... ...+++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999864 689999999875321 22234555544 56788999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++.... .+++.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT 153 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence 99998887543 6888899999999999999999998 9999999999999999999999999987543222 223
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+..... .+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~-------~~~~-------- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKPL-------RLKP-------- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-HHHHHHHHHcCCC-------CCCC--------
Confidence 34569999999999999999999999999999999999999996533 2222222211100 0111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMS 893 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~ 893 (955)
.....+.+++.+|++.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1236788999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=332.89 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=197.4
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccC-CCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 703 (955)
+|...+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 57899999987532 2234567889999999976 56888999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999998886543 5789999999999999999999988 9999999999999999999999999987542222
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+... .+..
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~-----------~~~~- 220 (324)
T cd05587 156 --KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEH-----------NVSY- 220 (324)
T ss_pred --CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-----------CCCC-
Confidence 123346799999999999999999999999999999999999999965432 2222222111 0111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 898 (955)
+.....++.+++.+||+.||.+|++. +++.++
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 221 ---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11223578899999999999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.56 Aligned_cols=249 Identities=28% Similarity=0.473 Sum_probs=205.7
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999874 78999999986544 45778999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.++++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999987665557899999999999999999999988 99999999999999999999999999987632211
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
....+..|+|||++..+.++.++||||||+++|||++ |..||.... ..+ +........ .+..
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~-~~~~~~~~~---------~~~~---- 220 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKD-VVPHVEKGY---------RMEA---- 220 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHH-HHHHHhcCC---------CCCC----
Confidence 2335678999999998899999999999999999997 999986432 111 111111110 0111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
....+..+.+++.+||..+|++||+++|+++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11234678899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=327.79 Aligned_cols=269 Identities=26% Similarity=0.435 Sum_probs=202.2
Q ss_pred CCCccCeeeccCceEEEEEEe-----CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQM 700 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 700 (955)
.|...+.||+|+||.||++++ .++..||+|.++... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999974 257899999987543 22346789999999999999999999999875 5689
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999886542 35899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH-HHHHHHHhhhhhhhhhhhcc
Q 002189 781 DSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV-REIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 781 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 858 (955)
..... .......++..|+|||++.+..++.++|||||||++|||+|++.|........ ......... .........+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ-MTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc-ccHHHHHHHH
Confidence 33221 11223456778999999998899999999999999999999877653211100 000000000 0000000000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
...............+.+++.+||+.+|++||+++++++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000111122446899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=356.84 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=206.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...++||+|+||+||+|+.. +|+.||||+++.... ...++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999864 589999999875322 22457899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCC---------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecc
Q 002189 704 EFVPNGSLGDSLSGK---------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 774 (955)
Q Consensus 704 e~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 774 (955)
||+++|+|.+++... .....++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999887531 1234677888999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCC----------------cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH
Q 002189 775 LSKSMSDSEK----------------DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838 (955)
Q Consensus 775 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~ 838 (955)
+++....... ........||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 001122469999999999999999999999999999999999999996532211
Q ss_pred HHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHHHc
Q 002189 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-TMSEVVKDIENILQQA 906 (955)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 906 (955)
..... ...+|.. .......+..+.+++.+|++.||++|| +++++.+.|+..++..
T Consensus 239 i~~~~------------~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 ISYRD------------VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhhhh------------hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 10000 0011110 011123346788999999999999995 6788888888887643
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.68 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=208.4
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.++|...++||+|+||+||+|...+++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 457888899999999999999988888999999886443 3467999999999999999999999999989999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++.......+++..+..++.+++.|++|||+.+ ++|+||||+||++++++.+|++|||+++....... .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 9999999998765567899999999999999999999988 99999999999999999999999999987643221 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .......... .....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~----------~~~~~--- 225 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERG----------YRMPR--- 225 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC----------CCCCC---
Confidence 1122335678999999998899999999999999999999 8989854322 2222211111 00000
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
....+..+.+++.+|+..+|++||+++++++.|+.
T Consensus 226 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11124678899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.96 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=204.7
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 698 (955)
..++|+..++||+|+||.||+|... .+..||+|.++.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567889999999999999999753 245899998875432 233568889999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEE
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
.++||||+++|+|.++++... ....++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999986422 234577788999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhh
Q 002189 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.... ..+.........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~- 238 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-NEQVLKFVMDGG- 238 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCC-
Confidence 99999986543332222222345678999999999999999999999999999999 777885422 222222111110
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.+. ........+.+++.+|++.||++||++.|+++.|+..+
T Consensus 239 ---------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 ---------YLD----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---------CCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 001 11122367899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.94 Aligned_cols=261 Identities=25% Similarity=0.459 Sum_probs=205.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC--------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 697 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 697 (955)
++|...+.||+|+||.||+|+.. ....||+|+++.... ....++..|+++++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 245799999875432 2345688999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999886432 235889999999999999999999988 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 842 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~ 842 (955)
+++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.... ..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence 999999999999987643222111122234567999999999999999999999999999999 888885432 212111
Q ss_pred HHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 843 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.. .... . .........++.+++.+||..+|++||++.|+++.|+++....
T Consensus 248 ~~-~~~~---------~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 248 LL-REGH---------R----MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HH-HcCC---------C----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11 1110 0 0111223467889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=331.40 Aligned_cols=241 Identities=25% Similarity=0.334 Sum_probs=192.6
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||.||+|+.. +|+.||+|+++... ....+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 68899999987532 12334567788888765 899999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++.... .+++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence 99998886543 5888999999999999999999998 9999999999999999999999999987532221 223
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~~-----------~~~~~~~---- 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-----------DTPHYPR---- 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-----------CCCCCCC----
Confidence 346799999999999999999999999999999999999999965432 121111110 0111111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMS-EVVK 897 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 897 (955)
....++.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1235678999999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.33 Aligned_cols=248 Identities=25% Similarity=0.427 Sum_probs=196.2
Q ss_pred eeeccCceEEEEEEeC---CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 635 DVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
.||+|+||.||+|.+. ++..||+|++...... ..+++.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999763 3567999998765332 3467899999999999999999999875 457899999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce-ee
Q 002189 711 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI-TT 789 (955)
Q Consensus 711 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~ 789 (955)
|.+++.... ..+++..+++++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999886432 36899999999999999999999988 99999999999999999999999999986543322111 11
Q ss_pred eeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 790 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 790 ~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
...++..|+|||.+..+.++.++|||||||++||+++ |..||...... +....+ .... ....+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~-~~~~-------------~~~~~~ 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFI-EQGK-------------RLDCPA 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHH-HCCC-------------CCCCCC
Confidence 1233578999999998889999999999999999996 99998654321 111111 1111 011122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.+..++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 3347888999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=325.64 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=204.4
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC------CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
.++|...+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567888999999999999998642 36899999875432 3345788999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 700 MLIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999886432 224788999999999999999999988 9999999999999999999999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhh
Q 002189 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 772 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
|||+++...............++..|+|||.+.++.++.++|||||||++||++| |..||.... ..+...... ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~-~~~- 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVI-DGG- 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHh-cCC-
Confidence 9999986654332222233456789999999998899999999999999999998 888885432 212111111 110
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
.+.. +......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 239 --------~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 --------HLDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------CCCC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0111 1122467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.05 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=205.0
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+|...+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3677788999999999999985 468999999988665555677899999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.++++.. .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 999999988643 4789999999999999999999988 99999999999999999999999999876543221
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||........... .... ..+.. ..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-~~~~----------~~~~~--~~ 238 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATN----------GTPEL--QN 238 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-HhcC----------CCCCC--CC
Confidence 12234688999999999988899999999999999999999999965433221111 1100 00111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||..||++||++.|++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 12234678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.89 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=203.0
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc-----hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ-----GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...+.||+|+||.||+|.. .+++.||+|.++..... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688889999999999999985 46899999988643221 23468889999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999886543 5788889999999999999999998 99999999999999999999999999976543
Q ss_pred CCCcce-eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHI-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~---------~~~ 226 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQP---------TNP 226 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccC---------CCC
Confidence 221111 123457889999999999889999999999999999999999997543332211 111100 011
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.........+.+++.+||..+|.+||++.|++++
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 ----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112234678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=323.54 Aligned_cols=255 Identities=28% Similarity=0.496 Sum_probs=202.2
Q ss_pred CCCccCeeeccCceEEEEEEeC-CC---cEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NG---QLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
+|...+.||+|+||.||+|+.. ++ ..||||.++... ....++|..|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999864 33 369999987542 233467999999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... ..+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999887543 36899999999999999999999988 9999999999999999999999999987664332
Q ss_pred Ccceeeeee---cCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 784 KDHITTQVK---GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 784 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
......... .+..|+|||++.+..++.++|||||||++|||++ |..||...... +....+ .... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i-~~~~---------~ 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAI-EQDY---------R 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHH-HcCC---------c
Confidence 211111111 2457999999999999999999999999999987 99998654321 111111 1100 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.......+..+.+++.+||+.+|++||++++++..|+++
T Consensus 230 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122346788999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.03 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=198.8
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcc
Q 002189 634 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 712 (955)
++||+|+||.||+|...+++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999998765433 2346889999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeee
Q 002189 713 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792 (955)
Q Consensus 713 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 792 (955)
+++.... ..+++..+..++.+++.||.|+|+.+ ++||||||+||++++++.+||+|||+++....... .......
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCC
Confidence 9886543 35789999999999999999999988 99999999999999999999999999875433221 1111223
Q ss_pred cCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 793 gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
++..|+|||++.++.++.++||||||+++|||++ |..||...... ...... ... ... ......+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~~~~~~-~~~---------~~~----~~~~~~~ 220 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQV-EKG---------YRM----SCPQKCP 220 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHH-HcC---------CCC----CCCCCCC
Confidence 4678999999998999999999999999999998 89898643221 111111 110 000 1111234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
.++.+++.+||..+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 67899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.32 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=201.1
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe-CCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~ 706 (955)
.+|...+.||+|+||.||+|... |..||+|.++... ..+.+.+|+.++++++|+|++++++++.. ++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778899999999999999874 7889999987543 34678999999999999999999998654 45789999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999987665556899999999999999999999988 9999999999999999999999999987653322
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+.. . ..+.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~~~~~~~-~---------~~~~---- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEK-G---------YKMD---- 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhc-C---------CCCC----
Confidence 12335678999999998899999999999999999998 888885432 2222211111 0 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
.....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111234678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.32 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=194.6
Q ss_pred CeeeccCceEEEEEEeC----CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEe-CCeEEEEEEecC
Q 002189 634 NDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQMLIYEFVP 707 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~ 707 (955)
+.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 24579999986432 2344678899999999999999999998764 556899999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc-
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH- 786 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~- 786 (955)
+|+|.+++.... ...++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999987543 24678888999999999999999988 9999999999999999999999999998654322111
Q ss_pred -eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 -ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 -~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......++..|+|||++.+..++.++|||||||++|||++|+.|........+......... .+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~--- 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR----------RLLQ--- 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC----------CCCC---
Confidence 11123467789999999988999999999999999999996544333322222222211110 0110
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
....+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 224 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 -PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1122357889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.81 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=195.6
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999987532 22335577888999888 699999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence 99998886543 6899999999999999999999988 9999999999999999999999999987532221 122
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .+.. ..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-~~~~~~i~~~-----------~~~~----~~ 217 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSILED-----------EVRY----PR 217 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcC-----------CCCC----CC
Confidence 345699999999999999999999999999999999999999964432 2221111111 0111 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTM-----SEVVKD 898 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 898 (955)
.....+.+++.+||+.||.+||++ .+++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 223678899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=335.12 Aligned_cols=238 Identities=31% Similarity=0.386 Sum_probs=193.0
Q ss_pred CeeeccCceEEEEEEe----CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 634 NDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
+.||+|+||+||+++. .+|+.||+|+++.... .....+..|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3588999999875322 233457789999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~ 154 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 154 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence 999999886543 6899999999999999999999998 99999999999999999999999999986543321 2
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+....+.... ..+ +
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~i~~~~-----------~~~----p 218 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-KETMTMILKAK-----------LGM----P 218 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-HHHHHHHHcCC-----------CCC----C
Confidence 2345799999999999988899999999999999999999999965432 22222111110 001 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSE 894 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~e 894 (955)
......+.+++.+||+.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112356789999999999999999543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.07 Aligned_cols=254 Identities=26% Similarity=0.463 Sum_probs=205.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.++|...+.||+|+||.||+|...++..+|+|.++... ...+.+.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35678889999999999999998778889999887543 234678899999999999999999999887 7789999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++.......+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 9999999997765567899999999999999999999988 99999999999999999999999999976543222 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......++..|+|||++..+.++.++|+|||||++||++| |..||...... +.... ..... . ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~-~~~~~---------~----~~ 223 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRA-LERGY---------R----MP 223 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHH-HhCCC---------C----CC
Confidence 2222346678999999998889999999999999999999 88888643221 11111 11110 0 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
.......++.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111234678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.70 Aligned_cols=270 Identities=26% Similarity=0.427 Sum_probs=205.5
Q ss_pred CCCccCeeeccCceEEEEEEeC-----CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEe--CCeEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQM 700 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 700 (955)
.|...+.||+|+||.||+|++. +++.||||+++..... ..++|.+|+++++.++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4667789999999999999864 3689999999865443 45789999999999999999999999987 55789
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999987543 25899999999999999999999988 9999999999999999999999999998775
Q ss_pred CCCCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 781 DSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 781 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
..... .......++..|+|||.+.+..++.++||||||+++|||+||..|+......................+.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 33221 11112345667999999998899999999999999999999999976432211000000000000000011111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
..........+..++.+++.+||+.+|++||++.||+++|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.54 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=203.4
Q ss_pred hcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
.++|...+.||+|+||.||+|... ++..||+|+++.... ...+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999853 467899999875433 3346789999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCcc
Q 002189 700 MLIYEFVPNGSLGDSLSGKN--------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSN 759 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~N 759 (955)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999886321 134788899999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHH
Q 002189 760 ILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIV 838 (955)
Q Consensus 760 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~ 838 (955)
|++++++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-E 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-H
Confidence 9999999999999999876543322111222345678999999998999999999999999999998 8788854322 2
Q ss_pred HHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+...... ... ..+ .......++.+++.+||+.||++||++.|+++.|+
T Consensus 240 ~~~~~~~-~~~--------~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIYYVR-DGN--------VLS-----CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHh-cCC--------CCC-----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 2222111 110 000 01123467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.01 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=197.3
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 703 (955)
+|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 578999999875422 2234566788888877 5899999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998886543 5889999999999999999999988 9999999999999999999999999997543222
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.... ..
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~-----------~~-- 219 (323)
T cd05616 156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHN-----------VA-- 219 (323)
T ss_pred --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-----------CC--
Confidence 122345699999999999999999999999999999999999999975432 22222221110 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 898 (955)
.+.....++.+++.+|++.||++|++. +++.++
T Consensus 220 --~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111223678899999999999999974 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.27 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=201.2
Q ss_pred CeeeccCceEEEEEEeCC--C--cEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLPN--G--QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||.||+|.+.+ + ..||||.++.... ...+.+.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999987665 456789999999999999999999999988 889999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc-ce
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-HI 787 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~ 787 (955)
|+|.+++.......+++...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999987654346899999999999999999999988 999999999999999999999999999876543221 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||++.+..++.++|||||||++|||++ |..||..... .+.......... .. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~-----------~~--~~ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKKIDKEGE-----------RL--ER 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC-----------cC--CC
Confidence 123457789999999999999999999999999999999 9999864322 222222211100 00 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
....+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1123467889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.35 Aligned_cols=249 Identities=31% Similarity=0.491 Sum_probs=195.9
Q ss_pred CeeeccCceEEEEEEeC-CCc--EEEEEEcccCC-cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQ--LIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999875 343 57889887533 23346788999999999 799999999999999999999999999
Q ss_pred CCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecc
Q 002189 709 GSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 774 (955)
Q Consensus 709 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 774 (955)
|+|.++++... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999886432 124789999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYN 853 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 853 (955)
+++..... ........+..|+|||++....++.++|||||||++|||++ |..||..... .+.......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~------- 226 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQ------- 226 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHHHhC-------
Confidence 98632211 11111234567999999998899999999999999999997 9999854321 111111110
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
............++.+++.+||+.+|.+||++.|+++.|++++
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000111123357889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.75 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=200.6
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
|+..+.||+|+||+||+|.. .+++.||+|.+...... ..+.+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999986 46899999998754322 234578899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++++|.+++...+...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999998886555457999999999999999999999988 99999999999999999999999999876543221
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.....|+..|+|||++.+..++.++|+|||||++|||++|..||........ ......... . ..+.
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~------~-~~~~---- 223 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVL------E-TEEV---- 223 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhh------c-cccc----
Confidence 1234689999999999989999999999999999999999999975433211 111111000 0 0001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
........+.+++.+|++.||++||+ +.+++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11123356789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=344.87 Aligned_cols=260 Identities=19% Similarity=0.327 Sum_probs=193.1
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeC--------C
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--------G 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~ 697 (955)
..+|...++||+|+||+||+|... +++.||||++.... ....+|+.+++.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457889999999999999999864 68999999886432 2345799999999999999999987542 1
Q ss_pred eEEEEEEecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecc
Q 002189 698 EQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFG 774 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFG 774 (955)
..++||||+++ +|.+++.. .....+++.....++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 36789999974 66665542 22346889999999999999999999998 99999999999999665 69999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-hhh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-ELY 852 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~ 852 (955)
+|+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...... +.+..+..... ...
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Confidence 9987643322 2235689999999998764 6899999999999999999999999654332 22222221100 000
Q ss_pred hhhhccCC--------cC-----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLYELIDP--------TI-----GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~~~~d~--------~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+ .. ....+.....++.+|+.+||+.||.+|||+.|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000 00 000111234678999999999999999999999976
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.60 Aligned_cols=249 Identities=31% Similarity=0.507 Sum_probs=203.7
Q ss_pred CeeeccCceEEEEEEeCC----CcEEEEEEcccCCcch-hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||.||+|...+ +..||+|.++...... .+.+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 7899999998654433 57889999999999999999999999999999999999999
Q ss_pred CCcccccCCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 709 GSLGDSLSGKN-------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 709 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999987642 357899999999999999999999988 99999999999999999999999999987764
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........++..|+|||.+....++.++||||+|+++|||++ |..||..... .+....... .. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~-~~---------~- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRK-GY---------R- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHc-CC---------C-
Confidence 432222334567889999999998899999999999999999999 6888865422 121111111 00 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
.........++.+++.+||..+|++||+++|+++.|+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.06 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=198.0
Q ss_pred CeeeccCceEEEEEEeC--C--CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP--N--GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~--~--g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
++||+|+||.||+|++. + +..||+|.++..... ..+++.+|+++++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 268999998865442 4567899999999999999999999875 4568999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce-
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI- 787 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~- 787 (955)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 6899999999999999999999988 99999999999999999999999999987644332111
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+.... ..... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~-~~~~~-------------~~~~ 219 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAM-LESGE-------------RLPR 219 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHH-HHcCC-------------cCCC
Confidence 111224568999999998999999999999999999998 9999865432 121111 11111 0011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
....+..+.+++.+||..+|++||++.++++.|+++
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 122346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.43 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=204.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-C---CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-N---GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||.||+|+.. + +..+|+|.++.... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 2 34799999875432 2346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++++|.+++.... ..+++.+++.++.|++.|++|||+.+ ++||||||+||++++++.++++|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999987543 36899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCcce-eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 783 EKDHI-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 783 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
..... .....++..|+|||++.++.++.++||||||+++||+++ |..||...... +...... ... .+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~-~~~---------~~ 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAIE-EGY---------RL 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHHh-CCC---------cC
Confidence 22111 111223568999999998899999999999999999887 99998644321 1111111 100 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
......+..+.+++.+||+.+|.+||+|.++++.|.++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01112346788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.51 Aligned_cols=261 Identities=20% Similarity=0.304 Sum_probs=204.0
Q ss_pred HHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEe
Q 002189 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 695 (955)
+.++....++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445555688999999999999999999865 68899999986421 2233557889999999999999999999999
Q ss_pred CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 696 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
++..++||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999988643 4788888899999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhC----CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 851 (955)
++....... .......||+.|||||++... .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~-- 264 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKN-- 264 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC--
Confidence 987643322 122345799999999999754 378999999999999999999999975433 222222221111
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 002189 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKDI 899 (955)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 899 (955)
.+...........+.+++.+|+..++.+ |++++|++++.
T Consensus 265 ---------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 ---------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0001111123466789999999844443 78999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.90 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=201.1
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
|+..+.||+|+||+||+|... +++.||||.+...... ..+.+..|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999864 6899999998654322 224577899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999886555456899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH--HHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV--REIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.......... ..
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~~-- 223 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ----------EE-- 223 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh----------hh--
Confidence 123468999999999999999999999999999999999999997543211 11111111100 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
........+.+++.+||+.||++||+ ++|++++
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 --YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11122356789999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.06 Aligned_cols=258 Identities=27% Similarity=0.384 Sum_probs=203.3
Q ss_pred HHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 623 VKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 623 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++.+++.+.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999854 678899999877655566789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeeccccccc
Q 002189 702 IYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSM 779 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~ 779 (955)
|+||+++++|.++++... ....++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999887542 112378888899999999999999988 999999999999986 678999999998765
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCC--CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
..... ......|+..|+|||++.... ++.++||||||+++|||++|+.||.............. .. .
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~--------~~-~ 228 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG--------MF-K 228 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh--------hh-c
Confidence 43221 122345889999999987543 78899999999999999999999864332211111100 00 0
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.+ +.....++.+++.+||+.+|++||++.|++++
T Consensus 229 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11111 11233678899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.10 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=201.1
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++.|+..++||+|.|+.||+... .+|+.+|+|.+... ...+.+++.+|+++.+.++|||||++...+.+.+..|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 44566778899999999999874 57899999877532 3335678999999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc---CCCceEEeecccccccC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMS 780 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGla~~~~ 780 (955)
|+|++++|..-+-.. .-+++...-..+.||+++|.|+|..+ |||||+||+|+++- ....+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997655332 34677778889999999999999999 99999999999994 34568999999999987
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
++ ......+||++|||||++...+|+..+|||+.||+||-++.|.+||.+.. ..+....+..... + +++
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-~~rlye~I~~g~y------d-~~~ 233 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYEQIKAGAY------D-YPS 233 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhcccc------C-CCC
Confidence 33 34456789999999999999999999999999999999999999996522 2222222222211 1 111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
.......++..+|+.+|+..||.+|.|+.|.++
T Consensus 234 ----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 ----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111222356789999999999999999998885
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=317.59 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=190.3
Q ss_pred eeeccCceEEEEEEeCC---CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 635 DVGSGGYGKVYKGTLPN---GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
.||+|+||+||+|...+ ...+|+|.+..... .....+.+|+++++.++|+||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 35788998765432 234568899999999999999999999999999999999999999
Q ss_pred cccccCCCCC---CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 711 LGDSLSGKNG---IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 711 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
|.+++..... ...++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 23567888899999999999999988 99999999999999999999999999875433222111
Q ss_pred eeeeecCCCCCCHHHhhh-------CCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 788 TTQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... +.......... ....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~-----~~~~~ 232 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVVREQD-----IKLPK 232 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhhccC-----ccCCC
Confidence 223346778999999853 356789999999999999999 77787644332 12222221111 11112
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
|.. .......+.+++..|| .||++||+++||++.|
T Consensus 233 ~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 233 PQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred Ccc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 221 1223356778889999 5999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.68 Aligned_cols=269 Identities=22% Similarity=0.332 Sum_probs=225.4
Q ss_pred HHHHHHHhcCCCccCeeeccCceEEEEEEeCC------CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEE
Q 002189 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGF 692 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~ 692 (955)
..|+.....+++....+-+|.||.||+|.|++ .+.|-||.++....+ ....+..|.-.+..+.|||+.++.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45566667788888899999999999997653 456778888765433 23567889889999999999999999
Q ss_pred EEeC-CeEEEEEEecCCCCcccccCC------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC
Q 002189 693 CFDR-GEQMLIYEFVPNGSLGDSLSG------KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER 765 (955)
Q Consensus 693 ~~~~-~~~~lV~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~ 765 (955)
+.++ +..+.+|.++.-|+|..++.. ...+.++..+...++.|++.|++|||.++ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 567889999999999999872 22456888899999999999999999999 9999999999999999
Q ss_pred CceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHH
Q 002189 766 LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTV 844 (955)
Q Consensus 766 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~ 844 (955)
.++||+|=.++|.+.+.++.........+..||+||.+....|+.++|||||||++|||+| |+.|+.+-+.. +.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-Em---- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-EM---- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-HH----
Confidence 9999999999999999988888777888999999999999999999999999999999999 88898643322 11
Q ss_pred HhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 845 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
...+....+...+..++++++.+|.-||..+|++||+++|++..|.++..+.
T Consensus 508 ----------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 508 ----------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ----------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 1222223344556678899999999999999999999999999999987664
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=337.04 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=198.8
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC-----eEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQM 700 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 700 (955)
+|+..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 47899999998653 2233467889999999999999999999998776 789
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+|+||+. ++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 57777775433 6899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----------
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK---------- 849 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~---------- 849 (955)
.... .......++..|+|||++.+. .++.++|||||||++|||++|+.||...... +.+..+.....
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHh
Confidence 3222 122334688999999999864 5789999999999999999999999654322 22221111000
Q ss_pred --hhh-hhh-hccCC-cCC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 --ELY-NLY-ELIDP-TIG--LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 --~~~-~~~-~~~d~-~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... .+. ....+ ... .........++.+++.+|++.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 000 00000 000 00111224678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.59 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=207.7
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-C-----CCcceEEEEEEeCCeEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-H-----KNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l 701 (955)
+|.+.+.||+|+||.|-||.. .+++.||||+++.... -..+-..|+.+|..++ | -|+|++++++..+++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999974 5799999999986433 2345677999999996 4 389999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC--CceEEeeccccccc
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER--LNAKVADFGLSKSM 779 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFGla~~~ 779 (955)
|+|.+ .-+|.++++.++-..++......++.||+.||..||+.+ |||+||||+||||.+. ..+||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99998 569999999888778999999999999999999999999 9999999999999753 47999999999875
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----------
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK---------- 849 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~---------- 849 (955)
... .. ....+..|+|||++.+..|+.+.||||||||++||++|. |+..|++..+++..+++-..
T Consensus 342 ~q~----vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~-PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 SQR----VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGE-PLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred CCc----ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCc-cccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 432 22 567888999999999999999999999999999999995 77778887777776654110
Q ss_pred -hhhhhhhc------------------------------cCCcCC-CC------CCHHHHHHHHHHHHHhhccCCCCCCC
Q 002189 850 -ELYNLYEL------------------------------IDPTIG-LS------TTLKGFEKYVDLALKCVQESGDDRPT 891 (955)
Q Consensus 850 -~~~~~~~~------------------------------~d~~l~-~~------~~~~~~~~l~~li~~cl~~dP~~RPs 891 (955)
......+. .+...+ .. .....-..+++++++|+..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00000000 000000 00 00122356899999999999999999
Q ss_pred HHHHHHH
Q 002189 892 MSEVVKD 898 (955)
Q Consensus 892 ~~evl~~ 898 (955)
..|++++
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999986
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=327.96 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=199.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 67899999986421 222345788999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999987532 36788899999999999999999988 9999999999999999999999999998764332
Q ss_pred CcceeeeeecCCCCCCHHHhhh-----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 784 KDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... .+....+...... . .+
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~----~-~~ 229 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHEER----F-QF 229 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-HHHHHHHHcCCCc----c-cC
Confidence 2 12233569999999999875 5678899999999999999999999965432 2222222211100 0 01
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 898 (955)
++. ......++.+++.+|+..++++ |+++++++++
T Consensus 230 p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111 1123467889999999876654 4688888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=339.19 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=198.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
...|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888999999999999999865 578999996432 3467899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+ .++|.+++.... ..++|.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 242 ~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 Y-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9 578888876432 36899999999999999999999998 999999999999999999999999999876433222
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc------hHHHHHHHHHhhhhhh-hhhh---
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK------YIVREIRTVMDKKKEL-YNLY--- 855 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~------~~~~~~~~~~~~~~~~-~~~~--- 855 (955)
.......||..|+|||++.+..++.++|||||||++|||++|..|+.... .....+..++...... ..+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 22334579999999999999999999999999999999999887664221 1112222222211100 0000
Q ss_pred ---------h----ccCCcCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ---------E----LIDPTIGLSTT---LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ---------~----~~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ...+....... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000000000 0112467899999999999999999999975
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.74 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=203.6
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+|+..+.||+|+||.||+++.. +++.+|+|.++... ....+.+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999864 68999999886432 334467889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++.......+++.....++.|++.||.|||+.+ ++|+||||+||++++++.++++|||+++...... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence 9999999886554556889999999999999999999988 9999999999999999999999999997664322 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ........... ..+ .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~---------~~~-~---- 220 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-KNLILKVCQGS---------YKP-L---- 220 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-HHHHHHHhcCC---------CCC-C----
Confidence 22345689999999999988999999999999999999999999975332 22221111110 010 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||+.||++||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.20 Aligned_cols=240 Identities=25% Similarity=0.323 Sum_probs=189.2
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHH-HHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEI-ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 678899999875321 1223444444 456788999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++.... .+.+.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~ 153 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT 153 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence 99999887543 5777888889999999999999998 9999999999999999999999999997543222 123
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ..+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~-------~~~~~-------- 217 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKP-------LQLKP-------- 217 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-HHHHHHHHhCC-------cCCCC--------
Confidence 345799999999999999999999999999999999999999975432 22222221110 00111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMSEVV 896 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~evl 896 (955)
.....+.+++.+|++.||.+||++.+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 2235788999999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.59 Aligned_cols=238 Identities=26% Similarity=0.332 Sum_probs=189.4
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHH-HHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIE-LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+. .+|+.||+|++.... ....+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 478999999986532 222345555654 46778999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|..++.... .+++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTT 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCc
Confidence 99988886543 6889999999999999999999998 9999999999999999999999999987542221 122
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~~~~~~-------~~~~~-------- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILHKP-------LVLRP-------- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-HHHHHHHHcCC-------ccCCC--------
Confidence 345799999999999999999999999999999999999999975432 22222221110 01111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMSE 894 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~e 894 (955)
.....+.+++.+|++.+|.+||++++
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 12356789999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.61 Aligned_cols=248 Identities=28% Similarity=0.461 Sum_probs=198.9
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcc
Q 002189 634 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 712 (955)
++||+|+||.||+|...+++.||+|+++..... ..+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998765443 4567999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeee
Q 002189 713 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792 (955)
Q Consensus 713 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 792 (955)
+++.... ..+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||+++...............
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9986543 36789999999999999999999988 9999999999999999999999999998654222111111223
Q ss_pred cCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 793 gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
++..|+|||.+.++.++.++|+|||||++|||+| |..||...... .... ..... .........+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~-~~~~~-------------~~~~~~~~~~ 221 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRE-RIESG-------------YRMPAPQLCP 221 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHH-HHhcC-------------CCCCCCccCC
Confidence 4567999999998899999999999999999999 78887543321 1111 11110 0011112234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
..+.+++.+||..+|++||++.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 67899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=330.05 Aligned_cols=244 Identities=24% Similarity=0.300 Sum_probs=193.7
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 678999999986422 2235578899999888 699999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|..++...+ .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTT 153 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cce
Confidence 99988876543 6899999999999999999999998 9999999999999999999999999987532221 123
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc-----hHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK-----YIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+......... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~- 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------PIRI- 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------CCCC-
Confidence 34679999999999999999999999999999999999999995311 1111221111110 0011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTM------SEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 898 (955)
+......+.+++.+||+.||.+|+++ ++++++
T Consensus 223 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 ---PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11123567899999999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=329.49 Aligned_cols=246 Identities=31% Similarity=0.450 Sum_probs=203.9
Q ss_pred eeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCccc
Q 002189 635 DVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 713 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 713 (955)
+||+|.||+||-|+.. +...+|||-+........+.+.+|+...++++|.|||+++|.|.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999965 456789999987666666788999999999999999999999999999999999999999999
Q ss_pred ccCCCCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-CCCceEEeecccccccCCCCCcceeeee
Q 002189 714 SLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 714 ~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
.|+..-+ ..-.+.+.-.+..||++||.|||+.. |||||||-+||||+ -.|.+||+|||.++.+.. ....+..+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9987543 22267777888999999999999988 99999999999996 578999999999988753 33456678
Q ss_pred ecCCCCCCHHHhhhC--CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHH
Q 002189 792 KGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~--~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 869 (955)
.||.-|||||++..+ .|..++|||||||++.||.||++||.........+-++- ++ .+.|.+ +.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--------my-KvHP~i----Pee 803 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--------MY-KVHPPI----PEE 803 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--------ce-ecCCCC----cHH
Confidence 899999999999865 588899999999999999999999975444332222211 11 123333 334
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 870 GFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 870 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+...+|.+|+.+||.+||++++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 45678899999999999999999999974
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.34 Aligned_cols=249 Identities=31% Similarity=0.493 Sum_probs=198.1
Q ss_pred CeeeccCceEEEEEEeCC-------CcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 634 NDVGSGGYGKVYKGTLPN-------GQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-----ceEEeeccc
Q 002189 706 VPNGSLGDSLSGKN-----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-----NAKVADFGL 775 (955)
Q Consensus 706 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-----~~kl~DFGl 775 (955)
+++|+|.++++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999886432 234789999999999999999999988 99999999999999887 899999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNL 854 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 854 (955)
++...............++..|+|||++.++.++.++|||||||++|||+| |+.||...... +....+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~~~~-~~~~----- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQHV-TAGG----- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHHHHH-hcCC-----
Confidence 986644332222223346788999999999999999999999999999998 99998644322 111111 1100
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
........+..+.+++.+||..+|.+||+++++++.|+
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01111223467889999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=326.52 Aligned_cols=263 Identities=22% Similarity=0.351 Sum_probs=198.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...+.||+|+||+||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999864 6789999998754322 234678899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++ +|.+++...+ ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 974 7877775443 35788899999999999999999988 99999999999999999999999999976533221
Q ss_pred ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----hhh-------h
Q 002189 786 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----ELY-------N 853 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----~~~-------~ 853 (955)
......++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... .+.......... ... .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV-EDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999999875 4689999999999999999999999964432 122211111000 000 0
Q ss_pred hhhccCCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....-.+.... ........++.+++.+|++.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000 0001123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.30 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=201.3
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
++|...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3566677899999999999985 468999999987654444567889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++...+ .+++.+...++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 9999999886544 6889999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred eeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 787 ITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......|+..|+|||++. ...++.++|||||||++|||++|+.||.......... ..... ....+...
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~~~~--------~~~~~~~~ 232 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKS--------NFQPPKLK 232 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hhhcc--------CCCCCccc
Confidence 123456899999999985 4568899999999999999999999986433221111 11000 00011111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+.+++.+|++.+|++||++++++++
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 233 --DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 011223568899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=332.73 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=197.9
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeC------
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------ 696 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 696 (955)
..++|...+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 68899999987532 22345678899999999999999999988653
Q ss_pred CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 346999999964 66665542 4788899999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-------
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK------- 849 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~------- 849 (955)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........+ ........
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHH
Confidence 8654321 223456899999999999999999999999999999999999999754432221 11111000
Q ss_pred -----hhhhhhh-------ccCCc------CC--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -----ELYNLYE-------LIDPT------IG--LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -----~~~~~~~-------~~d~~------l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+ ...+. .. .........++.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000 00 00111123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.49 Aligned_cols=251 Identities=29% Similarity=0.553 Sum_probs=202.9
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
.+|+..+.||+|+||.||+|.+.+++.+|+|.++.... ...+|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677889999999999999987788999999875433 34578999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.++++... ..+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 999999887543 35789999999999999999999988 99999999999999999999999999876543221 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++.+|+|||++.++.++.++||||||+++|||++ |..||..... .......... .....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~-------~~~~~~~~---- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAG-------FRLYKPRL---- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHhCC-------CCCCCCCC----
Confidence 122335678999999998899999999999999999998 8999864332 1222111110 01111221
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
....+.+++.+||+.+|++||++.|+++.|
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 236789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=324.21 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=201.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|+..+.||+|+||+||+|+.. ++..+|+|.++.... ....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999864 688899998875422 2335688999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
+++++|.++++... .+++.....++.|+++||+|||+ .+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999999987653 67888999999999999999997 46 9999999999999999999999999987653321
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhh-----------
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN----------- 853 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----------- 853 (955)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .. .............
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KE-LEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hh-HHHhhcCccccccccCCcccccCC
Confidence 2235689999999999888899999999999999999999999864331 11 1111110000000
Q ss_pred ----------------hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 ----------------LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ----------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......|.. .......++.+++.+||..+|++||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKL---PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccC---cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000111 001133568899999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=315.45 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=204.5
Q ss_pred cCCCccCeeeccCceEEEEEEeCC-CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
++|...+.||+|+||.||+|+..+ ++.+|+|.++.... .+++.+|++++++++|+||+++++++.+++..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 467888899999999999999764 78999999875432 578999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++.... ..+++..+..++.|+++|+.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999886432 46899999999999999999999988 99999999999999999999999999987654321
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......++..|+|||++.+..++.++||||||+++|||++|+.|+.......... .. .....+.. ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~----------~~~~~~~~--~~ 221 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MI----------PNKPPPTL--SD 221 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hh----------ccCCCCCC--Cc
Confidence 2233558899999999999899999999999999999999999986533221110 00 00001111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||+.||++||+++|++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 12233678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=328.45 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=193.5
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 703 (955)
+|+..+.||+|+||+||+|+.. +|+.||+|+++... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999864 68999999987532 223355778889998885 577889999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999886543 6899999999999999999999988 9999999999999999999999999987543222
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~-----------~~-- 219 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIMEHN-----------VS-- 219 (323)
T ss_pred --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-----------CC--
Confidence 122335699999999999998999999999999999999999999975432 22222222111 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTM 892 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 892 (955)
.+.....++.+++.+|++.+|.+|++.
T Consensus 220 --~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 --YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111223567899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.70 Aligned_cols=250 Identities=22% Similarity=0.391 Sum_probs=205.5
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+|+..+.||.|+||+||+|.. .+|+.||+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3578888999999999999985 578999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++... .+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 999999988643 5899999999999999999999998 99999999999999999999999999876543321
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......++..|+|||.+.+..++.++|||||||++|||++|+.||......... ....... .+.+ ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-~~~~~~~----------~~~~--~~ 237 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNG----------TPEL--QN 237 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcC----------Cccc--CC
Confidence 122346888999999999888999999999999999999999999765433221 1111100 0011 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||..||.+||++.+++++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 12233568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.51 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=208.2
Q ss_pred CCccCeeeccCceEEEEEEeCC-CcEEEEEEcccCCcch---hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
|..++.||+|.-|+||.+++++ +..+|+|++.+..... ..+.+.|-+||+.++||.+..||+.+..++..++||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4456779999999999999764 5899999998764443 34577899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC----
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD---- 781 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~---- 781 (955)
|+||+|...++++.+..++...+..++..|+-||+|||-.| ||.|||||+||||-++|++-|+||.|+.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 99999999999988889999999999999999999999999 99999999999999999999999998754321
Q ss_pred -----------------------------CCC---------------------cceeeeeecCCCCCCHHHhhhCCCCCh
Q 002189 782 -----------------------------SEK---------------------DHITTQVKGTMGYLDPEYYMTQQLTEK 811 (955)
Q Consensus 782 -----------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k 811 (955)
..+ ...+..++||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 000 001124679999999999999999999
Q ss_pred hhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 002189 812 SDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 891 (955)
Q Consensus 812 sDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 891 (955)
+|.|+|||++|||+.|..||.+...... +.. ++-..+...........+.|||.+.|.+||.+|..
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~T-l~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKET-LRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhh-HHH-------------HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 9999999999999999999976544322 222 22222233333355678899999999999999987
Q ss_pred ----HHHHHHH
Q 002189 892 ----MSEVVKD 898 (955)
Q Consensus 892 ----~~evl~~ 898 (955)
++||-++
T Consensus 382 ~~rGA~eIK~H 392 (459)
T KOG0610|consen 382 SKRGAAEIKRH 392 (459)
T ss_pred cccchHHhhcC
Confidence 7787764
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=316.88 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=188.9
Q ss_pred CeeeccCceEEEEEEeCC-------------CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 634 NDVGSGGYGKVYKGTLPN-------------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
+.||+|+||+||+|++.+ ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2358999887654444567889999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc-------eEEeec
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN-------AKVADF 773 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~-------~kl~DF 773 (955)
+||||+++|+|..+++... ..+++..+++++.|+++||+|||+.+ |+||||||+||+++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999988876432 35899999999999999999999988 999999999999987664 899999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhh-hCCCCChhhhHHHHHHHHHHH-hCCCCCcCCchHHHHHHHHHhhhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELL-TGRRPIERGKYIVREIRTVMDKKKEL 851 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwS~Gv~l~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~ 851 (955)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+.... ..+. .......
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~-~~~~~~~--- 225 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEK-ERFYEGQ--- 225 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHH-HHHHhcC---
Confidence 998755322 2245788999999987 567899999999999999998 5777775322 1111 1111000
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
... ......++.+++.+||+.||++||+++++++.|
T Consensus 226 ---~~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 ---CML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---ccC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 111235788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=318.90 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=204.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc----EEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.+|+..+.||+|+||+||+|.+. +|+ .||+|.++.... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677899999999999999864 333 689998876543 234678899999999999999999999987 78899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999987643 25899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........++..|+|||.+....++.++|+||||+++||+++ |+.||.... ..+... ...... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~-~~~~~~-------~~-- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIPD-LLEKGE-------RL-- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH-HHhCCC-------CC--
Confidence 332111112234568999999988899999999999999999999 999986532 222221 111111 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
..+.....++.+++.+||..+|.+||++.++++.|.++.+
T Consensus 231 ----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 ----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.98 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=197.3
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+|+..+.||+|+||.||+|+. .+++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999985 578999999986542 233467889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 999986542 4678888999999999999999998 9999999999999999999999999997654322
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHH--HHHHhhhhhhhhhhhccCCcCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREI--RTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ...... ......+...
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~~- 221 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC------IVDEDPPVLP- 221 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH------HhccCCCCCC-
Confidence 223568999999999998899999999999999999999999986421111000 000000 0000111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+++.+||+.+|++||+++|++++
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11223568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=316.13 Aligned_cols=251 Identities=26% Similarity=0.452 Sum_probs=201.7
Q ss_pred CCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc------chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM------QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
+|...+.||+|+||+||+|...+|+.+|||.++.... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999988899999998864321 1124588899999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999986543 5788999999999999999999988 999999999999999999999999998765321
Q ss_pred CC----cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 783 EK----DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 783 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
.. ........|+..|+|||++.+..++.++|||||||++|||++|..||........... .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~--------~~~ 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-IGAH--------RGL 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-hhhc--------cCC
Confidence 11 1112234688999999999988899999999999999999999999975433222111 1000 001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
.+... ......+.+++.+||+.+|++||++.|+++
T Consensus 227 ~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 123467889999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=326.95 Aligned_cols=263 Identities=19% Similarity=0.276 Sum_probs=195.3
Q ss_pred cCeeecc--CceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 633 ANDVGSG--GYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 633 ~~~lG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
.++||+| +||+||+++. .+|+.||+|+++.... ...+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7889999986 4789999999875432 223567789999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc--
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-- 785 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-- 785 (955)
+|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+.........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999986544446899999999999999999999988 999999999999999999999999865443221110
Q ss_pred ---ceeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhh-------
Q 002189 786 ---HITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN------- 853 (955)
Q Consensus 786 ---~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------- 853 (955)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 01112346778999999976 468999999999999999999999997433221111111000000000
Q ss_pred -h-----hhccCCcC-----------------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 -L-----YELIDPTI-----------------GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 -~-----~~~~d~~l-----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ....+... ...........+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 00000000 000111233578899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=331.96 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=205.1
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcc--c--CCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCe--EEEEEEec
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQ--Q--GSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE--QMLIYEFV 706 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~e~~ 706 (955)
.+||+|+|-+||||... +|..||--.++ + .+....+.|..|+++|+.|+|||||+++.+|.+... .-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 46999999999999864 57777743222 1 123334789999999999999999999999988655 77899999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccccccCCCCCc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~ 785 (955)
..|+|..|+++.+ ..+......|+.||++||.|||++. |||||||||.+||+|+. .|.|||+|.|||..+....
T Consensus 126 TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred cCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 9999999998766 5788889999999999999999975 88999999999999985 5899999999999875432
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.....|||.|||||.+. ..|+..+||||||+.++||+|+..||..-.+..+..+++..+.+.. .+..+-|
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~-sl~kV~d------ 270 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA-ALSKVKD------ 270 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH-HhhccCC------
Confidence 23378999999999887 8999999999999999999999999988888888777777665431 1222223
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.++.+||.+|+.. ..+|||+.|++++ .+++..
T Consensus 271 ------Pevr~fIekCl~~-~~~R~sa~eLL~d--~Ff~~d 302 (632)
T KOG0584|consen 271 ------PEVREFIEKCLAT-KSERLSAKELLKD--PFFDED 302 (632)
T ss_pred ------HHHHHHHHHHhcC-chhccCHHHHhhC--hhhccc
Confidence 4577999999999 9999999999985 444443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=325.32 Aligned_cols=237 Identities=25% Similarity=0.337 Sum_probs=187.5
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHH-HHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIE-LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
++||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 689999999865321 22334555544 67889999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|..++.... .+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT 153 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence 99988876543 5788888899999999999999988 9999999999999999999999999987542222 223
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|..||.... .......+.... .. .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~-----------~~----~~~ 217 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKP-----------LQ----LPG 217 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-HHHHHHHHhcCC-----------CC----CCC
Confidence 34579999999999999899999999999999999999999996543 222222111110 00 111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMS 893 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~ 893 (955)
.....+.+++.+|++.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2235788999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=318.89 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=199.1
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999864 689999999865322 2235788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 706 VPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
++ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888776433 356899999999999999999999988 9999999999999999999999999997654322
Q ss_pred cceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----------hhh
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----------ELY 852 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-----------~~~ 852 (955)
.......+++.|+|||++.+. .++.++|||||||++|||+||+.||........ ......... ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence 122234578899999998754 578999999999999999999999975433221 111111000 000
Q ss_pred hhhhccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLYELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....++..... ........++.+++.+||+.||++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 0011123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=337.18 Aligned_cols=261 Identities=19% Similarity=0.263 Sum_probs=200.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC---CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
..+|...+.||+|+||.||++... .+..||||.+... +.+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357899999999999999999753 3578999987643 34568999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+. ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 6888887433 36899999999999999999999998 9999999999999999999999999998765443
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch--HHHHHHHHHhhhhh-----------
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY--IVREIRTVMDKKKE----------- 850 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~--~~~~~~~~~~~~~~----------- 850 (955)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 32233346799999999999999999999999999999999999999964321 12222222211100
Q ss_pred -----hhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 -----LYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 -----~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.........+..... .......++.+++.+|+..||++||++.|++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000001100000 001123567889999999999999999999986
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=320.56 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=195.9
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhc---cCCCcceEEEEEEeC-----C
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRV---HHKNLVSLLGFCFDR-----G 697 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~ 697 (955)
+|...+.||+|+||+||+|+.. +|+.||+|.++..... ....+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 6899999988753222 223566777777665 699999999988652 4
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999997 58888887655456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh--hhhhh
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE--LYNLY 855 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~ 855 (955)
....... .....||..|+|||++.+..++.++||||+||++|||++|++||...... +....+...... ...+.
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence 7643221 22346899999999999889999999999999999999999998644332 222222211000 00000
Q ss_pred -------hccCCcCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 -------ELIDPTIG---LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 -------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+... .........++.+++.+|++.||++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00011233567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=315.86 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=190.3
Q ss_pred eeeccCceEEEEEEeCCC---cEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 635 DVGSGGYGKVYKGTLPNG---QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~~g---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
.||+|+||+||+|+..++ ..+++|.++.... ...+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 3566777664432 345679999999999999999999999999999999999999999
Q ss_pred cccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 711 LGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 711 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|.++++... ....++.....++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999987542 234667778899999999999999988 999999999999999999999999998643222111122
Q ss_pred eeeecCCCCCCHHHhhh-------CCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 789 TQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~-------~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+....+.... .....+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~-----~~~~~~~ 232 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQ-----QVKLFKP 232 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhc-----ccccCCC
Confidence 33568889999999853 245789999999999999997 4667754332 22222222221 1122333
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
.+... ...++.+++..|| .+|++||+++||++.|.
T Consensus 233 ~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33222 2356788999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=320.04 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=199.7
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
|+..+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455678999999999999865 5788999998765555567789999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
++|..++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...... ...
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 160 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence 9998877643 236899999999999999999999988 9999999999999999999999999987653221 122
Q ss_pred eeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 789 TQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
....++..|+|||++. +..++.++|||||||++|||++|++||...... +.+...... ..+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~----------~~~~~~ 229 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKS----------EPPTLA 229 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHHhhc----------CCCCCC
Confidence 3356899999999984 445788999999999999999999998643321 211111111 011111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+.+++.+||+.||++||++.+++++
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 --QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233678899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=323.27 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=202.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc----EEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...+.||+|+||.||+|++. +|+ .||+|.+...... ...++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999853 444 5789988754332 234688999999999999999999998754 4679
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999887543 35789999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||..... ........... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~-------~~~- 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGE-------RLP- 231 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC-------CCC-
Confidence 332222223345778999999999999999999999999999998 8889864321 11222221111 000
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. .......+.+++.+||..+|++||+++++++.++++.+.
T Consensus 232 ~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 Q-----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 111235788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.37 Aligned_cols=239 Identities=21% Similarity=0.412 Sum_probs=189.6
Q ss_pred CeeeccCceEEEEEEeCC--------CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 634 NDVGSGGYGKVYKGTLPN--------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+.||+|+||+||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 234888888655444556789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc--------eEEeeccccc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN--------AKVADFGLSK 777 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~--------~kl~DFGla~ 777 (955)
+++|+|.++++..+ ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999987653 26889999999999999999999988 999999999999987765 6999999987
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCC-CCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGR-RPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+.... ...... .....
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~~-~~~~~------- 221 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQ-FYEDR------- 221 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHHH-HHHcc-------
Confidence 55322 22458889999999986 45799999999999999999995 4443222 111111 11100
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
+.+. .....++.+++.+||+.||++||+++++++.|
T Consensus 222 ----~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ----HQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----ccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111 11225688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=332.81 Aligned_cols=261 Identities=24% Similarity=0.296 Sum_probs=197.1
Q ss_pred HhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCC-----
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG----- 697 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 697 (955)
..++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999986 468999999986532 233466889999999999999999999986543
Q ss_pred -eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 698 -EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 698 -~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
..++||||+++ +|.+.++. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 47999999965 56555532 4788888999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh------
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------ 850 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 850 (955)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+. ........
T Consensus 171 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~ 246 (359)
T cd07876 171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN-KVIEQLGTPSAEFM 246 (359)
T ss_pred cccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcCCCcHHHH
Confidence 764322 12233568999999999999999999999999999999999999997544322111 11110000
Q ss_pred ---hhhhhhc--cCCcCCC----------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 ---LYNLYEL--IDPTIGL----------------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ---~~~~~~~--~d~~l~~----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....... -.+.... .........+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0000000 0001123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=335.71 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=198.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999864 68999999987432 223356788999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999987543 5889999999999999999999998 9999999999999999999999999987543211
Q ss_pred Cc---------------------------------ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCC
Q 002189 784 KD---------------------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830 (955)
Q Consensus 784 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P 830 (955)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 001134699999999999999999999999999999999999999
Q ss_pred CcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002189 831 IERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MSEVVKD 898 (955)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 898 (955)
|..... ......+...... -.+++.. ....++.+++.+|+ .||.+|++ ++|++++
T Consensus 236 f~~~~~-~~~~~~i~~~~~~-----~~~p~~~------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETP-QETYRKVMNWKET-----LVFPPEV------PISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCH-HHHHHHHHcCCCc-----eecCCCC------CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 965432 2222222211100 0011111 12356778888876 49999984 7787765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.70 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=198.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC---CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+++.. +++.||||++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999864 6899999998642 1223356888999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999998643 235888899999999999999999998 9999999999999999999999999987654332
Q ss_pred CcceeeeeecCCCCCCHHHhhh-----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 784 KDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
. .......||+.|||||++.. +.++.++|||||||++|||++|+.||..... .+....+..... ... +
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-~~~~~~i~~~~~----~~~-~ 229 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKE----HFQ-F 229 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-HHHHHHHHcCCC----ccc-C
Confidence 2 12223569999999999973 4578899999999999999999999965432 222222221111 000 1
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGD--DRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 898 (955)
.+. .......+.+++.+|+..++. .||++++++++
T Consensus 230 ~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111 111345678888887765444 37899999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=323.64 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=204.6
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999985 578999999987655555677889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 999999988643 4788999999999999999999988 99999999999999999999999999876543321
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......+++.|+|||.+.+..++.++|||||||++|||++|..||.......... ..... -.+. ...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~~~----------~~~~--~~~ 237 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN----------GTPE--LQN 237 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eeccC----------CCCC--CCC
Confidence 1223468889999999999899999999999999999999999996433211110 00000 0011 111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||+.+|++||++++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12233567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.51 Aligned_cols=250 Identities=30% Similarity=0.507 Sum_probs=201.2
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch---------hHHHHHHHHHHHhccCCCcceEEEEEEeCCe
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG---------GQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 698 (955)
+|.....||+|+||.||+|.. .+++.||+|.+....... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999986 468899999886543221 1468889999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||+++++|.+++...+ .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999987543 5788899999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCc----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhh
Q 002189 779 MSDSEKD----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 854 (955)
Q Consensus 779 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 854 (955)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---------- 224 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKI---------- 224 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHH----------
Confidence 6522110 01122458889999999998899999999999999999999999997543321 11111
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+... ......+.+++.+||+.||.+||++.|++++
T Consensus 225 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111122221 2234678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.05 Aligned_cols=251 Identities=33% Similarity=0.528 Sum_probs=200.3
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhH--HHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
|+..+.||+|+||+||+++.. +++.||+|++......... ...+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 5679999999876444332 3456999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred cccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccc
Confidence 999999998732 36899999999999999999999998 99999999999999999999999999876421 112
Q ss_pred eeeeeecCCCCCCHHHhh-hCCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 787 ITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......++..|+|||++. +..++.++||||+|+++|+|++|..||.... .............. .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~---- 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL-----PSSSQ---- 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH-----HHHTT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc-----ccccc----
Confidence 334456899999999998 8889999999999999999999999997652 11111111111110 00000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+.+++.+||+.||++||++.+++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112688999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=313.13 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=205.6
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|+..+.||+|+||.||.++. .+++.+++|++.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999985 468899999876432 33446788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.+++.......+++..+..++.|+++|++|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999997654557899999999999999999999988 99999999999999999999999999987644331
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......|+..|+|||.+.+..++.++||||||+++|||++|..||.... ..+......... ..+.
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~~~---------~~~~---- 221 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-PLNLVVKIVQGN---------YTPV---- 221 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCC---------CCCC----
Confidence 2234568999999999988889999999999999999999999986433 222222221110 0110
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+++.+||+.+|++||+++|++++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12233678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=374.99 Aligned_cols=319 Identities=33% Similarity=0.467 Sum_probs=228.3
Q ss_pred CCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEE
Q 002189 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 142 (955)
..+++.|+|++|.+.+.+|..+.++++|++|+|++|+ +.+.+|..|+++++|++|+|++|++++.+|..|+++++|++|
T Consensus 163 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 241 (968)
T PLN00113 163 FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ-LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241 (968)
T ss_pred CCCCCEEECccCcccccCChhhhhCcCCCeeeccCCC-CcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEE
Confidence 3688999999999999999999999999999999996 888899999999999999999999999999999999999999
Q ss_pred EccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeee
Q 002189 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVL 222 (955)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~ 222 (955)
+|++|++++.+|..|+++++|++|+|++|++++.+|..+.+ +.+|++|+|++|++++.+|..+ ..+.+|+.|+
T Consensus 242 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~------l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~ 314 (968)
T PLN00113 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS------LQKLISLDLSDNSLSGEIPELV-IQLQNLEILH 314 (968)
T ss_pred ECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhh------ccCcCEEECcCCeeccCCChhH-cCCCCCcEEE
Confidence 99999999899999999999999999999999888876544 4556666777777766655433 3445566666
Q ss_pred ccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCC-----------------
Q 002189 223 FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLT----------------- 284 (955)
Q Consensus 223 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~----------------- 284 (955)
+++|.+.+.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|+|++|++++..| .+.
T Consensus 315 l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~ 394 (968)
T PLN00113 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394 (968)
T ss_pred CCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecc
Confidence 66666666666666666666666666666666666666666666666666666655443 233
Q ss_pred -------CCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc
Q 002189 285 -------GLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS 357 (955)
Q Consensus 285 -------~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 357 (955)
.+++|+.|+|++|++++ ..|..|.++++|+.|+|++|++++.+|..+..+++|+.|+|++|++.+.+|..+.
T Consensus 395 ~~p~~~~~~~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~ 473 (968)
T PLN00113 395 EIPKSLGACRSLRRVRLQDNSFSG-ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473 (968)
T ss_pred cCCHHHhCCCCCCEEECcCCEeee-ECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc
Confidence 44455555555555544 3445555555555555555555555555555566666666666666666665555
Q ss_pred hhhhhhhcccCCccccccCCCCCCCcceeEecC
Q 002189 358 YSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 390 (955)
Q Consensus 358 ~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n 390 (955)
..+|+.|+|++|++++..+..+..+.+|+.++.
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L 506 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKL 506 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEEC
Confidence 556666777777777666666655555555543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.87 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=205.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
++|...+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888899999999999999864 57899999988655555678999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++....... .
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 9999999886542 36889999999999999999999988 9999999999999999999999999987654322 1
Q ss_pred eeeeeecCCCCCCHHHhhhC---CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......++..|+|||.+.+. .++.++||||||+++|||+||+.|+......... ..... ..+.+. .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~---------~~~~~~-~ 225 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISK---------SNFPPP-K 225 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh---------ccCCCc-c
Confidence 12335688899999999876 8899999999999999999999999654322111 11110 001110 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..........+.+++.+||..+|.+||++++++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11223345678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=324.40 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=210.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch---hHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 701 (955)
...|...+.||+|.||.||+++.. +|+.+|+|.+++..... ...+.+|+++|+++. |||||.+++++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 446777789999999999999965 59999999998755433 358999999999998 9999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC----CceEEeeccccc
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER----LNAKVADFGLSK 777 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla~ 777 (955)
|||++.+|.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999988765 3899999999999999999999999 9999999999999643 579999999999
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... .+....
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~~--------- 254 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRGD--------- 254 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcCC---------
Confidence 8765 234556889999999999999999999999999999999999999997654333222 222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..............+.+++.+|+..||.+|+++.+++++
T Consensus 255 --~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 --FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111222223334678899999999999999999999996
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=330.78 Aligned_cols=260 Identities=23% Similarity=0.304 Sum_probs=197.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeC------C
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------G 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 697 (955)
.++|...+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 567899999999999999999854 68899999987532 23345688899999999999999999987543 3
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..|+||||+++ +|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 57999999964 66666642 4788899999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-------
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------- 850 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------- 850 (955)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+......
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 654321 2234568999999999999999999999999999999999999997544322 22222111000
Q ss_pred ----h-hhhh-----------hccCCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 ----L-YNLY-----------ELIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ----~-~~~~-----------~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .... +...+.... ........++.+++.+|++.||.+|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000 000000000 0011123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=315.87 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=203.9
Q ss_pred cCCCccCeeeccCceEEEEEEeCC----CcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.+|...+.||+|+||.||+|.+.+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 357778899999999999998643 2468999887654 3345679999999999999999999998865 567899
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++.... ..+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+|++|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999987543 35899999999999999999999988 999999999999999999999999999866443
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. .......++..|+|||.+....++.++||||||+++|||++ |..||...... +..... .... .+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~-~~~~---------~~~ 228 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRI-ENGE---------RLP 228 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH-HcCC---------cCC
Confidence 21 11122334568999999988889999999999999999996 99999654332 111111 1110 000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.....+..+.+++.+|+..+|++||++.++++.|+++...
T Consensus 229 ----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 ----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112346788999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=319.29 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=202.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|+..+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45667788999999999999864 68899999876543 23356789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
+++++|.+++...+ .+++.....++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999998886543 68899999999999999999997 46 9999999999999999999999999987543221
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH------HHHHHHHhhhhhhhhhhhcc
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV------REIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 858 (955)
.....|+..|+|||++.+..++.++|||||||++|||+||+.||....... ..+...... .....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 229 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ------IVQEP 229 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH------Hhhcc
Confidence 123568999999999988899999999999999999999999997432210 000011110 00000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
.+.+. ....+..+.+++.+||+.||++||+++|++++.
T Consensus 230 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111 112446788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.66 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=200.7
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc----------hhHHHHHHHHHHHhccCCCcceEEEEEEeCC
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ----------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 697 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 697 (955)
+|...+.||+|+||.||+|.. .+|+.||+|.++..... ..+.+.+|+++++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366778999999999999985 46899999987632111 1245788999999999999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..++||||+++|+|.++++... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++++|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999987653 6888999999999999999999988 9999999999999999999999999997
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCC--CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
...............|+..|+|||.+.... ++.++||||||+++||+++|..||.......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~------- 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-KLGNKR------- 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH-Hhhccc-------
Confidence 654322222223456889999999988654 8899999999999999999999996443322111 111000
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.............+.+++.+||..+|++||+++|++++
T Consensus 229 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 --SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 01111111112234678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=318.39 Aligned_cols=238 Identities=23% Similarity=0.382 Sum_probs=187.2
Q ss_pred eeeccCceEEEEEEeCC-------------------------CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceE
Q 002189 635 DVGSGGYGKVYKGTLPN-------------------------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 689 (955)
.||+|+||.||+|.+.. ...||+|++.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13589999876544445678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC---
Q 002189 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL--- 766 (955)
Q Consensus 690 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~--- 766 (955)
+++|.+....++||||+++|+|..++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 999999999999999999999998886532 36789999999999999999999988 99999999999998644
Q ss_pred ----ceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHH-hCCCCCcCCchHHHH
Q 002189 767 ----NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELL-TGRRPIERGKYIVRE 840 (955)
Q Consensus 767 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~ell-tg~~P~~~~~~~~~~ 840 (955)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3899999988654221 12347888999999875 56899999999999999995 6888886432211
Q ss_pred HHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 841 IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
......... .... .....+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~~~~~~~-----------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYEKKH-----------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHhcc-----------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111111100 0110 1124688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.65 Aligned_cols=195 Identities=26% Similarity=0.400 Sum_probs=159.6
Q ss_pred cCeeeccCceEEEEEEeC---CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe--CCeEEEEEEecC
Q 002189 633 ANDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQMLIYEFVP 707 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~ 707 (955)
.++||+|+||+||+|+.. +++.||+|.++.... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999864 467899999875432 3457889999999999999999998865 456789999985
Q ss_pred CCCcccccCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE----cCCCceEEeecccc
Q 002189 708 NGSLGDSLSGK-------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLS 776 (955)
Q Consensus 708 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGla 776 (955)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5776665421 1235888999999999999999999998 9999999999999 46678999999999
Q ss_pred cccCCCCCc-ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcC
Q 002189 777 KSMSDSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIER 833 (955)
Q Consensus 777 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~ 833 (955)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876433211 12234578999999999986 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.42 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=209.6
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch--------hHHHHHHHHHHHhc-cCCCcceEEEEE
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG--------GQEFKMEIELLSRV-HHKNLVSLLGFC 693 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~H~niv~l~~~~ 693 (955)
+...+.|...+.||+|..++|-++.. .+|+.+|+|++....... .+.-.+|+++|+++ .||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 44556788888999999999988875 468899999886432211 13345799999999 599999999999
Q ss_pred EeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 694 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
..+...++|+|.|+.|.|.|+|... ..+++....+|+.|+.+|++|||... ||||||||+|||+|++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999999754 47999999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhh------CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT------QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 847 (955)
|+|+.+.++.+ -...+||++|+|||.+.- ..|+..+|+||+||++|-++.|.+||...+... .++.++++
T Consensus 168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-MLR~ImeG 243 (411)
T KOG0599|consen 168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-MLRMIMEG 243 (411)
T ss_pred ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-HHHHHHhc
Confidence 99998876654 335789999999999863 357889999999999999999999996543322 22223322
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHHHHH
Q 002189 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD--IENILQQ 905 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~ 905 (955)
+. +.-.| ...+......+|+.+|++.||.+|.|++|++++ +.++.++
T Consensus 244 ky------qF~sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 244 KY------QFRSP-----EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred cc------ccCCc-----chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 21 11111 122333567899999999999999999999976 4455444
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.65 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=201.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999875 68999999886432 2233568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|++++.|..++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988887765433 5899999999999999999999988 99999999999999999999999999987654331
Q ss_pred cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-------hhh---
Q 002189 785 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-------LYN--- 853 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-------~~~--- 853 (955)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ........... ...
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhccccc
Confidence 1223457889999999876 567899999999999999999999997544322 11111110000 000
Q ss_pred hh-hccCCcCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LY-ELIDPTIGLSTT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~-~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. ....|....... ......+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000011100000 1123668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=318.33 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=203.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
++|...+.||+|+||+||+|... +++.||+|.++.......+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45778888999999999999864 68999999987665555678999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++...+ ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 9999999886543 36899999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred eeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 787 ITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...... +........ ..+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----------~~~~ 227 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKS----------EPPT 227 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcC----------CCCC
Confidence 223456899999999985 344678999999999999999999999654322 111111110 0111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+ .........+.+++.+||+.+|++||++.+++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 1112233578899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.07 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=203.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|+....||+|+||+||+|+.. +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999853 2467999988654333 3467999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCC-------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 701 LIYEFVPNGSLGDSLSGKNG-------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
+||||+++|+|.++++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999875431 25899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+......
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~~~~----- 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQAG----- 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHHHcC-----
Confidence 99875432221 12223456778999999998889999999999999999999 77788543221 111111100
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
..........+..+.+++.+||+.+|.+||++.|+++.|.
T Consensus 235 --------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 --------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0001111223467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.28 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=202.0
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeC-CeEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-GEQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e 704 (955)
+|...+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999864 578999999865322 3345688999999999999999999987644 45789999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++++|.+++.......+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999987655556899999999999999999999998 9999999999999999999999999998664322
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.......+++.|+|||++.+..++.++||||||+++|||++|+.||..... .......... .. +..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~---------~~-~~~-- 222 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-NSLVYRIIEG---------KL-PPM-- 222 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhc---------CC-CCC--
Confidence 122345688999999999999999999999999999999999999864332 2222211111 01 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+|++.+|++||++.+++++
T Consensus 223 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 --PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.04 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=201.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+.|+..++||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45777889999999999999865 58999999988765555677899999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|..++.... ..+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 9999988765432 36899999999999999999999988 9999999999999999999999999987543221 1
Q ss_pred eeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 787 ITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
......++..|+|||++. ...++.++|||||||++|||++|..|+...... ........ ...+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~----------~~~~~ 234 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAK----------SEPPT 234 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhc----------CCCcc
Confidence 223456889999999985 345688999999999999999999998643321 11111111 01111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. .......++.+++.+||+.+|++||+++|++++
T Consensus 235 ~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 LS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11 111233578899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.37 Aligned_cols=250 Identities=22% Similarity=0.397 Sum_probs=204.7
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|+..+.||+|+||+||+++. .+|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 468999999986432 23346789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++++|.+++.......+++.++..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999887655556889999999999999999999988 99999999999999999999999999976543221
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......|+..|+|||++.++.++.++|||||||+++||++|+.||...... +.+....... .+..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~~----------~~~~--- 221 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-NLVLKIIRGS----------YPPV--- 221 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-HHHHHHhcCC----------CCCC---
Confidence 122345888999999999889999999999999999999999999754322 2222221110 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+++.+||+.+|++||++.||+++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 -SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.52 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=203.7
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777888999999999999864 68999999987543 333467889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++...... .
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 999999998754 6899999999999999999999988 9999999999999999999999999998775432 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......++..|+|||++.+..++.++||||||+++|||+||+.||..... ........ ....+.....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~----------~~~~~~~~~~- 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-MRVLFLIP----------KNNPPSLEGN- 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-HHHHHHhh----------hcCCCCCccc-
Confidence 12335688899999999988899999999999999999999999964332 11111111 1111121111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+.+++.+||..+|++||++++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 134578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=327.48 Aligned_cols=192 Identities=23% Similarity=0.350 Sum_probs=165.3
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
..+|...+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++.+.+..++|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999865 5788999975432 235689999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+ .++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 139 ~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 139 Y-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred c-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 9 56888877643 346899999999999999999999998 999999999999999999999999999754322
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCc
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 832 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~ 832 (955)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 11234569999999999999999999999999999999999766653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=318.43 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=199.8
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455677999999999999864 57899999987543 2334678999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.+++... .+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++++|||+++....... .
T Consensus 86 ~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06642 86 GGSALDLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--h
Confidence 99999988643 5889999999999999999999988 99999999999999999999999999976643221 1
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+...... ..... +.....+.+ .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~----------~~~~~~~~~----~ 222 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-RVLFL----------IPKNSPPTL----E 222 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-hHHhh----------hhcCCCCCC----C
Confidence 22346888999999999889999999999999999999999998643211 11110 001111111 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+.+++.+||+.+|++||++.|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2234678899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.67 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=195.8
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-----chhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-----QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQM 700 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 700 (955)
+|...+.||+|+||.||+|... ++..||+|+++.... ...+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6788899999999999999864 689999998864321 2235688899999999999999999988763 5678
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+++||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999887543 5788999999999999999999988 9999999999999999999999999997654
Q ss_pred CCCC-cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 781 DSEK-DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 781 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
.... ........++..|+|||++.+..++.++|||||||++|||++|+.||.......... ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-~~~---------~~~~~ 227 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-KIA---------TQPTN 227 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-HHh---------cCCCC
Confidence 3211 111123458899999999998889999999999999999999999997543222111 110 00111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.. +......+.+++ +||..+|++||+++|++++
T Consensus 228 ~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 228 PQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 221 112234556666 7888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.89 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=204.4
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEe
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 695 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 695 (955)
+.++.+..+.++|...+.||+|+||+||+|+.. +++.+|+|+++... ....++.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566677889999999999999999999864 67899999876532 2235688899999999 69999999998853
Q ss_pred -----CCeEEEEEEecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 696 -----RGEQMLIYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 696 -----~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
++..++||||+++++|.++++.. ....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 35689999999999999876532 2346889999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhh-----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHH
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~ 843 (955)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.......... .
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-K 240 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-h
Confidence 9999999986643221 1223468999999999853 457889999999999999999999987543322111 1
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
.. ....+... .......++.+++.+||+.||++||++.|++++.
T Consensus 241 ~~----------~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IP----------RNPPPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cc----------ccCCCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00011110 1111235688999999999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=321.22 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=198.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...++||+|+||+||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999865 57889999986421 122345788999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997532 36888899999999999999999988 9999999999999999999999999987654322
Q ss_pred CcceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 784 KDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
. .......||+.|+|||++. .+.++.++|||||||++|||++|+.||..... .+....+...... .. +
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~----~~-~ 229 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKER----FQ-F 229 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-HHHHHHHhCCCcc----cc-C
Confidence 2 2223357999999999986 34688999999999999999999999975432 2222222221110 00 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 898 (955)
|. ........+.+++.+|+..++++ |++++|++++
T Consensus 230 -p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 01123467788999988665544 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.68 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=202.7
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999864 58899999987543 233467889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++... .+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 999999988643 5888999999999999999999988 99999999999999999999999999976643321
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......++..|+|||++.+..++.++|||||||++|||+||..|+...... ...... ........
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~--------------~~~~~~~~ 221 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-RVLFLI--------------PKNNPPTL 221 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-hHhhhh--------------hcCCCCCC
Confidence 122346888999999999889999999999999999999999998643321 111100 00001112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+..+.+++.+||+.+|++||++++++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23455778999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.02 Aligned_cols=246 Identities=28% Similarity=0.468 Sum_probs=198.8
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||.||+|.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 57889999986532 346789999999999999999999998654 5799999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.+++.......+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999987665556899999999999999999999988 9999999999999999999999999987643221
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....+..|+|||++.++.++.++|||||||++|||++ |+.||..... .+... ...... ..+ .
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~-~~~~~~-------~~~------~ 218 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKE-CVEKGY-------RME------P 218 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-HHHHH-HHhCCC-------CCC------C
Confidence 11234568999999998899999999999999999998 8888864432 12111 111110 011 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
....+..+.+++.+||+.+|++||+++++++.|+
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 1123467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.57 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=206.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|+..+.||.|+||+||+|... ++..+|+|++..... ...+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888999999999999999854 688999999875432 2456789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 706 VPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
+++++|.++++.... ..+++.....++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999875432 46899999999999999999999988 99999999999999999999999999987654332
Q ss_pred cc--eeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 785 DH--ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 785 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||........ ....... .++.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~----------~~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQN----------DPPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcC----------CCCC
Confidence 21 22345689999999999877 789999999999999999999999975433211 1111111 1111
Q ss_pred CCCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLST-TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..... .......+.+++.+||+.||++||+++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111 12334678899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.00 Aligned_cols=263 Identities=22% Similarity=0.349 Sum_probs=199.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999864 678999999875432 2234677899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++ ++|.+++.... ..+++.....++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 96 68888776542 35789999999999999999999988 99999999999999999999999999976543221
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-h-hhhhhccC---
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-L-YNLYELID--- 859 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~d--- 859 (955)
......+++.|+|||.+.+. .++.++|||||||++|||+||++||..... .+........... . ..+...++
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhcccc
Confidence 12234578899999998754 578899999999999999999999964432 2222221111000 0 00000000
Q ss_pred ------CcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 ------PTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
|.... .........+.+++.+|++.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0011223567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.22 Aligned_cols=237 Identities=23% Similarity=0.410 Sum_probs=189.5
Q ss_pred CeeeccCceEEEEEEeCCCc-----------EEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 634 NDVGSGGYGKVYKGTLPNGQ-----------LIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
+.||+|+||.||+|...+.. .|++|.++..... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975432 5788887654333 5788999999999999999999999988 788999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-------ceEEeeccc
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-------NAKVADFGL 775 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-------~~kl~DFGl 775 (955)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999875432 6889999999999999999999988 99999999999999888 799999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhC--CCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
++.... .....++..|+|||++... .++.++||||||+++|||++ |..|+..... ....... ...
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~~~-~~~---- 222 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKERFY-QDQ---- 222 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHHHH-hcC----
Confidence 986543 1223477889999999876 78999999999999999999 5667754321 1111111 000
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
..... .....+.+++.+||..+|++||++.|+++.|
T Consensus 223 -------~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 223 -------HRLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------CCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00000 0116788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.74 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=204.7
Q ss_pred CHHHHHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEe-
Q 002189 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD- 695 (955)
Q Consensus 619 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~- 695 (955)
++.++....+.|+..+.||+|+||+||+|+. .+++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4555566678889999999999999999986 468899999886533 2345688899999999 69999999999853
Q ss_pred -----CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEE
Q 002189 696 -----RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 696 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
.+..++||||+++|+|.+++.......+++..+..++.|+++|++|||+.+ ++||||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999887655556888889999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHH
Q 002189 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 845 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 845 (955)
+|||+++....... ......|+..|+|||.+. ...++.++|||||||++|||++|..||.......... ..
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~- 238 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LI- 238 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hH-
Confidence 99999876532211 122356899999999986 3468889999999999999999999996433221111 00
Q ss_pred hhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 846 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+... .......+.+++.+||+.||.+||++.|++++
T Consensus 239 ---------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 ---------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 011111111 11234678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=347.94 Aligned_cols=257 Identities=21% Similarity=0.406 Sum_probs=202.0
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeC--Ce
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GE 698 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 698 (955)
....++|.+.+.||+|+||+||+|+.. +++.||+|.+..... .....|..|+.++++++|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345578999999999999999999864 578899998875322 2346788999999999999999999988654 56
Q ss_pred EEEEEEecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccC----CCeeccCCCCccEEEcC--------
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELAN----PPIIHRDIKSSNILLDE-------- 764 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDlk~~NIll~~-------- 764 (955)
.||||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+.+. ..||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999886421 2368999999999999999999998542 34999999999999964
Q ss_pred ---------CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcC
Q 002189 765 ---------RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIER 833 (955)
Q Consensus 765 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~ 833 (955)
...+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||..||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998764322 1234569999999999864 4588999999999999999999999976
Q ss_pred CchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 834 GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+..+. .. |.+.. .....++.+|+.+||+.+|.+||++.|++.+
T Consensus 246 ~~~~~qli~~lk-~~-----------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNFSQLISELK-RG-----------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcHHHHHHHHh-cC-----------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 554433222211 10 11111 1123678899999999999999999999964
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.77 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=200.9
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-----chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-----QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
+|+..+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999875 789999998864321 2346788999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
+||+++++|.+++.... .+++..+..++.|+++|++|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999987543 5889999999999999999999988 999999999999999999999999998765433
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCC-CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
. ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||...... ........... .+.
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~---------~~~ 222 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAVFKIGRSKE---------LPP 222 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-HHHHHHHhccc---------CCC
Confidence 2 123456889999999998766 899999999999999999999999654421 11111111000 001
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .......+.+++.+||+.+|++||++++++++
T Consensus 223 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 I----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred c----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1 11223677899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.99 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=200.0
Q ss_pred CCCccCeeeccCceEEEEEEeCC--CcEEEEEEcccCC----------cchhHHHHHHHHHHHh-ccCCCcceEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPN--GQLIAIKRAQQGS----------MQGGQEFKMEIELLSR-VHHKNLVSLLGFCFD 695 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 695 (955)
+|+..+.||+|+||+||+|+... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778889999999999999754 6889999875321 1122456778888875 689999999999999
Q ss_pred CCeEEEEEEecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEee
Q 002189 696 RGEQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVAD 772 (955)
Q Consensus 696 ~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~D 772 (955)
++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999987743 223468999999999999999999996 55 99999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 773 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 773 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
||++....... ......|+..|+|||.+.++.++.++||||||+++|||++|+.||...... ..........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~---- 229 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATKIVEAV---- 229 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHHHhhcc----
Confidence 99998764432 233456899999999999888999999999999999999999998644322 2221111110
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
..+.. .......+.+++.+||+.||++||++.|+.++++
T Consensus 230 -----~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 -----YEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----CCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01100 1122367889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.44 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=198.3
Q ss_pred CCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCC------
Q 002189 630 FSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 697 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 697 (955)
|...+.||+|+||+||+|.+. +++.||||+++... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 36899999987542 233467889999999999999999999886542
Q ss_pred eEEEEEEecCCCCcccccCCC----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 698 EQMLIYEFVPNGSLGDSLSGK----NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
..++++||+++|+|.+++... ....+++....+++.|++.||+|||+.+ |+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998776422 2235788999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
|+++...............++..|++||.+..+.++.++||||||+++|||++ |++||..... .+........ .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~-~--- 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKG-N--- 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHHcC-C---
Confidence 99987643322222223345678999999998899999999999999999999 8888754322 1111111110 0
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
... ........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 ------~~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ------RLK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 1112346889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.78 Aligned_cols=251 Identities=31% Similarity=0.505 Sum_probs=202.3
Q ss_pred CCccCeeeccCceEEEEEEeCC-----CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTLPN-----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
|+..+.||+|+||.||+++..+ +..||+|+++..... ..+.+..|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999998653 488999999765443 4578999999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++++|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999987654333899999999999999999999988 9999999999999999999999999998765442
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
... .....++..|+|||.+.+..++.++||||+|+++|||++ |..||... ............ . .+
T Consensus 158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~~-~---------~~-- 223 (258)
T smart00219 158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEEVLEYLKKG-Y---------RL-- 223 (258)
T ss_pred ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcC-C---------CC--
Confidence 211 112337789999999988889999999999999999999 77777542 222222211111 1 00
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
........++.+++.+|+..||++|||+.|+++.|
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01112346789999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=340.43 Aligned_cols=264 Identities=19% Similarity=0.290 Sum_probs=195.0
Q ss_pred HHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCC------CcceEEEEEE
Q 002189 622 EVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK------NLVSLLGFCF 694 (955)
Q Consensus 622 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~ 694 (955)
++...+++|...++||+|+||+||+|... .++.||||+++... ...+++..|+++++.++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678999999999999999999864 57899999986532 2234567788888877654 5889999887
Q ss_pred eC-CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCC------
Q 002189 695 DR-GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERL------ 766 (955)
Q Consensus 695 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~------ 766 (955)
.. +..++|||++ +++|.+++...+ .+++..+..++.||+.||+|||+ .+ ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 64 5688999988 778888886543 68999999999999999999997 47 99999999999998765
Q ss_pred ----------ceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch
Q 002189 767 ----------NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 836 (955)
Q Consensus 767 ----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~ 836 (955)
.+||+|||.+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998864321 22346799999999999999999999999999999999999999975443
Q ss_pred HHHHHHHHHhhh----------------hhhhhhhhccCCcCCC---------C--CCHHHHHHHHHHHHHhhccCCCCC
Q 002189 837 IVREIRTVMDKK----------------KELYNLYELIDPTIGL---------S--TTLKGFEKYVDLALKCVQESGDDR 889 (955)
Q Consensus 837 ~~~~~~~~~~~~----------------~~~~~~~~~~d~~l~~---------~--~~~~~~~~l~~li~~cl~~dP~~R 889 (955)
. +.+..+.... .........+.+.... . ........+.+|+.+||+.||++|
T Consensus 351 ~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 351 L-EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred H-HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 2 1111111100 0000000000000000 0 000112457899999999999999
Q ss_pred CCHHHHHHH
Q 002189 890 PTMSEVVKD 898 (955)
Q Consensus 890 Ps~~evl~~ 898 (955)
||++|++++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999975
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=327.69 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=197.0
Q ss_pred HHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeC-----
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR----- 696 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 696 (955)
...++|...+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3456788999999999999999985 4688999999875322 2335677899999999999999999987543
Q ss_pred -CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 697 -GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 697 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
...++++|++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999988 78888777533 5899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-hhh-
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-ELY- 852 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~- 852 (955)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+........ ...
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9865432 223468999999999976 56899999999999999999999999644322 22222111000 000
Q ss_pred -----------hhhhccCCcCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 -----------NLYELIDPTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 -----------~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+ +...... .......+.+++.+|++.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000 00112457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=317.39 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=205.2
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEccc--CCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQ--GSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e 704 (955)
..|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|..|++.|.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45777889999999999999988889999997653 34444567999999999996 9999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|- +.+|..+|+.......+| .+..+..|++.++.++|.+| |||.||||.|+|+-. |.+||+|||.|..+.....
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 75 679999998877666667 67789999999999999999 999999999999865 4799999999998877766
Q ss_pred cceeeeeecCCCCCCHHHhhhCC-----------CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhh
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQ-----------LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN 853 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 853 (955)
.-.....+||+.||+||.+.... .++++||||+|||||+|+.|++||..-.+...-
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK------------- 581 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK------------- 581 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH-------------
Confidence 66667789999999999997432 568999999999999999999999643322221
Q ss_pred hhhccCCcCCCCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGLSTTL-KGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+..+.||.....++. ....+++++++.||+.||++||+..|++++
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 233445532211111 111238999999999999999999999964
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.43 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=199.4
Q ss_pred cCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 633 ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
...||+|+||.||++... ++..||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456999999999999864 6889999998765555556789999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeee
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
.+++... .+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........ .....
T Consensus 107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 178 (292)
T cd06658 107 TDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSL 178 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCcee
Confidence 9987543 5889999999999999999999988 99999999999999999999999999876543221 12335
Q ss_pred ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
.|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ...... ..+++.... .....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~----------~~~~~~~~~--~~~~~ 245 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIR----------DNLPPRVKD--SHKVS 245 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH----------hcCCCcccc--ccccC
Confidence 68999999999998899999999999999999999999997543321 111111 111111111 11223
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.+++.+||..||.+||+++|++++
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 567899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=318.55 Aligned_cols=263 Identities=28% Similarity=0.414 Sum_probs=201.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|+..+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 5899999988653322 34578899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++++|.++..... .+++.++..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999998887765433 4899999999999999999999988 99999999999999999999999999986643322
Q ss_pred cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-------hhhhh
Q 002189 785 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-------YNLYE 856 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 856 (955)
......++..|+|||++.+ ..++.++||||||+++|||++|++||...... +............ .....
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccch
Confidence 2233457889999999875 45788999999999999999999888644332 2222211110000 00000
Q ss_pred ----ccCCcCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 ----LIDPTIGLS-----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ----~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+..... ........+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 001111000 011224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.22 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=203.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||+|+||+||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999865 5899999998764333 3456889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+.+++|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999987655567899999999999999999999988 9999999999999999999999999987553221
Q ss_pred Ccc---------------------------eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch
Q 002189 784 KDH---------------------------ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY 836 (955)
Q Consensus 784 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~ 836 (955)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 01124688899999999988999999999999999999999999965433
Q ss_pred HHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 002189 837 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT----MSEVVKD 898 (955)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 898 (955)
.. ........ .............+.+++.+||+.||++||+ ++|++++
T Consensus 238 ~~-~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DE-TFSNILKK-------------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HH-HHHHHhcC-------------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 21 11111111 1111111113477899999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.01 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=200.2
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|+||+||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999864 689999999864322 2235678899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++ ++|.+++.... ..+++.....++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 57877765432 35899999999999999999999988 99999999999999999999999999986543221
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----hhhhhhccC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLYELID 859 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~d 859 (955)
......++..|+|||++.+. .++.++|||||||++|||+||+.|+..+.+.............. ...+.+..+
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 12234578899999998765 47899999999999999999999976555544433332221100 000000000
Q ss_pred C----cCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 P----TIGL-----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~----~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .... ........++.+++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0000 0011233677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=318.13 Aligned_cols=194 Identities=26% Similarity=0.403 Sum_probs=159.0
Q ss_pred CeeeccCceEEEEEEeC---CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe--CCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~ 708 (955)
.+||+|+||+||+|+.. ++..||+|.++.... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999864 357899999875432 3467889999999999999999999854 456799999986
Q ss_pred CCcccccCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE----cCCCceEEeeccccc
Q 002189 709 GSLGDSLSGK-------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLSK 777 (955)
Q Consensus 709 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGla~ 777 (955)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 4666655321 1235889999999999999999999988 9999999999999 567799999999998
Q ss_pred ccCCCCCc-ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcC
Q 002189 778 SMSDSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIER 833 (955)
Q Consensus 778 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~ 833 (955)
........ .......||+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76543221 11234578999999999976 4589999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.28 Aligned_cols=262 Identities=28% Similarity=0.439 Sum_probs=204.9
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEe
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 695 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 695 (955)
+.+.++..++++|...+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44556666788999999999999999999986 468899999986532 2345678899999999 79999999999876
Q ss_pred C-----CeEEEEEEecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 696 R-----GEQMLIYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 696 ~-----~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
. +..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999887532 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC-----CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHH
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~ 843 (955)
||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||........ +..
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFK 244 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHH
Confidence 9999999886543221 12234588999999998643 368899999999999999999999865432211 111
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... ...+.+ ....+....+.+++.+||+.+|++||++.|++++
T Consensus 245 ~~~----------~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPR----------NPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Hhc----------CCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 110 001111 1112233568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.06 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=203.4
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+|+..+.||+|+||.||+|... +++.||+|++..... ...+++.+|++++++++||||+++++++..++..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999875 689999999876532 34467889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++++|.+++.... ..+++.....++.|++.|++|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999887543 468889999999999999999999 77 99999999999999999999999999876532211
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc----hHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK----YIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~----~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ...+.+...... ..+.
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~ 223 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE----------PPPR 223 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC----------CCCC
Confidence 11568899999999999999999999999999999999999996542 222222221111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... ......+.+++.+||..||++||++.|++.+
T Consensus 224 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 1134678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.50 Aligned_cols=244 Identities=23% Similarity=0.374 Sum_probs=199.1
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcc
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 712 (955)
..||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999864 68999999987655455567889999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeee
Q 002189 713 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792 (955)
Q Consensus 713 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 792 (955)
+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ......
T Consensus 107 ~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~ 178 (297)
T cd06659 107 DIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLV 178 (297)
T ss_pred HHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccccee
Confidence 877542 5889999999999999999999988 99999999999999999999999999876543221 123356
Q ss_pred cCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHH
Q 002189 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872 (955)
Q Consensus 793 gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 872 (955)
|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......... ..+.. ........
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~----------~~~~~--~~~~~~~~ 245 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRLRDS----------PPPKL--KNAHKISP 245 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcc----------CCCCc--cccCCCCH
Confidence 899999999999889999999999999999999999999754322 111111100 00110 01112235
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 873 KYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 873 ~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+.+++.+||+.+|++||+++|++++
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 68899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.91 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=207.0
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch--hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.-|...+.||+|.|..|-.|++ -+|++||||++.+..... ...+.+|++.|+.++|||||++|++.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4466677899999999999984 489999999998654432 3467889999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE-cCCCceEEeecccccccCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL-DERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DFGla~~~~~~~ 783 (955)
+-++|+|.+||-++. ..+.+....+++.||+.|+.|+|..+ +|||||||+||.. ..-|-+|+.|||++-.+.++.
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999987654 25788888999999999999999999 9999999999866 567889999999998776654
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCC-ChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
+ -+..+|+..|-|||.+.+..|+ +++||||+|||||-+++|++||+...+... +-.++|...
T Consensus 174 k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImDCKY 236 (864)
T KOG4717|consen 174 K---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMDCKY 236 (864)
T ss_pred h---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhcccc
Confidence 3 3457899999999999999987 579999999999999999999986554322 122233322
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.....++.+||..|++.||.+|.+.+||+..
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2344556789999999999999999999998853
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.72 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=202.7
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|+..+.||+|+||.||+|.. .+++.+|||++.... ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999986 468899999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-CceEEeecccccccCCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~~~~~~~~ 784 (955)
+++++|.+++.......+++..+..++.++++|++|||+.+ ++||||+|+||+++++ +.+|++|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999997655556899999999999999999999988 9999999999999865 4689999999987654322
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ +..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~-- 221 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGTF----------API-- 221 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHHhcCC----------CCC--
Confidence 1234688999999999988899999999999999999999999865432 222222211110 001
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||+.+|++||+++|++++
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.61 Aligned_cols=252 Identities=28% Similarity=0.439 Sum_probs=203.5
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 6899999998765443 457889999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++++|.++++... .+++..+..++.++++|++|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999987543 5788899999999999999999998 999999999999999999999999999876543321
Q ss_pred ce--eeeeecCCCCCCHHHhhhCC---CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 786 HI--TTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 786 ~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
.. .....++..|+|||++.+.. .+.++||||||+++|||++|+.||............... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~ 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----------GHKP 225 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----------CCCC
Confidence 11 11346788999999998766 889999999999999999999999754332222111111 0111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
... ........+.+++.+||+.+|++||++.|++.
T Consensus 226 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 11122466789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.93 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=199.7
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|+..+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 6899999988753322 235688999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++ ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 68888887655567899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ceeeeeecCCCCCCHHHhhhCC-CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----------hhh
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----------LYN 853 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----------~~~ 853 (955)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ .......... ...
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhhhHHHH
Confidence 122345788999999887644 58899999999999999999999965443222 2221111100 000
Q ss_pred hhhccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+...... .........+.+++.+||+.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0001122567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=306.95 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=207.4
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+|+..+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5788899999999999999875 589999999876544 34578999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 82 DGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999998754 368999999999999999999999 88 999999999999999999999999999876543321
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.....++..|+|||.+.+..++.++||||||+++|||+||+.|+.... ...+....+... ..+..
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~- 223 (264)
T cd06623 157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----------PPPSL- 223 (264)
T ss_pred --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC----------CCCCC-
Confidence 223568899999999999999999999999999999999999997554 222222222111 11111
Q ss_pred CCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLK-GFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... ....+.+++.+||..+|++||++.|++++
T Consensus 224 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=309.02 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=206.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
+.|+.-++||+|+||+||-++.+ +|+.+|.|++.+... ........|-.+|.++..+.||.+-.+|..++..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56788899999999999999854 699999998865332 23345678999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
..|.+|+|.-+|...+...+++.+...++.+|+.||++||... ||.||+||+|||+|+.|+++|+|.|||..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999999888778999999999999999999999988 9999999999999999999999999999886554
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHH--HHHHHhhhhhhhhhhhccCCc
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVRE--IRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~ 861 (955)
. ....+||.+|||||++.++.|+...|.||+||+||||+.|+.||...+.-+.+ +...+.+ |
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-----------~-- 405 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-----------D-- 405 (591)
T ss_pred c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-----------c--
Confidence 3 33458999999999999999999999999999999999999999743332221 1111110 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVK 897 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 897 (955)
...++.+..++..++....+.+||.+|.. +++|.+
T Consensus 406 -~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 406 -PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred -hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 11233444567888999999999999963 455554
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.92 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=195.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHH-HHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIEL-LSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|+..+.||+|+||.||+|+.. +|+.||+|+++.... ....++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999864 689999999875432 233456666665 566689999999999999999999999
Q ss_pred ecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 705 FVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 705 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|++ |+|.+++... ....+++..++.++.|++.||+|||+. + ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6777766432 234689999999999999999999986 6 99999999999999999999999999986543
Q ss_pred CCCcceeeeeecCCCCCCHHHhhh----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMT----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
.. ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.......+........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE---------- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----------
Confidence 21 1223458889999998864 456889999999999999999999996543322222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.... .....++.+++.+||..+|++||++++++++
T Consensus 224 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 1234678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=308.30 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=196.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-----cchhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-----MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 699 (955)
.+|...+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999864 68999999875321 11235688899999999999999999988764 457
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||+++++|.+++.... .+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999886543 5788888999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 780 SDSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 780 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~---------~~~ 226 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIAT---------QPT 226 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-HHHhc---------CCC
Confidence 322110 1122345888999999999888999999999999999999999999654322211 11110 001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+. .+......+.+++.+|+. +|++||+++|++++
T Consensus 227 ~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111 122334677899999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=326.94 Aligned_cols=241 Identities=23% Similarity=0.280 Sum_probs=187.5
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhc---cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRV---HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
||+|+||+||+|+.. +++.||||++...... ....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 6899999998643221 123345566777655 699999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 99998886543 6889999999999999999999998 9999999999999999999999999987543222 122
Q ss_pred eeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 789 TQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
....||..|+|||++.+. .++.++|||||||++|||++|+.||..... .+....+.... ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-----------~~~~~--- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-QQMYRNIAFGK-----------VRFPK--- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-HHHHHHHHcCC-----------CCCCC---
Confidence 345699999999999764 489999999999999999999999965432 22221111110 01110
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRP----TMSEVVKD 898 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~ 898 (955)
......+.+++.+||+.||.+|| ++.|++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 01235678999999999999998 56677653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=311.38 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=201.7
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCC------
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG------ 697 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------ 697 (955)
.+++|+..+.||+|+||+||+|... +++.+|+|++..... ..+++.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999974 678999999875433 346789999999999 6999999999997654
Q ss_pred eEEEEEEecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
..++||||+++++|.++++... +..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999876533 457899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhh-----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... ......
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----- 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIP----- 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhh-----
Confidence 87654322 12233568899999999853 346789999999999999999999996432211 111111
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+.. .........+.+++.+||..||++|||++|++++
T Consensus 232 -----~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 -----RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0011111 1112244678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=315.27 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=196.6
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|+||+||+++.. +++.||+|++..... .....+.+|+.++.++. |+||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999864 689999999875432 34467889999999996 99999999999999999999999
Q ss_pred cCCCCcccc---cCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 706 VPNGSLGDS---LSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 706 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
++ +++.++ +.......+++.....++.+++.||+|||+. + ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 454442 2222334689999999999999999999974 6 99999999999999999999999999976543
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhC---CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.........+..... ..
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------~~ 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK----------GD 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC----------CC
Confidence 221 1233588999999999866 6899999999999999999999999654422222221111 11
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+.+..........++.+++.+||+.||++||+++|++++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1222222223345678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=313.83 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=200.2
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc-----hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-----GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
+|...+.||+|+||.||+|... +|+.||||+++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999864 6899999998765433 234577899999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999987643 36899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh--------hhh
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE--------LYN 853 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~--------~~~ 853 (955)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... +........... ...
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccc
Confidence 21 1222356788999999865 46789999999999999999997776543322 222222211000 000
Q ss_pred hhhccCCcCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGLS-----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
............ ........+.+++.+||+.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 011224678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=312.39 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=199.1
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+|+..+.||+|+||+||+|+.. +|+.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999975 78999999887542 223467889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 707 PNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 707 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
++++|..+++... ...+++..+..++.+++.||.|||+ .+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999988886532 2368999999999999999999996 46 9999999999999999999999999987653221
Q ss_pred cceeeeeecCCCCCCHHHhhhCC------CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQ------LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
.....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||...... .... .... .....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~-~~~~------~~~~~ 226 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFA-QLSA------IVDGD 226 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHH-HHHH------HhhcC
Confidence 22345888999999986543 588999999999999999999999643221 1111 1110 00111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+.. ......++.+++.+||+.+|++||++++++.+
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111 11244678899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=313.03 Aligned_cols=264 Identities=24% Similarity=0.380 Sum_probs=199.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|+..+.||+|+||+||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 6899999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++ ++|.+++.... ..+++.....++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 58988876543 26889999999999999999999988 99999999999999999999999999875432211
Q ss_pred ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-hhhh-h------
Q 002189 786 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-YNLY-E------ 856 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~-~------ 856 (955)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.......+.+.......... .... .
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346889999999875 4588999999999999999999999965543333332222110000 0000 0
Q ss_pred c-------cCCc-CCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 L-------IDPT-IGL-STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~-------~d~~-l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ..+. +.. .........+.+++.+|++.+|++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0000 000 0001112567899999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.96 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=200.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 703 (955)
++|...+.||.|++|.||+|... +++.+|+|.+..... ....++.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999974 688999999875433 3446789999999999999999999998654 3689999
Q ss_pred EecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 704 EFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 704 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||+++++|.+++.. .....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887643 22346888999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch----HHHHHHHHHhhhhhhhhhhhc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY----IVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 857 (955)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ..+....... .
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~--------- 223 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-M--------- 223 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-C---------
Confidence 221 234578899999999999999999999999999999999999975421 1111111111 0
Q ss_pred cCCcCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGL--STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
-.+.+.. .........+.+++.+||+.+|.+|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 224 PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0011111 1112234678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=312.33 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=201.6
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999865 58899999887532 22346789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++++.+..+.... ..+++.....++.+++.|++|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 82 VERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9987776655433 35889999999999999999999988 99999999999999999999999999987654332
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh-hhhhc--cCCc
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY-NLYEL--IDPT 861 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~d~~ 861 (955)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||...... +.+........... ..... .++.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 122335688899999999887 8899999999999999999999998644322 22211111000000 00000 0000
Q ss_pred CC--------------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IG--------------LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. .........++.+++.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00111225778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.20 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=201.4
Q ss_pred CCccCeeeccCceEEEEEEeCC-CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 630 FSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
|.++..||.|+||.||||..++ +-..|-|++........++|.-|+++|..++||+||++++.|+..+.+||..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445569999999999998765 344567888766666678899999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|-....+-.- +..++..++.-++.+++.||.|||+.. |||||||+.|||++-+|.++++|||.+...... -...
T Consensus 114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkR 187 (1187)
T KOG0579|consen 114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKR 187 (1187)
T ss_pred chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--Hhhh
Confidence 9887765433 347899999999999999999999988 999999999999999999999999997643221 1234
Q ss_pred eeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 789 TQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
..+.||++|||||+.+ ...|+.++||||||++|.||..+.+|-..-. ..+.+..+. .--+|.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-pMRVllKia----------KSePPTL- 255 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIA----------KSEPPTL- 255 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-hHHHHHHHh----------hcCCCcc-
Confidence 5688999999999986 4679999999999999999999998864322 222222221 1112333
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
-.+......|.+++.+|+.+||..||++++++++
T Consensus 256 -lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 -LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2344566789999999999999999999999853
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=315.17 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=204.2
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
++|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5678889999999999999985 467899999987555555577899999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++... .+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999988653 4789999999999999999999998 99999999999999999999999999876543322
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......|++.|+|||.+....++.++||||||+++||+++|+.||........ +..... .+......
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~------------~~~~~~~~ 237 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIAT------------NGTPELQN 237 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhc------------CCCCCCCC
Confidence 12234688899999999888899999999999999999999999965432211 111100 00111111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22234568899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=313.18 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=199.2
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
+++|...+.||+|+||.||+|.. .+|+.||+|+++..... ....+.+|+++++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 56788999999999999999985 46899999998754322 23467889999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|++ +++.+++.... ..+.+..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 995 67766664332 35778888899999999999999988 99999999999999999999999999876433221
Q ss_pred cceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----------hh
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----------LY 852 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----------~~ 852 (955)
......++..|+|||++.+. .++.++|||||||++|||++|..||.......+.+......... ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12234578899999998754 57889999999999999999999997654433333332211000 00
Q ss_pred hhhhccC----Cc-CC-CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLYELID----PT-IG-LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~~~~d----~~-l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....... +. .. ..........+.+++.+|++.||.+|||++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000 00 00 00001123567899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=308.65 Aligned_cols=254 Identities=25% Similarity=0.451 Sum_probs=200.8
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc------chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM------QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
+|+..+.||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 5789999999875331 123578899999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecccccccC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMS 780 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~ 780 (955)
||||+++++|.+++.... ++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999887543 6889999999999999999999998 99999999999998776 59999999987765
Q ss_pred CCCC--cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 781 DSEK--DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 781 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
.... ........++..|+|||.+.+..++.++||||+|+++|||++|..||....... .......... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~------~~~ 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIFKIAS------ATT 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHHHhc------cCC
Confidence 3311 111223468899999999988889999999999999999999999986432211 1111110000 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+. .+.....++.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 APS----IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCC----CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 111 122234678899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.37 Aligned_cols=250 Identities=30% Similarity=0.492 Sum_probs=205.9
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
+|...+.||+|++|.||+|... +++.+++|++........+.+.+|++++++++|+||+++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 689999999987655456789999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.+++.... ..+++..+..++.+++.|++|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999887643 46899999999999999999999988 99999999999999999999999999987654331
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
.....++..|+|||.+....++.++||||||+++|||++|+.|+........ ...... . ..+... ..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~--~--------~~~~~~--~~ 220 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFKIAT--N--------GPPGLR--NP 220 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh--c--------CCCCcC--cc
Confidence 2345688999999999988899999999999999999999999975432211 111110 0 001111 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+.+++.+||+.||++||++.|++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1124678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=313.67 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=198.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||.||++... .++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999864 578999999875432 22356889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++.....++.++++||+|||+.+ ++||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999986543 6889999999999999999999988 9999999999999999999999999986421110
Q ss_pred C-------------cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 784 K-------------DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 784 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
. ........++..|+|||++.+..++.++|+|||||++|||++|..||.... ..+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-~~~~~~~~~~~~-- 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDD-- 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcc--
Confidence 0 001112357889999999998899999999999999999999999996432 222222211110
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...|... ......+.+++.+||+.||++||++.++.+.
T Consensus 233 ------~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l 270 (305)
T cd05609 233 ------IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEV 270 (305)
T ss_pred ------cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHH
Confidence 0111111 1233668899999999999999996544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=341.07 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=210.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC----C----CcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeCC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP----N----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 697 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~----~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 697 (955)
++....+.||+|.||.|++|... . ...||||.++..... +.+.+..|+++|+.+ +|+||+.++|+|..++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 33445568999999999999742 1 457999999865443 457899999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCC------------C--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN------------G--IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
..++|+||+..|+|.++++... . ..++....+.++.|||.|++||++.. +|||||.++|||++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999997654 0 13888999999999999999999887 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeee-ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQV-KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREI 841 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~ 841 (955)
++..+||+|||+|+...+.+........ .-+.+|||||.+....|+.|+|||||||++|||+| |..||.+-....+..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 9999999999999976655443222111 13567999999999999999999999999999999 888885422122221
Q ss_pred HHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. .+.. ......+..+..+++++|+.||+.+|++||++.|+++.++..+..
T Consensus 533 ~-~l~~-------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 533 E-FLKE-------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred H-HHhc-------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1 2222 222333445568899999999999999999999999999997653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=305.63 Aligned_cols=250 Identities=25% Similarity=0.451 Sum_probs=202.7
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999865 58899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecccccccCCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~~~ 784 (955)
+++++|.+++.......+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999987655556899999999999999999999988 99999999999999885 469999999987643221
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+........ .+.+ .
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~---------~~~~-~-- 222 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKICQG---------YFAP-I-- 222 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhcc---------cCCC-C--
Confidence 2223458899999999988889999999999999999999999986432 22222222111 1111 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||..+|++||++.|++++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.63 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=200.6
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhcc---CCCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVH---HKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~ 703 (955)
.|+..+.||+|+||.||+|.. .+++.||+|.++... ....+++.+|++++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366778899999999999986 578999999987542 233467889999999997 999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.++++.. .+++.....++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988653 6899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. ......|+..|+|||.+.++ .++.++|||||||++|||++|..||...... ..... ......+.+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~----------~~~~~~~~~ 222 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-RAMML----------IPKSKPPRL 222 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-hhhhc----------cccCCCCCC
Confidence 2 12334688999999998754 4689999999999999999999999643321 11110 001111222
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... ....++.+++.+||+.||++||++.|++++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111 134678899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.24 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=200.9
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
-|+..+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778899999999999986 4688999998765432 23457889999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++++|.+++... .+++.....++.+++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 999999988643 5889999999999999999999988 99999999999999999999999999876643221
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......++..|+|||.+.+..++.++|||||||++|||++|..|+..... ......+. .. ..+..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~-~~---------~~~~~---- 221 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MKVLFLIP-KN---------NPPTL---- 221 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HHHHHHHh-cC---------CCCCC----
Confidence 12234688899999999988899999999999999999999999864322 11111111 00 01111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||+.+|.+||++++++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11233678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.72 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=201.5
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
|...+.||+|++|.||+|.. .+++.+|+|+++.......+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 46889999998755444556788999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
++|.+++... .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++++|||++....... ...
T Consensus 101 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~ 172 (285)
T cd06648 101 GALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR 172 (285)
T ss_pred CCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence 9999988762 5889999999999999999999998 9999999999999999999999999887554321 112
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ..+... ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~~~~~----------~~~~~~--~~~ 239 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDN----------LPPKLK--NLH 239 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHhc----------CCCCCc--ccc
Confidence 2346899999999999888999999999999999999999998654322 222211111 111111 111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+.+++.+||+.+|++||++++++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 233678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.27 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=201.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999864 689999999865322 23456889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999987653 6889999999999999999999988 999999999999999999999999999876443
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.||...... ......... .+.+.
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-----------~~~~~ 218 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEG-----------KVRFP 218 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcC-----------CccCC
Confidence 22346889999999998888999999999999999999999999754421 111111111 01111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
......+.+++.+||..||.+|+ +++|++++
T Consensus 219 ----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 219 ----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11236788999999999999998 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.03 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=200.7
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEe--CCeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 703 (955)
+|+..+.||.|+||.||+|.. .+|+.||+|+++.... ...+.+..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999985 4688999999875432 234568889999999999999999998764 34678999
Q ss_pred EecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 704 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELA--NPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 704 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
||+++++|.+++... ....+++...+.++.+++.||+|||..+ ...++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988643 2347899999999999999999999332 233999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...... ..... ..
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~-~~~~~---------~~ 227 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLAS-KIKEG---------KF 227 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHH-HHhcC---------CC
Confidence 54321 1233568999999999998889999999999999999999999997543 212111 11111 01
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+. ........+.+++.+|++.+|++||++++|+++
T Consensus 228 ~~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RR----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 112234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=310.61 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=199.6
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
|+..+.||+|++|+||+|... +|+.||+|++...... ..+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999864 7999999998754322 2356888999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
+ ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 4 68998887655456899999999999999999999988 99999999999999999999999999976543221
Q ss_pred eeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----------hhhh
Q 002189 787 ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----------LYNL 854 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----------~~~~ 854 (955)
......++..|+|||++.+. .++.++||||||+++|||++|+.||........ ...+...... ....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223568899999988754 578999999999999999999999975543322 2222211000 0000
Q ss_pred hhccC---CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 855 YELID---PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 855 ~~~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+. ..............+.+++.+|++.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 000000111223678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.67 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=206.2
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++.|...+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|+++++.++|+||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3456777788999999999999976 688999999876544 45678899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999997653 46899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
......++..|+|||.+.+..++.++|||||||++|||++|+.|+........ ........ . +. .
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~~~~~~---------~-~~--~ 236 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFLITTKG---------I-PP--L 236 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcC---------C-CC--C
Confidence 12234578899999999988899999999999999999999999865433221 11111100 0 00 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.........+.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111134678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.22 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=206.8
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 703 (955)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+.+. +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 689999999876543 3456789999999999999999999999988 8899999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999987654 7899999999999999999999988 9999999999999999999999999998765443
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.........++..|+|||.+.+...+.++||||||+++|||++|..||....+.......... ....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~~~ 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-------------SGEP 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-------------cCCC
Confidence 211123456889999999999888999999999999999999999999765532222221111 0000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..........+.+++.+|++.+|++||++.|++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11111224678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=313.33 Aligned_cols=246 Identities=28% Similarity=0.456 Sum_probs=196.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
..|...+.||+|+||+||+|+.. +|+.||+|++..... ...+++.+|+++++.++||||++++++|.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777889999999999999864 689999998864332 22356889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||++ |++.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 9996 67766654322 36899999999999999999999988 9999999999999999999999999987653321
Q ss_pred CcceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...++..|+|||++. .+.++.++||||||+++|||+||+.||........ ....... ..+
T Consensus 170 ------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~~~~~----------~~~ 232 (307)
T cd06607 170 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN----------DSP 232 (307)
T ss_pred ------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHHHhcC----------CCC
Confidence 245888999999874 45688999999999999999999999865433221 1111100 011
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... .......+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 TLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 12234678999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.67 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=201.8
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999864 689999999876442 2346789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+ +++|.+++.... ..+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999886543 46899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----------hhh
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----------LYN 853 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----------~~~ 853 (955)
.......|+..|+|||.+.+. .++.++||||+|+++|||++|.+||...... ............ ...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcch
Confidence 122334689999999998754 4689999999999999999997777543322 222222211000 000
Q ss_pred hhhccCCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+.... .........+.+++.+|++.+|.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0001223778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=308.33 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=197.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|...+.||+|+||+||+|+.. +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999864 689999999865322 223568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccccccCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~~ 783 (955)
|++ ++|.+++.......+++.....++.|++.||+|||+.+ ++||||+|+||++++ ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 57877776554445688888899999999999999988 999999999999985 5679999999997654321
Q ss_pred CcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-hhhhh------
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLY------ 855 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~------ 855 (955)
. ......+++.|+|||++.+. .++.++|||||||++|||+||+.||...... +........... .....
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccccccc
Confidence 1 11234578899999998764 5789999999999999999999999654332 222222111000 00000
Q ss_pred -h--ccCCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 -E--LIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 -~--~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ..-+.... ........++.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000000 0011223568899999999999999999999974
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=310.46 Aligned_cols=248 Identities=29% Similarity=0.471 Sum_probs=197.2
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
|...+.||+|+||+||+|+. .+++.||+|++..... ...+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55678899999999999986 4689999999864322 2235688899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++ |+|.+.+... ..++++.++..++.+++.|+.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 96 5777766533 236899999999999999999999988 999999999999999999999999998754322
Q ss_pred ceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 786 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||....... ......... .+..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~----------~~~~ 244 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE----------SPTL 244 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhcc----------CCCC
Confidence 2245888999999984 4578999999999999999999999986543221 111111110 0111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
........+.+++.+||+.+|.+||++.+++++...+
T Consensus 245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 1112335688999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=315.73 Aligned_cols=261 Identities=24% Similarity=0.323 Sum_probs=198.9
Q ss_pred HhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeC------
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------ 696 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 696 (955)
..++|+..+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999985 47899999998643 223345677899999999999999999988644
Q ss_pred CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
...++||||++ ++|.+.+.. .+++.....++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35699999995 578777653 2788899999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-hh----
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-EL---- 851 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-~~---- 851 (955)
+....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..... ..
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFM 241 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence 87643221 2234588999999999999999999999999999999999999975433221 111111000 00
Q ss_pred -------------------hhhhhccCC----cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 -------------------YNLYELIDP----TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 -------------------~~~~~~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.+.... .............+.+++.+||+.||++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00000011234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.99 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=198.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch--hHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 702 (955)
++|+..+.||+|+||.||+|... +++.+|+|.++...... ...+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778889999999999999975 68899999987543222 24567899999999999999999999887 889999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||++ ++|.+++.... ..+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 58888776543 26899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----------h
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----------E 850 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-----------~ 850 (955)
.. ......++..|+|||.+.+. .++.++|+||||+++|||++|..||...... +....+..... .
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhc
Confidence 21 12234578899999998754 4689999999999999999999998654322 22222111100 0
Q ss_pred hhh-----hhhccCCcCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 LYN-----LYELIDPTIGLSTTLK-GFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ~~~-----~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... ........+....... ....+.+++.+||+.||++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 0000000000011111 24668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=305.92 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=201.7
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcc
Q 002189 634 NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLG 712 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 712 (955)
.+||+|+||.||+|.. .+|+.||||++........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999986 478999999987555455567899999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeee
Q 002189 713 DSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792 (955)
Q Consensus 713 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 792 (955)
+++... .+++.....++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++........ ......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 887543 5789999999999999999999988 99999999999999999999999999876543221 123356
Q ss_pred cCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHH
Q 002189 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872 (955)
Q Consensus 793 gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 872 (955)
|+..|+|||++.+..++.++|+||||+++|||++|..||...... ......... .++... .......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~~~~~----------~~~~~~--~~~~~~~ 244 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDN----------LPPKLK--NLHKVSP 244 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhh----------CCcccC--CcccCCH
Confidence 889999999998888999999999999999999999998643322 211111111 111111 1112235
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 873 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 873 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
.+.+++.+||+.+|.+||++.+++++ ..+...+
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~--~~~~~~~ 277 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAG 277 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC--hHHhccC
Confidence 67899999999999999999999984 4444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=304.91 Aligned_cols=244 Identities=24% Similarity=0.356 Sum_probs=193.7
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
||+|+||+||+|... +|+.||+|.+..... ...+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 689999999865322 2234567899999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeee
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
.+++.......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99987655557899999999999999999999998 9999999999999999999999999987654321 12234
Q ss_pred ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
.++..|+|||++.++.++.++|||||||++|||++|+.||.......... ...... .. ... .......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~------~~-~~~----~~~~~~~ 222 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRRT------LE-MAV----EYPDKFS 222 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-HHHhcc------cc-ccc----cCCccCC
Confidence 57889999999998889999999999999999999999996543211100 000000 00 000 1111224
Q ss_pred HHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRP-----TMSEVVK 897 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RP-----s~~evl~ 897 (955)
..+.+++.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 6788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=305.04 Aligned_cols=258 Identities=17% Similarity=0.162 Sum_probs=182.4
Q ss_pred cCCCccCeeeccCceEEEEEEeCC----CcEEEEEEcccCCcch--h---------HHHHHHHHHHHhccCCCcceEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQG--G---------QEFKMEIELLSRVHHKNLVSLLGF 692 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~H~niv~l~~~ 692 (955)
++|...++||+|+||+||+|+..+ +..+|+|+........ . .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568888999999999999998654 3456666543222111 0 112233345566789999999998
Q ss_pred EEeCC----eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 693 CFDRG----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 693 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
+.... ..++++|++. .++.+.+.... ..++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 76554 3467777763 35544443321 3567888899999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHH
Q 002189 769 KVADFGLSKSMSDSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~ 843 (955)
+|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876432211 1112346999999999999999999999999999999999999999754322221111
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
...+. +.....+... ....+..+.+++..|+..+|++||+++++++.+
T Consensus 246 ~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDF-----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHH-----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11100 0000111111 111246788999999999999999999999865
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=308.01 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=196.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCe-----
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGE----- 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 698 (955)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999864 6899999987653222 2356888999999995 6999999999987665
Q ss_pred EEEEEEecCCCCcccccCCCC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFG 774 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFG 774 (955)
.|+||||+++ +|.+++.... ...+++.....++.||++||+|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 7888775432 246899999999999999999999988 999999999999998 8899999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh---
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE--- 850 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~--- 850 (955)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ...+......
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 9876543221 1122357889999999875 4578999999999999999999999965443322 2222211000
Q ss_pred -hh-hhhhccC----CcCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 -LY-NLYELID----PTIG----LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 -~~-~~~~~~d----~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. ......+ +... .........++.+++.+||+.||.+||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000000 0000 00001233668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=303.59 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=193.6
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhcc-CCCcceEEEEEEeC--CeEEEEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDR--GEQMLIYE 704 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~e 704 (955)
|...+.||+|+||.||+|.. .+++.||+|+++.... .......+|+.++.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 55678899999999999985 4689999999875422 22334557889999885 99999999999987 88999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|++ |+|.+.+.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 58877776432 36899999999999999999999988 999999999999999 9999999999987643322
Q ss_pred cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-hhhhhhccC---
Q 002189 785 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLYELID--- 859 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d--- 859 (955)
.....++..|+|||++.. +.++.++|||||||++|||++|..||..... .+.+......... ...+.....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 122457889999998754 5678899999999999999999999964432 2222211110000 000000000
Q ss_pred ------CcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 ------PTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.... .........+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 0011235789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.59 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=201.5
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
+|+..+.||.|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 589999999875322 334678999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++++|.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998755 36889999999999999999999988 9999999999999999999999999988764432
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchH-HHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI-VREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... .++....... ..+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~--- 219 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----------ADV--- 219 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----------ccc---
Confidence 123356888999999999888999999999999999999999999754431 1111111110 000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTM--SEVVK 897 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~ 897 (955)
..+......+.+++.+||+.||.+||++ +|+++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 220 -LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1111233788899999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=300.64 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=195.7
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 489999999875432 2346789999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeee
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++...... .....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99997643 5889999999999999999999988 9999999999999999999999999998765432 12234
Q ss_pred ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch-HHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHH
Q 002189 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY-IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 870 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (955)
.++..|+|||.+.+..++.++|+||||+++|||++|..||..... ..+.......... ....+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-------------KLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-------------CCCCCccc
Confidence 688999999999888899999999999999999999999975442 2222222211000 01111122
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 002189 871 FEKYVDLALKCVQESGDDRPT-----MSEVVK 897 (955)
Q Consensus 871 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 897 (955)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 467899999999999999999 566654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=286.71 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=202.9
Q ss_pred ccCHHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhcc-CCCcceEEEEE
Q 002189 617 CFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFC 693 (955)
Q Consensus 617 ~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~ 693 (955)
.....|++. +..||.|+.|+||+++.+ .|..+|||.+..... .+.+++.+.++++..-+ +|.||+.+|||
T Consensus 88 ~~dindl~~-------l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 88 QADINDLEN-------LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccChHHhhh-------HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 344555554 345999999999999975 589999999876543 34467778888877765 89999999999
Q ss_pred EeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 694 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
..+...++.||.|. ..+...++.- ..++++.-.-++...+++||.||.+.+ .|||||+||+|||+|+.|++|+|||
T Consensus 161 i~n~dV~IcMelMs-~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 161 ITNTDVFICMELMS-TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred eeCchHHHHHHHHH-HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecc
Confidence 99999999999984 3344444322 236777777889999999999998754 3999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhh---CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
|.+..+-+.. ..+...|-+.|||||.+.- ..|+-++||||||+.++|+.||+.||..-+...+.+..+..+.
T Consensus 237 GIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-- 311 (391)
T KOG0983|consen 237 GISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-- 311 (391)
T ss_pred cccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--
Confidence 9997775443 3345679999999999973 4688999999999999999999999987777777776665532
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.|.+... .....++.+++..|+.+|+.+||.+.+++++
T Consensus 312 --------PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 --------PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --------CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2333221 2245788999999999999999999999874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=308.80 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=195.6
Q ss_pred CCCccCeeeccCceEEEEEEeC---CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQM 700 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 700 (955)
+|+..++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999864 47899999988633 22335678899999999999999999999988 7899
Q ss_pred EEEEecCCCCcccccCCC---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC----CCceEEeec
Q 002189 701 LIYEFVPNGSLGDSLSGK---NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE----RLNAKVADF 773 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~----~~~~kl~DF 773 (955)
+||||+++ ++.+.+... ....+++.....++.|++.||+|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 666655322 1236889999999999999999999988 999999999999999 999999999
Q ss_pred ccccccCCCCC-cceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHH--------HHHHH
Q 002189 774 GLSKSMSDSEK-DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV--------REIRT 843 (955)
Q Consensus 774 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~--------~~~~~ 843 (955)
|+++....... ........++..|+|||++.+. .++.++|||||||++|||++|++||....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1112234678899999998764 57899999999999999999999986332111 11111
Q ss_pred HHhhhh-----------hhhhhhh---ccC-CcCCCCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 844 VMDKKK-----------ELYNLYE---LID-PTIGLSTTL-------KGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 844 ~~~~~~-----------~~~~~~~---~~d-~~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
++.... ....... ... ......... ....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111000 0000000 000 000000000 223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=335.17 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=190.4
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeC-----
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR----- 696 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 696 (955)
-++..+|.+++.||+||||.|||++.+ ||+.||||++.... ......+.+|++.+.+|+|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456778889999999999999999965 89999999998653 22235678899999999999999998654310
Q ss_pred --------------------------------------------------------------------------------
Q 002189 697 -------------------------------------------------------------------------------- 696 (955)
Q Consensus 697 -------------------------------------------------------------------------------- 696 (955)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 002189 697 ----------------------------------GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL 742 (955)
Q Consensus 697 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 742 (955)
...||-||||+...+.++++.+.... .....++++.+|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 01467788888777777776543111 3556788999999999999
Q ss_pred hhccCCCeeccCCCCccEEEcCCCceEEeecccccccC----------------CCCCcceeeeeecCCCCCCHHHhhhC
Q 002189 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS----------------DSEKDHITTQVKGTMGYLDPEYYMTQ 806 (955)
Q Consensus 743 H~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 806 (955)
|+.| ||||||||.||++|++..|||+|||+|+... ........+..+||.-|+|||.+.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 01112234567899999999999855
Q ss_pred ---CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC--CCHHHHHHHHHHHHHh
Q 002189 807 ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS--TTLKGFEKYVDLALKC 881 (955)
Q Consensus 807 ---~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~c 881 (955)
.|+.|+|+||+|||++||+. ||...-.-... +.+ +. ++.++.. +.......-..+|.+|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i----L~~------LR---~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI----LTN------LR---KGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH----HHh------cc---cCCCCCCcccccccchHHHHHHHHH
Confidence 49999999999999999995 66432211111 111 11 2222221 2222233446899999
Q ss_pred hccCCCCCCCHHHHHH
Q 002189 882 VQESGDDRPTMSEVVK 897 (955)
Q Consensus 882 l~~dP~~RPs~~evl~ 897 (955)
++.||.+|||+.|+++
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999985
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=303.03 Aligned_cols=263 Identities=22% Similarity=0.355 Sum_probs=199.4
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+|+..++||+|++|+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 6899999998764332 2356778999999999999999999999999999999999
Q ss_pred CCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 707 PNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 707 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++++|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 48888775433 346899999999999999999999988 99999999999999999999999999976543221
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----hhhhh--hc
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLY--EL 857 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~ 857 (955)
......++..|++||++.+. .++.++|||||||++|||++|+.||..... .+....+...... ...+. ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-EDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 12234578899999998754 578999999999999999999999875432 2222222211000 00000 00
Q ss_pred cCCcCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGL-------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....... .........+.+++.+|++.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 0001223567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=310.47 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=194.2
Q ss_pred eeecc--CceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 635 DVGSG--GYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 635 ~lG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
.||+| +||+||+|+. .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+++|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999986 47899999998754322 2367889999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc---
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH--- 786 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~--- 786 (955)
+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999887654446899999999999999999999988 9999999999999999999999998654332211100
Q ss_pred --eeeeeecCCCCCCHHHhhhC--CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-------------
Q 002189 787 --ITTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK------------- 849 (955)
Q Consensus 787 --~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~------------- 849 (955)
......++..|||||++.+. .++.++|||||||++|||++|+.||..................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 01112356679999999763 4789999999999999999999999754332221111110000
Q ss_pred hhh----hh----h----------hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ELY----NL----Y----------ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~~~----~~----~----------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... .. . ...+..+.......+...+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00 0 0000111111223345678999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=308.20 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=197.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch--hHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 701 (955)
.++|+..+.||+|+||+||+|... +|+.||+|+++...... ...+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 356888999999999999999864 68999999987533222 23467899999999999999999998765 46899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 57877776432 46899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-hhhhhh---
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLYE--- 856 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~--- 856 (955)
... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... .+.+..+...... ......
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhh
Confidence 321 1222346788999999875 4578999999999999999999999964432 2333222221100 000000
Q ss_pred ------ccC-CcCCCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 ------LID-PTIGLSTT----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ------~~d-~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+. +....... ......+.+++.+|++.||++||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000000 0123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=329.26 Aligned_cols=269 Identities=20% Similarity=0.290 Sum_probs=190.0
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeCC--CcEEEEE------------------EcccCCcchhHHHHHHHHHHHhccC
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLPN--GQLIAIK------------------RAQQGSMQGGQEFKMEIELLSRVHH 683 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H 683 (955)
....++|...++||+|+||+||++.++. +..+++| +++. .......+.+|+.++++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCC
Confidence 3456789999999999999999987532 2222222 1111 11223568899999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCCcccccCCCC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccE
Q 002189 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNI 760 (955)
Q Consensus 684 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI 760 (955)
||||++++++...+..|+|+|++. ++|.+++.... ...........++.|++.||+|||+.+ |+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 999999999999999999999984 56666654321 112335567789999999999999988 99999999999
Q ss_pred EEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCC-CcCC-chHH
Q 002189 761 LLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP-IERG-KYIV 838 (955)
Q Consensus 761 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P-~~~~-~~~~ 838 (955)
|++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +... ....
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999987654322 222345799999999999999999999999999999999998754 4322 1222
Q ss_pred HHHHHHHhhhh----hh----hhhhhccCCc-CCC--C------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 839 REIRTVMDKKK----EL----YNLYELIDPT-IGL--S------TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 839 ~~~~~~~~~~~----~~----~~~~~~~d~~-l~~--~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+..++.... +. ..+.+.++.. ... . .......++.+++.+|++.||.+||++.|++++
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22222222110 00 0001111000 000 0 000112457788999999999999999999975
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=306.22 Aligned_cols=251 Identities=25% Similarity=0.454 Sum_probs=195.7
Q ss_pred cCCCccCeeeccCceEEEEEEeCC-CcEEEEEEcccCCc-chhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|...+.||+|+||+||+|+..+ ++.||||+++.... ....++.+|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457778999999999999999764 89999999875433 23355677887777775 9999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
|++ +++.+++.... ..+++..+..++.++++||+|||+ .+ |+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 46666554322 378999999999999999999997 46 9999999999999999999999999997664322
Q ss_pred CcceeeeeecCCCCCCHHHhhhCC----CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQ----LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
. .....++..|+|||++.+.. ++.++||||||+++|||++|+.||.......+......... .
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------~ 236 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE----------P 236 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC----------C
Confidence 2 12235788999999987554 78899999999999999999999965433333322222211 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+... .......++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 111234678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=344.30 Aligned_cols=254 Identities=28% Similarity=0.390 Sum_probs=204.3
Q ss_pred HhcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.+-+++....||.|.||.||-|. ..+|+..|||-++.. .....+.+.+|+.++..++|||+|+++|+=.+++..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34577778899999999999998 567999999977642 333346788999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
||||++|+|.+.+.... -+++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999886543 4566666678899999999999999 999999999999999999999999999877644
Q ss_pred CC--cceeeeeecCCCCCCHHHhhhCC---CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 783 EK--DHITTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 783 ~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
.. .......+||+.|||||++.+.. -..+.||||+|||+.||+||++||..-++....+..+....
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh--------- 1458 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH--------- 1458 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC---------
Confidence 21 11223568999999999998644 45689999999999999999999986655544443333221
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.|.++ .....+-.+++.+|++.||++|.++.|++++
T Consensus 1459 -~Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -KPQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CCCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12222 2233556799999999999999999888764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=302.97 Aligned_cols=241 Identities=24% Similarity=0.321 Sum_probs=186.6
Q ss_pred eeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHh---ccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 635 DVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSR---VHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 689999998865322 112334455444443 479999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.+++...+ .+++.....++.|++.||+|||+.+ ++||||||+||++++++.++++|||++........
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 999998887544 6899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchH-HHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI-VREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
....|+..|+|||.+.+ ..++.++|||||||++|||++|..||...... ........ ...++.+
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~--- 218 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTVNVEL--- 218 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----------hcCCcCC---
Confidence 22468999999999874 56899999999999999999999999643211 11111110 0011111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
......++.+++.+||+.||.+|| +++|++++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 122346788999999999999999 58888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=308.00 Aligned_cols=259 Identities=22% Similarity=0.252 Sum_probs=192.7
Q ss_pred eeccCceEEEEEEeCCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCccc
Q 002189 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 713 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 713 (955)
+|.|+++.||++.. +++.||||+++.. .....+.+.+|+++++.++|+||+++++++.+++..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44455555555544 6899999998754 23344679999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC-----ccee
Q 002189 714 SLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK-----DHIT 788 (955)
Q Consensus 714 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-----~~~~ 788 (955)
++.......+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+|++|||.+..+..... ....
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 987654456889999999999999999999988 99999999999999999999999998875532211 1112
Q ss_pred eeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh----------hhhh
Q 002189 789 TQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY----------NLYE 856 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 856 (955)
....++..|+|||++.. ..++.++|||||||++|||++|..||..................... ....
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence 23457788999999875 35889999999999999999999999754433222221111000000 0000
Q ss_pred ----ccCCcC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 ----LIDPTI----GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ----~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..++.. ..........++.+++.+||+.||++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 011112233578899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.78 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=193.9
Q ss_pred HHHHHHHhcCCCccCee--eccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEe
Q 002189 620 FEEVKKYTNNFSDANDV--GSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 695 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~l--G~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 695 (955)
..+.....++|...+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556677777776 9999999999985 468899999986532221 122222223 69999999999999
Q ss_pred CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecc
Q 002189 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFG 774 (955)
Q Consensus 696 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFG 774 (955)
.+..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999987654 7899999999999999999999998 99999999999999998 99999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 854 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 854 (955)
+++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||.......-........
T Consensus 156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------- 222 (267)
T PHA03390 156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR------- 222 (267)
T ss_pred cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-------
Confidence 987654321 2358899999999999899999999999999999999999997432211001111100
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-MSEVVKD 898 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 898 (955)
..... .........+.+++.+||+.+|.+||+ ++|++++
T Consensus 223 ---~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 223 ---QQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---hcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00000 011123467889999999999999996 6888753
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.00 Aligned_cols=250 Identities=25% Similarity=0.449 Sum_probs=205.8
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|+||.||++... +++.||+|++..... ...+++.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999865 689999999876433 4456788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
+++++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887542 357899999999999999999999998 9999999999999999999999999998764432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... .+........ . .+.+.
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~---------~-~~~~~ 224 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-LELALKILKG---------Q-YPPIP 224 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-HHHHHHHhcC---------C-CCCCC
Confidence 223345688999999999988999999999999999999999999865432 2211111110 0 11111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+.+++.+||..+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 ----SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1233678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.95 Aligned_cols=247 Identities=30% Similarity=0.460 Sum_probs=203.6
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|...+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 678999999886544 3456789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999988755 36899999999999999999999988 999999999999999999999999999876543321
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.....++..|+|||...+..++.++||||+|+++|||++|+.|+........... ... . ..+..
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~--~--------~~~~~--- 219 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQ--D--------DHPPL--- 219 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-Hhc--c--------CCCCC---
Confidence 2335688999999999888889999999999999999999999875442211111 110 0 01111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
.......+.+++.+||..+|++||++.|++.
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122367889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.59 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=197.6
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC-----CcchhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG-----SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 699 (955)
.+|...+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688889999999999999986 46899999987532 122335788999999999999999999998764 457
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++|+||+++++|.+++...+ .+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999887543 4788889999999999999999988 999999999999999999999999999865
Q ss_pred CCCCC-cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 780 SDSEK-DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 780 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||........ +..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---------~~~ 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFKIAT---------QPT 226 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHHHHc---------CCC
Confidence 32111 1111235688999999999988899999999999999999999999965432221 111110 001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+. .+....+.+.+++.+||+ +|..||++.+++.+
T Consensus 227 ~~~----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 KPM----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCC----CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111 122333678899999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.07 Aligned_cols=267 Identities=24% Similarity=0.339 Sum_probs=199.8
Q ss_pred HHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCC----
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG---- 697 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 697 (955)
...++|+..+.||+|+||+||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678899999999999999999975 689999999875432 22356788999999999999999999987655
Q ss_pred ------eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 698 ------EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 698 ------~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 666666543 336899999999999999999999988 9999999999999999999999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-
Q 002189 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK- 849 (955)
Q Consensus 772 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~- 849 (955)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++||..... .+.+..+.....
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Confidence 9999987643321 11222346788999998865 4578999999999999999999999975443 222222222110
Q ss_pred hhhhhh-hc--------cCCcCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ELYNLY-EL--------IDPTIGL-----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~~~~~~-~~--------~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+ .. .++.... ......+..+.+++.+||+.||.+||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 00 0000000 0001124678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.88 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=197.9
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhc---cCCCcceEEEEEEeCCe-----
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRV---HHKNLVSLLGFCFDRGE----- 698 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 698 (955)
|+..+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999976 4899999998743222 224566788877766 59999999999988776
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.+++|||++ ++|.+++.......+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58888876554446899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhh--h-
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL--Y- 855 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~- 855 (955)
...... .....++..|+|||++.+..++.++|||||||++|||++|.+||.... ..+....+.+........ .
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhcCC
Confidence 643322 122357889999999999999999999999999999999988886433 333333333221100000 0
Q ss_pred ------hccCCcCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ------ELIDPTIG---LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........ ..........+.+++.+||+.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 00111234667899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=313.18 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=196.6
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCC-----eE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~ 699 (955)
.++|...+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46789999999999999999985 468999999986432 223456888999999999999999999876543 57
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++|+||++ ++|.+.+... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 4777776543 5899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCc-ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh--hhhhhh
Q 002189 780 SDSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--ELYNLY 855 (955)
Q Consensus 780 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~ 855 (955)
...... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ........... ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHH
Confidence 432211 11123468899999998765 56899999999999999999999999644321 11111111000 000000
Q ss_pred -----------hccC--CcCCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 -----------ELID--PTIGL-STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 -----------~~~d--~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.... +.... ........++.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00000 0001123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=313.13 Aligned_cols=265 Identities=24% Similarity=0.369 Sum_probs=199.0
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC--CcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeC--CeE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR--GEQ 699 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 699 (955)
..++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999865 6889999988542 223345677899999999 999999999998654 367
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||++ ++|..++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 5888887653 6889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCc---ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----
Q 002189 780 SDSEKD---HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE----- 850 (955)
Q Consensus 780 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~----- 850 (955)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||...... +...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHH
Confidence 543221 12234568999999998764 46788999999999999999999998643322 111111111000
Q ss_pred --------hhhhhhccC-CcC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 --------LYNLYELID-PTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 --------~~~~~~~~d-~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+.+.+. ... ..........++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000 000 000011134678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=303.88 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=199.2
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEEEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIYE 704 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 704 (955)
|...+.||+|+||.||+|+.. +|+.+|+|++.... ....+.+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999865 58899999998653 22345688999999999999999999999988 88999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|++ ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 48888776542 46899999999999999999999988 99999999999999999999999999987654331
Q ss_pred cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----hhhh----
Q 002189 785 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNL---- 854 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~---- 854 (955)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ............. ....
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccch
Confidence 12233457888999998764 4578999999999999999999999965442 2222222211100 0000
Q ss_pred -hhccCCcCC------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 855 -YELIDPTIG------LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 855 -~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+... ......+...+.+++.+||..+|.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 00001124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=300.47 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=194.8
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
||+|+||.||+|+.. +|+.+|+|++..... ...+.+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875433 3346788999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC------c
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK------D 785 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~------~ 785 (955)
.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99887644 6899999999999999999999988 99999999999999999999999999876543211 1
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.......++..|+|||.......+.++||||||+++||+++|..||..... ........... ... .
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~---------~~~----~ 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGK---------IEW----P 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCC---------cCC----C
Confidence 122345688899999999988899999999999999999999999965432 11111111100 010 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
........+.+++.+||+.+|++||++.++.+
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred ccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 01112467889999999999999999944443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.63 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=197.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC---C--CcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEe-CCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP---N--GQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 699 (955)
..|.....||+|+||.||||.-. + ...+|+|+++..... -.....+|+..++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45788899999999999999632 2 237899999865322 22457789999999999999999998877 7789
Q ss_pred EEEEEecCCCCcccccCCCC---CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC----CceEEee
Q 002189 700 MLIYEFVPNGSLGDSLSGKN---GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER----LNAKVAD 772 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~D 772 (955)
+|++||.+. +|...++.+. ...++......|+.||+.|+.|||+.. |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 7777665432 346888899999999999999999999 9999999999999877 8999999
Q ss_pred cccccccCCCCCcc-eeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCc--------hHHHHHH
Q 002189 773 FGLSKSMSDSEKDH-ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGK--------YIVREIR 842 (955)
Q Consensus 773 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~--------~~~~~~~ 842 (955)
||++|.+.+.-... ....++.|++|+|||.+.+. .||.+.||||.|||+.||+|-++-|...+ ...+++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999887654322 33457889999999999965 69999999999999999999776654221 1123333
Q ss_pred HHHhhhh-----hhhhhhhc---------cCCcCCCCCCH-HH-------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 843 TVMDKKK-----ELYNLYEL---------IDPTIGLSTTL-KG-------FEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 843 ~~~~~~~-----~~~~~~~~---------~d~~l~~~~~~-~~-------~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+++-.. ++..+... +..+....... .. ....++|+.+++..||.+|.|+++.+++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 3332100 00000000 00000000000 00 1236899999999999999999999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.80 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=200.9
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
|...+.||+|++|.||+|... +++.+|+|+++..... ....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999864 6899999998754332 3467888999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++ ++.+++.... ..+++..+..++.++++||+|||+.+ ++|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 64 8888776543 47899999999999999999999988 9999999999999999999999999998765433 1
Q ss_pred eeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-hhhhhccC-----
Q 002189 787 ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-YNLYELID----- 859 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d----- 859 (955)
......++..|+|||.+.+. .++.++||||||+++|||+||+.||...... +............ ......+.
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhhh
Confidence 12234578899999999876 7899999999999999999999998654432 2222222110000 00000000
Q ss_pred -----CcCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 -----PTIG----LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 -----~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+... .........++.+++.+||+.||.+||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00111234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=285.53 Aligned_cols=249 Identities=25% Similarity=0.293 Sum_probs=202.1
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHH---HHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~---~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|..+++||+|.||.|-.++- ..|+.+|+|++++...-..++. ..|-++|+..+||.+..+...+...+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 45678889999999999999984 4789999999998765544443 4588999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+.+|.|.-+|.... .+++.+...+-..|+.||.|||+.+ ||.||+|.+|.++|.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence 99999999999887654 5777788888899999999999988 9999999999999999999999999998532
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.....+..++||+.|+|||++....|..++|.|.+||++|||++|+.||...+...-.-...+. ++
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e---------d~----- 385 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME---------DL----- 385 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh---------hc-----
Confidence 2234556789999999999999999999999999999999999999999754332111011111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
.++.....+...|+...+.+||.+|. .++||.++
T Consensus 386 --kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 386 --KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred --cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11112225667889999999999995 46777654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=289.38 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=197.7
Q ss_pred cCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 633 ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
+..||.|+||+|+|-.++ .|+..|||+++.... .+.+++..|.+...+- +.||||+++|++..++..|+.||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 456999999999999864 699999999987554 4567888888766555 6999999999999999999999999 45
Q ss_pred Cccccc---CCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 710 SLGDSL---SGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 710 sL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
||..+. +......+++.-.-.|..-.++||.||.+.. .|||||+||+|||+|..|.+|+||||.+..+.+. .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---i 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---I 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---H
Confidence 665432 2223446777777788888899999998643 3999999999999999999999999998776432 2
Q ss_pred eeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
..+.-.|-..|||||.+.. ..|+-+|||||+|++|||+.||..|+..-.+..+++..++.... |.+..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp----------p~l~~ 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP----------PILLF 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC----------CeecC
Confidence 2334568889999999973 34899999999999999999999999876666666666554332 22211
Q ss_pred -CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 -STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+....+.+++.-|+.+|-.+||++.++.++
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1223455778999999999999999999999874
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=297.38 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=202.3
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+|+..+.||+|+||.||+++.. +++.+|+|++..... ....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999754 688999999875432 2345678899999999999999999999999999999999
Q ss_pred cCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
+++++|.+++... ....+++..++.++.++++||+|||+.+ ++|+||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 1346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ...... ... .. +..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~~~~-~~~--------~~-~~~- 221 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLRYKV-QRG--------KY-PPI- 221 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-hcC--------CC-CCC-
Confidence 122345888999999999989999999999999999999999999654321 111111 100 00 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+++.+|++.+|++||++.|++++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.30 Aligned_cols=261 Identities=24% Similarity=0.374 Sum_probs=195.2
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCC------
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 697 (955)
.++|...+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37888899999999999999985 4689999999875322 22356789999999999999999999987543
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..++|+||+.. +|..++. ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46999999953 6655442 25789999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-h-----
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-E----- 850 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-~----- 850 (955)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+........ .
T Consensus 166 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 653221 23457889999999876 46889999999999999999999999754322 22222221100 0
Q ss_pred -------hhhhhhccCCcCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHH
Q 002189 851 -------LYNLYELIDPTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD--IENI 902 (955)
Q Consensus 851 -------~~~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 902 (955)
........ +...... ......++.+++.+||+.||.+||+++|++.+ ++.+
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSL-PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhc-CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000 0000000 00123567899999999999999999999975 5444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=314.33 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=202.7
Q ss_pred CccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeC------CeEEEE
Q 002189 631 SDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------GEQMLI 702 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV 702 (955)
...+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++++|+|||++++.=.+. ....+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3446799999999999995 579999999998643 34557788999999999999999999875443 357899
Q ss_pred EEecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc--CCC--ceEEeeccccc
Q 002189 703 YEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD--ERL--NAKVADFGLSK 777 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~--~~~--~~kl~DFGla~ 777 (955)
||||.+|||...+...+ ...+++...+.+..+++.||.|||+++ |+||||||.||++- ++| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999998754 456999999999999999999999998 99999999999983 334 36999999999
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhh-hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchH---HHHHHHHHhhhhhhhh
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI---VREIRTVMDKKKELYN 853 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~ 853 (955)
.+.+.. ....++||..|.+||.+. .+.|+..+|.|||||++||.+||..||..-... .+.+......+...
T Consensus 173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~-- 247 (732)
T KOG4250|consen 173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG-- 247 (732)
T ss_pred cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc--
Confidence 987654 466789999999999999 488999999999999999999999999743222 22222222111100
Q ss_pred hhhccCCc----------C--CCCCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHHHHH
Q 002189 854 LYELIDPT----------I--GLSTTLKGFEKYVDLALKCVQESGDDRP--TMSEVVKDIENILQQ 905 (955)
Q Consensus 854 ~~~~~d~~----------l--~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~~ 905 (955)
+.-..+++ + ...-.......+..++..++..+|.+|- ...+....+..|++.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 00000111 0 1112233346677888888889999998 666666666655544
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=300.41 Aligned_cols=254 Identities=26% Similarity=0.312 Sum_probs=196.7
Q ss_pred CCCccCeeeccCceEEEEEEe----CCCcEEEEEEcccCCc----chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
+|...+.||+|+||.||+++. .+++.||||.++.... ...+.+.+|++++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999974 3578899999875321 2235688999999999 599999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||+++|+|.+++.... .+++.....++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999886543 6889999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCC--CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
..... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||........ ........ ..
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~------~~- 226 (288)
T cd05583 156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRI------LK- 226 (288)
T ss_pred ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHH------Hc-
Confidence 43322 1222356899999999987655 78899999999999999999999853221111 01111100 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
..+... ......+.+++.+||+.||++|||++++.+.|+
T Consensus 227 ~~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 227 SKPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred cCCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 011111 112356789999999999999999887765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=303.16 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=194.3
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCC------
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 697 (955)
.++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888999999999999999864 6899999988643222 2245678999999999999999999987654
Q ss_pred --eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 698 --EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 698 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
..++||||+. ++|.+.+.... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 3499999996 57777765432 36899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCc--ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHH--HHHHHHHhhhh-
Q 002189 776 SKSMSDSEKD--HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV--REIRTVMDKKK- 849 (955)
Q Consensus 776 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~--~~~~~~~~~~~- 849 (955)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|..||....... ..+........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 112234578899999998764 47889999999999999999999986543221 11111110000
Q ss_pred hhh------hhhhcc-CCcCCCC------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ELY------NLYELI-DPTIGLS------TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~~~------~~~~~~-d~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... .....+ .+..... ........+.+++.+||..||.+||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 000000 0000000 000112456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.10 Aligned_cols=239 Identities=23% Similarity=0.297 Sum_probs=185.9
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch---hHHHHHHHHHH-HhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG---GQEFKMEIELL-SRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||.||+|... +|+.||||+++...... ...+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 68999999987543221 22344555444 445899999999999999999999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999987543 5788889999999999999999988 99999999999999999999999999875432 1
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....++..|+|||.+.+..++.++||||||+++|||++|..||...... .......... .+ .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~---------~~--~~~~~~~ 218 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRR---------IN--WPEEVKE 218 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcc---------cC--CCCcccc
Confidence 2245888999999998888999999999999999999999999654321 2111111110 00 0001111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMSEV 895 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~ev 895 (955)
.....+.+++.+||+.+|++||++.++
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGY 245 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcH
Confidence 234678899999999999999976443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=303.25 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=194.2
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
|...+.||+|+||+||+|+.. +++.||+|.+.... ....+++.+|+++++.++|+|++++++++...+..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555678999999999999864 67899999886422 22235678899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+. |++.+.+.... ..+++..+..++.+++.|+.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 96 68877665332 35889999999999999999999988 999999999999999999999999998765432
Q ss_pred ceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 786 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
....++..|+|||.+. .+.++.++|||||||++|||++|..|+...... ......... ..+..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~----------~~~~~ 234 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN----------ESPAL 234 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhc----------CCCCc
Confidence 2245888999999985 356888999999999999999999998643221 111111100 01111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
. .......+.+++.+||+.+|++||++++++++-.
T Consensus 235 ~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 Q---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred C---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1 1123366889999999999999999999997633
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=308.94 Aligned_cols=268 Identities=24% Similarity=0.355 Sum_probs=202.1
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEE
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 694 (955)
....++...+++|...+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566777889999999999999999999985 578999999987532 223456788999999999999999999886
Q ss_pred eC------CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 695 DR------GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 695 ~~------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 43 3467888887 78888877543 5899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 847 (955)
||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~ 233 (345)
T cd07877 160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRL 233 (345)
T ss_pred EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence 99999998765322 223468889999999876 56889999999999999999999998643322 111111110
Q ss_pred hh-hhhhhh------------hccCC--cCC-CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 848 KK-ELYNLY------------ELIDP--TIG-LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 848 ~~-~~~~~~------------~~~d~--~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. ....+. ..++. ... .........++.+++.+|++.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 000000 00000 000 00000123567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=316.47 Aligned_cols=309 Identities=20% Similarity=0.225 Sum_probs=142.3
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEc
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 144 (955)
+++.|+|.+|.|+.+-.+++..++.|+.||||.|. |+.+.-.+|..-.++++|+|++|.|+..--..|.++.+|..|.|
T Consensus 126 hl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~-is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL 204 (873)
T KOG4194|consen 126 HLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL-ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL 204 (873)
T ss_pred ceeEEeeeccccccccHHHHHhHhhhhhhhhhhch-hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence 44444444444444444444444444444444443 33333334444444444444444444333344444444444444
Q ss_pred cCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeecc
Q 002189 145 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD 224 (955)
Q Consensus 145 s~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~ 224 (955)
+.|+|+...+..|.+|++|+.|+|..|+|. +...-.++.|.+|+.|.|..|.++ .+.++.|-.+.++++|+|.
T Consensus 205 srNrittLp~r~Fk~L~~L~~LdLnrN~ir------ive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~ 277 (873)
T KOG4194|consen 205 SRNRITTLPQRSFKRLPKLESLDLNRNRIR------IVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLE 277 (873)
T ss_pred ccCcccccCHHHhhhcchhhhhhcccccee------eehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecc
Confidence 444444333334444444444444444443 111122333444444444555554 4444444444455555555
Q ss_pred CCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCC
Q 002189 225 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASE 303 (955)
Q Consensus 225 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~ 303 (955)
.|++...-..++-+++.|+.|+||+|.|....++.+..+++|++|+|++|+|+..++ .|..+..|++|.|++|.++. .
T Consensus 278 ~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~-l 356 (873)
T KOG4194|consen 278 TNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDH-L 356 (873)
T ss_pred cchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHH-H
Confidence 555544444444445555555555555544444444445555555555555554444 34444555555555555433 2
Q ss_pred CChhhcCCCCCCEEECcCCcceecCCc---CCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccccccCCCC
Q 002189 304 VPSWFSSMQSLTTLMMENTNLKGQIPA---DLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGG 379 (955)
Q Consensus 304 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~ 379 (955)
-...|..+++|+.|||++|.|+..+-+ .|..|++|+.|+|.+|+|..+.-..+ ++..|++|||.+|.|..+.+.+|
T Consensus 357 ~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAF 436 (873)
T KOG4194|consen 357 AEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAF 436 (873)
T ss_pred HhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccc
Confidence 233344455555555555555443332 23345555555555555544433332 24444455555555555555555
Q ss_pred CCC
Q 002189 380 APA 382 (955)
Q Consensus 380 ~~~ 382 (955)
.++
T Consensus 437 e~m 439 (873)
T KOG4194|consen 437 EPM 439 (873)
T ss_pred ccc
Confidence 444
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=299.45 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=195.2
Q ss_pred CCCccCeeeccCceEEEEEEe----CCCcEEEEEEcccCCc----chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
+|+..+.||+|+||.||+|+. .+|+.||+|+++.... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999985 3689999999875322 2335688899999999 599999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||+++++|.+++.... .+++.....++.|+++||.|||+.+ ++||||+|+||++++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999987543 5788888899999999999999988 999999999999999999999999999866
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhC--CCCChhhhHHHHHHHHHHHhCCCCCcCCch---HHHHHHHHHhhhhhhhhh
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKY---IVREIRTVMDKKKELYNL 854 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwS~Gv~l~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~ 854 (955)
..... .......|+..|+|||.+... .++.++||||||+++|||++|..||..... ..........
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------- 226 (290)
T cd05613 156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-------- 226 (290)
T ss_pred ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--------
Confidence 43322 112235688999999998753 467899999999999999999999863211 1111111110
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
..+.. .......+.+++.+||+.||++|| ++++++.+
T Consensus 227 ---~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 227 ---SEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---cCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01111 112335778999999999999997 66666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=308.33 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=198.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeC-----Ce
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 698 (955)
.++|...+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688899999999999999985 46899999998753 222345677899999999999999999988654 34
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||+. ++|.+++.... .+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 78888876543 6899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh--------
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-------- 849 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-------- 849 (955)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ............
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhh
Confidence 64332 12233467889999999875 4689999999999999999999999864322 111111110000
Q ss_pred -----hhhhhhh----ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -----ELYNLYE----LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -----~~~~~~~----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....... ..++... ........++.+++.+||+.+|++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 0000000 0011234678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=306.79 Aligned_cols=265 Identities=20% Similarity=0.361 Sum_probs=199.1
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEe----CCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 699 (955)
.++|...+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999854 689999999875422 234567889999999999999999998753 3467
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||+. |+|.+++.... .+++.....++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 68988886543 5899999999999999999999988 999999999999999999999999999765
Q ss_pred CCCCCc--ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-------
Q 002189 780 SDSEKD--HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK------- 849 (955)
Q Consensus 780 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~------- 849 (955)
...... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHhh
Confidence 432211 11123468899999999865 46889999999999999999999999654322 11111111000
Q ss_pred ------hhhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ------ELYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ------~~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+......... .......++.+++.+||+.+|++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000001111000000 011234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=301.30 Aligned_cols=244 Identities=27% Similarity=0.456 Sum_probs=193.5
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
|...+.||+|+||+||+|+. .+|+.||+|++..... ...+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999986 4688999999864322 2235688899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+. |++.+++... ...+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 5777766543 236899999999999999999999988 99999999999999999999999999864322
Q ss_pred ceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 786 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.....|+..|+|||++. .+.++.++|||||||++|||++|..|+........ ....... ..+..
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~----------~~~~~ 240 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN----------DSPTL 240 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhc----------CCCCC
Confidence 12346889999999984 45688999999999999999999999865433221 1111110 01111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .......+.+++.+||+.+|.+||++.+++.+
T Consensus 241 ~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 Q---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11122568899999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=296.49 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=187.1
Q ss_pred eeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---hhHHHHHHHH---HHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 635 DVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIE---LLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
.||+|+||.||+|+. .+++.||+|.+...... ....+..|.. .++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 46899999988653222 1222344433 4444579999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.+++...+ .+++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 999998886543 6899999999999999999999988 99999999999999999999999999876543221
Q ss_pred eeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHH-HHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV-REIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
....|+..|+|||++.++ .++.++||||+||++|||++|+.||....... ....... ...++....
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~- 220 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTMAVELPD- 220 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh----------hccCCCCCC-
Confidence 234689999999999754 68999999999999999999999997542211 1111000 011112111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
....++.+++.+|+..+|.+|| ++.|++++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1236788999999999999999 89898753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.37 Aligned_cols=261 Identities=22% Similarity=0.343 Sum_probs=197.7
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEEec
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
|...+.||+|+||+||+|+.. +++.||||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999975 578999999875432 22334567999999999 999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
+|+|.+++.......+++..+..++.|++++|.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889998887655457899999999999999999999988 99999999999999999999999999986643222
Q ss_pred eeeeeecCCCCCCHHHhh-hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh--------hhhhhhc
Q 002189 787 ITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE--------LYNLYEL 857 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 857 (955)
.....++..|+|||++. ...++.++|+||||+++|||++|+.||..... .+.+......... .......
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE-IDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh-HHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 12345788999999875 45678999999999999999999998854322 1222111110000 0000000
Q ss_pred cCCcCC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIG-------LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
++.... ..........+.+++.+||+.+|++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 00001113678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=306.57 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=198.0
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCC---
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG--- 697 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--- 697 (955)
....++|...+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999985 4789999999864322 22356889999999999999999999987653
Q ss_pred ---eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecc
Q 002189 698 ---EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 774 (955)
Q Consensus 698 ---~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 774 (955)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|++|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 77888877642 5899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-hh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LY 852 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~ 852 (955)
+++...... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ............ ..
T Consensus 164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCH
Confidence 998654321 23457889999999876 46889999999999999999999999754332 222221110000 00
Q ss_pred hhhhccC-----------CcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLYELID-----------PTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~~~~d-----------~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+.+.+. +.... ........++.+++.+|++.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000 0011223568899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=298.33 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=202.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999864 78999999987532 223467889999999998 99999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999987654 6999999999999999999999988 999999999999999999999999998866433
Q ss_pred CCc------------------ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHH
Q 002189 783 EKD------------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 844 (955)
Q Consensus 783 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~ 844 (955)
... .......++..|+|||......++.++||||||++++|+++|+.||...... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHH
Confidence 211 1222346788999999999888999999999999999999999999755421 111111
Q ss_pred HhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 002189 845 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM----SEVVK 897 (955)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 897 (955)
... . ..........+.+++.+||+.+|++||++ +|+++
T Consensus 235 ~~~-----------~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 LKL-----------E----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred Hhc-----------C----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 110 0 01111224678899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=322.80 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=210.1
Q ss_pred HHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEe
Q 002189 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 695 (955)
..+++--.++|.++++||+|+||.|..++.+ +++.||+|++.+.. ..+..-|..|-++|..-..+-||+++.+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4455556789999999999999999999964 68899999998732 2344668999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 696 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
+...|+|||||+||+|-..+.+.. ++++.....++..|+-||.-||+.| +|||||||+|||||..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998766 5777777788999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhh----h-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYM----T-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
+-.+...+. -.....+|||.|++||++. + +.|...+|.||+||++|||+.|..||.. +.+++....++....
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~- 298 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKE- 298 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhh-
Confidence 987764443 3345578999999999997 2 5789999999999999999999999953 344454444444322
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT---MSEVVKD 898 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 898 (955)
.+......+..++..+||.+.+. +|+.|.. ++++-.+
T Consensus 299 ----------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 299 ----------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ----------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 11111122345677888887665 5677766 8888765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=259.01 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=205.0
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.|...++||+|.||+||||+. ..++.||+|+++..+.. -.....+|+-+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 355667899999999999985 56899999998754322 235678999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
|. -+|..+...-+ ..++......++.|+.+||.++|++. +.|||+||.|.+|+.+|+.|++|||+++-++-+-
T Consensus 83 cd-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred hh-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 94 47777665433 36888899999999999999999998 9999999999999999999999999999876433
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----hhhhhhhccC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----ELYNLYELID 859 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~d 859 (955)
.-.+..+.|.+|.+|.++.+. -|+...|+||-||++.|+....+|...+.+..+++..++.... .+..+....|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 223456789999999999875 5889999999999999999988898889888888887765322 1111112111
Q ss_pred ----CcCCCCCC-HHHH----HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 ----PTIGLSTT-LKGF----EKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ----~~l~~~~~-~~~~----~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
|....... .... ..=.+++++.+.-+|.+|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111100 1111 223688889999999999999887753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=301.39 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=195.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch--hHHHHHHHHHHHhccCCCcceEEEEEEeCC------
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 697 (955)
.++|...++||+|+||.||+|+.. +++.||||++......+ ...+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467899999999999999999864 68999999886533222 246788999999999999999999876543
Q ss_pred --eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 698 --EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 698 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
..++|+||++. ++...+... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999964 666665543 346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc---------ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHH
Q 002189 776 SKSMSDSEKD---------HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 845 (955)
Q Consensus 776 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 845 (955)
++........ ...+...++..|+|||.+.+. .++.++|||||||++|||++|++||..... ......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence 9865432211 111234678899999998754 578999999999999999999999864333 22222222
Q ss_pred hhhhhh--------hhhhhcc----CCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 846 DKKKEL--------YNLYELI----DPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 846 ~~~~~~--------~~~~~~~----d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...... ..+.... .+.... .........+.+++.+|++.||.+|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111000 0000000 000000 0001122568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=305.55 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=202.1
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCC-----eEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-----EQM 700 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 700 (955)
+|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 58999999987643 334467899999999999999999999998775 789
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||++ ++|.+++.... .+++..+..++.+++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58888886543 7899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCc-ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-------
Q 002189 781 DSEKD-HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL------- 851 (955)
Q Consensus 781 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~------- 851 (955)
..... .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||..... .+....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhh
Confidence 43210 112334678899999999877 889999999999999999999999864432 22222222211000
Q ss_pred ------hhhhhccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 ------YNLYELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 ------~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
............. .........+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000000 0001124678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=303.91 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=195.7
Q ss_pred cCCCc-cCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch--------------hHHHHHHHHHHHhccCCCcceEEE
Q 002189 628 NNFSD-ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG--------------GQEFKMEIELLSRVHHKNLVSLLG 691 (955)
Q Consensus 628 ~~f~~-~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~ 691 (955)
++|.. .+.||+|+||+||+|+.. +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 467999999999999854 68999999886532221 125778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 692 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
++..++..++||||++ |+|.+++.... .+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.+|++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 68988886533 5888999999999999999999988 9999999999999999999999
Q ss_pred ecccccccCCCCC------------cceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHH
Q 002189 772 DFGLSKSMSDSEK------------DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838 (955)
Q Consensus 772 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~ 838 (955)
|||+++....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9999976641110 0111223468889999998764 4689999999999999999999998654432
Q ss_pred HHHHHHHhhhhhh--hhhhhc--------cCCcCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 839 REIRTVMDKKKEL--YNLYEL--------IDPTIG---LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 839 ~~~~~~~~~~~~~--~~~~~~--------~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+....+....... ..+.+. ..+... .........++.+++.+||+.+|++||+++|++.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 2222222111000 000000 000000 00001123668899999999999999999999974
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=294.70 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=199.6
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999865 58999999988653 223356788999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
+ ++|.+++.... ..+++..+..++.++++||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 58999887642 36899999999999999999999988 99999999999999999999999999987643322
Q ss_pred eeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----h-hhhhhhc---
Q 002189 787 ITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----E-LYNLYEL--- 857 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----~-~~~~~~~--- 857 (955)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||..... .+....+..... . .......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-IDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12234467889999999876 889999999999999999999989865432 222222211100 0 0000000
Q ss_pred --cCCcCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 --IDPTIGLS----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 --~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.-+..... ........+.+++.+||+.||++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 001124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=280.08 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=206.3
Q ss_pred CHHHHHHHhcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeC
Q 002189 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDR 696 (955)
Q Consensus 619 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 696 (955)
.|+|+.+.|+ +.||+|+|+.|--++ +.+|..+|||++.+.....+.++.+|++++.+.+ |+||+++++|++++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4788888877 679999999999887 6789999999998877777888999999999996 99999999999999
Q ss_pred CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC---ceEEeec
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL---NAKVADF 773 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DF 773 (955)
+..|||||-|.+|+|..+|+.+. .+++....++..+||.||.+||..| |.|||+||+|||-.... -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999998665 6889999999999999999999999 99999999999986554 4899999
Q ss_pred ccccccCCCC-----CcceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcC----------
Q 002189 774 GLSKSMSDSE-----KDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIER---------- 833 (955)
Q Consensus 774 Gla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~---------- 833 (955)
.++.-..... .+..-...+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8875432111 111123467888999999875 23578899999999999999999999852
Q ss_pred CchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 834 GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
|+.-..-....++..++. .++..| ........+..+++...+..|+.+|.++.+++.+
T Consensus 304 Ge~Cr~CQ~~LFesIQEG--kYeFPd-----kdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEG--KYEFPD-----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCccHHHHHHHHHHHhcc--CCcCCh-----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 222222222222222210 112111 1122334567789999999999999999999873
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=292.83 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=195.2
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC-----CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG-----SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
+|...+.||+|+||+||+++.. .+..+++|.++.. ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677889999999999999864 3445566655432 122334577899999999999999999999999999999
Q ss_pred EEecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 703 YEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
|||+++++|.+++.. .....+++..++.++.|+++|+.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988753 22347899999999999999999999988 999999999999986 469999999987764
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+..... ......... ...+
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~~~~~~~~~----------~~~~ 223 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-LSVVLRIVE----------GPTP 223 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHc----------CCCC
Confidence 332 122335688899999999888899999999999999999999999864332 222221111 1111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. ......++.+++.+||..+|++||++.|++++
T Consensus 224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 12334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=305.52 Aligned_cols=263 Identities=19% Similarity=0.296 Sum_probs=195.2
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeC----------
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR---------- 696 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------- 696 (955)
.+|...+.||+|+||+||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788899999999999999986 46899999998765555567788999999999999999999876553
Q ss_pred ----CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-CCCceEEe
Q 002189 697 ----GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVA 771 (955)
Q Consensus 697 ----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~ 771 (955)
...++||||++ ++|.+++... .+++.....++.|++.||+|||+.+ ++||||||+||+++ +++.+|++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 5888777532 5889999999999999999999998 99999999999997 45678999
Q ss_pred ecccccccCCCCCc-ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh
Q 002189 772 DFGLSKSMSDSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 772 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 99999765432111 11122357889999998764 5678899999999999999999999975443222 111111100
Q ss_pred -----hhhhh----hhccC--CcCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -----ELYNL----YELID--PTIGLS----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -----~~~~~----~~~~d--~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.... ..... ...... .......++.+++.+||+.||.+||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 00000 000000 001123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=298.46 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=203.8
Q ss_pred cCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 633 ANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
.++||+|.||+||-|+. ++|+.||||++.+.. ...+..+++|+.+|++++||.||.+...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999986 479999999987643 334467899999999999999999999999999999999999 66
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC---CceEEeecccccccCCCCCcc
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~~~~~~~~~~ 786 (955)
+..+++-..+..++++.....++.||+.||.|||..+ |+|+||||+|||+... -++||||||+||..++..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 7767665555568888888889999999999999998 9999999999999654 469999999999987543
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
....++||+.|+|||++....|...-|+||.||++|--++|..||..++++.++++... .+-|. ..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-----------FMyPp---~P 787 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-----------FMYPP---NP 787 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-----------cccCC---Cc
Confidence 34457899999999999999999999999999999999999999999888877654321 11111 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
..+.....+++|...++..-.+|-+....+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2334467789999999999999998876553
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=304.03 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=204.5
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
...|.+...||+|.|++|..|+. ..|..||+|.+.+.... ....+.+|+++|..+.|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45678889999999999999985 46899999999865332 2345889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+.+|.+.+++..+++ ........+..|+.++++|||+.+ |+|||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc-
Confidence 99999999999987763 444777788999999999999998 999999999999999999999999999887633
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCC-ChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
......+|++-|.|||++.+..|. +++|+||+|+++|-|+.|..||++.. +...-..++.. .+
T Consensus 209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-lk~Lr~rvl~g-------------k~ 272 (596)
T KOG0586|consen 209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-LKELRPRVLRG-------------KY 272 (596)
T ss_pred --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-cccccchheee-------------ee
Confidence 334567899999999999988764 78999999999999999999997432 22111111111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
+..+ -...++.+++.+++..+|.+|++++++.++-+
T Consensus 273 rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 273 RIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred cccc--eeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 1111 11245678999999999999999999997644
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=301.60 Aligned_cols=265 Identities=24% Similarity=0.338 Sum_probs=198.1
Q ss_pred HHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEe-CC
Q 002189 622 EVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RG 697 (955)
Q Consensus 622 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 697 (955)
++...+++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456788999999999999999999854 78999999876422 2234678899999999999999999999876 55
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..++|+||+ +++|.++++.. ++++.....++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999998 56888877643 4788888899999999999999988 9999999999999999999999999987
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHH--HHHHHHhhh-h----
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR--EIRTVMDKK-K---- 849 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~--~~~~~~~~~-~---- 849 (955)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+....... .
T Consensus 157 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 543221 22457889999998765 5689999999999999999999999864432111 111110000 0
Q ss_pred -----hhhhhhhccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -----ELYNLYELIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -----~~~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+.......... .........+.+++.+|++.+|++||++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 0001123678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=299.57 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=193.0
Q ss_pred CCCccCeeeccCceEEEEEEeC-C--CcEEEEEEcccCC--cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeC----Ce
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-N--GQLIAIKRAQQGS--MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR----GE 698 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 698 (955)
+|...+.||+|+||.||+|+.. . +..||+|++.... ....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999864 3 7899999987432 12245678899999999 599999999976432 45
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++++||++ ++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999885 68888886543 6899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCc--ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh------
Q 002189 779 MSDSEKD--HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK------ 849 (955)
Q Consensus 779 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~------ 849 (955)
....... .......|+..|+|||++.+ ..++.++||||+||++|||++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 6432211 11223568999999998875 46899999999999999999999998654321 11111111000
Q ss_pred -------hhhhhhhccC--CcCCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -------ELYNLYELID--PTIGL-STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -------~~~~~~~~~d--~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......... +.... .........+.+++.+|++.||.+||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00000 0001123578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=322.44 Aligned_cols=145 Identities=29% Similarity=0.399 Sum_probs=130.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|.+.++||+|+||+||+|+.. +++.||||+++..... ....+.+|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999865 6899999998754322 2356888999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
||+++++|.++++..+ .+++...+.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987543 5788889999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=307.95 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=210.3
Q ss_pred HhcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEe-----CCe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD-----RGE 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~~~ 698 (955)
.++.|.+.++||.|.+|.||+++ .++|+.+|||+...... ..++++.|.++++.. .|||++.++|++.. ++.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 35667888999999999999998 45789999998775433 346788899999988 59999999999875 468
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
+|||||||.+||..|++++-.+..+.|..+.-|+..+++|+.+||... ++|||||-.|||++.++.+|+.|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 999999999999999998777788999999999999999999999888 99999999999999999999999999988
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhh-----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhh
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN 853 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 853 (955)
+.... .......||+.|||||++.. ..|+.++|+||+|++..||--|.+|+.+.... +.++.
T Consensus 173 ldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-----------raLF~ 239 (953)
T KOG0587|consen 173 LDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-----------RALFL 239 (953)
T ss_pred eeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----------hhhcc
Confidence 75432 23445789999999999963 34778999999999999999999998653221 11111
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.. .|......+.+...++.++|..|+.+|..+||++.+++++
T Consensus 240 IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 IPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 222 2333334566778899999999999999999999999853
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=303.65 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=198.0
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCe----
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE---- 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 698 (955)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999875 67899999986532 2233567789999999999999999998876654
Q ss_pred --EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 699 --QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 699 --~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 67898888643 5899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-hhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNL 854 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~ 854 (955)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..+...... ...+
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHH
Confidence 865432 123457889999999875 3678999999999999999999999965433 2222222211000 0000
Q ss_pred ------------hhccCCcCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 855 ------------YELIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 855 ------------~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+........ ......++.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000 00124678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=284.88 Aligned_cols=236 Identities=29% Similarity=0.367 Sum_probs=193.1
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 636 VGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
||+|+||.||++... +++.+|+|.++..... ..+.+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 5899999998764332 345788999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeee
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 791 (955)
.+++.... .+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99987553 5899999999999999999999988 9999999999999999999999999997764332 122345
Q ss_pred ecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 792 ~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
.++..|+|||...+...+.++|+||||+++|||++|..||..... .......... ... .+....
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~-----------~~~----~~~~~~ 217 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILKD-----------PLR----FPEFLS 217 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhcC-----------CCC----CCCCCC
Confidence 688899999999988899999999999999999999999965432 1111111110 001 111124
Q ss_pred HHHHHHHHHhhccCCCCCCCHHH
Q 002189 872 EKYVDLALKCVQESGDDRPTMSE 894 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs~~e 894 (955)
..+.+++.+||..||++||++++
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 67889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=276.32 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=200.4
Q ss_pred HhcCCCcc-CeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEe----CCe
Q 002189 626 YTNNFSDA-NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD----RGE 698 (955)
Q Consensus 626 ~~~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~ 698 (955)
.+++|++. ++||-|-.|.|-.+.. .+|+.+|+|++.+. ...++|++..-.. .|||||+++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566554 5799999999988875 47899999998753 3356677765555 59999999998864 457
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEeeccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFGL 775 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGl 775 (955)
+++|||.|+||.|...++.++...+++.+.-.|+.||+.|+.|||+.. |.||||||+|+|... |..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 789999999999999999998889999999999999999999999998 999999999999964 56799999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCC--chHHHHHHHHHhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG--KYIVREIRTVMDKKKELYN 853 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~--~~~~~~~~~~~~~~~~~~~ 853 (955)
|+.-.. .......+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||... ..+...++..+..+.
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq---- 283 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ---- 283 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC----
Confidence 987542 22334567899999999999999999999999999999999999999732 222222222222111
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
++..+ .......+...++|+.++..+|.+|.|+.|++.+
T Consensus 284 -y~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 -YEFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -ccCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111 2233455778899999999999999999999975
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=298.88 Aligned_cols=316 Identities=18% Similarity=0.204 Sum_probs=216.3
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEc
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 144 (955)
.+..|||++|.|..+-+..|.++++|++++|.+|. ...+|...+...+|+.|+|.+|.|+..-.+.+..++.|+.|||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~--Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNE--LTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccch--hhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 45568888888888777778888888888888775 4455655444455665555555555444444555555555555
Q ss_pred cCCCCc------------------------CcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccC
Q 002189 145 NSNGFS------------------------GRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200 (955)
Q Consensus 145 s~N~l~------------------------~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~ 200 (955)
|.|.|+ ..-...|.+|.+|..|.|++|+++ .+|. ..++.|++|+.|+|..
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~-----r~Fk~L~~L~~LdLnr 230 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQ-----RSFKRLPKLESLDLNR 230 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCH-----HHhhhcchhhhhhccc
Confidence 555555 444444444444444444444444 3331 1233344555555555
Q ss_pred CcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccC
Q 002189 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM 280 (955)
Q Consensus 201 N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 280 (955)
|+|. .+.--.|.++.+|+.|.|..|++...-...|..+.++++|+|+.|+++..--.++.++++|+.|+||+|.|..+.
T Consensus 231 N~ir-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih 309 (873)
T KOG4194|consen 231 NRIR-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIH 309 (873)
T ss_pred ccee-eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheee
Confidence 5554 333344555556666666666666555566777777777777777777666677778888888888888887766
Q ss_pred C-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCC----
Q 002189 281 P-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG---- 355 (955)
Q Consensus 281 ~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~---- 355 (955)
+ .+.-.++|+.|+||+|+|+. ..+..|..+..|++|+|++|.|...--..|..|.+|++|||++|.|+..+...
T Consensus 310 ~d~WsftqkL~~LdLs~N~i~~-l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f 388 (873)
T KOG4194|consen 310 IDSWSFTQKLKELDLSSNRITR-LDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAF 388 (873)
T ss_pred cchhhhcccceeEecccccccc-CChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhh
Confidence 5 46667788888888888875 66777888888888888888888666677888999999999999999877654
Q ss_pred cchhhhhhhcccCCccccccCCCCCCCcceeEecC
Q 002189 356 TSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 390 (955)
Q Consensus 356 ~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n 390 (955)
.++..|+.|+|.||+|..++.++|.++.+|..+|.
T Consensus 389 ~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL 423 (873)
T KOG4194|consen 389 NGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDL 423 (873)
T ss_pred ccchhhhheeecCceeeecchhhhccCcccceecC
Confidence 23777889999999999999999988877777754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=286.54 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=201.1
Q ss_pred hcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCC-cchh------HHHHHHHHHHHhccCCCcceEEEEEEe-CC
Q 002189 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGS-MQGG------QEFKMEIELLSRVHHKNLVSLLGFCFD-RG 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~~------~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 697 (955)
.++|-.++.||+|||++||||. +...+.||||+-..+. ..++ +...+|.++.+.+.||.||++|+|+.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3456667889999999999997 4567889999865321 1111 335689999999999999999999865 56
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEeecc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFG 774 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFG 774 (955)
..+-|+|||++.+|.-+|+.+. .+++.....|+.||+.||.||.+.. +||||-||||.|||+-+ -|.+||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7889999999999999998765 6889999999999999999999864 88999999999999954 4789999999
Q ss_pred cccccCCCCCcc-----eeeeeecCCCCCCHHHhhhC----CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHH
Q 002189 775 LSKSMSDSEKDH-----ITTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 845 (955)
Q Consensus 775 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 845 (955)
+++.+.+..... .+....||++|++||.+.-+ +.+.|+||||.|||+|..+.|+.||.......+.+..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe-- 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE-- 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh--
Confidence 999997655432 24457899999999998643 5788999999999999999999999765544433322
Q ss_pred hhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 846 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+ ...++ ..........+..++|.+|++..-++|....++..+
T Consensus 697 --NTIl-kAtEV-----qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 697 --NTIL-KATEV-----QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred --hchh-cceec-----cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1100 01111 111122233567899999999999999988887653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=300.33 Aligned_cols=265 Identities=22% Similarity=0.332 Sum_probs=183.5
Q ss_pred hcCCCccCeeeccCceEEEEEEe-----------------CCCcEEEEEEcccCCcchhHH--------------HHHHH
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-----------------PNGQLIAIKRAQQGSMQGGQE--------------FKMEI 675 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E~ 675 (955)
.++|...++||+|+||+||+|.+ .+++.||||+++.......++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 235689999987543322223 33477
Q ss_pred HHHHhccCCCc-----ceEEEEEEe--------CCeEEEEEEecCCCCcccccCCCC----------------------C
Q 002189 676 ELLSRVHHKNL-----VSLLGFCFD--------RGEQMLIYEFVPNGSLGDSLSGKN----------------------G 720 (955)
Q Consensus 676 ~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------~ 720 (955)
.++.+++|.++ ++++++|.. ++..+|||||+++|+|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77778876654 678888754 356899999999999999886421 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCH
Q 002189 721 IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800 (955)
Q Consensus 721 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 800 (955)
..++|..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..... .......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 23567788899999999999999988 99999999999999999999999999976543221 111223457899999
Q ss_pred HHhhhCCC----------------------CChhhhHHHHHHHHHHHhCCC-CCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 801 EYYMTQQL----------------------TEKSDVYSFGVLMLELLTGRR-PIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 801 E~~~~~~~----------------------~~ksDvwS~Gv~l~elltg~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
|.+..... ..+.||||+||+++||++|.. |+.............-.... .+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~---~~r~~ 456 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN---RWRMY 456 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH---HHHhh
Confidence 99864321 235799999999999999875 66432222111111000000 00000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESG---DDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 898 (955)
..................+++.+++..+| .+|+|++|++++
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00111111112233677899999999876 689999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=280.51 Aligned_cols=221 Identities=23% Similarity=0.194 Sum_probs=176.7
Q ss_pred cCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcccccCC
Q 002189 639 GGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG 717 (955)
Q Consensus 639 G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 717 (955)
|.||.||+++. .+++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999986 478999999987642 234455555566799999999999999999999999999999998865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCC
Q 002189 718 KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797 (955)
Q Consensus 718 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 797 (955)
.. .+++.....++.|+++||+|||+.+ ++||||||+||++++++.++++|||.+....... ....++..|
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 43 5899999999999999999999988 9999999999999999999999999886654321 123467789
Q ss_pred CCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHH
Q 002189 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDL 877 (955)
Q Consensus 798 ~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 877 (955)
+|||.+....++.++||||+|+++|||++|..|+....... . ......+ +......+.++
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~---------~~~~~~~----~~~~~~~~~~l 208 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------N---------THTTLNI----PEWVSEEARSL 208 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------c---------cccccCC----cccCCHHHHHH
Confidence 99999988889999999999999999999998864321100 0 0000001 11123678899
Q ss_pred HHHhhccCCCCCCCHHH
Q 002189 878 ALKCVQESGDDRPTMSE 894 (955)
Q Consensus 878 i~~cl~~dP~~RPs~~e 894 (955)
+.+|++.||++||++.+
T Consensus 209 i~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 209 LQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHccCCHHHhcCCCc
Confidence 99999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=272.01 Aligned_cols=238 Identities=31% Similarity=0.452 Sum_probs=195.0
Q ss_pred CceEEEEEEeC-CCcEEEEEEcccCCcch-hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcccccCC
Q 002189 640 GYGKVYKGTLP-NGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSG 717 (955)
Q Consensus 640 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 717 (955)
+||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999998655444 67899999999999999999999999999999999999999999998875
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCC
Q 002189 718 KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797 (955)
Q Consensus 718 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 797 (955)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++++|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 44 3889999999999999999999988 9999999999999999999999999998765432 22345688899
Q ss_pred CCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHH
Q 002189 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDL 877 (955)
Q Consensus 798 ~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 877 (955)
++||.+....++.++||||||+++|||++|..||.................. ... ........++.++
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~---------~~~---~~~~~~~~~~~~~ 220 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP---------PFP---PPEWKISPEAKDL 220 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC---------CCc---cccccCCHHHHHH
Confidence 9999999888999999999999999999999999653333222221111100 000 0000033678899
Q ss_pred HHHhhccCCCCCCCHHHHHH
Q 002189 878 ALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 878 i~~cl~~dP~~RPs~~evl~ 897 (955)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=268.22 Aligned_cols=263 Identities=23% Similarity=0.397 Sum_probs=192.3
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeC--------Ce
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--------GE 698 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~ 698 (955)
|....+||+|.||+||+|+.. +|+.||+|++-.+.. .-.....+|+++|..++|+|++.+++.|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 344567999999999999864 578899987543222 2234567899999999999999999888542 35
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.||||++|+. +|.-.|... ..+++...+.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+++.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 7999999976 676666543 357888899999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCC--cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHh---hh----
Q 002189 779 MSDSEK--DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD---KK---- 848 (955)
Q Consensus 779 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~---~~---- 848 (955)
+...+. ....+..+.|..|++||.+.+ +.|+++.|||.-||++.||+||.+-+ .+.+....+.-+.. ..
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim-qgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM-QGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc-cCChHHHHHHHHHHHhccCCccc
Confidence 653322 222445677999999999986 57899999999999999999988555 44443333322111 10
Q ss_pred h---hhhhhhhccCCc-CCCCCCH---HHH------HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 849 K---ELYNLYELIDPT-IGLSTTL---KGF------EKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 849 ~---~~~~~~~~~d~~-l~~~~~~---~~~------~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+ +...+++.+.-+ ++..... ... ....+++.+++..||++|+++++++.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 001122222101 1111111 111 357899999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=293.61 Aligned_cols=240 Identities=25% Similarity=0.301 Sum_probs=193.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++.|.....+|.|+|+.|-++.. .+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45566667799999999988874 468899999997652 2345577676666 69999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE-cCCCceEEeecccccccCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL-DERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DFGla~~~~~~~ 783 (955)
++.++-+.+.+.... .....+..|+.+++.++.|||++| +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999998877776543 222677789999999999999999 9999999999999 68999999999999877543
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
....+-|..|.|||++....|++++|+||||++||||++|+.||.......+... .+.. +.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-~i~~------------~~-- 530 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-RIQM------------PK-- 530 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-hhcC------------Cc--
Confidence 2234568899999999999999999999999999999999999985544322111 1111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.........+|+.+||+.||.+||+|.++..+
T Consensus 531 --~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 --FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 112334677899999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=276.94 Aligned_cols=241 Identities=24% Similarity=0.318 Sum_probs=194.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHH---HHHHHHHHHhc-cCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQE---FKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 701 (955)
..+|..+.+||+|+||.|-.|..+ +.+.+|||++++...-..++ -..|-++|... +-|.+++++.++..-+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 456888999999999999999754 46789999998764432222 23466677655 57899999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+.+|+|--+++.-+ .+.+.....+|..||-||-+||+.+ ||.||||..||++|.+|++||+|||+++.---
T Consensus 428 VMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999998888765 4666677889999999999999999 99999999999999999999999999985432
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.+ ..+..++||+.|+|||.+..+.|...+|.|||||+||||+.|++||++. +..+..+.+++..
T Consensus 503 ~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-DE~elF~aI~ehn------------- 566 (683)
T KOG0696|consen 503 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-DEDELFQAIMEHN------------- 566 (683)
T ss_pred CC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHcc-------------
Confidence 22 3455789999999999999999999999999999999999999999643 3333333333221
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRP 890 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RP 890 (955)
..++.....+..++....+.+.|.+|.
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112222336778899999999999995
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=303.25 Aligned_cols=263 Identities=19% Similarity=0.261 Sum_probs=171.6
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-C----CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEE------EE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-N----GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF------CF 694 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 694 (955)
..++|...+.||+|+||+||+|++. + +..||||++...... +.+..| .++...+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568899999999999999999864 4 689999987643211 111111 1222223333322221 24
Q ss_pred eCCeEEEEEEecCCCCcccccCCCCC------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCC
Q 002189 695 DRGEQMLIYEFVPNGSLGDSLSGKNG------------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756 (955)
Q Consensus 695 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 756 (955)
.++..++||||+++++|.++++.... .......+..++.|+++||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56788999999999999988864321 01112335578999999999999988 9999999
Q ss_pred CccEEEcC-CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC----------------------CCCChhh
Q 002189 757 SSNILLDE-RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ----------------------QLTEKSD 813 (955)
Q Consensus 757 ~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksD 813 (955)
|+|||+++ ++.+||+|||+|+.+..... .......++++|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999986643322 233456789999999976432 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC------CCHHHHHHHHHHHHHhhccCCC
Q 002189 814 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS------TTLKGFEKYVDLALKCVQESGD 887 (955)
Q Consensus 814 vwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~------~~~~~~~~l~~li~~cl~~dP~ 887 (955)
||||||++|||+++..|.+. ..................+...+++....+ ..........+|+.+|++.||.
T Consensus 362 VwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999997766432 211111111111111111111122211000 0000112456899999999999
Q ss_pred CCCCHHHHHHH
Q 002189 888 DRPTMSEVVKD 898 (955)
Q Consensus 888 ~RPs~~evl~~ 898 (955)
+|||++|++++
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=251.49 Aligned_cols=216 Identities=28% Similarity=0.435 Sum_probs=175.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++......||+|+||.|-+-++ .+|+..|||+++..- .+..++..+|+++..+. .+|.+|.++|.+......++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34445566799999999988875 589999999998542 34456777888877665 6999999999999999999999
Q ss_pred EecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 704 EFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 704 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|.| ..||..+-+. ..+...++.-.-+|+..+.+||.|||+.- .+||||+||+|||++.+|++|+||||.+-.+.+
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999 4577654432 22456788888899999999999999854 399999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhh----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhh
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMT----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 848 (955)
.-. .+.-.|-..|||||.+.. ..|+-|+||||+|+.+.||.+++.||+...+..++++.++++.
T Consensus 202 SiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 202 SIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred hhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 321 222457888999999863 3689999999999999999999999998888888777776543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=272.11 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=202.6
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhcc--CCC----cceEEEEEEeCCe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH--HKN----LVSLLGFCFDRGE 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~n----iv~l~~~~~~~~~ 698 (955)
.+.+|.+...+|+|+||.|-++... .+..||||+++.- ....+...-|+++++++. .|+ +|++.+|+...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3778999999999999999998753 4789999999853 233455677999999993 233 7888999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc---------------
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD--------------- 763 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~--------------- 763 (955)
.+||+|.+ +-|+.+++..++-.+++...+..++.|++++++|||+.+ ++|-||||+|||+.
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 99999988 669999999988889999999999999999999999998 99999999999983
Q ss_pred -----CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH
Q 002189 764 -----ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838 (955)
Q Consensus 764 -----~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~ 838 (955)
.+..+||+|||-|+.-... ....+.|..|+|||++.+-.++.++||||+||||.|+.||..-|..-++..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2345899999999864322 245778999999999999999999999999999999999999887544322
Q ss_pred --HHHHHHHhhhhh---------h------------------hhhhhccCCc-CCCCCCHHHHHHHHHHHHHhhccCCCC
Q 002189 839 --REIRTVMDKKKE---------L------------------YNLYELIDPT-IGLSTTLKGFEKYVDLALKCVQESGDD 888 (955)
Q Consensus 839 --~~~~~~~~~~~~---------~------------------~~~~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~ 888 (955)
..++.+...... - ..+.+...|- ........+..+|++|+.+|+..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 122222211000 0 0000001110 001122234467999999999999999
Q ss_pred CCCHHHHHHH
Q 002189 889 RPTMSEVVKD 898 (955)
Q Consensus 889 RPs~~evl~~ 898 (955)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=249.96 Aligned_cols=258 Identities=21% Similarity=0.350 Sum_probs=200.7
Q ss_pred hcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCC--eEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRG--EQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lV 702 (955)
.++|++.+++|+|.|++||.|. ..+.++++||++++- ..+.+.+|+++|+.++ ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4577888899999999999998 457899999999863 3467899999999997 999999999998754 56899
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccccccCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSD 781 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~ 781 (955)
+||+++.+...... .++...+...+.++++||.|||+.| |+|||+||.|++||. ....+++|+|+|..+.+
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999987766543 4666778889999999999999999 999999999999996 45699999999998876
Q ss_pred CCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhh--hhhhhh----h
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK--KKELYN----L 854 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~----~ 854 (955)
.....+ .+.+..|.-||.+.. +.|+..-|+|||||++.+|+..+.||..|.+..+++-++..- ..++.. .
T Consensus 186 ~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 654333 457778899999874 578899999999999999999999999777655554433221 001100 0
Q ss_pred hhccCCcCCC---CCC-------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 855 YELIDPTIGL---STT-------------LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 855 ~~~~d~~l~~---~~~-------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.-.+||+... ... --...+.++++.+.+..|-.+|+|++|.+.+
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1113333211 000 0112678899999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=277.08 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=202.2
Q ss_pred CCccCeeeccCceEEEEEEeCCCc-EEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTLPNGQ-LIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+..+..||-|+||.|-.++..... .+|+|.+++... ...+.+..|-++|...+.|.||++|-.|.+.+..|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344556999999999999875433 489998876433 3345577899999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
|-+|.|...+++++ .++......++..+.+|++|||+.+ ||.|||||+|.++|.+|.+||.|||+|+.+..+.+
T Consensus 502 ClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K- 575 (732)
T KOG0614|consen 502 CLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK- 575 (732)
T ss_pred hcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence 99999999998776 6788888889999999999999999 99999999999999999999999999999876654
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
+-.++||+.|.|||.+.+...+.++|.||+|+++||+++|.+||...+.... ...++.... . ..
T Consensus 576 --TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~ILkGid----~---------i~ 639 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNLILKGID----K---------IE 639 (732)
T ss_pred --eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHhhhh----h---------hh
Confidence 4458999999999999999999999999999999999999999975443321 222222211 0 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
++........+++++....+|.+|.. ..|+-++
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 22233466789999999999999975 6677766
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=255.60 Aligned_cols=274 Identities=22% Similarity=0.292 Sum_probs=209.4
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 701 (955)
.++|..+++||+|+|..|..+++. +.+.+|+|++++.-.. +.+-.+.|-.+..+. +||.+|-++.++..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357889999999999999999864 6789999999875333 233467788887777 69999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|.||+++|+|--+++.+. .+++.....+...|.-||.|||+.| ||.||||..|||+|..|++|++|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999987776554 6888888889999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCc------CCchHHHHHHHHHhhhhhhhhhh
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE------RGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~------~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
+ ...++.++||+.|+|||.+.+..|...+|.|++||+++||+.|+.||+ ...+..+.+-.++-+.+
T Consensus 404 ~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq------ 475 (593)
T KOG0695|consen 404 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ------ 475 (593)
T ss_pred C--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc------
Confidence 2 234567899999999999999999999999999999999999999997 12223333333322211
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC------CHHHHHHH------HHHHHHHcCCCCCCCCCCCcccc
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP------TMSEVVKD------IENILQQAGLNPNAESASSSASY 921 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP------s~~evl~~------L~~~~~~~~~~~~~~~~~~~~~~ 921 (955)
++. +.....+...+++.-+.+||.+|. .++++-.+ =++++++..+.++..+..++...
T Consensus 476 ------iri--prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~ 545 (593)
T KOG0695|consen 476 ------IRI--PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYG 545 (593)
T ss_pred ------ccc--cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccC
Confidence 111 111124556788899999999985 23444322 13445555555555544444433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=292.64 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=187.7
Q ss_pred CCccCeeeccCce-EEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 630 FSDANDVGSGGYG-KVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 630 f~~~~~lG~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
|...+++|.|+-| .||+|.+ +|+.||||++-... .+-.++|+..|+.- +|||||++++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4455678999988 5899998 57899999986432 23567899999988 5999999998888888999999999
Q ss_pred CCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---C--CceEEeecccccccC
Q 002189 708 NGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---R--LNAKVADFGLSKSMS 780 (955)
Q Consensus 708 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~--~~~kl~DFGla~~~~ 780 (955)
..+|.+++... ......-...+.+..|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 67999998763 1111111445678899999999999999 999999999999975 2 579999999999886
Q ss_pred CCCCcc-eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhC-CCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 781 DSEKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG-RRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 781 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
.+.... ......||-||+|||.+.....+.++||||+||++|..++| .+||... ..++. .+...... +.. +
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~-NIl~~~~~---L~~-L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQA-NILTGNYT---LVH-L 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhh-hhhcCccc---eee-e
Confidence 543321 23456799999999999999889999999999999999995 8898542 21211 12211111 111 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+ ..++ +..+||.+|+.+||..||++.+|+.+
T Consensus 736 ~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 EP------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cc------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 1111 67899999999999999999999953
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=275.24 Aligned_cols=202 Identities=25% Similarity=0.408 Sum_probs=169.7
Q ss_pred cCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchh---HHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.-|..++.||-|+||+|.+++ .++...+|.|.+++.+.-.+ ..++.|-+||...+.+-||+|+..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 357778899999999999997 45567899999987544332 34778999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC---
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS--- 780 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~--- 780 (955)
||+++|++-.+|-..+ -+.+.....++..+++|+++.|..| +|||||||+|||||.+|++||+||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999988876554 4677777788889999999999999 9999999999999999999999999985331
Q ss_pred CCCC----cce---------------------------------eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHH
Q 002189 781 DSEK----DHI---------------------------------TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 823 (955)
Q Consensus 781 ~~~~----~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~e 823 (955)
+..+ ++. .-..+||+.|+|||++....++..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0000 000 012469999999999999999999999999999999
Q ss_pred HHhCCCCCcCC
Q 002189 824 LLTGRRPIERG 834 (955)
Q Consensus 824 lltg~~P~~~~ 834 (955)
|+.|+.||-..
T Consensus 864 m~~g~~pf~~~ 874 (1034)
T KOG0608|consen 864 MLVGQPPFLAD 874 (1034)
T ss_pred HhhCCCCccCC
Confidence 99999999643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=255.99 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=191.8
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeC-----CeEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GEQML 701 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~l 701 (955)
.+..+.||-|+||.||.+.. ++|+.||+|++... +....+.+.+|+++|..++|.|++..++...-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34557899999999999985 58999999988642 233457888999999999999999888765433 35688
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+|.| ..+|...+-.. +.++...+.-+..||++||.|||+.+ |.||||||.|.|++.+...||||||+||....
T Consensus 135 ~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 99988 56888877544 36777778888999999999999999 99999999999999999999999999997654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHH---------------
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM--------------- 845 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~--------------- 845 (955)
.+. ...+..+.|..|+|||.+++ +.|+.+.||||.||++.|++..+--|.... .++++..+.
T Consensus 209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-PIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-hHHHHHHHHHHhCCCcHHHHHHHh
Confidence 443 33455678999999999996 479999999999999999997665554222 222222111
Q ss_pred hhhhhhhhhhhcc-CCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 846 DKKKELYNLYELI-DPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 846 ~~~~~~~~~~~~~-d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
+..+. .-+.... .|.... ........+.+++..+++..||++|.+.++.+.++
T Consensus 287 EGAk~-H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKN-HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHH-HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11110 0011101 111111 11112234567888899999999999999888753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-31 Score=286.35 Aligned_cols=313 Identities=23% Similarity=0.334 Sum_probs=225.4
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEc
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 144 (955)
++..|.+++|++. .+.+.++.|+.|+.+++.+|++-..-+|..+.+|..|+.|+||+|++. ..|..+...+++-.|+|
T Consensus 56 kLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEc
Confidence 3344444444444 334445555555555555555334445666666666666666666666 56666666666666666
Q ss_pred cCCCCcCcCCC-CCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 145 NSNGFSGRVPP-SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 145 s~N~l~~~~p~-~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|+|+|. .||. .|.+|+.|-+|||++|++. .+| +..+.|..|+.|.|++|.+. ..--.-...+.+|..|.+
T Consensus 134 S~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LP------PQ~RRL~~LqtL~Ls~NPL~-hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 134 SYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLP------PQIRRLSMLQTLKLSNNPLN-HFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred ccCccc-cCCchHHHhhHhHhhhccccchhh-hcC------HHHHHHhhhhhhhcCCChhh-HHHHhcCccchhhhhhhc
Confidence 666666 3443 3456666666666666665 333 23455666666666666554 111111112445666666
Q ss_pred cCCCcc-ccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCC
Q 002189 224 DSNNLT-GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDAS 302 (955)
Q Consensus 224 ~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 302 (955)
++.+-+ ..+|.++..+.+|..+|||+|.+. .+|+.+.++.+|+.|+||+|+|+.+......+.+|++|+||+|+++
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-- 281 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-- 281 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc--
Confidence 665444 458999999999999999999999 9999999999999999999999998888888899999999999996
Q ss_pred CCChhhcCCCCCCEEECcCCcce-ecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCC--
Q 002189 303 EVPSWFSSMQSLTTLMMENTNLK-GQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGG-- 379 (955)
Q Consensus 303 ~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~-- 379 (955)
..|.++..+++|+.|++.+|+|+ .-+|..+++|.+|+++..++|+|.-.+........|+.|.|+.|++-++|....
T Consensus 282 ~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL 361 (1255)
T KOG0444|consen 282 VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLPEAIHLL 361 (1255)
T ss_pred cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeechhhhhhc
Confidence 49999999999999999999998 569999999999999999999998777777889999999999999999887532
Q ss_pred CCCcceeEecCc
Q 002189 380 APAVNLTLIDNP 391 (955)
Q Consensus 380 ~~~~~L~~l~n~ 391 (955)
..+..|++-.||
T Consensus 362 ~~l~vLDlreNp 373 (1255)
T KOG0444|consen 362 PDLKVLDLRENP 373 (1255)
T ss_pred CCcceeeccCCc
Confidence 344555555554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=271.99 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=204.1
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|....++|.|+||.||||+. ..++..|||+++.....+.+-+++|+-+++..+|||||.++|.|...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35677888999999999999985 57899999999977666667788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
|.+|+|.+.-+.-+ ++++.++..++....+|++|||+.+ -+|||||-.||++++.|.+|++|||.+..+... -
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--i 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I 166 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--h
Confidence 99999999877654 7899999999999999999999998 799999999999999999999999998765421 1
Q ss_pred ceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC-c
Q 002189 786 HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP-T 861 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~ 861 (955)
.....+.||++|||||+.. .+.|..++|||+.|+...|+-.-++|....... +... +..+ ..++| .
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r~l~--LmTk-------S~~qpp~ 236 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-RALF--LMTK-------SGFQPPT 236 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-HHHH--Hhhc-------cCCCCCc
Confidence 2234578999999999975 467899999999999999998888886432111 1111 1111 11222 2
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
+. ...+....|-++++.|+-++|.+||+++.+++
T Consensus 237 lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 21 22234466789999999999999999988774
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=240.09 Aligned_cols=210 Identities=37% Similarity=0.591 Sum_probs=183.0
Q ss_pred eeccCceEEEEEEeCC-CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCccc
Q 002189 636 VGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 713 (955)
Q Consensus 636 lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 713 (955)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998865432 34678999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccccccCCCCCcceeeeee
Q 002189 714 SLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSDSEKDHITTQVK 792 (955)
Q Consensus 714 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 792 (955)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 887542 35889999999999999999999998 999999999999999 89999999999987654321 122345
Q ss_pred cCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHH
Q 002189 793 GTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871 (955)
Q Consensus 793 gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (955)
+...|++||..... ..+.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999877 888999999999999999
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 345689999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=246.55 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=194.2
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeC------CeE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------GEQ 699 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~ 699 (955)
+|.....+|.|.- .|..|.. -.++.||+|++... .....+...+|..++..+.|+||++++.++.-. .+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 5666677888887 5555542 25789999987542 233456788999999999999999999998643 357
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
|+||||| .++|...++- .++-.+...+..|+.+|++|||+.+ |+||||||+||++..+..+||.|||+|+.-
T Consensus 97 y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 9999999 6688887762 4778888999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----------
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK---------- 849 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~---------- 849 (955)
.. ....+..+.|..|.|||++.+..+.+.+||||.||++.||++|+--|.+...+.+|.+.+-.-+.
T Consensus 169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 32 23455678899999999999888999999999999999999999877644444444332111000
Q ss_pred -------------hhhhhhhccCCcC-C--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -------------ELYNLYELIDPTI-G--LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -------------~~~~~~~~~d~~l-~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+.+.... . .+........+.+++.+||..||++|.++++++++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0011111111110 0 01111223567899999999999999999999976
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=239.09 Aligned_cols=199 Identities=34% Similarity=0.521 Sum_probs=173.3
Q ss_pred CCccCeeeccCceEEEEEEeCC-CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 630 FSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
|...+.||+|++|+||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999764 899999999865544 56789999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.+++..... .+++.....++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL 155 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence 9999998875432 1789999999999999999999988 99999999999999999999999999987754421 12
Q ss_pred eeeeecCCCCCCHHHh-hhCCCCChhhhHHHHHHHHHHHhCCCCCcC
Q 002189 788 TTQVKGTMGYLDPEYY-MTQQLTEKSDVYSFGVLMLELLTGRRPIER 833 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~-~~~~~~~ksDvwS~Gv~l~elltg~~P~~~ 833 (955)
.....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2345688899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-29 Score=274.42 Aligned_cols=314 Identities=24% Similarity=0.302 Sum_probs=274.9
Q ss_pred CCCEeEEEecCCcCcc-ccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCc-cccCCCCc
Q 002189 63 NSRVTSITLSGMGLKG-QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDS-IGSLQELV 140 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~-~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~ 140 (955)
-.++.++++.+|++.. -+|..+..|..|+.||||+|+ ....|..+.+-+++-.|+||+|+|. +||.. |.+|+.|-
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNq--L~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLL 153 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQ--LREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLL 153 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecchhh--hhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHh
Confidence 3567788889998853 578889999999999999998 5578999999999999999999999 67765 77999999
Q ss_pred EEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCccc-ccCCccccCCcccee
Q 002189 141 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS-GSIPEKLFRPDMVLI 219 (955)
Q Consensus 141 ~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~-g~ip~~~~~~~~~L~ 219 (955)
.||||+|++. .+|+.+..|.+|++|+|++|.+. ...+..|..+++|+.|++++.+-+ ..+|..+ ..+.+|.
T Consensus 154 fLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~------hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl-d~l~NL~ 225 (1255)
T KOG0444|consen 154 FLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN------HFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL-DDLHNLR 225 (1255)
T ss_pred hhccccchhh-hcCHHHHHHhhhhhhhcCCChhh------HHHHhcCccchhhhhhhcccccchhhcCCCch-hhhhhhh
Confidence 9999999999 78889999999999999999886 345666777888899999987654 2566654 3467899
Q ss_pred eeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCC
Q 002189 220 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 299 (955)
Q Consensus 220 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 299 (955)
.++|+.|++. .+|+.+-++++|+.|+||+|+|+ .+........+|++|+||+|+++.+|..+.++++|+.|.+.+|++
T Consensus 226 dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL 303 (1255)
T KOG0444|consen 226 DVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKL 303 (1255)
T ss_pred hccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcc
Confidence 9999999999 89999999999999999999999 777788888999999999999999999999999999999999999
Q ss_pred CCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCC
Q 002189 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGG 379 (955)
Q Consensus 300 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~ 379 (955)
+-..+|..++.+.+|+.+.+++|.|. .+|+.+..++.|+.|.|+.|+|.+.+..+--++.+..|||.+|.=-..||..-
T Consensus 304 ~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPKP~ 382 (1255)
T KOG0444|consen 304 TFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPKPN 382 (1255)
T ss_pred cccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCCcc
Confidence 98889999999999999999999998 99999999999999999999999877666667788899999999777777655
Q ss_pred CCCcceeEecC
Q 002189 380 APAVNLTLIDN 390 (955)
Q Consensus 380 ~~~~~L~~l~n 390 (955)
..-+.|...+.
T Consensus 383 da~~~lefYNI 393 (1255)
T KOG0444|consen 383 DARKKLEFYNI 393 (1255)
T ss_pred hhhhcceeeec
Confidence 44455555443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=256.08 Aligned_cols=197 Identities=25% Similarity=0.359 Sum_probs=169.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch------h--HHHHHHHHHHHhcc---CCCcceEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG------G--QEFKMEIELLSRVH---HKNLVSLLGFCF 694 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~------~--~~~~~E~~~l~~l~---H~niv~l~~~~~ 694 (955)
..+|...+.+|+|+||.|+.|.++ +...|+||.+.+.+.-. + -.+-.|+.+|..++ |+||+|++.+|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456888999999999999999975 56789999887643321 1 12557999999997 999999999999
Q ss_pred eCCeEEEEEEecC-CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 695 DRGEQMLIYEFVP-NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 695 ~~~~~~lV~e~~~-~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
+++.+||+||-.. +-+|.+++..+. .+++....-|..||+.|+++||+.+ |||||||-+||.++.+|-+||+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 9999999999764 458899987665 6888899999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCC-hhhhHHHHHHHHHHHhCCCCCc
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE-KSDVYSFGVLMLELLTGRRPIE 832 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDvwS~Gv~l~elltg~~P~~ 832 (955)
|.|.....+. ...++||.+|.|||++.+..|-- .-|||++|++||-++....||.
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998765433 34578999999999999988864 5899999999999999888874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=242.52 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=197.1
Q ss_pred HHHHhcCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCC
Q 002189 623 VKKYTNNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRG 697 (955)
Q Consensus 623 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 697 (955)
+....+.|...++||+|.|++||+|.+. ..+.||+|.+...+. ...+..|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445678889999999999999999853 467899999875433 356899999999995 999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLS 776 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla 776 (955)
...+|+||+++....++.. .++...+..+...+..||+++|..| ||||||||+|+|.+. .+.-.|.|||+|
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999988887775 3667888889999999999999999 999999999999985 456789999999
Q ss_pred cccCCCC-------------C-----------------------------cceeeeeecCCCCCCHHHhhh-CCCCChhh
Q 002189 777 KSMSDSE-------------K-----------------------------DHITTQVKGTMGYLDPEYYMT-QQLTEKSD 813 (955)
Q Consensus 777 ~~~~~~~-------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksD 813 (955)
....... . ........||+||.|||++.. ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7221000 0 000112469999999999974 57899999
Q ss_pred hHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHh---hh---------hh--hh------hh------hhccC-CcC----
Q 002189 814 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMD---KK---------KE--LY------NL------YELID-PTI---- 862 (955)
Q Consensus 814 vwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~---~~---------~~--~~------~~------~~~~d-~~l---- 862 (955)
|||.|||++-+++++.||....+..+.+..+.. .. .. .. .. ++.++ ..+
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999999744433322221111 00 00 00 00 01111 000
Q ss_pred ----C-CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 ----G-LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ----~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .......+..+++++.+|+..||.+|.|++|.+++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 00111122468999999999999999999999964
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-28 Score=255.20 Aligned_cols=338 Identities=29% Similarity=0.339 Sum_probs=193.0
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEc
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 144 (955)
-++.|++.+|.+. .+|++++.+..+..|+.++|+ ...+|..+..+.+|..|++++|.+. .+|+.++.+..|+.|+.
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~--ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNK--LSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccch--HhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 4556666666666 556666666666666666665 3455555666666666666666655 45555555555555555
Q ss_pred cCCCCcCcCCCCCCCCCCc-----------------------CeeecCCceeeeccCCCCCCCCchhhhhccccccccCC
Q 002189 145 NSNGFSGRVPPSIGNLSNL-----------------------YWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 201 (955)
Q Consensus 145 s~N~l~~~~p~~~~~L~~L-----------------------~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N 201 (955)
.+|+|+ ..|+.+.++.+| ++||...|.++ .+|..++.+ .+|+.|+|..|
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l------~~L~~LyL~~N 216 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGL------ESLELLYLRRN 216 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcch------hhhHHHHhhhc
Confidence 555555 344444444444 44444444443 444444332 23333344444
Q ss_pred cccccCCccccCCccceeeeeccCCCccccCCcccC-CCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccC
Q 002189 202 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG-LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM 280 (955)
Q Consensus 202 ~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 280 (955)
+|. .+| -|.+...|.+|.++.|+|. .+|.+.. .+++|..|||..|+++ ..|+.+.-+.+|++||+|+|.|++.+
T Consensus 217 ki~-~lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp 291 (565)
T KOG0472|consen 217 KIR-FLP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLP 291 (565)
T ss_pred ccc-cCC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCC
Confidence 444 344 1333344444444444444 3333332 5555555555555555 55555555555555555555555555
Q ss_pred CCCCCCCCCCEEECcCCCCCC-----------------------------------------------------------
Q 002189 281 PNLTGLSVLSYLDMSNNSFDA----------------------------------------------------------- 301 (955)
Q Consensus 281 ~~~~~l~~L~~L~Ls~N~l~~----------------------------------------------------------- 301 (955)
+.++++ .|+.|-+-+|++..
T Consensus 292 ~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s 370 (565)
T KOG0472|consen 292 YSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVS 370 (565)
T ss_pred cccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccc
Confidence 555555 55555555555522
Q ss_pred ------------------------------------------------------CCCChhhcCCCCCCEEECcCCcceec
Q 002189 302 ------------------------------------------------------SEVPSWFSSMQSLTTLMMENTNLKGQ 327 (955)
Q Consensus 302 ------------------------------------------------------~~~p~~~~~l~~L~~L~Ls~N~l~~~ 327 (955)
.-+|..++.+++|+.|+|++|.+. .
T Consensus 371 ~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~ 449 (565)
T KOG0472|consen 371 DKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-D 449 (565)
T ss_pred ccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-h
Confidence 012444566777888888887777 7
Q ss_pred CCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEecCcchhcccCccccccccC
Q 002189 328 IPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQ 407 (955)
Q Consensus 328 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~~c~~~~~~~~~c~~~~ 407 (955)
+|..++.+..|+.||+++|++...+.-......++.+-.++|+|..+++.+..++.+|+.+|.. +.. -+
T Consensus 450 LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~----------nNd-lq 518 (565)
T KOG0472|consen 450 LPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQ----------NND-LQ 518 (565)
T ss_pred cchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccC----------CCc-hh
Confidence 7888888777888888888776554443444445556666677777777766667777666542 111 14
Q ss_pred CCCCCCCCCCCCCccccCCCCCCCC
Q 002189 408 PISPYSTKQKNCLPAPCNANQSSSP 432 (955)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (955)
.|||...+..+........|+.+.|
T Consensus 519 ~IPp~LgnmtnL~hLeL~gNpfr~P 543 (565)
T KOG0472|consen 519 QIPPILGNMTNLRHLELDGNPFRQP 543 (565)
T ss_pred hCChhhccccceeEEEecCCccCCC
Confidence 5777777777777777777776644
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-28 Score=256.15 Aligned_cols=295 Identities=28% Similarity=0.392 Sum_probs=222.1
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccc-cCCCCcEEE
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG-SLQELVLLS 143 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 143 (955)
++..||..+|-+. .+|+.++.|.+|..|+|..|+ + ..+| +|..+..|+.|+++.|+|. .+|.+.. ++.+|..||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nk-i-~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLD 258 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNK-I-RFLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLD 258 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcc-c-ccCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeee
Confidence 3344444444443 566666666666666666665 2 2344 5666666666666666666 5554443 777888888
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh---------------------------------
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML--------------------------------- 190 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L--------------------------------- 190 (955)
|.+|+++ ..|+.++-|.+|++||+++|.|+ .+|.++|++ .|..|
T Consensus 259 LRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~d 335 (565)
T KOG0472|consen 259 LRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDD 335 (565)
T ss_pred ccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccC
Confidence 8888888 78888888888888888888888 677777775 44322
Q ss_pred --------------------------hccccccccCCcccccCCccccCCcc--ceeeeeccCCCccccCCcccCCCCCC
Q 002189 191 --------------------------VRAKHFHFGKNQLSGSIPEKLFRPDM--VLIHVLFDSNNLTGELPATLGLVKSL 242 (955)
Q Consensus 191 --------------------------~~L~~L~L~~N~l~g~ip~~~~~~~~--~L~~L~L~~N~l~~~~p~~l~~l~~L 242 (955)
.+.+.|++++-+++ .+|+++|.... -....+++.|++. ++|..+..++.+
T Consensus 336 glS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkel 413 (565)
T KOG0472|consen 336 GLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKEL 413 (565)
T ss_pred CCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHH
Confidence 13566677777777 77777775432 3677888888888 778877777776
Q ss_pred cE-EEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcC
Q 002189 243 EV-VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMEN 321 (955)
Q Consensus 243 ~~-L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~ 321 (955)
.+ +.+++|.++ .+|..++.+++|..|+|++|.+..+|.+++.+..|+.||+|+|++. ..|.++..+..|+.+-.++
T Consensus 414 vT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr--~lP~~~y~lq~lEtllas~ 490 (565)
T KOG0472|consen 414 VTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR--MLPECLYELQTLETLLASN 490 (565)
T ss_pred HHHHHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccc--cchHHHhhHHHHHHHHhcc
Confidence 65 444555554 8899999999999999999999999889999999999999999885 5888888888888888899
Q ss_pred CcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccc
Q 002189 322 TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 372 (955)
Q Consensus 322 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~ 372 (955)
|++....+..+.+|.+|+.|||.+|.|..++|....+.++++|+|.||+|+
T Consensus 491 nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 491 NQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 999976677788999999999999999988888888889999999999988
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=222.35 Aligned_cols=246 Identities=19% Similarity=0.301 Sum_probs=180.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEE-EEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGF-CFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~ 703 (955)
.+.|.+.+.||+|.||.+-.++++ ..+.+++|.+...- ...++|.+|...--.| .|.||+.-++. +...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 345778889999999999999976 46788999876543 3357899998876666 49999977764 45567888999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc--CCCceEEeecccccccCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD--ERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFGla~~~~~ 781 (955)
||+|.|+|.+-+...+ +.+....+++.|++.|+.|+|+.. +||||||.+||||- +..++|+||||+.+..+.
T Consensus 102 E~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999998887653 777888899999999999999998 99999999999993 344799999999876532
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhC-----CCCChhhhHHHHHHHHHHHhCCCCCcCCc----hHHHHHHHHHhhhhhhh
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQ-----QLTEKSDVYSFGVLMLELLTGRRPIERGK----YIVREIRTVMDKKKELY 852 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwS~Gv~l~elltg~~P~~~~~----~~~~~~~~~~~~~~~~~ 852 (955)
......-+..|.|||..... ...+.+|||.||++++.++||..||+... ...+|.+...
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~------- 243 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK------- 243 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc-------
Confidence 12223356679999987632 35678999999999999999999997321 2222222111
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVV 896 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 896 (955)
...+.++..+ ....+++.++.++-+..+|.+|-...++-
T Consensus 244 ----rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 244 ----RKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ----ccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 1111111111 11225677888899999999994444333
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=237.05 Aligned_cols=131 Identities=25% Similarity=0.320 Sum_probs=112.0
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-----C---CCcceEEEEEEe---
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-----H---KNLVSLLGFCFD--- 695 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~--- 695 (955)
.+|...++||=|.|++||+|.. .+.+.||+|+.+.. ....+....|+++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6788999999999999999974 46789999998753 233456778999999984 3 369999999976
Q ss_pred -CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE
Q 002189 696 -RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762 (955)
Q Consensus 696 -~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 762 (955)
+.+.+||+|++ +.+|..+|.....+.++...+.+|+.||+.||.|||..+ .|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 778999998777778999999999999999999999765 39999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-26 Score=247.58 Aligned_cols=269 Identities=21% Similarity=0.239 Sum_probs=202.6
Q ss_pred HHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhcc------CCCcceEEEE
Q 002189 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH------HKNLVSLLGF 692 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~ 692 (955)
+.-.+..-.+|.+....|+|-|++|.+|... .|+.||||+++.+..- .+.=..|+++|++|. --|+++++-.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3333445678888888999999999999854 5789999999865322 244567999999995 3589999999
Q ss_pred EEeCCeEEEEEEecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEE
Q 002189 693 CFDRGEQMLIYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKV 770 (955)
Q Consensus 693 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl 770 (955)
|...+++|||+|-+ ..+|.+.|+..+ ...|....+..++.|+.-||..|..++ |+|+||||.|||+++.. .+||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence 99999999999977 568888887654 456778888899999999999999999 99999999999999764 5799
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
||||.|......+. +.+..+..|.|||.+.+-.|+...|+||.||+|||+.||+--|.+ .+..+++.-.++-+..
T Consensus 579 CDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG-~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 579 CDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG-RTNNQMLRLFMELKGK 653 (752)
T ss_pred ccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC-CCcHHHHHHHHHhcCC
Confidence 99999987765443 234456689999999999999999999999999999999987743 2222333222221100
Q ss_pred ----------------------------------hhhhhhccCCc------CC-----CCCCHHHHHHHHHHHHHhhccC
Q 002189 851 ----------------------------------LYNLYELIDPT------IG-----LSTTLKGFEKYVDLALKCVQES 885 (955)
Q Consensus 851 ----------------------------------~~~~~~~~d~~------l~-----~~~~~~~~~~l~~li~~cl~~d 885 (955)
...+...+.|. +. .........+|.+|+.+|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 00011112221 00 0112234567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 002189 886 GDDRPTMSEVVKD 898 (955)
Q Consensus 886 P~~RPs~~evl~~ 898 (955)
|++|.|..+++++
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999998864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=217.73 Aligned_cols=244 Identities=23% Similarity=0.398 Sum_probs=189.7
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 634 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
-+|.+...|+.|+|+|+. ..+++|+++.. .....++|.+|.-.|+.+.||||+.++|.|.......++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 458888999999999974 45566766532 333447899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe--ecccccccCCCCCcceee
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA--DFGLSKSMSDSEKDHITT 789 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~ 789 (955)
...++...+...+..+..+++.++|+|++|||+.. +-|..--+.+..|++|++.+++|+ |--++. ...
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf---------qe~ 344 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------QEV 344 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---------ecc
Confidence 99999988888889999999999999999999975 323345688999999999998874 222111 111
Q ss_pred eeecCCCCCCHHHhhhCCCC---ChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 790 QVKGTMGYLDPEYYMTQQLT---EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 790 ~~~gt~~y~aPE~~~~~~~~---~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
...-.+.||+||.++...-+ .++|+|||++++||+.|...||.+-....--++...+. +.-.+.|.+.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg------lrv~ippgis--- 415 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG------LRVHIPPGIS--- 415 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc------ccccCCCCcc---
Confidence 22356789999999866543 57999999999999999999997544332222222221 2233444432
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
..+.+++.-|+..||.+||.+..++-.|+++
T Consensus 416 -----~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 416 -----RHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -----HHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 5677899999999999999999999998876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=214.89 Aligned_cols=170 Identities=23% Similarity=0.257 Sum_probs=130.5
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCccee
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|+|.++++.. +..+++..++.++.|+++||+|||+.+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6888888753 236999999999999999999999865 999999999999999 99998764322
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
..||+.|||||++.+..++.++|||||||++|||+||+.||................... .++.. .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~~~~ 133 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-------DDPRD-RSNLE 133 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-------CCccc-cccHH
Confidence 258999999999999999999999999999999999999997544333333332222110 11110 01111
Q ss_pred HHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 869 KGFE--KYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 869 ~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.... ++.+++.+||..+|++||++.|+++++..+..+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 2222 689999999999999999999999998877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-25 Score=272.61 Aligned_cols=197 Identities=20% Similarity=0.243 Sum_probs=140.9
Q ss_pred hccC-CCcceEEEEE-------EeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCee
Q 002189 680 RVHH-KNLVSLLGFC-------FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751 (955)
Q Consensus 680 ~l~H-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 751 (955)
.++| +||+++++++ .+.+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+.+ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 4455 5888888887 2334567889987 66999999753 346899999999999999999999998 99
Q ss_pred ccCCCCccEEEcC-------------------CCceEEeecccccccCCCCC--------------cceeeeeecCCCCC
Q 002189 752 HRDIKSSNILLDE-------------------RLNAKVADFGLSKSMSDSEK--------------DHITTQVKGTMGYL 798 (955)
Q Consensus 752 HrDlk~~NIll~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 798 (955)
||||||+||||+. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44556666666653211000 00011245888999
Q ss_pred CHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHH
Q 002189 799 DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLA 878 (955)
Q Consensus 799 aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 878 (955)
|||++.+..++.++|||||||++|||++|.+|+........ ... ....++.. .....+..+++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~---~~~---------~~~~~~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS---SLR---------HRVLPPQI-----LLNWPKEASFC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH---HHH---------HhhcChhh-----hhcCHHHHHHH
Confidence 99999999999999999999999999999888643211111 110 00111111 11123456888
Q ss_pred HHhhccCCCCCCCHHHHHHH
Q 002189 879 LKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 879 ~~cl~~dP~~RPs~~evl~~ 898 (955)
.+||+++|.+||+|+|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 99999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-22 Score=223.64 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=201.8
Q ss_pred CCCccCeeeccCceEEEEEEeCCC--cEEEEEEcccCCcchhHHHHHHHHHHHhccC----CCcceEEEEE-EeCCeEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPNG--QLIAIKRAQQGSMQGGQEFKMEIELLSRVHH----KNLVSLLGFC-FDRGEQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 701 (955)
+|...+.||+|+||.||+|...+. ..+|+|............+..|+.++..+.. +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999986543 4788888765433333368889999999873 6888999888 47778899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-----CceEEeecccc
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-----LNAKVADFGLS 776 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-----~~~kl~DFGla 776 (955)
||+.+ +.+|.++........++..+.++|+.|++.+|+++|+.| ++||||||.|+.+... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 889999776555568999999999999999999999999 9999999999999865 46999999999
Q ss_pred c--ccCCCCCc----c-e-eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhh
Q 002189 777 K--SMSDSEKD----H-I-TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 777 ~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 848 (955)
+ .+...... . . .....||.+|.++....+...+++.|+||++.++.|++.|..||...+.... ........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 43222211 0 1 1235699999999999999999999999999999999999999965443222 11111111
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCC
Q 002189 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 909 (955)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 909 (955)
. .....+ .....+..+.++...+-..+..++|....+...+++.....+..
T Consensus 254 ~-----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 254 R-----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred h-----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 0 000110 11122355666777777799999999999999999988776543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=209.47 Aligned_cols=272 Identities=19% Similarity=0.265 Sum_probs=213.7
Q ss_pred CCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEEec
Q 002189 629 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.|.+.++||+|.||+.+.|+ +-+++.||||.-... .+.-++..|.+..+.|. .++|-..+.|..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 57888999999999999998 558899999975432 22346778888888885 799999998888888999999998
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-----CceEEeecccccccCC
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-----LNAKVADFGLSKSMSD 781 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-----~~~kl~DFGla~~~~~ 781 (955)
+-||+|++.-. +..++..++..+|.|++.-++|+|++. +|.|||||+|.||... ..+.++|||+|+.+.+
T Consensus 107 -GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 77888876533 457999999999999999999999998 9999999999999743 3589999999998876
Q ss_pred CCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhhh
Q 002189 782 SEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNL 854 (955)
Q Consensus 782 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~ 854 (955)
.... .......||.+||+-....+++.+.+.|+=|+|-++...+.|..||.+-+ +..+...++- +.++...+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG-e~Kr~T~i 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG-ETKRSTPI 260 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc-cccccCCH
Confidence 5531 22345679999999999999999999999999999999999999998543 2222222222 22222222
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCCCCCCCCC
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASS 917 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 917 (955)
.++ ....+.++..-+.-.-..+.++-|..+-+...+..++.+.|.+...+..|.
T Consensus 261 ~~L---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 261 EVL---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred HHH---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 221 122346777888888888999999999999999999999887665544443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=226.61 Aligned_cols=167 Identities=19% Similarity=0.182 Sum_probs=129.9
Q ss_pred HHhcCCCccCeeeccCceEEEEEEeC--CCcEEEEEEcccCC-----cchhHHHHHHHHHHHhccCCCcceEEEEEEeCC
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTLP--NGQLIAIKRAQQGS-----MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 697 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 697 (955)
...++|...+.||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34567899999999999999999864 57888999865331 1224568999999999999999853322 24
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCC-CCccEEEcCCCceEEeecccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI-KSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DFGla 776 (955)
..++||||+++++|... ... . ...++.+++++|+|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 68999999999999632 111 1 1457889999999999998 999999 999999999999999999999
Q ss_pred cccCCCCCcce------eeeeecCCCCCCHHHhhhC
Q 002189 777 KSMSDSEKDHI------TTQVKGTMGYLDPEYYMTQ 806 (955)
Q Consensus 777 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 806 (955)
+.+........ .+...+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 97754432111 1346788899999998744
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=198.54 Aligned_cols=266 Identities=18% Similarity=0.263 Sum_probs=203.4
Q ss_pred hcCCCccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccC-CCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e 704 (955)
...|..+++||+|+||.+|.|. ..+|+.||||.-...... -.+..|.++.+.++| ..|..+..|..+++.-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678899999999999999998 568999999987654333 356779999999975 677778888888999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC---CceEEeecccccccCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFGLSKSMSD 781 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~~~~~ 781 (955)
.+ +-+|.+.+.-. ...++..+.+.++-|++.-++|+|..+ +|||||||+|.|+.-+ ..+.++|||+|+.+.+
T Consensus 92 LL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 88 78998877543 346889999999999999999999999 9999999999999644 4588999999988765
Q ss_pred CCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHH-HHHHHhhhhhhhhhh
Q 002189 782 SEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVRE-IRTVMDKKKELYNLY 855 (955)
Q Consensus 782 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~ 855 (955)
.... .......||.+|.+-....+...+.+.|+-|+|.++.....|..||++-...... -.+.+.+++- ....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~-s~~i 245 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM-STPI 245 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc-CCCH
Confidence 4321 1123467999999998888889999999999999999999999999854332211 1111111110 0011
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 908 (955)
+.+ ....+.++.-.+..|-..-.++-|...-+.+.+.-+......
T Consensus 246 e~L--------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 246 EVL--------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred HHH--------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 111 222346788889999999999999998888777776655543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=242.37 Aligned_cols=268 Identities=26% Similarity=0.324 Sum_probs=206.6
Q ss_pred eCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCc
Q 002189 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 140 (955)
Q Consensus 61 C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 140 (955)
|-...-..|+|++++|+ .+|+.+. ++|+.|+|++|+ ++ .+|.. +++|++|+|++|+|+ .+|.. .++|+
T Consensus 198 Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~-Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~ 265 (788)
T PRK15387 198 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNN-LT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLL 265 (788)
T ss_pred HhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCc-CC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccc
Confidence 54445567899999999 6787775 489999999997 55 45643 578999999999999 56653 46899
Q ss_pred EEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceee
Q 002189 141 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIH 220 (955)
Q Consensus 141 ~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~ 220 (955)
.|+|++|.|+ .+|..+ ++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. ...|..
T Consensus 266 ~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---------p~~L~~LdLS~N~L~-~Lp~l----p~~L~~ 326 (788)
T PRK15387 266 ELSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---------PPGLQELSVSDNQLA-SLPAL----PSELCK 326 (788)
T ss_pred eeeccCCchh-hhhhch---hhcCEEECcCCccc-ccccc---------ccccceeECCCCccc-cCCCC----cccccc
Confidence 9999999998 566533 67889999999998 55532 356889999999999 67752 345888
Q ss_pred eeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCC
Q 002189 221 VLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 221 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 300 (955)
|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|+.++.. ..+|+.|+|++|+|+
T Consensus 327 L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt 395 (788)
T PRK15387 327 LWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLT 395 (788)
T ss_pred cccccCcccc-cccc---ccccceEecCCCccC-CCCCC---CcccceehhhccccccCccc---ccccceEEecCCccc
Confidence 9999999984 5542 257999999999999 56653 35788899999999976543 357899999999997
Q ss_pred CCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCC
Q 002189 301 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGG 379 (955)
Q Consensus 301 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~ 379 (955)
. +|.. .++|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+..+..+..+..+..|+|++|+|++..+..+
T Consensus 396 ~--LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 396 S--LPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred C--CCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 5 5543 367999999999998 46654 346888999999998765556667888899999999998766544
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-25 Score=251.12 Aligned_cols=317 Identities=26% Similarity=0.332 Sum_probs=182.3
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEc
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 144 (955)
++.+|||++|.+. ..|..+..+.+|+.|+++.|- ....|.+..++.+|++|+|.+|.+. ..|..+..+++|++|++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~--i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl 121 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY--IRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL 121 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhh--HhhCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence 5889999988887 677888888999999999985 4466788889999999999999888 88888999999999999
Q ss_pred cCCCCcCcCCCCCCCCCCcCe-------------------eecCCceeeeccCCCCCCCCc-------------hhhhhc
Q 002189 145 NSNGFSGRVPPSIGNLSNLYW-------------------LDLTDNKLEGEIPVSDGNSPG-------------LDMLVR 192 (955)
Q Consensus 145 s~N~l~~~~p~~~~~L~~L~~-------------------L~L~~N~l~g~ip~~~~~~~~-------------l~~L~~ 192 (955)
+.|.+. .+|..+..++.++. ++|..|.+.+.++.++++++. +..+.+
T Consensus 122 S~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~ 200 (1081)
T KOG0618|consen 122 SFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLAN 200 (1081)
T ss_pred chhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccc
Confidence 999888 66666555444443 444444455555555544433 222333
Q ss_pred cccccccCCcccccCCc------------------cccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCC-
Q 002189 193 AKHFHFGKNQLSGSIPE------------------KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS- 253 (955)
Q Consensus 193 L~~L~L~~N~l~g~ip~------------------~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~- 253 (955)
|+.|+...|+++ .+-. .......+|+.+++++|+++ .+|++++.+.+|+.|+..+|+|+
T Consensus 201 l~~l~c~rn~ls-~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~ 278 (1081)
T KOG0618|consen 201 LEVLHCERNQLS-ELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVA 278 (1081)
T ss_pred hhhhhhhhcccc-eEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhcccceEecccchhHHh
Confidence 344444444333 1100 00011234666666666666 34466666666666666666654
Q ss_pred ---------------------CCccccccCCCCCCEEEccCCcCcccCC-------------------------------
Q 002189 254 ---------------------GPVPSNLNNLTSVNDLYLSNNKLTGAMP------------------------------- 281 (955)
Q Consensus 254 ---------------------~~~p~~l~~l~~L~~L~Ls~N~l~~~~~------------------------------- 281 (955)
..+|.....+++|++|+|..|+|...++
T Consensus 279 lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~ 358 (1081)
T KOG0618|consen 279 LPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNH 358 (1081)
T ss_pred hHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhh
Confidence 0233333444445555555444443222
Q ss_pred -------------------CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEE
Q 002189 282 -------------------NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVV 342 (955)
Q Consensus 282 -------------------~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 342 (955)
-+.++++|+.|+|++|+|.. .....+.++..|++|+||+|.|+ .+|+.+..++.|++|.
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~-fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS-FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeeccccccc-CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 12233445555555555432 22233444555555555555555 4445555555555555
Q ss_pred eecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEecCc
Q 002189 343 MKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 343 Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~ 391 (955)
..+|+|...+ ....++.++.+||+.|+|+.+....-.+..+|+++|..
T Consensus 437 ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlS 484 (1081)
T KOG0618|consen 437 AHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLS 484 (1081)
T ss_pred hcCCceeech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeecc
Confidence 5555554433 45555566666666666666555444443455555444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-20 Score=205.90 Aligned_cols=259 Identities=30% Similarity=0.418 Sum_probs=198.3
Q ss_pred CCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCC-CcceEEEEEEeCCeEEEEEEe
Q 002189 630 FSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHK-NLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~e~ 705 (955)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999876 78999998764333 357799999999999988 799999999777778999999
Q ss_pred cCCCCcccccCCCCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~~ 783 (955)
+.++++.+++..... ..+.......++.+++.+++|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966654321 25788899999999999999999998 99999999999999988 79999999998665433
Q ss_pred Ccc----eeeeeecCCCCCCHHHhhh---CCCCChhhhHHHHHHHHHHHhCCCCCcCCchH--HHHHHHHHhhhhhhhhh
Q 002189 784 KDH----ITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI--VREIRTVMDKKKELYNL 854 (955)
Q Consensus 784 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~ 854 (955)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+...... .......+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---- 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT---- 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC----
Confidence 211 2355789999999999987 57889999999999999999999997654431 1122211111110
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+.............+.+++.+|+..+|..|.++.+....
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 -PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000011100002223567899999999999999999887765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-23 Score=218.31 Aligned_cols=148 Identities=26% Similarity=0.347 Sum_probs=119.3
Q ss_pred CCCCCCCC---ccEEeCC-----------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccc
Q 002189 49 NDPCGDNW---EGIGCTN-----------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKK 114 (955)
Q Consensus 49 ~~~C~~~w---~gv~C~~-----------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~ 114 (955)
+.+|.|+= .-|.|+. ...++|+|..|+|+.+.+.+|+.+.+|++||||+|+ |+.+-|++|..|.+
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~-Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNN-ISFIAPDAFKGLAS 116 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccc-hhhcChHhhhhhHh
Confidence 34565543 2388864 366788999999998888899999999999999996 89899999999999
Q ss_pred cccccccc-cccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhcc
Q 002189 115 LSNLMLVG-CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 193 (955)
Q Consensus 115 L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L 193 (955)
|.+|-+.+ |+|+...-..|++|..|+.|.+.-|++.....+.|..|++|..|.|.+|.+. .++. ..++.+..+
T Consensus 117 l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~-----~tf~~l~~i 190 (498)
T KOG4237|consen 117 LLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICK-----GTFQGLAAI 190 (498)
T ss_pred hhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhcc-----ccccchhcc
Confidence 99888877 8898555577999999999999999999888889999999999999999987 4443 234556666
Q ss_pred ccccccCCcc
Q 002189 194 KHFHFGKNQL 203 (955)
Q Consensus 194 ~~L~L~~N~l 203 (955)
+.+++..|.+
T Consensus 191 ~tlhlA~np~ 200 (498)
T KOG4237|consen 191 KTLHLAQNPF 200 (498)
T ss_pred chHhhhcCcc
Confidence 7777777764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=231.65 Aligned_cols=267 Identities=23% Similarity=0.374 Sum_probs=203.6
Q ss_pred EeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCC
Q 002189 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 139 (955)
Q Consensus 60 ~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 139 (955)
.|...+.+.|+|++++++ .+|..+. ++|+.|+|++|+ ++ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|
T Consensus 174 ~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~-Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L 243 (754)
T PRK15370 174 DCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNE-LK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTI 243 (754)
T ss_pred hhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCC-CC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccc
Confidence 455567889999999998 4666553 579999999997 66 5666554 58999999999998 6776654 479
Q ss_pred cEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCcccee
Q 002189 140 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLI 219 (955)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~ 219 (955)
+.|+|++|+|. .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|..+. ..|+
T Consensus 244 ~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--------~sL~~L~Ls~N~Lt-~LP~~lp---~sL~ 307 (754)
T PRK15370 244 QEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--------EELRYLSVYDNSIR-TLPAHLP---SGIT 307 (754)
T ss_pred cEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--------CCCcEEECCCCccc-cCcccch---hhHH
Confidence 99999999999 6777664 58999999999998 6776542 36788899999998 6886553 4688
Q ss_pred eeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCC
Q 002189 220 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 299 (955)
Q Consensus 220 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 299 (955)
.|++++|+++. +|..+. ++|+.|++++|.++ .+|..+. ++|+.|+|++|+|+.++..+. ++|++|+|++|+|
T Consensus 308 ~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~L 379 (754)
T PRK15370 308 HLNVQSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNAL 379 (754)
T ss_pred HHHhcCCcccc-CCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcC
Confidence 99999999984 565443 68999999999998 4776664 789999999999987665443 6899999999999
Q ss_pred CCCCCChhhcCCCCCCEEECcCCcceecCCcCC----CCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCcc
Q 002189 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADL----FSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRI 371 (955)
Q Consensus 300 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l 371 (955)
+. +|..+. ..|+.|++++|+|+ .+|..+ ..++++..|+|.+|+|+. ..+.+++.| ++.+.+
T Consensus 380 t~--LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~-----~tl~~L~~L-l~s~~~ 444 (754)
T PRK15370 380 TN--LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE-----RTIQNMQRL-MSSVGY 444 (754)
T ss_pred CC--CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH-----HHHHHHHHh-hhcccc
Confidence 74 666554 36889999999998 555543 445888999999999873 234445555 344443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.9e-21 Score=226.77 Aligned_cols=242 Identities=24% Similarity=0.306 Sum_probs=196.6
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|.+|+|+. +|. .+++|++|+|++|+ ++ .+|.. .++|+.|+|++|.|+ .+|..+ .+|+.|+
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~-Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~ 288 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQ-LT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLW 288 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCc-cC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEE
Confidence 478999999999995 554 36899999999997 66 45643 468999999999998 566533 5788999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|+|+ .+|.. +++|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|. ...+|+.|+|
T Consensus 289 Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~-~Lp~lp---------~~L~~L~Ls~N~L~-~LP~----lp~~Lq~LdL 349 (788)
T PRK15387 289 IFGNQLT-SLPVL---PPGLQELSVSDNQLA-SLPALP---------SELCKLWAYNNQLT-SLPT----LPSGLQELSV 349 (788)
T ss_pred CcCCccc-ccccc---ccccceeECCCCccc-cCCCCc---------ccccccccccCccc-cccc----cccccceEec
Confidence 9999999 56653 478999999999999 455421 34678899999998 6875 2357999999
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASE 303 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 303 (955)
++|+|++ +|.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++++.. .++|+.|+|++|+|+.
T Consensus 350 S~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Lss-- 416 (788)
T PRK15387 350 SDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLTS-- 416 (788)
T ss_pred CCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCcccCCCCc---ccCCCEEEccCCcCCC--
Confidence 9999995 5653 357889999999999 56754 36799999999999986653 3689999999999975
Q ss_pred CChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCC
Q 002189 304 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL 354 (955)
Q Consensus 304 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 354 (955)
+|.. ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+.
T Consensus 417 IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 417 LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 5654 346889999999999 7999999999999999999999986654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-23 Score=216.92 Aligned_cols=304 Identities=18% Similarity=0.190 Sum_probs=224.3
Q ss_pred cEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCC
Q 002189 58 GIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 137 (955)
Q Consensus 58 gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 137 (955)
+.+|++..=..+|-++.+++ .+|..+. +.-.+++|..|+ |+.+.|.+|+.+++|+.|+|++|+|+.+-|.+|..|.
T Consensus 40 pC~Cs~~~g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~-I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 40 PCTCSDVEGGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQ-ISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred CcccCCCCCceEEccCCCcc-cCcccCC--CcceEEEeccCC-cccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 77887633446688888888 5665543 356789999997 8988899999999999999999999999999999999
Q ss_pred CCcEEEccC-CCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCcc
Q 002189 138 ELVLLSLNS-NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDM 216 (955)
Q Consensus 138 ~L~~L~Ls~-N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~ 216 (955)
+|..|-+.+ |+|+..-...|.+|..|+.|.+.-|++.-... ..|..|.+|..|.+.+|.+. .|+...|..+.
T Consensus 116 ~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~------~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~ 188 (498)
T KOG4237|consen 116 SLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQ------DALRDLPSLSLLSLYDNKIQ-SICKGTFQGLA 188 (498)
T ss_pred hhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhH------HHHHHhhhcchhcccchhhh-hhccccccchh
Confidence 988877666 99996666689999999999999999983322 34677888888899999998 88888888888
Q ss_pred ceeeeeccCCCcc------------ccCCcccCCCCCCcEEEcccCCCCCCccccccCC-CCCCEEEccCCcCcccCC--
Q 002189 217 VLIHVLFDSNNLT------------GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNL-TSVNDLYLSNNKLTGAMP-- 281 (955)
Q Consensus 217 ~L~~L~L~~N~l~------------~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~~-- 281 (955)
.++.+.+..|.+. -..|..++...-..-..|.++++....+..|... ..+..=-.+.+...++.|
T Consensus 189 ~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~ 268 (498)
T KOG4237|consen 189 AIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAK 268 (498)
T ss_pred ccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHH
Confidence 8888888888833 2345555555555555666666654444433322 122211223333444444
Q ss_pred CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhh
Q 002189 282 NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSE 360 (955)
Q Consensus 282 ~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~ 360 (955)
.|.++++|+.|+|++|+|+. +.+.+|.++..|++|.|..|+|.......|.++..|+.|+|.+|+|+..-|..|. +..
T Consensus 269 cf~~L~~L~~lnlsnN~i~~-i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITR-IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred HHhhcccceEeccCCCccch-hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 37778888888888888876 6677888888888888888888877777777888888888888888887777665 444
Q ss_pred hhhhcccCCcccc
Q 002189 361 NLLVNLQNNRISA 373 (955)
Q Consensus 361 l~~L~L~~N~l~~ 373 (955)
+..|+|-.|++..
T Consensus 348 l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 348 LSTLNLLSNPFNC 360 (498)
T ss_pred eeeeehccCcccC
Confidence 5567777776654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-21 Score=228.09 Aligned_cols=337 Identities=17% Similarity=0.207 Sum_probs=193.1
Q ss_pred hhcCCHHHHHHHHHHHhhcCC-CCC----CCCCCC-CCCCCCC--------------ccEEeCCCCEeEEEecCCcCccc
Q 002189 20 AAVTNDNDFVILKALKDDIWE-NEP----PNWKNN-DPCGDNW--------------EGIGCTNSRVTSITLSGMGLKGQ 79 (955)
Q Consensus 20 ~~~~~~~~~~~L~~~k~~~~~-~~~----~~w~~~-~~C~~~w--------------~gv~C~~~~v~~L~L~~~~l~~~ 79 (955)
.+.+..++...+.+..+.+.- ... ..|.+. |+|.-.= .-|.|....|+.+..-+......
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence 444667888888777766532 222 348764 6684211 12889888898887766333221
Q ss_pred cCcCcCCCCcccEEe-cCCCCCCccCCC---CCc-----ccccccccccccccccCCCCCCccccCCCCcEEEccCCCCc
Q 002189 80 LSGDITGLTELHTLD-LSNNKDLRGPLP---TTI-----GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFS 150 (955)
Q Consensus 80 ~~~~l~~l~~L~~L~-Ls~N~~l~~~~p---~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 150 (955)
..+.-..-.+...-+ =..+. -.+..+ ..+ +-..+.+.|+|+++.++ .+|..+. ++|+.|+|++|+|+
T Consensus 137 ~~~~~~~~~~~~~w~~w~~~~-~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt 212 (754)
T PRK15370 137 ASGSKDAVNYELIWSEWVKEA-PAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK 212 (754)
T ss_pred CCCCCChhhHHHHHHHHHhcC-CCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC
Confidence 110000000000000 00000 000000 000 11134566677777666 4555443 35777777777777
Q ss_pred CcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccc
Q 002189 151 GRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 230 (955)
Q Consensus 151 ~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~ 230 (955)
.+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. .+|+.|+|++|+|+
T Consensus 213 -sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--------~~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~N~L~- 275 (754)
T PRK15370 213 -SLPENLQ--GNIKTLYANSNQLT-SIPATLP--------DTIQEMELSINRIT-ELPERLP---SALQSLDLFHNKIS- 275 (754)
T ss_pred -cCChhhc--cCCCEEECCCCccc-cCChhhh--------ccccEEECcCCccC-cCChhHh---CCCCEEECcCCccC-
Confidence 4555443 46777777777766 4554321 24566677777776 6666553 35677777777777
Q ss_pred cCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcC
Q 002189 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSS 310 (955)
Q Consensus 231 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~ 310 (955)
.+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|.++.++..+. ++|++|++++|.++. +|..+.
T Consensus 276 ~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~--LP~~l~- 345 (754)
T PRK15370 276 CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTS--LPASLP- 345 (754)
T ss_pred ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCcccc--CChhhc-
Confidence 4565543 46777777777777 4555443 467777788887776654432 577778888887764 555443
Q ss_pred CCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCC------CCCCcc
Q 002189 311 MQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERG------GAPAVN 384 (955)
Q Consensus 311 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~------~~~~~~ 384 (955)
++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..++... ..++.|++++|+|++++... ...+..
T Consensus 346 -~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~ 419 (754)
T PRK15370 346 -PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTR 419 (754)
T ss_pred -CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccE
Confidence 57888888888777 4665443 578888888888876544322 24667888888887765421 123455
Q ss_pred eeEecCcch
Q 002189 385 LTLIDNPIC 393 (955)
Q Consensus 385 L~~l~n~~c 393 (955)
|.+.+||+.
T Consensus 420 L~L~~Npls 428 (754)
T PRK15370 420 IIVEYNPFS 428 (754)
T ss_pred EEeeCCCcc
Confidence 666677753
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=237.24 Aligned_cols=314 Identities=18% Similarity=0.202 Sum_probs=224.8
Q ss_pred CCCEeEEEecCC------cCccccCcCcCCCC-cccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCcccc
Q 002189 63 NSRVTSITLSGM------GLKGQLSGDITGLT-ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 135 (955)
Q Consensus 63 ~~~v~~L~L~~~------~l~~~~~~~l~~l~-~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 135 (955)
..++..|.+..+ .+...+|..|..++ +|+.|++.+|. ...+|..| ...+|+.|+|.+|++. .++..+..
T Consensus 557 m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~--l~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~ 632 (1153)
T PLN03210 557 MRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYP--LRCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHS 632 (1153)
T ss_pred CccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCC--CCCCCCcC-CccCCcEEECcCcccc-cccccccc
Confidence 356777777554 23445677777764 58888888886 45677777 5688888888888887 67777888
Q ss_pred CCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCc
Q 002189 136 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPD 215 (955)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~ 215 (955)
+++|+.|+|++|.....+| .++.+++|+.|+|++|.....+|..+ ..|.+|+.|++++|..-+.+|..+ .+
T Consensus 633 l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si------~~L~~L~~L~L~~c~~L~~Lp~~i--~l 703 (1153)
T PLN03210 633 LTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSI------QYLNKLEDLDMSRCENLEILPTGI--NL 703 (1153)
T ss_pred CCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhh------hccCCCCEEeCCCCCCcCccCCcC--CC
Confidence 8888888888876544666 47788888888888877666777654 345667788888865444788765 46
Q ss_pred cceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCccc-------CC-CCCCCC
Q 002189 216 MVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA-------MP-NLTGLS 287 (955)
Q Consensus 216 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-------~~-~~~~l~ 287 (955)
.+|+.|+|++|...+.+|.. ..+|+.|+|++|.+. .+|..+ .+++|+.|+++++..... .+ .....+
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~ 778 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSP 778 (1153)
T ss_pred CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccc
Confidence 77888888888776666653 457888888888887 667655 577888888877543222 11 122346
Q ss_pred CCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhccc
Q 002189 288 VLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQ 367 (955)
Q Consensus 288 ~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~ 367 (955)
+|+.|+|++|.... .+|.+++++++|+.|+|++|...+.+|..+ .+++|+.|+|++|.....+|.. ..++..|+|+
T Consensus 779 sL~~L~Ls~n~~l~-~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--~~nL~~L~Ls 854 (1153)
T PLN03210 779 SLTRLFLSDIPSLV-ELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI--STNISDLNLS 854 (1153)
T ss_pred cchheeCCCCCCcc-ccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc--ccccCEeECC
Confidence 78888888887654 578888888888888888876555777765 6888888888887655544443 2456688888
Q ss_pred CCccccccCCCCCCCcceeEecCcchhcccCc
Q 002189 368 NNRISAYTERGGAPAVNLTLIDNPICQELGTA 399 (955)
Q Consensus 368 ~N~l~~~~~~~~~~~~~L~~l~n~~c~~~~~~ 399 (955)
+|.|+.++. .+..+.+|+.++...|.++...
T Consensus 855 ~n~i~~iP~-si~~l~~L~~L~L~~C~~L~~l 885 (1153)
T PLN03210 855 RTGIEEVPW-WIEKFSNLSFLDMNGCNNLQRV 885 (1153)
T ss_pred CCCCccChH-HHhcCCCCCEEECCCCCCcCcc
Confidence 888887654 3456677788877777777665
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.5e-23 Score=235.05 Aligned_cols=287 Identities=23% Similarity=0.265 Sum_probs=219.2
Q ss_pred CcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeee
Q 002189 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLD 167 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 167 (955)
++|+.|+.++|. ++...+ -..-.+|+++++++|+++ .+|+.++.+.+|+.|+..+|+|+ .+|..+..+++|++|+
T Consensus 219 ~~l~~L~a~~n~-l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~ 293 (1081)
T KOG0618|consen 219 PSLTALYADHNP-LTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLS 293 (1081)
T ss_pred cchheeeeccCc-ceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHH
Confidence 455666666664 442222 122347778888888887 56677888888888888888886 6777777778888888
Q ss_pred cCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccc-eeeeeccCCCccccCCcccCCCCCCcEEE
Q 002189 168 LTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMV-LIHVLFDSNNLTGELPATLGLVKSLEVVR 246 (955)
Q Consensus 168 L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~-L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 246 (955)
+..|.+. .+|.. +..+..|++|+|..|+|. .+|+..+..... |..|..+.|.+....-..=..++.|+.|+
T Consensus 294 ~~~nel~-yip~~------le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 294 AAYNELE-YIPPF------LEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY 365 (1081)
T ss_pred hhhhhhh-hCCCc------ccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence 8888877 55543 344666778888888887 888876665544 77777777777744322333467888999
Q ss_pred cccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcce
Q 002189 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 247 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
+.+|.++...-..+.+.++|+.|+|++|+|...+. .+.++..|+.|+||+|+++. +|..+.+++.|++|...+|+|.
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~--Lp~tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT--LPDTVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh--hhHHHHhhhhhHHHhhcCCcee
Confidence 99999998877788899999999999999998887 47889999999999999975 8899999999999999999998
Q ss_pred ecCCcCCCCCCCCcEEEeecCccee-eeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEecCc
Q 002189 326 GQIPADLFSIPHLQTVVMKTNELNG-TLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 326 ~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~ 391 (955)
.+| .+..++.|+.+|||.|+|+. .++.....++|++|||++|....+....+..+.++...++.
T Consensus 444 -~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~ 508 (1081)
T KOG0618|consen 444 -SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDIT 508 (1081)
T ss_pred -ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecc
Confidence 788 89999999999999999987 55555666889999999999766666666555555555444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=235.98 Aligned_cols=313 Identities=18% Similarity=0.204 Sum_probs=233.6
Q ss_pred CCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEE
Q 002189 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 142 (955)
...++.|++.++.+. .+|..| .+.+|++|+|++|+ + ..+|..+..+++|+.|+|++|...+.+|. +..+++|++|
T Consensus 588 p~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~-l-~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L 662 (1153)
T PLN03210 588 PPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSK-L-EKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETL 662 (1153)
T ss_pred CcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcc-c-cccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEE
Confidence 356889999998887 677776 57899999999997 4 46788889999999999998865557775 8889999999
Q ss_pred EccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeee
Q 002189 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVL 222 (955)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~ 222 (955)
+|++|.....+|..+.++++|+.|+|++|...+.+|..+ .+.+|+.|+|++|...+.+|.. ..+|+.|+
T Consensus 663 ~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-------~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~ 731 (1153)
T PLN03210 663 KLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-------NLKSLYRLNLSGCSRLKSFPDI----STNISWLD 731 (1153)
T ss_pred EecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-------CCCCCCEEeCCCCCCccccccc----cCCcCeee
Confidence 999987666889999999999999999876555777543 3667788899988766566643 45788999
Q ss_pred ccCCCccccCCcccCCCCCCcEEEcccCCCC-------CCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEEC
Q 002189 223 FDSNNLTGELPATLGLVKSLEVVRFDRNSLS-------GPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDM 294 (955)
Q Consensus 223 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-------~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L 294 (955)
|++|.+. .+|..+ .+++|+.|++.++... ...+..+...++|+.|+|++|...+..| .+.++++|+.|+|
T Consensus 732 L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~L 809 (1153)
T PLN03210 732 LDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI 809 (1153)
T ss_pred cCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEEC
Confidence 9999986 566655 5778888888764322 1122233345688888898886555444 6888888999999
Q ss_pred cCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccC-Ccccc
Q 002189 295 SNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN-NRISA 373 (955)
Q Consensus 295 s~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~-N~l~~ 373 (955)
++|.... .+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|++|.|+..+.....+.+|..|+|++ |++..
T Consensus 810 s~C~~L~-~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~C~~L~~ 884 (1153)
T PLN03210 810 ENCINLE-TLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQR 884 (1153)
T ss_pred CCCCCcC-eeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCccChHHHhcCCCCCEEECCCCCCcCc
Confidence 8875333 355554 6888888999888765555543 3578888899988887665556677888888888 55666
Q ss_pred ccCCCCCCCcceeEecCcchhcccCc
Q 002189 374 YTERGGAPAVNLTLIDNPICQELGTA 399 (955)
Q Consensus 374 ~~~~~~~~~~~L~~l~n~~c~~~~~~ 399 (955)
++. ....+.+|+.++...|.++...
T Consensus 885 l~~-~~~~L~~L~~L~l~~C~~L~~~ 909 (1153)
T PLN03210 885 VSL-NISKLKHLETVDFSDCGALTEA 909 (1153)
T ss_pred cCc-ccccccCCCeeecCCCcccccc
Confidence 555 3456788888888888776543
|
syringae 6; Provisional |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-21 Score=230.87 Aligned_cols=254 Identities=20% Similarity=0.255 Sum_probs=186.7
Q ss_pred ccCeeeccCceEEEEEEe-CCCcEEEEEEcccC--Ccchh----HHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 632 DANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGG----QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
..+++|.|++|.|+.+.. ...+..+.|.++.. ..... ..+..|+-+-..++|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456899999998887763 34455555544310 11111 225567778888899999888777777777666799
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|++. +|...+.... .+....+-.+..|+.+|+.|+|+.| +.|||+|++|++++.+|.+||+|||.+....-+..
T Consensus 402 ~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999887653 5777888899999999999999999 99999999999999999999999999976654444
Q ss_pred c--ceeeeeecCCCCCCHHHhhhCCCCCh-hhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 785 D--HITTQVKGTMGYLDPEYYMTQQLTEK-SDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 785 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
. ......+|+-.|+|||++.+..|++. .||||.|+++..|.+|+.||.......+......... ...+. .
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~------~~~~~-~ 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD------QRNIF-E 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc------ccccc-c
Confidence 3 45567889999999999999999875 8999999999999999999974332211110000000 00000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
-........+.....++.+|++.||.+|.|+++|+++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0011112233566789999999999999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.8e-20 Score=186.66 Aligned_cols=139 Identities=17% Similarity=0.207 Sum_probs=108.4
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc--h-------hHH-----------------HHHHHHHHHhccCCCc
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--G-------GQE-----------------FKMEIELLSRVHHKNL 686 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 686 (955)
...||+|+||+||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999878999999998754221 1 012 2349999999988876
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeeccCCCCccEEEcCC
Q 002189 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYL-HELANPPIIHRDIKSSNILLDER 765 (955)
Q Consensus 687 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlk~~NIll~~~ 765 (955)
.....+.. ...+|||||++++++....... ..+++.....++.|++.+|.|+ |+.+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 44333222 2348999999988776543222 3688899999999999999999 6888 99999999999998 4
Q ss_pred CceEEeeccccccc
Q 002189 766 LNAKVADFGLSKSM 779 (955)
Q Consensus 766 ~~~kl~DFGla~~~ 779 (955)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-20 Score=190.91 Aligned_cols=172 Identities=13% Similarity=0.135 Sum_probs=135.2
Q ss_pred HHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHH---------HHHHHHHHHhccCCCcceEEEEEEe
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQE---------FKMEIELLSRVHHKNLVSLLGFCFD 695 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~~~~~~ 695 (955)
...++|...+++|.|+||.||.+.. ++..+|||.++.......+. +.+|++.+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467999999999999999999766 57789999997643333222 6889999999999999999888664
Q ss_pred C--------CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc
Q 002189 696 R--------GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN 767 (955)
Q Consensus 696 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~ 767 (955)
. +..+|||||+++.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3 35789999999999977632 222 24558899999999999 99999999999999988
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHH
Q 002189 768 AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELL 825 (955)
Q Consensus 768 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ell 825 (955)
++++|||..+........ ..+.....+..++|+|+||+.+.-..
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988755321110 11455666778999999999887554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.7e-21 Score=221.16 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=177.9
Q ss_pred CCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCC-cchhHHHHHHHHH--HHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGS-MQGGQEFKMEIEL--LSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++...+.||++.|=+|.+|+.++|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999998887 8889875433 3344555554433 4455899999988887777788999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC-CCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS-DSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~-~~~~ 784 (955)
+.+ +|.|.+..+. -+...+...|+.|++.|+..+|..+ |+|||||.+||||+.-..+.|+||.--+... +.+.
T Consensus 103 vkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 954 8999887654 5777888899999999999999999 9999999999999999999999997654322 1121
Q ss_pred ----cceeeeeecCCCCCCHHHhhhC-----------CCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhh
Q 002189 785 ----DHITTQVKGTMGYLDPEYYMTQ-----------QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 785 ----~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 848 (955)
............|+|||.+... ..+++.||||.||+++|+++ |++||.- .+.......+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCc
Confidence 1112222344579999998642 15778999999999999999 5666631 11110000000
Q ss_pred hhhhh-hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 849 KELYN-LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 849 ~~~~~-~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..... +.++-| ..+..++..|++.||.+|.++++.++.
T Consensus 253 ~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00000 111112 246789999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-19 Score=179.58 Aligned_cols=140 Identities=15% Similarity=0.198 Sum_probs=111.4
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch--------------------------hHHHHHHHHHHHhccCCCc
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--------------------------GQEFKMEIELLSRVHHKNL 686 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 686 (955)
...||+|+||+||+|+..+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999997789999999987642210 1123578999999999988
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCcccc-cCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcC
Q 002189 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDS-LSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDE 764 (955)
Q Consensus 687 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~ 764 (955)
.....+... ..+|||||++++++... +.. ..++......++.+++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 654444333 34899999988865443 322 256778889999999999999999 88 99999999999999
Q ss_pred CCceEEeecccccccCC
Q 002189 765 RLNAKVADFGLSKSMSD 781 (955)
Q Consensus 765 ~~~~kl~DFGla~~~~~ 781 (955)
++.++|+|||+++....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=201.78 Aligned_cols=216 Identities=29% Similarity=0.470 Sum_probs=164.0
Q ss_pred HHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCC
Q 002189 678 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKS 757 (955)
Q Consensus 678 l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 757 (955)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.. ....++|.-...++.++++||+|+|... -..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 4578999999999999999999999999999999999986 3568999999999999999999999744 238999999
Q ss_pred ccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC---C----CCChhhhHHHHHHHHHHHhCCCC
Q 002189 758 SNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ---Q----LTEKSDVYSFGVLMLELLTGRRP 830 (955)
Q Consensus 758 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~ksDvwS~Gv~l~elltg~~P 830 (955)
+|+++|....+|++|||+.................-..-|.|||.+... . .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998766421111111122344569999999864 1 46789999999999999999999
Q ss_pred CcCCchHH---HHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 831 IERGKYIV---REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 831 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
|....... +.+..+.. . ....+.|.+.... +....+..++.+||..+|.+||+++++-..++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~-~-----~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-G-----GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh-c-----CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 97432221 12222111 0 1122333332111 344578999999999999999999999887776653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=173.86 Aligned_cols=185 Identities=15% Similarity=0.084 Sum_probs=140.4
Q ss_pred CccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch----hHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEEe
Q 002189 631 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG----GQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.....|++|+||+||.+.. ++.+++.+.+....... ...+.+|+++|+++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997765 67888888777543321 235889999999995 5889999886 346999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCC-CCccEEEcCCCceEEeecccccccCCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI-KSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
+++.+|...+.. ....+..+++++|+++|+.| |+|||| ||.||++++++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999888654321 11356788999999999999 999999 79999999999999999999986543321
Q ss_pred c----ce-------eeeeecCCCCCCHHHhhhC-CCC-ChhhhHHHHHHHHHHHhCCCCCc
Q 002189 785 D----HI-------TTQVKGTMGYLDPEYYMTQ-QLT-EKSDVYSFGVLMLELLTGRRPIE 832 (955)
Q Consensus 785 ~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~ksDvwS~Gv~l~elltg~~P~~ 832 (955)
. .. ......++.|++|+...-- ..+ .+.+.++-|+-+|.++|++.+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00 0113467889999865422 333 57799999999999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.7e-19 Score=199.65 Aligned_cols=225 Identities=29% Similarity=0.348 Sum_probs=177.4
Q ss_pred eeeccCceEEEEEE----eCCCcEEEEEEcccCCcch--hHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEEecC
Q 002189 635 DVGSGGYGKVYKGT----LPNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|+|.||.|+.++ .+.|..+|.|.+++..... ......|..++...+ ||.+|++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 2357889999887643322 123456888888887 9999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|.|...+.... .++..........+|-+++++|+.+ ++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 999988876544 5666666777788899999999999 999999999999999999999999999876544332
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
+||+.|||||++. .....+|.||||++.+||+||..||.. +....+.... ...+
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~---------------~~~p 207 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE---------------LEMP 207 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc---------------cCCc
Confidence 7999999999988 567899999999999999999999965 2222222111 1122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTM 892 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~ 892 (955)
........+++.++...+|..|.-.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2333556788888999999998644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.2e-18 Score=202.40 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=185.7
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc---CCCcceEEEEEEeCCeEE
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH---HKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~ 700 (955)
+..-+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....+ |.-=.+++.+|+ -+.|..+..++...+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34456788889999999999999998889999999987755432 322234444444 345666777777788899
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-------CCCceEEeec
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-------ERLNAKVADF 773 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-------~~~~~kl~DF 773 (955)
||+||.+.|+|.+++...+ -++|...+.++.++++.+++||..+ |||+||||+|.+|. +...++|+||
T Consensus 771 lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999999998443 6899999999999999999999999 99999999999994 3456899999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN 853 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 853 (955)
|.+-.+.--.........++|-.+-.+|...++.+++++|.|.++-+++-|+.|+.- . + ..+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------q-~-~~g~---- 908 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------E-V-KNGS---- 908 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------H-h-cCCc----
Confidence 999766533333455677899999999999999999999999999999999988631 1 1 1110
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
...++..+..-...+.. .+++..+|..|-..=|...++...+++++.+
T Consensus 909 -~~~~~~~~~Ry~~~~~W---~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 909 -SWMVKTNFPRYWKRDMW---NKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred -ceeccccchhhhhHHHH---HHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 00111111111112222 3445555554444447888888888877654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-18 Score=178.83 Aligned_cols=230 Identities=20% Similarity=0.244 Sum_probs=146.7
Q ss_pred CccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhcc----------CCCcceEEEEEE--
Q 002189 631 SDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVH----------HKNLVSLLGFCF-- 694 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~~-- 694 (955)
...+.||.|+|+.||.++.. +|+.+|||++.... ....+++++|.-....+. |-.++.-++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 34578999999999999975 58999999875332 223466777765554432 212222222221
Q ss_pred -------eC---C-----eEEEEEEecCCCCcccccCC---CC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccC
Q 002189 695 -------DR---G-----EQMLIYEFVPNGSLGDSLSG---KN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754 (955)
Q Consensus 695 -------~~---~-----~~~lV~e~~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 754 (955)
.. . ..+++|+-+ .++|.+.+.. .. ...+....++.+..|+++.+++||+.| ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 236677766 6688776431 11 223556677888899999999999999 99999
Q ss_pred CCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC--------CCCChhhhHHHHHHHHHHHh
Q 002189 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ--------QLTEKSDVYSFGVLMLELLT 826 (955)
Q Consensus 755 lk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~ksDvwS~Gv~l~ellt 826 (955)
|+|+|++++++|.++|+||+.....+.. .. ....+..|.+||..... .++.+.|.|++|+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR----YR-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE----EE-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce----ee-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987654321 11 13456789999987643 47889999999999999999
Q ss_pred CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 002189 827 GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDR 889 (955)
Q Consensus 827 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 889 (955)
|..||+....... .+.... .+.+.++.+.+||..+++.+|.+|
T Consensus 246 ~~lPf~~~~~~~~------------------~~~~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEAD------------------PEWDFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGST------------------SGGGGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccc------------------ccccch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 9999974322100 000111 222566889999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=169.94 Aligned_cols=137 Identities=20% Similarity=0.219 Sum_probs=106.9
Q ss_pred CCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-----cCCCcceEEEEEEeCC---e-EE
Q 002189 630 FSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-----HHKNLVSLLGFCFDRG---E-QM 700 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~-~~ 700 (955)
+...+.||+|+||.||. .-.++.. +||++........+++.+|+++++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 2234444 79988765455567899999999999 5799999999998864 3 33
Q ss_pred EEEEe--cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHH-HHhhhccCCCeeccCCCCccEEEcC----CCceEEeec
Q 002189 701 LIYEF--VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL-SYLHELANPPIIHRDIKSSNILLDE----RLNAKVADF 773 (955)
Q Consensus 701 lV~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlk~~NIll~~----~~~~kl~DF 773 (955)
+|+|| +++|+|.+++... .+++. ..++.+++.++ +|||+.+ |+||||||+||+++. +..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5579999999653 24444 35577888777 9999999 999999999999974 347999995
Q ss_pred ccc
Q 002189 774 GLS 776 (955)
Q Consensus 774 Gla 776 (955)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-19 Score=199.49 Aligned_cols=276 Identities=20% Similarity=0.203 Sum_probs=158.5
Q ss_pred EEEecCCcCc-cccCcCcCCCCcccEEecCCCCCCcc----CCCCCcccccccccccccccccCC------CCCCccccC
Q 002189 68 SITLSGMGLK-GQLSGDITGLTELHTLDLSNNKDLRG----PLPTTIGNLKKLSNLMLVGCSFSG------PIPDSIGSL 136 (955)
Q Consensus 68 ~L~L~~~~l~-~~~~~~l~~l~~L~~L~Ls~N~~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l 136 (955)
.|+|.++.++ ......+..+..|++|+|+++. ++. .++..+...++|++|+++++.+.+ .++..+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~-l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNT-LGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCC-CcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 4667777776 3344455666778888888775 432 234445566667777777776652 223345566
Q ss_pred CCCcEEEccCCCCcCcCCCCCCCCCC---cCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccC
Q 002189 137 QELVLLSLNSNGFSGRVPPSIGNLSN---LYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFR 213 (955)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~p~~~~~L~~---L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~ 213 (955)
++|+.|+|++|.+.+..+..+..+.+ |++|++++|++++.....+ ...+..+
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l--~~~l~~~----------------------- 135 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL--AKGLKDL----------------------- 135 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH--HHHHHhC-----------------------
Confidence 67777777777776544444444444 7777777776652100000 0011112
Q ss_pred CccceeeeeccCCCccc----cCCcccCCCCCCcEEEcccCCCCCC----ccccccCCCCCCEEEccCCcCcccCC----
Q 002189 214 PDMVLIHVLFDSNNLTG----ELPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAMP---- 281 (955)
Q Consensus 214 ~~~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~---- 281 (955)
..+|+.|++++|.+++ .++..+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++...
T Consensus 136 -~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 214 (319)
T cd00116 136 -PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALA 214 (319)
T ss_pred -CCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHH
Confidence 1345555555555552 2334455666777777777777632 33445556677777777777764322
Q ss_pred -CCCCCCCCCEEECcCCCCCCCCCChhhc----CCCCCCEEECcCCcce----ecCCcCCCCCCCCcEEEeecCcceeee
Q 002189 282 -NLTGLSVLSYLDMSNNSFDASEVPSWFS----SMQSLTTLMMENTNLK----GQIPADLFSIPHLQTVVMKTNELNGTL 352 (955)
Q Consensus 282 -~~~~l~~L~~L~Ls~N~l~~~~~p~~~~----~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 352 (955)
.+..+++|++|++++|.++...+..... ..+.|+.|++++|.++ ..+...+..+++|++|++++|.++...
T Consensus 215 ~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~ 294 (319)
T cd00116 215 ETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEG 294 (319)
T ss_pred HHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHH
Confidence 3555677778888877775411111111 2367888888888776 233445556677888888888887542
Q ss_pred ----CCCcc-h-hhhhhhcccCCc
Q 002189 353 ----DLGTS-Y-SENLLVNLQNNR 370 (955)
Q Consensus 353 ----~~~~~-~-~~l~~L~L~~N~ 370 (955)
...+. . ..++.|++.+|.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 295 AQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHHHHHHHhhcCCchhhcccCCCC
Confidence 21211 2 345566666664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=166.05 Aligned_cols=134 Identities=21% Similarity=0.340 Sum_probs=113.8
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEcccCCcc--------hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 634 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+.||+|++|.||+|+. +|..|+||+....... ....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6788999986643221 123577899999999999998888787788889999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
+++++|.+++.... + .+..++.+++.+|.++|+.+ ++|||++|+||+++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998886432 2 78899999999999999988 99999999999999 78899999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-17 Score=183.97 Aligned_cols=175 Identities=27% Similarity=0.380 Sum_probs=131.5
Q ss_pred eEEEEEEecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
..|+.|+++...+|.+|+.... ....++.....++.|++.|++| .+ .+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999997443 4567888999999999999999 56 899999999999999999999999999
Q ss_pred cccCCCC----CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 777 KSMSDSE----KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 777 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
....... ....++.-.||..||+||.+.+..|+.|+||||+|++++|++. +|.....-......+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r------- 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIR------- 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhh-------
Confidence 8776544 2233456789999999999999999999999999999999996 3321111111111000
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 895 (955)
...++|..-.+++ +=+.|+++++.+.|.+||++.++
T Consensus 474 --~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 --DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 0112222222222 23589999999999999954443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-16 Score=165.64 Aligned_cols=143 Identities=15% Similarity=0.186 Sum_probs=110.8
Q ss_pred CCCccCeeeccCceEEEEEE--eCCCcEEEEEEcccCCcc------------------------hhHHHHHHHHHHHhcc
Q 002189 629 NFSDANDVGSGGYGKVYKGT--LPNGQLIAIKRAQQGSMQ------------------------GGQEFKMEIELLSRVH 682 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 682 (955)
.|...+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 568999999998753210 0123568999999997
Q ss_pred CCC--cceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccE
Q 002189 683 HKN--LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNI 760 (955)
Q Consensus 683 H~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NI 760 (955)
+.. +.+.+++ ...++||||+++++|....... ..........++.|++.+++|||+.+ .++||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 633 3344442 2358999999998887765322 24556667889999999999999865 399999999999
Q ss_pred EEcCCCceEEeecccccccC
Q 002189 761 LLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 761 ll~~~~~~kl~DFGla~~~~ 780 (955)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=187.46 Aligned_cols=208 Identities=25% Similarity=0.321 Sum_probs=143.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+|..++.|-.|+||.||.++++ ..+.+|+|.=++.. +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee-------------------
Confidence 47888899999999999999875 36778884433211 1100 22222233332
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc-
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD- 785 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~- 785 (955)
|+-...++..+..+.+ ++.+++|+|+.+ |+|||+||+|.+|+.-|.+|++|||+++........
T Consensus 136 --gDc~tllk~~g~lPvd----------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVD----------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCCCCcch----------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 4444555543322222 267899999998 999999999999999999999999998753211110
Q ss_pred ------------ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhh
Q 002189 786 ------------HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN 853 (955)
Q Consensus 786 ------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 853 (955)
.....++||+.|+|||++..+.|...+|.|++|+++||.+-|..||+++ +..+.+..++.....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-tpeelfg~visd~i~--- 276 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIE--- 276 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-CHHHHHhhhhhhhcc---
Confidence 1122468999999999999999999999999999999999999999654 333333333332221
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 890 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 890 (955)
+.+- ....+.++.+++.+.++.+|.+|-
T Consensus 277 wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 WPEE---------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111 223346788999999999999994
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=161.63 Aligned_cols=144 Identities=18% Similarity=0.174 Sum_probs=111.9
Q ss_pred HHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc----------------------hhHHHHHHHHHHH
Q 002189 622 EVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ----------------------GGQEFKMEIELLS 679 (955)
Q Consensus 622 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 679 (955)
++......|...+.||+|+||.||+|...+|+.||||+++..... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333333347778899999999999999888999999987643210 0123677899999
Q ss_pred hccCCC--cceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCC
Q 002189 680 RVHHKN--LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKS 757 (955)
Q Consensus 680 ~l~H~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 757 (955)
.+.|++ +.+.++ ....++||||+++++|...... .....++.++++++.++|+.+ ++||||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 998874 444443 2456899999999998765431 234568889999999999988 99999999
Q ss_pred ccEEEcCCCceEEeecccccccC
Q 002189 758 SNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 758 ~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-19 Score=200.58 Aligned_cols=261 Identities=23% Similarity=0.245 Sum_probs=175.7
Q ss_pred CCEeEEEecCCcCcc----ccCcCcCCCCcccEEecCCCCCCcc------CCCCCcccccccccccccccccCCCCCCcc
Q 002189 64 SRVTSITLSGMGLKG----QLSGDITGLTELHTLDLSNNKDLRG------PLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 133 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~----~~~~~l~~l~~L~~L~Ls~N~~l~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 133 (955)
..++.|+|+++.++. .++..+...+.|++|+++++. +.+ .++..+..+++|+.|+|++|.+.+..+..+
T Consensus 23 ~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~-~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~ 101 (319)
T cd00116 23 LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE-TGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVL 101 (319)
T ss_pred hhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccc-cCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHH
Confidence 348999999999854 356667788999999999996 542 234567788899999999999987777777
Q ss_pred ccCCC---CcEEEccCCCCcC----cCCCCCCCC-CCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccc
Q 002189 134 GSLQE---LVLLSLNSNGFSG----RVPPSIGNL-SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 205 (955)
Q Consensus 134 ~~l~~---L~~L~Ls~N~l~~----~~p~~~~~L-~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g 205 (955)
..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++.....+ ...+..+..|++|++++|.+++
T Consensus 102 ~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~--~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 102 ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL--AKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH--HHHHHhCCCcCEEECcCCCCch
Confidence 76666 9999999999983 333456667 899999999999984322111 0112233345555555555442
Q ss_pred cCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCC----ccccccCCCCCCEEEccCCcCcccCC
Q 002189 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAMP 281 (955)
Q Consensus 206 ~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~ 281 (955)
... ..++..+..+++|+.|+|++|.+++. +...+..+++|+.|++++|.+++...
T Consensus 180 ~~~---------------------~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 180 AGI---------------------RALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HHH---------------------HHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence 100 12334455556777778877777633 34455667778888888887775221
Q ss_pred -CC-----CCCCCCCEEECcCCCCCCC---CCChhhcCCCCCCEEECcCCcceec----CCcCCCCC-CCCcEEEeecCc
Q 002189 282 -NL-----TGLSVLSYLDMSNNSFDAS---EVPSWFSSMQSLTTLMMENTNLKGQ----IPADLFSI-PHLQTVVMKTNE 347 (955)
Q Consensus 282 -~~-----~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~ 347 (955)
.+ ...+.|+.|++++|.++.. .+...+..+++|+.|++++|.++.. +...+... +.|+.|++.+|+
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 11 1246788888888887521 2234456667888888888888844 44444445 678888888886
Q ss_pred c
Q 002189 348 L 348 (955)
Q Consensus 348 l 348 (955)
+
T Consensus 319 ~ 319 (319)
T cd00116 319 F 319 (319)
T ss_pred C
Confidence 4
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-18 Score=161.51 Aligned_cols=166 Identities=30% Similarity=0.507 Sum_probs=114.9
Q ss_pred CcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCC
Q 002189 83 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSN 162 (955)
Q Consensus 83 ~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~ 162 (955)
.+.++++++.|.||+|+ + ..+|..+..|.+|+.|++++|+|. .+|.+++.|++|+.|+++-|++. .+|..|+.++.
T Consensus 28 gLf~~s~ITrLtLSHNK-l-~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNK-L-TVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred cccchhhhhhhhcccCc-e-eecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence 34566777777777776 3 355667777777777777777777 67777777777777777777777 67777777777
Q ss_pred cCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCC
Q 002189 163 LYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSL 242 (955)
Q Consensus 163 L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L 242 (955)
|+.|||..|++... .+|..+| .+..|..|+|++|.+. .+|..++++++|
T Consensus 104 levldltynnl~e~-----------------------------~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~l 152 (264)
T KOG0617|consen 104 LEVLDLTYNNLNEN-----------------------------SLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNL 152 (264)
T ss_pred hhhhhccccccccc-----------------------------cCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhcce
Confidence 77777777776521 2222222 2334455555555554 677777778888
Q ss_pred cEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCC
Q 002189 243 EVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLT 284 (955)
Q Consensus 243 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 284 (955)
+.|.+..|.+- .+|..++.++.|++|++.+|+++-++|++.
T Consensus 153 qil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~ 193 (264)
T KOG0617|consen 153 QILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELA 193 (264)
T ss_pred eEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhh
Confidence 88888887777 677888888888888888888777776544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=162.68 Aligned_cols=130 Identities=24% Similarity=0.355 Sum_probs=107.0
Q ss_pred eeeccCceEEEEEEeCCCcEEEEEEcccCCcc--------hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 635 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.||+|+||+||+|.+ +|..|++|+....... ..+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 5788999986543211 1245778999999999988766666666777789999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
++++|.+.+.... ..++.+++++|.++|+.+ ++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988775432 078999999999999998 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.5e-16 Score=186.13 Aligned_cols=141 Identities=21% Similarity=0.312 Sum_probs=113.3
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEE-cccC-Cc------chhHHHHHHHHHHHhccCCCcceEEEEEEe
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKR-AQQG-SM------QGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~-~~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 695 (955)
......|...+.||+|+||+||+|.+.+.. +++|+ ..+. .. ...+.+.+|+++++.++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 333445567789999999999999876544 33333 2221 11 112468899999999999999988888888
Q ss_pred CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 696 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
....++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+||++ +++.++|+|||+
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 788899999999999988774 35678999999999999998 9999999999999 577899999999
Q ss_pred cccc
Q 002189 776 SKSM 779 (955)
Q Consensus 776 a~~~ 779 (955)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 8753
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.1e-18 Score=159.49 Aligned_cols=155 Identities=21% Similarity=0.379 Sum_probs=114.3
Q ss_pred eeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCC
Q 002189 220 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 299 (955)
Q Consensus 220 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 299 (955)
.|.|++|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++...+..|+.++-|+.|||++|++
T Consensus 37 rLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl 114 (264)
T KOG0617|consen 37 RLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNL 114 (264)
T ss_pred hhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcccccc
Confidence 3334444444 55666677777777777777777 677777777777777777777777777777777777777777777
Q ss_pred CCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCC
Q 002189 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTER 377 (955)
Q Consensus 300 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~ 377 (955)
.....|..|..|..|+.|+|++|.+. .+|..+++|++|+.|.+..|.+...+...-.+..++.|.+++|+++-++|+
T Consensus 115 ~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 115 NENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred ccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeeecChh
Confidence 77677777777777777777777777 777777778888888888877777766666777777888888888877776
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.5e-16 Score=184.65 Aligned_cols=151 Identities=34% Similarity=0.596 Sum_probs=111.1
Q ss_pred hcCCHHHHHHHHHHHhhcCCCCCCCCCCCCCCC---CCCccEEeCC------CCEeEEEecCCcCccccCcCcCCCCccc
Q 002189 21 AVTNDNDFVILKALKDDIWENEPPNWKNNDPCG---DNWEGIGCTN------SRVTSITLSGMGLKGQLSGDITGLTELH 91 (955)
Q Consensus 21 ~~~~~~~~~~L~~~k~~~~~~~~~~w~~~~~C~---~~w~gv~C~~------~~v~~L~L~~~~l~~~~~~~l~~l~~L~ 91 (955)
+.+.+.|..+|+++|+++......+|.+ |+|+ +.|.||.|+. ..|+.|+|++|++.|.+|..+..|++|+
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 3456789999999999885332248975 5773 3699999952 1477888888888888888888888888
Q ss_pred EEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCC-CCcCeeecCC
Q 002189 92 TLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNL-SNLYWLDLTD 170 (955)
Q Consensus 92 ~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L-~~L~~L~L~~ 170 (955)
.|+|++|+ +.|.+|..++.+++|+.|+|++|+++|.+|..+++|++|++|+|++|+++|.+|..+..+ .++..+++.+
T Consensus 446 ~L~Ls~N~-l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~ 524 (623)
T PLN03150 446 SINLSGNS-IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524 (623)
T ss_pred EEECCCCc-ccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence 88888875 777777777777777777777777777777777777777777777777777777766543 3455555555
Q ss_pred cee
Q 002189 171 NKL 173 (955)
Q Consensus 171 N~l 173 (955)
|..
T Consensus 525 N~~ 527 (623)
T PLN03150 525 NAG 527 (623)
T ss_pred Ccc
Confidence 543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.7e-15 Score=157.38 Aligned_cols=194 Identities=21% Similarity=0.272 Sum_probs=133.3
Q ss_pred cCCCcceEEEEEEe---------------------------CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHH
Q 002189 682 HHKNLVSLLGFCFD---------------------------RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG 734 (955)
Q Consensus 682 ~H~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 734 (955)
+|||||++.++|.+ ....|+||.-.+ .+|.+++..+ ..+...+.-+..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999988754 234688888774 4788887654 3556667778899
Q ss_pred HHHHHHHhhhccCCCeeccCCCCccEEE--cCCC--ceEEeecccccccCCCC----CcceeeeeecCCCCCCHHHhhhC
Q 002189 735 AARGLSYLHELANPPIIHRDIKSSNILL--DERL--NAKVADFGLSKSMSDSE----KDHITTQVKGTMGYLDPEYYMTQ 806 (955)
Q Consensus 735 ia~gL~yLH~~~~~~ivHrDlk~~NIll--~~~~--~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~ 806 (955)
+++|+.|||.+| |.|||+|++|||+ |+|+ ...|+|||.+---.... ........-|...-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999999 9999999999998 3443 46789999763221100 00111123477789999998743
Q ss_pred C------CCChhhhHHHHHHHHHHHhCCCCCcC-CchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHH
Q 002189 807 Q------LTEKSDVYSFGVLMLELLTGRRPIER-GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLAL 879 (955)
Q Consensus 807 ~------~~~ksDvwS~Gv~l~elltg~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~ 879 (955)
. --.|+|.|+.|.+.||+++...||.. ++...+.. . ..+.--|.+ +..++..+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-~----------Yqe~qLPal----p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-T----------YQESQLPAL----PSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-h----------hhhhhCCCC----cccCChHHHHHHH
Confidence 2 13589999999999999999999874 22221111 1 011111222 2234466789999
Q ss_pred HhhccCCCCCCCHHHHHH
Q 002189 880 KCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 880 ~cl~~dP~~RPs~~evl~ 897 (955)
..++.||.+|++..-...
T Consensus 492 ~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHhcCCccccCCccHHHh
Confidence 999999999988654443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-14 Score=140.86 Aligned_cols=135 Identities=19% Similarity=0.210 Sum_probs=114.9
Q ss_pred ccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccC--CCcceEEEEEEeCCeEEEEEEecCCC
Q 002189 632 DANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH--KNLVSLLGFCFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~g 709 (955)
+.+.||+|.++.||++...+ ..+++|..+.... ...+.+|+.+++.++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999754 7899999876433 4678999999999986 58999999888888899999999888
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.+..+ +......++.+++++++++|......++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4566778899999999999986445599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=148.52 Aligned_cols=137 Identities=18% Similarity=0.238 Sum_probs=100.0
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch--hHH----------------------HHHHHHHHHhccCCC--c
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG--GQE----------------------FKMEIELLSRVHHKN--L 686 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--i 686 (955)
.+.||+|+||+||+|...+|+.||||+++...... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999887532211 111 135666666665443 4
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCcccc-cCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcC
Q 002189 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDS-LSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDE 764 (955)
Q Consensus 687 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~ 764 (955)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 455443 246899999998654321 21111 11 4567889999999999998 77 99999999999999
Q ss_pred CCceEEeecccccccCC
Q 002189 765 RLNAKVADFGLSKSMSD 781 (955)
Q Consensus 765 ~~~~kl~DFGla~~~~~ 781 (955)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.7e-14 Score=147.05 Aligned_cols=135 Identities=20% Similarity=0.209 Sum_probs=105.2
Q ss_pred cCeee-ccCceEEEEEEeCCCcEEEEEEcccCC-------------cchhHHHHHHHHHHHhccCCCc--ceEEEEEEeC
Q 002189 633 ANDVG-SGGYGKVYKGTLPNGQLIAIKRAQQGS-------------MQGGQEFKMEIELLSRVHHKNL--VSLLGFCFDR 696 (955)
Q Consensus 633 ~~~lG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 696 (955)
...|| .|+.|+||++... +..++||+++... ......+.+|++++.+++|++| ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999875 6789999875321 1123457889999999998875 6777765443
Q ss_pred C----eEEEEEEecCC-CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 697 G----EQMLIYEFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 697 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
. ..++||||+++ .+|.+++... .++.. .+.+++.++.+||+.| |+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6888887542 34433 3568899999999999 9999999999999999999999
Q ss_pred ecccccc
Q 002189 772 DFGLSKS 778 (955)
Q Consensus 772 DFGla~~ 778 (955)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.4e-15 Score=178.13 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=187.4
Q ss_pred CCCccCeeeccCceEEEEEEeC--CCcEEEEEEcccCC--cchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP--NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 703 (955)
.|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 3555667999999999887643 34567777665432 122234445777777776 999999999999999999999
Q ss_pred EecCCCCccccc-CCCCCCCCCHHHHHHHHHHHHHHHHHhh-hccCCCeeccCCCCccEEEcCCC-ceEEeecccccccC
Q 002189 704 EFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLH-ELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMS 780 (955)
Q Consensus 704 e~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~ 780 (955)
||..+|++.+-+ +... ...+....-....|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999988 4332 13444455667889999999999 777 99999999999999999 99999999998887
Q ss_pred C-CCCcceeeeeec-CCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 781 D-SEKDHITTQVKG-TMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 781 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
. .+.........| ++.|+|||...+. ......|+||.|+++.-+++|..|++................
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~--------- 247 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK--------- 247 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---------
Confidence 6 555555556778 9999999999874 446789999999999999999999974432211111111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+ ...............++..+++..+|..|.+.+++..+
T Consensus 248 -~-~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 -G-RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -c-ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0 00011111222556788889999999999999888754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.1e-12 Score=147.33 Aligned_cols=141 Identities=20% Similarity=0.255 Sum_probs=100.6
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch----------------------------------------hHHHH
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG----------------------------------------GQEFK 672 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~ 672 (955)
.+.||.|++|+||+|++.+|+.||||+.+++.... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999987542110 01244
Q ss_pred HHHHHHHhcc----CCCcceEEEEEE-eCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHH-HHHHhhhcc
Q 002189 673 MEIELLSRVH----HKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR-GLSYLHELA 746 (955)
Q Consensus 673 ~E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 746 (955)
+|.+.+.+++ |.+-+.+-..+. .....+|||||+++++|.+....... .. .+..++..+++ .+.++|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 5666555552 333233333332 24567999999999999887643211 12 23456666665 467889888
Q ss_pred CCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 747 ~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
++|+|+||.||++++++.++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.7e-15 Score=161.78 Aligned_cols=174 Identities=30% Similarity=0.428 Sum_probs=90.3
Q ss_pred CCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCee
Q 002189 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWL 166 (955)
Q Consensus 87 l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L 166 (955)
|+.-...||+.|+ ...+|..+..+..|+.|.|.+|.+. .+|..+.+|..|++|||+.|+++ .+|..++.|+ |+.|
T Consensus 74 ltdt~~aDlsrNR--~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 74 LTDTVFADLSRNR--FSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred ccchhhhhccccc--cccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3444445555554 2344445555555555555555555 45555555555555555555555 4444444432 4444
Q ss_pred ecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEE
Q 002189 167 DLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 246 (955)
Q Consensus 167 ~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 246 (955)
-+++|+++ .+|+++. ....|..|+.+.|++. .+|..++.+.+|+.|.
T Consensus 149 i~sNNkl~-------------------------------~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~ 195 (722)
T KOG0532|consen 149 IVSNNKLT-------------------------------SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLN 195 (722)
T ss_pred EEecCccc-------------------------------cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHH
Confidence 44444444 3444433 3344444444444444 4555566666666666
Q ss_pred cccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCC
Q 002189 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 247 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 300 (955)
+..|++. .+|..+. .-.|..||+|.|+++.+|..|.+|+.|++|-|.+|.|+
T Consensus 196 vrRn~l~-~lp~El~-~LpLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 196 VRRNHLE-DLPEELC-SLPLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred Hhhhhhh-hCCHHHh-CCceeeeecccCceeecchhhhhhhhheeeeeccCCCC
Confidence 6666665 5555555 33455566666666655556666666666666666664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.2e-13 Score=151.63 Aligned_cols=247 Identities=22% Similarity=0.212 Sum_probs=182.1
Q ss_pred CCCccCeeec--cCceEEEEEEe---CCCcEEEEEEcccC--CcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEE
Q 002189 629 NFSDANDVGS--GGYGKVYKGTL---PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 629 ~f~~~~~lG~--G~fg~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 700 (955)
.|.....+|. |.+|.||++.. .++..+|+|+-+.. .......=.+|+....+++ |+|.|+.+..+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4567788999 99999999986 36889999984432 2233334456777777774 999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHH----HHHHhhhccCCCeeccCCCCccEEEcCC-CceEEeeccc
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR----GLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGL 775 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGl 775 (955)
+-+|++ +.+|..+.+.... .++....+....+..+ |+.++|+.. ++|-|+||.||++..+ ..++++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 999998 5788777765432 3455556666677777 999999988 9999999999999999 8999999999
Q ss_pred ccccCCCCCccee---eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 776 SKSMSDSEKDHIT---TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 776 a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
...+++....... ....|...|++||.. .+.++..+|+|++|.++.|..++......+.+. .|
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W------------ 335 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SW------------ 335 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-Cc------------
Confidence 9988766532222 123678889999976 467889999999999999999987776443211 00
Q ss_pred hhhhccCCc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 853 NLYELIDPT-IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 853 ~~~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
..+++. ++.++......++...+..|++.+|..|++.+.+..
T Consensus 336 ---~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 ---SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 001110 112222222345566889999999999999888765
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.2e-13 Score=151.48 Aligned_cols=177 Identities=30% Similarity=0.438 Sum_probs=83.0
Q ss_pred ccccccccccccccccCCCCCCccccCC-CCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchh
Q 002189 110 GNLKKLSNLMLVGCSFSGPIPDSIGSLQ-ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188 (955)
Q Consensus 110 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~ 188 (955)
..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+
T Consensus 113 ~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~------ 183 (394)
T COG4886 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLS------ 183 (394)
T ss_pred hcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhh------
Confidence 33344555555555555 4444444442 5555555555555 34344455555555555555554 2221111
Q ss_pred hhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCE
Q 002189 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 268 (955)
Q Consensus 189 ~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 268 (955)
.+..|+.|++++|+++ .+|... .....|.+|.+++|.+. ..+..+.++.++..|.+.+|++. .++..+..+++|+.
T Consensus 184 ~~~~L~~L~ls~N~i~-~l~~~~-~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~ 259 (394)
T COG4886 184 NLSNLNNLDLSGNKIS-DLPPEI-ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLET 259 (394)
T ss_pred hhhhhhheeccCCccc-cCchhh-hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccce
Confidence 2333444444444444 343322 01122344444444322 33444555555555555555555 33455555555555
Q ss_pred EEccCCcCcccCCCCCCCCCCCEEECcCCCCC
Q 002189 269 LYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 269 L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 300 (955)
|++++|.++.+.. +..+.+|+.|++++|.+.
T Consensus 260 L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 260 LDLSNNQISSISS-LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred ecccccccccccc-ccccCccCEEeccCcccc
Confidence 5555555555444 555555555555555554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=150.85 Aligned_cols=206 Identities=30% Similarity=0.426 Sum_probs=149.0
Q ss_pred cccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCC-CcCeeecCCceeeeccCCCCCCCCchhhhhcccc
Q 002189 117 NLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLS-NLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 195 (955)
Q Consensus 117 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~-~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~ 195 (955)
.|++..|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+| ..+..+++|+.
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~------~~~~~l~~L~~ 167 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP------SPLRNLPNLKN 167 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhh------hhhhccccccc
Confidence 5778888875 23334566688889999999988 6777777774 8888888888887 443 23445666667
Q ss_pred ccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCc
Q 002189 196 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK 275 (955)
Q Consensus 196 L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 275 (955)
|++++|+++ .+|...+.+++|+.|++++|+++ .+|........|++|.+++|.
T Consensus 168 L~l~~N~l~--------------------------~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 168 LDLSFNDLS--------------------------DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cccCCchhh--------------------------hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 777777776 33444446677777788888877 667766666778888888887
Q ss_pred CcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCC
Q 002189 276 LTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG 355 (955)
Q Consensus 276 l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 355 (955)
+...+..+..+.++..|.+++|++.. .+..++.++.|+.|++++|.++...+ +..+.+|+.|++++|.++..++..
T Consensus 221 ~~~~~~~~~~~~~l~~l~l~~n~~~~--~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 221 IIELLSSLSNLKNLSGLELSNNKLED--LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred ceecchhhhhcccccccccCCceeee--ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 66666677777888888888888743 46777888888888888888884333 788888888888888888877766
Q ss_pred cchhhhh
Q 002189 356 TSYSENL 362 (955)
Q Consensus 356 ~~~~~l~ 362 (955)
.......
T Consensus 297 ~~~~~~~ 303 (394)
T COG4886 297 ALLLLLL 303 (394)
T ss_pred hccchhH
Confidence 5544333
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.5e-14 Score=155.13 Aligned_cols=182 Identities=32% Similarity=0.462 Sum_probs=147.8
Q ss_pred ccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhh
Q 002189 110 GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 189 (955)
Q Consensus 110 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~ 189 (955)
..+..-...+|+.|++. .+|..+..+..|+.|.|.+|.|. .+|..+++|..|++|||+.|+++
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS--------------- 134 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS--------------- 134 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh---------------
Confidence 44556667888888888 88888888888888888888888 78888888888888888888887
Q ss_pred hhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEE
Q 002189 190 LVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDL 269 (955)
Q Consensus 190 L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 269 (955)
.+|..++.. -|+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|
T Consensus 135 ----------------~lp~~lC~l--pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l 194 (722)
T KOG0532|consen 135 ----------------HLPDGLCDL--PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDL 194 (722)
T ss_pred ----------------cCChhhhcC--cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHH
Confidence 444444432 2788888999998 88989999999999999999998 889999999999999
Q ss_pred EccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCC
Q 002189 270 YLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADL 332 (955)
Q Consensus 270 ~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 332 (955)
++..|++..+++++..| .|..||+|.|+++. +|-.|.+|+.|++|-|.+|.|. .-|..+
T Consensus 195 ~vrRn~l~~lp~El~~L-pLi~lDfScNkis~--iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 195 NVRRNHLEDLPEELCSL-PLIRLDFSCNKISY--LPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred HHhhhhhhhCCHHHhCC-ceeeeecccCceee--cchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 99999999988887754 48888888888854 7888888888888888888887 334433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1e-12 Score=136.30 Aligned_cols=205 Identities=22% Similarity=0.292 Sum_probs=139.6
Q ss_pred HHHHHhccCCCcceEEEEEEeCC-----eEEEEEEecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccC
Q 002189 675 IELLSRVHHKNLVSLLGFCFDRG-----EQMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELAN 747 (955)
Q Consensus 675 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 747 (955)
.+-+-.+.|.|||+++.|+.+.. ...+++|||.-|++..+|+.-. ...+......+|+.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34455667999999999997644 4688999999999999997532 345666666789999999999999865
Q ss_pred CCeeccCCCCccEEEcCCCceEEeecccccccCC--CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHH
Q 002189 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD--SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELL 825 (955)
Q Consensus 748 ~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ell 825 (955)
|+|+|+++..+-|++..++-+|++--.-...... ...........+-++|.|||+-.....+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8899999999999999999888753211111000 00001111234678999999887777888999999999999998
Q ss_pred hCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 826 TGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 826 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
-|.---..+..-+..-..+ ... +...-++.- .+++.+|++..|..||+|.+++.+
T Consensus 277 ilEiq~tnseS~~~~ee~i-a~~-----i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENI-ANV-----IIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhh-hhh-----eeeccCccc------------cCcCcccccCCCCCCcchhhhhcC
Confidence 7664322221111000000 000 001111111 257889999999999999998753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-10 Score=135.36 Aligned_cols=145 Identities=16% Similarity=0.223 Sum_probs=96.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC-CcEEEEEEcccCCcch----------------------------------h---
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQG----------------------------------G--- 668 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~----------------------------------~--- 668 (955)
...|+. +.||+|++|+||+|++.+ |+.||||+.+++.... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445766 789999999999999887 9999999997542100 0
Q ss_pred ---HHHHHHHHHHHhcc----CCCcceEEEEEEe-CCeEEEEEEecCCCCcccc--cCCCCCCCCCHHHHHHHHHHHHH-
Q 002189 669 ---QEFKMEIELLSRVH----HKNLVSLLGFCFD-RGEQMLIYEFVPNGSLGDS--LSGKNGIRLDWIRRLKIALGAAR- 737 (955)
Q Consensus 669 ---~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~~ia~- 737 (955)
-+|.+|+.-+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.+. +...+ .+.. .++...++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHH
Confidence 12444555555443 4444444444433 4567899999999999764 22221 1211 12221111
Q ss_pred HHHHhhhccCCCeeccCCCCccEEEcCCC----ceEEeecccccccCC
Q 002189 738 GLSYLHELANPPIIHRDIKSSNILLDERL----NAKVADFGLSKSMSD 781 (955)
Q Consensus 738 gL~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGla~~~~~ 781 (955)
-+..++..| ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 272 ~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 133344567 99999999999999988 999999999887643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.5e-11 Score=121.89 Aligned_cols=131 Identities=19% Similarity=0.145 Sum_probs=98.0
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcc-eEEEEEEeCCeEEEEEEecCCCCc
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV-SLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
.+.|+.|.++.||+++.. ++.|++|....... ....+..|+++++.+.+.+++ +++.+ ..+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 356899999999999875 78899998765432 223567899999999766655 44443 23345899999999887
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA--NPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.+.- .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6531 011245678999999999876 23369999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=3e-11 Score=145.52 Aligned_cols=92 Identities=26% Similarity=0.461 Sum_probs=80.3
Q ss_pred CCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEe
Q 002189 265 SVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVM 343 (955)
Q Consensus 265 ~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 343 (955)
.++.|+|++|.+++..| .+..+++|+.|+|++|.+++ .+|..++.+++|+.|+|++|+++|.+|..+.+|++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g-~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccC-cCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 37789999999988776 58889999999999999987 68888999999999999999999999999999999999999
Q ss_pred ecCcceeeeCCCcc
Q 002189 344 KTNELNGTLDLGTS 357 (955)
Q Consensus 344 s~N~l~~~~~~~~~ 357 (955)
++|+++|.+|..+.
T Consensus 498 s~N~l~g~iP~~l~ 511 (623)
T PLN03150 498 NGNSLSGRVPAALG 511 (623)
T ss_pred cCCcccccCChHHh
Confidence 99999988876543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-12 Score=141.28 Aligned_cols=215 Identities=20% Similarity=0.182 Sum_probs=92.1
Q ss_pred cCCCCcEEEccCCCCcCcCC--CCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCcccc
Q 002189 135 SLQELVLLSLNSNGFSGRVP--PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLF 212 (955)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~~p--~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~ 212 (955)
++.+|+.+.|.+..+. ..+ .....+++++.|||+.|-|....| -+.-.+.|++|+.|+|+.|++........-
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~----v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~ 193 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFP----VLKIAEQLPSLENLNLSSNRLSNFISSNTT 193 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHH----HHHHHHhcccchhcccccccccCCccccch
Confidence 4445555555555544 222 133445555555555555541111 112233444555555555555422222222
Q ss_pred CCccceeeeeccCCCccccC-CcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccC--CCCCCCCCC
Q 002189 213 RPDMVLIHVLFDSNNLTGEL-PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM--PNLTGLSVL 289 (955)
Q Consensus 213 ~~~~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L 289 (955)
..++.|+.|.|+.|+|+... -..+..+++|+.|+|..|...+.-......+..|+.|||++|++.... +....++.|
T Consensus 194 ~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L 273 (505)
T KOG3207|consen 194 LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGL 273 (505)
T ss_pred hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccch
Confidence 23344555555555554211 112234455555555555322122223333444555555555544433 233444444
Q ss_pred CEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCccee--eeCCCcchhhhhhhccc
Q 002189 290 SYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG--TLDLGTSYSENLLVNLQ 367 (955)
Q Consensus 290 ~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~l~~L~L~ 367 (955)
+.|+++.+.+.....|+. ..-+....+++|++|+++.|++.. .......+.++..|...
T Consensus 274 ~~Lnls~tgi~si~~~d~-------------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~ 334 (505)
T KOG3207|consen 274 NQLNLSSTGIASIAEPDV-------------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT 334 (505)
T ss_pred hhhhccccCcchhcCCCc-------------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence 444444444443333322 000002234555555555555533 33333444555566666
Q ss_pred CCcccc
Q 002189 368 NNRISA 373 (955)
Q Consensus 368 ~N~l~~ 373 (955)
.|.|+.
T Consensus 335 ~n~ln~ 340 (505)
T KOG3207|consen 335 LNYLNK 340 (505)
T ss_pred cccccc
Confidence 666554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.8e-12 Score=129.47 Aligned_cols=137 Identities=15% Similarity=0.254 Sum_probs=96.0
Q ss_pred cccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCC
Q 002189 234 ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 313 (955)
Q Consensus 234 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~ 313 (955)
..+..++.|++||||+|.|+ .+.++..-++.++.|++|+|.|..+.. +..+++|+.||||+|.++. ...|-..+.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~--~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAE--CVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHh--hhhhHhhhcC
Confidence 34445566777777777777 666777777777777777777775443 6667777777777777753 5556667777
Q ss_pred CCEEECcCCcceecCCcCCCCCCCCcEEEeecCccee--eeCCCcchhhhhhhcccCCccccccC
Q 002189 314 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG--TLDLGTSYSENLLVNLQNNRISAYTE 376 (955)
Q Consensus 314 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~l~~L~L~~N~l~~~~~ 376 (955)
.++|.|+.|.|. .-..+.+|-+|..||+++|+|.. ....+..++.|++|.|.+|+|++++.
T Consensus 354 IKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 354 IKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred EeeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 777888877775 22345567778888888888876 44445567778888888888776554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7e-12 Score=128.27 Aligned_cols=131 Identities=22% Similarity=0.308 Sum_probs=93.4
Q ss_pred eeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCC
Q 002189 218 LIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 297 (955)
Q Consensus 218 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N 297 (955)
|++++|++|.|+ .+..+..-++.++.|++|+|.|. .+- .+..+++|+.||||+|.++.....-.++-+++.|.|++|
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhh
Confidence 444444444444 45556666777888888888887 332 377788888888888888766655556777888888888
Q ss_pred CCCCCCCChhhcCCCCCCEEECcCCcceec-CCcCCCCCCCCcEEEeecCcceeeeCC
Q 002189 298 SFDASEVPSWFSSMQSLTTLMMENTNLKGQ-IPADLFSIPHLQTVVMKTNELNGTLDL 354 (955)
Q Consensus 298 ~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 354 (955)
.|. .-..++.+-+|..||+++|+|... -...+++||.|++|.|.+|+|.+.+..
T Consensus 363 ~iE---~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 363 KIE---TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred hHh---hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 873 334466777788888888888742 334678899999999999999887654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-12 Score=137.03 Aligned_cols=200 Identities=21% Similarity=0.268 Sum_probs=93.3
Q ss_pred cCcCCCCcccEEecCCCCCCccC----CCCCcccccccccccccccc---cCCCCCCc-------cccCCCCcEEEccCC
Q 002189 82 GDITGLTELHTLDLSNNKDLRGP----LPTTIGNLKKLSNLMLVGCS---FSGPIPDS-------IGSLQELVLLSLNSN 147 (955)
Q Consensus 82 ~~l~~l~~L~~L~Ls~N~~l~~~----~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~-------~~~l~~L~~L~Ls~N 147 (955)
+.+..+..+++|+||+|. +... +-..+.+.++|+..+++.-- +...+|+. +...++|++||||+|
T Consensus 24 ~~~~~~~s~~~l~lsgnt-~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDN 102 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNT-FGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDN 102 (382)
T ss_pred HHhcccCceEEEeccCCc-hhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccc
Confidence 345667788888888885 4332 23345556667776665432 11223332 234456666666666
Q ss_pred CCcCcCCCCC----CCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 148 GFSGRVPPSI----GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 148 ~l~~~~p~~~----~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
-|.-..+..| .+.+.|+.|.|.||.+. |..-+. +. ..|..|. .|+. ....+.|+.+..
T Consensus 103 A~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg---~~ag~~---l~--~al~~l~--~~kk--------~~~~~~Lrv~i~ 164 (382)
T KOG1909|consen 103 AFGPKGIRGLEELLSSCTDLEELYLNNCGLG---PEAGGR---LG--RALFELA--VNKK--------AASKPKLRVFIC 164 (382)
T ss_pred ccCccchHHHHHHHHhccCHHHHhhhcCCCC---hhHHHH---HH--HHHHHHH--HHhc--------cCCCcceEEEEe
Confidence 6654333332 34455666666665554 100000 00 0011111 1110 011233555555
Q ss_pred cCCCcccc----CCcccCCCCCCcEEEcccCCCCC----CccccccCCCCCCEEEccCCcCcccCC-----CCCCCCCCC
Q 002189 224 DSNNLTGE----LPATLGLVKSLEVVRFDRNSLSG----PVPSNLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLS 290 (955)
Q Consensus 224 ~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~ 290 (955)
..|++-.. +...|...+.|+.+.++.|.|.. .+...|..+++|+.|||.+|.++.... .+..+++|+
T Consensus 165 ~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~ 244 (382)
T KOG1909|consen 165 GRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLR 244 (382)
T ss_pred eccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhe
Confidence 55554422 22334445555666666555541 122344555555555555555543222 244444555
Q ss_pred EEECcCCCCC
Q 002189 291 YLDMSNNSFD 300 (955)
Q Consensus 291 ~L~Ls~N~l~ 300 (955)
.|++++|.++
T Consensus 245 El~l~dcll~ 254 (382)
T KOG1909|consen 245 ELNLGDCLLE 254 (382)
T ss_pred eecccccccc
Confidence 5555555554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.5e-10 Score=115.56 Aligned_cols=142 Identities=22% Similarity=0.321 Sum_probs=111.2
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEcccCCc-chhHHHHHHHHHHHhccC--CCcceEEEEEEeCC---eEEEEEEecC
Q 002189 634 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHH--KNLVSLLGFCFDRG---EQMLIYEFVP 707 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lV~e~~~ 707 (955)
+.|+.|.++.||+++..+|+.+++|....... .....+..|+++++.+++ ..+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998765432 134578899999999975 34577787776543 5689999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----------------------------------------
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA----------------------------------------- 746 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 746 (955)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876642 24677788888888898888888521
Q ss_pred ------------CCCeeccCCCCccEEEcC--CCceEEeecccccc
Q 002189 747 ------------NPPIIHRDIKSSNILLDE--RLNAKVADFGLSKS 778 (955)
Q Consensus 747 ------------~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~ 778 (955)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 244799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.2e-11 Score=134.23 Aligned_cols=249 Identities=19% Similarity=0.184 Sum_probs=179.4
Q ss_pred HHHHhcCCCccCeeeccCceEEEEEEe--CCCcEEEEEEcccCCcchhHHH--HHHHHHHHhc-cCCCcceEEEEEEeCC
Q 002189 623 VKKYTNNFSDANDVGSGGYGKVYKGTL--PNGQLIAIKRAQQGSMQGGQEF--KMEIELLSRV-HHKNLVSLLGFCFDRG 697 (955)
Q Consensus 623 l~~~~~~f~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~~~~~~~~ 697 (955)
....+.+|..+..||.|.|+.||+... .++..+++|.+.+.......++ ..|+-+...+ .|.+++.....|...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 444567899999999999999999864 3678999998876544433332 3466666666 4899998888888888
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-CceEEeecccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLS 776 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla 776 (955)
..|+--||++++++...+.. ...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 88899999999988766522 235777788899999999999999888 9999999999999886 88899999998
Q ss_pred cccCCCCCcceeeeeecCCCCC--CHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYL--DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 854 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 854 (955)
..+.-.. ......-+++ +++......+-.+.|+||||.-+.|..+|..--..+.... .+
T Consensus 415 t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~--------------~i 475 (524)
T KOG0601|consen 415 TRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL--------------TI 475 (524)
T ss_pred cccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce--------------ee
Confidence 6432111 1122344455 4555556778889999999999999998774332221110 01
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
..-.-|... ....++..+...+..+++..||.+.++..+.+
T Consensus 476 ~~~~~p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 476 RSGDTPNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ecccccCCC-----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111111111 11256778888999999999999988876544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-11 Score=143.24 Aligned_cols=245 Identities=23% Similarity=0.264 Sum_probs=126.0
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
.+..++.+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+ .+..+..+
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~--------~i~~l~~l 139 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKIT--------KLEGLSTL 139 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccc--------cccchhhc
Confidence 3444444555555555 23333455555555555555555 23222445555555555555554 23334444
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCC-cccCCCCCCcEEEcccCCCCCCccccccCCCCCCEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP-ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDL 269 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 269 (955)
..|+.|++++|.|+ .+.. +..+..|+.+++++|++...-+ . ...+.+|+.++++.|.+.. ...+..+..+..+
T Consensus 140 ~~L~~L~l~~N~i~-~~~~--~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~ 213 (414)
T KOG0531|consen 140 TLLKELNLSGNLIS-DISG--LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLL 213 (414)
T ss_pred cchhhheeccCcch-hccC--CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHh
Confidence 44555555555555 3322 1124455555555555553333 2 4555666666666666652 2333444444555
Q ss_pred EccCCcCcccCCCCCCCC--CCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCc
Q 002189 270 YLSNNKLTGAMPNLTGLS--VLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 347 (955)
Q Consensus 270 ~Ls~N~l~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 347 (955)
++..|.++..-+ +..+. .|+.+++++|++.. .+..+..+.++..|++.+|.+... ..+...+.+..+.+..|+
T Consensus 214 ~l~~n~i~~~~~-l~~~~~~~L~~l~l~~n~i~~--~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~ 288 (414)
T KOG0531|consen 214 SLLDNKISKLEG-LNELVMLHLRELYLSGNRISR--SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNK 288 (414)
T ss_pred hcccccceeccC-cccchhHHHHHHhcccCcccc--ccccccccccccccchhhcccccc--ccccccchHHHhccCcch
Confidence 666666654332 11122 36667777776642 324455666666777776666522 123345556666666666
Q ss_pred ceee---eCC--CcchhhhhhhcccCCccccccC
Q 002189 348 LNGT---LDL--GTSYSENLLVNLQNNRISAYTE 376 (955)
Q Consensus 348 l~~~---~~~--~~~~~~l~~L~L~~N~l~~~~~ 376 (955)
+... ... ......+..+++.+|.+....+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 289 LALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hcchhhhhccccccccccccccccccCccccccc
Confidence 6531 111 2335556667777777666554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-09 Score=109.08 Aligned_cols=136 Identities=15% Similarity=0.144 Sum_probs=98.1
Q ss_pred CeeeccCceEEEEEEeCC-------CcEEEEEEcccCCc----------------------chhHHHH----HHHHHHHh
Q 002189 634 NDVGSGGYGKVYKGTLPN-------GQLIAIKRAQQGSM----------------------QGGQEFK----MEIELLSR 680 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~~ 680 (955)
..||.|.=+.||.|...+ +..+|||+.+.... ...+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 47999997752100 0122333 79999999
Q ss_pred ccC--CCcceEEEEEEeCCeEEEEEEecCCCCccc-ccCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeeccCCC
Q 002189 681 VHH--KNLVSLLGFCFDRGEQMLIYEFVPNGSLGD-SLSGKNGIRLDWIRRLKIALGAARGLSYL-HELANPPIIHRDIK 756 (955)
Q Consensus 681 l~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlk 756 (955)
+.. -++.+.+++ ...+|||||+.++.+.. .++. ..++..+...+..+++.+|.++ |..+ +||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 963 455666654 56789999997654432 2222 1344455667788999999999 7888 9999999
Q ss_pred CccEEEcCCCceEEeecccccccC
Q 002189 757 SSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 757 ~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+.||++++ +.+.|+|||.+....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCC
Confidence 99999974 679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-11 Score=132.19 Aligned_cols=185 Identities=21% Similarity=0.259 Sum_probs=125.3
Q ss_pred ccccccccccccccccCCCCC--CccccCCCCcEEEccCCCCcCcCC--CCCCCCCCcCeeecCCceeeeccCCCCCCCC
Q 002189 110 GNLKKLSNLMLVGCSFSGPIP--DSIGSLQELVLLSLNSNGFSGRVP--PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSP 185 (955)
Q Consensus 110 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~ 185 (955)
+++++|+.+.|.++.+. ..+ .....+++++.|||++|-+....+ .-...|++|+.|+|+.|++.-..- +..
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~----s~~ 192 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFIS----SNT 192 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcc----ccc
Confidence 45677888888887776 333 356678888888888888774222 224567888888888888862221 111
Q ss_pred chhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCcc--ccccCC
Q 002189 186 GLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVP--SNLNNL 263 (955)
Q Consensus 186 ~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~l~~l 263 (955)
. ..++.|+.|.|+.|.|+-.=-..+....++|..|+|..|.....-......+..|+.|||++|++- ..+ ...+.+
T Consensus 193 ~-~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l 270 (505)
T KOG3207|consen 193 T-LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTL 270 (505)
T ss_pred h-hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccc
Confidence 1 256677888888888862222223344677888999988644455555667788999999999887 333 456788
Q ss_pred CCCCEEEccCCcCcccC-CC------CCCCCCCCEEECcCCCCCC
Q 002189 264 TSVNDLYLSNNKLTGAM-PN------LTGLSVLSYLDMSNNSFDA 301 (955)
Q Consensus 264 ~~L~~L~Ls~N~l~~~~-~~------~~~l~~L~~L~Ls~N~l~~ 301 (955)
+.|..|+++.|.|..+- +. ...+++|++|+++.|+|..
T Consensus 271 ~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~ 315 (505)
T KOG3207|consen 271 PGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD 315 (505)
T ss_pred cchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccc
Confidence 89999999999887643 22 2446777777777777743
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.2e-11 Score=140.48 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=190.8
Q ss_pred CCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcC
Q 002189 85 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 164 (955)
Q Consensus 85 ~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~ 164 (955)
..+..+..+++..|. +. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|.|+... .+..++.|+
T Consensus 69 ~~l~~l~~l~l~~n~-i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNL-IA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhh-hh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchh
Confidence 467788888899986 44 34455888999999999999999 55555888999999999999999543 477888899
Q ss_pred eeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcE
Q 002189 165 WLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEV 244 (955)
Q Consensus 165 ~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 244 (955)
.|++++|.|+ .+..+..+..|+.+++++|++. .+.........+++.+.+.+|.+... ..+..+..+..
T Consensus 144 ~L~l~~N~i~--------~~~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~ 212 (414)
T KOG0531|consen 144 ELNLSGNLIS--------DISGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVL 212 (414)
T ss_pred hheeccCcch--------hccCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHH
Confidence 9999999998 3445666888999999999998 55551034566789999999999743 34455566666
Q ss_pred EEcccCCCCCCccccccCCC--CCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCC
Q 002189 245 VRFDRNSLSGPVPSNLNNLT--SVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322 (955)
Q Consensus 245 L~Ls~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 322 (955)
+++..|.++..-+ +..+. +|+.+++++|.+......+..+..+..|++++|++.. -..+...+.+..+.+..|
T Consensus 213 ~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~---~~~~~~~~~~~~~~~~~~ 287 (414)
T KOG0531|consen 213 LSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISN---LEGLERLPKLSELWLNDN 287 (414)
T ss_pred hhcccccceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhccccc---cccccccchHHHhccCcc
Confidence 6889999883322 22223 4899999999999776677888999999999999865 233556677888888888
Q ss_pred ccee---cCCcC-CCCCCCCcEEEeecCcceeeeCCC
Q 002189 323 NLKG---QIPAD-LFSIPHLQTVVMKTNELNGTLDLG 355 (955)
Q Consensus 323 ~l~~---~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~ 355 (955)
.+.. ..... ....+.++.+.+.+|++....+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
T KOG0531|consen 288 KLALSEAISQEYITSAAPTLVTLTLELNPIRKISSLD 324 (414)
T ss_pred hhcchhhhhccccccccccccccccccCccccccccc
Confidence 8773 22222 566889999999999998766543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-09 Score=124.30 Aligned_cols=166 Identities=19% Similarity=0.218 Sum_probs=121.7
Q ss_pred eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHH
Q 002189 649 LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 728 (955)
Q Consensus 649 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~ 728 (955)
..++.+|.|...+...........+-++.|+.+|||||++++..+..++..|||+|-+. .|..++... .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence 45788888888776544333456778999999999999999999999999999999873 344445432 23444
Q ss_pred HHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCC
Q 002189 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808 (955)
Q Consensus 729 ~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 808 (955)
...+.||+.||.+||+.++ ++|++|.-+-|++++.|+.||++|.++.....-.. ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 5567899999999986553 99999999999999999999999998865432111 001111222466666543222
Q ss_pred CChhhhHHHHHHHHHHHhC
Q 002189 809 TEKSDVYSFGVLMLELLTG 827 (955)
Q Consensus 809 ~~ksDvwS~Gv~l~elltg 827 (955)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.4e-10 Score=115.25 Aligned_cols=16 Identities=25% Similarity=0.536 Sum_probs=4.7
Q ss_pred CCCCCcEEEeecCcce
Q 002189 334 SIPHLQTVVMKTNELN 349 (955)
Q Consensus 334 ~l~~L~~L~Ls~N~l~ 349 (955)
.+++|+.|+|.+|+++
T Consensus 111 ~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 111 SLPKLRVLSLEGNPVC 126 (175)
T ss_dssp G-TT--EEE-TT-GGG
T ss_pred cCCCcceeeccCCccc
Confidence 3444444444444443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.1e-10 Score=115.94 Aligned_cols=57 Identities=21% Similarity=0.217 Sum_probs=22.2
Q ss_pred CCCCcEEEcccCCCCCC-ccccccCCCCCCEEEccCCcCcccCC----CCCCCCCCCEEECc
Q 002189 239 VKSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNKLTGAMP----NLTGLSVLSYLDMS 295 (955)
Q Consensus 239 l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~l~~L~~L~Ls 295 (955)
+++|+.|+|++|+|... .-..+..+++|+.|+|.+|.++.... -+..+|+|+.||-.
T Consensus 87 lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 87 LPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp -TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 34445555555554421 11344556666677777776665432 14556777776643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5e-09 Score=102.23 Aligned_cols=130 Identities=20% Similarity=0.313 Sum_probs=98.9
Q ss_pred eeeccCceEEEEEEeCCCcEEEEE-EcccCCcch-------hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 635 DVGSGGYGKVYKGTLPNGQLIAIK-RAQQGSMQG-------GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~~g~~vavK-~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+++|+=+.+|.+.+.+ ..+++| ++++.-... ...-.+|++++.+++--.|....=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 57899999999998754 445566 444332211 134567999999997666655555666778889999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
++-.|.+.+... +..++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998888887643 2456667777788899999 99999999999998875 99999999874
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.3e-11 Score=126.79 Aligned_cols=209 Identities=21% Similarity=0.270 Sum_probs=142.6
Q ss_pred CCCEeEEEecCCcCcc----ccCcCcCCCCcccEEecCCCCCCccCC----CCC-------cccccccccccccccccCC
Q 002189 63 NSRVTSITLSGMGLKG----QLSGDITGLTELHTLDLSNNKDLRGPL----PTT-------IGNLKKLSNLMLVGCSFSG 127 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~----~~~~~l~~l~~L~~L~Ls~N~~l~~~~----p~~-------~~~l~~L~~L~Ls~N~l~~ 127 (955)
...++.|+|++|.+.. .+.+.+...++|++.++|+- ++|.. |.. +...++|++|+||.|-|..
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~--ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~ 106 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM--FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP 106 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh--hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence 3578899999999864 44566788899999999984 57753 322 3445689999999999985
Q ss_pred CCCCc----cccCCCCcEEEccCCCCcCcCC-------------CCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 128 PIPDS----IGSLQELVLLSLNSNGFSGRVP-------------PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 128 ~~p~~----~~~l~~L~~L~Ls~N~l~~~~p-------------~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
.-+.. +.++..|++|.|.+|.+.-.-- ....+-++|+.+...+|++... + .+.
T Consensus 107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~-g-----a~~---- 176 (382)
T KOG1909|consen 107 KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENG-G-----ATA---- 176 (382)
T ss_pred cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccc-c-----HHH----
Confidence 54444 4567889999999999872111 1123345666666666666511 0 000
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccc----cCCcccCCCCCCcEEEcccCCCCC----CccccccC
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG----ELPATLGLVKSLEVVRFDRNSLSG----PVPSNLNN 262 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~l~~ 262 (955)
-...|...+.|..+.++.|.|.. .+..+|..+++|+.|||..|.++. .+...+..
T Consensus 177 -----------------~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s 239 (382)
T KOG1909|consen 177 -----------------LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSS 239 (382)
T ss_pred -----------------HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcc
Confidence 01223334455666666666552 345678889999999999999983 24667788
Q ss_pred CCCCCEEEccCCcCcccCC-----CC-CCCCCCCEEECcCCCCC
Q 002189 263 LTSVNDLYLSNNKLTGAMP-----NL-TGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 263 l~~L~~L~Ls~N~l~~~~~-----~~-~~l~~L~~L~Ls~N~l~ 300 (955)
+++|+.|++++|.++.... .+ ...++|++|.|.+|.|+
T Consensus 240 ~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 240 WPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred cchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 9999999999999986544 12 23677777777777775
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1e-08 Score=99.42 Aligned_cols=143 Identities=22% Similarity=0.255 Sum_probs=103.4
Q ss_pred ccCeeeccCceEEEEEEeCCCcEEEEE-EcccCCcc-------hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 632 DANDVGSGGYGKVYKGTLPNGQLIAIK-RAQQGSMQ-------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~~~~g~~vavK-~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
....|-+|+-+.|+++.+. |+...|| ++.+.-.. ..++-.+|++.+.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4577889999999999884 6777776 44332211 1245678999999997656654444555666678999
Q ss_pred EecCC-CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC---ceEEeecccccc
Q 002189 704 EFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL---NAKVADFGLSKS 778 (955)
Q Consensus 704 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGla~~ 778 (955)
||+++ -++.+++...-...........++..|-+.+.-||..+ ++|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99966 36777765443223333333678888889999999998 99999999999996654 358999999754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.5e-10 Score=132.46 Aligned_cols=249 Identities=19% Similarity=0.210 Sum_probs=166.4
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.+.|.+.+-+-+|.++.++.+.-. .|...+.|....... ...+....+-.++-..+||-++.....+.-....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 456667778889999999987632 344444444332211 1112233333344344567777666555567788999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
++|..+++|...++..+ ..+..........+..+.+|||... +.|||++|.|++...++..+++|||.....+..
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999888655 3343334445556677899999876 899999999999999999999999843322110
Q ss_pred ---------------------C-C-------cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcC
Q 002189 783 ---------------------E-K-------DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER 833 (955)
Q Consensus 783 ---------------------~-~-------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~ 833 (955)
. . ........||+.|.+||...+......+|.|+.|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0 0112235799999999999999999999999999999999999999964
Q ss_pred CchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 002189 834 GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 893 (955)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 893 (955)
.... ++++.. ....-|.. ....+......+++.+.+..+|.+|-.|.
T Consensus 1038 ~tpq-----~~f~ni------~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQ-----QIFENI------LNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchh-----hhhhcc------ccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 3221 111111 11111111 11222335567889999999999997765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.2e-08 Score=106.44 Aligned_cols=167 Identities=17% Similarity=0.284 Sum_probs=126.3
Q ss_pred eEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe----CCeEEEEEEecCC-CCccccc
Q 002189 642 GKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQMLIYEFVPN-GSLGDSL 715 (955)
Q Consensus 642 g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~l 715 (955)
.+.||+.. .||..|++||+.............-+++++++.|.|||++.+++.. +...++||+|.|+ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 47899974 5899999999954333322223345789999999999999998763 4568999999986 4666533
Q ss_pred CCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 716 SGK-------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 716 ~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
... .+...++...|.++.|++.||.++|+.| +..+-|.+++|+++.+.+++|+..|....+...
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 211 1335678889999999999999999999 889999999999999999999988877655433
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P 830 (955)
.. |.+.+ -.+-|.=.||.+++.+.||..-
T Consensus 447 ~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 21 11111 2367888999999999999654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.8e-09 Score=132.92 Aligned_cols=107 Identities=28% Similarity=0.390 Sum_probs=90.3
Q ss_pred CCEeEEEecCCc--CccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcE
Q 002189 64 SRVTSITLSGMG--LKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 141 (955)
Q Consensus 64 ~~v~~L~L~~~~--l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 141 (955)
..+++|-+.+|. +.....+.|..++.|++|||++|. -.+.+|..++.|-+|++|+|++..++ .+|..+.+|++|.+
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~-~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNS-SLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCC-ccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 368888888886 453333457889999999999986 56789999999999999999999999 89999999999999
Q ss_pred EEccCCCCcCcCCCCCCCCCCcCeeecCCce
Q 002189 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172 (955)
Q Consensus 142 L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~ 172 (955)
|++..+.-...+|.....|++|++|.+..-.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccc
Confidence 9999988766677777779999999997655
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-10 Score=130.73 Aligned_cols=130 Identities=26% Similarity=0.284 Sum_probs=94.5
Q ss_pred CCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChh-hcCCCCCCEEE
Q 002189 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSW-FSSMQSLTTLM 318 (955)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~-~~~l~~L~~L~ 318 (955)
..|...++++|.+. .+...+.-++.|+.|||++|+++.+. .+..+++|+.|||++|.+.. +|.. ..++ +|+.|+
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~--vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRH--VPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhcc--ccccchhhh-hheeee
Confidence 35666777777777 66677777777888888888877665 66777788888888888754 3332 1223 388888
Q ss_pred CcCCcceecCCcCCCCCCCCcEEEeecCccee--eeCCCcchhhhhhhcccCCccccccC
Q 002189 319 MENTNLKGQIPADLFSIPHLQTVVMKTNELNG--TLDLGTSYSENLLVNLQNNRISAYTE 376 (955)
Q Consensus 319 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~l~~L~L~~N~l~~~~~ 376 (955)
|+||.++. -..+.+|.+|+.|||++|-|.+ .+...+.+..|..|+|.+|++..-+.
T Consensus 239 lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 239 LRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred ecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 88888772 2346678888889999998887 55556778888899999999886554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1e-07 Score=102.29 Aligned_cols=140 Identities=17% Similarity=0.072 Sum_probs=100.4
Q ss_pred eeeccCceEEEEEEeCCCcEEEEEEcccCCcc-----------hhHHHHHHHHHHHhccCCC--cceEEEEEEe-----C
Q 002189 635 DVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ-----------GGQEFKMEIELLSRVHHKN--LVSLLGFCFD-----R 696 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~-----~ 696 (955)
.+-+.....|+++.+ +|+.|.||+....... ....+.+|...+.++...+ +.+.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344333345667766 5789999977543211 1114788999999885433 3455666543 2
Q ss_pred CeEEEEEEecCCC-CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-------CCce
Q 002189 697 GEQMLIYEFVPNG-SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-------RLNA 768 (955)
Q Consensus 697 ~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-------~~~~ 768 (955)
...+||||++++. +|.+++......+.+...+..++.+++..+.-||..| |+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999876 7888775322224556677789999999999999999 999999999999985 4689
Q ss_pred EEeecccccc
Q 002189 769 KVADFGLSKS 778 (955)
Q Consensus 769 kl~DFGla~~ 778 (955)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.9e-08 Score=97.63 Aligned_cols=126 Identities=22% Similarity=0.332 Sum_probs=80.1
Q ss_pred EEEEEEeCCCcEEEEEEcccCCc---------------------ch-----hHHHHHHHHHHHhccCC--CcceEEEEEE
Q 002189 643 KVYKGTLPNGQLIAIKRAQQGSM---------------------QG-----GQEFKMEIELLSRVHHK--NLVSLLGFCF 694 (955)
Q Consensus 643 ~Vy~~~~~~g~~vavK~~~~~~~---------------------~~-----~~~~~~E~~~l~~l~H~--niv~l~~~~~ 694 (955)
.||.|...+|..+|||..+.... .. ....++|.+.|.++..- ++-+.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999998753210 00 12356899999999765 455555432
Q ss_pred eCCeEEEEEEecC--CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHH-hhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 695 DRGEQMLIYEFVP--NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY-LHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 695 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
..+|||||++ +..+.. +.... ++......++.+++..+.. +|..| ++|+|+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhh-HHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4579999998 444433 32211 1122345566677775555 57888 9999999999999988 89999
Q ss_pred ecccccccC
Q 002189 772 DFGLSKSMS 780 (955)
Q Consensus 772 DFGla~~~~ 780 (955)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.8e-09 Score=109.57 Aligned_cols=203 Identities=22% Similarity=0.291 Sum_probs=122.2
Q ss_pred ccccccccccccccCC--CCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCC-Cchh
Q 002189 112 LKKLSNLMLVGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-PGLD 188 (955)
Q Consensus 112 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~-~~l~ 188 (955)
.+.++.|+|.+|.|+. .+...+.+|+.|++|+|++|++...|-..-..+.+|+.|-|.+..+. |... ..+.
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~------w~~~~s~l~ 143 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLS------WTQSTSSLD 143 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCC------hhhhhhhhh
Confidence 4566667777777762 33444567777777777777777544222245667777777776664 2222 2345
Q ss_pred hhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCc--ccCCCCCCcEEEcccCCCCCCccccccCCCCC
Q 002189 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA--TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 266 (955)
Q Consensus 189 ~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 266 (955)
.++.++.|+++.|++. .++++.|.+...-|. .+..++.+..+.++-|++. ..++++
T Consensus 144 ~lP~vtelHmS~N~~r---------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~-------r~Fpnv 201 (418)
T KOG2982|consen 144 DLPKVTELHMSDNSLR---------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLS-------RIFPNV 201 (418)
T ss_pred cchhhhhhhhccchhh---------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHH-------hhcccc
Confidence 5666677777777543 334444444422111 1122233333333333333 335778
Q ss_pred CEEEccCCcCcccCC--CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcC------CCCCCCC
Q 002189 267 NDLYLSNNKLTGAMP--NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPAD------LFSIPHL 338 (955)
Q Consensus 267 ~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------~~~l~~L 338 (955)
..+-+..|.|..... ....++.+..|+|+.|+|..-..-..+.++++|..|.+++|+|...+... ++.|+++
T Consensus 202 ~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v 281 (418)
T KOG2982|consen 202 NSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKV 281 (418)
T ss_pred hheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccce
Confidence 888888888877655 46667888888999998866555566788888888888888887543332 3445666
Q ss_pred cEEE
Q 002189 339 QTVV 342 (955)
Q Consensus 339 ~~L~ 342 (955)
+.|+
T Consensus 282 ~vLN 285 (418)
T KOG2982|consen 282 QVLN 285 (418)
T ss_pred EEec
Confidence 6554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.6e-08 Score=82.62 Aligned_cols=60 Identities=35% Similarity=0.530 Sum_probs=37.2
Q ss_pred ccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCcee
Q 002189 114 KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 173 (955)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l 173 (955)
+|++|+|++|+|+...+..|..+++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456666666666644445566666666666666666655555666666666666666654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.1e-08 Score=80.93 Aligned_cols=61 Identities=36% Similarity=0.520 Sum_probs=47.1
Q ss_pred CcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCC
Q 002189 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGF 149 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 149 (955)
++|++|+|++|+ +....+..|.++++|++|+|++|+++...|..|..+++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~-l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNK-LTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSST-ESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCC-CCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 467788888885 7766667778888888888888888766667788888888888888875
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=7e-07 Score=92.56 Aligned_cols=135 Identities=19% Similarity=0.234 Sum_probs=94.0
Q ss_pred CccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc----------------------hhHHHHHHHHHHHhccCC--Cc
Q 002189 631 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ----------------------GGQEFKMEIELLSRVHHK--NL 686 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~--ni 686 (955)
...+.||.|.=+.||.|..++|.++|||.-+.+..+ .+...++|.++|.++.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 345789999999999999999999999965432110 113457899999998644 56
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC
Q 002189 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 766 (955)
Q Consensus 687 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 766 (955)
.+.+++ +...+||||+++--|...-- +....-.++..|++-+.-+-..| +||+|+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 565543 45689999998866654321 11122233333333333333567 99999999999999999
Q ss_pred ceEEeeccccccc
Q 002189 767 NAKVADFGLSKSM 779 (955)
Q Consensus 767 ~~kl~DFGla~~~ 779 (955)
.+.++||-.+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999766543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.1e-08 Score=122.13 Aligned_cols=107 Identities=31% Similarity=0.411 Sum_probs=64.1
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCC-CccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKD-LRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+..+.+-+|.+. .++....+ +.|+.|-+..|.. +.......|..++.|+.|||++|.=-+.+|..+++|.+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 4444555555544 22222222 2566676666631 2223333466677777777776655556777777777777777
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
|++..|. .+|..+.+|..|.+|++..+.-.
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l 631 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRL 631 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheecccccccc
Confidence 7777777 67777777777777777666544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.3e-07 Score=105.33 Aligned_cols=141 Identities=18% Similarity=0.247 Sum_probs=95.3
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEcccCCcch----------------------------------------hHHHHH
Q 002189 634 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG----------------------------------------GQEFKM 673 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~~ 673 (955)
+.|+.++-|+||+|++.+|+.||||+.+++-... +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999987542210 012445
Q ss_pred HHHHHHhcc-----CCCcceEEEEE-EeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHH-HHHhhhcc
Q 002189 674 EIELLSRVH-----HKNLVSLLGFC-FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARG-LSYLHELA 746 (955)
Q Consensus 674 E~~~l~~l~-----H~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~ 746 (955)
|..-+.+++ .+++ ++=..| .......|+|||++|-.+.+...-.. ...+. ..++..++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHHHHhcC
Confidence 555555553 3333 233333 33567899999999988888742221 22442 2333333332 33333456
Q ss_pred CCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 747 ~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
+.|+|.+|.||+++.++.+.+.|||+...+.+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999998877543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-09 Score=123.12 Aligned_cols=113 Identities=24% Similarity=0.328 Sum_probs=55.5
Q ss_pred CCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcC
Q 002189 232 LPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSS 310 (955)
Q Consensus 232 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~ 310 (955)
+..++.-++.|+.|+|++|+++.. +.+..+++|++|||++|.|+.++- ...+.. |+.|.|++|.++. -..+.+
T Consensus 179 mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~t---L~gie~ 252 (1096)
T KOG1859|consen 179 MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTT---LRGIEN 252 (1096)
T ss_pred HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHh---hhhHHh
Confidence 334444455555555555555522 145555555555555555554443 222222 5555555555532 122445
Q ss_pred CCCCCEEECcCCcceecCC-cCCCCCCCCcEEEeecCccee
Q 002189 311 MQSLTTLMMENTNLKGQIP-ADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 311 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
+.+|+.|||++|-|.+..- .-++.|..|+.|+|.+|++-.
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 5555555666555553211 123345556666666666543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.5e-06 Score=85.71 Aligned_cols=147 Identities=14% Similarity=0.082 Sum_probs=107.5
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccC---C---cchhHHHHHHHHHHHhccCC--CcceEEEEEEeC---
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG---S---MQGGQEFKMEIELLSRVHHK--NLVSLLGFCFDR--- 696 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~--- 696 (955)
..+.+.---|+||-+.|++..+. |+.+-+|+-... + +.....|.+|...+.++... .+.+...+....
T Consensus 18 ~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~ 96 (216)
T PRK09902 18 GDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEG 96 (216)
T ss_pred CceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCC
Confidence 33333334578999999998774 457889986521 1 23457899999999999632 344544222221
Q ss_pred -CeEEEEEEecCC-CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc--eEEee
Q 002189 697 -GEQMLIYEFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN--AKVAD 772 (955)
Q Consensus 697 -~~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~D 772 (955)
-..+||+|-+++ -+|.+++....-.+.+...+..+..++++.+.-||+.+ +.|+|+.+.||+++.++. ++++|
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 235899997754 48888876544345677888899999999999999999 999999999999986666 99999
Q ss_pred cccccc
Q 002189 773 FGLSKS 778 (955)
Q Consensus 773 FGla~~ 778 (955)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=9.1e-06 Score=88.24 Aligned_cols=261 Identities=16% Similarity=0.155 Sum_probs=154.3
Q ss_pred ccCeeeccCceEEEEEE-eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEE------EeC-CeEEEE
Q 002189 632 DANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC------FDR-GEQMLI 702 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~------~~~-~~~~lV 702 (955)
..+.||+|+-+.+|-.- .. .. +-|+..........+ .++.|.+. .||-+-.=+.|= -++ ...-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~--d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR--DQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhh--ch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34679999999998542 22 22 335554332222121 22333333 465443211110 011 124456
Q ss_pred EEecCCC-CcccccC----CCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 703 YEFVPNG-SLGDSLS----GKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 703 ~e~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
|..+++. ...+++. .+.-...+|.-.++.+..+|.+.+-||+.| .+-+|+.++|+|+++++.+.+.|-.--.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 6666543 1112221 111235789999999999999999999999 8889999999999999999998754322
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhC-CCCCcCC-------chHHHHHH-H
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTG-RRPIERG-------KYIVREIR-T 843 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg-~~P~~~~-------~~~~~~~~-~ 843 (955)
.. .........+|...|.+||.-. +-.-+...|.|.+||++++++.| ++||.+- ......+. -
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 22 1223444567889999999765 23456789999999999999986 8898621 11110110 0
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHHHHHHcC
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQES--GDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~~~ 907 (955)
.+....+ -..-..|........-.+..+..+..+|+... +.-||+++..+..|..+.++..
T Consensus 243 ~f~ya~~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RFAYASD---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeeechh---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 0000000 00001111111112223367788899999764 5679999999988887766654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.1e-06 Score=89.06 Aligned_cols=106 Identities=26% Similarity=0.272 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHhccCC--CcceEEEEEEeCC----eEEEEEEecCCC-CcccccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 002189 669 QEFKMEIELLSRVHHK--NLVSLLGFCFDRG----EQMLIYEFVPNG-SLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 741 (955)
Q Consensus 669 ~~~~~E~~~l~~l~H~--niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y 741 (955)
....+|...+..++.. .+.+.+++..... ..++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4578899988888643 4457777766532 458999999874 78888875332 5566778899999999999
Q ss_pred hhhccCCCeeccCCCCccEEEcCCC---ceEEeeccccccc
Q 002189 742 LHELANPPIIHRDIKSSNILLDERL---NAKVADFGLSKSM 779 (955)
Q Consensus 742 LH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGla~~~ 779 (955)
||+.| |+|+|++++|||++.+. .+.++||+-++..
T Consensus 134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 99999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.9e-07 Score=107.47 Aligned_cols=153 Identities=20% Similarity=0.296 Sum_probs=104.4
Q ss_pred HHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc-------ceeeeeecCCCCCCHHHhh
Q 002189 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-------HITTQVKGTMGYLDPEYYM 804 (955)
Q Consensus 732 ~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~ 804 (955)
+.+++.|+.|+|... .+||+.|.|++|.++.++..||+.|+.+......... ....-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345568999999744 4999999999999999999999999987544331110 0111123445799999999
Q ss_pred hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhcc
Q 002189 805 TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQE 884 (955)
Q Consensus 805 ~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~ 884 (955)
+...+.++|+||+||++|.+..|+.+............ .....+..-...+..+.+.++.+=+.+++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----------FSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----------hhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 98899999999999999999966666532221110000 0000111111223345567888999999999
Q ss_pred CCCCCCCHHHHHH
Q 002189 885 SGDDRPTMSEVVK 897 (955)
Q Consensus 885 dP~~RPs~~evl~ 897 (955)
++.-||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998877764
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.3e-08 Score=97.79 Aligned_cols=261 Identities=21% Similarity=0.242 Sum_probs=129.5
Q ss_pred CCEeEEEecCCcCccc----cCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCC
Q 002189 64 SRVTSITLSGMGLKGQ----LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 139 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 139 (955)
..++.+||++|.|... +...+.+-.+|++.++++- ++|...+.+.. +|+. +-..+-.+++|
T Consensus 30 d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~--ftgr~kde~~~--~L~~-----------Ll~aLlkcp~l 94 (388)
T COG5238 30 DELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDA--FTGRDKDELYS--NLVM-----------LLKALLKCPRL 94 (388)
T ss_pred cceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhh--hhcccHHHHHH--HHHH-----------HHHHHhcCCcc
Confidence 4666778888777643 3344556677777777764 45544333211 1111 12245567788
Q ss_pred cEEEccCCCCcCcCCCCC----CCCCCcCeeecCCceeeeccCCCCCCC-CchhhhhccccccccCCcccccCCccccCC
Q 002189 140 VLLSLNSNGFSGRVPPSI----GNLSNLYWLDLTDNKLEGEIPVSDGNS-PGLDMLVRAKHFHFGKNQLSGSIPEKLFRP 214 (955)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~~----~~L~~L~~L~L~~N~l~g~ip~~~~~~-~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~ 214 (955)
+..+||+|.+....|..+ ++-+.|.+|.|+||.+. .+. -+.+ ++|..| ..|+=- ..
T Consensus 95 ~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlG-p~a--G~rigkal~~l--------a~nKKa--------a~ 155 (388)
T COG5238 95 QKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLG-PIA--GGRIGKALFHL--------AYNKKA--------AD 155 (388)
T ss_pred eeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCC-ccc--hhHHHHHHHHH--------HHHhhh--------cc
Confidence 888888888776665543 45577888888888775 211 1110 111111 111100 01
Q ss_pred ccceeeeeccCCCcccc----CCcccCCCCCCcEEEcccCCCCCC-----ccccccCCCCCCEEEccCCcCcccCC----
Q 002189 215 DMVLIHVLFDSNNLTGE----LPATLGLVKSLEVVRFDRNSLSGP-----VPSNLNNLTSVNDLYLSNNKLTGAMP---- 281 (955)
Q Consensus 215 ~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~~~---- 281 (955)
.+.|+.+....|++..- ....+..-.+|+.+.+..|.|.-. +-..+..+.+|+.|||++|.++....
T Consensus 156 kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La 235 (388)
T COG5238 156 KPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLA 235 (388)
T ss_pred CCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHH
Confidence 22233333344433311 111223335666677777766511 11123455677777777776664332
Q ss_pred -CCCCCCCCCEEECcCCCCCCCCCChhhc-----CCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCC
Q 002189 282 -NLTGLSVLSYLDMSNNSFDASEVPSWFS-----SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG 355 (955)
Q Consensus 282 -~~~~l~~L~~L~Ls~N~l~~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 355 (955)
.+..++.|+.|.+.+|-++.......+. ..++|..|-..+|.+.+.+... .+-|.+..
T Consensus 236 ~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~-----------~~l~~~e~----- 299 (388)
T COG5238 236 DALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILD-----------ISLNEFEQ----- 299 (388)
T ss_pred HHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeee-----------echhhhhh-----
Confidence 2455566666666666665422222221 1344555555555444322111 11111100
Q ss_pred cchhhhhhhcccCCccccc
Q 002189 356 TSYSENLLVNLQNNRISAY 374 (955)
Q Consensus 356 ~~~~~l~~L~L~~N~l~~~ 374 (955)
-.++.|..|-+.+|+|+..
T Consensus 300 ~~~p~L~~le~ngNr~~E~ 318 (388)
T COG5238 300 DAVPLLVDLERNGNRIKEL 318 (388)
T ss_pred cccHHHHHHHHccCcchhH
Confidence 1244566788888888764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 955 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-22 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 955 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-158 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-139 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-129 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-85 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-72 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-19 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-69 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 9e-69 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-67 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-66 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-62 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-62 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-61 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-60 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-60 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-56 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-55 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-54 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-51 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-33 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-26 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-14 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-57 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-57 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-56 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-54 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-47 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-39 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-27 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-21 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-46 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-44 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-44 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 7e-44 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-43 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-42 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-42 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-42 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-42 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-41 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-41 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-41 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-41 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-41 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-41 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 8e-41 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-40 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-34 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-33 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-33 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-31 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-29 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-23 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-40 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-40 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-40 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-40 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-39 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-39 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-39 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-39 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-39 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-39 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 7e-39 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-39 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 7e-39 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 8e-39 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-39 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-38 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-38 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-38 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-38 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-38 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-38 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-38 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-38 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-38 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-38 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-38 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-37 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-37 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-37 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-37 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-37 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-37 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-37 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-37 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-37 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-36 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-36 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-36 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-36 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-36 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-36 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-36 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-36 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-36 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-34 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-32 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-30 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-20 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-35 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-35 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-35 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-35 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-35 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-34 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-34 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-34 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-34 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-32 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-31 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-19 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-14 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-34 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-34 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-34 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-34 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 7e-34 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 8e-34 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-33 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-33 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-33 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-33 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-33 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-31 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-29 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-23 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-33 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-33 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-32 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-32 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-31 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 8e-31 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-30 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-30 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-30 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-30 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-30 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 7e-30 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-30 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 8e-30 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-25 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-29 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-29 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-29 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-28 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-28 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-28 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-28 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-28 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-19 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-28 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-27 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-27 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-24 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-24 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-19 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-13 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-27 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 9e-27 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-25 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-06 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-26 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-21 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-18 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-15 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-07 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-04 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-24 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-24 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-24 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-20 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-19 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-13 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-23 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-15 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-26 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-20 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-05 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-20 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-14 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-13 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-25 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-25 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-25 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-25 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-24 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-24 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-24 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-24 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-24 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-24 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 6e-24 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-24 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-23 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-23 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-23 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-23 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-23 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-23 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-19 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-15 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-11 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-23 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-21 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-16 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-23 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-23 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-22 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-22 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-21 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-15 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-13 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-22 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-22 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-22 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-22 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-22 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-10 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-06 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-22 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 9e-22 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 9e-22 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-18 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-15 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-21 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-21 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-21 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-21 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-19 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 9e-21 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-20 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-20 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-20 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-20 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-20 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-20 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-07 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-04 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-20 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 7e-20 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-20 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-20 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-18 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-11 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-19 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-18 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-09 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-07 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-19 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-19 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-19 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-12 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-19 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-19 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-19 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-19 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-19 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-18 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-18 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-16 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-18 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-18 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-16 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-18 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-17 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-17 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-09 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-07 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-17 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-15 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-06 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-17 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-17 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-16 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-16 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-16 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-12 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-06 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-16 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-16 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-05 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-15 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-10 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-04 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-11 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-08 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-14 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-13 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-11 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-06 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-05 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-06 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-12 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-10 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-10 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-05 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 9e-07 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-06 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-09 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-04 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-07 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-07 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 8e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-07 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-04 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-04 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-04 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-04 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 465 bits (1199), Expect = e-158
Identities = 123/307 (40%), Positives = 183/307 (59%), Gaps = 14/307 (4%)
Query: 605 SSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGS 664
S S + ++++ TNNF +G G +GKVYKG L +G +A+KR S
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 665 MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG--IR 722
QG +EF+ EIE LS H +LVSL+GFC +R E +LIY+++ NG+L L G + +
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 723 LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782
+ W +RL+I +GAARGL YLH IIHRD+KS NILLDE K+ DFG+SK ++
Sbjct: 136 MSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK-----YI 837
++ H++T VKGT+GY+DPEY++ +LTEKSDVYSFGV++ E+L R I + +
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 838 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ L +++DP + + K+ D A+KC+ S +DRP+M +V+
Sbjct: 253 AEWAVESHNNG----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 898 DIENILQ 904
+E L+
Sbjct: 309 KLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 416 bits (1073), Expect = e-139
Identities = 122/292 (41%), Positives = 189/292 (64%), Gaps = 7/292 (2%)
Query: 612 LKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQ-E 670
L + FS E++ ++NFS+ N +G GG+GKVYKG L +G L+A+KR ++ QGG+ +
Sbjct: 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ 73
Query: 671 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNG--IRLDWIRR 728
F+ E+E++S H+NL+ L GFC E++L+Y ++ NGS+ L + LDW +R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
+IALG+ARGL+YLH+ +P IIHRD+K++NILLDE A V DFGL+K M + H+T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVT 192
Query: 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848
T V+GT+G++ PEY T + +EK+DV+ +GV++LEL+TG+R + + + ++D
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 849 KELY---NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
K L L L+D + + + E+ + +AL C Q S +RP MSEVV+
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 391 bits (1008), Expect = e-129
Identities = 107/302 (35%), Positives = 173/302 (57%), Gaps = 23/302 (7%)
Query: 616 RCFSFEEVKKYTNNFSD------ANDVGSGGYGKVYKGTLPNGQLIAIKR----AQQGSM 665
FSF E+K TNNF + N +G GG+G VYKG + N +A+K+ +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 666 QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR-LD 724
+ Q+F EI+++++ H+NLV LLGF D + L+Y ++PNGSL D LS +G L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 725 WIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784
W R KIA GAA G+++LHE IHRDIKS+NILLDE AK++DFGL+++ +
Sbjct: 132 WHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK---YIVREI 841
+T+++ GT Y+ PE + ++T KSD+YSFGV++LE++TG ++ + ++
Sbjct: 189 TVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
+ D++K + + ID + E +A +C+ E + RP + +V + ++
Sbjct: 248 EEIEDEEK---TIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 902 IL 903
+
Sbjct: 304 MT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 1e-85
Identities = 69/313 (22%), Positives = 119/313 (38%), Gaps = 32/313 (10%)
Query: 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL 677
E + + G +G V+K + +A+K Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 678 LSRVHHKNLVSLLGFC----FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
L + H+N++ +G + LI F GSL D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAE 128
Query: 734 GAARGLSYLHE-------LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786
ARGL+YLHE P I HRDIKS N+LL L A +ADFGL+ +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 787 ITTQVKGTMGYLDPEY-----YMTQQLTEKSDVYSFGVLMLELLTGRRPIE--RGKY--- 836
T GT Y+ PE + + D+Y+ G+++ EL + + +Y
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 837 ---IVREIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTM 892
+ + ++ D ++ +++ P + G + +C + R +
Sbjct: 249 FEEEIGQHPSLEDMQE--VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 893 SEVVKDIENILQQ 905
V + I + +
Sbjct: 307 GCVGERITQMQRL 319
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 5e-72
Identities = 83/319 (26%), Positives = 140/319 (43%), Gaps = 24/319 (7%)
Query: 599 HWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSD---ANDVGSGGYGKVYKGTLPNGQLI 655
H S IP + + + D +G+G +G V++ +G +
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDV 63
Query: 656 AIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGD 713
A+K Q + EF E+ ++ R+ H N+V +G ++ E++ GSL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 714 SLSGKNGIR-LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 772
L LD RRL +A A+G++YLH NPPI+HR++KS N+L+D++ KV D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 773 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 832
FGLS+ + + + GT ++ PE + EKSDVYSFGV++ EL T ++P
Sbjct: 183 FGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 833 RGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM 892
+ + V K K I + + + C RP+
Sbjct: 241 -NLNPAQVVAAVGFKCKR---------LEIPRNLN----PQVAAIIEGCWTNEPWKRPSF 286
Query: 893 SEVVKDIENILQQAGLNPN 911
+ ++ + +++ A PN
Sbjct: 287 ATIMDLLRPLIKSAVPPPN 305
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 2e-71
Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 25/272 (9%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
VG G +G V K + +AIK+ + S + + F +E+ LSRV+H N+V L G C +
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 696 RGEQMLIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
L+ E+ GSL + L + + L ++G++YLH + +IHRD
Sbjct: 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 755 IKSSNILLDERLN-AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
+K N+LL K+ DFG + + T KG+ ++ PE + +EK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 814 VYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEK 873
V+S+G+++ E++T R+P + I + P + + +
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---------PPLIKNLP----KP 232
Query: 874 YVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
L +C + RP+M E+VK + ++++
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-71
Identities = 89/317 (28%), Positives = 139/317 (43%), Gaps = 24/317 (7%)
Query: 22 VTNDNDFVILKALKDDIWENEPP---NWK-NNDPCGDNWEGIGCTN----SRVTSITLSG 73
+ N D L +K D+ P +W D C W G+ C RV ++ LSG
Sbjct: 2 LCNPQDKQALLQIKKDL--GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59
Query: 74 MGLKGQ--LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD 131
+ L + + L L+ L + +L GP+P I L +L L + + SG IPD
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 132 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 191
+ ++ LV L + N SG +PPSI +L NL + N++ G IP S G+ L
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL---- 175
Query: 192 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 251
+N+L+G IP + L V N L G+ G K+ + + +NS
Sbjct: 176 -FTSMTISRNRLTGKIPPTFAN--LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232
Query: 252 LSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSS 310
L+ + + ++N L L NN++ G +P LT L L L++S N+ E+P +
Sbjct: 233 LAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-GEIPQ-GGN 289
Query: 311 MQSLTTL-MMENTNLKG 326
+Q N L G
Sbjct: 290 LQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 7/156 (4%)
Query: 223 FDSNNLTGELPATLGLVKSLEVVRFDRNSLSG--PVPSNLNNLTSVNDLYLSN-NKLTGA 279
+ G L T + + +L P+PS+L NL +N LY+ N L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 280 MPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHL 338
+P + L+ L YL +++ + +P + S +++L TL L G +P + S+P+L
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVS-GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 339 QTVVMKTNELNGTL--DLGTSYSENLLVNLQNNRIS 372
+ N ++G + G+ + + NR++
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-69
Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 41/303 (13%)
Query: 619 SFEEVKKYTNNFSD---ANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG------ 668
F + + T ++ +G GG+G V+KG + + ++AIK G +G
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 669 -QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR 727
QEF+ E+ ++S ++H N+V L G + ++ EFVP G L L + W
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLL-DKAHPIKWSV 123
Query: 728 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-----LNAKVADFGLSKSMSDS 782
+L++ L A G+ Y+ NPPI+HRD++S NI L + AKVADFGLS+
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----- 177
Query: 783 EKDHITTQVKGTMGYLDPEYYMTQQL--TEKSDVYSFGVLMLELLTGRRPIERGKYI-VR 839
+ H + + G ++ PE ++ TEK+D YSF +++ +LTG P + Y ++
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 840 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899
I + ++ PTI + ++ C RP S +VK++
Sbjct: 238 FINMIREEGLR---------PTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 900 ENI 902
+
Sbjct: 285 SEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 9e-69
Identities = 73/351 (20%), Positives = 128/351 (36%), Gaps = 54/351 (15%)
Query: 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE- 676
+ E +N +G G YG VYKG+L + + +A+K S Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 677 -LLSRVHHKNLVSLLGFC-----FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK 730
+ + H N+ + R E +L+ E+ PNGSL LS DW+ +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCR 115
Query: 731 IALGAARGLSYLHE------LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-- 782
+A RGL+YLH P I HRD+ S N+L+ ++DFGLS ++ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 783 ----EKDHITTQVKGTMGYLDPEYYM-------TQQLTEKSDVYSFGVLMLELLTGRRPI 831
E+D+ GT+ Y+ PE + ++ D+Y+ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 832 ERGKYIVREIRTV-MDKKKELYNLYELID--------PTI--GLSTTLKGFEKYVDLALK 880
G+ V E + + ++ P +
Sbjct: 236 FPGE-SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 881 CVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHH 931
C + + R T + + ++ N + + + HH
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH---------HHHH 336
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-67
Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 34/279 (12%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG----QEFKMEIELLSRVHHKNLVSLLG 691
+G GG+GKVY+ G +A+K A+ + + + E +L + + H N+++L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
C L+ EF G L LSGK R+ + A+ ARG++YLH+ A PII
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 752 HRDIKSSNILLDERL--------NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
HRD+KSSNIL+ +++ K+ DFGL++ + K G ++ PE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVI 186
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
++ SDV+S+GVL+ ELLTG P G + V K I
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYGVAMNKLA---------LPIP 236
Query: 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
+ E + L C RP+ + ++ + I
Sbjct: 237 STCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-66
Identities = 61/287 (21%), Positives = 110/287 (38%), Gaps = 50/287 (17%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
+ G+++KG G I +K + + S + ++F E L H N++ +LG C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 694 FDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
LI ++P GSL + L +D + +K AL ARG+++LH L P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIP 135
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL--- 808
+ S ++++DE + A+++ + S ++ PE +
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTN 188
Query: 809 TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT-IGLSTT 867
+D++SF VL+ EL+T P + + IG+
Sbjct: 189 RRSADMWSFAVLLWELVTREVP------------------------FADLSNMEIGMKVA 224
Query: 868 LKGF---------EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
L+G L C+ E RP +V +E + +
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 75/278 (26%), Positives = 132/278 (47%), Gaps = 28/278 (10%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFC 693
+GSG +G VYKG +G +A+K + Q FK E+ +L + H N++ +G+
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 694 FDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
Q+ ++ ++ SL L + + + + + IA ARG+ YLH IIH
Sbjct: 90 --TAPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL---T 809
RD+KS+NI L E K+ DFGL+ S H Q+ G++ ++ PE Q +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 810 EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV--MDKKKELYNLYELIDPTIGLSTT 867
+SDVY+FG+++ EL+TG+ P + I V +L +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK------- 256
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+ L +C+++ D+RP+ ++ +IE + ++
Sbjct: 257 -----RMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-61
Identities = 60/285 (21%), Positives = 116/285 (40%), Gaps = 34/285 (11%)
Query: 636 VGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G G +G+ K T G+++ +K + + + F E++++ + H N++ +G +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
I E++ G+L + + W +R+ A A G++YLH + IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRD 133
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKD------------HITTQVKGTMGYLDPEY 802
+ S N L+ E N VADFGL++ M D + V G ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY--ELIDP 860
+ EK DV+SFG+++ E++ + + + Y P
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADP---DYLPRTMDFGLNVRGFLDRYCPPNCPP 250
Query: 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+ + ++C + RP+ ++ +E +
Sbjct: 251 SF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-60
Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 35/284 (12%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFC 693
+G G +G+VY G +G+ +AI+ + FK E+ + H+N+V +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
+I +L + I LD + +IA +G+ YLH I+H+
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSD---SEKDHITTQVKGTMGYLDPEYYMTQQL-- 808
D+KS N+ D + DFGL ++ G + +L PE
Sbjct: 155 DLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 809 -------TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861
++ SDV++ G + EL P + + ++ + + P
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKT-----------QPAEAIIWQMGTGMKPN 262
Query: 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+ K D+ L C ++RPT ++++ +E + ++
Sbjct: 263 LSQIGMGKEI---SDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-60
Identities = 90/333 (27%), Positives = 150/333 (45%), Gaps = 27/333 (8%)
Query: 44 PNWKNN-DPCGDNWEGIGCTNSRVTSITLSGMGLK---GQLSGDITGLTELHTLDLSNNK 99
P+W +N +PC ++G+ C + +VTSI LS L +S + LT L +L LSN+
Sbjct: 31 PDWSSNKNPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS- 87
Query: 100 DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQELVLLSLNSNGFSGRVP-PS 156
+ G + L++L L S SGP+ S+GS L L+++SN
Sbjct: 88 HINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146
Query: 157 IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDM 216
L++L LDL+ N + G V S G L KH N++SG +
Sbjct: 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL---KHLAISGNKISGDVDVSRCVN-- 201
Query: 217 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKL 276
L + SNN + +P LG +L+ + N LSG ++ T + L +S+N+
Sbjct: 202 -LEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 277 TGAMPNLTGLSVLSYLDMSNNSFDASEVPSW-FSSMQSLTTLMMENTNLKGQIPADLFSI 335
G +P L L YL ++ N F E+P + + +LT L + + G +P S
Sbjct: 260 VGPIPP-LPLKSLQYLSLAENKFT-GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 336 PHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 368
L+++ + +N +G L + L+ ++
Sbjct: 318 SLLESLALSSNNFSGEL------PMDTLLKMRG 344
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-56
Identities = 81/320 (25%), Positives = 135/320 (42%), Gaps = 26/320 (8%)
Query: 64 SRVTSITLSGMGLKGQLSGDIT---GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120
+ + + LS + G G EL L +S NK + G + + L L +
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK-ISGDVD--VSRCVNLEFLDV 207
Query: 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVS 180
+FS IP +G L L ++ N SG +I + L L+++ N+ G IP
Sbjct: 208 SSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL 266
Query: 181 DGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVK 240
L ++ +N+ +G IP+ L L + N+ G +P G
Sbjct: 267 --PLKSL------QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318
Query: 241 SLEVVRFDRNSLSGPVP-SNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSV-LSYLDMSNN 297
LE + N+ SG +P L + + L LS N+ +G +P LT LS L LD+S+N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 298 SFDASEVPSWF--SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL--D 353
+F + + +L L ++N G+IP L + L ++ + N L+GT+
Sbjct: 379 NFS-GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 354 LGTSYSENL-LVNLQNNRIS 372
LG+ L + L N +
Sbjct: 438 LGS--LSKLRDLKLWLNMLE 455
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 5e-55
Identities = 97/318 (30%), Positives = 144/318 (45%), Gaps = 14/318 (4%)
Query: 57 EGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPT-TIGNLKKL 115
+ + +T + LSG G + + L +L LS+N G LP T+ ++ L
Sbjct: 287 DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN-FSGELPMDTLLKMRGL 345
Query: 116 SNLMLVGCSFSGPIPDSIGSL-QELVLLSLNSNGFSGRVPPSIGN--LSNLYWLDLTDNK 172
L L FSG +P+S+ +L L+ L L+SN FSG + P++ + L L L +N
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405
Query: 173 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
G+IP + N L L H N LSG+IP L L + N L GE+
Sbjct: 406 FTGKIPPTLSNCSELVSL------HLSFNYLSGTIPSSLGSLSK-LRDLKLWLNMLEGEI 458
Query: 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSY 291
P L VK+LE + D N L+G +PS L+N T++N + LSNN+LTG +P + L L+
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 351
L +SNNSF +P+ +SL L + G IPA +F +
Sbjct: 519 LKLSNNSFS-GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVY 577
Query: 352 LDLGTSYSENLLVNLQNN 369
+ E
Sbjct: 578 IKNDGMKKECHGAGNLLE 595
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 9e-54
Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 20/286 (6%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120
+ S++ + L L+G++ ++ + L TL L N L G +P+ + N L+ + L
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND-LTGEIPSGLSNCTNLNWISL 497
Query: 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVS 180
+G IP IG L+ L +L L++N FSG +P +G+ +L WLDL N G IP +
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
Query: 181 DGNSPGL----------------DMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD 224
G D + + H + G E+L R
Sbjct: 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST-RNPCNIT 616
Query: 225 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NL 283
S G T S+ + N LSG +P + ++ + L L +N ++G++P +
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
Query: 284 TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP 329
L L+ LD+S+N D +P S++ LT + + N NL G IP
Sbjct: 677 GDLRGLNILDLSSNKLD-GRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-51
Identities = 74/294 (25%), Positives = 134/294 (45%), Gaps = 16/294 (5%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120
+ + + L G G++ ++ +EL +L LS N L G +P+++G+L KL +L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY-LSGTIPSSLGSLSKLRDLKL 449
Query: 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVS 180
G IP + ++ L L L+ N +G +P + N +NL W+ L++N+L GEIP
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 181 DGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVK 240
G L +L N SG+IP +L LI + ++N G +PA +
Sbjct: 510 IGRLENLAILK------LSNNSFSGNIPAELGDCRS-LIWLDLNTNLFNGTIPAAMFKQS 562
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNN--KLTGAMPN-LTGLSVLSYLDMSNN 297
N ++G + N + + + N + G L LS + ++++
Sbjct: 563 GKI----AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
Query: 298 SFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 351
+ F + S+ L M L G IP ++ S+P+L + + N+++G+
Sbjct: 619 VYG-GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-36
Identities = 49/241 (20%), Positives = 89/241 (36%), Gaps = 16/241 (6%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120
+ + LS G + ++ L LDL+ N G +P + +
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL-FNGTIPAAMFKQS----GKI 565
Query: 121 VGCSFSGPIPDSIGSLQELVLLSLNSNG--FSGRVPPSIGNLSNLYWLDLTDNKLEGEIP 178
+G I + N F G + LS ++T G
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
Query: 179 VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVL-FDSNNLTGELPATLG 237
+ N+ + L N LSG IP+++ M + +L N+++G +P +G
Sbjct: 626 PTFDNNGSMMFL------DMSYNMLSGYIPKEIG--SMPYLFILNLGHNDISGSIPDEVG 677
Query: 238 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 297
++ L ++ N L G +P ++ LT + ++ LSNN L+G +P + NN
Sbjct: 678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNN 737
Query: 298 S 298
Sbjct: 738 P 738
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-33
Identities = 52/245 (21%), Positives = 99/245 (40%), Gaps = 18/245 (7%)
Query: 134 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 193
+ + L S N V S+ +L+ L L L+++ + G + S L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASL------ 102
Query: 194 KHFHFGKNQLSGSIPEKLFRPDMVLIHVL-FDSNNLTGELPATLGL-VKSLEVVRFDRNS 251
+N LSG + + L SN L + GL + SLEV+ NS
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162
Query: 252 LSGPVPSNL---NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 308
+SG + + L +S NK++G + ++ L +LD+S+N+F ++ +P
Sbjct: 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNF-STGIPF-L 219
Query: 309 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQ 367
+L L + L G + + L+ + + +N+ G + ++L +L
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLA 277
Query: 368 NNRIS 372
N+ +
Sbjct: 278 ENKFT 282
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-26
Identities = 41/150 (27%), Positives = 63/150 (42%), Gaps = 7/150 (4%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLM 119
+ + + +G S + L+ + ++++ G T N + L
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV-YGGHTSPTFDNNGSMMFLD 638
Query: 120 LVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPV 179
+ SG IP IGS+ L +L+L N SG +P +G+L L LDL+ NKL+G IP
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 180 SDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 209
+ L N LSG IPE
Sbjct: 699 AMSALTML------TEIDLSNNNLSGPIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-14
Identities = 33/155 (21%), Positives = 62/155 (40%), Gaps = 13/155 (8%)
Query: 239 VKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNS 298
V S+++ N V S+L +LT + L+LSN+ + G++ + L+ LD+S NS
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNS 111
Query: 299 FDASEVPS--WFSSMQSLTTLMMENTNLKGQIPA-DLFSIPHLQTVVMKTNELNGTLDLG 355
+ V + S L L + + L + L+ + + N ++G +G
Sbjct: 112 L-SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 356 TSYSENL----LVNLQNNRISAYTERGGAPAVNLT 386
S+ + + N+IS G
Sbjct: 171 WVLSDGCGELKHLAISGNKIS-----GDVDVSRCV 200
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-57
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 54/303 (17%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL--LSRVHHKNLVSLLGFC 693
VG G YG+V++G+ G+ +A+K S + + + E EL + H+N++ +
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 694 ----FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA--- 746
+ LI + GSL D L LD + L+I L A GL++LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 747 --NPPIIHRDIKSSNILLDERLNAKVADFGLS--KSMSDSEKDHITTQVKGTMGYLDPE- 801
P I HRD+KS NIL+ + +AD GL+ S S ++ D GT Y+ PE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 802 -----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856
++ D+++FG+++ E+ +++ K +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG-----------IVEDYKPPFYDVV 237
Query: 857 LIDPTIGLSTTLKGFEK-----------------YVDLALKCVQESGDDRPTMSEVVKDI 899
DP+ + ++ L +C ++ R T + K +
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 900 ENI 902
I
Sbjct: 298 TKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-56
Identities = 67/306 (21%), Positives = 111/306 (36%), Gaps = 54/306 (17%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE--LLSRVHHKNLVSLLGFC 693
+G G YG+V+ G G+ +A+K + E E + H+N++ +
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 694 ----FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA--- 746
+ LI ++ NGSL D L LD LK+A + GL +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 747 --NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK--DHITTQVKGTMGYLDPE- 801
P I HRD+KS NIL+ + +AD GL+ D GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 802 -----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856
Q +D+YSFG+++ E+ ++++ + Y+
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG-----------IVEEYQLPYHDLV 266
Query: 857 LIDPTIGLSTTLKGFEK-----------------YVDLALKCVQESGDDRPTMSEVVKDI 899
DP+ + +K L +C + R T V K +
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 900 ENILQQ 905
+ +
Sbjct: 327 AKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-54
Identities = 64/302 (21%), Positives = 120/302 (39%), Gaps = 40/302 (13%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE--LLSRVHHKNLVSLLGFC 693
+G G +G+V++G G+ +A+K S + + + E E + H+N++ +
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 694 FDRGEQ----MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE----- 744
L+ ++ +GSL D L+ + +K+AL A GL++LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLS--KSMSDSEKDHITTQVKGTMGYLDPE- 801
P I HRD+KS NIL+ + +AD GL+ + D GT Y+ PE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 802 -----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV-MDKKKELYNLY 855
+ +++D+Y+ G++ E+ I + + D ++
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG----IHEDYQLPYYDLVPSDPSVE 278
Query: 856 ELID--------PTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906
E+ P I + + + +C +G R T + K + + QQ
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338
Query: 907 GL 908
G+
Sbjct: 339 GI 340
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-47
Identities = 57/390 (14%), Positives = 119/390 (30%), Gaps = 48/390 (12%)
Query: 14 LQFLIIAAVTNDNDFVILKALKDDIWENEPPNWK---NNDPCGDNW------------EG 58
+ + D++ LK + D NW G NW G
Sbjct: 18 VPIKLSRTAEYIKDYLALKEIWD---ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPG 74
Query: 59 IGC-TNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGP---LPTTIGNLKK 114
+ +N RVT ++L G G G++ I LTEL L L ++ + P I
Sbjct: 75 VSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMS 134
Query: 115 LSNLMLVGCSFSGPIPDSIGSLQ--ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172
+ + D +L+ +NS+ + S + N
Sbjct: 135 DEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNN 194
Query: 173 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
+ + + L + F+ G + + + +
Sbjct: 195 ITF-VSKAVMRLTKL------RQFYMGNSPFVAENICEA------WENENSEYAQQYKTE 241
Query: 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA---------MPNL 283
+K L V +P+ L L + + ++ N+ + +
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301
Query: 284 TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVM 343
+ + + N+ V + M+ L L L+G++PA S L ++ +
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNL 360
Query: 344 KTNELNGTLDLGTSYSENLLV-NLQNNRIS 372
N++ ++E + + +N++
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK 390
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-39
Identities = 61/336 (18%), Positives = 110/336 (32%), Gaps = 53/336 (15%)
Query: 69 ITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGP 128
I+ + Q D ++ + + N P+ T++ +KKL L + G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 129 IPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL 187
+P + GS +L L+L N + +P + G + L NKL+ IP N
Sbjct: 346 LP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIP----NIFDA 398
Query: 188 DMLVRAKHFHFGKNQLSG-------SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVK 240
+ F N++ + F+ + + +N ++
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN-VSSINLSNNQISKFPKELFSTGS 457
Query: 241 SLEVVRFDRNSLSG-------PVPSNLNNLTSVNDLYLSNNKLTGAMPNL--TGLSVLSY 291
L + N L+ N N + + L NKLT + T L L
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVG 517
Query: 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENT------NLKGQIPADLFSIPHLQTVVMKT 345
+D+S NSF S+ P+ + +L + N + P + P L
Sbjct: 518 IDLSYNSF--SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT------ 569
Query: 346 NELNGTLDLG----TSYSENLLVNLQ-----NNRIS 372
L +G +E + N+ +N
Sbjct: 570 -----QLQIGSNDIRKVNEKITPNISVLDIKDNPNI 600
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-27
Identities = 35/265 (13%), Positives = 81/265 (30%), Gaps = 25/265 (9%)
Query: 87 LTELHTLDLSNNKDLRG-PLPTTIGNLKKLSNLMLVGCSFSG-------PIPDSIGSLQE 138
++ L ++NK L+ P ++ +S + P+ +
Sbjct: 376 TEQVENLSFAHNK-LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 139 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG-LDMLVRAKHFH 197
+ ++L++N S S L ++L N L S +
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID 494
Query: 198 FGKNQLSGSIPEKLFRPDMVLIHVLF-DSNNLTGELPATLGLVKSLEV------VRFDRN 250
N+L+ + + + + + N+ + P +L+ N
Sbjct: 495 LRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGN 552
Query: 251 SLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSS 310
P + S+ L + +N + + +S LD+ +N S S+
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPN-ISIDLSYVCP 609
Query: 311 MQSLTTLMM---ENTNLKGQIPADL 332
M+ + +++G D+
Sbjct: 610 YIEAGMYMLFYDKTQDIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-21
Identities = 33/246 (13%), Positives = 64/246 (26%), Gaps = 63/246 (25%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNK------DLRGPLPTTIGNLKK 114
V+SI LS + + + L +++L N + N
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489
Query: 115 LSNLMLVGCSFSGPIPDSI--GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172
L+++ L + + D +L LV + L+ N FS P N S L + + +
Sbjct: 490 LTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547
Query: 173 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
N E
Sbjct: 548 -------------------------------------------------DAQGNRTLREW 558
Query: 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA-MPNLTGLSVLSY 291
P + L SL ++ N + N++ L + +N + +
Sbjct: 559 PEGITLCPSLTQLQIGSNDIRKVNEKITPNISV---LDIKDNPNISIDLSYVCPYIEAGM 615
Query: 292 LDMSNN 297
+ +
Sbjct: 616 YMLFYD 621
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-46
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 637 GSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
G G +G+V+ G L + L+A+K ++ +F E +L + H N+V L+G C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
+ ++ E V G L G RL L++ AA G+ YL IHRD
Sbjct: 183 QKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRD 238
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ----VKGTMGYLDPEYYMTQQLTE 810
+ + N L+ E+ K++DFG+S+ +D VK T PE + +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEALNYGRYSS 294
Query: 811 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELID 859
+SDV+SFG+L+ E + G P Y + + ++ ++ L+
Sbjct: 295 ESDVWSFGILLWETFSLGASP-----YPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM- 348
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+C RP+ S + +++++I ++
Sbjct: 349 -------------------EQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 637 GSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 691
G G +G V G+++A+K+ Q + + ++F+ EIE+L + H N+V G
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 78
Query: 692 FCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
C+ G + LI E++P GSL D L K+ R+D I+ L+ +G+ YL
Sbjct: 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDPEYYM 804
IHRD+ + NIL++ K+ DFGL+K + + + + G PE
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVKEPGESPIFWYA---PESLT 190
Query: 805 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
+ + SDV+SFGV++ EL T + +R I + +++L EL+
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK---- 246
Query: 864 LSTTLKGF----------EKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
E Y + +C + + RP+ ++ ++ I
Sbjct: 247 -----NNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 81/350 (23%), Positives = 146/350 (41%), Gaps = 52/350 (14%)
Query: 579 VYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGS 638
Y +H + +N + + GS + + F +K +G
Sbjct: 3 YYHHHHHHDYDIPTTENLYF----QGAMGSAFEDRDPTQFEERHLKF-------LQQLGK 51
Query: 639 GGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
G +G V G+++A+K+ Q + + ++F+ EIE+L + H N+V G C
Sbjct: 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111
Query: 694 FDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
+ G + LI E++P GSL D L K+ R+D I+ L+ +G+ YL I
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKR---YI 167
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDPEYYMTQ 806
HRD+ + NIL++ K+ DFGL+K + + ++ + G PE
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWYA---PESLTES 223
Query: 807 QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865
+ + SDV+SFGV++ EL T + +R I + +++L EL+
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK------ 277
Query: 866 TTLKGF----------EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
E Y + +C + + RP+ ++ ++ I Q
Sbjct: 278 ---NNGRLPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-44
Identities = 79/310 (25%), Positives = 133/310 (42%), Gaps = 43/310 (13%)
Query: 637 GSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG 691
G G +G V G L+A+K+ Q ++F+ EI++L +H +V G
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91
Query: 692 FCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
+ G Q L+ E++P+G L D L ++ RLD R L + +G+ YL
Sbjct: 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDPEYYM 804
+HRD+ + NIL++ + K+ADFGL+K + +KD+ + G PE
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYA---PESLS 203
Query: 805 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
+ +SDV+SFGV++ EL T + +R + D L L EL++
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA-LSRLLELLE---- 258
Query: 864 LSTTLKGF----------EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ-AGLNPNA 912
+G E + +L C S DRP+ S + ++ + G +A
Sbjct: 259 -----EGQRLPAPPACPAEVH-ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
Query: 913 ESASSSASYE 922
+A +
Sbjct: 313 FTAHPEGKHH 322
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 29/271 (10%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQ--QGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+G G + VYKG +A Q + + Q FK E E+L + H N+V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 693 CFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
+ L+ E + +G+L L +++ +R +GL +LH P
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS--WCRQILKGLQFLHT-RTP 150
Query: 749 PIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
PIIHRD+K NI + + K+ D GL+ S V GT ++ PE Y ++
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY-EEK 205
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867
E DVY+FG+ MLE+ T P + + R V K + ++ P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKVAIP------E 258
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
+K C++++ D+R ++ +++
Sbjct: 259 VKEI------IEGCIRQNKDERYSIKDLLNH 283
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-42
Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 42/281 (14%)
Query: 637 GSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
G G YG+VY+G +A+K ++ +M+ +EF E ++ + H NLV LLG C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
+I EF+ G+L D L N + + L +A + + YL + IHR++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNL 344
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVY 815
+ N L+ E KVADFGLS+ M+ K + + PE + + KSDV+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 816 SFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDPTIGL 864
+FGVL+ E+ T G P Y ++ V + ++ Y +YEL+
Sbjct: 404 AFGVLLWEIATYGMSP-----YPGIDLSQVYELLEKDYRMERPEGCPEKVYELM------ 452
Query: 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
C Q + DRP+ +E+ + E + Q+
Sbjct: 453 --------------RACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 75/304 (24%), Positives = 134/304 (44%), Gaps = 61/304 (20%)
Query: 634 NDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 687
D+G G +GKV G+ +A+K + S + K EIE+L ++H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 688 SLLGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
G C + G LI EF+P+GSL + L KN +++ ++LK A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDP 800
+HRD+ + N+L++ K+ DFGL+K++ +++K++ T + P
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYA---P 198
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRT---------VMDKKKE 850
E M + SDV+SFGV + ELLT ++ I +++ KE
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258
Query: 851 LY----------NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900
+Y+L+ KC + +R + +++ E
Sbjct: 259 GKRLPCPPNCPDEVYQLM--------------------RKCWEFQPSNRTSFQNLIEGFE 298
Query: 901 NILQ 904
+L+
Sbjct: 299 ALLK 302
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-42
Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 32/276 (11%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
GSG +G V+ G N +AIK ++G+M ++F E E++ ++ H LV L G C ++
Sbjct: 17 GSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
L+ EF+ +G L D L L + L G++YL E A +IHRD+
Sbjct: 76 APICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIHRDLA 131
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMTQQLTEK 811
+ N L+ E KV+DFG+++ + D + + ++ VK PE + + + K
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWAS----PEVFSFSRYSSK 185
Query: 812 SDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 870
SDV+SFGVLM E+ + G+ P Y R V++ + LY ST +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP-----YENRSNSEVVEDISTGFRLY----KPRLASTHV-- 234
Query: 871 FEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906
Y + C +E +DRP S +++ + I +
Sbjct: 235 ---Y-QIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-42
Identities = 82/294 (27%), Positives = 140/294 (47%), Gaps = 41/294 (13%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
G G +G+V+ GT +AIK + G+M + F E +++ ++ H+ LV L +
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
++ E++ GSL D L G+ G L + + +A A G++Y+ + +HRD++
Sbjct: 252 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 307
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
++NIL+ E L KVADFGL++ + D+E + +K T PE + + T KSD
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKSD 363
Query: 814 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID-PTIGLSTTLKGF 871
V+SFG+L+ EL T GR P Y R V+D+ + Y + + P
Sbjct: 364 VWSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYRMPCPPECP----------- 407
Query: 872 EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDAS 925
E DL +C ++ ++RPT + +E+ S+ Y+
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT-----------STEPQYQPGE 450
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 82/283 (28%), Positives = 127/283 (44%), Gaps = 46/283 (16%)
Query: 637 GSGGYGKVYKGTLPNGQL-IAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
G G YG+VY+G L +A+K ++ +M+ +EF E ++ + H NLV LLG C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
+I EF+ G+L D L N + + L +A + + YL E N IHRD+
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKN--FIHRDL 137
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY--LDPEYYMTQQLTEKSD 813
+ N L+ E KVADFGLS+ M+ D T PE + + KSD
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 814 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDPTI 862
V++FGVL+ E+ T G P Y ++ V + ++ Y +YEL+
Sbjct: 195 VWAFGVLLWEIATYGMSP-----YPGIDLSQVYELLEKDYRMERPEGCPEKVYELM---- 245
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
C Q + DRP+ +E+ + E + Q+
Sbjct: 246 ----------------RACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 52/282 (18%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF-D 695
G G +G V G G +A+K + + Q F E +++++ H NLV LLG +
Sbjct: 202 GKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
+G ++ E++ GSL D L + L LK +L + YL +HRD+
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL 315
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTEKSD 813
+ N+L+ E AKV+DFGL+K ++ T + VK T PE ++ + KSD
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA----PEALREKKFSTKSD 368
Query: 814 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDPTI 862
V+SFG+L+ E+ + GR P Y ++ V+ + ++ Y +Y+++
Sbjct: 369 VWSFGILLWEIYSFGRVP-----YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM---- 419
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
C RPT ++ + +E+I
Sbjct: 420 ----------------KNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 67/276 (24%), Positives = 126/276 (45%), Gaps = 27/276 (9%)
Query: 637 GSGGYGKVYKGTL----PNGQL-IAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 690
GSG +G VYKG ++ +AIK ++ + +E E +++ V + ++ LL
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G C LI + +P G L D + ++ + L + A+G++YL + +
Sbjct: 84 GICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
+HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++ E + + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 811 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869
+SDV+S+GV + EL+T G +P Y + ++ L + TI +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP-----YDGIPASEISSILEKGERLPQPPICTIDV----- 248
Query: 870 GFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
Y + KC D RP E++ + + +
Sbjct: 249 ----Y-MIMRKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-41
Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 32/275 (11%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
GSG +G V G +A+K ++GSM EF E + + ++ H LV G C
Sbjct: 17 GSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
++ E++ NG L + L +G L+ + L++ G+++L E IHRD+
Sbjct: 76 YPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL-ESHQ--FIHRDLA 131
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMTQQLTEK 811
+ N L+D L KV+DFG+++ + D + ++++ VK + PE + + + K
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSA----PEVFHYFKYSSK 185
Query: 812 SDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 870
SDV++FG+LM E+ + G+ P Y + V+ K + + L S T+
Sbjct: 186 SDVWAFGILMWEVFSLGKMP-----YDLYTNSEVVLKVSQGHRL----YRPHLASDTI-- 234
Query: 871 FEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
Y + C E + RPT +++ IE + ++
Sbjct: 235 ---Y-QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 6e-41
Identities = 82/294 (27%), Positives = 140/294 (47%), Gaps = 41/294 (13%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
G G +G+V+ GT +AIK + G+M + F E +++ ++ H+ LV L +
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
++ E++ GSL D L G+ G L + + +A A G++Y+ + +HRD++
Sbjct: 335 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLR 390
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
++NIL+ E L KVADFGL++ + D+E + +K T PE + + T KSD
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKSD 446
Query: 814 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID-PTIGLSTTLKGF 871
V+SFG+L+ EL T GR P Y R V+D+ + Y + + P
Sbjct: 447 VWSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYRMPCPPECP----------- 490
Query: 872 EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDAS 925
E DL +C ++ ++RPT + +E+ S+ Y+
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT-----------STEPQYQPGE 533
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 76/273 (27%), Positives = 129/273 (47%), Gaps = 32/273 (11%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF-D 695
G G +G V G G +A+K + + Q F E +++++ H NLV LLG +
Sbjct: 30 GKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
+G ++ E++ GSL D L + L LK +L + YL E N +HRD+
Sbjct: 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FVHRDL 143
Query: 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ--VKGTMGYLDPEYYMTQQLTEKSD 813
+ N+L+ E AKV+DFGL+K ++ T + VK T PE ++ + KSD
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA----PEALREKKFSTKSD 196
Query: 814 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
V+SFG+L+ E+ + GR P Y ++ V+ + ++ Y + P G +
Sbjct: 197 VWSFGILLWEIYSFGRVP-----YPRIPLKDVVPRVEKGYKMDA---PD-GCPPAV---- 243
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
Y ++ C RP+ ++ + +E+I
Sbjct: 244 -Y-EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 34/276 (12%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
G+G +G V G +AIK ++GSM EF E +++ + H+ LV L G C +
Sbjct: 33 GTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
+I E++ NG L + L + R + L++ + YL E +HRD+
Sbjct: 92 RPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLHRDLA 147
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT------MGYLDPEYYMTQQLTE 810
+ N L++++ KV+DFGLS+ + D E T G+ PE M + +
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSP---PEVLMYSKFSS 200
Query: 811 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869
KSD+++FGVLM E+ + G+ P Y + + L S +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP-----YERFTNSETAEHIAQGLRL----YRPHLASEKV- 250
Query: 870 GFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
Y + C E D+RPT ++ +I +++ +
Sbjct: 251 ----Y-TIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-40
Identities = 63/343 (18%), Positives = 119/343 (34%), Gaps = 25/343 (7%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
+ +T + L+ L+ + + T ++L +LD+ N + P L L L L
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT-ISKLEPELCQKLPMLKVLNLQHN 83
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGN 183
S + L L L SN NL LDL+ N L +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 184 SPGLDMLVRAKHFHFGKNQLSGSIPEKL-FRPDMVLIHVLFDSNNLTGELPATLGLVKSL 242
L + N++ E+L + L + SN + P + L
Sbjct: 144 LENL------QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRL 197
Query: 243 EVVRFDRNSLSGPVPSNL---NNLTSVNDLYLSNNKLTGAMPN-LTGLSV--LSYLDMSN 296
+ + L + L TS+ +L LSN++L+ GL L+ LD+S
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257
Query: 297 NSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG- 355
N+ + F+ + L +E N++ L + +++ + +K + ++ L
Sbjct: 258 NNLNVVG-NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316
Query: 356 -TSYSENLL--------VNLQNNRISAYTERGGAPAVNLTLID 389
+ +N+++N I +NL +
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-34
Identities = 56/298 (18%), Positives = 109/298 (36%), Gaps = 21/298 (7%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120
CT S S + L Q+ D+ T + L+L++N+ LR +L++L +
Sbjct: 2 CTVSH-EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQ-LRRLPAANFTRYSQLTSLDV 56
Query: 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVS 180
+ S P+ L L +L+L N S + +NL L L N ++
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 181 DGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVK 240
L N LS + + + L +L +N + L +
Sbjct: 117 FVKQKNL------ITLDLSHNGLSSTKLGTQVQLEN-LQELLLSNNKIQALKSEELDIFA 169
Query: 241 --SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN----LTGLSVLSYLDM 294
SL+ + N + P + + + L+L+N +L ++ + + L +
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 295 SNNSFDASEVPSWFSSMQ--SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG 350
SN+ + + F ++ +LT L + NL +P L+ ++ N +
Sbjct: 230 SNSQLSTTS-NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-33
Identities = 59/329 (17%), Positives = 116/329 (35%), Gaps = 20/329 (6%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIG---NLKKLSN 117
NS + + LS +K G + L L L+N + L L + + N
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ-LGPSLTEKLCLELANTSIRN 226
Query: 118 LMLVGCSFSGPIPDSIGSLQ--ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG 175
L L S + L+ L +L L+ N + S L L + L N ++
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 176 EIPVSDGNSPGLDMLVRAKHF---HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
S + L + F L I + F+ L H+ + N++ G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK-IDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLN----NLTSVNDLYLSNNKLTGAMPN-LTGLS 287
+ +L+ + + S +N + ++ L L+ NK++ + + L
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 288 VLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 347
L LD+ N + ++++ + + +P LQ ++++
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 348 LNGTLDLGTSYSENL----LVNLQNNRIS 372
L +D S + L +++L NN I+
Sbjct: 466 LKN-VDSSPSPFQPLRNLTILDLSNNNIA 493
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-33
Identities = 56/335 (16%), Positives = 104/335 (31%), Gaps = 51/335 (15%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNL- 118
G + +T + LS L + L +L L N ++ ++ L + L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN-IQHLFSHSLHGLFNVRYLN 302
Query: 119 --------MLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 170
+ S S L+ L L++ N G L NL +L L++
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 171 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 230
+ L+ L L + N ++
Sbjct: 363 SFTSL-------------------------RTLTNETFVSLAHSP--LHILNLTKNKISK 395
Query: 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSN-LNNLTSVNDLYLSNNKLTGAMPN-LTGLSV 288
+ LEV+ N + + L ++ ++YLS NK N +
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 289 LSYLDMSNNSF-DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 347
L L + + + PS F +++LT L + N N+ L + L+ + ++ N
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515
Query: 348 LNGTLDLGTSYSENLLV----------NLQNNRIS 372
L L + + NL++N
Sbjct: 516 LA-RLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 54/292 (18%), Positives = 94/292 (32%), Gaps = 22/292 (7%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLP-TTIGNLKKLSNL 118
+S + + L+ + S + L L LDL N+ + L L+ + +
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE-IGQELTGQEWRGLENIFEI 435
Query: 119 MLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSG--RVPPSIGNLSNLYWLDLTDNKLEGE 176
L + +S + L L L P L NL LDL++N +
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 177 IPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVL-------FDSNNLT 229
L + N L+ + + L +SN
Sbjct: 496 NDDMLEGLEKL------EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 230 GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL--TGLS 287
+ L+++ N+L+ S NN S+ L L N +T +
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609
Query: 288 VLSYLDMSNNSFD-ASEVPSWFSSM--QSLTTLMMENTNLKGQIPADLFSIP 336
L+ LDM N FD E +WF + ++ T + +++ P P
Sbjct: 610 NLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP 661
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-29
Identities = 54/294 (18%), Positives = 94/294 (31%), Gaps = 21/294 (7%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 147
D S+ K L +P + ++ L L + +L L + N
Sbjct: 4 VSHEVADCSHLK-LTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 148 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 207
S P L L L+L N+L + L H N + I
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL------TELHLMSNSIQ-KI 112
Query: 208 PEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN--NLTS 265
F LI + N L+ T +++L+ + N + L+ +S
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
Query: 266 VNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFS--SMQSLTTLMMENT 322
+ L LS+N++ P + L L ++N S + S+ L + N+
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232
Query: 323 NLKGQIPADLFS---IPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 372
L F +L + + N LN + ++ L L+ N I
Sbjct: 233 QLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-23
Identities = 51/254 (20%), Positives = 84/254 (33%), Gaps = 25/254 (9%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRG--PLPTTIGNLKKLSNLMLV 121
+ I LS + L L L L+ P+ L+ L+ L L
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA-LKNVDSSPSPFQPLRNLTILDLS 488
Query: 122 GCSFSGPIPDSIGSLQELVLLSLNSN--------GFSGRVPPSIGNLSNLYWLDLTDNKL 173
+ + D + L++L +L L N G + LS+L+ L+L N
Sbjct: 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 174 EGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP 233
+ + L ++ G N L+ +P +F + L + N +T
Sbjct: 549 DEIPVEVFKDLFELKII------DLGLNNLNT-LPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 234 ATLG-LVKSLEVVRFDRNSLSGPVPS-----NLNNLTSVNDLYLSNNKLTGAMPNLTGLS 287
G ++L + N S N N T N LS++ L P+ G
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP 661
Query: 288 VLSYLDMSNNSFDA 301
V D S+ A
Sbjct: 662 VRL-FDTSSCKDSA 674
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 68/292 (23%), Positives = 129/292 (44%), Gaps = 47/292 (16%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH 682
K++ +F + +GSGG+G+V+K +G+ IKR + + + + E++ L+++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLD 62
Query: 683 HKNLVSLLGFCFDRGEQM----------------LIYEFVPNGSLGDSLSGKNGIRLDWI 726
H N+V G + EF G+L + + G +LD +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 727 RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786
L++ +G+ Y+H +I+RD+K SNI L + K+ DFGL S+ + K
Sbjct: 123 LALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-- 177
Query: 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
T+ KGT+ Y+ PE +Q ++ D+Y+ G+++ ELL ++R
Sbjct: 178 -RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR---- 232
Query: 847 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
+ +++ K L K + + +DRP SE+++
Sbjct: 233 -DGIISDIF---------DKKEK------TLLQKLLSKKPEDRPNTSEILRT 268
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 69/303 (22%), Positives = 118/303 (38%), Gaps = 65/303 (21%)
Query: 637 GSGGYGKVYKGTLPN-----GQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
G G +GKV G+++A+K +A G +K EI++L ++H++++
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEIDILRTLYHEHIIKY 98
Query: 690 LGFCFDRGEQ--MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
G C D G L+ E+VP GSL D L + + L A G++YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH- 154
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT-----MGYLDPEY 802
IHRD+ + N+LLD K+ DFGL+K++ + ++ + G PE
Sbjct: 155 --YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYA---PEC 208
Query: 803 YMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRT---------VMDKKKELY 852
+ SDV+SFGV + ELLT + I + + +
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 853 ----------NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
+Y L+ C + RPT ++ ++ +
Sbjct: 269 RLPRPDKCPAEVYHLM--------------------KNCWETEASFRPTFENLIPILKTV 308
Query: 903 LQQ 905
++
Sbjct: 309 HEK 311
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 73/329 (22%), Positives = 126/329 (38%), Gaps = 69/329 (20%)
Query: 637 GSGGYGKVYKGTLPNG----QLIAIKRAQQGSMQGGQ--EFKMEIELLSRVHHKNLVSLL 690
G G +G V + L +A+K + + EF E + H ++ L+
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 691 GFCFDRGEQ------MLIYEFVPNGSLGDSL----SGKNGIRLDWIRRLKIALGAARGLS 740
G + M+I F+ +G L L G+N L ++ + A G+
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL-- 798
YL ++ IHRD+ + N +L E + VADFGLS+ + + +G L
Sbjct: 152 YL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-----YYRQGCASKLPV 203
Query: 799 ---DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------IERGKYIVREIRTVMDK- 847
E T SDV++FGV M E++T G+ P E Y++ R + +
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--LKQP 261
Query: 848 ---KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+E+Y+ L +C RP+ + + ++ENIL
Sbjct: 262 PECMEEVYD-----------------------LMYQCWSADPKQRPSFTCLRMELENILG 298
Query: 905 QAGLNPNAESASSSASYEDASKGNFHHPY 933
+ + S S Y + + + HH +
Sbjct: 299 ----HLSVLSTSQDPLYINIERAHHHHHH 323
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 48/282 (17%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
G+G +G+V+ G +A+K +QGSM F E L+ ++ H+ LV L
Sbjct: 22 GAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
+I E++ NGSL D L +GI+L + L +A A G++++ E N IHRD++
Sbjct: 81 P-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERN--YIHRDLR 136
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
++NIL+ + L+ K+ADFGL++ + D+E ++ +K T PE T KSD
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFTIKSD 192
Query: 814 VYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDPTI 862
V+SFG+L+ E++T GR P Y V+ + Y LY+L+
Sbjct: 193 VWSFGILLTEIVTHGRIP-----YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM---- 243
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
C +E +DRPT + +E+
Sbjct: 244 ----------------RLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G G YG VY G L N IAIK + + Q EI L + HKN+V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNG--------IRLDWIRRLKIALGAARGLSYLHELA 746
+ G + E VP GSL L K G I + +++ L GL YLH+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQI---L---EGLKYLHDNQ 142
Query: 747 NPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM- 804
I+HRDIK N+L++ K++DFG SK ++ T GT+ YM
Sbjct: 143 ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTL------QYMA 191
Query: 805 -------TQQLTEKSDVYSFGVLMLELLTGRRP 830
+ + +D++S G ++E+ TG+ P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 81/295 (27%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 637 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLG 691
GSG G+V G L P + + AIK + G + ++F E ++ + H N++ L G
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
M++ E++ NGSL L + + ++ + + G G+ YL +L +
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMTQ 806
HRD+ + N+L+D L KV+DFGLS+ + D TT ++ T PE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEAIAFR 229
Query: 807 QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865
+ SDV+SFGV+M E+L G RP Y R V+ +E Y L +G
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP-----YWNMTNRDVISSVEEGYRLP----APMGCP 280
Query: 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSAS 920
L + L L C + RP S++V ++ +++ +P + A+++ S
Sbjct: 281 HAL-----H-QLMLDCWHKDRAQRPRFSQIVSVLDALIR----SPESLRATATVS 325
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 34/281 (12%)
Query: 636 VGSGGYGKVYKGTLPNG----QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLL 690
+G G +G VY GTL + A+K + + +F E ++ H N++SLL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 691 GFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
G C +++ ++ +G L + + + L A+G+ YL
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASKK--- 148
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL-----DPEYYM 804
+HRD+ + N +LDE+ KVADFGL++ M D E + T L E
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMALESLQ 205
Query: 805 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
TQ+ T KSDV+SFGVL+ EL+T G P Y + + L
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRL----LQPEY 256
Query: 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
L Y ++ LKC + RP+ SE+V I I
Sbjct: 257 CPDPL-----Y-EVMLKCWHPKAEMRPSFSELVSRISAIFS 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 30/277 (10%)
Query: 637 GSGGYGKVYKGTLPNGQL---IAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLG 691
GSG +G V KG ++ +A+K + + E E ++ ++ + +V ++G
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
C + ML+ E G L L + + +++ + G+ YL E +N +
Sbjct: 86 IC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL-EESN--FV 139
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GYLDPEYYMTQQLT 809
HRD+ + N+LL + AK++DFGLSK++ E ++ Q G + PE + +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 810 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868
KSDV+SFGVLM E + G++P Y + V ++ + +
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP-----YRGMKGSEVTAMLEKGERMGCPAGCPREM---- 249
Query: 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
Y DL C ++RP + V + N
Sbjct: 250 -----Y-DLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-39
Identities = 77/307 (25%), Positives = 135/307 (43%), Gaps = 71/307 (23%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696
G+G +G+V+ T +A+K + GSM + F E ++ + H LV L
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756
+I EF+ GSL D L G + + + + A G++++ E N IHRD++
Sbjct: 256 P-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN--YIHRDLR 311
Query: 757 SSNILLDERLNAKVADFGLSKSMSDSE---KDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
++NIL+ L K+ADFGL++ + D+E ++ +K T PE T KSD
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTIKSD 367
Query: 814 VYSFGVLMLELLT-GRRP------------IERGKYIVREIRTVMDK----KKELYNLYE 856
V+SFG+L++E++T GR P +ERG Y M + +ELY
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-Y-------RMPRPENCPEELY---- 415
Query: 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESAS 916
++ ++C + ++RPT + +++ +
Sbjct: 416 -------------------NIMMRCWKNRPEERPTFEYIQSVLDDFYT-----------A 445
Query: 917 SSASYED 923
+ + YE+
Sbjct: 446 TESQYEE 452
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 637 GSGGYGKVYKGTL--PNGQL-IAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGF 692
G G +G V +G Q+ +AIK +QG+ + +E E +++ ++ + +V L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
C ML+ E G L L + ++ + G+ YL E N +H
Sbjct: 79 C-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL-EEKN--FVH 133
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GYLDPEYYMTQQLTE 810
RD+ + N+LL R AK++DFGLSK++ + + T + G + PE ++ +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 811 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELID 859
+SDV+S+GV M E L+ G++P Y + VM ++ LY L+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP-----YKKMKGPEVMAFIEQGKRMECPPECPPELYALM- 246
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
C +DRP V + +
Sbjct: 247 -------------------SDCWIYKWEDRPDFLTVEQRMRACYY 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 62/273 (22%), Positives = 110/273 (40%), Gaps = 37/273 (13%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKNLVSLLG 691
+G G + +VY+ L +G +A+K+ Q + + EI+LL +++H N++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
+ E ++ E G L + K + K + L ++H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--- 156
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
++HRDIK +N+ + K+ D GL + S S+ + V GT Y+ PE
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 810 EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID-------PTI 862
KSD++S G L+ E+ + P K LY+L + I+ P+
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFY-------------GDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895
S L+ L C+ + RP ++ V
Sbjct: 262 HYSEELR------QLVNMCINPDPEKRPDVTYV 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 33/284 (11%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G GG+ V L +G A+KR Q +E + E ++ +H N++ L+ +C
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 695 DRGEQM----LIYEFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
L+ F G+L + + G L + L + LG RGL +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---K 153
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV-------KGTMGYLDPE 801
HRD+K +NILL + + D G + + T+ Y PE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 802 ---YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858
+ E++DV+S G ++ ++ G P + + + + I
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS-------I 266
Query: 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
+ S+ L L + RP + ++ +E +
Sbjct: 267 PQSPRHSSALW------QLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-39
Identities = 79/300 (26%), Positives = 124/300 (41%), Gaps = 37/300 (12%)
Query: 636 VGSGGYGKVYKGTLPNG----QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLL 690
+G G +G VY GTL + A+K + + +F E ++ H N++SLL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 691 GFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
G C +++ ++ +G L + + + L A+G+ +L
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASKK--- 212
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL-----DPEYYM 804
+HRD+ + N +LDE+ KVADFGL++ M D E D + T L E
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD---SVHNKTGAKLPVKWMALESLQ 269
Query: 805 TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
TQ+ T KSDV+SFGVL+ EL+T G P Y + + L
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRL----LQPEY 320
Query: 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYED 923
L Y ++ LKC + RP+ SE+V I I +A+Y +
Sbjct: 321 CPDPL-----Y-EVMLKCWHPKAEMRPSFSELVSRISAIFST---FIGEHYVHVNATYVN 371
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 58/289 (20%), Positives = 116/289 (40%), Gaps = 49/289 (16%)
Query: 637 GSGGYGKVYKGTL--------PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
G G + K++KG + + +K + + F ++S++ HK+LV
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
G C E +L+ EFV GSL L KN ++ + +L++A A + +L E
Sbjct: 77 NYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EENT- 133
Query: 749 PIIHRDIKSSNILLD--------ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
+IH ++ + NILL K++D G+S ++ D + ++ P
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--DILQERIPWVP----P 186
Query: 801 E---YYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYE 856
E + L +D +SFG + E+ + G +P + + + ++ + L
Sbjct: 187 ECIENP--KNLNLATDKWSFGTTLWEICSGGDKP-----LSALDSQRKLQFYEDRHQLPA 239
Query: 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+ +L C+ D RP+ +++D+ ++
Sbjct: 240 PKAAEL-----------A-NLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-39
Identities = 79/310 (25%), Positives = 142/310 (45%), Gaps = 34/310 (10%)
Query: 637 GSGGYGKVYKGTLPNG----QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLG 691
G+G +G+V G L +AIK + G + ++F E ++ + H N++ L G
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
M++ E++ NGSL L K+ + I+ + + G A G+ YL ++ +
Sbjct: 114 VVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMTQ 806
HRD+ + NIL++ L KV+DFGL + + D + TT+ ++ T PE +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----PEAIAYR 225
Query: 807 QLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865
+ T SDV+S+G+++ E+++ G RP Y + V+ E Y L +D L
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP-----YWEMSNQDVIKAVDEGYRLPPPMDCPAAL- 279
Query: 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDAS 925
Y L L C Q+ ++RP ++V ++ +++ G SA++ S
Sbjct: 280 --------Y-QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLD 330
Query: 926 KGNFHHPYCN 935
+ N
Sbjct: 331 QSNVDITTFR 340
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 27/276 (9%)
Query: 637 GSGGYGKVYKGTL----PNGQL-IAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 690
GSG +G VYKG ++ +AIK ++ + +E E +++ V + ++ LL
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G C LI + +P G L D + ++ + L + A+G++YL + +
Sbjct: 84 GICLTS-TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
+HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++ E + + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 811 KSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLK 869
+SDV+S+GV + EL+T G +P Y + ++ L + TI +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKP-----YDGIPASEISSILEKGERLPQPPICTIDV----- 248
Query: 870 GFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
Y + +KC D RP E++ + + +
Sbjct: 249 ----Y-MIMVKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 61/318 (19%), Positives = 123/318 (38%), Gaps = 44/318 (13%)
Query: 599 HWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIK 658
H + SSG + F+ + +S +GSGG KV++ Q+ AIK
Sbjct: 2 HHHHHHSSGVDLGTENLY---FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 58
Query: 659 R-----AQQGSMQGGQEFKMEIELLSRVHHKNL--VSLLGFCFDRGEQMLIYEFVPNGSL 711
A ++ ++ EI L+++ + + L + ++ E N L
Sbjct: 59 YVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL 114
Query: 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771
L K I + + + +H+ I+H D+K +N L+ + K+
Sbjct: 115 NSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLI 168
Query: 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPE-----------YYMTQQLTEKSDVYSFGVL 820
DFG++ M + GT+ Y+ PE +++ KSDV+S G +
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 821 MLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALK 880
+ + G+ P ++ + ++ ++D +E+ P I L+ D+
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAIIDPN------HEIEFPDI-PEKDLQ------DVLKC 275
Query: 881 CVQESGDDRPTMSEVVKD 898
C++ R ++ E++
Sbjct: 276 CLKRDPKQRISIPELLAH 293
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 76/280 (27%), Positives = 134/280 (47%), Gaps = 35/280 (12%)
Query: 637 GSGGYGKVYKGTL--PNGQ---LIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLL 690
G+G +G+VYKG L +G+ +AIK + G + +F E ++ + H N++ L
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G M+I E++ NG+L L + ++ + + G A G+ YL +
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYYMT 805
+HRD+ + NIL++ L KV+DFGLS+ + D + TT ++ T PE
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAISY 224
Query: 806 QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864
++ T SDV+SFG++M E++T G RP Y VM + + L +D +
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP-----YWELSNHEVMKAINDGFRLPTPMDCPSAI 279
Query: 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
Y L ++C Q+ RP +++V ++ +++
Sbjct: 280 ---------Y-QLMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 61/303 (20%), Positives = 116/303 (38%), Gaps = 64/303 (21%)
Query: 634 NDVGSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNL 686
++G G +G VY+G +AIK + + EF E ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSL--------GDSLSGKNGIRLDWIRRLKIALGAARG 738
V LLG ++I E + G L + + +++A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
++YL+ +HRD+ + N ++ E K+ DFG+++ + +++ KG G L
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLL 202
Query: 799 -----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPI------ERGKYIVREIRTVMD 846
PE T SDV+SFGV++ E+ T +P + ++++ +D
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--LD 260
Query: 847 K----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
K L+ L C Q + RP+ E++ I+
Sbjct: 261 KPDNCPDMLFE-----------------------LMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 903 LQQ 905
++
Sbjct: 298 MEP 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 87/320 (27%), Positives = 143/320 (44%), Gaps = 57/320 (17%)
Query: 637 GSGGYGKVYKGTLPNG---QLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLVSLLG 691
G G +G+V K + AIKR ++ + + ++F E+E+L ++ HH N+++LLG
Sbjct: 34 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 93
Query: 692 FCFDRGEQMLIYEFVPNGSL--------------GDSLSGKNGIRLDWIRRLKIALGAAR 737
C RG L E+ P+G+L +++ L + L A AR
Sbjct: 94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
G+ Y L+ IHRD+ + NIL+ E AK+ADFGLS+ E VK TMG
Sbjct: 154 GMDY---LSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQE-----VYVKKTMGR 202
Query: 798 L-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKEL 851
L E T SDV+S+GVL+ E+++ G P Y + +K +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----YCGMTCAELYEKLPQG 257
Query: 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ------ 905
Y L + + + Y DL +C +E +RP+ ++++ + +L++
Sbjct: 258 YRL----EKPLNCDDEV-----Y-DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 307
Query: 906 AGLNPNAESASSSASYEDAS 925
L A S E+A+
Sbjct: 308 TTLYEKFTYAGIDCSAEEAA 327
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGF 692
+G G +GK +G+ IK M +E + E+ +L+ + H N+V
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
+ G ++ ++ G L ++ + G+ + L + L ++H+ I+H
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILH 148
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
RDIKS NI L + ++ DFG+++ ++ S + + GT YL PE + KS
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-GTPYYLSPEICENKPYNNKS 206
Query: 813 DVYSFGVLMLELLTGRRP 830
D+++ G ++ EL T +
Sbjct: 207 DIWALGCVLYELCTLKHA 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 73/290 (25%), Positives = 117/290 (40%), Gaps = 54/290 (18%)
Query: 637 GSGGYGKVYKGTLPNG----QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLG 691
G G +G VY G + AIK + MQ + F E L+ ++H N+++L+G
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 692 FCFDR-GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G ++ ++ +G L + + L ARG+ YL E
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQK---F 145
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL-----DPEYYMT 805
+HRD+ + N +LDE KVADFGL++ + D E + + L E T
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDRE---YYSVQQHRHARLPVKWTALESLQT 202
Query: 806 QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NL 854
+ T KSDV+SFGVL+ ELLT G P Y + + + +L
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPP-----YRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257
Query: 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
Y+++ +C + RPT +V ++E I+
Sbjct: 258 YQVM--------------------QQCWEADPAVRPTFRVLVGEVEQIVS 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-38
Identities = 53/278 (19%), Positives = 108/278 (38%), Gaps = 35/278 (12%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNL--VSLLG 691
+GSGG KV++ Q+ AIK ++ EI L+++ + + L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
+ ++ E N L L K I + + + +H+ I+
Sbjct: 77 YEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG---IV 130
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE---------- 801
H D+K +N L+ + K+ DFG++ M + GT+ Y+ PE
Sbjct: 131 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 802 -YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860
+++ KSDV+S G ++ + G+ P ++ + ++ ++D +E+ P
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN------HEIEFP 243
Query: 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
L+ D+ C++ R ++ E++
Sbjct: 244 D-IPEKDLQ------DVLKCCLKRDPKQRISIPELLAH 274
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-38
Identities = 74/299 (24%), Positives = 116/299 (38%), Gaps = 64/299 (21%)
Query: 637 GSGGYGKVYKGTLPNG----QLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
G G +G V +G L +A+K + S + +EF E + H N++ LL
Sbjct: 43 GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102
Query: 691 GFCFDRGEQ-----MLIYEFVPNGSLGDSL----SGKNGIRLDWIRRLKIALGAARGLSY 741
G C + Q M+I F+ G L L + LK + A G+ Y
Sbjct: 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY 162
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL--- 798
L +N +HRD+ + N +L + + VADFGLSK + + +G + +
Sbjct: 163 L---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-----YYRQGRIAKMPVK 214
Query: 799 --DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------IERGKYIVREIRTVMDK-- 847
E + T KSDV++FGV M E+ T G P E Y++ R + +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--LKQPE 272
Query: 848 --KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
ELY + C + DRPT S + +E +L+
Sbjct: 273 DCLDELYE-----------------------IMYSCWRTDPLDRPTFSVLRLQLEKLLE 308
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 59/292 (20%)
Query: 637 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLG 691
G G +G+VY+G G+ I A+K ++ ++F E ++ + H ++V L+G
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
+ +I E P G LG L +N L + + +L + ++YL E N +
Sbjct: 81 II-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN--CV 135
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT------MGYLDPEYYMT 805
HRDI NIL+ K+ DFGLS+ + D + + T M PE
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMS---PESINF 188
Query: 806 QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NL 854
++ T SDV+ F V M E+L+ G++P + E + V+ ++ L
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP-----FFWLENKDVIGVLEKGDRLPKPDLCPPVL 243
Query: 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906
Y L+ +C DRP +E+V + ++ Q
Sbjct: 244 YTLM--------------------TRCWDYDPSDRPRFTELVCSLSDVYQME 275
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 71/310 (22%), Positives = 128/310 (41%), Gaps = 81/310 (26%)
Query: 637 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
G G +GKV+ N L+A+K + ++ ++F+ E ELL+ + H+++V
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 691 GFCFDRGEQMLIYEFVPNGSL--------------GDSLSGKNGIRLDWIRRLKIALGAA 736
G C D ++++E++ +G L D + L + L IA A
Sbjct: 84 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
G+ YL +HRD+ + N L+ L K+ DFG+S+ + ++ G
Sbjct: 144 SGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYRVGGHT 195
Query: 797 YL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERGKYIV 838
L PE M ++ T +SDV+SFGV++ E+ T G++P I +G+
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR--- 252
Query: 839 REIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSE 894
V+++ KE+Y+ + L C Q R + E
Sbjct: 253 -----VLERPRVCPKEVYD-----------------------VMLGCWQREPQQRLNIKE 284
Query: 895 VVKDIENILQ 904
+ K + + +
Sbjct: 285 IYKILHALGK 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 67/312 (21%), Positives = 127/312 (40%), Gaps = 80/312 (25%)
Query: 634 NDVGSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
++G G +GKV+ N L+A+K ++ S Q+F+ E ELL+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSL-------------GDSLSGKNGIRLDWIRRLKIALG 734
G C + ++++E++ +G L L + L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 735 AARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT 794
A G+ YL L +HRD+ + N L+ + L K+ DFG+S+ + ++ G
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----YYRVGG 218
Query: 795 MGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERGKY 836
L PE + ++ T +SDV+SFGV++ E+ T G++P I +G+
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR- 277
Query: 837 IVREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM 892
+++ E+Y + C Q R ++
Sbjct: 278 -------ELERPRACPPEVYA-----------------------IMRGCWQREPQQRHSI 307
Query: 893 SEVVKDIENILQ 904
+V ++ + Q
Sbjct: 308 KDVHARLQALAQ 319
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGF 692
+G+G YG+ K +G+++ K GSM Q E+ LL + H N+V
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 693 CFDRGEQML--IYEFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAARGLSYLHE--LA 746
DR L + E+ G L ++ K LD L++ L H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
++HRD+K +N+ LD + N K+ DFGL++ ++ + T V GT Y+ PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
EKSD++S G L+ EL P I GK+
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-37
Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 62/304 (20%)
Query: 637 GSGGYGKVYKGTL--PNGQL-IAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGF 692
G G +G V +G Q+ +AIK +QG+ + +E E +++ ++ + +V L+G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
C ML+ E G L L + ++ + G+ YL E N +H
Sbjct: 405 C-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL-EEKN--FVH 459
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY--LDPEYYMTQQLTE 810
R++ + N+LL R AK++DFGLSK++ + + T + G PE ++ +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 811 KSDVYSFGVLMLELLT-GRRP------------IERGKYIVREIRTVMDK----KKELYN 853
+SDV+S+GV M E L+ G++P IE+GK R M+ ELY
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---R-----MECPPECPPELY- 569
Query: 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAE 913
L C +DRP V + + L E
Sbjct: 570 ----------------------ALMSDCWIYKWEDRPDFLTVEQRMRACYY--SLASKVE 605
Query: 914 SASS 917
S+
Sbjct: 606 GGSA 609
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 68/276 (24%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 637 GSGGYGKVYKGTL----PNGQL-IAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
GSG +G V+KG + ++ + IK + G Q + + + H ++V L
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHMLAIGSLDHAHIVRL 80
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
LG C L+ +++P GSL D + ++ L L + A+G+ YL E
Sbjct: 81 LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEHG--- 135
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
++HR++ + N+LL +VADFG++ + +K + ++ K + ++ E + T
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 810 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868
+SDV+S+GV + EL+T G P Y + V D ++ L + TI +
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEP-----YAGLRLAEVPDLLEKGERLAQPQICTIDV---- 246
Query: 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
Y + +KC + RPT E+ + + +
Sbjct: 247 -----Y-MVMVKCWMIDENIRPTFKELANEFTRMAR 276
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 19/202 (9%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
VG G +G+V++ G A+K R + ++ E+ + + +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
+ + E + GSLG + + D A GL YLH I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLGQALEGLEYLHTRR---ILH 173
Query: 753 RDIKSSNILLDER-LNAKVADFGLSKSMSDSEKDHITTQ---VKGTMGYLDPEYYMTQQL 808
D+K+ N+LL A + DFG + + + GT ++ PE M +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 809 TEKSDVYSFGVLMLELLTGRRP 830
K D++S +ML +L G P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 69/307 (22%)
Query: 637 GSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLVS 688
G G +G+V + + +A+K ++G+ + E+++L + HH N+V+
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 689 LLGFCFDRGE-QMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIAL 733
LLG C G M+I EF G+L L L + +
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
A+G+ +L A+ IHRD+ + NILL E+ K+ DFGL++ + V+
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRK 207
Query: 794 TMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRT- 843
L PE + T +SDV+SFGVL+ E+ + G P ++ + R ++
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 844 -VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
M E+Y L C RPT SE+V+
Sbjct: 268 TRMRAPDYTTPEMYQT-----------------------MLDCWHGEPSQRPTFSELVEH 304
Query: 899 IENILQQ 905
+ N+LQ
Sbjct: 305 LGNLLQA 311
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 5e-37
Identities = 57/343 (16%), Positives = 119/343 (34%), Gaps = 49/343 (14%)
Query: 582 YHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDAND------ 635
+H + + K ++ N
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 636 --VGSGGYGKVYKGTLPNGQLIAIKR-----AQQGSMQGGQEFKMEIELLSRVHHKNL-- 686
+GSGG KV++ Q+ AIK A ++ ++ EI L+++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKI 118
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 746
+ L + ++ E N L L K I + + + +H+
Sbjct: 119 IRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG 175
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE----- 801
I+H D+K +N L+ + K+ DFG++ M + G + Y+ PE
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 802 ------YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855
+++ KSDV+S G ++ + G+ P ++ + ++ ++D +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN------H 285
Query: 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
E+ P I L+ D+ C++ R ++ E++
Sbjct: 286 EIEFPDI-PEKDLQ------DVLKCCLKRDPKQRISIPELLAH 321
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 637 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSL 689
G G +G V +G P+G+ + A+K + + +F E+ + + H+NL+ L
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86
Query: 690 LGFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
G ++ E P GSL D L K+ + A+ A G+ YL E
Sbjct: 87 YGVVL--TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL-ESKR- 141
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQ-----VKGTMGYLDPEYY 803
IHRD+ + N+LL R K+ DFGL +++ ++ ++ + PE
Sbjct: 142 -FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PESL 196
Query: 804 MTQQLTEKSDVYSFGVLMLELLT-GRRP 830
T+ + SD + FGV + E+ T G+ P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 75/375 (20%), Positives = 134/375 (35%), Gaps = 87/375 (23%)
Query: 580 YAYHQKRRAEKANEQNPFAHWDMNKSSGSI-PQLKGARCFSFEEVKKYT---NNFSDAND 635
+ Y ++ R E M + +GS + +E K+ N
Sbjct: 1 HKYKKQFRYES--------QLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKV 52
Query: 636 VGSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLV 687
+GSG +GKV T +A+K ++ + + E+++++++ H+N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSL---------------------SGKNGIRLDWI 726
+LLG C G LI+E+ G L + L ++ L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 727 RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786
L A A+G+ +L +HRD+ + N+L+ K+ DFGL++ +
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS--- 226
Query: 787 ITTQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYI 837
V L PE T KSDV+S+G+L+ E+ + G P I
Sbjct: 227 --NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284
Query: 838 VREIRT--VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 891
+ I+ MD+ +E+Y + C RP+
Sbjct: 285 YKLIQNGFKMDQPFYATEEIY-----------------------IIMQSCWAFDSRKRPS 321
Query: 892 MSEVVKDIENILQQA 906
+ + L A
Sbjct: 322 FPNLTSFLGCQLADA 336
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 75/317 (23%), Positives = 133/317 (41%), Gaps = 84/317 (26%)
Query: 637 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSL 689
G G +GKV K T + +A+K ++ + ++ E +L +V+H +++ L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 690 LGFCFDRGEQMLIYEFVPNGSL----------------------GDSLSGKNGIRLDWIR 727
G C G +LI E+ GSL SL + L
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 728 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787
+ A ++G+ Y LA ++HRD+ + NIL+ E K++DFGLS+ + + +
Sbjct: 152 LISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED---- 204
Query: 788 TTQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKY----- 836
+ VK + G + E T +SDV+SFGVL+ E++T G P Y
Sbjct: 205 -SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-----YPGIPP 258
Query: 837 --IVREIRT--VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDD 888
+ ++T M++ +E+Y L L+C ++ D
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMY-----------------------RLMLQCWKQEPDK 295
Query: 889 RPTMSEVVKDIENILQQ 905
RP +++ KD+E ++ +
Sbjct: 296 RPVFADISKDLEKMMVK 312
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 68/287 (23%), Positives = 110/287 (38%), Gaps = 51/287 (17%)
Query: 637 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLG 691
G G +G V++G P + AIK + + ++F E + + H ++V L+G
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
+I E G L L LD + A + L+YL +
Sbjct: 84 VI-TENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR---FV 138
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GYLDPEYYMTQQLT 809
HRDI + N+L+ K+ DFGLS+ M DS KG + ++ PE ++ T
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRRFT 195
Query: 810 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELY----------NLYELI 858
SDV+ FGV M E+L G +P + + V+ + + LY L+
Sbjct: 196 SASDVWMFGVCMWEILMHGVKP-----FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 250
Query: 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
KC RP +E+ + IL++
Sbjct: 251 --------------------TKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 75/315 (23%), Positives = 124/315 (39%), Gaps = 85/315 (26%)
Query: 637 GSGGYGKVYKGTL--------PNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNL 686
G G +G+V +A+K + + + + E+E++ + HKN+
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIA 732
++LLG C G +I E+ G+L + L + ++ + +
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 733 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792
ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++ +++ + K
Sbjct: 210 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKK 261
Query: 793 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERG 834
T G L PE + T +SDV+SFGVLM E+ T G P ++ G
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321
Query: 835 KYIVREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 890
MDK ELY + C RP
Sbjct: 322 H--------RMDKPANCTNELYM-----------------------MMRDCWHAVPSQRP 350
Query: 891 TMSEVVKDIENILQQ 905
T ++V+D++ IL
Sbjct: 351 TFKQLVEDLDRILTL 365
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 75/316 (23%), Positives = 124/316 (39%), Gaps = 85/316 (26%)
Query: 637 GSGGYGKVYKGTLP--------NGQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNL 686
G G +G+V +A+K + + + + E+E++ + HKN+
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIA 732
++LLG C G +I E+ G+L + L + ++ + +
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 733 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792
ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++ +++ + K
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKK 215
Query: 793 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERG 834
T G L PE + T +SDV+SFGVLM E+ T G P ++ G
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 835 KYIVREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 890
MDK ELY + C RP
Sbjct: 276 H--------RMDKPANCTNELYM-----------------------MMRDCWHAVPSQRP 304
Query: 891 TMSEVVKDIENILQQA 906
T ++V+D++ IL
Sbjct: 305 TFKQLVEDLDRILTLT 320
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 63/301 (20%), Positives = 120/301 (39%), Gaps = 49/301 (16%)
Query: 625 KYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVH 682
+Y +F +G GG+G V++ + AIKR + + + ++ E++ L+++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 683 HKNLVSLLGFCFDRGE---------QMLIY---EFVPNGSLGDSLSGKNGIR-LDWIRRL 729
H +V ++ ++ +Y + +L D ++G+ I + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 730 KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT- 788
I L A + +LH ++HRD+K SNI KV DFGL +M E++
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 789 ---------TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 839
T GT Y+ PE + K D++S G+++ ELL P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS------- 228
Query: 840 EIRTVMDKKKELYNLYELIDPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
T M++ + L ++ L P + + + S +RP +++
Sbjct: 229 ---TQMERVRTLTDVRNLKFPPLFTQKYPCEY------VMVQDMLSPSPMERPEAINIIE 279
Query: 898 D 898
+
Sbjct: 280 N 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 67/307 (21%), Positives = 116/307 (37%), Gaps = 58/307 (18%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 693
+ GG+ VY+ + +G+ A+KR + + E+ + ++ H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 694 FDRGEQM-------LIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
E+ L+ + G L + L ++ L LKI R + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK----------GTM 795
PPIIHRD+K N+LL + K+ DFG + ++S + Q + T
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 796 GYLDPE---YYMTQQLTEKSDVYSFGVLMLELLTGRRP--------IERGKYIVREIRTV 844
Y PE Y + EK D+++ G ++ L + P I GKY
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY-------- 266
Query: 845 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
I P T L +Q + ++R +++EVV ++ I
Sbjct: 267 ------------SIPPHDTQYTVFH------SLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 905 QAGLNPN 911
+NP
Sbjct: 309 ARNVNPK 315
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 63/307 (20%), Positives = 118/307 (38%), Gaps = 58/307 (18%)
Query: 625 KYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH 683
+Y ++F + +G G +G+V K + + AIK+ + + E+ LL+ ++H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNH 61
Query: 684 KNLVSLLGFCFDRGEQML----------IY---EFVPNGSLGDSLSGKNGIRLDWIRRLK 730
+ +V +R + ++ E+ NG+L D + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWR 120
Query: 731 IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS-------- 782
+ LSY+H IIHRD+K NI +DE N K+ DFGL+K++ S
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 783 -----EKDHITTQVKGTMGYLDPE------YYMTQQLTEKSDVYSFGVLMLELLTGRRPI 831
D++T+ + GT Y+ E +Y EK D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYPFSTG 231
Query: 832 ERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT 891
I++++R D K + + + RP
Sbjct: 232 MERVNILKKLR------SVSIEFPPDFDDNK--MKVEK------KIIRLLIDHDPNKRPG 277
Query: 892 MSEVVKD 898
++
Sbjct: 278 ARTLLNS 284
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 70/309 (22%)
Query: 637 GSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLVS 688
G+G +GKV + T +A+K + + + E+++LS + +H N+V+
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 689 LLGFCFDRGEQMLIYEFVPNGSL----------------GDSLSGKNGIRLDWIRRLKIA 732
LLG C G ++I E+ G L ++ + + LD L +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 733 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792
A+G+++L A+ IHRD+ + NILL K+ DFGL++ + + V
Sbjct: 152 YQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NYVV 203
Query: 793 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRT 843
L PE T +SDV+S+G+ + EL + G P + + I+
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263
Query: 844 --VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
M E+Y D+ C RPT ++V+
Sbjct: 264 GFRMLSPEHAPAEMY-----------------------DIMKTCWDADPLKRPTFKQIVQ 300
Query: 898 DIENILQQA 906
IE + ++
Sbjct: 301 LIEKQISES 309
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 74/321 (23%), Positives = 124/321 (38%), Gaps = 68/321 (21%)
Query: 637 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSL 689
G G +G+VY+G + +A+K + Q +F ME ++S+ +H+N+V
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSL-----SGKNGIRLDWIRRLKIALGAARGLSYLHE 744
+G + ++ E + G L L L + L +A A G YL E
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158
Query: 745 LANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL--- 798
IHRDI + N LL AK+ DFG+++ + + KG L
Sbjct: 159 NH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPVK 210
Query: 799 --DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPI------ERGKYIVREIRTVMDK-- 847
PE +M T K+D +SFGVL+ E+ + G P E +++ R MD
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--MDPPK 268
Query: 848 --KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+Y + +C Q +DRP + +++ IE Q
Sbjct: 269 NCPGPVYR-----------------------IMTQCWQHQPEDRPNFAIILERIEYCTQ- 304
Query: 906 AGLNPNAESASSSASYEDASK 926
+P+ + + Y +
Sbjct: 305 ---DPDVINTALPIEYGPLVE 322
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-36
Identities = 49/271 (18%), Positives = 88/271 (32%), Gaps = 12/271 (4%)
Query: 71 LSGMGLKGQLSGDITGLTELHTLDLSNNK-DLRGPLPTTIGNLKKLSNLMLVGCSFSGPI 129
L+ KG + L L LDLS N +G + L L L +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 130 PDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188
+ L++L L + S+ +L NL +LD++ L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL- 447
Query: 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 248
+ N + +F L + L P + SL+V+
Sbjct: 448 -----EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 249 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTG--LSVLSYLDMSNNSFDASEVPS 306
N+ L S+ L S N + + S L++L+++ N F +
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
Query: 307 WFSS-MQSLTTLMMENTNLKGQIPADLFSIP 336
F ++ L++E ++ P+D +P
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 62/321 (19%), Positives = 107/321 (33%), Gaps = 25/321 (7%)
Query: 60 GCTNSRVTSITLSGMGLK-GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNL 118
G N + L+ + + LT + + L + + +L
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT-IERVKD--FSYNFGWQHL 309
Query: 119 MLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL--EGE 176
LV C F + SL+ L S S +L +L +LDL+ N L +G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-----AFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 177 IPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA-T 235
SD + L K+ N + F L H+ F +NL
Sbjct: 365 CSQSDFGTTSL------KYLDLSFNGVITMSSN--FLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 236 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP--NLTGLSVLSYLD 293
+++L + N L+S+ L ++ N T L L++LD
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 294 MSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLD 353
+S + P+ F+S+ SL L M + N + LQ + N + +
Sbjct: 477 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 354 LGTSYSENLL--VNLQNNRIS 372
+ + L +NL N +
Sbjct: 536 QELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 51/286 (17%), Positives = 83/286 (29%), Gaps = 39/286 (13%)
Query: 90 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGF 149
LDLS N LR + + +L L L C + SL L L L N
Sbjct: 30 TKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 150 SGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 209
+ LS+L L + L G+ L K + N +
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL------KELNVAHNLIQS---- 138
Query: 210 KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS---- 265
+LP + +LE + N + ++L L
Sbjct: 139 --------------------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 266 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325
L LS N + P L L + NN + + + + L + +
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 326 GQI---PADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 368
+ D ++ L + ++ L LD +L L N
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLA-YLDYYLDDIIDLFNCLTN 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-30
Identities = 58/300 (19%), Positives = 96/300 (32%), Gaps = 27/300 (9%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG------PIPDSIGSLQEL 139
LH L L NN D + T I L L LV F ++ L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 140 VLLSLNSN---GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 196
+ + + L+N+ L +E S + G +H
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGW------QHL 309
Query: 197 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS--G 254
+ P + L + G + + SLE + RN LS G
Sbjct: 310 ELVNCKFGQ-FPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 255 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 314
+ TS+ L LS N + N GL L +LD +++ S F S+++L
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 315 TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 372
L + +T+ + + L+ + M N + NL +L ++
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-20
Identities = 32/180 (17%), Positives = 63/180 (35%), Gaps = 6/180 (3%)
Query: 58 GIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSN 117
+ + + + +S + +G GL+ L L ++ N LP L+ L+
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 118 LMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEI 177
L L C P + SL L +L+++ N F L++L LD + N +
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534
Query: 178 PVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF-DSNNLTGELPATL 236
+ P L + +N + + + F + L + + P+
Sbjct: 535 KQELQHFPS--SL---AFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 80/350 (22%), Positives = 129/350 (36%), Gaps = 92/350 (26%)
Query: 637 GSGGYGKVYKGTLPN--------GQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNL 686
G G +G+V +A+K + + + + E+E++ + HKN+
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIA 732
++LLG C G +I E+ G+L + L S +L + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 733 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792
ARG+ YL A+ IHRD+ + N+L+ E K+ADFGL++ + + K
Sbjct: 198 YQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----YYKK 249
Query: 793 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERG 834
T G L PE + T +SDV+SFGVL+ E+ T G P ++ G
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309
Query: 835 KYIVREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP 890
MDK ELY + C RP
Sbjct: 310 H--------RMDKPSNCTNELYM-----------------------MMRDCWHAVPSQRP 338
Query: 891 TMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHHPYCNEEGFD 940
T ++V+D++ I+ S Y ++ P F+
Sbjct: 339 TFKQLVEDLDRIVA-------LTSNQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 63/304 (20%), Positives = 115/304 (37%), Gaps = 66/304 (21%)
Query: 637 GSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQG-GQEFKMEIELLSRV-HHKNLVS 688
G+G +GKV + T +A+K + + + E++++S + H+N+V+
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 689 LLGFCFDRGEQMLIYEFVPNGSL------------GDSLSGKNGIRLDWIRRLKIALGAA 736
LLG C G ++I E+ G L D L + A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
+G+++L A+ IHRD+ + N+LL AK+ DFGL++ + + +
Sbjct: 175 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----NYIVKGNA 226
Query: 797 YL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVREIRT--VM 845
L PE T +SDV+S+G+L+ E+ + G P I + ++ M
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 846 DK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
+ K +Y + C RPT ++ ++
Sbjct: 287 AQPAFAPKNIY-----------------------SIMQACWALEPTHRPTFQQICSFLQE 323
Query: 902 ILQQ 905
Q+
Sbjct: 324 QAQE 327
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 42/284 (14%)
Query: 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM--QGGQEFKMEI 675
SF+ + + +G G YG+V+K +G+L A+KR+ + E+
Sbjct: 58 SFQRLSR----------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 676 ELLSRV-HHKNLVSLLGFCFDRGEQMLIY-EFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
+V H V L ++ G + + E SL G L +
Sbjct: 108 GSHEKVGQHPCCVRLEQ-AWEEGGILYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLR 164
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
L++LH ++H D+K +NI L R K+ DFGL + + +G
Sbjct: 165 DTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEG 218
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN 853
Y+ PE + +DV+S G+ +LE+ G + ++L
Sbjct: 219 DPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGG-----------EGWQQLRQ 266
Query: 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
Y + T GLS+ L+ + + ++ R T ++
Sbjct: 267 GYLPPEFTAGLSSELR------SVLVMMLEPDPKLRATAEALLA 304
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 62/308 (20%), Positives = 113/308 (36%), Gaps = 82/308 (26%)
Query: 637 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSL 689
G +GKVYKG L Q +AIK + + +EF+ E L +R+ H N+V L
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKIALGA 735
LG +I+ + +G L + L L+ + +
Sbjct: 78 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 795
A G+ YL ++H+D+ + N+L+ ++LN K++D GL + + ++
Sbjct: 138 AAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD-----YYKLLGN 189
Query: 796 GYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP------------IERGKYI 837
L PE M + + SD++S+GV++ E+ + G +P I +
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ-- 247
Query: 838 VREIRTVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 893
V+ +Y L ++C E RP
Sbjct: 248 ------VLPCPDDCPAWVYA-----------------------LMIECWNEFPSRRPRFK 278
Query: 894 EVVKDIEN 901
++ +
Sbjct: 279 DIHSRLRA 286
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G G +G VY + ++A+K +AQ + + E+E+ S + H N++ L G+
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
D LI E+ P G++ L K + D R A LSY H +IH
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQ-KLS-KFDEQRTATYITELANALSYCHSKR---VIH 132
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
RDIK N+LL K+ADFG S + S + GT+ YL PE + EK
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDLC---GTLDYLPPEMIEGRMHDEKV 188
Query: 813 DVYSFGVLMLELLTGRRPIE 832
D++S GVL E L G+ P E
Sbjct: 189 DLWSLGVLCYEFLVGKPPFE 208
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 66/318 (20%), Positives = 126/318 (39%), Gaps = 84/318 (26%)
Query: 637 GSGGYGKVYKGTLPNG------QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSL 689
G G +G+V++ P ++A+K ++ + +F+ E L++ + N+V L
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 690 LGFCFDRGEQMLIYEFVPNGSL----------------------GDSLSGKNGIRLDWIR 727
LG C L++E++ G L +S L
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 728 RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787
+L IA A G++YL E +HRD+ + N L+ E + K+ADFGLS+++ ++
Sbjct: 176 QLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---- 228
Query: 788 TTQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKY----- 836
+ PE + T +SDV+++GV++ E+ + G +P Y
Sbjct: 229 -YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-----YYGMAH 282
Query: 837 --IVREIRT--VMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDD 888
++ +R ++ ELYN L C + D
Sbjct: 283 EEVIYYVRDGNILACPENCPLELYN-----------------------LMRLCWSKLPAD 319
Query: 889 RPTMSEVVKDIENILQQA 906
RP+ + + ++ + ++A
Sbjct: 320 RPSFCSIHRILQRMCERA 337
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-34
Identities = 70/277 (25%), Positives = 111/277 (40%), Gaps = 31/277 (11%)
Query: 637 GSGGYGKVYKGTL--PNGQLI--AIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLG 691
G G +G V++G P + AIK + + ++F E + + H ++V L+G
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458
Query: 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751
+I E G L L LD + A + L+YL +
Sbjct: 459 VI-TENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKR---FV 513
Query: 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM--GYLDPEYYMTQQLT 809
HRDI + N+L+ K+ DFGLS+ M DS KG + ++ PE ++ T
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRRFT 570
Query: 810 EKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868
SDV+ FGV M E+L G +P + + V+ + + L TL
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP-----FQGVKNNDVIGRIENGERL----PMPPNCPPTL 621
Query: 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
Y L KC RP +E+ + IL++
Sbjct: 622 -----Y-SLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 75/321 (23%), Positives = 125/321 (38%), Gaps = 68/321 (21%)
Query: 637 GSGGYGKVYKGTLPNG------QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSL 689
G G +G+VY+G + +A+K + S Q +F ME ++S+ +H+N+V
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSL-----SGKNGIRLDWIRRLKIALGAARGLSYLHE 744
+G + ++ E + G L L L + L +A A G YL E
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199
Query: 745 LANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL--- 798
IHRDI + N LL AK+ DFG+++ + + KG L
Sbjct: 200 NH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAMLPVK 251
Query: 799 --DPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPI------ERGKYIVREIRTVMDK-- 847
PE +M T K+D +SFGVL+ E+ + G P E +++ R MD
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--MDPPK 309
Query: 848 --KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+Y + +C Q +DRP + +++ IE Q
Sbjct: 310 NCPGPVYR-----------------------IMTQCWQHQPEDRPNFAIILERIEYCTQ- 345
Query: 906 AGLNPNAESASSSASYEDASK 926
+P+ + + Y +
Sbjct: 346 ---DPDVINTALPIEYGPLVE 363
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-34
Identities = 57/405 (14%), Positives = 111/405 (27%), Gaps = 54/405 (13%)
Query: 30 ILKALKDDIWENEPP---------NWKNNDPCGD--NWEGIGCTN-SRVTSITLSGMGLK 77
I +AL W NW N + G+ N RVT ++L+G G K
Sbjct: 277 IWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAK 336
Query: 78 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 137
G++ I LTEL L + + L + + Q
Sbjct: 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQ 396
Query: 138 ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 197
L L L + + P + + + L D ++ S + L + + +
Sbjct: 397 RLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIY 454
Query: 198 FGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVP 257
F + + + D + +K L V +P
Sbjct: 455 FANSPFTYDNIA------VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
Query: 258 SNLNNLTSVNDLYLSNNKLTGAM----------PNLTGLSVLSYLDMSNNSFDASEVPSW 307
L +L + L ++ N+ A + + M N+ + +
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568
Query: 308 FSSMQSLTTLMMENTNLKG---------------------QIPADLFS-IPHLQTVVMKT 345
M L L + ++ +IP D + ++ +
Sbjct: 569 LQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSH 628
Query: 346 NELNGTLD-LGTSYSENLLV-NLQNNRISAYTERGGAPAVNLTLI 388
N+L + + + N+I + + I
Sbjct: 629 NKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGI 673
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-32
Identities = 49/311 (15%), Positives = 106/311 (34%), Gaps = 31/311 (9%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS-LQEL 139
S + + +L LD +NK +R G KL++L L IP+ + ++
Sbjct: 566 SASLQKMVKLGLLDCVHNK-VRHL--EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQV 621
Query: 140 VLLSLNSNGFSGRVPP--SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 197
L + N +P + ++ + +D + NK+ + S + A
Sbjct: 622 EGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVT 679
Query: 198 FGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT-------GELPATLGLVKSLEVVRFDRN 250
N++ E LF + ++ +N +T L + N
Sbjct: 680 LSYNEIQKFPTE-LFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 251 SLSG-PVPSNLNNLTSVNDLYLSNNKLT------GAMPNLTGLSVLSYLDMSNNSFDASE 303
L+ L ++++ +S N + L + D N +
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRI-LRQ 797
Query: 304 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT--SYSEN 361
P+ ++ SL L + + +++ + L P L + + N ++D+ + Y E
Sbjct: 798 WPTGITTCPSLIQLQIGSNDIRK-VDEKLT--PQLYILDIADNPNI-SIDVTSVCPYIEA 853
Query: 362 LLVNLQNNRIS 372
+ L ++
Sbjct: 854 GMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-31
Identities = 50/311 (16%), Positives = 103/311 (33%), Gaps = 27/311 (8%)
Query: 80 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 139
+S I LT+L + +N+ S +L++L
Sbjct: 440 ISKAIQRLTKLQIIYFANSP-FTYDNIAVDWEDANSDYAKQ-----YENEELSWSNLKDL 493
Query: 140 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS---PGLDMLVRAKHF 196
+ L + ++P + +L L L++ N+ + + D + + F
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 197 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPV 256
+ G N L + + L + N + L A G L ++ D N +
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIP 611
Query: 257 PSNLNNLTSVNDLYLSNNKLTG--AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ-- 312
V L S+NKL + N + V+ +D S N SE + SM
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDY 670
Query: 313 ---SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL-------NGTLDLGTSYSENL 362
+ +T+ + ++ + + T+++ N + D + L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 363 LV-NLQNNRIS 372
+L+ N+++
Sbjct: 731 TTIDLRFNKLT 741
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 5e-19
Identities = 35/262 (13%), Positives = 73/262 (27%), Gaps = 63/262 (24%)
Query: 71 LSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS---- 126
+ G S D T+ LS N+ ++ +S ++L +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNE-IQKFPTELFATGSPISTIILSNNLMTSIPE 714
Query: 127 ---GPIPDSIGSLQELVLLSLNSNGFSGRVPPSI--GNLSNLYWLDLTDNKLEGEIPVSD 181
P + + L + L N + + L L +D++ N P
Sbjct: 715 NSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQP 772
Query: 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKS 241
NS L K F + + N + + P +
Sbjct: 773 LNSSQL------KAFGIRHQR-------------------DAEGNRILRQWPTGIT---- 803
Query: 242 LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDA 301
+L L + +N + L L LD+++N +
Sbjct: 804 -----------------TCPSLIQ---LQIGSNDIRKVDEKL--TPQLYILDIADNPNIS 841
Query: 302 SEVPSWFSSMQSLTTLMMENTN 323
+V S +++ +++ +
Sbjct: 842 IDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 28/159 (17%), Positives = 46/159 (28%), Gaps = 19/159 (11%)
Query: 78 GQLSGDITGLTELHTLDLSNNKDLRG-PLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSL 136
G+ L T+DL NK L L LSN+ + FS P +
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNK-LTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775
Query: 137 QELVLLSL------NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190
+L + N + P I +L L + N + ++ + +P L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD--EKLTPQL--- 829
Query: 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT 229
N SI P + + +
Sbjct: 830 ---YILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 66/304 (21%), Positives = 108/304 (35%), Gaps = 44/304 (14%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 693
+G G V++G G L AIK S + E E+L +++HKN+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI- 75
Query: 694 FDRGEQMLIY---EFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
+ EF P GSL L N L L + G+++L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 750 IIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY-- 803
I+HR+IK NI+ D + K+ DFG ++ + D E+ + GT YL P+ Y
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYER 189
Query: 804 ------MTQQLTEKSDVYSFGVLMLELLTGRRP----------------IERGKYIVREI 841
++ D++S GV TG P I GK
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901
+ + ++ LS L+ + ++ + + + +
Sbjct: 250 GVQKAENGPIDWSGDMPVSC-SLSRGLQ--VLLTPVLANILEADQEKCWGFDQFFAETSD 306
Query: 902 ILQQ 905
IL +
Sbjct: 307 ILHR 310
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 28/219 (12%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK-----RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
G G + VY+ + G +AIK + M Q + E+++ ++ H +++ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQLKHPSILELY 77
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ D L+ E NG + L + G+ YLH I
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYLHSHG---I 133
Query: 751 IHRDIKSSNILLDERLNAKVADFGLS-KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
+HRD+ SN+LL +N K+ADFGL+ + EK + T GT Y+ PE
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-TLC--GTPNYISPEIATRSAHG 190
Query: 810 EKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+SDV+S G + LL GR P + Y
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 42/320 (13%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 693
+G G V++G G L AIK S + E E+L +++HKN+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 694 FDRGEQM--LIYEFVPNGSLGDSLSGK-NGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ + LI EF P GSL L N L L + G+++L E I
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 751 IHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY--- 803
+HR+IK NI+ D + K+ DFG ++ + D E+ + GT YL P+ Y
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLY-GTEEYLHPDMYERA 190
Query: 804 -----MTQQLTEKSDVYSFGVLMLELLTGRRP----------------IERGKYIVREIR 842
++ D++S GV TG P I GK
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 843 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
+ + ++ LS L+ + ++ + + + +I
Sbjct: 251 VQKAENGPIDWSGDMPVSC-SLSRGLQ--VLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 903 LQQAGLNPNAESASSSASYE 922
L + ++ + ++
Sbjct: 308 LHRMVIHVFSLQQMTAHKIY 327
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLG 691
+G GG VY +AIK + + F+ E+ S++ H+N+VS+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 692 FCFDRGEQMLIY----EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
D E+ Y E++ +L + + +G L + G+ + H++
Sbjct: 77 --IDVDEEDDCYYLVMEYIEGPTLSEYIE-SHG-PLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
I+HRDIK NIL+D K+ DFG++K++S++ T V GT+ Y PE +
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEA 188
Query: 808 LTEKSDVYSFGVLMLELLTGRRP 830
E +D+YS G+++ E+L G P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 28/208 (13%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIK--RAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLG 691
VG GG G VY+ +++A+K S + + E R+ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI-- 99
Query: 692 FCFDRGEQ-------MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
D GE M + L L + G L R + I L H
Sbjct: 100 --HDFGEIDGQLYVDM---RLINGVDLAAMLR-RQG-PLAPPRAVAIVRQIGSALDAAHA 152
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT--QVKGTMGYLDPEY 802
HRD+K NIL+ A + DFG++ + +D +T GT+ Y+ PE
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE---KLTQLGNTVGTLYYMAPER 206
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ T ++D+Y+ ++ E LTG P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLG 691
+G GG +V+ L + + +A+K RA F+ E + + ++H +V++
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 692 FCFDRGEQMLIY----EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
+ E+V +L D + G + R +++ A + L++ H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEG-PMTPKRAIEVIADACQALNFSHQNG- 136
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-HITTQVKGTMGYLDPEYYMTQ 806
IIHRD+K +NI++ KV DFG++++++DS T V GT YL PE
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP 830
+ +SDVYS G ++ E+LTG P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G GG+ K ++ + ++ A K ++ ++ MEI + + H+++V GF
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
D ++ E SL + + + R + G YLH +IH
Sbjct: 84 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLHRNR---VIH 138
Query: 753 RDIKSSNILLDERLNAKVADFGLS-KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 811
RD+K N+ L+E L K+ DFGL+ K D E+ + GT Y+ PE + + +
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFE 195
Query: 812 SDVYSFGVLMLELLTGRRP------------IERGKY 836
DV+S G +M LL G+ P I++ +Y
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 232
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 637 GSGGYGKVYKG-TLPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G G +G VY N ++A+K ++Q + + EIE+ S + H N++ + +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
DR L+ EF P G L L K+G R D R A L Y HE +IH
Sbjct: 83 FHDRKRIYLMLEFAPRGELYKELQ-KHG-RFDEQRSATFMEELADALHYCHERK---VIH 137
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
RDIK N+L+ + K+ADFG S + S + GT+ YL PE + EK
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRTMC---GTLDYLPPEMIEGKTHDEKV 193
Query: 813 DVYSFGVLMLELLTGRRPIE 832
D++ GVL E L G P +
Sbjct: 194 DLWCAGVLCYEFLVGMPPFD 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G GG+ K ++ + ++ A K ++ ++ MEI + + H+++V GF
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
D ++ E SL + + + R + G YLH +IH
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLHRNR---VIH 164
Query: 753 RDIKSSNILLDERLNAKVADFGLS-KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEK 811
RD+K N+ L+E L K+ DFGL+ K D E+ + GT Y+ PE + + +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFE 221
Query: 812 SDVYSFGVLMLELLTGRRP------------IERGKY 836
DV+S G +M LL G+ P I++ +Y
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 258
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 59/294 (20%), Positives = 95/294 (32%), Gaps = 16/294 (5%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 145
L TL L+ N L T + K L +L + S + + + L L L
Sbjct: 79 SQHRLDTLVLTANP-LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 146 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 205
SN S P L LD +N + + L + N ++
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL----SLNLNGNDIA- 192
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGL--VKSLEVVRFDRNSLSGPVPSNLNNL 263
I F V + F + L ++SL + F+ P+ L
Sbjct: 193 GIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 264 --TSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320
SV + L + N S L LD++ SE+PS + +L L++
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL--SELPSGLVGLSTLKKLVLS 309
Query: 321 NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 372
+ + P L + +K N L G ENL +L ++ I
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-33
Identities = 59/320 (18%), Positives = 108/320 (33%), Gaps = 16/320 (5%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLM 119
G V SI L S + L LDL+ L LP+ + L L L+
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH-LSE-LPSGLVGLSTLKKLV 307
Query: 120 LVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPP-SIGNLSNLYWLDLTDNKLEGEIP 178
L F S + L LS+ N + + NL NL LDL+ + +E
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SD 366
Query: 179 VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG-ELPATLG 237
+ L L + + N+ S+ + F+ L + L + +
Sbjct: 367 CCNLQLRNLSHL---QSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
Query: 238 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG----AMPNLTGLSVLSYLD 293
+ L+V+ + L + L ++ L L N +L L L L
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 294 MSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLD 353
+S + + F+S++ + + + + L + S + + +N ++ L
Sbjct: 483 LSFCDLSSID-QHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASNHISIILP 540
Query: 354 LGTSYSENLL-VNLQNNRIS 372
+NL+ N +
Sbjct: 541 SLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-31
Identities = 53/316 (16%), Positives = 104/316 (32%), Gaps = 14/316 (4%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
+ + G+ + L +L L +N + +KL L
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH-ISSIKLPKGFPTEKLKVLDFQNN 163
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNG-FSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 182
+ + + SLQ+ LSLN NG + P + + L+ + I
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFR--PDMVLIHVLFDSNNLTGELPATLGLVK 240
NS + F I +F +M + + + T
Sbjct: 224 NST----IQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSF 299
L+ + LS +PS L L+++ L LS NK + L++L + N+
Sbjct: 279 GLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337
Query: 300 DASEVPSWFSSMQSLTTLMMENTNLK--GQIPADLFSIPHLQTVVMKTNELNGTLDLGTS 357
++++L L + + +++ L ++ HLQ++ + NE
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 358 YSENLLV-NLQNNRIS 372
L + +L R+
Sbjct: 398 ECPQLELLDLAFTRLK 413
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-29
Identities = 57/325 (17%), Positives = 106/325 (32%), Gaps = 22/325 (6%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGN-LKKLSNL 118
+ S+ L+G + G + +L+ ++L + ++ L
Sbjct: 175 SLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 119 MLVGCSFSGPIPDSIGSLQELVL--LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE 176
P L E+ + ++L + F + S L LDLT L E
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-E 292
Query: 177 IPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL-PAT 235
+P L K N+ + + L H+ N EL
Sbjct: 293 LPSGLVGLSTL------KKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 236 LGLVKSLEVVRFDRNSL--SGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYL 292
L +++L + + + S L NL+ + L LS N+ L L
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 293 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGT 351
D++ + S F ++ L L + ++ L LF +P LQ + ++ N
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 352 LDLGTSYSENL----LVNLQNNRIS 372
T+ + L ++ L +S
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLS 489
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-25
Identities = 49/337 (14%), Positives = 102/337 (30%), Gaps = 34/337 (10%)
Query: 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG 127
+ +GL ++ G + L+ S N L TT L L+ L L C
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNV-LPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 128 PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL 187
D+ S L L L +N ++ L L + + N L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 188 DML------------------VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD-SNNL 228
+ L + K F N + + ++ ++ + + N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGND 190
Query: 229 TGELPATLGLVKSLEVVRFDRNSLSGPVPSNL--NNLTSVNDLYLSNNKLT----GAMPN 282
+ + + F + L + + S+ +
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 283 LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVV 342
L +S + +++ + F + F L L + T+L ++P+ L + L+ +V
Sbjct: 251 LCEMS-VESINLQKHYFFNIS-SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307
Query: 343 MKTNELNGTLDLGTSYSENLLV-NLQNNRISAYTERG 378
+ N+ + S +L +++ N G
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 42/199 (21%), Positives = 67/199 (33%), Gaps = 7/199 (3%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQEL 139
+ + L+ L +L+LS N+ +L L L S +L L
Sbjct: 369 NLQLRNLSHLQSLNLSYNE-PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 140 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 199
+L+L+ + L L L+L N + L L +
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL---EILVLS 484
Query: 200 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 259
LS SI + F ++ HV N LT L +K + + N +S +PS
Sbjct: 485 FCDLS-SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542
Query: 260 LNNLTSVNDLYLSNNKLTG 278
L L+ + L N L
Sbjct: 543 LPILSQQRTINLRQNPLDC 561
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 22/247 (8%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLL---- 690
G+GG+G V + G+ +AIK+ +Q +E + +EI+++ +++H N+VS
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 691 --GFCFDRGEQMLIYEFVPNGSLGDSLSGK---NGIRLDWIRRLKIALGAARGLSYLHEL 745
+L E+ G L L+ G++ IR L + +A L YLHE
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLHEN 140
Query: 746 ANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
IIHRD+K NI+L +RL K+ D G +K + E T V GT+ YL PE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFV-GTLQYLAPEL 194
Query: 803 YMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862
++ T D +SFG L E +TG RP V+ V +K E +Y+ + +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 863 GLSTTLK 869
S+ L
Sbjct: 255 KFSSVLP 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQ-QGSMQGGQEFKMEIELLSRVHHKN 685
++F +++G+G G V+K + P+G ++A K + + E+++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+V G + GE + E + GSL L I + K+++ +GL+YL E
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREK 150
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
I+HRD+K SNIL++ R K+ DFG+S + DS + + V GT Y+ PE
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQG 204
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRPI 831
+ +SD++S G+ ++E+ GR PI
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-32
Identities = 48/207 (23%), Positives = 78/207 (37%), Gaps = 31/207 (14%)
Query: 636 VGSGGYGKVYKG--TLPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGF 692
+ GG G +Y NG+ + +K Q E + L+ V H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI--- 144
Query: 693 CFDRGE------QMLIY---EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
F+ E + Y E+V SL S +L + L LSYLH
Sbjct: 145 -FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH 199
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
+ +++ D+K NI+L E K+ D G ++ + GT G+ PE
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV 249
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRP 830
T T +D+Y+ G + L
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 57/271 (21%), Positives = 107/271 (39%), Gaps = 30/271 (11%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 695
G G G + + + + +A+KR E++LL H N++ D
Sbjct: 33 GHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCTEKD 89
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
R Q + E +L + + K+ L + + + GL++LH L I+HRD+
Sbjct: 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLHSLN---IVHRDL 144
Query: 756 KSSNILLDE-----RLNAKVADFGLSKSMSDSEK-DHITTQVKGTMGYLDPEYY---MTQ 806
K NIL+ ++ A ++DFGL K ++ + V GT G++ PE +
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 807 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
T D++S G + +++ GK + R+ ++ + + P
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANILLGACS-----LDCLHPEKHEDV 258
Query: 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ +L K + RP+ V+K
Sbjct: 259 IAR------ELIEKMIAMDPQKRPSAKHVLK 283
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 47/238 (19%), Positives = 91/238 (38%), Gaps = 45/238 (18%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIK-----------------RAQQGSMQGGQEFKMEIELLS 679
G + K+ + + A+K + +FK E+++++
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 680 RVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA---- 735
+ ++ ++ G + E +IYE++ N S+ + ++ + I +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 736 --ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
SY+H N I HRD+K SNIL+D+ K++DFG S+ M D I G
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSR-G 212
Query: 794 TMGYLDPEYYMTQQLT--EKSDVYSFGVLMLELLTGRRP-------------IERGKY 836
T ++ PE++ + K D++S G+ + + P I
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 66/278 (23%), Positives = 122/278 (43%), Gaps = 32/278 (11%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKR-AQQGSMQGGQEFKMEIE-LLSRVHHK 684
++ ++G G YG V K +P+GQ++A+KR + Q + M+++ + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL----SGKNGIRLDWIRRLKIALGAARGLS 740
V+ G F G+ + E + + SL I D + KIA+ + L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALE 123
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
+LH + +IHRD+K SN+L++ K+ DFG+S + D G Y+ P
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDA-GCKPYMAP 178
Query: 801 E----YYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856
E + + KSD++S G+ M+EL R P + ++++ V+++
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-------- 230
Query: 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSE 894
P + F + +C++++ +RPT E
Sbjct: 231 --SPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPE 263
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 59/302 (19%)
Query: 625 KYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRV 681
+YT F + +GSG +G V+K +G + AIKR+++ Q E+ + +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 682 -HHKNLVSLLGFCFDRGEQMLIY-EFVPNGSLGDSLS--GKNGIRLDWIRRLKIALGAAR 737
H ++V + + MLI E+ GSL D++S + + L R
Sbjct: 68 GQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDE-------------------RLNAKVADFGLSKS 778
GL Y+H ++ ++H DIK SNI + ++ K+ D G
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 837
+S +G +L E K+D+++ + ++ G
Sbjct: 184 ISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-Q 236
Query: 838 VREIRTVMDKKKELYNLYELIDPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895
EIR + L P I LS +L + + RP+ +
Sbjct: 237 WHEIR-----QGRL--------PRIPQVLSQEFT------ELLKVMIHPDPERRPSAMAL 277
Query: 896 VK 897
VK
Sbjct: 278 VK 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 40/244 (16%), Positives = 73/244 (29%), Gaps = 23/244 (9%)
Query: 636 VGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
+G G + +VY+ T N Q +K + + +E L +
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGD---SLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 746
+ +L+ E G+L + + + A+ + +H+
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192
Query: 747 NPPIIHRDIKSSNILL-----------DERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 795
IIH DIK N +L D + D G S M K I T T
Sbjct: 193 ---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 796 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855
G+ E + + D + + +L G + + + + + L
Sbjct: 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWN 309
Query: 856 ELID 859
E
Sbjct: 310 EFFH 313
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQ-QGSMQGGQEFKMEIE-LLSRVHHK 684
+ D ++G G YG V K P+GQ++A+KR + + ++ M+++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLS-----GKNGIRLDWIRRLKIALGAARGL 739
+V G F G+ + E + + S + I + + KI L + L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG--KITLATVKAL 138
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
++L E IIHRDIK SNILLD N K+ DFG+S + DS T G Y+
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDA-GCRPYMA 193
Query: 800 PE----YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
PE Q +SDV+S G+ + EL TGR P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 25/299 (8%), Positives = 64/299 (21%), Gaps = 53/299 (17%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G V+ + + A+K + S + +R+ ++
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 693 C--------------------------FDRGEQMLIYEFVPNGSLGDSLS-----GKNGI 721
+ +L+ + L S
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFRG 189
Query: 722 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781
+ + R + L ++H N+ + + D +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 782 SEKDHITTQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 839
+ Y E+ T T + + G+ + + P ++
Sbjct: 247 R-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 840 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
+ + L +K L + + R E ++
Sbjct: 302 GSWKRPSLRVPGTDSLAF-GSCTPLPDFVK------TLIGRFLNFDRRRRLLPLEAMET 353
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLV 687
F+ +G G +G+V+KG +++AIK + ++ + EI +LS+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 688 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 746
G + + ++ +I E++ GS D L + I I +GL YLH
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIA--TILREILKGLDYLHSEK 139
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
IHRDIK++N+LL E K+ADFG++ ++D++ T GT ++ PE
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP 830
K+D++S G+ +EL G P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 21/208 (10%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRA--QQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
G V P G+ + ++R + S + + E+ + +H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA-T 94
Query: 694 FDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLD--WIRRLKIALGAARGLSYLHELANPPI 750
F ++ ++ F+ GS D + ++ I I G + L Y+H +
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YILQGVLKALDYIHHMG---Y 149
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK-----GTMGYLDPEYYMT 805
+HR +K+S+IL+ ++ + SM + + +L PE +
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE-VLQ 208
Query: 806 QQL---TEKSDVYSFGVLMLELLTGRRP 830
Q L KSD+YS G+ EL G P
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQ-QGSMQGGQEFKMEIE-LLSRVHHK 684
N+ + ++GSG G+V+K G +IA+K+ + G+ + + M+++ +L
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
+V G + + E + + + I + K+ + + L YL E
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG--KMTVAIVKALYYLKE 142
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
+IHRD+K SNILLDER K+ DFG+S + D + G Y+ PE
Sbjct: 143 KHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSA-GCAAYMAPERID 197
Query: 805 TQQLTE-----KSDVYSFGVLMLELLTGRRP 830
T+ ++DV+S G+ ++EL TG+ P
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
+ ++G G +GKVYK G L A K + S + +++ +EIE+L+ H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSL-SGKNGIRLDWIRRLKIALGAARGLSYLHELA 746
LLG + ++ ++ EF P G++ + G+ I+ + L++LH
Sbjct: 81 LLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSKR 137
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
IIHRD+K+ N+L+ + ++ADFG+S + + + GT ++ PE M +
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 807 QLTE-----KSDVYSFGVLMLELLTGRRP 830
+ + K+D++S G+ ++E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
++ +G G G VY + GQ +AI++ + EI ++ + N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L + G+++ ++ E++ GSL D ++ + + I + + L +LH
Sbjct: 82 YLD-SYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAA--VCRECLQALEFLHSNQ- 136
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
+IHRDIKS NILL + K+ DFG ++ + T + GT ++ PE +
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 808 LTEKSDVYSFGVLMLELLTGRRP 830
K D++S G++ +E++ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 50/313 (15%), Positives = 105/313 (33%), Gaps = 25/313 (7%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
++++ L+ L + + + L L G S + +L LL+L+S
Sbjct: 9 GNRYKIEKVTDSS-LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 206
N + +LS L LDL +N ++ E+ P ++ L H N +S
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETL------HAANNNIS-R 113
Query: 207 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTS 265
+ + ++ +N +T G ++ + N + + +
Sbjct: 114 VSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 266 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325
+ L L N + + + L LD+S+N + + F S +T + + N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKL--AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 326 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGA--PAV 383
I L +L+ ++ N + + + + T +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 384 NLTLIDNPICQEL 396
L C++L
Sbjct: 287 TLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 52/284 (18%), Positives = 96/284 (33%), Gaps = 22/284 (7%)
Query: 57 EGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLS 116
+ + V + LSG L + D+ T+L L+LS+N L L + +L L
Sbjct: 27 ASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV-LYETLD--LESLSTLR 83
Query: 117 NLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE 176
L L + + L +N S RV S + L +NK+
Sbjct: 84 TLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITML 135
Query: 177 IPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF-DSNNLTGELPAT 235
+ +G + L N++ ++ + L N + ++
Sbjct: 136 RDLDEGCRSRVQYL------DLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187
Query: 236 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMS 295
+ L+ + N L+ + + V + L NNKL L L + D+
Sbjct: 188 VVF-AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLR 245
Query: 296 NNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQ 339
N F + +FS Q + T+ + + ++P L
Sbjct: 246 GNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 74/326 (22%), Positives = 131/326 (40%), Gaps = 44/326 (13%)
Query: 582 YHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGY 641
+H + +N + D+ + G K + K +GSG Y
Sbjct: 2 HHHHHHSS--GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVK---------KLGSGAY 50
Query: 642 GKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNLVSLLGFCFDRGE 698
G+V AIK ++ S+ + E+ +L + H N++ L F D+
Sbjct: 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110
Query: 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL-KIALGAARGLSYLHELANPPIIHRDIKS 757
L+ E G L D + + + K L ++YLH+ I+HRD+K
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG---VTYLHKHN---IVHRDLKP 164
Query: 758 SNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 814
N+LL ++ K+ DFGLS + +K + ++ GT Y+ PE + ++ EK DV
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERL-GTAYYIAPE-VLRKKYDEKCDV 220
Query: 815 YSFGVLMLELLTGRRPI--ERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
+S GV++ LL G P + + I+R++ +K Y +S K
Sbjct: 221 WSIGVILFILLAGYPPFGGQTDQEILRKV------EKGKYTFDS--PEWKNVSEGAK--- 269
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKD 898
DL + +Q R + + ++
Sbjct: 270 ---DLIKQMLQFDSQRRISAQQALEH 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKR----AQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
+GSG V P + +AIKR Q SM E EI+ +S+ HH N+VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD---ELLKEIQAMSQCHHPNIVSYY 79
Query: 691 GFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLK---IAL---GAARGLSYLH 743
F +++ L+ + + GS+ D + L IA GL YLH
Sbjct: 80 T-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK---GTMGYLDP 800
+ IHRD+K+ NILL E + ++ADFG+S ++ K GT P
Sbjct: 139 KNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT-----P 190
Query: 801 EYYM----TQQLT---EKSDVYSFGVLMLELLTGRRP 830
+M +Q+ K+D++SFG+ +EL TG P
Sbjct: 191 -CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKN 685
F +G G YG VYK GQ++AIK Q QE EI ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSPH 85
Query: 686 LVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLH 743
+V G + + + ++ E+ GS+ D + +N + D I I +GL YLH
Sbjct: 86 VVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLH 142
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
+ IHRDIK+ NILL+ +AK+ADFG++ ++D+ T V GT ++ PE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRP 830
+D++S G+ +E+ G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 37/309 (11%), Positives = 82/309 (26%), Gaps = 76/309 (24%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSR----------- 680
+G + T G+ + ++ ++ K E+ L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 681 -----------VHHKNLVSLLGFCFDRGEQMLIYEFVP-------NGSLGDSLS--GKNG 720
V ++ D + ++ F + G+ L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 721 IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780
L RL++ L R L+ LH ++H ++ +I+LD+R + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 781 DSEKDHITTQVKGTMGYLDPEY----------YMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ G+ PE + +T D ++ G+ + + P
Sbjct: 263 A------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 831 IERGKYIVREIRTVMDKKKELYNLYELI-DPTIGLSTTLKGFEKYVDLALKCVQESGDDR 889
E I + ++ L ++ +DR
Sbjct: 317 NTDD---------------AALGGSEWIFRSCKNIPQPVR------ALLEGFLRYPKEDR 355
Query: 890 PTMSEVVKD 898
+ ++
Sbjct: 356 LLPLQAMET 364
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 11/203 (5%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
+G G G V +G+ +A+K Q + E+ ++ H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
+ + GE++ ++ EF+ G+L D +S + + + I + + L+YLH
Sbjct: 107 MYK-SYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIAT--VCEAVLQALAYLHAQG- 161
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
+IHRDIKS +ILL K++DFG +S + + GT ++ PE
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217
Query: 808 LTEKSDVYSFGVLMLELLTGRRP 830
+ D++S G++++E++ G P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 66/289 (22%), Positives = 106/289 (36%), Gaps = 49/289 (16%)
Query: 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD 695
G G G V G+ +A+KR MEI+LL+ H N++
Sbjct: 24 GYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSETT 80
Query: 696 RGEQMLIYEFVPNGSLGD-----SLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ E N +L D ++S +N + + A G+++LH L I
Sbjct: 81 DRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---I 136
Query: 751 IHRDIKSSNILLD-------------ERLNAKVADFGLSKSMSDSEKDHITT--QVKGTM 795
IHRD+K NIL+ E L ++DFGL K + + T GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 796 GYLDPE-------YYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847
G+ PE ++LT D++S G + +L+ G+ P I
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI------ 250
Query: 848 KKELYNLYELIDPT-IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEV 895
+ +++L E+ L DL + + RPT +V
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEAT------DLISQMIDHDPLKRPTAMKV 293
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 66/354 (18%), Positives = 122/354 (34%), Gaps = 100/354 (28%)
Query: 625 KYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVH 682
+Y +F +G GG+G V++ + AIKR + + + +E E++ L+++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 683 HKNLVSLLGFCFDRGEQML-----------------------IYEFVPNGSLGDSLSGKN 719
H +V + + + D S KN
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 720 GIRL-----------------------DWIRR------------LKIALGAARGLSYLHE 744
+ DW+ R L I + A + +LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT----------TQVKGT 794
++HRD+K SNI KV DFGL +M E++ T GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 854
Y+ PE + K D++S G+++ ELL T M++ + + ++
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-------------FSTQMERVRIITDV 286
Query: 855 YELIDPTIGLSTTLKGFEKY----VDLALKCVQESGDDRPTMSEVVKD--IENI 902
L P + F + + + S +RP ++++++ EN+
Sbjct: 287 RNLKFPLL--------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-28
Identities = 79/312 (25%), Positives = 120/312 (38%), Gaps = 72/312 (23%)
Query: 623 VKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK-------------RAQQGS 664
V+K ++ +GSG YG+V AIK +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 665 MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLD 724
+ +E EI LL + H N++ L D+ L+ EF G L +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-----------FE 135
Query: 725 WIRRLKIALG------AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNA 768
I I AA G+ YLH+ I+HRDIK NILL + LN
Sbjct: 136 QI----INRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188
Query: 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 828
K+ DFGLS S K + ++ GT Y+ PE + ++ EK DV+S GV+M LL G
Sbjct: 189 KIVDFGLSSFFSKDYK--LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
Query: 829 RPI--ERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESG 886
P + + I++++ +K Y + +S K +L +
Sbjct: 245 PPFGGQNDQDIIKKV------EKGKYYFDF--NDWKNISDEAK------ELIKLMLTYDY 290
Query: 887 DDRPTMSEVVKD 898
+ R T E +
Sbjct: 291 NKRCTAEEALNS 302
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 53/291 (18%), Positives = 116/291 (39%), Gaps = 30/291 (10%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
++ L +L L + NK + + + NL L L L + S P + +L ++ L+
Sbjct: 84 LSNLVKLTNLYIGTNK-ITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138
Query: 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 203
L +N + N++ L +L +T++K++ + + L NQ+
Sbjct: 139 LGANHNLS-DLSPLSNMTGLNYLTVTESKVK--------DVTPIANLTDLYSLSLNYNQI 189
Query: 204 SGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262
P L L + N +T P + + L ++ N ++ S L N
Sbjct: 190 EDISPLASLTS----LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLAN 241
Query: 263 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322
L+ + L + N+++ + + L+ L L++ +N S++ +++ L +L + N
Sbjct: 242 LSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI--SDISV-LNNLSQLNSLFLNNN 297
Query: 323 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 372
L + + + +L T+ + N + L + + + N I
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRPL--ASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 58/320 (18%), Positives = 121/320 (37%), Gaps = 47/320 (14%)
Query: 84 ITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 141
L + L ++ K ++G I L L L L G + P + +L +L
Sbjct: 40 QEELESITKLVVAGEKVASIQG-----IEYLTNLEYLNLNGNQITDISP--LSNLVKLTN 92
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 201
L + +N + ++ NL+NL L L ++ + L L + + G N
Sbjct: 93 LYIGTNKITD--ISALQNLTNLRELYLNEDNISD--------ISPLANLTKMYSLNLGAN 142
Query: 202 QLSGSIPE--KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 259
+ + L ++ + + + + + L + + N + S
Sbjct: 143 HNLSDLSPLSNMTG----LNYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIED--ISP 194
Query: 260 LNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM 319
L +LTS++ N++T + + ++ L+ L + NN +++ +++ LT L +
Sbjct: 195 LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI--TDLSP-LANLSQLTWLEI 250
Query: 320 ENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL----LVNLQNNRISAYT 375
+ I A + + L+ + + +N+++ L NL + L NN++
Sbjct: 251 GTNQISD-INA-VKDLTKLKMLNVGSNQISDISVLN-----NLSQLNSLFLNNNQLGNED 303
Query: 376 ERGGAPAVNLT---LIDNPI 392
NLT L N I
Sbjct: 304 MEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 57/328 (17%), Positives = 123/328 (37%), Gaps = 33/328 (10%)
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
++ + Q+ D L E L + + L+ ++ L++ G +
Sbjct: 3 ATLATLPAPIN-QIFPD-ADLAEGIRAVLQKAS-VTDVVT--QEELESITKLVVAGEKVA 57
Query: 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG 186
I L L L+LN N + + NL L L + NK+ +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--------DISA 105
Query: 187 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 246
L L + + ++ +S P ++ ++ L N + L + L +
Sbjct: 106 LQNLTNLRELYLNEDNISDISPLA----NLTKMYSLNLGANHNLSDLSPLSNMTGLNYLT 161
Query: 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
+ + + + NLT + L L+ N++ + L L+ L Y N +++
Sbjct: 162 VTESKVKD--VTPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQI--TDITP 216
Query: 307 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVN 365
++M L +L + N + P L ++ L + + TN+++ ++ L ++N
Sbjct: 217 -VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLN 271
Query: 366 LQNNRISAYTERGGAPA-VNLTLIDNPI 392
+ +N+IS + +L L +N +
Sbjct: 272 VGSNQISDISVLNNLSQLNSLFLNNNQL 299
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 51/287 (17%), Positives = 104/287 (36%), Gaps = 53/287 (18%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 145
G L TL N+ +L + +L S + + L+ + L +
Sbjct: 1 GAATLATLPAPINQI------FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVA 52
Query: 146 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 205
+ I L+NL +L+L N++ P+S+ LV+ + + G N+++
Sbjct: 53 GEKVAS--IQGIEYLTNLEYLNLNGNQITDISPLSN--------LVKLTNLYIGTNKIT- 101
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 265
I L + +L + + +++S S L NLT
Sbjct: 102 DISA--------------------------LQNLTNLRELYLNEDNISDI--SPLANLTK 133
Query: 266 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325
+ L L N + L+ ++ L+YL ++ + +++ L +L + ++
Sbjct: 134 MYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYNQIE 190
Query: 326 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 372
P L S+ L N++ + N L + NN+I+
Sbjct: 191 DISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSL-KIGNNKIT 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-28
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 38/290 (13%)
Query: 623 VKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKME 674
V+ T FSD +G G +G+V GQ A+K + Q + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 675 IELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL-KIAL 733
++LL ++ H N++ L F D+G L+ E G L D + + R+ + L
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQ 790
++Y+H+ I+HRD+K N+LL + N ++ DFGLS S+K + +
Sbjct: 137 SG---ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDK 188
Query: 791 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI--ERGKYIVREIRTVMDKK 848
+ GT Y+ PE + EK DV+S GV++ LL+G P I++++ +
Sbjct: 189 I-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV------E 240
Query: 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
K Y +S + K DL K + R + + +
Sbjct: 241 KGKYTFEL--PQWKKVSESAK------DLIRKMLTYVPSMRISARDALDH 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 39/309 (12%), Positives = 85/309 (27%), Gaps = 77/309 (24%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK------RAQQGSMQGGQEFKMEIELLSRV-------- 681
G + T G+ + R +++ +E + + LL +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 682 --------------HHKNLVSLLGFCFDRGEQMLIYEF-VPNGSLGDSLS-----GKNGI 721
K ++ + D + + +L
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 722 RLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781
L RL++ L R L+ LH ++H ++ +I+LD+R + F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV---- 254
Query: 782 SEKDHITTQVKGTMGYLDPEYYMTQQL-----------TEKSDVYSFGVLMLELLTGRRP 830
+D + G+ PE + T D ++ G+++ + P
Sbjct: 255 --RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 831 IERGKYIVREIRTVMDKKKELYNLYELI-DPTIGLSTTLKGFEKYVDLALKCVQESGDDR 889
I K E I + ++ L ++ +DR
Sbjct: 313 IT---------------KDAALGGSEWIFRSCKNIPQPVR------ALLEGFLRYPKEDR 351
Query: 890 PTMSEVVKD 898
+ ++
Sbjct: 352 LLPLQAMET 360
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 43/265 (16%), Positives = 94/265 (35%), Gaps = 32/265 (12%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
L+L + L P L L ++ + +PD++ L L+L
Sbjct: 80 QPGRVALELRSVP-LPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 206
N +P SI +L+ L L + E+P ++ +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN----------- 184
Query: 207 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 266
L + + + LPA++ +++L+ ++ + LS + +++L +
Sbjct: 185 -----------LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 267 NDLYLS-NNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME-NTNL 324
+L L L P G + L L + + S + +P + L L + NL
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCS-NLLTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 325 KGQIPADLFSIPHLQTVVMKTNELN 349
++P+ + +P +++ +
Sbjct: 291 S-RLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/326 (15%), Positives = 103/326 (31%), Gaps = 62/326 (19%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPI----------------- 129
+ L + LR P + ++ N +
Sbjct: 11 SSGRENLYFQGSTALR-PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK 69
Query: 130 --PDSIGSLQE--LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSP 185
D + + V L L S + P LS+L + + L E+P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 186 GLDMLVRAKHFHFGKNQLSGSIPE---KLFRPDMVLIHVLFDSNNLTGELPATLGLV--- 239
GL + +N L ++P L R L + + ELP L
Sbjct: 128 GL------ETLTLARNPLR-ALPASIASLNR----LRELSIRACPELTELPEPLASTDAS 176
Query: 240 ------KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLD 293
+L+ +R + + +P+++ NL ++ L + N+ L+ P + L L LD
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELD 235
Query: 294 MSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL----- 348
+ + P F L L++++ + +P D+ + L+ + ++
Sbjct: 236 LRGCTA-LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 349 --------NGTLDLGTSYSENLLVNL 366
N + + L +
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 47/228 (20%), Positives = 81/228 (35%), Gaps = 25/228 (10%)
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
+T+ GL +L + L TL L+ N LR LP +I +L +L L + C
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNP-LRA-LPASIASLNRLRELSIRACPEL 163
Query: 127 GPIPDSIGS---------LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEI 177
+P+ + S L L L L G +P SI NL NL L + ++ L +
Sbjct: 164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-AL 221
Query: 178 PVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF--DSNNLTGELPAT 235
+ + L + + + P + L D +NL LP
Sbjct: 222 GPAIHH------LPKLEELDLRGCTALRNYPPIFG--GRAPLKRLILKDCSNLL-TLPLD 272
Query: 236 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL 283
+ + LE + +PS + L + + + + +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 48/245 (19%), Positives = 85/245 (34%), Gaps = 32/245 (13%)
Query: 109 IGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 168
+ NL G + P D + Q N N +N
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETR 63
Query: 169 TDNKLEGEIP--VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF-DS 225
T L+ + D PG L L P++ FR + + + D+
Sbjct: 64 TGRALK-ATADLLEDATQPGRVAL------ELRSVPLP-QFPDQAFR--LSHLQHMTIDA 113
Query: 226 NNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLS-NNKLT------- 277
L ELP T+ LE + RN L +P+++ +L + +L + +LT
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 278 --GAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSI 335
A GL L L + +P+ +++Q+L +L + N+ L + + +
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGI--RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228
Query: 336 PHLQT 340
P L+
Sbjct: 229 PKLEE 233
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 30/228 (13%), Positives = 69/228 (30%), Gaps = 23/228 (10%)
Query: 130 PDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 189
L + + Y D NS +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQI 60
Query: 190 LVRAKHFHFGKNQLSGSIPEKLFRPDMV-LIHVLFDSNNLTGELPATLGLVKSLEVVRFD 248
R L + + L + + S L + P + L+ + D
Sbjct: 61 ETR------TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID 112
Query: 249 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN--------SFD 300
L +P + + L L+ N L ++ L+ L L +
Sbjct: 113 AAGLME-LPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 301 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 348
+++ + +L +L +E T ++ +PA + ++ +L+++ ++ + L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 72/219 (32%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRV-HHKN 685
F VG+G YG+VYKG + GQL AIK + G +E K EI +L + HH+N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 686 LVSLLGFCFDRGEQM-------LIYEFVPNGSLGDSLSGKNGIRL--DWIRRLKIALGAA 736
+ + G F + L+ EF GS+ D + G L +WI I
Sbjct: 83 IATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREIL 139
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
RGLS+LH+ +IHRDIK N+LL E K+ DFG+S + + T GT
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 797 YLDPEYYMTQQLTE-----KSDVYSFGVLMLELLTGRRP 830
++ PE + + KSD++S G+ +E+ G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 76/326 (23%), Positives = 126/326 (38%), Gaps = 63/326 (19%)
Query: 619 SFEEVKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEF 671
S E + F++ +G G +G+V K Q A+K + S +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 672 KMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 731
E+ELL ++ H N++ L D ++ E G L D I I
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-----------FDEI----I 113
Query: 732 ALG------AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGL 775
AAR G++Y+H+ I+HRD+K NILL ++ + K+ DFGL
Sbjct: 114 KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI--ER 833
S + K + ++ GT Y+ PE + EK DV+S GV++ LL+G P +
Sbjct: 171 STCFQQNTK--MKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 834 GKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 893
I++ + + Y +S K DL K + R T +
Sbjct: 227 EYDILKRV------ETGKYAFDL--PQWRTISDDAK------DLIRKMLTFHPSLRITAT 272
Query: 894 EVVKD--IENILQQAGLNPNAESASS 917
+ ++ I+ + + S S
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPSLES 298
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKR---AQQGSMQGGQEFKMEIELLSRVHHKN 685
FSD ++G G +G VY + N +++AIK+ + + S + Q+ E+ L ++ H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 686 LVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLH 743
+ G C+ R L+ E+ GS D L ++ I + GA +GL+YLH
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAYLH 171
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
+IHRD+K+ NILL E K+ DFG + M+ + + V GT ++ PE
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFV-GTPYWMAPEVI 222
Query: 804 MTQQLTE---KSDVYSFGVLMLELLTGRRP 830
+ + K DV+S G+ +EL + P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 57/306 (18%), Positives = 95/306 (31%), Gaps = 26/306 (8%)
Query: 79 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG------PIPDS 132
+ +LH L L N + + T + NL L L+ F P
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 133 IGSLQELVL--LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190
+ L ++ + L L+N+ + L ++ L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSL 312
Query: 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 250
+ QL L + L + N + L SL + RN
Sbjct: 313 ------SIIRCQLKQFPTLDLPF-----LKSLTLTMNKGSISFKKVAL-PSLSYLDLSRN 360
Query: 251 SLSGPVPSNLNNL--TSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 308
+LS + ++L S+ L LS N N GL L +LD +++ S F
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 309 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYS-ENLLV-NL 366
S++ L L + TN K + L T+ M N + NL +L
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 367 QNNRIS 372
++
Sbjct: 481 SKCQLE 486
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-26
Identities = 53/311 (17%), Positives = 95/311 (30%), Gaps = 30/311 (9%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLM 119
G + + L+ L + + L+ ++ K +L
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS-IKYLEDVP--KHFKWQSLS 313
Query: 120 LVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPV 179
++ C + L+ L +L N G + L +L +LDL+ N L
Sbjct: 314 IIRCQLKQFPTLDLPFLKSL---TLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCC 368
Query: 180 SDGN-------------------SPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIH 220
S + S L +H F + L F L++
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428
Query: 221 VLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN-LNNLTSVNDLYLSNNKLTGA 279
+ N + + SL ++ NS SN N T++ L LS +L
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 280 MPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHL 338
L L L+MS+N+ S ++ + SL+TL ++ L
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNL-LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSL 547
Query: 339 QTVVMKTNELN 349
+ N +
Sbjct: 548 AFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 63/318 (19%), Positives = 107/318 (33%), Gaps = 24/318 (7%)
Query: 84 ITGLTELHTLDLSNNK-DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142
+ GL ++ + + L +S + L G S + + + L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSL 312
Query: 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 202
S+ +L L L LT NK I P L L +N
Sbjct: 313 SIIRCQLKQ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYL------DLSRNA 361
Query: 203 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLN 261
LS S + L S N + A ++ L+ + F ++L S
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
Query: 262 NLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320
+L + L +S GL+ L+ L M+ NSF + + + F++ +LT L +
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 321 NTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRISAYTER 377
L+ I +F + LQ + M N L LD + +L + NRI
Sbjct: 482 KCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCSFNRIETSKGI 539
Query: 378 GGAPAVNLTLID---NPI 392
+L + N +
Sbjct: 540 LQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-23
Identities = 44/260 (16%), Positives = 83/260 (31%), Gaps = 11/260 (4%)
Query: 77 KGQLSGDITGLTELHTLDLSNNK-DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 135
KG +S L L LDLS N G + L +L L + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG 397
Query: 136 LQELVLLSLNSNGFSGRVPPS-IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 194
L+EL L + S +L L +LD++ + + L
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL------N 451
Query: 195 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG 254
N + +F L + L + L+++ N+L
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 255 PVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSS-MQ 312
S+ N L S++ L S N++ + L++ +++NNS F ++
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVK 571
Query: 313 SLTTLMMENTNLKGQIPADL 332
++ + P ++
Sbjct: 572 EQKQFLVNVEQMTCATPVEM 591
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-22
Identities = 47/296 (15%), Positives = 85/296 (28%), Gaps = 22/296 (7%)
Query: 90 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGF 149
+DLS N L+ + N +L L L C + L L L L N
Sbjct: 34 TKNIDLSFNP-LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 150 SGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 209
P S L++L L + KL G L L + N +
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL------NVAHNFIHSCKLP 146
Query: 210 KLFRPDMVLIHVLFDSNNLTGELPATL----GLVKSLEVVRFDRNSLSGPVPSNLNNLTS 265
F L+HV N + L + + N + +
Sbjct: 147 AYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIK 205
Query: 266 VNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFD-----ASEVPSWFSSMQSLTT-- 316
+++L L N + + L L+ L + F PS + +T
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
Query: 317 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 372
+ TN + ++ + + + D+ + L ++ ++
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSL-SIIRCQLK 320
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 23/129 (17%), Positives = 39/129 (30%), Gaps = 7/129 (5%)
Query: 48 NNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPT 107
N + + + +T + LS L+ G L L L++S+N L +
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN-LLFLDSS 515
Query: 108 TIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWL 166
L LS L + L +L +N + I + L W+
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-----CICEHQKFLQWV 570
Query: 167 DLTDNKLEG 175
L
Sbjct: 571 KEQKQFLVN 579
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 65/332 (19%), Positives = 115/332 (34%), Gaps = 28/332 (8%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
+ +T ++ + + ++ L+L++ + + + L +
Sbjct: 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFN 103
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDG 182
+ P ++ L +L L N S +P I N L L +++N LE I
Sbjct: 104 AIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 161
Query: 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSL 242
L ++ N+L+ + L L H N L+ TL + ++
Sbjct: 162 Q--ATTSL---QNLQLSSNRLT-HVDLSLIPS---LFHANVSYNLLS-----TLAIPIAV 207
Query: 243 EVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDAS 302
E + NS++ LT L L +N LT L L +D+S N
Sbjct: 208 EELDASHNSINVVRGPVNVELTI---LKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL--E 261
Query: 303 EVP-SWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSEN 361
++ F MQ L L + N L + IP L+ + + N L ++ +
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
Query: 362 L-LVNLQNNRISAYTERGGAPAVNLTLIDNPI 392
L + L +N I NLTL N
Sbjct: 320 LENLYLDHNSIVTLKLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 49/276 (17%), Positives = 95/276 (34%), Gaps = 26/276 (9%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 145
+ L + N +R P N+ L+ L+L S + +L LS++
Sbjct: 91 YAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 149
Query: 146 SNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVS----------DGNSPG-LDMLVRA 193
+N R+ ++L L L+ N+L + +S N L + +
Sbjct: 150 NNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAV 207
Query: 194 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 253
+ N ++ + + L + NNLT + L L V N L
Sbjct: 208 EELDASHNSIN-VVRGPVNVE---LTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNELE 261
Query: 254 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 313
+ + + LY+SNN+L + L LD+S+N V
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHL--LHVERNQPQFDR 319
Query: 314 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349
L L +++ ++ + L+ + + N+ +
Sbjct: 320 LENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 51/306 (16%), Positives = 106/306 (34%), Gaps = 40/306 (13%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
++H +D+ G T+ N K ++ + + S +++ LL+LN
Sbjct: 23 FYDVH-IDMQTQDVYFGFEDITLNNQKIVT---FKNSTMRKLPAALLDSFRQVELLNLND 78
Query: 147 NGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 205
+ + L + N + + + +L +N LS
Sbjct: 79 LQIE-EIDTYAFAYAHTIQKLYMGFNAIRY---LPPHVFQNVPLL---TVLVLERNDLS- 130
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 265
S+P +F L + +NNL T SL+ ++ N L+ S + +L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFH 190
Query: 266 VNDLYLSNNKLT--GAMPNLTGLSV---------------LSYLDMSNNSFDASEVPSWF 308
+S N L+ + L L+ L + +N+ ++ W
Sbjct: 191 ---ANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL--TDTA-WL 244
Query: 309 SSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYSENL-LVNL 366
+ L + + L+ +I F + L+ + + N L L+L L +++L
Sbjct: 245 LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302
Query: 367 QNNRIS 372
+N +
Sbjct: 303 SHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 38/250 (15%), Positives = 78/250 (31%), Gaps = 29/250 (11%)
Query: 129 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188
I ++ + ++ L+N + ++ + ++P + LD
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL-----LD 66
Query: 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 248
+ + + Q+ I F + + N + P V L V+ +
Sbjct: 67 SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 249 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSW 307
RN LS +N + L +SNN L + + L L +S+N + V
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL--THVD-- 181
Query: 308 FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQ 367
S + SL + L L ++ + N + + V L
Sbjct: 182 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-------NVVRGPVNVELT 229
Query: 368 -----NNRIS 372
+N ++
Sbjct: 230 ILKLQHNNLT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 23/158 (14%), Positives = 57/158 (36%), Gaps = 9/158 (5%)
Query: 220 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA 279
+ + + + L V D + L + + N+ +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60
Query: 280 MPN-LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLFS-IP 336
L + L++++ E+ + F+ ++ L M ++ +P +F +P
Sbjct: 61 PAALLDSFRQVELLNLNDLQI--EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP 117
Query: 337 HLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 372
L +V++ N+L+ +L G + L ++ NN +
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 19/111 (17%), Positives = 32/111 (28%), Gaps = 30/111 (27%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
R+ + +S L L+ + L LDLS+N +L
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN------------HLLH--------- 309
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174
+ + L L L+ N + L L L+ N +
Sbjct: 310 -----VERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 58/292 (19%), Positives = 115/292 (39%), Gaps = 36/292 (12%)
Query: 84 ITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 141
T L ++ TL + G + L L+ + + P + +L +LV
Sbjct: 42 QTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 94
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 201
+ +N+N + + NL+NL L L +N++ P+ + L N
Sbjct: 95 ILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDPLKN--------LTNLNRLELSSN 144
Query: 202 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 261
+S + + L N +T P L + +LE + N +S S L
Sbjct: 145 TISDISALS----GLTSLQQLSFGNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLA 196
Query: 262 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMEN 321
LT++ L +NN+++ + L L+ L L ++ N ++ + +S+ +LT L + N
Sbjct: 197 KLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL--KDIGT-LASLTNLTDLDLAN 252
Query: 322 TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 372
+ P L + L + + N+++ L + L + L N++
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQISNISPL--AGLTALTNLELNENQLE 300
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 57/301 (18%), Positives = 114/301 (37%), Gaps = 38/301 (12%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
+ LT L+ L+LS+N + + + L L L G + P + +L L L
Sbjct: 130 LKNLTNLNRLELSSNT-ISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183
Query: 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVS----------DGNS----PGLDM 189
++SN S + L+NL L T+N++ P+ +GN L
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLAS 241
Query: 190 LVRAKHFHFGKNQLSGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 248
L NQ+S P L + L + +N ++ P L + +L + +
Sbjct: 242 LTNLTDLDLANNQISNLAPLSGLTK----LTELKLGANQISNISP--LAGLTALTNLELN 295
Query: 249 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 308
N L S ++NL ++ L L N ++ + ++ L+ L L NN S
Sbjct: 296 ENQLED--ISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFFYNNKV---SDVSSL 349
Query: 309 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 368
+++ ++ L + + P L ++ + + + + + ++ ++N
Sbjct: 350 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKN 406
Query: 369 N 369
Sbjct: 407 V 407
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 65/291 (22%), Positives = 131/291 (45%), Gaps = 34/291 (11%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
+ LT+L + ++NN+ + P + NL L+ L L + P + +L L L
Sbjct: 86 LKNLTKLVDILMNNNQ-IADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140
Query: 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 203
L+SN S ++ L++L L N++ P+++ L + N++
Sbjct: 141 LSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLAN--------LTTLERLDISSNKV 189
Query: 204 SG-SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262
S S+ KL L ++ +N ++ P LG++ +L+ + + N L L +
Sbjct: 190 SDISVLAKLTN----LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLAS 241
Query: 263 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322
LT++ DL L+NN+++ + L+GL+ L+ L + N S + + + +LT L +
Sbjct: 242 LTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI--SNISP-LAGLTALTNLELNEN 297
Query: 323 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 372
L+ P + ++ +L + + N ++ + S L NN++S
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFYNNKVS 344
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 34/290 (11%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
+ LT L LD+S+NK + + + L L +L+ S P +G L L LS
Sbjct: 173 LANLTTLERLDISSNK-VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELS 227
Query: 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 203
LN N ++ +L+NL LDL +N++ P+S L + G NQ+
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSG--------LTKLTELKLGANQI 277
Query: 204 SGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262
S P L L ++ + N L P + +K+L + N++S S +++
Sbjct: 278 SNISPLAGLTA----LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSS 329
Query: 263 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322
LT + L+ NNK++ + +L L+ +++L +N S++ +++ +T L + +
Sbjct: 330 LTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI--SDLTP-LANLTRITQLGLNDQ 385
Query: 323 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 372
++ TV + G L + S+ + I+
Sbjct: 386 AWTNAPVNYKANVSIPNTV----KNVTGALIAPATISD--GGSYTEPDIT 429
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 33/312 (10%)
Query: 83 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142
+ LT L L L NN+ + + NL L+ L L + S + L L L
Sbjct: 107 PLANLTNLTGLTLFNNQ-ITD--IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQL 161
Query: 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 202
S + + NL+ L LD++ NK+ L L + NQ
Sbjct: 162 SFGNQVTD---LKPLANLTTLERLDISSNKVSDI--------SVLAKLTNLESLIATNNQ 210
Query: 203 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262
+S P + L + + N L TL + +L + N +S + L+
Sbjct: 211 ISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSG 263
Query: 263 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322
LT + +L L N+++ + L GL+ L+ L+++ N ++ S++++LT L +
Sbjct: 264 LTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL--EDISP-ISNLKNLTYLTLYFN 319
Query: 323 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAP 381
N+ P + S+ LQ + N+++ L N+ ++ +N+IS T
Sbjct: 320 NISDISP--VSSLTKLQRLFFYNNKVSDVSSLAN--LTNINWLSAGHNQISDLTPLANLT 375
Query: 382 AVN-LTLIDNPI 392
+ L L D
Sbjct: 376 RITQLGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-20
Identities = 58/269 (21%), Positives = 104/269 (38%), Gaps = 27/269 (10%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
+ LT L L L+ N+ L+ T+ +L L++L L S P + L +L L
Sbjct: 217 LGILTNLDELSLNGNQ-LKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 203
L +N S + L+ L L+L +N+LE + + L + N +
Sbjct: 272 LGANQISN--ISPLAGLTALTNLELNENQLE--------DISPISNLKNLTYLTLYFNNI 321
Query: 204 SGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262
S P L + L + F +N ++ ++L + ++ + N +S + L N
Sbjct: 322 SDISPVSSLTK----LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDL--TPLAN 373
Query: 263 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322
LT + L L++ T + + +S + N A P+ S S T +
Sbjct: 374 LTRITQLGLNDQAWTN--APVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITW- 430
Query: 323 NLKGQIPADLFSIPHLQTVVMKTNELNGT 351
NL ++ T+ T +GT
Sbjct: 431 NLPSYTNEVSYTFSQPVTIGKGTTTFSGT 459
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-19
Identities = 45/266 (16%), Positives = 100/266 (37%), Gaps = 49/266 (18%)
Query: 107 TTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWL 166
T L + +L + + + L ++ L + G + L+NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73
Query: 167 DLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN 226
+ ++N+L P+ + L + NQ++ P
Sbjct: 74 NFSNNQLTDITPLKN--------LTKLVDILMNNNQIADITP------------------ 107
Query: 227 NLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGL 286
L + +L + N ++ L NLT++N L LS+N ++ + L+GL
Sbjct: 108 ---------LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD-ISALSGL 155
Query: 287 SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTN 346
+ L L N D +++ +L L + + + + L + +L++++ N
Sbjct: 156 TSLQQLSFGNQVTDLKP----LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNN 209
Query: 347 ELNGTLDLGTSYSENLLVNLQNNRIS 372
+++ LG + + L +L N++
Sbjct: 210 QISDITPLGILTNLDEL-SLNGNQLK 234
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 36/195 (18%), Positives = 69/195 (35%), Gaps = 42/195 (21%)
Query: 83 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142
+ GLT L L+L+ N+ L P I NLK L+ L L + S P + SL +L L
Sbjct: 282 PLAGLTALTNLELNENQ-LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 202
+N S S+ NL+N+ WL N++ P++ L +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA-----NLTRI---TQLGLNDQA 386
Query: 203 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262
+ + ++ + + + + P+ +++
Sbjct: 387 WTNAPVNYK--ANVSIPNTVKNVTGAL-------------------------IAPATISD 419
Query: 263 LTSVNDLYLSNNKLT 277
S + ++ N +
Sbjct: 420 GGSYTEPDITWNLPS 434
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 56/352 (15%), Positives = 105/352 (29%), Gaps = 34/352 (9%)
Query: 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVG 122
+R ++ LK L+ + LDLS N L + KL L L
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP-LSQISAADLAPFTKLELLNLSS 67
Query: 123 CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 182
+ + SL L L LN+N + ++ L +N + + S G
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 183 NS-PGLDM---------------LVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN 226
+ + R ++ N++ ++ + L
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQY 178
Query: 227 NLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGL 286
N ++ + L+ + N L+ + + V + L NNKL L
Sbjct: 179 NFIYDVKGQVVF-AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFS 236
Query: 287 SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME-NTNLKGQIPADLFSIPHLQTVVMKT 345
L + D+ N F + +FS Q + T+ + L GQ +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 346 NEL-NGTLD--LGTSYSENLLVNLQNNRISAYTERGGAPA--VNLTLIDNPI 392
+L D + E+ L++ Q + A + +
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 41/298 (13%), Positives = 89/298 (29%), Gaps = 20/298 (6%)
Query: 105 LPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 164
+ N + + S + S + L L+ N S + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 165 WLDLTDNKLEGEIPVS----------DGNS-PGLDMLVRAKHFHFGKNQLSGSIPEKLFR 213
L+L+ N L + + + N L + + H N +S + +
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ 120
Query: 214 PDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLS 272
++ +N +T G ++ + N + + ++ L L
Sbjct: 121 G---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 273 NNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADL 332
N + + + L LD+S+N + + F S +T + + N L I L
Sbjct: 178 YNFIY-DVKGQVVFAKLKTLDLSSNKL--AFMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 333 FSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 390
+L+ ++ N + + + + T + TL
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 38/336 (11%), Positives = 80/336 (23%), Gaps = 35/336 (10%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
L L+L N + + + KL L L + + S + +S
Sbjct: 165 AASSDTLEHLNLQYNF-IYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220
Query: 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP--------------------VSDGN 183
L +N + ++ NL DL N ++ N
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 184 SPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLE 243
+ + + L ++L +L + T L
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339
Query: 244 VVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTG--LSVLSYLDMSNNSFDA 301
+ + + + L L + N + L + +
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIEL 399
Query: 302 SEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSEN 361
S +Q L ++ + + + + + L EN
Sbjct: 400 QHATEEQSPLQLLRAIVKRYEEMYVEQQSV-----QNNAIRDWDMYQHKETQL---AEEN 451
Query: 362 LLVNLQNNRISAYTERGGAPAVNLTLIDNPICQELG 397
+ N A L + + + +LG
Sbjct: 452 ARLKKLNGEADLALASANATLQELVVREQNLASQLG 487
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 56/231 (24%), Positives = 86/231 (37%), Gaps = 48/231 (20%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 693
+GSG +G V+ +G IK + Q E + EIE+L + H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLS 740
D ++ E G L L+ I + A L+
Sbjct: 90 EDYHNMYIVMETCEGGEL-----------LERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 741 YLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
Y H ++H+D+K NIL K+ DFGL++ E T GT Y
Sbjct: 139 YFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA-GTALY 192
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+ PE + +T K D++S GV+M LLTG P +
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G G YG+V + +A+K + + K EI + ++H+N+V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYGH 73
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL---KIALGAARGLSYLHELANPP 749
+ Q L E+ G L D + G+ +R +A G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG--- 125
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
I HRDIK N+LLDER N K++DFGL+ + ++ + ++ GT+ Y+ PE ++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 810 -EKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 842
E DV+S G+++ +L G P ++ +E
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 68/325 (20%), Positives = 108/325 (33%), Gaps = 36/325 (11%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
L + N+ +R + + +++ L L + + L +
Sbjct: 50 LNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108
Query: 147 NGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 205
N +PP + N+ L L L N L +P G L N L
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLP--RGIFHNTPKL---TTLSMSNNNLE- 160
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNL---- 260
I + F+ L ++ SN LT + L L+ SL N LS +P +
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELD 217
Query: 261 ---NNLTSVND--------LYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP-SWF 308
N++ V L L +N LT L L +D+S N ++ F
Sbjct: 218 ASHNSINVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL--EKIMYHPF 274
Query: 309 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQ 367
MQ L L + N L + IP L+ + + N L ++ + L + L
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332
Query: 368 NNRISAYTERGGAPAVNLTLIDNPI 392
+N I NLTL N
Sbjct: 333 HNSIVTLKLSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-20
Identities = 51/277 (18%), Positives = 98/277 (35%), Gaps = 28/277 (10%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSL 144
+ L + N +R P N+ L+ L+L S +P I + +L LS+
Sbjct: 97 YAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSM 154
Query: 145 NSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVS----------DGNS-PGLDMLVR 192
++N R+ ++L L L+ N+L + +S N L + +
Sbjct: 155 SNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIA 212
Query: 193 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 252
+ N ++ + + L + NNLT + L L V N L
Sbjct: 213 VEELDASHNSIN-VVRGPVNVE---LTILKLQHNNLT-DTAWLLNY-PGLVEVDLSYNEL 266
Query: 253 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 312
+ + + LY+SNN+L + L LD+S+N V
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHL--LHVERNQPQFD 324
Query: 313 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349
L L +++ ++ + L+ + + N+ +
Sbjct: 325 RLENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 3e-16
Identities = 53/323 (16%), Positives = 116/323 (35%), Gaps = 58/323 (17%)
Query: 95 LSNNKDLRGP----LPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFS 150
N R P + + + ++ + + +L +++ ++
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 151 GRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 209
++P ++ + + L+L D ++E EI + + + G N + +P
Sbjct: 65 -KLPAALLDSFRQVELLNLNDLQIE-EID--TYAFAYAHTI---QKLYMGFNAIR-YLPP 116
Query: 210 KLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 268
+F+ +L ++ + N+L+ LP L + N+L TS+ +
Sbjct: 117 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 269 LYLSNNKLT----GAMPNLTGLSV-------------LSYLDMSNNSFDASEVP------ 305
L LS+N+LT +P+L +V + LD S+NS + V
Sbjct: 176 LQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI--NVVRGPVNVE 233
Query: 306 --------------SWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNG 350
+W + L + + L+ +I F + L+ + + N L
Sbjct: 234 LTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV- 291
Query: 351 TLDLGTSYSENL-LVNLQNNRIS 372
L+L L +++L +N +
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 43/318 (13%), Positives = 86/318 (27%), Gaps = 48/318 (15%)
Query: 79 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 138
L+ + L LDLS+N L + + +
Sbjct: 292 ALNLYGQPIPTLKVLDLSHN---------------HLLH-----------VERNQPQFDR 325
Query: 139 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG----EIPVSDGNSPGLDMLVRAK 194
L L L+ N + L L L+ N + + + D K
Sbjct: 326 LENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCK 382
Query: 195 HFHFGKNQLSGSIPEKLFRP----DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 250
+ ++ L +K + + L V+ G AT + + +
Sbjct: 383 IDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQ 442
Query: 251 SLSGPVPSNLNNLTSVNDLYLSNNKLTG----AMPNLTGLSVLSYLDMSNNSFDASEVPS 306
P+ N VN+L +LT L GL ++ +
Sbjct: 443 QGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLAR 502
Query: 307 WFSSMQSLTTLMMENTNLKGQIPADLFS-----IPHLQTVVMKTNELNGTLDLGTSYSEN 361
++ + T + E K + + + + + L LD +
Sbjct: 503 SSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAE 562
Query: 362 LL--VNLQNNRISAYTER 377
L +L+ ++ +
Sbjct: 563 LRQETSLKRQKVKQLEAK 580
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 51/229 (22%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
GSG + +V+ G+L A+K ++ + EI +L ++ H+N+V+L
Sbjct: 18 GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77
Query: 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLSYL 742
L+ + V G L D I + G A+ + YL
Sbjct: 78 TTHYYLVMQLVSGGEL-----------FDRI----LERGVYTEKDASLVIQQVLSAVKYL 122
Query: 743 HELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
HE I+HRD+K N+L +E + DFGLSK E++ I + GT GY+
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVA 175
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
PE + ++ D +S GV+ LL G P I+ G Y
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 60/264 (22%), Positives = 89/264 (33%), Gaps = 67/264 (25%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK-----RAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
+G G YG V + AIK + +Q + + + K E+ L+ ++HH N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG--------------- 734
D L+ E G L D L+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 735 ----------------AAR-------GLSYLHELANPPIIHRDIKSSNILLDERLNA--K 769
+ L YLH I HRDIK N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 770 VADFGLSK---SMSDSEKDHITTQVKGTMGYLDPE--YYMTQQLTEKSDVYSFGVLMLEL 824
+ DFGLSK +++ E +TT+ GT ++ PE + K D +S GVL+ L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 825 LTGRRP------------IERGKY 836
L G P + K
Sbjct: 270 LMGAVPFPGVNDADTISQVLNKKL 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 49/233 (21%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLG 691
G G YGKV + A+K + + + G+ K EI+LL R+ HKN++ L+
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 692 FCFDRGEQM--LIYEFVPNGS--LGDSLSGKNGIRLDWIRRLKIALGAAR--------GL 739
++ +Q ++ E+ G + DS+ K R + A GL
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------RFPVC--QAHGYFCQLIDGL 122
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI--TTQVKGTMGY 797
YLH I+H+DIK N+LL K++ G+++++ D T+Q G+ +
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAF 177
Query: 798 LDPEYYMTQQLTE--KSDVYSFGVLMLELLTGRRP------------IERGKY 836
PE K D++S GV + + TG P I +G Y
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G G YG+V + +A+K + + K EI + ++H+N+V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYGH 73
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL---KIALGAARGLSYLHELANPP 749
+ Q L E+ G L D + G+ +R +A G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG--- 125
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT 809
I HRDIK N+LLDER N K++DFGL+ + ++ + ++ GT+ Y+ PE ++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 810 -EKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 842
E DV+S G+++ +L G P ++ +E
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 59/275 (21%), Positives = 113/275 (41%), Gaps = 31/275 (11%)
Query: 584 QKRRAEKANEQNPFAHWDMNKSSGS-IPQLKGARCFSFEEVKKYTNNFSDANDV----GS 638
++RR +EQ SS + + + V+ ++ D D+ G+
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 639 GGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 697
G +G V++ T G A K + + EI+ +S + H LV+L D
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 698 EQMLIYEFVPNGSLGDSLSGKNGI--RLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755
E ++IYEF+ G L + ++ ++ + + ++ GL ++HE +H D+
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHENN---YVHLDL 281
Query: 756 KSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSD 813
K NI+ + + K+ DFGL+ + + + GT + PE + + +D
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTT-GTAEFAAPEVAEGKPVGYYTD 338
Query: 814 VYSFGVLMLELLTGRRP------------IERGKY 836
++S GVL LL+G P ++ +
Sbjct: 339 MWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 57/259 (22%), Positives = 94/259 (36%), Gaps = 67/259 (25%)
Query: 624 KKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK---------RAQQGSMQGGQ 669
T+ F + +G G V + P + A+K + + + +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 670 EFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 728
E+++L +V H N++ L L+++ + G L D++
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-----------FDYL-- 115
Query: 729 LKIALG------AAR-------GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775
+ + LH+L I+HRD+K NILLD+ +N K+ DFG
Sbjct: 116 --TEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 776 SKSMSDSEKDHITTQVKGTMGYLDPE------YYMTQQLTEKSDVYSFGVLMLELLTGRR 829
S + EK + GT YL PE ++ D++S GV+M LL G
Sbjct: 171 SCQLDPGEK--LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
Query: 830 P------------IERGKY 836
P I G Y
Sbjct: 228 PFWHRKQMLMLRMIMSGNY 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 51/230 (22%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G G +G+V A K+ + ++ FK EIE++ + H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLSY 741
D + L+ E G L + + + AAR ++Y
Sbjct: 77 DNTDIYLVMELCTGGEL-----------FERV----VHKRVFRESDAARIMKDVLSAVAY 121
Query: 742 LHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
H+L + HRD+K N L K+ DFGL+ + + T+V GT Y+
Sbjct: 122 CHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYV 175
Query: 799 DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
P+ + + D +S GV+M LL G P I G +
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE--FKMEIELLSRVHHKNLVSLLGFC 693
G G +G+V K Q A+K + S + E+ELL ++ H N++ L
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLS 740
D ++ E G L D I I AAR G++
Sbjct: 91 EDSSSFYIVGELYTGGEL-----------FDEI----IKRKRFSEHDAARIIKQVFSGIT 135
Query: 741 YLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
Y+H+ I+HRD+K NILL ++ + K+ DFGLS + K + ++ GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI-GTAYY 189
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+ PE + EK DV+S GV++ LL+G P +E GKY
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 61/282 (21%), Positives = 117/282 (41%), Gaps = 36/282 (12%)
Query: 576 LAGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDAND 635
+ G + +H + P + K + + V+ + D D
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKI---NDYDKFYEDIWKK---YVPQPVEVKQGSVYDYYD 54
Query: 636 V----GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
+ GSG +G V++ G++ K K EI +++++HH L++L
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI--RLDWIRRLKIALGAARGLSYLHELANP 748
D+ E +LI EF+ G L D ++ ++ + I ++ A GL ++HE +
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEHS-- 169
Query: 749 PIIHRDIKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
I+H DIK NI+ + + + K+ DFGL+ ++ E + T + PE +
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTT-ATAEFAAPEIVDRE 225
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+ +D+++ GVL LL+G P ++R +
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 54/258 (20%), Positives = 94/258 (36%), Gaps = 66/258 (25%)
Query: 624 KKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK-------RAQQGSMQGGQE- 670
F + +G G V + G A+K R ++ +E
Sbjct: 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 671 FKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL 729
+ E +L +V H ++++L+ L+++ + G L D++
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-----------FDYL--- 191
Query: 730 KIALG------AAR-------GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776
+S+LH I+HRD+K NILLD+ + +++DFG S
Sbjct: 192 -TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 777 KSMSDSEKDHITTQVKGTMGYLDPE------YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ EK + GT GYL PE ++ D+++ GV++ LL G P
Sbjct: 248 CHLEPGEK--LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
Query: 831 ------------IERGKY 836
I G+Y
Sbjct: 305 FWHRRQILMLRMIMEGQY 322
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 65/271 (23%), Positives = 105/271 (38%), Gaps = 48/271 (17%)
Query: 605 SSGSIPQLKGARCFSF-------EEVKKYTNNFSDANDV----GSGGYGKVYKGT-LPNG 652
++ S L +R F ++ Y D + GSG G+V
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 653 QLIAIK--------RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704
+ +AI+ + EIE+L +++H ++ + F FD + ++ E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLE 219
Query: 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL-- 762
+ G L D + G ++ + + + YLHE IIHRD+K N+LL
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLYFYQM--LLAVQYLHENG---IIHRDLKPENVLLSS 274
Query: 763 -DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE---YYMTQQLTEKSDVYSFG 818
+E K+ DFG SK + ++ + T GT YL PE T D +S G
Sbjct: 275 QEEDCLIKITDFGHSKILGETSL--MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 819 VLMLELLTGRRP-------------IERGKY 836
V++ L+G P I GKY
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKR------AQQGSMQGGQEFKMEIELLSRVHHK--NLV 687
GSGG+G VY G + + +AIK + G + G ME+ LL +V ++
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 688 SLLGFCFDRGEQMLIYEFV-PNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------G 738
LL + +LI E P L D ++ + L+ L AR
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITER--------GALQEEL--ARSFFWQVLEA 161
Query: 739 LSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
+ + H ++HRDIK NIL+D R K+ DFG + D+ T GT Y
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFD-GTRVY 214
Query: 798 LDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRP------IERGKYIVR 839
PE+ + + V+S G+L+ +++ G P I RG+ R
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 38/230 (16%)
Query: 620 FEEVKKYT-NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIK---------RAQQGSM 665
F+E + ++F +G G +GKV T ++ A+K R + ++
Sbjct: 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNV 62
Query: 666 QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLD 724
E++++ + H LV+L + F E M ++ + + G L L +N +
Sbjct: 63 ------FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKE 114
Query: 725 WIRRLKIA-LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783
+L I L A L YL IIHRD+K NILLDE + + DF ++ +
Sbjct: 115 ETVKLFICELVMA--LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
Query: 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKS---DVYSFGVLMLELLTGRRP 830
+ T + GT Y+ PE + +++ S D +S GV ELL GRRP
Sbjct: 170 Q---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 42/247 (17%)
Query: 618 FSFEEVKKYTNNFSD------ANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE 670
F V + +G G +G+V+K G +A K + M+ +E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 671 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSL-------GDSLSGKNGIRL 723
K EI +++++ H NL+ L + + +L+ E+V G L +L+ + I
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 724 DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA--KVADFGLSKSMSD 781
++++ G+ ++H++ I+H D+K NIL R K+ DFGL++
Sbjct: 193 --MKQI------CEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP----------- 830
EK + GT +L PE ++ +D++S GV+ LL+G P
Sbjct: 242 REK--LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 831 -IERGKY 836
I ++
Sbjct: 299 NILACRW 305
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 58/245 (23%), Positives = 98/245 (40%), Gaps = 56/245 (22%)
Query: 627 TNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLS 679
+ FSD ++G G + V + G A K ++ S + Q+ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 680 RVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG----- 734
++ H N+V L + L+++ V G L + I +A
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-----------FEDI----VAREFYSEA 105
Query: 735 -AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSE 783
A+ ++Y H I+HR++K N+LL + K+ADFGL+ ++DSE
Sbjct: 106 DASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
Query: 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------I 831
GT GYL PE ++ D+++ GV++ LL G P I
Sbjct: 163 A--WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219
Query: 832 ERGKY 836
+ G Y
Sbjct: 220 KAGAY 224
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 43/229 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 689
GSG + V K G A K R + S +G +E + E+ +L +V H N+++L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
+R + +LI E V G L D SLS + I+++ G++YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQI------LDGVNYLH 132
Query: 744 ELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
I H D+K NI+L + K+ DFGL+ + D + + GT ++
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVA 186
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
PE + L ++D++S GV+ LL+G P I Y
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 59/241 (24%), Positives = 89/241 (36%), Gaps = 63/241 (26%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK--------RAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
GSG G+V + +AIK + EIE+L +++H ++
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR---- 737
+ F FD + ++ E + G L D + +
Sbjct: 79 KIKNF-FDAEDYYIVLELMEGGEL-----------FDKV----VGNKRLKEATCKLYFYQ 122
Query: 738 ---GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQV 791
+ YLHE IIHRD+K N+LL +E K+ DFG SK + ++ + T
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLC 177
Query: 792 KGTMGYLDPE---YYMTQQLTEKSDVYSFGVLMLELLTGRRP-------------IERGK 835
GT YL PE T D +S GV++ L+G P I GK
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 836 Y 836
Y
Sbjct: 237 Y 237
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 39/228 (17%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK-----RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
G G + V + GQ A+K + ++ K E + + H ++V LL
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSL--SGKNGIRL------DWIRRLKIALGAARGLSYL 742
G +++EF+ L + G ++R++ L A L Y
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI---LEA---LRYC 146
Query: 743 HELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
H+ IIHRD+K +LL + K+ FG++ + +S + GT ++
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMA 201
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP-----------IERGKY 836
PE + + DV+ GV++ LL+G P I +GKY
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY 249
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 51/231 (22%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
G G + V + + GQ A ++ S + Q+ + E + + H N+V L
Sbjct: 20 GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR-------GLS 740
+ G LI++ V G L + I +A A+ +
Sbjct: 80 SEEGHHYLIFDLVTGGEL-----------FEDI----VAREYYSEADASHCIQQILEAVL 124
Query: 741 YLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
+ H++ ++HR++K N+LL + K+ADFGL+ + + E+ GT GY
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFA-GTPGY 179
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
L PE + D+++ GV++ LL G P I+ G Y
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY 230
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 31/222 (13%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGF 692
G G + V + GQ A K + ++ E EI +L +++L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL---DWIRRLKIALGAARGLSYLHELANPP 749
+ E +LI E+ G + + + D IR +K L G+ YLH+
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVYYLHQNN--- 151
Query: 750 IIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
I+H D+K NILL + K+ DFG+S+ + + + + + GT YL PE
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIM-GTPEYLAPEILNYD 208
Query: 807 QLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+T +D+++ G++ LLT P I +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 43/229 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 689
GSG + V K G A K R + S +G +E + E+ +L +V H N+++L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
+R + +LI E V G L D SLS + I+++ G++YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQI------LDGVNYLH 132
Query: 744 ELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
I H D+K NI+L + K+ DFGL+ + D + GT ++
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIF-GTPEFVA 186
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
PE + L ++D++S GV+ LL+G P I Y
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 45/228 (19%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKR------AQQGSMQGGQEFKMEIELLSRVH----HKN 685
G GG+G V+ G L + +AIK + +E+ LL +V H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI-RRLKIALGAAR------- 737
++ LL + + ML+ E D L D+I + + G +R
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPA--QD-L-------FDYITEKGPLGEGPSRCFFGQVV 149
Query: 738 -GLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 795
+ + H ++HRDIK NIL+D R AK+ DFG + D T GT
Sbjct: 150 AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFD-GTR 202
Query: 796 GYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRP------IERGKY 836
Y PE+ Q + V+S G+L+ +++ G P I +
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 60/251 (23%), Positives = 97/251 (38%), Gaps = 56/251 (22%)
Query: 621 EEVKKYTNNFSDANDV----GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKM 673
E + + FSD DV G G + V + G A K + Q+ +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 674 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
E + ++ H N+V L + L+++ V G L + I +A
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-----------FEDI----VAR 122
Query: 734 G------AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSK 777
A+ ++Y H I+HR++K N+LL + K+ADFGL+
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------- 830
++DSE GT GYL PE ++ D+++ GV++ LL G P
Sbjct: 180 EVNDSEA--WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 236
Query: 831 -----IERGKY 836
I+ G Y
Sbjct: 237 RLYAQIKAGAY 247
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 43/227 (18%), Positives = 86/227 (37%), Gaps = 45/227 (19%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL 690
+G G +G V++ + + K + K EI +L+ H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-----VLVKKEISILNIARHRNILHLH 67
Query: 691 GFCFDRGEQMLIYEFVPNGSL-------GDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
E ++I+EF+ + L+ + + + ++ L +LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--VHQV------CEALQFLH 119
Query: 744 ELANPPIIHRDIKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
I H DI+ NI+ R ++ K+ +FG ++ + + Y PE
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLF-TAPEYYAPE 173
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+ ++ +D++S G L+ LL+G P I +Y
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 43/229 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 689
GSG + V K G+ A K R S +G +E + E+ +L + H N+++L
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
++ + +LI E V G L D SL+ + ++++ G+ YLH
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--LKQI------LDGVHYLH 125
Query: 744 ELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
I H D+K NI+L K+ DFG++ + + GT ++
Sbjct: 126 SKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIF-GTPEFVA 179
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
PE + L ++D++S GV+ LL+G P I Y
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 59/310 (19%), Positives = 109/310 (35%), Gaps = 23/310 (7%)
Query: 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVG 122
+ + L +K + L L+L+ N + P NL L L L
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLGLRS 89
Query: 123 CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSD 181
L L L ++ N + + +L NL L++ DN L I
Sbjct: 90 NRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YIS--H 145
Query: 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKS 241
GL+ L + K L+ SIP + LI + N+ + +
Sbjct: 146 RAFSGLNSL---EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 242 LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSF 299
L+V+ + N ++ L +++ LT A+P + L L +L++S N
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260
Query: 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSY 358
E S + L + + L + F + +L+ + + N+L T+
Sbjct: 261 STIE-GSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL-------TTL 311
Query: 359 SENLLVNLQN 368
E++ ++ N
Sbjct: 312 EESVFHSVGN 321
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 47/248 (18%), Positives = 84/248 (33%), Gaps = 16/248 (6%)
Query: 129 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188
+P+ I E LL L N + +L L+L +N + V G L
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA---VEPGAFNNLF 80
Query: 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 248
L + N+L IP +F L + N + L + +L+ +
Sbjct: 81 NL---RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 249 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSW 307
N L + L S+ L L LT L+ L L L + + + + + +
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI--NAIRDY 194
Query: 308 -FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENL-LV 364
F + L L + + + + +L ++ + L + + L +
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253
Query: 365 NLQNNRIS 372
NL N IS
Sbjct: 254 NLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 39/220 (17%), Positives = 70/220 (31%), Gaps = 33/220 (15%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 140
+GL L L L L + +L L L L + + S L L
Sbjct: 145 HRAFSGLNSLEQLTLEKCN-LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 141 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200
+L ++ + + P+ NL L +T L +P + LV + +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP-----YLAVRHLVYLRFLNLSY 257
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
N +S +I + L L+ ++ L+ P
Sbjct: 258 NPIS-TIEGSMLH-------------ELL-----------RLQEIQLVGGQLAVVEPYAF 292
Query: 261 NNLTSVNDLYLSNNKLTGAMPNL-TGLSVLSYLDMSNNSF 299
L + L +S N+LT ++ + L L + +N
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 14/173 (8%)
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 265
++PE + + N + LE + + N +S P NNL +
Sbjct: 25 AVPEGIPTE---TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81
Query: 266 VNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENT 322
+ L L +N+L +P TGLS L+ LD+S N + F + +L +L + +
Sbjct: 82 LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI--VILLDYMFQDLYNLKSLEVGDN 138
Query: 323 NLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 372
+L I FS + L+ + ++ L ++ S+ L+V L++ I+
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-23
Identities = 68/324 (20%), Positives = 106/324 (32%), Gaps = 46/324 (14%)
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
++ +SG L L GL EL LP L KL + G +
Sbjct: 84 RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH-----LPALPSGLCKLW---IFGNQLT 134
Query: 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG 186
+P LQE LS++ N + +P L L+ +N+L +P+
Sbjct: 135 S-LPVLPPGLQE---LSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSG--- 182
Query: 187 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 246
L L NQL+ S+P L + +N LT LPA L+ +
Sbjct: 183 LQEL------SVSDNQLA-SLPTLPSE----LYKLWAYNNRLT-SLPALPS---GLKELI 227
Query: 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
N L+ +P + L L +S N+LT ++P L S L L + N + +P
Sbjct: 228 VSGNRLTS-LPVLPSELKE---LMVSGNRLT-SLPML--PSGLLSLSVYRNQL--TRLPE 278
Query: 307 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNL 366
+ S TT+ +E L + L
Sbjct: 279 SLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
Query: 367 QNNRISAYTERGGAPAVNLTLIDN 390
+ + E APA +
Sbjct: 338 AADWLVPAREGEPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 58/328 (17%), Positives = 100/328 (30%), Gaps = 53/328 (16%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
L++ + L LP + ++ L++ + + +P L+ L ++
Sbjct: 39 NNGNAVLNVGESG-LTT-LPDCLP--AHITTLVIPDNNLTS-LPALPPELRTL---EVSG 90
Query: 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP------VSDGNSPGLDMLVRA-KHFHFG 199
N + +P L L L + L +L +
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVS 149
Query: 200 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 259
NQL+ S+P L + +N LT LP L+ + N L+ +P+
Sbjct: 150 DNQLA-SLPALPSE----LCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-LPTL 199
Query: 260 LNNLTSVNDLYLSNNKLT---GAMPNLTGLSV--------------LSYLDMSNNSFDAS 302
+ L L+ NN+LT L L V L L +S N +
Sbjct: 200 PSELYK---LWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRL--T 254
Query: 303 EVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL 362
+P L +L + L ++P L + TV ++ N L+ L
Sbjct: 255 SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITS 309
Query: 363 LVNLQNNRISAYTERGGAPAVNLTLIDN 390
I AP L
Sbjct: 310 APGYSGPIIRFDMAGASAPRETRALHLA 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 6e-16
Identities = 49/257 (19%), Positives = 84/257 (32%), Gaps = 35/257 (13%)
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS 126
+++S L L + L +L NN+ L LP L++LS + +
Sbjct: 144 QELSVSDNQLA-SLPALPSELCKL---WAYNNQ-LTS-LPMLPSGLQELS---VSDNQLA 194
Query: 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG 186
+P L +L + +P L L ++ N+L +PV
Sbjct: 195 S-LPTLPSELYKLWAYNNRLT----SLPALPSGLK---ELIVSGNRLT-SLPVLPSE--- 242
Query: 187 LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR 246
L L N+L+ S+P L+ + N LT LP +L + S V
Sbjct: 243 LKEL------MVSGNRLT-SLPMLPSG----LLSLSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
+ N LS L +TS + A + + +L ++ A E
Sbjct: 291 LEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE--G 348
Query: 307 WFSSMQSLTTLMMENTN 323
+ E+
Sbjct: 349 EPAPADRWHMFGQEDNA 365
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 57/245 (23%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 601 DMNKSSGSIPQLKGARCFSFEEVKKYT-NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIK 658
D + + +K +F +G G + V + AIK
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61
Query: 659 RAQQGSMQGGQEF---KMEIELLSRVHHKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDS 714
++ + + E +++SR+ H V L F F D + + NG L
Sbjct: 62 ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGEL--- 117
Query: 715 LSGKNGIRLDWIRRL-KIALGAAR--------GLSYLHELANPPIIHRDIKSSNILLDER 765
L +IR++ R L YLH IIHRD+K NILL+E
Sbjct: 118 --------LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNED 166
Query: 766 LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELL 825
++ ++ DFG +K +S K GT Y+ PE + + SD+++ G ++ +L+
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 826 TGRRP 830
G P
Sbjct: 227 AGLPP 231
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 66/296 (22%)
Query: 579 VYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDV-- 636
++ +H +N + + ++ + P + + + SD +V
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPG-TASLVPDYWIDGSNRDALSDFFEVES 59
Query: 637 --GSGGYGKVYKGT-LPNGQLIAI----KRAQQGSMQGGQEFKMEIELLSRVHHKNLVSL 689
G G VY+ + A+ K + + + EI +L R+ H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK------KIVRTEIGVLLRLSHPNIIKL 113
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG------AAR------ 737
E L+ E V G L D I + G AA
Sbjct: 114 KEIFETPTEISLVLELVTGGEL-----------FDRI----VEKGYYSERDAADAVKQIL 158
Query: 738 -GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
++YLHE I+HRD+K N+L K+ADFGLSK + + T G
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC-G 212
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP-------------IERGKY 836
T GY PE + D++S G++ LL G P I +Y
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-23
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G G +GKV G G +A+K R + S+ + K EI+ L H +++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLSYLHE 744
+ ++ E+V G L D + R++ AR + Y H
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEM--EARRLFQQILSAVDYCHR 129
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
++HRD+K N+LLD +NAK+ADFGLS MSD E + G+ Y PE
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS 183
Query: 805 TQQLT-EKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+ + D++S GV++ LL G P I G +
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF 228
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 1e-22
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVH 682
+ +G G YG V+K +++A+KR + G EI LL +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELK 59
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 740
HKN+V L + L++EF DS +G + + ++ L +GL
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQL--LKGLG 115
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
+ H ++HRD+K N+L++ K+A+FGL+++ + + + +V T+ Y P
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPP 170
Query: 801 EYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
+ + + D++S G + EL RP+ G
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 64/338 (18%), Positives = 108/338 (31%), Gaps = 39/338 (11%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
+ + LS ++ + L +L L+L + NL L L L
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPS--IGNLSNLYWLDLTDNKLEGEIPVSD 181
PD+ L L L L G S V NL L LDL+ N++
Sbjct: 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL--- 140
Query: 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRP--DMVLIHVLFDSNNLTGELPATLGLV 239
P L K F NQ+ + E P L +N+L + G
Sbjct: 141 --HPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
Query: 240 ------KSLEVVRFDRNSLSGPVPSNLNN------------LTSVNDLYLSNNKLT---- 277
LE++ N + + N +N + + +
Sbjct: 198 MNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257
Query: 278 GAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IP 336
L S + +LD+S+ + F +++ L L + + +I + F +
Sbjct: 258 NTFAGLARSS-VRHLDLSHGFVFSLN-SRVFETLKDLKVLNLAYNKIN-KIADEAFYGLD 314
Query: 337 HLQTVVMKTNELNGTLDLGTSYS-ENLLV-NLQNNRIS 372
+LQ + + N L L Y + +LQ N I+
Sbjct: 315 NLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 58/297 (19%), Positives = 103/297 (34%), Gaps = 28/297 (9%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLM 119
G S V + LS + S L +L L+L+ NK + L L L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK-INKIADEAFYGLDNLQVLN 320
Query: 120 LVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPV 179
L + L ++ + L N + + L L LDL DN L
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT----- 375
Query: 180 SDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG-ELPATLGL 238
+ + N+L ++P+ + N L ++ L
Sbjct: 376 ------TIHFIPSIPDIFLSGNKLV-TLPKINLT----ANLIHLSENRLENLDILYFLLR 424
Query: 239 VKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNNKLTGAMPN------LTGLSVLSY 291
V L+++ ++N S + S+ L+L N L A GLS L
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 348
L +++N ++ P FS + +L L + + L + + +L+ + + N+L
Sbjct: 485 LYLNHNYLNSLP-PGVFSHLTALRGLSLNSNRLT-VLSHNDLP-ANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 40/271 (14%), Positives = 83/271 (30%), Gaps = 29/271 (10%)
Query: 120 LVGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEI 177
+ F +P + + + L L+ N S L L L+L I
Sbjct: 8 IAFYRFCNLTQVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 178 PVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL--PAT 235
L + G +++ + F+ L + L+ +
Sbjct: 65 DKEA-----FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118
Query: 236 LGLVKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLS 290
+K+L + +N + + + L S+ + S+N++ + L G + LS
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT-LS 177
Query: 291 YLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG----QIPADLFS--IPHLQTVVMK 344
+ ++ NS + W M +++E ++ G FS I Q +
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI 237
Query: 345 TNELNGTLDLG----TSYSENLLVNLQNNRI 371
G +N L + +
Sbjct: 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 52/264 (19%), Positives = 95/264 (35%), Gaps = 26/264 (9%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
+V I L + L +L TLDL +N TTI + + ++ L G
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA------LTTIHFIPSIPDIFLSGN 391
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSG-RVPPSIGNLSNLYWLDLTDNKLEG-EIPVSD 181
+P + L+ L+ N + + + +L L L N+ +
Sbjct: 392 KLVT-LPKINLTAN---LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447
Query: 182 GNSPGLDMLVRAKHFHFGKNQLSG----SIPEKLFRPDMVLIHVLFDSNNLTGELPATLG 237
+P L + G+N L + +F L + + N L P
Sbjct: 448 SENPSL------EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501
Query: 238 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 297
+ +L + + N L+ ++L ++ L +S N+L PN LS LD+++N
Sbjct: 502 HLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLL--APNPDVFVSLSVLDITHN 557
Query: 298 SFDASEVPSWFSSMQSLTTLMMEN 321
F S F + + T + +
Sbjct: 558 KFICECELSTFINWLNHTNVTIAG 581
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 55/226 (24%), Positives = 108/226 (47%), Gaps = 27/226 (11%)
Query: 618 FSFEEVKKYT-NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK 672
+ + E + T N F +G GG+G+V + T G++ A K+ ++ ++ +
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEA 229
Query: 673 M---EIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLS--GKNGIRLDWI 726
M E ++L +V+ + +VSL + ++ + + L+ + G L + G+ G
Sbjct: 230 MALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 727 R--RLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784
+I G L LH I++RD+K NILLD+ + +++D GL+ + + +
Sbjct: 289 VFYAAEICCG----LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341
Query: 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
GT+GY+ PE ++ T D ++ G L+ E++ G+ P
Sbjct: 342 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 49/232 (21%), Positives = 88/232 (37%), Gaps = 29/232 (12%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK--------RAQQGSMQGGQEFKME 674
+Y+ +S + +GSG +G V+ + + +K + +E
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 675 IELLSRVHHKNLVSLLGFCFDRGEQMLIYEF-VPNGSLGDSLSGKNGIRLDWIRRL--KI 731
I +LSRV H N++ +L ++G L+ E L + + + ++
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
+ YL IIHRDIK NI++ E K+ DFG + + + + T
Sbjct: 140 V----SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--TFC 190
Query: 792 KGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRP------IERGKY 836
GT+ Y PE M + +++S GV + L+ P
Sbjct: 191 -GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G G + KV + G+ +AIK + Q + F+ E+ ++ ++H N+V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEV 82
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
LI E+ G + D L ++ R + +A + Y H+ I+H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCHQKR---IVH 137
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT-EK 811
RD+K+ N+LLD +N K+ADFG S + K + G Y PE + ++ +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFC-GAPPYAAPELFQGKKYDGPE 194
Query: 812 SDVYSFGVLMLELLTGRRP------------IERGKY 836
DV+S GV++ L++G P + RGKY
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK----RAQQGSMQGG--QEFKMEIELLSRVHHKNLVSL 689
GSG + V K G A K R + S +G ++ + E+ +L + H N+++L
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGD------SLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
++ + +LI E V G L D SL+ + ++++ G+ YLH
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQI------LNGVYYLH 131
Query: 744 ELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
L I H D+K NI+L + K+ DFGL+ + + GT ++
Sbjct: 132 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF-GTPEFVA 185
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------------IERGKY 836
PE + L ++D++S GV+ LL+G P + Y
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 45/242 (18%)
Query: 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFK----M 673
+ E +K + F G G +G V G G +AIK+ Q F+
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQ 68
Query: 674 EIELLSRVHHKNLVSLLGFCFDRGEQ-------MLIYEFVPNGSLGDSLSGKNGIRLDWI 726
++ L+ +HH N+V L + + GE+ ++ E+VP D+L R +
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTL--HRCCRNYYR 121
Query: 727 RRLKIALG--------AARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNA-KVADFGLS 776
R++ R + LH N + HRDIK N+L++E K+ DFG +
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 777 KSMSDSEK--DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIER 833
K +S SE +I ++ Y PE Q T D++S G + E++ G PI R
Sbjct: 180 KKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFR 233
Query: 834 GK 835
G
Sbjct: 234 GD 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 41/229 (17%)
Query: 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHK 684
+++D +G+G +G VY+ L +G+L+AIK+ Q + FK E++++ ++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 685 NLVSLLGFCFDRGEQM------LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG---- 734
N+V L F + GE+ L+ ++VP +++ R + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETV--YRVARHYSRAKQTLPVIYVKL 160
Query: 735 ----AARGLSYLHELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEK--DHI 787
R L+Y+H I HRDIK N+LLD K+ DFG +K + E +I
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 788 TTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
++ Y PE T DV+S G ++ ELL G +PI G
Sbjct: 218 CSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGD 260
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 60/292 (20%), Positives = 114/292 (39%), Gaps = 23/292 (7%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
+ L + GD L LHTL L NNK + P L KL L L
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKN 110
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDG 182
+P+ + L L ++ N + +V S+ L+ + ++L N L+ + +G
Sbjct: 111 QLKE-LPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK-SSGIENG 165
Query: 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKS 241
G+ L + ++ +IP+ L L + D N +T ++ A +L + +
Sbjct: 166 AFQGMKKL---SYIRIADTNIT-TIPQGLPPS---LTELHLDGNKIT-KVDAASLKGLNN 217
Query: 242 LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF-- 299
L + NS+S +L N + +L+L+NNKL L + + + NN+
Sbjct: 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 277
Query: 300 ---DASEVPSWFSSMQSLTTLMMENTNLK-GQIPADLFS-IPHLQTVVMKTN 346
+ P + + S + + + + ++ +I F + V +
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 59/290 (20%), Positives = 109/290 (37%), Gaps = 56/290 (19%)
Query: 129 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPG-L 187
+P + + LL L +N + NL NL+ L L +NK+ +I PG
Sbjct: 46 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KIS------PGAF 96
Query: 188 DMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 247
LV+ + + KNQL +PEK+ + L + N +T + + + VV
Sbjct: 97 APLVKLERLYLSKNQLK-ELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVEL 152
Query: 248 DRNSL-SGPVPSN-LNNLTSVNDLYLSNNKLT----GAMPNLT----------------- 284
N L S + + + ++ + +++ +T G P+LT
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASL 212
Query: 285 -GLSVLSYLDMSNNSFDASEVPSW-FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVV 342
GL+ L+ L +S NS S V + ++ L L + N L ++P L ++Q V
Sbjct: 213 KGLNNLAKLGLSFNSI--SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 343 MKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 392
+ N ++ + + ++L NP+
Sbjct: 270 LHNNNIS-AIGSNDFCPPGYNTKKASYS-------------GVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 40/216 (18%), Positives = 68/216 (31%), Gaps = 52/216 (24%)
Query: 85 TGLTELHTLDLSNNKDLRGPLP-TTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVL- 141
GL ++ ++L N + +KKLS + + + + IP + SL EL L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPPSLTELHLD 200
Query: 142 --------------------LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 181
L L+ N S S+ N +L L L +NKL ++P
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKS 241
+ + + + N +S +I F P P S
Sbjct: 260 ADHKYI------QVVYLHNNNIS-AIGSNDFCP------------------PGYNTKKAS 294
Query: 242 LEVVRFDRNSLS-GPVPSNL-NNLTSVNDLYLSNNK 275
V N + + + + + L N K
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 29/154 (18%), Positives = 61/154 (39%), Gaps = 13/154 (8%)
Query: 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN- 282
L ++P L ++ N ++ + NL +++ L L NNK++ P
Sbjct: 39 SDLGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95
Query: 283 LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTV 341
L L L +S N E+P ++L L + + ++ +F+ + + V
Sbjct: 96 FAPLVKLERLYLSKNQL--KELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVV 150
Query: 342 VMKTNEL-NGTLDLGT-SYSENLLV-NLQNNRIS 372
+ TN L + ++ G + L + + I+
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-22
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHH 683
+ VG G YG VYK G+++A+KR + + G EI LL +HH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG--IPSTAIREISLLKELHH 78
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 741
N+VSL+ L++EF+ + D G++ I+ L RG+++
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKT--GLQDSQIKIYLYQL--LRGVAH 134
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
H+ I+HRD+K N+L++ K+ADFGL+++ + + T +V T+ Y P+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPD 189
Query: 802 YYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
M +++ + D++S G + E++T +P+ G
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGV 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 26/206 (12%), Positives = 55/206 (26%), Gaps = 44/206 (21%)
Query: 635 DVGSGGYGKVYKGT---LPNGQLIAIK--RAQQGSMQGGQE-FKMEIELLSRVHHKNLVS 688
G + ++ L + +A+ Q + LSR+ +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
+L R +++ E++ GSL + + ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
+ S + + + +A TM +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDANPQ------- 182
Query: 809 TEKSDVYSFGVLMLELLTGRRPIERG 834
D+ G + LL R P+
Sbjct: 183 ---DDIRGIGASLYALLVNRWPLPEA 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-22
Identities = 59/212 (27%), Positives = 86/212 (40%), Gaps = 28/212 (13%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVS 688
+G G + +V K T GQ+ A+K + M E F+ E ++L + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 689 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR-RLKIA-LGAARGLSYLHEL 745
L F F D L+ E+ G L LS K G R+ R +A + A + +H L
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVMA--IDSVHRL 181
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
+HRDIK NILLD + ++ADFG + V GT YL PE
Sbjct: 182 G---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQA 237
Query: 806 QQLTEKSDVY-------SFGVLMLELLTGRRP 830
+ Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 57/252 (22%), Positives = 89/252 (35%), Gaps = 68/252 (26%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK--------------------RAQQGSMQGGQEFKM-- 673
G G YG V + A+K + Q
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 674 ----EIELLSRVHHKNLVSLLGFCFDRGEQML--IYEFVPNGSLGDSLSGKNGIRLDWIR 727
EI +L ++ H N+V L+ D E L ++E V G + ++
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-----------MEVPT 130
Query: 728 RLKIALGAAR--------GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779
++ AR G+ YLH IIHRDIK SN+L+ E + K+ADFG+S
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLT---EKSDVYSFGVLMLELLTGRRP------ 830
S+ T GT ++ PE + + DV++ GV + + G+ P
Sbjct: 188 KGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 831 ------IERGKY 836
I+
Sbjct: 246 MCLHSKIKSQAL 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 57/312 (18%), Positives = 118/312 (37%), Gaps = 20/312 (6%)
Query: 79 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 138
++ LT L TL + N + L L+ L + S S+ S+++
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 139 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 198
+ L+L+ + + + LS++ +L+L D L + +
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
Query: 199 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG---------ELPATLGLVK--SLEVVRF 247
S + KL R + L V FD L G ++ + LG V+ ++ +
Sbjct: 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293
Query: 248 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVP 305
+ L + + + L V + + N+K+ +P L L +LD+S N +
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 306 SW--FSSMQSLTTLMMENTNLKG-QIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYSEN 361
+ + SL TL++ +L+ Q ++ + +L ++ + N + + + E
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411
Query: 362 LLV-NLQNNRIS 372
+ NL + I
Sbjct: 412 MRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 53/323 (16%), Positives = 107/323 (33%), Gaps = 27/323 (8%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
+ +LDLS NK + + L L+L + D+ SL L L L+
Sbjct: 25 TAAMKSLDLSFNK-ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83
Query: 147 NGFSGRVPPS-IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 205
N S + S G LS+L +L+L N + + G + L + G +
Sbjct: 84 NHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-----TLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 265
I F L + + +L +L ++ + + + + + + L+S
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 266 VNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSF---DASEVPSWFSSMQSLTTLM 318
V L L + L +P S + L + +E+ + L+ +
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 319 MENTNLKGQIPADLFSI-----------PHLQTVVMKTNELNGTLDLGTSYSENLLV-NL 366
++ L G + ++ + + L L S E + +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 367 QNNRISAYTERGGAPAVNLTLID 389
+N+++ +L +D
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLD 340
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-16
Identities = 53/323 (16%), Positives = 112/323 (34%), Gaps = 28/323 (8%)
Query: 34 LKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTL 93
L+D + D + + S +T + + + +L I L+E+
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL---KLLRYILELSEVEFD 259
Query: 94 DLSNN--KDLRGPLPTTIGNLKK-----LSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
D + N D + L K + L + + L+++ +++ +
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319
Query: 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 206
+ +L +L +LDL++N + E + L + +N L S
Sbjct: 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL---QTLVLSQNHLR-S 375
Query: 207 IPE--KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 264
+ + ++ + + L S N +P + + + + + V + +
Sbjct: 376 MQKTGEILLT-LKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQ 431
Query: 265 SVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNL 324
++ L +SNN L L L L +S N +P S L + + L
Sbjct: 432 TLEVLDVSNNNLDSFSLFLPRLQE---LYISRNKL--KTLPDA-SLFPVLLVMKISRNQL 485
Query: 325 KGQIPADLF-SIPHLQTVVMKTN 346
K +P +F + LQ + + TN
Sbjct: 486 K-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-15
Identities = 43/224 (19%), Positives = 71/224 (31%), Gaps = 21/224 (9%)
Query: 57 EGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNK--DLRGPLPTTIGNLKK 114
+ +V IT+ + L L LDLS N + G
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 115 LSNLMLVGCSFS--GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172
L L+L + + +L+ L L ++ N F +P S + +L+L+
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421
Query: 173 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
+ + + + N L S L R L + N L L
Sbjct: 422 IR-VVK--------TCIPQTLEVLDVSNNNLD-SFSLFLPR----LQELYISRNKLK-TL 466
Query: 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKL 276
P L V++ RN L + LTS+ ++L N
Sbjct: 467 PDASLF-PVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 35/231 (15%)
Query: 622 EVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKM----EI 675
+VK + + +G G + VYK Q++AIK+ + G ++ EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 676 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA 735
+LL + H N++ LL + L+++F+ D L I+ + L
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET----D-LEV-------IIKDNSLVLTP 111
Query: 736 A----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785
+ +GL YLH+ I+HRD+K +N+LLDE K+ADFGL+KS +
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168
Query: 786 HITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
+ T QV T Y PE + D+++ G ++ ELL R P G
Sbjct: 169 Y-THQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGD 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 614 GARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFK 672
G F+ ++KY N VG G YG V K G+++AIK+ + K
Sbjct: 15 GTENLYFQSMEKYEN----LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM--VK 68
Query: 673 M----EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR 728
EI+LL ++ H+NLV+LL C + L++EFV + L D NG+ +++
Sbjct: 69 KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQK 128
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
+ G+ + H IIHRDIK NIL+ + K+ DFG +++++ + +
Sbjct: 129 YLFQI--INGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYD 182
Query: 789 TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
+V T Y PE + + + DV++ G L+ E+ G P+ G
Sbjct: 183 DEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGD 228
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHH 683
+ +G G YG VYK G+ A+K+ + G EI +L + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG--IPSTTIREISILKELKH 59
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 741
N+V L + +L++E + L D G G+ + + L G++Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQL--LNGIAY 115
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
H+ ++HRD+K N+L++ K+ADFGL+++ + + T ++ T+ Y P+
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPD 170
Query: 802 YYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
M +++ + D++S G + E++ P+ G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGV 204
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-21
Identities = 55/230 (23%), Positives = 104/230 (45%), Gaps = 32/230 (13%)
Query: 618 FSFEEVKKYT-NNFSDANDVGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEFK 672
+ + E + + F D +G GG+G+V+ K T G+L A K+ + ++ + ++
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQ 230
Query: 673 M---EIELLSRVHHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRR 728
E ++L++VH + +VSL + F+ + L+ + G + + I
Sbjct: 231 GAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI------RYHIYNVDEDN 283
Query: 729 LKIALGAAR--------GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780
A GL +LH+ II+RD+K N+LLD+ N +++D GL+
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV--E 338
Query: 781 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
T GT G++ PE + ++ D ++ GV + E++ R P
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHKN 685
+++ +G+G +G V++ L +AIK+ Q + FK E++++ V H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93
Query: 686 LVSLLGFCFDRGEQM------LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA--- 736
+V L F + G++ L+ E+VP +++ +LK +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR----ASRHYAKLKQTMPMLLIK 144
Query: 737 -------RGLSYLHELANPPIIHRDIKSSNILLDERLNA-KVADFGLSKSMSDSEK--DH 786
R L+Y+H + I HRDIK N+LLD K+ DFG +K + E +
Sbjct: 145 LYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 787 ITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
I ++ Y PE T D++S G +M EL+ G +P+ G+
Sbjct: 202 ICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFPGE 245
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 60/255 (23%), Positives = 96/255 (37%), Gaps = 62/255 (24%)
Query: 620 FEEVKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKME 674
+++ + + F+D D+G G Y + A+K + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEE 65
Query: 675 IELLSR-VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
IE+L R H N+++L D ++ E + G L LD I +
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-----------LDKI----LRQ 110
Query: 734 G------AAR-------GLSYLHELANPPIIHRDIKSSNILL-DERLNA---KVADFGLS 776
A+ + YLH ++HRD+K SNIL DE N ++ DFG +
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA 167
Query: 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------ 830
K + +E + T T ++ PE Q D++S GVL+ +LTG P
Sbjct: 168 KQL-RAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
Query: 831 ---------IERGKY 836
I GK+
Sbjct: 226 DTPEEILARIGSGKF 240
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-21
Identities = 59/297 (19%), Positives = 100/297 (33%), Gaps = 29/297 (9%)
Query: 90 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG------PIPDSIGSLQELVLLS 143
LH L L NN D + T I L L LV F ++ L L +
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 144 LNSNG---FSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200
+ + L+N+ L +E + + + +
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK----DFSYNFGWQHLELVNCKF 316
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS--GPVPS 258
Q + L L ++N G + + L SLE + RN LS G
Sbjct: 317 GQFPTLKLKSL--------KRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQ 367
Query: 259 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 318
+ TS+ L LS N + N GL L +LD +++ S F S+++L L
Sbjct: 368 SDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 319 MENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYS-ENLLV-NLQNNRIS 372
+ +T+ + +F+ + L+ + M N NL +L ++
Sbjct: 428 ISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-19
Identities = 59/299 (19%), Positives = 108/299 (36%), Gaps = 25/299 (8%)
Query: 60 GCTNSRVTSITLSGMGLKG-QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNL 118
G N + L+ + + LT + + L + + + +L
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT-IERVKDFS--YNFGWQHL 309
Query: 119 MLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP 178
LV C F + SL+ L S S +L +L +LDL+ N L
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA-----FSEVDLPSLEFLDLSRNGLS-FKG 363
Query: 179 VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA--TL 236
+ G L K+ N + ++ F L H+ F +NL ++
Sbjct: 364 CCSQSDFGTTSL---KYLDLSFNGVI-TMSS-NFLGLEQLEHLDFQHSNLK-QMSEFSVF 417
Query: 237 GLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDM 294
+++L + N L+S+ L ++ N T L L++LD+
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 295 SNNSFDASEVP-SWFSSMQSLTTLMMENTNLKGQIPADLF-SIPHLQTVVMKTNELNGT 351
S ++ + F+S+ SL L M + LK +P +F + LQ + + TN + +
Sbjct: 478 SQCQL--EQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-19
Identities = 53/319 (16%), Positives = 94/319 (29%), Gaps = 23/319 (7%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 147
LDLS N LR + + +L L L C + SL L L L N
Sbjct: 28 FSTKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 148 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 207
+ LS+L L + L G+ L L + N +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL------NVAHNLIQSFK 140
Query: 208 PEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVR----FDRNSLSGPVPSNLNNL 263
+ F L H+ SN + L ++ + ++ N ++ +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE 199
Query: 264 TSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFD-----ASEVPSWFSSMQSLTT 316
++ L L NN + + + GL+ L + F S + +LT
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 317 LMMENTNLKG---QIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISA 373
L I + ++ + + + + D ++ L L N +
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL-ELVNCKFGQ 318
Query: 374 YTERGGAPAVNLTLIDNPI 392
+ LT N
Sbjct: 319 FPTLKLKSLKRLTFTSNKG 337
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 9e-21
Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G G +GKV G G +A+K R + S+ + + EI+ L H +++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLSYLHE 744
+ ++ E+V G L D + KNG RL +R G+ Y H
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYIC-KNG-------RLDEK--ESRRLFQQILSGVDYCHR 134
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
++HRD+K N+LLD +NAK+ADFGLS MSD E + G+ Y PE
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS 188
Query: 805 TQQLT-EKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+ + D++S GV++ LL G P I G +
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF 233
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVH 682
+ F +G+G Y VYKG G +A+K + S +G EI L+ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELK 61
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKN---GIRLDWIRRLKIALGAAR 737
H+N+V L + L++EF+ N DS + N G+ L+ ++ + L +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQ 119
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
GL++ HE I+HRD+K N+L+++R K+ DFGL+++ +++V T+ Y
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLWY 174
Query: 798 LDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
P+ M ++ + D++S G ++ E++T +P+ G
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGT 212
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVH 682
+ + +G G Y VYKG L+A+K + +G E+ LL +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLK 58
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 740
H N+V+L L++E++ D N I + ++ L RGL+
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQL--LRGLA 114
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
Y H ++HRD+K N+L++ER K+ADFGL+++ S K + +V T+ Y P
Sbjct: 115 YCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYRPP 169
Query: 801 EYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
+ + + + + D++ G + E+ T RP+ G
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGS 204
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKM----EIELL--- 678
+ + ++G G YG VYK +G +A+K + + GG + E+ LL
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 679 SRVHHKNLVSLLGFCFDRGEQ-----MLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKI 731
H N+V L+ C L++E V + D G+ + I+ L
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP-GLPAETIKDLMR 127
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
RGL +LH I+HRD+K NIL+ K+ADFGL++ S +T V
Sbjct: 128 QF--LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVV 180
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
T+ Y PE + D++S G + E+ R+P+ G
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGN 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 32/213 (15%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVS 688
+G G +G+V K ++ A+K + M E F+ E ++L K + +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 689 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGI-RLDWIR----RLKIALGAARGLSYL 742
L + F D L+ ++ G L LS + R + IA+ +
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------SV 191
Query: 743 HELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEY 802
H+L +HRDIK NIL+D + ++ADFG + + + V GT Y+ PE
Sbjct: 192 HQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEI 247
Query: 803 YMTQQLTEKS-----DVYSFGVLMLELLTGRRP 830
+ + D +S GV M E+L G P
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 42/225 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
G G +GKV T Q +A+K R + EI L + H +++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLSYLHE 744
+ +++ E+ G L D + K +R+ R + Y H
Sbjct: 78 ITTPTDIVMVIEYA-GGELFDYIVEK--------KRMTED--EGRRFFQQIICAIEYCHR 126
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
I+HRD+K N+LLD+ LN K+ADFGLS M+D + G+ Y PE
Sbjct: 127 HK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIN 180
Query: 805 TQQLT-EKSDVYSFGVLMLELLTGRRP------------IERGKY 836
+ + DV+S G+++ +L GR P + Y
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY 225
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM--EIELLSRVHHK 684
+ + +G G YG+VYK + +AIKR + + G E+ LL + H+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
N++ L LI+E+ N L + + + I+ L G+++ H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL--INGVNFCHS 150
Query: 745 LANPPIIHRDIKSSNILLDERLNA-----KVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
+HRD+K N+LL + K+ DFGL+++ + T ++ T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLWYRP 205
Query: 800 PEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
PE + ++ + D++S + E+L + P+ G
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGD 241
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF--KMEIELLSRVHHKNLVSL 689
+G G +GKV+ QL A+K ++ +++ KME ++L V+H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 690 LGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GLS 740
+ F ++ LI +F+ G L LS + + + L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALD 140
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLD 799
+LH L II+RD+K NILLDE + K+ DFGLSK S+ +K GT+ Y+
Sbjct: 141 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMA 194
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
PE + T+ +D +SFGVLM E+LTG P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-20
Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 19/203 (9%)
Query: 635 DVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC 693
D+GSG +G +L+A+K ++G+ + EI + H N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRL---KIALGAARGLSYLHELANPPI 750
+I E+ G L + + D R ++ G+SY H + I
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYCHSMQ---I 137
Query: 751 IHRDIKSSNILLDE--RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL 808
HRD+K N LLD K+ DFG SKS + + V GT Y+ PE + Q+
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEVLLRQEY 194
Query: 809 T-EKSDVYSFGVLMLELLTGRRP 830
+ +DV+S GV + +L G P
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYP 217
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 21/270 (7%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 147
+ +LDLSNN+ + + + L L+L + DS SL L L L+ N
Sbjct: 52 EAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 148 GFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 206
S + S LS+L +L+L N + + + L + + G
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLG----ETSLFSHLTKLQILRVGNMDTFTK 164
Query: 207 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 266
I K F L + D+++L P +L ++++ + + ++ +SV
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224
Query: 267 NDLYLSNNKL---------TGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 317
L L + L TG +L + +++ S +V + + L L
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL--FQVMKLLNQISGLLEL 282
Query: 318 MMENTNLKGQIPADLF-SIPHLQTVVMKTN 346
LK +P +F + LQ + + TN
Sbjct: 283 EFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 43/226 (19%), Positives = 76/226 (33%), Gaps = 20/226 (8%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSL 144
L L LDLS N L + L L+ L L+G + S+ L +L +L +
Sbjct: 98 SLGSLEHLDLSYNY-LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 145 NSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 203
+ ++ L+ L L++ + L+ L + H Q
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYE-----PKSLKSIQNVSHLILHMKQH 210
Query: 204 SGSIPEKLFRPDMVLIHVLFDSNNLTG----ELPA----TLGLVKSLEVVRFDRNSLSGP 255
+ E + + +L EL +L + V+ SL
Sbjct: 211 I-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-Q 268
Query: 256 VPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFD 300
V LN ++ + +L S N+L L+ L + + N +D
Sbjct: 269 VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 35/176 (19%), Positives = 70/176 (39%), Gaps = 13/176 (7%)
Query: 225 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL- 283
S +L +P+ GL ++++ + N ++ S+L ++ L L++N + +
Sbjct: 40 SGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF 96
Query: 284 TGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTV 341
+ L L +LD+S N S + S WF + SLT L + K LFS + LQ +
Sbjct: 97 SSLGSLEHLDLSYNYL--SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154
Query: 342 VMKTNELNGTLDLGTSYS-ENLLV-NLQNNRISAYTERGGAPAVNLT---LIDNPI 392
+ + + L + + + +Y + N++ L
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 21/165 (12%), Positives = 51/165 (30%), Gaps = 29/165 (17%)
Query: 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTI--GNLKKLSNLMLVGCS 124
+ + L+ + + + L L + + + S++ +
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ------HILLLEIFVDVTSSVECL--- 227
Query: 125 FSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS 184
L++ L + + + S S+ + +TD L ++
Sbjct: 228 ----------ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM------ 270
Query: 185 PGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT 229
L+ + F +NQL S+P+ +F L + +N
Sbjct: 271 KLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM----EIELLSRVHHKNLVSLL 690
+G G YG V+K GQ++AIK+ + K EI +L ++ H NLV+LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV--IKKIALREIRMLKQLKHPNLVNLL 68
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ L++E+ + L + + G+ ++ + + +++ H+
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT--LQAVNFCHKHN---C 123
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE------YYM 804
IHRD+K NIL+ + K+ DFG ++ ++ D+ +V T Y PE Y
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEV-ATRWYRSPELLVGDTQYG 181
Query: 805 TQQLTEKSDVYSFGVLMLELLTGR 828
DV++ G + ELL+G
Sbjct: 182 PP-----VDVWAIGCVFAELLSGV 200
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 47/233 (20%), Positives = 88/233 (37%), Gaps = 38/233 (16%)
Query: 618 FSFEEVKKYTNNFSDANDV-----GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEF 671
F+ + +D + G G GKV + GQ A+K + +
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKA 68
Query: 672 KMEIELLSRV-HHKNLVSLLGFCFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRL--- 723
+ E++ + ++V +L + +I E + G L + +
Sbjct: 69 RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER 128
Query: 724 ---DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSK 777
+ +R + + +LH I HRD+K N+L ++ K+ DFG +K
Sbjct: 129 EAAEIMRDI------GTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ + + T T Y+ PE ++ + D++S GV+M LL G P
Sbjct: 180 ETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-20
Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKM----EIELLSRV 681
+ + +G G +G+V+K GQ +A+K+ M+ +E F + EI++L +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 682 HHKNLVSLLGFCFDRGEQM--------LIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKI 731
H+N+V+L+ C + L+++F + L ++ K L I+R+
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQ 131
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI---T 788
L GL Y+H I+HRD+K++N+L+ K+ADFGL+++ S ++ T
Sbjct: 132 ML--LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 789 TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
+V T+ Y PE + + D++ G +M E+ T R PI +G
Sbjct: 187 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGN 232
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-20
Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 57/302 (18%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
+ H L+L+N L LP +L+ L C+ +P+ SL+ L++ + N
Sbjct: 70 DRQAHELELNNLG-LS-SLPELPPHLESLV----ASCNSLTELPELPQSLKSLLVDNNNL 123
Query: 147 NGFSGRVP---------------PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 191
S P P + N S L +D+ +N L+ ++P D+
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP---------DLPP 173
Query: 192 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 251
+ G NQL +PE P + I+ D+N+L +LP SLE + N
Sbjct: 174 SLEFIAAGNNQLE-ELPELQNLPFLTAIYA--DNNSLK-KLPDLPL---SLESIVAGNNI 226
Query: 252 LSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSM 311
L L NL + +Y NN L +P+L L L++ +N +++P S+
Sbjct: 227 LE--ELPELQNLPFLTTIYADNNLLK-TLPDL--PPSLEALNVRDNYL--TDLPELPQSL 279
Query: 312 QSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNR 370
L + L P+L + +NE+ DL +L N+ NN+
Sbjct: 280 TFLDVSENIFSGLSE-------LPPNLYYLNASSNEIRSLCDL----PPSLEELNVSNNK 328
Query: 371 IS 372
+
Sbjct: 329 LI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 55/295 (18%), Positives = 100/295 (33%), Gaps = 48/295 (16%)
Query: 79 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE 138
L L ++ NN L + NL L+ + +PD SL+
Sbjct: 206 SLKKLPDLPLSLESIVAGNNI-LE--ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEA 261
Query: 139 LVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 198
L + P +L+ L + + L P L + +
Sbjct: 262 LNVRDNYLTDL----PELPQSLTFLDVSENIFSGLSELPP-------NL------YYLNA 304
Query: 199 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS 258
N++ S+ + L + +N L ELPA LE + N L+ VP
Sbjct: 305 SSNEIR-SLCDLPPS----LEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPE 354
Query: 259 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 318
NL L++ N L P++ + L M+++ +EVP Q+L L
Sbjct: 355 LPQNLKQ---LHVEYNPLR-EFPDI--PESVEDLRMNSHL---AEVP---ELPQNLKQLH 402
Query: 319 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRIS 372
+E L+ + P S+ L+ M + + + ++ L +++
Sbjct: 403 VETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 55/244 (22%), Positives = 88/244 (36%), Gaps = 41/244 (16%)
Query: 129 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188
+P +++ + + PP G + L D
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR-------------- 71
Query: 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 248
+A LS S+PE L ++ N+LT ELP +KSL V +
Sbjct: 72 ---QAHELELNNLGLS-SLPELPPH----LESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 249 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 308
+L L L +SNN+L +P L S L +D+ NNS ++P
Sbjct: 123 LKAL----SDLPPLLEY---LGVSNNQLE-KLPELQNSSFLKIIDVDNNSL--KKLPDLP 172
Query: 309 SSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 368
SL + N L+ ++P +L ++P L + N L DL S E++ N
Sbjct: 173 P---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLPDLPLSL-ESI--VAGN 224
Query: 369 NRIS 372
N +
Sbjct: 225 NILE 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 43/233 (18%), Positives = 80/233 (34%), Gaps = 40/233 (17%)
Query: 153 VPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLF 212
+ P + + L + L E+PV N + ++ ++ + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAEN------VKSKTEYYNAWSEWERNAPPGNG 55
Query: 213 RPDMVLIHVLFD------------SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
+ + L D + L+ LP LE + NSL+ +P
Sbjct: 56 EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELP 110
Query: 261 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320
+L S+ + L+ P L YL +SNN ++P + L + ++
Sbjct: 111 QSLKSLLVDNNNLKALSDLPPLLE------YLGVSNNQL--EKLPE-LQNSSFLKIIDVD 161
Query: 321 NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRIS 372
N +LK ++P P L+ + N+L +L L NN +
Sbjct: 162 NNSLK-KLPD---LPPSLEFIAAGNNQLEELPELQN--LPFLTAIYADNNSLK 208
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 1e-19
Identities = 65/253 (25%), Positives = 110/253 (43%), Gaps = 35/253 (13%)
Query: 593 EQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYT-NNFSDANDVGSGGYGKVY----KG 647
+ F + + Q K + E T N+FS +G GG+G+VY
Sbjct: 158 RGDVFQKFIESDKFTRFCQWK-----NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD 212
Query: 648 TLPNGQLIAIKRAQQGSMQGGQEFKM---EIELLSRVHHKN---LVSLLGFCFDRGEQM- 700
T G++ A+K + ++ Q + E +LS V + +V + + F +++
Sbjct: 213 T---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLS 268
Query: 701 LIYEFVPNGSLGDSLSGKNGIRLDWIR--RLKIALGAARGLSYLHELANPPIIHRDIKSS 758
I + + G L LS +R +I LG L ++H +++RD+K +
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMHNRF---VVYRDLKPA 321
Query: 759 NILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS-DVYSF 817
NILLDE + +++D GL+ D K V GT GY+ PE + S D +S
Sbjct: 322 NILLDEHGHVRISDLGLAC---DFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 818 GVLMLELLTGRRP 830
G ++ +LL G P
Sbjct: 378 GCMLFKLLRGHSP 390
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 54/232 (23%)
Query: 627 TNNFSDANDV-------GSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEI 675
+ F D+ G G + K + Q A+K + + + Q EI
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEI 56
Query: 676 ELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALG 734
L H N+V L D+ L+ E + G L + I
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL-----------FERI----KKKK 101
Query: 735 ------AAR-------GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKS 778
A+ +S++H++ ++HRD+K N+L ++ L K+ DFG ++
Sbjct: 102 HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ + T T+ Y PE E D++S GV++ +L+G+ P
Sbjct: 159 KPP-DNQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 56/294 (19%), Positives = 102/294 (34%), Gaps = 28/294 (9%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
T + L + D GL L+ L L NNK + L+KL L +
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK-ISKIHEKAFSPLRKLQKLYISKN 112
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDG 182
IP LV L ++ N +VP + L N+ +++ N LE G
Sbjct: 113 HLVE-IPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPG 167
Query: 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKS 241
GL + + + +L+ IP+ L L + D N + + L
Sbjct: 168 AFDGL----KLNYLRISEAKLT-GIPKDLPET---LNELHLDHNKIQ-AIELEDLLRYSK 218
Query: 242 LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDA 301
L + N + +L+ L ++ +L+L NNKL+ L L +L + + N+
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNI-- 276
Query: 302 SEVPS-------WFSSMQSLTTLMMENTNLK-GQIPADLFS-IPHLQTVVMKTN 346
++V + + + N + ++ F + +
Sbjct: 277 TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 61/302 (20%), Positives = 107/302 (35%), Gaps = 49/302 (16%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 147
+ LDL NN + L+ L L+LV S + L++L L ++ N
Sbjct: 54 PDTTLLDLQNND-ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 148 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL-SGS 206
+PP++ S+L L + DN++ V G GL + G N L +
Sbjct: 113 HLV-EIPPNL--PSSLVELRIHDNRIRK---VPKGVFSGLRNM---NCIEMGGNPLENSG 163
Query: 207 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSV 266
F + L ++ LT +P L ++L + D N + +L + +
Sbjct: 164 FEPGAFD-GLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKL 219
Query: 267 NDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325
L L +N++ L+ L L L + NN L+
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK---------------LSR--------- 255
Query: 326 GQIPADLFSIPHLQTVVMKTNELN-------GTLDLGTSYSENLLVNLQNNRISAYTERG 378
+PA L + LQ V + TN + + G + ++L NN + + +
Sbjct: 256 --VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 379 GA 380
Sbjct: 314 AT 315
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 34/215 (15%), Positives = 59/215 (27%), Gaps = 51/215 (23%)
Query: 85 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL--- 141
+GL ++ +++ N + KL+ L + +G D +L EL L
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHN 203
Query: 142 ------------------LSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDG 182
L L N + L L L L +NKL +P
Sbjct: 204 KIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVP---- 257
Query: 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSL 242
GL L + + N ++ + F P +
Sbjct: 258 --AGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRA------------------YY 296
Query: 243 EVVRFDRNSLSGPV--PSNLNNLTSVNDLYLSNNK 275
+ N + P+ +T + N K
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 29/154 (18%), Positives = 58/154 (37%), Gaps = 12/154 (7%)
Query: 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN- 282
L +P + ++ N +S + L + L L NNK++
Sbjct: 41 SDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA 97
Query: 283 LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTV 341
+ L L L +S N E+P + SL L + + ++ ++P +FS + ++ +
Sbjct: 98 FSPLRKLQKLYISKNHL--VEIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCI 152
Query: 342 VMKTNEL-NGTLDLGTSYSENLLV-NLQNNRISA 373
M N L N + G L + +++
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG 186
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 50/219 (22%), Positives = 84/219 (38%), Gaps = 40/219 (18%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCF 694
G G + +V L Q A+K ++ E+E+L + H+N++ L+ F
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK---------IALGAARGLSYLHEL 745
+ L++E + GS+ L I + + + A L +LH
Sbjct: 82 EEDRFYLVFEKMRGGSI-----------LSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 746 ANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSM------SDSEKDHITTQVKGTMG 796
I HRD+K NIL ++ K+ DF L + S + T G+
Sbjct: 131 G---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAE 186
Query: 797 YLDPEYYMTQQLTEKS-----DVYSFGVLMLELLTGRRP 830
Y+ PE D++S GV++ LL+G P
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 39/215 (18%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHHKNLVS 688
+G G +G+V K T ++ A+K + M + F E ++++ + +V
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 689 LLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------GL 739
L + F D ++ E++P G L ++ + + AR L
Sbjct: 134 LF-YAFQDDRYLYMVMEYMPGGDL-----------VNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
+H + IHRD+K N+LLD+ + K+ADFG M+ T V GT Y+
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 237
Query: 800 PEYYMTQQLTEK----SDVYSFGVLMLELLTGRRP 830
PE +Q D +S GV + E+L G P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 50/245 (20%), Positives = 84/245 (34%), Gaps = 19/245 (7%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNK-DLRGPLPTTIGNLKKLSNLMLVG 122
S T + L L+ G LT+L L LS+N +G + L L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 123 CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSD 181
+ + L++L L + S+ +L NL +LD++ +
Sbjct: 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV---AFN 143
Query: 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLV 239
G GL L + N + +F L + L +L T L
Sbjct: 144 GIFNGLSSL---EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSL- 198
Query: 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMS 295
SL+V+ N+ L S+ L S N + + + S L++L+++
Sbjct: 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF--PSSLAFLNLT 256
Query: 296 NNSFD 300
N F
Sbjct: 257 QNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 35/172 (20%), Positives = 64/172 (37%), Gaps = 9/172 (5%)
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS--GPVPSNLNNL 263
S+P + + +SN L + L + N LS G +
Sbjct: 21 SVPTGIPSS---ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 264 TSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 323
TS+ L LS N + N GL L +LD +++ S F S+++L L + +T+
Sbjct: 78 TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 324 LKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRIS 372
+ +F+ + L+ + M N + NL +L ++
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 24/206 (11%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRVHHKNLVS 688
+G G +GKV K T G+ A+K ++ + E E +L H L +
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 689 LLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIR--RLKIALGAARGLSYLHEL 745
L + F +++ + E+ G L LS + D R +I L YLH
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LDYLHSE 267
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYYM 804
N +++RD+K N++LD+ + K+ DFGL K + D GT YL PE
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLE 322
Query: 805 TQQLTEKSDVYSFGVLMLELLTGRRP 830
D + GV+M E++ GR P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 60/257 (23%), Positives = 93/257 (36%), Gaps = 56/257 (21%)
Query: 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKR--AQQGSMQGGQEFKM---- 673
YT + SG YG V G G +AIKR +
Sbjct: 18 HAMQSPYTV----QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 674 -----EIELLSRVHHKNLVSLLG-FCFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRL 723
EI LL+ HH N++ L F M L+ E +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT--------------- 118
Query: 724 DW---IRRLKIALGAA----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770
D I +I + GL LHE A ++HRD+ NILL + + +
Sbjct: 119 DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITI 175
Query: 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRR 829
DF L++ D+ + T V Y PE M + T+ D++S G +M E+ R+
Sbjct: 176 CDFNLAR--EDTADANKTHYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRK 231
Query: 830 PIERGKYIVREIRTVMD 846
+ RG ++ +++
Sbjct: 232 ALFRGSTFYNQLNKIVE 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 628 NNFSDANDVGSGGYGKVYKG--TLPNGQLIAIKRAQQGSMQGGQEFKM----EIELL--- 678
+ ++G G YGKV+K G+ +A+KR + + + G + E+ +L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHL 68
Query: 679 SRVHHKNLVSLLGFCFDRGEQ-----MLIYEFVPN--GSLGDSLSGKNGIRLDWIRRLKI 731
H N+V L C L++E V + D + G+ + I+ +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMF 127
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
L RGL +LH ++HRD+K NIL+ K+ADFGL++ S +T+ V
Sbjct: 128 QL--LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 180
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
T+ Y PE + D++S G + E+ R+P+ RG
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 7e-19
Identities = 57/218 (26%), Positives = 84/218 (38%), Gaps = 49/218 (22%)
Query: 636 VGSGGYGKV----YKGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRVH 682
+G G +GKV K T G+ A+K + + E +L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHT------VTESRVLQNTR 63
Query: 683 HKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR---- 737
H L +L + F +++ + E+ G L LS R AR
Sbjct: 64 HPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS----------RERVFTEERARFYGA 112
Query: 738 ----GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVK 792
L YLH +++RDIK N++LD+ + K+ DFGL K +SD
Sbjct: 113 EIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFC 166
Query: 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
GT YL PE D + GV+M E++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 7e-19
Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 46/192 (23%)
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
+ + A+G+ +L A+ IHRD+ + NILL E+ K+ DFGL++ +
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----- 247
Query: 789 TQVKGTMGYLD-----PEYYMTQQLTEKSDVYSFGVLMLELLT-GRRP---IERGKYIVR 839
V+ L PE + T +SDV+SFGVL+ E+ + G P ++ + R
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
Query: 840 EIR--TVMDK----KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS 893
++ T M E+Y L C RPT S
Sbjct: 308 RLKEGTRMRAPDYTTPEMY-----------------------QTMLDCWHGEPSQRPTFS 344
Query: 894 EVVKDIENILQQ 905
E+V+ + N+LQ
Sbjct: 345 ELVEHLGNLLQA 356
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 8e-19
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 636 VGSGGYGKVY-------KGTLPNGQLIAIKRAQQGS-MQGGQEF---KMEIELLSRVHHK 684
+G GGYGKV+ T G++ A+K ++ ++ ++ K E +L V H
Sbjct: 25 LGKGGYGKVFQVRKVTGANT---GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 685 NLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR------ 737
+V L+ + F G ++ LI E++ G L L R A
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE----------REGIFMEDTACFYLAEI 130
Query: 738 --GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGT 794
L +LH+ II+RD+K NI+L+ + + K+ DFGL K S+ D T GT
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGT 184
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ Y+ PE M D +S G LM ++LTG P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 32/209 (15%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCF 694
G G GKV + + A+K +Q + + E+EL R ++V ++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 695 DRGEQM----LIYEFVPNGSLGDSLSGKNGIRL------DWIRRLKIALGAARGLSYLHE 744
+ ++ E + G L + + + ++ + + YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI------GEAIQYLHS 179
Query: 745 LANPPIIHRDIKSSNILL-DERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
+ I HRD+K N+L +R NA K+ DFG +K + +TT T Y+ PE
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYYVAPE 233
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
++ + D++S GV+M LL G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 45/241 (18%)
Query: 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVH 682
+ + +GSG G V + +AIK R Q + ++ E+ L+ V+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL-------DWIRRLKIALGA 735
HKN++ LL F P SL + + + + + +++ L
Sbjct: 83 HKNIIGLLNV------------FTPQKSLEE----FQDVYIVMELMDANLCQVIQMELDH 126
Query: 736 A----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785
G+ +LH A IIHRD+K SNI++ K+ DFGL+++ S
Sbjct: 127 ERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 181
Query: 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVM 845
+T V T Y PE + E D++S G +M E++ G + G + + V+
Sbjct: 182 MMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVI 239
Query: 846 D 846
+
Sbjct: 240 E 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 60/283 (21%), Positives = 91/283 (32%), Gaps = 40/283 (14%)
Query: 116 SNLMLVGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 173
+ V C+ G +P I L+L N + +L +L L L N +
Sbjct: 54 NQFSKVVCTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 174 EGEIPVSDGNSPG-LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
+I G + L N L+ IP F L + +N +
Sbjct: 112 R-QIE------VGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIP 163
Query: 233 PATLGLVKSLEVVRFDR-NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSY 291
V SL + L L ++ L L + MPNLT L L
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEE 222
Query: 292 LDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELN 349
L+MS N F E+ F + SL L + N+ + I + F + L + + N L
Sbjct: 223 LEMSGNHF--PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNL- 278
Query: 350 GTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 392
+S +L L+ L L NP
Sbjct: 279 ------SSLPHDLFTPLRYLV-------------ELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 50/261 (19%), Positives = 93/261 (35%), Gaps = 39/261 (14%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
S + L ++ + L L L L N +R L L+ L L
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTLELFDN 133
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDG 182
+ + L +L L L +N +P + +L LDL +
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL----------- 181
Query: 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSL 242
+L I E F L ++ N+ ++P LV L
Sbjct: 182 ------------------KKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLV-GL 220
Query: 243 EVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDA 301
E + N P + + L+S+ L++ N++++ N GL+ L L++++N+
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL-- 278
Query: 302 SEVP-SWFSSMQSLTTLMMEN 321
S +P F+ ++ L L + +
Sbjct: 279 SSLPHDLFTPLRYLVELHLHH 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 3e-18
Identities = 46/241 (19%), Positives = 82/241 (34%), Gaps = 36/241 (14%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146
+ + L L+ L LP + +++ L + + +P+ SL+ L
Sbjct: 58 INQFSELQLNRLN-LSS-LPDNLP--PQITVLEITQNALI-SLPELPASLEYL---DACD 109
Query: 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 206
N S +P +L +L D+ +N+L +P L+ + + NQL+
Sbjct: 110 NRLS-TLPELPASLKHL---DVDNNQLT-MLPELPAL---LEYI------NADNNQLT-M 154
Query: 207 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG--PVPSNLNNLT 264
+PE L + +N LT LP SLE + N L VP ++
Sbjct: 155 LPELPTS----LEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLESLPAVPVRNHHSE 206
Query: 265 SVN-DLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 323
N++T N+ L + + +N S S Q+
Sbjct: 207 ETEIFFRCRENRITHIPENILSLDPTCTIILEDNPL--SSRIRESLSQQTAQPDYHGPRI 264
Query: 324 L 324
Sbjct: 265 Y 265
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 3e-18
Identities = 51/277 (18%), Positives = 91/277 (32%), Gaps = 43/277 (15%)
Query: 79 QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKL--SNLMLVGCSFSGPIPDSIGSL 136
+ + N+ + I +L + L L +PD++
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS------LPDNLP-- 79
Query: 137 QELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 196
++ +L + N +P +L +LD DN+L +P + LD+
Sbjct: 80 PQITVLEITQNALI-SLPELPASLE---YLDACDNRLS-TLPELPASLKHLDV------- 127
Query: 197 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPV 256
NQL+ +PE L ++ D+N LT LP SLEV+ N L+ +
Sbjct: 128 --DNNQLT-MLPELPAL----LEYINADNNQLT-MLPELPT---SLEVLSVRNNQLTF-L 175
Query: 257 PSNLNNLTSVNDLYLSNNKLTG---AMPNLTGL-SVLSYLDMSNNSFDASEVPSWFSSMQ 312
P +L L +S N L + N + +P S+
Sbjct: 176 PELPESLE---ALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI--THIPENILSLD 230
Query: 313 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349
T+++E+ L +I L +
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 2e-16
Identities = 45/295 (15%), Positives = 104/295 (35%), Gaps = 55/295 (18%)
Query: 10 LSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGI-----GCTNS 64
+S+ L +++ ++ + + D + W+ G+N C +
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTISGTYADY-FSAWDKWEKQALPGENRNEAVSLLKECLIN 59
Query: 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKL--SNLMLVG 122
+ + + L+ + L L ++ ++ L+++ N L LP +L+ L + L
Sbjct: 60 QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNA-LI-SLPELPASLEYLDACDNRLST 114
Query: 123 CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNL-----------------SNLYW 165
+P+ SL+ L +++N + +P L ++L
Sbjct: 115 ------LPELPASLKHL---DVDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSLEV 164
Query: 166 LDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE---KLFRPDMVLIHVL 222
L + +N+L +P + L + N L S+P + + I
Sbjct: 165 LSVRNNQLT-FLP------ELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 223 FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT 277
N +T +P + + + + N LS + +L+ T+ D + +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 18/99 (18%), Positives = 27/99 (27%), Gaps = 7/99 (7%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG----PIPDSIGSLQELVLL 142
L LD+S N L LP + IP++I SL +
Sbjct: 179 PESLEALDVSTNL-LES-LPAVPVRNHHSEET-EIFFRCRENRITHIPENILSLDPTCTI 235
Query: 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 181
L N S R+ S+ + +
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 34/272 (12%)
Query: 589 EKANEQNPFAHWDMNKSSGSIP----QLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKV 644
++ + H++M+KS ++ + F +K+Y + +GSG G V
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDST---FTVLKRYQ----NLKPIGSGAQGIV 78
Query: 645 YKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLL------GFCF 694
+ +AIK R Q + ++ E+ L+ V+HKN++SLL
Sbjct: 79 CAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLE 137
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
+ + L+ E + +L + LD R + G+ +LH A IIHRD
Sbjct: 138 EFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS-AG--IIHRD 189
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 814
+K SNI++ K+ DFGL+++ +T V T Y PE + E D+
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYV-VTRYYRAPEVILGMGYKENVDI 246
Query: 815 YSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
+S G +M E++ + + G+ + + V++
Sbjct: 247 WSVGCIMGEMVRH-KILFPGRDYIDQWNKVIE 277
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 25/218 (11%)
Query: 636 VGSGGYGKVYKG---TLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
VG G YG VYK + + A+K+ + + EI LL + H N++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 86
Query: 693 CFDRGEQ--MLIYEFVPN------GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
++ L++++ + S + K ++L + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 745 LANPPIIHRDIKSSNILLDERLNA----KVADFGLSKSMSDSEKD--HITTQVKGTMGYL 798
++HRD+K +NIL+ K+AD G ++ + K + V T Y
Sbjct: 147 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 799 DPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
PE + + T+ D+++ G + ELLT PI +
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCR 239
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 1e-17
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 636 VGSGGYGKV----YKGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRV-HHKNLV 687
+G G +GKV KGT +L A+K ++ + + +E +L+ L
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 688 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIR--RLKIALGAARGLSYLHE 744
L CF +++ + E+V G L + + +IA+G L +L
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQS 460
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGYLDPEYY 803
II+RD+K N++LD + K+ADFG+ K ++ D T GT Y+ PE
Sbjct: 461 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEII 514
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRP 830
Q + D ++FGVL+ E+L G+ P
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 636 VGSGGYGKV----YKGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRV- 681
+G G +GKV KGT +L A+K +E +L+
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECT------MVEKRVLALPG 78
Query: 682 HHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--- 737
L L CF +++ + E+V G L + + + A
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----------QVGRFKEPHAVFYA 127
Query: 738 -----GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQV 791
GL +L II+RD+K N++LD + K+ADFG+ K ++ D T
Sbjct: 128 AEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTF 181
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
GT Y+ PE Q + D ++FGVL+ E+L G+ P
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 67/277 (24%), Positives = 109/277 (39%), Gaps = 44/277 (15%)
Query: 581 AYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDAND----- 635
A+H E+ A + G L + + +
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVG-IENFELLK 60
Query: 636 -VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF----KMEIELLSRV-HHKN 685
+G+G YGKV+ G+L A+K ++ ++ + + E ++L +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 686 LVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR------- 737
LV+L + F + LI +++ G L LS +R + +
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIV 169
Query: 738 -GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTM 795
L +LH+L II+RDIK NILLD + + DFGLSK ++D + GT+
Sbjct: 170 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD--ETERAYDFCGTI 224
Query: 796 GYLDPE--YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
Y+ P+ + D +S GVLM ELLTG P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 53/245 (21%), Positives = 92/245 (37%), Gaps = 19/245 (7%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120
C N + + GL+ + I + L N+ + + + L+ L L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNR-ISHVPAASFRACRNLTILWL 63
Query: 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPV 179
+ + L L L L+ N V P+ L L+ L L L+ E+
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG- 121
Query: 180 SDGNSPG-LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL-- 236
PG L ++ + N L ++P+ FR L H+ N ++ +P
Sbjct: 122 -----PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFR 174
Query: 237 GLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMS 295
GL SL+ + +N ++ P +L + LYL N L+ L L L YL ++
Sbjct: 175 GLH-SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
Query: 296 NNSFD 300
+N +
Sbjct: 234 DNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 30/175 (17%), Positives = 67/175 (38%), Gaps = 15/175 (8%)
Query: 206 SIPEKLFRPDMVLIHVLF-DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 264
++P + +F N ++ A+ ++L ++ N L+ + L
Sbjct: 25 AVPVGIP----AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80
Query: 265 SVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMEN 321
+ L LS+N ++ GL L L + E+ F + +L L +++
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL--QELGPGLFRGLAALQYLYLQD 138
Query: 322 TNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGT-SYSENLLV-NLQNNRISA 373
L+ +P D F + +L + + N ++ ++ +L L NR++
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH 191
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 49/254 (19%), Positives = 99/254 (38%), Gaps = 59/254 (23%)
Query: 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM-EIELLSRVHHK 684
+ +S +G+G +G V + + +G+ A+K+ Q +K E++++ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWI------------------ 726
N++ L+ + + G++ P+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 727 -----RRLKIALGAA----------------RGLSYLHELANPPIIHRDIKSSNILLDER 765
+ LK + + R + ++H I HRDIK N+L++ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LG--ICHRDIKPQNLLVNSK 177
Query: 766 LNA-KVADFGLSKSMSDSEK--DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLM 821
N K+ DFG +K + SE +I ++ Y PE + + T D++S G +
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 822 LELLTGRRPIERGK 835
EL+ G +P+ G+
Sbjct: 233 GELILG-KPLFSGE 245
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 53/254 (20%), Positives = 81/254 (31%), Gaps = 28/254 (11%)
Query: 61 CTNSRVTSI-----------TLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTI 109
C S+VT I L+ G +G +L +++S N L
Sbjct: 16 CQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75
Query: 110 GNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLD 167
NL KL + + + I +L L L +++ G +P + LD
Sbjct: 76 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLD 134
Query: 168 LTDNKLEGEIP--VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDS 225
+ DN I G S +L KN + I F + L D+
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVIL------WLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187
Query: 226 NNLTGELPA-TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLT 284
NNL ELP ++ R + L NL + N K +P L
Sbjct: 188 NNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLE 243
Query: 285 GLSVLSYLDMSNNS 298
L L ++ S
Sbjct: 244 KLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 27/136 (19%), Positives = 55/136 (40%), Gaps = 7/136 (5%)
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSF 299
S V + ++ +PS+L + +L KL +G L +++S N
Sbjct: 10 SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSY 358
FS++ L + +E N I + F +P+LQ +++ + D+ +
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
Query: 359 SENLLV-NLQ-NNRIS 372
S ++ ++Q N I
Sbjct: 127 SLQKVLLDIQDNINIH 142
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 55/307 (17%), Positives = 107/307 (34%), Gaps = 41/307 (13%)
Query: 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSF 125
S + ++ + L L +LD N+ D+ G I L L+ L+ +
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG-----IEKLTGLTKLICTSNNI 76
Query: 126 SGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSP 185
+ + + L L+ +SN + + L+ L +L+ NKL ++ VS +P
Sbjct: 77 TT-LD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLDVS--QNP 127
Query: 186 GLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVV 245
L L + +N L+ I L + N +L + L +
Sbjct: 128 LLTYL------NCARNTLT-EIDVSHNT---QLTELDCHLNKKITKLD--VTPQTQLTTL 175
Query: 246 RFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVP 305
N ++ +++ +N L N +T +L L++LD S+N +E+
Sbjct: 176 DCSFNKITE---LDVSQNKLLNRLNCDTNNIT--KLDLNQNIQLTFLDCSSNKL--TEID 228
Query: 306 SWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVN 365
+ + LT L ++ L T+ +L +DL +
Sbjct: 229 --VTPLTQLTYFDCSVNPLT-ELDVSTL--SKLTTLHCIQTDLL-EIDLTHNTQLIYFQA 282
Query: 366 LQNNRIS 372
+I
Sbjct: 283 EGCRKIK 289
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 64/321 (19%), Positives = 115/321 (35%), Gaps = 48/321 (14%)
Query: 61 CTNSRVTSITLSGMG-LKG------QLSG-DITGLTELHTLDLSNNKDLRGPLPTTIGNL 112
CT++ +T++ LS L +L+ D+T LT+L L+ NK T ++
Sbjct: 71 CTSNNITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNK-------LTKLDV 123
Query: 113 KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172
+ L + C+ + + +L L + N + + L LD + NK
Sbjct: 124 SQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNK 181
Query: 173 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
+ E+ VS + L + N ++ + ++ L + SN LT E+
Sbjct: 182 IT-ELDVS--QNKLL------NRLNCDTNNIT-KLD---LNQNIQLTFLDCSSNKLT-EI 227
Query: 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYL 292
+ + L N L+ S L+ LT+ L+ L +LT + L Y
Sbjct: 228 D--VTPLTQLTYFDCSVNPLTELDVSTLSKLTT---LHCIQTDLLEI--DLTHNTQLIYF 280
Query: 293 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352
+ L L + + DL P L + + EL L
Sbjct: 281 QAEGCRKIKELD---VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL 333
Query: 353 DLGTSYSENL-LVNLQNNRIS 372
D+ S++ L ++ N I
Sbjct: 334 DV--SHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 50/281 (17%), Positives = 94/281 (33%), Gaps = 33/281 (11%)
Query: 113 KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172
++ + S L L L +++ + I L+ L L T N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN 75
Query: 173 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
+ + +S L + N+L+ ++ P L ++ D+N LT +L
Sbjct: 76 IT-TLDLS-----QNTNL---TYLACDSNKLT-NLD---VTPLTKLTYLNCDTNKLT-KL 121
Query: 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYL 292
+ L + RN+L+ S+ LT L NK ++T + L+ L
Sbjct: 122 D--VSQNPLLTYLNCARNTLTEIDVSHNTQLTE---LDCHLNKKIT-KLDVTPQTQLTTL 175
Query: 293 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352
D S N + S + L L + N+ DL L + +N+L +
Sbjct: 176 DCSFNKITELD----VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EI 227
Query: 353 DLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 392
D+ + + N ++ + L I +
Sbjct: 228 DVTPLTQLTYF--DCSVNPLTELDVSTLSKLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 32/220 (14%), Positives = 68/220 (30%), Gaps = 49/220 (22%)
Query: 83 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142
D+T LT+L D S N + L KL+ L + I L+
Sbjct: 228 DVTPLTQLTYFDCSVNPLTELD----VSTLSKLTTLHCIQTDLL-----EIDLTHNTQLI 278
Query: 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 202
+ G + + + LY LD + E+ +S +P L + + +
Sbjct: 279 YFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLS--QNPKL------VYLYLNNTE 329
Query: 203 LSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262
L+ + + L+ + + S++
Sbjct: 330 LT-ELD---------------------------VSHNTKLKSLSCVNAHIQD--FSSVGK 359
Query: 263 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDAS 302
+ ++N+ + + + MP T + + +S + D
Sbjct: 360 IPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQF 398
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 29/180 (16%), Positives = 63/180 (35%), Gaps = 14/180 (7%)
Query: 214 PDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN 273
PD + + + + + +L + +S++ + + LT + L ++
Sbjct: 16 PDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73
Query: 274 NKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLF 333
N +T +L+ + L+YL +N + + + + LT L + L D+
Sbjct: 74 NNITT--LDLSQNTNLTYLACDSNKL--TNLD--VTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 334 SIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPA-VNLTLIDNPI 392
P L + N L +D+ + L + N+ + L N I
Sbjct: 125 QNPLLTYLNCARNTLT-EIDVSHNTQLTEL-DCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 46/226 (20%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIEL 677
+ Y +G G Y +V++ + N + + +K + ++ K EI++
Sbjct: 31 EWGNQDDYQ----LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKI 83
Query: 678 LSRV-HHKNLVSLLGFCFDRGEQM--LIYEFVPNG---SLGDSLSGKNGIRLDWIRRLKI 731
L + N+++L D + L++E V N L +L+ IR
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYMY 137
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQ 790
+ + L Y H I+HRD+K N+++D E ++ D+GL++ +
Sbjct: 138 EI--LKALDYCHS-MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR 190
Query: 791 VKGTMGYLDPEYYMTQQLTEKS-DVYSFGVLMLELLTGRRPIERGK 835
V + + PE + Q+ + S D++S G ++ ++ + P G
Sbjct: 191 V-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 52/249 (20%)
Query: 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEI 675
+E K Y VGSG YG V +G+ +AIK R Q + + ++ E+
Sbjct: 20 WELPKTYV----SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-EL 74
Query: 676 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL-------DWIRR 728
LL + H+N++ LL F P SL + L D +
Sbjct: 75 LLLKHMQHENVIGLLDV------------FTPASSLRN----FYDFYLVMPFMQTDLQKI 118
Query: 729 LKIALGAA----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778
+ + +GL Y+H A ++HRD+K N+ ++E K+ DFGL++
Sbjct: 119 MGLKFSEEKIQYLVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 837
++ T+ Y PE ++ + D++S G +M E+LTG + + +GK
Sbjct: 176 ADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDY 229
Query: 838 VREIRTVMD 846
+ ++ ++
Sbjct: 230 LDQLTQILK 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 58/219 (26%), Positives = 85/219 (38%), Gaps = 50/219 (22%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRV- 681
+G G +GKV K T G L A+K E +LS
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECT------MTEKRILSLAR 81
Query: 682 HHKNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--- 737
+H L L CF +++ + EFV G L + + + AR
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ----------KSRRFDEARARFYA 130
Query: 738 -----GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQV 791
L +LH+ II+RD+K N+LLD + K+ADFG+ K + + T
Sbjct: 131 AEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATF 184
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
GT Y+ PE D ++ GVL+ E+L G P
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 38/213 (17%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGS-MQGGQEFKMEIE---LLSRVHHKNLV 687
+G G +GKV K A+K Q+ + ++ +E + E LL V H LV
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 688 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------G 738
L F F +++ + +++ G L L R AR
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQ----------RERCFLEPRARFYAAEIASA 151
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGY 797
L YLH L I++RD+K NILLD + + + DFGL K ++ + T+ GT Y
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEY 205
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
L PE Q D + G ++ E+L G P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 46/217 (21%)
Query: 636 VGSGGYGKV----YKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIE--------LLSRVHH 683
+G G +GKV +K T Q AIK ++ + ++E L H
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLM----DDDVECTMVEKRVLSLAWEH 77
Query: 684 KNLVSLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR----- 737
L + F E + + E++ G L + K L A
Sbjct: 78 PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAAE 126
Query: 738 ---GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKG 793
GL +LH I++RD+K NILLD+ + K+ADFG+ K +M K T G
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCG 180
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
T Y+ PE + Q+ D +SFGVL+ E+L G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 48/216 (22%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRVH 682
+G+G +G+V K + G A+K Q E +L V+
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVN 99
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR----- 737
LV L D ++ E+V G + L R + + AR
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----------RIGRFSEPHARFYAAQ 149
Query: 738 ---GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGT 794
YLH L +I+RD+K N+L+D++ +V DFG +K T + GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
L PE +++ + D ++ GVL+ E+ G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 46/244 (18%), Positives = 83/244 (34%), Gaps = 39/244 (15%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 140
L L L LS N +R L L+ L L + + L +L
Sbjct: 81 VNSFKHLRHLEILQLSRNH-IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLK 139
Query: 141 LLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 199
L L +N +P + +L LDL +
Sbjct: 140 ELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL---------------------------- 170
Query: 200 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN 259
+LS I E F L ++ NL E+P L+ L+ + N LS P +
Sbjct: 171 -KRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLI-KLDELDLSGNHLSAIRPGS 226
Query: 260 LNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVP-SWFSSMQSLTTL 317
L + L++ +++ N L L +++++N+ + +P F+ + L +
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL--TLLPHDLFTPLHHLERI 284
Query: 318 MMEN 321
+ +
Sbjct: 285 HLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 59/287 (20%), Positives = 103/287 (35%), Gaps = 48/287 (16%)
Query: 116 SNLMLVGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 173
+ V C +PD I + LL+L+ N S +L +L L L+ N +
Sbjct: 43 NQFSKVICVRKNLREVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 174 EGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP 233
I G GL L N+L+ +IP F L+
Sbjct: 101 R-TIE--IGAFNGLANL---NTLELFDNRLT-TIPNGAFV-------------YLS---- 136
Query: 234 ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLS-NNKLTGAMPN-LTGLSVLSY 291
L+ + N + N + S+ L L +L+ GLS L Y
Sbjct: 137 -------KLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRY 189
Query: 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNG 350
L+++ + E+P+ + + L L + +L I F + HLQ + M +++
Sbjct: 190 LNLAMCNL--REIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ- 244
Query: 351 TLDLGT-SYSENL-LVNLQNNRISAYTERGGAPAVNLTLI---DNPI 392
++ ++L +NL +N ++ P +L I NP
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 40/191 (20%), Positives = 65/191 (34%), Gaps = 11/191 (5%)
Query: 85 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144
GL L+TL+L +N+ L L KL L L + + L L L
Sbjct: 109 NGLANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167
Query: 145 NSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 203
+ LSNL +L+L L P L L++ N L
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR--------EIPNLTPLIKLDELDLSGNHL 219
Query: 204 SGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNL 263
S +I F+ M L + + + ++SL + N+L+ L
Sbjct: 220 S-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278
Query: 264 TSVNDLYLSNN 274
+ ++L +N
Sbjct: 279 HHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 36/173 (20%), Positives = 55/173 (31%), Gaps = 11/173 (6%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQEL 139
+G L++L L L NN + + L L L I + L L
Sbjct: 129 NGAFVYLSKLKELWLRNNP-IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL 187
Query: 140 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFG 199
L+L P++ L L LDL+ N L I L+ +
Sbjct: 188 RYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLS-AIRPGS-----FQGLMHLQKLWMI 239
Query: 200 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 252
++Q+ I F L+ + NNLT + LE + N
Sbjct: 240 QSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 38/213 (17%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRV-HHKNLV 687
+G G Y KV K T ++ A+K ++ + ++ + E + + +H LV
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 688 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------G 738
L CF ++ + E+V G L + R+ K+ AR
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLA 122
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGY 797
L+YLHE II+RD+K N+LLD + K+ D+G+ K + + T+ GT Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 176
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ PE + D ++ GVLM E++ GR P
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 58/329 (17%), Positives = 102/329 (31%), Gaps = 44/329 (13%)
Query: 66 VTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSF 125
V + LS + + L +L L + T L L L L F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 126 SGPIPDSI-GSLQELVLLSLNSNGF-SGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDG 182
+ L L +L+L + + L++L L L DN ++ P
Sbjct: 92 LQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP---- 146
Query: 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSL 242
+ + R N++ SI E+ N G+ L L S+
Sbjct: 147 -ASFFLNMRRFHVLDLTFNKVK-SICEEDL-------------LNFQGKHFTLLRL-SSI 190
Query: 243 EVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNS 298
+ + L N TS+ L LS N + + + L +SN+
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 299 FDASEVPS-----------WFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTN 346
S + T + + + + +FS L+ + + N
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQN 309
Query: 347 ELNGTLDLGTSYS-ENLLV-NLQNNRISA 373
E+N +D + +LL NL N + +
Sbjct: 310 EIN-KIDDNAFWGLTHLLKLNLSQNFLGS 337
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 46/277 (16%), Positives = 92/277 (33%), Gaps = 37/277 (13%)
Query: 85 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144
+ H LDL+ NK ++ + N + +L L + L +
Sbjct: 151 LNMRRFHVLDLTFNK-VKSICEEDLLNFQGKHFTLL--------------RLSSITLQDM 195
Query: 145 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH------- 197
N + +++ LDL+ N + + ++ + +
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 198 FGKNQLSGSIPEKLFR--PDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLS 253
FG F+ + + + L ++ LE + +N ++
Sbjct: 256 FGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHF-TDLEQLTLAQNEIN 312
Query: 254 GPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPS-WFSS 310
+ LT + L LS N L ++ + L L LD+S N + F
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI--RALGDQSFLG 369
Query: 311 MQSLTTLMMENTNLKGQIPADLF-SIPHLQTVVMKTN 346
+ +L L ++ LK +P +F + LQ + + TN
Sbjct: 370 LPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 51/264 (19%), Positives = 92/264 (34%), Gaps = 57/264 (21%)
Query: 43 PPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSG---DITGLTELHTLDLSNNK 99
W + CG+ + N+ +T++ LSG G K ++ D T++ +L LSN+
Sbjct: 196 NEYWLGWEKCGNPF-----KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 100 DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-G 158
++ T N K N G SG + L+ + + S+
Sbjct: 251 NMGSSFGHT--NFKDPDNFTFKGLEASG-----------VKTCDLSKSKIF-ALLKSVFS 296
Query: 159 NLSNLYWLDLTDNKLEGEIPVSDGNSPG-LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMV 217
+ ++L L L N++ +I L + +N L SI ++F
Sbjct: 297 HFTDLEQLTLAQNEIN-KID------DNAFWGLTHLLKLNLSQNFLG-SIDSRMFE---- 344
Query: 218 LIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT 277
NL LEV+ N + + L ++ +L L N+L
Sbjct: 345 ---------NLD-----------KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384
Query: 278 GAMPN-LTGLSVLSYLDMSNNSFD 300
L+ L + + N +D
Sbjct: 385 SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 26/139 (18%), Positives = 54/139 (38%), Gaps = 7/139 (5%)
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNS 298
+ V NS++ ++ + L + L + + N GLS L L + N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 299 FDASEVPSWFSSMQSLTTLMMENTNLKG-QIPADLFS-IPHLQTVVMKTNELNGTLDLGT 356
F E F+ + +L L + NL G + + F + L+ +V++ N +
Sbjct: 91 FLQLE-TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 357 SYSENLL--VNLQNNRISA 373
+ ++L N++ +
Sbjct: 150 FLNMRRFHVLDLTFNKVKS 168
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 60/222 (27%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIK---------RAQQGSMQGGQEFKMEIELLSRVH 682
+G+G +G+V+ + G+ A+K Q E +LS V
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHT------NDERLMLSIVT 64
Query: 683 HKNLVSLLGFCF-DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLK----------- 730
H ++ + F D + +I +++ G L +R+ +
Sbjct: 65 HPFIIRMW-GTFQDAQQIFMIMDYIEGGEL-----------FSLLRKSQRFPNPVAKFYA 112
Query: 731 --IALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
+ L L YLH II+RD+K NILLD+ + K+ DFG +K +T
Sbjct: 113 AEVCLA----LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVT 160
Query: 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ GT Y+ PE T+ + D +SFG+L+ E+L G P
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 38/213 (17%)
Query: 636 VGSGGYGKVY----KGTLPNGQLIAIKRAQQGSMQGGQEF---KMEIELLSRV-HHKNLV 687
+G G Y KV K T ++ A++ ++ + ++ + E + + +H LV
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 688 SLLGFCFDRGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR--------G 738
L CF ++ + E+V G L + R+ K+ AR
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----------RQRKLPEEHARFYSAEISLA 165
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK-SMSDSEKDHITTQVKGTMGY 797
L+YLHE II+RD+K N+LLD + K+ D+G+ K + + T+ GT Y
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 219
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ PE + D ++ GVLM E++ GR P
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 49/243 (20%)
Query: 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVH 682
+ D VGSG YG V G +AIK R Q + + ++ E+ LL +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGI------------------RLD 724
H+N++ L+ F P+ +L D +L
Sbjct: 83 HENVIG------------LLDVFTPDETLDDF----TDFYLVMPFMGTDLGKLMKHEKLG 126
Query: 725 WIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784
R + +GL Y+H A IIHRD+K N+ ++E K+ DFGL++
Sbjct: 127 EDRIQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183
Query: 785 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843
++ T+ Y PE + + T+ D++S G +M E++TG + + +G + +++
Sbjct: 184 GYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKE 237
Query: 844 VMD 846
+M
Sbjct: 238 IMK 240
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-15
Identities = 55/308 (17%), Positives = 106/308 (34%), Gaps = 17/308 (5%)
Query: 80 LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 139
+ + LT+L L LS K + L L LV G +S+
Sbjct: 138 VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-T 196
Query: 140 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE-IPVSDGNSPGLDMLVRAKHFHF 198
+L L + S +++ L L L++ KL E L +
Sbjct: 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256
Query: 199 GKNQLSGSIPEKLFRP--DMVLIHVLFDSNNLTG-----ELPATLGLVKSLEVVRFDRNS 251
+ + KLF+ + ++ + +T E + +KSL +
Sbjct: 257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316
Query: 252 LSGPVPSNLNNLTSVNDLYLSNNKLTG-AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSS 310
+ + +N LS + M S ++L+ + N F V S+
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCST 375
Query: 311 MQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN----GTLDLGTSYSENLLV-N 365
++ L TL+++ LK ++ ++ LN D +++E++LV N
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 366 LQNNRISA 373
L +N ++
Sbjct: 435 LSSNMLTG 442
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 43/243 (17%), Positives = 86/243 (35%), Gaps = 21/243 (8%)
Query: 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVG-- 122
+ ++T++ + + + T L L + N +++ ML
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQ-VFLFSKEALYSVFAEMNIKMLSISD 340
Query: 123 -CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 181
P S S L + N F+ V L L L L N L+
Sbjct: 341 TPFIHMVCPPSPSSFTFL---NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVA 396
Query: 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKS 241
+ + L + N L+ ++ ++ + SN LTG L
Sbjct: 397 LMTKNMSSL---ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS--VFRCLPPK 451
Query: 242 LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNN 297
++V+ N + +P ++ +L ++ +L +++N+L G LT L Y+ + +N
Sbjct: 452 VKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLT---SLQYIWLHDN 507
Query: 298 SFD 300
+D
Sbjct: 508 PWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 49/285 (17%), Positives = 94/285 (32%), Gaps = 22/285 (7%)
Query: 48 NNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDI------TGLTELHTLDLSNNKDL 101
N + + ++TL + + S + + L+ +L+ + +
Sbjct: 233 ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERI 292
Query: 102 RGPLPTTIGN-LKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNL 160
T LK L + F E+ + L+ + +
Sbjct: 293 DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSP 352
Query: 161 SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPD--MVL 218
S+ +L+ T N +D G L R + +N L + + L
Sbjct: 353 SSFTFLNFTQNVF------TDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSL 405
Query: 219 IHVLFDSNNLT-GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT 277
+ N+L T +S+ V+ N L+G V L V L L NN++
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463
Query: 278 GAMPNLTGLSVLSYLDMSNNSFDASEVP-SWFSSMQSLTTLMMEN 321
++T L L L++++N VP F + SL + + +
Sbjct: 464 SIPKDVTHLQALQELNVASNQL--KSVPDGVFDRLTSLQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 52/347 (14%), Positives = 111/347 (31%), Gaps = 52/347 (14%)
Query: 67 TSITLSGMGLKGQLSGDITGLTELHT----LDLSNNKDLRGPLPT-TIGNLKKLSNLMLV 121
T + LS + D+ + LH LDL + G + I N L +
Sbjct: 149 TFLGLSAAKFR---QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205
Query: 122 GCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPS----IGNLSNLYWLDLTDNKLEGEI 177
FS + S+ +L L L ++ N + + + + L + L + +
Sbjct: 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265
Query: 178 PVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVL--------------- 222
V + ++ + ++ I + F + L
Sbjct: 266 SVKLFQFFWPRPV---EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 223 --FDS-----------NNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDL 269
+ ++ S + F +N + V + L + L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 270 YLSNNKLTGAMPN----LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325
L N L +S L LD+S NS ++ + +S+ L + + L
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
Query: 326 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRI 371
G + L P ++ + + N + ++ ++ + L N+ +N++
Sbjct: 442 GSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 59/355 (16%), Positives = 111/355 (31%), Gaps = 58/355 (16%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTI-GNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 139
DI+ L+EL L LS+N+ +R L + + L L + I + L
Sbjct: 69 MPDISFLSELRVLRLSHNR-IRS-LDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASL 123
Query: 140 VLLSLNSNGFSGRVPPS--IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 197
L L+ N F +P GNL+ L +L L+ K P + +
Sbjct: 124 RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-----QLDLLPVAHLHLSCILLD 177
Query: 198 FGKNQLSGSIPEKLFRPDMVLIHVLFDSNNL---------------------------TG 230
+ G E L P+ ++H++F N+L
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237
Query: 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND-----LYLSNNKLTGAMP---- 281
+ L + ++ + ++ L + N +T +
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297
Query: 282 --NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIP-HL 338
+ T L L + N F S+ + +S + M+ ++ I P
Sbjct: 298 TYSETALKSLMIEHVKNQVFLFSK-EALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSF 355
Query: 339 QTVVMKTNELNGTLDLGTSYSENL-LVNLQNNRISAYTERGGAPA--VNLTLIDN 390
+ N ++ G S + L + LQ N + + + +L +D
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 45/324 (13%), Positives = 96/324 (29%), Gaps = 26/324 (8%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120
+N + + S L + D+ L LS N + I L +L L L
Sbjct: 28 FSNELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNS-ISELRMPDISFLSELRVLRL 83
Query: 121 VGCSFSGPIPDSI-GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPV 179
+ + Q+L L ++ N + +++L LDL+ N +
Sbjct: 84 SHNRIRS-LDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFD----- 134
Query: 180 SDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV 239
L + + + + I + S ++ G +L +
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194
Query: 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA--------MPNLTGLSVLSY 291
+ + + V N+ ++ ++ L LSN KL + LT L
Sbjct: 195 NTTVLHLVFHPNSLFSVQVNM-SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLN 253
Query: 292 LDMSNNSFDASEVPSWFSSMQ--SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL- 348
+ + + F + L + N + +I + F+ + +
Sbjct: 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313
Query: 349 NGTLDLGTSYSENLLVNLQNNRIS 372
N ++ + +S
Sbjct: 314 NQVFLFSKEALYSVFAEMNIKMLS 337
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 40/284 (14%), Positives = 96/284 (33%), Gaps = 25/284 (8%)
Query: 223 FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN 282
N+++ + + L V+R N + + L +S+N+L +
Sbjct: 59 LSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS- 116
Query: 283 LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVV 342
++ L +LD+S N FD V F ++ LT L + + DL + HL
Sbjct: 117 CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSC 173
Query: 343 MKTNELNGTLDLGTSYSENL-------LVNLQNNRISAYTERGGAPAVNLTLIDNPICQE 395
+ + ++ + G + S + LV N+ S +L L + +
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL--- 230
Query: 396 LGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLG 455
+ +L +S + + + + + + V L+ +L
Sbjct: 231 --NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV-EYLNIYNL- 286
Query: 456 NTTYYEILEQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSI 499
+ + + + + + S+ + + F + + ++
Sbjct: 287 ------TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 54/263 (20%), Positives = 97/263 (36%), Gaps = 65/263 (24%)
Query: 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK---RAQQGSMQGGQEFKME 674
+ Y + +G G YG VY + +AIK R + + + + E
Sbjct: 21 NVHVPDNYI----IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-E 75
Query: 675 IELLSRVHHKNLVSLL-------GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIR 727
I +L+R+ ++ L FD E ++ E + D L +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFD--ELYIVLEIADS----D---------LKKLF 120
Query: 728 RLKIALGAA----------RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777
+ I L G +++HE + IIHRD+K +N LL++ + KV DFGL++
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE--------------------KS-DVYS 816
+++ + +I ++ + +QLT KS D++S
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 817 FGVLMLELLTGRRPIERGKYIVR 839
G + ELL +
Sbjct: 238 TGCIFAELLNMLQSHINDPTNRF 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 55/342 (16%), Positives = 112/342 (32%), Gaps = 80/342 (23%)
Query: 577 AGVYAYHQKRRAEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDV 636
+ A ++ + + + A + + + + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKM-------EIELLSRVHHKNLVS 688
G+G YG V + +++AIK+ + E + EI +L+R++H ++V
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKK-----ILRVFEDLIDCKRILREIAILNRLNHDHVVK 116
Query: 689 LLG-FCFDRGEQM----LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA------- 736
+L E+ ++ E + D + R + L
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS----D---------FKKLFRTPVYLTELHIKTLLY 163
Query: 737 ---RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
G+ Y+H A I+HRD+K +N L+++ + KV DFGL++++ E + +
Sbjct: 164 NLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 794 T-----MGYLDPEYYMTQQLTE--------------------KS-DVYSFGVLMLELLT- 826
+ + +QLT ++ DV+S G + ELL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 827 ---------GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
R P+ G ++ D
Sbjct: 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD 322
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 51/304 (16%), Positives = 78/304 (25%), Gaps = 37/304 (12%)
Query: 49 NDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSG-----------DITGLTELHTLDLSN 97
+DP D C + + G L+ L DI L L +
Sbjct: 18 SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRA 77
Query: 98 NK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPP 155
+ + + L L L +G P + L LN S
Sbjct: 78 ARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRD 137
Query: 156 SIGN------LSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG--SI 207
+ L L + P L N G +
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL------STLDLSDNPELGERGL 191
Query: 208 PEKLFRPDMVLIHVLFDSNN----LTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNN 262
L + VL N +G A L+ + NSL + +
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 263 LTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322
+ +N L LS L L + LS LD+S N PS + + L ++
Sbjct: 252 PSQLNSLNLSFTGLKQVPKGL--PAKLSVLDLSYNRL--DRNPS-PDELPQVGNLSLKGN 306
Query: 323 NLKG 326
Sbjct: 307 PFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 41/249 (16%), Positives = 77/249 (30%), Gaps = 21/249 (8%)
Query: 135 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 194
SL+ L + + + +S L L L + ++ G P + G D+
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL----N 124
Query: 195 HFHFGKNQLSG--SIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDRNS 251
+ + + +L + + VL + + + + +L + N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 252 LSGPVPSN----LNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFDASE 303
G ++ L L N + L LD+S+NS +
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 304 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYS-ENL 362
L +L + T LK Q+P L L + + N L+ NL
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPSPDELPQVGNL 301
Query: 363 LVNLQNNRI 371
+L+ N
Sbjct: 302 --SLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 45/267 (16%), Positives = 77/267 (28%), Gaps = 32/267 (11%)
Query: 123 CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 182
C+FS P PD + L + G G S Y L D + +
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYG---------GGRSLEYLLKRVDTEADLGQFTDII 65
Query: 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMV--LIHVLFDSNNLTGELPATLGLV- 239
S + K ++ I R + L + ++ +TG P L
Sbjct: 66 KS------LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119
Query: 240 -KSLEVVRFDRNSLSGPVP--SNLNNL--TSVNDLYLSNNKLTGAMPNLTG-LSVLSYLD 293
L ++ S + + L + L ++ LS LD
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 294 MSNN------SFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 347
+S+N ++ P F ++Q L G A + LQ + + N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 348 LNGTLDLGT-SYSENLLV-NLQNNRIS 372
L + + L NL +
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 38/236 (16%), Positives = 59/236 (25%), Gaps = 49/236 (20%)
Query: 56 WEGIGCTNSRVTSITLSGMGLKGQLS--GDITGL--TELHTLDLSNNKDLRGPLPTTIGN 111
+ T + + L + + + ++ L L ++ L +
Sbjct: 113 PPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ-VRV 171
Query: 112 LKKLSNLMLVGCSFSGPI-------PDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 164
LS L L G P +LQ L L + SG L
Sbjct: 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231
Query: 165 WLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD 224
LDL N L + L +
Sbjct: 232 GLDL------------------------------SHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 225 SNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNNKLTGA 279
L ++P GL L V+ N L P P L + + L L N +
Sbjct: 262 FTGLK-QVPK--GLPAKLSVLDLSYNRLDRNPSPDELPQVGN---LSLKGNPFLDS 311
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 29/197 (14%), Positives = 65/197 (32%), Gaps = 21/197 (10%)
Query: 129 IPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188
IPDS + + + L + + + +++L ++ L + + + G++
Sbjct: 17 IPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT--------DLTGIE 63
Query: 189 MLVRAKHFHFGKNQLSGSIP-EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 247
K + P L L + ++T + L + SL ++
Sbjct: 64 YAHNIKDLTINNIHATNYNPISGLSN----LERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 248 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSW 307
++ + + +N L VN + LS N + L L L L++ +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY---RG 176
Query: 308 FSSMQSLTTLMMENTNL 324
L L + +
Sbjct: 177 IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 23/110 (20%), Positives = 44/110 (40%), Gaps = 9/110 (8%)
Query: 66 VTSITLSGMGLKGQLSGDITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGC 123
+T ITL+ + + L+G I + L ++N + I L L L ++G
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNY-----NPISGLSNLERLRIMGK 98
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 173
+ ++ L L LL ++ + + I L + +DL+ N
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 30/207 (14%), Positives = 64/207 (30%), Gaps = 45/207 (21%)
Query: 76 LKGQLSGDIT--GLTELHTLDLSNN--KDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD 131
L + +IT + L + L+N DL G I + +L + + P
Sbjct: 30 LGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHATNYNP- 83
Query: 132 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 191
I L L L + + P++ L++L LD++ + + I P ++ +
Sbjct: 84 -ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142
Query: 192 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 251
N ++ L + L+ + +
Sbjct: 143 -------------------------------LSYNGAITDIMP-LKTLPELKSLNIQFDG 170
Query: 252 LSGPVPSNLNNLTSVNDLYLSNNKLTG 278
+ + + +N LY + + G
Sbjct: 171 VHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 18/135 (13%), Positives = 51/135 (37%), Gaps = 9/135 (6%)
Query: 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 299
K+ ++S + + +N+LT + L+N +T + + + L ++N
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTY---ITLANINVTD-LTGIEYAHNIKDLTINNIHA 78
Query: 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYS 359
+ S + +L L + ++ +L + L + + + + ++ +
Sbjct: 79 ---TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 360 ENLLV-NLQ-NNRIS 372
+ +L N I+
Sbjct: 136 PKVNSIDLSYNGAIT 150
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 4e-14
Identities = 49/327 (14%), Positives = 106/327 (32%), Gaps = 42/327 (12%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI------------ 133
L LDLS N P+ GN+ +L L L I
Sbjct: 88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
Query: 134 ----------GSLQELVLLSL-----NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP 178
LQ+ SL + F + S+ ++NL ++ + +
Sbjct: 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 179 VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRP-------DMVLIHVLFDSNNLTGE 231
L + + + + + ++ + + +V +
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 232 LPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG-AMPNLTGLSVLS 290
+ +K+L + + + P +++N + + M + +S
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327
Query: 291 YLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP--ADLF-SIPHLQTVVMKTNE 347
+LD SNN V + L TL+++ LK ++ A++ + LQ + + N
Sbjct: 328 HLDFSNNLL-TDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNS 385
Query: 348 LNGTLDLGTSYS-ENLLV-NLQNNRIS 372
++ G ++LL N+ +N ++
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 6e-13
Identities = 52/301 (17%), Positives = 109/301 (36%), Gaps = 23/301 (7%)
Query: 87 LTELHTLDLSNNKDLRGPLPTTIGNLKKLS------NLMLVGCSFSGPIPDSIGSLQELV 140
LH + +N + L ++ + L L CS+ I + + +L
Sbjct: 165 TESLHIVFPTNK-EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223
Query: 141 LLSLNSNGFSGRVPPSIGNL---SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFH 197
L+LN+ + I L + +++ +++ KL+G++ D + G L
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS-LKALSIHQ 282
Query: 198 FGKNQLSGSIPEKLFRPDMVLIHVL-FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPV 256
+ ++ +++ F + + + F N L+ V
Sbjct: 283 VVSDVFG-FPQSYIYE-IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTV 340
Query: 257 PSNLNNLTSVNDLYLSNNKLTGAMPNLTG----LSVLSYLDMSNNSFDASEVPSWFSSMQ 312
N +LT + L L N+L + + + L LD+S NS E S +
Sbjct: 341 FENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 313 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV-NLQNNRI 371
SL +L M + L P ++ + + +N++ ++ E L N+ +N++
Sbjct: 400 SLLSLNMSSNILT-DTIFRCLP-PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
Query: 372 S 372
Sbjct: 457 K 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 43/297 (14%), Positives = 89/297 (29%), Gaps = 21/297 (7%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 147
+ L++S N + + I +L KL L++ QEL L L+ N
Sbjct: 21 QKTTILNISQNY-ISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 148 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 207
S NL LDL+ N + + + + K L S
Sbjct: 80 KLVK---ISCHPTVNLKHLDLSFNAFD-----ALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 208 PEKLFRPDMVLIHVLFDSNNLTGELPATLG--LVKSLEVVRFDRNSLSGPVPSNLNNLTS 265
+ ++ + ++ E P L +SL +V + ++ + +
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 266 VNDLYLSNNKLTGAM-------PNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ--SLTT 316
+ + L LS L ++N + + ++
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 317 LMMENTNLKGQIPADLFSIPHLQTVVMKTNEL-NGTLDLGTSYSENLLVNLQNNRIS 372
+ N L+GQ+ F + +++ + SY + N+ +
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 55/312 (17%), Positives = 112/312 (35%), Gaps = 30/312 (9%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 140
+ DI L++L L +S+N+ ++ + ++L L L +L+
Sbjct: 38 TSDILSLSKLRILIISHNR-IQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKH-- 94
Query: 141 LLSLNSNGFSGRVPPS--IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 198
L L+ N F +P GN+S L +L L+ LE + + +L
Sbjct: 95 -LDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL-----LVL 147
Query: 199 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP-------ATLGLVKSLEVVRFDRNS 251
G+ PE L + +H++F +N + A L L V+ ++ S
Sbjct: 148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 252 LSGPVPSNLNNLTSVNDLYLSNNKLTG----AMPNLTGLSVLSYLDMSNNSFDASEVPSW 307
+ + L +++L L+N + T + L + + Y +SN
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 308 FS----SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENL 362
F S+++L+ + + + ++ I + T + + S
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGF-PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 363 LV-NLQNNRISA 373
L + NN ++
Sbjct: 327 LHLDFSNNLLTD 338
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 36/242 (14%), Positives = 76/242 (31%), Gaps = 65/242 (26%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
S + + G + + ++ LD SNN L++
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN---------------LLTDT----- 339
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG---NLSNLYWLDLTDNKLEGEIPVS 180
+ ++ G L EL L L N + + +L LD++ N +
Sbjct: 340 -----VFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVS-----Y 388
Query: 181 DGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVK 240
D + N L+ +I L
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--------------------------- 421
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNS 298
++V+ N + +P + L ++ +L +++N+L ++P+ L+ L + + N
Sbjct: 422 RIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNP 479
Query: 299 FD 300
+D
Sbjct: 480 WD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 40/281 (14%), Positives = 82/281 (29%), Gaps = 17/281 (6%)
Query: 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL 283
N ++ + + + L ++ N + S + L LS+NKL +
Sbjct: 29 SQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI--SC 86
Query: 284 TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVM 343
L +LD+S N+FDA + F +M L L + T+L+ + + ++ V++
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHLNISKVLL 145
Query: 344 KTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYC 403
E G + + +L + T+ + + +
Sbjct: 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 404 QLSQPISPYSTKQKNCLPAPCNANQSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEIL 463
+ L N ++ N R L Y+ I
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNS----------FIRILQLVWHTTVWYFSIS 255
Query: 464 EQSVTTSFQSTYKLPIDSISLSNPHKNNFEYLELSIQFFPS 504
Q S ++ + + + FP
Sbjct: 256 NV----KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 42/209 (20%), Positives = 74/209 (35%), Gaps = 53/209 (25%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCF 694
G G GKV + + A+K +Q + + E+EL R ++V ++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVYE 81
Query: 695 DRGEQM----LIYEFVPNGSLGDSLSGKNGIRL------DWIRRLKIALGAARGLSYLHE 744
+ ++ E + G L + + + ++ + + YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI------GEAIQYLHS 135
Query: 745 LANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
+ I HRD+K N+L K+ DFG +K + G Y
Sbjct: 136 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTGE-KY---- 175
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
+ D++S GV+M LL G P
Sbjct: 176 -------DKSCDMWSLGVIMYILLCGYPP 197
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 49/289 (16%), Positives = 100/289 (34%), Gaps = 52/289 (17%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 145
L + + T +L ++ L G + + + L L+ L L
Sbjct: 17 ALANAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 146 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG 205
N + + P + NL+ + L+L+ N L+ N + L K Q++
Sbjct: 72 DNQIT-DLAP-LKNLTKITELELSGNPLK--------NVSAIAGLQSIKTLDLTSTQITD 121
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 265
P L + +L+V+ D N ++ S L LT+
Sbjct: 122 VTP---------------------------LAGLSNLQVLYLDLNQIT--NISPLAGLTN 152
Query: 266 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325
+ L + N +++ + L LS L+ L +N S++ +S+ +L + ++N +
Sbjct: 153 LQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI--SDISP-LASLPNLIEVHLKNNQIS 208
Query: 326 GQIPADLFSIPHLQTVVMKTNEL--NGTLDLGTSYSENLLVNLQNNRIS 372
P L + +L V + + N++ I+
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA 255
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 59/257 (22%), Positives = 104/257 (40%), Gaps = 56/257 (21%)
Query: 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIE 676
+ + + +G G YG V T P G+++AIK + + + EI+
Sbjct: 7 YNISSDFQL----KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIK 61
Query: 677 LLSRVHHKNLVSLLG-FCFDRGEQM----LIYEFVP--------NGSLGDSLSGKNGIRL 723
+L H+N++++ D E +I E + L D +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD-------DHI 114
Query: 724 DWI-----RRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778
+ R +K LH +N +IHRD+K SN+L++ + KV DFGL++
Sbjct: 115 QYFIYQTLRAVK----------VLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 779 MSDSEKDHITTQVKG--------TMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRR 829
+ +S D+ + T Y PE +T + + DV+S G ++ EL RR
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RR 220
Query: 830 PIERGKYIVREIRTVMD 846
PI G+ ++ +
Sbjct: 221 PIFPGRDYRHQLLLIFG 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 37/113 (32%), Positives = 63/113 (55%), Gaps = 8/113 (7%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD--SEKDHITTQVKGT 794
RGL Y+H AN ++HRD+K SN+LL+ + K+ DFGL++ +T V T
Sbjct: 139 RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-AT 194
Query: 795 MGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
Y PE + + T+ D++S G ++ E+L+ RPI GK+ + ++ ++
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILG 246
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 36/111 (32%), Positives = 61/111 (54%), Gaps = 10/111 (9%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
RGL Y+H A+ IIHRD+K SN+ ++E K+ DFGL++ +D ++ T+
Sbjct: 143 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 797 YLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
Y PE + + D++S G +M ELLTG R + G + +++ ++
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILR 244
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 46/215 (21%), Positives = 75/215 (34%), Gaps = 39/215 (18%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG-PIPDSIGSLQELVLLSLNS 146
+ L LS N L T+ +L+ L L + + ++ L L L+
Sbjct: 31 KDTTILHLSENL-LYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL---DLSH 86
Query: 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQLSG 205
N +P L L LD++ N+L +P G L + + N+L
Sbjct: 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLP------LGALRGLGELQELYLKGNELK- 137
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS 265
++P L P L + +NNLT ELPA L + L +
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL----------LN-------------GLEN 173
Query: 266 VNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFD 300
++ L L N L G +L + + N +
Sbjct: 174 LDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 56/292 (19%), Positives = 98/292 (33%), Gaps = 38/292 (13%)
Query: 86 GLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGC---SFSGPIPDSIGSLQELV 140
E +L D T L + ++ S G I L +
Sbjct: 19 AFAETIKDNLKKKSVTDA-----VTQNELNSIDQIIANNSDIKSVQG-----IQYLPNVT 68
Query: 141 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200
L LN N + + P + NL NL WL L +NK++ ++ L L + K
Sbjct: 69 KLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-------SSLKDLKKLKSLSLEH 118
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
N +S I L + + L+ NN ++ L L+ + + N +S L
Sbjct: 119 NGIS-DI-NGL--VHLPQLESLYLGNNKITDITVLSRL-TKLDTLSLEDNQISD--IVPL 171
Query: 261 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320
LT + +LYLS N ++ + L GL L L++ + ++ + S++ T+
Sbjct: 172 AGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQEC-LNKPINHQSNLVVPNTV--- 226
Query: 321 NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 372
N G + S+ V + +
Sbjct: 227 -KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 5e-11
Identities = 47/347 (13%), Positives = 110/347 (31%), Gaps = 32/347 (9%)
Query: 135 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 194
+ E + +L + V L+++ + ++ ++ + G+ L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--------SVQGIQYLPNVT 68
Query: 195 HFHFGKNQLSGSIP--EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 252
N+L+ I L L + D N + +L + L K L+ + + N +
Sbjct: 69 KLFLNGNKLT-DIKPLTNLKN----LGWLFLDENKIK-DLSSLKDLKK-LKSLSLEHNGI 121
Query: 253 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQ 312
S + L +L + LYL NNK+T + L+ L+ L L + +N S++ + +
Sbjct: 122 S--DINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI--SDIVP-LAGLT 175
Query: 313 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL--NGTLDLGTSYSENLLVNLQNNR 370
L L + ++ + A L + +L + + + E N + N +
Sbjct: 176 KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
Query: 371 ISAYTERGGAPAVNLTLIDNPICQELG---TAKGYCQLSQPISPYSTKQKNCLPAPCNAN 427
++ + + + + + + + L +
Sbjct: 234 VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVS 293
Query: 428 QSSSPNCQCAYPYTGTLVFRSLSFSDLGNTTYYEILEQSVTTSFQST 474
GT + + G E++ +
Sbjct: 294 YDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFN 340
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 26/103 (25%), Positives = 42/103 (40%), Gaps = 9/103 (8%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQELVL 141
++ LT+L TL L +N+ + I L L+ L + S + I D ++ L+ L +
Sbjct: 149 LSRLTKLDTLSLEDNQ------ISDIVPLAGLTKLQNLYLSKN-HISDLRALAGLKNLDV 201
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS 184
L L S + NL + TD L +SD
Sbjct: 202 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD 244
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 34/114 (29%), Positives = 66/114 (57%), Gaps = 9/114 (7%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMS--DSEKDHITTQVKG 793
RGL Y+H AN ++HRD+K +N+ ++ E L K+ DFGL++ M S K H++ +
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL-V 186
Query: 794 TMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846
T Y P ++ T+ D+++ G + E+LTG + + G + + +++ +++
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHELEQMQLILE 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 45/276 (16%), Positives = 82/276 (29%), Gaps = 71/276 (25%)
Query: 61 CTNSRVTSI----------TLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIG 110
T + I L L+ S + L + + +S + L +
Sbjct: 18 VTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTL-----QQLE 72
Query: 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLT 169
+ SF L ++ + + + + P L L +L +
Sbjct: 73 SH-----------SFYN--------LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 170 DNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT 229
+ L+ P + + N SIP F+
Sbjct: 114 NTGLK-MFP----DLTKVYSTDIFFILEITDNPYMTSIPVNAFQ---------------- 152
Query: 230 GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGL- 286
GL ++ N + V N T ++ +YL+ NK + G+
Sbjct: 153 -------GLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 287 SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322
S S LD+S S + +PS ++ L L+ NT
Sbjct: 205 SGPSLLDVSQTSV--TALPS--KGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 9/137 (6%)
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSF 299
E R + +PS + + L L L + + L +S + +S +
Sbjct: 12 QEEDFRVTCKDIQR-IPSLPPSTQT---LKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLGTSY 358
F ++ +T + + NT I D +P L+ + + L DL Y
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVY 127
Query: 359 SENLLVNL---QNNRIS 372
S ++ L N ++
Sbjct: 128 STDIFFILEITDNPYMT 144
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 24/161 (14%), Positives = 51/161 (31%), Gaps = 16/161 (9%)
Query: 223 FDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPSNL-NNLTSVNDLYLSNNKLTGA 279
+L +P+ L ++ + + + S+ NL+ V + + N +
Sbjct: 38 LIETHLR-TIPSHAFSNL-PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY 95
Query: 280 MPN--LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS--I 335
+ L L +L +L + N + S L + + IP + F
Sbjct: 96 IDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155
Query: 336 PHLQTVVMKTNEL----NGTLDLGTSYSENLLVNLQNNRIS 372
T+ + N + GT L +N ++
Sbjct: 156 NETLTLKLYNNGFTSVQGYAFN-GTKLDAVYL--NKNKYLT 193
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 31/119 (26%), Positives = 53/119 (44%), Gaps = 24/119 (20%)
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMG 796
+ + YLH ++HRD+K SNILL+ + KVADFGLS+S + + +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 797 YLDPEY---YMT-----------------QQLTEKSDVYSFGVLMLELLTGRRPIERGK 835
+ + +T + T+ D++S G ++ E+L +PI G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFPGS 234
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 7e-12
Identities = 38/285 (13%), Positives = 77/285 (27%), Gaps = 65/285 (22%)
Query: 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIK--------RAQQGSMQGGQ 669
F T +G G +G+V++ + +AIK + +
Sbjct: 11 VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 670 EFKMEIELLSRVH---------HKNLVSLLGFCFDRGE---------------------- 698
E EI + + + + L +G
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 699 --------QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
++ EF G + + K I L+
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--F 183
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
HRD+ N+LL + K+ KS + + + Y +++ +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID---------YTLSRLERD 234
Query: 811 KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855
V+ + +L TG + Y R ++ + + Y+ Y
Sbjct: 235 GIVVFCDVSMDEDLFTGDGDYQFDIY--RLMKKENNNRWGEYHPY 277
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 55/291 (18%), Positives = 101/291 (34%), Gaps = 61/291 (20%)
Query: 86 GLTELHTLDLSNN--KDLRGPLPTTIGNLKKLSNLMLVGC---SFSGPIPDSIGSLQELV 140
E +L D T L + ++ S G I L +
Sbjct: 22 AFAETIKDNLKKKSVTDA-----VTQNELNSIDQIIANNSDIKSVQG-----IQYLPNVT 71
Query: 141 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200
L LN N + + P + NL NL WL L +NK++ + L L + K
Sbjct: 72 KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK--------DLSSLKDLKKLKSLSLEH 121
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
N +S ++ G L + LE + N ++ + L
Sbjct: 122 NGIS----------------------DING-----LVHLPQLESLYLGNNKITD--ITVL 152
Query: 261 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320
+ LT ++ L L +N+++ + L GL+ L L +S N S++ + + +++L L +
Sbjct: 153 SRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI--SDLRA-LAGLKNLDVLELF 208
Query: 321 N---TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQN 368
+ N ++L ++ D G N+ +L
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 45/264 (17%), Positives = 90/264 (34%), Gaps = 49/264 (18%)
Query: 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 170
+ L S + + L + + N++ V I L N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 171 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 230
NKL + L L +N++ D ++L
Sbjct: 78 NKLT--------DIKPLANLKNLGWLFLDENKVK-------------------DLSSLKD 110
Query: 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLS 290
+K L+ + + N +S + L +L + LYL NNK+T + L+ L+ L
Sbjct: 111 --------LKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLD 159
Query: 291 YLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL-- 348
L + +N S++ + + L L + ++ + A L + +L + + + E
Sbjct: 160 TLSLEDNQI--SDIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLN 214
Query: 349 NGTLDLGTSYSENLLVNLQNNRIS 372
N + N + ++
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVT 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 39/197 (19%), Positives = 69/197 (35%), Gaps = 46/197 (23%)
Query: 83 DITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELV 140
+ L L L L NK DL + +LKKL +L L S + + L +L
Sbjct: 85 PLANLKNLGWLFLDENKVKDLSS-----LKDLKKLKSLSLEHNGIS--DINGLVHLPQLE 137
Query: 141 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200
L L +N + + L+ L L L DN++ + L L + ++ + K
Sbjct: 138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS--------DIVPLAGLTKLQNLYLSK 187
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
N +S + L +K+L+V+ ++
Sbjct: 188 NHIS-DLRA--------------------------LAGLKNLDVLELFSQECLNKPINHQ 220
Query: 261 NNLTSVNDLYLSNNKLT 277
+NL N + ++ L
Sbjct: 221 SNLVVPNTVKNTDGSLV 237
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 49/223 (21%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVH----------- 682
G G + V+ + N +A+K R + + + EI+LL RV+
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDSMG 84
Query: 683 HKNLVSLLGFCFD-RGEQM----LIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKI 731
+++ LL F+ +G +++E LG++L GI L +++ +I
Sbjct: 85 ANHILKLLDH-FNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVK--QI 136
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDE------RLNAKVADFGLSKSMSDSEKD 785
+ GL Y+H IIH DIK N+L++ + K+AD G + +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG----NACWYDE 190
Query: 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR 828
H T ++ T Y PE + +D++S L+ EL+TG
Sbjct: 191 HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 33/210 (15%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRV------HHKNL 686
+G G +G+V K + +AIK + ++ + Q +E+ LL + +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKYYI 118
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGLS 740
V L R L++E L +L + G+ L+ R K A L
Sbjct: 119 VHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTR--KFAQQMCTALL 171
Query: 741 YLHELANPPIIHRDIKSSNILL--DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
+L IIH D+K NILL +R K+ DFG S I ++ + Y
Sbjct: 172 FLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQYIQ-SRFYR 225
Query: 799 DPEYYMTQQLTEKSDVYSFGVLMLELLTGR 828
PE + D++S G +++E+ TG
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 40/203 (19%), Positives = 70/203 (34%), Gaps = 22/203 (10%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVG---CSFSGPIPDSIGSLQ 137
S EL LDLS + ++ +L LS L+L G S + + SLQ
Sbjct: 45 SYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103
Query: 138 ELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKH 195
+ L + + G+L L L++ N ++ P L +H
Sbjct: 104 K---LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFK-----LPEYFSNLTNLEH 153
Query: 196 FHFGKNQLSGSIPEKLFRP----DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS 251
N++ SI R ++ + + N + + L+ + D N
Sbjct: 154 LDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQ 211
Query: 252 LSGPVPSNLNNLTSVNDLYLSNN 274
L + LTS+ ++L N
Sbjct: 212 LKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 32/205 (15%), Positives = 71/205 (34%), Gaps = 21/205 (10%)
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPS 258
N L + F L + + + L L + N + +
Sbjct: 38 NPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS-HLSTLILTGNPIQS-LAL 93
Query: 259 NL-NNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 315
+ L+S+ L L ++ N + L L L++++N + ++P +FS++ +L
Sbjct: 94 GAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 316 TLMMENTNLKGQIPADLF-SIPHLQTVVMK----TNELNGTLDLGTSYSENLLV-NLQNN 369
L + + ++ I + + + + N +N + G L L N
Sbjct: 153 HLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN 210
Query: 370 RISAYTERGGAPAVNLTLI---DNP 391
++ + + +L I NP
Sbjct: 211 QLKSVPDGIFDRLTSLQKIWLHTNP 235
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 40/206 (19%), Positives = 71/206 (34%), Gaps = 45/206 (21%)
Query: 121 VGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSI--GNLSNLYWLDLTDNKLEGE 176
+ CS +P S+ S LL L+ N S R+ L+NL+ L L+ N L
Sbjct: 23 LSCSKQQLPNVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-F 78
Query: 177 IPVSDGNSPG-LDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPAT 235
I + ++ N L ++ E LF +L
Sbjct: 79 IS------SEAFVPVPNLRYLDLSSNHLH-TLDEFLFS-------------DLQ------ 112
Query: 236 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSY 291
+LEV+ N + + ++ + LYLS N+++ + + L L
Sbjct: 113 -----ALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML 167
Query: 292 LDMSNNSFDASEVPSWFSSMQSLTTL 317
LD+S+N + + +
Sbjct: 168 LDLSSNKL-KKLPLTDLQKLPAWVKN 192
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 43/269 (15%), Positives = 74/269 (27%), Gaps = 101/269 (37%)
Query: 85 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144
T LT LH+L LS+N L +
Sbjct: 61 TRLTNLHSLLLSHNH-----------------------------------------LNFI 79
Query: 145 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 204
+S F + NL +LDL+ N L + L + N +
Sbjct: 80 SSEAFVP--------VPNLRYLDLSSNHLH-TLDEFL-----FSDLQALEVLLLYNNHIV 125
Query: 205 GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVP----SNL 260
+ F ++ L+ + +N +S P +
Sbjct: 126 -VVDRNAFE-------------DMA-----------QLQKLYLSQNQISR-FPVELIKDG 159
Query: 261 NNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFD----ASEVPSWFSSMQ 312
N L + L LS+NKL + L + L + NN + ++ S + Q
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV-KNGLYLHNNPLECDCKLYQLFSHWQYRQ 218
Query: 313 SLTTLMMENT-------NLKGQIPADLFS 334
+ + + L D F+
Sbjct: 219 LSSVMDFQEDLYCMHSKKLHNIFSLDFFN 247
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 35/210 (16%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHK------NL 686
+G G +G+V K Q +A+K R ++ + EI +L + + N+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQDKDNTMNV 161
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGLS 740
+ +L R + +E L +L + G L +R K A + L
Sbjct: 162 IHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVR--KFAHSILQCLD 214
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
LH+ IIH D+K NILL ++ + KV DFG S E + T ++ + Y
Sbjct: 215 ALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVYTYIQ-SRFYR 266
Query: 799 DPEYYMTQQLTEKSDVYSFGVLMLELLTGR 828
PE + + D++S G ++ ELLTG
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 53/217 (24%), Positives = 77/217 (35%), Gaps = 39/217 (17%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQELVLLSLNS 146
+ LDL +NK L L KL L L +P I L+ L L +
Sbjct: 37 ADTKKLDLQSNK-LSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTD 94
Query: 147 NGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQLS 204
N +P + L NL L L N+L+ +P P + D L + + G N+L
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLP------PRVFDSLTKLTYLSLGYNELQ 146
Query: 205 GSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 264
S+P+ +F L + +N L +P FD LT
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLK-RVPEGA----------FD-------------KLT 181
Query: 265 SVNDLYLSNNKLTGAMPNL-TGLSVLSYLDMSNNSFD 300
+ L L NN+L L L L + N +D
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 24/160 (15%)
Query: 225 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL- 283
S LT +P+ + + + N LS + LT + LYL++NKL +
Sbjct: 25 SKKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF 81
Query: 284 TGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLF-SIPHLQTV 341
L L L +++N +P F + +L L ++ LK +P +F S+ L +
Sbjct: 82 KELKNLETLWVTDNKL--QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL 138
Query: 342 VMKTNELNGTLDLGTSYSENL---LVNLQ-----NNRISA 373
+ NEL S + + L +L+ NN++
Sbjct: 139 SLGYNEL-------QSLPKGVFDKLTSLKELRLYNNQLKR 171
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 19/221 (8%)
Query: 130 PDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 189
+ ++L L+ S + + + L L+ +NK + + LD
Sbjct: 342 CRDSATDEQLFRCELSVE-KSTVLQSELESCKELQELEP-ENKWCLLTIILLMRA--LDP 397
Query: 190 LVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 249
L+ K + L P + D + L E + V+
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL-------ENSVLKMEYADVRVLHLAH 450
Query: 250 NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 309
L+ V +L L V L LS+N+L P L L L L S+N+ V +
Sbjct: 451 KDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL--ENVDG-VA 505
Query: 310 SMQSLTTLMMENTNLKGQIPA--DLFSIPHLQTVVMKTNEL 348
++ L L++ N L+ Q A L S P L + ++ N L
Sbjct: 506 NLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 9e-07
Identities = 29/141 (20%), Positives = 48/141 (34%), Gaps = 14/141 (9%)
Query: 37 DIWENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLS 96
D + + + + V + L+ L L + L + LDLS
Sbjct: 415 DPMRAAYLDDLRS-KFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLS 471
Query: 97 NNKDLRGPLPTTIGNLKKLSNLMLVGC---SFSGPIPDSIGSLQELVLLSLNSNGFSG-R 152
+N+ LR LP + L+ L L + G + +L L L L +N
Sbjct: 472 HNR-LRA-LPPALAALRCLEVLQASDNALENVDG-----VANLPRLQELLLCNNRLQQSA 524
Query: 153 VPPSIGNLSNLYWLDLTDNKL 173
+ + L L+L N L
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 39/279 (13%), Positives = 81/279 (29%), Gaps = 42/279 (15%)
Query: 38 IWENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSN 97
+W + P ND + + T S + D +L +LS
Sbjct: 299 VWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSV 358
Query: 98 NKDLRGP-LPTTIGNLKKLS----------NLMLVGCSFSGPIPDSIGSLQELVLL---- 142
K + L++L L++ +++ L +
Sbjct: 359 EKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418
Query: 143 ----SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHF 198
+ F +++ L L L + L+ L+ H
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-------HLEQLLLVTHLDL 470
Query: 199 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVP 257
N+L ++P L + + VL S+N + + + L+ + N L
Sbjct: 471 SHNRLR-ALPPAL--AALRCLEVLQASDNALENVDG-VANLPRLQELLLCNNRLQQSAAI 526
Query: 258 SNLNNLTSVNDLYLSNN----------KLTGAMPNLTGL 286
L + + L L N +L +P+++ +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 55/271 (20%), Positives = 87/271 (32%), Gaps = 95/271 (35%)
Query: 636 VGSGGYGKVYKG-TLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHH-------KN 685
+G G + V+ + + +A+K ++ + + + EI LL V + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 686 LVSLLGFCFD-RGEQMLIYEFVPNGS--------LGDSL------SGKNGIRLDWIRRLK 730
+V L F G NG+ LG L S G+ L +++
Sbjct: 102 MVVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK-- 150
Query: 731 IALGAARGLSYLHELANPPIIHRDIKSSNILL---------------------------- 762
I +GL YLH IIH DIK NILL
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 763 ---------------------DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPE 801
E+L K+AD G + + + I T+ Y E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLE 263
Query: 802 YYMTQQLTEKSDVYSFGVLMLELLTGRRPIE 832
+ +D++S + EL TG E
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 41/216 (18%), Positives = 72/216 (33%), Gaps = 50/216 (23%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQELVL 141
GL +L T + + K+LS + S I + L
Sbjct: 15 DPGLANAVKQNLGKQSV------TDLVSQKELSGVQNFNGDNSN-IQSLAGMQFFTNLKE 67
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 201
L L+ N S + P + +L+ L L + N+L+ ++ S L L N
Sbjct: 68 LHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRL------FLDNN 116
Query: 202 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 261
+L L +L +LE++ N L L
Sbjct: 117 ELRD-------------TDSL---IHLK-----------NLEILSIRNNKLK--SIVMLG 147
Query: 262 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 297
L+ + L L N++T LT L ++++D++
Sbjct: 148 FLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 35/195 (17%), Positives = 67/195 (34%), Gaps = 26/195 (13%)
Query: 133 IGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVR 192
L V +L + V LS + + ++ ++ + G+
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--------SLAGMQFFTN 64
Query: 193 AKHFHFGKNQLSGSIP--EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 250
K H NQ+S + + L + L + + N L L L + D N
Sbjct: 65 LKELHLSHNQIS-DLSPLKDLTK----LEELSVNRNRLK-NLNGIPSA--CLSRLFLDNN 116
Query: 251 SLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSS 310
L +L +L ++ L + NNKL ++ L LS L LD+ N + +
Sbjct: 117 ELRDT--DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI--TNTGG-LTR 170
Query: 311 MQSLTTLMMENTNLK 325
++ + + +
Sbjct: 171 LKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 35/218 (16%), Positives = 68/218 (31%), Gaps = 53/218 (24%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLV 121
S V + ++ L+G + T L L LS+N+ DL + +L KL L +
Sbjct: 41 SGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQISDLSP-----LKDLTKLEELSVN 93
Query: 122 GCSFSGPIPDSIGSLQELVL--LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPV 179
++ + L L L++N S+ +L NL L + +NKL+
Sbjct: 94 RNRLK-----NLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK----- 141
Query: 180 SDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV 239
+ L L + + N+++ + L +
Sbjct: 142 ---SIVMLGFLSKLEVLDLHGNEIT-NTGG--------------------------LTRL 171
Query: 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT 277
K + + L N + + +
Sbjct: 172 KKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 33/158 (20%), Positives = 56/158 (35%), Gaps = 31/158 (19%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG-PIPD--SIGSLQELV 140
+ LT+L L ++ N+ + NL + + L + D S+ L+ L
Sbjct: 81 LKDLTKLEELSVNRNR---------LKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLE 131
Query: 141 LLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200
+LS+ +N +G LS L LDL N++ N+ GL L +
Sbjct: 132 ILSIRNNKLK--SIVMLGFLSKLEVLDLHGNEIT--------NTGGLTRLKKVNWIDLTG 181
Query: 201 NQLSGS---------IPEKLFRPDMVLIHVLFDSNNLT 229
+ I + PD I + SN +
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGS 219
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 2/114 (1%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLM 119
C + + + G L + G L L + N + L+ + L +L NL
Sbjct: 4 ACCPHGSSGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 120 LVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 173
+V PD+ L L+L+ N + +L L L+ N L
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 20/109 (18%), Positives = 38/109 (34%), Gaps = 6/109 (5%)
Query: 243 EVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFD 300
+ +L +L ++ +LY+ N + + L GL L L + +
Sbjct: 12 GLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 301 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349
P F L+ L + L+ + LQ +V+ N L+
Sbjct: 70 FVA-PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 20/107 (18%), Positives = 39/107 (36%), Gaps = 4/107 (3%)
Query: 267 NDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 326
+ L + + ++ +L G L+ L + N + L L + + L+
Sbjct: 11 SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR- 69
Query: 327 QIPADLFS-IPHLQTVVMKTNELNGTLDLGTSYSENLL-VNLQNNRI 371
+ D F P L + + N L +L T +L + L N +
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 50/269 (18%), Positives = 96/269 (35%), Gaps = 34/269 (12%)
Query: 636 VGSGGYGKVYKGTLPNGQLI------AIKRAQQGSMQGGQEFKMEIEL-----LSRVHHK 684
+G GG+G +Y + + + + +K + E K + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 685 NLVSLLGFCF-----DRGEQMLIYEFVPNGSLGDSLS---GKNGIRLDWIRRLKIALGAA 736
+ LG + Y F+ G L N R L+++L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKV--ADFGLSKSMSDSE-KDHITTQVK- 792
L Y+HE +H DIK+SN+LL+ + +V D+GL+ K
Sbjct: 163 DILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219
Query: 793 ---GTMGY--LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDK 847
GT+ + +D + + + D+ G M++ LTG P E + +R +
Sbjct: 220 CHDGTIEFTSIDAHNGVAP--SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR 277
Query: 848 -KKELYNLYELIDPTIGLSTTLKGFEKYV 875
++ + +L + P + + + V
Sbjct: 278 YRENIASLMDKCFPAANAPGEIAKYMETV 306
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 39/238 (16%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+GSG +G +Y GT + G+ +AIK + + +E ++ K + +G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIY-----KMMQGGVGIPT 69
Query: 695 DRGEQMLIYEFVPNGS--------LGDSLS---GKNGIRLDWIRRLKIALGAARGLSYLH 743
I G LG SL + L +A + Y+H
Sbjct: 70 -------IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 744 ELANPPIIHRDIKSSNILLDERLNAK---VADFGLSKSMSDSE-KDHI----TTQVKGTM 795
IHRD+K N L+ + DFGL+K D+ HI + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 796 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKKKEL 851
Y ++ + + + D+ S G +++ G P + K + + + +KK
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 49/233 (21%), Positives = 94/233 (40%), Gaps = 27/233 (11%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV-SLLGFC 693
+G G +G +++GT L N Q +AIK + S + + E + + ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 694 FDRGEQMLIYEFVPNGSLGDSLS---GKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ +L+ + LG SL G + A + +HE + +
Sbjct: 76 QEGLHNVLVIDL-----LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 127
Query: 751 IHRDIKSSNILLDERLNAK-----VADFGLSKSMSDSE-KDHI----TTQVKGTMGYLDP 800
++RDIK N L+ + V DFG+ K D K HI + GT Y+
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKKKEL 851
++ ++ + + D+ + G + + L G P + K + + + +KK+
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 59/231 (25%)
Query: 637 GSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRV-----HHKNLVS 688
G G +G+V + N + A+K R + + K+E ++L ++ ++ N+V
Sbjct: 44 GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQNDDINNNNIVK 100
Query: 689 LLGFCFD-RGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGLSY 741
G F LI+E LG SL + NG ++ I+ + + L+Y
Sbjct: 101 YHG-KFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIK--LYCIEILKALNY 152
Query: 742 LHELANPPIIHRDIKSSNILLDERLNA-------------------------KVADFGLS 776
L +++ + H D+K NILLD+ K+ DFG
Sbjct: 153 LRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 827
+ + D+ + + T Y PE + SD++SFG ++ EL TG
Sbjct: 208 -CATF-KSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 43/221 (19%), Positives = 83/221 (37%), Gaps = 45/221 (20%)
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 201
+L + L+++ + ++ ++ G+ L ++ G N
Sbjct: 24 ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--------QGIQYLPNVRYLALGGN 73
Query: 202 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPSN 259
+L I + L +++ N L LP + L L+ + N L +P
Sbjct: 74 KLH-DIS--ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTN-LKELVLVENQLQS-LPDG 127
Query: 260 L-NNLTSVNDLYLSNNKLTGAMPNLTG----LSVLSYLDMSNNSFDASEVPS-WFSSMQS 313
+ + LT++ L L++N+L ++P G L+ L+ LD+S N +P F +
Sbjct: 128 VFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSYNQL--QSLPEGVFDKLTQ 182
Query: 314 LTTLMMENTNLKGQIPADLFSIPH--------LQTVVMKTN 346
L L + LK S+P LQ + + N
Sbjct: 183 LKDLRLYQNQLK--------SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 51/223 (22%), Positives = 77/223 (34%), Gaps = 69/223 (30%)
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
I L + L L NK L + + +L L
Sbjct: 59 IQYLPNVRYLALGGNK------------LHDI------------SALKELTNLTY---LI 91
Query: 144 LNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKN 201
L N +P + L+NL L L +N+L+ +P G+ D L + + N
Sbjct: 92 LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLP------DGVFDKLTNLTYLNLAHN 143
Query: 202 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 261
QL S+P+ +F L + N L LP G+ FD+
Sbjct: 144 QLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE--GV--------FDK------------ 179
Query: 262 NLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFD 300
LT + DL L N+L G LT L + +L +N +D
Sbjct: 180 -LTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI-WLH--DNPWD 218
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 51/238 (21%), Positives = 88/238 (36%), Gaps = 77/238 (32%)
Query: 637 GSGGYGKVYKG--TLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHK------NL 686
G G +GKV + G+ +A+K + + + EI++L ++
Sbjct: 23 GEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---RSEIQVLEHLNTTDPNSTFRC 79
Query: 687 VSLLGFCFD-RGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARGL 739
V +L F+ G +++E LG S +G RLD IR K+A + +
Sbjct: 80 VQMLE-WFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIR--KMAYQICKSV 131
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNA-------------------KVADFGLSKSMS 780
++LH + H D+K NIL + KV DFG S +
Sbjct: 132 NFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SAT 185
Query: 781 DSEKDHITTQVKGTMGYLD------PE-----YYMTQQLTEKSDVYSFGVLMLELLTG 827
++ H T + PE + ++ DV+S G +++E G
Sbjct: 186 YDDEHHST--------LVSTRHYRAPEVILALGW-----SQPCDVWSIGCILIEYYLG 230
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 54/218 (24%), Positives = 74/218 (33%), Gaps = 40/218 (18%)
Query: 60 GCT-NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNL 118
GCT N + G L SG I TE LDL + T L KL+ L
Sbjct: 9 GCTCNEGKKEVDCQGKSLDSVPSG-IPADTE--KLDLQSTGLATLS-DATFRGLTKLTWL 64
Query: 119 MLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEI 177
L L EL L L +N + +P + +L+ L L L N+L+ +
Sbjct: 65 NLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SL 122
Query: 178 PVSDGNSPGL-DMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL 236
P G+ D L + K NQL SIP F L + +N L
Sbjct: 123 P------SGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-------- 167
Query: 237 GLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNN 274
+S+ FD L + + L N
Sbjct: 168 ---QSVPHGAFD-------------RLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 44/183 (24%), Positives = 69/183 (37%), Gaps = 37/183 (20%)
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGK 200
L L S G + + L+ L WL+L N+L+ + G+ D L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LS------AGVFDDLTELGTLGLAN 92
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
NQL+ S+P +F L + N L LP+ + FDR
Sbjct: 93 NQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV----------FDR----------- 129
Query: 261 NNLTSVNDLYLSNNKLTGAMPN--LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 318
LT + +L L+ N+L ++P L+ L L +S N S F + L T+
Sbjct: 130 --LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTIT 185
Query: 319 MEN 321
+
Sbjct: 186 LFG 188
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 54/261 (20%), Positives = 93/261 (35%), Gaps = 54/261 (20%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+GSGG+G +Y + A + + G F E++ RV K+ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKW---- 99
Query: 695 DRGEQMLIYEFVPN----GS---------------LGDSLSGKNGIRLDWIRR------L 729
+ L Y +P G LG L L
Sbjct: 100 -IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKI----SGQNGTFKKSTVL 154
Query: 730 KIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV--ADFGLSKSMSDSEKD-H 786
++ + L Y+HE +H DIK++N+LL + +V AD+GLS +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 787 ITTQVK----GTMGY--LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP---IERGKYI 837
+ GT+ + LD + + +SDV G ML L G+ P +
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVAL--SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269
Query: 838 VREIRT-VMDKKKELYNLYEL 857
V+ +T ++D+ + +
Sbjct: 270 VQTAKTNLLDELPQSVLKWAP 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 51/228 (22%), Positives = 82/228 (35%), Gaps = 55/228 (24%)
Query: 636 VGSGGYGKVYKG--TLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHK------N 685
+G G +GKV + +A+K R + ++EI +L ++ K
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIKEKDKENKFL 83
Query: 686 LVSLLGFCFD-RGEQMLIYEFVPNGSLGDSL------SGKNGIRLDWIRRLKIALGAARG 738
V + F+ G + +E LG + + L +R +A
Sbjct: 84 CVLMSD-WFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVR--HMAYQLCHA 135
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNA-------------------KVADFGLSKSM 779
L +LHE + H D+K NIL +VADFG S +
Sbjct: 136 LRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATF 191
Query: 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTG 827
+ +H TT V T Y PE + + DV+S G ++ E G
Sbjct: 192 ---DHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 26/139 (18%), Positives = 51/139 (36%), Gaps = 24/139 (17%)
Query: 258 SNLNNLTSVNDLYLSNNKLTGAMPNLT-GLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 316
+ N +L L K+ + NL L +D S+N + F ++ L T
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG---FPLLRRLKT 68
Query: 317 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTE 376
L++ N + ++P L +++ N L DL + L +L++
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL------DPLASLKSLTY----- 117
Query: 377 RGGAPAVNLTLIDNPICQE 395
L ++ NP+ +
Sbjct: 118 --------LCILRNPVTNK 128
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 47/242 (19%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+GSG +G++Y GT + + +AIK + + E ++ + L G
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIY-----RILQGGTGIPN 67
Query: 695 DRGEQMLIYEFVPNGS--------LGDSLSGKNGIRLDWIRR-------LKIALGAARGL 739
+ F G LG SL ++ R L +A +
Sbjct: 68 -------VRWFGVEGDYNVLVMDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINRV 116
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAK---VADFGLSKSMSDSE-KDHI----TTQV 791
++H + +HRDIK N L+ A + DFGL+K D+ HI +
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKKK 849
GT Y ++ + + + D+ S G +++ L G P + K ++ + + +KK
Sbjct: 174 TGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
Query: 850 EL 851
Sbjct: 234 AT 235
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 52/279 (18%), Positives = 101/279 (36%), Gaps = 55/279 (19%)
Query: 636 VGSGGYGKVYKGT---------LPNGQLIAIKR-AQQGSMQGGQEF------KMEIELLS 679
G +Y+ P Q ++K A+ G + Q F +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 680 RVHHKNLV---SLLGFCFDRGE-QMLIYEFVPNGSLGDSLSGKNGIRLDWIRR------- 728
+++ L+ + +GF + + + L+ LG SL LD +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-----LGRSLQSA----LDVSPKHVLSERS 160
Query: 729 -LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV--ADFGLSKSMSDSEKD 785
L++A L +LHE +H ++ + NI +D ++V A +G + S K
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK- 216
Query: 786 HI------TTQVKGTMGY--LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYI 837
H+ + +G + + +D + +SD+ S G ML+ L G P
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGP--SRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274
Query: 838 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVD 876
+I K+K + + P + +KY+
Sbjct: 275 TEDIMK--QKQKFVDKPGPFVGPCGHWIRPSETLQKYLK 311
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 37/134 (27%), Positives = 56/134 (41%), Gaps = 10/134 (7%)
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGK 200
L L+ N + P +L NL L L N+L +P G+ D L + G
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALP------VGVFDSLTQLTVLDLGT 97
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
NQL+ +P +F + L + N LT ELP + + L + D+N L
Sbjct: 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155
Query: 261 NNLTSVNDLYLSNN 274
+ L+S+ YL N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 37/142 (26%), Positives = 53/142 (37%), Gaps = 35/142 (24%)
Query: 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 145
L L L L +N+ L L G + D SL +L +L L
Sbjct: 62 SLINLKELYLGSNQ------------LGALP---------VG-VFD---SLTQLTVLDLG 96
Query: 146 SNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 204
+N + +P ++ L +L L + NKL E+P G++ L H +NQL
Sbjct: 97 TNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELP------RGIERLTHLTHLALDQNQLK 148
Query: 205 GSIPEKLFRPDMVLIHVLFDSN 226
SIP F L H N
Sbjct: 149 -SIPHGAFDRLSSLTHAYLFGN 169
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 55/240 (22%), Positives = 89/240 (37%), Gaps = 41/240 (17%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+G G +G++ G L + +AIK + + Q E++ +L S + + F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYYF 73
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLS---GKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
++ E LG SL L IA+ + Y+H
Sbjct: 74 GPCGKYNAMVLEL-----LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--- 125
Query: 750 IIHRDIKSSNILLDERLNAK-----VADFGLSKSMSDSE-KDHI----TTQVKGTMGYLD 799
+I+RD+K N L+ N + DF L+K D E K HI + GT
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA---- 181
Query: 800 PEYYM---TQQLTEKS---DVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKKKEL 851
YM T E+S D+ + G + + L G P + K + R + D K+
Sbjct: 182 --RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 4e-06
Identities = 69/616 (11%), Positives = 160/616 (25%), Gaps = 219/616 (35%)
Query: 454 LGNTTYYEILEQSVTTSFQSTYKLPIDSISLSNP-----------HKNNFEYLELSIQFF 502
L I+ + T +L ++ LS + N+++L I+
Sbjct: 46 LSKEEIDHIIMSK--DAVSGTLRL-FWTL-LSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 503 PSGQESFNRTGVSSVGFVLSNQIYSPPPLFGPMFFN-GDPYQYFAESGGSHKSTSIGVII 561
R + +++Y+ +F + PY ++ + +I
Sbjct: 102 QRQPSMMTRMYIEQR-----DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 562 GAAAAGCVVLLLLLLA----------GVY----AYHQKRRAEKANEQNPFAHWDMNKSSG 607
G +G + L + ++ Q D N +S
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 608 -----SIPQ----LKGA-----------RCF-------SFEEVKKY---------TNNFS 631
+I ++ C + + + T
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 632 DANDVGSGGYGKV----YKGTLPNGQLIAI-------------KRAQQG-----SMQGG- 668
+ + + + + TL ++ ++ + S+
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336
Query: 669 -QEFKMEIELLSRVHHKNLVSLLGFCFDR---GEQMLIYE----F-----VPNGSLGDSL 715
++ + V+ L +++ + E +++ F +P L
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS--- 393
Query: 716 SGKNGIRLDW---------------IRRLKIALGAARGLSYLHEL--------ANPPIIH 752
+ W + + + + N +H
Sbjct: 394 ------LI-WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-----HITTQVKGTMGYLDPEYYMTQ- 806
R ++D K D S + D HI G+ ++
Sbjct: 447 R------SIVDHYNIPKTFD---SDDLIPPYLDQYFYSHI--------GH-----HLKNI 484
Query: 807 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
+ E+ + F ++ L+ R +E+ K +R T + + N L
Sbjct: 485 EHPERMTL--FRMVFLDF----RFLEQ-K--IRHDSTAWNASGSILNT--LQQ------- 526
Query: 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN----------------ILQQAGLNP 910
LK ++ Y+ D+ P +V I + +L+ A +
Sbjct: 527 -LKFYKPYIC----------DNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAE 575
Query: 911 NAESASSSASYEDASK 926
+ A +E+A K
Sbjct: 576 D------EAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 3e-04
Identities = 58/416 (13%), Positives = 111/416 (26%), Gaps = 153/416 (36%)
Query: 4 KRKVFLLSVYLQFLIIAAVTNDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGC-- 61
R++ Y L++ L ++ + W + + C
Sbjct: 234 LRRLLKSKPYENCLLV--------------L-LNVQNAK--AWNAFN--------LSCKI 268
Query: 62 --TNSRVTSITLSGMGLKGQ---LSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLS 116
T +R +T L LT L L L +L +
Sbjct: 269 LLT-TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL-----LLKYLDCRPQDLPREV 322
Query: 117 NLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE 176
+ + P + + E + R + + W + +KL
Sbjct: 323 ------LTTN---PRRLSIIAESI-----------RDGLATWD----NWKHVNCDKLTTI 358
Query: 177 IPVSDGNSPGLDML----VRAKHFH----FGKNQLSGSIPEKLFR----------PDMVL 218
I S L++L R K F F + IP L +V+
Sbjct: 359 IESS------LNVLEPAEYR-KMFDRLSVFPPSAH---IPTILLSLIWFDVIKSDVMVVV 408
Query: 219 -------------------IHVLFDSNNLTGELPATL--GLVKSLEVVR-FDRNSLSGPV 256
I ++ + E L +V + + FD + L P
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP- 467
Query: 257 PSNLNNLTSVNDLY--------LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEV---- 304
D Y L N + M + +LD F ++
Sbjct: 468 ---------YLDQYFYSHIGHHLKNIEHPERMTLFRMV----FLDF---RFLEQKIRHDS 511
Query: 305 PSWFSSMQSLTTL---------MMENTNLKGQIPADL--FSIPHLQTVVMKTNELN 349
+W +S L TL + +N ++ + F +P ++ ++ + +
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF-LPKIEENLICSKYTD 566
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 28/136 (20%), Positives = 59/136 (43%), Gaps = 13/136 (9%)
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL-TGLSVLSYLDMSNNSF 299
++ +R ++N++ P + + + LSNN+++ P+ GL L+ L + N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 300 DASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLF-SIPHLQTVVMKTNEL----NGTLD 353
+E+P F + SL L++ + + D F + +L + + N+L GT
Sbjct: 93 --TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 354 LGTSYSENLLVNLQNN 369
+ ++L N
Sbjct: 150 PLRAIQ---TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 13/127 (10%)
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATL--GLVKSLEVVRFDRNSLSGPVPS 258
N + IP F P L + +N ++ EL GL SL + N ++ S
Sbjct: 42 NTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR-SLNSLVLYGNKITELPKS 98
Query: 259 NLNNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 314
L S+ L L+ NK+ A +L L+ L + +N + FS ++++
Sbjct: 99 LFEGLFSLQLLLLNANKINCLRVDAFQDLHN---LNLLSLYDNKL-QTIAKGTFSPLRAI 154
Query: 315 TTLMMEN 321
T+ +
Sbjct: 155 QTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 81 SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI-GSLQEL 139
G + +L +DLSNN+ + P L+ L++L+L G + +P S+ L L
Sbjct: 49 PGAFSPYKKLRRIDLSNNQ-ISELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSL 106
Query: 140 VLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKL 173
LL LN+N + + +L NL L L DNKL
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 24/141 (17%), Positives = 50/141 (35%), Gaps = 33/141 (23%)
Query: 135 SLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 193
++L + L++N S + P L +L L L NK+ E+P S + L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSL-----FEGLFSL 106
Query: 194 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 253
+ N+++ + F+ +L +L ++ N L
Sbjct: 107 QLLLLNANKIN-CLRVDAFQ-------------DLH-----------NLNLLSLYDNKLQ 141
Query: 254 GPVPSNLNNLTSVNDLYLSNN 274
+ L ++ ++L+ N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 26/129 (20%), Positives = 54/129 (41%), Gaps = 11/129 (8%)
Query: 224 DSNNLTGELPATLGL--VKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP 281
++N T L AT + L + F N ++ + VN++ L++N+L +
Sbjct: 40 NNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQ 97
Query: 282 N--LTGLSVLSYLDMSNNSFDASEVPS-WFSSMQSLTTLMMENTNLKGQIPADLF-SIPH 337
+ GL L L + +N + V + F + S+ L + + + + F ++
Sbjct: 98 HKMFKGLESLKTLMLRSNRI--TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154
Query: 338 LQTVVMKTN 346
L T+ + N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 21/141 (14%), Positives = 41/141 (29%), Gaps = 11/141 (7%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 147
L L+NN+ L +L + + + + + L SN
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 148 GFSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQLSG 205
V + L +L L L N++ + L + NQ++
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRIT-CVG------NDSFIGLSSVRLLSLYDNQIT- 142
Query: 206 SIPEKLFRPDMVLIHVLFDSN 226
++ F L + +N
Sbjct: 143 TVAPGAFDTLHSLSTLNLLAN 163
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 40/164 (24%), Positives = 62/164 (37%), Gaps = 40/164 (24%)
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGK 200
L L +N L++L L L NKL+ +P G+ + L + +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLP------NGVFNKLTSLTYLNLST 85
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
NQL S+P +F L + ++N L LP + FD+
Sbjct: 86 NQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGV----------FDK----------- 122
Query: 261 NNLTSVNDLYLSNNKLT----GAMPNLTGLSVLSYLDMSNNSFD 300
LT + DL L N+L G LT L + +L +N +D
Sbjct: 123 --LTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI-WLH--DNPWD 161
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 28/121 (23%), Positives = 40/121 (33%), Gaps = 28/121 (23%)
Query: 55 NWEGIGCTNSRVTSITLSGMGLK-GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLK 113
+ E T + V + L G++ G L L L N L
Sbjct: 15 HLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV------------GLI 62
Query: 114 KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 173
+SNL L +L L L+ N G + L NL L+L+ NKL
Sbjct: 63 SVSNL---------------PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 174 E 174
+
Sbjct: 108 K 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 25/138 (18%), Positives = 44/138 (31%), Gaps = 28/138 (20%)
Query: 262 NLTSVNDLYLSNNKLT-GAMPNLTG-LSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM 319
+V +L L N K G + LT L +L + N + + L L +
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN---LPKLPKLKKLEL 78
Query: 320 ENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL--LVNLQNNRISAYTER 377
+ G + +P+L + + N+L L E L L L+
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-----EPLKKLECLK---------- 123
Query: 378 GGAPAVNLTLIDNPICQE 395
+L L + +
Sbjct: 124 ------SLDLFNCEVTNL 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 5/94 (5%)
Query: 256 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 315
+P + V +LYL N+ T L+ L+ +D+SNN FS+M L
Sbjct: 25 LPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLS-NQSFSNMTQLL 81
Query: 316 TLMMENTNLKGQIPADLF-SIPHLQTVVMKTNEL 348
TL++ L+ IP F + L+ + + N++
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 28/123 (22%), Positives = 51/123 (41%), Gaps = 6/123 (4%)
Query: 221 VLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM 280
VL +S + G+L + LE + L+ +NL L + L LS+N+++G +
Sbjct: 23 VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGGL 80
Query: 281 PNL-TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL-MMEN--TNLKGQIPADLFSIP 336
L L++L++S N +++L +L + TNL +P
Sbjct: 81 EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP 140
Query: 337 HLQ 339
L
Sbjct: 141 QLT 143
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 28/119 (23%), Positives = 39/119 (32%), Gaps = 28/119 (23%)
Query: 57 EGIGCTNSRVTSITLSGMGLK-GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKL 115
E T S V + L G+L G EL L N L +
Sbjct: 10 ELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV------------GLTSI 57
Query: 116 SNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174
+NL L +L L L+ N SG + NL L+L+ NK++
Sbjct: 58 ANL---------------PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 9e-04
Identities = 23/138 (16%), Positives = 45/138 (32%), Gaps = 28/138 (20%)
Query: 262 NLTSVNDLYLSNNKLT-GAMPNLTG-LSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM 319
+ V +L L N++ G + LT L +L N + + L L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN---LPKLNKLKKLEL 71
Query: 320 ENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENL--LVNLQNNRISAYTER 377
+ + G + P+L + + N++ + E L L NL+
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-----EPLKKLENLK---------- 116
Query: 378 GGAPAVNLTLIDNPICQE 395
+L L + +
Sbjct: 117 ------SLDLFNCEVTNL 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 24/143 (16%), Positives = 53/143 (37%), Gaps = 30/143 (20%)
Query: 256 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 315
+ + L+ L + L LS N + + +L+G+ L L + N ++ + + +L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLI--KKIENLDAVADTLE 96
Query: 316 TLMMEN---TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 372
L + +L G + + +L+ + M N++ ++ L L
Sbjct: 97 ELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDK------LAALDKLE-- 143
Query: 373 AYTERGGAPAVNLTLIDNPICQE 395
+L L NP+ +
Sbjct: 144 -----------DLLLAGNPLYND 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 39/275 (14%), Positives = 79/275 (28%), Gaps = 47/275 (17%)
Query: 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS----GPIPDSIGSLQELVLLS 143
++ +LD+ + + L++ + L C + I ++ L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 144 LNSNGFSGRVPPSIGNL-----SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA----- 193
L SN + + L L + L G G +L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA---------GCGVLSSTLRTLP 113
Query: 194 --KHFHFGKNQLSGS----IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV----KSLE 243
+ H N L + + E L P L + + +L+ L V +
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 244 VVRFDRNSLSGPVPSNL-----NNLTSVNDLYLSNNKLTGA-----MPNLTGLSVLSYLD 293
+ N ++ L ++ + L L + +T + + L L
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 294 MSNNSFDASEV----PSWFSSMQSLTTLMMENTNL 324
+ +N + P L TL + +
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 955 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.98 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.98 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.98 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.83 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.74 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.74 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.69 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.68 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.66 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.59 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.54 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.54 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.53 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.53 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.38 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.14 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.09 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.06 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.76 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.69 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.61 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.5 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.24 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.14 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.44 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.38 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.31 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.95 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.84 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.61 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.49 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.04 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.41 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.42 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.08 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.9 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.76 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 90.81 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.61 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 88.11 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=464.55 Aligned_cols=260 Identities=25% Similarity=0.452 Sum_probs=217.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677889999999999999864 478899999987766667889999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEE
Q 002189 702 IYEFVPNGSLGDSLSGKN-----------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
|||||++|+|.++|+..+ ...++|.+++.++.|||+||+|||+.+ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 357999999999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhh
Q 002189 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
+|||+|+.....+.........||++|||||++.++.++.++|||||||++|||+| |+.||..... .+.+..+.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCC
Confidence 99999997755444333344679999999999999999999999999999999999 8999975432 232222222110
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
+. .+..++.++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 249 ----------~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 249 ----------LQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 1223447889999999999999999999999999998755
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=467.70 Aligned_cols=260 Identities=24% Similarity=0.449 Sum_probs=209.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34666789999999999999864 478999999987766667889999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 702 IYEFVPNGSLGDSLSGKN-------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
|||||++|+|.++++... ..+++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999987542 236999999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 847 (955)
||+|||+|+.....+.........||++|||||++.+..++.++|||||||++|||+| |+.||..... .+.+..+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-HHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcC
Confidence 9999999997765544444456789999999999999999999999999999999999 8999975443 2222222221
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. .+. .+..++.++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 277 ~----------~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 277 R----------ELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp C----------CCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C----------CCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 111 1223447889999999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=462.63 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=211.5
Q ss_pred CCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
+++..++||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3456788999999999999863 468999999976433 335789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc
Q 002189 702 IYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN 767 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~ 767 (955)
|||||++|+|.++|+... ...++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999986432 235899999999999999999999988 999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHh
Q 002189 768 AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMD 846 (955)
Q Consensus 768 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~ 846 (955)
+||+|||+|+.....+.....+...||++|||||++.++.++.++|||||||++|||+| |+.||..... .+.+..+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~~~~~~i~- 261 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEMIR- 261 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-HHHHHHHH-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-
Confidence 99999999987755444344455679999999999999999999999999999999999 8999965432 23222222
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 847 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
... . ...+..++..+.+|+.+||+.||++||||+||++.|+.+
T Consensus 262 ~~~--------~-----~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 NRQ--------V-----LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTC--------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred cCC--------C-----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111 0 111223457889999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=451.54 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=205.3
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...++||+|+||+||+|++.+ .||||+++.... ...++|.+|+++|++++|||||+++|+|. ++..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEc
Confidence 456778899999999999999753 699999875433 33467999999999999999999999885 4578999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
|++|+|.++++..+ ..++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+........
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999997543 36999999999999999999999988 999999999999999999999999999876544433
Q ss_pred ceeeeeecCCCCCCHHHhhh---CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 786 HITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.......||+.|||||++.+ +.|+.++|||||||++|||+||+.||........ +...+... ...|.+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~--------~~~p~~ 259 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRG--------YASPDL 259 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTT--------CCCCCS
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcC--------CCCCCc
Confidence 34456789999999999974 4589999999999999999999999975443322 22222211 112222
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
. .....++..+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 260 ~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 260 S-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp T-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred c-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 122334578899999999999999999999999998774
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=455.61 Aligned_cols=269 Identities=26% Similarity=0.402 Sum_probs=220.1
Q ss_pred HHHHHHhcCCCccCeeeccCceEEEEEEeCC------CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccC-CCcceEEEE
Q 002189 621 EEVKKYTNNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHH-KNLVSLLGF 692 (955)
Q Consensus 621 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H-~niv~l~~~ 692 (955)
.+.+...++|...+.||+|+||+||+|++.. ++.||||+++..... ..++|.+|+++|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444456788999999999999999998642 468999999865443 34679999999999965 999999999
Q ss_pred EEeC-CeEEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCC
Q 002189 693 CFDR-GEQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKS 757 (955)
Q Consensus 693 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 757 (955)
|.+. +..+||||||++|+|.++|+... ...++|.+++.++.|||+||+|||+.+ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 9775 56899999999999999996432 235899999999999999999999988 99999999
Q ss_pred ccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCch
Q 002189 758 SNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKY 836 (955)
Q Consensus 758 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~ 836 (955)
+|||+++++.+||+|||+|+.+.............||++|||||++.++.|+.++|||||||++|||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998765544444556789999999999999999999999999999999998 8999975443
Q ss_pred HHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 837 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
... +...+.... .+.. +..+..++.+++.+||+.||++|||++||+++|+.+++..
T Consensus 294 ~~~-~~~~i~~g~---------~~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 294 DEE-FCRRLKEGT---------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp SHH-HHHHHHHTC---------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH-HHHHHHcCC---------CCCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 222 222222211 1111 1223467899999999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=448.33 Aligned_cols=251 Identities=22% Similarity=0.411 Sum_probs=206.5
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5789999999999999999986 4799999999976433 234679999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
||++|+|.+++...+...+++.+...++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999997666667899999999999999999999998 9999999999999999999999999998764321
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||... +..+.+..+.... . |..
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~---------~-~~~-- 245 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-SMKNLVLKIISGS---------F-PPV-- 245 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHTC---------C-CCC--
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCC---------C-CCC--
Confidence 2234467999999999999999999999999999999999999999654 3333333333221 1 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+|+.+||+.||++|||++|++++
T Consensus 246 --~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 --SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11233678899999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=444.73 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=211.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+.|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45788899999999999999964 79999999997655555677899999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++... .+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+.... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 225 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--C
Confidence 999999988753 5899999999999999999999999 9999999999999999999999999999775432 2
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+..+... ..+.+. .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~----------~~~~~~--~ 292 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-PLKAMKMIRDN----------LPPRLK--N 292 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHS----------SCCCCS--C
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-HHHHHHHHHcC----------CCCCCC--c
Confidence 2345789999999999999999999999999999999999999996543 23333322211 122211 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+|+.+||+.||++|||++|++++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22334678999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=439.67 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=209.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+.|...++||+|+||+||+|+.. +|+.||||+++.... ..+|++++++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45677789999999999999964 689999999976432 246999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecccccccCCCCCc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~~~~ 785 (955)
++|+|.++++..+ .+++.....++.||+.||+|||+.+ ||||||||+||||+.++ .+||+|||+|+.+......
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997654 6999999999999999999999998 99999999999999987 6999999999977543221
Q ss_pred c---eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 786 H---ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 786 ~---~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .....+||+.|||||++.+..|+.++|||||||++|||+||++||...... .....+...... ..
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~~---~~------- 276 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPP---IR------- 276 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-CCHHHHHHSCCG---GG-------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHcCCCC---ch-------
Confidence 1 123457999999999999999999999999999999999999999643221 111222221110 00
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
..+......+.+++.+||+.||++|||++|++++|..+++..+
T Consensus 277 --~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 277 --EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp --GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 0112234678899999999999999999999999999987754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=438.73 Aligned_cols=267 Identities=24% Similarity=0.353 Sum_probs=203.9
Q ss_pred CCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC----eEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG----EQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e 704 (955)
+|...++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|+|.+++ ..|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466778999999999999998 589999999975321 1223345666667889999999999998764 5799999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA-----NPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
||++|+|.++++.. .++|..+.+++.|+|+||+|||+.+ .++||||||||+||||++++++||+|||+|+..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999754 5899999999999999999999862 345999999999999999999999999999877
Q ss_pred CCCCCc--ceeeeeecCCCCCCHHHhhhC------CCCChhhhHHHHHHHHHHHhCCCCCcCCc-------------hHH
Q 002189 780 SDSEKD--HITTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVLMLELLTGRRPIERGK-------------YIV 838 (955)
Q Consensus 780 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwS~Gv~l~elltg~~P~~~~~-------------~~~ 838 (955)
...... .......||++|||||++.+. .++.++|||||||++|||+||.+|+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543321 122346799999999999764 36789999999999999999987764211 111
Q ss_pred HHHHHHHhhhhhhhhhhhccCCcCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002189 839 REIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908 (955)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 908 (955)
..+.... ..+..+|.++.. ...+.+..+.+|+.+||+.||++||||+||++.|+++.++.++
T Consensus 239 ~~~~~~~--------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 239 EEMRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHH--------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred HHHHHHH--------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 1121111 112234443322 2335667899999999999999999999999999999876553
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=430.49 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=199.8
Q ss_pred CccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEe----CCeEEEEE
Q 002189 631 SDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQMLIY 703 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 703 (955)
...++||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|++++|||||+++++|.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999864 68999999987543 2334679999999999999999999999875 34579999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccccccCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~ 782 (955)
|||++|+|.++++..+ .+++..+..++.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999997643 6899999999999999999999875 46999999999999984 79999999999986432
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||............+..... .+..
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~---------~~~~ 251 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------PASF 251 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------CGGG
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC---------CCCC
Confidence 22345689999999998864 6999999999999999999999999765554433332222111 0111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.....++.+|+.+||+.||++|||++|++++
T Consensus 252 ----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123568899999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=433.75 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=211.6
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688999999999999999986 479999999987532 223467899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.++++..+ .+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997654 6899999999999999999999999 9999999999999999999999999999876554
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+....+.... ...
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~-----------~~~- 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-EGLIFAKIIKLE-----------YDF- 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTC-----------CCC-
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC-----------CCC-
Confidence 4444556789999999999999999999999999999999999999996543 333333333211 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.....++.+|+.+||+.||++|||++|++.+
T Consensus 254 ---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 254 ---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---CcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 11223678899999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=446.08 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=212.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+.|...++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888999999999999999964 69999999998766666677999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++.. .+++.++..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+.... .
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 302 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence 999999988643 5899999999999999999999999 9999999999999999999999999998775432 2
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.+..+... ..+.+. .
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~----------~~~~~~--~ 369 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDN----------LPPRLK--N 369 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHS----------CCCCCS--C
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcC----------CCCCCc--c
Confidence 23457899999999999999999999999999999999999999965432 2333222211 122221 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+|+.+||+.||++|||++|++++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12234678899999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=415.43 Aligned_cols=246 Identities=24% Similarity=0.377 Sum_probs=193.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||+|+||+||+|+. .+|+.||||++++... ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999986 4799999999975432 22457899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+ +|+|.+++...+ .+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 689999887554 6999999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||... +.......+.... +.+
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-~~~~~~~~i~~~~-----------~~~ 231 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-SIPVLFKNISNGV-----------YTL 231 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTC-----------CCC
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCC-----------CCC
Confidence 2345689999999999998876 57999999999999999999999653 3333333222211 111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .....++.+++.+||+.||++|||++|++++
T Consensus 232 p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 232 P----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C----CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 1123678899999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=424.68 Aligned_cols=247 Identities=30% Similarity=0.362 Sum_probs=198.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|+..+.||+|+||+||+|+.. .++.||||+++.... .....+.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999852 478999999875422 233568899999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|||||++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997654 6899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||... +..+....+.... +.
T Consensus 179 ~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~-----------~~ 244 (304)
T 3ubd_A 179 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKAK-----------LG 244 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCC-----------CC
T ss_pred CC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-CHHHHHHHHHcCC-----------CC
Confidence 32 2233468999999999999999999999999999999999999999654 3333333332211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVK 897 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 897 (955)
. +.....++.+|+.+||+.||++|||+ +|+++
T Consensus 245 ~----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 M----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 11233678899999999999999984 56664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=416.48 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=190.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCe------
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE------ 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 698 (955)
.++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 456889999999999999999864 7899999999754433 34678999999999999999999999976543
Q ss_pred ------EEEEEEecCCCCcccccCCCCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 699 ------QMLIYEFVPNGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 699 ------~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
.|+|||||++|+|.+++..... ...++..++.++.|+++||+|||+.+ ||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 6899999999999999976542 23567778899999999999999998 9999999999999999999999
Q ss_pred ecccccccCCCCCcc----------eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHH
Q 002189 772 DFGLSKSMSDSEKDH----------ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREI 841 (955)
Q Consensus 772 DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~ 841 (955)
|||+|+.+....... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.........+
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 999998775432211 1234579999999999999999999999999999999996 775432221111
Q ss_pred HHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.. .-.|. ........+.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~----------~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TDVRN----------LKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHT----------TCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhc----------CCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11110 00010 011222456789999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=407.20 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=205.7
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCe
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 698 (955)
....+.|...++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +|||||++++++.+++.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999753 46899999987543 345688999999998 69999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-CceEEeeccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSK 777 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~ 777 (955)
.|+||||+++|+|.+++. .+++.+...++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999884 4889999999999999999999999 9999999999999877 799999999998
Q ss_pred ccCCCCCc--------------------------ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCC
Q 002189 778 SMSDSEKD--------------------------HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRP 830 (955)
Q Consensus 778 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P 830 (955)
...+.... ......+||+.|||||++.+. .++.++||||+||++|||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432210 112335799999999999875 589999999999999999999999
Q ss_pred CcCCchHHHHHHHHHhhhhh--h----------------------hhhhhc---c---CCcC---------CCCCCHHHH
Q 002189 831 IERGKYIVREIRTVMDKKKE--L----------------------YNLYEL---I---DPTI---------GLSTTLKGF 871 (955)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~--~----------------------~~~~~~---~---d~~l---------~~~~~~~~~ 871 (955)
|..+.+..+.+..+..-... . ....+. . .|.. .........
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 98777665555443321100 0 000000 0 0000 000111223
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 872 EKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 872 ~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.++.+|+.+||+.||.+|||++|++++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 578899999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=408.18 Aligned_cols=264 Identities=20% Similarity=0.318 Sum_probs=204.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEe------CCe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFD------RGE 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 698 (955)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4688899999999999999986 4799999999975433 234678899999999999999999998764 357
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.|||||||+ |+|.+++...+ .+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 78999987654 7999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCC--cceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh----
Q 002189 779 MSDSEK--DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL---- 851 (955)
Q Consensus 779 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~---- 851 (955)
+..... .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+. +..+.+..+.......
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCChHH
Confidence 643221 1223457899999999998875 5699999999999999999999999644 3334444433221100
Q ss_pred ---------hhhhhccCCcCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 ---------YNLYELIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 ---------~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+.+...... ......++.+|+.+||+.||.+|||++|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000011111110000 00123578899999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=396.53 Aligned_cols=281 Identities=43% Similarity=0.742 Sum_probs=236.7
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG 697 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 697 (955)
+++.++...+++|...+.||+|+||+||+|++.+|+.||||++........+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34444556678999999999999999999998889999999988776666788999999999999999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997654 235899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc-----hHHHHHHHHHhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK-----YIVREIRTVMDKKKE 850 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~-----~~~~~~~~~~~~~~~ 850 (955)
++...............||+.|+|||++.+..++.++||||||+++|||+||+.||.... ....+......
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---- 261 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN---- 261 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT----
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc----
Confidence 987654333333445679999999999999999999999999999999999999986422 12222222111
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
...+...+++.............+.+++.+||+.||++||+++|++++|+.+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 1224455666666666778889999999999999999999999999999999754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=393.31 Aligned_cols=284 Identities=42% Similarity=0.746 Sum_probs=236.2
Q ss_pred CCCcccCHHHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEE
Q 002189 613 KGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLG 691 (955)
Q Consensus 613 ~~~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~ 691 (955)
.....+++.++....++|...+.||+|+||+||+|+..+|+.||||+++..... ....+.+|++++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 345789999999999999999999999999999999888999999999764332 2347899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceE
Q 002189 692 FCFDRGEQMLIYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAK 769 (955)
Q Consensus 692 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 769 (955)
++.+.+..++||||+++|+|.++++... ...+++..+..++.|++.||+|||+...+.|+||||||+||++++++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999987653 34599999999999999999999998222399999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcC-------CchHHHHHH
Q 002189 770 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIER-------GKYIVREIR 842 (955)
Q Consensus 770 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~-------~~~~~~~~~ 842 (955)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.. .....+++.
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999987654332 334445699999999999999999999999999999999999999952 112222222
Q ss_pred HHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 843 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
.... ........++.............+.+++.+||+.||.+|||++||+++|++
T Consensus 254 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLK----EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTS----SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhh----chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 2111 122344556666666778888999999999999999999999999999885
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=418.43 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=211.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|+.++|||||++++++.+++..||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367899999999999999999864 7999999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC--CceEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER--LNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFGla~~~~~~~ 783 (955)
|++|+|.+++.... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999886442 36899999999999999999999999 9999999999999854 899999999999875432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.....+||+.|||||++.+..|+.++||||+||++|||++|..||..... .+.+..+..... .+++.
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-~~~~~~i~~~~~-------~~~~~-- 378 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDW-------NMDDS-- 378 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCC-------CCCSG--
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHhCCC-------CCCcc--
Confidence 33456899999999999999999999999999999999999999965433 233332222111 01111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......++.+|+.+||+.||.+|||++|++++
T Consensus 379 --~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223678899999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=411.20 Aligned_cols=247 Identities=24% Similarity=0.323 Sum_probs=200.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHH---HHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFK---MEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|...++||+|+||+||+|+.. +|+.||||++++... .....+. .++++++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57889999999999999999864 699999999864321 1122233 3466777789999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
||||||++|+|.++|...+ .+++.....++.||+.||+|||+.+ ||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999997654 6899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhhhhhc
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
... ....+||+.|||||++.. ..|+.++||||+||++|||++|++||.... +.......+...
T Consensus 344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---------- 409 (689)
T 3v5w_A 344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------- 409 (689)
T ss_dssp SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----------
T ss_pred CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----------
Confidence 432 234689999999999975 579999999999999999999999996432 221111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
++.. +.....++.+|+.+||+.||.+|++ ++||+++
T Consensus 410 -~~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 -AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -CCCC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -CCCC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1111 1122367889999999999999998 7888875
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=424.49 Aligned_cols=360 Identities=20% Similarity=0.295 Sum_probs=288.8
Q ss_pred CHHHHHHHHHHHhhcCCCC----------CCCCCCCCCCCCCC---ccEEeCC-CCEeEEEecCCcCccccCcCcCCCCc
Q 002189 24 NDNDFVILKALKDDIWENE----------PPNWKNNDPCGDNW---EGIGCTN-SRVTSITLSGMGLKGQLSGDITGLTE 89 (955)
Q Consensus 24 ~~~~~~~L~~~k~~~~~~~----------~~~w~~~~~C~~~w---~gv~C~~-~~v~~L~L~~~~l~~~~~~~l~~l~~ 89 (955)
...|+.||++|++++.... ..+|..+.+|| .| .||+|+. ++|+.|+|++++++|.+|+.|+.|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 3579999999998873211 13798665553 79 9999975 69999999999999999999999999
Q ss_pred ccEEecCCCCC---------------------------------------------------------------------
Q 002189 90 LHTLDLSNNKD--------------------------------------------------------------------- 100 (955)
Q Consensus 90 L~~L~Ls~N~~--------------------------------------------------------------------- 100 (955)
|++|+|++|..
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 99999999841
Q ss_pred --------CccCCCCCcccccccccccccccccCCC-----------------CCCccc--cCCCCcEEEccCCCCcCcC
Q 002189 101 --------LRGPLPTTIGNLKKLSNLMLVGCSFSGP-----------------IPDSIG--SLQELVLLSLNSNGFSGRV 153 (955)
Q Consensus 101 --------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N~l~~~~ 153 (955)
+++ +|..|+++++|++|+|++|++++. +|..++ ++++|++|+|++|++.+.+
T Consensus 187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 334 788899999999999999999985 999999 9999999999999999999
Q ss_pred CCCCCCCCCcCeeecCCce-eee-ccCCCCCCCCchhhhhccccccccCCcccccCCc-cccCCccceeeeeccCCCccc
Q 002189 154 PPSIGNLSNLYWLDLTDNK-LEG-EIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE-KLFRPDMVLIHVLFDSNNLTG 230 (955)
Q Consensus 154 p~~~~~L~~L~~L~L~~N~-l~g-~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~-~~~~~~~~L~~L~L~~N~l~~ 230 (955)
|..|+++++|++|+|++|+ ++| .+|..++.+..+..+++|++|++++|+++ .+|. ..+..+++|+.|++++|+++|
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g 344 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEG 344 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEE
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCcc
Confidence 9999999999999999998 998 88877665544455688888899999988 8887 355567788888999998888
Q ss_pred cCCcccCCCCCCcEEEcccCCCCCCccccccCCCC-CCEEEccCCcCcccCCCCCCCC--CCCEEECcCCCCCCCCCChh
Q 002189 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS-VNDLYLSNNKLTGAMPNLTGLS--VLSYLDMSNNSFDASEVPSW 307 (955)
Q Consensus 231 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~p~~ 307 (955)
.+| .|+.+++|+.|+|++|.++ .+|..+..+++ |+.|+|++|.++.++..+..++ +|++|+|++|.+++ ..|..
T Consensus 345 ~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~ 421 (636)
T 4eco_A 345 KLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS-VDGKN 421 (636)
T ss_dssp ECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTTT-TTTCS
T ss_pred chh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCCC-cchhh
Confidence 888 8888888888888888888 78888888888 8888888888886665555543 78888888888876 56666
Q ss_pred hc-------CCCCCCEEECcCCcceecCCcC-CCCCCCCcEEEeecCcceeeeCCCcchh--------hhhhhcccCCcc
Q 002189 308 FS-------SMQSLTTLMMENTNLKGQIPAD-LFSIPHLQTVVMKTNELNGTLDLGTSYS--------ENLLVNLQNNRI 371 (955)
Q Consensus 308 ~~-------~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~--------~l~~L~L~~N~l 371 (955)
|. .+++|+.|+|++|+++ .+|.. +..+++|+.|+|++|+++..++..+... +|+.|+|++|+|
T Consensus 422 l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 500 (636)
T 4eco_A 422 FDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500 (636)
T ss_dssp SCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCC
T ss_pred hcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcC
Confidence 66 6778888888888888 45544 4457888888888888885555444433 677888888888
Q ss_pred ccccCCCC-CCCcceeEecC
Q 002189 372 SAYTERGG-APAVNLTLIDN 390 (955)
Q Consensus 372 ~~~~~~~~-~~~~~L~~l~n 390 (955)
+.++...+ ..+.+|+.++.
T Consensus 501 ~~lp~~~~~~~l~~L~~L~L 520 (636)
T 4eco_A 501 TKLSDDFRATTLPYLVGIDL 520 (636)
T ss_dssp CBCCGGGSTTTCTTCCEEEC
T ss_pred CccChhhhhccCCCcCEEEC
Confidence 87766544 35555555544
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=425.82 Aligned_cols=393 Identities=20% Similarity=0.274 Sum_probs=270.2
Q ss_pred CCHHHHHHHHHHHhhcCCCCCCCCCCC------CCCCCCC------------ccEEeCC-CCEeEEEecCCcCccccCcC
Q 002189 23 TNDNDFVILKALKDDIWENEPPNWKNN------DPCGDNW------------EGIGCTN-SRVTSITLSGMGLKGQLSGD 83 (955)
Q Consensus 23 ~~~~~~~~L~~~k~~~~~~~~~~w~~~------~~C~~~w------------~gv~C~~-~~v~~L~L~~~~l~~~~~~~ 83 (955)
+...|+.||++||+++.+ + +|+.+ ++|+|.| .||+|+. ++|+.|+|++++++|.+|+.
T Consensus 266 ~~~~d~~ALl~~k~~l~~-~--~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~ 342 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDG-K--NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342 (876)
T ss_dssp HHHHHHHHHHHHHHHTTG-G--GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGG
T ss_pred cchHHHHHHHHHHHHcCC-C--CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchH
Confidence 346799999999999843 2 78644 4555689 9999984 89999999999999999999
Q ss_pred cCCCCcccEEec-CCCCCCccC----------------------------------------------------------
Q 002189 84 ITGLTELHTLDL-SNNKDLRGP---------------------------------------------------------- 104 (955)
Q Consensus 84 l~~l~~L~~L~L-s~N~~l~~~---------------------------------------------------------- 104 (955)
|++|++|+.|+| ++|. +.|.
T Consensus 343 l~~L~~L~~LdLss~N~-lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 343 IGQLTELKVLSFGTHSE-TVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGCTTCCEEESCCTTH-HHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HhccccceEeeeccccc-ccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 999999999999 7763 4333
Q ss_pred ------------------CCCCcccccccccccccccccCC-----------------CCCCccc--cCCCCcEEEccCC
Q 002189 105 ------------------LPTTIGNLKKLSNLMLVGCSFSG-----------------PIPDSIG--SLQELVLLSLNSN 147 (955)
Q Consensus 105 ------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~Ls~N 147 (955)
+|..|+++++|++|+|++|+|++ .+|..++ ++++|++|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 78899999999999999999998 3899988 9999999999999
Q ss_pred CCcCcCCCCCCCCCCcCeeecCCce-eee-ccCCCCCCCC-chhhhhccccccccCCcccccCCc-cccCCccceeeeec
Q 002189 148 GFSGRVPPSIGNLSNLYWLDLTDNK-LEG-EIPVSDGNSP-GLDMLVRAKHFHFGKNQLSGSIPE-KLFRPDMVLIHVLF 223 (955)
Q Consensus 148 ~l~~~~p~~~~~L~~L~~L~L~~N~-l~g-~ip~~~~~~~-~l~~L~~L~~L~L~~N~l~g~ip~-~~~~~~~~L~~L~L 223 (955)
++.+.+|..|+++++|+.|+|++|+ ++| .+|..++.+. .+..+++|++|+|++|+++ .+|. ..+..+.+|+.|+|
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~L 580 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDC 580 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEEC
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEEC
Confidence 9999999999999999999999998 998 7887665544 4445557777777777777 7776 34455667777777
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCC-CCEEEccCCcCcccCCCCCCCC--CCCEEECcCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTS-VNDLYLSNNKLTGAMPNLTGLS--VLSYLDMSNNSFD 300 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~l~--~L~~L~Ls~N~l~ 300 (955)
++|+++ .+| .|+.+++|+.|+|++|.++ .+|..+.++++ |+.|+|++|.|+.++..+..++ +|+.|+|++|+++
T Consensus 581 s~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~ 657 (876)
T 4ecn_A 581 VHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657 (876)
T ss_dssp TTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTT
T ss_pred CCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchhhhccccCCCCEEECcCCcCC
Confidence 777777 666 6777777777777777777 66777777776 7777777777765444333332 2455555555444
Q ss_pred CC---------------------------CCChh-hcCCCCCCEEECcCCcceecCCcCCCCC--------CCCcEEEee
Q 002189 301 AS---------------------------EVPSW-FSSMQSLTTLMMENTNLKGQIPADLFSI--------PHLQTVVMK 344 (955)
Q Consensus 301 ~~---------------------------~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------~~L~~L~Ls 344 (955)
+. .+|.. +..+++|+.|+|++|+|+ .+|..+... ++|+.|+|+
T Consensus 658 g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls 736 (876)
T 4ecn_A 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLR 736 (876)
T ss_dssp TTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECC
T ss_pred CccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECC
Confidence 31 13333 235566666666666666 444443332 256666666
Q ss_pred cCcceeeeCCCc--chhhhhhhcccCCccccccCCCCCCCcceeEecCcchhcccCccccccccCCCCCCCCCCCCCCcc
Q 002189 345 TNELNGTLDLGT--SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPA 422 (955)
Q Consensus 345 ~N~l~~~~~~~~--~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~~c~~~~~~~~~c~~~~~~~~~~~~~~~~~~~ 422 (955)
+|+|+..+.... .+.+|+.|+|++|+|++++ ..+..+.+|+.++...|.. .+.|.+.+.+|............
T Consensus 737 ~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~lp-~~l~~L~~L~~L~Ls~N~~----ls~N~l~~~ip~~l~~L~~L~~L 811 (876)
T 4ecn_A 737 FNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFP-TQPLNSSQLKAFGIRHQRD----AEGNRILRQWPTGITTCPSLIQL 811 (876)
T ss_dssp SSCCCCCCGGGSTTTCTTCCEEECCSSCCSSCC-CGGGGCTTCCEEECCCCBC----TTCCBCCCCCCTTGGGCSSCCEE
T ss_pred CCCCccchHHhhhccCCCcCEEEeCCCCCCccc-hhhhcCCCCCEEECCCCCC----cccccccccChHHHhcCCCCCEE
Confidence 666664333333 4556666666666666643 2233444555444332210 11234444455444444444444
Q ss_pred ccCCCCC
Q 002189 423 PCNANQS 429 (955)
Q Consensus 423 ~~~~~~~ 429 (955)
....|..
T Consensus 812 ~Ls~N~L 818 (876)
T 4ecn_A 812 QIGSNDI 818 (876)
T ss_dssp ECCSSCC
T ss_pred ECCCCCC
Confidence 4444443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=372.35 Aligned_cols=280 Identities=38% Similarity=0.649 Sum_probs=229.5
Q ss_pred CcccCHHHHHHHhcCCCcc------CeeeccCceEEEEEEeCCCcEEEEEEcccCC----cchhHHHHHHHHHHHhccCC
Q 002189 615 ARCFSFEEVKKYTNNFSDA------NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGS----MQGGQEFKMEIELLSRVHHK 684 (955)
Q Consensus 615 ~~~~~~~el~~~~~~f~~~------~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~ 684 (955)
...|++.++..++++|... +.||+|+||+||+|+. +++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4678999999999999988 8999999999999987 57899999986532 22346789999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 685 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
||+++++++.+.+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 99999999999999999999999999999886432 346899999999999999999999998 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch---HHHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY---IVRE 840 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~---~~~~ 840 (955)
+++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|..||..... ....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999987654433333344579999999998865 589999999999999999999999974332 1122
Q ss_pred HHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 841 IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
........ ..+.+.+++.+. .........+.+++.+||+.||.+||+++|+++.|+++.
T Consensus 247 ~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 247 KEEIEDEE---KTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHTTS---CCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHhhhhh---hhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22111111 112333444432 345567788999999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.52 Aligned_cols=251 Identities=22% Similarity=0.388 Sum_probs=210.9
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788999999999999999985 57899999998765555567789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999998754 5899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... +.. .
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~----------~~~--~ 237 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGT----------PEL--Q 237 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCS----------CCC--S
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC----------CCC--C
Confidence 23346799999999999999999999999999999999999999975543322 221111111 111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122334678899999999999999999999874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=426.76 Aligned_cols=351 Identities=28% Similarity=0.418 Sum_probs=224.9
Q ss_pred hhcCCHHHHHHHHHHHhhcCCC-CCCCCCCCCCCCCCCccEEeCCCCEeEEEecCCcCccc---cCcCcCCCCcccEEec
Q 002189 20 AAVTNDNDFVILKALKDDIWEN-EPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQ---LSGDITGLTELHTLDL 95 (955)
Q Consensus 20 ~~~~~~~~~~~L~~~k~~~~~~-~~~~w~~~~~C~~~w~gv~C~~~~v~~L~L~~~~l~~~---~~~~l~~l~~L~~L~L 95 (955)
++++.+.|.+||++||+++.+. .+.+|..+++|| .|.||+|+.++|+.|+|+++++.|. +++.+..|++|+.+++
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~ 84 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFL 84 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEEC
T ss_pred cccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCC
Confidence 3344578999999999998533 357898655553 7999999989999999999999998 7776666666666666
Q ss_pred CCCCCCccCCCCCcccccccccccccccccCCCCCC--ccccCCCCcEEEccCCCCcCcCCCCC-CCCCCcCeeecCCce
Q 002189 96 SNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD--SIGSLQELVLLSLNSNGFSGRVPPSI-GNLSNLYWLDLTDNK 172 (955)
Q Consensus 96 s~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~L~~L~~L~L~~N~ 172 (955)
+.|. + ..+|..|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|+
T Consensus 85 ~~~~-~-~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 85 SNSH-I-NGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp TTSC-E-EECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred cCCC-c-CCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 6664 2 23455666666666666666666666665 66666666666666666666555544 566666666666666
Q ss_pred eeeccCCC---CCCCCch----------------hhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCC
Q 002189 173 LEGEIPVS---DGNSPGL----------------DMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP 233 (955)
Q Consensus 173 l~g~ip~~---~~~~~~l----------------~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p 233 (955)
+++..|.. +.+++.| ..+++|++|+|++|++++.+|. +..+++|++|+|++|++++.+|
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~ 240 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFS 240 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCccc
Confidence 66554433 2221111 2344556666666666654544 4455566666666666666666
Q ss_pred cccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCC-CCCCEEECcCCCCCCCCCChhhcCC
Q 002189 234 ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGL-SVLSYLDMSNNSFDASEVPSWFSSM 311 (955)
Q Consensus 234 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l-~~L~~L~Ls~N~l~~~~~p~~~~~l 311 (955)
..+..+++|++|+|++|.+++.+|.. .+++|++|+|++|.+++..| .+..+ ++|++|+|++|.+++ .+|..|+++
T Consensus 241 ~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~-~~p~~~~~l 317 (768)
T 3rgz_A 241 RAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG-AVPPFFGSC 317 (768)
T ss_dssp HHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEE-CCCGGGGGC
T ss_pred HHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCC-ccchHHhcC
Confidence 66666666666666666666555544 56666666666666665444 34443 667777777776654 466666777
Q ss_pred CCCCEEECcCCcceecCCcC-CCCCCCCcEEEeecCcceeeeCCCcc-hh-hhhhhcccCCccccccCCC
Q 002189 312 QSLTTLMMENTNLKGQIPAD-LFSIPHLQTVVMKTNELNGTLDLGTS-YS-ENLLVNLQNNRISAYTERG 378 (955)
Q Consensus 312 ~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~-~l~~L~L~~N~l~~~~~~~ 378 (955)
++|+.|+|++|+++|.+|.. +..+++|++|+|++|++++.+|..+. +. +++.|+|++|++++..+..
T Consensus 318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~ 387 (768)
T 3rgz_A 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387 (768)
T ss_dssp TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTT
T ss_pred CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChh
Confidence 77777777777776666655 66677777777777777666655543 33 5666777777766554443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=386.90 Aligned_cols=262 Identities=25% Similarity=0.443 Sum_probs=213.3
Q ss_pred hcCCCccCeeeccCceEEEEEEeC--------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeC
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDR 696 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 696 (955)
.++|...+.||+|+||+||+|+.. ++..||||+++..... ..+.+.+|+++++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356788899999999999999852 3568999999865332 346789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 762 (955)
+..|+||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999986542 235899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHH
Q 002189 763 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREI 841 (955)
Q Consensus 763 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~ 841 (955)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 9999999999999987654433222333457789999999999999999999999999999999 9999864322 1111
Q ss_pred HHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
..+ ... ..+. .+......+.+++.+||+.||.+||+++|+++.|+++++..
T Consensus 316 ~~~-~~~---------~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 316 KLL-KEG---------HRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHH-HTT---------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH-hcC---------CCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111 111 0111 12233467899999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=373.42 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=205.6
Q ss_pred HhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
..++|...+.||+|+||+||+|+. +|+.||||++...... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356788899999999999999987 5889999998765433 3357899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 704 EFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999997643 224899999999999999999999875 45999999999999999999999999999865432
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+.... ....
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~~~~~~---------~~~~- 259 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKC---------KRLE- 259 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-HHHHHHHHSC---------CCCC-
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcC---------CCCC-
Confidence 2 2233467999999999999999999999999999999999999999754332 2211111110 0111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.......++.+++.+||+.||.+||+++|+++.|+.++++.
T Consensus 260 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 260 ---IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11223367899999999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=372.60 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=218.3
Q ss_pred cccCHHHHHHHhcC----------CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCC
Q 002189 616 RCFSFEEVKKYTNN----------FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK 684 (955)
Q Consensus 616 ~~~~~~el~~~~~~----------f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 684 (955)
..+++++++.+++. |...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46888999988875 566779999999999999975 7999999999876666667899999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC
Q 002189 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE 764 (955)
Q Consensus 685 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~ 764 (955)
||+++++++...+..++||||+++|+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999988743 5899999999999999999999998 999999999999999
Q ss_pred CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHH
Q 002189 765 RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTV 844 (955)
Q Consensus 765 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~ 844 (955)
++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +....+
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-~~~~~~ 253 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRL 253 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHH
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 99999999999987654322 223457999999999999999999999999999999999999999754332 222211
Q ss_pred HhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 845 MDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. ...+... ........+.+++.+||+.||++||+++|++++
T Consensus 254 ~~----------~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 RD----------SPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH----------SSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hc----------CCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1111111 112234678899999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=375.91 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=210.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||+||+|++. .+..||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999974 345699999986533 3346799999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.++++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999986542 36899999999999999999999998 999999999999999999999999999877543
Q ss_pred CC-cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 783 EK-DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 783 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
.. ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... +....+... ..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~----------~~- 272 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-DVISSVEEG----------YR- 272 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHHTT----------CC-
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHcC----------CC-
Confidence 22 112233456778999999999999999999999999999999 99999654332 222211111 01
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
..........+.+++.+||+.||.+||+++|+++.|+.+++..
T Consensus 273 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 ---LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1112234467899999999999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=381.92 Aligned_cols=272 Identities=26% Similarity=0.419 Sum_probs=219.0
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceE
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSL 689 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l 689 (955)
+...+.....++|...+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|++++.++ +|||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34445555678899999999999999999974 24689999999865433 346799999999999 79999999
Q ss_pred EEEEEeCCe-EEEEEEecCCCCcccccCCCCC------------------------------------------------
Q 002189 690 LGFCFDRGE-QMLIYEFVPNGSLGDSLSGKNG------------------------------------------------ 720 (955)
Q Consensus 690 ~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------ 720 (955)
++++.+.+. .++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 8999999999999998875432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 721 ----------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 721 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12889999999999999999999998 99999999999999999999999999987655444
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
........||+.|+|||++.+..++.++|||||||++|||+| |..||........... ...... .+..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~---------~~~~- 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-RLKEGT---------RMRA- 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-HHHHTC---------CCCC-
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-HHHcCC---------CCCC-
Confidence 344455678999999999999999999999999999999998 9999975433222222 111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
......++.+++.+||+.||.+||+++|++++|+++++..
T Consensus 318 ---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 318 ---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1123367889999999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=382.69 Aligned_cols=261 Identities=28% Similarity=0.494 Sum_probs=202.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.+|...+.||+|+||+||+|+.. ++..||||+++.... ...++|.+|++++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999864 577899999986432 3346799999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.++++.. ...+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999754 346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 783 EKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 783 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+ ....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-~~~~~~i-~~~~----------- 267 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAV-DEGY----------- 267 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-HHHHHHH-HTTE-----------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH-HcCC-----------
Confidence 221 11222346788999999999999999999999999999998 9999965432 1222111 1110
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
........+..+.+++.+||+.||.+||+++|+++.|+++++..+
T Consensus 268 --~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 268 --RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp --ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred --CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 011122344778999999999999999999999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=371.79 Aligned_cols=258 Identities=23% Similarity=0.429 Sum_probs=211.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
++|...+.||+|+||+||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46778899999999999999974 68999999987766666788999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999998753 236899999999999999999999998 9999999999999999999999999998765432211
Q ss_pred e------------eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH----HHHHHHHhhhhh
Q 002189 787 I------------TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV----REIRTVMDKKKE 850 (955)
Q Consensus 787 ~------------~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~----~~~~~~~~~~~~ 850 (955)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+....... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~----- 240 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL----- 240 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-----
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-----
Confidence 0 113569999999999999999999999999999999999999885321100 0000000
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.....+ ..+..+.+++.+||+.||++||+++|+++.|+++....
T Consensus 241 ----~~~~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 241 ----DRYCPP--------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ----HHTCCT--------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----cccCCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 001111 12246789999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=375.55 Aligned_cols=264 Identities=25% Similarity=0.357 Sum_probs=209.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC----eEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG----EQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV 702 (955)
.++|...++||+|+||+||+|++. ++.||||+++... .....+.+|+.++++++|||||++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357888999999999999999875 7999999987532 23345667999999999999999999998854 36999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------cCCCeeccCCCCccEEEcCCCceEEee
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL----------ANPPIIHRDIKSSNILLDERLNAKVAD 772 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivHrDlk~~NIll~~~~~~kl~D 772 (955)
|||+++|+|.++++.. .+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999754 489999999999999999999998 7 99999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCHHHhhhC-----CCCChhhhHHHHHHHHHHHhCCCCCcCCchH----------
Q 002189 773 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-----QLTEKSDVYSFGVLMLELLTGRRPIERGKYI---------- 837 (955)
Q Consensus 773 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~---------- 837 (955)
||+++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999877654433333346799999999999863 4567899999999999999999998642210
Q ss_pred ----HHHHHHHHhhhhhhhhhhhccCCcCCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 838 ----VREIRTVMDKKKELYNLYELIDPTIGL-STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 838 ----~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
........ ......|.+.. .........+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 255 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVV--------VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHH--------TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhh--------hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01111110 01111222211 122345677999999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=387.30 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=211.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|++. +++.||||+++..... ..++|.+|++++++++|||||++++++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356788899999999999999975 7899999998764332 23568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|+|.++++.. +..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999998753 235899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
........+++.|+|||.+.++.++.++|||||||++|||+| |..||...... .+........ .
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~---------~---- 333 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGG---------R---- 333 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTC---------C----
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---------C----
Confidence 111122346778999999999999999999999999999998 99998654322 1111211111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
...+..++..+.+++.+||+.||++|||++++++.|+++.++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 111122346789999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=373.19 Aligned_cols=271 Identities=25% Similarity=0.465 Sum_probs=208.6
Q ss_pred cCCCccCeeeccCceEEEEEEe-----CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 700 (955)
++|+..+.||+|+||+||+|++ .+++.||||+++.......+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5678889999999999999984 36889999999876655667899999999999999999999998654 5689
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999987543 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----hhhhhh
Q 002189 781 DSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----ELYNLY 855 (955)
Q Consensus 781 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----~~~~~~ 855 (955)
..... .......++..|+|||.+.+..++.++||||||+++|||+||..|+....... .. ...... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MR-MIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--HH-HHCTTCCTHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH--Hh-hhcCccccchhHHHHH
Confidence 43221 11223446778999999999999999999999999999999999986422111 00 000000 000011
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
+.+..............++.+++.+||+.||++|||++|+++.|+++.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111122234457899999999999999999999999999999765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=363.15 Aligned_cols=257 Identities=28% Similarity=0.497 Sum_probs=212.4
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||+||+|+..+++.||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46778899999999999999998899999999986543 34679999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ..
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 163 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-cc
Confidence 999999986543 36899999999999999999999998 99999999999999999999999999986643221 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .+....+... ..+..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-~~~~~~~~~~----------~~~~~---- 228 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG----------FRLYK---- 228 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTT----------CCCCC----
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHhcC----------ccCCC----
Confidence 223346778999999999999999999999999999999 8999865432 2222222111 01111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.......+.+++.+||+.||.+||+++|++++|+++.++
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 112236788999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=368.18 Aligned_cols=271 Identities=18% Similarity=0.252 Sum_probs=218.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...+.||+|+||+||+|+. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5688889999999999999985 5789999999875432 34688999999999 899999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc-----eEEeecccccccC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN-----AKVADFGLSKSMS 780 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DFGla~~~~ 780 (955)
+ +++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9 99999998754 247999999999999999999999998 999999999999999887 9999999998765
Q ss_pred CCCCcc-----eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCC--chHHHHHHHHHhhhhhhhh
Q 002189 781 DSEKDH-----ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG--KYIVREIRTVMDKKKELYN 853 (955)
Q Consensus 781 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~--~~~~~~~~~~~~~~~~~~~ 853 (955)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+....+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 239 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-- 239 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS--
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC--
Confidence 433211 123567999999999999999999999999999999999999999753 22333333222211100
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCCCCCCCC
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESAS 916 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 916 (955)
..+... ...+ ++.+++.+||+.||.+||+++++++.|+++.++.+........|
T Consensus 240 ~~~~~~--------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 240 PIEVLC--------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp CHHHHT--------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred CHHHHh--------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 000000 0122 78999999999999999999999999999999887655443333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=363.38 Aligned_cols=262 Identities=23% Similarity=0.410 Sum_probs=207.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|...+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 356888999999999999999864 689999999864332 2336789999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++...+ .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999987543 6899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.. .......||+.|+|||.+.+..++.++||||||+++|||+||+.||........... ...... +..
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~----------~~~ 232 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-HIQDSV----------PNV 232 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-HHSSCC----------CCH
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhhccC----------CCc
Confidence 22 223346799999999999999999999999999999999999999976543322221 111110 000
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRP-TMSEVVKDIENILQQ 905 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~ 905 (955)
........+..+.+++.+||+.||.+|| +++++.+.|+.++..
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0011112336788999999999999998 899999988877533
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=379.56 Aligned_cols=264 Identities=25% Similarity=0.424 Sum_probs=215.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC--------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeC
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDR 696 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 696 (955)
.++|...+.||+|+||+||+|+.. ++..||||+++..... ..+.+.+|+++++++ +|||||++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 356788899999999999999852 2468999999765333 346789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 762 (955)
+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 99999999999999999886543 235899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHH
Q 002189 763 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREI 841 (955)
Q Consensus 763 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~ 841 (955)
++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHH
Confidence 9999999999999987755433233344567889999999999999999999999999999999 999986433 22222
Q ss_pred HHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002189 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908 (955)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 908 (955)
..+ .... .+. .......++.+++.+||+.||++||+++|++++|++++.....
T Consensus 304 ~~~-~~~~---------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 304 KLL-KEGH---------RMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHH-HTTC---------CCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHH-HcCC---------CCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 211 1111 111 1122346789999999999999999999999999999877543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=371.05 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=206.3
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 457889999999999999999865 789999999865432 223568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999997553 6899999999999999999999998 99999999999999999999999999987643333
Q ss_pred cceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.................. ..+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------~~~---- 229 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------YLN---- 229 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-------TST----
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-------cCC----
Confidence 233345679999999999987775 77999999999999999999999754433222222111110 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+.+++.+||+.||.+|||++|++++
T Consensus 230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112233678899999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=370.20 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=206.8
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788899999999999999986 579999999987542 233467889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999986543 5899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCC-ChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .....||+.|+|||++.+..++ .++||||+||++|||++|+.||.... .......+..... ..
T Consensus 169 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~-----------~~ 233 (328)
T 3fe3_A 169 K---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVLRGKY-----------RI 233 (328)
T ss_dssp G---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC-----------CC
T ss_pred c---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCC-----------CC
Confidence 2 2345799999999999988875 78999999999999999999996543 2222222221110 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.....++.+++.+||+.||.+|||++|++++
T Consensus 234 ----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 ----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11123678899999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=383.24 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=211.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|...+.||+|+||+||+|++. +++.||||+++... .....++.+|+.++++++|||||++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56788899999999999999853 46789999997543 334457889999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC---ceEEee
Q 002189 701 LIYEFVPNGSLGDSLSGKN-----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL---NAKVAD 772 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~D 772 (955)
+||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999986532 245899999999999999999999998 99999999999999554 599999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhh
Q 002189 773 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKEL 851 (955)
Q Consensus 773 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 851 (955)
||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||..... .+....+....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-~~~~~~i~~~~--- 303 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGG--- 303 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTC---
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC---
Confidence 999986533222222334568899999999999999999999999999999998 9999865432 22222221111
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
. ..........+.+++.+||+.||.+||+++|++++|+.+.+..+
T Consensus 304 -------~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 304 -------R----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp -------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -------C----CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 0 01112234678899999999999999999999999999976543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.32 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=216.7
Q ss_pred hcCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 698 (955)
.++|...+.||+|+||+||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35688889999999999999984 3468999999986543 3346789999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCC----------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNG----------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 762 (955)
.++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999998865432 25899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHH
Q 002189 763 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREI 841 (955)
Q Consensus 763 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~ 841 (955)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |..||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence 9999999999999987765544333444568889999999999999999999999999999999 99998754332221
Q ss_pred HHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
....... ..+. ........+.+++.+||+.||.+||+++|+++.|+++++..
T Consensus 258 ~~~~~~~---------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 258 YKMIKEG---------FRML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHT---------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhccC---------CCCC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1111111 1111 11123367899999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=391.00 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=212.4
Q ss_pred HhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
..++|...+.||+|+||+||+|++.+++.||||+++... ...++|.+|+++|++++|||||++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 356788889999999999999999888999999998654 34678999999999999999999999986 6678999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.++++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~- 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-
Confidence 99999999998654456889999999999999999999998 99999999999999999999999999987643211
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.......+|+.|+|||++..+.++.++|||||||++|||+| |+.||..... .+....+... . . .
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~~-~---------~----~ 404 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALERG-Y---------R----M 404 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHHT-C---------C----C
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC-C---------C----C
Confidence 11223346788999999999999999999999999999999 9999965432 2222222111 0 0 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
..+..++.++.+++.+||+.||++|||+++|++.|+.+.
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111234478899999999999999999999999998775
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=368.54 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=214.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
.++|...+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45678889999999999999985 2458999999976433 3346789999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCC
Q 002189 700 MLIYEFVPNGSLGDSLSGKNG----------------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKS 757 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 757 (955)
++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999875432 34889999999999999999999998 99999999
Q ss_pred ccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCch
Q 002189 758 SNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKY 836 (955)
Q Consensus 758 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~ 836 (955)
+||++++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755433222334557888999999999999999999999999999999 9999864332
Q ss_pred HHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 837 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
. ... ....... .+. ........+.+++.+||+.||++||+++|++++|+++++++
T Consensus 259 ~-~~~-~~~~~~~---------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 259 E-RLF-NLLKTGH---------RME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp G-GHH-HHHHTTC---------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred H-HHH-HHhhcCC---------cCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 1 111 1111110 111 11233467899999999999999999999999999998653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=384.70 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=209.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC-eEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG-EQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|++. |+.||||+++... ..+.|.+|+++|++++|||||++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356778899999999999999985 7899999998654 4578999999999999999999999988765 78999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.++++..+...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 99999999998665555899999999999999999999998 999999999999999999999999999865322
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||...... +....+. ... . .
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~-~~~---------~----~ 405 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVE-KGY---------K----M 405 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHHHH-TTC---------C----C
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCC---------C----C
Confidence 122357899999999999999999999999999999998 99999643321 1111111 110 0 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
..+..++..+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11223447889999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=374.06 Aligned_cols=263 Identities=25% Similarity=0.422 Sum_probs=213.2
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 698 (955)
..++|...+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578899999999999999999874 3489999999865333 34679999999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCC
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN----------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIK 756 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk 756 (955)
.++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 999999999999999886532 146899999999999999999999998 9999999
Q ss_pred CccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCc
Q 002189 757 SSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGK 835 (955)
Q Consensus 757 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~ 835 (955)
|+||++++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654332223344568899999999999999999999999999999999 999996543
Q ss_pred hHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 836 YIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
. .+....+... . .+. ........+.+++.+||+.||++||+++|+++.|+++.++.
T Consensus 282 ~-~~~~~~~~~~-~---------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 H-EEVIYYVRDG-N---------ILA----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp H-HHHHHHHHTT-C---------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred h-HHHHHHHhCC-C---------cCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 2 2222211111 0 001 11223467899999999999999999999999999986543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.13 Aligned_cols=265 Identities=19% Similarity=0.253 Sum_probs=214.9
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|+++++.+ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 5688899999999999999985 578999999986543 235688999999999 799999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc-----eEEeecccccccC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN-----AKVADFGLSKSMS 780 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DFGla~~~~ 780 (955)
+ +++|.+++...+ ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||+++...
T Consensus 88 ~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 88 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 9 999999987543 36899999999999999999999988 999999999999987776 9999999998775
Q ss_pred CCCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhh
Q 002189 781 DSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYN 853 (955)
Q Consensus 781 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~ 853 (955)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........+...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-cc
Confidence 43321 12234679999999999999999999999999999999999999997532 222222222221110 00
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCC
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 909 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 909 (955)
..+ ..+ ..+..+.+++.+||+.||++||++++|++.|++++++.+..
T Consensus 242 ~~~-~~~--------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 242 LRE-LCA--------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHH-HTT--------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHH-HHh--------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 001 111 12367899999999999999999999999999999887643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=361.90 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=210.3
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.++|...+.||+|+||+||+|++.++..||||+++..... .+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3567888999999999999999988889999999865433 467999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 176 (283)
T 3gen_A 102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 176 (283)
T ss_dssp TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence 9999999987532 36899999999999999999999998 99999999999999999999999999987643221 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +....+... ..+..
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~----------~~~~~--- 242 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQG----------LRLYR--- 242 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTT----------CCCCC---
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-HHHHHHhcc----------cCCCC---
Confidence 1222346778999999999999999999999999999998 99999754332 222211111 11111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.......+.+++.+||+.||.+||+++|++++|++++.+
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 112236788999999999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=368.28 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=207.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc------hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
.+.|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457888999999999999999865 6899999998764332 246799999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC----ceEEeeccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL----NAKVADFGL 775 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGl 775 (955)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997643 6899999999999999999999998 99999999999998877 799999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... .+....+.....
T Consensus 166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~------ 235 (361)
T 2yab_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANITAVSY------ 235 (361)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCC------
T ss_pred ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCC------
Confidence 987654322 2345799999999999999999999999999999999999999965432 222222221110
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+++.. .......+.+++.+||..||.+|||++|++++
T Consensus 236 -~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 -DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001000 01123568899999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=372.06 Aligned_cols=263 Identities=23% Similarity=0.388 Sum_probs=212.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 698 (955)
.++|...+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788899999999999999985 245689999997542 23446799999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCC
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNG---------------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKS 757 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~ 757 (955)
.++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 9999999999999999875432 24799999999999999999999998 99999999
Q ss_pred ccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCch
Q 002189 758 SNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKY 836 (955)
Q Consensus 758 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~ 836 (955)
+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654443334445678899999999999999999999999999999998 9999975433
Q ss_pred HHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 837 IVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
... ........ ..+. ........+.+++.+||+.||.+||+++|++++|+.+++..
T Consensus 281 ~~~-~~~~~~~~---------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 281 DAN-FYKLIQNG---------FKMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SHH-HHHHHHTT---------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHH-HHHHHhcC---------CCCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 222 11121111 1111 11223467899999999999999999999999999987553
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.02 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=212.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.++|...+.||+|+||+||+|+..++..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 356788899999999999999998888999999986543 3467999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V 160 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence 9999999986542 35899999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +......... ....|
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~-------~~~~~----- 227 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-EVVLKVSQGH-------RLYRP----- 227 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTTC-------CCCCC-----
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-HHHHHHHcCC-------CCCCC-----
Confidence 2233456678999999999999999999999999999999 99999654332 2111111110 01111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
......+.+++.+||+.||.+|||++|+++.|+.+.+
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 --HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1123578899999999999999999999999988743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.81 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=197.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC-C---cEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE-
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN-G---QLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ- 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~- 699 (955)
.++|...+.||+|+||+||+|+... + ..||||+++.. .....+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4578899999999999999998653 3 27999999764 334457899999999999999999999999887655
Q ss_pred -----EEEEEecCCCCcccccCCCC----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEE
Q 002189 700 -----MLIYEFVPNGSLGDSLSGKN----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 700 -----~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999885422 235899999999999999999999998 999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhh
Q 002189 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +.........
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~~- 256 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-EIYNYLIGGN- 256 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTC-
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-HHHHHHhcCC-
Confidence 99999987655443333334567889999999999999999999999999999999 89998654332 1111111111
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 910 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 910 (955)
. ..........+.+++.+||+.||.+||+++|+++.|+++++......
T Consensus 257 ---------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 257 ---------R----LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp ---------C----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred ---------C----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 0 11112334678999999999999999999999999999998765433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.47 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=202.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc----EEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...+.||+|+||+||+|++. +++ +||+|.++... ....+++.+|++++++++||||++++++|.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46788899999999999999864 444 46888886432 234578999999999999999999999998754 789
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999987543 36899999999999999999999998 99999999999999999999999999988765
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... . +........
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~-~~~~~~~~~----------- 236 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-ISSILEKGE----------- 236 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-G-HHHHHHTTC-----------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-H-HHHHHHcCC-----------
Confidence 544333444567889999999999999999999999999999999 99999643321 1 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
...........+.+++.+||+.||.+||+++|++++|+.+.+
T Consensus 237 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111122234678999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=362.02 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=206.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc------hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
.+.|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999865 6899999998754322 346799999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC----ceEEeeccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL----NAKVADFGL 775 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGl 775 (955)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999997543 6899999999999999999999998 99999999999999887 799999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... .+....+.....
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~------ 234 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSAVNY------ 234 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHTCC------
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-HHHHHHHHhcCC------
Confidence 987653322 2345699999999999999999999999999999999999999965432 222222211110
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.............+.+++.+||+.||.+|||++|++++
T Consensus 235 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000001123568899999999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=362.54 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=202.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHh--ccCCCcceEEEEEEeC----CeEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSR--VHHKNLVSLLGFCFDR----GEQM 700 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~ 700 (955)
.++|...+.||+|+||+||+|+. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788999999999999999988 6899999998643 34566777777776 7899999999997653 4579
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hccCCCeeccCCCCccEEEcCCCceEEee
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH--------ELANPPIIHRDIKSSNILLDERLNAKVAD 772 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlk~~NIll~~~~~~kl~D 772 (955)
+||||+++|+|.++++.. .+++..++.++.|+++||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999643 6899999999999999999999 767 99999999999999999999999
Q ss_pred cccccccCCCCCcc--eeeeeecCCCCCCHHHhhhC------CCCChhhhHHHHHHHHHHHhC----------CCCCcCC
Q 002189 773 FGLSKSMSDSEKDH--ITTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVLMLELLTG----------RRPIERG 834 (955)
Q Consensus 773 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwS~Gv~l~elltg----------~~P~~~~ 834 (955)
||+++......... ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998765433211 11234799999999999876 455799999999999999999 7887532
Q ss_pred c---hHHHHHHHHHhhhhhhhhhhhccCCcCCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 835 K---YIVREIRTVMDKKKELYNLYELIDPTIGL-STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 835 ~---~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
. ............ ....+.... .........+.+++.+||+.||.+|||++|+++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCV--------DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhc--------cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 111222221111 111122211 12234667899999999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=387.63 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=207.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.++|...+.||+|+||+||+|++.++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 456788899999999999999998888899999986543 35689999999999999999999999866 6789999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++...+..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence 9999999997644446899999999999999999999998 99999999999999999999999999987653322 2
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......+++.|+|||++.++.++.++|||||||++|||+| |+.||..... .+....+. ... . ..
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~-~~~---------~----~~ 401 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVE-RGY---------R----MP 401 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHH-TTC---------C----CC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCC---------C----CC
Confidence 2233457889999999999999999999999999999999 8999865432 22222211 110 0 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.+..++..+.+++.+||+.||++|||++++++.|+.+...
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1223446789999999999999999999999999987533
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=392.42 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=213.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC-CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
..+|...+.||+|+||+||+|++.. +..||||+++.... ..++|.+|+++|++++|||||+++++|.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4567888999999999999999764 88999999986543 357899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.++++......+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 99999999998665567999999999999999999999998 99999999999999999999999999987643321
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.......+++.|+|||++.+..++.++|||||||++|||+| |..||...... +.. ..+... ...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~-~~~~~~-------------~~~ 438 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVY-ELLEKD-------------YRM 438 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHH-HHHHTT-------------CCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHH-HHHHcC-------------CCC
Confidence 22223456778999999999999999999999999999999 88998643321 111 111111 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.....+...+.+++.+||+.||.+||+++|+++.|+.++
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 122234478899999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=364.37 Aligned_cols=271 Identities=26% Similarity=0.419 Sum_probs=211.7
Q ss_pred CCccCeeeccCceEEEEEEeC-----CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-----NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQML 701 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 701 (955)
|...+.||+|+||+||++++. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477899999999999998753 688999999986533 3356789999999999999999999999884 57899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999754 4899999999999999999999998 99999999999999999999999999987754
Q ss_pred CCCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
.... .......+|..|+|||++.+..++.++||||||+++|||+||+.||......................+.+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 4321 122345678889999999999999999999999999999999999864322111100000000000001111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.............+.+++.+||+.||.+||+++|+++.|+.+.++.
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1112223344578999999999999999999999999999998765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=364.24 Aligned_cols=272 Identities=26% Similarity=0.412 Sum_probs=219.3
Q ss_pred CHHHHHHHhcCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEE
Q 002189 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLL 690 (955)
Q Consensus 619 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~ 690 (955)
...+.....++|...+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444445567899999999999999999974 35689999999865433 346789999999999 799999999
Q ss_pred EEEEeCC-eEEEEEEecCCCCcccccCCCCC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCC
Q 002189 691 GFCFDRG-EQMLIYEFVPNGSLGDSLSGKNG--------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDI 755 (955)
Q Consensus 691 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl 755 (955)
+++...+ ..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9998755 48999999999999999876542 12889999999999999999999998 999999
Q ss_pred CCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCC
Q 002189 756 KSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERG 834 (955)
Q Consensus 756 k~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~ 834 (955)
||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987655443333445678999999999999999999999999999999998 99999654
Q ss_pred chHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 835 KYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
........... ... .+.. .......+.+++.+||+.||.+||+++|++++|+.+++...
T Consensus 255 ~~~~~~~~~~~-~~~---------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 255 KIDEEFCRRLK-EGT---------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCSHHHHHHHH-HTC---------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred chhHHHHHHhc-cCc---------cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 33222222111 111 0111 11223678899999999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.47 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=208.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +++.||+|.++.. ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888999999999999999865 6889999998754 33456788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC--CCceEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE--RLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~~~~~~ 783 (955)
+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999987542 36899999999999999999999998 999999999999997 7899999999998775432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... .+....+...... .++.
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~-------~~~~-- 225 (321)
T 1tki_A 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYT-------FDEE-- 225 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC-------CCHH--
T ss_pred ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-HHHHHHHHcCCCC-------CChh--
Confidence 23456799999999999988899999999999999999999999965432 2223222221110 0000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......++.+++.+||+.||.+|||++|++++
T Consensus 226 --~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 --AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001123678899999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=372.59 Aligned_cols=280 Identities=16% Similarity=0.194 Sum_probs=212.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC------CcEEEEEEcccCCcchh-----------HHHHHHHHHHHhccCCCcceE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGG-----------QEFKMEIELLSRVHHKNLVSL 689 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l 689 (955)
.++|...+.||+|+||+||+|++.+ ++.||||++........ ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999998754 47899999875432111 123345566777789999999
Q ss_pred EEEEEeC----CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc--
Q 002189 690 LGFCFDR----GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-- 763 (955)
Q Consensus 690 ~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-- 763 (955)
++++... ...+|||||+ +++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 9999875 4579999999 99999998754 346999999999999999999999998 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~ 838 (955)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999876533211 11123459999999999999999999999999999999999999997533222
Q ss_pred HHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCCCCCCCC
Q 002189 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESAS 916 (955)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 916 (955)
........... ..+.+.+++.+. ....+.++.+++.+||+.||.+||+++++++.|+++++..+........|
T Consensus 269 ~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 269 KYVRDSKIRYR--ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp HHHHHHHHHHH--HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred HHHHHHHHHhh--hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 22221111111 011222222211 01223678999999999999999999999999999999887655443333
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=354.98 Aligned_cols=253 Identities=30% Similarity=0.513 Sum_probs=197.2
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc----hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ----GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|++. |+.||||+++..... ..+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 46788899999999999999974 899999998754322 2367899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC--------CCceEEeeccc
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE--------RLNAKVADFGL 775 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~--------~~~~kl~DFGl 775 (955)
||+++++|.+++... .+++..+..++.|+++||+|||+.+..+|+||||||+||+++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999988643 6899999999999999999999987556899999999999986 77899999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~-------- 229 (271)
T 3dtc_A 163 AREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-YGVAMN-------- 229 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-HHHHTS--------
T ss_pred cccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HhhhcC--------
Confidence 98664332 22356999999999999999999999999999999999999999754432211 111111
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
... ..........+.+++.+||+.||.+||+++|++++|+++
T Consensus 230 -~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -KLA----LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CCC----CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 011 111223346789999999999999999999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=365.59 Aligned_cols=248 Identities=23% Similarity=0.278 Sum_probs=206.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888999999999999999865 68999999987532 223456889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999887543 6899999999999999999999998 9999999999999999999999999998643322
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ...
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~-----------~~~- 224 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEE-----------IRF- 224 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC-----------CCC-
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-HHHHHHHHcCC-----------CCC-
Confidence 223456799999999999999999999999999999999999999965432 22222222111 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
+.....++.+++.+||+.||.+|| +++|++++
T Consensus 225 ---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112236788999999999999999 89999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=370.02 Aligned_cols=275 Identities=25% Similarity=0.393 Sum_probs=212.4
Q ss_pred cCCCccCeeeccCceEEEEEEe-----CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe--CCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 700 (955)
++|...+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4678889999999999999984 3688999999987666666789999999999999999999999874 55689
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999987532 25899999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCCcc-eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 781 DSEKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 781 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......................+.+.+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 433211 1223457888999999999999999999999999999999999986432211000000000000000111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
..............+.+++.+||+.||.+||+++|++++|+.+....
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11112223344578899999999999999999999999999887554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.11 Aligned_cols=272 Identities=25% Similarity=0.411 Sum_probs=207.3
Q ss_pred cCCCccCeeeccCceEEEEEEe-----CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 699 (955)
+.|...+.||+|+||+||+|++ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477889999999999999984 368999999987543 23346789999999999999999999999876 668
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999985432 36899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 780 SDSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 780 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
...... .......||..|+|||.+.+..++.++||||||+++|||+||..|+......................+...+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 543321 1222345778899999999999999999999999999999999986432211110000000000000011111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
...............+.+++.+||+.||.+|||++|+++.|++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111122234478899999999999999999999999999886
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=355.98 Aligned_cols=259 Identities=30% Similarity=0.470 Sum_probs=212.9
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||+||+|+..+++.||||+++.... ..+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 56788899999999999999988888999999976543 3577999999999999999999999876 456899999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....... ..
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 166 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TA 166 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-EC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-cc
Confidence 999999997654446899999999999999999999998 99999999999999999999999999987654321 12
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||.+.++.++.++||||||+++|||++ |+.||..... .+....+... ..+. .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~----------~~~~----~ 231 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERG----------YRMV----R 231 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTT----------CCCC----C
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-HHHHHHHhcc----------cCCC----C
Confidence 223457789999999999999999999999999999999 8989865432 2222211111 0111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
.......+.+++.+||+.||++||+++++++.|+++.....
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 12234678999999999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.78 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=198.3
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--------------------------hhHHHHHHHHHHHh
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--------------------------GGQEFKMEIELLSR 680 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~ 680 (955)
++|...+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5788899999999999999986 46899999998754321 12568899999999
Q ss_pred ccCCCcceEEEEEEe--CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCc
Q 002189 681 VHHKNLVSLLGFCFD--RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSS 758 (955)
Q Consensus 681 l~H~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~ 758 (955)
++||||+++++++.+ .+..++||||+++|+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 999999999999987 56789999999999999876543 6899999999999999999999998 999999999
Q ss_pred cEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCC---CCChhhhHHHHHHHHHHHhCCCCCcCCc
Q 002189 759 NILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPIERGK 835 (955)
Q Consensus 759 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwS~Gv~l~elltg~~P~~~~~ 835 (955)
||+++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999998765432 2234467999999999998665 3778999999999999999999997543
Q ss_pred hHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 836 YIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ......+.... .. .........++.+++.+||+.||++||+++|++++
T Consensus 245 ~-~~~~~~~~~~~---------~~----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 I-MCLHSKIKSQA---------LE----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp H-HHHHHHHHHCC---------CC----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred H-HHHHHHHhccc---------CC----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 2 12211111110 00 00111233678999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=381.32 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=212.5
Q ss_pred CHHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEE
Q 002189 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCF 694 (955)
Q Consensus 619 ~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 694 (955)
.+.+++...++|...++||+|+||+||+|+.. +++.||||++++... ...+.+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555566789999999999999999999975 578999999875221 12234889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecc
Q 002189 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 774 (955)
Q Consensus 695 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 774 (955)
+++..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999997632 36899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
+++....... .......||+.|+|||++. .+.++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKE 298 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHH
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhhccc
Confidence 9987654332 2233467999999999997 4568999999999999999999999997543 3333333332221
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 898 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 898 (955)
. ..-|... .....++.+++.+|+..+|++ ||+++|++++
T Consensus 299 ~------~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 R------FQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp H------CCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred c------ccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1 0111110 112367889999999888888 9999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.46 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=206.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999975 689999999875433 234678899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++ ++.+.+... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9975 555554432 236899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cceeeeeecCCCCCCHHHhhhCC-CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-----hhhhhcc
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-----YNLYELI 858 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 858 (955)
......||+.|+|||++.+.. ++.++|||||||++|||++|..|+..+.+..+....+....... .......
T Consensus 157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 223456899999999998765 89999999999999999999999876666655555544321100 0000000
Q ss_pred C--C--c-----CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 D--P--T-----IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d--~--~-----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+ + . ............+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0 0 0001112234678899999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.90 Aligned_cols=263 Identities=25% Similarity=0.448 Sum_probs=214.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC--------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeC
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDR 696 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 696 (955)
.++|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888999999999999999863 467899999986533 3346789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcccccCCCCC--------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNG--------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 762 (955)
+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999875431 24899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHH
Q 002189 763 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREI 841 (955)
Q Consensus 763 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~ 841 (955)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-HHHHH
Confidence 9999999999999987765433223334567888999999999999999999999999999999 999986433 22222
Q ss_pred HHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
..+. ... .+. ........+.+++.+||+.||.+||+++|+++.|+++++...
T Consensus 270 ~~~~-~~~---------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 270 KLLK-EGH---------RMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHH-HTC---------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHh-cCC---------CCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 2111 111 111 112234678999999999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=367.43 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=199.9
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccC--CCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHH--KNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|...+++.||||++...... ..+.+.+|++++++++| +||+++++++.+++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 457888999999999999999888999999998754332 34678999999999986 99999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
|| .+|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 89 e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp CC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred eC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 95 5889999987643 6899999999999999999999998 99999999999997 5789999999998775444
Q ss_pred CcceeeeeecCCCCCCHHHhhh-----------CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 784 KDHITTQVKGTMGYLDPEYYMT-----------QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------- 234 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------- 234 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh-------
Confidence 3333445679999999999976 6789999999999999999999999975444333222222
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
++.............+.+++.+||+.||.+|||++|++++-
T Consensus 235 ------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 235 ------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11111112222236788999999999999999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=365.52 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=207.7
Q ss_pred HHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
...++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567999999999999999999864 689999999975433 234678899999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC---CceEEeecccccc
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFGLSKS 778 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~~ 778 (955)
||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.+ +.+||+|||+++.
T Consensus 106 v~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999887543 6899999999999999999999998 9999999999999865 4599999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
...... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.....
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~~~--------- 247 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAY--------- 247 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC---------
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCC---------
Confidence 654322 2345799999999999999999999999999999999999999975432 222222211110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+ ...........++.+++.+||+.||++||+++|++++
T Consensus 248 ~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 D--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp C--CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0001112234678899999999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.30 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=202.2
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...+.||+|+||+||+|+..+|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468888999999999999999888999999998754322 236788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++ +|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 975 8888876542 36899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----hhhhh--hc
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLY--EL 857 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~ 857 (955)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +....+...... ..... ..
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCChhhchhhhcccc
Confidence 22345689999999999764 5899999999999999999999999754432 222222221100 00000 01
Q ss_pred cCCcCCC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGL-------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.++.... ........++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111110 0111234678899999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=357.67 Aligned_cols=260 Identities=29% Similarity=0.444 Sum_probs=217.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 456788899999999999999975 48899999997643 3457799999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 166 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 166 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-
Confidence 99999999998766667999999999999999999999999 99999999999999999999999999987654332
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .... ..... ..+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~-~~~~~---------~~~---- 231 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYE-LLEKD---------YRM---- 231 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHH-HHHTT---------CCC----
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH-HHhcc---------CCC----
Confidence 33344567889999999999999999999999999999999 88898643321 1111 11110 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.........+.+++.+||+.||.+||+++|+++.|+.+.+..
T Consensus 232 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 112233467899999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.76 Aligned_cols=265 Identities=22% Similarity=0.321 Sum_probs=201.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+..+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467888999999999999999998899999999875432 224678899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|++ |+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 997 57877776543 36899999999999999999999998 99999999999999999999999999987653322
Q ss_pred cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchH--HHHHHHHHhhhhh--hh---h---
Q 002189 785 DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI--VREIRTVMDKKKE--LY---N--- 853 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~--~~~~~~~~~~~~~--~~---~--- 853 (955)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+......... .. .
T Consensus 175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 2334568999999999986 56899999999999999999999999743322 1111111110000 00 0
Q ss_pred hhhccCCcCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGLS----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
............ .......++.+++.+||+.||.+|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000000 001123578899999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=365.86 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=204.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc----EEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...+.||+|+||+||+|++. +++ +||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778899999999999999864 444 38888876432 223356788999999999999999999885 567899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999998754 236888999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........||..|+|||++.++.++.++|||||||++|||+| |+.||...... .. ........ ....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~-~~~~~~~~------~~~~- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EV-PDLLEKGE------RLAQ- 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HH-HHHHHTTC------BCCC-
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HH-HHHHHcCC------CCCC-
Confidence 544444455678889999999999999999999999999999999 99999754321 11 11111111 0001
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
.......+.+++.+||+.||.+||+++|++++|+++..
T Consensus 239 ------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 ------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11122456789999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.09 Aligned_cols=260 Identities=28% Similarity=0.510 Sum_probs=197.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+.. ..||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 356888999999999999999864 3699999875433 2346789999999999999999999965 5667899999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999886543 46899999999999999999999998 99999999999999999999999999986654333
Q ss_pred cceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 785 DHITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||............. .... ..+.
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~--------~~~~ 246 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-GRGS--------LSPD 246 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH-HHTS--------CCCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh-cccc--------cCcc
Confidence 23334567999999999997 5678899999999999999999999997654433322222 2111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.. ......+..+.+++.+||+.||.+||+++|+++.|+++.
T Consensus 247 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 247 LS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11 112234478899999999999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.79 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=207.5
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeC--CeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR--GEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 703 (955)
++|...+.||+|+||+||+|++. ++.||||+++.... ...+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46788899999999999999985 88999999876432 3346799999999999999999999999887 7789999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.++++......+++..++.++.|+++||+|||+.+ ++++||||||+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~- 166 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP- 166 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeeccc-
Confidence 9999999999998766567999999999999999999999865 55999999999999999999999999987653322
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCC---hhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTE---KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... ........ ...+
T Consensus 167 ------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~---------~~~~ 230 (271)
T 3kmu_A 167 ------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-IGMKVALE---------GLRP 230 (271)
T ss_dssp ------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-HHHHHHHS---------CCCC
T ss_pred ------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-HHHHHHhc---------CCCC
Confidence 235899999999998765444 8999999999999999999997544322 11111111 1111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.. .......+.+++.+||+.||++|||++|+++.|+++.
T Consensus 231 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 TI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 1223467899999999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=367.73 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=209.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457889999999999999999864 6899999999876555567899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC--CCceEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE--RLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~~~~~~ 783 (955)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999988754 346899999999999999999999998 999999999999974 5779999999998775432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... +....+..... ..++.
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~-------~~~~~-- 272 (387)
T 1kob_A 206 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDW-------EFDED-- 272 (387)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCC-------CCCSS--
T ss_pred ---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC-------CCCcc--
Confidence 233457999999999999999999999999999999999999999754332 22222211110 01111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......++.+++.+||+.||.+|||++|++++
T Consensus 273 --~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 --AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112234678899999999999999999999975
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=361.80 Aligned_cols=292 Identities=28% Similarity=0.483 Sum_probs=212.3
Q ss_pred cCCHHHHHHHHHHHhhcCCC-CCCCCCCC-CCCCCCCccEEeCC----CCEeEEEecCCcCcc--ccCcCcCCCCcccEE
Q 002189 22 VTNDNDFVILKALKDDIWEN-EPPNWKNN-DPCGDNWEGIGCTN----SRVTSITLSGMGLKG--QLSGDITGLTELHTL 93 (955)
Q Consensus 22 ~~~~~~~~~L~~~k~~~~~~-~~~~w~~~-~~C~~~w~gv~C~~----~~v~~L~L~~~~l~~--~~~~~l~~l~~L~~L 93 (955)
.+.++|.+||++||+++.+. ...+|..+ |+|.+.|.||+|+. ++|+.|+|+++++++ .+|..|..+++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 36778999999999998532 24689765 44534599999985 689999999999999 899999999999999
Q ss_pred ecCC-CCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCce
Q 002189 94 DLSN-NKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172 (955)
Q Consensus 94 ~Ls~-N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~ 172 (955)
+|++ |+ +.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|.|++.+|..|.++++|++|+|++|+
T Consensus 82 ~L~~~n~-l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 82 YIGGINN-LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETT-EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eCCCCCc-ccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 9995 75 888899999999999999999999988889889999999999999999998888888889999999988888
Q ss_pred eeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCC
Q 002189 173 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSL 252 (955)
Q Consensus 173 l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 252 (955)
++|.+|..++. ....|+.|+|++|++++.+|..+..++ |+.|+|++|.+
T Consensus 161 l~~~~p~~l~~------------------------------l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 161 ISGAIPDSYGS------------------------------FSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp CEEECCGGGGC------------------------------CCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred ccCcCCHHHhh------------------------------hhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 88666644332 112345555555555555666666665 77777777777
Q ss_pred CCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCC
Q 002189 253 SGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADL 332 (955)
Q Consensus 253 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 332 (955)
++..|..|..+++|+.|+|++|.+++.++.+..+++|++|+|++|++ ++.+|..+
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l-------------------------~~~~p~~l 264 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRI-------------------------YGTLPQGL 264 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCC-------------------------EECCCGGG
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcc-------------------------cCcCChHH
Confidence 76667777777777777777777665555444445555555555544 44555555
Q ss_pred CCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCc
Q 002189 333 FSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNR 370 (955)
Q Consensus 333 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~ 370 (955)
..+++|++|+|++|++++.+|....+.++..|++++|+
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCCccccccChHHhcCCC
Confidence 55555555555555555555555445555566666665
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=356.37 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=199.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC----CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.++|...+.||+|+||+||+|+... +..||+|+++.... ...+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 3567888999999999999998642 45799999876433 3346789999999999999999999997 4567899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999998754 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... +....+.... .+
T Consensus 169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~i~~~~----------~~ 236 (281)
T 1mp8_A 169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGE----------RL 236 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTC----------CC
T ss_pred ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHHHHcCC----------CC
Confidence 322 12233457788999999999999999999999999999997 89998644322 1111111110 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.........+.+++.+||+.||++||+++|+++.|++++++.
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111233467889999999999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=358.20 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=200.2
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||+||+|++. ++.||||+++.. ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 45778899999999999999885 789999998753 34578999999999999999999999876 45799999999
Q ss_pred CCCcccccCCCCC-CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc-eEEeecccccccCCCCCc
Q 002189 708 NGSLGDSLSGKNG-IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN-AKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 708 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~-~kl~DFGla~~~~~~~~~ 785 (955)
+|+|.++++.... ..+++..++.++.|+++||+|||+.+...|+||||||+||+++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976542 24788999999999999999999943333999999999999998886 799999999765422
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||................. ..+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~--- 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG---------TRPPL--- 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT---------CCCCC---
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC---------CCCCc---
Confidence 2234699999999999999999999999999999999999999974322211111111110 11111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.......+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 226 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp -BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred -ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 1123367889999999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=366.27 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=192.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467888999999999999999975 57899999997543 346788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEeecccccccCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla~~~~~~ 782 (955)
+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 130 VTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999987654 6899999999999999999999998 999999999999975 889999999999876432
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||............+..... ....
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~------~~~~--- 272 (349)
T 2w4o_A 205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY------YFIS--- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC------CCCT---
T ss_pred c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC------ccCC---
Confidence 2 233467999999999999999999999999999999999999999765443323322222111 0011
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........++.+++.+||+.||++||+++|++++
T Consensus 273 --~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 --PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112234678899999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=374.71 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=207.3
Q ss_pred HHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
...++|...+.||+|+||+||+|.. .+|+.||+|++...... ..+.+.+|++++++++|||||++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3466799999999999999999985 47899999998765432 34568899999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc---CCCceEEeecccccc
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKS 778 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGla~~ 778 (955)
||||+++|+|.+.+.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 88 v~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999887554 6899999999999999999999998 99999999999998 467899999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
...... ......||+.|+|||++.+..++.++||||+||++|||++|..||..... .+....+..... ...
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~------~~~ 233 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAY------DFP 233 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCC------CCC
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCC------CCC
Confidence 654322 22346799999999999999999999999999999999999999965432 222222221111 111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+ .......++.+++.+||+.||.+|||++|++++
T Consensus 234 ~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 111234678899999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=367.46 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=201.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 701 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|.+++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467899999999999999999865 68999999987532 12335678899999988 69999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999987543 6899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+..... .
T Consensus 177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~-----------~ 242 (353)
T 3txo_A 177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAILNDEV-----------V 242 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC-----------C
T ss_pred CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCC-----------C
Confidence 22 23345679999999999999999999999999999999999999996543 2233333322110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTM------SEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 898 (955)
. +......+.+++.+||+.||.+||++ +|++++
T Consensus 243 ~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 Y----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 11123678899999999999999998 788764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=356.68 Aligned_cols=270 Identities=23% Similarity=0.322 Sum_probs=213.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCC--eEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG--EQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46788899999999999999975 589999999875332 33467889999999999999999999998765 779999
Q ss_pred EecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE----cCCCceEEeecccccc
Q 002189 704 EFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKS 778 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGla~~ 778 (955)
||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997643 234899999999999999999999998 9999999999999 8888899999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhh--------hCCCCChhhhHHHHHHHHHHHhCCCCCcCC---chHHHHHHHHHhh
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYM--------TQQLTEKSDVYSFGVLMLELLTGRRPIERG---KYIVREIRTVMDK 847 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDvwS~Gv~l~elltg~~P~~~~---~~~~~~~~~~~~~ 847 (955)
...... .....||+.|+|||++. +..++.++|||||||++|||+||+.||... ....+.+..+...
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 754332 23456999999999987 467899999999999999999999999632 2233333333332
Q ss_pred hhhh--hhhhhc------cCCc--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 848 KKEL--YNLYEL------IDPT--IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 848 ~~~~--~~~~~~------~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.... ..+... ..+. ............+.+++.+||+.||++|||++|++++..+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 2100 000000 0001 112334566678999999999999999999999999987653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=359.22 Aligned_cols=255 Identities=22% Similarity=0.381 Sum_probs=205.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CC-------cEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NG-------QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
++|...+.||+|+||+||+|+.. ++ ..||+|+++.......+.+.+|++++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56788899999999999999854 23 57999999776656667899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc--------eEEe
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN--------AKVA 771 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~--------~kl~ 771 (955)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999997543 34899999999999999999999998 999999999999998887 9999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 772 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
|||+++..... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.............. ..
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-~~-- 234 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DR-- 234 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TT--
T ss_pred cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-cc--
Confidence 99998765322 22458999999999987 7799999999999999999996665544433322221111 10
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 908 (955)
..+.+. ...++.+++.+||+.||.+|||++|++++|++++.+.+.
T Consensus 235 -----~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 235 -----HQLPAP--------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp -----CCCCCC--------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred -----CCCCCC--------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 001111 123577999999999999999999999999998765543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.82 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=199.7
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCe-----
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE----- 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 698 (955)
..++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4567889999999999999999975 79999999987543 3345779999999999999999999999876542
Q ss_pred ----------------------------------------------------EEEEEEecCCCCcccccCCCCC-CCCCH
Q 002189 699 ----------------------------------------------------QMLIYEFVPNGSLGDSLSGKNG-IRLDW 725 (955)
Q Consensus 699 ----------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~-~~l~~ 725 (955)
.++||||+++|+|.+++..... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7999999999999999876542 34677
Q ss_pred HHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc----------ceeeeeecCC
Q 002189 726 IRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD----------HITTQVKGTM 795 (955)
Q Consensus 726 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~ 795 (955)
..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 788999999999999999998 999999999999999999999999999877644211 1123356999
Q ss_pred CCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHH
Q 002189 796 GYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYV 875 (955)
Q Consensus 796 ~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 875 (955)
.|+|||++.+..++.++|||||||++|||++|..|+..... ..... . ....|. .......++.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---~~~~~----~------~~~~~~----~~~~~~~~~~ 303 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---IITDV----R------NLKFPL----LFTQKYPQEH 303 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---HHHHH----H------TTCCCH----HHHHHCHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---HHHHh----h------ccCCCc----ccccCChhHH
Confidence 99999999999999999999999999999998877532111 11100 0 000000 0122335678
Q ss_pred HHHHHhhccCCCCCCCHHHHHHH
Q 002189 876 DLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 876 ~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+++.+||+.||.+||+++|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=353.06 Aligned_cols=257 Identities=28% Similarity=0.483 Sum_probs=211.7
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||+||+|+..+++.||+|+++.... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46778899999999999999988889999999986543 34679999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++....... ..
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 161 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-cc
Confidence 999999987542 36899999999999999999999998 99999999999999999999999999987643211 11
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+....+.... .+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~i~~~~----------~~~~---- 226 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGF----------RLYK---- 226 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC----------CCCC----
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-HHHHHHHhcCC----------cCCC----
Confidence 122346778999999999999999999999999999999 8999865432 22222221110 0111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.......+.+++.+||+.||.+||+++|++++|+++.++
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 112236788999999999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=376.42 Aligned_cols=260 Identities=21% Similarity=0.308 Sum_probs=210.4
Q ss_pred HHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEe
Q 002189 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 695 (955)
+.+++...++|...++||+|+||+||+|+.. +++.||+|++++.. ....+.+.+|+++++.++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3444455678999999999999999999975 58999999986421 1223458899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccc
Q 002189 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGL 775 (955)
Q Consensus 696 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 775 (955)
.+..|+||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999988653 5889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCC----CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ----LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 851 (955)
++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+....+......
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~- 291 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNS- 291 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHHH-
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-hhhHHHHHHhcccc-
Confidence 987654322 2233567999999999998765 7899999999999999999999997543 33333333332210
Q ss_pred hhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 002189 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDD--RPTMSEVVKD 898 (955)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 898 (955)
..-|. ......++.+++.+||..+|.+ ||+++|++++
T Consensus 292 -----~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 -----LTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -----CCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -----ccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00111 1112367889999999999988 9999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=358.82 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=197.6
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCe----
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE---- 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 698 (955)
.++|...+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999996 57899999999764332 23568899999999999999999999877543
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||+++|+|.++++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999987543 6899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 779 MSDSEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 779 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-~~~~~~~~~~-------- 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDP-------- 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCC--------
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhcCCC--------
Confidence 6543221 12234569999999999999999999999999999999999999997544322 2221111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH-HHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK-DIENI 902 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~~ 902 (955)
..+. ........++.+++.+||+.||.+||++.++++ .+.++
T Consensus 237 ~~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 IPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCcc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000 001112367889999999999999997766654 45444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.29 Aligned_cols=269 Identities=17% Similarity=0.225 Sum_probs=212.4
Q ss_pred cCCCccCeeeccCceEEEEEEeCC---------CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcce----------
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN---------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVS---------- 688 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 688 (955)
++|...+.||+|+||+||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 568888999999999999998753 789999998753 46889999999999999988
Q ss_pred -----EEEEEEe-CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE
Q 002189 689 -----LLGFCFD-RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL 762 (955)
Q Consensus 689 -----l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll 762 (955)
+++++.. ++..++||||+ +|+|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 6778876 67889999999 999999998654457999999999999999999999998 9999999999999
Q ss_pred cCCC--ceEEeecccccccCCCCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc
Q 002189 763 DERL--NAKVADFGLSKSMSDSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK 835 (955)
Q Consensus 763 ~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~ 835 (955)
+.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999876532211 11123479999999999999999999999999999999999999997543
Q ss_pred hHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 002189 836 YIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 910 (955)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 910 (955)
.....+......... ......++.. ........+.+++.+||+.||.+||+++|+++.|++++++.+...
T Consensus 273 ~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 273 PNTEDIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp TCHHHHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred cCHHHHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 222222222111110 0111111110 011223678999999999999999999999999999998877544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=367.18 Aligned_cols=264 Identities=22% Similarity=0.376 Sum_probs=213.0
Q ss_pred HHHHHhcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEE
Q 002189 622 EVKKYTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCF 694 (955)
Q Consensus 622 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 694 (955)
+.+...++|...+.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678899999999999999999854 368899999975433 33457899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCcccccCCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC
Q 002189 695 DRGEQMLIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 766 (955)
Q Consensus 695 ~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 766 (955)
+.+..++||||+++|+|.++++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 9999999999999999999886422 135789999999999999999999998 99999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHH
Q 002189 767 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVM 845 (955)
Q Consensus 767 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~ 845 (955)
.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||..... .+....+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~ 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVM 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-HHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-HHHHHHHH
Confidence 999999999986644332222233467889999999999999999999999999999999 8888865432 22222111
Q ss_pred hhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 846 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
... . + .........+.+++.+||+.||.+||+++|++++|++++
T Consensus 255 ~~~---------~-~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 255 EGG---------L-L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp TTC---------C-C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred cCC---------c-C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 110 0 0 111223467889999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=352.47 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=211.7
Q ss_pred CCCccC-eeeccCceEEEEEEeC---CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDAN-DVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
+|...+ .||+|+||+||+|++. +++.||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 444555 8999999999999853 578899999986433 3456789999999999999999999999 566799999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp ECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999998643 346899999999999999999999998 9999999999999999999999999998775433
Q ss_pred Ccc-eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 784 KDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 784 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... +....+. ... .+.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~i~-~~~---------~~~ 233 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIE-QGK---------RME 233 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHH-TTC---------CCC
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHh-cCC---------cCC
Confidence 211 1123356889999999999999999999999999999999 99999754332 2111111 110 111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 910 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 910 (955)
........+.+++.+||+.||.+||+++|++++|+++..+.+...
T Consensus 234 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 234 ----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 112334788999999999999999999999999999998875543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=368.23 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=202.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 701 (955)
.++|...++||+|+||+||+|+.. +++.||||++++... ...+.+.+|..++.++ +|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356888999999999999999975 578999999875422 2234588899999887 89999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999887543 6899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch-------HHHHHHHHHhhhhhhhhh
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY-------IVREIRTVMDKKKELYNL 854 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~-------~~~~~~~~~~~~~~~~~~ 854 (955)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.......
T Consensus 206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------ 277 (396)
T 4dc2_A 206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------ 277 (396)
T ss_dssp TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC------
T ss_pred CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc------
Confidence 22 223456899999999999999999999999999999999999999963211 111111111111
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM------SEVVKD 898 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 898 (955)
.... +.....++.+++.+||+.||.+||++ +|++++
T Consensus 278 ----~~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 278 ----QIRI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----CCCC----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----ccCC----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1111 11233678899999999999999985 677764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=359.88 Aligned_cols=274 Identities=24% Similarity=0.372 Sum_probs=209.3
Q ss_pred HHHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhc--cCCCcceEEEEEEeC-
Q 002189 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV--HHKNLVSLLGFCFDR- 696 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~- 696 (955)
........++|...+.||+|+||+||+|+.. |+.||||++... ....+.+|.+++... +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3444556678999999999999999999885 899999998643 234455666666655 899999999999887
Q ss_pred ---CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeeccCCCCccEEEcCCCce
Q 002189 697 ---GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA-----NPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 697 ---~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~ 768 (955)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.+ .+.|+||||||+||+++.++.+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7889999999999999999654 5899999999999999999999871 1129999999999999999999
Q ss_pred EEeecccccccCCCCCcc--eeeeeecCCCCCCHHHhhhCCCCCh------hhhHHHHHHHHHHHhC----------CCC
Q 002189 769 KVADFGLSKSMSDSEKDH--ITTQVKGTMGYLDPEYYMTQQLTEK------SDVYSFGVLMLELLTG----------RRP 830 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDvwS~Gv~l~elltg----------~~P 830 (955)
||+|||+++......... ......||+.|+|||++.+...+.+ +|||||||++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999998765432211 1123579999999999988776665 9999999999999999 666
Q ss_pred CcCC---chHHHHHHHHHhhhhhhhhhhhccCCcCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 831 IERG---KYIVREIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 831 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
|... ............ .....+..... ....+..++.+++.+||+.||.+||+++|++++|+++.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVC--------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHT--------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCCchhhhHHHHh--------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 6422 111111211111 11112222111 12356788999999999999999999999999999998765
Q ss_pred CC
Q 002189 907 GL 908 (955)
Q Consensus 907 ~~ 908 (955)
+.
T Consensus 334 ~~ 335 (337)
T 3mdy_A 334 DI 335 (337)
T ss_dssp TC
T ss_pred cc
Confidence 43
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=386.88 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=205.2
Q ss_pred eeeccCceEEEEEEeC---CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 635 DVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
.||+|+||+||+|.+. ++..||||+++.... ...++|.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 467899999986533 345789999999999999999999999876 56899999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc-ceee
Q 002189 711 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-HITT 789 (955)
Q Consensus 711 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 789 (955)
|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ....
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99998754 346899999999999999999999998 999999999999999999999999999876543221 1122
Q ss_pred eeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 790 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 790 ~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
...+|+.|+|||++.++.++.++|||||||++|||+| |+.||...... +....+ .... ....+.
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i-~~~~-------------~~~~p~ 562 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFI-EQGK-------------RMECPP 562 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-HHHHHH-HTTC-------------CCCCCT
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHH-HcCC-------------CCCCCC
Confidence 3446789999999999999999999999999999998 99999754332 222111 1111 011122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 910 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 910 (955)
.++.++.+++.+||+.||++||++++|++.|+.+....+...
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 344789999999999999999999999999999987765433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=356.54 Aligned_cols=245 Identities=26% Similarity=0.368 Sum_probs=205.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999865 68999999987532 123456788999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999997543 6899999999999999999999998 999999999999999999999999999876432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ...
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~-----------~~~- 222 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAE-----------LRF- 222 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCC-----------CCC-
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-----------CCC-
Confidence 2245799999999999999999999999999999999999999975433 22222222211 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
+.....++.+++.+|++.||.+|| +++|++++
T Consensus 223 ---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 ---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 112236788999999999999999 89999865
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=365.81 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=200.2
Q ss_pred ccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 632 DANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 356799999999999986 4689999999987666667789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE--cCCCceEEeecccccccCCCCCccee
Q 002189 711 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL--DERLNAKVADFGLSKSMSDSEKDHIT 788 (955)
Q Consensus 711 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll--~~~~~~kl~DFGla~~~~~~~~~~~~ 788 (955)
|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 173 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 173 LFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp EHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 99888643 236899999999999999999999998 9999999999999 5678999999999987754332 2
Q ss_pred eeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCH
Q 002189 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTL 868 (955)
Q Consensus 789 ~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (955)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+..+...... +.+. ...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~-------~~~~----~~~ 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWD-------LEDE----EFQ 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC-------SCSG----GGT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCC-------CChh----hhc
Confidence 234699999999999999999999999999999999999999975443 2233333222110 0100 011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 869 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....++.+++.+||+.||.+||+++|++++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 223678999999999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=363.60 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=204.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC-----CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG-----SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
.+.|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888999999999999999864 6899999998632 1123567999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc---eEEeeccc
Q 002189 701 LIYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN---AKVADFGL 775 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGl 775 (955)
+||||+++|+|.+++... .+..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877543 2345899999999999999999999998 999999999999987655 99999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.....
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~------ 249 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKY------ 249 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCC------
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCC------
Confidence 98775432 223345799999999999999999999999999999999999999975432 11222211110
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..++.. .......+.+++.+||+.||++||++.|++++
T Consensus 250 -~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 -KMNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -CCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CCCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001000 01123678899999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=362.54 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=213.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC------CcEEEEEEcccCCc-chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSM-QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 698 (955)
.++|...+.||+|+||+||+|+... +..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678889999999999999998642 24899999976533 3346789999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 766 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 766 (955)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 999999999999999886432 235799999999999999999999998 99999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHH
Q 002189 767 NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVM 845 (955)
Q Consensus 767 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~ 845 (955)
.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |..||........ .....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHH
Confidence 999999999987654433333344567889999999999999999999999999999999 8889865432221 11222
Q ss_pred hhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 846 DKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.... .+. ........+.+++.+||+.||.+||+++|+++.|+++.+.
T Consensus 281 ~~~~---------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 281 KDGY---------QMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHTC---------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCC---------CCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111 111 1112236788999999999999999999999999998765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=369.87 Aligned_cols=251 Identities=21% Similarity=0.352 Sum_probs=200.0
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc--chhHHHHHHHHHHHhcc--CCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVH--HKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~ 703 (955)
.+|...+.||+|+||+||+|...+++.||||++..... ...+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45888999999999999999988899999999875432 33467899999999996 599999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
| +.+++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+....
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999987654 6889999999999999999999998 99999999999996 5789999999998775443
Q ss_pred CcceeeeeecCCCCCCHHHhhh-----------CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 784 KDHITTQVKGTMGYLDPEYYMT-----------QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+..+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~------ 282 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID------ 282 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC------
Confidence 3223345679999999999975 46899999999999999999999999754433333322221
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+......+......+.+++.+||+.||.+||+++|++++
T Consensus 283 -------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 -------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111123678899999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.70 Aligned_cols=264 Identities=21% Similarity=0.333 Sum_probs=201.9
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688899999999999999986 578999999987532 233467889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 704 EFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 704 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999988642 2346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.................. . +.
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~-~~ 257 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------Y-PP 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--------S-CC
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--------C-CC
Confidence 32 1223456899999999999999999999999999999999999999754322221111111110 0 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 908 (955)
.. ......++.+++.+||+.||.+||+++|+++.|+++......
T Consensus 258 ~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 LP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred Cc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 11 112336788999999999999999999999999999877654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.93 Aligned_cols=265 Identities=23% Similarity=0.373 Sum_probs=191.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999864 689999999875432 234678899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCC----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 705 FVPNGSLGDSLSGKN----GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
|++ |+|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69988775321 235899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh----hh-hh
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE----LY-NL 854 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~----~~-~~ 854 (955)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +....+...... .. ..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhh
Confidence 3321 2234568999999999986 46899999999999999999999999754432 222222221100 00 00
Q ss_pred hh--ccCCcCCC------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 855 YE--LIDPTIGL------------STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 855 ~~--~~d~~l~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. ...+.... ........++.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 00000000 0001123578999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=359.25 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=200.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc----EEEEEEcccC-CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...+.||+|+||+||+|++. +++ +||+|.++.. .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888999999999999999864 444 4678877643 3334578999999999999999999999998754 789
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999987543 36899999999999999999999998 99999999999999999999999999987754
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... . +........
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~-~~~~~~~~~----------- 236 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-ISSILEKGE----------- 236 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-G-HHHHHHTTC-----------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-H-HHHHHHcCC-----------
Confidence 443333344567888999999999999999999999999999999 99999643321 1 111111110
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
..........++.+++.+||+.||.+||+++|+++.|+++..
T Consensus 237 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 --RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 011122234678899999999999999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=358.51 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=196.4
Q ss_pred hcCCCccCeeeccCceEEEEEEe----CCCcEEEEEEcccCCc----chhHHHHHHHHHHHhccCCCcceEEEEEEeCCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 698 (955)
.++|...+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35688899999999999999986 4789999999976432 233567889999999999999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999887543 5889999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .+
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~-------~~ 240 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTIDKILKCKL-------NL 240 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCC-------CC
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCC-------CC
Confidence 43222 122345699999999999999999999999999999999999999975432 222222222110 01
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
. ......+.+++.+||+.||.+|| +++|++++
T Consensus 241 p--------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 P--------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp C--------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C--------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1 12236788999999999999999 78888875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=391.16 Aligned_cols=257 Identities=29% Similarity=0.471 Sum_probs=210.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.++|...+.||+|+||+||+|++.++..||||+++.... ..++|.+|+++|++++|||||++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456788899999999999999998888999999986543 35689999999999999999999999866 6789999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++...+..+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-H
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-e
Confidence 9999999997644446899999999999999999999998 99999999999999999999999999987643211 1
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......++..|+|||++..+.++.++|||||||++|||+| |+.||..... .+....+. ... . ..
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-~~~~~~i~-~~~---------~----~~ 484 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVE-RGY---------R----MP 484 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-HHHHHHHH-TTC---------C----CC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCC---------C----CC
Confidence 1122346788999999999999999999999999999999 8999865432 22222111 110 0 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
....+...+.+|+.+||+.||++||++++|++.|+.+..
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 112344678999999999999999999999999988753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=370.10 Aligned_cols=268 Identities=19% Similarity=0.272 Sum_probs=204.0
Q ss_pred cCCCccCeeecc--CceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSG--GYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...++||+| +||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 468888999999 99999999975 789999999875432 2346688899999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999987664457999999999999999999999998 999999999999999999999999998654322
Q ss_pred CC-----cceeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhh--
Q 002189 783 EK-----DHITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN-- 853 (955)
Q Consensus 783 ~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 853 (955)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 11 011122468889999999987 679999999999999999999999997433221111110000000000
Q ss_pred -------------------hhhcc---CCc------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 -------------------LYELI---DPT------IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 -------------------~~~~~---d~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.+ .+. ............+.+|+.+||+.||.+|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 000 0000112233678999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=360.46 Aligned_cols=261 Identities=25% Similarity=0.283 Sum_probs=203.8
Q ss_pred HHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC-----CcchhHHHHHHHHHHHhccCCCcceEEEEEEeC
Q 002189 623 VKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG-----SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696 (955)
Q Consensus 623 l~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 696 (955)
+....++|...+.||+|+||+||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445677899999999999999999986 46889999998643 234457899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCcccccCCCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKN--------------------------------------GIRLDWIRRLKIALGAARG 738 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~g 738 (955)
+..++||||+++|+|.+++.... ...+++..+..++.|+++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999885210 1124567788899999999
Q ss_pred HHHhhhccCCCeeccCCCCccEEEcCCC--ceEEeecccccccCCCCC--cceeeeeecCCCCCCHHHhhh--CCCCChh
Q 002189 739 LSYLHELANPPIIHRDIKSSNILLDERL--NAKVADFGLSKSMSDSEK--DHITTQVKGTMGYLDPEYYMT--QQLTEKS 812 (955)
Q Consensus 739 L~yLH~~~~~~ivHrDlk~~NIll~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~ks 812 (955)
|+|||+.+ |+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999986543221 112344679999999999975 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002189 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM 892 (955)
Q Consensus 813 DvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 892 (955)
|||||||++|||++|+.||...... +....+..... .............+.+++.+||+.||.+||++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKL-----------CFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-----------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhccc-----------ccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 9999999999999999999654432 22222222111 00001111234678899999999999999999
Q ss_pred HHHHHH
Q 002189 893 SEVVKD 898 (955)
Q Consensus 893 ~evl~~ 898 (955)
.|++++
T Consensus 326 ~~~l~h 331 (345)
T 3hko_A 326 MRALQH 331 (345)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=364.73 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=195.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 356888999999999999999975 789999999976433 236788999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc--eEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN--AKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFGla~~~~~~~ 783 (955)
+++|+|.+++...+ .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999886543 6899999999999999999999998 999999999999987765 9999999997543222
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCCh-hhhHHHHHHHHHHHhCCCCCcCCch---HHHHHHHHHhhhhhhhhhhhccC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEK-SDVYSFGVLMLELLTGRRPIERGKY---IVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwS~Gv~l~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||..... ....+......
T Consensus 173 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~------------ 237 (361)
T 3uc3_A 173 ---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV------------ 237 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT------------
T ss_pred ---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC------------
Confidence 2234579999999999998888766 8999999999999999999974332 12222211111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.............+.+++.+||+.||.+|||++|++++
T Consensus 238 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 -KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111223678899999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=363.13 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=205.3
Q ss_pred HHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
...++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578899999999999999999975 68999999987532 12345678899999987 899999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999987543 6899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+... .
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~-----------~ 234 (345)
T 1xjd_A 169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMD-----------N 234 (345)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHC-----------C
T ss_pred ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHhC-----------C
Confidence 3322 123456799999999999999999999999999999999999999965432 2222222111 1
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMS-EVVKD 898 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~ 898 (955)
+... .....++.+++.+||+.||.+||++. |++++
T Consensus 235 ~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 235 PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1111 11236788999999999999999997 77653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=360.89 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=202.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999975 689999999976432 2235678899999988 899999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999887543 6899999999999999999999998 999999999999999999999999999864322
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch-------HHHHHHHHHhhhhhhhhhh
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY-------IVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~-------~~~~~~~~~~~~~~~~~~~ 855 (955)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.......
T Consensus 164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------- 234 (345)
T 3a8x_A 164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------- 234 (345)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-------
T ss_pred C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-------
Confidence 2 223446799999999999999999999999999999999999999963211 111111111110
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM------SEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 898 (955)
.... +.....++.+++.+||+.||.+||++ +|++++
T Consensus 235 ---~~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 235 ---QIRI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CCCC----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCC----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111 11233678899999999999999995 677764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=349.98 Aligned_cols=253 Identities=32% Similarity=0.568 Sum_probs=201.7
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchh-------HHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGG-------QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
++|...+.||+|+||+||+|+. .+++.||||++........ +.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5678889999999999999986 4789999999865433211 67899999999999999999999986544
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc-----eEEeecc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN-----AKVADFG 774 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DFG 774 (955)
++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||||+||+++.++. +||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 79999999999988876543 46899999999999999999999875 45999999999999988776 9999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhh--hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.................
T Consensus 175 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 245 (287)
T 4f0f_A 175 LSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE---- 245 (287)
T ss_dssp TCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS----
T ss_pred ccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc----
Confidence 9985432 233467999999999984 45678999999999999999999999975432221111111111
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
...+.. .......+.+++.+||+.||.+||+++|+++.|++
T Consensus 246 ----~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 ----GLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ----CCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----CCCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111111 12234678999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.91 Aligned_cols=268 Identities=20% Similarity=0.317 Sum_probs=207.7
Q ss_pred HhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEE-EeCCeEEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC-FDRGEQMLIY 703 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~ 703 (955)
..++|...+.||+|+||+||+|+. .+++.||||++..... .+.+.+|+++++.++|++++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 5789999998764332 24588899999999988877766666 5667789999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE---cCCCceEEeecccccccC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMS 780 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~ 780 (955)
||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999886432 36899999999999999999999998 9999999999999 789999999999998765
Q ss_pred CCCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch--HHHHHHHHHhhhhhhhh
Q 002189 781 DSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY--IVREIRTVMDKKKELYN 853 (955)
Q Consensus 781 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~ 853 (955)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .............. .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 237 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--T 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--S
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc--c
Confidence 44321 112345799999999999999999999999999999999999999974221 11111111111100 0
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 910 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 910 (955)
......+ ..+..+.+++.+||+.||++||+++|+++.|+++.++.+...
T Consensus 238 ~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 238 PIEVLCK--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp CHHHHTT--------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hhhhhhc--------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 0000111 113678999999999999999999999999999998887543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=348.08 Aligned_cols=255 Identities=26% Similarity=0.411 Sum_probs=207.5
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
..++|...+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467889999999999999999875 78999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999997543 6899999999999999999999998 9999999999999999999999999998664332
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.................. ...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~--- 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------YLN--- 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-------TST---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-------ccC---
Confidence 2222334578999999999987665 77999999999999999999999754432222221111110 000
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+.+++.+||+.||.+|||++|++++
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 111233678899999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.85 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=206.8
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
..++|...+.||+|+||+||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3457889999999999999999865 578999999987655666789999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE---cCCCceEEeecccccccCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~~ 781 (955)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999886543 5899999999999999999999998 9999999999999 8889999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... +....+..... ..+.
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--------~~~~ 228 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-EVMLKIREGTF--------TFPE 228 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--------CCCH
T ss_pred ccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCC--------CCCc
Confidence 332 234569999999999865 4899999999999999999999999754432 22222211110 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.........+.+++.+||+.||.+||++.|++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 ---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000123678899999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=347.83 Aligned_cols=266 Identities=20% Similarity=0.325 Sum_probs=210.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEE-EeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFC-FDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+. .+|+.||||++..... .+++.+|+++++.++|++++..+.++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 45788899999999999999996 5789999999875433 35689999999999988877666665 55677899999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE---cCCCceEEeecccccccCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~~ 781 (955)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999886332 36899999999999999999999998 9999999999999 5889999999999987654
Q ss_pred CCCcc-----eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch--HHHHHHHHHhhhhhhhhh
Q 002189 782 SEKDH-----ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY--IVREIRTVMDKKKELYNL 854 (955)
Q Consensus 782 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~ 854 (955)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .......+...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 238 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--TP 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--SC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC--Cc
Confidence 43211 12345799999999999999999999999999999999999999974221 11111111111100 00
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCC
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 909 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 909 (955)
...+.+ ..+.++.+++.+||+.||++||+++|+++.|+++.+..+..
T Consensus 239 ~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 239 IEVLCK--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHTT--------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHh--------hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 000111 12367889999999999999999999999999999887653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=349.54 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=207.2
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe---------
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--------- 695 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 695 (955)
...+|...+.||+|+||.||+|+.. +|+.||||+++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567889999999999999999975 78999999987543 357789999999999999999998865
Q ss_pred -------CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 696 -------RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 696 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
....++||||+++|+|.+++.......+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 445799999999999999997654457999999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 848 (955)
||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...... ....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-------~~~~ 231 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF-------FTDL 231 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH-------HHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH-------HHHh
Confidence 9999999987754332 23356999999999999999999999999999999999999887432111 1100
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. ...+.+ .....+.+++.+||+.||.+||+++|++++|+.+.+.
T Consensus 232 ~-----~~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 232 R-----DGIISD--------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp H-----TTCCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred h-----cccccc--------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0 001111 1225678999999999999999999999999988543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.22 Aligned_cols=265 Identities=24% Similarity=0.308 Sum_probs=203.6
Q ss_pred HhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc-----chhHHHHHHHHHHHhcc---CCCcceEEEEEEeC
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-----QGGQEFKMEIELLSRVH---HKNLVSLLGFCFDR 696 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 696 (955)
..++|...+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 5789999999864221 12346778888887775 99999999999876
Q ss_pred C-----eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 697 G-----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 697 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
. ..++||||++ |+|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 4799999996 69999998766556999999999999999999999998 9999999999999999999999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh
Q 002189 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851 (955)
Q Consensus 772 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 851 (955)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.......
T Consensus 163 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-HHHHHHHHHHHCCC
T ss_pred eCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCC
Confidence 9999987653322 2345789999999999999999999999999999999999999965433 23333332211100
Q ss_pred --hhhhh-------ccCCcCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 --YNLYE-------LIDPTIGL---STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 --~~~~~-------~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.. .+.+.... .........+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000 00000000 0001233678899999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.27 Aligned_cols=246 Identities=22% Similarity=0.269 Sum_probs=195.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|+..++||+|+||+||+|+.. +|+.||||++...... ....+..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357899999999999999999975 7999999998654332 234455666666665 899999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+ +++|.+++...+ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 779988876543 46999999999999999999999988 999999999999999999999999999876533
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. ......||++|+|||++.+ .++.++|||||||++|||++|..|+........ ... . ...+..
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----~~~-~--------~~~~~~ 273 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ----LRQ-G--------YLPPEF 273 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH----HTT-T--------CCCHHH
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----Hhc-c--------CCCccc
Confidence 2 2334569999999998875 799999999999999999999877654322111 110 0 011111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+++.+||+.||++|||++|++++
T Consensus 274 ----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 ----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11123678999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=361.74 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=207.6
Q ss_pred hcCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
.++|...+.||+|+||+||+|++ .+++.||||++.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35788899999999999999984 247789999997543 33456789999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCC-----CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEe
Q 002189 700 MLIYEFVPNGSLGDSLSGKNG-----IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVA 771 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~ 771 (955)
++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999875431 35899999999999999999999998 999999999999984 4569999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhh
Q 002189 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 772 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |..||..... .+....+....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~-- 262 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGG-- 262 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTC--
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-HHHHHHHhcCC--
Confidence 9999986544332222334567889999999999999999999999999999998 8899865432 22222111110
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
.+. ........+.+++.+||+.||.+||+++|++++|+.+.+...
T Consensus 263 --------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 263 --------RMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp --------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred --------CCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 011 112234678899999999999999999999999999876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=366.02 Aligned_cols=260 Identities=30% Similarity=0.480 Sum_probs=196.8
Q ss_pred CCCccCeeeccCceEEEEEEeC--CC--cEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEe-CCeEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP--NG--QLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQMLI 702 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV 702 (955)
.|...+.||+|+||+||+|++. ++ ..||||.++... ....++|.+|+.++++++||||++++++|.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556688999999999999863 22 468999987543 3345779999999999999999999999765 4578999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.++++... ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997543 36889999999999999999999998 999999999999999999999999999876443
Q ss_pred CCc--ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 783 EKD--HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 783 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
... .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...... +........ . ....
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~~~~~~~~-~------~~~~ 317 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQG-R------RLLQ 317 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CHHHHHHTT-C------CCCC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HHHHHHHcC-C------CCCC
Confidence 221 11233567889999999999999999999999999999999 66666533221 111111111 0 0011
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
+......+.+++.+||+.||++||+++|+++.|++++....
T Consensus 318 -------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 318 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 12234678999999999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=355.82 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=199.4
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCe-
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE- 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~- 698 (955)
..++|...+.||+|+||+||+|+.. .++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3467788899999999999999853 345899999875433 234678999999999999999999999987653
Q ss_pred ----EEEEEEecCCCCcccccCC----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEE
Q 002189 699 ----QMLIYEFVPNGSLGDSLSG----KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKV 770 (955)
Q Consensus 699 ----~~lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 770 (955)
.++||||+++|+|.+++.. .....+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 4999999999999998732 22346999999999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhh
Q 002189 771 ADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ..........
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~- 266 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-EMYDYLLHGH- 266 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTC-
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHHcCC-
Confidence 99999987654433233334567889999999999999999999999999999999 88888644322 1111111110
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.+. ........+.+++.+||+.||.+||++++++++|++++++.
T Consensus 267 ---------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 267 ---------RLK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ---------CCC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---------CCC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 11223467899999999999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=360.72 Aligned_cols=271 Identities=26% Similarity=0.470 Sum_probs=211.5
Q ss_pred cCCCccCeeeccCceEEEEEEe-----CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC--eEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-----PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG--EQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~ 700 (955)
++|...+.||+|+||+||+|++ .+|+.||||+++.......+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577889999999999999984 368999999998766666678999999999999999999999987654 679
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999987543 36899999999999999999999988 9999999999999999999999999998775
Q ss_pred CCCCcc-eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----hhhhhh
Q 002189 781 DSEKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----ELYNLY 855 (955)
Q Consensus 781 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----~~~~~~ 855 (955)
...... ......++..|+|||.+.+..++.++||||||+++|||+||..|+........ . ...... ....+.
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM--R-MIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH--H-HHCTTCCTHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH--H-hhccccchhhhHHHHH
Confidence 433211 11224567789999999999999999999999999999999999863211110 0 000000 000011
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
+.+..............++.+++.+||+.||++||+++|+++.|+++.++
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111112233457889999999999999999999999999998765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=351.98 Aligned_cols=261 Identities=29% Similarity=0.443 Sum_probs=204.6
Q ss_pred cCCCccCeeeccCceEEEEEEeCC----CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEe-CCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l 701 (955)
.+|...+.||+|+||+||+|+..+ +..||||+++.... ...+.+.+|++++++++||||+++++++.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 356778899999999999998642 23689999876433 334678999999999999999999998754 557899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999753 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCC--cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 782 SEK--DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 782 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
... ........||+.|+|||.+.+..++.++||||||+++|||++|..|+..+....+.......... ...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 253 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------LLQ 253 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-------CCC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-------CCC
Confidence 321 11223456788999999999999999999999999999999955444333222222222211110 011
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.......+.+++.+||+.||.+||+++|+++.|++++...
T Consensus 254 -------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 254 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1122367899999999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.60 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=205.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 68999999986532 123457889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999987543 5899999999999999999999998 999999999999999999999999999876432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ...
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~-----------~~~- 257 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGK-----------VRF- 257 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC-----------CCC-
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-HHHHHHHHcCC-----------CCC-
Confidence 2235799999999999999999999999999999999999999975432 22222222211 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
+......+.+++.+||+.||.+||+ ++|++++
T Consensus 258 ---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1123367889999999999999998 8898865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=350.61 Aligned_cols=260 Identities=26% Similarity=0.351 Sum_probs=207.4
Q ss_pred CCccCeeeccCceEEEEEEeC-C---CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE-EEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-N---GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ-MLIY 703 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV~ 703 (955)
|...++||+|+||+||+|++. + +..||+|+++.... ...+.+.+|++++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 445688999999999999853 2 23799999876433 3346789999999999999999999999876655 9999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 103 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred ecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999998763 346899999999999999999999998 9999999999999999999999999998654322
Q ss_pred C--cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 784 K--DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 784 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
. ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.......+......... .+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~----------~~- 247 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR----------RL- 247 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC----------CC-
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC----------CC-
Confidence 1 1122234678899999999999999999999999999999997666554433322222111111 00
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
.........+.+++.+||+.||.+|||++|+++.|++++++..
T Consensus 248 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 248 ---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ---CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1112233678999999999999999999999999999988753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.34 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=206.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc------hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 699 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888999999999999999865 6899999998754322 246799999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC----ceEEeeccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL----NAKVADFGL 775 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGl 775 (955)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999997543 6899999999999999999999998 99999999999999888 799999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..||..... .+....+.....
T Consensus 166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~------ 235 (321)
T 2a2a_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANITSVSY------ 235 (321)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCC------
T ss_pred ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhccc------
Confidence 987654322 2345699999999999999999999999999999999999999965432 222222211100
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..++.. .......+.+++.+||+.||++|||++|++++
T Consensus 236 -~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 -DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001000 01123578899999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=357.73 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=203.5
Q ss_pred cCCCccCeeeccCceEEEEEEeCC-----CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN-----GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.+|...+.||+|+||+||+|+... +..||||+++.... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 345667899999999999998642 24699999976433 234578999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999998753 246899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 782 SEKD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 782 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
.... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... .+....+... . .
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-~~~~~~~~~~-~---------~ 268 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG-F---------R 268 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTT-C---------C
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHCC-C---------c
Confidence 3221 11223346788999999999999999999999999999999 9999965432 1222111111 0 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
+ .........+.+++.+||+.||.+||+++|+++.|+++++..
T Consensus 269 ~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 L----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp C----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred C----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 111233467899999999999999999999999999998654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=350.49 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=201.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeC-CeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-GEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. |+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 356888899999999999999874 8899999997543 446799999999999999999999997654 478999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999987554334789999999999999999999998 9999999999999999999999999998654321
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... +....+. . ...+
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~-~---------~~~~---- 233 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVE-K---------GYKM---- 233 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHT-T---------TCCC----
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHh-c---------CCCC----
Confidence 22357899999999999999999999999999999998 99998643221 1111111 0 0111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.........+.+++.+||+.||.+||+++|+++.|+++....
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 112233467899999999999999999999999999987653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=370.34 Aligned_cols=264 Identities=22% Similarity=0.266 Sum_probs=210.5
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEE
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFC 693 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~ 693 (955)
+.+++.+...++|...++||+|+||+||+|+.. +|+.||||++++... ...+.+.+|.+++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344555556789999999999999999999974 789999999875321 1224588999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 694 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
.+.+..|+||||+++|+|.+++...+ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997532 36899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhh-------CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 846 (955)
|+++....... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+....+..
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~ 284 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-AETYGKIVH 284 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHT
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Confidence 99987654332 22234679999999999983 5689999999999999999999999975433 233333332
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 002189 847 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDR---PTMSEVVKD 898 (955)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 898 (955)
.... ...|.. ......++.+++.+||. +|.+| |+++|++++
T Consensus 285 ~~~~------~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEH------LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHH------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccC------cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2110 001111 11223678899999999 99998 689999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=349.36 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=204.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeCC----CcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.++|...+.||+|+||+||+|++.+ +..||||+++.... ...+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3567888999999999999998542 34699999886533 345679999999999999999999998764 56789
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999998653 235899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... ..... .... .+
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~~~-~~~~---------~~ 233 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVL-EKGD---------RL 233 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHHHH-HHTC---------CC
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHHHH-hcCC---------CC
Confidence 322 12233457888999999999999999999999999999998 999996433221 11111 1110 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. ........+.+++.+||+.||++||+++|+++.|+++.+.
T Consensus 234 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 P----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0 1112336788999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.34 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=207.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcE--EEEEEcccCC-cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQL--IAIKRAQQGS-MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||+||+|+.. +|.. ||||+++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888899999999999999864 5664 4999887532 23346789999999999 899999999999999999999
Q ss_pred EEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 703 YEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
|||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999987543 246899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDK 847 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 847 (955)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... +....+. .
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~~~~-~ 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLP-Q 256 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHGG-G
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-HHHHHhh-c
Confidence 99999999743221 11223457889999999999999999999999999999998 99999654321 1111111 1
Q ss_pred hhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 848 KKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
...+ .........+.+++.+||+.||.+||+++|+++.|+++++...
T Consensus 257 ---------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 257 ---------GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ---------TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------CCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0111 1122334678999999999999999999999999999987653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=364.76 Aligned_cols=247 Identities=24% Similarity=0.333 Sum_probs=202.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999865 68899999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999987643 6899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeeeeecCCCCCCHHHhhh---CCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhhhhhcc
Q 002189 784 KDHITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ............
T Consensus 170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----------- 235 (384)
T 4fr4_A 170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----------- 235 (384)
T ss_dssp ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----------
T ss_pred ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----------
Confidence 2344679999999999974 458999999999999999999999997432 221211111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-MSEVVK 897 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 897 (955)
... .+......+.+++.+||+.||.+||+ ++++.+
T Consensus 236 ~~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 VVT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ccC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 001 11123367899999999999999998 777765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=359.14 Aligned_cols=264 Identities=18% Similarity=0.215 Sum_probs=199.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCcch-----------hHHHHHHHHHHHhccCCCcceEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSMQG-----------GQEFKMEIELLSRVHHKNLVSLLGF 692 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~~~ 692 (955)
++|...+.||+|+||+||+|+.. ++..||||++....... .+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56788899999999999999975 57889999987643221 1346678889999999999999999
Q ss_pred EEe----CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC--
Q 002189 693 CFD----RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-- 766 (955)
Q Consensus 693 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-- 766 (955)
+.. ....++||||+ +++|.+++...+ .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 988 67889999999 999999998654 7899999999999999999999998 99999999999999887
Q ss_pred ceEEeecccccccCCCCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHH
Q 002189 767 NAKVADFGLSKSMSDSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREI 841 (955)
Q Consensus 767 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~ 841 (955)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999876432211 11134579999999999999999999999999999999999999996422211111
Q ss_pred HHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 842 RTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
......... .+...+..... ....+.++.+++.+||+.||++||++++|++.|+++
T Consensus 271 ~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 271 QTAKTNLLD--ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHH--TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHhhcc--cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111100 00000000000 012336789999999999999999999999988765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=364.51 Aligned_cols=273 Identities=22% Similarity=0.319 Sum_probs=211.9
Q ss_pred CcccCHHHHHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-----CCCcce
Q 002189 615 ARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-----HKNLVS 688 (955)
Q Consensus 615 ~~~~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~ 688 (955)
...+++.+.....++|...++||+|+||+||+|+. .+++.||||+++.. ....+.+..|+++++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455555556678999999999999999999986 47899999998743 233466788999999996 999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC----
Q 002189 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---- 764 (955)
Q Consensus 689 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---- 764 (955)
+++++...+..++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 999999999999999999 999999998665556999999999999999999999998 999999999999975
Q ss_pred ---------------------CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHH
Q 002189 765 ---------------------RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 823 (955)
Q Consensus 765 ---------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~e 823 (955)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7899999999998654322 23568999999999999999999999999999999
Q ss_pred HHhCCCCCcCCchHHHHHHHHHhhhhhhh----------hhhhccCC-c----CCC-CCCHH---------------HHH
Q 002189 824 LLTGRRPIERGKYIVREIRTVMDKKKELY----------NLYELIDP-T----IGL-STTLK---------------GFE 872 (955)
Q Consensus 824 lltg~~P~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~-~----l~~-~~~~~---------------~~~ 872 (955)
|++|+.||...... +....+........ .....++. . ... ..... ...
T Consensus 252 ll~g~~pf~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 252 LYTGSLLFRTHEHM-EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHSSCSCCCSSHH-HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHCCCCCCCCcHH-HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 99999999754332 22221111000000 00000000 0 000 00000 015
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 873 KYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 873 ~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+.+++.+||+.||.+|||++|++++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 67899999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=350.05 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=206.4
Q ss_pred cCCCccC-eeeccCceEEEEEEe---CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDAN-DVGSGGYGKVYKGTL---PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~-~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
++|...+ .||+|+||+||+|.+ .+++.||||+++.... ...+++.+|+++++.++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 899999999999964 2468999999875432 2346799999999999999999999999 6678899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 95 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999997643 5899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcc-eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 782 SEKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 782 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... +. ........ .
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~-~~~~~~~~---------~ 238 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EV-TAMLEKGE---------R 238 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HH-HHHHHTTC---------C
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HH-HHHHHcCC---------C
Confidence 33211 1222346788999999999899999999999999999999 99999754331 11 11111111 1
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
+. ........+.+++.+||+.||.+||+++|+++.|++++.+.
T Consensus 239 ~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 239 MG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11 11233467899999999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=361.18 Aligned_cols=246 Identities=25% Similarity=0.353 Sum_probs=202.3
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 578999999986431 122357899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+ +|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 789988886543 6899999999999999999999999 9999999999999999999999999998765433
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+...+...
T Consensus 163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---------------~~~~~i~~~- 223 (336)
T 3h4j_B 163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP---------------NLFKKVNSC- 223 (336)
T ss_dssp T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST---------------TCBCCCCSS-
T ss_pred c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH---------------HHHHHHHcC-
Confidence 2 234569999999999987776 68999999999999999999999643211 011111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+......+.+++.+||+.||.+|||++|++++
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011122234678899999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=361.74 Aligned_cols=246 Identities=28% Similarity=0.459 Sum_probs=201.4
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
+.|...+.||+|+||+||+|+. .+|+.||||++...... ..+++.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4478889999999999999985 57899999998754332 2356889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9996 6887777532 236899999999999999999999998 999999999999999999999999999876432
Q ss_pred CcceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||...... ..+....... .+
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~~~~~~~~~~----------~~ 271 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE----------SP 271 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSC----------CC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcC----------CC
Confidence 2356999999999985 567899999999999999999999999755432 2222222111 11
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... .......+.+++.+||+.||.+|||++|++++
T Consensus 272 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 11223678899999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.22 Aligned_cols=273 Identities=23% Similarity=0.380 Sum_probs=215.9
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHh--ccCCCcceEEEEEEe
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSR--VHHKNLVSLLGFCFD 695 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~ 695 (955)
.++.......++|...+.||+|+||+||+|+. +|+.||||+++.. ..+.+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34444556678899999999999999999998 5899999998642 34668889999987 689999999999988
Q ss_pred CC----eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hccCCCeeccCCCCccEEEc
Q 002189 696 RG----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH--------ELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 696 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlk~~NIll~ 763 (955)
.+ ..++||||+++|+|.+++... .+++..++.++.|+++||+||| +.+ |+||||||+||+++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 76 789999999999999999653 5899999999999999999999 667 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcc--eeeeeecCCCCCCHHHhhhCC------CCChhhhHHHHHHHHHHHhC--------
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDH--ITTQVKGTMGYLDPEYYMTQQ------LTEKSDVYSFGVLMLELLTG-------- 827 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwS~Gv~l~elltg-------- 827 (955)
.++.+||+|||+++......... ......||+.|+|||.+.+.. ++.++|||||||++|||+||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999998765433211 123457999999999998652 33689999999999999999
Q ss_pred --CCCCcCCch---HHHHHHHHHhhhhhhhhhhhccCCcCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 828 --RRPIERGKY---IVREIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 828 --~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
..||..... ....+...... ....+.+... ........+.+++.+||+.||++||+++|++++|++
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVVCE--------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTT--------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHHHHHHH--------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 678753211 11211111111 1122222211 233566789999999999999999999999999999
Q ss_pred HHHHcCC
Q 002189 902 ILQQAGL 908 (955)
Q Consensus 902 ~~~~~~~ 908 (955)
+.++.+.
T Consensus 334 i~~~~~~ 340 (342)
T 1b6c_B 334 LSQQEGI 340 (342)
T ss_dssp HHHTTC-
T ss_pred HHHHhcC
Confidence 9887653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=385.97 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=201.1
Q ss_pred CeeeccCceEEEEEEeC---CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
+.||+|+||+||+|.+. .++.||||+++.... ...+++.+|+++|++++|||||+++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 467899999986433 23578999999999999999999999986 4568999999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC-cce
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK-DHI 787 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~-~~~ 787 (955)
|+|.++++... .+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..... ...
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999996543 6899999999999999999999998 99999999999999999999999999987754332 122
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.. ..+.... . ...
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~-~~i~~~~---------~----~~~ 593 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVT-AMLEKGE---------R----MGC 593 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHH-HHHHTTC---------C----CCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHH-HHHHcCC---------C----CCC
Confidence 233457889999999999999999999999999999998 99999654332 111 1111111 0 111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
...+..++.+++.+||+.||++||++++|++.|+++...
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 223447889999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.98 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=200.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 357888999999999999999975 5899999998654332 2456889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999988876543 5899999999999999999999998 9999999999999999999999999998765332
Q ss_pred CcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh------------
Q 002189 784 KDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------------ 850 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------------ 850 (955)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ....+......
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHTC
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhcccccccccccccc
Confidence 2 2234578999999999986 678999999999999999999999997544322 22111111000
Q ss_pred -hhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 -LYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 -~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........++..... ........+.+++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000111110000 001233568899999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.68 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=205.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 701 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467889999999999999999975 47899999987532 12345678899999988 79999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999987543 5899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.... ..
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~-----------~~ 239 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHN-----------VA 239 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCC-----------CC
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCC-----------CC
Confidence 22 22344679999999999999999999999999999999999999996543 223222222211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
. +.....++.+++.+||+.||.+||+ ++|++++
T Consensus 240 ~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1123367889999999999999995 5888765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=374.06 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=196.6
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC---CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG---SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|...+.||+|+||+||+|+. .+|+.||||+++.. .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35688899999999999999986 46899999998753 223335678899999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999886543 68999999999999999999998 77 99999999999999999999999999986433
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... ..
T Consensus 302 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~-----------~~ 367 (446)
T 4ejn_A 302 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEE-----------IR 367 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC-----------CC
T ss_pred CC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCC-----------CC
Confidence 22 223446799999999999999999999999999999999999999965433 22222222111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
. +.....++.+++.+||+.||.+|| +++|++++
T Consensus 368 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 F----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 112236788999999999999999 99999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=361.26 Aligned_cols=254 Identities=17% Similarity=0.189 Sum_probs=209.1
Q ss_pred hcCCCccCeeeccCceEEEEEE------eCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc---CCCcceEEEEEEeCC
Q 002189 627 TNNFSDANDVGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH---HKNLVSLLGFCFDRG 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~ 697 (955)
.++|...+.||+|+||+||+|+ ..+++.||||+++.. ...++.+|++++++++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4678888999999999999994 446889999999754 3456888888888886 999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCC---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC----------
Q 002189 698 EQMLIYEFVPNGSLGDSLSGK---NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---------- 764 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---------- 764 (955)
..++||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence 999999999999999998632 2346999999999999999999999988 999999999999998
Q ss_pred -CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHH
Q 002189 765 -RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843 (955)
Q Consensus 765 -~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~ 843 (955)
++.+||+|||+|+.+.............||++|||||++.+..++.++|||||||++|||+||+.||......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------ 291 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------ 291 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT------
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC------
Confidence 8999999999997654333334445677999999999999999999999999999999999999998643210
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHHHHHc
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDR-PTMSEVVKDIENILQQA 906 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~~ 906 (955)
. ..+....... ...+.+.+++.+|+..+|.+| |+++++.+.|++++++.
T Consensus 292 ----------~-~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 292 ----------E-CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ----------E-EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----------c-eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 0011111111 123567789999999999998 78999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=353.69 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=209.5
Q ss_pred cCHHHHHHHhcCCCcc-CeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhcc-CCCcceEEEE
Q 002189 618 FSFEEVKKYTNNFSDA-NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVH-HKNLVSLLGF 692 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~ 692 (955)
+.++..+...+.|... +.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+++.++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344455666777777 88999999999999865 68999999987532 233567899999999995 6999999999
Q ss_pred EEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceE
Q 002189 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAK 769 (955)
Q Consensus 693 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~k 769 (955)
+.+.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999999987665567999999999999999999999998 999999999999998 78999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh
Q 002189 770 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 770 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+....
T Consensus 175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~- 249 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TYLNISQVN- 249 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC-
T ss_pred EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhcc-
Confidence 99999998765332 2234579999999999999999999999999999999999999997544322 111111110
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..............+.+++.+||+.||.+|||++|++++
T Consensus 250 ----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 ----------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 011111112334678899999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=377.04 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=208.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++++++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999875 79999999986532 22345688999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999987765556999999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch--HHHHHHHHHhhhhhhhhhhhccCC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY--IVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+....... ..
T Consensus 340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----------~~ 406 (576)
T 2acx_A 340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------PE 406 (576)
T ss_dssp C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----------CC
T ss_pred c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----------cc
Confidence 2 23345799999999999998999999999999999999999999975421 112222111111 11
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
.. ......++.+++.+||+.||.+|| +++|++++
T Consensus 407 ~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 EY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11 122336788999999999999999 78999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=355.36 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=200.8
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHH--HHhccCCCcceEEEEEEe-----CCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIEL--LSRVHHKNLVSLLGFCFD-----RGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~-----~~~~~ 700 (955)
++|...+.||+|+||+||+|+. +++.||||+++.. ....+..|.++ +..++||||+++++++.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5688889999999999999987 6899999998643 23445555554 445899999999987653 22568
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------cCCCeeccCCCCccEEEcCCCceEEe
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL---------ANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
+||||+++|+|.+++... ..++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 999999999999999654 358999999999999999999998 6 9999999999999999999999
Q ss_pred ecccccccCCCCC------cceeeeeecCCCCCCHHHhhh-------CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH
Q 002189 772 DFGLSKSMSDSEK------DHITTQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838 (955)
Q Consensus 772 DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~ 838 (955)
|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+..+....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987653321 111223469999999999986 456779999999999999999988875332210
Q ss_pred ----------------HHHHHHHhhhhhhhhhhhccCCcCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 839 ----------------REIRTVMDKKKELYNLYELIDPTIGL--STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 839 ----------------~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
......... ....+.+.. ........++.+++.+||+.||.+|||++|+++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSR--------EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTT--------SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcc--------cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 111111100 111122211 122345678999999999999999999999999999
Q ss_pred HHHHHcCC
Q 002189 901 NILQQAGL 908 (955)
Q Consensus 901 ~~~~~~~~ 908 (955)
+++.....
T Consensus 315 ~ll~~~~~ 322 (336)
T 3g2f_A 315 ELMMIWER 322 (336)
T ss_dssp HHHHCCCC
T ss_pred HHHHHHHh
Confidence 99976543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.30 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=202.9
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 703 (955)
..++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+|++++.++ +||||+++++++.+++..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567899999999999999999865 689999999976433 245688888888 7999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC----CceEEeeccccccc
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER----LNAKVADFGLSKSM 779 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla~~~ 779 (955)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999887554 6899999999999999999999998 9999999999998543 35999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhhhhhc
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ...+....+....
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--------- 239 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--------- 239 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC---------
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC---------
Confidence 54322 2334578999999999998889999999999999999999999997532 2222222222111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+ ............+.+++.+||+.||++||+++|++++
T Consensus 240 ~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 240 FS--LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CC--CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cc--cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 1111112234678899999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=363.05 Aligned_cols=273 Identities=23% Similarity=0.320 Sum_probs=215.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCC--eEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG--EQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~ 703 (955)
++|...++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46788899999999999999975 589999999875332 23467889999999999999999999998765 779999
Q ss_pred EecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE----cCCCceEEeecccccc
Q 002189 704 EFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL----DERLNAKVADFGLSKS 778 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGla~~ 778 (955)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997654 234899999999999999999999998 9999999999999 7888899999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhh--------CCCCChhhhHHHHHHHHHHHhCCCCCcCC---chHHHHHHHHHhh
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMT--------QQLTEKSDVYSFGVLMLELLTGRRPIERG---KYIVREIRTVMDK 847 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDvwS~Gv~l~elltg~~P~~~~---~~~~~~~~~~~~~ 847 (955)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ....+.+..+...
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 654322 234569999999999875 56788999999999999999999999632 2223333333332
Q ss_pred hhhh--hhhhhc------cCCc--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 848 KKEL--YNLYEL------IDPT--IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 848 ~~~~--~~~~~~------~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.... ..+... ..+. ............+.+++.+||+.||++||+++|+++.+++++++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 2100 000000 0001 112233566678899999999999999999999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=343.96 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=206.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++|...+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999864 689999999865432 23467889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc---eEEeecccccccC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN---AKVADFGLSKSMS 780 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGla~~~~ 780 (955)
||+++|+|.+.+.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999988876543 6899999999999999999999998 999999999999987655 9999999998765
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..... ....+
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~------~~~~~ 229 (284)
T 3kk8_A 160 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAY------DYPSP 229 (284)
T ss_dssp SSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC------CCCTT
T ss_pred cCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhccc------cCCch
Confidence 4322 23456999999999999999999999999999999999999999654332 22222211110 10111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+.+++.+||+.||++||+++|++++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 -----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111233678899999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=365.65 Aligned_cols=266 Identities=24% Similarity=0.375 Sum_probs=194.5
Q ss_pred HHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC--CcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCC--e
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRG--E 698 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~ 698 (955)
...++|...+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999986 47899999998653 2233466889999999997 999999999998654 6
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.|+||||++ |+|.++++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 6898888653 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCC-------------------CcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH
Q 002189 779 MSDSE-------------------KDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838 (955)
Q Consensus 779 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~ 838 (955)
..... .....+...||+.|+|||++.+ ..++.++||||+||++|||++|++||..... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~ 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-M 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-H
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-H
Confidence 64311 1112334679999999999986 6789999999999999999999999965433 2
Q ss_pred HHHHHHHhhhhh--hhhhh---------------hcc---CCcCCCC------------CCHHHHHHHHHHHHHhhccCC
Q 002189 839 REIRTVMDKKKE--LYNLY---------------ELI---DPTIGLS------------TTLKGFEKYVDLALKCVQESG 886 (955)
Q Consensus 839 ~~~~~~~~~~~~--~~~~~---------------~~~---d~~l~~~------------~~~~~~~~l~~li~~cl~~dP 886 (955)
+.+..+...... ...+. ... ....... .......++.+|+.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 333332211100 00000 000 0000000 000223578899999999999
Q ss_pred CCCCCHHHHHHH
Q 002189 887 DDRPTMSEVVKD 898 (955)
Q Consensus 887 ~~RPs~~evl~~ 898 (955)
++|||++|++++
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=345.16 Aligned_cols=252 Identities=29% Similarity=0.391 Sum_probs=201.5
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
.|.....||+|+||+||+|+. .+++.||||+++.......+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345566899999999999986 4688999999987665556789999999999999999999999999999999999999
Q ss_pred CCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccccccCCCCCc
Q 002189 708 NGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 708 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999887542 345778999999999999999999998 999999999999987 8999999999998764322
Q ss_pred ceeeeeecCCCCCCHHHhhhCC--CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.......||+.|+|||++.+.. ++.++||||||+++|||++|+.||............... ....+.+.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~~~ 248 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM---------FKVHPEIP 248 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH---------HCCCCCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc---------cccccccc
Confidence 1223456899999999998654 889999999999999999999999653332221111100 01112221
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....++.+++.+||+.||++||+++|++++
T Consensus 249 ----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 249 ----ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2233678899999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=364.93 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=192.5
Q ss_pred cCCCcc-CeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHh-ccCCCcceEEEEEEe----CCeEE
Q 002189 628 NNFSDA-NDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSR-VHHKNLVSLLGFCFD----RGEQM 700 (955)
Q Consensus 628 ~~f~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~~ 700 (955)
++|... ++||+|+||+||+|+.. +|+.||||+++. ...+.+|++++.+ .+||||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345555 68999999999999864 689999999864 2457788888754 489999999999876 56789
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEeeccccc
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFGLSK 777 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla~ 777 (955)
+||||+++|+|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998765567999999999999999999999998 999999999999998 7899999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHH---HHHHHHHhhhhhhhhh
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV---REIRTVMDKKKELYNL 854 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~---~~~~~~~~~~~~~~~~ 854 (955)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+....
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~------ 283 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 283 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC------
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc------
Confidence 764322 2334679999999999999999999999999999999999999996432210 0111111110
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
.....+ .......++.+++.+||+.||++|||++|++++-
T Consensus 284 ~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 284 YEFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CCCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ccCCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000011 1112346789999999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.44 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=204.3
Q ss_pred HHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--------hhHHHHHHHHHHHhccCCCcceEEEEEEe
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--------GGQEFKMEIELLSRVHHKNLVSLLGFCFD 695 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 695 (955)
...++|...+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999985 47899999998764321 22457789999999999999999999999
Q ss_pred CCeEEEEEEecCCC-CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecc
Q 002189 696 RGEQMLIYEFVPNG-SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 774 (955)
Q Consensus 696 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 774 (955)
.+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 99999999999877 9999887654 6899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYN 853 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 853 (955)
+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 9987654332 234679999999999998876 78999999999999999999999642210
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+ ......++.+++.+||+.||.+||+++|++++
T Consensus 237 ~~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111 11123678899999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.64 Aligned_cols=243 Identities=25% Similarity=0.320 Sum_probs=192.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHH-HHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIEL-LSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||+||+|+.. +++.||||++++.... ..+.+.+|..+ ++.++|||||++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999975 5889999999764322 23456667766 5678999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999887543 6888999999999999999999998 999999999999999999999999999864332
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .......||+.|+|||++.+..++.++|||||||++|||++|..||..... .+....+..... .+.+
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~~-------~~~~-- 260 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPL-------QLKP-- 260 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-HHHHHHHHHSCC-------CCCS--
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccc-------CCCC--
Confidence 2 223456799999999999999999999999999999999999999975432 222222222110 0111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMS 893 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 893 (955)
.....+.+++.+||+.||.+||++.
T Consensus 261 ------~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 261 ------NITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ------SSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ------CCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1236788999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=367.30 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=205.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46788899999999999999975 799999999865321 22357889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999997644 6899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ......+.... ..
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~---------~~--- 234 (476)
T 2y94_A 171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-PTLFKKICDGI---------FY--- 234 (476)
T ss_dssp C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-HHHHHHHHTTC---------CC---
T ss_pred c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCC---------cC---
Confidence 2 234579999999999998765 6899999999999999999999975432 22222222111 00
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+......+.+++.+||+.||.+|||++|++++
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 011123578899999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=364.83 Aligned_cols=266 Identities=20% Similarity=0.317 Sum_probs=211.4
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccC-CCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...++||+|+||+||+|+. .+++.||||+++.... ..++.+|+++++.++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35788999999999999999986 5789999998775433 2458899999999986 566677777778888999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE---cCCCceEEeecccccccCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~~ 781 (955)
|+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+..
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999986432 36999999999999999999999998 9999999999999 6889999999999987764
Q ss_pred CCCcc-----eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhhh
Q 002189 782 SEKDH-----ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYNL 854 (955)
Q Consensus 782 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~ 854 (955)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+..+...... . .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~-~ 236 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-T-S 236 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-S-C
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-c-c
Confidence 43211 1225679999999999999999999999999999999999999997532 222222222221110 0 0
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCC
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 909 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 909 (955)
.+.+.. ....++.+++.+||+.||++||++++|++.|++++.+.+..
T Consensus 237 ~~~l~~--------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 237 IEALCR--------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHHHHT--------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHhc--------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 000101 12367899999999999999999999999999998876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.95 Aligned_cols=256 Identities=20% Similarity=0.270 Sum_probs=197.2
Q ss_pred cCCCcc-CeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDA-NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 704 (955)
+.|... +.||+|+||+||+|+. .+++.||||+++.......+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456664 6799999999999985 47899999999876555567899999999985 79999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc---eEEeecccccccCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN---AKVADFGLSKSMSD 781 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGla~~~~~ 781 (955)
|+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999987543 6899999999999999999999998 999999999999998776 99999999976542
Q ss_pred CCC-----cceeeeeecCCCCCCHHHhhh-----CCCCChhhhHHHHHHHHHHHhCCCCCcCCchH-------------H
Q 002189 782 SEK-----DHITTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI-------------V 838 (955)
Q Consensus 782 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~-------------~ 838 (955)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 111223469999999999975 56899999999999999999999999643210 0
Q ss_pred HHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+...+.... ..............+.+++.+||+.||.+|||++|++++
T Consensus 247 ~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGK----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCC----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccC----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111111100 000000001123678899999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.25 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=201.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|...+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467899999999999999999965 6899999998754322 236788999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999987543 6899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+........ ..+
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~--------~~~-- 254 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI--------PRP-- 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC--------CCG--
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC--------CCc--
Confidence 22 2223456899999999999999999999999999999999999999754332 1111111110 000
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHHHc
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRP-TMSEVVKDIENILQQA 906 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 906 (955)
.......+..+.+++.+||+.||++|| +++++++.|++++...
T Consensus 255 -~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 -STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 011112235788999999999999999 9999999999876444
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=357.16 Aligned_cols=245 Identities=21% Similarity=0.304 Sum_probs=180.5
Q ss_pred cCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 633 ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
.+.||+|+||+||+|+.. +|+.||||++... ....+.+|+++++.++ ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 6899999998642 3467889999999997 9999999999999999999999999999
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC---ceEEeecccccccCCCCCcce
Q 002189 711 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL---NAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 711 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGla~~~~~~~~~~~ 787 (955)
|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+++...... ..
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 165 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP 165 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence 999987643 6899999999999999999999998 99999999999998765 89999999998764432 22
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch------HHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY------IVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~------~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+....+... +..
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-----------~~~ 234 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-----------DFS 234 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-----------CCC
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-----------CCC
Confidence 3345689999999999999999999999999999999999999974322 11111111110 000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...........++.+++.+||+.||.+||+++|++++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0100011234678999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=357.89 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=193.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEe--------CC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFD--------RG 697 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--------~~ 697 (955)
.+|...++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++.++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 46788899999999999999964 78999999987666556678999999999996 9999999999953 33
Q ss_pred eEEEEEEecCCCCcccccCCC-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGK-NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
..++||||++ |+|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence 5799999995 7998887642 2346999999999999999999999865 45999999999999999999999999999
Q ss_pred cccCCCCCcc----------eeeeeecCCCCCCHHHh---hhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHH
Q 002189 777 KSMSDSEKDH----------ITTQVKGTMGYLDPEYY---MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843 (955)
Q Consensus 777 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~ 843 (955)
+......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----- 260 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----- 260 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----
Confidence 8765432211 11134689999999998 56678999999999999999999999996432210
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNP 910 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 910 (955)
..... .. ..........+.+++.+||+.||.+||+++|++++|+.+.+.....+
T Consensus 261 ~~~~~---------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 261 IVNGK---------YS----IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp --------------CC----CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred hhcCc---------cc----CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 11100 00 00011112457799999999999999999999999999988765443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.57 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=202.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc------hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999975 6899999998754321 3567999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC----ceEEeecccc
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL----NAKVADFGLS 776 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGla 776 (955)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999986543 6899999999999999999999998 99999999999999877 8999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (955)
+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +....+.....
T Consensus 160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~------- 228 (283)
T 3bhy_A 160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAVNY------- 228 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCC-------
T ss_pred eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHhHhccc-------
Confidence 8764332 123456899999999999999999999999999999999999999754322 22221111100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..++. ........+.+++.+||+.||.+||+++|++++
T Consensus 229 ~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 DFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00000 001123678899999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=367.53 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=196.1
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeC------C
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------G 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 697 (955)
.++|...+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999854 6899999998753 223346788999999999999999999999654 3
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..|+||||+++ +|.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 57999999975 46555543 4889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-hhh---
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYN--- 853 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~--- 853 (955)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +.+..++..... ...
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred ecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence 765332 234567999999999999999999999999999999999999999654433 333333221100 000
Q ss_pred -----hhhccC--CcCC--------------CC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 854 -----LYELID--PTIG--------------LS--TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 854 -----~~~~~d--~~l~--------------~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+. +... .. .......++.+|+.+||+.||++|||++|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000 00 001124678999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.50 Aligned_cols=247 Identities=30% Similarity=0.462 Sum_probs=201.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 456888999999999999999865 578999999864321 2235688999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999886543 6899999999999999999999988 999999999999999999999999998654332
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .....||+.|+|||.+.+..++.++||||||+++|||++|..||...... +....+... ....
T Consensus 163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-----------~~~~ 226 (279)
T 3fdn_A 163 R----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRV-----------EFTF 226 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHT-----------CCCC
T ss_pred c----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-HHHHHHHhC-----------CCCC
Confidence 2 23457999999999999999999999999999999999999999754322 222211111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+......+.+++.+||+.||.+||+++|++++
T Consensus 227 ----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 ----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11223678899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=364.85 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=193.7
Q ss_pred HHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--------chhHHHHHHHHHHHhccCCCcceEEEEEEe
Q 002189 625 KYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--------QGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695 (955)
Q Consensus 625 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 695 (955)
...++|...+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999864 689999999864321 11235889999999999999999999974
Q ss_pred CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC---CceEEee
Q 002189 696 RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVAD 772 (955)
Q Consensus 696 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~D 772 (955)
.+..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 556899999999999999987654 6899999999999999999999998 9999999999999754 4599999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCHHHhhh---CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh
Q 002189 773 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 773 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............+.....
T Consensus 286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 9999876533 22344679999999999863 67888999999999999999999999753322111111111100
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ..+.. .......+.+++.+||+.||.+||+++|++++
T Consensus 363 ------~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 363 ------N-FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ------C-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------C-CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 00000 01123678899999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=354.02 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=209.0
Q ss_pred HHHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--------hhHHHHHHHHHHHhc-cCCCcceE
Q 002189 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--------GGQEFKMEIELLSRV-HHKNLVSL 689 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l 689 (955)
+.......++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4455666788999999999999999999975 7999999998754321 134678899999999 79999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceE
Q 002189 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAK 769 (955)
Q Consensus 690 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 769 (955)
++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999987543 6899999999999999999999998 99999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC------CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHH
Q 002189 770 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843 (955)
Q Consensus 770 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~ 843 (955)
|+|||++..+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....
T Consensus 241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~ 316 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LMLRM 316 (365)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 999999987754332 2346799999999998743 5788999999999999999999999754332 22222
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+..... ....+.. ......+.+++.+||+.||.+||+++|++++
T Consensus 317 i~~~~~------~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IMEGQY------QFSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHTCC------CCCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCC------CCCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 211110 0000000 0123568899999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.50 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=195.2
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch--hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG--GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++|...+.||+|+||+||+|+. .+++.||||+++...... .+.+.+|++++++++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46788999999999999999985 478999999997543322 356789999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE-----cCCCceEEeecccccc
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL-----DERLNAKVADFGLSKS 778 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll-----~~~~~~kl~DFGla~~ 778 (955)
||++ |+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||++ ++++.+||+|||+++.
T Consensus 113 e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9997 59999887554 5899999999999999999999998 9999999999999 4556699999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-h----
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-Y---- 852 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~---- 852 (955)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +....+....... .
T Consensus 187 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 187 FGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTST
T ss_pred cCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhhh
Confidence 65332 223345689999999999875 4899999999999999999999999755433 3333332211100 0
Q ss_pred hhhhc-----cCCcCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLYEL-----IDPTIGLSTT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~~~-----~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..... ..+....... .....++.+++.+||+.||.+|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000 0000000000 0123678899999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.65 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=198.4
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356888999999999999999864 68999999987543 2345789999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE---cCCCceEEeeccccccc
Q 002189 705 FVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSM 779 (955)
Q Consensus 705 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~ 779 (955)
|+++|+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988542 2346899999999999999999999998 9999999999999 45678999999999866
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
.... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...... +........ .
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-~~~~~~~~~-----------~ 241 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-EVQQKATYK-----------E 241 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC-----------C
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-HHHhhhccC-----------C
Confidence 4332 233456999999999875 57899999999999999999999999754321 111111110 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.... .......++.+++.+||+.||.+||+++|++++
T Consensus 242 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 001123678899999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=353.26 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=199.8
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch-----hHHHHHHHHHHHhccCCCcceEEEEEEeCC
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG-----GQEFKMEIELLSRVHHKNLVSLLGFCFDRG 697 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 697 (955)
....++|...+.||+|+||+||+|+.. +|+.||||+++...... .+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 445678999999999999999999964 68999999987532221 246889999999999999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..++||||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999975 888877654 346888899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-----
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL----- 851 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~----- 851 (955)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||..... .+.+..+.......
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTS
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhh
Confidence 765332 223345789999999999764 589999999999999999999998865443 33333333221100
Q ss_pred hhhhh---ccCCcCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 YNLYE---LIDPTIGLSTT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 ~~~~~---~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..... .+......... .....++.+++.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 00000000000 1223678999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=342.28 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=201.0
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC--CcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 701 (955)
..++|...+.||+|+||+||+|+.. +++.||||+++.. ......++.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567899999999999999999975 7899999998754 233456788999999999 89999999999999999999
Q ss_pred EEEecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---------------
Q 002189 702 IYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE--------------- 764 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~--------------- 764 (955)
||||+++|+|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999987532 246899999999999999999999998 999999999999984
Q ss_pred ----CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHH
Q 002189 765 ----RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 839 (955)
Q Consensus 765 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~ 839 (955)
...+||+|||+++....... ..||+.|+|||.+.+. .++.++|||||||++|||++|.+|+........
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 239 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred ccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence 44799999999987654322 3489999999999866 566899999999999999999987654432211
Q ss_pred HHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 840 EIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.... ..+... ......+.+++.+||+.||++||+++|++++
T Consensus 240 ----~~~~----------~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 240 ----IRQG----------RLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----HHTT----------CCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----HHcC----------CCCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1110 111111 1223678899999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.93 Aligned_cols=264 Identities=28% Similarity=0.387 Sum_probs=201.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 356888899999999999999975 5899999998654333 2356789999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999988765443 5899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----------h
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----------L 851 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----------~ 851 (955)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+...... .
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL-YHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHHHHHC
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCChhhhhHhhhc
Confidence 223345699999999999875 7899999999999999999999999765443222 211111000 0
Q ss_pred hhhhhccCCcCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 YNLYELIDPTIGLSTT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 ~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........+....... ......+.+++.+||+.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000111111111111 1234678999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=368.65 Aligned_cols=194 Identities=25% Similarity=0.422 Sum_probs=154.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeC-----CeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 699 (955)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++... +..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57889999999999999999864 78999999987532 23446789999999999999999999999543 568
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
|+||||+ +|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 578988887543 6899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc-------------------------ceeeeeecCCCCCCHHHhh-hCCCCChhhhHHHHHHHHHHHhC
Q 002189 780 SDSEKD-------------------------HITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTG 827 (955)
Q Consensus 780 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwS~Gv~l~elltg 827 (955)
...... ...+..+||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 532211 1234467899999999874 56799999999999999999993
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=355.66 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=203.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...+.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46888899999999999999975 689999999876532 3346789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
+++|+|.+++.... .+++..+..++.+++.||+|||+. + |+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999987543 589999999999999999999985 7 999999999999999999999999999765321
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHH--HHhhh--------------
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT--VMDKK-------------- 848 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~--~~~~~-------------- 848 (955)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .....
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 223457999999999999999999999999999999999999999754321110000 00000
Q ss_pred ---------------hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 849 ---------------KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 849 ---------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.....+.....+.. .......++.+++.+||+.||.+|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKL---PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCC---CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCC---CcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000001111 111234578999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=347.13 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=203.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999865 7899999999865554556789999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE---cCCCceEEeecccccccCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~~~~ 782 (955)
+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999886543 6899999999999999999999998 9999999999999 78899999999999765332
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..... . .++
T Consensus 163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~------~-~~~-- 228 (304)
T 2jam_A 163 I----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIKEGYY------E-FES-- 228 (304)
T ss_dssp T----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHCCC------C-CCT--
T ss_pred c----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCCC------C-CCc--
Confidence 1 2234689999999999999999999999999999999999999965432 222222211110 0 011
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.........+.+++.+||+.||.+||+++|++++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 229 --PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112234678999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=370.58 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=205.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999975 699999999865322 22356889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 704 EFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999886543 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch---HHHHHHHHHhhhhhhhhhhhcc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY---IVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+....
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~---------- 409 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA---------- 409 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC----------
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc----------
Confidence 332 22345799999999999999999999999999999999999999975421 122222221110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 898 (955)
.. .+......+.+++.+||+.||.+||++ +|++++
T Consensus 410 -~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 -VT----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -CC----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -cC----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 01 112233678899999999999999965 677753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=343.45 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=205.2
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56788899999999999999975 57899999986532 223467889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999876543 6899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +........ ....
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~-----------~~~~- 234 (294)
T 2rku_A 170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKN-----------EYSI- 234 (294)
T ss_dssp C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTT-----------CCCC-
T ss_pred c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhc-----------cCCC-
Confidence 2 223456999999999999999999999999999999999999999754322 211111111 0011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||+.||++||+++|++++
T Consensus 235 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 ---PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223578899999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.83 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=183.4
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc---chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM---QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688889999999999999986 5789999999864321 12367899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999887542 46899999999999999999999998 9999999999999999999999999998765332
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ... .......
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~-------------~~~~~~~- 229 (278)
T 3cok_A 167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLN-------------KVVLADY- 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSSCC-
T ss_pred C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHH-------------HHhhccc-
Confidence 2 1223568999999999999899999999999999999999999997433211 000 0000000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.....++.+++.+||+.||++||+++|++++
T Consensus 230 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1112233678899999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=344.27 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=189.7
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch-h-HHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG-G-QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++|+..+.||+|+||+||+|+. .+|+.||||+++...... . +.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45788899999999999999996 478999999997643322 2 33445556688889999999999999999999999
Q ss_pred EecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 704 EFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 704 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
||++ |+|.+++.. .....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588776653 1234799999999999999999999998 8 9999999999999999999999999998765
Q ss_pred CCCCcceeeeeecCCCCCCHHHh----hhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhh
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYY----MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (955)
.... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||.................
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 230 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-------- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC--------
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC--------
Confidence 4322 2334699999999996 456789999999999999999999999976444333333332221
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+... ......++.+++.+||+.||++|||++|++++
T Consensus 231 --~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 231 --SPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --CCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --CCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11111 11233678999999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=350.55 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=205.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56788899999999999999975 57899999986532 233467889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 121 e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999876543 6899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
. ......||..|+|||++.+..++.++||||||+++|||++|+.||...... +....+.... ..+.
T Consensus 196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~-----------~~~~ 261 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNE-----------YSIP 261 (335)
T ss_dssp C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTC-----------CCCC
T ss_pred c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHhcCC-----------CCCC
Confidence 2 223456999999999999999999999999999999999999999754322 2221111110 0111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+.+++.+||+.||++||+++|++++
T Consensus 262 ----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 ----KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123568899999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.79 Aligned_cols=257 Identities=19% Similarity=0.329 Sum_probs=203.7
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEe--CCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFD--RGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688889999999999999985 57899999998743 3467899999999997 9999999999988 66789999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecccccccCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDS 782 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~ 782 (955)
||+++++|.+++. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999998875 3788999999999999999999998 99999999999999776 8999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh--hhhhhhh---
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--ELYNLYE--- 856 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~--- 856 (955)
.. .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||..+....+.+........ .......
T Consensus 185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 32 233568999999999987 67899999999999999999999999765544443333222111 0000000
Q ss_pred -ccCCc----------------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 -LIDPT----------------IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 -~~d~~----------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..++. ...........++.+++.+||+.||.+|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0011111234778999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.13 Aligned_cols=246 Identities=28% Similarity=0.421 Sum_probs=204.5
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999865 67899999986432 122367899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999887543 6899999999999999999999988 9999999999999999999999999997654322
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.....|++.|+|||.+.+..++.++||||||+++|||++|..||...... +....+... +...
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-----------~~~~- 231 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-ETHRRIVNV-----------DLKF- 231 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTT-----------CCCC-
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-HHHHHHhcc-----------ccCC-
Confidence 22356899999999999999999999999999999999999999754332 111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+......+.+++.+||+.||.+||+++|++++
T Consensus 232 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 ---PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ---CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11223678899999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=355.07 Aligned_cols=260 Identities=21% Similarity=0.353 Sum_probs=203.2
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe----CCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~l 701 (955)
.++|...+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788899999999999999986 5789999999876655666789999999999999999999999873 347899
Q ss_pred EEEecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 702 IYEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
||||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988642 2346899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCcc-------eeeeeecCCCCCCHHHhhhCC---CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh
Q 002189 780 SDSEKDH-------ITTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 780 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 3211000 011235799999999987543 6899999999999999999999985211000000001100
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.............+.+++.+||+.||.+||+++|+++.|+.+
T Consensus 263 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 263 -----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp -----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 000111122346789999999999999999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=355.24 Aligned_cols=264 Identities=20% Similarity=0.328 Sum_probs=207.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcch-----------------hHHHHHHHHHHHhccCCCcceE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQG-----------------GQEFKMEIELLSRVHHKNLVSL 689 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 689 (955)
.++|...+.||+|+||+||+|+. +|+.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788999999999999999998 89999999986432111 1789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCcccc------cCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEE
Q 002189 690 LGFCFDRGEQMLIYEFVPNGSLGDS------LSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILL 762 (955)
Q Consensus 690 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll 762 (955)
++++.+.+..++||||+++|+|.++ +.......+++..+..++.|++.||+|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999999 665445689999999999999999999998 88 9999999999999
Q ss_pred cCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC-CCCC-hhhhHHHHHHHHHHHhCCCCCcCCchHHHH
Q 002189 763 DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTE-KSDVYSFGVLMLELLTGRRPIERGKYIVRE 840 (955)
Q Consensus 763 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDvwS~Gv~l~elltg~~P~~~~~~~~~~ 840 (955)
+.++.+||+|||+++..... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||.......+.
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999999876432 23345699999999999877 6666 999999999999999999999765443333
Q ss_pred HHHHHhhhhhhhhhh-hccCC---cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 841 IRTVMDKKKELYNLY-ELIDP---TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 841 ~~~~~~~~~~~~~~~-~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+........... ....+ .............+.+++.+||+.||.+||+++|++++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 332222111000000 00000 00000012334678999999999999999999999963
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=341.95 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=200.0
Q ss_pred CCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEe----CCeEEEE
Q 002189 630 FSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQMLI 702 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV 702 (955)
|...+.||+|+||+||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 556678999999999999864 68899999987543 2334678999999999999999999999876 3458999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-CCCceEEeecccccccCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~~~~ 781 (955)
|||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||||||+||+++ +++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999997543 6899999999999999999999865 4599999999999998 789999999999976543
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
. ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.................. +.
T Consensus 185 ~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~~ 249 (290)
T 1t4h_A 185 S----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------PA 249 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------CG
T ss_pred c----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC----------cc
Confidence 2 223456999999999876 56999999999999999999999999765554443332222111 00
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........++.+++.+||+.||.+|||++|++++
T Consensus 250 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0111122578899999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.82 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=201.6
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC----cchhHHHHHHHHHHHhccCCCcceEEEEEE--eCCe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS----MQGGQEFKMEIELLSRVHHKNLVSLLGFCF--DRGE 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~ 698 (955)
..++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3568999999999999999999964 68999999987532 234567999999999999999999999985 3457
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||++++ |.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999876 666665544557999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCC--CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhh
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (955)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~i~~~~-------- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-YKLFENIGKGS-------- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHCC--------
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHHHhcCC--------
Confidence 65433333344567999999999998644 37799999999999999999999975432 22222211110
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... .......+.+++.+||+.||.+||+++|++++
T Consensus 230 ---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ---YAI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CCC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CCC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011 11233678899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.65 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=207.5
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
+.|...+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4578889999999999999986 4689999999875432 3457899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 102 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 9999999998753 5899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.. ...+...
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~----------~~~~~~~-- 240 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-KVLFLIPK----------NNPPTLE-- 240 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHH----------SCCCCCC--
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-HHHHHhhc----------CCCCCCc--
Confidence 223456899999999999999999999999999999999999999754322 11111111 1111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
......+.+++.+||+.||.+||+++|++++..
T Consensus 241 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 241 --GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp --SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred --cccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 122367889999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=357.33 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=201.2
Q ss_pred cCCCccCeeeccCceEEEEEEe----CCCcEEEEEEcccCCc----chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGE 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 698 (955)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999987 3689999999875321 2335677899999999 69999999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999987543 6899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCCcCCc---hHHHHHHHHHhhhhhhhh
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPIERGK---YIVREIRTVMDKKKELYN 853 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~~~~~---~~~~~~~~~~~~~~~~~~ 853 (955)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ............
T Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------ 281 (355)
T 1vzo_A 209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------ 281 (355)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc------
Confidence 643222 22234579999999999986 347899999999999999999999996322 121211111111
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
.+.. .......+.+++.+||+.||.+|| +++|++++
T Consensus 282 -----~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 -----EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -----CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1111 112336788999999999999999 99999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=353.71 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=196.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch-hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG-GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...+.||+|+||+||+|+.. +++.||||+++...... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999975 78999999987543221 22456799999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 154 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence 97 68888876543 36899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh--hhhh-------
Q 002189 786 HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL--YNLY------- 855 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~------- 855 (955)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+....... ..+.
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHhchhhhcchh
Confidence 22334568999999999986 5689999999999999999999999965432 22222222211000 0000
Q ss_pred --hccCCcCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 --ELIDPTIGLS----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 --~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....+..... .......++.+++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 001123678899999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.95 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=202.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEe--CCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 701 (955)
.++|...+.||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888899999999999999875 789999999875433 234678999999999999999999998865 567899
Q ss_pred EEEecCCCCcccccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 702 IYEFVPNGSLGDSLSGKN--GIRLDWIRRLKIALGAARGLSYLHELA--NPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986532 345899999999999999999999876 2449999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+....+... .
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~i~~~-~-------- 232 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREG-K-------- 232 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHT-C--------
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-HHHHHHHhhc-c--------
Confidence 764332 112235689999999999999999999999999999999999999975432 1222111111 1
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDI 899 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 899 (955)
.+.+ ......++.+++.+||+.||.+||+++|+++++
T Consensus 233 -~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 233 -FRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp -CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred -cccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 0111 112336789999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=356.43 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=197.6
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeC------
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------ 696 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 696 (955)
+...++|...+.||+|+||+||+|+. .+|+.||||++..... ...+|+++++.++|||||++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 5789999999875432 234799999999999999999998543
Q ss_pred --------------------------------CeEEEEEEecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHh
Q 002189 697 --------------------------------GEQMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYL 742 (955)
Q Consensus 697 --------------------------------~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 742 (955)
...++||||++ |+|.+.+.. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999997 577776653 2234789999999999999999999
Q ss_pred hhccCCCeeccCCCCccEEEc-CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHH
Q 002189 743 HELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVL 820 (955)
Q Consensus 743 H~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~ 820 (955)
|+.+ |+||||||+||+++ +++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999998 688999999999987654332 2345689999999999875 48999999999999
Q ss_pred HHHHHhCCCCCcCCchHHHHHHHHHhhhh-h----hhh----hhhccCCcCCCC-----CCHHHHHHHHHHHHHhhccCC
Q 002189 821 MLELLTGRRPIERGKYIVREIRTVMDKKK-E----LYN----LYELIDPTIGLS-----TTLKGFEKYVDLALKCVQESG 886 (955)
Q Consensus 821 l~elltg~~P~~~~~~~~~~~~~~~~~~~-~----~~~----~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP 886 (955)
+|||++|+.||...... +.+..++.... . +.. ..+..-|..... ........+.+++.+||+.||
T Consensus 232 l~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999999754433 22322222110 0 000 000000111000 111234678999999999999
Q ss_pred CCCCCHHHHHHH
Q 002189 887 DDRPTMSEVVKD 898 (955)
Q Consensus 887 ~~RPs~~evl~~ 898 (955)
.+|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999965
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=353.12 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=202.1
Q ss_pred HHHHHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEe--
Q 002189 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD-- 695 (955)
Q Consensus 620 ~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-- 695 (955)
+.++....++|...+.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334444567889999999999999999996 478999999987543 3356789999999999 79999999999987
Q ss_pred ----CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 696 ----RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 696 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 467899999999999999997655557899999999999999999999998 9999999999999999999999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHh
Q 002189 772 DFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846 (955)
Q Consensus 772 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 846 (955)
|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||....... .......
T Consensus 172 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~ 248 (326)
T 2x7f_A 172 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPR 248 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred eCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhc
Confidence 999998764322 1223456899999999997 5678999999999999999999999996544322 1111111
Q ss_pred hhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 847 KKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ..+... .......+.+++.+||..||.+||+++|++++
T Consensus 249 ~----------~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 249 N----------PAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp S----------CCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred C----------ccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 111111 11223678899999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=367.14 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=200.4
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++|...+.||+|+||+||+|+.. +++.||||+++... ......+.+|+++++.++|||||++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888999999999999999975 68999999987543 233567899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEeecccccccC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFGLSKSMS 780 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla~~~~ 780 (955)
||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999998886543 6899999999999999999999998 999999999999976 4559999999998765
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... ......||+.|+|||++. +.++.++||||+||++|||++|..||..... .+....+..... ....+
T Consensus 191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~------~~~~~ 259 (494)
T 3lij_A 191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKY------TFDSP 259 (494)
T ss_dssp TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC------CCCSG
T ss_pred CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC------CCCch
Confidence 432 233457999999999886 5799999999999999999999999975433 222222222111 00011
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .......+.+++.+||+.||.+|||++|++++
T Consensus 260 ~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 260 E-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp G-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred h-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 11223678899999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=368.51 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=206.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888999999999999999975 78999999986542 23456799999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE---cCCCceEEeeccccccc
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSM 779 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGla~~~ 779 (955)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999887554 6899999999999999999999998 9999999999999 56789999999999877
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
..... .....||+.|+|||++.+ .++.++||||+||++|||++|.+||..... .+....+..... .
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~---------~ 245 (484)
T 3nyv_A 180 EASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKY---------T 245 (484)
T ss_dssp CCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC---------C
T ss_pred ccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCCC---------C
Confidence 54332 233569999999999865 799999999999999999999999975432 222222222111 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
............+.+++.+||+.||.+|||++|++++
T Consensus 246 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 --FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0011112234678899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=359.89 Aligned_cols=261 Identities=20% Similarity=0.225 Sum_probs=203.1
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhc------cCCCcceEEEEEEeCCeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRV------HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~ 699 (955)
..+|...+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 346888999999999999999864 58999999997532 2345678899998888 467999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc--eEEeeccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN--AKVADFGLSK 777 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFGla~ 777 (955)
++||||++ ++|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 69999887665556999999999999999999999998 999999999999999987 9999999997
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh----h--
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE----L-- 851 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~----~-- 851 (955)
...... ....||+.|+|||++.+..++.++|||||||++|||+||.+||..... .+.+..+...... .
T Consensus 251 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 251 YEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE-GDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp ETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred ecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHH
Confidence 654322 235689999999999999999999999999999999999999965433 2233222221000 0
Q ss_pred --hhhhhccCCc------------------------------CCCCCC------HHHHHHHHHHHHHhhccCCCCCCCHH
Q 002189 852 --YNLYELIDPT------------------------------IGLSTT------LKGFEKYVDLALKCVQESGDDRPTMS 893 (955)
Q Consensus 852 --~~~~~~~d~~------------------------------l~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~ 893 (955)
......++.. ...... ......+.+|+.+||+.||++|||++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0000000000 000000 01135688999999999999999999
Q ss_pred HHHHH
Q 002189 894 EVVKD 898 (955)
Q Consensus 894 evl~~ 898 (955)
|++++
T Consensus 405 e~L~H 409 (429)
T 3kvw_A 405 QALRH 409 (429)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.91 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=187.9
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46788999999999999999985 468999999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCcccccCC------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 705 FVPNGSLGDSLSG------KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 705 ~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
|+++|+|.+++.. .....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999998863 12346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCC---cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhh
Q 002189 779 MSDSEK---DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 854 (955)
Q Consensus 779 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 854 (955)
...... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........... ....... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~--~~ 247 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-TLQNDPP--SL 247 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-HHTSSCC--CT
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-HhccCCC--cc
Confidence 643321 112234579999999999976 5789999999999999999999999975443222111 1111100 00
Q ss_pred hh-ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 855 YE-LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 855 ~~-~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. ..++. ........+.+++.+||+.||.+||+++|++++
T Consensus 248 ~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 00111 111233678899999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.54 Aligned_cols=261 Identities=21% Similarity=0.352 Sum_probs=202.0
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc--chhHHHHHHHHHHHhcc--CCCcceEEEEE
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVH--HKNLVSLLGFC 693 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--H~niv~l~~~~ 693 (955)
+.++.+....++|...+.||+|+||+||+|+..+++.||||++..... ...+.+.+|++++++++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 333334444567889999999999999999988899999999875432 33467899999999997 59999999999
Q ss_pred EeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 694 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
.+++..++||| +.+++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||++++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 56889999987543 6899999999999999999999998 999999999999975 79999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhh-----------CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHH
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-----------QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIR 842 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~ 842 (955)
|+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 99987654433223344579999999999875 4788899999999999999999999976544333322
Q ss_pred HHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 843 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.... +.............+.+++.+||+.||.+||+++|++++
T Consensus 251 ~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AIID-------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHC-------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHh-------------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 2221 111111111223678899999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=354.56 Aligned_cols=272 Identities=20% Similarity=0.289 Sum_probs=202.8
Q ss_pred cCHHHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc-----------hhHHHHHHHHHHHhccCCCc
Q 002189 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ-----------GGQEFKMEIELLSRVHHKNL 686 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~ni 686 (955)
....++....++|...+.||+|+||+||+|+..+|+.||||++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4467888899999999999999999999999888999999998643221 12678999999999999999
Q ss_pred ceEEEEEEeC-----CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEE
Q 002189 687 VSLLGFCFDR-----GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNIL 761 (955)
Q Consensus 687 v~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIl 761 (955)
+++++++... ...++||||++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999998653 35799999997 6888877643 346899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHH
Q 002189 762 LDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVRE 840 (955)
Q Consensus 762 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~ 840 (955)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~ 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQ 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 9999999999999997544322 2334578999999999987 67899999999999999999999999754332 22
Q ss_pred HHHHHhhhhhh--h--------hhhhccCCcC---CC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 841 IRTVMDKKKEL--Y--------NLYELIDPTI---GL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 841 ~~~~~~~~~~~--~--------~~~~~~d~~l---~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+....... . ...+.+.... .. .........+.+++.+||+.||.+|||++|++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 22222111000 0 0000000000 00 0011123568899999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=363.43 Aligned_cols=242 Identities=14% Similarity=0.156 Sum_probs=190.4
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccC---CcchhHHHHHHHH---HHHhccCCCcceEE-------EE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQG---SMQGGQEFKMEIE---LLSRVHHKNLVSLL-------GF 692 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~H~niv~l~-------~~ 692 (955)
.++|...+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++ .+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35677889999999999999996 56999999998743 3334577899994 55555799999998 66
Q ss_pred EEeCCe-----------------EEEEEEecCCCCcccccCCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCe
Q 002189 693 CFDRGE-----------------QMLIYEFVPNGSLGDSLSGKN-----GIRLDWIRRLKIALGAARGLSYLHELANPPI 750 (955)
Q Consensus 693 ~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 750 (955)
+.+.+. .++||||+ +|+|.+++.... ...+++..++.++.|+++||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 689999987532 123446888899999999999999998 9
Q ss_pred eccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhC-----------CCCChhhhHHHHH
Q 002189 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ-----------QLTEKSDVYSFGV 819 (955)
Q Consensus 751 vHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwS~Gv 819 (955)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999988 8999999999999
Q ss_pred HHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 820 LMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 820 ~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
++|||++|+.||...... .. ...... . ......++.+++.+||+.||++||++.|++++
T Consensus 302 il~elltg~~Pf~~~~~~-----------~~---~~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL-----------GG---SEWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC-----------------CC---SGGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccc-----------cc---hhhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999999542210 00 001111 0 01223678899999999999999999999964
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=358.83 Aligned_cols=266 Identities=21% Similarity=0.298 Sum_probs=197.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeC-----Ce
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 698 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357888999999999999999864 68899999997532 23446789999999999999999999999776 57
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.|+||||++ |+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999995 69999887543 6899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc--------------------ceeeeeecCCCCCCHHHhh-hCCCCChhhhHHHHHHHHHHHhCCCCC------
Q 002189 779 MSDSEKD--------------------HITTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVLMLELLTGRRPI------ 831 (955)
Q Consensus 779 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwS~Gv~l~elltg~~P~------ 831 (955)
....... ...+...||+.|+|||++. ...++.++||||+||++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6543221 1234567999999999974 567999999999999999999854443
Q ss_pred ----cCCch-----------------HHHHHHHHHhhhh-------------hhhhhhhccCCcCCCC---CCHHHHHHH
Q 002189 832 ----ERGKY-----------------IVREIRTVMDKKK-------------ELYNLYELIDPTIGLS---TTLKGFEKY 874 (955)
Q Consensus 832 ----~~~~~-----------------~~~~~~~~~~~~~-------------~~~~~~~~~d~~l~~~---~~~~~~~~l 874 (955)
..+.. ..+.+..++.... ................ .......++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 22211 1122222211000 0000001111110000 001123678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 002189 875 VDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 875 ~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+|+.+||+.||.+|||++|++++
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhcCCcccCCCHHHHhcC
Confidence 899999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=345.89 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=199.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 457888999999999999999975 5899999999876656667899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999887642 236899999999999999999999998 9999999999999999999999999976432111
Q ss_pred ceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 786 HITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
.......||+.|+|||++. +..++.++||||||+++|||++|+.||...... .......... .+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~----------~~ 240 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSD----------PP 240 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSC----------CC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHhccC----------Cc
Confidence 1122356899999999984 567889999999999999999999999754432 2221111110 11
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. .........+.+++.+||+.||.+|||++|++++
T Consensus 241 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 TL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 1122334678999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.80 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=196.9
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--------chhHHHHHHHHHHHhccCCCcceEEEEEEeC
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--------QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 696 (955)
..++|...+.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567899999999999999999864 689999999875321 1123588999999999999999999998665
Q ss_pred CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc---eEEeec
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN---AKVADF 773 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DF 773 (955)
+ .++||||+++|+|.+++.... .+++.....++.|+++||+|||+.+ |+||||||+||+++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 899999999999999887543 6899999999999999999999998 999999999999987664 999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
|+++...... ......||+.|+|||++. ...++.++|||||||++|||++|..||............+.....
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 237 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY- 237 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC-
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc-
Confidence 9998764322 223356899999999985 467899999999999999999999999754322111111111100
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
. ..+.. .......+.+++.+||+.||++||+++|+++
T Consensus 238 -----~-~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 -----N-FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -----C-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----c-cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 00000 0112367889999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=343.68 Aligned_cols=258 Identities=23% Similarity=0.393 Sum_probs=197.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC--CCc--EEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP--NGQ--LIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|...+.||+|+||+||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.+.+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46788899999999999999853 333 68999987542 234567899999999999999999999987654 88
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999887532 35899999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCCcc-eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 781 DSEKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 781 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+....+.....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~--------- 242 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGE--------- 242 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTSCC---------
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-HHHHHHHHccCC---------
Confidence 433211 1223457788999999999999999999999999999999 9999965432 222222211110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
. ..........+.+++.+||+.||++||+++++++.|+++..
T Consensus 243 ~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 R----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred C----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0 11112334778999999999999999999999999988743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=366.84 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=204.1
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
..++|...+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++|||||++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567899999999999999999865 7899999998642 223356789999999999999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc---CCCceEEeeccccccc
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSM 779 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGla~~~ 779 (955)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999998886543 6899999999999999999999998 99999999999995 4567999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
.... ......||+.|+|||++.+ .++.++||||+||++|||++|..||..... .+....+..... .
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~---------~ 240 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKY---------A 240 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC---------C
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC---------C
Confidence 5432 2234569999999999875 699999999999999999999999965432 222222222111 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ...........+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 F--DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S--CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C--CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 001112234678899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=336.27 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=196.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999975 78999999986432 122457889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999986543 5899999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ......+.... ...
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~-----------~~~ 230 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-PTLFKKIRGGV-----------FYI 230 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC-----------CCC
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCc-----------ccC
Confidence 2234568999999999987765 6899999999999999999999965432 12221111110 001
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+......+.+++.+||+.||.+||+++|++++
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11123678899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=363.44 Aligned_cols=251 Identities=29% Similarity=0.383 Sum_probs=201.8
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-------------chhHHHHHHHHHHHhccCCCcceEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-------------QGGQEFKMEIELLSRVHHKNLVSLLGF 692 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 692 (955)
.++|...++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 567899999999999999999965 688999999875432 224678899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC---ceE
Q 002189 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL---NAK 769 (955)
Q Consensus 693 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~---~~k 769 (955)
+.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999886543 6899999999999999999999998 99999999999998776 699
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh
Q 002189 770 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 770 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
|+|||+++....... .....||+.|+|||++. +.++.++||||+||++|||++|..||..... .+....+.....
T Consensus 190 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~ 264 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDIIKKVEKGKY 264 (504)
T ss_dssp ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC
T ss_pred EEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC
Confidence 999999987654322 23456999999999986 5699999999999999999999999965432 222222222110
Q ss_pred hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .+. ........++.+++.+||+.||.+|||++|++++
T Consensus 265 ~-------~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 Y-------FDF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp C-------CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C-------CCc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 000 0001123678899999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=342.64 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=202.4
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
..++|...+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567889999999999999999875 58999999987643 34678999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|+|.+++... ...+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999988632 236899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....... ..+..
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----------~~~~~-- 245 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-IFMIPTN----------PPPTF-- 245 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS----------CCCCC--
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcC----------CCccc--
Confidence 22345689999999999999999999999999999999999999975443221 1111110 11111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.........+.+++.+||+.||.+||+++|++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122234678999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=351.29 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=193.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCC------e
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------E 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 698 (955)
++|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57888999999999999999864 689999999875322 23467889999999999999999999997765 7
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||++ |+|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 899999996 578777752 4889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-hhhhhhc
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-LYNLYEL 857 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 857 (955)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...... .......
T Consensus 177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHTT
T ss_pred ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHH
Confidence 64321 2334679999999999999999999999999999999999999997554332 22222211000 0000000
Q ss_pred ----------cCCcCC------------CC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 ----------IDPTIG------------LS----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ----------~d~~l~------------~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
-.+... .. .......++.+|+.+||+.||.+|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 00 011224678999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=357.68 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=193.9
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC------eEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------EQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 701 (955)
+|...+.||+|+||+||+|+.. +|+.||||++.... +.+.+|++++++++|||||++++++...+ ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5778899999999999999975 68999999986542 22347999999999999999999986532 2579
Q ss_pred EEEecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-CceEEeecccccc
Q 002189 702 IYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSKS 778 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGla~~ 778 (955)
||||+++ ++.+.+.. .....+++..+..++.|+++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 55554432 12347899999999999999999999988 9999999999999965 5789999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----hhh
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----ELY 852 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-----~~~ 852 (955)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+..++.... .+.
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 654322 2335789999999999765 7999999999999999999999999754432 33333322110 000
Q ss_pred hh----hhccCCcCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NL----YELIDPTIGLS-----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~----~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. .+...|.+... .......++.+|+.+||+.||.+||++.|++++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 00000111100 111224678999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.18 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=196.7
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCC------
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 697 (955)
.++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35688889999999999999986 4789999999865322 23467889999999999999999999997653
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..|+||||+ +++|.++++.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 88999988653 5899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh------
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------ 850 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 850 (955)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+.+..+......
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence 76432 223568999999999987 6899999999999999999999999975443 2333332221100
Q ss_pred -------hhhhhhccCCcCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 -------LYNLYELIDPTIG---LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 -------~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+..... ..........+.+++.+||+.||.+|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000000 00111234678999999999999999999999985
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=389.14 Aligned_cols=318 Identities=31% Similarity=0.478 Sum_probs=196.8
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCC-cccccccccccccccccCCCCCCccccCC-CCcE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTT-IGNLKKLSNLMLVGCSFSGPIPDSIGSLQ-ELVL 141 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~ 141 (955)
.+++.|+|++|.+++.+|..|..+++|++|+|++|+ +.+.+|.. |.++++|++|+|++|++++.+|..+.+++ +|++
T Consensus 294 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~ 372 (768)
T 3rgz_A 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN-FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 372 (768)
T ss_dssp TTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSE-EEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSE
T ss_pred CcCCEEECcCCcCCCccchHHhcCCCccEEECCCCc-ccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcE
Confidence 456677777777776666666666667777766665 55555544 66666666666666666666666555554 4555
Q ss_pred EEccCCCCc--------------------------CcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhcccc
Q 002189 142 LSLNSNGFS--------------------------GRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 195 (955)
Q Consensus 142 L~Ls~N~l~--------------------------~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~ 195 (955)
|+|++|+++ +.+|..|.++++|++|+|++|++++.+|..+ ..+++|+.
T Consensus 373 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l------~~l~~L~~ 446 (768)
T 3rgz_A 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL------GSLSKLRD 446 (768)
T ss_dssp EECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGG------GGCTTCCE
T ss_pred EEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHH------hcCCCCCE
Confidence 555554444 4444445555555555555555554444332 23445566
Q ss_pred ccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCc
Q 002189 196 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK 275 (955)
Q Consensus 196 L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 275 (955)
|++++|+++|.+|..+. .+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|.++..+++|+.|+|++|+
T Consensus 447 L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 525 (768)
T 3rgz_A 447 LKLWLNMLEGEIPQELM-YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525 (768)
T ss_dssp EECCSSCCCSCCCGGGG-GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EECCCCcccCcCCHHHc-CCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCc
Confidence 66666666655555433 34556666777777766666666667777777777777766667667667777777777777
Q ss_pred CcccCC-CCCCCCCCCEEECcCCCCCCCCCChh-----------------------------------------------
Q 002189 276 LTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSW----------------------------------------------- 307 (955)
Q Consensus 276 l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~----------------------------------------------- 307 (955)
+++.+| .+..+++|++|+|++|++++ .+|..
T Consensus 526 l~~~~p~~l~~l~~L~~L~Ls~N~l~g-~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (768)
T 3rgz_A 526 FSGNIPAELGDCRSLIWLDLNTNLFNG-TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604 (768)
T ss_dssp CEEECCGGGGGCTTCCEEECCSSEEES-BCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGG
T ss_pred ccCcCCHHHcCCCCCCEEECCCCccCC-cCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhh
Confidence 766555 46666667777776666654 22322
Q ss_pred -----------------------hcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhh
Q 002189 308 -----------------------FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLL 363 (955)
Q Consensus 308 -----------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~ 363 (955)
+..+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+. +..|+.
T Consensus 605 ~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~ 684 (768)
T 3rgz_A 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684 (768)
T ss_dssp GGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred hccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCE
Confidence 22345566677777777777777777777777777777777766665433 555667
Q ss_pred hcccCCccccccCCCCCCCcceeEecC
Q 002189 364 VNLQNNRISAYTERGGAPAVNLTLIDN 390 (955)
Q Consensus 364 L~L~~N~l~~~~~~~~~~~~~L~~l~n 390 (955)
|||++|++++..|..+..+++|+.++.
T Consensus 685 LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 685 LDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp EECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred EECCCCcccCcCChHHhCCCCCCEEEC
Confidence 777777777666666665555555544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.79 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=195.7
Q ss_pred HhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe---------
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--------- 695 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 695 (955)
..++|...+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 456788999999999999999996 47899999998642 2334678899999999999999999999865
Q ss_pred ----CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEe
Q 002189 696 ----RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVA 771 (955)
Q Consensus 696 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 771 (955)
.+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 35679999999999999999753 346788999999999999999999998 9999999999999999999999
Q ss_pred ecccccccCCCCC------------cceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHH
Q 002189 772 DFGLSKSMSDSEK------------DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838 (955)
Q Consensus 772 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~ 838 (955)
|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++ |+..+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 9999986643210 1122345699999999999864 78999999999999999998 554333222
Q ss_pred HHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........ ................+.+++.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILKKLRS-----------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHS-----------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhccc-----------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 22221111 11111122233344678899999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=337.15 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=205.3
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---------chhHHHHHHHHHHHhcc-CCCcceEEEEEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---------QGGQEFKMEIELLSRVH-HKNLVSLLGFCF 694 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~ 694 (955)
..++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3567889999999999999999975 689999999875431 12356789999999996 999999999999
Q ss_pred eCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecc
Q 002189 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 774 (955)
Q Consensus 695 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 774 (955)
.++..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999987543 6899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhh------hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhh
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYM------TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 848 (955)
+++....... .....|++.|+|||++. ...++.++||||||+++|||++|+.||...... .....+....
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~ 245 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGN 245 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTC
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhcCC
Confidence 9987654322 23356899999999986 346889999999999999999999999654332 2222222111
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. .............+.+++.+||+.||.+||+++|++++
T Consensus 246 ~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 246 Y-----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp C-----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred c-----------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 0 00111112334678999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.05 Aligned_cols=265 Identities=22% Similarity=0.358 Sum_probs=199.9
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEe--------C
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFD--------R 696 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 696 (955)
++|...+.||+|+||+||+|+. .+|+.||||++...... ....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688899999999999999997 57899999998654322 24578899999999999999999999987 3
Q ss_pred CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999974 7766665432 36899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCC--cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-h
Q 002189 777 KSMSDSEK--DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-Y 852 (955)
Q Consensus 777 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~ 852 (955)
+.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+....... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCh
Confidence 87653221 122234568999999999986 45899999999999999999999999754332 2222222111000 0
Q ss_pred ---------hhhhccCCcCCCCCCH-H------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 ---------NLYELIDPTIGLSTTL-K------GFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ---------~~~~~~d~~l~~~~~~-~------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+.+.......... . ....+.+++.+||+.||.+|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000000000 0 02457899999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=349.14 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=184.8
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeC------Ce
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------GE 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 698 (955)
++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 5788899999999999999985 478999999987532 23346788999999999999999999998754 56
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 79999999 78999988753 6899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-------
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------- 850 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------- 850 (955)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.+..+......
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHHT
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence 5432 234579999999999987 6789999999999999999999999965443 2333332221100
Q ss_pred ------hhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 ------LYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ------~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+....... ........+.+|+.+||+.||.+|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000000 001123568899999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=342.03 Aligned_cols=261 Identities=20% Similarity=0.293 Sum_probs=205.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe--CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCC------cceEEEEEEeCCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL--PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKN------LVSLLGFCFDRGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 698 (955)
.++|...+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788899999999999999986 36889999998753 233467889999999997665 9999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC--------------
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-------------- 764 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-------------- 764 (955)
.++||||+ +++|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 899999987766567899999999999999999999998 999999999999987
Q ss_pred -----CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHH
Q 002189 765 -----RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 839 (955)
Q Consensus 765 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~ 839 (955)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 241 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE- 241 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred cccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence 6689999999998754322 23568999999999999999999999999999999999999997543321
Q ss_pred HHHHHHhhhhhhh-hh---------------------------hhccCCcC-CCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 002189 840 EIRTVMDKKKELY-NL---------------------------YELIDPTI-GLSTTLKGFEKYVDLALKCVQESGDDRP 890 (955)
Q Consensus 840 ~~~~~~~~~~~~~-~~---------------------------~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RP 890 (955)
............. .+ .....+.. ..........++.+++.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1111111000000 00 00000000 0112234567899999999999999999
Q ss_pred CHHHHHHH
Q 002189 891 TMSEVVKD 898 (955)
Q Consensus 891 s~~evl~~ 898 (955)
|++|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=373.69 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=207.1
Q ss_pred hcCCCccCeeeccCceEEEEEEeC----CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP----NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.++|...+.||+|+||+||+|++. .+..||||+++.... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 456788899999999999999864 256899999876433 23467999999999999999999999984 567899
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999999998754 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .+....+.... .+
T Consensus 544 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~~~~~i~~~~----------~~ 611 (656)
T 2j0j_A 544 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGE----------RL 611 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHHTC----------CC
T ss_pred Ccc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCC----------CC
Confidence 332 22233457789999999999999999999999999999997 8999865432 22222221111 01
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
. .+......+.+++.+||+.||.+||+++|+++.|+++++..
T Consensus 612 ~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 P----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1 11223467899999999999999999999999999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=342.18 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=204.2
Q ss_pred HhcCCCccCeeeccCceEEEEEEe--CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhc---cCCCcceEEEEEE----
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTL--PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRV---HHKNLVSLLGFCF---- 694 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---- 694 (955)
+.++|...+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 356789999999999999999997 4688999999864322 2224567788887777 7999999999997
Q ss_pred -eCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 695 -DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 695 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
.....++||||++ |+|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 4567899999997 69999887655556899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh--h
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE--L 851 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~--~ 851 (955)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...... +....+...... .
T Consensus 165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCG
T ss_pred cccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCc
Confidence 9998654321 223456899999999999999999999999999999999999999755432 223333221110 0
Q ss_pred hhhhh-------ccC---CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 852 YNLYE-------LID---PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 852 ~~~~~-------~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.. ... ..............+.+++.+||+.||.+||+++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000 000001112234678899999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=355.28 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=194.6
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCe------EEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE------QML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~l 701 (955)
.+|...+.||+|+||+||+|+..++..||+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 45788899999999999999987777799998865322 22469999999999999999999976543 789
Q ss_pred EEEecCCCCcccccC-CCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-CCCceEEeeccccccc
Q 002189 702 IYEFVPNGSLGDSLS-GKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSM 779 (955)
Q Consensus 702 V~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~~ 779 (955)
||||++++.+..... ......+++..+..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999997654333221 111346899999999999999999999998 99999999999999 7999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh-----hhh-
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK-----ELY- 852 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~-----~~~- 852 (955)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+..+..... ...
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 44332 2335689999999999765 5899999999999999999999999754432 22222222100 000
Q ss_pred ---hhhhccCCcCCCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 ---NLYELIDPTIGLS-----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ---~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+..-|..... .......++.+++.+||+.||.+|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000111000 111234678999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=346.64 Aligned_cols=269 Identities=23% Similarity=0.326 Sum_probs=192.7
Q ss_pred HHHHHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCe-
Q 002189 621 EEVKKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE- 698 (955)
Q Consensus 621 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~- 698 (955)
.+.....++|...+.||+|+||+||+|+.. +|+.||||++..... ....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667889999999999999999999974 689999999865432 23456778889999999999999999977544
Q ss_pred ------EEEEEEecCCCCcccccCC--CCCCCCCHHHHHHHHHHHHHHHHHhh--hccCCCeeccCCCCccEEEcC-CCc
Q 002189 699 ------QMLIYEFVPNGSLGDSLSG--KNGIRLDWIRRLKIALGAARGLSYLH--ELANPPIIHRDIKSSNILLDE-RLN 767 (955)
Q Consensus 699 ------~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDlk~~NIll~~-~~~ 767 (955)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+||+++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999976 44433321 12346889999999999999999999 777 999999999999997 899
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCC-CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHh
Q 002189 768 AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD 846 (955)
Q Consensus 768 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 846 (955)
+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+..+..
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHH
Confidence 99999999987654332 22356899999999997654 899999999999999999999999754432 22222221
Q ss_pred hhh-hhhhhhhccCCcC----------------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 847 KKK-ELYNLYELIDPTI----------------GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 847 ~~~-~~~~~~~~~d~~l----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
... ........+++.. ..........++.+++.+||+.||.+|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 100 0000011111100 001112245789999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=377.46 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=206.4
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEE
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 700 (955)
..++|...++||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467899999999999999999965 68899999987531 22345678899999988 7999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
|||||+++|+|.++++..+ .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999997654 6899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~----------- 559 (674)
T 3pfq_A 494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNV----------- 559 (674)
T ss_dssp CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHSSCC-----------
T ss_pred cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCC-----------
Confidence 322 22345689999999999999999999999999999999999999997543 2233333322110
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTM-----SEVVKD 898 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 898 (955)
. .+.....++.+|+.+||+.||.+||++ +||+++
T Consensus 560 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred C----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1 111233678999999999999999997 777764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=356.27 Aligned_cols=254 Identities=9% Similarity=-0.002 Sum_probs=183.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhc--cCCCcceEE-------EEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRV--HHKNLVSLL-------GFCF 694 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l--~H~niv~l~-------~~~~ 694 (955)
..|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34778899999999999999964 7899999999875432 235677886555555 599988755 4554
Q ss_pred eC-----------------CeEEEEEEecCCCCcccccCCCCCCCCCHHHH------HHHHHHHHHHHHHhhhccCCCee
Q 002189 695 DR-----------------GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRR------LKIALGAARGLSYLHELANPPII 751 (955)
Q Consensus 695 ~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv 751 (955)
.. ...++||||++ |+|.+++...+. .+.+..+ ..++.|+++||+|||+.+ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 33 23799999998 899999875421 3355555 788899999999999998 99
Q ss_pred ccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCC
Q 002189 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRR 829 (955)
Q Consensus 752 HrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~ 829 (955)
||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876421 113457799999999987 789999999999999999999999
Q ss_pred CCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 830 PIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 830 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
||........ ...........................+.+++.+||+.||++||+++|++++
T Consensus 292 Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIK-------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCT-------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccc-------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9975421100 0000000001111111111122345788999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=346.00 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=200.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeC-----CeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 699 (955)
.++|...+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999864 6889999999754332 336788999999999999999999999765 368
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 6898888643 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCc-ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-------
Q 002189 780 SDSEKD-HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------- 850 (955)
Q Consensus 780 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------- 850 (955)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+..+......
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence 532211 112345799999999997754 58999999999999999999999997543221 11111110000
Q ss_pred ------hhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 ------LYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ------~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
............... .......++.+++.+||+.||.+|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 001123678899999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=352.04 Aligned_cols=262 Identities=21% Similarity=0.242 Sum_probs=202.1
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc--------CCCcceEEEEEE---
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH--------HKNLVSLLGFCF--- 694 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~--- 694 (955)
.++|...++||+|+||+||+|+. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36789999999999999999985 46899999999753 233467889999999996 788999999988
Q ss_pred -eCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCC------
Q 002189 695 -DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERL------ 766 (955)
Q Consensus 695 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~------ 766 (955)
.....++||||+ +++|.+++.......+++..+..++.|+++||+|||+. + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 456789999999 66777766554445799999999999999999999997 8 99999999999999775
Q ss_pred -------------------------------------------ceEEeecccccccCCCCCcceeeeeecCCCCCCHHHh
Q 002189 767 -------------------------------------------NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803 (955)
Q Consensus 767 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 803 (955)
.+||+|||+++..... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999876432 2234689999999999
Q ss_pred hhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch-----HHHHHHHHHhhhhhhh-------hh-hhccCC--cC------
Q 002189 804 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY-----IVREIRTVMDKKKELY-------NL-YELIDP--TI------ 862 (955)
Q Consensus 804 ~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~-----~~~~~~~~~~~~~~~~-------~~-~~~~d~--~l------ 862 (955)
.+..++.++|||||||++|||+||+.||..... ..+.+........... .. .+.... ..
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999974221 1122221111100000 00 000000 00
Q ss_pred -----------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 -----------GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 -----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...........+.+|+.+||+.||++|||++|++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012245566789999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=347.83 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=199.9
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+..+ .||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4578888999999999999998753 499999875322 223567889999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++ ++.+||+|||+++.......
T Consensus 110 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999997643 46899999999999999999999998 99999999999998 67999999999876532111
Q ss_pred ---cceeeeeecCCCCCCHHHhhh---------CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 785 ---DHITTQVKGTMGYLDPEYYMT---------QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 785 ---~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~----- 258 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-AIIWQMGTG----- 258 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-HHHHHHHTT-----
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhccC-----
Confidence 112233468999999999974 35788999999999999999999999754322 111111111
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
..+.... ......+.+++.+||+.||.+||+++|+++.|+++.++..
T Consensus 259 -----~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 259 -----MKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp -----CCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred -----CCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111111 1122467899999999999999999999999998876643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=339.31 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=195.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEE------------
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF------------ 694 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~------------ 694 (955)
++|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57888999999999999999975 58999999998766556678999999999999999999999873
Q ss_pred --eCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-CCCceEEe
Q 002189 695 --DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVA 771 (955)
Q Consensus 695 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~ 771 (955)
+.+..++||||++ |+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++ +++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 6999988643 5899999999999999999999998 99999999999997 56799999
Q ss_pred ecccccccCCCCC-cceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh
Q 002189 772 DFGLSKSMSDSEK-DHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK 849 (955)
Q Consensus 772 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 849 (955)
|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...... +....+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcC
Confidence 9999987643211 111223457999999999875 67899999999999999999999999755432 22222222110
Q ss_pred h-----hhhhhh---------ccCCcCC-CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 E-----LYNLYE---------LIDPTIG-LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 ~-----~~~~~~---------~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ...+.. ...+... .........++.+++.+||+.||++||+++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 000000 0000000 00001234678999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=343.77 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=202.8
Q ss_pred HhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CC-----CcceEEEEEEeCCe
Q 002189 626 YTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HK-----NLVSLLGFCFDRGE 698 (955)
Q Consensus 626 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~ 698 (955)
..++|...+.||+|+||+||+|+.. +++.||||+++.. ....+++.+|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999865 6889999999753 223466788999999885 55 49999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc--CCCceEEeecccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD--ERLNAKVADFGLS 776 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFGla 776 (955)
.++||||++ |+|.+++.......+++..+..++.|++.||+|||.+ ...|+||||||+|||++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999995 6999998766545689999999999999999999952 12399999999999994 5788999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh------
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------ 850 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 850 (955)
+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.+..+......
T Consensus 209 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 209 CQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV-DQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred eeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 8764322 2356899999999999999999999999999999999999999754332 223322221100
Q ss_pred -----hhhhhhcc-C-----------------CcC--------------------CCCCCHHHHHHHHHHHHHhhccCCC
Q 002189 851 -----LYNLYELI-D-----------------PTI--------------------GLSTTLKGFEKYVDLALKCVQESGD 887 (955)
Q Consensus 851 -----~~~~~~~~-d-----------------~~l--------------------~~~~~~~~~~~l~~li~~cl~~dP~ 887 (955)
.......+ + +.. ..........++.+|+.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 00000000 0 000 0001123345789999999999999
Q ss_pred CCCCHHHHHHH
Q 002189 888 DRPTMSEVVKD 898 (955)
Q Consensus 888 ~RPs~~evl~~ 898 (955)
+|||++|++++
T Consensus 363 ~Rpta~e~L~h 373 (382)
T 2vx3_A 363 TRIQPYYALQH 373 (382)
T ss_dssp TSCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=349.58 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=183.0
Q ss_pred CCCc-cCeeeccCceEEEEEEeC---CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe--CCeEEEE
Q 002189 629 NFSD-ANDVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQMLI 702 (955)
Q Consensus 629 ~f~~-~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 702 (955)
.|.. .++||+|+||+||+|+.. +++.||||+++.... .+.+.+|++++++++|||||++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 457999999999999965 578999999975433 3568899999999999999999999965 6688999
Q ss_pred EEecCCCCcccccCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE----cCCCceEEe
Q 002189 703 YEFVPNGSLGDSLSGK-------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL----DERLNAKVA 771 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~ 771 (955)
|||++ |+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 5777766421 1235899999999999999999999998 9999999999999 778999999
Q ss_pred ecccccccCCCCC-cceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchH--------HHHH
Q 002189 772 DFGLSKSMSDSEK-DHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYI--------VREI 841 (955)
Q Consensus 772 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~--------~~~~ 841 (955)
|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .+.+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987653221 1223346799999999999874 5899999999999999999999999643221 1222
Q ss_pred HHHHhhhhh-----hhhh---------hhccCCc-CCCCC--------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 842 RTVMDKKKE-----LYNL---------YELIDPT-IGLST--------TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 842 ~~~~~~~~~-----~~~~---------~~~~d~~-l~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..++..... +..+ ...+... ..... .......+.+|+.+||+.||.+|||++|++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 222211100 0000 0000000 00000 00012467899999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=343.79 Aligned_cols=258 Identities=22% Similarity=0.355 Sum_probs=197.5
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeE----
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQ---- 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---- 699 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888899999999999999864 6899999999764332 246788999999999999999999999877654
Q ss_pred --EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 700 --MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 700 --~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
++||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 688777743 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh------
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------ 850 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 850 (955)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+..+......
T Consensus 193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHH
Confidence 65432 233568999999999987 78999999999999999999999999754432 222222221100
Q ss_pred -------hhhhhhccCCcCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 -------LYNLYELIDPTIGLS---TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 -------~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+....... ........+.+|+.+||+.||++|||++|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000011000000 001123678999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=339.36 Aligned_cols=257 Identities=22% Similarity=0.358 Sum_probs=197.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCe------
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE------ 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 698 (955)
++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46788899999999999999864 6899999998754322 24678899999999999999999999987654
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||++ |+|.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999996 688887753 4899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-------
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------- 850 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------- 850 (955)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+..+......
T Consensus 176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHHT
T ss_pred CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 5422 234568999999999987 67899999999999999999999999754432 222222211000
Q ss_pred ------hhhhhhccCCcCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 ------LYNLYELIDPTIG---LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ------~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+..... ..........+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000110000 01112334788999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.54 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=204.6
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
....++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999975 78999999986532 234567899999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC---CceEEeeccccc
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER---LNAKVADFGLSK 777 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGla~ 777 (955)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.+ +.+||+|||+++
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998876543 6899999999999999999999998 9999999999999754 469999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
....... .....||+.|+|||.+.+ .++.++||||||+++|||++|..||..... .+....+.....
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~-------- 239 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKY-------- 239 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC--------
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC--------
Confidence 7654322 223458999999998875 589999999999999999999999975432 222222211110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.... ........++.+++.+||+.||++||+++|++++
T Consensus 240 -~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 -AFDL--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -CCCS--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -CCCc--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000 0011223678899999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=342.66 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=179.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHH-HHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIE-LLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 56788899999999999999974 789999999976433 23345566665 6777899999999999999999999999
Q ss_pred ecCCCCcccccCC---CCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 705 FVPNGSLGDSLSG---KNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 705 ~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
|+++ +|.+++.. .....+++..+..++.|+++||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9974 77776642 1234689999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCCCcceeeeeecCCCCCCHHHh----hhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhh
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYY----MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (955)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......+.... ...
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----------~~~ 244 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ----------VVK 244 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC----------CCC
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH----------Hhc
Confidence 332 12334699999999998 4567899999999999999999999999754322111110 111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...+.+...........+.+++.+||+.||++||+++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111222221222344688999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=337.87 Aligned_cols=262 Identities=19% Similarity=0.276 Sum_probs=202.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CC-cEEEEEEcccCCcchhHHHHHHHHHHHhccCCC------cceEEEEEEeCCe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NG-QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKN------LVSLLGFCFDRGE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 698 (955)
.++|...+.||+|+||+||+|+.. ++ +.||||+++.. ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 367889999999999999999864 34 78999999753 233467889999999998766 9999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEE----------------
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILL---------------- 762 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll---------------- 762 (955)
.++||||+ ++++.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 677777776555457999999999999999999999998 9999999999999
Q ss_pred ---cCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHH
Q 002189 763 ---DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR 839 (955)
Q Consensus 763 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~ 839 (955)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 678899999999998654322 235699999999999999999999999999999999999999975443221
Q ss_pred --HHHHHHhhhhh-hh------------------------hhhhccCCc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 002189 840 --EIRTVMDKKKE-LY------------------------NLYELIDPT-IGLSTTLKGFEKYVDLALKCVQESGDDRPT 891 (955)
Q Consensus 840 --~~~~~~~~~~~-~~------------------------~~~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 891 (955)
.+......... .. ...+...+. ...........++.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 11111100000 00 000000000 001112234568899999999999999999
Q ss_pred HHHHHHH
Q 002189 892 MSEVVKD 898 (955)
Q Consensus 892 ~~evl~~ 898 (955)
++|++++
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.22 Aligned_cols=251 Identities=19% Similarity=0.229 Sum_probs=175.5
Q ss_pred hcCCCccC-eeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe----CCeEE
Q 002189 627 TNNFSDAN-DVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQM 700 (955)
Q Consensus 627 ~~~f~~~~-~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 700 (955)
.++|...+ .||+|+||+||+|+.. +|+.||||++... .+...+....++.++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46777755 6999999999999875 6899999998653 1222223344666789999999999976 44589
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEeeccccc
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFGLSK 777 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla~ 777 (955)
+||||+++|+|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998766667999999999999999999999998 999999999999976 4559999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHH--HHHHHHhhhhhhhhhh
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR--EIRTVMDKKKELYNLY 855 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~ 855 (955)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .........
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 248 (336)
T 3fhr_A 180 ETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG------- 248 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc-------
Confidence 664322 2345689999999999888899999999999999999999999964322110 000000000
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..............++.+++.+||+.||.+|||++|++++
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111112334678999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.88 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=182.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcch-h-HHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQG-G-QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++...... . +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356788899999999999999975 78999999997653322 2 33445556788889999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
||+ ++.+..+.. .....+++..+..++.|+++||+|||+. + ++||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 444443332 2234689999999999999999999985 8 999999999999999999999999999766433
Q ss_pred CCcceeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 783 EKDHITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
. ......||+.|+|||++. ...++.++||||||+++|||++|+.||.......+..........
T Consensus 179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 247 (318)
T 2dyl_A 179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-------- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC--------
T ss_pred c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC--------
Confidence 2 223456999999999994 567899999999999999999999999765444443333332211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.... .......+.+++.+||+.||.+||+++|++++
T Consensus 248 --~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 --PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11110 11233678899999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=340.33 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=200.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeC-----CeE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GEQ 699 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 699 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457888999999999999999965 689999999975433 2345788999999999999999999998764 678
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
++||||++ |+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6898887653 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCcc--------eeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 780 SDSEKDH--------ITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 780 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-HQLLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Confidence 5322111 1123468999999999875 67899999999999999999999999754432 222222111000
Q ss_pred h--------------hhhhhccCCcCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 L--------------YNLYELIDPTIGLS----TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ~--------------~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ......+ +..... .......++.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSL-PMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTS-CCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcc-cCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000000 000000 001233678899999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.53 Aligned_cols=245 Identities=26% Similarity=0.408 Sum_probs=193.2
Q ss_pred HHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc------hhHHHHHHHHHHHhc----cCCCcceEEE
Q 002189 623 VKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRV----HHKNLVSLLG 691 (955)
Q Consensus 623 l~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~~ 691 (955)
.....++|...+.||+|+||+||+|+. .+++.||||+++..... ....+.+|++++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345567899999999999999999986 47899999999754332 223456799999999 8999999999
Q ss_pred EEEeCCeEEEEEEe-cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-CCCceE
Q 002189 692 FCFDRGEQMLIYEF-VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAK 769 (955)
Q Consensus 692 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~k 769 (955)
++.+.+..++|||| +++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++ +++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 78999999987543 6899999999999999999999998 99999999999999 889999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCC-ChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhh
Q 002189 770 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 770 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 848 (955)
|+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||...... ....
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~ 249 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------LEAE 249 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHTC
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------hhhc
Confidence 99999998765432 2345699999999999877765 5899999999999999999999643211 1100
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. ........+.+++.+||+.||++||+++|++++
T Consensus 250 -----------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 -----------LH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----------CC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----------cC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 111223678899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=349.65 Aligned_cols=250 Identities=24% Similarity=0.301 Sum_probs=187.8
Q ss_pred CCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 630 FSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+++..++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456789999999998776668999999998653 235678899999987 89999999999999999999999995
Q ss_pred CCcccccCCCCCCC-----CCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC-------------CceEE
Q 002189 709 GSLGDSLSGKNGIR-----LDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER-------------LNAKV 770 (955)
Q Consensus 709 gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~-------------~~~kl 770 (955)
|+|.+++....... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 79999987654211 123345789999999999999998 9999999999999754 48999
Q ss_pred eecccccccCCCCCcc--eeeeeecCCCCCCHHHhhh-------CCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHH
Q 002189 771 ADFGLSKSMSDSEKDH--ITTQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVRE 840 (955)
Q Consensus 771 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~ 840 (955)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||........
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~- 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-
Confidence 9999998775433211 1234579999999999975 678999999999999999999 8999964432211
Q ss_pred HHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 841 IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
.+..... . .+............++.+++.+||+.||.+||+++|+++
T Consensus 249 --~i~~~~~------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 --NIIRGIF------S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHTCC------C--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHhcCCC------C--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111110 0 111122223455678999999999999999999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=350.68 Aligned_cols=334 Identities=17% Similarity=0.129 Sum_probs=264.1
Q ss_pred CCCCCCCccEEeCC----------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccC-CCCCcccccccccc
Q 002189 50 DPCGDNWEGIGCTN----------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGP-LPTTIGNLKKLSNL 118 (955)
Q Consensus 50 ~~C~~~w~gv~C~~----------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~-~p~~~~~l~~L~~L 118 (955)
+.|.|.+..|.|+. .+++.|+|++|.+++..|..|..+++|++|+|++|. +.+. .|..|.++++|++|
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~-~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQT-PGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCS-TTCEECTTTTTTCTTCCEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCc-ccceECcccccccccCCEE
Confidence 34543444488864 468999999999999989999999999999999997 6644 46789999999999
Q ss_pred cccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCC--CCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccc
Q 002189 119 MLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPS--IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 196 (955)
Q Consensus 119 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L 196 (955)
+|++|++++..|..|+++++|++|+|++|++++.++.. |.++++|++|+|++|++++..|..+ +..+++|++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~~l~~L~~L 159 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF-----FLNMRRFHVL 159 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGG-----GGGCTTCCEE
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccc-----cCCCCcccEE
Confidence 99999999888999999999999999999999855544 9999999999999999996666432 5667888999
Q ss_pred cccCCcccccCCccccCC-ccceeeeeccCCCccccCCccc--------CCCCCCcEEEcccCCCCCCccccccC-----
Q 002189 197 HFGKNQLSGSIPEKLFRP-DMVLIHVLFDSNNLTGELPATL--------GLVKSLEVVRFDRNSLSGPVPSNLNN----- 262 (955)
Q Consensus 197 ~L~~N~l~g~ip~~~~~~-~~~L~~L~L~~N~l~~~~p~~l--------~~l~~L~~L~Ls~N~l~~~~p~~l~~----- 262 (955)
++++|++++..|..+... ...|+.|++++|.+.+..+..+ ..+++|++|++++|.+++..|..+..
T Consensus 160 ~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~ 239 (455)
T 3v47_A 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239 (455)
T ss_dssp ECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTC
T ss_pred eCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcccccc
Confidence 999999996666554332 2567777777777776544432 35567777777777776555544322
Q ss_pred ----------------------------------CCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChh
Q 002189 263 ----------------------------------LTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSW 307 (955)
Q Consensus 263 ----------------------------------l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~ 307 (955)
.++|+.|+|++|.+++.++ .+..+++|++|+|++|++++ ..|..
T Consensus 240 ~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~ 318 (455)
T 3v47_A 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK-IDDNA 318 (455)
T ss_dssp CEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE-ECTTT
T ss_pred ceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccc-cChhH
Confidence 2578888888888888776 47778888888888888875 56778
Q ss_pred hcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCCccee
Q 002189 308 FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLT 386 (955)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~ 386 (955)
|.++++|+.|+|++|.+++..|..+..+++|++|+|++|++++..|..+ .+.+|+.|+|++|+|+++++..+..+++|+
T Consensus 319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 398 (455)
T 3v47_A 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ 398 (455)
T ss_dssp TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCccc
Confidence 8888888888888888888878888888888888888888888877654 467788888888888888887776666665
Q ss_pred EecC
Q 002189 387 LIDN 390 (955)
Q Consensus 387 ~l~n 390 (955)
.++.
T Consensus 399 ~L~l 402 (455)
T 3v47_A 399 KIWL 402 (455)
T ss_dssp EEEC
T ss_pred EEEc
Confidence 5543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=342.04 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=201.2
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-----------CCCcceEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-----------HKNLVSLLGFCFD 695 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 695 (955)
++|...+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688899999999999999986 57899999998753 233467889999999886 8999999999987
Q ss_pred CC----eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-cCCCeeccCCCCccEEEc------C
Q 002189 696 RG----EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL-ANPPIIHRDIKSSNILLD------E 764 (955)
Q Consensus 696 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDlk~~NIll~------~ 764 (955)
.+ ..++||||+ +++|.+++.......+++..+..++.|++.||+|||+. + |+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcC
Confidence 54 789999999 89999998765555699999999999999999999997 8 99999999999994 4
Q ss_pred CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch-----HHH
Q 002189 765 RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY-----IVR 839 (955)
Q Consensus 765 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~-----~~~ 839 (955)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 458999999999876432 2234689999999999999999999999999999999999999974321 111
Q ss_pred HHHHHHhhhhhhhh--------hhhccCCc-------------------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 002189 840 EIRTVMDKKKELYN--------LYELIDPT-------------------IGLSTTLKGFEKYVDLALKCVQESGDDRPTM 892 (955)
Q Consensus 840 ~~~~~~~~~~~~~~--------~~~~~d~~-------------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 892 (955)
.+..+......... ....++.. ...........++.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 12221111000000 00000000 0112334566889999999999999999999
Q ss_pred HHHHHH
Q 002189 893 SEVVKD 898 (955)
Q Consensus 893 ~evl~~ 898 (955)
+|++++
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=339.72 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=200.5
Q ss_pred HHHHHHhcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc------hhHHHHHHHHHHHhcc--CCCcceEEE
Q 002189 621 EEVKKYTNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVH--HKNLVSLLG 691 (955)
Q Consensus 621 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~ 691 (955)
.+.....++|...+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 33444567899999999999999999985 47899999998754322 2245778999999996 599999999
Q ss_pred EEEeCCeEEEEEEecCC-CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-CCCceE
Q 002189 692 FCFDRGEQMLIYEFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAK 769 (955)
Q Consensus 692 ~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~k 769 (955)
++.+.+..++||||+.+ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++ +++.+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999976 89999887543 6899999999999999999999998 99999999999999 789999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhh
Q 002189 770 VADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 770 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 848 (955)
|+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ....
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~ 259 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQ 259 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHCC
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------hccc
Confidence 99999998765332 223569999999999987776 67899999999999999999999643211 1000
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.... .....++.+++.+||+.||++||+++|++++
T Consensus 260 -------~~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 -------VFFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -------CCCS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------cccc--------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 1123678899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=343.94 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=186.9
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
.+|...++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+.+..++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45778889999999996655556789999999875433 2356899999999 7999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-----CCceEEeecccccccCC
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-----RLNAKVADFGLSKSMSD 781 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DFGla~~~~~ 781 (955)
+ |+|.+++.... ....+..+..++.|+++||+|||+.+ |+||||||+||+++. ...+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 5 69999887554 23444456789999999999999998 999999999999953 34588999999987654
Q ss_pred CCCc-ceeeeeecCCCCCCHHHhh---hCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhh
Q 002189 782 SEKD-HITTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYE 856 (955)
Q Consensus 782 ~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (955)
.... .......||+.|+|||++. ...++.++|||||||++|||+| |..||...... ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~~~~~~~~--------- 244 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILLGA--------- 244 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--HHHHHTTC---------
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--HHHHHhcc---------
Confidence 3211 2233467999999999997 4677889999999999999999 88888543221 11111100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.... ...........+.+++.+||+.||.+||+++|++++
T Consensus 245 -~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 245 -CSLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -CCCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCcc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000 011122344567899999999999999999999953
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=344.95 Aligned_cols=310 Identities=17% Similarity=0.150 Sum_probs=214.2
Q ss_pred CCccEEeCC-----------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCccccccccccccccc
Q 002189 55 NWEGIGCTN-----------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123 (955)
Q Consensus 55 ~w~gv~C~~-----------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N 123 (955)
.|..|.|.. ..++.|+|++|+|++..+..|..+++|++|+|++|+ +.+..|..|.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSC-CCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCc-cCEeChhhhhCCccCCEEECCCC
Confidence 467788863 356677777777777666777777777777777775 66666777777777777777777
Q ss_pred ccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcc
Q 002189 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL 203 (955)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l 203 (955)
++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+. .+.+|+.|+|++|++
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~------~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS------GLNSLEQLTLEKCNL 164 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSST------TCTTCCEEEEESCCC
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhcc------CCCCCCEEECCCCcC
Confidence 77755555567777777777777777766667777777777777777777755554433 345566667777777
Q ss_pred cccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-C
Q 002189 204 SGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-N 282 (955)
Q Consensus 204 ~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~ 282 (955)
+ .+|...+..+.+|+.|+|++|++.+..+..|..+++|+.|++++|.+.+.+|..+....+|+.|+|++|.|+++++ .
T Consensus 165 ~-~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 243 (477)
T 2id5_A 165 T-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243 (477)
T ss_dssp S-SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHH
T ss_pred c-ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHH
Confidence 6 5666666666777777777777776666677777777777777776666666666666677777777777776554 3
Q ss_pred CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc-chhhh
Q 002189 283 LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSEN 361 (955)
Q Consensus 283 ~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l 361 (955)
+..+++|++|+|++|.+++ ..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+ .+.+|
T Consensus 244 ~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 322 (477)
T 2id5_A 244 VRHLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322 (477)
T ss_dssp HTTCTTCCEEECCSSCCCE-ECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGC
T ss_pred hcCccccCeeECCCCcCCc-cChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCccc
Confidence 6667777777777777764 445566777777777777777777667777777777777777777776665543 35566
Q ss_pred hhhcccCCcccc
Q 002189 362 LLVNLQNNRISA 373 (955)
Q Consensus 362 ~~L~L~~N~l~~ 373 (955)
+.|+|++|++.+
T Consensus 323 ~~L~l~~N~l~c 334 (477)
T 2id5_A 323 ETLILDSNPLAC 334 (477)
T ss_dssp CEEECCSSCEEC
T ss_pred CEEEccCCCccC
Confidence 677777777654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=346.73 Aligned_cols=315 Identities=18% Similarity=0.207 Sum_probs=209.2
Q ss_pred CccEEeCC-----------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccc
Q 002189 56 WEGIGCTN-----------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCS 124 (955)
Q Consensus 56 w~gv~C~~-----------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~ 124 (955)
+..+.|.. ..++.|+|++|.|++..|..|.++++|++|+|++|+ +.+..|..|.++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~-i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQ-IYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCC-CCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCc-cceeChhhccCccccCeeeCCCCc
Confidence 45688853 478999999999999889999999999999999997 888999999999999999999999
Q ss_pred cCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeec-cCCCCCCCCchh---------------
Q 002189 125 FSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE-IPVSDGNSPGLD--------------- 188 (955)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~-ip~~~~~~~~l~--------------- 188 (955)
+++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++. +|..+ .++.|+
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF-PTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTC-CCTTCCEEECCSSCCCEECHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCccccc-CCcccCEEEcccCcccccChh
Confidence 9988899999999999999999999987788899999999999999999863 34332 233222
Q ss_pred ---hhhccc--cccccCCcccccCCccccCCc------------------------------------------------
Q 002189 189 ---MLVRAK--HFHFGKNQLSGSIPEKLFRPD------------------------------------------------ 215 (955)
Q Consensus 189 ---~L~~L~--~L~L~~N~l~g~ip~~~~~~~------------------------------------------------ 215 (955)
.+.+|+ .|++++|++++..|. .|...
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~-~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~ 250 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPG-AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTT-TTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred hhhhhcccceeEEecCCCccCccChh-HhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhch
Confidence 233445 566666666633322 22110
Q ss_pred ---cceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCE
Q 002189 216 ---MVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSY 291 (955)
Q Consensus 216 ---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 291 (955)
..|+.|++++|++++..+..|..+++|++|++++|.++ .+|..+..+++|++|+|++|.+++.++ .+..+++|++
T Consensus 251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 329 (606)
T 3t6q_A 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329 (606)
T ss_dssp GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence 14556666666666555556666666666666666666 566666666666666666666666544 4555555555
Q ss_pred EECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecC--CcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccC
Q 002189 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI--PADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQN 368 (955)
Q Consensus 292 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~ 368 (955)
|++++|.+.+...+..+..+++|+.|++++|.+++.. +..+..+++|++|+|++|++++..+..+. +.+|+.|+|++
T Consensus 330 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 409 (606)
T 3t6q_A 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409 (606)
T ss_dssp EECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTT
T ss_pred EECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCC
Confidence 5555555544333334445555555555555554433 44444444555555555544444443322 33344444444
Q ss_pred Cccccc
Q 002189 369 NRISAY 374 (955)
Q Consensus 369 N~l~~~ 374 (955)
|++++.
T Consensus 410 n~l~~~ 415 (606)
T 3t6q_A 410 TRLKVK 415 (606)
T ss_dssp CCEECC
T ss_pred CcCCCc
Confidence 444443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=359.23 Aligned_cols=240 Identities=22% Similarity=0.339 Sum_probs=194.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC--CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCe-----E
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP--NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE-----Q 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~ 699 (955)
++|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999875 689999999875432 334578899999999999999999999988765 7
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
||||||+++++|.+++.. .+++.+++.++.||++||+|||+.+ |+||||||+||+++++ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999987754 5899999999999999999999998 9999999999999986 8999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
... ....||++|+|||++.++. +.++|||||||++|||++|.+|+..... ..+.
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-------------------~~~~ 285 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-------------------DGLP 285 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-------------------SSCC
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-------------------cccc
Confidence 533 2356999999999987654 8999999999999999999988753110 0000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-MSEVVKDIENILQ 904 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~~~ 904 (955)
...........+.+++.+||+.||.+||+ ++++.+.|..++.
T Consensus 286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00111122367889999999999999995 6666777776653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=358.65 Aligned_cols=273 Identities=25% Similarity=0.328 Sum_probs=207.8
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEe------CCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD------RGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~ 699 (955)
++|...+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999986 468999999987642 3335678999999999999999999998765 6678
Q ss_pred EEEEEecCCCCcccccCCCC-CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCc---eEEeeccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKN-GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLN---AKVADFGL 775 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGl 775 (955)
++||||+++|+|.+++.... ...+++..+..++.+++.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999987643 335888899999999999999999998 999999999999997665 99999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 776 SKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 776 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
++....... .....||+.|+|||.+.+..++.++|||||||++|||++|..||........+...............
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 987654332 23467999999999999999999999999999999999999999765444333221111111000001
Q ss_pred hccCCc--------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHHHHHHc
Q 002189 856 ELIDPT--------IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSE-----VVKDIENILQQA 906 (955)
Q Consensus 856 ~~~d~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~~~ 906 (955)
+..... ............+.+++.+||..||.+|||++| ..+.++.+++..
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 111110 111233456788999999999999999999988 456677776543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=362.12 Aligned_cols=336 Identities=19% Similarity=0.159 Sum_probs=188.3
Q ss_pred CCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccc
Q 002189 55 NWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 134 (955)
Q Consensus 55 ~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 134 (955)
+|..|.+...+++.|||++|.|++..+..|.++++|++|+|++|..+....|..|.++++|++|+|++|.+++..|..|.
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~ 94 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence 45555554467777777777777766666666666666666555312222245555555555555555555555555555
Q ss_pred cCCCCcEEEccCCCCcCcCCCC--CCCCCCcCeeecCCceeeeccC-CCCCCCCchhhh--------------------h
Q 002189 135 SLQELVLLSLNSNGFSGRVPPS--IGNLSNLYWLDLTDNKLEGEIP-VSDGNSPGLDML--------------------V 191 (955)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~L~~L~L~~N~l~g~ip-~~~~~~~~l~~L--------------------~ 191 (955)
++++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..| ..+++++.|+.| .
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~ 174 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHC
T ss_pred CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCC
Confidence 5555555555555555433332 4455555555555555443322 122222221110 1
Q ss_pred c------------------------------cccccccCCcccccC----------------------------------
Q 002189 192 R------------------------------AKHFHFGKNQLSGSI---------------------------------- 207 (955)
Q Consensus 192 ~------------------------------L~~L~L~~N~l~g~i---------------------------------- 207 (955)
+ |+.|++++|++++.+
T Consensus 175 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~ 254 (844)
T 3j0a_A 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254 (844)
T ss_dssp SSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTT
T ss_pred ccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCC
Confidence 1 333444444333222
Q ss_pred ---------------------------CccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccc
Q 002189 208 ---------------------------PEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260 (955)
Q Consensus 208 ---------------------------p~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 260 (955)
+...|..+++|+.|+|++|++++..|..|..+++|++|+|++|.+++..|..|
T Consensus 255 ~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 334 (844)
T 3j0a_A 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF 334 (844)
T ss_dssp GGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSC
T ss_pred CChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHh
Confidence 22233344455556666666665555566666666666666666665556666
Q ss_pred cCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCC------------------------------------
Q 002189 261 NNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASE------------------------------------ 303 (955)
Q Consensus 261 ~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~------------------------------------ 303 (955)
..+++|+.|+|++|.|++.++ .+..+++|++|+|++|.+++..
T Consensus 335 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~ 414 (844)
T 3j0a_A 335 YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE 414 (844)
T ss_dssp SSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCC
T ss_pred cCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccc
Confidence 666666666666666665555 3555666666666666554311
Q ss_pred ---CChhhcCCCCCCEEECcCCccee------------------------------cCCcCCCCCCCCcEEEeecCccee
Q 002189 304 ---VPSWFSSMQSLTTLMMENTNLKG------------------------------QIPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 304 ---~p~~~~~l~~L~~L~Ls~N~l~~------------------------------~~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
.+..+.++++|+.|+|++|++++ ..+..|..+++|+.|+|++|+|++
T Consensus 415 ~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 494 (844)
T 3j0a_A 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494 (844)
T ss_dssp SSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTT
T ss_pred cCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccc
Confidence 01112345555555555555542 122346678899999999999999
Q ss_pred eeCCCc-chhhhhhhcccCCccccccCCCCC-CCcceeEecC
Q 002189 351 TLDLGT-SYSENLLVNLQNNRISAYTERGGA-PAVNLTLIDN 390 (955)
Q Consensus 351 ~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~-~~~~L~~l~n 390 (955)
.++..+ .+.+|+.|+|++|+|+++++..+. .+..|.+.+|
T Consensus 495 ~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N 536 (844)
T 3j0a_A 495 LPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRN 536 (844)
T ss_dssp CCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEE
T ss_pred cChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCC
Confidence 888765 577888999999999999887765 2344444443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=354.86 Aligned_cols=322 Identities=17% Similarity=0.237 Sum_probs=215.5
Q ss_pred CCCEeEEEecCCcCccc-----------------cCcCcC--CCCcccEEecCCCCCCccCCCCCccccccccccccccc
Q 002189 63 NSRVTSITLSGMGLKGQ-----------------LSGDIT--GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~~-----------------~~~~l~--~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N 123 (955)
..+++.|+|++|.+++. +|..++ ++++|++|+|++|+ +.+.+|..|+++++|++|+|++|
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~Ls~n 283 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP-NLTKLPTFLKALPEMQLINVACN 283 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT-TCSSCCTTTTTCSSCCEEECTTC
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc-CCccChHHHhcCCCCCEEECcCC
Confidence 36899999999999986 899998 99999999999997 89999999999999999999999
Q ss_pred c-cCC-CCCCccccC------CCCcEEEccCCCCcCcCCC--CCCCCCCcCeeecCCceeeeccCCCCCCCCchh-----
Q 002189 124 S-FSG-PIPDSIGSL------QELVLLSLNSNGFSGRVPP--SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD----- 188 (955)
Q Consensus 124 ~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~----- 188 (955)
+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .++++++|++|+|++|+++|.+| .++.++.|+
T Consensus 284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~ 361 (636)
T 4eco_A 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361 (636)
T ss_dssp TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECC
T ss_pred CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECC
Confidence 8 888 788888876 89999999999999 7888 89999999999999999998888 554432222
Q ss_pred ------------hhhc-cccccccCCcccccCCccccCC-ccceeeeeccCCCccccCCcccC-------CCCCCcEEEc
Q 002189 189 ------------MLVR-AKHFHFGKNQLSGSIPEKLFRP-DMVLIHVLFDSNNLTGELPATLG-------LVKSLEVVRF 247 (955)
Q Consensus 189 ------------~L~~-L~~L~L~~N~l~g~ip~~~~~~-~~~L~~L~L~~N~l~~~~p~~l~-------~l~~L~~L~L 247 (955)
.+.+ |++|++++|+++ .+|..+... ..+|+.|++++|++++.+|..|. .+++|+.|+|
T Consensus 362 ~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~L 440 (636)
T 4eco_A 362 YNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440 (636)
T ss_dssp SSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEEC
T ss_pred CCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEEC
Confidence 2233 555555555555 555433222 22556666666666655555555 5556666666
Q ss_pred ccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCC-C-------CCCCEEECcCCCCCCCCCChhhc--CCCCCCEE
Q 002189 248 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTG-L-------SVLSYLDMSNNSFDASEVPSWFS--SMQSLTTL 317 (955)
Q Consensus 248 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-l-------~~L~~L~Ls~N~l~~~~~p~~~~--~l~~L~~L 317 (955)
++|.++...+..+..+++|+.|+|++|+|+.+++.+.. . ++|++|+|++|+++ .+|..+. .+++|+.|
T Consensus 441 s~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~~~l~~L~~L 518 (636)
T 4eco_A 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT--KLSDDFRATTLPYLVGI 518 (636)
T ss_dssp CSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC--BCCGGGSTTTCTTCCEE
T ss_pred cCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC--ccChhhhhccCCCcCEE
Confidence 66666632223344456666666666666644443222 1 26666666666665 3555554 66666666
Q ss_pred ECcCCcceecCCcCCCCCCCCcEEEe------ecCcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCCcceeEecC
Q 002189 318 MMENTNLKGQIPADLFSIPHLQTVVM------KTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 390 (955)
Q Consensus 318 ~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n 390 (955)
+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+ .+.+|+.|+|++|+|+.++...+..+..|++.+|
T Consensus 519 ~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ip~~~~~~L~~L~Ls~N 597 (636)
T 4eco_A 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDN 597 (636)
T ss_dssp ECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSCCCTTCCEEECCSC
T ss_pred ECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCCccCHhHhCcCCEEECcCC
Confidence 666666665 5666666666666666 3455555555443 3455556666666665555554444444444444
Q ss_pred c
Q 002189 391 P 391 (955)
Q Consensus 391 ~ 391 (955)
+
T Consensus 598 ~ 598 (636)
T 4eco_A 598 P 598 (636)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=348.65 Aligned_cols=312 Identities=19% Similarity=0.221 Sum_probs=204.9
Q ss_pred CCCccEEeCC-------------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccc
Q 002189 54 DNWEGIGCTN-------------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120 (955)
Q Consensus 54 ~~w~gv~C~~-------------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~L 120 (955)
|.|.|+ |+. .+++.|+|++|++++..|..|..+++|++|+|++|+ +.+..|..|.++++|++|+|
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~-i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR-INTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSC-CCEECTTTTTTCTTCCEEEC
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCC-cCccChhhccccccCCEEEC
Confidence 368887 752 378999999999998888889999999999999996 88888888999999999999
Q ss_pred cccccCCCCCCccccCCCCcEEEccCCCCcCc-CCCCCCCCCCcCeeecCCceeeeccC---------------------
Q 002189 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGR-VPPSIGNLSNLYWLDLTDNKLEGEIP--------------------- 178 (955)
Q Consensus 121 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~L~~N~l~g~ip--------------------- 178 (955)
++|++++..|..|+++++|++|+|++|++++. +|..++++++|++|+|++|++.+.+|
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 99998877766788888888888888888752 45566677777777776666433443
Q ss_pred ----CCCCCCCchh------------------hhhccccccccCCcccccC--CccccCC--------------------
Q 002189 179 ----VSDGNSPGLD------------------MLVRAKHFHFGKNQLSGSI--PEKLFRP-------------------- 214 (955)
Q Consensus 179 ----~~~~~~~~l~------------------~L~~L~~L~L~~N~l~g~i--p~~~~~~-------------------- 214 (955)
..++.++.|+ .+++|++|++++|++++.. |..+...
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 241 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHH
T ss_pred ccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHH
Confidence 3333333222 1345555666666555310 0000000
Q ss_pred -------------------------------------------------------------------ccceeeeeccCCC
Q 002189 215 -------------------------------------------------------------------DMVLIHVLFDSNN 227 (955)
Q Consensus 215 -------------------------------------------------------------------~~~L~~L~L~~N~ 227 (955)
..+|+.|++++|+
T Consensus 242 ~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~ 321 (549)
T 2z81_A 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321 (549)
T ss_dssp HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSC
T ss_pred HHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCc
Confidence 0123333333333
Q ss_pred ccccCCccc-CCCCCCcEEEcccCCCCCCccc---cccCCCCCCEEEccCCcCcccCC---CCCCCCCCCEEECcCCCCC
Q 002189 228 LTGELPATL-GLVKSLEVVRFDRNSLSGPVPS---NLNNLTSVNDLYLSNNKLTGAMP---NLTGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 228 l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~---~l~~l~~L~~L~Ls~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~ 300 (955)
+. .+|..+ ..+++|++|+|++|.+++.+|. .+..+++|+.|+|++|+|++.++ .+..+++|++|+|++|+++
T Consensus 322 l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 400 (549)
T 2z81_A 322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400 (549)
T ss_dssp CC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred cc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc
Confidence 33 234333 4577888888888888766543 36777788888888888876653 3667778888888888876
Q ss_pred CCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccC
Q 002189 301 ASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTE 376 (955)
Q Consensus 301 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~ 376 (955)
.+|..+..+++|+.|+|++|.++ .+|..+. ++|++|+|++|+|++.+ ..+.+|+.|+|++|+|+.++.
T Consensus 401 --~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~---~~l~~L~~L~Ls~N~l~~ip~ 468 (549)
T 2z81_A 401 --PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS---LFLPRLQELYISRNKLKTLPD 468 (549)
T ss_dssp --CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSSCCC
T ss_pred --cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc---ccCChhcEEECCCCccCcCCC
Confidence 36777777777888888777776 3333321 45666666666665543 234455566666666655543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=344.32 Aligned_cols=327 Identities=23% Similarity=0.201 Sum_probs=235.2
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.+++..+..|.++++|++|+|++|+ +.+..|..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCE-IETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC-CCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCc-ccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 478888999998888888888888888888888886 8888888888888888888888888877788888888888888
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeee-ccCCCCCCCCchhhh------------------hcc----ccccccC
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG-EIPVSDGNSPGLDML------------------VRA----KHFHFGK 200 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g-~ip~~~~~~~~l~~L------------------~~L----~~L~L~~ 200 (955)
|++|++++..+..|+++++|++|+|++|++++ .+|..+++++.|+.| .+| ..|++++
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 88888887666778888888888888888875 456655544333221 111 1344444
Q ss_pred CcccccCCccccCCccceeeeeccCCCcc---------------------------------------------------
Q 002189 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLT--------------------------------------------------- 229 (955)
Q Consensus 201 N~l~g~ip~~~~~~~~~L~~L~L~~N~l~--------------------------------------------------- 229 (955)
|+++ .++...+... +|+.|++++|.++
T Consensus 191 n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 268 (606)
T 3vq2_A 191 NPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268 (606)
T ss_dssp CCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred CCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence 4444 3333333332 3444444444332
Q ss_pred ---------------------------------------------------ccCC--------------------cccCC
Q 002189 230 ---------------------------------------------------GELP--------------------ATLGL 238 (955)
Q Consensus 230 ---------------------------------------------------~~~p--------------------~~l~~ 238 (955)
+.+| ..+..
T Consensus 269 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred cccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhcc
Confidence 1122 12334
Q ss_pred CCCCcEEEcccCCCCCC--ccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCE
Q 002189 239 VKSLEVVRFDRNSLSGP--VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 316 (955)
Q Consensus 239 l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 316 (955)
+++|++|++++|.+++. +|..+..+++|+.|+|++|.+++.+..+..+++|++|++++|++++......+.++++|+.
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 55666666666666644 2667777778888888888877777777888888888888888876333367888888888
Q ss_pred EECcCCcceecCCcCCCCCCCCcEEEeecCccee-eeCCC-cchhhhhhhcccCCccccccCCCCCCCcceeEecCcch
Q 002189 317 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG-TLDLG-TSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPIC 393 (955)
Q Consensus 317 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~-~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~~c 393 (955)
|++++|.+++..|..+..+++|++|+|++|++++ .+|.. ..+.+|+.|+|++|+++++++..+..+.+|+.++...|
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 507 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCC
Confidence 8888888888888888888888888888888887 45554 44677888888888888888888877777777766543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.46 Aligned_cols=230 Identities=13% Similarity=0.069 Sum_probs=183.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++.+++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999975 5899999999865332 2367899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++++|.++++.. ....+..+++.|+++||+|||+.+ |+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999998542 355578889999999999999998 9999999999999999999997443
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
|++ .++.++|||||||++|||+||+.||........ .......+.....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-----------~~~~~~~~~~~~~ 223 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-----------LAPAERDTAGQPI 223 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-----------SEECCBCTTSCBC
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-----------hHHHHHHhccCCC
Confidence 343 368899999999999999999999975332100 0000000000000
Q ss_pred --CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 864 --LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 864 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.........++.+++.+||+.||++| |++|+++.|+++...
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00111233678999999999999999 999999999998644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=342.02 Aligned_cols=338 Identities=18% Similarity=0.190 Sum_probs=216.0
Q ss_pred CCCCCccEEeCC-----------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccc
Q 002189 52 CGDNWEGIGCTN-----------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120 (955)
Q Consensus 52 C~~~w~gv~C~~-----------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~L 120 (955)
|.|.+..|.|+. .+++.|+|++|++++..+..|..+++|++|+|++|+ +.+..|..|+++++|++|+|
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~L 80 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT-ISKLEPELCQKLPMLKVLNL 80 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSC-CCCCCTTHHHHCTTCCEEEC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCc-cCccCHHHHhcccCcCEEEC
Confidence 545566677752 478999999999998888889999999999999997 88888999999999999999
Q ss_pred cccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh----------
Q 002189 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML---------- 190 (955)
Q Consensus 121 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L---------- 190 (955)
++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++.++.|+.|
T Consensus 81 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 9999996555679999999999999999997777889999999999999999998777776655444322
Q ss_pred ----------hccccccccCCcccccCCccccCC--------------------------ccceeeeeccCCCccccCCc
Q 002189 191 ----------VRAKHFHFGKNQLSGSIPEKLFRP--------------------------DMVLIHVLFDSNNLTGELPA 234 (955)
Q Consensus 191 ----------~~L~~L~L~~N~l~g~ip~~~~~~--------------------------~~~L~~L~L~~N~l~~~~p~ 234 (955)
++|+.|++++|++++..|..+... ..+|+.|++++|++++..|.
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~ 240 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence 456677777777764333221100 02233333444444443444
Q ss_pred ccCCCCC--CcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-------------------------------
Q 002189 235 TLGLVKS--LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP------------------------------- 281 (955)
Q Consensus 235 ~l~~l~~--L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~------------------------------- 281 (955)
.|..++. |+.|+|++|.+++..|..|..+++|+.|+|++|.+++.++
T Consensus 241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i 320 (680)
T 1ziw_A 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320 (680)
T ss_dssp TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence 4443332 5555555555544444444555555555555554444333
Q ss_pred ---CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEEC----------------------------cCCcceecCCc
Q 002189 282 ---NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM----------------------------ENTNLKGQIPA 330 (955)
Q Consensus 282 ---~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~L----------------------------s~N~l~~~~p~ 330 (955)
.+..+++|++|+|++|.+++ ..+..|.++++|+.|++ ++|++++..|.
T Consensus 321 ~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~ 399 (680)
T 1ziw_A 321 DDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCC-CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTT
T ss_pred ChhhcccCCCCCEEECCCCccCC-CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChh
Confidence 23344555555555555544 33444444444444443 44445555566
Q ss_pred CCCCCCCCcEEEeecCcceeeeCC--CcchhhhhhhcccCCccccccCCCCCCCcceeEecCc
Q 002189 331 DLFSIPHLQTVVMKTNELNGTLDL--GTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 331 ~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~ 391 (955)
.+..+++|+.|+|++|++++.++. +..+.+++.|+|++|+++++.+..+..+.+|+.++..
T Consensus 400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~ 462 (680)
T 1ziw_A 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462 (680)
T ss_dssp TTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECT
T ss_pred hhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhc
Confidence 666666666666666666665442 2335556666777776666666666665555555443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=316.82 Aligned_cols=227 Identities=21% Similarity=0.291 Sum_probs=180.2
Q ss_pred cCCCcc-CeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHH-HhccCCCcceEEEEEEe----CCeEE
Q 002189 628 NNFSDA-NDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELL-SRVHHKNLVSLLGFCFD----RGEQM 700 (955)
Q Consensus 628 ~~f~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~ 700 (955)
++|... +.||+|+||+||+|+. .+++.||||+++. ...+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 6799999999999986 4789999999864 24677899888 55589999999999987 67789
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEeeccccc
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFGLSK 777 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla~ 777 (955)
+||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999998766567999999999999999999999998 999999999999998 7889999999987
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
... +..++.++|||||||++|||++|+.||........ ... ....
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~~------~~~~ 213 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPG------MKTR 213 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CC------SCCS
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hHH------HHHH
Confidence 542 13467899999999999999999999964322110 000 0000
Q ss_pred cCCcCCCCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIGLSTT----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+... ..... .....++.+++.+||+.||.+||+++|++++
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 00111 1234678999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=333.60 Aligned_cols=241 Identities=15% Similarity=0.148 Sum_probs=180.0
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccC-CCcc----------e----
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHH-KNLV----------S---- 688 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H-~niv----------~---- 688 (955)
..|...+.||+|+||+||+|++ .+|+.||||+++..... ..+.+.+|+.+++.++| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466678999999999999995 57999999998743222 24679999999999987 3211 1
Q ss_pred -------EEEEEEe-----CCeEEEEEEecCCCCcccccC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCee
Q 002189 689 -------LLGFCFD-----RGEQMLIYEFVPNGSLGDSLS-----GKNGIRLDWIRRLKIALGAARGLSYLHELANPPII 751 (955)
Q Consensus 689 -------l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 751 (955)
+..++.. ....+++|+++ +++|.+++. ......+++..++.++.|+++||+|||+.+ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 22457777765 789998884 223346888999999999999999999998 99
Q ss_pred ccCCCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHh----------hhCCCCChhhhHHHHHHH
Q 002189 752 HRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY----------MTQQLTEKSDVYSFGVLM 821 (955)
Q Consensus 752 HrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDvwS~Gv~l 821 (955)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999865322 334567 999999999 444588899999999999
Q ss_pred HHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 822 LELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 822 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
|||+||+.||....... .....+... ...+..+.+++.+||+.||++||++.|++++
T Consensus 308 ~elltg~~Pf~~~~~~~--------------~~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALG--------------GSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGGS--------------CSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchhh--------------hHHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999996433210 001111100 1223678999999999999999999888643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=343.56 Aligned_cols=326 Identities=19% Similarity=0.165 Sum_probs=273.1
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.+++..|..|.++++|++|+|++|+ +.+..|..|+++++|++|+|++|.+++..+..|+++++|++|+
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP-IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC-CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc-ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 588999999999998888889999999999999997 8888899999999999999999999877778899999999999
Q ss_pred ccCCCCcC-cCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCch-----------------------------------
Q 002189 144 LNSNGFSG-RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL----------------------------------- 187 (955)
Q Consensus 144 Ls~N~l~~-~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l----------------------------------- 187 (955)
|++|.+++ .+|..|+++++|++|+|++|++++..|..++.+..+
T Consensus 135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n 214 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214 (606)
T ss_dssp CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCC
Confidence 99999986 568889999999999999999887666544332211
Q ss_pred --------------------------------------------------------------------------------
Q 002189 188 -------------------------------------------------------------------------------- 187 (955)
Q Consensus 188 -------------------------------------------------------------------------------- 187 (955)
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~ 294 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence
Q ss_pred ---------hhhhccccccccCCcccccCCcc-------------------ccCCccceeeeeccCCCcccc--CCcccC
Q 002189 188 ---------DMLVRAKHFHFGKNQLSGSIPEK-------------------LFRPDMVLIHVLFDSNNLTGE--LPATLG 237 (955)
Q Consensus 188 ---------~~L~~L~~L~L~~N~l~g~ip~~-------------------~~~~~~~L~~L~L~~N~l~~~--~p~~l~ 237 (955)
..+.+|+.|++++|++ +.+|.. .+..+++|+.|++++|++++. +|..+.
T Consensus 295 ~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 373 (606)
T 3vq2_A 295 VSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373 (606)
T ss_dssp CCCCCCCCCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHH
T ss_pred ccchhhhhccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhc
Confidence 1122444555555555 244421 122456788888888898876 488999
Q ss_pred CCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC--CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCC
Q 002189 238 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP--NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 315 (955)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 315 (955)
.+++|++|++++|.++ .+|..+..+++|+.|++++|.+++.++ .+..+++|++|++++|.+++ ..|..+.++++|+
T Consensus 374 ~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~ 451 (606)
T 3vq2_A 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI-DFDGIFLGLTSLN 451 (606)
T ss_dssp CCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEE-CCTTTTTTCTTCC
T ss_pred cCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCc-cchhhhcCCCCCC
Confidence 9999999999999999 577899999999999999999999877 58899999999999999986 6788899999999
Q ss_pred EEECcCCccee-cCCcCCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCCcceeEecCcch
Q 002189 316 TLMMENTNLKG-QIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPIC 393 (955)
Q Consensus 316 ~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~~c 393 (955)
.|+|++|++++ .+|..+..+++|+.|+|++|++++.+|..+ .+.+|+.|+|++|+++++.+..+..+.+|+.++...|
T Consensus 452 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 531 (606)
T 3vq2_A 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531 (606)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTS
T ss_pred EEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCC
Confidence 99999999998 489999999999999999999999888765 5788889999999999999998888888888877543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=331.57 Aligned_cols=307 Identities=17% Similarity=0.220 Sum_probs=257.6
Q ss_pred CCCEeEEEecCCcCcccc-CcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCc--cccCCCC
Q 002189 63 NSRVTSITLSGMGLKGQL-SGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDS--IGSLQEL 139 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~~~-~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L 139 (955)
..+++.|+|++|.+.+.+ +..|.++++|++|+|++|+ +.+..|..|+++++|++|+|++|++++.+|.. |..+++|
T Consensus 53 l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L 131 (455)
T 3v47_A 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL 131 (455)
T ss_dssp CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCT-TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTC
T ss_pred CccccEEECcCCcccceECcccccccccCCEEeCCCCc-cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccC
Confidence 368999999999998666 4679999999999999997 88888999999999999999999999755544 9999999
Q ss_pred cEEEccCCCCcCcCCCC-CCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCcccc------
Q 002189 140 VLLSLNSNGFSGRVPPS-IGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLF------ 212 (955)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~-~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~------ 212 (955)
++|+|++|+|++..|.. +.++++|++|+|++|++++..|..+..+.. .+|+.|++++|.+. .++...+
T Consensus 132 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~----~~L~~L~l~~n~l~-~~~~~~~~~~~~~ 206 (455)
T 3v47_A 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG----KHFTLLRLSSITLQ-DMNEYWLGWEKCG 206 (455)
T ss_dssp CEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTT----CEEEEEECTTCBCT-TCSTTCTTHHHHC
T ss_pred CEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccc----ccccccccccCccc-ccchhhccccccc
Confidence 99999999999887876 899999999999999999888876654321 35566666666665 3332221
Q ss_pred --CCccceeeeeccCCCccccCCcccC---------------------------------------CCCCCcEEEcccCC
Q 002189 213 --RPDMVLIHVLFDSNNLTGELPATLG---------------------------------------LVKSLEVVRFDRNS 251 (955)
Q Consensus 213 --~~~~~L~~L~L~~N~l~~~~p~~l~---------------------------------------~l~~L~~L~Ls~N~ 251 (955)
....+|++|++++|++++..|..+. ..++|+.|++++|.
T Consensus 207 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 286 (455)
T 3v47_A 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK 286 (455)
T ss_dssp CTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSC
T ss_pred cccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCcc
Confidence 1234566666666666554443331 13689999999999
Q ss_pred CCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCc
Q 002189 252 LSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPA 330 (955)
Q Consensus 252 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 330 (955)
+++..|..+..+++|+.|+|++|.+++.++ .+.++++|++|+|++|.+++ ..+..|.++++|+.|+|++|++++..|.
T Consensus 287 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 365 (455)
T 3v47_A 287 IFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQ 365 (455)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE-ECGGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCC-cChhHhcCcccCCEEECCCCcccccChh
Confidence 998899999999999999999999999977 68899999999999999975 6688899999999999999999999999
Q ss_pred CCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccccccC
Q 002189 331 DLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTE 376 (955)
Q Consensus 331 ~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~ 376 (955)
.+..+++|++|+|++|+|++.++..+ .+.+|+.|+|++|+|++-.+
T Consensus 366 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 366 SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999999999999999999887764 57889999999999997655
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=318.64 Aligned_cols=243 Identities=14% Similarity=0.163 Sum_probs=186.8
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc--------chhHHHHHHHHHHHhcc---------CCCcceEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM--------QGGQEFKMEIELLSRVH---------HKNLVSLL 690 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------H~niv~l~ 690 (955)
++|...+.||+|+||+||+|+. +|+.||||+++.... ...+.+.+|+++++.++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577889999999999999988 689999999975432 22367899999999886 88888888
Q ss_pred EEEE------------------------------eCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 002189 691 GFCF------------------------------DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 740 (955)
Q Consensus 691 ~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 740 (955)
+.+. +.+..++||||+++|++.+.+.. ..+++..+..++.|++.||+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence 7754 26789999999999987777654 35899999999999999999
Q ss_pred Hhh-hccCCCeeccCCCCccEEEcCCC--------------------ceEEeecccccccCCCCCcceeeeeecCCCCCC
Q 002189 741 YLH-ELANPPIIHRDIKSSNILLDERL--------------------NAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799 (955)
Q Consensus 741 yLH-~~~~~~ivHrDlk~~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 799 (955)
||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|||
T Consensus 176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a 245 (336)
T 2vuw_A 176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence 999 888 99999999999999887 8999999999876432 3479999999
Q ss_pred HHHhhhCCCCChhhhHHHHHH-HHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHH
Q 002189 800 PEYYMTQQLTEKSDVYSFGVL-MLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLA 878 (955)
Q Consensus 800 PE~~~~~~~~~ksDvwS~Gv~-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 878 (955)
||++.+.. +.++||||+|++ .+++++|..||................. ................++.+|+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM--------TFKTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC--------CCSSCCCSHHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh--------ccCcccchhhhhhcCHHHHHHH
Confidence 99998666 899999998777 7889999999843111111111111100 0111111111234567899999
Q ss_pred HHhhccCCCCCCCHHHHH-HH
Q 002189 879 LKCVQESGDDRPTMSEVV-KD 898 (955)
Q Consensus 879 ~~cl~~dP~~RPs~~evl-~~ 898 (955)
.+||+.| |++|++ ++
T Consensus 317 ~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 317 RTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHGGGSS-----SHHHHHHHC
T ss_pred HHHhccC-----CHHHHHhcC
Confidence 9999976 999988 53
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=322.47 Aligned_cols=328 Identities=18% Similarity=0.164 Sum_probs=273.2
Q ss_pred CCCCCCCCCCCCCCccEEe---C------------------CCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCC
Q 002189 43 PPNWKNNDPCGDNWEGIGC---T------------------NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDL 101 (955)
Q Consensus 43 ~~~w~~~~~C~~~w~gv~C---~------------------~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l 101 (955)
.++|.....|++.|.+..| + -.+++.|+++++.++...+..|..+++|++|+|++|+ +
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~-i 81 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ-I 81 (390)
T ss_dssp ----CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSC-C
T ss_pred cCCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCc-c
Confidence 3578877777765555444 2 0578899999999996665668999999999999997 8
Q ss_pred ccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCC
Q 002189 102 RGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 181 (955)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~ 181 (955)
.+..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+|+...+..|.++++|++|+|++|++++..|..+
T Consensus 82 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 161 (390)
T 3o6n_A 82 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 161 (390)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred cccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhc
Confidence 88888899999999999999999998888889999999999999999995555557999999999999999996656554
Q ss_pred CCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCcccccc
Q 002189 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 261 (955)
Q Consensus 182 ~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 261 (955)
..+++|++|++++|+++ .++. ...+.|+.|++++|.+++ +...++|+.|++++|.++ .+|...
T Consensus 162 ------~~l~~L~~L~l~~n~l~-~~~~---~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~-~~~~~~- 224 (390)
T 3o6n_A 162 ------QATTSLQNLQLSSNRLT-HVDL---SLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGPV- 224 (390)
T ss_dssp ------SSCTTCCEEECCSSCCS-BCCG---GGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCC-EEECCC-
T ss_pred ------cCCCCCCEEECCCCcCC-cccc---ccccccceeecccccccc-----cCCCCcceEEECCCCeee-eccccc-
Confidence 44677899999999998 4543 345789999999999885 345578999999999998 445433
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEE
Q 002189 262 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTV 341 (955)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 341 (955)
.++|+.|+|++|.+++. +.+..+++|++|+|++|.+++ ..|..|..+++|+.|+|++|++++ +|..+..+++|++|
T Consensus 225 -~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L 300 (390)
T 3o6n_A 225 -NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVL 300 (390)
T ss_dssp -CSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCE-EESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEE
T ss_pred -cccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCC-cChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEE
Confidence 58999999999999976 568889999999999999986 568899999999999999999995 67777889999999
Q ss_pred EeecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEecCcc
Q 002189 342 VMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 392 (955)
Q Consensus 342 ~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~~ 392 (955)
+|++|++++.++....+.+|+.|+|++|+|+.++...+..+..|.+.+|++
T Consensus 301 ~L~~n~l~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~ 351 (390)
T 3o6n_A 301 DLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDW 351 (390)
T ss_dssp ECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCE
T ss_pred ECCCCcceecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCc
Confidence 999999998777667788999999999999999888888888888888884
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=325.72 Aligned_cols=319 Identities=19% Similarity=0.164 Sum_probs=279.3
Q ss_pred cEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCC
Q 002189 58 GIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 137 (955)
Q Consensus 58 gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 137 (955)
+..|... -..++.++++++ .+|..+. ++|+.|+|++|+ +.+..|..|.++++|++|+|++|.+++..|..|.+++
T Consensus 6 ~C~C~~~-~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 80 (477)
T 2id5_A 6 RCECSAQ-DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNR-IKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF 80 (477)
T ss_dssp TCEEETT-TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSC-CCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred CCeECCC-CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCc-cceECHhHccCCCCCCEEECCCCccCEeChhhhhCCc
Confidence 5567643 236789999998 5666553 689999999997 8988899999999999999999999988899999999
Q ss_pred CCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccc
Q 002189 138 ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMV 217 (955)
Q Consensus 138 ~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~ 217 (955)
+|++|+|++|+|+...+..|.++++|++|+|++|++++..|..+. .+.+|++|+|++|+++ .++...|..+.+
T Consensus 81 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~------~l~~L~~L~l~~n~l~-~~~~~~~~~l~~ 153 (477)
T 2id5_A 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQ------DLYNLKSLEVGDNDLV-YISHRAFSGLNS 153 (477)
T ss_dssp TCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTT------TCTTCCEEEECCTTCC-EECTTSSTTCTT
T ss_pred cCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHcc------ccccCCEEECCCCccc-eeChhhccCCCC
Confidence 999999999999976667799999999999999999977776654 4667889999999999 666667788899
Q ss_pred eeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccC-CCCCCCCCCCEEECcC
Q 002189 218 LIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAM-PNLTGLSVLSYLDMSN 296 (955)
Q Consensus 218 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~ 296 (955)
|++|+|++|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|+|++|.+.+.. +......+|++|+|++
T Consensus 154 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~ 233 (477)
T 2id5_A 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233 (477)
T ss_dssp CCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEES
T ss_pred CCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcC
Confidence 999999999999888888999999999999999999888889999999999999998866554 4566677999999999
Q ss_pred CCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCcccccc
Q 002189 297 NSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYT 375 (955)
Q Consensus 297 N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~ 375 (955)
|.++. ..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..+..+ .+.+|+.|+|++|+|++++
T Consensus 234 n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 312 (477)
T 2id5_A 234 CNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLE 312 (477)
T ss_dssp SCCCS-CCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCC
T ss_pred Ccccc-cCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeC
Confidence 99975 444679999999999999999999889999999999999999999999888765 4778899999999999999
Q ss_pred CCCCCCCcceeEec
Q 002189 376 ERGGAPAVNLTLID 389 (955)
Q Consensus 376 ~~~~~~~~~L~~l~ 389 (955)
+..|..+.+|+.++
T Consensus 313 ~~~~~~l~~L~~L~ 326 (477)
T 2id5_A 313 ESVFHSVGNLETLI 326 (477)
T ss_dssp GGGBSCGGGCCEEE
T ss_pred HhHcCCCcccCEEE
Confidence 98887766655553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=334.29 Aligned_cols=136 Identities=24% Similarity=0.233 Sum_probs=112.2
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.+++..+..|..+++|++|+|++|+ +++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR-IRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCC-CCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCC-CCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 588999999999998888899999999999999997 88888999999999999999999999 67766 899999999
Q ss_pred ccCCCCcC-cCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcc--cccCCcc
Q 002189 144 LNSNGFSG-RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQL--SGSIPEK 210 (955)
Q Consensus 144 Ls~N~l~~-~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l--~g~ip~~ 210 (955)
|++|+|++ .+|..|+++++|++|+|++|++++. .+..+..+ +|+.|++++|++ ++..|..
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~------~~~~l~~L-~L~~L~L~~n~l~~~~~~~~~ 190 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL------DLLPVAHL-HLSCILLDLVSYHIKGGETES 190 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT------TTGGGTTS-CEEEEEEEESSCCCCSSSCCE
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccC------chhhhhhc-eeeEEEeecccccccccCccc
Confidence 99999996 3467899999999999999998731 12223333 347777777777 5444443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=338.52 Aligned_cols=328 Identities=18% Similarity=0.163 Sum_probs=280.9
Q ss_pred CCCCCCCCCCCCC---CccEEeCC------------------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCC
Q 002189 43 PPNWKNNDPCGDN---WEGIGCTN------------------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDL 101 (955)
Q Consensus 43 ~~~w~~~~~C~~~---w~gv~C~~------------------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l 101 (955)
..+|....+|++. |.++.|+. .+++.|+++++.+....+..|..+++|++|+|++|+ +
T Consensus 9 l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~-l 87 (597)
T 3oja_B 9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ-I 87 (597)
T ss_dssp --CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSC-C
T ss_pred ccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCC-C
Confidence 4678877777643 66665541 467889999999997777778999999999999997 8
Q ss_pred ccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCC
Q 002189 102 RGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 181 (955)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~ 181 (955)
.+..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|++|.+++..|..+
T Consensus 88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 167 (597)
T 3oja_B 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167 (597)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence 98888999999999999999999998888889999999999999999996666668999999999999999997777665
Q ss_pred CCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCcccccc
Q 002189 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 261 (955)
Q Consensus 182 ~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 261 (955)
+. +++|++|+|++|+++ .++.. .++.|+.|++++|.+++ +....+|+.|++++|.++ .++..+
T Consensus 168 ~~------l~~L~~L~L~~N~l~-~~~~~---~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~-~~~~~~- 230 (597)
T 3oja_B 168 QA------TTSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGPV- 230 (597)
T ss_dssp TT------CTTCCEEECTTSCCS-BCCGG---GCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCC-EEECSC-
T ss_pred hc------CCcCcEEECcCCCCC-CcChh---hhhhhhhhhcccCcccc-----ccCCchhheeeccCCccc-cccccc-
Confidence 44 667889999999999 45533 35679999999999985 345678999999999998 444433
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEE
Q 002189 262 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTV 341 (955)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 341 (955)
.++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++ ..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|
T Consensus 231 -~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L 306 (597)
T 3oja_B 231 -NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVL 306 (597)
T ss_dssp -CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCE-EESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEE
T ss_pred -CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCC-CCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEE
Confidence 37899999999999984 668889999999999999986 678899999999999999999996 67788889999999
Q ss_pred EeecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEecCcc
Q 002189 342 VMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 392 (955)
Q Consensus 342 ~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~~ 392 (955)
+|++|++++.++....+.+|..|+|++|+|++++...+..+..|.+.+|++
T Consensus 307 ~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~ 357 (597)
T 3oja_B 307 DLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDW 357 (597)
T ss_dssp ECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCE
T ss_pred ECCCCCCCccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCC
Confidence 999999997766666788999999999999999988888888888888884
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=346.41 Aligned_cols=312 Identities=19% Similarity=0.285 Sum_probs=199.9
Q ss_pred CCEeEEEecCCcCcc-----------------ccCcCcC--CCCcccEEecCCCCCCccCCCCCcccccccccccccccc
Q 002189 64 SRVTSITLSGMGLKG-----------------QLSGDIT--GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCS 124 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~-----------------~~~~~l~--~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~ 124 (955)
.+++.|+|++|.+++ .+|..++ ++++|++|+|++|+ +.+.+|..|+++++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~-l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP-NMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT-TCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC-CCccChHHHhCCCCCCEEECcCCC
Confidence 689999999999998 3888888 99999999999997 899999999999999999999998
Q ss_pred -cCC-CCCCccccCC-------CCcEEEccCCCCcCcCCC--CCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhcc
Q 002189 125 -FSG-PIPDSIGSLQ-------ELVLLSLNSNGFSGRVPP--SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 193 (955)
Q Consensus 125 -l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L 193 (955)
+++ .+|..++.++ +|++|+|++|+|+ .+|. .|+++++|+.|+|++|+++ .+| .++. +++|
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~------L~~L 597 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGT------NVKL 597 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCT------TSEE
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcC------CCcc
Confidence 887 7887777666 8999999999999 7888 8899999999999999988 777 5544 4445
Q ss_pred ccccccCCcccccCCccccCCccc-eeeeeccCCCccccCCcccCCCCC--CcEEEcccCCCCCCc--------------
Q 002189 194 KHFHFGKNQLSGSIPEKLFRPDMV-LIHVLFDSNNLTGELPATLGLVKS--LEVVRFDRNSLSGPV-------------- 256 (955)
Q Consensus 194 ~~L~L~~N~l~g~ip~~~~~~~~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~-------------- 256 (955)
+.|+|++|+++ .+|..+.. +.+ |+.|+|++|+++ .+|..+..++. |+.|+|++|.+++.+
T Consensus 598 ~~L~Ls~N~l~-~lp~~l~~-l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~ 674 (876)
T 4ecn_A 598 TDLKLDYNQIE-EIPEDFCA-FTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674 (876)
T ss_dssp SEEECCSSCCS-CCCTTSCE-ECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred eEEECcCCccc-cchHHHhh-ccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCC
Confidence 55556666555 55554332 233 555555555555 44544444332 444444444444433
Q ss_pred --------------cccc-cCCCCCCEEEccCCcCcccCCCCCC--------CCCCCEEECcCCCCCCCCCChhhc--CC
Q 002189 257 --------------PSNL-NNLTSVNDLYLSNNKLTGAMPNLTG--------LSVLSYLDMSNNSFDASEVPSWFS--SM 311 (955)
Q Consensus 257 --------------p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~~p~~~~--~l 311 (955)
|..+ ..+++|+.|+|++|+|+.++..+.. +++|+.|+|++|+|+ .+|..+. .+
T Consensus 675 L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~--~lp~~l~~~~l 752 (876)
T 4ecn_A 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT--SLSDDFRATTL 752 (876)
T ss_dssp EEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC--CCCGGGSTTTC
T ss_pred cCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc--cchHHhhhccC
Confidence 3322 3455555555555555544443222 125555555555554 3455554 55
Q ss_pred CCCCEEECcCCcceecCCcCCCCCCCCcEEEeec------CcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCCcc
Q 002189 312 QSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKT------NELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVN 384 (955)
Q Consensus 312 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~~~ 384 (955)
++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..+ .+.+|+.|+|++|+|..++...+..+..
T Consensus 753 ~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~Ip~~l~~~L~~ 831 (876)
T 4ecn_A 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYI 831 (876)
T ss_dssp TTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSCCCSSSCE
T ss_pred CCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCCCccCHhhcCCCCE
Confidence 555555555555554 455555555555555544 44555444433 2445555555555555554444433333
Q ss_pred eeEecCc
Q 002189 385 LTLIDNP 391 (955)
Q Consensus 385 L~~l~n~ 391 (955)
|++.+|+
T Consensus 832 LdLs~N~ 838 (876)
T 4ecn_A 832 LDIADNP 838 (876)
T ss_dssp EECCSCT
T ss_pred EECCCCC
Confidence 4443443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=335.26 Aligned_cols=107 Identities=24% Similarity=0.281 Sum_probs=65.5
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.+++..+..|..+++|++|+|++|+ +.+..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNR-IQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSC-CCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCc-cCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 456666666666665555566666666666666665 55555666666666666666666666 44444 566666666
Q ss_pred ccCCCCcC-cCCCCCCCCCCcCeeecCCceee
Q 002189 144 LNSNGFSG-RVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 144 Ls~N~l~~-~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
|++|+|++ .+|..|+++++|++|+|++|+++
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~ 128 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCC
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccc
Confidence 66666664 34556666666666666666554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=334.24 Aligned_cols=324 Identities=20% Similarity=0.218 Sum_probs=199.2
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|++++..+..|.++++|++|+|++|+ +.+..|..|.++++|++|+|++|++++..+..|+++++|++|+
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 130 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP-IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC-CCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEE
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCc-CCccCHhhhcCccccccccccccccccCCCccccccccccEEe
Confidence 355556666666655555556666666666666664 5555555566666666666666666544444466666666666
Q ss_pred ccCCCCcC-cCCCCCCCCCCcCeeecCCceeeeccCCCCCCC--------------------------------------
Q 002189 144 LNSNGFSG-RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-------------------------------------- 184 (955)
Q Consensus 144 Ls~N~l~~-~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~-------------------------------------- 184 (955)
|++|.+++ .+|..|+++++|++|++++|++++..|..++.+
T Consensus 131 L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n 210 (570)
T 2z63_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210 (570)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccc
Confidence 66666654 245666666666666666666554332211110
Q ss_pred -----------------------------------------------------------------Cchhhhhcccccccc
Q 002189 185 -----------------------------------------------------------------PGLDMLVRAKHFHFG 199 (955)
Q Consensus 185 -----------------------------------------------------------------~~l~~L~~L~~L~L~ 199 (955)
..+..+++|+.|+++
T Consensus 211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~ 290 (570)
T 2z63_A 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290 (570)
T ss_dssp CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence 011223445555555
Q ss_pred CCcccccCCccccCCccceeeeeccCCCccccCCcc-c-------------------CCCCCCcEEEcccCCCCCCc--c
Q 002189 200 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPAT-L-------------------GLVKSLEVVRFDRNSLSGPV--P 257 (955)
Q Consensus 200 ~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~-l-------------------~~l~~L~~L~Ls~N~l~~~~--p 257 (955)
+|+++ .+|..+... +|++|++++|++. .+|.. + ..+++|+.|++++|.+++.. |
T Consensus 291 ~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 366 (570)
T 2z63_A 291 SVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366 (570)
T ss_dssp SCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEE
T ss_pred Cccch-hhhhhhccC--CccEEeeccCccc-ccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccc
Confidence 55555 454443322 3444444444443 22211 1 45677778888888877443 6
Q ss_pred ccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCC
Q 002189 258 SNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPH 337 (955)
Q Consensus 258 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 337 (955)
..+..+++|+.|+|++|.+++.++.+..+++|++|++++|.+++......+.++++|+.|++++|.+.+..|..+..+++
T Consensus 367 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 446 (570)
T 2z63_A 367 QSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446 (570)
T ss_dssp HHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred ccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCc
Confidence 67777788888888888877776667777778888888887765333356777777888888888777777777777778
Q ss_pred CcEEEeecCcce-eeeCCC-cchhhhhhhcccCCccccccCCCCCCCcceeEecCcc
Q 002189 338 LQTVVMKTNELN-GTLDLG-TSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNPI 392 (955)
Q Consensus 338 L~~L~Ls~N~l~-~~~~~~-~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~~ 392 (955)
|++|+|++|+++ +.+|.. ..+.+|+.|+|++|+++++.+..+..+.+|+.++...
T Consensus 447 L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 503 (570)
T 2z63_A 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503 (570)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence 888888888776 345544 3466677778888887777777777777777766553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=329.72 Aligned_cols=318 Identities=20% Similarity=0.206 Sum_probs=246.3
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.+++..+..|.++++|++|+|++|+ +.+..|..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~-i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCC-CCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCc-CCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 478999999999999888999999999999999997 8888889999999999999999999988889999999999999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeee-ccCCCCCCCCchhhhhccccccccCCcccc-----------------
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG-EIPVSDGNSPGLDMLVRAKHFHFGKNQLSG----------------- 205 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g-~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g----------------- 205 (955)
|++|++++..+..|+++++|++|+|++|++++ .+|..+++ +++|++|++++|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~ 180 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN------LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGG------CTTCCEEECTTSCCCEECGGGGHHHHTCTTCCC
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcc------cCCCCEEeCcCCccceecHHHccchhccchhhh
Confidence 99999997666689999999999999999986 46765544 4445555555555542
Q ss_pred ----------cCCccccCC-------------------------------------------------------------
Q 002189 206 ----------SIPEKLFRP------------------------------------------------------------- 214 (955)
Q Consensus 206 ----------~ip~~~~~~------------------------------------------------------------- 214 (955)
.++...|..
T Consensus 181 ~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~ 260 (570)
T 2z63_A 181 SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260 (570)
T ss_dssp EEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEE
T ss_pred hcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchh
Confidence 122222221
Q ss_pred --------------------ccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCcccc-c-------------
Q 002189 215 --------------------DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN-L------------- 260 (955)
Q Consensus 215 --------------------~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l------------- 260 (955)
..+|+.|++++|.+. .+|..+..+ +|+.|++++|.+. .+|.. +
T Consensus 261 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~ 337 (570)
T 2z63_A 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKG 337 (570)
T ss_dssp EEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBS
T ss_pred hhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcccccccCEEeCcCCcc
Confidence 122333333333333 233334444 4444444444444 22221 1
Q ss_pred ------cCCCCCCEEEccCCcCcccC---CCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCC-c
Q 002189 261 ------NNLTSVNDLYLSNNKLTGAM---PNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP-A 330 (955)
Q Consensus 261 ------~~l~~L~~L~Ls~N~l~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~ 330 (955)
..+++|+.|++++|.+++.. ..+..+++|++|+|++|.+++ .+..+..+++|+.|++++|.+.+..+ .
T Consensus 338 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 415 (570)
T 2z63_A 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT--MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415 (570)
T ss_dssp CCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE--EEEEEETCTTCCEEECTTSEEESCTTSC
T ss_pred ccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc--ccccccccCCCCEEEccCCccccccchh
Confidence 46788999999999998874 357889999999999999975 45559999999999999999998776 5
Q ss_pred CCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccc-cccCCCCCCCcceeEecCcch
Q 002189 331 DLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRIS-AYTERGGAPAVNLTLIDNPIC 393 (955)
Q Consensus 331 ~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~-~~~~~~~~~~~~L~~l~n~~c 393 (955)
.+..+++|++|+|++|++++..+..+ .+.+|+.|+|++|+++ +..+..+..+.+|+.++...|
T Consensus 416 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n 480 (570)
T 2z63_A 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480 (570)
T ss_dssp TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred hhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence 78899999999999999999888765 4788999999999998 566777888888887766544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-32 Score=329.12 Aligned_cols=318 Identities=18% Similarity=0.187 Sum_probs=161.6
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccc--cccccccccCCCCCCccccC-----
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLS--NLMLVGCSFSGPIPDSIGSL----- 136 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~--~L~Ls~N~l~~~~p~~~~~l----- 136 (955)
.+++.|+|++|.+++...+.+..+++|++|+|++|+ +.+..|..|+.+++|+ .|++++|.+++..|..|...
T Consensus 129 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L 207 (606)
T 3t6q_A 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA-IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSL 207 (606)
T ss_dssp TTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC-CCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEE
T ss_pred CcccEEECCCCcccccCcccccCCcccCEEEcccCc-ccccChhhhhhhcccceeEEecCCCccCccChhHhhhcccccc
Confidence 466677777777766444445456677777777665 6655566666666666 56666666655444433211
Q ss_pred ----------------------------------------------CCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCC
Q 002189 137 ----------------------------------------------QELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 170 (955)
Q Consensus 137 ----------------------------------------------~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~ 170 (955)
.+|+.|++++|.+++..+..|.++++|++|+|++
T Consensus 208 ~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 287 (606)
T 3t6q_A 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287 (606)
T ss_dssp ECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTT
T ss_pred ccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccC
Confidence 0455555555555554444555555555555555
Q ss_pred ceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCc-ccCCCCCCcEEEccc
Q 002189 171 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA-TLGLVKSLEVVRFDR 249 (955)
Q Consensus 171 N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~ 249 (955)
|+++ .+|..++. +++|++|++++|+++ .++...+..+++|+.|++++|.+.+.+|. .+..+++|++|++++
T Consensus 288 n~l~-~lp~~l~~------l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 359 (606)
T 3t6q_A 288 THLS-ELPSGLVG------LSTLKKLVLSANKFE-NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359 (606)
T ss_dssp SCCS-CCCSSCCS------CTTCCEEECTTCCCS-BGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCS
T ss_pred CccC-CCChhhcc------cccCCEEECccCCcC-cCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCC
Confidence 5555 44443322 334445555555555 23223333344455555555555544433 245555555555555
Q ss_pred CCCCCCc--cccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCccee
Q 002189 250 NSLSGPV--PSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 326 (955)
Q Consensus 250 N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 326 (955)
|.+++.. +..+..+++|+.|+|++|.+++.++ .+..+++|++|+|++|++++...+..+..+++|+.|++++|.+++
T Consensus 360 n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 439 (606)
T 3t6q_A 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439 (606)
T ss_dssp SCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBT
T ss_pred CccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCC
Confidence 5554333 4445555555555555555554443 344455555555555555443333334555555555555555554
Q ss_pred cCCcCCCCCCCCcEEEeecCccee-eeCC---CcchhhhhhhcccCCccccccCCCCCCCcceeEecC
Q 002189 327 QIPADLFSIPHLQTVVMKTNELNG-TLDL---GTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDN 390 (955)
Q Consensus 327 ~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~---~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n 390 (955)
..|..+..+++|++|+|++|++++ .++. ...+.+|+.|+|++|+++++.+..+..+.+|+.++.
T Consensus 440 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 507 (606)
T 3t6q_A 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507 (606)
T ss_dssp TCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEEC
Confidence 445555555555555555555544 1111 122344445555555555555544444444444443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=9e-32 Score=322.48 Aligned_cols=306 Identities=17% Similarity=0.175 Sum_probs=250.9
Q ss_pred eEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccC
Q 002189 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146 (955)
Q Consensus 67 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 146 (955)
+.++++++++++ +|..+. ++|++|+|++|+ +.+..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~-i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNS-ISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSC-CCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCC-ccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 789999999995 676554 899999999997 8888888999999999999999999988899999999999999999
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCceeee-ccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccc--eeeeec
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEG-EIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMV--LIHVLF 223 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N~l~g-~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~--L~~L~L 223 (955)
|+|+ .+|.. .+++|++|+|++|++++ .+|. .+..+++|++|++++|++++ .. +..+.. |+.|++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~------~~~~l~~L~~L~L~~n~l~~-~~---~~~l~~L~L~~L~L 176 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCK------EFGNLTKLTFLGLSAAKFRQ-LD---LLPVAHLHLSCILL 176 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCG------GGGGCTTCCEEEEECSBCCT-TT---TGGGTTSCEEEEEE
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchH------hhcccCcccEEecCCCcccc-Cc---hhhhhhceeeEEEe
Confidence 9999 67766 89999999999999984 2333 46667889999999999984 22 233334 499999
Q ss_pred cCCCc--cccCCcccCCCC-------------------------------------------------------------
Q 002189 224 DSNNL--TGELPATLGLVK------------------------------------------------------------- 240 (955)
Q Consensus 224 ~~N~l--~~~~p~~l~~l~------------------------------------------------------------- 240 (955)
++|++ ++..|..+..+.
T Consensus 177 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L 256 (562)
T 3a79_B 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256 (562)
T ss_dssp EESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEE
T ss_pred ecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEe
Confidence 99988 776666665543
Q ss_pred --------------------CCcEEEcccCCCCCCccccc----------------------------------------
Q 002189 241 --------------------SLEVVRFDRNSLSGPVPSNL---------------------------------------- 260 (955)
Q Consensus 241 --------------------~L~~L~Ls~N~l~~~~p~~l---------------------------------------- 260 (955)
+|++|++++|.++|.+|..+
T Consensus 257 ~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L 336 (562)
T 3a79_B 257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336 (562)
T ss_dssp EEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEE
T ss_pred cCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEE
Confidence 67778888888887777655
Q ss_pred -------------cCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCC-CCChhhcCCCCCCEEECcCCcce
Q 002189 261 -------------NNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDAS-EVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 261 -------------~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~-~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
..+++|++|+|++|.+++..+ .+.++++|++|+|++|++++. ..|..|.++++|+.|+|++|+++
T Consensus 337 ~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~ 416 (562)
T 3a79_B 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416 (562)
T ss_dssp EEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCB
T ss_pred EccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCC
Confidence 677889999999999998655 688899999999999999752 12466889999999999999999
Q ss_pred ecCCcC-CCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEecCc
Q 002189 326 GQIPAD-LFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 326 ~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~ 391 (955)
+.+|.. +..+++|+.|+|++|++++..+..+. .+|+.|+|++|+|+.+++..+ .+.+|+.++..
T Consensus 417 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-~~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~L~ 481 (562)
T 3a79_B 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIMSIPKDVT-HLQALQELNVA 481 (562)
T ss_dssp SCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-TTCSEEECCSSCCCCCCTTTT-SSCCCSEEECC
T ss_pred CccChhhhcCcccCCEEECCCCCCCcchhhhhc-CcCCEEECCCCcCcccChhhc-CCCCCCEEECC
Confidence 856654 77889999999999999887666554 678899999999998888777 67777776654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=324.92 Aligned_cols=314 Identities=20% Similarity=0.176 Sum_probs=214.7
Q ss_pred eEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccC
Q 002189 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146 (955)
Q Consensus 67 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 146 (955)
+.||+++|+++ .+|..+. ++|++|+|++|+ +.+..|..|.++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~-i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNY-ISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSC-CCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCc-ccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence 47899999999 5777666 899999999997 8888888999999999999999999988899999999999999999
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCceeee-ccCCCCCCCCchhh---------------hhcc--ccccccCCcc--ccc
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEG-EIPVSDGNSPGLDM---------------LVRA--KHFHFGKNQL--SGS 206 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N~l~g-~ip~~~~~~~~l~~---------------L~~L--~~L~L~~N~l--~g~ 206 (955)
|+|+ .+|.. .+++|++|+|++|++++ .+|..++.++.|+. +.+| +.|++++|++ ++.
T Consensus 79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~ 155 (520)
T 2z7x_B 79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155 (520)
T ss_dssp SCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSC
T ss_pred Ccee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeeccccccccc
Confidence 9999 67766 89999999999999986 46666555443322 1233 4445555544 333
Q ss_pred CCccccC-------------------------Ccc---------------------------------------------
Q 002189 207 IPEKLFR-------------------------PDM--------------------------------------------- 216 (955)
Q Consensus 207 ip~~~~~-------------------------~~~--------------------------------------------- 216 (955)
+|..+.. .+.
T Consensus 156 ~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~ 235 (520)
T 2z7x_B 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235 (520)
T ss_dssp CTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHH
T ss_pred ccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHH
Confidence 3332221 011
Q ss_pred ------------ceeeeeccCCCccccCCccc-----CCCCCCcEEEcccCCCCCCcc-cc-------------------
Q 002189 217 ------------VLIHVLFDSNNLTGELPATL-----GLVKSLEVVRFDRNSLSGPVP-SN------------------- 259 (955)
Q Consensus 217 ------------~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~------------------- 259 (955)
+|++|++++|+++|.+|..+ ..+++|+.+++++|.+ .+| ..
T Consensus 236 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~ 313 (520)
T 2z7x_B 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTR 313 (520)
T ss_dssp HHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSC
T ss_pred HHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCc
Confidence 34444444444544555544 4444444444444443 112 00
Q ss_pred ------ccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCC-CCChhhcCCCCCCEEECcCCcceecCCcC
Q 002189 260 ------LNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDAS-EVPSWFSSMQSLTTLMMENTNLKGQIPAD 331 (955)
Q Consensus 260 ------l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 331 (955)
+..+++|++|+|++|++++..+ .+..+++|++|+|++|++++. .+|..+..+++|+.|+|++|.+++.+|..
T Consensus 314 l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~ 393 (520)
T 2z7x_B 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393 (520)
T ss_dssp CCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGC
T ss_pred cccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccc
Confidence 1566777777777777777444 567777777777777777531 23456777777777777777777655554
Q ss_pred -CCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEecCc
Q 002189 332 -LFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 332 -~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~ 391 (955)
+..+++|+.|+|++|++++..+..+. .+++.|+|++|+|+.++...+ .+.+|+.++..
T Consensus 394 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~l~~ip~~~~-~l~~L~~L~L~ 452 (520)
T 2z7x_B 394 DCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNKIKSIPKQVV-KLEALQELNVA 452 (520)
T ss_dssp SCCCCTTCCEEECCSSCCCGGGGGSCC-TTCCEEECCSSCCCCCCGGGG-GCTTCCEEECC
T ss_pred hhccCccCCEEECcCCCCCcchhhhhc-ccCCEEECCCCcccccchhhh-cCCCCCEEECC
Confidence 66677777777777777765555443 566777777777776666544 55555555544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-31 Score=328.30 Aligned_cols=321 Identities=19% Similarity=0.173 Sum_probs=178.1
Q ss_pred CEeEEEecCCcCccccCcCcCCCCc--ccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCcccc-------
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTE--LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS------- 135 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~--L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------- 135 (955)
.++.|+|++|.+++..+..|..++. |++|+|++|+ +.+..|..|+++++|++|+|++|++++..|..|..
T Consensus 223 ~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN-LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSC-CCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred cccEEEccCCcccccChhHhhccCcCCCCEEECCCCC-cCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 3444555555555544444444433 5555555553 44444444555555555555555555444444444
Q ss_pred --------------------------CCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeec-cCCCCCCCCchh
Q 002189 136 --------------------------LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE-IPVSDGNSPGLD 188 (955)
Q Consensus 136 --------------------------l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~-ip~~~~~~~~l~ 188 (955)
+++|++|+|++|++++..+..|.++++|++|+|++|.+++. ++... +..+
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~--f~~~- 378 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET--FVSL- 378 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTT--TGGG-
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhh--hccc-
Confidence 45555555555555544444455555555555554443211 11000 0000
Q ss_pred hhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCC-cccCCCCCCcEEEcccCCCCCCccccccCCCCCC
Q 002189 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP-ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVN 267 (955)
Q Consensus 189 ~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 267 (955)
...+|+.|++++|+++ .++...|..+.+|+.|+|++|++++.+| ..|..+++|++|++++|++.+..+..|..+++|+
T Consensus 379 ~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~ 457 (680)
T 1ziw_A 379 AHSPLHILNLTKNKIS-KIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457 (680)
T ss_dssp TTSCCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCC
T ss_pred ccCcCceEECCCCCCC-eEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccc
Confidence 0124566666666666 3333445556666666666666666554 4566666666666666666656666666666666
Q ss_pred EEEccCCcCcc--c-CCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCC--------cCCCCCC
Q 002189 268 DLYLSNNKLTG--A-MPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP--------ADLFSIP 336 (955)
Q Consensus 268 ~L~Ls~N~l~~--~-~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~ 336 (955)
.|++++|.+++ . +..+..+++|++|+|++|++++ ..+..|.++++|+.|+|++|++++..+ ..+..++
T Consensus 458 ~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~ 536 (680)
T 1ziw_A 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536 (680)
T ss_dssp EEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCT
T ss_pred cchhccccccccccCCcccccCCCCCEEECCCCCCCc-CChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCC
Confidence 66666666652 2 2246666667777777776664 445556666777777777776664321 2255666
Q ss_pred CCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCCcceeEecCc
Q 002189 337 HLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 337 ~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~ 391 (955)
+|++|+|++|+++..++..+ .+.+|+.|+|++|+|+++++..|..+.+|+.++..
T Consensus 537 ~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~ 592 (680)
T 1ziw_A 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECC
Confidence 77777777777765544433 35566667777777776666666666666655544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=301.68 Aligned_cols=242 Identities=25% Similarity=0.449 Sum_probs=179.8
Q ss_pred CcccEEecCCCCCCcc--CCCCCcccccccccccccc-cccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcC
Q 002189 88 TELHTLDLSNNKDLRG--PLPTTIGNLKKLSNLMLVG-CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 164 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~ 164 (955)
.+++.|+|++|+ +.+ .+|..|.++++|++|+|++ |++.+.+|..|+++++|++|+|++|+|++.+|..|.++++|+
T Consensus 50 ~~l~~L~L~~~~-l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLN-LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCC-CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ceEEEEECCCCC-ccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 578889999886 777 7888888888888888885 888888888888888888888888888888888888888888
Q ss_pred eeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcE
Q 002189 165 WLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEV 244 (955)
Q Consensus 165 ~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 244 (955)
+|+|++|++++.+| ..+..+++|++
T Consensus 129 ~L~Ls~N~l~~~~p-------------------------------------------------------~~~~~l~~L~~ 153 (313)
T 1ogq_A 129 TLDFSYNALSGTLP-------------------------------------------------------PSISSLPNLVG 153 (313)
T ss_dssp EEECCSSEEESCCC-------------------------------------------------------GGGGGCTTCCE
T ss_pred EEeCCCCccCCcCC-------------------------------------------------------hHHhcCCCCCe
Confidence 88888888874444 23334445555
Q ss_pred EEcccCCCCCCccccccCCC-CCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCC
Q 002189 245 VRFDRNSLSGPVPSNLNNLT-SVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322 (955)
Q Consensus 245 L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 322 (955)
|+|++|.+++.+|..+..++ +|+.|+|++|++++..+ .+..++ |++|+|++|.+++ ..|..|..+++|+.|+|++|
T Consensus 154 L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N 231 (313)
T 1ogq_A 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKN 231 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE-CCGGGCCTTSCCSEEECCSS
T ss_pred EECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccC-cCCHHHhcCCCCCEEECCCC
Confidence 55555555555555555554 55555555555554444 344444 6666666666654 46677788888888888888
Q ss_pred cceecCCcCCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCCcceeEec
Q 002189 323 NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLID 389 (955)
Q Consensus 323 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~ 389 (955)
.+++.+|. +..+++|++|+|++|++++.+|..+ .+.+|+.|+|++|+|++..|.. ..+.+|+.++
T Consensus 232 ~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~ 297 (313)
T 1ogq_A 232 SLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSA 297 (313)
T ss_dssp EECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGG
T ss_pred ceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHH
Confidence 88866666 7889999999999999999888765 4778889999999999877765 5555555443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=296.72 Aligned_cols=277 Identities=20% Similarity=0.287 Sum_probs=129.1
Q ss_pred CCCCCccEEeCC-----------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccc
Q 002189 52 CGDNWEGIGCTN-----------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120 (955)
Q Consensus 52 C~~~w~gv~C~~-----------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~L 120 (955)
|.|.|..+.|+. .+++.|+|++|.+++..+..|.++++|++|+|++|+ +.+..|..|.++++|++|+|
T Consensus 31 c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 31 CHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK-ISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC-CCEECGGGSTTCTTCCEEEC
T ss_pred CcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCc-cCccCHhHhhCcCCCCEEEC
Confidence 444566666642 234455555555554444455555555555555553 44444455555555555555
Q ss_pred cccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeee--ccCCCCCCCCchhhhhccccccc
Q 002189 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG--EIPVSDGNSPGLDMLVRAKHFHF 198 (955)
Q Consensus 121 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g--~ip~~~~~~~~l~~L~~L~~L~L 198 (955)
++|+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++. ..|..+.. + +|+.|++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~------l-~L~~L~l 179 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG------L-KLNYLRI 179 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS------C-CCSCCBC
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC------C-ccCEEEC
Confidence 555554 3343333 445555555555553333344555555555555555531 22222211 1 3444455
Q ss_pred cCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcc
Q 002189 199 GKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG 278 (955)
Q Consensus 199 ~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 278 (955)
++|+++ .+|..++ ++|++|+|++|.+++..+..|..+++|+.|+|++|.+++
T Consensus 180 ~~n~l~-~l~~~~~---------------------------~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 180 SEAKLT-GIPKDLP---------------------------ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp CSSBCS-SCCSSSC---------------------------SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred cCCCCC-ccCcccc---------------------------CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence 555554 3444333 344455555555544444445555555555555555554
Q ss_pred cCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCC------CCCCcEEEeecCcce--
Q 002189 279 AMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFS------IPHLQTVVMKTNELN-- 349 (955)
Q Consensus 279 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~-- 349 (955)
.++ .+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|.. .++|+.|+|++|++.
T Consensus 232 ~~~~~~~~l~~L~~L~L~~N~l~--~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 232 IENGSLSFLPTLRELHLDNNKLS--RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp CCTTGGGGCTTCCEEECCSSCCC--BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred CChhHhhCCCCCCEEECCCCcCe--ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 444 2444455555555555553 24444555555555555555555443333332 234555555555554
Q ss_pred eeeCCCc-chhhhhhhcccCC
Q 002189 350 GTLDLGT-SYSENLLVNLQNN 369 (955)
Q Consensus 350 ~~~~~~~-~~~~l~~L~L~~N 369 (955)
+..+..+ .+..++.++|++|
T Consensus 310 ~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 310 EVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp GSCGGGGTTBCCSTTEEC---
T ss_pred ccCcccccccchhhhhhcccc
Confidence 2333322 2334445555554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=293.52 Aligned_cols=285 Identities=22% Similarity=0.284 Sum_probs=168.6
Q ss_pred EEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCC
Q 002189 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 147 (955)
Q Consensus 68 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 147 (955)
.+++++++++ .+|..+. +.|+.|+|++|+ +++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 35 ~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 35 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EEECTTSCCC-SCCCSCC--TTCCEEECCSSC-CCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred EEEecCCCcc-ccCccCC--CCCeEEECCCCc-CCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 3344444444 3333332 456666666665 55555556666666666666666666555666666666666666666
Q ss_pred CCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccc-cCCccccCCccceeeeeccCC
Q 002189 148 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG-SIPEKLFRPDMVLIHVLFDSN 226 (955)
Q Consensus 148 ~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g-~ip~~~~~~~~~L~~L~L~~N 226 (955)
+|+ .+|..+. ++|++|++++|++++..+.. +..+++|+.|++++|+++. .+....+..+++|+.|++++|
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~------~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n 181 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHENEITKVRKSV------FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCCCBBCHHH------HTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred cCC-ccChhhc--ccccEEECCCCcccccCHhH------hcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence 666 4444443 56666666666665332221 3344555666666666641 133344455566666666666
Q ss_pred CccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCC
Q 002189 227 NLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVP 305 (955)
Q Consensus 227 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p 305 (955)
+++. +|..+. ++|++|++++|.+++..|..|..+++|+.|+|++|.+++.++ .+..+++|++|+|++|+++ .+|
T Consensus 182 ~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~lp 256 (330)
T 1xku_A 182 NITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV--KVP 256 (330)
T ss_dssp CCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS--SCC
T ss_pred cccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc--cCC
Confidence 6663 444332 567777777777776666667777777777777777776665 4666677777777777775 366
Q ss_pred hhhcCCCCCCEEECcCCcceecCCcCCCC------CCCCcEEEeecCccee--eeCCCcc-hhhhhhhcccCCc
Q 002189 306 SWFSSMQSLTTLMMENTNLKGQIPADLFS------IPHLQTVVMKTNELNG--TLDLGTS-YSENLLVNLQNNR 370 (955)
Q Consensus 306 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~~~~~~-~~~l~~L~L~~N~ 370 (955)
.++..+++|+.|+|++|+|++..+..|.. .+.|+.|+|++|++.. ..|..+. +..+..++|++|+
T Consensus 257 ~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred hhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 66677777777777777777555555543 3567777777777754 3333333 4456677777764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=300.96 Aligned_cols=272 Identities=17% Similarity=0.248 Sum_probs=180.2
Q ss_pred HHHHHHHHHHHhhcCCCC---CCCCC----CCCCCCCCCccEEeCC----------CCEeEEEecCCcCccccCcCcCCC
Q 002189 25 DNDFVILKALKDDIWENE---PPNWK----NNDPCGDNWEGIGCTN----------SRVTSITLSGMGLKGQLSGDITGL 87 (955)
Q Consensus 25 ~~~~~~L~~~k~~~~~~~---~~~w~----~~~~C~~~w~gv~C~~----------~~v~~L~L~~~~l~~~~~~~l~~l 87 (955)
.+|..+|++||+++..+. ...|. ....| |.|.|+.|.. .+|+.|+|++|+++ .+|..+..+
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~-~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l 103 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI-ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRL 103 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTS-CCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGG
T ss_pred chHHHHHHHHHHhccCCchhhhhhhcccccccccc-cccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhC
Confidence 578999999999774332 35673 23333 3699999952 56777777777766 556666666
Q ss_pred CcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeee
Q 002189 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLD 167 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 167 (955)
++|++|+|++|+ +. .+|..|+++++|++|+|++|+++ .+|..|+++++|++|+|++|++.+.+|..+... .
T Consensus 104 ~~L~~L~L~~n~-l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------~ 174 (328)
T 4fcg_A 104 SHLQHMTIDAAG-LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------D 174 (328)
T ss_dssp TTCSEEEEESSC-CC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE------C
T ss_pred CCCCEEECCCCC-cc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc------c
Confidence 666666666665 44 56666666666666666666666 556666666666666666666555555544330 0
Q ss_pred cCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEc
Q 002189 168 LTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 247 (955)
Q Consensus 168 L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 247 (955)
+. ..+. .+.+|++|+|++|+++ .+|..+..+++|++|+|
T Consensus 175 -----~~----------~~~~-------------------------~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L 213 (328)
T 4fcg_A 175 -----AS----------GEHQ-------------------------GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213 (328)
T ss_dssp ------C----------CCEE-------------------------ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEE
T ss_pred -----ch----------hhhc-------------------------cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEc
Confidence 00 0011 1223444444444444 55556667777777777
Q ss_pred ccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCccee
Q 002189 248 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 326 (955)
Q Consensus 248 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 326 (955)
++|.++ .+|..+..+++|+.|+|++|.+.+..| .+.++++|++|+|++|++.+ .+|..+.++++|+.|+|++|++.+
T Consensus 214 ~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp ESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCC-BCCTTGGGCTTCCEEECTTCTTCC
T ss_pred cCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchh-hcchhhhcCCCCCEEeCCCCCchh
Confidence 777777 456667777777777777777776665 46777778888888877765 677778888888888888888888
Q ss_pred cCCcCCCCCCCCcEEEeecCccee
Q 002189 327 QIPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 327 ~~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
.+|..+.++++|+.+++..|.+..
T Consensus 292 ~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 292 RLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp CCCGGGGGSCTTCEEECCGGGSCC
T ss_pred hccHHHhhccCceEEeCCHHHHHH
Confidence 888888888888888888776653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=320.31 Aligned_cols=314 Identities=18% Similarity=0.189 Sum_probs=233.8
Q ss_pred EeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCC
Q 002189 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL 139 (955)
Q Consensus 60 ~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 139 (955)
.|....+ .|+++++++ .+|..+. ++|++|+|++|+ +.+..|..|.++++|++|+|++|++++..|..|.++++|
T Consensus 3 ~C~~~~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 76 (549)
T 2z81_A 3 SCDASGV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNK-ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76 (549)
T ss_dssp EECTTSE--EECTTSCCS-SCCSCCC--TTCCEEECCSSC-CCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred cCCCCce--EECCCCccc-cccccCC--CCccEEECcCCc-cCccChhhhhcCCcccEEECCCCCcCccChhhccccccC
Confidence 5776665 799999999 5666554 799999999997 898889999999999999999999998888999999999
Q ss_pred cEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeee-ccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccce
Q 002189 140 VLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEG-EIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVL 218 (955)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g-~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L 218 (955)
++|+|++|++++..|..|+++++|++|+|++|++++ .+|.. +..+++|++|++++|++.+.+|...+..+++|
T Consensus 77 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~------~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L 150 (549)
T 2z81_A 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL------FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150 (549)
T ss_dssp CEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCS------CTTCTTCCEEEEEESSSCCEECTTTTTTCCEE
T ss_pred CEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhh------hhccCCccEEECCCCccccccCHhhhhccccc
Confidence 999999999998777779999999999999999985 24444 44567789999999997668998888889999
Q ss_pred eeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCcccc-ccCCCCCCEEEccCCcCcccCC---CC-----------
Q 002189 219 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSN-LNNLTSVNDLYLSNNKLTGAMP---NL----------- 283 (955)
Q Consensus 219 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~~---~~----------- 283 (955)
++|++++|++++..|..+..+++|+.|+++.|.+. .+|.. +..+++|+.|+|++|++++... .+
T Consensus 151 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~ 229 (549)
T 2z81_A 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229 (549)
T ss_dssp EEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEE
T ss_pred CeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccccee
Confidence 99999999999999999988777777777777765 33333 3456666666666666665310 00
Q ss_pred ------------------------------------------------C-----------------------------CC
Q 002189 284 ------------------------------------------------T-----------------------------GL 286 (955)
Q Consensus 284 ------------------------------------------------~-----------------------------~l 286 (955)
. ..
T Consensus 230 l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~ 309 (549)
T 2z81_A 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309 (549)
T ss_dssp EESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHS
T ss_pred ccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhc
Confidence 0 01
Q ss_pred CCCCEEECcCCCCCCCCCChhh-cCCCCCCEEECcCCcceecCC---cCCCCCCCCcEEEeecCcceeeeC---CCcchh
Q 002189 287 SVLSYLDMSNNSFDASEVPSWF-SSMQSLTTLMMENTNLKGQIP---ADLFSIPHLQTVVMKTNELNGTLD---LGTSYS 359 (955)
Q Consensus 287 ~~L~~L~Ls~N~l~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~~ 359 (955)
++|+.|++++|.++ .+|..+ ..+++|+.|+|++|++++.+| ..+..+++|+.|+|++|++++..+ ....+.
T Consensus 310 ~~L~~L~l~~n~l~--~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~ 387 (549)
T 2z81_A 310 EKVKRITVENSKVF--LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387 (549)
T ss_dssp TTCCEEEEESSCCC--CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCT
T ss_pred ccceEEEeccCccc--cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCC
Confidence 34555666666654 355544 467777777777777776553 336667777777777777766442 234456
Q ss_pred hhhhhcccCCccccccCCCCCCCcceeEec
Q 002189 360 ENLLVNLQNNRISAYTERGGAPAVNLTLID 389 (955)
Q Consensus 360 ~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~ 389 (955)
+|+.|+|++|+|+.++.. +..+.+|+.++
T Consensus 388 ~L~~L~Ls~N~l~~lp~~-~~~~~~L~~L~ 416 (549)
T 2z81_A 388 NLTSLDISRNTFHPMPDS-CQWPEKMRFLN 416 (549)
T ss_dssp TCCEEECTTCCCCCCCSC-CCCCTTCCEEE
T ss_pred CCCEEECCCCCCccCChh-hcccccccEEE
Confidence 666777777777765543 33334444443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=317.40 Aligned_cols=135 Identities=21% Similarity=0.248 Sum_probs=118.2
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
..++.|||++|.|+++.+..|.++++|++|+|++|+ +.++.|.+|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~-i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC-CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc-CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 478999999999998888899999999999999997 8888889999999999999999999977777899999999999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeec-cCCCCCCCCchhhhhccccccccCCcccc
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE-IPVSDGNSPGLDMLVRAKHFHFGKNQLSG 205 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~-ip~~~~~~~~l~~L~~L~~L~L~~N~l~g 205 (955)
|++|+|++..+..|+++++|++|+|++|++++. +|.. +..+++|++|+|++|+|++
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~------~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY------FSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGG------GGGCTTCCEEECCSSCCCE
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchh------hccchhhhhhcccCccccc
Confidence 999999987777899999999999999999742 3433 4456667777777777763
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=330.39 Aligned_cols=314 Identities=19% Similarity=0.157 Sum_probs=259.3
Q ss_pred EEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCC-CCccccCCCCcEEEccC
Q 002189 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPI-PDSIGSLQELVLLSLNS 146 (955)
Q Consensus 68 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~ 146 (955)
..+.++++++. +|. ..++|++|||++|+ +++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus 8 ~~dcs~~~L~~-vP~---lp~~l~~LdLs~N~-i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 8 IAFYRFCNLTQ-VPQ---VLNTTERLLLSFNY-IRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEESCCCSSC-CCS---SCTTCCEEEEESCC-CCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred EEEccCCCCCC-CCC---CCCCcCEEECCCCc-CCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 45677888884 454 55899999999997 99999999999999999999999776666 78899999999999999
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCC
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN 226 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N 226 (955)
|+|++..|..|.++++|++|+|++|++++.+|.. ..+..+++|++|+|++|++++..+...|..+++|++|+|++|
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~----~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N 158 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD----GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTT----CCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESS
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccC----ccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCC
Confidence 9999988999999999999999999999766654 124457788999999999996666677888999999999999
Q ss_pred CccccCCcccCCC--CCCcEEEcccCCCCCCccccccCCCC------CCEEEccCCcCcccCCC----------------
Q 002189 227 NLTGELPATLGLV--KSLEVVRFDRNSLSGPVPSNLNNLTS------VNDLYLSNNKLTGAMPN---------------- 282 (955)
Q Consensus 227 ~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~~~~---------------- 282 (955)
++++..+..+..+ ++|+.|+|+.|.+.+..|..+..+++ |+.|+|++|.+++..+.
T Consensus 159 ~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l 238 (844)
T 3j0a_A 159 QIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238 (844)
T ss_dssp CCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEEC
T ss_pred cCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceec
Confidence 9999999888877 88999999999998888877776665 88888888877654331
Q ss_pred ---------------------CCC--CCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCc
Q 002189 283 ---------------------LTG--LSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQ 339 (955)
Q Consensus 283 ---------------------~~~--l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 339 (955)
+.+ .++|+.|+|++|.+++ ..+..|..+++|+.|+|++|++++..|..|..+++|+
T Consensus 239 ~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 317 (844)
T 3j0a_A 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317 (844)
T ss_dssp CSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCE-ECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCC
T ss_pred ccccccccccccccCCCChhhhhccccCCccEEECCCCcccc-cChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCC
Confidence 111 2678888888888875 5677788888888888888888888888888888888
Q ss_pred EEEeecCcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCCcceeEecCc
Q 002189 340 TVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 340 ~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~ 391 (955)
+|+|++|++++..+..+ .+.+|+.|+|++|+|+.+++..+..+.+|+.++..
T Consensus 318 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls 370 (844)
T 3j0a_A 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR 370 (844)
T ss_dssp EEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEE
T ss_pred EEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECC
Confidence 88888888888766554 47778888888888888888777766666665443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=294.18 Aligned_cols=286 Identities=17% Similarity=0.183 Sum_probs=240.4
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.+++..+..|..+++|++|+|++|+ +.+..|..|+++++|++|+|++|+++...+..|.++++|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCC-CCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 589999999999998888899999999999999997 8888889999999999999999999955555579999999999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|++++..|..|.++++|++|+|++|++++. .+..+++|+.|++++|.+++ ++ ....|+.|++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---------~~~~l~~L~~L~l~~n~l~~-~~-----~~~~L~~L~l 212 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---------DLSLIPSLFHANVSYNLLST-LA-----IPIAVEELDA 212 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---------CGGGCTTCSEEECCSSCCSE-EE-----CCSSCSEEEC
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCcc---------ccccccccceeecccccccc-cC-----CCCcceEEEC
Confidence 999999988888999999999999999999842 25567788888999998873 32 2346888999
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDAS 302 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~ 302 (955)
++|++... |. ...++|+.|++++|.+++. ..+..+++|+.|+|++|.+++.++ .+..+++|++|+|++|++++
T Consensus 213 ~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~- 286 (390)
T 3o6n_A 213 SHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA- 286 (390)
T ss_dssp CSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-
T ss_pred CCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-
Confidence 99988855 33 2347889999999998853 578888999999999999988866 57888999999999998865
Q ss_pred CCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCcccccc
Q 002189 303 EVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYT 375 (955)
Q Consensus 303 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~ 375 (955)
++..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+... ...+.+|+.|+|++|++++..
T Consensus 287 -~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 287 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp -EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred -cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccchh
Confidence 5666778889999999999888 56777778889999999999988764 445667888999999988643
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=301.90 Aligned_cols=279 Identities=23% Similarity=0.382 Sum_probs=130.5
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.+++..+ +..+++|++|+|++|+ +.+..+ +.++++|++|+|++|.+++. +. +..+++|++|+
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~-l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~ 140 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ-IADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLE 140 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC-CCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCc-cccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEE
Confidence 355556666655554432 5555556666665554 443332 55555555555555555532 22 55555555555
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|.+++ ++ .+..+++|+.|+++ |.+. ....+..+++|+.|++++|+++ .++. +..+++|++|++
T Consensus 141 l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~--------~~~~~~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l 206 (466)
T 1o6v_A 141 LSSNTISD-IS-ALSGLTSLQQLSFG-NQVT--------DLKPLANLTTLERLDISSNKVS-DISV--LAKLTNLESLIA 206 (466)
T ss_dssp EEEEEECC-CG-GGTTCTTCSEEEEE-ESCC--------CCGGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCSEEEC
T ss_pred CCCCccCC-Ch-hhccCCcccEeecC-Cccc--------CchhhccCCCCCEEECcCCcCC-CChh--hccCCCCCEEEe
Confidence 55555553 21 12222222222221 1111 0111333445555555555554 2221 333445555555
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASE 303 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 303 (955)
++|++.+..| ++.+++|+.|++++|.+++ + ..+..+++|+.|++++|.+++.++ +..+++|++|+|++|.+++
T Consensus 207 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-- 279 (466)
T 1o6v_A 207 TNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISN-- 279 (466)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCC--
T ss_pred cCCccccccc--ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCc--
Confidence 5555554433 4445555555555555542 1 234445555555555555544433 4444555555555555543
Q ss_pred CChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccc
Q 002189 304 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAY 374 (955)
Q Consensus 304 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~ 374 (955)
.+. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..+ ...+.+|+.|++++|+++++
T Consensus 280 ~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 280 ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC
T ss_pred ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc
Confidence 222 4445555555555555543222 3444555555555555544433 22344444455555554444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=309.89 Aligned_cols=285 Identities=17% Similarity=0.176 Sum_probs=241.5
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.+++..+..|..+++|++|+|++|. +.+..|..|+++++|++|+|++|.|++..+..|+++++|++|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCc-CCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 589999999999999888999999999999999997 9998888999999999999999999966666689999999999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|.|++..|..|.++++|++|+|++|++++. + +..+++|+.|++++|.+++ + .....|+.|++
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--------~~~l~~L~~L~l~~n~l~~-l-----~~~~~L~~L~l 218 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--------LSLIPSLFHANVSYNLLST-L-----AIPIAVEELDA 218 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--------GGGCTTCSEEECCSSCCSE-E-----ECCTTCSEEEC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--------hhhhhhhhhhhcccCcccc-c-----cCCchhheeec
Confidence 999999998888999999999999999999843 2 4556778888999998873 2 23456888999
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDAS 302 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~ 302 (955)
++|.+....+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.|++.++ .+..+++|++|+|++|.+++
T Consensus 219 s~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~- 292 (597)
T 3oja_B 219 SHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA- 292 (597)
T ss_dssp CSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-
T ss_pred cCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-
Confidence 999888544332 3688899999999885 4678888999999999999988866 57888899999999998875
Q ss_pred CCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccc
Q 002189 303 EVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAY 374 (955)
Q Consensus 303 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~ 374 (955)
+|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++.. ...+..|..|+|++|++++.
T Consensus 293 -l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 293 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp -EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHH
T ss_pred -CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCCh
Confidence 5777778889999999999988 67777888889999999999988764 34466788899999988864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=288.28 Aligned_cols=283 Identities=23% Similarity=0.305 Sum_probs=213.3
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEc
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 144 (955)
+++.+++++++++ .+|..+. ++|+.|+|++|+ +.+..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNND-ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSC-CCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCc-CCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 3456677777766 4454442 566667777665 56555666666666666666666666555666666666666666
Q ss_pred cCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeecc
Q 002189 145 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD 224 (955)
Q Consensus 145 s~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~ 224 (955)
++|+|+ .+|..+. ++|++|+|++|+++ .+|...+..+++|+.|+++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~-------------------------------~~~~~~~~~l~~L~~L~l~ 155 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIR-------------------------------KVPKGVFSGLRNMNCIEMG 155 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCC-------------------------------CCCSGGGSSCSSCCEEECC
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccC-------------------------------ccCHhHhCCCccCCEEECC
Confidence 666666 4444443 55666666655555 4555556666677777777
Q ss_pred CCCcc--ccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCC
Q 002189 225 SNNLT--GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDA 301 (955)
Q Consensus 225 ~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~ 301 (955)
+|+++ +..+..+..+ +|+.|++++|.++ .+|..+. ++|+.|+|++|.+++.++ .+..+++|++|+|++|++++
T Consensus 156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred CCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence 77775 3667788888 9999999999999 4676654 799999999999999886 68899999999999999986
Q ss_pred CCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-------hhhhhhhcccCCccc--
Q 002189 302 SEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-------YSENLLVNLQNNRIS-- 372 (955)
Q Consensus 302 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-------~~~l~~L~L~~N~l~-- 372 (955)
..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..+. ...+..|++++|++.
T Consensus 232 -~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 232 -IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp -CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred -CChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 56678999999999999999999 8999999999999999999999998776553 345678999999998
Q ss_pred cccCCCCCCCcceeEecCc
Q 002189 373 AYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 373 ~~~~~~~~~~~~L~~l~n~ 391 (955)
++.+..|..+.+|+.++..
T Consensus 310 ~~~~~~~~~l~~L~~l~l~ 328 (332)
T 2ft3_A 310 EVQPATFRCVTDRLAIQFG 328 (332)
T ss_dssp GSCGGGGTTBCCSTTEEC-
T ss_pred ccCcccccccchhhhhhcc
Confidence 7777888877777776654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=283.44 Aligned_cols=286 Identities=21% Similarity=0.228 Sum_probs=221.7
Q ss_pred CCCCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCC--
Q 002189 50 DPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG-- 127 (955)
Q Consensus 50 ~~C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-- 127 (955)
+.|.|.|.+|.|+... ++ .+|..+ .++|++|+|++|+ +....+..|.++++|++|+|++|+++.
T Consensus 3 ~~C~C~~~~l~c~~~~----------l~-~ip~~~--~~~l~~L~L~~n~-l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 68 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKG----------LT-SVPTGI--PSSATRLELESNK-LQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68 (306)
T ss_dssp TTCEEETTEEECCSSC----------CS-SCCSCC--CTTCCEEECCSSC-CCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred CCCeeCCCEEEcCCCC----------cc-cCCCCC--CCCCCEEECCCCc-cCccCHhHhhccccCCEEECCCCccCccc
Confidence 4577788888887544 44 334433 2689999999997 775555568999999999999999883
Q ss_pred CCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccC
Q 002189 128 PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI 207 (955)
Q Consensus 128 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~i 207 (955)
..+..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+
T Consensus 69 ~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~----------------------------- 118 (306)
T 2z66_A 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE----------------------------- 118 (306)
T ss_dssp EEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTT-----------------------------
T ss_pred CcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCccccccc-----------------------------
Confidence 23667778899999999999998 577778899999999999999883222
Q ss_pred CccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCC-CccccccCCCCCCEEEccCCcCcccCC-CCCC
Q 002189 208 PEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSG-PVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTG 285 (955)
Q Consensus 208 p~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~ 285 (955)
...+..+++|++|++++|++.+..+..+..+++|++|+|++|.+++ .+|..+..+++|+.|+|++|.+++.++ .+..
T Consensus 119 -~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 197 (306)
T 2z66_A 119 -FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197 (306)
T ss_dssp -TTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred -chhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcC
Confidence 0223334456666666666666777778888999999999999886 578889999999999999999998866 5788
Q ss_pred CCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCC-CCcEEEeecCcceeeeCCC--cc-hhhh
Q 002189 286 LSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIP-HLQTVVMKTNELNGTLDLG--TS-YSEN 361 (955)
Q Consensus 286 l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~--~~-~~~l 361 (955)
+++|++|+|++|++++ ..+..+..+++|+.|+|++|++++..|..+..++ +|+.|+|++|++++..+.. .. +...
T Consensus 198 l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~ 276 (306)
T 2z66_A 198 LSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQ 276 (306)
T ss_dssp CTTCCEEECTTSCCSB-CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHT
T ss_pred CCCCCEEECCCCccCc-cChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhh
Confidence 9999999999999976 5566789999999999999999999999999985 9999999999999865432 22 2234
Q ss_pred hhhcccCCccccccCCCCCC
Q 002189 362 LLVNLQNNRISAYTERGGAP 381 (955)
Q Consensus 362 ~~L~L~~N~l~~~~~~~~~~ 381 (955)
..+.+..+.+.+..|....+
T Consensus 277 ~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 277 RQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp GGGBSCGGGCBEEESGGGTT
T ss_pred hhhhccccccccCCchhhCC
Confidence 45666777777766654443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-30 Score=287.16 Aligned_cols=296 Identities=22% Similarity=0.320 Sum_probs=210.7
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+++++.+... + .+..+++|++|+|++|+ +.+..+ +.++++|++|+|++|.++. ++ .+..+++|++|+
T Consensus 44 ~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~-i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~ 116 (347)
T 4fmz_A 44 ESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQ-ITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELY 116 (347)
T ss_dssp TTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSC-CCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred ccccEEEEeCCccccc-h-hhhhcCCccEEEccCCc-cccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEE
Confidence 5777888888887743 3 47778888888888886 554433 7788888888888888874 43 578888888888
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|.+++..+ +..+++|++|++++|.....+ ..+..+++|++|++++|.++ .++. +..+++|+.|++
T Consensus 117 l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-------~~~~~l~~L~~L~l~~~~~~-~~~~--~~~l~~L~~L~l 184 (347)
T 4fmz_A 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDL-------SPLSNMTGLNYLTVTESKVK-DVTP--IANLTDLYSLSL 184 (347)
T ss_dssp CTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-------GGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCSEEEC
T ss_pred CcCCcccCchh--hccCCceeEEECCCCCCcccc-------cchhhCCCCcEEEecCCCcC-Cchh--hccCCCCCEEEc
Confidence 88888875333 778888888888888544222 23556677777888888877 3333 555677888888
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASE 303 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 303 (955)
++|++.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++.++ +..+++|++|++++|.++.
T Consensus 185 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-- 257 (347)
T 4fmz_A 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-- 257 (347)
T ss_dssp TTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC--
T ss_pred cCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC--
Confidence 8888775433 7777888888888888875443 7777888888888888877666 7777888888888887764
Q ss_pred CChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCC
Q 002189 304 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPA 382 (955)
Q Consensus 304 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~ 382 (955)
+ ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..+..+ .+.+|+.|+|++|+++++++ +..+
T Consensus 258 ~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l 332 (347)
T 4fmz_A 258 I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASL 332 (347)
T ss_dssp C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGC
T ss_pred C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhh
Confidence 2 4577778888888888887753 356777888888888888877665543 36677788888888887766 3344
Q ss_pred cceeEecC
Q 002189 383 VNLTLIDN 390 (955)
Q Consensus 383 ~~L~~l~n 390 (955)
.+|+.++.
T Consensus 333 ~~L~~L~l 340 (347)
T 4fmz_A 333 SKMDSADF 340 (347)
T ss_dssp TTCSEESS
T ss_pred hccceeeh
Confidence 44444443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=282.41 Aligned_cols=283 Identities=21% Similarity=0.237 Sum_probs=243.5
Q ss_pred cccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeec
Q 002189 89 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 168 (955)
Q Consensus 89 ~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 168 (955)
+|+.++++++. +. .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 32 ~l~~l~~~~~~-l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLG-LE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSC-CC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCC-cc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 57899999997 44 5676665 68999999999999877778999999999999999999888999999999999999
Q ss_pred CCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccc--cCCcccCCCCCCcEEE
Q 002189 169 TDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG--ELPATLGLVKSLEVVR 246 (955)
Q Consensus 169 ~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~ 246 (955)
++|+++ .+|..+. .+|++|++++|+++ .++...+..+.+|+.|++++|++.. ..+..+..+++|++|+
T Consensus 108 s~n~l~-~l~~~~~--------~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~ 177 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--------KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177 (330)
T ss_dssp CSSCCS-BCCSSCC--------TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred CCCcCC-ccChhhc--------ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEE
Confidence 999998 6776543 57899999999999 7888888889999999999999964 7788999999999999
Q ss_pred cccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcce
Q 002189 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 247 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
+++|.++ .+|..+. ++|+.|+|++|.+++..+ .+..+++|++|+|++|.+++ ..+..+..+++|+.|+|++|+++
T Consensus 178 l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 178 IADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp CCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE-ECTTTGGGSTTCCEEECCSSCCS
T ss_pred CCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce-eChhhccCCCCCCEEECCCCcCc
Confidence 9999999 5666654 899999999999999876 58899999999999999976 56668999999999999999999
Q ss_pred ecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-------hhhhhhhcccCCcccc--ccCCCCCCCcceeEecC
Q 002189 326 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-------YSENLLVNLQNNRISA--YTERGGAPAVNLTLIDN 390 (955)
Q Consensus 326 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-------~~~l~~L~L~~N~l~~--~~~~~~~~~~~L~~l~n 390 (955)
.+|..+..+++|++|+|++|+|++..+..+. ...+..|++++|++.. +.+..|..+.+|+.++.
T Consensus 254 -~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L 326 (330)
T 1xku_A 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 326 (330)
T ss_dssp -SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC
T ss_pred -cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEe
Confidence 8899999999999999999999998776653 3456689999999875 56666666665555543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-30 Score=286.57 Aligned_cols=282 Identities=20% Similarity=0.303 Sum_probs=245.3
Q ss_pred CCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEE
Q 002189 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 142 (955)
..+++.|+|++|.+++..+ +..+++|++|+|++|+ +.. +| .|.++++|++|+|++|.+++ ++. +..+++|++|
T Consensus 65 ~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~-i~~-~~-~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L 137 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK-ITD-IS-ALQNLTNLRELYLNEDNISD-ISP-LANLTKMYSL 137 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC-CCC-CG-GGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCCEE
T ss_pred cCCccEEEccCCccccchh--hhcCCcCCEEEccCCc-ccC-ch-HHcCCCcCCEEECcCCcccC-chh-hccCCceeEE
Confidence 4689999999999996544 9999999999999997 665 33 69999999999999999995 444 8999999999
Q ss_pred EccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeee
Q 002189 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVL 222 (955)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~ 222 (955)
++++|.....++ .+..+++|++|++++|.+.+.. .+..+++|+.|++++|+++ .++. +....+|+.|+
T Consensus 138 ~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~--------~~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~ 205 (347)
T 4fmz_A 138 NLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVT--------PIANLTDLYSLSLNYNQIE-DISP--LASLTSLHYFT 205 (347)
T ss_dssp ECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCG--------GGGGCTTCSEEECTTSCCC-CCGG--GGGCTTCCEEE
T ss_pred ECCCCCCccccc-chhhCCCCcEEEecCCCcCCch--------hhccCCCCCEEEccCCccc-cccc--ccCCCccceee
Confidence 999997664444 4999999999999999998332 2677889999999999998 5555 66788999999
Q ss_pred ccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCC
Q 002189 223 FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDAS 302 (955)
Q Consensus 223 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 302 (955)
+++|++.+..+ +..+++|++|++++|.+++..+ +..+++|+.|+|++|.+++. +.+..+++|++|++++|.++.
T Consensus 206 l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~- 279 (347)
T 4fmz_A 206 AYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD- 279 (347)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-
T ss_pred cccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-
Confidence 99999997655 8899999999999999995444 99999999999999999986 568889999999999999976
Q ss_pred CCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccc
Q 002189 303 EVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRIS 372 (955)
Q Consensus 303 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~ 372 (955)
+ ..+..+++|+.|++++|++++..+..+..+++|++|+|++|++++..| ...+.+|+.|++++|+|+
T Consensus 280 -~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 280 -I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK 346 (347)
T ss_dssp -C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC---
T ss_pred -C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhccc
Confidence 3 468999999999999999999999999999999999999999999877 667888999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=296.94 Aligned_cols=296 Identities=25% Similarity=0.367 Sum_probs=250.9
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|++.++++.. ++ .+..+++|++|+|++|+ +.+..| +.++++|++|+|++|++++..+ +.++++|++|+
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~-l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQ-LTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSC-CCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCc-cCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 589999999999985 44 48899999999999997 776544 9999999999999999996554 99999999999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|++++..+ +.++++|++|+|++|++++ + +.+..+.+|+.|+++ |.+. .++. +..+.+|+.|++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-------~~~~~l~~L~~L~l~-~~~~-~~~~--~~~l~~L~~L~l 184 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-I-------SALSGLTSLQQLSFG-NQVT-DLKP--LANLTTLERLDI 184 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-C-------GGGTTCTTCSEEEEE-ESCC-CCGG--GTTCTTCCEEEC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCC-C-------hhhccCCcccEeecC-Cccc-Cchh--hccCCCCCEEEC
Confidence 99999996543 9999999999999999983 2 346677888999996 5665 3332 677889999999
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASE 303 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 303 (955)
++|++.+. ..+..+++|++|++++|.+++..| +..+++|+.|++++|.+++. +.+..+++|++|++++|.+++
T Consensus 185 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~-- 257 (466)
T 1o6v_A 185 SSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISN-- 257 (466)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC--
T ss_pred cCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCcccc--
Confidence 99999864 358999999999999999997665 78899999999999999975 467889999999999999976
Q ss_pred CChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCCc
Q 002189 304 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAV 383 (955)
Q Consensus 304 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~ 383 (955)
.+. +..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++..+ ...+.+|+.|+|++|+++++.+ +..+.
T Consensus 258 ~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~ 331 (466)
T 1o6v_A 258 LAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLT 331 (466)
T ss_dssp CGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCT
T ss_pred chh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCc
Confidence 333 8999999999999999996544 8899999999999999998766 5567889999999999999877 44556
Q ss_pred ceeEecCcch
Q 002189 384 NLTLIDNPIC 393 (955)
Q Consensus 384 ~L~~l~n~~c 393 (955)
+|+.++...|
T Consensus 332 ~L~~L~l~~n 341 (466)
T 1o6v_A 332 KLQRLFFYNN 341 (466)
T ss_dssp TCCEEECCSS
T ss_pred cCCEeECCCC
Confidence 6666655443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=290.06 Aligned_cols=276 Identities=19% Similarity=0.199 Sum_probs=197.4
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|++++. | .+..+++|++|+|++|+ +.+. | ++.+++|++|+|++|++++. + ++++++|++|+
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~-l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNN-ITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSC-CSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCc-CCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 6888999999999875 4 68889999999999997 7664 3 88889999999999998864 4 88889999999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|++++ +| ++++++|++|++++|++++ ++ +..+++|++|++++|+..+.++ +..+++|+.|++
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--------l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~l 177 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--------VSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDC 177 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--------CTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEEC
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--------cccCCcCCEEECCCCCcccccc---cccCCcCCEEEC
Confidence 99999986 44 8888999999999999885 32 3445667777888886555553 445677888888
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASE 303 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 303 (955)
++|++++ +| +..+++|+.|++++|.+++. .+..+++|+.|+|++|++++++ +..+++|++|++++|++++.
T Consensus 178 s~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~- 248 (457)
T 3bz5_A 178 SFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTEL- 248 (457)
T ss_dssp CSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC-
T ss_pred CCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCc-
Confidence 8888876 34 77777888888888888754 3777778888888888887753 67777888888888887762
Q ss_pred CChhhcCCC-------CCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCC---------Ccchhhhhhhccc
Q 002189 304 VPSWFSSMQ-------SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL---------GTSYSENLLVNLQ 367 (955)
Q Consensus 304 ~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---------~~~~~~l~~L~L~ 367 (955)
.+..+.++. +|+.|++++|.+.+.+| +..+++|+.|+|++|++.+.+|. ...+.+|+.|+|+
T Consensus 249 ~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~ 326 (457)
T 3bz5_A 249 DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLN 326 (457)
T ss_dssp CCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECT
T ss_pred CHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECC
Confidence 233333333 34455555555555554 35567777777777766655442 1123455566777
Q ss_pred CCccccc
Q 002189 368 NNRISAY 374 (955)
Q Consensus 368 ~N~l~~~ 374 (955)
+|+|+++
T Consensus 327 ~N~l~~l 333 (457)
T 3bz5_A 327 NTELTEL 333 (457)
T ss_dssp TCCCSCC
T ss_pred CCccccc
Confidence 7777765
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=288.60 Aligned_cols=283 Identities=20% Similarity=0.223 Sum_probs=235.1
Q ss_pred CCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCC
Q 002189 52 CGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD 131 (955)
Q Consensus 52 C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 131 (955)
|.|.|.|+ | ++++++++ .+|..+. ++|++|+|++|+ +.+..+..|.++++|++|+|++|++++..|.
T Consensus 28 ~~C~~~~~-c--------~~~~~~l~-~iP~~~~--~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 94 (353)
T 2z80_A 28 LSCDRNGI-C--------KGSSGSLN-SIPSGLT--EAVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGINTIEED 94 (353)
T ss_dssp CEECTTSE-E--------ECCSTTCS-SCCTTCC--TTCCEEECTTSC-CCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred CCCCCCeE-e--------eCCCCCcc-ccccccc--ccCcEEECCCCc-CcccCHHHhccCCCCCEEECCCCccCccCHh
Confidence 33478887 6 45677888 5565554 589999999997 8877777899999999999999999988888
Q ss_pred ccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccc
Q 002189 132 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKL 211 (955)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~ 211 (955)
.|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+|. ...+..+++|++|++++|+..+.++...
T Consensus 95 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~----~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 169 (353)
T 2z80_A 95 SFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGE----TSLFSHLTKLQILRVGNMDTFTKIQRKD 169 (353)
T ss_dssp TTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCS----SCSCTTCTTCCEEEEEESSSCCEECTTT
T ss_pred hcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCc----hhhhccCCCCcEEECCCCccccccCHHH
Confidence 8999999999999999999655555899999999999999998 4543 0124557788999999995333787778
Q ss_pred cCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCC----CCCCC
Q 002189 212 FRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN----LTGLS 287 (955)
Q Consensus 212 ~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~----~~~l~ 287 (955)
+..+.+|++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|+.|+|++|.+++.++. .....
T Consensus 170 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~ 249 (353)
T 2z80_A 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS 249 (353)
T ss_dssp TTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCC
T ss_pred ccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccc
Confidence 88889999999999999999999999999999999999999844444456689999999999999987653 33477
Q ss_pred CCCEEECcCCCCCCC---CCChhhcCCCCCCEEECcCCcceecCCcC-CCCCCCCcEEEeecCcceeeeC
Q 002189 288 VLSYLDMSNNSFDAS---EVPSWFSSMQSLTTLMMENTNLKGQIPAD-LFSIPHLQTVVMKTNELNGTLD 353 (955)
Q Consensus 288 ~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~ 353 (955)
.++.++|++|.+++. .+|.++..+++|+.|+|++|+++ .+|.. |..+++|++|+|++|++++..|
T Consensus 250 ~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 250 LIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 899999999998652 35778899999999999999999 56666 5899999999999999998765
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=290.40 Aligned_cols=308 Identities=18% Similarity=0.178 Sum_probs=247.3
Q ss_pred CCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEE
Q 002189 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 142 (955)
..+++.|+|++|.+++. + ++.+++|++|+|++|+ +.+. | |+++++|++|+|++|++++ +| ++.+++|++|
T Consensus 63 l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~-l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L 132 (457)
T 3bz5_A 63 LTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNK-LTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYL 132 (457)
T ss_dssp CTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSC-CSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEE
T ss_pred cCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCC-Ccee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEE
Confidence 36899999999999985 3 9999999999999997 7764 3 9999999999999999996 55 8999999999
Q ss_pred EccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeee
Q 002189 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVL 222 (955)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~ 222 (955)
++++|+|++ ++ ++++++|++|++++|+..+.++ +..+++|+.|++++|+++ .+| +...++|+.|+
T Consensus 133 ~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~--------~~~l~~L~~L~ls~n~l~-~l~---l~~l~~L~~L~ 197 (457)
T 3bz5_A 133 NCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLD--------VTPQTQLTTLDCSFNKIT-ELD---VSQNKLLNRLN 197 (457)
T ss_dssp ECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC--------CTTCTTCCEEECCSSCCC-CCC---CTTCTTCCEEE
T ss_pred ECCCCccce-ec--cccCCcCCEEECCCCCcccccc--------cccCCcCCEEECCCCccc-eec---cccCCCCCEEE
Confidence 999999997 43 8899999999999997665552 455778899999999999 476 56678999999
Q ss_pred ccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCC----------EE
Q 002189 223 FDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLS----------YL 292 (955)
Q Consensus 223 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~----------~L 292 (955)
+++|++++. .++.+++|+.|++++|++++ +| +..+++|+.|++++|++++.++ ..+++|+ .|
T Consensus 198 l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~--~~l~~L~~L~l~~n~L~~L 269 (457)
T 3bz5_A 198 CDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV--STLSKLTTLHCIQTDLLEI 269 (457)
T ss_dssp CCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC--TTCTTCCEEECTTCCCSCC
T ss_pred CcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH--HHCCCCCEEeccCCCCCEE
Confidence 999999976 48999999999999999996 66 8899999999999999999864 3444454 55
Q ss_pred ECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCc--------CCCCCCCCcEEEeecCcceeeeCCCcchhhhhhh
Q 002189 293 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPA--------DLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLV 364 (955)
Q Consensus 293 ~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L 364 (955)
++++|.+.+ .+| ++.+++|+.|+|++|...+.+|. .+..+++|+.|+|++|+|++. + ...+.+|+.|
T Consensus 270 ~l~~n~~~~-~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~-l~~l~~L~~L 344 (457)
T 3bz5_A 270 DLTHNTQLI-YFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D-VSHNTKLKSL 344 (457)
T ss_dssp CCTTCTTCC-EEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C-CTTCTTCSEE
T ss_pred ECCCCccCC-ccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c-cccCCcCcEE
Confidence 555555433 223 46789999999999998776664 356678999999999999995 3 6668889999
Q ss_pred cccCCccccccCCCCCCCcceeEecCc-----chhcccCc-cccccccCCCCCCC
Q 002189 365 NLQNNRISAYTERGGAPAVNLTLIDNP-----ICQELGTA-KGYCQLSQPISPYS 413 (955)
Q Consensus 365 ~L~~N~l~~~~~~~~~~~~~L~~l~n~-----~c~~~~~~-~~~c~~~~~~~~~~ 413 (955)
++++|+|++++ .+..|....|. -+..+... .+...+.+.||+..
T Consensus 345 ~l~~N~l~~l~-----~L~~L~l~~n~l~g~~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 345 SCVNAHIQDFS-----SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp ECCSSCCCBCT-----TGGGSSGGGTSEEEEEEEEECCCBCCBTTBEEEECCTTC
T ss_pred ECCCCCCCCcc-----ccccccccCCcEEecceeeecCccccccCcEEEEcChhH
Confidence 99999999853 34444433333 22334443 55667777776543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=306.28 Aligned_cols=323 Identities=21% Similarity=0.217 Sum_probs=223.0
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|+|+++.+.+|.+|++|++|+|++|+ +++..+..|.++++|++|+|++|++++..+..|+++++|++|+
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~-l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~ 154 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP-IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 154 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC-CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc-CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence 589999999999998888899999999999999997 8888788899999999999999999987778899999999999
Q ss_pred ccCCCCcCc-CCCCCCCCCCcCeeecCCceeeeccCCCCCCCCch-----------------------------------
Q 002189 144 LNSNGFSGR-VPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL----------------------------------- 187 (955)
Q Consensus 144 Ls~N~l~~~-~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l----------------------------------- 187 (955)
|++|+|++. +|..++.+++|++|+|++|+|++..|..+..+..+
T Consensus 155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n 234 (635)
T 4g8a_A 155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 234 (635)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence 999999863 57788999999999999999986554332110000
Q ss_pred --------------------------------------------------------------------------------
Q 002189 188 -------------------------------------------------------------------------------- 187 (955)
Q Consensus 188 -------------------------------------------------------------------------------- 187 (955)
T Consensus 235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence
Q ss_pred ----------hhhhccccccccCCcccccCCcccc-------------------CCccceeeeeccCCCccc--cCCccc
Q 002189 188 ----------DMLVRAKHFHFGKNQLSGSIPEKLF-------------------RPDMVLIHVLFDSNNLTG--ELPATL 236 (955)
Q Consensus 188 ----------~~L~~L~~L~L~~N~l~g~ip~~~~-------------------~~~~~L~~L~L~~N~l~~--~~p~~l 236 (955)
.....|+.|++.+|++. .++...+ ..+++|+.|+++.|.+.. ..+..+
T Consensus 315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~-~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 393 (635)
T 4g8a_A 315 SVTIERVKDFSYNFGWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 393 (635)
T ss_dssp SCEEEECGGGGSCCCCSEEEEESCEES-SCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHH
T ss_pred ccccccccccccchhhhhhhccccccc-CcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccch
Confidence 00012333444444443 2221111 124567888888888753 233344
Q ss_pred CC-----------------------CCCCcEEEcccCCCCCCc-cccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCE
Q 002189 237 GL-----------------------VKSLEVVRFDRNSLSGPV-PSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSY 291 (955)
Q Consensus 237 ~~-----------------------l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 291 (955)
.. +++|+.++++.|.+.... +..+..+++|+.+++++|.+++..+ .+..+++|+.
T Consensus 394 ~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~ 473 (635)
T 4g8a_A 394 FGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 473 (635)
T ss_dssp HSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred hhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 44 444555555544443322 2345566666667777777666655 3556677777
Q ss_pred EECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCc
Q 002189 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNR 370 (955)
Q Consensus 292 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~ 370 (955)
|+|++|.+.....|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.++..+. +.+|+.|+|++|+
T Consensus 474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~ 553 (635)
T 4g8a_A 474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 553 (635)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSC
T ss_pred hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCc
Confidence 777777654444566677777777777777777777777777777777777777777776665443 5566677777777
Q ss_pred cccccCCCCCCC-cceeEe
Q 002189 371 ISAYTERGGAPA-VNLTLI 388 (955)
Q Consensus 371 l~~~~~~~~~~~-~~L~~l 388 (955)
|+++++..+..+ .+|+.+
T Consensus 554 l~~~~~~~l~~l~~~L~~L 572 (635)
T 4g8a_A 554 IMTSKKQELQHFPSSLAFL 572 (635)
T ss_dssp CCBCCSSCTTCCCTTCCEE
T ss_pred CCCCCHHHHHhhhCcCCEE
Confidence 777777666544 344433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=264.79 Aligned_cols=276 Identities=18% Similarity=0.187 Sum_probs=185.6
Q ss_pred cEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCC
Q 002189 58 GIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 137 (955)
Q Consensus 58 gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 137 (955)
+..|.....+.++.++++++. +|..+ .++|++|+|++|+ +.+..+..|.++++|++|+|++|.+++..|..|..++
T Consensus 5 ~C~C~~~~~~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~-i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 80 (285)
T 1ozn_A 5 ACVCYNEPKVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (285)
T ss_dssp TCEEECSSSCEEECCSSCCSS-CCTTC--CTTCSEEECTTSC-CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CceECCCCCeEEEcCcCCccc-CCcCC--CCCceEEEeeCCc-CCccCHHHcccCCCCCEEECCCCccceeCHhhcCCcc
Confidence 445765555678888888884 45433 4689999999996 7877777888888888888888888877788888888
Q ss_pred CCcEEEccCCC-CcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCcc
Q 002189 138 ELVLLSLNSNG-FSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDM 216 (955)
Q Consensus 138 ~L~~L~Ls~N~-l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~ 216 (955)
+|++|+|++|. ++...|..|..+++|++|+|++|++++..
T Consensus 81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------------------------- 121 (285)
T 1ozn_A 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG--------------------------------------- 121 (285)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCC---------------------------------------
T ss_pred CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEEC---------------------------------------
Confidence 88888888887 77666778888888888888888776322
Q ss_pred ceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCC-CCCCCCCCEEECc
Q 002189 217 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMS 295 (955)
Q Consensus 217 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls 295 (955)
|..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++.++. +..+++|++|+|+
T Consensus 122 ----------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 185 (285)
T 1ozn_A 122 ----------------PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185 (285)
T ss_dssp ----------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ----------------HhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC
Confidence 22334445555555555555544444455566666666666666655553 5556666666666
Q ss_pred CCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCcccccc
Q 002189 296 NNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYT 375 (955)
Q Consensus 296 ~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~ 375 (955)
+|.+++ ..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.+..+.......+..+..+.|.+.+..
T Consensus 186 ~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~ 264 (285)
T 1ozn_A 186 QNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (285)
T ss_dssp SSCCCE-ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred CCcccc-cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCC
Confidence 666654 3456666667777777777777655555567777777777777777766555444445666777777777666
Q ss_pred CCCCCC--CcceeEecCcch
Q 002189 376 ERGGAP--AVNLTLIDNPIC 393 (955)
Q Consensus 376 ~~~~~~--~~~L~~l~n~~c 393 (955)
|..+.+ +..++..+..+|
T Consensus 265 p~~l~g~~l~~l~~~~l~~C 284 (285)
T 1ozn_A 265 PQRLAGRDLKRLAANDLQGC 284 (285)
T ss_dssp SGGGTTCBGGGSCGGGSCCC
T ss_pred chHhCCcChhhcCHHHhccC
Confidence 654433 344444444444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=283.63 Aligned_cols=274 Identities=20% Similarity=0.243 Sum_probs=140.7
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccc-----------------------------
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKK----------------------------- 114 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~----------------------------- 114 (955)
.++++|++++|++ |.+|..+++|++|++|+|++|+ +.|.+|..++++++
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~-~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSE-WERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHH-HHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCc-ccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence 3455555555555 4555555555555555555554 55555555555444
Q ss_pred ----cccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 115 ----LSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 115 ----L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
|++|+|++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|+|++|++++ +| + +..+
T Consensus 89 ~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~------~~~l 152 (454)
T 1jl5_A 89 LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-E------LQNS 152 (454)
T ss_dssp CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-C------CTTC
T ss_pred CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-c------cCCC
Confidence 4444444444443 3322 1344444444444442 2211 1467777777777763 55 2 3445
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
++|++|++++|+++ .+|... .+|++|++++|++++ +| .++.+++|+.|++++|.+++ +|... ++|+.|+
T Consensus 153 ~~L~~L~l~~N~l~-~lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~ 221 (454)
T 1jl5_A 153 SFLKIIDVDNNSLK-KLPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIV 221 (454)
T ss_dssp TTCCEEECCSSCCS-CCCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEE
T ss_pred CCCCEEECCCCcCc-ccCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEE
Confidence 66677778888777 466533 367777777777775 45 57777777777777777774 44322 4666777
Q ss_pred ccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCccee
Q 002189 271 LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 271 Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
+++|.++.++ .+..+++|++|++++|++++ +|.. +++|+.|++++|++++ +|.. +++|+.|+|++|++++
T Consensus 222 l~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~--l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 222 AGNNILEELP-ELQNLPFLTTIYADNNLLKT--LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CCSSCCSSCC-CCTTCTTCCEEECCSSCCSS--CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE
T ss_pred CcCCcCCccc-ccCCCCCCCEEECCCCcCCc--cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc
Confidence 7777666433 46666667777777766654 3322 3555666666665553 3332 2445555555555544
Q ss_pred ee--CCCc--------------ch-hhhhhhcccCCccccccC
Q 002189 351 TL--DLGT--------------SY-SENLLVNLQNNRISAYTE 376 (955)
Q Consensus 351 ~~--~~~~--------------~~-~~l~~L~L~~N~l~~~~~ 376 (955)
.. |... .+ ..++.|++++|++++++.
T Consensus 292 l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~lp~ 334 (454)
T 1jl5_A 292 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA 334 (454)
T ss_dssp ESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCC
T ss_pred ccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCccccccc
Confidence 21 1000 11 356677777777777544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=275.91 Aligned_cols=248 Identities=21% Similarity=0.220 Sum_probs=191.2
Q ss_pred EEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCC
Q 002189 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSN 147 (955)
Q Consensus 68 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 147 (955)
.++..+.+++ .+|..+. ++++.|+|++|+ +.+..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~-i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQ-IQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSCC-CCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEEccCCc-CCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 4455556666 5565554 689999999997 88888899999999999999999999777788999999999999999
Q ss_pred CCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCC
Q 002189 148 GFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNN 227 (955)
Q Consensus 148 ~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~ 227 (955)
+|+...+..|.++++|++|+|++|+|++..+ ..|..+++|+.|+|++|+
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-------------------------------~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPS-------------------------------YAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECT-------------------------------TTTTTCTTCCEEECCCCT
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCH-------------------------------HHhhhCcccCEeCCCCCC
Confidence 9997667789999999999999999883322 223333344444554422
Q ss_pred -ccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCC
Q 002189 228 -LTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVP 305 (955)
Q Consensus 228 -l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p 305 (955)
+....+..|..+++|++|+|++|.|+ .+| .+..+++|+.|+|++|+|++..+ .|.++++|+.|+|++|+|++ ..+
T Consensus 172 ~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~ 248 (440)
T 3zyj_A 172 RLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IER 248 (440)
T ss_dssp TCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE-ECT
T ss_pred CcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE-ECh
Confidence 22223345677777777777777777 445 37777888888888888888766 57778888888888888875 567
Q ss_pred hhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeC
Q 002189 306 SWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLD 353 (955)
Q Consensus 306 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 353 (955)
..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred hhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 778888889999999998887777778889999999999999987654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=276.91 Aligned_cols=249 Identities=21% Similarity=0.219 Sum_probs=180.7
Q ss_pred EEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCC
Q 002189 69 ITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG 148 (955)
Q Consensus 69 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 148 (955)
++.++.+++ .+|..+. ++|++|+|++|+ +.+..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 59 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~-i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 59 VVCTRRGLS-EVPQGIP--SNTRYLNLMENN-IQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSC-CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcC-ccCCCCC--CCccEEECcCCc-CceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 344445555 4554443 689999999997 888889999999999999999999998888889999999999999999
Q ss_pred CcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCc
Q 002189 149 FSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNL 228 (955)
Q Consensus 149 l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l 228 (955)
|++..+..|.++++|++|+|++|+|++..+..+ ..+++|+.|++++|+..+.++.
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~l~~~~~l~~i~~------------------- 189 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAF------NRVPSLMRLDLGELKKLEYISE------------------- 189 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTT------TTCTTCCEEECCCCTTCCEECT-------------------
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHH------hcCCcccEEeCCCCCCccccCh-------------------
Confidence 997777779999999999999999883322222 2233444445544322223333
Q ss_pred cccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChh
Q 002189 229 TGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSW 307 (955)
Q Consensus 229 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~ 307 (955)
..|..+++|++|+|++|++++ +| .+..+++|+.|+|++|.|++.++ .+.++++|+.|+|++|++++ ..+..
T Consensus 190 -----~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~ 261 (452)
T 3zyi_A 190 -----GAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNA 261 (452)
T ss_dssp -----TTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE-ECTTT
T ss_pred -----hhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce-ECHHH
Confidence 345666666666666666663 33 36666777777777777776655 46667777777777777765 45667
Q ss_pred hcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCC
Q 002189 308 FSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL 354 (955)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 354 (955)
|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+....
T Consensus 262 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred hcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 77788888888888888877777788889999999999998876543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-29 Score=276.77 Aligned_cols=248 Identities=20% Similarity=0.204 Sum_probs=162.7
Q ss_pred cCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccC-CCCCCccc-------cCCCCcEEEccCCCCcCcCCC
Q 002189 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFS-GPIPDSIG-------SLQELVLLSLNSNGFSGRVPP 155 (955)
Q Consensus 84 l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~ 155 (955)
+..+++|+.|++++|. + .+|..+... |+.|+|++|.++ +.+|..+. ++++|++|+|++|+|++.+|.
T Consensus 39 ~~~~~~L~~l~l~~n~-l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDT-E--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCT-T--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeecccc-c--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 4556778888888886 5 667766654 888888888884 45666555 688888888888888888888
Q ss_pred CC--CCCCCcCeeecCCceeeeccCCCCCCCCchhhh-----hccccccccCCcccccCCccccCCccceeeeeccCCCc
Q 002189 156 SI--GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML-----VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNL 228 (955)
Q Consensus 156 ~~--~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L-----~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l 228 (955)
.+ ..+++|++|+|++|++++. |.. +..+ ++|++|+|++|+++ .++...+..+++|++|+|++|++
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~------~~~l~~~~~~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l 185 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAW------LAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPE 185 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSH------HHHHHTTCCTTCCEEEEESCSCC-CCCTTTCCCCSSCCEEECCSCTT
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHH------HHHHHHhhcCCCcEEEeeCCCCc-cchHHHhccCCCCCEEECCCCCc
Confidence 76 7888888888888888854 532 3334 56666666666666 44444455556666666666666
Q ss_pred ccc--CCccc--CCCCCCcEEEcccCCCCC--Ccc-ccccCCCCCCEEEccCCcCcccCC--CCCCCCCCCEEECcCCCC
Q 002189 229 TGE--LPATL--GLVKSLEVVRFDRNSLSG--PVP-SNLNNLTSVNDLYLSNNKLTGAMP--NLTGLSVLSYLDMSNNSF 299 (955)
Q Consensus 229 ~~~--~p~~l--~~l~~L~~L~Ls~N~l~~--~~p-~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l 299 (955)
.+. ++..+ ..+++|++|+|++|+|++ .++ ..+.++++|+.|+|++|+|++.++ .+..+++|++|+|++|+|
T Consensus 186 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l 265 (312)
T 1wwl_A 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265 (312)
T ss_dssp CHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCC
T ss_pred CcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCcc
Confidence 554 23333 666677777777776662 112 333456667777777777666553 345566666666666666
Q ss_pred CCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCccee
Q 002189 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 300 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
+ .+|..+. ++|+.|+|++|+|++. |. +..+++|++|+|++|+|++
T Consensus 266 ~--~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 266 K--QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp S--SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred C--hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5 3455444 5666666666666644 44 6666666666666666653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=289.24 Aligned_cols=284 Identities=26% Similarity=0.333 Sum_probs=233.7
Q ss_pred CCCCCCCCCCCCccE--------EeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccc
Q 002189 45 NWKNNDPCGDNWEGI--------GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLS 116 (955)
Q Consensus 45 ~w~~~~~C~~~w~gv--------~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~ 116 (955)
.|....+|+ .|.|. .|....++.|++++|+|+ .+|..+. ++|++|+|++|+ ++ .+|. .+++|+
T Consensus 14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~-l~-~lp~---~l~~L~ 84 (622)
T 3g06_A 14 AWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNN-LT-SLPA---LPPELR 84 (622)
T ss_dssp HHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCC-CS-CCCC---CCTTCC
T ss_pred HHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCC-CC-CCCC---cCCCCC
Confidence 465555553 57653 344567999999999999 7777665 899999999997 66 4565 578999
Q ss_pred cccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccc
Q 002189 117 NLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 196 (955)
Q Consensus 117 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L 196 (955)
+|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|.. +++|++|
T Consensus 85 ~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~---------l~~L~~L 146 (622)
T 3g06_A 85 TLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL---------PPGLQEL 146 (622)
T ss_dssp EEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC---------CTTCCEE
T ss_pred EEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC---------CCCCCEE
Confidence 9999999999 5776 77999999999999995 555 6789999999999998 46643 3678999
Q ss_pred cccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcC
Q 002189 197 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKL 276 (955)
Q Consensus 197 ~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 276 (955)
+|++|+++ .+|. ...+|+.|++++|+|++ +| ..+++|+.|+|++|.|++ +|.. +++|+.|++++|.|
T Consensus 147 ~Ls~N~l~-~l~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l 213 (622)
T 3g06_A 147 SVSDNQLA-SLPA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRL 213 (622)
T ss_dssp ECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred ECcCCcCC-CcCC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcc
Confidence 99999999 6665 34679999999999996 55 567899999999999994 5543 48999999999999
Q ss_pred cccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc
Q 002189 277 TGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT 356 (955)
Q Consensus 277 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 356 (955)
+.++.. +++|++|+|++|.|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+..++.+.
T Consensus 214 ~~l~~~---~~~L~~L~Ls~N~L~~--lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~ 281 (622)
T 3g06_A 214 TSLPAL---PSGLKELIVSGNRLTS--LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLI 281 (622)
T ss_dssp SSCCCC---CTTCCEEECCSSCCSC--CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGG
T ss_pred cccCCC---CCCCCEEEccCCccCc--CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHh
Confidence 977653 4889999999999976 55 56789999999999999 5666 67899999999999996655556
Q ss_pred chhhhhhhcccCCccccccCCCCC
Q 002189 357 SYSENLLVNLQNNRISAYTERGGA 380 (955)
Q Consensus 357 ~~~~l~~L~L~~N~l~~~~~~~~~ 380 (955)
.+.+|..|+|++|+|++..+..+.
T Consensus 282 ~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 282 HLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp GSCTTCEEECCSCCCCHHHHHHHH
T ss_pred hccccCEEEecCCCCCCcCHHHHH
Confidence 688889999999999987776443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=266.25 Aligned_cols=239 Identities=18% Similarity=0.269 Sum_probs=206.6
Q ss_pred CCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCe
Q 002189 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYW 165 (955)
Q Consensus 86 ~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~ 165 (955)
..+.++.|+|++|+ +. .+|..+.++++|++|+|++|.++ .+|..++.+++|++|+|++|+|+ .+|..+.++++|++
T Consensus 79 ~~~~l~~L~L~~n~-l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~ 154 (328)
T 4fcg_A 79 TQPGRVALELRSVP-LP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154 (328)
T ss_dssp TSTTCCEEEEESSC-CS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCE
T ss_pred cccceeEEEccCCC-ch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCE
Confidence 35789999999997 55 77888999999999999999999 88999999999999999999999 78888999999999
Q ss_pred eecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEE
Q 002189 166 LDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVV 245 (955)
Q Consensus 166 L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 245 (955)
|+|++|++.+.+|..++. ..++..|..+++|++|
T Consensus 155 L~L~~n~~~~~~p~~~~~----------------------------------------------~~~~~~~~~l~~L~~L 188 (328)
T 4fcg_A 155 LSIRACPELTELPEPLAS----------------------------------------------TDASGEHQGLVNLQSL 188 (328)
T ss_dssp EEEEEETTCCCCCSCSEE----------------------------------------------EC-CCCEEESTTCCEE
T ss_pred EECCCCCCccccChhHhh----------------------------------------------ccchhhhccCCCCCEE
Confidence 999988877666644321 0223457889999999
Q ss_pred EcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcce
Q 002189 246 RFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 246 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
+|++|.|+ .+|..+.++++|+.|+|++|.++++++.+..+++|++|+|++|++.+ .+|..+.++++|+.|+|++|++.
T Consensus 189 ~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~-~~p~~~~~l~~L~~L~L~~n~~~ 266 (328)
T 4fcg_A 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILKDCSNL 266 (328)
T ss_dssp EEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCC-BCCCCTTCCCCCCEEECTTCTTC
T ss_pred ECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchh-hhHHHhcCCCCCCEEECCCCCch
Confidence 99999999 88999999999999999999999988889999999999999999987 68889999999999999999999
Q ss_pred ecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCccccccC
Q 002189 326 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNRISAYTE 376 (955)
Q Consensus 326 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~l~~~~~ 376 (955)
+.+|..+..+++|+.|+|++|++.+.+|..+. +.++..+++..|.+..+..
T Consensus 267 ~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l~~ 318 (328)
T 4fcg_A 267 LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318 (328)
T ss_dssp CBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC---
T ss_pred hhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHHhh
Confidence 99999999999999999999999998887654 6677788888777665443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-27 Score=271.01 Aligned_cols=246 Identities=21% Similarity=0.205 Sum_probs=203.9
Q ss_pred cEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCC
Q 002189 91 HTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 170 (955)
Q Consensus 91 ~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~ 170 (955)
..++.+++. ++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 57 ~~v~c~~~~-l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 57 SKVVCTRRG-LS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp CEEECCSSC-CS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred cEEEECCCC-cC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456777765 43 5666554 5788888888888877788888888888888888888877778888888888888888
Q ss_pred ceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEccc-
Q 002189 171 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR- 249 (955)
Q Consensus 171 N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~- 249 (955)
|+|+ .+|...|..+++|++|+|++|++.+..+..|..+++|+.|+|++
T Consensus 133 n~l~-------------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~ 181 (452)
T 3zyi_A 133 NWLT-------------------------------VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL 181 (452)
T ss_dssp SCCS-------------------------------BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC
T ss_pred CcCC-------------------------------ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC
Confidence 8887 34444455556677777777777766667888999999999998
Q ss_pred CCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCC
Q 002189 250 NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP 329 (955)
Q Consensus 250 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 329 (955)
|.+....+..|.++++|+.|+|++|+|++. +.+..+++|++|+|++|.|++ ..|..|.++++|+.|+|++|++++..+
T Consensus 182 ~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~ 259 (452)
T 3zyi_A 182 KKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPE-IRPGSFHGLSSLKKLWVMNSQVSLIER 259 (452)
T ss_dssp TTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSE-ECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred CCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcc-cCcccccCccCCCEEEeCCCcCceECH
Confidence 455534445799999999999999999976 578899999999999999986 678899999999999999999999999
Q ss_pred cCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCcccc
Q 002189 330 ADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNRISA 373 (955)
Q Consensus 330 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~l~~ 373 (955)
..|..+++|+.|+|++|+|++.++..+. +.+|+.|+|++|++.+
T Consensus 260 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred HHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 9999999999999999999988877654 7778899999998875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-28 Score=269.77 Aligned_cols=267 Identities=19% Similarity=0.194 Sum_probs=201.2
Q ss_pred ccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecC
Q 002189 90 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT 169 (955)
Q Consensus 90 L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~ 169 (955)
++.++++.+. +...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ +..+++|++|+|+
T Consensus 12 l~i~~ls~~~-l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 12 YKIEKVTDSS-LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEESCCTTT-HHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred eeEeeccccc-hhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 4445555554 444444444556667777777777776555667777777777777777765444 6777777777777
Q ss_pred CceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEccc
Q 002189 170 DNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 249 (955)
Q Consensus 170 ~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 249 (955)
+|++++.. ..++|++|++++|++++ ++... ..+|+.|++++|++++..+..+..+++|++|+|++
T Consensus 89 ~n~l~~l~-----------~~~~L~~L~l~~n~l~~-~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 153 (317)
T 3o53_A 89 NNYVQELL-----------VGPSIETLHAANNNISR-VSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153 (317)
T ss_dssp SSEEEEEE-----------ECTTCCEEECCSSCCSE-EEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTT
T ss_pred CCcccccc-----------CCCCcCEEECCCCccCC-cCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCC
Confidence 77776322 12566777777777773 33332 35688999999999988888899999999999999
Q ss_pred CCCCCCccccc-cCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecC
Q 002189 250 NSLSGPVPSNL-NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI 328 (955)
Q Consensus 250 N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 328 (955)
|.+++..+..+ ..+++|+.|+|++|.|++.+. ...+++|++|+|++|++++ +|..+..+++|+.|+|++|+|+ .+
T Consensus 154 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~--l~~~~~~l~~L~~L~L~~N~l~-~l 229 (317)
T 3o53_A 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAF--MGPEFQSAAGVTWISLRNNKLV-LI 229 (317)
T ss_dssp SCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSSCCCE--ECGGGGGGTTCSEEECTTSCCC-EE
T ss_pred CCCCcccHHHHhhccCcCCEEECCCCcCccccc-ccccccCCEEECCCCcCCc--chhhhcccCcccEEECcCCccc-ch
Confidence 99997777776 478999999999999998854 3458999999999999975 5666999999999999999999 57
Q ss_pred CcCCCCCCCCcEEEeecCcce-eeeCCC-cchhhhhhhccc-CCccccccCCC
Q 002189 329 PADLFSIPHLQTVVMKTNELN-GTLDLG-TSYSENLLVNLQ-NNRISAYTERG 378 (955)
Q Consensus 329 p~~~~~l~~L~~L~Ls~N~l~-~~~~~~-~~~~~l~~L~L~-~N~l~~~~~~~ 378 (955)
|..+..+++|+.|+|++|+++ +.++.+ ..+..++.|+++ .+.+++..+..
T Consensus 230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 888999999999999999999 455544 447788899999 44566655543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-29 Score=275.56 Aligned_cols=266 Identities=17% Similarity=0.176 Sum_probs=221.2
Q ss_pred CCCCCCCCCCCCCCcc--EEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCC-ccCCCCCcc-------cc
Q 002189 43 PPNWKNNDPCGDNWEG--IGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDL-RGPLPTTIG-------NL 112 (955)
Q Consensus 43 ~~~w~~~~~C~~~w~g--v~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l-~~~~p~~~~-------~l 112 (955)
...|.....|.+ +.. +.|...+++.|++++|.+ .+|..+... |+.|+|++|+ + ...+|..+. ++
T Consensus 21 ~~~~~~~~~c~~-~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~-l~~~~~~~~~~~~~~~~~~l 94 (312)
T 1wwl_A 21 KPDWSSAFNCLG-AADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLT-VRAARIPSRILFGALRVLGI 94 (312)
T ss_dssp SCCGGGGGGSSS-CSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEE-EEEEECBHHHHHHHHHHHTT
T ss_pred ccchHHHhhhhc-cccEEEEccCCCceeEeeccccc--ccHHHHHHH--Hhhccccccc-ccCCCcCHHHHHHHHHhcCc
Confidence 356765555542 444 567777899999999999 677766554 9999999997 6 556777666 79
Q ss_pred cccccccccccccCCCCCCcc--ccCCCCcEEEccCCCCcCcCCCCCCCC-----CCcCeeecCCceeeeccCCCCCCCC
Q 002189 113 KKLSNLMLVGCSFSGPIPDSI--GSLQELVLLSLNSNGFSGRVPPSIGNL-----SNLYWLDLTDNKLEGEIPVSDGNSP 185 (955)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~L-----~~L~~L~L~~N~l~g~ip~~~~~~~ 185 (955)
++|++|+|++|++++.+|..+ ..+++|++|+|++|+|++. |..+..+ ++|++|+|++|++++..|..++.
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~-- 171 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV-- 171 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC--
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc--
Confidence 999999999999999999886 8999999999999999976 8888887 99999999999999766666554
Q ss_pred chhhhhccccccccCCcccccC--Ccc-ccCCccceeeeeccCCCccc--cCC-cccCCCCCCcEEEcccCCCCCCcc-c
Q 002189 186 GLDMLVRAKHFHFGKNQLSGSI--PEK-LFRPDMVLIHVLFDSNNLTG--ELP-ATLGLVKSLEVVRFDRNSLSGPVP-S 258 (955)
Q Consensus 186 ~l~~L~~L~~L~L~~N~l~g~i--p~~-~~~~~~~L~~L~L~~N~l~~--~~p-~~l~~l~~L~~L~Ls~N~l~~~~p-~ 258 (955)
+++|++|+|++|++.|.+ |.. .+..+++|++|+|++|++++ .++ ..+..+++|++|+|++|+|++..| .
T Consensus 172 ----l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 247 (312)
T 1wwl_A 172 ----FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247 (312)
T ss_dssp ----CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCS
T ss_pred ----CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchh
Confidence 567789999999988663 333 34778899999999999993 223 455788999999999999998775 5
Q ss_pred cccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCccee
Q 002189 259 NLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 326 (955)
Q Consensus 259 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 326 (955)
.+..+++|+.|+|++|.|+.++..+. ++|++|+|++|+|++ .|. +..+++|+.|+|++|++++
T Consensus 248 ~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~--~p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 248 SCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDR--NPS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCCS--CCC-TTTSCEEEEEECTTCTTTC
T ss_pred hhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCCC--Chh-HhhCCCCCEEeccCCCCCC
Confidence 67778999999999999997766666 899999999999987 366 8999999999999999985
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=268.18 Aligned_cols=247 Identities=21% Similarity=0.204 Sum_probs=208.0
Q ss_pred ccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecC
Q 002189 90 LHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT 169 (955)
Q Consensus 90 L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~ 169 (955)
...++.++++ + ..+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~-l-~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKN-L-REVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCC-C-SSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCC-c-CcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3467777776 4 46676665 588889999999987777889999999999999999987777888888889988888
Q ss_pred CceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEccc
Q 002189 170 DNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR 249 (955)
Q Consensus 170 ~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 249 (955)
+|+|+ .+|...|..+.+|++|+|++|++.+..+..|..+++|+.|+|++
T Consensus 121 ~n~l~-------------------------------~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~ 169 (440)
T 3zyj_A 121 DNRLT-------------------------------TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE 169 (440)
T ss_dssp SSCCS-------------------------------SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCC
T ss_pred CCcCC-------------------------------eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCC
Confidence 88887 44445555566788888888888877788999999999999999
Q ss_pred C-CCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecC
Q 002189 250 N-SLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI 328 (955)
Q Consensus 250 N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 328 (955)
| .+....+..|.++++|+.|+|++|.|+.+ +.+..+++|++|+|++|+|++ ..|..|.++++|+.|+|++|+|++..
T Consensus 170 ~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~ 247 (440)
T 3zyj_A 170 LKRLSYISEGAFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIE 247 (440)
T ss_dssp CTTCCEECTTTTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred CCCcceeCcchhhcccccCeecCCCCcCccc-cccCCCcccCEEECCCCccCc-cChhhhccCccCCEEECCCCceeEEC
Confidence 5 55544455799999999999999999966 468889999999999999986 66889999999999999999999999
Q ss_pred CcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCcccc
Q 002189 329 PADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNRISA 373 (955)
Q Consensus 329 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~l~~ 373 (955)
+..|..+++|+.|+|++|+|++.++..+. +.+|+.|+|++|++.+
T Consensus 248 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp TTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred hhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 99999999999999999999988877654 7788899999998874
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=270.19 Aligned_cols=269 Identities=23% Similarity=0.271 Sum_probs=193.1
Q ss_pred CcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCC-------------cEEEccCCCC
Q 002189 83 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQEL-------------VLLSLNSNGF 149 (955)
Q Consensus 83 ~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l 149 (955)
.-...++|++|++++|+ + +.+|.+|+++++|++|++++|.++|.+|..++++.+| ++|++++|.+
T Consensus 6 ~~~~~~~L~~L~l~~n~-l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l 83 (454)
T 1jl5_A 6 RNVSNTFLQEPLRHSSN-L-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83 (454)
T ss_dssp ------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCC
T ss_pred cccccccchhhhcccCc-h-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcc
Confidence 33356899999999997 6 8999999999999999999999999999999999875 9999999999
Q ss_pred cCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCcc
Q 002189 150 SGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT 229 (955)
Q Consensus 150 ~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~ 229 (955)
++ +|.. .++|++|+|++|++++ +|.. +.+|++|++++|+++ .+|.. ..+|++|++++|+++
T Consensus 84 ~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---------~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 84 SS-LPEL---PPHLESLVASCNSLTE-LPEL---------PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLE 144 (454)
T ss_dssp SC-CCSC---CTTCSEEECCSSCCSS-CCCC---------CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCS
T ss_pred cc-CCCC---cCCCCEEEccCCcCCc-cccc---------cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCC
Confidence 95 5542 3799999999999996 7743 256788899999998 45542 267999999999999
Q ss_pred ccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhc
Q 002189 230 GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 309 (955)
Q Consensus 230 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 309 (955)
+ +| .|+.+++|++|++++|++++ +|..+ .+|++|++++|++++.+ .+.++++|++|++++|.+++ +|..
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~--l~~~-- 213 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK--LPDL-- 213 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS--CCCC--
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCc--CCCC--
Confidence 6 67 59999999999999999984 66543 58999999999999854 78889999999999999875 4443
Q ss_pred CCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEec
Q 002189 310 SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLID 389 (955)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~ 389 (955)
.++|+.|++++|.++ .+| .+..+++|++|+|++|++++.++ . ..+++.|++++|++++++.. ...+..|.+.+
T Consensus 214 -~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~-~--~~~L~~L~l~~N~l~~l~~~-~~~L~~L~ls~ 286 (454)
T 1jl5_A 214 -PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPD-L--PPSLEALNVRDNYLTDLPEL-PQSLTFLDVSE 286 (454)
T ss_dssp -CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCS-C--CTTCCEEECCSSCCSCCCCC-CTTCCEEECCS
T ss_pred -cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcccc-c--ccccCEEECCCCcccccCcc-cCcCCEEECcC
Confidence 258999999999998 677 48889999999999999987443 2 36778899999999886643 23334444333
Q ss_pred C
Q 002189 390 N 390 (955)
Q Consensus 390 n 390 (955)
|
T Consensus 287 N 287 (454)
T 1jl5_A 287 N 287 (454)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-28 Score=273.17 Aligned_cols=272 Identities=18% Similarity=0.154 Sum_probs=232.9
Q ss_pred CCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcE
Q 002189 62 TNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVL 141 (955)
Q Consensus 62 ~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 141 (955)
+..++..++++.+.+...+...+..+++|++|+|++|+ +.+..|..|.++++|++|+|++|++++..+ |..+++|++
T Consensus 8 ~g~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~ 84 (317)
T 3o53_A 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP-LSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRT 84 (317)
T ss_dssp ETTEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSC-CCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCE
T ss_pred CcCceeEeeccccchhhhHHHHhccCCCCCEEECcCCc-cCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCE
Confidence 34566777888888877666777888999999999997 888888899999999999999999986555 999999999
Q ss_pred EEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeee
Q 002189 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHV 221 (955)
Q Consensus 142 L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L 221 (955)
|+|++|+|++.. ..++|++|++++|++++..+.. +.+|+.|++++|+++ .++...+..+++|+.|
T Consensus 85 L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---------~~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L 149 (317)
T 3o53_A 85 LDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---------GQGKKNIYLANNKIT-MLRDLDEGCRSRVQYL 149 (317)
T ss_dssp EECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---------CSSCEEEECCSSCCC-SGGGBCTGGGSSEEEE
T ss_pred EECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---------cCCCCEEECCCCCCC-CccchhhhccCCCCEE
Confidence 999999999533 3489999999999999665433 456899999999999 6766677778899999
Q ss_pred eccCCCccccCCccc-CCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCC
Q 002189 222 LFDSNNLTGELPATL-GLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 222 ~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 300 (955)
+|++|++++..+..+ ..+++|++|+|++|.|++. +. ...+++|+.|+|++|+|++.++.+..+++|++|+|++|+|+
T Consensus 150 ~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred ECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc
Confidence 999999999888877 4799999999999999954 43 33599999999999999999888999999999999999997
Q ss_pred CCCCChhhcCCCCCCEEECcCCcce-ecCCcCCCCCCCCcEEEee-cCcceeeeCCC
Q 002189 301 ASEVPSWFSSMQSLTTLMMENTNLK-GQIPADLFSIPHLQTVVMK-TNELNGTLDLG 355 (955)
Q Consensus 301 ~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~ 355 (955)
. +|..+..+++|+.|+|++|++. +.++..+..+++|+.|+++ .+.+++..+..
T Consensus 228 ~--l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 228 L--IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp E--ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred c--hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 4 7888999999999999999999 8888899999999999999 55566655443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-28 Score=292.70 Aligned_cols=185 Identities=18% Similarity=0.139 Sum_probs=131.0
Q ss_pred eeeccCceEEEEEE-eCCCcEEEEEEcccCCc----------chhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEE
Q 002189 635 DVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM----------QGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 635 ~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 702 (955)
..+.|++|.+..++ +--|+.+|||++..... ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777777664 34689999999865321 1235699999999999 699999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||++|++|.++|...+ +++.. +|+.||+.||+|+|+.| ||||||||+|||+++++.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999998654 55654 48899999999999999 999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P 830 (955)
.. .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22 2334679999999999875 567789999999998887665444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=257.04 Aligned_cols=110 Identities=24% Similarity=0.242 Sum_probs=103.2
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccc-cCCCCCCccccCCCCcEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCS-FSGPIPDSIGSLQELVLL 142 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L 142 (955)
.+++.|+|++|.+++..+..|..+++|++|+|++|+ +.+..|..|.++++|++|+|++|. ++...|..|..+++|++|
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSC-CCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCc-cceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 478999999999998888899999999999999997 888889999999999999999997 886668899999999999
Q ss_pred EccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
+|++|++++..|..|.++++|++|+|++|+++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 142 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCccc
Confidence 99999999888889999999999999999987
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=265.97 Aligned_cols=275 Identities=18% Similarity=0.163 Sum_probs=229.3
Q ss_pred cccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeec
Q 002189 89 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 168 (955)
Q Consensus 89 ~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 168 (955)
.....++++|+ ++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 32 ~~~~c~~~~~~-l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 32 RNGICKGSSGS-LN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp TTSEEECCSTT-CS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCeEeeCCCCC-cc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 33457888886 44 5677665 48999999999999776778999999999999999999888889999999999999
Q ss_pred CCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCc-cccCCccceeeeeccCC-CccccCCcccCCCCCCcEEE
Q 002189 169 TDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE-KLFRPDMVLIHVLFDSN-NLTGELPATLGLVKSLEVVR 246 (955)
Q Consensus 169 ~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~-~~~~~~~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~ 246 (955)
++|++++ +|.. .+..+++|++|++++|+++ .+|. ..+..+++|++|++++| .+.+..+..|..+++|++|+
T Consensus 108 s~n~l~~-~~~~-----~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 180 (353)
T 2z80_A 108 SYNYLSN-LSSS-----WFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180 (353)
T ss_dssp CSSCCSS-CCHH-----HHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CCCcCCc-CCHh-----HhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence 9999983 3321 2556778899999999999 7887 78888999999999999 47777788999999999999
Q ss_pred cccCCCCCCccccccCCCCCCEEEccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhh---cCCCCCCEEECcCC
Q 002189 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWF---SSMQSLTTLMMENT 322 (955)
Q Consensus 247 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~---~~l~~L~~L~Ls~N 322 (955)
+++|.+++..|..+..+++|++|+|++|.++..+.. +..+++|++|+|++|.+++. .+..+ .....++.++|++|
T Consensus 181 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~l~~~~~~~~l~~l~L~~~ 259 (353)
T 2z80_A 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF-HFSELSTGETNSLIKKFTFRNV 259 (353)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTC-CCC------CCCCCCEEEEESC
T ss_pred CCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccc-cccccccccccchhhccccccc
Confidence 999999988899999999999999999999876664 34589999999999999863 22222 34677889999999
Q ss_pred ccee----cCCcCCCCCCCCcEEEeecCcceeeeCCC-cchhhhhhhcccCCcccccc
Q 002189 323 NLKG----QIPADLFSIPHLQTVVMKTNELNGTLDLG-TSYSENLLVNLQNNRISAYT 375 (955)
Q Consensus 323 ~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~l~~L~L~~N~l~~~~ 375 (955)
.+++ .+|..+..+++|+.|+|++|+|+..++.. ..+.+|+.|+|++|++.+..
T Consensus 260 ~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 260 KITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp BCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 9886 47778889999999999999999766665 35788889999999988644
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=253.61 Aligned_cols=247 Identities=22% Similarity=0.241 Sum_probs=190.2
Q ss_pred cEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCc--CCCCCCCCCCcCeeec
Q 002189 91 HTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGR--VPPSIGNLSNLYWLDL 168 (955)
Q Consensus 91 ~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~L~~L~~L~L 168 (955)
+.++.+++. + ..+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+|+.. .+..+..+++|++|+|
T Consensus 10 ~~l~c~~~~-l-~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKG-L-TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSC-C-SSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCC-c-ccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 356666664 3 34454443 4677777777777744344467777777777777777632 2455556677777777
Q ss_pred CCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCC-cccCCCCCCcEEEc
Q 002189 169 TDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP-ATLGLVKSLEVVRF 247 (955)
Q Consensus 169 ~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L 247 (955)
++|.++ .+|.. +..+.+|++|++++|++++..+ ..+..+++|++|++
T Consensus 86 s~n~i~-------------------------------~l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 133 (306)
T 2z66_A 86 SFNGVI-------------------------------TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 133 (306)
T ss_dssp CSCSEE-------------------------------EEEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEEC
T ss_pred CCCccc-------------------------------cChhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEEC
Confidence 777666 23332 2234556677777777765554 67999999999999
Q ss_pred ccCCCCCCccccccCCCCCCEEEccCCcCcc--cCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcce
Q 002189 248 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG--AMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 248 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
++|.+++..+..+..+++|+.|+|++|.+++ .+..+..+++|++|+|++|.+++ ..|..|..+++|+.|+|++|+++
T Consensus 134 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~ 212 (306)
T 2z66_A 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFF 212 (306)
T ss_dssp TTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCC-cCHHHhcCCCCCCEEECCCCccC
Confidence 9999998889999999999999999999987 45578999999999999999976 56888999999999999999999
Q ss_pred ecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-h-hhhhhhcccCCccccc
Q 002189 326 GQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-Y-SENLLVNLQNNRISAY 374 (955)
Q Consensus 326 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~-~~l~~L~L~~N~l~~~ 374 (955)
+..+..+..+++|+.|+|++|++++..+..+. + .+++.|+|++|++++.
T Consensus 213 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp BCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred ccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 87777899999999999999999998877654 4 3788999999999864
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=272.47 Aligned_cols=236 Identities=20% Similarity=0.179 Sum_probs=189.1
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
.+++|++|+|++|.+++..|..|..+++|++|+|++|.|++..| |..+++|++|+|++|.|++..+ .
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----------~ 98 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----------G 98 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----------C
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----------C
Confidence 44477777777777776666777777777777777777776555 7777778888888877774322 2
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCcccccc-CCCCCCEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN-NLTSVNDL 269 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L 269 (955)
++|+.|++++|+|++. +.. .+++|+.|+|++|++++..|..++.+++|+.|+|++|.|++..|..+. .+++|+.|
T Consensus 99 ~~L~~L~L~~N~l~~~-~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L 174 (487)
T 3oja_A 99 PSIETLHAANNNISRV-SCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (487)
T ss_dssp TTCCEEECCSSCCCCE-EEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECcCCcCCCC-Ccc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence 5667778888887743 332 236799999999999999899999999999999999999988888886 79999999
Q ss_pred EccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcce
Q 002189 270 YLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349 (955)
Q Consensus 270 ~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 349 (955)
+|++|.|++.++ +..+++|++|+|++|.|++ +|..+..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|++.
T Consensus 175 ~Ls~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~--~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 175 NLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAF--MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp ECTTSCCCEEEC-CCCCTTCCEEECCSSCCCE--ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred ecCCCccccccc-cccCCCCCEEECCCCCCCC--CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 999999998854 4469999999999999986 56669999999999999999995 7888999999999999999998
Q ss_pred -eeeCCC-cchhhhhhhccc
Q 002189 350 -GTLDLG-TSYSENLLVNLQ 367 (955)
Q Consensus 350 -~~~~~~-~~~~~l~~L~L~ 367 (955)
+.+|.+ ..+..+..++++
T Consensus 251 c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 251 CGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHHHHHHTTCHHHHHHHHH
T ss_pred CcchHHHHHhCCCCcEEecc
Confidence 344443 346667777775
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-27 Score=273.64 Aligned_cols=239 Identities=18% Similarity=0.144 Sum_probs=199.6
Q ss_pred cCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCc
Q 002189 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNL 163 (955)
Q Consensus 84 l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L 163 (955)
...+++|++|+|++|+ +.+..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|
T Consensus 30 ~~~~~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L 101 (487)
T 3oja_A 30 RQSAWNVKELDLSGNP-LSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSI 101 (487)
T ss_dssp STTGGGCCEEECCSSC-CCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTC
T ss_pred cccCCCccEEEeeCCc-CCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCc
Confidence 3344589999999986 888778888999999999999999886665 8888999999999999885432 3889
Q ss_pred CeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccC-CCCCC
Q 002189 164 YWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLG-LVKSL 242 (955)
Q Consensus 164 ~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~-~l~~L 242 (955)
++|+|++|+|++..+.. +++|+.|+|++|++++ ++...+..+++|+.|+|++|++++..|..+. .+++|
T Consensus 102 ~~L~L~~N~l~~~~~~~---------l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L 171 (487)
T 3oja_A 102 ETLHAANNNISRVSCSR---------GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171 (487)
T ss_dssp CEEECCSSCCCCEEECC---------CSSCEEEECCSSCCCS-GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC
T ss_pred CEEECcCCcCCCCCccc---------cCCCCEEECCCCCCCC-CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcc
Confidence 99999999988655432 3567888999999984 4444455678899999999999998888886 79999
Q ss_pred cEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCC
Q 002189 243 EVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENT 322 (955)
Q Consensus 243 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N 322 (955)
+.|+|++|.|++. |. +..+++|+.|+|++|.|++.++.+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|
T Consensus 172 ~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~--lp~~l~~l~~L~~L~l~~N 247 (487)
T 3oja_A 172 EHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL--IEKALRFSQNLEHFDLRGN 247 (487)
T ss_dssp CEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE--ECTTCCCCTTCCEEECTTC
T ss_pred cEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc--cchhhccCCCCCEEEcCCC
Confidence 9999999999955 33 446999999999999999999999999999999999999975 7888999999999999999
Q ss_pred cce-ecCCcCCCCCCCCcEEEee
Q 002189 323 NLK-GQIPADLFSIPHLQTVVMK 344 (955)
Q Consensus 323 ~l~-~~~p~~~~~l~~L~~L~Ls 344 (955)
++. +.+|..+..++.|+.|+++
T Consensus 248 ~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 248 GFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCcCcchHHHHHhCCCCcEEecc
Confidence 998 7788888888888888876
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=236.13 Aligned_cols=211 Identities=23% Similarity=0.284 Sum_probs=137.7
Q ss_pred CCccEEeCC-CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCcc
Q 002189 55 NWEGIGCTN-SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 133 (955)
Q Consensus 55 ~w~gv~C~~-~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 133 (955)
.|.|+.|.. ..++.+++++++++. +|..+. ++|++|+|++|+ +.+..+..|.++++|++|+|++|+++...+..|
T Consensus 6 ~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~ 81 (270)
T 2o6q_A 6 KKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNK-LSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF 81 (270)
T ss_dssp GGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSC-CSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTT
T ss_pred CCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCC-CCeeCHHHhcCCCCCCEEECCCCccCeeChhhh
Confidence 799998864 467789999999994 665554 678999999996 777777788888888888888888886555667
Q ss_pred ccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccC
Q 002189 134 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFR 213 (955)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~ 213 (955)
..+++|++|+|++|+|++..+..|.++++|++|+|++|++++. +.
T Consensus 82 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------------------------~~---- 126 (270)
T 2o6q_A 82 KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSL-------------------------------PP---- 126 (270)
T ss_dssp SSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCC-------------------------------CT----
T ss_pred cCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCee-------------------------------CH----
Confidence 8888888888888888866666778888888888888877622 22
Q ss_pred CccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCC-CCCCCCCCEE
Q 002189 214 PDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYL 292 (955)
Q Consensus 214 ~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L 292 (955)
..|..+++|++|+|++|.|++..+..|..+++|+.|+|++|.|+++++. +..+++|++|
T Consensus 127 --------------------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 186 (270)
T 2o6q_A 127 --------------------RVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTL 186 (270)
T ss_dssp --------------------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred --------------------HHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEE
Confidence 2233344444444444444433333344445555555555555544442 4445555555
Q ss_pred ECcCCCCCCCCCChhhcCCCCCCEEECcCCcce
Q 002189 293 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 293 ~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
+|++|++++ ..+..|..+++|+.|+|++|++.
T Consensus 187 ~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 187 KLDNNQLKR-VPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp ECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCcCCc-CCHHHhccccCCCEEEecCCCee
Confidence 555555543 23334555555666666666554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-24 Score=231.75 Aligned_cols=223 Identities=20% Similarity=0.169 Sum_probs=145.2
Q ss_pred cCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcC
Q 002189 72 SGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSG 151 (955)
Q Consensus 72 ~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 151 (955)
.+.+++ .+|..+. ++|++|+|++|+ +.+..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++
T Consensus 15 ~~~~l~-~ip~~l~--~~l~~L~ls~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (276)
T 2z62_A 15 MELNFY-KIPDNLP--FSTKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (276)
T ss_dssp TTSCCS-SCCSSSC--TTCCEEECTTCC-CCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred cCCCcc-ccCCCCC--CCccEEECCCCc-ccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence 344444 3454443 578999999996 777777788888899999999998887777788888889999999998887
Q ss_pred cCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCcccc
Q 002189 152 RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGE 231 (955)
Q Consensus 152 ~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~ 231 (955)
..+..|.++++|++|++++|++++..+.. +..+++|++|++++|++++.
T Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------------------------------~~~l~~L~~L~l~~n~l~~~ 139 (276)
T 2z62_A 91 LALGAFSGLSSLQKLVAVETNLASLENFP-------------------------------IGHLKTLKELNVAHNLIQSF 139 (276)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCC-------------------------------CTTCTTCCEEECCSSCCCCC
T ss_pred cChhhhcCCccccEEECCCCCccccCchh-------------------------------cccCCCCCEEECcCCcccee
Confidence 77778888888888888888887322212 22223344444444444432
Q ss_pred -CCcccCCCCCCcEEEcccCCCCCCccccccCCCCCC----EEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCCh
Q 002189 232 -LPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVN----DLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306 (955)
Q Consensus 232 -~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~ 306 (955)
+|..+..+++|++|+|++|++++..+..+..+++|+ .|++++|.+++.++......+|++|+|++|+
T Consensus 140 ~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~-------- 211 (276)
T 2z62_A 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQ-------- 211 (276)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSC--------
T ss_pred cCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCc--------
Confidence 455666666666666666666655555555555554 5666666666555544444445555555554
Q ss_pred hhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCC
Q 002189 307 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL 354 (955)
Q Consensus 307 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 354 (955)
+++..+..+..+++|+.|+|++|++++..+.
T Consensus 212 -----------------l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 212 -----------------LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp -----------------CSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred -----------------eeecCHhHhcccccccEEEccCCcccccCCc
Confidence 4434444456666777777777777665543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=265.42 Aligned_cols=185 Identities=17% Similarity=0.212 Sum_probs=146.0
Q ss_pred CccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc--------hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 631 SDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--------GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
...+.||+|+||+||+|+. .++.+|+|+....... ..+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999955 5688899876432211 124589999999999999999777777788888999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.++++. +..++.|+++||+|||+.+ |+||||||+|||+++ .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999875 4689999999999999998 999999999999999 9999999999987543
Q ss_pred CCcc-----eeeeeecCCCCCCHHHhhh--CCCCChhhhHHHHHHHHHHHhCCCCC
Q 002189 783 EKDH-----ITTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVLMLELLTGRRPI 831 (955)
Q Consensus 783 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwS~Gv~l~elltg~~P~ 831 (955)
.... ......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 1235679999999999986 66888899999998888888777665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.6e-24 Score=253.17 Aligned_cols=244 Identities=24% Similarity=0.295 Sum_probs=206.7
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++.|+|++|.|+. +|. .+++|++|+|++|+ ++ .+|. .+++|++|+|++|++++ +|. .+++|+.|+
T Consensus 61 ~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~-l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~ 127 (622)
T 3g06_A 61 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQ-LT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLW 127 (622)
T ss_dssp TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCC-CS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEE
T ss_pred CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCc-CC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEE
Confidence 589999999999994 555 67999999999997 66 4565 77999999999999994 565 678999999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|+|++ +|.. +++|++|+|++|+++ .+|.. +.+|+.|++++|+|+ .+| ....+|+.|+|
T Consensus 128 L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~-~l~~~---------~~~L~~L~L~~N~l~-~l~----~~~~~L~~L~L 188 (622)
T 3g06_A 128 IFGNQLTS-LPVL---PPGLQELSVSDNQLA-SLPAL---------PSELCKLWAYNNQLT-SLP----MLPSGLQELSV 188 (622)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCCC---------CTTCCEEECCSSCCS-CCC----CCCTTCCEEEC
T ss_pred CCCCCCCc-CCCC---CCCCCEEECcCCcCC-CcCCc---------cCCCCEEECCCCCCC-CCc----ccCCCCcEEEC
Confidence 99999994 6654 489999999999998 45532 356788999999999 687 34578999999
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASE 303 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 303 (955)
++|+|++ +|.. +++|+.|++++|.|+ .+|.. +++|+.|+|++|.|++++ ..+++|++|+|++|+|+.
T Consensus 189 s~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~-- 255 (622)
T 3g06_A 189 SDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTS-- 255 (622)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC--
T ss_pred CCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCc--
Confidence 9999996 4543 479999999999999 56643 589999999999999876 456899999999999975
Q ss_pred CChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc
Q 002189 304 VPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT 356 (955)
Q Consensus 304 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 356 (955)
+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++.++..+
T Consensus 256 lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l 304 (622)
T 3g06_A 256 LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304 (622)
T ss_dssp CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHH
T ss_pred CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHH
Confidence 555 6789999999999999 889999999999999999999998766543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-29 Score=289.55 Aligned_cols=304 Identities=18% Similarity=0.174 Sum_probs=140.4
Q ss_pred CEeEEEecCCcCcc----ccCcCcCCCCcccEEecCCCCCCccCCCCCcc-ccc----ccccccccccccCC----CCCC
Q 002189 65 RVTSITLSGMGLKG----QLSGDITGLTELHTLDLSNNKDLRGPLPTTIG-NLK----KLSNLMLVGCSFSG----PIPD 131 (955)
Q Consensus 65 ~v~~L~L~~~~l~~----~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~-~l~----~L~~L~Ls~N~l~~----~~p~ 131 (955)
+++.|+|++|++++ .++..+..+++|++|+|++|+ +....+..+. .++ +|++|+|++|+++. .++.
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~-l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE-LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCC-CHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCc-CChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 45555555555553 233445555555555555554 4332222221 222 45555555555552 3344
Q ss_pred ccccCCCCcEEEccCCCCcCcCCCCC-----CCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCccccc
Q 002189 132 SIGSLQELVLLSLNSNGFSGRVPPSI-----GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS 206 (955)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ 206 (955)
.+..+++|++|+|++|.+++..+..+ ..+++|++|+|++|++++.....+ ...+..+++|++|++++|+++..
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l--~~~l~~~~~L~~L~L~~n~i~~~ 185 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL--ASVLRAKPDFKELTVSNNDINEA 185 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH--HHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH--HHHHhhCCCCCEEECcCCCcchH
Confidence 55555555555555555543222221 123445555555555553211000 01233344555555555555432
Q ss_pred CCccccC----CccceeeeeccCCCcccc----CCcccCCCCCCcEEEcccCCCCCCc-----cccccCCCCCCEEEccC
Q 002189 207 IPEKLFR----PDMVLIHVLFDSNNLTGE----LPATLGLVKSLEVVRFDRNSLSGPV-----PSNLNNLTSVNDLYLSN 273 (955)
Q Consensus 207 ip~~~~~----~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~-----p~~l~~l~~L~~L~Ls~ 273 (955)
.+..+.. ...+|++|+|++|++++. ++..+..+++|++|+|++|.+++.. +..+..+++|+.|+|++
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~ 265 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcC
Confidence 2222211 123555555555555542 3444555555555555555554321 22223455555555555
Q ss_pred CcCccc-----CCCCCCCCCCCEEECcCCCCCCCCCChhhc-----CCCCCCEEECcCCcceec----CCcCCCCCCCCc
Q 002189 274 NKLTGA-----MPNLTGLSVLSYLDMSNNSFDASEVPSWFS-----SMQSLTTLMMENTNLKGQ----IPADLFSIPHLQ 339 (955)
Q Consensus 274 N~l~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~ 339 (955)
|.++.. +..+..+++|++|+|++|.++. ..+..+. ..++|+.|+|++|.+++. ++..+..+++|+
T Consensus 266 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~ 344 (461)
T 1z7x_W 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGD-EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH-HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCC
T ss_pred CCCCHHHHHHHHHHHhhCCCcceEECCCCCCch-HHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCcc
Confidence 555542 2233445555555555555532 1111121 124555555555555543 333444455555
Q ss_pred EEEeecCcceeeeCCCcc------hhhhhhhcccCCccc
Q 002189 340 TVVMKTNELNGTLDLGTS------YSENLLVNLQNNRIS 372 (955)
Q Consensus 340 ~L~Ls~N~l~~~~~~~~~------~~~l~~L~L~~N~l~ 372 (955)
+|+|++|++++..+..+. ..+++.|+|++|+|+
T Consensus 345 ~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp EEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred EEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 555555555543222111 234555555555555
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-24 Score=229.39 Aligned_cols=143 Identities=15% Similarity=0.140 Sum_probs=96.9
Q ss_pred cCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCccc--CCCCCCCCCCCEEECcCCCCCCCCCChhh
Q 002189 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA--MPNLTGLSVLSYLDMSNNSFDASEVPSWF 308 (955)
Q Consensus 231 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~ 308 (955)
..+..|..+++|++|++++|.+++..+..+..+++|++|+|++|.+++. +..+..+++|++|+|++|++++ ..+..+
T Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~ 169 (276)
T 2z62_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDL 169 (276)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE-ECGGGG
T ss_pred cChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc-CCHHHh
Confidence 3334455555666666666666644444566666666666666666552 2245666666666666666654 344556
Q ss_pred cCCCCCC----EEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCcccccc
Q 002189 309 SSMQSLT----TLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYT 375 (955)
Q Consensus 309 ~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~ 375 (955)
..+++|+ .|++++|.+++..+..+ ...+|+.|+|++|++++.++..+ .+.+|+.|+|++|+|++--
T Consensus 170 ~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp HHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred hhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 5555555 88999999986555544 44589999999999999887764 4778889999999999744
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.3e-23 Score=222.88 Aligned_cols=206 Identities=24% Similarity=0.300 Sum_probs=150.6
Q ss_pred cccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccc
Q 002189 115 LSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK 194 (955)
Q Consensus 115 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~ 194 (955)
++.+++++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------- 74 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-------------------- 74 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS--------------------
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC--------------------
Confidence 444555555555 3443332 34555555555555444445555555555555555554
Q ss_pred cccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCC
Q 002189 195 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNN 274 (955)
Q Consensus 195 ~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 274 (955)
.+|...|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|
T Consensus 75 -----------~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 143 (270)
T 2o6q_A 75 -----------TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYN 143 (270)
T ss_dssp -----------CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred -----------eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCC
Confidence 333333334444555555555555455556778899999999999999888888999999999999999
Q ss_pred cCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeC
Q 002189 275 KLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLD 353 (955)
Q Consensus 275 ~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 353 (955)
.|++.++. +..+++|++|+|++|.++. ..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.+..+
T Consensus 144 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 144 ELQSLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cCCccCHhHccCCcccceeEecCCcCcE-eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 99998885 7889999999999999986 556678999999999999999997777778899999999999999988765
Q ss_pred CC
Q 002189 354 LG 355 (955)
Q Consensus 354 ~~ 355 (955)
..
T Consensus 223 ~~ 224 (270)
T 2o6q_A 223 GI 224 (270)
T ss_dssp SS
T ss_pred cH
Confidence 43
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-27 Score=274.37 Aligned_cols=327 Identities=17% Similarity=0.153 Sum_probs=246.1
Q ss_pred CCEeEEEecCCcCccccCcCc-CCCC----cccEEecCCCCCCcc----CCCCCcccccccccccccccccCCCCCCccc
Q 002189 64 SRVTSITLSGMGLKGQLSGDI-TGLT----ELHTLDLSNNKDLRG----PLPTTIGNLKKLSNLMLVGCSFSGPIPDSIG 134 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l-~~l~----~L~~L~Ls~N~~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 134 (955)
.+++.|+|++|.+++..+..+ ..++ +|++|+|++|+ +.. .++..|..+++|++|+|++|.+++..+..+.
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~-i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 134 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC-LTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLC 134 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSC-CBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCC-CCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHH
Confidence 689999999999987554433 3355 79999999997 774 5688899999999999999998754443333
Q ss_pred -----cCCCCcEEEccCCCCcCc----CCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchh-hhhccccccccCCccc
Q 002189 135 -----SLQELVLLSLNSNGFSGR----VPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD-MLVRAKHFHFGKNQLS 204 (955)
Q Consensus 135 -----~l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~-~L~~L~~L~L~~N~l~ 204 (955)
.+++|++|+|++|++++. ++..+..+++|++|+|++|.+++..+..+. ..+. .+.+|++|++++|+++
T Consensus 135 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~--~~l~~~~~~L~~L~L~~n~l~ 212 (461)
T 1z7x_W 135 EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC--QGLKDSPCQLEALKLESCGVT 212 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH--HHHHHSCCCCCEEECTTSCCB
T ss_pred HHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHH--HHHhcCCCCceEEEccCCCCc
Confidence 356899999999999974 355677789999999999998743221110 0011 1348899999999998
Q ss_pred cc----CCccccCCccceeeeeccCCCccccC-----CcccCCCCCCcEEEcccCCCCCC----ccccccCCCCCCEEEc
Q 002189 205 GS----IPEKLFRPDMVLIHVLFDSNNLTGEL-----PATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYL 271 (955)
Q Consensus 205 g~----ip~~~~~~~~~L~~L~L~~N~l~~~~-----p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L 271 (955)
+. ++.. +...++|++|++++|++++.. +..+..+++|++|+|++|.++.. ++..+..+++|++|+|
T Consensus 213 ~~~~~~l~~~-l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 291 (461)
T 1z7x_W 213 SDNCRDLCGI-VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291 (461)
T ss_dssp TTHHHHHHHH-HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEEC
T ss_pred HHHHHHHHHH-HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEEC
Confidence 42 3332 334678999999999998653 33344689999999999999954 6788888999999999
Q ss_pred cCCcCcccCCC------CCCCCCCCEEECcCCCCCCCC---CChhhcCCCCCCEEECcCCcceecCCcCCCC-----CCC
Q 002189 272 SNNKLTGAMPN------LTGLSVLSYLDMSNNSFDASE---VPSWFSSMQSLTTLMMENTNLKGQIPADLFS-----IPH 337 (955)
Q Consensus 272 s~N~l~~~~~~------~~~l~~L~~L~Ls~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~ 337 (955)
++|.+++..+. ....++|++|+|++|.+++.. ++..+..+++|+.|+|++|.+++..+..+.. .++
T Consensus 292 s~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~ 371 (461)
T 1z7x_W 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371 (461)
T ss_dssp TTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred CCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCc
Confidence 99999765431 223479999999999997521 4667788899999999999998765544432 789
Q ss_pred CcEEEeecCccee----eeCCC-cchhhhhhhcccCCcccccc--------CCCCCCCcceeEecCcchh
Q 002189 338 LQTVVMKTNELNG----TLDLG-TSYSENLLVNLQNNRISAYT--------ERGGAPAVNLTLIDNPICQ 394 (955)
Q Consensus 338 L~~L~Ls~N~l~~----~~~~~-~~~~~l~~L~L~~N~l~~~~--------~~~~~~~~~L~~l~n~~c~ 394 (955)
|+.|+|++|++++ .++.. ..+.+|+.|+|++|+|++.. +.....+..|++.++.+..
T Consensus 372 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 372 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp CCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred eEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 9999999999986 44444 34678889999999998652 2334457778887777543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=8.2e-23 Score=222.93 Aligned_cols=205 Identities=20% Similarity=0.255 Sum_probs=145.4
Q ss_pred cccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchh
Q 002189 109 IGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188 (955)
Q Consensus 109 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~ 188 (955)
++++++|+.|++++|+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+ . .
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-------~ 74 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-------G 74 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-------S
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-------C
Confidence 455556666666666666 4454443 466666777777666556666666777777777666663211 1 1
Q ss_pred hhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCE
Q 002189 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 268 (955)
Q Consensus 189 ~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 268 (955)
.+++ |+.|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.
T Consensus 75 ~l~~-------------------------L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~ 128 (290)
T 1p9a_G 75 TLPV-------------------------LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128 (290)
T ss_dssp CCTT-------------------------CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCE
T ss_pred CCCc-------------------------CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCE
Confidence 2223 333333344333 45556677788888888888888666778888888888
Q ss_pred EEccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCc
Q 002189 269 LYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 347 (955)
Q Consensus 269 L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 347 (955)
|+|++|+|++.++. +..+++|+.|+|++|+|+. ..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+
T Consensus 129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np 206 (290)
T 1p9a_G 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (290)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred EECCCCCCCccChhhcccccCCCEEECCCCcCCc-cCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCC
Confidence 88888888887774 6778888888888888875 45566788999999999999998 788888889999999999999
Q ss_pred ceeee
Q 002189 348 LNGTL 352 (955)
Q Consensus 348 l~~~~ 352 (955)
+.+..
T Consensus 207 ~~C~c 211 (290)
T 1p9a_G 207 WLCNC 211 (290)
T ss_dssp BCCSG
T ss_pred ccCcC
Confidence 98754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=232.22 Aligned_cols=203 Identities=17% Similarity=0.163 Sum_probs=117.6
Q ss_pred CCcEEEccCCCCcCcCCCCC--CCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCc
Q 002189 138 ELVLLSLNSNGFSGRVPPSI--GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPD 215 (955)
Q Consensus 138 ~L~~L~Ls~N~l~~~~p~~~--~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~ 215 (955)
+|++|+|++|.+++..|..+ .++++|++|+|++|++++..|..- ...+..+++|++|+|++|+++ .++...+..+
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~--~~~~~~~~~L~~L~Ls~n~l~-~~~~~~~~~l 168 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLA--ELQQWLKPGLKVLSIAQAHSP-AFSCEQVRAF 168 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHH--HHHTTBCSCCCEEEEECCSSC-CCCTTSCCCC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhH--HHHhhhccCCCEEEeeCCCcc-hhhHHHhccC
Confidence 34444444444444444444 444444444444444443221000 000112334444455555554 3444444455
Q ss_pred cceeeeeccCCCcccc--C--CcccCCCCCCcEEEcccCCCCCCccc----cccCCCCCCEEEccCCcCcccC-CCCCCC
Q 002189 216 MVLIHVLFDSNNLTGE--L--PATLGLVKSLEVVRFDRNSLSGPVPS----NLNNLTSVNDLYLSNNKLTGAM-PNLTGL 286 (955)
Q Consensus 216 ~~L~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~~~-~~~~~l 286 (955)
++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++. .+..+++|++|+|++|+|++.. +.+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 5566666666665542 1 223356777777888888776 3333 2466778888888888887773 344444
Q ss_pred ---CCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCccee
Q 002189 287 ---SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 287 ---~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
++|++|+|++|+|+. +|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 248 ~~~~~L~~L~Ls~N~l~~--lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLEQ--VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCCS--CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCCc--hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 688888888888863 565553 6888888888888853 33 6677888888888888864
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.1e-23 Score=221.41 Aligned_cols=227 Identities=20% Similarity=0.228 Sum_probs=158.8
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
.+.++..+++..+.+.... .+..+++|+.|++++|.++. + ..+..+++|++|+|++|++++ + ..+..+
T Consensus 17 ~~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-------~~l~~l 84 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-------SALKEL 84 (272)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-------GGGTTC
T ss_pred hHHHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-------hhhcCC
Confidence 3455666677777666432 35667777777777777773 3 347777777777777777762 1 123333
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
++ |++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+
T Consensus 85 ~~-------------------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 85 TN-------------------------LTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TT-------------------------CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CC-------------------------CCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 33 44444444444444455566777777777777777766666677778888888
Q ss_pred ccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcce
Q 002189 271 LSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349 (955)
Q Consensus 271 Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 349 (955)
|++|.+++.++. +..+++|++|+|++|++++ ..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCc-cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence 888888777764 5677888888888888875 45566788888888888888888777777888888888888888887
Q ss_pred eeeCCCcchhhhhhhcccCCccccccCCCCCC
Q 002189 350 GTLDLGTSYSENLLVNLQNNRISAYTERGGAP 381 (955)
Q Consensus 350 ~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~ 381 (955)
+..| .+..|++..|.+++..|.....
T Consensus 219 ~~~~------~l~~l~~~~n~~~g~ip~~~~~ 244 (272)
T 3rfs_A 219 CTCP------GIRYLSEWINKHSGVVRNSAGS 244 (272)
T ss_dssp CCTT------TTHHHHHHHHHTGGGBBCTTSC
T ss_pred ccCc------HHHHHHHHHHhCCCcccCcccc
Confidence 6544 5678888889888877765543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=225.45 Aligned_cols=204 Identities=19% Similarity=0.258 Sum_probs=97.4
Q ss_pred cccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchh
Q 002189 109 IGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188 (955)
Q Consensus 109 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~ 188 (955)
+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ + ..+.++++|++|+|++|++++..+..++
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~------ 106 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFD------ 106 (272)
T ss_dssp HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTT------
T ss_pred cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhc------
Confidence 445555555555555555 222 25555555555555555553 2 2455555555555555555522221111
Q ss_pred hhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCE
Q 002189 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 268 (955)
Q Consensus 189 ~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 268 (955)
.+++|++|+|++| ++++..+..|..+++|++|+|++|.+++..+..|..+++|+.
T Consensus 107 ~l~~L~~L~L~~n-------------------------~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 161 (272)
T 3rfs_A 107 KLTNLKELVLVEN-------------------------QLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE 161 (272)
T ss_dssp TCTTCCEEECTTS-------------------------CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCcCCCEEECCCC-------------------------cCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence 1222222233333 333233333444444555555555554444444445555555
Q ss_pred EEccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCc
Q 002189 269 LYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 347 (955)
Q Consensus 269 L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 347 (955)
|+|++|++++.++. +..+++|++|+|++|++++ ..+..+..+++|+.|+|++|++.+ .+++|+.|++..|+
T Consensus 162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~ 233 (272)
T 3rfs_A 162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINK 233 (272)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHH
T ss_pred EECCCCCcCccCHHHhcCCccCCEEECCCCcCCc-cCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHh
Confidence 55555555544443 3445555555555555543 333444555555555555555542 23345555666666
Q ss_pred ceeeeCCC
Q 002189 348 LNGTLDLG 355 (955)
Q Consensus 348 l~~~~~~~ 355 (955)
++|.+|..
T Consensus 234 ~~g~ip~~ 241 (272)
T 3rfs_A 234 HSGVVRNS 241 (272)
T ss_dssp TGGGBBCT
T ss_pred CCCcccCc
Confidence 66555544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=218.94 Aligned_cols=199 Identities=22% Similarity=0.244 Sum_probs=133.4
Q ss_pred CcccEEecCCCCCCccCCCCCcccccccccccccccc-cCCCCCCccccCCCCcEEEccC-CCCcCcCCCCCCCCCCcCe
Q 002189 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCS-FSGPIPDSIGSLQELVLLSLNS-NGFSGRVPPSIGNLSNLYW 165 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~L~~L~~ 165 (955)
++|++|+|++|+ +++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|++
T Consensus 31 ~~l~~L~l~~n~-l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETH-LRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCC-CSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCc-ceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 389999999997 888877789999999999999997 8866667899999999999998 9999777778999999999
Q ss_pred eecCCceeeeccCCCCCCCCchhhhhccccccccCC-cccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCc-
Q 002189 166 LDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN-QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLE- 243 (955)
Q Consensus 166 L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N-~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~- 243 (955)
|+|++|++++ +|. +..++.+ ..|+.|++++| +++ .+|. ..|..+++|+
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L---~~L~~L~l~~N~~l~-~i~~------------------------~~~~~l~~L~~ 159 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYST---DIFFILEITDNPYMT-SIPV------------------------NAFQGLCNETL 159 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBC---CSEEEEEEESCTTCC-EECT------------------------TTTTTTBSSEE
T ss_pred EeCCCCCCcc-ccc-ccccccc---ccccEEECCCCcchh-hcCc------------------------ccccchhccee
Confidence 9999999984 554 3332222 11335555555 554 3444 4455555555
Q ss_pred EEEcccCCCCCCccccccCCCCCCEEEccCCc-CcccCC-CCCCC-CCCCEEECcCCCCCCCCCChhhcCCCCCCEEECc
Q 002189 244 VVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK-LTGAMP-NLTGL-SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320 (955)
Q Consensus 244 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~-~~~~l-~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 320 (955)
.|++++|+++ .+|......++|+.|+|++|+ ++++++ .+.++ ++|+.|+|++|+++. +|.. .+++|+.|+++
T Consensus 160 ~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~--l~~~--~~~~L~~L~l~ 234 (239)
T 2xwt_C 160 TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA--LPSK--GLEHLKELIAR 234 (239)
T ss_dssp EEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC--CCCT--TCTTCSEEECT
T ss_pred EEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc--CChh--HhccCceeecc
Confidence 5555555555 333332222556666666663 655544 24555 666666666666643 3322 45566666666
Q ss_pred CC
Q 002189 321 NT 322 (955)
Q Consensus 321 ~N 322 (955)
++
T Consensus 235 ~~ 236 (239)
T 2xwt_C 235 NT 236 (239)
T ss_dssp TC
T ss_pred Cc
Confidence 54
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-23 Score=228.21 Aligned_cols=226 Identities=14% Similarity=0.125 Sum_probs=156.4
Q ss_pred cccEEecCCCCCCccCC-CC--CcccccccccccccccccCCCCCCcc--ccCCCCcEEEccCCCCcCcCC----CCCCC
Q 002189 89 ELHTLDLSNNKDLRGPL-PT--TIGNLKKLSNLMLVGCSFSGPIPDSI--GSLQELVLLSLNSNGFSGRVP----PSIGN 159 (955)
Q Consensus 89 ~L~~L~Ls~N~~l~~~~-p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 159 (955)
.++.|.+.++. +.... .. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.|++..+ ..+..
T Consensus 65 ~l~~l~l~~~~-~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 65 RVRRLTVGAAQ-VPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCEEEECSCC-CBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred ceeEEEEeCCc-CCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 45667777664 33210 00 12234557777777777777777766 777777777777777776444 23446
Q ss_pred CCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCccccc--CC-ccccCCccceeeeeccCCCcccc--CCc
Q 002189 160 LSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGS--IP-EKLFRPDMVLIHVLFDSNNLTGE--LPA 234 (955)
Q Consensus 160 L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~--ip-~~~~~~~~~L~~L~L~~N~l~~~--~p~ 234 (955)
+++|++|+|++|++++..|..++ .+++|++|+|++|++.+. ++ ...+..+++|++|+|++|+++.. .+.
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~------~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~ 217 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVR------AFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCA 217 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCC------CCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhc------cCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHH
Confidence 77777777777777655554443 345567777777776542 22 22335566788888888888622 122
Q ss_pred -ccCCCCCCcEEEcccCCCCCCccccccCC---CCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcC
Q 002189 235 -TLGLVKSLEVVRFDRNSLSGPVPSNLNNL---TSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSS 310 (955)
Q Consensus 235 -~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~ 310 (955)
.++.+++|++|+|++|+|++..|..+..+ ++|++|+|++|+|+.++..+. ++|++|+|++|+|++ +|. +..
T Consensus 218 ~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~--~~~-~~~ 292 (310)
T 4glp_A 218 ALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNR--APQ-PDE 292 (310)
T ss_dssp HHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCS--CCC-TTS
T ss_pred HHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCC--Cch-hhh
Confidence 35778899999999999997778777776 699999999999997766664 789999999999976 333 678
Q ss_pred CCCCCEEECcCCccee
Q 002189 311 MQSLTTLMMENTNLKG 326 (955)
Q Consensus 311 l~~L~~L~Ls~N~l~~ 326 (955)
+++|+.|+|++|+++.
T Consensus 293 l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 293 LPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCCSCEECSSTTTSC
T ss_pred CCCccEEECcCCCCCC
Confidence 8999999999999874
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=218.86 Aligned_cols=201 Identities=22% Similarity=0.267 Sum_probs=92.9
Q ss_pred CCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcC
Q 002189 85 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 164 (955)
Q Consensus 85 ~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~ 164 (955)
.++++|+++++++|+ ++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|.|++..+ . ..+++|+
T Consensus 7 ~~l~~l~~l~~~~~~-l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~ 80 (290)
T 1p9a_G 7 SKVASHLEVNCDKRN-LT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLG 80 (290)
T ss_dssp ECSTTCCEEECTTSC-CS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCC
T ss_pred cccCCccEEECCCCC-CC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCC
Confidence 344455555555554 32 3333332 345555555555554444555555555555555555553222 1 4555555
Q ss_pred eeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcE
Q 002189 165 WLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEV 244 (955)
Q Consensus 165 ~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 244 (955)
+|+|++|+|+ .+|..+ ..+++|++|+|++|+|+ .+|. ..|..+++|++
T Consensus 81 ~L~Ls~N~l~-~l~~~~------~~l~~L~~L~l~~N~l~-~l~~------------------------~~~~~l~~L~~ 128 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLG------QTLPALTVLDVSFNRLT-SLPL------------------------GALRGLGELQE 128 (290)
T ss_dssp EEECCSSCCS-SCCCCT------TTCTTCCEEECCSSCCC-CCCS------------------------STTTTCTTCCE
T ss_pred EEECCCCcCC-cCchhh------ccCCCCCEEECCCCcCc-ccCH------------------------HHHcCCCCCCE
Confidence 5555555554 333221 11222233333333333 3333 33444444444
Q ss_pred EEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCc
Q 002189 245 VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 323 (955)
Q Consensus 245 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 323 (955)
|+|++|+|++..+..|..+++|+.|+|++|+|+++++. +..+++|++|+|++|+|+ .+|..+..+.+|+.|+|++|+
T Consensus 129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~--~ip~~~~~~~~L~~l~L~~Np 206 (290)
T 1p9a_G 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY--TIPKGFFGSHLLPFAFLHGNP 206 (290)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC--CCCTTTTTTCCCSEEECCSCC
T ss_pred EECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC--ccChhhcccccCCeEEeCCCC
Confidence 44444444433334444444455555555555444442 334455555555555553 244444444455555555555
Q ss_pred ce
Q 002189 324 LK 325 (955)
Q Consensus 324 l~ 325 (955)
+.
T Consensus 207 ~~ 208 (290)
T 1p9a_G 207 WL 208 (290)
T ss_dssp BC
T ss_pred cc
Confidence 44
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=215.64 Aligned_cols=189 Identities=24% Similarity=0.330 Sum_probs=133.7
Q ss_pred CCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCC
Q 002189 52 CGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPD 131 (955)
Q Consensus 52 C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 131 (955)
|+ .|.|++|.. ..+.+++++++++ .+|..+. ++|+.|+|++|+ +.+..+..|.++++|++|+|++|+|++..+.
T Consensus 4 Cp-~~~gC~C~~-~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 4 CE-TVTGCTCNE-GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTG-LATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp CH-HHHSSEEEG-GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSC-CCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred CC-CCCceEcCC-CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCC-cCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 54 699999953 3447899999888 5555554 578888888886 7777777888888888888888888877777
Q ss_pred ccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccc
Q 002189 132 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKL 211 (955)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~ 211 (955)
.|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|.
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------------~~~~-- 124 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-------------------------------SLPS-- 124 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------------CCCT--
T ss_pred HhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC-------------------------------CcCh--
Confidence 7888888888888888888666667777888888887777776 2222
Q ss_pred cCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCC
Q 002189 212 FRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLS 290 (955)
Q Consensus 212 ~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~ 290 (955)
..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.++ .+..+++|+
T Consensus 125 ----------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 182 (251)
T 3m19_A 125 ----------------------GVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQ 182 (251)
T ss_dssp ----------------------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred ----------------------hHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCC
Confidence 223445556666666666664444456666666666666666666655 355666677
Q ss_pred EEECcCCCCCC
Q 002189 291 YLDMSNNSFDA 301 (955)
Q Consensus 291 ~L~Ls~N~l~~ 301 (955)
+|+|++|++++
T Consensus 183 ~L~l~~N~~~c 193 (251)
T 3m19_A 183 TITLFGNQFDC 193 (251)
T ss_dssp EEECCSCCBCT
T ss_pred EEEeeCCceeC
Confidence 77777776654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=5.6e-22 Score=218.39 Aligned_cols=198 Identities=22% Similarity=0.380 Sum_probs=135.0
Q ss_pred cccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchh
Q 002189 109 IGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLD 188 (955)
Q Consensus 109 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~ 188 (955)
+..+++|++|++++|.++ .+| .+..+++|++|+|++|+|++..+ +..+++|++|+|++|++++ + +.+.
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~-------~~~~ 104 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-------SAIA 104 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-------GGGT
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-c-------hhhc
Confidence 445666666666666666 344 36666666666666666664333 6666666666666666652 1 1233
Q ss_pred hhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCE
Q 002189 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 268 (955)
Q Consensus 189 ~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 268 (955)
.+.+ |++|+|++|++++ ++ .+..+++|+.|+|++|.+++..+ +..+++|+.
T Consensus 105 ~l~~-------------------------L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~ 155 (308)
T 1h6u_A 105 GLQS-------------------------IKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQY 155 (308)
T ss_dssp TCTT-------------------------CCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred CCCC-------------------------CCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccE
Confidence 3333 4444444444443 22 26777888888888888875433 778888888
Q ss_pred EEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcc
Q 002189 269 LYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 348 (955)
Q Consensus 269 L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 348 (955)
|+|++|.+++.++ +..+++|+.|+|++|.+++ ++. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++
T Consensus 156 L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 156 LSIGNAQVSDLTP-LANLSKLTTLKADDNKISD--ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229 (308)
T ss_dssp EECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC--CGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEE
T ss_pred EEccCCcCCCChh-hcCCCCCCEEECCCCccCc--Chh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCee
Confidence 8888888887666 7788888888888888865 333 7888899999999999986553 78899999999999999
Q ss_pred eeeeC
Q 002189 349 NGTLD 353 (955)
Q Consensus 349 ~~~~~ 353 (955)
++.+.
T Consensus 230 ~~~~~ 234 (308)
T 1h6u_A 230 TNQPV 234 (308)
T ss_dssp ECCCE
T ss_pred ecCCe
Confidence 87443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.5e-22 Score=216.70 Aligned_cols=152 Identities=12% Similarity=0.046 Sum_probs=121.4
Q ss_pred HHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCc------------------chhHHHHHHHHHHHhccC
Q 002189 622 EVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSM------------------QGGQEFKMEIELLSRVHH 683 (955)
Q Consensus 622 el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H 683 (955)
.+......|...+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444456667799999999999999997799999999874322 12456889999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 684 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
| +++.+++.. +..++||||+++|+|.+ +... ....++.|+++||+|||+.+ |+||||||+|||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~--------~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRVE--------NPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCS--------CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cchh--------hHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 4 566665433 55699999999999998 5321 23469999999999999998 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhh
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 805 (955)
++.+||+|||+|+. +..|+|||++..
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999863 345789999853
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-24 Score=242.66 Aligned_cols=257 Identities=18% Similarity=0.165 Sum_probs=167.5
Q ss_pred EEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCC----CCccccc-ccccccccccccCCCCCCccccC-----C
Q 002189 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLP----TTIGNLK-KLSNLMLVGCSFSGPIPDSIGSL-----Q 137 (955)
Q Consensus 68 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~ 137 (955)
.++|+.++++|.+|..+...++|++|+|++|+ +.+..+ ..|.+++ +|++|+|++|.+++..+..|..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~-l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNN-LYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSC-GGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCC-CChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 35778888888877777777778888888886 666655 5667777 78888888888886666666665 7
Q ss_pred CCcEEEccCCCCcCcCCCCCC----CC-CCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCcccc
Q 002189 138 ELVLLSLNSNGFSGRVPPSIG----NL-SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLF 212 (955)
Q Consensus 138 ~L~~L~Ls~N~l~~~~p~~~~----~L-~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~ 212 (955)
+|++|+|++|+|++..+..+. .+ ++|++|+|++|++++..+..+. ..+..+
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~--~~l~~~---------------------- 136 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFK--QAFSNL---------------------- 136 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH--HHHTTS----------------------
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHH--HHHHhC----------------------
Confidence 888888888888765555433 33 6788888888877632221110 001110
Q ss_pred CCccceeeeeccCCCcccc----CCcccCCCC-CCcEEEcccCCCCCCccccc----cCC-CCCCEEEccCCcCccc---
Q 002189 213 RPDMVLIHVLFDSNNLTGE----LPATLGLVK-SLEVVRFDRNSLSGPVPSNL----NNL-TSVNDLYLSNNKLTGA--- 279 (955)
Q Consensus 213 ~~~~~L~~L~L~~N~l~~~----~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l----~~l-~~L~~L~Ls~N~l~~~--- 279 (955)
..+|++|+|++|++++. ++..+..++ +|++|+|++|+|++..+..+ ..+ ++|+.|+|++|.|++.
T Consensus 137 --~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~ 214 (362)
T 3goz_A 137 --PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA 214 (362)
T ss_dssp --CTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH
T ss_pred --CCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH
Confidence 12455555555555532 233444454 77778888887776555433 334 5788888888887762
Q ss_pred --CCCCCC-CCCCCEEECcCCCCCCCCC---ChhhcCCCCCCEEECcCCccee-------cCCcCCCCCCCCcEEEeecC
Q 002189 280 --MPNLTG-LSVLSYLDMSNNSFDASEV---PSWFSSMQSLTTLMMENTNLKG-------QIPADLFSIPHLQTVVMKTN 346 (955)
Q Consensus 280 --~~~~~~-l~~L~~L~Ls~N~l~~~~~---p~~~~~l~~L~~L~Ls~N~l~~-------~~p~~~~~l~~L~~L~Ls~N 346 (955)
+..+.. .++|++|+|++|.++.... ...+..+++|+.|+|++|.+.+ .++..+..+++|+.|||++|
T Consensus 215 ~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N 294 (362)
T 3goz_A 215 ELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK 294 (362)
T ss_dssp HHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCC
Confidence 223333 3478888888888765211 2344667788888888887432 34456778888899999999
Q ss_pred cceee
Q 002189 347 ELNGT 351 (955)
Q Consensus 347 ~l~~~ 351 (955)
++...
T Consensus 295 ~l~~~ 299 (362)
T 3goz_A 295 EIHPS 299 (362)
T ss_dssp BCCGG
T ss_pred cCCCc
Confidence 88765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=219.24 Aligned_cols=246 Identities=17% Similarity=0.194 Sum_probs=159.0
Q ss_pred CCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCC-
Q 002189 52 CGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIP- 130 (955)
Q Consensus 52 C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p- 130 (955)
|.|.|..|.|+ +++++ .+|..+ .++|++|+|++|+ ++...+..|.++++|++|+|++|++.+.+|
T Consensus 7 C~C~~~~v~C~----------~~~Lt-~iP~~l--~~~l~~L~Ls~N~-i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 7 CHCSNRVFLCQ----------ESKVT-EIPSDL--PRNAIELRFVLTK-LRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp SEEETTEEEEE----------STTCC-SCCTTC--CTTCSEEEEESCC-CSEECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred cEeeCCEEEec----------CCCCC-ccCcCc--CCCCCEEEccCCc-CCCcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 55556666665 45555 456555 3689999999997 877767789999999999999999876666
Q ss_pred CccccCCCCcE-EEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCc
Q 002189 131 DSIGSLQELVL-LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 209 (955)
Q Consensus 131 ~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~ 209 (955)
..|.++++|++ +.++.|+|+...|..|.++++|++|++++|+|++..+..+.. ..++..|++.+
T Consensus 73 ~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~------~~~l~~l~l~~--------- 137 (350)
T 4ay9_X 73 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH------SLQKVLLDIQD--------- 137 (350)
T ss_dssp TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCC------BSSCEEEEEES---------
T ss_pred hHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcc------cchhhhhhhcc---------
Confidence 46889988775 667789999877889999999999999999998333222111 11223333322
Q ss_pred cccCCccceeeeeccCCCccccCCcccCCCC-CCcEEEcccCCCCCCccccccCCCCCCEEEccC-CcCcccCCC-CCCC
Q 002189 210 KLFRPDMVLIHVLFDSNNLTGELPATLGLVK-SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN-NKLTGAMPN-LTGL 286 (955)
Q Consensus 210 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~-~~~l 286 (955)
.|++....+..|..+. .++.|+|++|+|+ .+|.......+|+.|++++ |.++.+++. |.++
T Consensus 138 ---------------~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l 201 (350)
T 4ay9_X 138 ---------------NINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGA 201 (350)
T ss_dssp ---------------CTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTE
T ss_pred ---------------ccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccC
Confidence 1333333333444443 4566666666666 4444444455666666653 555555553 5666
Q ss_pred CCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCc
Q 002189 287 SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNE 347 (955)
Q Consensus 287 ~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 347 (955)
++|++|||++|+|+. +|. ..+.+|+.|.+.++.-...+| .+.++++|+.++++++.
T Consensus 202 ~~L~~LdLs~N~l~~--lp~--~~~~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 202 SGPVILDISRTRIHS--LPS--YGLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp ECCSEEECTTSCCCC--CCS--SSCTTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred cccchhhcCCCCcCc--cCh--hhhccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence 777777777777654 332 234555566555544344566 36777888888876554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.7e-22 Score=209.38 Aligned_cols=196 Identities=15% Similarity=0.196 Sum_probs=139.4
Q ss_pred ccccccccccccCCCCCCccccCCCCcEEEccCCC-CcCcCCCCCCCCCCcCeeecCC-ceeeeccCCCCCCCCchhhhh
Q 002189 114 KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG-FSGRVPPSIGNLSNLYWLDLTD-NKLEGEIPVSDGNSPGLDMLV 191 (955)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~L~~L~~L~L~~-N~l~g~ip~~~~~~~~l~~L~ 191 (955)
+|++|+|++|++++..+..|.++++|++|+|++|+ ++...+..|.++++|++|+|++ |++++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~---------------- 95 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY---------------- 95 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE----------------
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE----------------
Confidence 78888888888886666678888888888888886 8766666788888888888887 77772
Q ss_pred ccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCc---EEEcccC-CCCCCccccccCCCCCC
Q 002189 192 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLE---VVRFDRN-SLSGPVPSNLNNLTSVN 267 (955)
Q Consensus 192 ~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~---~L~Ls~N-~l~~~~p~~l~~l~~L~ 267 (955)
+|...|..+++|++|++++|++++ +|. |..+++|+ +|++++| .+++..+..|.++++|+
T Consensus 96 ---------------i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~ 158 (239)
T 2xwt_C 96 ---------------IDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158 (239)
T ss_dssp ---------------ECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred ---------------cCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcce
Confidence 333333334445555555555553 444 66666666 8888888 88766566688888888
Q ss_pred -EEEccCCcCcccCCCCCCCCCCCEEECcCCC-CCCCCCChhhcCC-CCCCEEECcCCcceecCCcCCCCCCCCcEEEee
Q 002189 268 -DLYLSNNKLTGAMPNLTGLSVLSYLDMSNNS-FDASEVPSWFSSM-QSLTTLMMENTNLKGQIPADLFSIPHLQTVVMK 344 (955)
Q Consensus 268 -~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 344 (955)
.|+|++|.++.+++.....++|+.|+|++|+ ++. ..+..|.++ ++|+.|+|++|+++ .+|.. .+++|+.|+++
T Consensus 159 ~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~-i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~ 234 (239)
T 2xwt_C 159 LTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTV-IDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIAR 234 (239)
T ss_dssp EEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCE-ECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECT
T ss_pred eEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCccc-CCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeecc
Confidence 8888888888766654444788888888884 764 445667777 78888888888887 34443 56677777777
Q ss_pred cC
Q 002189 345 TN 346 (955)
Q Consensus 345 ~N 346 (955)
++
T Consensus 235 ~~ 236 (239)
T 2xwt_C 235 NT 236 (239)
T ss_dssp TC
T ss_pred Cc
Confidence 65
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.2e-21 Score=204.88 Aligned_cols=181 Identities=21% Similarity=0.315 Sum_probs=128.0
Q ss_pred ccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhcc
Q 002189 114 KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 193 (955)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L 193 (955)
..++++++++.++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~------------------- 72 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ------------------- 72 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-------------------
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC-------------------
Confidence 3455556666555 4444443 35555666666655555555555555555555555554
Q ss_pred ccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccC
Q 002189 194 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN 273 (955)
Q Consensus 194 ~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 273 (955)
+..+..|..+++|++|+|++|.|++..+..|..+++|+.|+|++
T Consensus 73 ------------------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 116 (251)
T 3m19_A 73 ------------------------------------TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGG 116 (251)
T ss_dssp ------------------------------------CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ------------------------------------ccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCC
Confidence 33344566677777888888888766667777888888888888
Q ss_pred CcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeee
Q 002189 274 NKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352 (955)
Q Consensus 274 N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 352 (955)
|+|++.++. +..+++|++|+|++|+|++ ..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..
T Consensus 117 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 117 NQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CcCCCcChhHhccCCcccEEECcCCcCCc-cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 888877775 5778888888888888875 45557888888999999999988777778888999999999999998764
Q ss_pred C
Q 002189 353 D 353 (955)
Q Consensus 353 ~ 353 (955)
.
T Consensus 196 ~ 196 (251)
T 3m19_A 196 C 196 (251)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.9e-24 Score=238.64 Aligned_cols=262 Identities=14% Similarity=0.170 Sum_probs=175.5
Q ss_pred CCccEEeCCCCEeEEEecCCcCccccCcCcCCC--CcccEEecCCCCCCccCCCCCcccccccccccccccccCCC-CCC
Q 002189 55 NWEGIGCTNSRVTSITLSGMGLKGQLSGDITGL--TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGP-IPD 131 (955)
Q Consensus 55 ~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l--~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~ 131 (955)
.|.++.|+...++.|+++++.+. +..+..+ ++++.|++++|. +.+..+. +.++++|++|+|++|.+++. +|.
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~-l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~ 112 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSF-MDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHG 112 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCE-ECSCCCS-CCCCBCCCEEECTTCEECHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCcc-ccccchh-hccCCCCCEEEccCCCcCHHHHHH
Confidence 69999888778999999999887 4556666 899999999996 7776665 66799999999999998865 788
Q ss_pred ccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCc-eeeec-cCCCCCCCCchhhhhccccccccCC-cccccCC
Q 002189 132 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDN-KLEGE-IPVSDGNSPGLDMLVRAKHFHFGKN-QLSGSIP 208 (955)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N-~l~g~-ip~~~~~~~~l~~L~~L~~L~L~~N-~l~g~ip 208 (955)
.+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. +|. .+..+++|++|++++| +++
T Consensus 113 ~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~------~~~~~~~L~~L~l~~~~~l~---- 182 (336)
T 2ast_B 113 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT------LLSSCSRLDELNLSWCFDFT---- 182 (336)
T ss_dssp HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHH------HHHHCTTCCEEECCCCTTCC----
T ss_pred HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHH------HHhcCCCCCEEcCCCCCCcC----
Confidence 8899999999999999999888888889999999999999 56632 221 1334455555555555 554
Q ss_pred ccccCCccceeeeeccCCCcccc-CCcccCCCC-CCcEEEcccC--CCC-CCccccccCCCCCCEEEccCCc-Cccc-CC
Q 002189 209 EKLFRPDMVLIHVLFDSNNLTGE-LPATLGLVK-SLEVVRFDRN--SLS-GPVPSNLNNLTSVNDLYLSNNK-LTGA-MP 281 (955)
Q Consensus 209 ~~~~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~-~L~~L~Ls~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~-~~ 281 (955)
+. ++..+..++ +|++|+|++| .++ +.+|..+..+++|+.|+|++|. +++. ++
T Consensus 183 ---------------------~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 241 (336)
T 2ast_B 183 ---------------------EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 241 (336)
T ss_dssp ---------------------HHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG
T ss_pred ---------------------hHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH
Confidence 32 344455556 6666666666 343 3445555666666666666666 4432 33
Q ss_pred CCCCCCCCCEEECcCCC-CCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCC-CCCcEEEeecCcceeeeCCCcc
Q 002189 282 NLTGLSVLSYLDMSNNS-FDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSI-PHLQTVVMKTNELNGTLDLGTS 357 (955)
Q Consensus 282 ~~~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~ 357 (955)
.+..+++|++|+|++|. +.. .....+.++++|+.|+|++| +.. ..+..+ .+|+.|++++|++++..|....
T Consensus 242 ~l~~l~~L~~L~l~~~~~~~~-~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 242 EFFQLNYLQHLSLSRCYDIIP-ETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp GGGGCTTCCEEECTTCTTCCG-GGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred HHhCCCCCCEeeCCCCCCCCH-HHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence 45566666666666664 211 11124566677777777766 221 122222 2255555677777776665443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-22 Score=236.92 Aligned_cols=109 Identities=19% Similarity=0.344 Sum_probs=77.4
Q ss_pred CCCCC---CCccE-EeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCccccccccccccccccc
Q 002189 50 DPCGD---NWEGI-GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSF 125 (955)
Q Consensus 50 ~~C~~---~w~gv-~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l 125 (955)
++|.. .|.|+ .|...+++.|+|++|+|++ +|..+ +++|++|+|++|+ ++ .+| ..+++|++|+|++|+|
T Consensus 41 ~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~-l~-~ip---~~l~~L~~L~Ls~N~l 112 (571)
T 3cvr_A 41 LPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNA-LI-SLP---ELPASLEYLDACDNRL 112 (571)
T ss_dssp CTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSC-CS-CCC---CCCTTCCEEECCSSCC
T ss_pred CccccccchhhhccccccCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCC-Cc-ccc---cccCCCCEEEccCCCC
Confidence 45643 59998 7887889999999999987 66655 3788888888886 55 556 3466777777777777
Q ss_pred CCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 126 SGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 126 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|+
T Consensus 113 ~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~ 153 (571)
T 3cvr_A 113 ST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLT 153 (571)
T ss_dssp SC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred CC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccC
Confidence 74 565 554 67777777777775 554 4566666666666665
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=214.89 Aligned_cols=221 Identities=23% Similarity=0.372 Sum_probs=175.7
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
.+.++..+.+..+.++..+. +..+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+
T Consensus 17 ~l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--------~~~l 84 (308)
T 1h6u_A 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--------LKNL 84 (308)
T ss_dssp HHHHHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--------GTTC
T ss_pred HHHHHHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--------HccC
Confidence 45556666777777774333 5678899999999999984 55 68888999999999998872211 3333
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
+ +|++|+|++|++++. ..+..+++|+.|+|++|.+++ ++. +..+++|+.|+
T Consensus 85 ~-------------------------~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 85 T-------------------------KITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp C-------------------------SCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred C-------------------------CCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 3 455555555555432 368889999999999999995 443 99999999999
Q ss_pred ccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCccee
Q 002189 271 LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 271 Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
|++|.+++.++ +..+++|++|+|++|.+++ ++. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++
T Consensus 136 l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~ 209 (308)
T 1h6u_A 136 LDLNQITNISP-LAGLTNLQYLSIGNAQVSD--LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD 209 (308)
T ss_dssp CCSSCCCCCGG-GGGCTTCCEEECCSSCCCC--CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCcCcc-ccCCCCccEEEccCCcCCC--Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCc
Confidence 99999998776 8889999999999999975 444 8999999999999999996544 8889999999999999998
Q ss_pred eeCCCcchhhhhhhcccCCccccccCCCC
Q 002189 351 TLDLGTSYSENLLVNLQNNRISAYTERGG 379 (955)
Q Consensus 351 ~~~~~~~~~~l~~L~L~~N~l~~~~~~~~ 379 (955)
..+ ...+.+|+.|+|++|+|++.+....
T Consensus 210 ~~~-l~~l~~L~~L~l~~N~i~~~~~~~~ 237 (308)
T 1h6u_A 210 VSP-LANTSNLFIVTLTNQTITNQPVFYN 237 (308)
T ss_dssp CGG-GTTCTTCCEEEEEEEEEECCCEECC
T ss_pred ccc-ccCCCCCCEEEccCCeeecCCeeec
Confidence 775 5668889999999999998666543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-23 Score=240.13 Aligned_cols=256 Identities=19% Similarity=0.214 Sum_probs=163.3
Q ss_pred ccCcCcCCCCcccEEecCCCCCCccC----CCCCcccccccccccccccc---cCCCCCCcc-------ccCCCCcEEEc
Q 002189 79 QLSGDITGLTELHTLDLSNNKDLRGP----LPTTIGNLKKLSNLMLVGCS---FSGPIPDSI-------GSLQELVLLSL 144 (955)
Q Consensus 79 ~~~~~l~~l~~L~~L~Ls~N~~l~~~----~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~-------~~l~~L~~L~L 144 (955)
.++..+..+++|++|+|++|+ +... ++..|..+++|++|+|++|. +++.+|..+ ..+++|++|+|
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~-i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~L 101 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNT-IGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRL 101 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSE-ECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEEC
T ss_pred HHHHHHhcCCCccEEECCCCC-CCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEEC
Confidence 345566777888888888886 6654 33346678888888888753 444455444 57788888888
Q ss_pred cCCCCcC----cCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceee
Q 002189 145 NSNGFSG----RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIH 220 (955)
Q Consensus 145 s~N~l~~----~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~ 220 (955)
++|.|++ .+|..+.++++|++|+|++|.+++..+..+.. .+..+ ..|++++.. ++|++
T Consensus 102 s~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~--~l~~l--------~~~~~~~~~--------~~L~~ 163 (386)
T 2ca6_A 102 SDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQEL--------AVNKKAKNA--------PPLRS 163 (386)
T ss_dssp CSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHH--------HHHHHHHTC--------CCCCE
T ss_pred CCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH--HHHHH--------hhhhhcccC--------CCCcE
Confidence 8888876 36667777888888888888776332211110 01111 111111110 34666
Q ss_pred eeccCCCcc-ccCC---cccCCCCCCcEEEcccCCCC--C---CccccccCCCCCCEEEccCCcCc----c-cCCCCCCC
Q 002189 221 VLFDSNNLT-GELP---ATLGLVKSLEVVRFDRNSLS--G---PVPSNLNNLTSVNDLYLSNNKLT----G-AMPNLTGL 286 (955)
Q Consensus 221 L~L~~N~l~-~~~p---~~l~~l~~L~~L~Ls~N~l~--~---~~p~~l~~l~~L~~L~Ls~N~l~----~-~~~~~~~l 286 (955)
|+|++|+++ +.++ ..+..+++|++|+|++|.|+ | ..+..+..+++|+.|+|++|.|+ + ++..+..+
T Consensus 164 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred EECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 666666665 3333 45667777888888888776 2 33446777778888888888774 2 23346677
Q ss_pred CCCCEEECcCCCCCCC---CCChhhc--CCCCCCEEECcCCccee----cCCcCC-CCCCCCcEEEeecCcceeeeC
Q 002189 287 SVLSYLDMSNNSFDAS---EVPSWFS--SMQSLTTLMMENTNLKG----QIPADL-FSIPHLQTVVMKTNELNGTLD 353 (955)
Q Consensus 287 ~~L~~L~Ls~N~l~~~---~~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~~ 353 (955)
++|++|+|++|.|++. .++..+. .+++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..+
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 7788888888877541 1244553 37788888888888876 466666 457888888888888876543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-23 Score=239.72 Aligned_cols=242 Identities=19% Similarity=0.250 Sum_probs=170.9
Q ss_pred CCEeEEEecCCcCccc----cCcCcCCCCcccEEecCCCC--CCccCCCCCc-------ccccccccccccccccCC---
Q 002189 64 SRVTSITLSGMGLKGQ----LSGDITGLTELHTLDLSNNK--DLRGPLPTTI-------GNLKKLSNLMLVGCSFSG--- 127 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N~--~l~~~~p~~~-------~~l~~L~~L~Ls~N~l~~--- 127 (955)
.+++.|+|++|++++. ++..|..+++|++|+|++|. .+.+.+|..+ .++++|++|+|++|.+++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 5799999999999976 44558899999999999973 2555666555 688999999999999997
Q ss_pred -CCCCccccCCCCcEEEccCCCCcCcCCCCC----CCC---------CCcCeeecCCceee-eccCCCCCCCCchhhhhc
Q 002189 128 -PIPDSIGSLQELVLLSLNSNGFSGRVPPSI----GNL---------SNLYWLDLTDNKLE-GEIPVSDGNSPGLDMLVR 192 (955)
Q Consensus 128 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~L---------~~L~~L~L~~N~l~-g~ip~~~~~~~~l~~L~~ 192 (955)
.+|..+..+++|++|+|++|.|+...+..+ ..+ ++|++|+|++|+++ +.+|.- ...+..+++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l---~~~l~~~~~ 188 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW---AKTFQSHRL 188 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHH---HHHHHHCTT
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHH---HHHHHhCCC
Confidence 477789999999999999999975444444 334 89999999999886 222210 012333444
Q ss_pred cccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCC----CCccccccCCCCCCE
Q 002189 193 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS----GPVPSNLNNLTSVND 268 (955)
Q Consensus 193 L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~----~~~p~~l~~l~~L~~ 268 (955)
|++|+|++|+++.. + +....+..+..+++|+.|+|++|.|+ +.+|..+..+++|+.
T Consensus 189 L~~L~L~~n~l~~~---g-----------------~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~ 248 (386)
T 2ca6_A 189 LHTVKMVQNGIRPE---G-----------------IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 248 (386)
T ss_dssp CCEEECCSSCCCHH---H-----------------HHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred cCEEECcCCCCCHh---H-----------------HHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCE
Confidence 45555555544300 0 00023446677778888888888875 467777788888888
Q ss_pred EEccCCcCccc-----CCCC--CCCCCCCEEECcCCCCCCC---CCChhh-cCCCCCCEEECcCCcceecC
Q 002189 269 LYLSNNKLTGA-----MPNL--TGLSVLSYLDMSNNSFDAS---EVPSWF-SSMQSLTTLMMENTNLKGQI 328 (955)
Q Consensus 269 L~Ls~N~l~~~-----~~~~--~~l~~L~~L~Ls~N~l~~~---~~p~~~-~~l~~L~~L~Ls~N~l~~~~ 328 (955)
|+|++|.|++. +..+ ..+++|++|+|++|.++.. .+|..+ .++++|+.|+|++|++++..
T Consensus 249 L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred EECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 88888888765 1233 3478888888888888541 255555 56788888888888888655
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.5e-21 Score=196.72 Aligned_cols=187 Identities=21% Similarity=0.250 Sum_probs=128.5
Q ss_pred CCCCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCC
Q 002189 50 DPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPI 129 (955)
Q Consensus 50 ~~C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 129 (955)
+.|.|.|.+|.|+... ++ .+|..+ .++|++|+|++|+ +.+..+..|.++++|++|+|++|++++..
T Consensus 3 ~~C~C~~~~v~c~~~~----------l~-~~p~~~--~~~l~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQG----------RT-SVPTGI--PAQTTYLDLETNS-LKSLPNGVFDELTSLTQLYLGGNKLQSLP 68 (208)
T ss_dssp TTCEEETTEEECCSSC----------CS-SCCSCC--CTTCSEEECCSSC-CCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCCEECCCEEEecCCC----------cc-CCCCCC--CCCCcEEEcCCCc-cCcCChhhhcccccCcEEECCCCccCccC
Confidence 4577789999997543 33 233322 3578889999986 77777777888899999999999988666
Q ss_pred CCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCc
Q 002189 130 PDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 209 (955)
Q Consensus 130 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~ 209 (955)
+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+.. +..+++|++|++++|+++ .+|.
T Consensus 69 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------~~~l~~L~~L~l~~N~l~-~~~~ 141 (208)
T 2o6s_A 69 NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGV------FDKLTQLKDLRLYQNQLK-SVPD 141 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT------TTTCTTCCEEECCSSCCS-CCCT
T ss_pred hhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhH------hccCCcCCEEECCCCccc-eeCH
Confidence 667888899999999999998766667888899999999998888433322 233455566666666666 4555
Q ss_pred cccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCC
Q 002189 210 KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 264 (955)
Q Consensus 210 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 264 (955)
..+..+.+|+.|++++|.+.+ .+++|+.|+++.|+++|.+|..++.++
T Consensus 142 ~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 142 GVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred HHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 555555556666666665542 234555666666666666665555444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-22 Score=228.77 Aligned_cols=255 Identities=17% Similarity=0.160 Sum_probs=174.9
Q ss_pred EecCCCCCCccCCCCCcccccccccccccccccCCCCC----CccccCC-CCcEEEccCCCCcCcCCCCCCCC-----CC
Q 002189 93 LDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIP----DSIGSLQ-ELVLLSLNSNGFSGRVPPSIGNL-----SN 162 (955)
Q Consensus 93 L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~L-----~~ 162 (955)
++|++|+ +++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|+|++..+..+..+ ++
T Consensus 3 ~~ls~n~-~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHP-GSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCT-TCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccc-chHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 5667775 677766666666667777777777775544 5566666 67777777777776555555554 67
Q ss_pred cCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcc----cCC
Q 002189 163 LYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPAT----LGL 238 (955)
Q Consensus 163 L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~----l~~ 238 (955)
|++|+|++|++++..+..+.. .+..+ ..+|++|+|++|++++..+.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~--~l~~~------------------------~~~L~~L~Ls~N~l~~~~~~~l~~~l~~ 135 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVK--TLAAI------------------------PFTITVLDLGWNDFSSKSSSEFKQAFSN 135 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHH--HHHTS------------------------CTTCCEEECCSSCGGGSCHHHHHHHHTT
T ss_pred ccEEECcCCcCChHHHHHHHH--HHHhC------------------------CCCccEEECcCCcCCcHHHHHHHHHHHh
Confidence 777777777766332211100 01111 145666666666666555544 444
Q ss_pred -CCCCcEEEcccCCCCCC----ccccccCCC-CCCEEEccCCcCcccCC-----CCCCC-CCCCEEECcCCCCCCCC---
Q 002189 239 -VKSLEVVRFDRNSLSGP----VPSNLNNLT-SVNDLYLSNNKLTGAMP-----NLTGL-SVLSYLDMSNNSFDASE--- 303 (955)
Q Consensus 239 -l~~L~~L~Ls~N~l~~~----~p~~l~~l~-~L~~L~Ls~N~l~~~~~-----~~~~l-~~L~~L~Ls~N~l~~~~--- 303 (955)
.++|++|+|++|.|++. ++..+..++ +|++|+|++|+|++..+ .+..+ ++|++|+|++|.|+...
T Consensus 136 ~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~ 215 (362)
T 3goz_A 136 LPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAE 215 (362)
T ss_dssp SCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHH
T ss_pred CCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHH
Confidence 36999999999999954 344556665 99999999999998765 24445 59999999999996421
Q ss_pred CChhhcC-CCCCCEEECcCCcceecCC----cCCCCCCCCcEEEeecCcceeeeC--------CCcchhhhhhhcccCCc
Q 002189 304 VPSWFSS-MQSLTTLMMENTNLKGQIP----ADLFSIPHLQTVVMKTNELNGTLD--------LGTSYSENLLVNLQNNR 370 (955)
Q Consensus 304 ~p~~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~~~l~~L~L~~N~ 370 (955)
++..+.. .++|+.|+|++|.+++..+ ..+..+++|+.|+|++|.+.+..+ ....+.+++.|||++|+
T Consensus 216 l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~ 295 (362)
T 3goz_A 216 LAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295 (362)
T ss_dssp HHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCB
T ss_pred HHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCc
Confidence 3445555 4699999999999996544 456788999999999999554332 23346667899999999
Q ss_pred cccc
Q 002189 371 ISAY 374 (955)
Q Consensus 371 l~~~ 374 (955)
|...
T Consensus 296 l~~~ 299 (362)
T 3goz_A 296 IHPS 299 (362)
T ss_dssp CCGG
T ss_pred CCCc
Confidence 8765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6e-22 Score=220.86 Aligned_cols=251 Identities=16% Similarity=0.173 Sum_probs=188.3
Q ss_pred cccEEecCCCCCCccCCCCCcccc--cccccccccccccCCCCCCccccCCCCcEEEccCCCCcCc-CCCCCCCCCCcCe
Q 002189 89 ELHTLDLSNNKDLRGPLPTTIGNL--KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGR-VPPSIGNLSNLYW 165 (955)
Q Consensus 89 ~L~~L~Ls~N~~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~ 165 (955)
.++.|+|++|+ +. +..+..+ ++|+.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++
T Consensus 48 ~~~~l~l~~~~-~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 48 LWQTLDLTGKN-LH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp TSSEEECTTCB-CC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred hheeecccccc-CC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 47788888886 44 4566777 7888888888888866555 55788888888888888755 6667778888888
Q ss_pred eecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCC-Cccc-cCCcccCCCCCCc
Q 002189 166 LDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN-NLTG-ELPATLGLVKSLE 243 (955)
Q Consensus 166 L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N-~l~~-~~p~~l~~l~~L~ 243 (955)
|+|++|++++..|..++ ..++|++|+|++| .+++ .++..+..+++|+
T Consensus 123 L~L~~~~l~~~~~~~l~-------------------------------~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 123 LSLEGLRLSDPIVNTLA-------------------------------KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp EECTTCBCCHHHHHHHT-------------------------------TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred EeCcCcccCHHHHHHHh-------------------------------cCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 88888877644433221 1345666666666 4554 3566788899999
Q ss_pred EEEcccC-CCCCC-ccccccCCC-CCCEEEccCCc--Cc--ccCCCCCCCCCCCEEECcCCC-CCCCCCChhhcCCCCCC
Q 002189 244 VVRFDRN-SLSGP-VPSNLNNLT-SVNDLYLSNNK--LT--GAMPNLTGLSVLSYLDMSNNS-FDASEVPSWFSSMQSLT 315 (955)
Q Consensus 244 ~L~Ls~N-~l~~~-~p~~l~~l~-~L~~L~Ls~N~--l~--~~~~~~~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l~~L~ 315 (955)
+|++++| .+++. ++..+..++ +|++|+|++|. ++ +.+..+..+++|++|+|++|. ++. ..+..+..+++|+
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~-~~~~~l~~l~~L~ 250 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN-DCFQEFFQLNYLQ 250 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCG-GGGGGGGGCTTCC
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCH-HHHHHHhCCCCCC
Confidence 9999999 99854 688889999 99999999994 54 333356679999999999999 654 5677899999999
Q ss_pred EEECcCCc-ceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-h-hhhhhhcccCCccccccCCCCC
Q 002189 316 TLMMENTN-LKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-Y-SENLLVNLQNNRISAYTERGGA 380 (955)
Q Consensus 316 ~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~-~~l~~L~L~~N~l~~~~~~~~~ 380 (955)
.|+|++|. +.......+.++++|+.|+|++| ++ +..+. + ..+..|++++|+++++.+..+.
T Consensus 251 ~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 251 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred EeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 99999995 44333346788999999999999 32 22322 3 2467899999999998887653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-20 Score=208.73 Aligned_cols=200 Identities=12% Similarity=0.090 Sum_probs=95.5
Q ss_pred ccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccc-
Q 002189 116 SNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAK- 194 (955)
Q Consensus 116 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~- 194 (955)
++++.++++++ .+|..+ .++|++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|... +..++++.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~-----f~~L~~l~~ 83 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV-----FSNLPKLHE 83 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTS-----BCSCTTCCE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhH-----hhcchhhhh
Confidence 45667777777 566555 2467777777777774444567777777777777777654444321 11122211
Q ss_pred cccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEccc-CCCCCCccccccCCC-CCCEEEcc
Q 002189 195 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR-NSLSGPVPSNLNNLT-SVNDLYLS 272 (955)
Q Consensus 195 ~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~-~L~~L~Ls 272 (955)
.+.+..|+|+ .++...|..+++|+.|++++|++.+..+..+....++..|++.+ |.+....+..|..+. .|+.|+|+
T Consensus 84 ~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~ 162 (350)
T 4ay9_X 84 IRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162 (350)
T ss_dssp EEEEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred hhcccCCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccc
Confidence 1233334444 34444444444444444444444433333344444444444432 333322233333332 34444444
Q ss_pred CCcCcccCCCCCCCCCCCEEECcC-CCCCCCCCChhhcCCCCCCEEECcCCcce
Q 002189 273 NNKLTGAMPNLTGLSVLSYLDMSN-NSFDASEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 273 ~N~l~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
+|+|+.+++......+|+.|++++ |.++. ..+..|.++++|+.|+|++|+|+
T Consensus 163 ~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~-i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 163 KNGIQEIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp SSCCCEECTTSSTTEEEEEEECTTCTTCCC-CCTTTTTTEECCSEEECTTSCCC
T ss_pred cccccCCChhhccccchhHHhhccCCcccC-CCHHHhccCcccchhhcCCCCcC
Confidence 444444444433444444444443 23321 22233444444444444444444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-20 Score=219.42 Aligned_cols=123 Identities=28% Similarity=0.381 Sum_probs=73.8
Q ss_pred ceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcC
Q 002189 217 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSN 296 (955)
Q Consensus 217 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~ 296 (955)
+|+.|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++++. +. ++|++|+|++
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~ 189 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVST 189 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCS
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcC
Confidence 34444444444443 333 35566666666666663 444 45566666666666666444 43 6666666666
Q ss_pred CCCCCCCCChhhcCCCCC-------CEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCc
Q 002189 297 NSFDASEVPSWFSSMQSL-------TTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT 356 (955)
Q Consensus 297 N~l~~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 356 (955)
|+|+. +|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+
T Consensus 190 N~L~~--lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 190 NLLES--LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250 (571)
T ss_dssp SCCSS--CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHH
T ss_pred CCCCc--hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHH
Confidence 66653 444 333 45 77777777777 567777777778888888888777655443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.80 E-value=4.8e-22 Score=239.46 Aligned_cols=306 Identities=13% Similarity=0.062 Sum_probs=197.0
Q ss_pred CCEeEEEecCCcCccc----cCcCcCCCCcccEEecCCCCCCc----cCCCCCcccccccccccccccccCCCCCCcccc
Q 002189 64 SRVTSITLSGMGLKGQ----LSGDITGLTELHTLDLSNNKDLR----GPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 135 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~----~~~~l~~l~~L~~L~Ls~N~~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 135 (955)
.+++.|+|++|.+++. ++..+..+++|++|+|++|+ +. +.++..+.++++|++|+|++|.+.+ +|..+..
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~-~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTE-FAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCC-CSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccC-CCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 5788888888887655 44455667888888888886 55 2334445677888888888887763 5555666
Q ss_pred CCCCcEEEccCCCCc--------------------------CcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhh
Q 002189 136 LQELVLLSLNSNGFS--------------------------GRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDM 189 (955)
Q Consensus 136 l~~L~~L~Ls~N~l~--------------------------~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~ 189 (955)
+++|++|+++.+... +.+|..+..+++|++|+|++|.+++.... ..+..
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~-----~~~~~ 316 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHC-----TLIQK 316 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHH-----HHHTT
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHH-----HHHHh
Confidence 666666666532211 13444455566666666666665432210 11234
Q ss_pred hhccccccccCCcccccCCccccCCccceeeeecc-----------CCCccccC-CcccCCCCCCcEEEcccCCCCCCcc
Q 002189 190 LVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD-----------SNNLTGEL-PATLGLVKSLEVVRFDRNSLSGPVP 257 (955)
Q Consensus 190 L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~-----------~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p 257 (955)
+++|++|+++ |.++......++...++|++|+++ .|.+++.. +..+..+++|++|+++.|.+++..+
T Consensus 317 ~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~ 395 (592)
T 3ogk_B 317 CPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395 (592)
T ss_dssp CTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHH
T ss_pred CcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHH
Confidence 5556666666 333322222333345567778877 35665432 2234457888888888888887666
Q ss_pred ccccC-CCCCCEEEcc----CCcCcccCCC------CCCCCCCCEEECcCCC--CCCCCCChhhcCCCCCCEEECcCCcc
Q 002189 258 SNLNN-LTSVNDLYLS----NNKLTGAMPN------LTGLSVLSYLDMSNNS--FDASEVPSWFSSMQSLTTLMMENTNL 324 (955)
Q Consensus 258 ~~l~~-l~~L~~L~Ls----~N~l~~~~~~------~~~l~~L~~L~Ls~N~--l~~~~~p~~~~~l~~L~~L~Ls~N~l 324 (955)
..+.. +++|+.|+|+ .|.+++.+.. +.++++|+.|+|++|. +++.........+++|+.|+|++|++
T Consensus 396 ~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l 475 (592)
T 3ogk_B 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGE 475 (592)
T ss_dssp HHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCS
T ss_pred HHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCC
Confidence 66665 7888888886 6677764321 4558889999987543 54422222234588899999999998
Q ss_pred ee-cCCcCCCCCCCCcEEEeecCcceee-eCCC-cchhhhhhhcccCCccccccCC
Q 002189 325 KG-QIPADLFSIPHLQTVVMKTNELNGT-LDLG-TSYSENLLVNLQNNRISAYTER 377 (955)
Q Consensus 325 ~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~-~~~~~l~~L~L~~N~l~~~~~~ 377 (955)
++ .++..+..+++|++|+|++|++++. ++.. ..+++|+.|+|++|+++.....
T Consensus 476 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~ 531 (592)
T 3ogk_B 476 SDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQD 531 (592)
T ss_dssp SHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTT
T ss_pred CHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHH
Confidence 86 3455567789999999999998753 3332 2467788999999998876443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=186.62 Aligned_cols=96 Identities=19% Similarity=0.271 Sum_probs=57.9
Q ss_pred CcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCC
Q 002189 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSM 311 (955)
Q Consensus 233 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l 311 (955)
+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.|++.++. +..+++|++|+|++|.+.+ .+
T Consensus 93 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--------~~ 164 (208)
T 2o6s_A 93 NGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--------TC 164 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC--------CT
T ss_pred HhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec--------CC
Confidence 33455566666666666666655555566666666666666666665553 4556666666666665533 34
Q ss_pred CCCCEEECcCCcceecCCcCCCCCC
Q 002189 312 QSLTTLMMENTNLKGQIPADLFSIP 336 (955)
Q Consensus 312 ~~L~~L~Ls~N~l~~~~p~~~~~l~ 336 (955)
++|++|+++.|+++|.+|..++.++
T Consensus 165 ~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 165 PGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred CCHHHHHHHHHhCCceeeccCcccc
Confidence 4566666666666666666555544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-21 Score=229.96 Aligned_cols=205 Identities=17% Similarity=0.135 Sum_probs=134.1
Q ss_pred ccccccccccccccccCCCCCCccccCCCCcEEEccCCC-------------CcCcCCCCCCCCCCcCeee-cCCceeee
Q 002189 110 GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG-------------FSGRVPPSIGNLSNLYWLD-LTDNKLEG 175 (955)
Q Consensus 110 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~L~~L~~L~-L~~N~l~g 175 (955)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 44566667777777776 666667777777777765554 4556666677777777777 5555442
Q ss_pred ccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCC
Q 002189 176 EIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGP 255 (955)
Q Consensus 176 ~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 255 (955)
.|..+.+++|.++ .+|.. .|+.|+|++|+|++ +|. |+.+++|+.|+|++|.|+ .
T Consensus 424 ----------------~L~~l~l~~n~i~-~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~ 477 (567)
T 1dce_A 424 ----------------DLRSKFLLENSVL-KMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-A 477 (567)
T ss_dssp ----------------HHHHHHHHHHHHH-HHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-C
T ss_pred ----------------hhhhhhhhccccc-ccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-c
Confidence 3455566777776 33321 36677777777775 454 777777777777777777 6
Q ss_pred ccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcC---C
Q 002189 256 VPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPAD---L 332 (955)
Q Consensus 256 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~---~ 332 (955)
+|..|.++++|+.|+|++|.|++++ .+..+++|++|+|++|+|++...|..|..+++|+.|+|++|++++..|.. +
T Consensus 478 lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~ 556 (567)
T 1dce_A 478 LPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 556 (567)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHH
T ss_pred cchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHH
Confidence 6777777777777777777777654 66777777777777777765222667777777777777777777543322 1
Q ss_pred CCCCCCcEEEe
Q 002189 333 FSIPHLQTVVM 343 (955)
Q Consensus 333 ~~l~~L~~L~L 343 (955)
..+|+|+.|+|
T Consensus 557 ~~lp~L~~L~l 567 (567)
T 1dce_A 557 EMLPSVSSILT 567 (567)
T ss_dssp HHCTTCSEEEC
T ss_pred HHCcccCccCC
Confidence 12666666654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.3e-19 Score=191.31 Aligned_cols=193 Identities=22% Similarity=0.319 Sum_probs=118.7
Q ss_pred ccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhh
Q 002189 112 LKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLV 191 (955)
Q Consensus 112 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~ 191 (955)
+.++..+.+..+.+++..+ +..+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +..++
T Consensus 23 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--------l~~l~ 90 (291)
T 1h6t_A 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--------LANLK 90 (291)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--------GTTCT
T ss_pred HHHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--------cccCC
Confidence 3344445555555543222 3455666666666666653 22 35556666666666666552111 22233
Q ss_pred ccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEc
Q 002189 192 RAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYL 271 (955)
Q Consensus 192 ~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 271 (955)
+|++|++++|+++ + + ..+..+++|++|+|++|++++. ..+..+++|+.|+|
T Consensus 91 ~L~~L~l~~n~l~-------------------------~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 91 NLGWLFLDENKVK-------------------------D-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYL 141 (291)
T ss_dssp TCCEEECCSSCCC-------------------------C-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEEC
T ss_pred CCCEEECCCCcCC-------------------------C-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEc
Confidence 3333333333333 2 1 1256677777777777777742 45677777788888
Q ss_pred cCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceee
Q 002189 272 SNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGT 351 (955)
Q Consensus 272 s~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 351 (955)
++|.+++. +.+..+++|+.|+|++|++++ .+. +..+++|+.|+|++|.+++ ++ .+..+++|+.|+|++|+++..
T Consensus 142 ~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~--~~~-l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 142 GNNKITDI-TVLSRLTKLDTLSLEDNQISD--IVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CSSCCCCC-GGGGGCTTCSEEECCSSCCCC--CGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred cCCcCCcc-hhhccCCCCCEEEccCCcccc--chh-hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 88877766 556777788888888888765 333 7778888888888888874 33 377888888888888888763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.77 E-value=5.3e-22 Score=239.12 Aligned_cols=306 Identities=11% Similarity=0.022 Sum_probs=175.7
Q ss_pred CEeEEEecCCc-Ccc-ccCcCcCCCCcccEEecCCCCCCccC----CCCCcccccccccccccccccCC----CCCCccc
Q 002189 65 RVTSITLSGMG-LKG-QLSGDITGLTELHTLDLSNNKDLRGP----LPTTIGNLKKLSNLMLVGCSFSG----PIPDSIG 134 (955)
Q Consensus 65 ~v~~L~L~~~~-l~~-~~~~~l~~l~~L~~L~Ls~N~~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~ 134 (955)
+++.|+|++|. ++. .++..+..+++|++|+|++|. +.+. ++..+.++++|++|+|++|.+++ .++..+.
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~-~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESS-FSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCE-EECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECcccc-ccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 49999999886 221 122334578999999999996 6655 33345678999999999999983 3444567
Q ss_pred cCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee---eccCCCCCCCCc-----------------hhhhhccc
Q 002189 135 SLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE---GEIPVSDGNSPG-----------------LDMLVRAK 194 (955)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~---g~ip~~~~~~~~-----------------l~~L~~L~ 194 (955)
++++|++|+|++|.+.+ +|..+.++++|+.|+++.+... +..+..+..++. +..+++|+
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~ 296 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIR 296 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCC
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCc
Confidence 89999999999999995 6778889999999999864322 111111221111 12334555
Q ss_pred cccccCCcccccCCccccCCccceeeeeccCCCcc-ccCCcccCCCCCCcEEEcc-----------cCCCCCC-cccccc
Q 002189 195 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT-GELPATLGLVKSLEVVRFD-----------RNSLSGP-VPSNLN 261 (955)
Q Consensus 195 ~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls-----------~N~l~~~-~p~~l~ 261 (955)
+|+|++|.+++.....++...++|+.|+++ |.+. +.++..+..+++|++|+|+ .|.+++. ++..+.
T Consensus 297 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~ 375 (592)
T 3ogk_B 297 KLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ 375 (592)
T ss_dssp EEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHH
T ss_pred EEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHh
Confidence 555555554433332333444555555555 2222 2223333445556666665 2444422 122233
Q ss_pred CCCCCCEEEccCCcCcccCC-CCCC-CCCCCEEECc----CCCCCCC----CCChhhcCCCCCCEEECcCCc--ceecCC
Q 002189 262 NLTSVNDLYLSNNKLTGAMP-NLTG-LSVLSYLDMS----NNSFDAS----EVPSWFSSMQSLTTLMMENTN--LKGQIP 329 (955)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~~-~~~~-l~~L~~L~Ls----~N~l~~~----~~p~~~~~l~~L~~L~Ls~N~--l~~~~p 329 (955)
.+++|++|+++.|.+++... .+.. +++|+.|+|+ .|.+++. .++..+.++++|+.|+|++|. +++..+
T Consensus 376 ~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~ 455 (592)
T 3ogk_B 376 GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455 (592)
T ss_dssp HCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHH
T ss_pred hCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHH
Confidence 45666666666566554332 2222 5566666664 4555431 122234556666666665432 444333
Q ss_pred cCCCC-CCCCcEEEeecCccee-eeCCC-cchhhhhhhcccCCcccc
Q 002189 330 ADLFS-IPHLQTVVMKTNELNG-TLDLG-TSYSENLLVNLQNNRISA 373 (955)
Q Consensus 330 ~~~~~-l~~L~~L~Ls~N~l~~-~~~~~-~~~~~l~~L~L~~N~l~~ 373 (955)
..+.. +++|+.|+|++|++++ .++.. ..+.+|+.|+|++|+|+.
T Consensus 456 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 456 SYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp HHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred HHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 33332 5667777777776655 22222 234556667777776653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=2e-18 Score=181.41 Aligned_cols=114 Identities=22% Similarity=0.271 Sum_probs=76.7
Q ss_pred CCCCCCCCCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccc
Q 002189 45 NWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCS 124 (955)
Q Consensus 45 ~w~~~~~C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~ 124 (955)
.|.+...| +|.+|.|+..+ ++ .+|..+. ++|++|+|++|+ +.+..|..|.++++|++|+|++|+
T Consensus 12 ~~~~~~~C--s~~~v~c~~~~----------l~-~ip~~~~--~~L~~L~Ls~n~-i~~~~~~~~~~l~~L~~L~L~~N~ 75 (229)
T 3e6j_A 12 ACPSQCSC--SGTTVDCRSKR----------HA-SVPAGIP--TNAQILYLHDNQ-ITKLEPGVFDSLINLKELYLGSNQ 75 (229)
T ss_dssp CCCTTCEE--ETTEEECTTSC----------CS-SCCSCCC--TTCSEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCCCCEE--eCCEeEccCCC----------cC-ccCCCCC--CCCCEEEcCCCc-cCccCHHHhhCccCCcEEECCCCC
Confidence 34444445 79999997544 33 3343332 678888888886 777777777777777777777777
Q ss_pred cCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 125 FSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
|+...+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus 76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 76 LGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT 125 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc
Confidence 76555555677777777777777777555555666677776666666665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=3e-19 Score=213.62 Aligned_cols=191 Identities=24% Similarity=0.382 Sum_probs=109.8
Q ss_pred CcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeee
Q 002189 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLD 167 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 167 (955)
..+..++|..+. +.... .+..|.+|+.|+|++|.+. .+| .|..|++|+.|+|++|+|++..+ +..+++|+.|+
T Consensus 21 ~~l~~l~l~~~~-i~~~~--~~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 21 AETIKDNLKKKS-VTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHTTCSC-TTSEE--CHHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHhccCCC-ccccc--chhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 344455565554 44332 2456667777777777766 334 36667777777777777765443 66677777777
Q ss_pred cCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEc
Q 002189 168 LTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 247 (955)
Q Consensus 168 L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 247 (955)
|++|+|++ + +.+..+.+|+.|+|++|+|+ + + ..+..+++|+.|+|
T Consensus 94 Ls~N~l~~-l-------~~l~~l~~L~~L~Ls~N~l~-------------------------~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 94 LDENKIKD-L-------SSLKDLKKLKSLSLEHNGIS-------------------------D-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp CCSSCCCC-C-------TTSTTCTTCCEEECTTSCCC-------------------------C-C-GGGGGCTTCSEEEC
T ss_pred CcCCCCCC-C-------hhhccCCCCCEEEecCCCCC-------------------------C-C-ccccCCCccCEEEC
Confidence 77776652 1 12333444445555555444 2 1 23445556666666
Q ss_pred ccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCccee
Q 002189 248 DRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 326 (955)
Q Consensus 248 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 326 (955)
++|.|++. ..+..+++|+.|+|++|.|++.++ +..+++|+.|+|++|.|++ + ..+..+++|+.|+|++|++.+
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~--l-~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD--L-RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB--C-GGGTTCTTCSEEECCSEEEEC
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC--C-hHHccCCCCCEEEccCCcCcC
Confidence 66666533 455566666666666666665555 5556666666666666643 2 245666666666666666664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.4e-18 Score=179.49 Aligned_cols=155 Identities=20% Similarity=0.279 Sum_probs=136.2
Q ss_pred ccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccC
Q 002189 194 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN 273 (955)
Q Consensus 194 ~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 273 (955)
+.+++++|.++ .+|..+. ..|+.|+|++|+|++..+..|..+++|+.|+|++|.|++..|..|.++++|+.|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 34566666666 7777654 5688899999999988888999999999999999999988899999999999999999
Q ss_pred CcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeee
Q 002189 274 NKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352 (955)
Q Consensus 274 N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 352 (955)
|.|+.+++. |.++++|++|+|++|+|++ ..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCE-eCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 999988885 6789999999999999986 66888999999999999999999888888999999999999999998754
Q ss_pred C
Q 002189 353 D 353 (955)
Q Consensus 353 ~ 353 (955)
.
T Consensus 169 ~ 169 (220)
T 2v9t_B 169 H 169 (220)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7.1e-19 Score=210.31 Aligned_cols=198 Identities=21% Similarity=0.296 Sum_probs=160.5
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
.+..+..+.|..+.+...++ +..|++|+.|+|++|.|.. ++ .+..+++|+.|+|++|+|++..| +..+
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--------l~~l 86 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--------LTNL 86 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--------GGGC
T ss_pred HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--------hccC
Confidence 46677788888888885443 5788899999999999984 44 58889999999999998874322 4455
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
.+|+.|+|++|+|+ + +| .+..+++|+.|+|++|.|++ + ..+..+++|+.|+
T Consensus 87 ~~L~~L~Ls~N~l~-------------------------~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 87 KNLGWLFLDENKIK-------------------------D-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECCSSCCC-------------------------C-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCEEECcCCCCC-------------------------C-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 55556666655554 2 22 57889999999999999995 3 4689999999999
Q ss_pred ccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCccee
Q 002189 271 LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 271 Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
|++|.|+++ +.+..+++|+.|+|++|.|++ .+. +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++
T Consensus 138 Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~--~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 138 LGNNKITDI-TVLSRLTKLDTLSLEDNQISD--IVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCSSCCCCC-GGGGSCTTCSEEECCSSCCCC--CGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CCCCccCCc-hhhcccCCCCEEECcCCcCCC--chh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 999999987 678899999999999999976 333 99999999999999999964 468999999999999999988
Q ss_pred eeCCC
Q 002189 351 TLDLG 355 (955)
Q Consensus 351 ~~~~~ 355 (955)
.+...
T Consensus 212 ~p~~~ 216 (605)
T 1m9s_A 212 KPINH 216 (605)
T ss_dssp CCCCC
T ss_pred Ccccc
Confidence 65433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5e-19 Score=193.03 Aligned_cols=197 Identities=18% Similarity=0.289 Sum_probs=151.4
Q ss_pred CCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCcc
Q 002189 137 QELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDM 216 (955)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~ 216 (955)
.++..+.+..+.+++.. .+..+++|+.|++++|.++ .+ +.+.. ++
T Consensus 24 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~-------~~~~~-------------------------l~ 68 (291)
T 1h6t_A 24 AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SV-------QGIQY-------------------------LP 68 (291)
T ss_dssp HHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCC-CC-------TTGGG-------------------------CT
T ss_pred HHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcc-cC-------hhHhc-------------------------CC
Confidence 34445556666665432 2445666666776666665 11 12333 34
Q ss_pred ceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcC
Q 002189 217 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSN 296 (955)
Q Consensus 217 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~ 296 (955)
+|+.|+|++|++++..+ +..+++|+.|+|++|.+++ ++ .+..+++|+.|+|++|++++. +.+..+++|++|+|++
T Consensus 69 ~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~ 143 (291)
T 1h6t_A 69 NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGN 143 (291)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCS
T ss_pred CCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccC
Confidence 55556666666654433 8899999999999999995 44 499999999999999999986 5688899999999999
Q ss_pred CCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccC
Q 002189 297 NSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTE 376 (955)
Q Consensus 297 N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~ 376 (955)
|++++ + ..+..+++|+.|+|++|++++..+ +..+++|+.|+|++|+|++. +....+.+|+.|+|++|+++..+.
T Consensus 144 n~l~~--~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~~~~ 217 (291)
T 1h6t_A 144 NKITD--I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKPI 217 (291)
T ss_dssp SCCCC--C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEECCCE
T ss_pred CcCCc--c-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccCCcc
Confidence 99976 3 679999999999999999997655 89999999999999999985 446678889999999999998665
Q ss_pred CCC
Q 002189 377 RGG 379 (955)
Q Consensus 377 ~~~ 379 (955)
...
T Consensus 218 ~~~ 220 (291)
T 1h6t_A 218 NHQ 220 (291)
T ss_dssp ECC
T ss_pred ccc
Confidence 544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=7.5e-20 Score=224.24 Aligned_cols=126 Identities=17% Similarity=0.092 Sum_probs=37.9
Q ss_pred HHHHHHHHHHHhhcCC---CCCCCCCCC-CCCCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCC
Q 002189 25 DNDFVILKALKDDIWE---NEPPNWKNN-DPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKD 100 (955)
Q Consensus 25 ~~~~~~L~~~k~~~~~---~~~~~w~~~-~~C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~ 100 (955)
+.+..+|.++..+... .....|... .++. .|.+++++..+++.|+|.++++... + ...|+.++|+.|.
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~~l~L~~n~~~~~-~-----~~~l~~l~Ls~~~- 202 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSG-TATNSAVSTPLTPKIELFANGKDEA-N-----QALLQHKKLSQYS- 202 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccc-cCCCceecCCccceEEeeCCCCCcc-h-----hhHhhcCccCccc-
Confidence 4567778777755421 122456433 4443 6999999999999999999998853 2 2335556666664
Q ss_pred CccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 101 LRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 101 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
+ ..++++.|.+. ..|..|..+++|+.|+|++|.|. .+|..+.++++|++|+|++|+|+
T Consensus 203 i--------------~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~ 260 (727)
T 4b8c_D 203 I--------------DEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT 260 (727)
T ss_dssp ----------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS
T ss_pred c--------------cCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc
Confidence 2 23345556665 56667777777777777777777 56666667777777777776665
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-18 Score=178.87 Aligned_cols=155 Identities=18% Similarity=0.284 Sum_probs=125.6
Q ss_pred cccccCCcccccCCccccCCccceeeeeccCCCccccCC-cccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccC
Q 002189 195 HFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELP-ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN 273 (955)
Q Consensus 195 ~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 273 (955)
.+++++|.++ .+|..+.. .++.|+|++|+|++..+ ..|..+++|+.|+|++|.|++..+..|.++++|++|+|++
T Consensus 15 ~l~~s~n~l~-~iP~~~~~---~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIPQ---YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCSCCCT---TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCccCCCC---CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4555555555 56655432 35677788888877654 4578888888889988888877777888888999999999
Q ss_pred CcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeee
Q 002189 274 NKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352 (955)
Q Consensus 274 N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 352 (955)
|.|++.++. +.++++|++|+|++|+|++ ..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++.+..
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCC-BCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCe-ECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 998888774 7788899999999999876 56788899999999999999999888999999999999999999999866
Q ss_pred CC
Q 002189 353 DL 354 (955)
Q Consensus 353 ~~ 354 (955)
+.
T Consensus 170 ~l 171 (220)
T 2v70_A 170 YL 171 (220)
T ss_dssp GG
T ss_pred ch
Confidence 53
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=4e-18 Score=182.97 Aligned_cols=172 Identities=17% Similarity=0.239 Sum_probs=109.6
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
++.++..+++++|.+++ ++ .+..+++|++|++++|+|+ .++ .+..+++|++|+|++|+|++.
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-------------- 78 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-------------- 78 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC--------------
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC--------------
Confidence 56667777777777773 33 4677777777777777777 344 566777777777777766511
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
+. +..+++|+.|+|++|++++ +|.... ++|+.|+
T Consensus 79 ------------------------------------------~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~ 112 (263)
T 1xeu_A 79 ------------------------------------------SP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLF 112 (263)
T ss_dssp ------------------------------------------GG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEE
T ss_pred ------------------------------------------hh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEE
Confidence 11 3334445555555555542 222111 5566666
Q ss_pred ccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCccee
Q 002189 271 LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 271 Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
|++|.|++. +.+..+++|+.|+|++|+|++ ++ .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++
T Consensus 113 L~~N~l~~~-~~l~~l~~L~~L~Ls~N~i~~--~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 113 LDNNELRDT-DSLIHLKNLEILSIRNNKLKS--IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CCSSCCSBS-GGGTTCTTCCEEECTTSCCCB--CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred ccCCccCCC-hhhcCcccccEEECCCCcCCC--Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 666666554 345666677777777777654 23 567777788888888887755 667788888888888888876
Q ss_pred ee
Q 002189 351 TL 352 (955)
Q Consensus 351 ~~ 352 (955)
.+
T Consensus 187 ~~ 188 (263)
T 1xeu_A 187 EP 188 (263)
T ss_dssp CC
T ss_pred Cc
Confidence 54
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-20 Score=223.34 Aligned_cols=193 Identities=19% Similarity=0.191 Sum_probs=158.0
Q ss_pred ccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCce-------------eeeccCCCCCCCCchhhhhcccccc-cc
Q 002189 134 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK-------------LEGEIPVSDGNSPGLDMLVRAKHFH-FG 199 (955)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~-------------l~g~ip~~~~~~~~l~~L~~L~~L~-L~ 199 (955)
..+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|. .+..|.+|+.|+ ++
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~------~l~~l~~L~~L~~l~ 418 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKE------TLQYFSTLKAVDPMR 418 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHH------HHHHHHHHHHHCGGG
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHH------HHHHHHhcccCcchh
Confidence 57889999999999998 789999999999999998876 3333332 345667777777 67
Q ss_pred CCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCccc
Q 002189 200 KNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGA 279 (955)
Q Consensus 200 ~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 279 (955)
.|.+. .|..+.+++|.++...+ ..|+.|+|++|.|++ +|. |..+++|+.|+|++|.|+.+
T Consensus 419 ~n~~~------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~l 478 (567)
T 1dce_A 419 AAYLD------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRAL 478 (567)
T ss_dssp HHHHH------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCC
T ss_pred hcccc------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccccc
Confidence 66654 46667777777775332 248899999999995 676 99999999999999999977
Q ss_pred CCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecC-CcCCCCCCCCcEEEeecCcceeeeCCCc
Q 002189 280 MPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI-PADLFSIPHLQTVVMKTNELNGTLDLGT 356 (955)
Q Consensus 280 ~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 356 (955)
|..+..+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|+|++.++...
T Consensus 479 p~~~~~l~~L~~L~Ls~N~l~~--lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 553 (567)
T 1dce_A 479 PPALAALRCLEVLQASDNALEN--VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553 (567)
T ss_dssp CGGGGGCTTCCEEECCSSCCCC--CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred chhhhcCCCCCEEECCCCCCCC--Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence 7788999999999999999976 56 7899999999999999999876 8999999999999999999998877553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.4e-18 Score=191.67 Aligned_cols=65 Identities=25% Similarity=0.376 Sum_probs=31.8
Q ss_pred cCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCC----CCCCCCCEEECcCCCCC
Q 002189 236 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL----TGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 236 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~----~~l~~L~~L~Ls~N~l~ 300 (955)
|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+++++.+ ..+++|+.|+|++|+|+
T Consensus 108 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 108 FSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred hCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 344455555555555555444555555555555555555555444332 23445555555555544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-17 Score=174.96 Aligned_cols=155 Identities=19% Similarity=0.194 Sum_probs=136.3
Q ss_pred ccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccC
Q 002189 194 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN 273 (955)
Q Consensus 194 ~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 273 (955)
+.+++++++++ .+|..+. .+|+.|+|++|+|++..|..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++
T Consensus 22 ~~v~c~~~~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEeEccCCCcC-ccCCCCC---CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 45666677776 7777654 6788999999999998899999999999999999999866667789999999999999
Q ss_pred CcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeee
Q 002189 274 NKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352 (955)
Q Consensus 274 N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 352 (955)
|+|+++++. +..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC--SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc--ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 999998885 688999999999999997 47888999999999999999999777778999999999999999998866
Q ss_pred CC
Q 002189 353 DL 354 (955)
Q Consensus 353 ~~ 354 (955)
+.
T Consensus 176 ~~ 177 (229)
T 3e6j_A 176 RD 177 (229)
T ss_dssp GG
T ss_pred ch
Confidence 53
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.3e-18 Score=190.95 Aligned_cols=107 Identities=21% Similarity=0.136 Sum_probs=82.2
Q ss_pred EEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcc-cccccccccccccccCCCCCCccccCCCCcEEEccC
Q 002189 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIG-NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146 (955)
Q Consensus 68 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 146 (955)
.+++++++|+. +|..+. ..++.|+|++|+ +++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~-l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNN-LSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSC-CCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCC-CCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 56777888874 565443 458889999986 7777777777 888888888888888876677788888888888888
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCceeeeccC
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIP 178 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip 178 (955)
|+|++..+..|.++++|++|+|++|+|++..|
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 129 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDR 129 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECH
Confidence 88886666678888888888888888774433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-17 Score=174.71 Aligned_cols=101 Identities=24% Similarity=0.324 Sum_probs=49.3
Q ss_pred EEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCC
Q 002189 69 ITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG 148 (955)
Q Consensus 69 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 148 (955)
+++++++++ .+|..+. ++|++|+|++|+ +.+..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~-i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSC-CCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCc-CCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 344455555 3444332 456666666664 555444455555555555555555554444444444445555444444
Q ss_pred CcCcCCCCCCCCCCcCeeecCCcee
Q 002189 149 FSGRVPPSIGNLSNLYWLDLTDNKL 173 (955)
Q Consensus 149 l~~~~p~~~~~L~~L~~L~L~~N~l 173 (955)
|+...+..|.++++|++|+|++|+|
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l 116 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKI 116 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCHhHccCCCCCCEEECCCCCC
Confidence 4433333334444444444444443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.74 E-value=8.7e-22 Score=237.29 Aligned_cols=327 Identities=11% Similarity=0.082 Sum_probs=200.5
Q ss_pred CCEeEEEecCCcCccccCcCcC-CCCcccEEecCCCCCCccC-CCCCcccccccccccccccccCCCCCCccc----cCC
Q 002189 64 SRVTSITLSGMGLKGQLSGDIT-GLTELHTLDLSNNKDLRGP-LPTTIGNLKKLSNLMLVGCSFSGPIPDSIG----SLQ 137 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~-~l~~L~~L~Ls~N~~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~ 137 (955)
.+++.|+|+++.+++..+..+. .+++|++|+|++|..+... ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 5888999999998877766665 6889999999988424332 344455788999999999988765544443 566
Q ss_pred CCcEEEccCCC--CcCc-CCCCCCCCCCcCeeecCCc-eeeeccCCCC------------------------------CC
Q 002189 138 ELVLLSLNSNG--FSGR-VPPSIGNLSNLYWLDLTDN-KLEGEIPVSD------------------------------GN 183 (955)
Q Consensus 138 ~L~~L~Ls~N~--l~~~-~p~~~~~L~~L~~L~L~~N-~l~g~ip~~~------------------------------~~ 183 (955)
+|++|+|++|. ++.. ++..+.++++|++|+|++| .+.+ +|..+ .+
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 89999998887 2211 1112244688888888877 2221 11110 00
Q ss_pred CCc--------------h----hhhhccccccccCCcccccCCccccCCccceeeeeccCCCcccc-CCcccCCCCCCcE
Q 002189 184 SPG--------------L----DMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGE-LPATLGLVKSLEV 244 (955)
Q Consensus 184 ~~~--------------l----~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~ 244 (955)
++. + ..+++|++|+|++|.+++.....+....++|+.|++++| ++.. ++.....+++|+.
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence 110 1 134667777777777664433444445566777777766 3322 2222334677777
Q ss_pred EEcc---------cCCCCCCcccccc-CCCCCCEEEccCCcCcccCC-CCC-CCCCCCEEECc--C----CCCCCCC---
Q 002189 245 VRFD---------RNSLSGPVPSNLN-NLTSVNDLYLSNNKLTGAMP-NLT-GLSVLSYLDMS--N----NSFDASE--- 303 (955)
Q Consensus 245 L~Ls---------~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~-~~~-~l~~L~~L~Ls--~----N~l~~~~--- 303 (955)
|+++ .|.+++.....+. .+++|+.|+++.|.+++... .+. .+++|+.|+|+ + |.++...
T Consensus 343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~ 422 (594)
T 2p1m_B 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI 422 (594)
T ss_dssp EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH
T ss_pred EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh
Confidence 7773 3445433222232 36777777777777765433 232 46788888888 4 5554211
Q ss_pred -CChhhcCCCCCCEEECcCCcceecCCcCCCC-CCCCcEEEeecCcceeeeCCC--cchhhhhhhcccCCccccccCC-C
Q 002189 304 -VPSWFSSMQSLTTLMMENTNLKGQIPADLFS-IPHLQTVVMKTNELNGTLDLG--TSYSENLLVNLQNNRISAYTER-G 378 (955)
Q Consensus 304 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~~~~--~~~~~l~~L~L~~N~l~~~~~~-~ 378 (955)
++..+.++++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..... ..+++|+.|+|++|+++..... .
T Consensus 423 ~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~ 501 (594)
T 2p1m_B 423 GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN 501 (594)
T ss_dssp HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHT
T ss_pred HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHH
Confidence 122356778888888877 666555555554 788889999888886643322 2366788889998888654433 2
Q ss_pred CCCCcceeEecCcch
Q 002189 379 GAPAVNLTLIDNPIC 393 (955)
Q Consensus 379 ~~~~~~L~~l~n~~c 393 (955)
...+.+|+.++...|
T Consensus 502 ~~~l~~L~~L~l~~~ 516 (594)
T 2p1m_B 502 ASKLETMRSLWMSSC 516 (594)
T ss_dssp GGGGGGSSEEEEESS
T ss_pred HHhCCCCCEEeeeCC
Confidence 233455665555444
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.9e-18 Score=183.53 Aligned_cols=136 Identities=16% Similarity=0.178 Sum_probs=104.7
Q ss_pred CCccCeeeccCceEEEEEEe-CCCcE--EEEEEcccCCcc------------------------hhHHHHHHHHHHHhcc
Q 002189 630 FSDANDVGSGGYGKVYKGTL-PNGQL--IAIKRAQQGSMQ------------------------GGQEFKMEIELLSRVH 682 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 682 (955)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999997 68889 999987543111 0135788999999999
Q ss_pred CCCc--ceEEEEEEeCCeEEEEEEecC-CC----CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hccCCCeeccC
Q 002189 683 HKNL--VSLLGFCFDRGEQMLIYEFVP-NG----SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH-ELANPPIIHRD 754 (955)
Q Consensus 683 H~ni--v~l~~~~~~~~~~~lV~e~~~-~g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrD 754 (955)
|+++ ..++++ +..+|||||+. +| +|.++... .++.....++.|++.||.||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8864 344432 35689999995 25 44433221 224456789999999999999 888 99999
Q ss_pred CCCccEEEcCCCceEEeeccccccc
Q 002189 755 IKSSNILLDERLNAKVADFGLSKSM 779 (955)
Q Consensus 755 lk~~NIll~~~~~~kl~DFGla~~~ 779 (955)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 8999999999764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-17 Score=171.85 Aligned_cols=103 Identities=17% Similarity=0.155 Sum_probs=51.8
Q ss_pred EEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCC-CCcccccccccccccccccCCCCCCccccCCCCcEEEccC
Q 002189 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLP-TTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146 (955)
Q Consensus 68 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 146 (955)
.|++++++++. +|..+. ..+++|+|++|+ +.+..| ..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNE-FTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSC-CCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCc-CCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 55666677663 454432 234666666665 555433 2345555555555555555544444455555555555555
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
|+|++..+..|.++++|++|+|++|+|+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 118 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRIT 118 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCC
Confidence 5554444444444444444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=9e-18 Score=180.21 Aligned_cols=82 Identities=20% Similarity=0.270 Sum_probs=69.9
Q ss_pred CCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCe
Q 002189 86 GLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYW 165 (955)
Q Consensus 86 ~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~ 165 (955)
.+.++..++|++|. +.+. + .+..+++|++|++++|+++ .+| .+..+++|++|+|++|+|++..+ +.++++|++
T Consensus 17 ~l~~l~~l~l~~~~-i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQS-VTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSC-TTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred HHHHHHHHHhcCCC-cccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence 46778888999986 6544 3 6889999999999999998 566 68999999999999999996554 999999999
Q ss_pred eecCCceee
Q 002189 166 LDLTDNKLE 174 (955)
Q Consensus 166 L~L~~N~l~ 174 (955)
|+|++|+++
T Consensus 90 L~L~~N~l~ 98 (263)
T 1xeu_A 90 LSVNRNRLK 98 (263)
T ss_dssp EECCSSCCS
T ss_pred EECCCCccC
Confidence 999999987
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.9e-17 Score=166.44 Aligned_cols=132 Identities=18% Similarity=0.231 Sum_probs=69.0
Q ss_pred ccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccc
Q 002189 132 SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKL 211 (955)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~ 211 (955)
....+++|++|++++|.|+ .+| .+..+++|++|++++|.++ ..+.+..+
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--------~~~~l~~l--------------------- 87 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--------NYNPISGL--------------------- 87 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--------CCGGGTTC---------------------
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--------cchhhhcC---------------------
Confidence 3466777777777777777 455 5777777777777777554 01111112
Q ss_pred cCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCc-CcccCCCCCCCCCCC
Q 002189 212 FRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK-LTGAMPNLTGLSVLS 290 (955)
Q Consensus 212 ~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~l~~L~ 290 (955)
++|++|++++|++++..+..++.+++|++|+|++|.+++..|..+..+++|+.|+|++|. ++.. +.+..+++|+
T Consensus 88 ----~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~ 162 (197)
T 4ezg_A 88 ----SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELK 162 (197)
T ss_dssp ----TTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCC
T ss_pred ----CCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCC
Confidence 223333333333333344445555555555555555555455555555555555555554 3332 2344444444
Q ss_pred EEECcCCCC
Q 002189 291 YLDMSNNSF 299 (955)
Q Consensus 291 ~L~Ls~N~l 299 (955)
+|+|++|++
T Consensus 163 ~L~l~~n~i 171 (197)
T 4ezg_A 163 SLNIQFDGV 171 (197)
T ss_dssp EEECTTBCC
T ss_pred EEECCCCCC
Confidence 444444444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-19 Score=218.36 Aligned_cols=301 Identities=14% Similarity=0.081 Sum_probs=198.1
Q ss_pred CCEeEEEecCC-cCccc-cCcCcCCCCcccEEecCCCCCCccCCCCCcc----cccccccccccccc--cCC-CCCCccc
Q 002189 64 SRVTSITLSGM-GLKGQ-LSGDITGLTELHTLDLSNNKDLRGPLPTTIG----NLKKLSNLMLVGCS--FSG-PIPDSIG 134 (955)
Q Consensus 64 ~~v~~L~L~~~-~l~~~-~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~----~l~~L~~L~Ls~N~--l~~-~~p~~~~ 134 (955)
.+++.|+|++| .++.. ++..+..+++|++|+|++|. +++..+..+. .+++|++|+|++|. ++. .++..+.
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~-i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESD-VDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCE-EECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCc-cCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHH
Confidence 47778888777 44432 33334467778888887775 5554433332 45577777777775 110 0111123
Q ss_pred cCCCCcEEEccCCC--------------------------------------------------CcC----cCCCCCCCC
Q 002189 135 SLQELVLLSLNSNG--------------------------------------------------FSG----RVPPSIGNL 160 (955)
Q Consensus 135 ~l~~L~~L~Ls~N~--------------------------------------------------l~~----~~p~~~~~L 160 (955)
.+++|++|+|++|. +.. .++..+..+
T Consensus 209 ~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~ 288 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288 (594)
T ss_dssp HCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHH
T ss_pred hCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhh
Confidence 34666666666651 111 112222356
Q ss_pred CCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec---------cCCCcccc
Q 002189 161 SNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF---------DSNNLTGE 231 (955)
Q Consensus 161 ~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L---------~~N~l~~~ 231 (955)
++|++|+|++|.+++.... ..+..+++|+.|++++| ++......+....++|++|++ ..+.+++.
T Consensus 289 ~~L~~L~L~~~~l~~~~l~-----~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLV-----KLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp TTCCEEECTTCCCCHHHHH-----HHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred CCCCEEEccCCCCCHHHHH-----HHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 8899999999887643211 11345678899999988 542222233334677999988 44566654
Q ss_pred CCcccC-CCCCCcEEEcccCCCCCCcccccc-CCCCCCEEEcc--C----CcCcccCC------CCCCCCCCCEEECcCC
Q 002189 232 LPATLG-LVKSLEVVRFDRNSLSGPVPSNLN-NLTSVNDLYLS--N----NKLTGAMP------NLTGLSVLSYLDMSNN 297 (955)
Q Consensus 232 ~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls--~----N~l~~~~~------~~~~l~~L~~L~Ls~N 297 (955)
....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.+++.+. -+..+++|+.|+|++
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~- 441 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG- 441 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-
Confidence 444443 489999999999999876666665 58999999999 4 66664332 145688999999987
Q ss_pred CCCCCCCChhhcC-CCCCCEEECcCCcceecCCcCC-CCCCCCcEEEeecCcceeeeCC-C-cchhhhhhhcccCCcccc
Q 002189 298 SFDASEVPSWFSS-MQSLTTLMMENTNLKGQIPADL-FSIPHLQTVVMKTNELNGTLDL-G-TSYSENLLVNLQNNRISA 373 (955)
Q Consensus 298 ~l~~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~-~-~~~~~l~~L~L~~N~l~~ 373 (955)
.++. ..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++.... . ..+.+|+.|++++|+++.
T Consensus 442 ~l~~-~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 442 LLTD-KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp SCCH-HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred cccH-HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 6654 23344444 8999999999999987655555 5689999999999999654332 3 347889999999999853
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.68 E-value=7.5e-17 Score=165.07 Aligned_cols=155 Identities=13% Similarity=0.186 Sum_probs=106.6
Q ss_pred CcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCch
Q 002189 108 TIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL 187 (955)
Q Consensus 108 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l 187 (955)
....+++|++|++++|.++ .+| .+..+++|++|++++|.++. + ..+..+++|++|+|++|++++..|..++.
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~-~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~---- 110 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN-Y-NPISGLSNLERLRIMGKDVTSDKIPNLSG---- 110 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC-C-GGGTTCTTCCEEEEECTTCBGGGSCCCTT----
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc-c-hhhhcCCCCCEEEeECCccCcccChhhcC----
Confidence 3466777777777777777 555 57777778888888776652 2 36777777888888777777544443322
Q ss_pred hhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCC-CCCCccccccCCCCC
Q 002189 188 DMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNS-LSGPVPSNLNNLTSV 266 (955)
Q Consensus 188 ~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L 266 (955)
+ ++|+.|+|++|++++..|..+..+++|++|+|++|. ++ .+| .+..+++|
T Consensus 111 --l-------------------------~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L 161 (197)
T 4ezg_A 111 --L-------------------------TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPEL 161 (197)
T ss_dssp --C-------------------------TTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSC
T ss_pred --C-------------------------CCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCC
Confidence 2 234444444445555566677788888888888887 55 555 68888888
Q ss_pred CEEEccCCcCcccCCCCCCCCCCCEEECcCCCCC
Q 002189 267 NDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 267 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 300 (955)
+.|+|++|.+++.+ .+..+++|++|++++|+|.
T Consensus 162 ~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 162 KSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CEEECTTBCCCCCT-TGGGCSSCCEEEECBC---
T ss_pred CEEECCCCCCcChH-HhccCCCCCEEEeeCcccC
Confidence 88888888888755 6677778888888888764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-17 Score=203.02 Aligned_cols=169 Identities=21% Similarity=0.284 Sum_probs=115.5
Q ss_pred CEeEEEecCCcCcc---------ccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCcccc
Q 002189 65 RVTSITLSGMGLKG---------QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGS 135 (955)
Q Consensus 65 ~v~~L~L~~~~l~~---------~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 135 (955)
.+..++|+++.|.+ ..+..|..++.|+.|+|++|+ +. .+|..+.++++|++|+|++|.|+ .+|..|++
T Consensus 192 ~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~-l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 268 (727)
T 4b8c_D 192 LLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQ-IF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKN 268 (727)
T ss_dssp ------------------------------CCCCCCEEECTTSC-CS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGG
T ss_pred HhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCC-CC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhC
Confidence 34445555555443 457789999999999999997 55 77888889999999999999999 88999999
Q ss_pred CCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCc
Q 002189 136 LQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPD 215 (955)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~ 215 (955)
|++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..++. |.+|+.|+|++|+|+|.+|..++...
T Consensus 269 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~------l~~L~~L~L~~N~l~~~~p~~~~~~~ 340 (727)
T 4b8c_D 269 LSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGN------LCNLQFLGVEGNPLEKQFLKILTEKS 340 (727)
T ss_dssp GTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTS------CTTCCCEECTTSCCCSHHHHHHHHHH
T ss_pred CCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhc------CCCccEEeCCCCccCCCChHHHhhcc
Confidence 999999999999999 78999999999999999999997 77766544 56678888999988877776665443
Q ss_pred cceeeeeccCCCccccCCcccCCCCCCcEEEcccC
Q 002189 216 MVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 250 (955)
Q Consensus 216 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 250 (955)
..+..|+|++|.+++.+|.. |+.|+++.|
T Consensus 341 ~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 341 VTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp HHHHHHHHHHCCCCCCCCCC---------------
T ss_pred hhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 34445677777777776653 344555555
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-16 Score=159.73 Aligned_cols=138 Identities=17% Similarity=0.196 Sum_probs=91.6
Q ss_pred CCcEEEcccCCCCCCccc-cccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEE
Q 002189 241 SLEVVRFDRNSLSGPVPS-NLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 318 (955)
Q Consensus 241 ~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 318 (955)
+|++|+|++|.|++..+. .|..+++|+.|+|++|.|++..+ .+.++++|++|+|++|+|++ ..+..|.++++|+.|+
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE-ECSSSSTTCTTCCEEE
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCc-cCHHHhcCCCCCCEEE
Confidence 556666666666544332 35666666666666666666644 46666666666667776654 4555677788888888
Q ss_pred CcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCC
Q 002189 319 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGG 379 (955)
Q Consensus 319 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~ 379 (955)
|++|+|++..|..+..+++|++|+|++|++++..+..+-...+....+..+......|...
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~l 169 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChHH
Confidence 8888888888889999999999999999999876643322334444555555554444433
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.9e-16 Score=161.41 Aligned_cols=133 Identities=23% Similarity=0.270 Sum_probs=111.7
Q ss_pred eEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCC-CcccccccccccccccccCCCCCCccccCCCCcEEEcc
Q 002189 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPT-TIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLN 145 (955)
Q Consensus 67 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 145 (955)
+.|++++++++ .+|..+.. +|++|+|++|+ +.+..+. .|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~-i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNE-LGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCC-CCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCc-CCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 35677777886 56665543 89999999997 7777664 48999999999999999998889999999999999999
Q ss_pred CCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCc
Q 002189 146 SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPE 209 (955)
Q Consensus 146 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~ 209 (955)
+|+|++..+..|.++++|++|+|++|+|++.+|..+.. +++|++|+|++|.+++..+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH------LNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTT------CTTCCEEECTTCCBCCSGGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhc------CCCCCEEEeCCCCccCcCcc
Confidence 99999888888999999999999999999888876544 56678889999998876554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=152.33 Aligned_cols=139 Identities=23% Similarity=0.318 Sum_probs=98.2
Q ss_pred CCCCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCC
Q 002189 50 DPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPI 129 (955)
Q Consensus 50 ~~C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 129 (955)
+.|.|.|.+|.|+.. +++ .+|..+ .++|++|+|++|+ +.+..+..|.++++|++|+|++|++++..
T Consensus 3 ~~C~C~~~~l~~~~~----------~l~-~~p~~~--~~~l~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK----------GLT-SVPTGI--PSSATRLELESNK-LQSLPHGVFDKLTQLTKLSLSQNQIQSLP 68 (177)
T ss_dssp TTCEEETTEEECCSS----------CCS-SCCTTC--CTTCSEEECCSSC-CCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCCEeCCCEEEecCC----------CCc-cCCCCC--CCCCcEEEeCCCc-ccEeCHHHhcCcccccEEECCCCcceEeC
Confidence 457677888877643 343 233222 2578888888886 77666667788888888888888888666
Q ss_pred CCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCC
Q 002189 130 PDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIP 208 (955)
Q Consensus 130 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip 208 (955)
+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++ +|... +..+++|++|+|++|++++..|
T Consensus 69 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~-----~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 69 DGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS-VPDGI-----FDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTT-----TTTCTTCCEEECCSSCBCCCHH
T ss_pred hhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE-eCHHH-----hcCCcccCEEEecCCCeeccCc
Confidence 6667888888888888888886666667888888888888888873 33321 3345667778888888876554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.60 E-value=6.9e-16 Score=171.32 Aligned_cols=289 Identities=13% Similarity=0.071 Sum_probs=158.1
Q ss_pred cccCcCcCC--CCcccEEecCCCCCCccCCCCCccc-ccccccccccccccC--CCCCCccccCCCCcEEEccCCCCcCc
Q 002189 78 GQLSGDITG--LTELHTLDLSNNKDLRGPLPTTIGN-LKKLSNLMLVGCSFS--GPIPDSIGSLQELVLLSLNSNGFSGR 152 (955)
Q Consensus 78 ~~~~~~l~~--l~~L~~L~Ls~N~~l~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~ 152 (955)
|.++..+.. +.+|++|.++++ +...--..+.. +++|+.|+|++|++. ...+. .++.+..+.+..|.|.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~--i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I~-- 85 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK--LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFVP-- 85 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE--ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEEC--
T ss_pred CcHHhhccchhhCceeEEEEecc--ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccccC--
Confidence 344444443 667788888765 22111112223 556777777777776 22222 2222455555555332
Q ss_pred CCCCCCC--------CCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeecc
Q 002189 153 VPPSIGN--------LSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD 224 (955)
Q Consensus 153 ~p~~~~~--------L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~ 224 (955)
+.+|.+ +++|+.|+|.+ +++ .|+. ..+..+.+|+.|++.+|.++ .|+...|.....+..+.+.
T Consensus 86 -~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~-----~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~ 156 (329)
T 3sb4_A 86 -AYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIED-----AAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLG 156 (329)
T ss_dssp -TTTTEEEETTEEEECTTCCC-CBCT-TCC-EECT-----TTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTT
T ss_pred -HHHhcccccccccccCCCcEEECCc-ccc-chhH-----HHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCc
Confidence 345666 77777777777 555 2332 12344555666677777666 6666666665555555544
Q ss_pred CCC----ccccCCcccCCCCCCc-EEEcccCCCCCCccccc----cCCCCCCEEEccCCcCcccCCCCC-CCCCCCEEEC
Q 002189 225 SNN----LTGELPATLGLVKSLE-VVRFDRNSLSGPVPSNL----NNLTSVNDLYLSNNKLTGAMPNLT-GLSVLSYLDM 294 (955)
Q Consensus 225 ~N~----l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~l----~~l~~L~~L~Ls~N~l~~~~~~~~-~l~~L~~L~L 294 (955)
.+. .......+|..+.+|+ .+.+.... .++..+ ....++..+.+.++-.......+. .+++|+.|+|
T Consensus 157 ~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L 233 (329)
T 3sb4_A 157 SSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDI 233 (329)
T ss_dssp CTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEEC
T ss_pred chhhhhccccccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEEC
Confidence 421 1112233344444444 33332211 112111 123344444444332111111111 2567777777
Q ss_pred cCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCc-EEEeecCcceeeeCCCcc-hhhhhhhcccCCccc
Q 002189 295 SNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQ-TVVMKTNELNGTLDLGTS-YSENLLVNLQNNRIS 372 (955)
Q Consensus 295 s~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~l~ 372 (955)
++|+++. .....|.++++|+.|+|.+| ++..-+..|.++++|+ .|+|.+ .++.+.+..|. +.+|+.++|++|.++
T Consensus 234 ~~n~i~~-I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~ 310 (329)
T 3sb4_A 234 SKTNATT-IPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT 310 (329)
T ss_dssp TTBCCCE-ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred CCCCcce-ecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence 7777754 45556777777777777776 6656666677777777 777777 66666655554 456667777778888
Q ss_pred cccCCCCCCCcceeEe
Q 002189 373 AYTERGGAPAVNLTLI 388 (955)
Q Consensus 373 ~~~~~~~~~~~~L~~l 388 (955)
.+...+|.+..+|+.+
T Consensus 311 ~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 311 TLGDELFGNGVPSKLI 326 (329)
T ss_dssp EECTTTTCTTCCCCEE
T ss_pred ccchhhhcCCcchhhh
Confidence 8888888887777665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.9e-15 Score=166.53 Aligned_cols=138 Identities=14% Similarity=0.145 Sum_probs=100.5
Q ss_pred CCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc--------------hhHH--------HHHHHHHHHhccCCCc
Q 002189 629 NFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--------------GGQE--------FKMEIELLSRVHHKNL 686 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------------~~~~--------~~~E~~~l~~l~H~ni 686 (955)
-|.+.++||+|+||.||+|...+|+.||||+++..... .... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 37888999999999999999889999999987632110 0011 2346667777755444
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC
Q 002189 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL 766 (955)
Q Consensus 687 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~ 766 (955)
.-..-+.. ...+|||||+++++|.+..... ....++.|++.+|.|||+.| ||||||||.|||+++++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~~--------~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSVP--------DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCCS--------CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhcccH--------HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence 21111111 1347999999998887765321 12467889999999999998 99999999999998877
Q ss_pred ----------ceEEeeccccccc
Q 002189 767 ----------NAKVADFGLSKSM 779 (955)
Q Consensus 767 ----------~~kl~DFGla~~~ 779 (955)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999977643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.59 E-value=8e-16 Score=170.82 Aligned_cols=203 Identities=11% Similarity=0.042 Sum_probs=131.6
Q ss_pred ccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeec----cCCCCCCCCch
Q 002189 112 LKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGE----IPVSDGNSPGL 187 (955)
Q Consensus 112 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~----ip~~~~~~~~l 187 (955)
+++|+.|+|.+ +++..-+.+|.++++|+.|+|++|.++...+.+|.++.++..|.+..+..... -...+.++..+
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 77777777777 66645555677777777777777777655566676666666666555322100 00001011111
Q ss_pred h--------------------hhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEc
Q 002189 188 D--------------------MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 247 (955)
Q Consensus 188 ~--------------------~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 247 (955)
. .+.+++.+.+.++-.. .-...+.....+|+.|+|++|+++...+.+|..+++|+.|+|
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 1 0111122222211000 000011112567999999999999777788999999999999
Q ss_pred ccCCCCCCccccccCCCCCC-EEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEEC
Q 002189 248 DRNSLSGPVPSNLNNLTSVN-DLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMM 319 (955)
Q Consensus 248 s~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~L 319 (955)
.+| ++...+..|.++++|+ .|+|.+ .++.+.+ .|.++++|+.|+|+.|+++. ..+..|.++++|+.|+.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~-I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITT-LGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCE-ECTTTTCTTCCCCEEEC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCc-cchhhhcCCcchhhhcc
Confidence 988 7766678899999999 999988 7777766 58889999999999999975 56778999999998874
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.1e-15 Score=150.01 Aligned_cols=133 Identities=19% Similarity=0.219 Sum_probs=77.1
Q ss_pred cceeeeeccCCCcc-ccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCC-CCCCCCCCEEE
Q 002189 216 MVLIHVLFDSNNLT-GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLD 293 (955)
Q Consensus 216 ~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~ 293 (955)
..|+.|++++|+++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+++.++. +..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44666666666665 55566666666666666666666643 5566666666666666666664443 33366666666
Q ss_pred CcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCC---cCCCCCCCCcEEEeecCccee
Q 002189 294 MSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP---ADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 294 Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
|++|.+++...+..+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 666666542222455666666666666666663333 255556666666666665543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.1e-15 Score=149.90 Aligned_cols=137 Identities=16% Similarity=0.148 Sum_probs=98.9
Q ss_pred CCCCcEEEcccCCCC-CCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEE
Q 002189 239 VKSLEVVRFDRNSLS-GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 317 (955)
Q Consensus 239 l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 317 (955)
.++|+.|++++|.++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|++|+|++|.+++ .+|..+..+++|+.|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFG-GLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCS-CCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCch-HHHHHHhhCCCCCEE
Confidence 467777777777776 66777777777777888877777776 667777777788888777765 366767777777888
Q ss_pred ECcCCcceec-CCcCCCCCCCCcEEEeecCcceeeeC----CCcchhhhhhhcccCCccccccCC
Q 002189 318 MMENTNLKGQ-IPADLFSIPHLQTVVMKTNELNGTLD----LGTSYSENLLVNLQNNRISAYTER 377 (955)
Q Consensus 318 ~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~~~l~~L~L~~N~l~~~~~~ 377 (955)
+|++|++++. .+..+..+++|+.|+|++|++++.++ .+..+++|+.|++++|.+..++..
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcccc
Confidence 8887777753 22667777777788888777777665 334466777777777777766543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-14 Score=148.57 Aligned_cols=112 Identities=20% Similarity=0.302 Sum_probs=87.3
Q ss_pred CCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEE
Q 002189 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 318 (955)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 318 (955)
++|+.|+|++|.|+ .+|..|.++++|+.|+|++|.|+++++ .|.++++|++|+|++|+|++ ..+..|.++++|+.|+
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~L~ 108 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLS 108 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCE-eCHHHhCCCCCCCEEE
Confidence 46777777777777 666777777777777777777777766 47777888888888888865 5566788888888888
Q ss_pred CcCCcceecCCcCCCCCCCCcEEEeecCcceeeeC
Q 002189 319 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLD 353 (955)
Q Consensus 319 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 353 (955)
|++|+|++..+..|..+++|+.|+|++|++.+...
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 109 LHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 88888886666678889999999999999987554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-13 Score=156.40 Aligned_cols=269 Identities=11% Similarity=0.102 Sum_probs=194.0
Q ss_pred CCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcC
Q 002189 85 TGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 164 (955)
Q Consensus 85 ~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~ 164 (955)
.....++.+.+-++ ++.+-..+|.+. +|+.+.|..| ++..-..+|.+. +|+.+.|.. .++..-+.+|.++++|+
T Consensus 110 ~~~~~l~~i~ip~~--i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~ 183 (401)
T 4fdw_A 110 EILKGYNEIILPNS--VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLK 183 (401)
T ss_dssp EECSSCSEEECCTT--CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCC
T ss_pred EecCCccEEEECCc--cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCC
Confidence 34467778888765 566667777774 7888888766 664555667774 688888875 66656667888888888
Q ss_pred eeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcE
Q 002189 165 WLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEV 244 (955)
Q Consensus 165 ~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 244 (955)
.++|.+|+++ .+|..... ..+|+.+.|..+ ++ .|+...|....+|+.+.+..| ++..-..+|.. .+|+.
T Consensus 184 ~l~l~~n~l~-~I~~~aF~------~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~ 252 (401)
T 4fdw_A 184 KADLSKTKIT-KLPASTFV------YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITT 252 (401)
T ss_dssp EEECTTSCCS-EECTTTTT------TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSE
T ss_pred eeecCCCcce-EechhhEe------ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccE
Confidence 8888888887 45543222 246677777744 66 788888888888888888764 66566667777 78888
Q ss_pred EEcccCCCCCCccccccCCCCCCEEEccCCcCc-----ccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEE
Q 002189 245 VRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLT-----GAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 318 (955)
Q Consensus 245 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-----~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 318 (955)
+.| .|.++......|.++++|+.+++.+|.+. .+.. .|.++++|+.++|.+ .++. .....|.++++|+.|.
T Consensus 253 i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~-I~~~aF~~c~~L~~l~ 329 (401)
T 4fdw_A 253 VKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRI-LGQGLLGGNRKVTQLT 329 (401)
T ss_dssp EEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCE-ECTTTTTTCCSCCEEE
T ss_pred EEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEE-EhhhhhcCCCCccEEE
Confidence 888 45566556778888888888888888776 3443 578888888888884 4653 5667788888899988
Q ss_pred CcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hh-hhhhhcccCCcccccc
Q 002189 319 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YS-ENLLVNLQNNRISAYT 375 (955)
Q Consensus 319 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~-~l~~L~L~~N~l~~~~ 375 (955)
|.+| ++......|.++ +|+.|++++|.+....+..+. +. .+..|++..|.+....
T Consensus 330 lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~y~ 386 (401)
T 4fdw_A 330 IPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEKYK 386 (401)
T ss_dssp ECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHHHH
T ss_pred ECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHHhh
Confidence 8655 666777788888 899999988888776655544 32 4557777777666443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.3e-14 Score=144.77 Aligned_cols=127 Identities=22% Similarity=0.335 Sum_probs=105.1
Q ss_pred ccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccC
Q 002189 194 KHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN 273 (955)
Q Consensus 194 ~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 273 (955)
+.+++++|+++ .+|..++ ..|++|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|.++++|+.|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 34566666666 6776554 46788888888887 6778899999999999999999987788899999999999999
Q ss_pred CcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCccee
Q 002189 274 NKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKG 326 (955)
Q Consensus 274 N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 326 (955)
|+|+++++ .|.++++|++|+|++|+|+. ..+..|..+++|+.|+|++|++..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCe-eChhhhhcCccccEEEeCCCCeec
Confidence 99999887 48889999999999999975 455578899999999999999873
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.7e-14 Score=141.43 Aligned_cols=114 Identities=19% Similarity=0.257 Sum_probs=88.4
Q ss_pred CCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEE
Q 002189 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLM 318 (955)
Q Consensus 240 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~ 318 (955)
++|+.|++++|++++..+..|..+++|++|+|++|.|++.++. +..+++|++|+|++|.|++ ..+..|..+++|+.|+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELA 106 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccc-cCHHHhhCCcccCEEE
Confidence 5677777777777766566677778888888888888777664 5778888888888888875 4555678888888888
Q ss_pred CcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCC
Q 002189 319 MENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL 354 (955)
Q Consensus 319 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 354 (955)
|++|++++..+..+..+++|+.|+|++|++++..+.
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 888888866666678899999999999999886653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.9e-13 Score=155.26 Aligned_cols=261 Identities=13% Similarity=0.089 Sum_probs=208.2
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
....++.+.+.+ .++..-..+|.+. +|+.+.|..| ++..-..+|.+ .+|+.+.|.+ .++ .|+. ..+..+
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~-~I~~-----~aF~~c 179 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLE-QLKE-----DIFYYC 179 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCC-EECS-----STTTTC
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-Ccc-EehH-----HHhhCc
Confidence 346677777764 4554556778875 7999999877 77566778888 5799999986 555 2322 235667
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
.+|+.++|..|+++ .|+...|.. ..|+.+.|.. ++...-..+|..+++|+.++|..| ++..-..+|.+ .+|+.+.
T Consensus 180 ~~L~~l~l~~n~l~-~I~~~aF~~-~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~ 254 (401)
T 4fdw_A 180 YNLKKADLSKTKIT-KLPASTFVY-AGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVK 254 (401)
T ss_dssp TTCCEEECTTSCCS-EECTTTTTT-CCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEE
T ss_pred ccCCeeecCCCcce-EechhhEee-cccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEE
Confidence 78899999999999 999999984 7899999984 488778889999999999999975 56455677777 8999999
Q ss_pred ccCCcCcccCC-CCCCCCCCCEEECcCCCCCC----CCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeec
Q 002189 271 LSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDA----SEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKT 345 (955)
Q Consensus 271 Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 345 (955)
| .|.++.+.. .|.++++|+.+++.+|.+.. ......|.++++|+.++|. |.++..-...|.++++|+.|+|..
T Consensus 255 l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 255 L-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPA 332 (401)
T ss_dssp E-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECT
T ss_pred e-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECc
Confidence 9 566777766 68999999999999998741 1467789999999999999 458877888899999999999965
Q ss_pred CcceeeeCCCcchhhhhhhcccCCccccccCCCCCCC-cceeEecC
Q 002189 346 NELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPA-VNLTLIDN 390 (955)
Q Consensus 346 N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~-~~L~~l~n 390 (955)
| ++......|...+|+.+++++|.+..+....|.+. .++..+.-
T Consensus 333 ~-l~~I~~~aF~~~~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~v 377 (401)
T 4fdw_A 333 N-VTQINFSAFNNTGIKEVKVEGTTPPQVFEKVWYGFPDDITVIRV 377 (401)
T ss_dssp T-CCEECTTSSSSSCCCEEEECCSSCCBCCCSSCCCSCTTCCEEEE
T ss_pred c-ccEEcHHhCCCCCCCEEEEcCCCCcccccccccCCCCCccEEEe
Confidence 5 88877777776688899999999999999888776 34444433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.53 E-value=3.3e-15 Score=145.30 Aligned_cols=127 Identities=18% Similarity=0.219 Sum_probs=66.3
Q ss_pred cceeeeeccCCCcc-ccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCC-CCCCCCCCEEE
Q 002189 216 MVLIHVLFDSNNLT-GELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYLD 293 (955)
Q Consensus 216 ~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~ 293 (955)
.+|+.|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|+|++|.+++.++. +..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34555555555555 45555555555566666666555533 4555555555555555555553332 33355555555
Q ss_pred CcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCC---cCCCCCCCCcEEEee
Q 002189 294 MSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIP---ADLFSIPHLQTVVMK 344 (955)
Q Consensus 294 Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls 344 (955)
|++|.+++...+..+..+++|+.|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555431122445555555555555555554333 244555555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.52 E-value=8e-15 Score=142.60 Aligned_cols=129 Identities=16% Similarity=0.172 Sum_probs=112.2
Q ss_pred CCCCCcEEEcccCCCC-CCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCE
Q 002189 238 LVKSLEVVRFDRNSLS-GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 316 (955)
Q Consensus 238 ~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 316 (955)
..++|+.|++++|.++ +.+|..+..+++|+.|+|++|.+++. +.+..+++|++|+|++|.+++ .+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSG-GLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCS-CTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccc-hHHHHhhhCCCCCE
Confidence 3478999999999998 78999999999999999999999988 778999999999999999976 47888888999999
Q ss_pred EECcCCcceec-CCcCCCCCCCCcEEEeecCcceeeeC----CCcchhhhhhhcccC
Q 002189 317 LMMENTNLKGQ-IPADLFSIPHLQTVVMKTNELNGTLD----LGTSYSENLLVNLQN 368 (955)
Q Consensus 317 L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~~~l~~L~L~~ 368 (955)
|++++|.+++. .+..+..+++|++|+|++|++++.++ .+..+++|+.|++++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999999973 45889999999999999999998766 233466777777753
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=3.8e-14 Score=142.00 Aligned_cols=129 Identities=16% Similarity=0.233 Sum_probs=64.9
Q ss_pred ccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCC-CCCCCCCEEE
Q 002189 215 DMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNL-TGLSVLSYLD 293 (955)
Q Consensus 215 ~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~l~~L~~L~ 293 (955)
..+|+.|++++|+++. +|......++|+.|+|++|.|++. ..|..+++|+.|+|++|.|++.++.+ ..+++|++|+
T Consensus 18 ~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 3445555555555553 233222222555555555555532 44555555555555555555554443 4455555555
Q ss_pred CcCCCCCCCCCCh--hhcCCCCCCEEECcCCcceecCCcC----CCCCCCCcEEEeecCcce
Q 002189 294 MSNNSFDASEVPS--WFSSMQSLTTLMMENTNLKGQIPAD----LFSIPHLQTVVMKTNELN 349 (955)
Q Consensus 294 Ls~N~l~~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 349 (955)
|++|+|+. +|. .+..+++|+.|++++|+++ .+|.. +..+++|+.||+++|.+.
T Consensus 95 L~~N~i~~--~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLVE--LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCCC--GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCCc--chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 55555532 333 4555555555555555554 33332 444555555555555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.1e-16 Score=161.83 Aligned_cols=131 Identities=23% Similarity=0.352 Sum_probs=71.3
Q ss_pred cccccccccccccccccCCCCCC------ccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCC
Q 002189 109 IGNLKKLSNLMLVGCSFSGPIPD------SIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 182 (955)
Q Consensus 109 ~~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~ 182 (955)
+.....++.++++.+.+++.+|. .|..+++|++|+|++|+|++ +| .+.++++|++|+|++|+++
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-------- 83 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-------- 83 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC--------
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc--------
Confidence 34455666666666666666555 45555555555555555553 34 4555555555555555544
Q ss_pred CCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccC
Q 002189 183 NSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNN 262 (955)
Q Consensus 183 ~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 262 (955)
.+|..+..+++|+.|+|++|++++ +| .+..
T Consensus 84 ------------------------------------------------~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~ 113 (198)
T 1ds9_A 84 ------------------------------------------------KIENLDAVADTLEELWISYNQIAS-LS-GIEK 113 (198)
T ss_dssp ------------------------------------------------SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHH
T ss_pred ------------------------------------------------cccchhhcCCcCCEEECcCCcCCc-CC-cccc
Confidence 122233334567777777777764 44 4666
Q ss_pred CCCCCEEEccCCcCcccCC--CCCCCCCCCEEECcCCCC
Q 002189 263 LTSVNDLYLSNNKLTGAMP--NLTGLSVLSYLDMSNNSF 299 (955)
Q Consensus 263 l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l 299 (955)
+++|+.|+|++|.|++.++ .+..+++|++|++++|++
T Consensus 114 l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l 152 (198)
T 1ds9_A 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHH
T ss_pred CCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcc
Confidence 6666666666666654332 344444444444444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-15 Score=156.21 Aligned_cols=87 Identities=21% Similarity=0.265 Sum_probs=76.5
Q ss_pred cCCCCcccEEecCCCCCCccCCCC------CcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCC
Q 002189 84 ITGLTELHTLDLSNNKDLRGPLPT------TIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI 157 (955)
Q Consensus 84 l~~l~~L~~L~Ls~N~~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 157 (955)
+.....++.++|+.+. +.+.+|. .|..+++|++|+|++|++++ +| .+..+++|++|+|++|+|+ .+|..+
T Consensus 14 ~~~~~~l~~l~l~~~~-l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~ 89 (198)
T 1ds9_A 14 FEERKSVVATEAEKVE-LHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD 89 (198)
T ss_dssp HHHTTCCCCTTCSEEE-CCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred HHhcccccCcchheeE-eccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh
Confidence 4556788888888886 8888787 89999999999999999995 77 8999999999999999999 678778
Q ss_pred CCCCCcCeeecCCceee
Q 002189 158 GNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 158 ~~L~~L~~L~L~~N~l~ 174 (955)
..+++|++|+|++|+++
T Consensus 90 ~~~~~L~~L~L~~N~l~ 106 (198)
T 1ds9_A 90 AVADTLEELWISYNQIA 106 (198)
T ss_dssp HHHHHCSEEEEEEEECC
T ss_pred hcCCcCCEEECcCCcCC
Confidence 88889999999988887
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.44 E-value=7.1e-14 Score=140.07 Aligned_cols=136 Identities=13% Similarity=0.123 Sum_probs=106.1
Q ss_pred ccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCC
Q 002189 235 TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSL 314 (955)
Q Consensus 235 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L 314 (955)
.+..+.+|+.|++++|.++ .+|......++|+.|+|++|.|++. +.+..+++|++|+|++|.|++ ..+..|..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccc-cCcchhhcCCCC
Confidence 4567788899999999888 4555333344899999999998887 678888899999999999875 344556888899
Q ss_pred CEEECcCCcceecCCc--CCCCCCCCcEEEeecCcceeeeCC----CcchhhhhhhcccCCccccc
Q 002189 315 TTLMMENTNLKGQIPA--DLFSIPHLQTVVMKTNELNGTLDL----GTSYSENLLVNLQNNRISAY 374 (955)
Q Consensus 315 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~~~l~~L~L~~N~l~~~ 374 (955)
+.|+|++|+|+ .+|. .+..+++|+.|+|++|+++..++. ...+++++.||+++|.+...
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 99999999886 4555 778888999999999998865543 44577788899998887754
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=3.5e-13 Score=134.19 Aligned_cols=105 Identities=25% Similarity=0.272 Sum_probs=93.0
Q ss_pred eEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccC
Q 002189 67 TSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146 (955)
Q Consensus 67 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 146 (955)
+.|++++++++. +|..+ .++|++|+|++|+ +.+..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 12 ~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~-i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQ-ITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCSEEECCSSC-CCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccC--CCCCcEEEcCCCc-CCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 356778888884 66555 3899999999997 9999899999999999999999999977777889999999999999
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCceeee
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEG 175 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N~l~g 175 (955)
|+|++..+..|.++++|++|+|++|.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 99997777789999999999999999973
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=130.05 Aligned_cols=110 Identities=24% Similarity=0.314 Sum_probs=85.0
Q ss_pred CcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECc
Q 002189 242 LEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320 (955)
Q Consensus 242 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 320 (955)
.+.|++++|.|+ .+|..+. ++|+.|+|++|.|+++++ .|.++++|++|+|++|+|++ ..+..|.++++|+.|+|+
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCc-cChhhccCCCCCCEEECC
Confidence 456777777777 4665553 777888888888887766 47778888888888888875 555667888888888888
Q ss_pred CCcceecCCcCCCCCCCCcEEEeecCcceeeeCCC
Q 002189 321 NTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG 355 (955)
Q Consensus 321 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 355 (955)
+|+|++..+..|..+++|++|+|++|++++..+..
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l 121 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDI 121 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhH
Confidence 88888766777889999999999999998766543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-12 Score=129.99 Aligned_cols=110 Identities=22% Similarity=0.299 Sum_probs=96.0
Q ss_pred cEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCC
Q 002189 58 GIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 137 (955)
Q Consensus 58 gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 137 (955)
+..|.. +.|++++++++ .+|..+. ++|++|+|++|+ +.+..|..|.++++|++|+|++|+|++..+..|..++
T Consensus 9 ~C~C~~---~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~ 81 (174)
T 2r9u_A 9 QCSCDQ---TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQ-ITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLT 81 (174)
T ss_dssp TSEECS---SEEECCSSCCS-SCCSCCC--TTCSEEECCSSC-CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCEECC---cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCC-ccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcc
Confidence 344642 57899999997 6676664 899999999997 8988899999999999999999999976666789999
Q ss_pred CCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 138 ELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 138 ~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
+|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 82 ~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 82 QLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred hhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence 9999999999999766667999999999999999997
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=3e-12 Score=127.85 Aligned_cols=109 Identities=22% Similarity=0.280 Sum_probs=79.2
Q ss_pred cEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcC
Q 002189 243 EVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMEN 321 (955)
Q Consensus 243 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~ 321 (955)
+.+++++|+++ .+|..+. ++|+.|+|++|+|+++++ .|.++++|++|+|++|+|++ ..+..|.++++|+.|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCC
Confidence 46677777775 5565553 677777777777777765 46677777777777777765 3444567888888888888
Q ss_pred CcceecCCcCCCCCCCCcEEEeecCcceeeeCCC
Q 002189 322 TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLG 355 (955)
Q Consensus 322 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 355 (955)
|+|++..+..|..+++|+.|+|++|++....+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~ 124 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDI 124 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccccH
Confidence 8888655556888899999999999988765543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.25 E-value=3e-10 Score=129.11 Aligned_cols=302 Identities=12% Similarity=0.056 Sum_probs=186.3
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEc
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSL 144 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 144 (955)
.++++.|.. +++.+-..+|.++++|+.++|.++ +..+-...|.++.+|+.+.+..+ +...-...|.++..++....
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~--l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS--VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT--CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECC
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC--ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccC
Confidence 556666643 355444455666666666666543 34444455666666666555433 22233344444433322222
Q ss_pred cCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeecc
Q 002189 145 NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFD 224 (955)
Q Consensus 145 s~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~ 224 (955)
.. +......+|.++++|+.+.+.++..+ ++. ..+..+.+|+.+.+..| ++ .|+...|.....|+.+.+.
T Consensus 148 ~~--~~~i~~~aF~~c~~L~~i~l~~~~~~--I~~-----~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~~ 216 (394)
T 4fs7_A 148 EG--VTVIGDEAFATCESLEYVSLPDSMET--LHN-----GLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEFP 216 (394)
T ss_dssp TT--CCEECTTTTTTCTTCCEEECCTTCCE--ECT-----TTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCCC
T ss_pred cc--ccccchhhhcccCCCcEEecCCccce--ecc-----ccccCCCCceEEEcCCC-ce-EeCchhhccccccceeecC
Confidence 22 22123456777777777777655432 222 12344555666677655 54 6677777777777777666
Q ss_pred CCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCC
Q 002189 225 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEV 304 (955)
Q Consensus 225 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 304 (955)
.+... +........+|+.+.+..+ ++......|.++.+|+.+.+..+..+-....+.....|+.+.+..+.+ .
T Consensus 217 ~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i----~ 289 (394)
T 4fs7_A 217 NSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV----P 289 (394)
T ss_dssp TTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE----C
T ss_pred CCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee----c
Confidence 55432 2233344567777777543 332445667778888888887775553344677788888888777654 3
Q ss_pred ChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCccccccCCCCCCCc
Q 002189 305 PSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNRISAYTERGGAPAV 383 (955)
Q Consensus 305 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~l~~~~~~~~~~~~ 383 (955)
...|..+.+|+.+.+.++ ++..-...|.++.+|+.++|..+ ++......|. ..+|+.++|..| ++.+...+|.+..
T Consensus 290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 456778888888888765 66566677888888999888654 7766666665 467778888776 8888888898888
Q ss_pred ceeEecCc
Q 002189 384 NLTLIDNP 391 (955)
Q Consensus 384 ~L~~l~n~ 391 (955)
+|+.++.|
T Consensus 367 ~L~~i~lp 374 (394)
T 4fs7_A 367 NLKKVELP 374 (394)
T ss_dssp TCCEEEEE
T ss_pred CCCEEEEC
Confidence 88877765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=7.6e-12 Score=139.65 Aligned_cols=110 Identities=26% Similarity=0.326 Sum_probs=94.6
Q ss_pred CC-CCCCccEEeCCCCEeEEEecCC-cCccccCcCcCCCCcccEEecCC-CCCCccCCCCCcccccccccccccccccCC
Q 002189 51 PC-GDNWEGIGCTNSRVTSITLSGM-GLKGQLSGDITGLTELHTLDLSN-NKDLRGPLPTTIGNLKKLSNLMLVGCSFSG 127 (955)
Q Consensus 51 ~C-~~~w~gv~C~~~~v~~L~L~~~-~l~~~~~~~l~~l~~L~~L~Ls~-N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 127 (955)
.| .|.|..|.|+ ++ +|+. +|. |..+++|++|+|++ |+ +.+..+..|.+|++|+.|+|++|+|++
T Consensus 4 ~c~~C~~~~v~~~----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~-l~~~~~~~~~~l~~L~~L~l~~N~l~~ 70 (347)
T 2ifg_A 4 ACCPHGSSGLRCT----------RDGALDS-LHH-LPGAENLTELYIENQQH-LQHLELRDLRGLGELRNLTIVKSGLRF 70 (347)
T ss_dssp SSCCSSSSCEECC----------SSCCCTT-TTT-SCSCSCCSEEECCSCSS-CCEECGGGSCSCCCCSEEECCSSCCCE
T ss_pred cCccccCCEEEcC----------CCCCCCc-cCC-CCCCCCeeEEEccCCCC-CCCcChhHhccccCCCEEECCCCccce
Confidence 46 5567666665 44 6774 677 99999999999996 86 888888899999999999999999999
Q ss_pred CCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 128 PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 128 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
..|..|.+|++|++|+|++|+|++..+..|..++ |+.|+|.+|.|.
T Consensus 71 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp ECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred eCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 9999999999999999999999976666676666 999999999987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=4.2e-11 Score=128.00 Aligned_cols=147 Identities=17% Similarity=0.152 Sum_probs=114.6
Q ss_pred HHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEE
Q 002189 623 VKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 623 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 701 (955)
+......|.....++.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4455667887788888899999999754 6899999987532223346889999999995 6778899999999899999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----------------------------------
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA----------------------------------- 746 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------- 746 (955)
||||++|.+|.+.+... .....++.+++++++.||+..
T Consensus 88 v~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999887754211 123467888999999999811
Q ss_pred ---------------------CCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 747 ---------------------NPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 747 ---------------------~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876667799998764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=4.6e-13 Score=150.64 Aligned_cols=162 Identities=20% Similarity=0.157 Sum_probs=88.1
Q ss_pred CCCCcEEEccCCCCcCcCCCCCCC-----CCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCcc
Q 002189 136 LQELVLLSLNSNGFSGRVPPSIGN-----LSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEK 210 (955)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~p~~~~~-----L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~ 210 (955)
++.|+.|+|++|.|+......+.. .++|+.|+|++|.|+......+ ...+.+|+.|+|++|
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l-----~~~L~~L~~L~Ls~n--------- 136 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL-----LPVFLRARKLGLQLN--------- 136 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHT-----HHHHHTEEEEECCSS---------
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHH-----HHHHHhccHhhcCCC---------
Confidence 456888888888887543333322 2678888888887752211000 112333444444444
Q ss_pred ccCCccceeeeeccCCCccccCCccc-----CCCCCCcEEEcccCCCCC----CccccccCCCCCCEEEccCCcCcccC-
Q 002189 211 LFRPDMVLIHVLFDSNNLTGELPATL-----GLVKSLEVVRFDRNSLSG----PVPSNLNNLTSVNDLYLSNNKLTGAM- 280 (955)
Q Consensus 211 ~~~~~~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~- 280 (955)
+|+......+ ...++|+.|+|++|.|+. .++..+..+++|++|+|++|.|+...
T Consensus 137 ----------------~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~ 200 (372)
T 3un9_A 137 ----------------SLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGL 200 (372)
T ss_dssp ----------------CCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHH
T ss_pred ----------------CCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHH
Confidence 4433222222 234567777777777653 23444566667777777777766432
Q ss_pred ----CCCCCCCCCCEEECcCCCCCCC---CCChhhcCCCCCCEEECcCCcceec
Q 002189 281 ----PNLTGLSVLSYLDMSNNSFDAS---EVPSWFSSMQSLTTLMMENTNLKGQ 327 (955)
Q Consensus 281 ----~~~~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~ 327 (955)
..+...++|++|+|++|.|+.. .+...+...++|++|+|++|.|+..
T Consensus 201 ~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 201 ELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 1244455677777777766431 1223344456677777777766643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.14 E-value=5.8e-11 Score=132.50 Aligned_cols=103 Identities=17% Similarity=0.127 Sum_probs=72.4
Q ss_pred ccccCC-cccccCCccccCCccceeeeeccC-CCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccC
Q 002189 196 FHFGKN-QLSGSIPEKLFRPDMVLIHVLFDS-NNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSN 273 (955)
Q Consensus 196 L~L~~N-~l~g~ip~~~~~~~~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 273 (955)
++++++ +|+ .||. +..+.+|+.|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 13 v~~~~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp EECCSSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEcCCCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 355555 555 5665 44455677777775 777766667777788888888888888777777777888888888888
Q ss_pred CcCcccCCCCCCCCCCCEEECcCCCCCC
Q 002189 274 NKLTGAMPNLTGLSVLSYLDMSNNSFDA 301 (955)
Q Consensus 274 N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 301 (955)
|+|+++++.+.....|+.|+|++|++..
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccC
Confidence 8887777754443347788888877765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.4e-10 Score=123.56 Aligned_cols=129 Identities=19% Similarity=0.193 Sum_probs=98.5
Q ss_pred eccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc--ceEEEEEEeCCeEEEEEEecCCCCcccc
Q 002189 637 GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL--VSLLGFCFDRGEQMLIYEFVPNGSLGDS 714 (955)
Q Consensus 637 G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~lV~e~~~~gsL~~~ 714 (955)
+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.++ .+++++...++..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998777888999997653 22457889999999975554 56888888888899999999998884
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------------------------
Q 002189 715 LSGKNGIRLDWIRRLKIALGAARGLSYLHELA------------------------------------------------ 746 (955)
Q Consensus 715 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 746 (955)
... .+ ...++.++++.|+.||+..
T Consensus 104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 221 11 2356777888888888642
Q ss_pred -------CCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 747 -------NPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 747 -------~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
...++|+|++|.||+++++..+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12289999999999998876677999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.1e-09 Score=122.12 Aligned_cols=292 Identities=11% Similarity=0.053 Sum_probs=219.6
Q ss_pred cCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCC
Q 002189 75 GLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVP 154 (955)
Q Consensus 75 ~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 154 (955)
.++.+-..+|.++++|+.+.|..+ ++.+-..+|.++++|+.++|..+ ++..-...|.++.+|+.+.+..+ +.....
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~--i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~ 133 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST--VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV 133 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT--CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC--ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc
Confidence 345555678999999999999864 67777788999999999999765 66455677999999999888755 444556
Q ss_pred CCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCc
Q 002189 155 PSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA 234 (955)
Q Consensus 155 ~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~ 234 (955)
.+|.+...++.........-| -..+..+.+|+.+.+.++ +. .|+...|....+|+.+.+..| +......
T Consensus 134 ~aF~~~~~~~~~~~~~~~~i~--------~~aF~~c~~L~~i~l~~~-~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~ 202 (394)
T 4fs7_A 134 EAFKGCDFKEITIPEGVTVIG--------DEAFATCESLEYVSLPDS-ME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDY 202 (394)
T ss_dssp TTTTTCCCSEEECCTTCCEEC--------TTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCBCCCCTT-CCEECTT
T ss_pred eeeecccccccccCccccccc--------hhhhcccCCCcEEecCCc-cc-eeccccccCCCCceEEEcCCC-ceEeCch
Confidence 678777655544444433221 123556677788888755 44 788999999999999999876 6656677
Q ss_pred ccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCC
Q 002189 235 TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQS 313 (955)
Q Consensus 235 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~ 313 (955)
+|..+..|+.+.+..+... +........+|+.+.+..+ ++.+.. .+.+..+|+.+.+..+..+ .....|..+..
T Consensus 203 ~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~--i~~~~F~~~~~ 277 (394)
T 4fs7_A 203 CFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR--IGGSLFYNCSG 277 (394)
T ss_dssp TTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE--ECSCTTTTCTT
T ss_pred hhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce--eeccccccccc
Confidence 8999999999988876543 3445556688999988654 344443 5788999999999888653 46677889999
Q ss_pred CCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCccccccCCCCCCCcceeEecCc
Q 002189 314 LTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNRISAYTERGGAPAVNLTLIDNP 391 (955)
Q Consensus 314 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~n~ 391 (955)
|+.+.+..+.+ ....|..+.+|+.+.+.++ ++......+. ..+|+.++|.++ ++.+...+|.+..+|+.+..|
T Consensus 278 l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp 351 (394)
T 4fs7_A 278 LKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFP 351 (394)
T ss_dssp CCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCC
T ss_pred cceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEEC
Confidence 99998877653 3456778999999999765 7776666665 567888999754 899999999999999888776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.5e-12 Score=144.69 Aligned_cols=135 Identities=21% Similarity=0.198 Sum_probs=80.1
Q ss_pred cceeeeeccCCCccccCCccc-CCCCCCcEEEcccCCCCCCccccc-----cCCCCCCEEEccCCcCcccCC-----CCC
Q 002189 216 MVLIHVLFDSNNLTGELPATL-GLVKSLEVVRFDRNSLSGPVPSNL-----NNLTSVNDLYLSNNKLTGAMP-----NLT 284 (955)
Q Consensus 216 ~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~~-----~~~ 284 (955)
..|++|+|++|+++......+ ..+++|+.|+|++|.|+......+ ...++|+.|+|++|.|+.... .+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 456667777776654333222 234577788888887764333333 245677788888777765321 235
Q ss_pred CCCCCCEEECcCCCCCCC---CCChhhcCCCCCCEEECcCCcceec----CCcCCCCCCCCcEEEeecCccee
Q 002189 285 GLSVLSYLDMSNNSFDAS---EVPSWFSSMQSLTTLMMENTNLKGQ----IPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 285 ~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
.+++|++|+|++|.|+.. .++..+...++|+.|+|++|.|+.. +...+...++|++|+|++|+|+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 566777777777776431 1134455566777777777777642 33333445667777777776654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-08 Score=116.07 Aligned_cols=103 Identities=13% Similarity=0.118 Sum_probs=63.6
Q ss_pred EeEEEecCCcCccccCcCcCCCCcccEEecCCCC--CCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 66 VTSITLSGMGLKGQLSGDITGLTELHTLDLSNNK--DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 66 v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~--~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
++++.|.. .++.+-..+|.++++|+.+.+..|. .++.+-..+|.++.+|+.+.+..+ ++......|..+.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 66666654 3665556677777777777776542 134444556777777777766544 3434455677777777777
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCc
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDN 171 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N 171 (955)
+..+. .......|.++.+|+.+.+.++
T Consensus 144 lp~~~-~~I~~~~F~~c~~L~~i~~~~~ 170 (394)
T 4gt6_A 144 IPEGV-TSVADGMFSYCYSLHTVTLPDS 170 (394)
T ss_dssp CCTTC-CEECTTTTTTCTTCCEEECCTT
T ss_pred cccee-eeecccceecccccccccccce
Confidence 76443 3244556677777777777654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.3e-09 Score=118.77 Aligned_cols=142 Identities=18% Similarity=0.286 Sum_probs=107.3
Q ss_pred ccCeeeccCceEEEEEEeCCCcEEEEEEcc--cCCc-chhHHHHHHHHHHHhcc--CCCcceEEEEEEeC---CeEEEEE
Q 002189 632 DANDVGSGGYGKVYKGTLPNGQLIAIKRAQ--QGSM-QGGQEFKMEIELLSRVH--HKNLVSLLGFCFDR---GEQMLIY 703 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~ 703 (955)
..+.|+.|.++.||+....+ ..+++|+.. .... .....+.+|+++++.+. +..+.++++++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998754 678888876 3321 22356888999999997 45678999988776 4589999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-------------------------------------
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA------------------------------------- 746 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 746 (955)
||+++..+.+... ..++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999888755221 13678888899999999999999731
Q ss_pred ------------------CCCeeccCCCCccEEEcCCCc--eEEeecccccc
Q 002189 747 ------------------NPPIIHRDIKSSNILLDERLN--AKVADFGLSKS 778 (955)
Q Consensus 747 ------------------~~~ivHrDlk~~NIll~~~~~--~kl~DFGla~~ 778 (955)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245899999999999997753 68999998764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.9e-08 Score=114.13 Aligned_cols=295 Identities=8% Similarity=0.069 Sum_probs=177.8
Q ss_pred CccccCcCcCCCC-cccEEecCCCCCCccCCCCCcccccccccccccccc---cCCCCCCccccCCCCcEEEccCCCCcC
Q 002189 76 LKGQLSGDITGLT-ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCS---FSGPIPDSIGSLQELVLLSLNSNGFSG 151 (955)
Q Consensus 76 l~~~~~~~l~~l~-~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 151 (955)
++.+-..+|.+.. .|+.+.|-.+ ++.+-..+|.++++|+.+.+..|. ++..-..+|..+.+|+.+.+..+ ++.
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s--vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~ 127 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT--VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE 127 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT--CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC--eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence 3434456788774 6999999875 677788899999999999998875 55445677999999999988765 554
Q ss_pred cCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCcccc
Q 002189 152 RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGE 231 (955)
Q Consensus 152 ~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~ 231 (955)
....+|.++.+|+.+.+..+.-. ++. ..+.....|+.+.+..+ ++ .|....|.. ..|+.+.+..+- ...
T Consensus 128 I~~~aF~~c~~L~~i~lp~~~~~--I~~-----~~F~~c~~L~~i~~~~~-~~-~I~~~aF~~-~~l~~i~ip~~~-~~i 196 (394)
T 4gt6_A 128 IDSEAFHHCEELDTVTIPEGVTS--VAD-----GMFSYCYSLHTVTLPDS-VT-AIEERAFTG-TALTQIHIPAKV-TRI 196 (394)
T ss_dssp ECTTTTTTCTTCCEEECCTTCCE--ECT-----TTTTTCTTCCEEECCTT-CC-EECTTTTTT-CCCSEEEECTTC-CEE
T ss_pred ehhhhhhhhcccccccccceeee--ecc-----cceecccccccccccce-ee-Eeccccccc-cceeEEEECCcc-ccc
Confidence 66678999999999999765432 222 22344556666677654 55 677777765 457777776543 335
Q ss_pred CCcccCCCCCCcEEEcccCCCCCCcccc--------------ccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcC
Q 002189 232 LPATLGLVKSLEVVRFDRNSLSGPVPSN--------------LNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSN 296 (955)
Q Consensus 232 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~--------------l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~ 296 (955)
...+|..+.+|+......+.... +... +.....+..+.+. +.++.+.. .|.++.+|+.+.+..
T Consensus 197 ~~~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~ 274 (394)
T 4gt6_A 197 GTNAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPD 274 (394)
T ss_dssp CTTTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCT
T ss_pred ccchhhhccccceeccccccccc-ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEeccc
Confidence 55677777777777665544331 1111 1111222333332 12222222 355566666666655
Q ss_pred CCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCcccccc
Q 002189 297 NSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNRISAYT 375 (955)
Q Consensus 297 N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~l~~~~ 375 (955)
+..+ .....|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++......|. ..+|+.+.|..+ ++.+.
T Consensus 275 ~~~~--I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~ 349 (394)
T 4gt6_A 275 SVVS--IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIP 349 (394)
T ss_dssp TCCE--ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCC
T ss_pred ccce--ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEh
Confidence 4431 344555666666666664 3344444455566666666666543 5444444444 345556666433 66666
Q ss_pred CCCCCCCcceeEecCc
Q 002189 376 ERGGAPAVNLTLIDNP 391 (955)
Q Consensus 376 ~~~~~~~~~L~~l~n~ 391 (955)
..+|.+..+|+.++.+
T Consensus 350 ~~aF~~C~~L~~i~~~ 365 (394)
T 4gt6_A 350 ESAFSNCTALNNIEYS 365 (394)
T ss_dssp GGGGTTCTTCCEEEES
T ss_pred HhHhhCCCCCCEEEEC
Confidence 6666666555555444
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.8e-09 Score=116.44 Aligned_cols=186 Identities=20% Similarity=0.222 Sum_probs=121.6
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCC--cceEEEEEEeCC---eEEEEEEec
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKN--LVSLLGFCFDRG---EQMLIYEFV 706 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~e~~ 706 (955)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+.+......+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 46888886432 33467899999999884 433 335554443333 348899999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL----------------------------------------- 745 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 745 (955)
++.++.+... ..++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988865322 1356677778888888888888851
Q ss_pred --------------cCCCeeccCCCCccEEEcC--CCceEEeecccccccCCCCCccee-------------eeeecCCC
Q 002189 746 --------------ANPPIIHRDIKSSNILLDE--RLNAKVADFGLSKSMSDSEKDHIT-------------TQVKGTMG 796 (955)
Q Consensus 746 --------------~~~~ivHrDlk~~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~-------------~~~~gt~~ 796 (955)
..+.++|+|+++.||++++ +..+.|+||+.+..-... .+-.. ......++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1235899999999999998 556889999988653221 10000 00001111
Q ss_pred CCC-HHHhhhCCCCChhhhHHHHHHHHHHHhCCCCC
Q 002189 797 YLD-PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPI 831 (955)
Q Consensus 797 y~a-PE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~ 831 (955)
+.. |+.... .....+.|++|.++|++.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222 222211 122368999999999999998775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.76 E-value=3.1e-10 Score=126.52 Aligned_cols=204 Identities=16% Similarity=0.186 Sum_probs=115.9
Q ss_pred CCEeEEEecCCcCcc-c-------cCcCcCCCCcccEEecCCCCCCc---------cCCCCCcccccccccccccccccC
Q 002189 64 SRVTSITLSGMGLKG-Q-------LSGDITGLTELHTLDLSNNKDLR---------GPLPTTIGNLKKLSNLMLVGCSFS 126 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~-~-------~~~~l~~l~~L~~L~Ls~N~~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~ 126 (955)
.+|+.|.+...++.| . +..++..+++|+.|.+.++. .. +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~-~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDID-FEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCC-TTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcc-hhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 478888887666542 1 13345567888888887653 21 112233455567777777766311
Q ss_pred CCCCCccccCCCCcEEEccCCCCcCcCCCCCC--CCCCcCeeecCC--ceeeeccCCCCCCCCchhhhhccccccccCCc
Q 002189 127 GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG--NLSNLYWLDLTD--NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQ 202 (955)
Q Consensus 127 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~L~~L~~L~L~~--N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~ 202 (955)
.++. + .+++|++|+|..|.++......+. .+++|+.|+|+. |...|.. .+..+
T Consensus 186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--------~~~~l------------ 242 (362)
T 2ra8_A 186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--------DMNVF------------ 242 (362)
T ss_dssp -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--------CGGGT------------
T ss_pred -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--------hHHHH------------
Confidence 2232 3 266777777777766543222332 567777777642 2211100 00000
Q ss_pred ccccCCcccc-CCccceeeeeccCCCccccCCccc---CCCCCCcEEEcccCCCCCC----ccccccCCCCCCEEEccCC
Q 002189 203 LSGSIPEKLF-RPDMVLIHVLFDSNNLTGELPATL---GLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNN 274 (955)
Q Consensus 203 l~g~ip~~~~-~~~~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N 274 (955)
...+. ...++|+.|.|.+|.+.+..+..+ ..+++|++|+|+.|.|.+. ++..+..+++|+.|+|++|
T Consensus 243 -----~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 243 -----RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp -----GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred -----HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 00000 124567777777777765433333 2578899999999988853 3444456789999999999
Q ss_pred cCcccCC-CCCC-CCCCCEEECcCCC
Q 002189 275 KLTGAMP-NLTG-LSVLSYLDMSNNS 298 (955)
Q Consensus 275 ~l~~~~~-~~~~-l~~L~~L~Ls~N~ 298 (955)
.|+.... .+.. + ...++++.|+
T Consensus 318 ~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 318 YLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp BCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred cCCHHHHHHHHHHc--CCEEEecCCc
Confidence 8875432 1221 1 3568888887
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.69 E-value=1.4e-09 Score=121.29 Aligned_cols=40 Identities=25% Similarity=0.312 Sum_probs=22.0
Q ss_pred CCCCCEEECcCCcceec----CCcCCCCCCCCcEEEeecCccee
Q 002189 311 MQSLTTLMMENTNLKGQ----IPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 311 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
+++|+.|+|+.|.|.+. ++..+..+++|+.|+|++|.|+.
T Consensus 278 ~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp GGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 45566666666655542 23333345666666666666654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.61 E-value=1.8e-06 Score=97.03 Aligned_cols=294 Identities=9% Similarity=0.052 Sum_probs=132.5
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.+++++.+.. +++.+-..+|.++.+|+.++|..+ ++.+-..+|.+. +|+.+.+..+ +...-..+|.. .+|+.+.
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~--v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~ 119 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST--VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFE 119 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT--CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEE
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc--ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCccccc
Confidence 3566666653 566555567777777777777654 455555666665 5666655433 34233334443 3677777
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCC-----------cccc
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIP-----------EKLF 212 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip-----------~~~~ 212 (955)
+..+- +......|.+. +|+.+.+..+--. .-...+ .....++.+.+..+....... ...+
T Consensus 120 lp~~~-~~i~~~~F~~~-~l~~~~~~~~v~~-i~~~~f------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (379)
T 4h09_A 120 FPGAT-TEIGNYIFYNS-SVKRIVIPKSVTT-IKDGIG------YKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESY 190 (379)
T ss_dssp CCTTC-CEECTTTTTTC-CCCEEEECTTCCE-ECSCTT------TTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEEC
T ss_pred CCCcc-ccccccccccc-eeeeeeccceeec-cccchh------cccccccccccccccceeecccceecccccceeccc
Confidence 76543 21333344432 4554444433111 111111 122222332322222110000 0001
Q ss_pred CCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCE
Q 002189 213 RPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSY 291 (955)
Q Consensus 213 ~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 291 (955)
.....+..+.+..+ ........+....+|+.+.+..+ +.......|.++.+|+.+.+..+ ++.+.. .+.++.+|+.
T Consensus 191 ~~~~~~~~~~~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~ 267 (379)
T 4h09_A 191 PAAKTGTEFTIPST-VKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKT 267 (379)
T ss_dssp CTTCCCSEEECCTT-CCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred cccccccccccccc-eeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcc
Confidence 11111222222111 11123334455555555555443 22233445555666666666544 333333 3455555666
Q ss_pred EECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCc
Q 002189 292 LDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNR 370 (955)
Q Consensus 292 L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~ 370 (955)
+.+..+ ++. .....|.++++|+.+.+.++.++..-...|.++.+|+.++|..+ ++.+....|. ..+|..+.+..+
T Consensus 268 i~l~~~-i~~-i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~- 343 (379)
T 4h09_A 268 LNFYAK-VKT-VPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS- 343 (379)
T ss_dssp EEECCC-CSE-ECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-
T ss_pred cccccc-cee-ccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-
Confidence 655443 221 23344555666666666555555444555555666666655433 4443333333 233444444332
Q ss_pred cccccCCCC
Q 002189 371 ISAYTERGG 379 (955)
Q Consensus 371 l~~~~~~~~ 379 (955)
++.+...+|
T Consensus 344 v~~I~~~aF 352 (379)
T 4h09_A 344 ITLIESGAF 352 (379)
T ss_dssp CCEECTTTT
T ss_pred cCEEchhHh
Confidence 444444444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.56 E-value=2e-06 Score=96.68 Aligned_cols=287 Identities=10% Similarity=0.020 Sum_probs=191.4
Q ss_pred CcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCC
Q 002189 83 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSN 162 (955)
Q Consensus 83 ~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~ 162 (955)
.+....+|+.+.+..+ ++.+-..+|.++.+|+.++|..+ ++..-..+|.++ +|+.+.+..+ ++..-..+|.+ .+
T Consensus 41 ~~~~~~~i~~v~ip~~--vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~ 114 (379)
T 4h09_A 41 WYKDRDRISEVRVNSG--ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD 114 (379)
T ss_dssp TGGGGGGCSEEEECTT--EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred ccccccCCEEEEeCCC--ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence 4566678999999764 67777788999999999999754 664556678776 6888887654 55344456655 58
Q ss_pred cCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccc------------
Q 002189 163 LYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG------------ 230 (955)
Q Consensus 163 L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~------------ 230 (955)
|+.+.+.++-.. .-...+.+. +|+.+.+. +.++ .+....|.....+..+.+..+....
T Consensus 115 L~~i~lp~~~~~-i~~~~F~~~-------~l~~~~~~-~~v~-~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (379)
T 4h09_A 115 LDDFEFPGATTE-IGNYIFYNS-------SVKRIVIP-KSVT-TIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNK 184 (379)
T ss_dssp CSEEECCTTCCE-ECTTTTTTC-------CCCEEEEC-TTCC-EECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTS
T ss_pred cccccCCCcccc-ccccccccc-------eeeeeecc-ceee-ccccchhcccccccccccccccceeecccceeccccc
Confidence 999988765332 111112211 22333332 2233 5556666666667666665544321
Q ss_pred cCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhc
Q 002189 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFS 309 (955)
Q Consensus 231 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 309 (955)
.....+.....+..+.+..+.-. .....+..+.+|+.+.+..+ ++.+.. .+.+..+|+.+.+..+ ++. .....|.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~-I~~~aF~ 260 (379)
T 4h09_A 185 TILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTS-IGSFLLQ 260 (379)
T ss_dssp SEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCE-ECTTTTT
T ss_pred ceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccE-eCccccc
Confidence 12233444555666655543332 44566777888888888655 444443 5778888999998776 432 4566788
Q ss_pred CCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-hhhhhhhcccCCccccccCCCCCCCcceeEe
Q 002189 310 SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-YSENLLVNLQNNRISAYTERGGAPAVNLTLI 388 (955)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l 388 (955)
++.+|+.+.+..+ +.......|..+++|+.+.+.+|.++...+..|. ..+|..++|..+ ++.+...+|.+..+|+.+
T Consensus 261 ~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 338 (379)
T 4h09_A 261 NCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI 338 (379)
T ss_dssp TCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred eeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence 8889999988654 5556666788899999999998888887777765 467778888654 888888888888888777
Q ss_pred cCc
Q 002189 389 DNP 391 (955)
Q Consensus 389 ~n~ 391 (955)
..|
T Consensus 339 ~ip 341 (379)
T 4h09_A 339 SYP 341 (379)
T ss_dssp CCC
T ss_pred EEC
Confidence 665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.50 E-value=6.6e-10 Score=117.65 Aligned_cols=145 Identities=17% Similarity=0.160 Sum_probs=84.1
Q ss_pred CCccEEeCCC--CEeEEEecC---CcCccccC-cCcCCCCcccEEecCCCCCCccCCC-CCccccccccc--cccccccc
Q 002189 55 NWEGIGCTNS--RVTSITLSG---MGLKGQLS-GDITGLTELHTLDLSNNKDLRGPLP-TTIGNLKKLSN--LMLVGCSF 125 (955)
Q Consensus 55 ~w~gv~C~~~--~v~~L~L~~---~~l~~~~~-~~l~~l~~L~~L~Ls~N~~l~~~~p-~~~~~l~~L~~--L~Ls~N~l 125 (955)
+|.|+.|+.. +|+.+...+ ..+.+.+. +.+..++. .|...+|. ..+.++ +.|...+.|.. ++++.|..
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~-~~~~LdLs~l~~dp~L~~~~l~l~~N~~ 155 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDG-SQQALDLKGLRSDPDLVAQNIDVVLNRR 155 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEET-TTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccch-hccccCHHHcCCCcchhhcCccccCCHH
Confidence 6999999753 777766655 33334333 22222222 22233332 222221 12555556666 67777744
Q ss_pred C---CCCCCccccCCCCcEEEccCCCCcC--cCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccC
Q 002189 126 S---GPIPDSIGSLQELVLLSLNSNGFSG--RVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGK 200 (955)
Q Consensus 126 ~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~ 200 (955)
. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+..+ +|+.|+|++
T Consensus 156 ~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-----~~l~~l~~l-~L~~L~L~~ 229 (267)
T 3rw6_A 156 SCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-----RELDKIKGL-KLEELWLDG 229 (267)
T ss_dssp HHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-----GGGGGGTTS-CCSEEECTT
T ss_pred HHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-----hhhhhcccC-CcceEEccC
Confidence 3 2222223568899999999999997 4556777899999999999999832 112222222 566666666
Q ss_pred CcccccCC
Q 002189 201 NQLSGSIP 208 (955)
Q Consensus 201 N~l~g~ip 208 (955)
|.+.+.+|
T Consensus 230 Npl~~~~~ 237 (267)
T 3rw6_A 230 NSLCDTFR 237 (267)
T ss_dssp STTGGGCS
T ss_pred CcCccccC
Confidence 66654444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.30 E-value=6.8e-08 Score=102.21 Aligned_cols=63 Identities=24% Similarity=0.262 Sum_probs=35.9
Q ss_pred CCCCCCcEEEcccCCCCC--CccccccCCCCCCEEEccCCcCcccCC--CCCCCCCCCEEECcCCCCC
Q 002189 237 GLVKSLEVVRFDRNSLSG--PVPSNLNNLTSVNDLYLSNNKLTGAMP--NLTGLSVLSYLDMSNNSFD 300 (955)
Q Consensus 237 ~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~ 300 (955)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++... .+..+ +|++|+|++|+++
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLC 233 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTG
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCc
Confidence 345667777777777765 334555566666666666666665411 22222 5555555555554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=6.2e-06 Score=89.80 Aligned_cols=136 Identities=21% Similarity=0.226 Sum_probs=92.7
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCC---CcceEEEEEE-eCCeEEEEEEecCC
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK---NLVSLLGFCF-DRGEQMLIYEFVPN 708 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~e~~~~ 708 (955)
.+.++.|....||+. |+.++||+... ......+.+|.++|+.+.+. .+.+.+.++. ..+..++||||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888988999988 56788887432 22346788999999999753 2556677664 34567899999998
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL------------------------------------------- 745 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 745 (955)
..+.+.... .++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 877652111 133444445555555555555532
Q ss_pred --------------cCCCeeccCCCCccEEEcC---CCc-eEEeecccccc
Q 002189 746 --------------ANPPIIHRDIKSSNILLDE---RLN-AKVADFGLSKS 778 (955)
Q Consensus 746 --------------~~~~ivHrDlk~~NIll~~---~~~-~kl~DFGla~~ 778 (955)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2334799999999999997 455 48999997754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.20 E-value=1.1e-07 Score=95.60 Aligned_cols=119 Identities=17% Similarity=0.125 Sum_probs=74.2
Q ss_pred CCcccCCCCCCcEEEcccC-CCCC----CccccccCCCCCCEEEccCCcCcccCC-----CCCCCCCCCEEECcCCCCCC
Q 002189 232 LPATLGLVKSLEVVRFDRN-SLSG----PVPSNLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLSYLDMSNNSFDA 301 (955)
Q Consensus 232 ~p~~l~~l~~L~~L~Ls~N-~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~~ 301 (955)
+...+...++|++|+|++| .|.. .+...+...++|++|+|++|.|..... .+...++|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445566677777777777 6652 234455666777777777777754321 23445667777777777743
Q ss_pred C---CCChhhcCCCCCCEEEC--cCCcceec----CCcCCCCCCCCcEEEeecCccee
Q 002189 302 S---EVPSWFSSMQSLTTLMM--ENTNLKGQ----IPADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 302 ~---~~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
. .+...+...+.|+.|+| ++|.|... +...+...++|+.|+|++|.+..
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCCh
Confidence 1 12344556667777777 66777743 33344455778888888887753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=4.1e-06 Score=93.31 Aligned_cols=81 Identities=12% Similarity=0.069 Sum_probs=57.8
Q ss_pred Cee-eccCceEEEEEEeC-------CCcEEEEEEcccCC---cchhHHHHHHHHHHHhcc-C--CCcceEEEEEEeC---
Q 002189 634 NDV-GSGGYGKVYKGTLP-------NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVH-H--KNLVSLLGFCFDR--- 696 (955)
Q Consensus 634 ~~l-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--- 696 (955)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 557 78888999998764 26788999865432 111245788999999885 3 3466788887655
Q ss_pred CeEEEEEEecCCCCcccc
Q 002189 697 GEQMLIYEFVPNGSLGDS 714 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~ 714 (955)
+..++||||+++..+.+.
T Consensus 106 g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp SSCEEEEECCCCBCCCBT
T ss_pred CCceEEEEecCCCChhhc
Confidence 356899999998877653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.14 E-value=3.5e-07 Score=91.82 Aligned_cols=112 Identities=13% Similarity=0.124 Sum_probs=83.4
Q ss_pred CccceeeeeccCC-Ccccc----CCcccCCCCCCcEEEcccCCCCCC----ccccccCCCCCCEEEccCCcCcccC----
Q 002189 214 PDMVLIHVLFDSN-NLTGE----LPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAM---- 280 (955)
Q Consensus 214 ~~~~L~~L~L~~N-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~---- 280 (955)
....|++|+|++| ++... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|....
T Consensus 34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 3455777777777 66642 455667788999999999998732 4555667788999999999998642
Q ss_pred -CCCCCCCCCCEEEC--cCCCCCCCC---CChhhcCCCCCCEEECcCCcce
Q 002189 281 -PNLTGLSVLSYLDM--SNNSFDASE---VPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 281 -~~~~~l~~L~~L~L--s~N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
..+...++|++|+| ++|.|.... +...+...++|++|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 24667788999999 889985411 2345566789999999999986
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=5.9e-06 Score=88.11 Aligned_cols=136 Identities=18% Similarity=0.155 Sum_probs=94.5
Q ss_pred CeeeccCce-EEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 634 NDVGSGGYG-KVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 634 ~~lG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
+.+..|..| .||+.... ++..++||+-... ...++.+|.+.|+.+. +--+-++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345566665 69988754 5678899986532 3457889999999885 3336688999999999999999999877
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 002189 711 LGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL--------------------------------------------- 745 (955)
Q Consensus 711 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 745 (955)
+.+..... ......++.++++.|+.||..
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 65533211 112223444555555555532
Q ss_pred ----------cCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 746 ----------ANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 746 ----------~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112378999999999999887778999997653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=7.8e-05 Score=82.11 Aligned_cols=139 Identities=16% Similarity=0.209 Sum_probs=81.1
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccC--CCcceEEE------EEEeCCeEEEEEEe
Q 002189 634 NDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH--KNLVSLLG------FCFDRGEQMLIYEF 705 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~------~~~~~~~~~lV~e~ 705 (955)
+.|+.|..+.||+....+| .+++|+.... ..++..|.++++.+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677889999987655 5899988752 2344556666666631 12333332 12346678999999
Q ss_pred cCCCCccc--------------ccCC----C--C-C-----CCCCHHHHH------------------------------
Q 002189 706 VPNGSLGD--------------SLSG----K--N-G-----IRLDWIRRL------------------------------ 729 (955)
Q Consensus 706 ~~~gsL~~--------------~l~~----~--~-~-----~~l~~~~~~------------------------------ 729 (955)
+++..+.. .+|. . . . ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 0110 0 0 0 012332211
Q ss_pred -HHHHHHHHHHHHhhh----------ccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 730 -KIALGAARGLSYLHE----------LANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 730 -~i~~~ia~gL~yLH~----------~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
.+...+.+++++|++ .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666653 134569999999999999888889999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00016 Score=78.54 Aligned_cols=138 Identities=16% Similarity=0.195 Sum_probs=93.0
Q ss_pred ccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc---CCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 632 DANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH---HKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
..+.|+.|....+|+... +++.++||+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456789999999999986 4678889986542 3467889999999884 35678899998888899999999998
Q ss_pred CCccc-----------ccCCCCC--------------------CCCCHHHHH-----HHHHH--------------HH-H
Q 002189 709 GSLGD-----------SLSGKNG--------------------IRLDWIRRL-----KIALG--------------AA-R 737 (955)
Q Consensus 709 gsL~~-----------~l~~~~~--------------------~~l~~~~~~-----~i~~~--------------ia-~ 737 (955)
..+.. .||.... ..-+|.... .-..+ +. +
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86632 1111100 012454322 11111 11 1
Q ss_pred HHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecc
Q 002189 738 GLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFG 774 (955)
Q Consensus 738 gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 774 (955)
....|.. ...+.++|+|+.+.|++++.++ +.|.||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223321 2246699999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=9.7e-05 Score=79.47 Aligned_cols=78 Identities=15% Similarity=0.205 Sum_probs=58.2
Q ss_pred CCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCC---CcceEEEEEEeCCeEEEEEEec
Q 002189 630 FSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK---NLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 630 f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~lV~e~~ 706 (955)
....+.+|.|..+.||+.+..||+.|+||+...........|..|.+.|+.+.-. -+.+.+++. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 3446778999999999999999999999987655444445788999999988421 244555542 347899999
Q ss_pred CCCCc
Q 002189 707 PNGSL 711 (955)
Q Consensus 707 ~~gsL 711 (955)
+.+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=6e-05 Score=85.20 Aligned_cols=75 Identities=17% Similarity=0.164 Sum_probs=50.2
Q ss_pred cCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-------chhHHHHHHHHHHHhccC--CCcc-eEEEEEEeCCeEEE
Q 002189 633 ANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-------QGGQEFKMEIELLSRVHH--KNLV-SLLGFCFDRGEQML 701 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~niv-~l~~~~~~~~~~~l 701 (955)
.+.||.|.++.||++... +++.++||....... .....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 468899997653211 123456789999988842 4444 55543 4556789
Q ss_pred EEEecCCC
Q 002189 702 IYEFVPNG 709 (955)
Q Consensus 702 V~e~~~~g 709 (955)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00053 Score=74.81 Aligned_cols=158 Identities=11% Similarity=0.093 Sum_probs=91.4
Q ss_pred ccCHHHHHHHhcCCCc-----cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCC--cceE
Q 002189 617 CFSFEEVKKYTNNFSD-----ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKN--LVSL 689 (955)
Q Consensus 617 ~~~~~el~~~~~~f~~-----~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l 689 (955)
.++.+++......|.. .+.|+.|....+|+....+| .+++|+.... ....++..|+++++.+.... +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4566777777777765 23466688889999987665 6889987652 12245677888888774222 2233
Q ss_pred EEE------EEeCCeEEEEEEecCCCCcccc--------------cCCC----CCC-----C-CCHHHHHHH--------
Q 002189 690 LGF------CFDRGEQMLIYEFVPNGSLGDS--------------LSGK----NGI-----R-LDWIRRLKI-------- 731 (955)
Q Consensus 690 ~~~------~~~~~~~~lV~e~~~~gsL~~~--------------l~~~----~~~-----~-l~~~~~~~i-------- 731 (955)
+.. ....+..++|++|+++..+... +|.. ... . ..|...+.-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 1234567899999988665321 1100 000 0 123321110
Q ss_pred ----HHHHHHHHHHhhhc----cCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 732 ----ALGAARGLSYLHEL----ANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 732 ----~~~ia~gL~yLH~~----~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
...+.+.++++++. ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01133445555432 13458999999999999987666899998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.38 E-value=2.6e-05 Score=76.56 Aligned_cols=39 Identities=10% Similarity=0.176 Sum_probs=26.1
Q ss_pred CEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCcc
Q 002189 65 RVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRG 103 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~ 103 (955)
++++|||+++.|+..--..+..+++|++|+|++|..++.
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD 100 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED 100 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCH
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCH
Confidence 677777777777665555566777777777777753443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00046 Score=78.51 Aligned_cols=73 Identities=16% Similarity=0.186 Sum_probs=45.4
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccC------C-c--chhHHHHHHHHHHHh-ccCCCcceEEEEEEeCCeEEEE
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG------S-M--QGGQEFKMEIELLSR-VHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~------~-~--~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV 702 (955)
.+.||.|..+.||++.. +++.++||..... . . .....+..|+..+.. ..+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45789999999999965 5678999943211 1 0 122334444433322 2234566677665 5677999
Q ss_pred EEec-CC
Q 002189 703 YEFV-PN 708 (955)
Q Consensus 703 ~e~~-~~ 708 (955)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.21 E-value=6.5e-05 Score=73.71 Aligned_cols=35 Identities=9% Similarity=0.099 Sum_probs=19.3
Q ss_pred CCCEEECcCCc-ceecCCcCCCCCCCCcEEEeecCc
Q 002189 313 SLTTLMMENTN-LKGQIPADLFSIPHLQTVVMKTNE 347 (955)
Q Consensus 313 ~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~ 347 (955)
+|+.|+|++|. |+..--..+..+++|+.|+|++++
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 45555555553 554333445556666666666654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0049 Score=67.17 Aligned_cols=158 Identities=9% Similarity=0.070 Sum_probs=90.9
Q ss_pred ccCHHHHHHHhcCCCc-----cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCC--cceE
Q 002189 617 CFSFEEVKKYTNNFSD-----ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKN--LVSL 689 (955)
Q Consensus 617 ~~~~~el~~~~~~f~~-----~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l 689 (955)
..+.+++..+.+.|.. ...++ |....||+....+|+.+++|+...... ....+..|..+++.+.... +.++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecce
Confidence 3445555555554432 33566 778899998877787899999874322 3456778888888885222 3444
Q ss_pred EEE-----EEeCCeEEEEEEecCCCCcccc--------------cCC----CC---CCCCCHHHH----HHH--------
Q 002189 690 LGF-----CFDRGEQMLIYEFVPNGSLGDS--------------LSG----KN---GIRLDWIRR----LKI-------- 731 (955)
Q Consensus 690 ~~~-----~~~~~~~~lV~e~~~~gsL~~~--------------l~~----~~---~~~l~~~~~----~~i-------- 731 (955)
+.. ....+..++||||+++..+... +|. .. ....++... ..+
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 432 2234567889999987654310 110 00 011222211 000
Q ss_pred -------HHHHHHHHHHhhhc----cCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 732 -------ALGAARGLSYLHEL----ANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 732 -------~~~ia~gL~yLH~~----~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
...+.+.++.+... ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 00111122222221 234588999999999999 4 899999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0016 Score=74.03 Aligned_cols=74 Identities=14% Similarity=0.233 Sum_probs=50.8
Q ss_pred cCeeeccCceEEEEEEeCC--------CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc-ceEEEEEEeCCeEEEEE
Q 002189 633 ANDVGSGGYGKVYKGTLPN--------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL-VSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~ 703 (955)
.+.|+.|....||++...+ ++.+++|+...... ...+.+|..+++.+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3567888889999998753 57899998743211 1456689999998854444 56776543 2 3899
Q ss_pred EecCCCCcc
Q 002189 704 EFVPNGSLG 712 (955)
Q Consensus 704 e~~~~gsL~ 712 (955)
||+++.++.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999865553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0027 Score=68.50 Aligned_cols=71 Identities=8% Similarity=0.111 Sum_probs=46.0
Q ss_pred cCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc-ceEEEEEEeCCeEEEEEEec-CCCC
Q 002189 633 ANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL-VSLLGFCFDRGEQMLIYEFV-PNGS 710 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~-~~gs 710 (955)
.+.|+.|....+|+. +.+++|+...... ...+..+|+.+++.+....+ .+++++ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 577899999999998 5588888764321 11224568888888753334 355543 344457899999 5545
Q ss_pred c
Q 002189 711 L 711 (955)
Q Consensus 711 L 711 (955)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0011 Score=72.60 Aligned_cols=140 Identities=14% Similarity=0.130 Sum_probs=72.6
Q ss_pred CeeeccCceE-EEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCC--CcceEEEEEEeCCeEEEEEEecCCCC
Q 002189 634 NDVGSGGYGK-VYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHK--NLVSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 634 ~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
+.|+.|+... +|+....+|+.+++|....... .++..|+++++.+... .+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465555444 6677654467788876544221 3355677888777422 3456776643333 78999997655
Q ss_pred cccccC---------------------CCC--CC-CCCHHHHH-------H-------------HHHHHHHHHHHhh---
Q 002189 711 LGDSLS---------------------GKN--GI-RLDWIRRL-------K-------------IALGAARGLSYLH--- 743 (955)
Q Consensus 711 L~~~l~---------------------~~~--~~-~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 743 (955)
+.+++. ... .. .++..... . ....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 533221 100 00 11111000 0 0001111222221
Q ss_pred hccCCCeeccCCCCccEEEcCC----CceEEeecccccc
Q 002189 744 ELANPPIIHRDIKSSNILLDER----LNAKVADFGLSKS 778 (955)
Q Consensus 744 ~~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla~~ 778 (955)
....+.++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6799999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00049 Score=68.76 Aligned_cols=91 Identities=13% Similarity=0.127 Sum_probs=40.0
Q ss_pred cccCCCCCCEEEccCCcCcccCC-----CCCCCCCCCEEECcCCCCCCC---CCChhhcCCCCCCEEECcCC---ccee-
Q 002189 259 NLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLSYLDMSNNSFDAS---EVPSWFSSMQSLTTLMMENT---NLKG- 326 (955)
Q Consensus 259 ~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L~Ls~N---~l~~- 326 (955)
.+..-+.|+.|+|++|.|..... .+..-+.|+.|+|++|.|... .+.+.+..-+.|+.|+|++| .+..
T Consensus 65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~ 144 (197)
T 1pgv_A 65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQ 144 (197)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHH
T ss_pred HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHH
Confidence 33444444444444444443221 122334455555555554320 01112233344555665543 2221
Q ss_pred ---cCCcCCCCCCCCcEEEeecCcce
Q 002189 327 ---QIPADLFSIPHLQTVVMKTNELN 349 (955)
Q Consensus 327 ---~~p~~~~~l~~L~~L~Ls~N~l~ 349 (955)
.+...+..-+.|+.|+|+.|.+.
T Consensus 145 g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 145 VEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 23334444566777777766553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00015 Score=72.39 Aligned_cols=111 Identities=14% Similarity=0.105 Sum_probs=71.1
Q ss_pred ccceeeeeccCC-Cccc----cCCcccCCCCCCcEEEcccCCCCC----CccccccCCCCCCEEEccCCcCcccCC----
Q 002189 215 DMVLIHVLFDSN-NLTG----ELPATLGLVKSLEVVRFDRNSLSG----PVPSNLNNLTSVNDLYLSNNKLTGAMP---- 281 (955)
Q Consensus 215 ~~~L~~L~L~~N-~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~---- 281 (955)
...|++|+|++| +|.. .+..++..-+.|+.|+|++|.|.. .+...+...+.|+.|+|++|.|.....
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 455777888775 6653 245566677788888888888862 344555667778888888888865332
Q ss_pred -CCCCCCCCCEEECcCCC---CCC---CCCChhhcCCCCCCEEECcCCcce
Q 002189 282 -NLTGLSVLSYLDMSNNS---FDA---SEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 282 -~~~~l~~L~~L~Ls~N~---l~~---~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
.+..-+.|++|+|++|. +.. ..+...+..-+.|+.|+++.|.+.
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 35556668888887653 211 012334555677888888777654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0045 Score=68.90 Aligned_cols=139 Identities=18% Similarity=0.243 Sum_probs=81.4
Q ss_pred CeeeccCceEEEEEEeC--------CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc-ceEEEEEEeCCeEEEEEE
Q 002189 634 NDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL-VSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e 704 (955)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+.-..+ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777889999864 3578999986332 2234567789999998853333 466665532 28999
Q ss_pred ecCCCCcccc-c----------------CCCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 002189 705 FVPNGSLGDS-L----------------SGKN---GIRLD--WIRRLKIALGAAR-------------------GLSYLH 743 (955)
Q Consensus 705 ~~~~gsL~~~-l----------------~~~~---~~~l~--~~~~~~i~~~ia~-------------------gL~yLH 743 (955)
|+++..|..- + |... ..... |.+..++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998666421 1 1110 11222 3344444433311 122332
Q ss_pred ----hc-cCCCeeccCCCCccEEEcCC----CceEEeeccccc
Q 002189 744 ----EL-ANPPIIHRDIKSSNILLDER----LNAKVADFGLSK 777 (955)
Q Consensus 744 ----~~-~~~~ivHrDlk~~NIll~~~----~~~kl~DFGla~ 777 (955)
.. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 11 22358899999999999876 789999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.01 Score=67.82 Aligned_cols=75 Identities=15% Similarity=0.006 Sum_probs=49.0
Q ss_pred cCeeeccCceEEEEEEeCC-CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc-ceEEEEEEeCCeEEEEEEecCCCC
Q 002189 633 ANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL-VSLLGFCFDRGEQMLIYEFVPNGS 710 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~~~gs 710 (955)
.+.|+.|-...+|+....+ +..+++|+...... ..-+..+|..+++.+...++ .++++++ .+ .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 3567888889999998765 57888988754321 11122579999999975555 4677665 22 35999998765
Q ss_pred cc
Q 002189 711 LG 712 (955)
Q Consensus 711 L~ 712 (955)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0043 Score=69.07 Aligned_cols=73 Identities=14% Similarity=0.097 Sum_probs=45.1
Q ss_pred CeeeccCceEEEEEEeCC---------CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc-ceEEEEEEeCCeEEEEE
Q 002189 634 NDVGSGGYGKVYKGTLPN---------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL-VSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~ 703 (955)
+.|+.|....+|+....+ ++.+++|+..... ....+...|.++++.+...++ .++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999998754 2688888875432 111234678888888854344 3666543 2 36899
Q ss_pred EecCCCCc
Q 002189 704 EFVPNGSL 711 (955)
Q Consensus 704 e~~~~gsL 711 (955)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0085 Score=65.78 Aligned_cols=66 Identities=11% Similarity=0.103 Sum_probs=43.5
Q ss_pred cCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccC---CCcceEEEE------EEeCCeEEEEEEecCCC
Q 002189 639 GGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH---KNLVSLLGF------CFDRGEQMLIYEFVPNG 709 (955)
Q Consensus 639 G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~------~~~~~~~~lV~e~~~~g 709 (955)
|....||+....+| .+++|+...... ..|+++++.+.. |.+.+.+.. ....+..++||||+++.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33579999987777 899998765432 346666666631 224444432 23356789999999987
Q ss_pred Cc
Q 002189 710 SL 711 (955)
Q Consensus 710 sL 711 (955)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 66
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.011 Score=54.94 Aligned_cols=40 Identities=25% Similarity=0.311 Sum_probs=25.1
Q ss_pred CCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeee
Q 002189 313 SLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352 (955)
Q Consensus 313 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 352 (955)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|++...-
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC 71 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC 71 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence 4556666666666444445566777777777777776543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0062 Score=56.66 Aligned_cols=56 Identities=16% Similarity=0.161 Sum_probs=35.1
Q ss_pred cccccccccC-CCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 117 NLMLVGCSFS-GPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 117 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
.++.++++++ ..+|..+. .+|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555554 23443322 25777777777777555556777777777777777765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.42 E-value=0.17 Score=56.90 Aligned_cols=75 Identities=15% Similarity=0.156 Sum_probs=49.1
Q ss_pred cCeeeccCceEEEEEEeCC--------CcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc-ceEEEEEEeCCeEEEEE
Q 002189 633 ANDVGSGGYGKVYKGTLPN--------GQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL-VSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~ 703 (955)
.+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+.-.++ .++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3456667778999998753 5789999865432 111234678888888853333 4556533 2 37899
Q ss_pred EecCCCCcc
Q 002189 704 EFVPNGSLG 712 (955)
Q Consensus 704 e~~~~gsL~ 712 (955)
||+++..|.
T Consensus 150 efI~G~~l~ 158 (424)
T 3mes_A 150 EFIDGEPLT 158 (424)
T ss_dssp ECCCSEECC
T ss_pred EEeCCccCC
Confidence 999986653
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.028 Score=40.67 Aligned_cols=30 Identities=13% Similarity=0.114 Sum_probs=16.0
Q ss_pred eEEehhhHHHHHHHHHHHHHHHHhhhhcch
Q 002189 558 GVIIGAAAAGCVVLLLLLLAGVYAYHQKRR 587 (955)
Q Consensus 558 ~~ii~~~~~~~v~ll~l~~~~~~~~~~~~~ 587 (955)
+.|++++++|++++++++++.++++|+|+.
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 446666666666655555444444444433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.90 E-value=0.023 Score=40.95 Aligned_cols=32 Identities=16% Similarity=0.161 Sum_probs=16.9
Q ss_pred eeEEehhhHHHHHHHHHHHHHHHHhhhhcchh
Q 002189 557 IGVIIGAAAAGCVVLLLLLLAGVYAYHQKRRA 588 (955)
Q Consensus 557 ~~~ii~~~~~~~v~ll~l~~~~~~~~~~~~~~ 588 (955)
.+.|++++++|+++++++++..++++|+|+++
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 34466666666666555554444444444333
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.76 E-value=0.33 Score=48.74 Aligned_cols=98 Identities=15% Similarity=0.113 Sum_probs=61.7
Q ss_pred CcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcceee
Q 002189 710 SLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITT 789 (955)
Q Consensus 710 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 789 (955)
+|.+.|... +.++++.+.|.++.|.+++|.-+-....+ ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence 566666544 45899999999999999887665211111 1233456899999999988764 1110
Q ss_pred eeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh
Q 002189 790 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT 826 (955)
Q Consensus 790 ~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt 826 (955)
.....+.|||... ...+.+.=|||+|+++|..+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122356787653 345678889999999999885
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=90.81 E-value=0.12 Score=36.23 Aligned_cols=30 Identities=20% Similarity=0.071 Sum_probs=15.9
Q ss_pred cceeEEehhhHHHHHHHHHHHHHHHHhhhh
Q 002189 555 TSIGVIIGAAAAGCVVLLLLLLAGVYAYHQ 584 (955)
Q Consensus 555 ~~~~~ii~~~~~~~v~ll~l~~~~~~~~~~ 584 (955)
.+-+.|+|++++.++.+++++++.+|++||
T Consensus 8 ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 344556666665555555555555554443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.61 E-value=0.95 Score=50.52 Aligned_cols=29 Identities=34% Similarity=0.500 Sum_probs=24.6
Q ss_pred eeccCCCCccEEE------cCCCceEEeecccccc
Q 002189 750 IIHRDIKSSNILL------DERLNAKVADFGLSKS 778 (955)
Q Consensus 750 ivHrDlk~~NIll------~~~~~~kl~DFGla~~ 778 (955)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988753
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=88.11 E-value=0.19 Score=36.17 Aligned_cols=17 Identities=18% Similarity=0.184 Sum_probs=6.7
Q ss_pred HHHHHHHHHHhhhhcch
Q 002189 571 LLLLLLAGVYAYHQKRR 587 (955)
Q Consensus 571 ll~l~~~~~~~~~~~~~ 587 (955)
+++++++.+++|.|||+
T Consensus 23 l~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 23 LVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhheehhh
Confidence 33333333344444333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 955 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-73 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-70 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-61 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 2e-75
Identities = 73/280 (26%), Positives = 129/280 (46%), Gaps = 18/280 (6%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
+ +GSG +G VYKG + + + Q Q FK E+ +L + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
+G+ + ++ ++ SL L + + I+ + IA A+G+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH---A 122
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
IIHRD+KS+NI L E L K+ DFGL+ S H Q+ G++ ++ PE Q
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 808 ---LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864
+ +SDVY+FG+++ EL+TG+ P + ++ Y +L
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+K L +C+++ D+RP +++ IE + +
Sbjct: 239 PKAMK------RLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 3e-73
Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 20/276 (7%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
+G+G +G+V+ G +A+K +QGSM F E L+ ++ H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L +I E++ NGSL D L +GI+L + L +A A G++++ E
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
IHRD++++NIL+ + L+ K+ADFGL++ + D+E K + + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGT 186
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867
T KSDV+SFG+L+ E++T R G I+ + Y ++ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------YRMVRPD-NCPEE 238
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903
L L C +E +DRPT + +E+
Sbjct: 239 LY------QLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 8e-70
Identities = 71/277 (25%), Positives = 132/277 (47%), Gaps = 20/277 (7%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
+ + ++GSG +G V+ G N +AIK ++G+ ++F E E++ ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L G C ++ L++EF+ +G L L + L G++YL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
+IHRD+ + N L+ E KV+DFG+++ + D + +T K + + PE + +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSR 178
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867
+ KSDV+SFGVLM E+ + + R+ + +++ + L P + ST
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYEN-------RSNSEVVEDISTGFRLYKPRL-ASTH 230
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+ + C +E +DRP S +++ + I +
Sbjct: 231 VY------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 230 bits (586), Expect = 4e-69
Identities = 78/312 (25%), Positives = 138/312 (44%), Gaps = 39/312 (12%)
Query: 618 FSFEEVKKYTNNFSDAND---------VGSGGYGKVYKGTLP----NGQLIAIKRAQQGS 664
F+FE+ + F+ D +G+G +G+V G L +AIK + G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 665 MQGG-QEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRL 723
+ ++F E ++ + H N++ L G M+I EF+ NGSL DS +N +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 724 DWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783
I+ + + G A G+ YL + +HRD+ + NIL++ L KV+DFGLS+ + D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 784 KDHITTQV---KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVRE 840
D T K + + PE ++ T SDV+S+G++M E+++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------ 236
Query: 841 IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900
++ I+ L + L L C Q+ + RP ++V ++
Sbjct: 237 --------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 901 NILQQAGLNPNA 912
+++ NPN+
Sbjct: 289 KMIR----NPNS 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 227 bits (579), Expect = 3e-68
Identities = 78/296 (26%), Positives = 138/296 (46%), Gaps = 20/296 (6%)
Query: 619 SFEEVKKYTNNFSDANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQEFKMEIEL 677
++++ + + + + +G G YG+VY+G +A+K ++ +M+ +EF E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 678 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR 737
+ + H NLV LLG C +I EF+ G+L D L N + + L +A +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 738 GLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGY 797
+ YL + IHRD+ + N L+ E KVADFGLS+ M+ + K + +
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKW 182
Query: 798 LDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857
PE + + KSDV++FGVL+ E+ T +L +YEL
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------PYPGIDLSQVYEL 228
Query: 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAE 913
++ + EK +L C Q + DRP+ +E+ + E + Q++ ++ E
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-67
Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 20/275 (7%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
+ + ++G+G +G V G +AIK ++GSM EF E +++ + H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L G C + +I E++ NG L + L R + L++ + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
+HRD+ + N L++++ KV+DFGLS+ + D E + K + + PE M +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK 177
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867
+ KSD+++FGVLM E+ + + T + + + L P +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYER-------FTNSETAEHIAQGLRLYRPHLAS--- 227
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902
EK + C E D+RPT ++ +I ++
Sbjct: 228 ----EKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 7e-66
Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 26/271 (9%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G G +G V G G +A+K + + Q F E +++++ H NLV LLG +
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 696 RGEQM-LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
+ ++ E++ GSL D L + L LK +L + YL +HRD
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 128
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 814
+ + N+L+ E AKV+DFGL+K S + K + + PE ++ + KSDV
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 815 YSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 874
+SFG+L+ E+ + R + + V K +D G +
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPDGCPPAVY----- 230
Query: 875 VDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
++ C RP+ ++ + +E+I
Sbjct: 231 -EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 1e-65
Identities = 60/296 (20%), Positives = 118/296 (39%), Gaps = 28/296 (9%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD 695
+G G +G+V++G G+ +A+K + + EI + H+N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68
Query: 696 RGEQ----MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-----LA 746
L+ ++ +GSL D L+ + +K+AL A GL++LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK--DHITTQVKGTMGYLDPEYYM 804
P I HRD+KS NIL+ + +AD GL+ + D GT Y+ PE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 805 TQ------QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858
+ +++D+Y+ G++ E+ + ++ + + +++
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 859 -----DPTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908
P I + + + +C +G R T + K + + QQ G+
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 6e-65
Identities = 72/277 (25%), Positives = 129/277 (46%), Gaps = 20/277 (7%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
+ +G G +G+V+ GT +AIK + G+M + F E +++ ++ H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
L ++ E++ GSL D L G+ G L + + +A A G++Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
+HRD++++NIL+ E L KVADFGL++ + D+E K + + PE + +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 190
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867
T KSDV+SFG+L+ EL T R G + + ++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPG--------------MVNREVLDQVERGYRMPCP 236
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+ E DL +C ++ ++RPT + +E+
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 7e-65
Identities = 68/301 (22%), Positives = 127/301 (42%), Gaps = 38/301 (12%)
Query: 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHK 684
++F +++G+G G V+K + P+G ++A K + E+++L +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
+V G + GE + E + GSL L R+ K+++ +GL+YL E
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE 122
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
I+HRD+K SNIL++ R K+ DFG+S + DS GT Y+ PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQ 176
Query: 805 TQQLTEKSDVYSFGVLMLELLTGRRPIE------------------------RGKYIVRE 840
+ +SD++S G+ ++E+ GR PI R + R
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 841 IRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY----VDLALKCVQESGDDRPTMSEVV 896
+ + + ++EL+D + + D KC+ ++ +R + +++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 897 K 897
Sbjct: 297 V 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (556), Expect = 7e-65
Identities = 67/306 (21%), Positives = 126/306 (41%), Gaps = 46/306 (15%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGGQ-EFKMEIELLSR 680
NN D+G G +G+V++ P ++A+K ++ + Q +F+ E L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 681 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL----------------------SGK 718
+ N+V LLG C L++E++ G L + L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 719 NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778
L +L IA A G++YL E +HRD+ + N L+ E + K+ADFGLS++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIV 838
+ ++ + ++ PE + T +SDV+++GV++ E+ + G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 839 REIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
I V D ++ L +L C + DRP+ + +
Sbjct: 250 EVIYYVRDGN--------ILACPENCPLELY------NLMRLCWSKLPADRPSFCSIHRI 295
Query: 899 IENILQ 904
++ + +
Sbjct: 296 LQRMCE 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-64
Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 26/278 (9%)
Query: 636 VGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLL 690
+G G +G VY GTL + A+K + + G +F E ++ H N++SLL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 691 GFCFDR-GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
G C G +++ ++ +G L + + L A+G+ +L +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKK 150
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD--HITTQVKGTMGYLDPEYYMTQQ 807
+HRD+ + N +LDE+ KVADFGL++ M D E D H T K + ++ E TQ+
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867
T KSDV+SFGVL+ EL+T P D L L+ P
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDITVYLLQGRRLLQPE-YCPDP 262
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
L ++ LKC + RP+ SE+V I I
Sbjct: 263 LY------EVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 5e-64
Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 25/284 (8%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQ-----LIAIKRAQQGSMQGGQ-EFKMEIELLSRV 681
+ + +G+G +G+VYKG L +AIK + G + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 682 HHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSY 741
H N++ L G M+I E++ NG+L L K+G ++ + + G A G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKY 125
Query: 742 LHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSM-SDSEKDHITTQVKGTMGYLDP 800
L N +HRD+ + NIL++ L KV+DFGLS+ + D E + T+ K + + P
Sbjct: 126 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860
E ++ T SDV+SFG++M E++T + + + + I+
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAIND 228
Query: 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
L T + L ++C Q+ RP +++V ++ +++
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 2e-63
Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 40/294 (13%)
Query: 636 VGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRV-HHKNLV 687
+G+G +GKV + T +A+K + + + E+++LS + +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 688 SLLGFCFDRGEQMLIYEFVPNGSLGDSLSGK----------------NGIRLDWIRRLKI 731
+LLG C G ++I E+ G L + L K + + LD L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
+ A+G+++L IHRD+ + NILL K+ DFGL++ + + +
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851
+ + ++ PE T +SDV+S+G+ + EL + G + + ++ +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG--- 264
Query: 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+ ++ P + D+ C RPT ++V+ IE + +
Sbjct: 265 ---FRMLSPE-HAPAEMY------DIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-61
Identities = 84/318 (26%), Positives = 139/318 (43%), Gaps = 40/318 (12%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQL---IAIKR-AQQGSMQGGQEFKMEIELLSRV-H 682
N+ + +G G +G+V K + L AIKR + S ++F E+E+L ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 683 HKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRR 728
H N+++LLG C RG L E+ P+G+L D L + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
L A ARG+ YL + IHRD+ + NIL+ E AK+ADFGLS+ K
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848
T + + ++ E T SDV+S+GVL+ E+++ G
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-------------- 229
Query: 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908
LYE + L L ++ DL +C +E +RP+ ++++ + +L++
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 909 NPNAE-SASSSASYEDAS 925
N + + D S
Sbjct: 290 YVNTTLYEKFTYAGIDCS 307
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-61
Identities = 65/302 (21%), Positives = 119/302 (39%), Gaps = 39/302 (12%)
Query: 637 GSGGYGKVYKGTL---PNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHKNLVSLLGF 692
G G +G V +G +AIK +QG+ + +E E +++ ++ + +V L+G
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
C ML+ E G L L GK + ++ + G+ YL +H
Sbjct: 78 CQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE---EKNFVH 132
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKD-HITTQVKGTMGYLDPEYYMTQQLTEK 811
RD+ + N+LL R AK++DFGLSK++ + + K + + PE ++ + +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 812 SDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGF 871
SDV+S+GV M E L+ + + + + I+ + +
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKK--------------MKGPEVMAFIEQGKRMECPPECP 238
Query: 872 EKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASKGNFHH 931
+ L C +DRP V + + S +G+ HH
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY---------------SLASKVEGHHHH 283
Query: 932 PY 933
+
Sbjct: 284 HH 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-61
Identities = 70/317 (22%), Positives = 130/317 (41%), Gaps = 26/317 (8%)
Query: 630 FSDANDVGSGGYGKVYKGT-LPNGQLIAIKRA-----QQGSMQGGQEFKMEIELLSRVHH 683
F +GSG +G VYKG +P G+ + I A + S + +E E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
++ LLG C LI + +P G L D + + L + A+G++YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE 128
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
+ ++HRD+ + N+L+ + K+ DFGL+K + EK++ K + ++ E
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863
+ + T +SDV+S+GV + EL+T G + +++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSILEKGER 231
Query: 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYED 923
L + +KC D RP E++ + + + +
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG-DERMHLPS 290
Query: 924 ASKGNFHHPYCNEEGFD 940
+ NF+ +EE D
Sbjct: 291 PTDSNFYRALMDEEDMD 307
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 7e-61
Identities = 73/282 (25%), Positives = 122/282 (43%), Gaps = 34/282 (12%)
Query: 624 KKYT-NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQ---EFKMEIELL 678
+++ +F +G G +G VY + ++A+K + ++ + + E+E+
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 679 SRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARG 738
S + H N++ L G+ D LI E+ P G++ L + + D R A
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANA 118
Query: 739 LSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYL 798
LSY H +IHRDIK N+LL K+ADFG S S T + GT+ YL
Sbjct: 119 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYL 171
Query: 799 DPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858
PE + EK D++S GVL E L G+ P E + +E Y +
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA------------NTYQETYKRISRV 219
Query: 859 DPTI--GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
+ T ++ + DL + ++ + RP + EV++
Sbjct: 220 EFTFPDFVTEGAR------DLISRLLKHNPSQRPMLREVLEH 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 7e-61
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 25/275 (9%)
Query: 636 VGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLL 690
+G G +G V++G + +AIK + + +E F E + + H ++V L+
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
G + +I E G L S LD + A + L+YL
Sbjct: 75 GVITE-NPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 129
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
+HRDI + N+L+ K+ DFGLS+ M DS + ++ K + ++ PE ++ T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTS 188
Query: 811 KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKG 870
SDV+ FGV M E+L +G I + + E + PT+
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--ENGERLPMPPNCPPTL-------- 238
Query: 871 FEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
L KC RP +E+ + IL++
Sbjct: 239 ----YSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 8e-61
Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 41/291 (14%)
Query: 618 FSFEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG---QEFKM 673
F ++ +K FSD ++G G +G VY + N +++AIK+ Q Q+
Sbjct: 8 FFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 674 EIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIAL 733
E+ L ++ H N + G L+ E+ + K L + +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTH 122
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
GA +GL+YLH +IHRD+K+ NILL E K+ DFG + M+ G
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVG 173
Query: 794 TMGYLDPEYYMTQ---QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850
T ++ PE + Q K DV+S G+ +EL + P+ M+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-----------MNAMSA 222
Query: 851 LYNLYELIDPTI---GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
LY++ + P + S + + C+Q+ DRPT ++K
Sbjct: 223 LYHIAQNESPALQSGHWSEYFR------NFVDSCLQKIPQDRPTSEVLLKH 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 1e-60
Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 26/279 (9%)
Query: 629 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKN 685
++ +G+G YG+ K +G+++ K GSM Q E+ LL + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 686 LVSLLGFCFDRGEQML--IYEFVPNGSLGDSL--SGKNGIRLDWIRRLKIALGAARGLSY 741
+V DR L + E+ G L + K LD L++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 742 LHEL--ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
H ++HRD+K +N+ LD + N K+ DFGL++ ++ GT Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMS 182
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
PE EKSD++S G L+ EL P + + K + I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREGK------FRRIP 235
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
S L ++ + + RP++ E++++
Sbjct: 236 YRY--SDELN------EIITRMLNLKDYHRPSVEEILEN 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-60
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 21/266 (7%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIELLSRVHHKNLVSLLGFC 693
+G G YG+V + +A+K E K EI + ++H+N+V G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHR 753
+ Q L E+ G L D + + I + + G+ YLH + I HR
Sbjct: 73 REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHR 127
Query: 754 DIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL-TEKS 812
DIK N+LLDER N K++DFGL+ + ++ + ++ GT+ Y+ PE ++ E
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
DV+S G+++ +L G P ++ +E +KK L +P + +
Sbjct: 188 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------NPWKKIDSAPL--- 237
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKD 898
L K + E+ R T+ ++ KD
Sbjct: 238 ---ALLHKILVENPSARITIPDIKKD 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-60
Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 26/280 (9%)
Query: 632 DANDVGSGGYGKVYKGTLPN---GQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHKNL 686
+ ++GSG +G V KG + +A+K + + E E ++ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 746
V ++G C + ML+ E G L L + +++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSM-SDSEKDHITTQVKGTMGYLDPEYYMT 805
+HRD+ + N+LL + AK++DFGLSK++ +D T K + + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865
+ + KSDV+SFGVLM E + + RG + + +++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRG--------------MKGSEVTAMLEKGERMG 230
Query: 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905
+ DL C ++RP + V + N
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 4e-60
Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 28/288 (9%)
Query: 620 FEEVKKYTN---NFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEI 675
+E V + N + ++G G +GKVYK L A K S + +++ +EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 676 ELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGA 735
++L+ H N+V LL + ++ EF G++ D++ + L + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQT 119
Query: 736 ARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTM 795
L+YLH+ IIHRD+K+ NIL + K+ADFG+S + + GT
Sbjct: 120 LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTP 174
Query: 796 GYLDPEYYMTQQL-----TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850
++ PE M + K+DV+S G+ ++E+ P +R + + +
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAKSEPP 233
Query: 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
D KC++++ D R T S++++
Sbjct: 234 TLAQPSRWSSNF------------KDFLKKCLEKNVDARWTTSQLLQH 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 8e-60
Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 29/271 (10%)
Query: 636 VGSGGYGKVYKGTLP-NGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+G G + VYKG +A + ++ + Q FK E E+L + H N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 693 CFDRGEQ----MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
+ +L+ E + +G+L L K + +GL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTR-TP 133
Query: 749 PIIHRDIKSSNILL-DERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
PIIHRD+K NI + + K+ D GL+ + V GT ++ PE Y ++
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMY-EEK 188
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867
E DVY+FG+ MLE+ T P + + R V K + ++ P +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKVAIPEV----- 242
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
++ C++++ D+R ++ +++
Sbjct: 243 -------KEIIEGCIRQNKDERYSIKDLLNH 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-59
Identities = 62/337 (18%), Positives = 126/337 (37%), Gaps = 59/337 (17%)
Query: 599 HWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFS---DAND------VGSGGYGKVYKGTL 649
M + +GS + + + ++Y + + +GSG +GKV T
Sbjct: 4 QLQMVQVTGSSDNE-----YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATA 58
Query: 650 PN------GQLIAIKRAQQGSMQGGQE-FKMEIELLSRV-HHKNLVSLLGFCFDRGEQML 701
+A+K ++ + +E E+++++++ H+N+V+LLG C G L
Sbjct: 59 YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118
Query: 702 IYEFVPNGSLGDSLSGKNGI---------------------RLDWIRRLKIALGAARGLS 740
I+E+ G L + L K L + L A A+G+
Sbjct: 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
+L +HRD+ + N+L+ K+ DFGL++ + + + + ++ P
Sbjct: 179 FLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235
Query: 801 EYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860
E T KSDV+S+G+L+ E+ + G + ++ ++ D
Sbjct: 236 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-------DQ 288
Query: 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897
+ + + C RP+ +
Sbjct: 289 PFYATEEIY------IIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-57
Identities = 60/264 (22%), Positives = 112/264 (42%), Gaps = 22/264 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G G G VY + GQ +AI++ + EI ++ + N+V+ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
E ++ E++ GSL D ++ +D + + + L +LH +IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDV 814
IKS NILL + K+ DFG ++ + + GT ++ PE + K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 815 YSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKY 874
+S G++ +E++ G P + +R + + EL +P LS +
Sbjct: 200 WSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGT-----PELQNPE-KLSAIFR----- 247
Query: 875 VDLALKCVQESGDDRPTMSEVVKD 898
D +C+ + R + E+++
Sbjct: 248 -DFLNRCLDMDVEKRGSAKELLQH 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-57
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 39/292 (13%)
Query: 636 VGSGGYGKVYKGT------LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSR-VHHKNLV 687
+G G +G+V + + +A+K ++G+ + E+++L HH N+V
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 688 SLLGFCFDRGEQ-MLIYEFVPNGSLGDSLSGKNG--------------IRLDWIRRLKIA 732
+LLG C G M+I EF G+L L K L + +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 733 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792
A+G+ +L IHRD+ + NILL E+ K+ DFGL++ + +
Sbjct: 141 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852
+ ++ PE + T +SDV+SFGVL+ E+ + G I E + + +
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM- 256
Query: 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
D T + L C RPT SE+V+ + N+LQ
Sbjct: 257 ---RAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-56
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 30/279 (10%)
Query: 636 VGSGGYGKVYKGTLP----NGQLIAIKR---AQQGSMQGGQEFKMEIELLSRVHHKNLVS 688
+G G +G V +G +A+K + +F E+ + + H+NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
L G ++ E P GSL D L G + A+ A G+ YL
Sbjct: 76 LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLES---K 130
Query: 749 PIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI-TTQVKGTMGYLDPEYYMTQQ 807
IHRD+ + N+LL R K+ DFGL +++ ++ ++ K + PE T+
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 808 LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867
+ SD + FGV + E+ T + G + + + + + L +
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--------- 241
Query: 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906
+ ++ ++C +DRPT + L +A
Sbjct: 242 ----QDIYNVMVQCWAHKPEDRPTFVALRD----FLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 9e-56
Identities = 61/292 (20%), Positives = 119/292 (40%), Gaps = 32/292 (10%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPN------GQLIAIKRAQQGSMQGG-QEFKMEIELLSR 680
+ + ++G G +G VY+G +AIK + + EF E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 681 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIR--------LDWIRRLKIA 732
+ ++V LLG ++I E + G L L + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 733 LGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVK 792
A G++YL+ +HRD+ + N ++ E K+ DFG+++ + +++ +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 793 GTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852
+ ++ PE T SDV+SFGV++ E+ T +G + +R VM+
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG---- 252
Query: 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
L+D L +L C Q + RP+ E++ I+ ++
Sbjct: 253 ----LLDKPDNCPDMLF------ELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-55
Identities = 60/285 (21%), Positives = 102/285 (35%), Gaps = 26/285 (9%)
Query: 624 KKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSM---QGGQEFKMEIELLS 679
KK +F +G G + V L + AIK ++ + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 680 RVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGL 739
R+ H V L D + + NG L + R A +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 118
Query: 740 SYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
S L L IIHRD+K NILL+E ++ ++ DFG +K +S K GT Y+
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
PE + + SD+++ G ++ +L+ G P R + ++ + D
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLE---------YD 228
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+ DL K + R E ++ +
Sbjct: 229 FPEKFFPKAR------DLVEKLLVLDATKRLGCEE-MEGYGPLKA 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 7e-55
Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 41/293 (13%)
Query: 636 VGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSMQGG-QEFKMEIELLSRV-HHKN 685
+G G +G+V +A+K + + + + E+E++ + HKN
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSL--------------SGKNGIRLDWIRRLKI 731
+++LLG C G +I E+ G+L + L S +L +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQV 791
A ARG+ YL IHRD+ + N+L+ E K+ADFGL++ + + TT
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 792 KGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL 851
+ + ++ PE + T +SDV+SFGVL+ E+ T G +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------------VPV 243
Query: 852 YNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
L++L+ + + + C RPT ++V+D++ I+
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 191 bits (485), Expect = 2e-54
Identities = 62/266 (23%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G+G +G V++ T G A K + + EI+ +S + H LV+L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
D E ++IYEF+ G L + ++ ++ ++ ++ +GL ++HE +H D
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD 149
Query: 755 IKSSNILLDERLN--AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
+K NI+ + + K+ DFGL+ + + +TT GT + PE + + +
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYT 206
Query: 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
D++S GVL LL+G P + T+ + K +N+ + G+S K
Sbjct: 207 DMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFS--GISEDGK--- 257
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKD 898
D K + + R T+ + ++
Sbjct: 258 ---DFIRKLLLADPNTRMTIHQALEH 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 188 bits (478), Expect = 2e-53
Identities = 62/266 (23%), Positives = 116/266 (43%), Gaps = 22/266 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+GSG +G V++ G++ K K EI +++++HH L++L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
D+ E +LI EF+ G L D ++ ++ + A GL ++HE I+H D
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLD 152
Query: 755 IKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
IK NI+ + + + K+ DFGL+ ++ D I T + PE + + +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
D+++ GVL LL+G P ++ T+ + K+ + E ++ S K
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGED----DLETLQNVKRCDWEFDEDAFSSV--SPEAK--- 260
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKD 898
D +Q+ R T+ + ++
Sbjct: 261 ---DFIKNLLQKEPRKRLTVHDALEH 283
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 175 bits (444), Expect = 8e-50
Identities = 64/278 (23%), Positives = 121/278 (43%), Gaps = 27/278 (9%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG---QEFKMEIELLSRVHHKNLVSLLG 691
+G GG +V+ L + +A+K + + F+ E + + ++H +V++
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74
Query: 692 FCFDRGEQ----MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
++ E+V +L D + + + R +++ A + L++ H+
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--- 129
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI-TTQVKGTMGYLDPEYYMTQ 806
IIHRD+K +NI++ KV DFG++++++DS T V GT YL PE
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 807 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
+ +SDVYS G ++ E+LTG P + +E GLS
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQHVREDPIPPSARHE--GLSA 243
Query: 867 TLKGFEKYVDLALKCVQESGDDRP-TMSEVVKDIENIL 903
L + LK + ++ ++R T +E+ D+ +
Sbjct: 244 DLD------AVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 50/266 (18%), Positives = 101/266 (37%), Gaps = 23/266 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G G +G V++ + + K + K EI +L+ H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
E ++I+EF+ + + ++ + L+ + L +LH I H D
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 755 IKSSNILLDERLNA--KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
I+ NI+ R ++ K+ +FG ++ + + + Y PE + ++ +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFE 872
D++S G L+ LL+G P + + + Y E I S
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAET----NQQIIENIMNAEYTFDEEAFKEI--SIEAM--- 235
Query: 873 KYVDLALKCVQESGDDRPTMSEVVKD 898
D + + + R T SE ++
Sbjct: 236 ---DFVDRLLVKERKSRMTASEALQH 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 2e-48
Identities = 53/285 (18%), Positives = 108/285 (37%), Gaps = 23/285 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+GSG +G +Y GT + G+ +AIK + + +E ++ + + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
G+ ++ + SL + L + L +A + Y+H IHRD
Sbjct: 73 AEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128
Query: 755 IKSSNIL---LDERLNAKVADFGLSKSMSDSE-----KDHITTQVKGTMGYLDPEYYMTQ 806
+K N L + + DFGL+K D+ + GT Y ++
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 807 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
+ + + D+ S G +++ G P + K + + +K++ E++ G +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK--GYPS 246
Query: 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPN 911
C DD+P S + + N+ + G + +
Sbjct: 247 EFA------TYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 171 bits (433), Expect = 3e-48
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 39/281 (13%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKR---------AQQGSMQGGQEFKMEIELLSRVH-HK 684
+G G V + P + A+K + + + + E+++L +V H
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE 744
N++ L L+++ + G L D L + L KI + LH+
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHK 128
Query: 745 LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
L I+HRD+K NILLD+ +N K+ DFG S + EK +V GT YL PE
Sbjct: 129 L---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIE 182
Query: 805 TQQL------TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858
++ D++S GV+M LL G P + + +R +M Y+
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLMLRMIMSGN------YQFG 235
Query: 859 DPTI-GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
P S T+K DL + + R T E +
Sbjct: 236 SPEWDDYSDTVK------DLVSRFLVVQPQKRYTAEEALAH 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 1e-47
Identities = 61/284 (21%), Positives = 118/284 (41%), Gaps = 25/284 (8%)
Query: 620 FEEVKKYTNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE-FKMEIEL 677
+++ + + + + +G+G + +V +L+AIK + +++G + + EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 678 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAAR 737
L ++ H N+V+L G LI + V G L D + K ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 738 GLSYLHELANPPIIHRDIKSSNILL---DERLNAKVADFGLSKSMSDSEKDHITTQVKGT 794
+ YLH+ I+HRD+K N+L DE ++DFGLSK + + GT
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGT 172
Query: 795 MGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNL 854
GY+ PE + ++ D +S GV+ LL G P + + ++ + E
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEF--- 228
Query: 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
+S + K D +++ + R T + ++
Sbjct: 229 --DSPYWDDISDSAK------DFIRHLMEKDPEKRFTCEQALQH 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 1e-46
Identities = 57/285 (20%), Positives = 111/285 (38%), Gaps = 32/285 (11%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQ------EFKMEIELLSR 680
N+FS +G GG+G+VY G++ A+K + ++ Q ++ + L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 681 VHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 740
+V + + I + + G L LS +R A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--YAAEIILGLE 121
Query: 741 YLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDP 800
++H +++RD+K +NILLDE + +++D GL+ S + GT GY+ P
Sbjct: 122 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAP 174
Query: 801 EYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELID 859
E +D +S G ++ +LL G P + + + + + + +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-----FRQHKTKDKHEIDRMTLTMAVELP 229
Query: 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+ S L+ L +Q + R + + + +
Sbjct: 230 DSF--SPELR------SLLEGLLQRDVNRRLGCLG--RGAQEVKE 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 164 bits (416), Expect = 6e-46
Identities = 55/286 (19%), Positives = 109/286 (38%), Gaps = 21/286 (7%)
Query: 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKN 685
+ +G G YG VYK G+ A+K R ++ EI +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+V L + +L++E + + G L+ + L G++Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD- 118
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
++HRD+K N+L++ K+ADFGL+++ + + + +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-IVTLWYRAPDVLMGS 175
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRP------------IERGKYIVREIRTVMDKKKELYN 853
++ + D++S G + E++ G I R + Y+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 854 LYELIDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 898
+ + + LKG E +DL K ++ + R T + ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-45
Identities = 61/305 (20%), Positives = 107/305 (35%), Gaps = 33/305 (10%)
Query: 625 KYTNNFSDANDVGSGGYGKVYKGT--LPNGQLIAIKRAQQGSMQGGQEFKMEIEL----- 677
+ + ++G G YGKV+K G+ +A+KR + + + G E+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 678 LSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN----GSLGDSLSGKNGIRLDWIRRLKIAL 733
L H N+V L C + L L + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 734 GAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKG 793
RGL +LH ++HRD+K NIL+ K+ADFGL++ S T V
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 177
Query: 794 TMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------IERGKYIVREIRTVMDK 847
T+ Y PE + D++S G + E+ + +++ I+ I ++
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 848 KKELYNLYELIDPTIGLSTTLKGFEKYV-----DLALKCVQESGDDRPTMSEV-----VK 897
+ ++ F + DL LKC+ + R + +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 898 DIENI 902
D+E
Sbjct: 298 DLERC 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 7e-45
Identities = 48/287 (16%), Positives = 100/287 (34%), Gaps = 25/287 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCF 694
+G G +G +++GT L N Q +AIK + S + + E + + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 695 DRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754
G ++ + G + L G + A + +HE +++RD
Sbjct: 71 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD 126
Query: 755 IKSSNILLDERLN-----AKVADFGLSKSMSDSE-----KDHITTQVKGTMGYLDPEYYM 804
IK N L+ + V DFG+ K D + GT Y+ ++
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 805 TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864
++ + + D+ + G + + L G P + + T K + + +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLP-----WQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPN 911
+ + F KY+ + D P + +L++ +
Sbjct: 242 AGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-45
Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 43/281 (15%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKR------AQQGSMQGGQEFKMEIELLSRVH--HKNL 686
+GSGG+G VY G + + +AIK + G + G ME+ LL +V +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 746
+ LL + +LI E + G L + + H
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC- 129
Query: 747 NPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
++HRDIK NIL+D R K+ DFG + KD + T GT Y PE+
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 183
Query: 806 QQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864
+ + V+S G+L+ +++ G P E + I+R + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR----------------V 227
Query: 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD--IENIL 903
S+ + L C+ DRPT E+ ++++L
Sbjct: 228 SSECQ------HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-44
Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 32/270 (11%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRV-HHKNLVSLL 690
+G G +GKV+ Q AIK ++ + + +E +LS H L +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 691 GFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPI 750
+ + E++ G L + ++ + D R A GL +LH I
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS---KGI 124
Query: 751 IHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTE 810
++RD+K NILLD+ + K+ADFG+ K + GT Y+ PE + Q+
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNH 182
Query: 811 KSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI--GLSTTL 868
D +SFGVL+ E+L G+ P ++EL++ + +P L
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHG------------QDEEELFHSIRMDNPFYPRWLEKEA 230
Query: 869 KGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
K DL +K + R + ++
Sbjct: 231 K------DLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 67/282 (23%), Positives = 114/282 (40%), Gaps = 26/282 (9%)
Query: 636 VGSGGYGKVYKGTLPN-GQLIAIKRAQQGSMQGGQE-----FKMEIELLSRVHHKNLVSL 689
+G G + VYK N Q++AIK+ + G ++ EI+LL + H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 690 LGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
L + L+++F+ + I+ L +GL YLH+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA--YMLMTLQGLEYLHQ---HW 120
Query: 750 IIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL- 808
I+HRD+K +N+LLDE K+ADFGL+KS + + T T Y PE ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMY 178
Query: 809 TEKSDVYSFGVLMLELLTGRRP------IERGKYIVREIRT-----VMDKKKELYNLYEL 857
D+++ G ++ ELL +++ I + T D +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 858 IDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 898
P I L + +DL + R T ++ +K
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 57/286 (19%), Positives = 103/286 (36%), Gaps = 21/286 (7%)
Query: 629 NFSDANDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKN 685
NF +G G YG VYK G+++A+K R + EI LL ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
+V LL + L++EF+ + L + + +GL++ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMT 805
++HRD+K N+L++ K+ADFGL+++ + + T +V
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGC 177
Query: 806 QQLTEKSDVYSFGVLMLELLTGRRP------------IERGKYIVREIRTVMDKKKELYN 853
+ + D++S G + E++T R I R E+ Y
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 854 LYELIDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 898
S + E L + + + R + +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 3e-44
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHH 683
+F +G+G +G+V+ NG+ A+K ++ + ++ E +LS V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
++ + G D + +I +++ G L L + + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
L + II+RD+K NILLD+ + K+ DFG +K + D T + GT Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVV 173
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRP 830
T+ + D +SFG+L+ E+L G P
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-44
Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 23/292 (7%)
Query: 627 TNNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG-QEFKMEIELLSRVHHK 684
+++ + +G G YG V N +AIK+ Q Q EI++L R H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 685 NLVSLLGFCFDRGEQMLIYEFVPNGSLG-DSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
N++ + + + ++ +G D L RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT-TQVKGTMGYLDPEY 802
++HRD+K SN+LL+ + K+ DFGL++ T+ T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 803 YMTQQL-TEKSDVYSFGVLMLELLTGRRPIE--------------RGKYIVREIRTVMDK 847
+ + T+ D++S G ++ E+L+ R G ++ +++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 848 KKELYNLYELIDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 898
K Y L + + K +DL K + + R + + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-44
Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 30/300 (10%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFC 693
+G G GKV + + A+K +Q + + E+EL R ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 694 FD----RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPP 749
+ R +++ E + G L + + +I + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 131
Query: 750 IIHRDIKSSNILLDERLN---AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
I HRD+K N+L + K+ DFG +K + T Y+ PE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPE 188
Query: 807 QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866
+ + D++S GV+M LL G P + I M + + +S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLNPNAESASSSASYEDASK 926
+K L ++ R T++E + + Q+ P +S ED +
Sbjct: 247 EVK------MLIRNLLKTEPTQRMTITEFMNH--PWIMQSTKVPQTPLHTSRVLKEDKER 298
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-44
Identities = 57/274 (20%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG------QEFKMEIELLSRVHHKNLVS 688
+GSG + V K G A K ++ + ++ + E+ +L + H N+++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 689 LLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANP 748
L ++ + +LI E V G L D L+ K + + + L+ ++ L +
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNGVYYLHSL 132
Query: 749 PIIHRDIKSSNILLDER----LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYM 804
I H D+K NI+L +R K+ DFGL+ + + + GT ++ PE
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVN 189
Query: 805 TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864
+ L ++D++S GV+ LL+G P + T+ + Y +
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANVSAVNYEFEDEYFSNT-- 243
Query: 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898
S K D + + + R T+ + ++
Sbjct: 244 SALAK------DFIRRLLVKDPKKRMTIQDSLQH 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-44
Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 31/292 (10%)
Query: 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV 687
+++D +G+G +G VY+ L +G+L+AIK+ Q E++++ ++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 688 SLLGFCFDRGEQM------LIYEFVPNGSLGDSLS-GKNGIRLDWIRRLKIALGAARGLS 740
L F + GE+ L+ ++VP + + L I R L+
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 741 YLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
Y+H I HRDIK N+LLD + K+ DFG +K + E + + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAP 191
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------IERGKYIVREIRTVMDK--KKEL 851
+ T DV+S G ++ ELL G+ +++ I++ + T + ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 852 YNLYELIDPTIGLSTTLKGFEKYV-----DLALKCVQESGDDRPTMSEVVKD 898
N E P I K F L + ++ + R T E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-43
Identities = 53/280 (18%), Positives = 105/280 (37%), Gaps = 23/280 (8%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
+G G YG V+K +++A+K R EI LL + HKN+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 693 CFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIH 752
+ L++EF S + + ++ + L L + ++H
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNVLH 124
Query: 753 RDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKS 812
RD+K N+L++ K+A+FGL+++ + + + +V + + +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 813 DVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD-------------KKKELYNLYELID 859
D++S G + EL RP+ G + +++ + K Y Y +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 860 PTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 898
T L + DL ++ + R + E ++
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 62/301 (20%), Positives = 122/301 (40%), Gaps = 35/301 (11%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGG--QEFKMEIELLSRVHHK 684
+ + +G G +G+V+K GQ +A+K+ + + G EI++L + H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 685 NLVSLLGFCFDRGEQM--------LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAA 736
N+V+L+ C + L+++F + G + L I+R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 737 RGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT--TQVKGT 794
L+ L+ + I+HRD+K++N+L+ K+ADFGL+++ S ++ T T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 795 MGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRP------------IERGKY-IVRE 840
+ Y PE + ++ D++ G +M E+ T I + I E
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 841 IRTVMDKKKELYNLYELIDPTIGLSTTLKGF---EKYVDLALKCVQESGDDRPTMSEVVK 897
+ +D + L + + LK + +DL K + R + +
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
Query: 898 D 898
Sbjct: 305 H 305
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-39
Identities = 61/283 (21%), Positives = 100/283 (35%), Gaps = 33/283 (11%)
Query: 628 NNFSDANDVGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQE---FKMEIELLSRVHH 683
N+F +G G +GKV G+ A+K ++ + E E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 684 KNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLH 743
L +L + E+ G L LS + + R A +S L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119
Query: 744 ELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYY 803
L + +++RDIK N++LD+ + K+ DFGL K GT YL PE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 177
Query: 804 MTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI- 862
D + GV+M E++ GR P + L+ L + +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------------QDHERLFELILMEEIRFP 225
Query: 863 -GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
LS K L +++ R D + +++
Sbjct: 226 RTLSPEAK------SLLAGLLKKDPKQRLGGGP--SDAKEVME 260
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 8e-38
Identities = 54/247 (21%), Positives = 99/247 (40%), Gaps = 19/247 (7%)
Query: 588 AEKANEQNPFAHWDMNKSSGSIPQLKGARCFSFEEVKKYTNNFSDANDVGSGGYGKVYKG 647
A+K +EQ + + + + + + + F +G+G +G+V
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWE-----TPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 648 T-LPNGQLIAIK---RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703
+G A+K + + ++ + E +L V+ LV L D ++
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763
E+V G + L R A YLH L +I+RD+K N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLID 175
Query: 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLE 823
++ +V DFG +K + T + GT L PE +++ + D ++ GVL+ E
Sbjct: 176 QQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 824 LLTGRRP 830
+ G P
Sbjct: 231 MAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-37
Identities = 68/305 (22%), Positives = 110/305 (36%), Gaps = 31/305 (10%)
Query: 618 FSFEEVKKYTNNFSDA----NDVGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQE 670
F +EV K VGSG YG V G +AIK S +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 671 FKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGK--NGIRLDWIRR 728
E+ LL + H+N++ LL +F + GK +L R
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 729 LKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHIT 788
+ +GL Y+H IIHRD+K N+ ++E K+ DFGL++ +T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMT 176
Query: 789 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------IERGKYIVREIR 842
V + T+ D++S G +M E++TG+ +++ K I++
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 843 TVMDKKKELYNLYELIDPTIGLSTTLKGF---------EKYVDLALKCVQESGDDRPTMS 893
T + + E + GL K V+L K + + R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 894 EVVKD 898
E +
Sbjct: 297 EALAH 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 2e-34
Identities = 54/311 (17%), Positives = 117/311 (37%), Gaps = 48/311 (15%)
Query: 622 EVKKYTNNFSDAND------VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKME 674
+ + + + + +D +G G Y +V++ + N + + +K + + + K E
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKRE 79
Query: 675 IELLSRV-HHKNLVSLLGFCFDRGEQM--LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKI 731
I++L + N+++L D + L++E V N L
Sbjct: 80 IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFY 134
Query: 732 ALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDSEKDHITTQ 790
+ L Y H + I+HRD+K N+++D E ++ D+GL++ ++ ++
Sbjct: 135 MYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV- 190
Query: 791 VKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGK-------YIVREIR 842
+ + PE + Q+ D++S G ++ ++ + P G I + +
Sbjct: 191 --ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 843 TVMDKKKELYNLYELID--PTIGLSTTLKGFEKYV-------------DLALKCVQESGD 887
T EL I + K +E++V D K ++
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 888 DRPTMSEVVKD 898
R T E ++
Sbjct: 309 SRLTAREAMEH 319
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-33
Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 35/282 (12%)
Query: 636 VGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRV-HHKNL 686
+G+G YGKV+ G+L A+K ++ ++ + + + E ++L + L
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 687 VSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA 746
V+L + LI +++ G L LS + ++ + L L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI-----YVGEIVLALEHLH 146
Query: 747 NPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQ 806
II+RDIK NILLD + + DFGLSK E + GT+ Y+ P+
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGG 205
Query: 807 Q--LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI-- 862
+ D +S GVLM ELLTG P + + + E+ +P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPF--------TVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904
+S K DL + + + R +D + I +
Sbjct: 258 EMSALAK------DLIQRLLMKDPKKRLGCGP--RDADEIKE 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-32
Identities = 64/286 (22%), Positives = 104/286 (36%), Gaps = 33/286 (11%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGF 692
VGSG YG V G +A+K S+ + E+ LL + H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 693 CFDR-----GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELAN 747
+ + + L + + + +L + RGL Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS--- 139
Query: 748 PPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQ 807
IIHRD+K SN+ ++E K+ DFGL++ D +T V
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH 195
Query: 808 LTEKSDVYSFGVLMLELLTGRRP------------IERGKYIVRE--IRTVMDKKKELYN 853
+ D++S G +M ELLTGR I R ++ + + Y
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 854 LYELIDPTIGLSTTLKGF-EKYVDLALKCVQESGDDRPTMSEVVKD 898
P + + G VDL K + D R T ++ +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 67/320 (20%), Positives = 115/320 (35%), Gaps = 52/320 (16%)
Query: 620 FEEVKKYTNNFSDAND------VGSGGYGKVYKGT-LPNGQLIAIK--RAQQGSMQGGQE 670
F V+ + F+ +GSG G V + +AIK + +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 671 FKMEIELLSRVHHKNLVSLLGFCFDRG------EQMLIYEFVPNGSLGDSLSGKNGIRLD 724
E+ L+ V+HKN++SLL + + L+ E + LD
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELD 117
Query: 725 WIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784
R + G+ +LH IIHRD+K SNI++ K+ DFGL+++ S
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
Query: 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRP------IERGKYIV 838
T T Y PE + E D++S G +M E++ + I++ ++
Sbjct: 175 ---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 839 REIRT----VMDKKKELYNLYELIDPTIGLSTTLKGFEKYV----------------DLA 878
++ T M K + Y P T K F + DL
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 879 LKCVQESGDDRPTMSEVVKD 898
K + R ++ + ++
Sbjct: 292 SKMLVIDPAKRISVDDALQH 311
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 5e-27
Identities = 42/211 (19%), Positives = 77/211 (36%), Gaps = 19/211 (9%)
Query: 636 VGSGGYGKVYKGT-LPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLG--- 691
+G G + V+ + N +A+K + + + + EI+LL RV+ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 692 -----------FCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLS 740
G +++ V +L + + I +I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 741 YLHELANPPIIHRDIKSSNILLDER-LNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLD 799
Y+H IIH DIK N+L++ + ++ + D T T Y
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 800 PEYYMTQQLTEKSDVYSFGVLMLELLTGRRP 830
PE + +D++S L+ EL+TG
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 105 bits (262), Expect = 2e-25
Identities = 75/302 (24%), Positives = 115/302 (38%), Gaps = 28/302 (9%)
Query: 24 NDNDFVILKALKDDIWENEPP---NWKNN-DPCGDNWEGIGCTNS----RVTSITLSGMG 75
N D L +K D+ P +W D C W G+ C RV ++ LSG+
Sbjct: 4 NPQDKQALLQIKKDL--GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 76 LKG--QLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSI 133
L + + L L+ L + +L GP+P I L +L L + + SG IPD +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 134 GSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRA 193
++ LV L + N SG +PPSI +L NL + N++ G IP S G+ L +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 194 KHFHFGKNQLSGSIPEKLFRPDM----------------VLIHVLFDSNNLTGELPATLG 237
L D+ + + N +G
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241
Query: 238 LVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNN 297
L K+L + N + G +P L L ++ L +S N L G +P L +NN
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 298 SF 299
Sbjct: 302 KC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.5 bits (132), Expect = 9e-09
Identities = 18/66 (27%), Positives = 27/66 (40%), Gaps = 1/66 (1%)
Query: 113 KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172
K L+ L L G +P + L+ L L+++ N G +P GNL +NK
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 173 LEGEIP 178
P
Sbjct: 303 CLCGSP 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 4e-22
Identities = 30/199 (15%), Positives = 66/199 (33%), Gaps = 26/199 (13%)
Query: 636 VGSGGYGKVYKGTLPNGQLIAIK----------RAQQGSMQGGQEFKMEIELLSRVHHKN 685
+G G V+ +K + ++ G F + +R +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 686 LVSLLGFCFDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHEL 745
L L G + +Y + N L + + K R+ ++ ++ +
Sbjct: 68 LQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 746 ANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE-KDHITTQVKGTMGYLDPEYYM 804
I+H D+ N+L+ E + DF S + + ++ + V+ + Y Y
Sbjct: 122 --RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY-- 176
Query: 805 TQQLTEKSDVYSFGVLMLE 823
+ D+ S +L+
Sbjct: 177 ----RTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 1e-17
Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 20/199 (10%)
Query: 110 GNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT 169
L L +L+ S P I + L LSLN N ++ +L+NL LDL
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 170 DNKLEGEIP-----------VSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVL 218
+N++ P + + L + + L
Sbjct: 250 NNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 219 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTG 278
++ NN++ P + + L+ + F N +S S+L NLT++N L +N+++
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 279 AMPNLTGLSVLSYLDMSNN 297
+ L L+ ++ L +++
Sbjct: 366 -LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.6 bits (161), Expect = 4e-12
Identities = 65/356 (18%), Positives = 133/356 (37%), Gaps = 45/356 (12%)
Query: 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGC 123
+VT++ +G+K + G + L L ++ SNN+ L P + NL KL ++++
Sbjct: 44 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ-LTDITP--LKNLTKLVDILMNNN 98
Query: 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG---------NLSNLYWLDLTDNKLE 174
+ P + + + L N + +S++ L + +
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 175 GEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPA 234
+ L L + N++S LI +N ++ P
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIA---TNNQISDITPL 215
Query: 235 TLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDM 294
++ +L+ + + N L L +LT++ DL L+NN+++ + L+GL+ L+ L +
Sbjct: 216 G--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKL 270
Query: 295 SNNSFDASEVPSWFSSMQS-------------------LTTLMMENTNLKGQIPADLFSI 335
N + +++ + LT L + N+ P + S+
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL 328
Query: 336 PHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAV-NLTLIDN 390
LQ + N+++ L + N L + +N+IS T + L L D
Sbjct: 329 TKLQRLFFANNKVSDVSSLANLTNINWL-SAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.9 bits (141), Expect = 1e-09
Identities = 49/236 (20%), Positives = 81/236 (34%), Gaps = 44/236 (18%)
Query: 39 WENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNN 98
+ N ++ + I LS G + + G + LT L LDL+NN
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANN 251
Query: 99 KDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIG 158
+ + P + L KL+ L L S P + + + L+ N I
Sbjct: 252 Q-ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED----ISPIS 304
Query: 159 NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVL 218
NL NL +L L N + PVS L + + F N++S
Sbjct: 305 NLKNLTYLTLYFNNISDISPVSS--------LTKLQRLFFANNKVSD------------- 343
Query: 219 IHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNN 274
++L + ++ + N +S P L NLT + L L++
Sbjct: 344 --------------VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 7e-08
Identities = 43/311 (13%), Positives = 92/311 (29%), Gaps = 40/311 (12%)
Query: 111 NLKKLSNLMLVGCSFSGPIPDS-IGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLT 169
L + +L + + + + + + L L G + L+NL ++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 170 DNKLEGEIPVSD----------------------------GNSPGLDMLVRAKHFHFGKN 201
+N+L P+ + + +
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 202 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 261
+ + + ++ L + R D +S S L
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 262 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMEN 321
LT++ L +NN+++ P + L L ++ N + +S+ +LT L + N
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTN-LDELSLNGNQL---KDIGTLASLTNLTDLDLAN 250
Query: 322 TNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAP 381
+ P L + L + + N+++ L + L +N
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 382 AVNLTLIDNPI 392
LTL N I
Sbjct: 309 LTYLTLYFNNI 319
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.5 bits (184), Expect = 3e-15
Identities = 51/270 (18%), Positives = 99/270 (36%), Gaps = 25/270 (9%)
Query: 115 LSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174
+ L L + +L+ L L L +N S P + L L L L+ N+L+
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 175 GEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKL-FRPDMVLIHVLFDSNNLTGELP 233
E+P M + +N+++ M+++ + + +G
Sbjct: 93 -ELPEK--------MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 234 ATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPN-LTGLSVLSYL 292
+K L +R +++ +LT L+L NK+T L GL+ L+ L
Sbjct: 144 GAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLAKL 200
Query: 293 DMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352
+S NS + ++ L L + N L ++P L ++Q V + N ++ +
Sbjct: 201 GLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AI 257
Query: 353 DLGTSYSENLL--------VNLQNNRISAY 374
V+L +N + +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.1 bits (157), Expect = 8e-12
Identities = 46/310 (14%), Positives = 84/310 (27%), Gaps = 82/310 (26%)
Query: 51 PCGDNWEGIGCTNSRVTSI-----------TLSGMGLKGQLSGDITGLTELHTLDLSNNK 99
C + + C++ + + L + GD L LHTL L NN
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN- 65
Query: 100 DLRGPLPTTIGNLKKLSNLMLVG------------------------------------- 122
+ P L KL L L
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125
Query: 123 ----------CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNK 172
SG + +++L + + + +P + +L L L NK
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 182
Query: 173 LEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGEL 232
+ S L L + + + S + L + +NN ++
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL--------NNNKLVKV 234
Query: 233 PATLGLVKSLEVVRFDRNSLSG------PVPSNLNNLTSVNDLYLSNNKLT------GAM 280
P L K ++VV N++S P S + + L +N +
Sbjct: 235 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294
Query: 281 PNLTGLSVLS 290
+ + +
Sbjct: 295 RCVYVRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 30/209 (14%), Positives = 59/209 (28%), Gaps = 30/209 (14%)
Query: 31 LKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLK--GQLSGDITGLT 88
LK L + + + + + + + +++ + L LK G +G G+
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 89 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG 148
+L + +++ P G L+ L L G + S+ L L L L+ N
Sbjct: 151 KLSYIRIADTNITTIPQ----GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 149 FSGRV-----------------------PPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSP 185
S P + + + + L +N +
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 186 GLDMLVRAKHFHFGKNQLS-GSIPEKLFR 213
N + I FR
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (154), Expect = 1e-11
Identities = 37/213 (17%), Positives = 67/213 (31%), Gaps = 18/213 (8%)
Query: 113 KKLSNLMLVGCSFSG--PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 170
K+++ + V C +P + + +L L+ N ++ + L L+L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 171 NKLE--------------GEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDM 216
+L + P L + A S+P R
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 217 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKL 276
L + N L P L LE + N+L+ LN L +++ L L N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 277 TGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 309
G +L + + N + + +F
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFR 217
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 2e-11
Identities = 43/232 (18%), Positives = 81/232 (34%), Gaps = 5/232 (2%)
Query: 78 GQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 137
Q + + +DLSN+ L + KL NL L G S PI +++
Sbjct: 36 DQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
Query: 138 ELVLLSL--NSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKH 195
LV L+L S + + + S L L+L+ E V + + + +
Sbjct: 96 NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 155
Query: 196 FHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDR-NSLSG 254
+ KN + + R ++ L DS L + + L+ + R +
Sbjct: 156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215
Query: 255 PVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
L + ++ L + G + L L +L ++ + F P+
Sbjct: 216 ETLLELGEIPTLKTLQVFGIVPDGTLQLL--KEALPHLQINCSHFTTIARPT 265
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 8e-09
Identities = 40/255 (15%), Positives = 71/255 (27%), Gaps = 11/255 (4%)
Query: 91 HTLDLSNNKDLRGPLPTTIGNL--KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG 148
TLDL+ P G L + + P+ + + + + L+++
Sbjct: 3 QTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSV 57
Query: 149 FSGRVPPSI-GNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML--VRAKHFHFGKNQLSG 205
I S L L L +L I + + L L F Q
Sbjct: 58 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117
Query: 206 SIPEKLFRPDMVLIHVLFDSNNLTG-ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLT 264
S +L ++ + + + +L R +
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 265 SVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNL 324
DL S L+ L +L +S E + +L TL +
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237
Query: 325 KGQIPADLFSIPHLQ 339
G + ++PHLQ
Sbjct: 238 DGTLQLLKEALPHLQ 252
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 26/204 (12%), Positives = 57/204 (27%), Gaps = 4/204 (1%)
Query: 250 NSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 309
+L V L + + + + + + ++D+SN+ + S + S
Sbjct: 10 KNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILS 68
Query: 310 SMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNN 369
L L +E L I L +L + + +G + + L
Sbjct: 69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC--SGFSEFALQTLLSSCSRLDEL 126
Query: 370 RISAYTERGGAPAVNLTLIDNPICQELGTAKGYCQLSQPISPYSTKQKNCLPAPCNANQS 429
+S + + GY + Q + ++ + + S
Sbjct: 127 NLSWCFDFTEKHVQV-AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 185
Query: 430 SSPNCQCAYPYTGTLVFRSLSFSD 453
C + + LS S
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSR 209
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 25/119 (21%), Positives = 41/119 (34%), Gaps = 3/119 (2%)
Query: 45 NWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGP 104
++ N D + + V + LK + L L L LS D+
Sbjct: 157 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE 216
Query: 105 LPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNL 163
+G + L L + G G + +L L +N + F+ P+IGN N
Sbjct: 217 TLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQ 272
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 2e-08
Identities = 32/217 (14%), Positives = 66/217 (30%), Gaps = 38/217 (17%)
Query: 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 170
L + + + + + L + LS G + + L+NL L+L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 171 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 230
N++ P+ + L + SI + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 231 EL-------------------------------PATLGLVKSLEVVRFDRNSLSGPVPSN 259
L L + L ++ D N +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 260 LNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSN 296
L +L ++ +++L NN+++ + L S L + ++N
Sbjct: 191 LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 19/62 (30%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 109 IGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 168
+ NL KL+ L S P + SL L+ + L +N S + N SNL+ + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTL 224
Query: 169 TD 170
T+
Sbjct: 225 TN 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 8e-08
Identities = 44/293 (15%), Positives = 86/293 (29%), Gaps = 37/293 (12%)
Query: 61 CTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLML 120
C N + + GL+ + I ++ + L N+ + + + L+ L L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNR-ISHVPAASFRACRNLTILWL 63
Query: 121 VGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPP-SIGNLSNLYWLDLTDNKLEGEIPV 179
+ + L L L L+ N V P + L L+ L L
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD---------- 113
Query: 180 SDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV 239
+ LFR L ++ N L T +
Sbjct: 114 ---------------------RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 240 KSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 299
+L + N +S L S++ L L N++ P+ +
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 300 DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352
++ + +++L L + + A LQ ++E+ +L
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSL 264
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 38/208 (18%), Positives = 69/208 (33%), Gaps = 22/208 (10%)
Query: 104 PLPTTIG------NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSI 157
+PT I + L S + + + L + + N++ I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGI 64
Query: 158 GNLSNLYWLDLTDNKLEGEIPVSD---------GNSPGLDMLVRAKHFHFGKNQLSGSIP 208
L N+ L L NKL P+++ + D+ L +
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 209 EKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 268
+ + N L + L+ + + N +S VP L LT + +
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182
Query: 269 LYLSNNKLTGAMPNLTGLSVLSYLDMSN 296
LYLS N ++ + L GL L L++ +
Sbjct: 183 LYLSKNHISD-LRALAGLKNLDVLELFS 209
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 6e-07
Identities = 26/124 (20%), Positives = 41/124 (33%), Gaps = 27/124 (21%)
Query: 244 VVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVL-------------- 289
V+ L+ V +L L V L LS+N+L P L L L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 290 --------SYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQ--IPADLFS-IPHL 338
L + NN S S L L ++ +L + I L +P +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 339 QTVV 342
+++
Sbjct: 120 SSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 6e-05
Identities = 22/96 (22%), Positives = 35/96 (36%), Gaps = 7/96 (7%)
Query: 83 DITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLV-GCSFSGPIPDSIGSLQELVL 141
+ L + LDLS+N+ L L L L ++ + D + +L L
Sbjct: 15 HLEQLLLVTHLDLSHNR-----LRALPPALAALRCLEVLQASDNALENVDGVANLPRLQE 69
Query: 142 LSLNSNGF-SGRVPPSIGNLSNLYWLDLTDNKLEGE 176
L L +N + + L L+L N L E
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 23/155 (14%), Positives = 38/155 (24%), Gaps = 45/155 (29%)
Query: 142 LSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKN 201
L L + V + L + LDL+ N+L P L L + N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-------ALPPALAALRCLEVLQASDN 53
Query: 202 QLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 261
L L+ +N L L
Sbjct: 54 ALENVDGVANLPRLQELL---LCNNRLQ-----------------------QSAAIQPLV 87
Query: 262 NLTSVNDLYLSNNKLTG----------AMPNLTGL 286
+ + L L N L +P+++ +
Sbjct: 88 SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.003
Identities = 20/119 (16%), Positives = 38/119 (31%), Gaps = 27/119 (22%)
Query: 225 SNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPS--NLNNLTSVN--------------- 267
+LT L + + + N L P+ L L +
Sbjct: 7 HKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL 64
Query: 268 ----DLYLSNNKLTG--AMPNLTGLSVLSYLDMSNNSF--DASEVPSWFSSMQSLTTLM 318
+L L NN+L A+ L L L++ NS + + S+++++
Sbjct: 65 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 13/89 (14%), Positives = 28/89 (31%), Gaps = 9/89 (10%)
Query: 89 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSG----PIPDSIGSLQELVLLSL 144
++ +LD+ + + L++ + L C + I ++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 145 NSNGFSGRVPPSIG-----NLSNLYWLDL 168
SN + + L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 15/98 (15%), Positives = 38/98 (38%), Gaps = 13/98 (13%)
Query: 257 PSNLNNLTSVNDLYLSNNKLTGAMPN-----LTGLSVLSYLDMSNNSFDASEVPSWFSSM 311
+ + L+L++ ++ + + L L LD+SNN + + S+
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 312 QS----LTTLMMENTNLKGQIPADLFSI----PHLQTV 341
+ L L++ + ++ L ++ P L+ +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 24/110 (21%), Positives = 44/110 (40%), Gaps = 11/110 (10%)
Query: 225 SNNLTGE-LPATLGLVKSLEVVRFDRNSLSG----PVPSNLNNLTSVNDLYLSNNKLT-- 277
L+ L L++ +VVR D L+ + S L ++ +L L +N+L
Sbjct: 11 CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV 70
Query: 278 GAMPNLTGLSV----LSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 323
G L GL + L + N + S++++L TL + +
Sbjct: 71 GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 21/111 (18%), Positives = 43/111 (38%), Gaps = 12/111 (10%)
Query: 45 NWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQ----LSGDITGLTELHTLDLSNNK- 99
N + + +G+G S + + L+ + L+ + L LDLSNN
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 100 ---DLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQE----LVLLS 143
+ + + L L+L +S + D + +L++ L ++S
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 17/103 (16%), Positives = 33/103 (32%), Gaps = 17/103 (16%)
Query: 233 PATLGLVKSLEVVRFDRNSLSG----PVPSNLNNLTSVNDLYLSNNKLT--GAMPNLTGL 286
L V+ +S + + L S+ +L LSNN L G + + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 287 ----SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325
+L L + + + L L + +L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSE-------EMEDRLQALEKDKPSLR 457
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 22/128 (17%), Positives = 43/128 (33%), Gaps = 10/128 (7%)
Query: 37 DIWENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLS 96
D + + P + D E I S + ++ L L++S
Sbjct: 233 DNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 292
Query: 97 NNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPS 156
NNK + LP L++L + +P+ +L++ L + N P
Sbjct: 293 NNKLIE--LPALPPRLERLI---ASFNHLAE-VPELPQNLKQ---LHVEYNPLRE-FPDI 342
Query: 157 IGNLSNLY 164
++ +L
Sbjct: 343 PESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 9/93 (9%)
Query: 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPS 306
+ N+ S + S + S+ +L +SNNKL +P L L L S N +EVP
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHL--AEVP- 320
Query: 307 WFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQ 339
Q+L L +E L+ + P S+ L+
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 2e-05
Identities = 20/139 (14%), Positives = 39/139 (28%)
Query: 201 NQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNL 260
+ L + + + + +L L + L + ++ L P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 261 NNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320
+ ++ L LS N L L L +S N S W + +
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVP 136
Query: 321 NTNLKGQIPADLFSIPHLQ 339
L+ L +P+
Sbjct: 137 EQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 27/152 (17%), Positives = 45/152 (29%), Gaps = 7/152 (4%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLM 119
C + + + G L + G L L + N + L+ + L +L NL
Sbjct: 4 ACCPHGSSGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 120 LVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPV 179
+V PD+ L L+L+ N + +L L L+ N L
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH----- 116
Query: 180 SDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKL 211
L + +L L
Sbjct: 117 CSCALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 17/116 (14%), Positives = 38/116 (32%), Gaps = 5/116 (4%)
Query: 241 SLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLT--GLSVLSYLDMSNNS 298
+R R+ +L ++ +LY+ N + + GL L L + +
Sbjct: 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 299 FDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDL 354
++ + + + N + LQ +V+ N L+ + L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALE--SLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 26/189 (13%), Positives = 65/189 (34%), Gaps = 12/189 (6%)
Query: 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTD 170
L + +L + + + + L ++ L + G + L+NL ++ ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 171 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTG 230
N+L P+ + ++ + ++ + + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSN-------LNNLTSVNDLYLSNNKLTGAMPNL 283
L + + + + + SN L NLT++ L +S+NK++ + L
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-ISVL 190
Query: 284 TGLSVLSYL 292
L+ L L
Sbjct: 191 AKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.9 bits (99), Expect = 6e-05
Identities = 34/193 (17%), Positives = 64/193 (33%), Gaps = 15/193 (7%)
Query: 60 GCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLM 119
C T++ +G GLK ++ DI L L++N+ R G L L L
Sbjct: 5 MCHCE-GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLE 60
Query: 120 LVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPV 179
L +G P++ + L L N L L L+L DN++ +P
Sbjct: 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120
Query: 180 SDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLV 239
S + L + N + + F + + + P+ +
Sbjct: 121 SFEHLNSLT------SLNLASNPFNCNCHLAWFAEWLRKKSL--NGGAARCGAPSKV--- 169
Query: 240 KSLEVVRFDRNSL 252
+ +++ +
Sbjct: 170 RDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 3e-04
Identities = 26/159 (16%), Positives = 53/159 (33%), Gaps = 5/159 (3%)
Query: 24 NDNDFVILKALKDDIWENEPPNWKNNDPCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGD 83
++ I + + S + + L +K +
Sbjct: 38 DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKM 97
Query: 84 ITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143
GL +L TL+L +N+ + +P + +L L++L L F+ + L S
Sbjct: 98 FLGLHQLKTLNLYDNQ-ISCVMPGSFEHLNSLTSLNLASNPFNC-NCHLAWFAEWLRKKS 155
Query: 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDG 182
LN P + ++ DL ++ + S+G
Sbjct: 156 LNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 19/93 (20%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 258 SNLNNLTSVNDLYLSNNKLTGAMPNL-TGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 316
+ N +L L K+ + NL L +D S+N + F ++ L T
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD---GFPLLRRLKT 67
Query: 317 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349
L++ N + ++P L +++ N L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 21/139 (15%), Positives = 41/139 (29%), Gaps = 3/139 (2%)
Query: 231 ELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLS 290
+L + D L +L L ++ + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 291 YLDMSNNSF-DASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349
L++SNN ++ S +L L + LK + D L+ + + N L+
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 350 GTLDLGTSYSENLLVNLQN 368
T ++Y +
Sbjct: 129 DTFRDQSTYISAIRERFPK 147
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 955 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.4 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.4 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.4 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.4 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.34 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.3 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.23 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.23 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.18 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.41 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.5 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.26 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.76 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=432.73 Aligned_cols=258 Identities=28% Similarity=0.486 Sum_probs=206.2
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...+.||+|+||+||+|++.+++.||||+++.... ..++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 35777889999999999999998899999999986443 45789999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.+++.... ..++|..++.++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 999999887543 46899999999999999999999988 99999999999999999999999999987754432 22
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
.....||+.|||||++.+..++.++|||||||++|||+|++.|+.......+....+..... ...|
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------~~~p------- 224 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------LYKP------- 224 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-------CCCC-------
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-------CCCc-------
Confidence 33467999999999999999999999999999999999966665555444443333322111 1111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
..+..++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 12236789999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=432.25 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=215.8
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|++. ++..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 46778899999999999999998889999999986543 4578999999999999999999999875 456799999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.+++.......++|..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+..... ..
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TA 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-EC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-cc
Confidence 999999887666567999999999999999999999988 99999999999999999999999999998754332 23
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
.....||+.|||||++.++.++.++|||||||++|||+||+.|+.......+....+... ..+.. +
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~----------~~~~~----p 232 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------YRMVR----P 232 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------CCCCC----C
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----------CCCCC----c
Confidence 334678999999999999999999999999999999999777766555444433332211 11111 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
...+.++.+|+.+||+.||++||||+||++.|+.+..+
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 22346789999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=430.30 Aligned_cols=262 Identities=28% Similarity=0.483 Sum_probs=206.7
Q ss_pred hcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccC--CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQG--SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|...+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++. ++..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 356888999999999999999875 36999998754 3334578999999999999999999999875 456899999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|+|.++++..+ ..+++..+..++.|||+||+|||+.+ ||||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999997543 36999999999999999999999988 99999999999999999999999999987765444
Q ss_pred cceeeeeecCCCCCCHHHhhh---CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 785 DHITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
........||+.|||||++.+ ..++.++|||||||++|||+||+.||........ +........ ..|.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~--------~~p~ 230 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGY--------LSPD 230 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTS--------CCCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCC--------CCCc
Confidence 344456789999999999974 3589999999999999999999999975543332 222222211 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. ......++.++.+++.+||+.||++||||+|++++|+.+.+.
T Consensus 231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1 011223346889999999999999999999999999988653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-50 Score=434.03 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=218.2
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|++. +|+.||||+++.... ..++|.+|+++|++++|||||+++++|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356778899999999999999975 588999999976443 457899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+++|+|.+++.......+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~- 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence 99999999997666668999999999999999999999988 99999999999999999999999999987654332
Q ss_pred ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.......||+.|||||++.++.++.++|||||||++|||++|+.|+..+.+...... .+... ..+.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~-~i~~~---------~~~~---- 236 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKD---------YRME---- 236 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HHHTT---------CCCC----
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH-HHhcC---------CCCC----
Confidence 334446789999999999999999999999999999999998888766555433322 22111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
.+...+.++.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122334678999999999999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=426.39 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=207.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 356888999999999999999964 789999999875432 234568999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999997544 7999999999999999999999998 99999999999999999999999999997754443
Q ss_pred cceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.................. .
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-------------~ 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------------Y 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-------------T
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------C
Confidence 334455789999999999998876 57899999999999999999999755433222222211111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVK 897 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 897 (955)
.........++.+|+.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111122367889999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-49 Score=432.62 Aligned_cols=258 Identities=28% Similarity=0.489 Sum_probs=199.6
Q ss_pred CCCccCeeeccCceEEEEEEeC-CC---cEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NG---QLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
+|...++||+|+||+||+|++. ++ ..||||++..... ...++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 3445678999999999999874 23 3689999876433 34567999999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
|||++|+|.+++.... ..++|.++..++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+......
T Consensus 107 Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp ECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999887543 36899999999999999999999988 9999999999999999999999999998775433
Q ss_pred Ccce---eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccC
Q 002189 784 KDHI---TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELID 859 (955)
Q Consensus 784 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (955)
.... .....||+.|||||++.++.++.++|||||||++|||+| |+.||..... .+.+..+.... .
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-~~~~~~i~~~~----------~ 251 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQDY----------R 251 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC----------C
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC----------C
Confidence 2111 223467899999999999999999999999999999998 8999865432 22222221111 1
Q ss_pred CcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 860 PTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 860 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
...+...+.++.+++.+||+.||++||||+||++.|+++++.
T Consensus 252 ----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 ----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111223457789999999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=422.31 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=210.8
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
++|...+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688999999999999999986 479999999987655555678999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence 999999887643 5899999999999999999999998 99999999999999999999999999987754332
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
......||+.|||||++.++.++.++|||||||++|||+||+.||...... +.+........ +.. ..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~----------~~~--~~ 238 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGT----------PEL--QN 238 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCS----------CCC--SS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCC----------CCC--CC
Confidence 234567999999999999999999999999999999999999999654432 22222222211 111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22334678899999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=415.56 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=212.7
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|...++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 47888999999999999999998889999999987544 45789999999999999999999999999999999999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|.+++.... ..+++..+++++.|+|+||+|||+.+ |+||||||+||++++++.+||+|||+++....... ..
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 157 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence 999999876543 36889999999999999999999988 99999999999999999999999999987654433 23
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+....+.. .. ....|
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~~-~~------~~~~p------ 223 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQ-GL------RLYRP------ 223 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHHT-TC------CCCCC------
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHHHHh-CC------CCCCc------
Confidence 334679999999999999999999999999999999998 788986543 2222222221 11 11111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIEN 901 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 901 (955)
.....++.+++.+||+.||++|||++|++++|.+
T Consensus 224 -~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 -HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2233678999999999999999999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=419.43 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=205.4
Q ss_pred cCCCccCeeeccCceEEEEEEeCCC-----cEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNG-----QLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
+.|+..++||+|+||+||+|++++. ..||||+++..... ..++|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3567788999999999999987532 47999999764333 34579999999999999999999999999999999
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
||||+++|++.+.+... ...++|.+++.++.|+++||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999998877543 246999999999999999999999988 99999999999999999999999999987654
Q ss_pred CCC-cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEK-DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
... ........||+.|||||++.++.++.++|||||||++|||++|+.|+..+....+....+... ..+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~----------~~~ 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG----------FRL 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----------CCC
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc----------CCC
Confidence 322 222334568999999999999999999999999999999999777766554443333322211 111
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. .+...+.++.+|+.+||+.||++||||+||++.|+++++.
T Consensus 233 ~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 P----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp C----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 1223447789999999999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=416.89 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=208.5
Q ss_pred CCCccC-eeeccCceEEEEEEeC---CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 629 NFSDAN-DVGSGGYGKVYKGTLP---NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 629 ~f~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
+|...+ +||+|+||+||+|.++ ++..||||+++.... ...++|.+|+++|++++|||||+++|+|.+ +..|+||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 444555 4999999999999864 356899999976543 345789999999999999999999999864 5689999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... ..+++..+..++.|+|+||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+....
T Consensus 88 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp ECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999876442 36899999999999999999999988 9999999999999999999999999999876543
Q ss_pred Cc-ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 784 KD-HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 784 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. .......||+.|||||++.++.++.++|||||||++|||+| |+.||..... .+....+. ... .+.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~~~i~-~~~---------~~~ 232 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIE-QGK---------RME 232 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHH-TTC---------CCC
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCC---------CCC
Confidence 22 12234568999999999999999999999999999999998 8999975433 22222221 111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
. +...+.++.+|+.+||+.||++||||.+|++.|+.+..+
T Consensus 233 ~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 233 C----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp C----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1 223447889999999999999999999999999887654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=419.05 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=209.0
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVP 707 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 707 (955)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|+|. ++..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 5688899999999999999999888899999997643 34578999999999999999999999985 566899999999
Q ss_pred CCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcce
Q 002189 708 NGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDHI 787 (955)
Q Consensus 708 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 787 (955)
+|+|..++.......++|.+++.++.||++||+|||+.+ |+||||||+|||||+++.+||+|||+|+....... ..
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-ee
Confidence 999999887655557999999999999999999999988 99999999999999999999999999987654332 23
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLSTT 867 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (955)
.....||+.|+|||++..+.++.++|||||||++|||+||+.|+.......+.+..+.... .+. ..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~----------~~~----~~ 236 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----------RMP----CP 236 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------CCC----CC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------CCC----CC
Confidence 3446799999999999999999999999999999999998888766655544444332211 111 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 868 LKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 868 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.....++.+++.+||+.||++||+|++|++.|+.+.
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 233467899999999999999999999999888765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=416.19 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=195.7
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEe--CCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFD--RGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 702 (955)
++|+..+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788999999999999999986 47899999998765433 34568899999999999999999999975 4568999
Q ss_pred EEecCCCCcccccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 703 YEFVPNGSLGDSLSGK--NGIRLDWIRRLKIALGAARGLSYLHELA--NPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
|||+++|+|.+++... .+..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988642 2347999999999999999999999865 23599999999999999999999999999998
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
+.... .......||+.|||||++.+..++.++|||||||++|||+||+.||.... ..+....+....
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-~~~~~~~i~~~~---------- 230 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGK---------- 230 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTC----------
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-HHHHHHHHHcCC----------
Confidence 75432 22345689999999999999999999999999999999999999996433 223222222111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+.+. .....++.+++.+||+.||.+|||++|++++
T Consensus 231 ~~~~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 FRRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCC----cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01111 1233678899999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=411.55 Aligned_cols=246 Identities=29% Similarity=0.449 Sum_probs=206.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999974 68999999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999987544 6899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+....+... ++..
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~-----------~~~~- 223 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRISRV-----------EFTF- 223 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTT-----------CCCC-
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-HHHHHHHHHcC-----------CCCC-
Confidence 234679999999999999999999999999999999999999996433 22222222211 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.....++.+++.+||+.||++|||++|++++
T Consensus 224 ---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11233678899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=414.45 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=201.3
Q ss_pred CeeeccCceEEEEEEeCC---CcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEecCC
Q 002189 634 NDVGSGGYGKVYKGTLPN---GQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFVPN 708 (955)
Q Consensus 634 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 708 (955)
++||+|+||+||+|.+++ ++.||||+++... ....++|.+|+++|++++|||||+++|+|. .+..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 579999999999998643 4689999997532 223467999999999999999999999985 4567899999999
Q ss_pred CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc-e
Q 002189 709 GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH-I 787 (955)
Q Consensus 709 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-~ 787 (955)
|+|.++++... .+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999987543 6999999999999999999999988 9999999999999999999999999998775443322 2
Q ss_pred eeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCCC
Q 002189 788 TTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLST 866 (955)
Q Consensus 788 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (955)
.....||++|||||.+.++.++.++|||||||++|||+| |+.||..... .+... .+.... .+. .
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~~~~-~i~~~~---------~~~----~ 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTA-MLEKGE---------RMG----C 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHH-HHHTTC---------CCC----C
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-HHHHH-HHHcCC---------CCC----C
Confidence 234578999999999999999999999999999999998 8999975432 22222 221111 111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 867 TLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 867 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
+...+.++.+|+.+||+.||++|||++||++.|+....
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 22344778999999999999999999999998887653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=419.20 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=207.9
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35788899999999999999964 68999999998766666788999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~ 165 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 165 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence 999999987643 236999999999999999999999998 9999999999999999999999999997653211 1
Q ss_pred eeeeeecCCCCCCHHHhh-----hCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 787 ITTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
......||+.|||||++. ...++.++|||||||++|||+||+.||...... +.+..+.... .+.
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~~----------~~~ 234 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKSE----------PPT 234 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHSC----------CCC
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCC----------CCC
Confidence 223467999999999984 456899999999999999999999999754332 2222222111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+ ........++.+|+.+||+.||++|||++|++++
T Consensus 235 ~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1122344788999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=425.73 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=208.5
Q ss_pred cCCCccCeeeccCceEEEEEEeCC-C-----cEEEEEEcccC-CcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN-G-----QLIAIKRAQQG-SMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
++|...++||+|+||+||+|++.. + ..||||++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568888999999999999998642 2 36999998653 333446789999999998 899999999999999999
Q ss_pred EEEEEecCCCCcccccCCCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNG---------------------IRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSS 758 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~ 758 (955)
++||||+++|+|.++++.... ..+++..++.++.||++||+|||+.+ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999875431 35899999999999999999999988 999999999
Q ss_pred cEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchH
Q 002189 759 NILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYI 837 (955)
Q Consensus 759 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~ 837 (955)
||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987765544444455778999999999999999999999999999999998 89999654332
Q ss_pred HHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 002189 838 VREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIE 900 (955)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 900 (955)
..+..++.... .+. .+.....++.+|+.+||+.||++|||++||+++|.
T Consensus 274 -~~~~~~~~~~~---------~~~----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 -ANFYKLIQNGF---------KMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -HHHHHHHHTTC---------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHHhcCC---------CCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 22222222211 111 12233467899999999999999999999999885
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=409.55 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=199.0
Q ss_pred CccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEe----CCeEEEEE
Q 002189 631 SDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD----RGEQMLIY 703 (955)
Q Consensus 631 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 703 (955)
...++||+|+||+||+|+.. +++.||+|++.... ....+.|.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34467999999999999864 68899999987543 2334678999999999999999999999875 34579999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc-CCCceEEeecccccccCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD-ERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGla~~~~~~ 782 (955)
||+++|+|.+++.... .+++..+..++.||++||+|||+.+ ++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 9999999999987543 6899999999999999999999865 5599999999999996 5789999999999865332
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
......||+.|||||++.+ .++.++|||||||++|||++|+.||....+.......+..... ++..
T Consensus 169 ----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~---------~~~~ 234 (270)
T d1t4ha_ 169 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------PASF 234 (270)
T ss_dssp ----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------CGGG
T ss_pred ----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC---------Cccc
Confidence 2335679999999998865 6999999999999999999999999765544433332222111 0111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......++.+++.+||+.||++|||++|++++
T Consensus 235 ----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11123568899999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-48 Score=420.36 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=214.2
Q ss_pred HHHhcCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeC
Q 002189 624 KKYTNNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDR 696 (955)
Q Consensus 624 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 696 (955)
+..+++|+..+.||+|+||+||+|++. +++.||||+++..... ..++|.+|++++++++||||++++++|.+.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334578999999999999999999863 4578999999865443 346799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCcccccCCCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccC
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKN----------------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRD 754 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 754 (955)
+..++||||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ |||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 99999999999999999885321 235899999999999999999999988 99999
Q ss_pred CCCccEEEcCCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCC
Q 002189 755 IKSSNILLDERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERG 834 (955)
Q Consensus 755 lk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~ 834 (955)
|||+|||+|.++.+||+|||+|+...........+...||+.|+|||.+.+..++.++|||||||++|||++|..|+..+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998776554444455677999999999999999999999999999999999996543333
Q ss_pred chHHHHHHHHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 835 KYIVREIRTVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
.+..+....+..... +.. +...+.++.+|+.+||+.||++||||.||+++|+++.
T Consensus 246 ~~~~e~~~~v~~~~~----------~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNI----------LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHHHHHHHHHTTCC----------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHcCCC----------CCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 343343333322111 111 1223467899999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=423.72 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=206.1
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC-cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS-MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.++|+..++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46788999999999999999996 478999999987543 3334678999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
|+++|+|.+++...+ .+++..+..++.|+++||+|||+ ++ |+||||||+|||+++++.+||+|||+|+...+.
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 999999999997554 68999999999999999999997 47 999999999999999999999999999876432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHh--hh-h-----------
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMD--KK-K----------- 849 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~--~~-~----------- 849 (955)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||............... .. .
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 223468999999999999999999999999999999999999999754332111100000 00 0
Q ss_pred -----------------hhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 850 -----------------ELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 850 -----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..........|... ......++.+++.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000011111 01123578899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=414.00 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=205.3
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688899999999999999986 478999999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999887554 6899999999999999999999998 9999999999999999999999999999876544
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
.........||+.|||||++.+..++.++||||+||++|||+||+.||.... .......+.... +..
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~~i~~~~-----------~~~- 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKIIKLE-----------YDF- 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHTTC-----------CCC-
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-HHHHHHHHHcCC-----------CCC-
Confidence 4344455679999999999999999999999999999999999999997543 222222222111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+.....++.+|+.+||+.||.+|||++|++++
T Consensus 230 ---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 ---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11233678899999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-46 Score=417.05 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=212.1
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35789999999999999999986 47899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc--CCCceEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD--ERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFGla~~~~~~~ 783 (955)
|++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999886443 36999999999999999999999999 99999999999996 46789999999998875433
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......||+.|||||++.+..++.++||||+||++|||+||+.||... +..+.+..+..... ...
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~-----------~~~ 245 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDW-----------NMD 245 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCC-----------CSC
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCC-----------CCC
Confidence 234567999999999999999999999999999999999999999643 33333333322211 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.........++.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112233678899999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=406.14 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=200.5
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEe-CCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFD-RGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~ 706 (955)
++|...+.||+|+||+||+|++. |+.||||+++... ..++|.+|++++++++|||||+++|+|.+ ++..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677889999999999999984 7899999997643 34779999999999999999999999965 45689999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCcc
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKDH 786 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~ 786 (955)
++|+|.++++......++|..+++++.||++||+|||+.+ |+||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999997654446899999999999999999999988 999999999999999999999999999875432
Q ss_pred eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCCC
Q 002189 787 ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGLS 865 (955)
Q Consensus 787 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (955)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.|+... ...+....+... ..+..
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i~~~----------~~~~~--- 221 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG----------YKMDA--- 221 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTT----------CCCCC---
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcC----------CCCCC---
Confidence 223468999999999999999999999999999999999 56666533 222222222111 11222
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 866 TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 866 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
+.....++.+++.+||+.||.+||||+|++++|+++..+
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 222336788999999999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-47 Score=414.47 Aligned_cols=245 Identities=27% Similarity=0.437 Sum_probs=202.7
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch---hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG---GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.|+..+.||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999986 478999999987654332 3568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
||++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999987665443 36899999999999999999999998 999999999999999999999999999865432
Q ss_pred cceeeeeecCCCCCCHHHhhh---CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 785 DHITTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||...... +.+..+.... .+.
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~----------~~~ 233 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNE----------SPA 233 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSC----------CCC
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCC----------CCC
Confidence 23569999999999964 46899999999999999999999999754432 2222222211 111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.. .......+.+|+.+||+.||.+|||++|++++
T Consensus 234 ~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11 11233678899999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=411.95 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=192.6
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
.+.|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456888999999999999999964 6899999998754332 34568899999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc---CCCceEEeecccccccCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGla~~~~~ 781 (955)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||++. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999997644 6999999999999999999999998 99999999999994 578999999999987643
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. ......||+.|||||++.++.++.++|||||||++|||++|+.||..... .+....+..... .
T Consensus 163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~-----------~ 227 (307)
T d1a06a_ 163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-AKLFEQILKAEY-----------E 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHTTCC-----------C
T ss_pred CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHhccCC-----------C
Confidence 32 23346799999999999999999999999999999999999999975433 222222222111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...........++.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111112234678999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=412.14 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=202.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeCC-e
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG-E 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~ 698 (955)
++|...++||+|+||+||+|++. +++.||||+++..... ..+.+.+|..++.++ +|+|||++++++.+.+ .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57888999999999999999853 3468999999764333 346688888888887 6899999999987654 6
Q ss_pred EEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC
Q 002189 699 QMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE 764 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~ 764 (955)
.++||||+++|+|.++++... ...+++.++..++.||++||+|||+.+ |+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 899999999999999986432 235899999999999999999999988 999999999999999
Q ss_pred CCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCC-CCCcCCchHHHHHHH
Q 002189 765 RLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGR-RPIERGKYIVREIRT 843 (955)
Q Consensus 765 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~-~P~~~~~~~~~~~~~ 843 (955)
++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+||. +||...... +.+..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HHHHH
Confidence 9999999999998765544433444567999999999999999999999999999999999975 466543332 22222
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.+.... .+.. +.....++.+++.+||+.||++|||++|++++|++++++.
T Consensus 249 ~~~~~~---------~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 249 RLKEGT---------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp HHHHTC---------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcCC---------CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 222211 1111 1123467899999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=410.60 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=203.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc----EEEEEEcccC-CcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ----LIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 701 (955)
.+|+..++||+|+||+||+|++. +|+ +||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999864 444 6899988753 334467899999999999999999999999765 5678
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCC
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSD 781 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~ 781 (955)
|+||+.+|+|.+++... ...+++..++.++.|||+||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999877654 347899999999999999999999988 99999999999999999999999999998765
Q ss_pred CCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCC
Q 002189 782 SEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDP 860 (955)
Q Consensus 782 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (955)
...........||+.|||||++.++.++.++|||||||++|||+| |.+||..... .+. ...+..+. .+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~-~~~i~~~~---------~~ 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI-SSILEKGE---------RL 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGH-HHHHHHTC---------CC
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HHH-HHHHHcCC---------CC
Confidence 554444455679999999999999999999999999999999999 7778764322 111 11221111 01
Q ss_pred cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 002189 861 TIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQ 904 (955)
Q Consensus 861 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 904 (955)
..+.....++.+++.+||+.||.+|||++|++++|+.+.+
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1122334678999999999999999999999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5e-46 Score=413.76 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=211.3
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEec
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEFV 706 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 706 (955)
++|+..+.||+|+||+||+|+. .+|+.||||+++.....+.+.+.+|+++|++++|||||++++++.+++..||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688999999999999999986 479999999998766566678899999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc--CCCceEEeecccccccCCCCC
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD--ERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFGla~~~~~~~~ 784 (955)
++|+|.+++... +.++++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 999998877644 346999999999999999999999998 99999999999998 67899999999999876433
Q ss_pred cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
......||+.|||||++.+..++.++||||+||++|||+||+.||..... .+....+.... .....
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~-----------~~~~~ 249 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCD-----------WEFDE 249 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHCC-----------CCCCS
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC-----------CCCCc
Confidence 34456799999999999999999999999999999999999999965433 22222222111 11111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
........++.+|+.+||+.||.+|||++|++++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122234678899999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=407.48 Aligned_cols=260 Identities=30% Similarity=0.454 Sum_probs=209.1
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCc--EEEEEEcccC-CcchhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQ--LIAIKRAQQG-SMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 702 (955)
++|+..++||+|+||+||+|++. +|. .||||+++.. .....++|.+|+++|.++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56778899999999999999875 444 5788887643 333456799999999999 799999999999999999999
Q ss_pred EEecCCCCcccccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCce
Q 002189 703 YEFVPNGSLGDSLSGK--------------NGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNA 768 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 768 (955)
|||+++|+|.++++.. ....+++..+..++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998754 2357999999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhh
Q 002189 769 KVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKK 848 (955)
Q Consensus 769 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 848 (955)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|..|+..+.+..+....+...
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~- 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-
Confidence 9999999986543221 223568999999999999999999999999999999999876544444443333322211
Q ss_pred hhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcC
Q 002189 849 KELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAG 907 (955)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 907 (955)
..+.. +.....++.+|+.+||+.||++||||+||+++|++++++..
T Consensus 243 ---------~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 243 ---------YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ---------CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------CCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 11111 22334688999999999999999999999999999987543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=405.49 Aligned_cols=255 Identities=30% Similarity=0.494 Sum_probs=205.9
Q ss_pred cCeeeccCceEEEEEEeCCC----cEEEEEEcccC-CcchhHHHHHHHHHHHhccCCCcceEEEEEEeC-CeEEEEEEec
Q 002189 633 ANDVGSGGYGKVYKGTLPNG----QLIAIKRAQQG-SMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-GEQMLIYEFV 706 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~ 706 (955)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|+|.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36799999999999997532 36899999753 334457899999999999999999999998764 5889999999
Q ss_pred CCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc-
Q 002189 707 PNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD- 785 (955)
Q Consensus 707 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~- 785 (955)
++|+|.++++... ...++..+++++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999887543 46788999999999999999999988 999999999999999999999999999876543321
Q ss_pred -ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCCC
Q 002189 786 -HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIGL 864 (955)
Q Consensus 786 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (955)
.......||+.|+|||.+.++.++.++||||||+++|||+||+.||....+..+....+....+ ...|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-------~~~p---- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------LLQP---- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-------CCCC----
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------CCCc----
Confidence 1223356899999999999999999999999999999999988888765444433333322211 1111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 865 STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 865 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.....++.+++.+||+.||++||+|+||+++|+++.++
T Consensus 257 ---~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 ---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12346789999999999999999999999999999865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=402.78 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=206.6
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc------chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM------QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5788999999999999999997 4789999999865322 22467999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC----ceEEeecccc
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL----NAKVADFGLS 776 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGla 776 (955)
||||||++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+|++|||+|
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999987654 6999999999999999999999998 99999999999998776 4999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (955)
+....... .....||+.|||||++.+..++.++|||||||++|||+||+.||.... ..+....+.....
T Consensus 165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~~i~~~~~------- 233 (293)
T d1jksa_ 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSAVNY------- 233 (293)
T ss_dssp EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHTTCC-------
T ss_pred hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCC-------
Confidence 87754322 234579999999999999999999999999999999999999997543 2222222222111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.............+.+|+.+||+.||++|||++|++++
T Consensus 234 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000001123578899999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=407.35 Aligned_cols=262 Identities=25% Similarity=0.396 Sum_probs=216.4
Q ss_pred cCCCccCeeeccCceEEEEEEe------CCCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeCCeE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL------PNGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 699 (955)
++|...++||+|+||+||+|++ .+++.||||+++..... ...+|.+|+.++.++ +|||||+++++|.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677889999999999999985 24678999999865433 345789999999999 699999999999999999
Q ss_pred EEEEEecCCCCcccccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 700 MLIYEFVPNGSLGDSLSGKN----------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
++||||+++|+|.++++... ...+++..+..++.||++||+|||+.+ ++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999886432 235899999999999999999999998 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRT 843 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~ 843 (955)
.++.+|++|||+++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+.........+..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999999876655545555678999999999999999999999999999999999965555444333333333
Q ss_pred HHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 844 VMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
.+.... .+.. +......+.+|+.+||+.||.+||||+||+++|+++++.
T Consensus 260 ~i~~~~---------~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 260 MIKEGF---------RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHTC---------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCC---------CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 333221 1111 112336789999999999999999999999999988755
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=400.54 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=199.2
Q ss_pred cCCCccCeeeccCceEEEEEEeCC----CcEEEEEEcccCCcc-hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPN----GQLIAIKRAQQGSMQ-GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...+.||+|+||+||+|++.. +..||||+++..... ..+.|.+|++++++++|||||++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 567888999999999999998642 457999998754333 3467999999999999999999999985 5678999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+|+.....
T Consensus 86 ~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999876543 346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCc
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELIDPT 861 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (955)
.. .......||+.|+|||++.++.++.++|||||||++|||+| |.+||..... .+....+.... .+.
T Consensus 162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-~~~~~~i~~~~----------~~~ 229 (273)
T d1mp8a_ 162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGE----------RLP 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTC----------CCC
T ss_pred cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCC----------CCC
Confidence 32 23345678999999999999999999999999999999998 7888864432 22222222111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHc
Q 002189 862 IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQA 906 (955)
Q Consensus 862 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 906 (955)
.+...+.++.+|+.+||+.||++|||++||+++|+.++++.
T Consensus 230 ----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 230 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 12233467899999999999999999999999999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=399.51 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=197.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC--CC--cEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP--NG--QLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|+..+.||+|+||+||+|++. ++ ..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45788899999999999999863 23 378999987542 2334679999999999999999999999965 5678
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++|++.+++.... ..+++..++.++.|+|+||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998776543 36999999999999999999999988 9999999999999999999999999999875
Q ss_pred CCCCcc-eeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHHHHHhhhhhhhhhhhcc
Q 002189 781 DSEKDH-ITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 781 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (955)
...... ......||..|+|||++.+..++.++|||||||++|||+| |+.||... +..+....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~~~~~~~i~~~~~--------- 232 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGE--------- 232 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCC---------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-CHHHHHHHHHhCCC---------
Confidence 543322 2234567889999999999999999999999999999998 89998643 33333333322211
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENI 902 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 902 (955)
.+ ......+..+.+++.+||+.||++||||+||++.|++.
T Consensus 233 ~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 11222346788999999999999999999999888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=401.56 Aligned_cols=260 Identities=25% Similarity=0.434 Sum_probs=208.6
Q ss_pred cCCCccCeeeccCceEEEEEEeC--------CCcEEEEEEcccCCcc-hhHHHHHHHHHHHhc-cCCCcceEEEEEEeCC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP--------NGQLIAIKRAQQGSMQ-GGQEFKMEIELLSRV-HHKNLVSLLGFCFDRG 697 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 697 (955)
++|...+.||+|+||+||+|+.. ++..||||+++..... ...++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46778899999999999999853 2347999999865443 346788999999888 7999999999999999
Q ss_pred eEEEEEEecCCCCcccccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKN--------------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD 763 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~ 763 (955)
..++||||+++|+|.++++... ...+++.++++++.|++.||+|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 9999999999999999986543 245899999999999999999999998 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHh-CCCCCcCCchHHHHHH
Q 002189 764 ERLNAKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLT-GRRPIERGKYIVREIR 842 (955)
Q Consensus 764 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~ellt-g~~P~~~~~~~~~~~~ 842 (955)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+| |.+||.... ... +.
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-~~~-~~ 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE-LF 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHH-HH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-HHH-HH
Confidence 999999999999987765544444445678999999999999999999999999999999998 677775433 222 22
Q ss_pred HHHhhhhhhhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 002189 843 TVMDKKKELYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQ 905 (955)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 905 (955)
..+.... .+.. +.....++.+|+.+||+.||.+|||++||++.|+++++-
T Consensus 248 ~~i~~~~---------~~~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 248 KLLKEGH---------RMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHTTC---------CCCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCC---------CCCC----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2222111 1111 122346789999999999999999999999999999753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=406.30 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=212.4
Q ss_pred cCCCccCeeeccCceEEEEEEeC------CCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP------NGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|...+.||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++++|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56778899999999999999863 357899999976433 33456899999999999999999999999999999
Q ss_pred EEEEecCCCCcccccCCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEee
Q 002189 701 LIYEFVPNGSLGDSLSGKN--------GIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVAD 772 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 772 (955)
+||||+++|+|.+++.... ...+++..+.+++.|+|+||.|||+.+ |+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999876421 235799999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh
Q 002189 773 FGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY 852 (955)
Q Consensus 773 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 852 (955)
||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||..|+..+.+..+....+.....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~--- 253 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--- 253 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC---
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC---
Confidence 99998775544433344557999999999999999999999999999999999986444344444444433332111
Q ss_pred hhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 002189 853 NLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENIL 903 (955)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 903 (955)
+. .+......+.+++.+||+.||++||||+||+++|++.+
T Consensus 254 -------~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 254 -------LD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -------CC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 11123367999999999999999999999999987764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=401.14 Aligned_cols=266 Identities=24% Similarity=0.363 Sum_probs=205.1
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHH--HHHHHHhccCCCcceEEEEEEeCC----eEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKM--EIELLSRVHHKNLVSLLGFCFDRG----EQML 701 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~~~~~~~~----~~~l 701 (955)
++|...++||+|+||+||+|++ +|+.||||+++.. ..+++.+ |+..+.+++|||||+++++|.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4566778999999999999997 5899999998643 2234444 555556789999999999998764 5799
Q ss_pred EEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 702 IYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA-----NPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
|||||++|+|.++++.. .++|..+++++.|+|.||+|+|+.+ .++|+||||||+||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999754 5899999999999999999999741 244999999999999999999999999999
Q ss_pred cccCCCCCc--ceeeeeecCCCCCCHHHhhhCC------CCChhhhHHHHHHHHHHHhCCCCCcCCc-------------
Q 002189 777 KSMSDSEKD--HITTQVKGTMGYLDPEYYMTQQ------LTEKSDVYSFGVLMLELLTGRRPIERGK------------- 835 (955)
Q Consensus 777 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwS~Gv~l~elltg~~P~~~~~------------- 835 (955)
+........ .......||++|||||++.+.. ++.++|||||||++|||+||..|+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877544321 1233467999999999987643 5679999999999999999988764211
Q ss_pred hHHHHHHHHHhhhhhhhhhhhccCCcCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCC
Q 002189 836 YIVREIRTVMDKKKELYNLYELIDPTIGLS-TTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGL 908 (955)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 908 (955)
.......... ..+..+|.+... .....+..+.+++.+||+.||.+|||+.||+++|+++.++.++
T Consensus 236 ~~~~~~~~~~--------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 236 PSVEEMRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CCHHHHHHHH--------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred chHHHHHHHH--------hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 1111111111 112233333222 1234557799999999999999999999999999999988765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.6e-45 Score=392.95 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=204.2
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---hhHHHHHHHHHHHhccCCCcceEEEEEEeCCe----
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGE---- 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 698 (955)
.++|...+.||+|+||+||+|+. .+|+.||||+++..... ..+.|.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35788999999999999999986 57999999999764332 23568999999999999999999999987543
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.|+||||+++|+|.+++...+ .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++..+++|||.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999998886554 6899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCC-cceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhc
Q 002189 779 MSDSEK-DHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYEL 857 (955)
Q Consensus 779 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (955)
...... ........||+.|||||++.+..++.++|||||||++|||+||+.||..... .+..........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~~~~~~~-------- 231 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-VSVAYQHVREDP-------- 231 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHCCC--------
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-HHHHHHHHhcCC--------
Confidence 543322 2233456799999999999999999999999999999999999999965432 333333322211
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHH
Q 002189 858 IDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-TMSEVVKDIENIL 903 (955)
Q Consensus 858 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 903 (955)
..+. ......+.++.+++.+||+.||.+|| +++++.+.|.++.
T Consensus 232 ~~~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCc---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111 11112336788999999999999999 8999999988774
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-45 Score=398.93 Aligned_cols=245 Identities=26% Similarity=0.374 Sum_probs=205.7
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999996 469999999987432 223467899999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|..++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999999998887554 6788888899999999999999998 9999999999999999999999999998865332
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
....||+.|||||++.+..++.++||||+||++|||+||+.||..... .+....+..... .+++
T Consensus 159 -----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~-------~~p~--- 222 (316)
T d1fota_ 159 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAEL-------RFPP--- 222 (316)
T ss_dssp -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCCC-------CCCT---
T ss_pred -----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-HHHHHHHHcCCC-------CCCC---
Confidence 346799999999999999999999999999999999999999975432 233332222111 0111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
....++.+++.+||+.||.+|+ +++|++++
T Consensus 223 -----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 223 -----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 2236788999999999999996 89999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=401.96 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=207.3
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688999999999999999996 479999999987532 223467889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++++|.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999887654 6888899999999999999999999 9999999999999999999999999998764332
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
. .....+||+.|||||++.+..++.++||||+||++|||++|++||..... .+........ .+..
T Consensus 160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-~~~~~~i~~~-----------~~~~- 224 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILME-----------EIRF- 224 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHC-----------CCCC-
T ss_pred c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-HHHHHHHhcC-----------CCCC-
Confidence 2 23456899999999999999999999999999999999999999975432 2222222111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
+.....++.+|+.+||++||.+||+ ++|++++
T Consensus 225 ---p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1123367889999999999999994 8899874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-44 Score=388.97 Aligned_cols=251 Identities=27% Similarity=0.351 Sum_probs=206.7
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc---------hhHHHHHHHHHHHhcc-CCCcceEEEEEEeC
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ---------GGQEFKMEIELLSRVH-HKNLVSLLGFCFDR 696 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 696 (955)
++|...+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999986 57899999998754321 1235889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
+..||||||+++|+|.++++..+ .+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997654 6899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhC------CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE 850 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 850 (955)
+....... .....||+.|+|||.+.+. .++.++||||+||++|||+||+.||..... ......+.....
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-~~~~~~i~~~~~- 232 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNY- 232 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC-
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-HHHHHHHHhCCC-
Confidence 88754322 2346799999999999742 468899999999999999999999975543 222332322211
Q ss_pred hhhhhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 LYNLYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
............++.+++.+||+.||++|||++|++++
T Consensus 233 ----------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 ----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111122344678999999999999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=392.47 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=208.0
Q ss_pred hcCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.++|...+.||+|+||+||+|+.. +|+.||||+++... .+...+.+|+++|+.++|||||++++++.+++..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467889999999999999999864 68999999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCC--CceEEeecccccccCCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDER--LNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFGla~~~~~~~ 783 (955)
|++|+|.+++...+ ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999997543 36899999999999999999999998 9999999999999854 579999999998764432
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
......||+.|+|||.+.+..++.++||||+||++|||++|..||..... .+....+...... ......+
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-~~~~~~i~~~~~~---~~~~~~~--- 228 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYT---FDEEAFK--- 228 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC---CCHHHHT---
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC---CChhhcc---
Confidence 33456799999999999999999999999999999999999999965432 2333333222110 0000000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
....++.+|+.+||+.||.+|||++|++++
T Consensus 229 -----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 -----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123568899999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-44 Score=397.81 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=206.3
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 703 (955)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46889999999999999999864 79999999986422 223457889999999999999999999999999999999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSE 783 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~ 783 (955)
||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999887554 6899999999999999999999998 9999999999999999999999999999875332
Q ss_pred CcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcCC
Q 002189 784 KDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTIG 863 (955)
Q Consensus 784 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (955)
....||+.|||||++.+..++.++|||||||++|||+||+.||.... .......+.... +..
T Consensus 196 -----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~-----------~~~- 257 (350)
T d1rdqe_ 196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGK-----------VRF- 257 (350)
T ss_dssp -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCC-----------CCC-
T ss_pred -----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-HHHHHHHHhcCC-----------CCC-
Confidence 24679999999999999999999999999999999999999996543 333333222211 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 864 LSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 864 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
+.....++.+++.+||+.||.+|+ +++|++++
T Consensus 258 ---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 112336788999999999999994 89999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=398.44 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=200.7
Q ss_pred hcCCCccC-eeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhc-cCCCcceEEEEEEe----CCeE
Q 002189 627 TNNFSDAN-DVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRV-HHKNLVSLLGFCFD----RGEQ 699 (955)
Q Consensus 627 ~~~f~~~~-~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~ 699 (955)
.++|.+.. .||+|+||+||+|+. .+|+.||||+++. .+.+.+|++++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35677765 599999999999986 5789999999864 25678899987655 89999999999876 4568
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC---CCceEEeecccc
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE---RLNAKVADFGLS 776 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGla 776 (955)
|+|||||++|+|.+++...+...+++..+..++.|++.||+|||+.+ |+||||||+|||+++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999998766667999999999999999999999998 999999999999985 567999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYE 856 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (955)
+....... .....||+.|||||++.+..++.++|||||||++|||+||+.||....... ......... .
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~~i-------~ 230 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRI-------R 230 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CC-------C
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHHHH-------h
Confidence 87654332 334679999999999999999999999999999999999999996432211 000010000 0
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 857 LIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 857 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
................++.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000011111112344678999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=387.77 Aligned_cols=259 Identities=24% Similarity=0.308 Sum_probs=196.9
Q ss_pred ccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcch-----hHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 632 DANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQG-----GQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
.+++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999996 468999999987543221 24688999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
++++++....... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 9988877666543 36888889999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----hhhhhhccC
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLYELID 859 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~d 859 (955)
......||+.|||||++... .++.++|||||||++|||+||.+||..... .+.+..+...... .........
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-HHHHHHHHHhcCCCChhhccchhccch
Confidence 22345799999999998754 579999999999999999999999865433 3333333321100 000000000
Q ss_pred C-cCC--CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 860 P-TIG--LSTT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 860 ~-~l~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
. ... .... .....++.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 000 0000 1123678999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.2e-44 Score=398.99 Aligned_cols=248 Identities=24% Similarity=0.324 Sum_probs=198.7
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc---chhHHHHH---HHHHHHhccCCCcceEEEEEEeCCeEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM---QGGQEFKM---EIELLSRVHHKNLVSLLGFCFDRGEQM 700 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 700 (955)
++|...++||+|+||+||+|+.. +|+.||||++..... .....+.+ |+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999964 699999999864221 11223444 466777778999999999999999999
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999987654 6889999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchH-HHHHHHHHhhhhhhhhhhhcc
Q 002189 781 DSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYI-VREIRTVMDKKKELYNLYELI 858 (955)
Q Consensus 781 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 858 (955)
... .....||+.|||||++.. ..++.++|||||||++|||+||+.||...... ...+. ... ...
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~-------~~~ 224 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT-------LTM 224 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HHS-------SSC
T ss_pred CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhc-------ccC
Confidence 432 234579999999999975 56899999999999999999999999753321 11111 000 001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 002189 859 DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPT-----MSEVVKD 898 (955)
Q Consensus 859 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 898 (955)
.+.. +.....++.+|+.+||+.||.+||| ++|++++
T Consensus 225 ~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1111 1123367899999999999999999 6899875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=394.08 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=202.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCC---cchhHHHHHHHHHHH-hccCCCcceEEEEEEeCCeEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGS---MQGGQEFKMEIELLS-RVHHKNLVSLLGFCFDRGEQMLI 702 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV 702 (955)
++|...++||+|+||+||+|+.. +|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999864 68999999997432 122345667777665 68999999999999999999999
Q ss_pred EEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCC
Q 002189 703 YEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 703 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~ 782 (955)
|||+++|+|.++++... .+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997554 6888999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhhhccCCcC
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLYELIDPTI 862 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (955)
. .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.. ..+....+... .+..
T Consensus 157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~-----------~~~~ 222 (320)
T d1xjda_ 157 D--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMD-----------NPFY 222 (320)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHC-----------CCCC
T ss_pred c--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHcC-----------CCCC
Confidence 2 22344679999999999999999999999999999999999999996543 22222222111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 002189 863 GLSTTLKGFEKYVDLALKCVQESGDDRPTMS-EVVK 897 (955)
Q Consensus 863 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 897 (955)
. .....++.+|+.+||+.||++||++. |+++
T Consensus 223 p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 P----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 12236788999999999999999995 7765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=386.38 Aligned_cols=264 Identities=21% Similarity=0.332 Sum_probs=202.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|...+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999996 57999999999754322 24678999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
|+.+ ++.+++.......+++..+..++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9965 4444444344457999999999999999999999998 99999999999999999999999999987754332
Q ss_pred cceeeeeecCCCCCCHHHhhhCC-CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-----hhhhhc-
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-----YNLYEL- 857 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----~~~~~~- 857 (955)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||..... .+....+....... ......
T Consensus 158 --~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp --CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-HHHHHHHHHhcCCCchhhcccccccc
Confidence 233457999999999987665 57899999999999999999999975433 23333322211100 000000
Q ss_pred -cCCcCCC--CCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 -IDPTIGL--STT-----LKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 -~d~~l~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+.... ... .....++.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000 000 1122678899999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-43 Score=382.03 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=202.6
Q ss_pred cCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...++||+|+||+||+|+..+|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++..++|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578889999999999999999989999999999754322 246899999999999999999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCCc
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEKD 785 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~~ 785 (955)
+.++.+..+.+.. ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9887776666544 36999999999999999999999988 99999999999999999999999999987654322
Q ss_pred ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh-----hhhhhhc--
Q 002189 786 HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-----LYNLYEL-- 857 (955)
Q Consensus 786 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-- 857 (955)
......|++.|+|||.+.+. .++.++||||+||++|||++|+.||..... .+....+...... .......
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhhccchhhhhh
Confidence 23345689999999999754 568999999999999999999999975433 2333322211100 0000000
Q ss_pred cCCcCC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 858 IDPTIG-------LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 858 ~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+.... ..........+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00111223678899999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-44 Score=382.64 Aligned_cols=240 Identities=26% Similarity=0.422 Sum_probs=196.5
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc------hhHHHHHHHHHHHhcc--CCCcceEEEEEEeCCe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ------GGQEFKMEIELLSRVH--HKNLVSLLGFCFDRGE 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 698 (955)
++|+..+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788899999999999999986 47899999998753221 1234678999999996 8999999999999999
Q ss_pred EEEEEEecCC-CCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-CCceEEeecccc
Q 002189 699 QMLIYEFVPN-GSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-RLNAKVADFGLS 776 (955)
Q Consensus 699 ~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGla 776 (955)
.++||||+.+ +++.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 57777765443 6899999999999999999999998 999999999999985 479999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCHHHhhhCCC-CChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhhhhh
Q 002189 777 KSMSDSEKDHITTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELYNLY 855 (955)
Q Consensus 777 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (955)
+..... ..+...||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ....
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-------~~~~------- 220 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQ------- 220 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHCC-------
T ss_pred eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-------hhcc-------
Confidence 875432 2334679999999999998776 56789999999999999999999653211 1110
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
..+++ ....++.+++.+||+.||++|||++|++++
T Consensus 221 ~~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 VFFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111 123678899999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=376.73 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=198.4
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CC-CcEEEEEEcccCCc--chhHHHHHHHHHHHhc---cCCCcceEEEEEEe----
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PN-GQLIAIKRAQQGSM--QGGQEFKMEIELLSRV---HHKNLVSLLGFCFD---- 695 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 695 (955)
.++|...++||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+++++.+ +|||||++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36789999999999999999986 34 67899999864322 2234567788887776 79999999999864
Q ss_pred -CCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecc
Q 002189 696 -RGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFG 774 (955)
Q Consensus 696 -~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 774 (955)
....+++|||+++|++..... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 246799999998876654333 23346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh--h
Q 002189 775 LSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL--Y 852 (955)
Q Consensus 775 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~ 852 (955)
+++..... .......||+.|||||++.+..++.++||||+||++|||+||+.||..... .+.+..+....... .
T Consensus 162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGG
T ss_pred hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCchh
Confidence 98865432 233456799999999999999999999999999999999999999975433 33333332211000 0
Q ss_pred hhh-------hcc---CCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLY-------ELI---DPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~-------~~~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.+. ... .+.............+.+|+.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000 0000001111223678899999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-41 Score=367.95 Aligned_cols=265 Identities=19% Similarity=0.247 Sum_probs=211.8
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccC-CCcceEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~ 705 (955)
++|...++||+|+||+||+|+.. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57888999999999999999964 68999999886542 23457889999999975 8999999999999999999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcC-----CCceEEeecccccccC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDE-----RLNAKVADFGLSKSMS 780 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DFGla~~~~ 780 (955)
+ +|+|.++++..+ ..+++.++..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+|+...
T Consensus 83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 789988876443 46899999999999999999999999 999999999999974 5789999999998765
Q ss_pred CCCCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCc--hHHHHHHHHHhhhhhhhh
Q 002189 781 DSEKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGK--YIVREIRTVMDKKKELYN 853 (955)
Q Consensus 781 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~ 853 (955)
..... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.... ........+..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCC
Confidence 43221 12334679999999999999999999999999999999999999997432 22222222222111 000
Q ss_pred hhhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCC
Q 002189 854 LYELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 909 (955)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 909 (955)
..+ +.+ ..++++.+++..|+..+|++||+++.+.+.|++++++.+..
T Consensus 237 ~~~-l~~--------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 237 LRE-LCA--------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHH-HTT--------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hHH-hcC--------CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 111 111 12367889999999999999999999999999999887653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=370.23 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=202.4
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcc-eEEEEEEeCCeEEEEEEe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV-SLLGFCFDRGEQMLIYEF 705 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~e~ 705 (955)
++|+..+.||+|+||+||+|+. .+|+.||||++..... .+++.+|+++++.++|+|++ .+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688899999999999999986 4689999998875432 24588999999999877655 555556777888999999
Q ss_pred cCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEc---CCCceEEeecccccccCCC
Q 002189 706 VPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLD---ERLNAKVADFGLSKSMSDS 782 (955)
Q Consensus 706 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGla~~~~~~ 782 (955)
+ +|++.+.+... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++ .+..+|++|||+|+.+...
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 55666655432 236899999999999999999999999 99999999999986 4567999999999987644
Q ss_pred CCc-----ceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHH--HHHHHHhhhhhhhhhh
Q 002189 783 EKD-----HITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVR--EIRTVMDKKKELYNLY 855 (955)
Q Consensus 783 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~ 855 (955)
... .......||+.|||||.+.+..++.++|||||||++|||+||+.||........ .+........ ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~ 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM--STPI 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH--HSCH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC--CCCh
Confidence 321 122346799999999999999999999999999999999999999974332211 1111111100 0000
Q ss_pred hccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHcCCC
Q 002189 856 ELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKDIENILQQAGLN 909 (955)
Q Consensus 856 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 909 (955)
+...+ ..+.++.+++.+||+.||++||+++++.+.|+.+..+.+..
T Consensus 238 ~~~~~--------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 238 EVLCK--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp HHHTT--------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hHhcc--------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 00111 12367889999999999999999999999999998776653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=370.66 Aligned_cols=265 Identities=21% Similarity=0.332 Sum_probs=196.2
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCC--cchhHHHHHHHHHHHhccCCCcceEEEEEEe--------C
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGS--MQGGQEFKMEIELLSRVHHKNLVSLLGFCFD--------R 696 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 696 (955)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788999999999999999996 579999999986432 2234678999999999999999999999865 3
Q ss_pred CeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccc
Q 002189 697 GEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLS 776 (955)
Q Consensus 697 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla 776 (955)
+..++||||++++.+....... ..++...+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 4679999999887776554433 36788889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc--ceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-h
Q 002189 777 KSMSDSEKD--HITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-Y 852 (955)
Q Consensus 777 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~ 852 (955)
+........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+....... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHHHHhcCCCCh
Confidence 876543221 122235799999999999865 6899999999999999999999999754332 2222222111000 0
Q ss_pred hhhhccC---------CcCCCCCCHH-------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 NLYELID---------PTIGLSTTLK-------GFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ~~~~~~d---------~~l~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......+ .......... ....+.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 0000001111 12456799999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=366.63 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=210.3
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeCCeEEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRGEQMLIYE 704 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 704 (955)
++|+..++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+++.++|||||++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788999999999999999996 5789999999875432 334678999999999999999999999999999999999
Q ss_pred ecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccCCCCC
Q 002189 705 FVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMSDSEK 784 (955)
Q Consensus 705 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~~~~~ 784 (955)
++.++++..+++..+ .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999888776543 6789999999999999999999998 99999999999999999999999999988754332
Q ss_pred cceeeeeecCCCCCCHHHhhhCC-CCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhhh-----hhhhcc
Q 002189 785 DHITTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKELY-----NLYELI 858 (955)
Q Consensus 785 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 858 (955)
......++..|+|||.+.... ++.++||||+||++|||++|+.||..+.+..+....+........ ......
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 223345788899999998665 689999999999999999999998877776666555443221100 000000
Q ss_pred C----CcC-----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 859 D----PTI-----GLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 859 d----~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
+ +.. ...........+.+|+.+||+.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000 001112223578899999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=376.03 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=193.7
Q ss_pred CCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcceEEEEEEeCC------eEEE
Q 002189 629 NFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------EQML 701 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 701 (955)
+|...++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|||||++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4677889999999999999974 699999999976432 2347999999999999999999986532 4689
Q ss_pred EEEecCCCCcccccCC-CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeeccccccc
Q 002189 702 IYEFVPNGSLGDSLSG-KNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSM 779 (955)
Q Consensus 702 V~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~ 779 (955)
||||+++|.+....+. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999986644333221 22347999999999999999999999998 99999999999999775 8999999999877
Q ss_pred CCCCCcceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh----h-hh-
Q 002189 780 SDSEKDHITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK----E-LY- 852 (955)
Q Consensus 780 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----~-~~- 852 (955)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... +.+..+..... + ..
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhh
Confidence 54332 233579999999999875 46899999999999999999999999754432 22222221100 0 00
Q ss_pred ---hhhhccCCcCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 ---NLYELIDPTIG-----LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 ---~~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......-+... .........++.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 00111234678899999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-40 Score=366.48 Aligned_cols=257 Identities=18% Similarity=0.312 Sum_probs=200.1
Q ss_pred cCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeC--CeEEEEE
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDR--GEQMLIY 703 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~ 703 (955)
++|...++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999986 57899999999753 3467899999999995 99999999999854 5689999
Q ss_pred EecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCC-ceEEeecccccccCCC
Q 002189 704 EFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERL-NAKVADFGLSKSMSDS 782 (955)
Q Consensus 704 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGla~~~~~~ 782 (955)
||+++|+|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987643 5889999999999999999999999 99999999999998655 6999999999876543
Q ss_pred CCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhh--hhh-------
Q 002189 783 EKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKK--ELY------- 852 (955)
Q Consensus 783 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~------- 852 (955)
.. .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..+.+..+....+..... ...
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 2345689999999998865 4799999999999999999999999866554433222211000 000
Q ss_pred -----hhhhccCCc--------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 -----NLYELIDPT--------IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 -----~~~~~~d~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
......... ...........++.+|+.+||+.||.+|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 0000111223678899999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=372.02 Aligned_cols=258 Identities=25% Similarity=0.379 Sum_probs=193.7
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcc--hhHHHHHHHHHHHhccCCCcceEEEEEEeCC------
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQ--GGQEFKMEIELLSRVHHKNLVSLLGFCFDRG------ 697 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 697 (955)
.++|...++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35788899999999999999986 46999999999754332 3457889999999999999999999997654
Q ss_pred eEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 698 EQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 698 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
..|+||||+ +++|....+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 469999999 55676665432 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh------
Q 002189 778 SMSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE------ 850 (955)
Q Consensus 778 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 850 (955)
...... +...||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ..........
T Consensus 170 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHH
T ss_pred ccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHH
Confidence 765332 345699999999999864 568999999999999999999999975543322 1111110000
Q ss_pred -------hhhhhhccCCcCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 -------LYNLYELIDPTIGL----STTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 -------~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.......+ +.... .........+.+|+.+||+.||.+|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 01000 0111223567899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=371.31 Aligned_cols=265 Identities=21% Similarity=0.295 Sum_probs=196.2
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc-chhHHHHHHHHHHHhccCCCcceEEEEEEeCC----eEE
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM-QGGQEFKMEIELLSRVHHKNLVSLLGFCFDRG----EQM 700 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 700 (955)
+.+|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 34688899999999999999985 5799999999975433 33467899999999999999999999997643 234
Q ss_pred EEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccccC
Q 002189 701 LIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKSMS 780 (955)
Q Consensus 701 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~~~ 780 (955)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 555667799999998643 5899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc-ceeeeeecCCCCCCHHHhhh-CCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh--------
Q 002189 781 DSEKD-HITTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-------- 850 (955)
Q Consensus 781 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-------- 850 (955)
..... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ...........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH-HHHHHhhhccCCChhhhhh
Confidence 33221 12234679999999999864 467899999999999999999999997543322 11111110000
Q ss_pred -----hhhhhhccCCcCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 -----LYNLYELIDPTIGLST---TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 -----~~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
................ ......++.+|+.+||+.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000000 00112568899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-41 Score=367.46 Aligned_cols=251 Identities=28% Similarity=0.358 Sum_probs=200.4
Q ss_pred cCCCccCeeeccCceEEEEEEe----CCCcEEEEEEcccCCc----chhHHHHHHHHHHHhccC-CCcceEEEEEEeCCe
Q 002189 628 NNFSDANDVGSGGYGKVYKGTL----PNGQLIAIKRAQQGSM----QGGQEFKMEIELLSRVHH-KNLVSLLGFCFDRGE 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 698 (955)
++|+..++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5689999999999999999985 2488999999865321 224568899999999976 899999999999999
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++||||+.+|+|.+++.... .+.......++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999987654 5677888899999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhC--CCCChhhhHHHHHHHHHHHhCCCCCcCCch--HHHHHHHHHhhhhhhhhh
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVLMLELLTGRRPIERGKY--IVREIRTVMDKKKELYNL 854 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwS~Gv~l~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~ 854 (955)
+..... .......|++.|+|||.+.+. .++.++||||+||++|||+||+.||..... ....+......
T Consensus 179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~------- 250 (322)
T d1vzoa_ 179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK------- 250 (322)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-------
T ss_pred hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc-------
Confidence 654332 223346799999999999764 468899999999999999999999964321 11111111100
Q ss_pred hhccCCcCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 002189 855 YELIDPTIGLSTTLKGFEKYVDLALKCVQESGDDRP-----TMSEVVKD 898 (955)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 898 (955)
..+.. ......++.+++.+||++||++|| +++|++++
T Consensus 251 ---~~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 ---SEPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ---CCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---CCCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 01111 122347889999999999999999 47888864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=363.50 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=190.0
Q ss_pred cCCCccCeeeccCceEEEEEEeC-CCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeC------Ce
Q 002189 628 NNFSDANDVGSGGYGKVYKGTLP-NGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR------GE 698 (955)
Q Consensus 628 ~~f~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 698 (955)
++|+..++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999965 699999999975433 2335688999999999999999999999643 67
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.|+||||+.++.+. .+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 89999999765544 443 24789999999999999999999999 99999999999999999999999999887
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhh--------
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKE-------- 850 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-------- 850 (955)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+......
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH-HHHHHHHHHhccCCCHHHHHH
Confidence 65432 23456799999999999999999999999999999999999999965432 2222222211000
Q ss_pred ----hhhh------------hhccCCcC-C--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 851 ----LYNL------------YELIDPTI-G--LSTTLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 851 ----~~~~------------~~~~d~~l-~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
.... ........ . .........++.+|+.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000000 0 00112234678999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=359.96 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=196.0
Q ss_pred hcCCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCc--chhHHHHHHHHHHHhccCCCcceEEEEEEeC-----Ce
Q 002189 627 TNNFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSM--QGGQEFKMEIELLSRVHHKNLVSLLGFCFDR-----GE 698 (955)
Q Consensus 627 ~~~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 698 (955)
.++|+..++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45788999999999999999985 5799999999976433 2345788999999999999999999998643 34
Q ss_pred EEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeecccccc
Q 002189 699 QMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADFGLSKS 778 (955)
Q Consensus 699 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~~ 778 (955)
.++|+||+.+|+|.++++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 46677888899999998654 5999999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCCCcceeeeeecCCCCCCHHHhhhC-CCCChhhhHHHHHHHHHHHhCCCCCcCCchHHHHHHHHHhhhhhh-h----
Q 002189 779 MSDSEKDHITTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVLMLELLTGRRPIERGKYIVREIRTVMDKKKEL-Y---- 852 (955)
Q Consensus 779 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwS~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~---- 852 (955)
.... .....||+.|+|||...+. .++.++||||+||++|||++|+.||...... .....+....... .
T Consensus 171 ~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 171 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHT
T ss_pred cCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhh
Confidence 5322 2335699999999998765 4688999999999999999999999754432 2222222111100 0
Q ss_pred --------hhhhccCCcCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 002189 853 --------NLYELIDPTIGLST----TLKGFEKYVDLALKCVQESGDDRPTMSEVVKD 898 (955)
Q Consensus 853 --------~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 898 (955)
...... +...... ......++.+|+.+||+.||.+|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhc-ccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000 0000000 01123568899999999999999999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.7e-38 Score=349.13 Aligned_cols=291 Identities=28% Similarity=0.474 Sum_probs=211.1
Q ss_pred CCHHHHHHHHHHHhhcCCC-CCCCCCCC-CCCCCCCccEEeCC----CCEeEEEecCCcCcc--ccCcCcCCCCcccEEe
Q 002189 23 TNDNDFVILKALKDDIWEN-EPPNWKNN-DPCGDNWEGIGCTN----SRVTSITLSGMGLKG--QLSGDITGLTELHTLD 94 (955)
Q Consensus 23 ~~~~~~~~L~~~k~~~~~~-~~~~w~~~-~~C~~~w~gv~C~~----~~v~~L~L~~~~l~~--~~~~~l~~l~~L~~L~ 94 (955)
+.++|.+||++||+++.++ .+.+|..+ |+|.+.|.||+|+. .||+.|+|++++++| .+|+.+++|++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~ 82 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence 6789999999999998643 24788754 55545799999975 379999999999998 5788999999999999
Q ss_pred cCC-CCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCcee
Q 002189 95 LSN-NKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKL 173 (955)
Q Consensus 95 Ls~-N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l 173 (955)
|++ |+ +.|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+++++|++.+.+|..+.++++|+.+++++|.+
T Consensus 83 Ls~~N~-l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 83 IGGINN-LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEETT-EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccc-cccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 986 64 8888899999999999999999999888888888889999999999998888888888888888888888888
Q ss_pred eeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCC
Q 002189 174 EGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLS 253 (955)
Q Consensus 174 ~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 253 (955)
+|.+|..++.+ ...++.++++.|++++..|..+..+..+ .+++++|.+.
T Consensus 162 ~~~ip~~~~~l------------------------------~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 162 SGAIPDSYGSF------------------------------SKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp EEECCGGGGCC------------------------------CTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred ccccccccccc------------------------------cccccccccccccccccccccccccccc-cccccccccc
Confidence 87766544332 2223445555555555666666655443 5777777777
Q ss_pred CCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCC
Q 002189 254 GPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLF 333 (955)
Q Consensus 254 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 333 (955)
+.+|..+..+++|+.|++++|.+++.++.+..+++|++|+|++|+++ |.+|..+.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~-------------------------g~iP~~l~ 265 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY-------------------------GTLPQGLT 265 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCE-------------------------ECCCGGGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccCccCeec-------------------------ccCChHHh
Confidence 77777777777777777777777766655555555555555555554 44454555
Q ss_pred CCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCc
Q 002189 334 SIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNR 370 (955)
Q Consensus 334 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~ 370 (955)
++++|++|+|++|+|+|.+|....+.+|..+++++|+
T Consensus 266 ~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred CCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCc
Confidence 5555555555555555555544445555556666665
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-35 Score=328.02 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=189.6
Q ss_pred CCCccCeeeccCceEEEEEEe-CCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-----------CCCcceEEEEEEeC
Q 002189 629 NFSDANDVGSGGYGKVYKGTL-PNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-----------HKNLVSLLGFCFDR 696 (955)
Q Consensus 629 ~f~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~ 696 (955)
+|...++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+++++.++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488899999999999999986 5799999999986432 2456788999998875 57899999988653
Q ss_pred --CeEEEEEEecCCCCccc-ccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCc-----
Q 002189 697 --GEQMLIYEFVPNGSLGD-SLSGKNGIRLDWIRRLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLN----- 767 (955)
Q Consensus 697 --~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~----- 767 (955)
...+++++++..+.... .........+++..+..++.|+++||+|||+ .+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 45667777765554322 2222334568889999999999999999997 77 999999999999986653
Q ss_pred -eEEeecccccccCCCCCcceeeeeecCCCCCCHHHhhhCCCCChhhhHHHHHHHHHHHhCCCCCcCCch-----HHHHH
Q 002189 768 -AKVADFGLSKSMSDSEKDHITTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVLMLELLTGRRPIERGKY-----IVREI 841 (955)
Q Consensus 768 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS~Gv~l~elltg~~P~~~~~~-----~~~~~ 841 (955)
++++|||.++..... .....||+.|+|||++....++.++||||+||+++||++|+.||..... ..+..
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 999999999865432 2335699999999999999999999999999999999999999863321 11111
Q ss_pred HHHHhhhh--------------hhhh---hhhccCCc----------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 002189 842 RTVMDKKK--------------ELYN---LYELIDPT----------IGLSTTLKGFEKYVDLALKCVQESGDDRPTMSE 894 (955)
Q Consensus 842 ~~~~~~~~--------------~~~~---~~~~~d~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 894 (955)
...+.... .... ....+... ...........++.+|+.+|++.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11111000 0000 00000000 011223455678999999999999999999999
Q ss_pred HHHH
Q 002189 895 VVKD 898 (955)
Q Consensus 895 vl~~ 898 (955)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=2.1e-29 Score=276.00 Aligned_cols=243 Identities=24% Similarity=0.427 Sum_probs=177.8
Q ss_pred CcccEEecCCCCCCcc--CCCCCcccccccccccccc-cccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcC
Q 002189 88 TELHTLDLSNNKDLRG--PLPTTIGNLKKLSNLMLVG-CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLY 164 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~ 164 (955)
.+++.|+|++|. +.| .+|.+|++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+
T Consensus 50 ~~v~~L~L~~~~-l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 50 YRVNNLDLSGLN-LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCC-CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEEEEECCCCC-CCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 367888888886 666 4677888888888888876 677777888888888888888888888877777777777777
Q ss_pred eeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcE
Q 002189 165 WLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEV 244 (955)
Q Consensus 165 ~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 244 (955)
.+++++|++.+.+ |..+..+++|+.
T Consensus 129 ~l~l~~N~~~~~~-------------------------------------------------------p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 129 TLDFSYNALSGTL-------------------------------------------------------PPSISSLPNLVG 153 (313)
T ss_dssp EEECCSSEEESCC-------------------------------------------------------CGGGGGCTTCCE
T ss_pred ccccccccccccC-------------------------------------------------------chhhccCcccce
Confidence 7777777776433 334445556666
Q ss_pred EEcccCCCCCCccccccCCCCC-CEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCc
Q 002189 245 VRFDRNSLSGPVPSNLNNLTSV-NDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTN 323 (955)
Q Consensus 245 L~Ls~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~ 323 (955)
+++++|.+++.+|..+..+.++ +.+++++|++++..+.......+..+++++|.+.+ .+|..+..+++|+.|++++|.
T Consensus 154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~-~~~~~~~~~~~l~~l~~~~~~ 232 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG-DASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEE-CCGGGCCTTSCCSEEECCSSE
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 6666666666666666665554 66666666666666543222334467777777665 567778888889999999999
Q ss_pred ceecCCcCCCCCCCCcEEEeecCcceeeeCCCc-chhhhhhhcccCCccccccCCCCCCCcceeEec
Q 002189 324 LKGQIPADLFSIPHLQTVVMKTNELNGTLDLGT-SYSENLLVNLQNNRISAYTERGGAPAVNLTLID 389 (955)
Q Consensus 324 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~ 389 (955)
+.+.++ .+..+++|+.|+|++|+++|.+|..+ .+.+|+.|+|++|+|++..|. +..+.+|+.++
T Consensus 233 l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~ 297 (313)
T d1ogqa_ 233 LAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSA 297 (313)
T ss_dssp ECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGG
T ss_pred cccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHH
Confidence 887655 68889999999999999999888754 578889999999999976664 34556665544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.3e-25 Score=242.68 Aligned_cols=279 Identities=22% Similarity=0.296 Sum_probs=201.0
Q ss_pred CCCCCCccEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCC
Q 002189 51 PCGDNWEGIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIP 130 (955)
Q Consensus 51 ~C~~~w~gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 130 (955)
.|.|.|.+|.|+. ++++ .+|..+. ++|++|+|++|+ ++...+.+|.++++|++|++++|.+....|
T Consensus 7 ~c~c~~~~~~C~~----------~~L~-~lP~~l~--~~l~~L~Ls~N~-i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~ 72 (305)
T d1xkua_ 7 RCQCHLRVVQCSD----------LGLE-KVPKDLP--PDTALLDLQNNK-ITEIKDGDFKNLKNLHTLILINNKISKISP 72 (305)
T ss_dssp TCEEETTEEECTT----------SCCC-SCCCSCC--TTCCEEECCSSC-CCCBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred CCEecCCEEEecC----------CCCC-ccCCCCC--CCCCEEECcCCc-CCCcChhHhhccccccccccccccccccch
Confidence 4666788888874 3444 4455443 578888888886 666666678888888888888888887677
Q ss_pred CccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccc-cCCc
Q 002189 131 DSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSG-SIPE 209 (955)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g-~ip~ 209 (955)
..|.++++|++|++++|+|+ .+|..+. ..|+.|++.+|.+.+..+.. +.....+..+++..|.... ....
T Consensus 73 ~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~------~~~~~~~~~l~~~~n~~~~~~~~~ 143 (305)
T d1xkua_ 73 GAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSV------FNGLNQMIVVELGTNPLKSSGIEN 143 (305)
T ss_dssp TTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHH------HTTCTTCCEEECCSSCCCGGGBCT
T ss_pred hhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhh------hhccccccccccccccccccCCCc
Confidence 77888888888888888888 4554433 57788888888877332211 2223344556666664431 2233
Q ss_pred cccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCC
Q 002189 210 KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSV 288 (955)
Q Consensus 210 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~ 288 (955)
..+..+..|+.+++++|++.. +|..+ +++|+.|++++|.+++..+..|..++.++.|++++|.+++.++ .+.++++
T Consensus 144 ~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~ 220 (305)
T d1xkua_ 144 GAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220 (305)
T ss_dssp TGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred cccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccc
Confidence 455666778888888888874 44433 5788889999998888888888888999999999999988876 4677889
Q ss_pred CCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcC------CCCCCCCcEEEeecCccee--eeCCCcc
Q 002189 289 LSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPAD------LFSIPHLQTVVMKTNELNG--TLDLGTS 357 (955)
Q Consensus 289 L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~~--~~~~~~~ 357 (955)
|++|+|++|+|+. +|.+|..+++|+.|+|++|+|+..-... +..+++|+.|+|++|+++. ..|..+.
T Consensus 221 L~~L~L~~N~L~~--lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~ 295 (305)
T d1xkua_ 221 LRELHLNNNKLVK--VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295 (305)
T ss_dssp CCEEECCSSCCSS--CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGT
T ss_pred ceeeecccccccc--cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhc
Confidence 9999999998864 6778888999999999999988543333 3457889999999999863 3344443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=1.1e-24 Score=237.28 Aligned_cols=272 Identities=22% Similarity=0.263 Sum_probs=226.1
Q ss_pred cccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeec
Q 002189 89 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 168 (955)
Q Consensus 89 ~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 168 (955)
.++.+|=++++ ++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|++
T Consensus 11 ~~~~~~C~~~~-L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLG-LE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSC-CC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCC-CC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 34556666665 44 5677764 68999999999999655668999999999999999999877889999999999999
Q ss_pred CCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCcc--ccCCcccCCCCCCcEEE
Q 002189 169 TDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLT--GELPATLGLVKSLEVVR 246 (955)
Q Consensus 169 ~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~ 246 (955)
++|+|+ .+|..+. ..+..|++.+|.+. .++...+.....+..+....|... ...+..+..+++|+.++
T Consensus 87 ~~n~l~-~l~~~~~--------~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~ 156 (305)
T d1xkua_ 87 SKNQLK-ELPEKMP--------KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156 (305)
T ss_dssp CSSCCS-BCCSSCC--------TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred cCCccC-cCccchh--------hhhhhhhccccchh-hhhhhhhhccccccccccccccccccCCCccccccccccCccc
Confidence 999998 6665432 35678899999998 788888877778888888887554 44567889999999999
Q ss_pred cccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcce
Q 002189 247 FDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 247 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
+++|.++ .+|..+ +++|+.|++++|.+++.++ .+.+++.+++|++++|.+++ ..+.++.++++|++|+|++|+|+
T Consensus 157 l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~-~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 157 IADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp CCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE-ECTTTGGGSTTCCEEECCSSCCS
T ss_pred cccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccc-cccccccccccceeeeccccccc
Confidence 9999998 566554 6899999999999998877 58889999999999999986 56788999999999999999998
Q ss_pred ecCCcCCCCCCCCcEEEeecCcceeeeCCCc-------chhhhhhhcccCCcccc--ccCCCC
Q 002189 326 GQIPADLFSIPHLQTVVMKTNELNGTLDLGT-------SYSENLLVNLQNNRISA--YTERGG 379 (955)
Q Consensus 326 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------~~~~l~~L~L~~N~l~~--~~~~~~ 379 (955)
.+|..+..+++|++|+|++|+|+......+ ...++..|+|++|+++. +.+..|
T Consensus 233 -~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f 294 (305)
T d1xkua_ 233 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294 (305)
T ss_dssp -SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGG
T ss_pred -ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHh
Confidence 678899999999999999999998655443 24567789999999873 455544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=1.8e-24 Score=242.91 Aligned_cols=301 Identities=24% Similarity=0.327 Sum_probs=234.4
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
.++++|++++++|+.. +.+..|++|++|+|++|+ +++.. .|+++++|++|+|++|++++. + .++.+++|+.|+
T Consensus 44 ~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~-l~~l~--~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ-LTDIT--PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp TTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSC-CCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCc-CCCCc--cccCCcccccccccccccccc-c-cccccccccccc
Confidence 5899999999999853 468889999999999997 77653 399999999999999999954 3 389999999999
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCC-----------------------------------CCCCCCchh
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPV-----------------------------------SDGNSPGLD 188 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~-----------------------------------~~~~~~~l~ 188 (955)
+++|.+++..+ ......+..+....|.+....+. .........
T Consensus 117 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (384)
T d2omza2 117 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred ccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccc
Confidence 99999986443 33445666666666655321110 111123455
Q ss_pred hhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCE
Q 002189 189 MLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVND 268 (955)
Q Consensus 189 ~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 268 (955)
.+++++.+++++|++++..|. ....+|+.|++++|+++.. ..+..+++|+.|++++|.+++..+ +..+++|+.
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~ 267 (384)
T d2omza2 195 KLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGGG---GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred cccccceeeccCCccCCCCcc---cccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCE
Confidence 667788999999999854332 3356789999999998852 468889999999999999986443 788999999
Q ss_pred EEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcc
Q 002189 269 LYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNEL 348 (955)
Q Consensus 269 L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 348 (955)
|++++|++++.++ +..++.++.++++.|.+++ ...+..+++++.|++++|++++.. .+..+++|++|+|++|+|
T Consensus 268 L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~---~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 268 LKLGANQISNISP-LAGLTALTNLELNENQLED---ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV 341 (384)
T ss_dssp EECCSSCCCCCGG-GTTCTTCSEEECCSSCCSC---CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred eeccCcccCCCCc-ccccccccccccccccccc---ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCC
Confidence 9999999987654 7788899999999999864 345888999999999999998643 378899999999999999
Q ss_pred eeeeCCCcchhhhhhhcccCCccccccCCCCCCCcceeEec
Q 002189 349 NGTLDLGTSYSENLLVNLQNNRISAYTERGGAPAVNLTLID 389 (955)
Q Consensus 349 ~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~~l~ 389 (955)
++. +....+++|+.|+|++|+|+++++ +..+++|+.++
T Consensus 342 ~~l-~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~ 379 (384)
T d2omza2 342 SDV-SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 379 (384)
T ss_dssp CCC-GGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEE
T ss_pred CCC-hhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEee
Confidence 874 455667889999999999999876 44555555554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.1e-25 Score=235.68 Aligned_cols=260 Identities=17% Similarity=0.189 Sum_probs=160.9
Q ss_pred cEEeCCCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCC
Q 002189 58 GIGCTNSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQ 137 (955)
Q Consensus 58 gv~C~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 137 (955)
+..|....-..++.++++++ .+|..+. +.+++|+|++|+ ++...+..|.++++|++|++++|++....+..+..+.
T Consensus 5 ~C~C~~~~~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~-i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~ 80 (284)
T d1ozna_ 5 ACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (284)
T ss_dssp TCEEECSSSCEEECCSSCCS-SCCTTCC--TTCSEEECTTSC-CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCEEcCCCCeEEEcCCCCCC-ccCCCCC--CCCCEEECcCCc-CCCCCHHHhhccccccccccccccccccccccccccc
Confidence 44464433344566777777 5565443 568899999997 7777777888888899999888888877777788888
Q ss_pred CCcEEEcc-CCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCcc
Q 002189 138 ELVLLSLN-SNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDM 216 (955)
Q Consensus 138 ~L~~L~Ls-~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~ 216 (955)
.++.++.. .|.++...+..|.++++|++|+|++|.+.. ++..
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~-------------------------------~~~~------ 123 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-------------------------------LGPG------ 123 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------------------CCTT------
T ss_pred cccccccccccccccccchhhcccccCCEEecCCccccc-------------------------------cccc------
Confidence 88888764 566776667788888888888888887751 2222
Q ss_pred ceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECc
Q 002189 217 VLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMS 295 (955)
Q Consensus 217 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls 295 (955)
.+....+|+.+++++|.|++..+..|..+++|+.|+|++|+|+++++ .+.++++|++|+++
T Consensus 124 ------------------~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~ 185 (284)
T d1ozna_ 124 ------------------LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185 (284)
T ss_dssp ------------------TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ------------------ccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhh
Confidence 22333344444444444443334444455555555555555555444 24445555555555
Q ss_pred CCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCcccccc
Q 002189 296 NNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYT 375 (955)
Q Consensus 296 ~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~ 375 (955)
+|++++ ..|..|.++++|+.|++++|.+.+..+..|..+++|++|+|++|++.+..+..+-...++.+....+++.+..
T Consensus 186 ~N~l~~-i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~ 264 (284)
T d1ozna_ 186 QNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (284)
T ss_dssp SSCCCE-ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred hccccc-cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCC
Confidence 555543 3455555566666666666666655555666666666666666666665543333334555666666666544
Q ss_pred CC
Q 002189 376 ER 377 (955)
Q Consensus 376 ~~ 377 (955)
|.
T Consensus 265 p~ 266 (284)
T d1ozna_ 265 PQ 266 (284)
T ss_dssp SG
T ss_pred ch
Confidence 43
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.1e-24 Score=232.48 Aligned_cols=118 Identities=23% Similarity=0.246 Sum_probs=103.2
Q ss_pred CccEEeCC-----------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCccccccccccccc-cc
Q 002189 56 WEGIGCTN-----------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLV-GC 123 (955)
Q Consensus 56 w~gv~C~~-----------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls-~N 123 (955)
|.-|.|+. ..++.|+|++|.|+...+..|.++++|++|++++|+ +....+..+.++..++.+... .|
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~-l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSC-CCEECTTTTTTCTTCCEEECCSCT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhcccccccccccccc-cccccccccccccccccccccccc
Confidence 34478864 357899999999997777889999999999999997 888888899999999998764 67
Q ss_pred ccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 124 SFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
.++...+..|.++++|++|+|++|.+....+..+...++|+.+++++|+|+
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~ 142 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc
Confidence 777777888999999999999999999777788889999999999999987
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=5.9e-23 Score=230.38 Aligned_cols=278 Identities=22% Similarity=0.313 Sum_probs=219.5
Q ss_pred CCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEE
Q 002189 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 142 (955)
-.+++.|+|++|+|++.. .|+++++|++|+|++|+ +.+.. .++++++|+.|++++|.+++..+ ......+..+
T Consensus 65 L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~-i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~ 137 (384)
T d2omza2 65 LNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQ-IADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRL 137 (384)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC-CCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred CCCCCEEeCcCCcCCCCc--cccCCcccccccccccc-ccccc--ccccccccccccccccccccccc--cccccccccc
Confidence 368999999999999754 39999999999999997 76543 48999999999999999885332 2333444444
Q ss_pred EccCCCCcC-----------------------------------------cCCCCCCCCCCcCeeecCCceeeeccCCCC
Q 002189 143 SLNSNGFSG-----------------------------------------RVPPSIGNLSNLYWLDLTDNKLEGEIPVSD 181 (955)
Q Consensus 143 ~Ls~N~l~~-----------------------------------------~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~ 181 (955)
....|.+.. .....+..+++++.|++++|.+++..|
T Consensus 138 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--- 214 (384)
T d2omza2 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--- 214 (384)
T ss_dssp EEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG---
T ss_pred ccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc---
Confidence 444433321 122346678899999999999884433
Q ss_pred CCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCcccccc
Q 002189 182 GNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLN 261 (955)
Q Consensus 182 ~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 261 (955)
.....+|+.|++++|+++ .++ .+....+|+.|++++|++++..+ +..+++|+.|++++|++++.. .+.
T Consensus 215 -----~~~~~~L~~L~l~~n~l~-~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~ 282 (384)
T d2omza2 215 -----LGILTNLDELSLNGNQLK-DIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLA 282 (384)
T ss_dssp -----GGGCTTCCEEECCSSCCC-CCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGT
T ss_pred -----ccccCCCCEEECCCCCCC-Ccc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccc
Confidence 445677889999999998 554 34566789999999999986543 788999999999999998543 377
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEE
Q 002189 262 NLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTV 341 (955)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 341 (955)
.++.++.+++++|.+++. +.+..+++++.|++++|++++ ++ .+..+++|+.|+|++|+|++ ++ .+..+++|++|
T Consensus 283 ~~~~l~~l~~~~n~l~~~-~~~~~~~~l~~L~ls~n~l~~--l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L 356 (384)
T d2omza2 283 GLTALTNLELNENQLEDI-SPISNLKNLTYLTLYFNNISD--IS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWL 356 (384)
T ss_dssp TCTTCSEEECCSSCCSCC-GGGGGCTTCSEEECCSSCCSC--CG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred cccccccccccccccccc-cccchhcccCeEECCCCCCCC--Cc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEE
Confidence 899999999999999874 357788999999999999975 33 38899999999999999984 33 68889999999
Q ss_pred EeecCcceeeeCCCcchhhhhhhcccCC
Q 002189 342 VMKTNELNGTLDLGTSYSENLLVNLQNN 369 (955)
Q Consensus 342 ~Ls~N~l~~~~~~~~~~~~l~~L~L~~N 369 (955)
+|++|+|++..| ...+++|+.|+|++|
T Consensus 357 ~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 357 SAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred ECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 999999998765 566788899999988
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.7e-22 Score=213.48 Aligned_cols=200 Identities=24% Similarity=0.256 Sum_probs=141.3
Q ss_pred CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEE
Q 002189 64 SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLS 143 (955)
Q Consensus 64 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 143 (955)
....++|.++++|+ .+|+.+. ++|++|+|++|+ +++..+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~-i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~ 83 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENL-LYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLD 83 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSC-CSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEE
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCc-CCCcCHHHhhcccccccccccccccc-cccc-ccccccccccc
Confidence 45556788888888 4666553 578899999996 77776678888888888888888888 4543 57788888888
Q ss_pred ccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 144 LNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 144 Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
|++|+++ ..+..+.++++|+.|++++|.+. .++...+..+.++..|++
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~-------------------------------~~~~~~~~~l~~l~~L~l 131 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-------------------------------SLPLGALRGLGELQELYL 131 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCC-------------------------------CCCSSTTTTCTTCCEEEC
T ss_pred ccccccc-ccccccccccccccccccccccc-------------------------------eeeccccccccccccccc
Confidence 8888888 45667888888888888888776 333333444445555666
Q ss_pred cCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCC
Q 002189 224 DSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDA 301 (955)
Q Consensus 224 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 301 (955)
++|.+....+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+.+++.+..+++|+.|+|++|++..
T Consensus 132 ~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCC
Confidence 666666555556666667777777777777666666667777777777777777665566666666777777666643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.4e-22 Score=213.91 Aligned_cols=203 Identities=21% Similarity=0.268 Sum_probs=147.5
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
+...+..++.++++|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|. ...+
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-------~~~l 76 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-------DGTL 76 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-------CSCC
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-------cccc
Confidence 3444555566666666 4565443 35677777777777555556777777777777777766 2221 1112
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
++ |+.|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+|+.|+
T Consensus 77 ~~-------------------------L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~ 130 (266)
T d1p9ag_ 77 PV-------------------------LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (266)
T ss_dssp TT-------------------------CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred cc-------------------------cccccccccccc-ccccccccccccccccccccccceeecccccccccccccc
Confidence 23 333334444433 3345667778888888888888877777888888999999
Q ss_pred ccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcce
Q 002189 271 LSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELN 349 (955)
Q Consensus 271 Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 349 (955)
+++|.++.+++. +..+++|+.|++++|+|++ ..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccceeccccccccccchhcccccccccc-cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 999998888775 5678899999999999976 56677899999999999999999 89999999999999999999998
Q ss_pred eee
Q 002189 350 GTL 352 (955)
Q Consensus 350 ~~~ 352 (955)
+..
T Consensus 209 CdC 211 (266)
T d1p9ag_ 209 CNC 211 (266)
T ss_dssp CSG
T ss_pred CCc
Confidence 754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3.7e-22 Score=201.19 Aligned_cols=163 Identities=13% Similarity=0.136 Sum_probs=119.4
Q ss_pred ccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcc------------------hhHHHHHHHHHHHhccCCCcceEEEEE
Q 002189 632 DANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQ------------------GGQEFKMEIELLSRVHHKNLVSLLGFC 693 (955)
Q Consensus 632 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~l~~~~ 693 (955)
..++||+|+||+||+|+..+|+.||||+++..... .......|...+.++.|.++++.+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46789999999999999889999999987632110 012345688999999999999887653
Q ss_pred EeCCeEEEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeeccCCCCccEEEcCCCceEEeec
Q 002189 694 FDRGEQMLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELANPPIIHRDIKSSNILLDERLNAKVADF 773 (955)
Q Consensus 694 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 773 (955)
..++||||++++.+.+. +......++.|++++++|||+.+ |+||||||+|||++++ .++|+||
T Consensus 84 ----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 ----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred ----CCEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 23799999987655432 22334578999999999999998 9999999999999976 5899999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCC--HH---HhhhCCCCChhhhHHHHHHH
Q 002189 774 GLSKSMSDSEKDHITTQVKGTMGYLD--PE---YYMTQQLTEKSDVYSFGVLM 821 (955)
Q Consensus 774 Gla~~~~~~~~~~~~~~~~gt~~y~a--PE---~~~~~~~~~ksDvwS~Gv~l 821 (955)
|+|+....+.... |.. .+ ....+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~----------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWRE----------ILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHH----------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHH----------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9998764332110 111 00 01246788899999975433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.77 E-value=6.9e-18 Score=185.87 Aligned_cols=284 Identities=24% Similarity=0.301 Sum_probs=184.9
Q ss_pred CCCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEE
Q 002189 63 NSRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLL 142 (955)
Q Consensus 63 ~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 142 (955)
..++++|||++++|+ .+|+. +++|++|+|++|+ ++ .+|..+ .+|+.|++++|+++ .++.. .+.|++|
T Consensus 37 ~~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~-l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L 103 (353)
T d1jl5a_ 37 DRQAHELELNNLGLS-SLPEL---PPHLESLVASCNS-LT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYL 103 (353)
T ss_dssp HHTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSC-CS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEE
T ss_pred HcCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCC-Cc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccc
Confidence 357889999999998 56653 5789999999997 66 667664 47888899999988 45432 1469999
Q ss_pred EccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCC-------------CchhhhhccccccccCCcccccCCc
Q 002189 143 SLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNS-------------PGLDMLVRAKHFHFGKNQLSGSIPE 209 (955)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~-------------~~l~~L~~L~~L~L~~N~l~g~ip~ 209 (955)
++++|.|+ .+|. ++.+++|+.|++++|.+.. .|.....+ ..+..+..++.+++.+|.+. .++.
T Consensus 104 ~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~-~~~~ 179 (353)
T d1jl5a_ 104 GVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPD 179 (353)
T ss_dssp ECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCC
T ss_pred cccccccc-cccc-hhhhccceeeccccccccc-cccccccccchhhccccccccccccccccceeccccccccc-cccc
Confidence 99999999 5664 6889999999999999873 33332221 22344555666667766665 3332
Q ss_pred cccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCC---
Q 002189 210 KLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGL--- 286 (955)
Q Consensus 210 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l--- 286 (955)
.. .....+.+..+.+. .++ .+..++.|+.+++++|... .++. ...++..+.+.+|.+...+.....+
T Consensus 180 ~~----~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~~~~~~~l~~~ 249 (353)
T d1jl5a_ 180 LP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPELPQSLTFL 249 (353)
T ss_dssp CC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCCCCCCTTCCEE
T ss_pred cc----cccccccccccccc-ccc-ccccccccccccccccccc-cccc---cccccccccccccccccccccccccccc
Confidence 21 12233344433333 222 3567788888888888776 3333 3456777777777776543321110
Q ss_pred --------------CCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeecCcceeee
Q 002189 287 --------------SVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352 (955)
Q Consensus 287 --------------~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 352 (955)
......++..|.+.+ ....+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+..
T Consensus 250 ~~~~~~~~~l~~l~~~~~~~~~~~~~~~~-----~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~l- 319 (353)
T d1jl5a_ 250 DVSENIFSGLSELPPNLYYLNASSNEIRS-----LCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAEV- 319 (353)
T ss_dssp ECCSSCCSEESCCCTTCCEEECCSSCCSE-----ECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSCC-
T ss_pred ccccccccccccccchhcccccccCcccc-----ccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCcc-
Confidence 122333444443322 2334678999999999988 56643 67888999999998854
Q ss_pred CCCcchhhhhhhcccCCccccccCCCCCCCccee
Q 002189 353 DLGTSYSENLLVNLQNNRISAYTERGGAPAVNLT 386 (955)
Q Consensus 353 ~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~~~L~ 386 (955)
|.. +.+|+.|+|++|+|+.++.. ...+.+|+
T Consensus 320 ~~~--~~~L~~L~L~~N~L~~lp~~-~~~L~~L~ 350 (353)
T d1jl5a_ 320 PEL--PQNLKQLHVEYNPLREFPDI-PESVEDLR 350 (353)
T ss_dssp CCC--CTTCCEEECCSSCCSSCCCC-CTTCCEEE
T ss_pred ccc--cCCCCEEECcCCcCCCCCcc-ccccCeeE
Confidence 332 34678899999999877642 23344443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.1e-18 Score=180.68 Aligned_cols=207 Identities=22% Similarity=0.351 Sum_probs=131.9
Q ss_pred cccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeec
Q 002189 89 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDL 168 (955)
Q Consensus 89 ~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 168 (955)
++..++++.++ +++.+ .+..+.+|+.|++.+|+|+ .++ .+..+++|++|+|++|+|++..| +.++++|++|++
T Consensus 20 ~~~~~~l~~~~-~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 20 NAIKIAAGKSN-VTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHHHTTCSS-TTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHhCCCC-cCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccc
Confidence 33445555554 44432 3456666777777777766 343 36667777777777777664333 666677777777
Q ss_pred CCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcc
Q 002189 169 TDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFD 248 (955)
Q Consensus 169 ~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 248 (955)
++|.++ .+..+..+++|+.+++++|+.. +. ..+...+.++.+.++
T Consensus 93 ~~n~~~--------~i~~l~~l~~L~~l~l~~~~~~-------------------------~~--~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 93 SGNPLK--------NVSAIAGLQSIKTLDLTSTQIT-------------------------DV--TPLAGLSNLQVLYLD 137 (227)
T ss_dssp CSCCCS--------CCGGGTTCTTCCEEECTTSCCC-------------------------CC--GGGTTCTTCCEEECC
T ss_pred cccccc--------cccccccccccccccccccccc-------------------------cc--chhccccchhhhhch
Confidence 766655 1223334444444444444433 21 234556677777777
Q ss_pred cCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecC
Q 002189 249 RNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQI 328 (955)
Q Consensus 249 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 328 (955)
.+.+... ..+..+++|+.|++++|.++...+ +.++++|++|+|++|++++ ++ .++++++|++|+|++|+|++.
T Consensus 138 ~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~--l~-~l~~l~~L~~L~Ls~N~lt~i- 210 (227)
T d1h6ua2 138 LNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD--IS-PLASLPNLIEVHLKNNQISDV- 210 (227)
T ss_dssp SSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC--CG-GGGGCTTCCEEECTTSCCCBC-
T ss_pred hhhhchh--hhhccccccccccccccccccchh-hcccccceecccCCCccCC--Ch-hhcCCCCCCEEECcCCcCCCC-
Confidence 7777633 235667778888888887765433 6777888888888888864 33 378888888888888888853
Q ss_pred CcCCCCCCCCcEEEeec
Q 002189 329 PADLFSIPHLQTVVMKT 345 (955)
Q Consensus 329 p~~~~~l~~L~~L~Ls~ 345 (955)
+ .+.++++|++|+|++
T Consensus 211 ~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 211 S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp G-GGTTCTTCCEEEEEE
T ss_pred c-ccccCCCCCEEEeeC
Confidence 3 377888888888874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=6.7e-18 Score=176.24 Aligned_cols=215 Identities=16% Similarity=0.178 Sum_probs=131.6
Q ss_pred EEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCC-CCccccCCCCcEEEccC-
Q 002189 69 ITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPI-PDSIGSLQELVLLSLNS- 146 (955)
Q Consensus 69 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~- 146 (955)
++.++.+++ .+|+.+. +++++|+|++|+ +....+..|.++++|++|+|++|.+...+ +..|..++++++|++..
T Consensus 13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~-i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTK-LRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEESCSCS-SCCSCSC--SCCSEEEEESCC-CCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEeCCCCC-CcCCCCC--CCCCEEECcCCc-CCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 444556666 5665543 578999999997 77776778999999999999999988655 45688999999999764
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCC
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSN 226 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N 226 (955)
|++....+..|.++++|+.|++++|++.. ++. ...+..+..+..+...++++. .++...|....
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~-~~~----~~~~~~l~~l~~~~~~n~~l~-~i~~~~~~~~~---------- 152 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKH-LPD----VHKIHSLQKVLLDIQDNINIH-TIERNSFVGLS---------- 152 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCS-CCC----CTTTCBSSCEEEEEESCTTCC-EECTTSSTTSB----------
T ss_pred ccccccccccccccccccccccchhhhcc-ccc----ccccccccccccccccccccc-ccccccccccc----------
Confidence 78887788889999999999999999872 221 112223333444444555554 44444333221
Q ss_pred CccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEE-EccCCcCcccCCC-CCCCCCCCEEECcCCCCCCCCC
Q 002189 227 NLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDL-YLSNNKLTGAMPN-LTGLSVLSYLDMSNNSFDASEV 304 (955)
Q Consensus 227 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L-~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~ 304 (955)
..++.|++++|+++ .++....+.++++.+ ++++|+|+.+++. |.++++|++|+|++|+|+. ..
T Consensus 153 -------------~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~-l~ 217 (242)
T d1xwdc1 153 -------------FESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS-LP 217 (242)
T ss_dssp -------------SSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC-CC
T ss_pred -------------ccceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCc-cC
Confidence 24445555555555 223333333333333 3455555555442 4555566666666665543 22
Q ss_pred ChhhcCCCCCCEEE
Q 002189 305 PSWFSSMQSLTTLM 318 (955)
Q Consensus 305 p~~~~~l~~L~~L~ 318 (955)
+..|.++++|+.|+
T Consensus 218 ~~~~~~l~~L~~l~ 231 (242)
T d1xwdc1 218 SYGLENLKKLRARS 231 (242)
T ss_dssp SSSCTTCCEEESSS
T ss_pred HHHHcCCcccccCc
Confidence 33344444444433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=6.5e-18 Score=174.67 Aligned_cols=202 Identities=20% Similarity=0.272 Sum_probs=128.0
Q ss_pred EEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCC
Q 002189 69 ITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNG 148 (955)
Q Consensus 69 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 148 (955)
+++..+.+++.. .+..|.+|+.|++.+|+ ++. + ..+.++++|++|+|++|++++..| +..+++|++|++++|.
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~-i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTG-VTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSC-CCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCC-CCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 345555555432 44566777888888875 554 3 357788888888888888774433 7788888888888888
Q ss_pred CcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCc
Q 002189 149 FSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNL 228 (955)
Q Consensus 149 l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l 228 (955)
++ .++ .+.++++|+.|++++|...+. ..+.....++.+.++++.+.
T Consensus 97 ~~-~i~-~l~~l~~L~~l~l~~~~~~~~--------~~~~~~~~~~~l~~~~~~~~------------------------ 142 (227)
T d1h6ua2 97 LK-NVS-AIAGLQSIKTLDLTSTQITDV--------TPLAGLSNLQVLYLDLNQIT------------------------ 142 (227)
T ss_dssp CS-CCG-GGTTCTTCCEEECTTSCCCCC--------GGGTTCTTCCEEECCSSCCC------------------------
T ss_pred cc-ccc-ccccccccccccccccccccc--------chhccccchhhhhchhhhhc------------------------
Confidence 77 343 577788888888888876622 22333333444444444433
Q ss_pred cccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhh
Q 002189 229 TGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWF 308 (955)
Q Consensus 229 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~ 308 (955)
.. ..+..+++|+.|++++|.++... .+.++++|+.|+|++|++++++ .+.++++|++|+|++|+|+. ++ .+
T Consensus 143 -~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~-~l~~l~~L~~L~Ls~N~lt~--i~-~l 213 (227)
T d1h6ua2 143 -NI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISD--VS-PL 213 (227)
T ss_dssp -CC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECTTSCCCB--CG-GG
T ss_pred -hh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCCh-hhcCCCCCCEEECcCCcCCC--Cc-cc
Confidence 21 12445566677777777666322 2666777777777777776543 36667777777777777754 33 26
Q ss_pred cCCCCCCEEECc
Q 002189 309 SSMQSLTTLMME 320 (955)
Q Consensus 309 ~~l~~L~~L~Ls 320 (955)
.++++|+.|+|+
T Consensus 214 ~~l~~L~~L~ls 225 (227)
T d1h6ua2 214 ANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEEEE
T ss_pred ccCCCCCEEEee
Confidence 777777777775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=2.1e-17 Score=172.50 Aligned_cols=214 Identities=15% Similarity=0.132 Sum_probs=155.4
Q ss_pred CCCCCCccEEeCC-----------CCEeEEEecCCcCccccCcCcCCCCcccEEecCCCCCCcc-CCCCCcccccccccc
Q 002189 51 PCGDNWEGIGCTN-----------SRVTSITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRG-PLPTTIGNLKKLSNL 118 (955)
Q Consensus 51 ~C~~~w~gv~C~~-----------~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~-~~p~~~~~l~~L~~L 118 (955)
.|.|....|.|.. ..+++|+|++|.|+...+..|.++++|++|+|++|. +.. ..+..|.+++++++|
T Consensus 5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~-~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND-VLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCT-TCCEECSSSEESCTTCCEE
T ss_pred cCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhcccc-ccceeeccccccccccccc
Confidence 4767788899963 378999999999997767789999999999999997 555 445678999999999
Q ss_pred cccc-cccCCCCCCccccCCCCcEEEccCCCCcCcCCC-CCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccc
Q 002189 119 MLVG-CSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPP-SIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHF 196 (955)
Q Consensus 119 ~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L 196 (955)
.+.+ |++....+..|.++++|++|++++|++....+. .+..+..|..+...++++...-+..+..+ ...++.|
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~-----~~~l~~L 158 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL-----SFESVIL 158 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS-----BSSCEEE
T ss_pred cccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccc-----cccceee
Confidence 9864 678877888899999999999999999854332 34567778888888888874333333221 1356778
Q ss_pred cccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEc
Q 002189 197 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYL 271 (955)
Q Consensus 197 ~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 271 (955)
++++|+++ .++...|.....++.+.+++|+++...+..|..+++|+.|+|++|+|+...+..|.++++|+.|++
T Consensus 159 ~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 159 WLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred eccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 89999998 777777766554555556666676444445666677777777776666433444555555555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.3e-17 Score=168.16 Aligned_cols=186 Identities=22% Similarity=0.315 Sum_probs=110.6
Q ss_pred cccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhc
Q 002189 113 KKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVR 192 (955)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~ 192 (955)
.++...++..+.+++.++. ..+.+|++|++++|.|+. ++ .+..+++|++|+|++|+|++. ..+..+++
T Consensus 24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l--------~~~~~l~~ 91 (210)
T d1h6ta2 24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI--------KPLANLKN 91 (210)
T ss_dssp HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC--------GGGTTCTT
T ss_pred HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc--------cccccCcc
Confidence 3444445555555544432 345566666666666663 22 356666666666666666521 11222333
Q ss_pred cccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEcc
Q 002189 193 AKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLS 272 (955)
Q Consensus 193 L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls 272 (955)
|+.|++++|+|+ + ++ .+..+++|+.|++++|.+. .+ ..+..+++|+.++++
T Consensus 92 L~~L~l~~n~i~-------------------------~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 92 LGWLFLDENKVK-------------------------D-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLG 142 (210)
T ss_dssp CCEEECCSSCCC-------------------------C-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECC
T ss_pred cccccccccccc-------------------------c-cc-ccccccccccccccccccc-cc-ccccccccccccccc
Confidence 344444444433 1 22 3556667777777777665 22 346667777777777
Q ss_pred CCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCCCCcEEEeec
Q 002189 273 NNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIPHLQTVVMKT 345 (955)
Q Consensus 273 ~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 345 (955)
+|.+++.. .+..+++|+++++++|++++ ++ .+.++++|++|+|++|+|+. ++ .+.++++|++|+|++
T Consensus 143 ~n~l~~~~-~~~~l~~L~~l~l~~n~l~~--i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 143 NNKITDIT-VLSRLTKLDTLSLEDNQISD--IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp SSCCCCCG-GGGGCTTCSEEECCSSCCCC--CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccccccc-cccccccccccccccccccc--cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 77776432 35566777777777777754 33 36777888888888888773 44 577788888888764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=3.9e-17 Score=166.50 Aligned_cols=165 Identities=25% Similarity=0.396 Sum_probs=88.4
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
.+.+|+.|++++|.++. ++ .+..+++|++|+|++|+|++.. .++++++|++|++++|+|++ + +.+..+
T Consensus 44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l-------~~l~~l 111 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-L-------SSLKDL 111 (210)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-G-------GGGTTC
T ss_pred HhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-c-------cccccc
Confidence 45555666666666552 22 2555666666666666665422 24556666666666666551 1 223334
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
++|+.|++++|.+. .+ ..+..+++|+.+++++|.+++ +..+..+++|+.++
T Consensus 112 ~~L~~L~l~~~~~~-~~--------------------------~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~ 162 (210)
T d1h6ta2 112 KKLKSLSLEHNGIS-DI--------------------------NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLS 162 (210)
T ss_dssp TTCCEEECTTSCCC-CC--------------------------GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEE
T ss_pred cccccccccccccc-cc--------------------------ccccccccccccccccccccc--cccccccccccccc
Confidence 44444444444433 11 124445555666666666552 22345566666666
Q ss_pred ccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECc
Q 002189 271 LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMME 320 (955)
Q Consensus 271 Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls 320 (955)
+++|+++++. .+.++++|+.|+|++|+|+. ++ .+.++++|++|+|+
T Consensus 163 l~~n~l~~i~-~l~~l~~L~~L~Ls~N~i~~--l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 163 LEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CCSSCCCCCG-GGTTCTTCCEEECCSSCCCB--CG-GGTTCTTCSEEEEE
T ss_pred cccccccccc-cccCCCCCCEEECCCCCCCC--Ch-hhcCCCCCCEEEcc
Confidence 6666666543 25566666666666666643 33 36666667776665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=2.2e-17 Score=165.82 Aligned_cols=127 Identities=24% Similarity=0.296 Sum_probs=99.0
Q ss_pred EEEecCCcCccccCcCcCCCCcccEEecCCCCCCcc-CCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccC
Q 002189 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRG-PLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNS 146 (955)
Q Consensus 68 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 146 (955)
.++.++++++ .+|..+. +++++|+|++|+ |+. ..+..|.++++|+.|+|++|++.+..+..|..+++|++|+|++
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~-i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNE-LGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCC-CCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCC-CcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 4566677777 5565553 689999999997 765 4466789999999999999999988889999999999999999
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCccc
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLS 204 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~ 204 (955)
|+|+...|..|.++++|++|+|++|+|++..|..|. .+.+|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~------~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE------HLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSST------TCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhc------CCcccccccccccccc
Confidence 999987788899999999999999999844443332 2344555566666555
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=6.6e-17 Score=162.34 Aligned_cols=142 Identities=17% Similarity=0.180 Sum_probs=98.5
Q ss_pred CCCcEEEcccCCCCCC-ccccccCCCCCCEEEccCCcCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEE
Q 002189 240 KSLEVVRFDRNSLSGP-VPSNLNNLTSVNDLYLSNNKLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 317 (955)
Q Consensus 240 ~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 317 (955)
+++++|+|++|+|++. .+..|.++++|+.|+|++|.+...++ .+..+++|++|+|++|+|+. ..+..|.++++|++|
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~-l~~~~F~~l~~L~~L 107 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTL 107 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE-ECSSSSTTCTTCCEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccc-cCHHHHhCCCccccc
Confidence 3556666666666542 24455666666666666666666655 35566667777777777654 455667778888888
Q ss_pred ECcCCcceecCCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCccccccCCCCCCC
Q 002189 318 MMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISAYTERGGAPA 382 (955)
Q Consensus 318 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~~~~~~~~~~ 382 (955)
+|++|+|++..+..|..+++|++|+|++|++.+..+..+-...+..+.+..|.++...|..+.+.
T Consensus 108 ~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~l~~~ 172 (192)
T d1w8aa_ 108 NLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV 172 (192)
T ss_dssp ECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTTTS
T ss_pred ccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChhhcCC
Confidence 88888888777788888889999999999888766554444456678888888887766655443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.1e-16 Score=161.70 Aligned_cols=98 Identities=24% Similarity=0.387 Sum_probs=50.7
Q ss_pred cCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCC
Q 002189 236 LGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLT 315 (955)
Q Consensus 236 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~ 315 (955)
+..+++|+.|++++|.+... ..+..+++|+.|++++|++... +.+..+++|++|++++|++++ ++ .++++++|+
T Consensus 102 l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~--l~-~l~~l~~L~ 175 (199)
T d2omxa2 102 LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTD--LK-PLANLTTLE 175 (199)
T ss_dssp GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC--CG-GGTTCTTCC
T ss_pred cccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccccC--Cc-cccCCCCCC
Confidence 34445555555555555421 2344555555555555555432 234555555566666655543 22 255566666
Q ss_pred EEECcCCcceecCCcCCCCCCCCcEE
Q 002189 316 TLMMENTNLKGQIPADLFSIPHLQTV 341 (955)
Q Consensus 316 ~L~Ls~N~l~~~~p~~~~~l~~L~~L 341 (955)
.|++++|++++ ++ .+.++++|+.|
T Consensus 176 ~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 176 RLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp EEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred EEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 66666666553 22 35556666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.66 E-value=3e-15 Score=164.31 Aligned_cols=263 Identities=23% Similarity=0.233 Sum_probs=169.8
Q ss_pred CcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeee
Q 002189 88 TELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLD 167 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~ 167 (955)
.+|++|||++|. ++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. +. +.|++|+
T Consensus 38 ~~l~~LdLs~~~-L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLG-LS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSC-CS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEEE
T ss_pred cCCCEEEeCCCC-CC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hc--ccccccc
Confidence 368899999997 65 57764 468999999999999 788754 57999999999998 4443 21 4699999
Q ss_pred cCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEc
Q 002189 168 LTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRF 247 (955)
Q Consensus 168 L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 247 (955)
|++|.+. .+|. ...+.+|++|++++|.++ ..+.. ...+..+.+..+... ....+..++.++.|++
T Consensus 105 L~~n~l~-~lp~-------~~~l~~L~~L~l~~~~~~-~~~~~----~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l 169 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-------LQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYA 169 (353)
T ss_dssp CCSSCCS-SCCC-------CTTCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCS--SCCCCTTCTTCCEEEC
T ss_pred ccccccc-cccc-------hhhhccceeecccccccc-ccccc----cccccchhhcccccc--ccccccccccceeccc
Confidence 9999998 4552 345677899999999987 44432 234555555554443 3445667778888888
Q ss_pred ccCCCCCCc------------------cccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhc
Q 002189 248 DRNSLSGPV------------------PSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFS 309 (955)
Q Consensus 248 s~N~l~~~~------------------p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~ 309 (955)
++|.+.... ...+..++.|+.+++++|.....+. ...++..+.+.+|.+.. .+.
T Consensus 170 ~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~---~~~~l~~~~~~~~~~~~--~~~--- 241 (353)
T d1jl5a_ 170 DNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLTD--LPE--- 241 (353)
T ss_dssp CSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCCSC--CCC---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc--ccc---
Confidence 877765211 1123456677777777776654432 23456666666666543 111
Q ss_pred CCCCCCEEECcCCcceec----------------CCcCCCCCCCCcEEEeecCcceeeeCCCcchhhhhhhcccCCcccc
Q 002189 310 SMQSLTTLMMENTNLKGQ----------------IPADLFSIPHLQTVVMKTNELNGTLDLGTSYSENLLVNLQNNRISA 373 (955)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~----------------~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~L~~N~l~~ 373 (955)
....+..+++..|.+.+. ++.....+++|++|+|++|+|+..+ . .+.+|+.|+|++|+|+.
T Consensus 242 ~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp-~--~~~~L~~L~L~~N~L~~ 318 (353)
T d1jl5a_ 242 LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELP-A--LPPRLERLIASFNHLAE 318 (353)
T ss_dssp CCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCC-C--CCTTCCEEECCSSCCSC
T ss_pred ccccccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccCccc-c--ccCCCCEEECCCCcCCc
Confidence 122333344333332211 1111233678999999999998644 3 25678899999999998
Q ss_pred ccCCCCCCCcceeEecC
Q 002189 374 YTERGGAPAVNLTLIDN 390 (955)
Q Consensus 374 ~~~~~~~~~~~L~~l~n 390 (955)
++.. ...+..|.+.+|
T Consensus 319 l~~~-~~~L~~L~L~~N 334 (353)
T d1jl5a_ 319 VPEL-PQNLKQLHVEYN 334 (353)
T ss_dssp CCCC-CTTCCEEECCSS
T ss_pred cccc-cCCCCEEECcCC
Confidence 7643 233444444333
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=1.2e-16 Score=161.45 Aligned_cols=184 Identities=21% Similarity=0.322 Sum_probs=104.9
Q ss_pred cccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhh
Q 002189 111 NLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDML 190 (955)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L 190 (955)
++.++..+.++.+.+++.++ ...+.+|++|++++|.|+. + +.+..+++|++|+|++|++++. ..+..+
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~--------~~l~~l 83 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI--------TPLKNL 83 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC--------GGGTTC
T ss_pred HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc--------ccccCC
Confidence 45566667777777775443 3567788888888888873 3 3477778888888888877621 123444
Q ss_pred hccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEE
Q 002189 191 VRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLY 270 (955)
Q Consensus 191 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 270 (955)
++|++|++++|.+. .++. +..+..|+.|++++|.+... ..+..+++|+.|++++|++. .++ .+..+++|+.|+
T Consensus 84 ~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~ 156 (199)
T d2omxa2 84 TKLVDILMNNNQIA-DITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLN 156 (199)
T ss_dssp TTCCEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred cccccccccccccc-cccc--cccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccc
Confidence 55555566655554 3332 33445555555555555432 23455555555555555554 222 355555555555
Q ss_pred ccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEE
Q 002189 271 LSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTL 317 (955)
Q Consensus 271 Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L 317 (955)
+++|++++.+ .+.++++|++|+|++|+++. ++ .++++++|++|
T Consensus 157 l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~~--i~-~l~~L~~L~~L 199 (199)
T d2omxa2 157 FSSNQVTDLK-PLANLTTLERLDISSNKVSD--IS-VLAKLTNLESL 199 (199)
T ss_dssp CCSSCCCCCG-GGTTCTTCCEEECCSSCCCC--CG-GGGGCTTCSEE
T ss_pred cccccccCCc-cccCCCCCCEEECCCCCCCC--Cc-cccCCCCCCcC
Confidence 5555555443 24555555555555555543 22 34555555543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=9.2e-18 Score=191.59 Aligned_cols=308 Identities=17% Similarity=0.155 Sum_probs=194.9
Q ss_pred CEeEEEecCCcCcccc-CcCcCCCCcccEEecCCCCCCcc----CCCCCcccccccccccccccccCCC----CCCccc-
Q 002189 65 RVTSITLSGMGLKGQL-SGDITGLTELHTLDLSNNKDLRG----PLPTTIGNLKKLSNLMLVGCSFSGP----IPDSIG- 134 (955)
Q Consensus 65 ~v~~L~L~~~~l~~~~-~~~l~~l~~L~~L~Ls~N~~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~- 134 (955)
+|+.||++++++++.. ...+..+++|++|+|++|. ++. .+...+..+++|+.|+|++|.|+.. +...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~-i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCG-LTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSC-CCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCC-CCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 5788999999998632 3445667888899999986 653 2344567788899999999987521 122222
Q ss_pred cCCCCcEEEccCCCCcCc----CCCCCCCCCCcCeeecCCceeeeccCCCC------------------CC---------
Q 002189 135 SLQELVLLSLNSNGFSGR----VPPSIGNLSNLYWLDLTDNKLEGEIPVSD------------------GN--------- 183 (955)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~l~g~ip~~~------------------~~--------- 183 (955)
...+|++|+|++|+|+.. ++..+..+++|++|+|++|.++..-...+ ..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 234799999999998753 35567788899999999988753100000 00
Q ss_pred CCchhhhhccccccccCCccccc--------------------------CCc------cccCCccceeeeeccCCCccc-
Q 002189 184 SPGLDMLVRAKHFHFGKNQLSGS--------------------------IPE------KLFRPDMVLIHVLFDSNNLTG- 230 (955)
Q Consensus 184 ~~~l~~L~~L~~L~L~~N~l~g~--------------------------ip~------~~~~~~~~L~~L~L~~N~l~~- 230 (955)
...+.....++.++++++.+... ... ........++.+.+..|++..
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 00011122344444444332200 000 001123457778888887653
Q ss_pred ----cCCcccCCCCCCcEEEcccCCCCCC----ccccccCCCCCCEEEccCCcCcccCC-----C-CCCCCCCCEEECcC
Q 002189 231 ----ELPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAMP-----N-LTGLSVLSYLDMSN 296 (955)
Q Consensus 231 ----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~-~~~l~~L~~L~Ls~ 296 (955)
...........|+.|++++|.+... ....+...+.++.+++++|.++.... . ......|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 2344456678899999999988732 33445678889999999998865322 1 22356799999999
Q ss_pred CCCCCCC---CChhhcCCCCCCEEECcCCcceec----CCcCCC-CCCCCcEEEeecCcceeee----CCC-cchhhhhh
Q 002189 297 NSFDASE---VPSWFSSMQSLTTLMMENTNLKGQ----IPADLF-SIPHLQTVVMKTNELNGTL----DLG-TSYSENLL 363 (955)
Q Consensus 297 N~l~~~~---~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~~----~~~-~~~~~l~~ 363 (955)
|.++... +...+...++|++|+|++|+|++. ++..+. ..+.|++|+|++|+|+... ... ....+|++
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~ 401 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence 9886421 122345567899999999998743 333343 3567999999999997631 111 23466789
Q ss_pred hcccCCcccc
Q 002189 364 VNLQNNRISA 373 (955)
Q Consensus 364 L~L~~N~l~~ 373 (955)
|+|++|+|+.
T Consensus 402 L~Ls~N~i~~ 411 (460)
T d1z7xw1 402 LDLSNNCLGD 411 (460)
T ss_dssp EECCSSSCCH
T ss_pred EECCCCcCCH
Confidence 9999999875
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.1e-13 Score=127.63 Aligned_cols=102 Identities=23% Similarity=0.245 Sum_probs=65.3
Q ss_pred eeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCC
Q 002189 220 HVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSF 299 (955)
Q Consensus 220 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 299 (955)
.|+|++|+++ .++ .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|.|+..+ .+..+++|++|++++|+|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCcc
Confidence 3455555555 233 3566667777777777776 55666677777777777777776553 466667777777777777
Q ss_pred CCCCCChhhcCCCCCCEEECcCCcce
Q 002189 300 DASEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 300 ~~~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
+.......+..+++|+.|++++|+++
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCchhhcCCCCCCEEECCCCcCC
Confidence 55333345666667777777777666
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=9.9e-14 Score=134.37 Aligned_cols=111 Identities=15% Similarity=0.109 Sum_probs=55.3
Q ss_pred CCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCE
Q 002189 237 GLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 316 (955)
Q Consensus 237 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 316 (955)
.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|.|+.+ +.+..+++|++|+|++|+++. ..+..+..+++|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccC-CCcccccccccccc
Confidence 34445555555555555 3344444555555555555555544 334555555555555555543 22233445555555
Q ss_pred EECcCCcceecC-CcCCCCCCCCcEEEeecCccee
Q 002189 317 LMMENTNLKGQI-PADLFSIPHLQTVVMKTNELNG 350 (955)
Q Consensus 317 L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~ 350 (955)
|+|++|+|+... ...+..+++|++|+|++|+++.
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ceeccccccccccccccccccccchhhcCCCcccc
Confidence 555555554221 1234455555555555555543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=3.1e-16 Score=178.65 Aligned_cols=301 Identities=18% Similarity=0.184 Sum_probs=195.4
Q ss_pred CcccEEecCCCCCCccCC-CCCcccccccccccccccccCC----CCCCccccCCCCcEEEccCCCCcCc----CCCCCC
Q 002189 88 TELHTLDLSNNKDLRGPL-PTTIGNLKKLSNLMLVGCSFSG----PIPDSIGSLQELVLLSLNSNGFSGR----VPPSIG 158 (955)
Q Consensus 88 ~~L~~L~Ls~N~~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~ 158 (955)
.+|++|||++|+ +++.. ..-+..+++|++|+|++|+|+. .+...+..+++|++|||++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~-i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~ 80 (460)
T d1z7xw1 2 LDIQSLDIQCEE-LSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 80 (460)
T ss_dssp EEEEEEEEESCC-CCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CCCCEEEeeCCc-CChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHh
Confidence 368999999998 66532 3446778999999999999872 3455678899999999999999632 223333
Q ss_pred -CCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccC----Ccccc---------------------
Q 002189 159 -NLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSI----PEKLF--------------------- 212 (955)
Q Consensus 159 -~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~i----p~~~~--------------------- 212 (955)
...+|++|+|++|+++..--..+ ...+..+++|++|+|++|+++..- ...+.
T Consensus 81 ~~~~~L~~L~L~~n~it~~~~~~l--~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 158 (460)
T d1z7xw1 81 TPSCKIQKLSLQNCCLTGAGCGVL--SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 158 (460)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHH--HHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred cCCCCCCEEECCCCCccccccccc--cchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhh
Confidence 33589999999999973210000 012455678899999999886210 00000
Q ss_pred -------CCccceeeeeccCCCcc-----------------------------cc----CCcccCCCCCCcEEEcccCCC
Q 002189 213 -------RPDMVLIHVLFDSNNLT-----------------------------GE----LPATLGLVKSLEVVRFDRNSL 252 (955)
Q Consensus 213 -------~~~~~L~~L~L~~N~l~-----------------------------~~----~p~~l~~l~~L~~L~Ls~N~l 252 (955)
.....++.+.++.+.+. .. ....+...+.++.++++.|.+
T Consensus 159 ~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~ 238 (460)
T d1z7xw1 159 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 238 (460)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccc
Confidence 00112333443333322 11 112234567888999998887
Q ss_pred CC-----CccccccCCCCCCEEEccCCcCcccCC-----CCCCCCCCCEEECcCCCCCCCCCChhh-----cCCCCCCEE
Q 002189 253 SG-----PVPSNLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLSYLDMSNNSFDASEVPSWF-----SSMQSLTTL 317 (955)
Q Consensus 253 ~~-----~~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~p~~~-----~~l~~L~~L 317 (955)
.. ...........|+.|++++|.+..... .+...+.++.+++++|.++. .....+ .....|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~-~~~~~l~~~l~~~~~~L~~l 317 (460)
T d1z7xw1 239 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD-EGARLLCETLLEPGCQLESL 317 (460)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH-HHHHHHHHHHTSTTCCCCEE
T ss_pred cccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccc-cccchhhccccccccccccc
Confidence 52 234455667899999999999876432 24567899999999999853 111111 234689999
Q ss_pred ECcCCcceecCCcC----CCCCCCCcEEEeecCcceeee----CCCc--chhhhhhhcccCCccccccCC----C---CC
Q 002189 318 MMENTNLKGQIPAD----LFSIPHLQTVVMKTNELNGTL----DLGT--SYSENLLVNLQNNRISAYTER----G---GA 380 (955)
Q Consensus 318 ~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~----~~~~--~~~~l~~L~L~~N~l~~~~~~----~---~~ 380 (955)
++++|.++...... +...++|++|+|++|+|+... ...+ ....|+.|+|++|+|+..... . ..
T Consensus 318 ~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 397 (460)
T d1z7xw1 318 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 397 (460)
T ss_dssp ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred cccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCC
Confidence 99999998653333 345678999999999997632 2111 234577999999999863221 1 23
Q ss_pred CCcceeEecCcc
Q 002189 381 PAVNLTLIDNPI 392 (955)
Q Consensus 381 ~~~~L~~l~n~~ 392 (955)
.+..|.+.+|++
T Consensus 398 ~L~~L~Ls~N~i 409 (460)
T d1z7xw1 398 SLRELDLSNNCL 409 (460)
T ss_dssp CCCEEECCSSSC
T ss_pred CCCEEECCCCcC
Confidence 445555555553
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=8.8e-14 Score=134.74 Aligned_cols=58 Identities=17% Similarity=0.221 Sum_probs=22.5
Q ss_pred ccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceee
Q 002189 114 KLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLE 174 (955)
Q Consensus 114 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 174 (955)
+|+.|+|++|+|+ .++..+..+++|+.|+|++|+|+ .+ +.|..+++|++|+|++|+++
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~ 76 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRIC 76 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCC
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-cc-CCcccCcchhhhhccccccc
Confidence 3344444444443 22333333444444444444444 22 12334444444444444433
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.40 E-value=3e-13 Score=124.55 Aligned_cols=83 Identities=27% Similarity=0.418 Sum_probs=43.7
Q ss_pred CcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCcCcccCC--CCCCCCCCCEEECcCCCCCCCC--CChhh
Q 002189 233 PATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNKLTGAMP--NLTGLSVLSYLDMSNNSFDASE--VPSWF 308 (955)
Q Consensus 233 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~~~~--~p~~~ 308 (955)
|..++.+++|+.|++++|.|+ .+| .+..+++|+.|++++|+|+..+. .+..+++|++|++++|+++... ....+
T Consensus 36 p~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~ 113 (124)
T d1dcea3 36 PPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113 (124)
T ss_dssp CGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHH
T ss_pred hhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHH
Confidence 334445555555666666555 233 35556666666666666655443 3555666666666666664311 12233
Q ss_pred cCCCCCCEE
Q 002189 309 SSMQSLTTL 317 (955)
Q Consensus 309 ~~l~~L~~L 317 (955)
..+|+|+.|
T Consensus 114 ~~lp~L~~L 122 (124)
T d1dcea3 114 EMLPSVSSI 122 (124)
T ss_dssp HHCTTCSEE
T ss_pred HHCcCcceE
Confidence 445555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=8.9e-15 Score=156.05 Aligned_cols=221 Identities=14% Similarity=0.154 Sum_probs=112.3
Q ss_pred EEEecCCcCccccCcCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCC-CCCccccCCCCcEEEccC
Q 002189 68 SITLSGMGLKGQLSGDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGP-IPDSIGSLQELVLLSLNS 146 (955)
Q Consensus 68 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~ 146 (955)
.|||+++.+.......+.. ..+..+.++... +... ........+|++|+|++|.++.. +...+..+++|++|+|++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~-~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSF-MDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCE-ECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccc-cccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 6788877775433222211 234556666553 3322 23344556888888888887633 344567788888888888
Q ss_pred CCCcCcCCCCCCCCCCcCeeecCCc-eeeeccCCCCCCCCc-hhhhhccccccccCC-cccc-cCCccccCCccceeeee
Q 002189 147 NGFSGRVPPSIGNLSNLYWLDLTDN-KLEGEIPVSDGNSPG-LDMLVRAKHFHFGKN-QLSG-SIPEKLFRPDMVLIHVL 222 (955)
Q Consensus 147 N~l~~~~p~~~~~L~~L~~L~L~~N-~l~g~ip~~~~~~~~-l~~L~~L~~L~L~~N-~l~g-~ip~~~~~~~~~L~~L~ 222 (955)
|.+++..+..++.+++|++|+|+++ .++.. .+.. ...+++|++|+++++ .++. .+...+....+.|+.|+
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~------~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~ 154 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF------ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLN 154 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHH------HHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEE
T ss_pred cCCCcHHHHHHhcCCCCcCcccccccccccc------ccchhhHHHHhccccccccccccccccchhhhcccccccchhh
Confidence 8887766777778888888888874 44411 0111 234556666666664 2321 01111112223445555
Q ss_pred ccCC--Ccccc-CCcccCCCCCCcEEEcccC-CCCCCccccccCCCCCCEEEccCC-cCcccCC-CCCCCCCCCEEECcC
Q 002189 223 FDSN--NLTGE-LPATLGLVKSLEVVRFDRN-SLSGPVPSNLNNLTSVNDLYLSNN-KLTGAMP-NLTGLSVLSYLDMSN 296 (955)
Q Consensus 223 L~~N--~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~-~~~~l~~L~~L~Ls~ 296 (955)
++++ .++.. +...+..+++|++|++++| .+++.....+.++++|++|+|++| .+++... .+..+++|+.|++++
T Consensus 155 l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 155 LSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp CCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred hcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence 5432 12211 1122233445555555443 244344444444555555555542 3332221 233444444444444
Q ss_pred C
Q 002189 297 N 297 (955)
Q Consensus 297 N 297 (955)
+
T Consensus 235 ~ 235 (284)
T d2astb2 235 I 235 (284)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.34 E-value=2.5e-14 Score=157.14 Aligned_cols=250 Identities=17% Similarity=0.162 Sum_probs=142.2
Q ss_pred cCcCCCCcccEEecCCCCCCccC----CCCCcccccccccccccccccCCC----------CCCccccCCCCcEEEccCC
Q 002189 82 GDITGLTELHTLDLSNNKDLRGP----LPTTIGNLKKLSNLMLVGCSFSGP----------IPDSIGSLQELVLLSLNSN 147 (955)
Q Consensus 82 ~~l~~l~~L~~L~Ls~N~~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~Ls~N 147 (955)
..+.....|++|+|++|. +... +-..+...++|+.|+++++.+... +...+..+++|++|+|++|
T Consensus 25 ~~L~~~~~l~~L~Ls~n~-i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNT-IGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp HHHHHCSCCCEEECTTSE-ECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHhhCCCCCEEECcCCc-CCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 345556666677776664 3221 222345556666666666544311 1223456778999999999
Q ss_pred CCcCc----CCCCCCCCCCcCeeecCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeec
Q 002189 148 GFSGR----VPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLF 223 (955)
Q Consensus 148 ~l~~~----~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 223 (955)
.++.. +...+...++|+.|++++|.++..-.. .+. ..+..+.... .......|+.+.+
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~------~l~--~~l~~~~~~~----------~~~~~~~L~~l~l 165 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA------KIA--RALQELAVNK----------KAKNAPPLRSIIC 165 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH------HHH--HHHHHHHHHH----------HHHTCCCCCEEEC
T ss_pred ccccccccchhhhhcccccchheecccccccccccc------ccc--cccccccccc----------ccccCcccceeec
Confidence 88753 233445678899999999887511000 000 0011111000 0011234556666
Q ss_pred cCCCcccc----CCcccCCCCCCcEEEcccCCCCCC-----ccccccCCCCCCEEEccCCcCcccC-----CCCCCCCCC
Q 002189 224 DSNNLTGE----LPATLGLVKSLEVVRFDRNSLSGP-----VPSNLNNLTSVNDLYLSNNKLTGAM-----PNLTGLSVL 289 (955)
Q Consensus 224 ~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~~-----~~~~~l~~L 289 (955)
+.|++... +...+...+.|+.|+|++|.|+.. +...+..+++|+.|+|++|.++... ..+...++|
T Consensus 166 ~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L 245 (344)
T d2ca6a1 166 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245 (344)
T ss_dssp CSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred ccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccc
Confidence 66665522 333455667788888888887631 3344666778888888888775431 235667778
Q ss_pred CEEECcCCCCCCCC---CChhhcC--CCCCCEEECcCCcceec----CCcCCC-CCCCCcEEEeecCccee
Q 002189 290 SYLDMSNNSFDASE---VPSWFSS--MQSLTTLMMENTNLKGQ----IPADLF-SIPHLQTVVMKTNELNG 350 (955)
Q Consensus 290 ~~L~Ls~N~l~~~~---~p~~~~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~ 350 (955)
++|+|++|.|+... +...+.. .+.|++|++++|+|+.. +...+. ++++|+.|+|++|++..
T Consensus 246 ~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 88888888775311 1112222 35678888888877642 222232 46678888888888754
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=1e-13 Score=147.63 Aligned_cols=249 Identities=16% Similarity=0.157 Sum_probs=149.8
Q ss_pred cEEecCCCCCCccCCCCCcccccc--cccccccccccCCCCCCccccCCCCcEEEccCCCCcCc-CCCCCCCCCCcCeee
Q 002189 91 HTLDLSNNKDLRGPLPTTIGNLKK--LSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGR-VPPSIGNLSNLYWLD 167 (955)
Q Consensus 91 ~~L~Ls~N~~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~ 167 (955)
++|||+++. +. |+.+..+.. +..+.+++..+...+ .......+|++|||++|.++.. +...+..+++|++|+
T Consensus 3 ~~lDLs~~~-l~---~~~l~~l~~~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~ 77 (284)
T d2astb2 3 QTLDLTGKN-LH---PDVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 77 (284)
T ss_dssp SEEECTTCB-CC---HHHHHHHHHTTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred CEEECCCCC-CC---chHHHHHHhccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccc
Confidence 478998875 43 334443322 344455555555322 3344566899999998887743 344567888999999
Q ss_pred cCCceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCcccc-CCcccCCCCCCcEEE
Q 002189 168 LTDNKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGE-LPATLGLVKSLEVVR 246 (955)
Q Consensus 168 L~~N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~ 246 (955)
|++|.+++..+.. +..+++|++|+++++. +++.. +...+..+++|++|+
T Consensus 78 L~~~~l~~~~~~~------l~~~~~L~~L~Ls~c~------------------------~itd~~l~~l~~~~~~L~~L~ 127 (284)
T d2astb2 78 LEGLRLSDPIVNT------LAKNSNLVRLNLSGCS------------------------GFSEFALQTLLSSCSRLDELN 127 (284)
T ss_dssp CTTCBCCHHHHHH------HTTCTTCSEEECTTCB------------------------SCCHHHHHHHHHHCTTCCEEE
T ss_pred ccccCCCcHHHHH------HhcCCCCcCccccccc------------------------cccccccchhhHHHHhccccc
Confidence 9988876443322 2233445555555431 23211 112234567788888
Q ss_pred cccC-CCCCC-cccccc-CCCCCCEEEccCC--cCcccC-CC-CCCCCCCCEEECcCCC-CCCCCCChhhcCCCCCCEEE
Q 002189 247 FDRN-SLSGP-VPSNLN-NLTSVNDLYLSNN--KLTGAM-PN-LTGLSVLSYLDMSNNS-FDASEVPSWFSSMQSLTTLM 318 (955)
Q Consensus 247 Ls~N-~l~~~-~p~~l~-~l~~L~~L~Ls~N--~l~~~~-~~-~~~l~~L~~L~Ls~N~-l~~~~~p~~~~~l~~L~~L~ 318 (955)
++++ .++.. +...+. ..++|+.|+++++ .++... .. ...+++|++|+|++|. ++. .....+..+++|++|+
T Consensus 128 ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd-~~~~~l~~~~~L~~L~ 206 (284)
T d2astb2 128 LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN-DCFQEFFQLNYLQHLS 206 (284)
T ss_dssp CCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCG-GGGGGGGGCTTCCEEE
T ss_pred cccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCc-hhhhhhcccCcCCEEE
Confidence 8774 44421 222233 3467888888764 343221 12 3457788888888865 443 4566778888899999
Q ss_pred CcCC-cceecCCcCCCCCCCCcEEEeecCcceeeeCCCcc-h-hhhhhhcccCCccccccCCCC
Q 002189 319 MENT-NLKGQIPADLFSIPHLQTVVMKTNELNGTLDLGTS-Y-SENLLVNLQNNRISAYTERGG 379 (955)
Q Consensus 319 Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~-~~l~~L~L~~N~l~~~~~~~~ 379 (955)
|++| .+++.....+.++++|+.|+++++ ++ +.... + ..+..|.+..++++.+.+...
T Consensus 207 L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp~L~i~~~~ls~~~~~~~ 266 (284)
T d2astb2 207 LSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTI 266 (284)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred CCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCccccccCccCCCCCCCcc
Confidence 9884 677776777888899999999886 22 11211 1 234467777788777654433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.29 E-value=3.4e-14 Score=156.00 Aligned_cols=255 Identities=16% Similarity=0.158 Sum_probs=160.2
Q ss_pred CCCCcccccccccccccccccCCC----CCCccccCCCCcEEEccCCCCcCc----------CCCCCCCCCCcCeeecCC
Q 002189 105 LPTTIGNLKKLSNLMLVGCSFSGP----IPDSIGSLQELVLLSLNSNGFSGR----------VPPSIGNLSNLYWLDLTD 170 (955)
Q Consensus 105 ~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~p~~~~~L~~L~~L~L~~ 170 (955)
+...+.+...|+.|+|++|.|... +...+..+++|+.|+++++.+... +...+...++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 344566677888888888887532 333466778888888887765421 112245567788888888
Q ss_pred ceeeeccCCCCCCCCchhhhhccccccccCCcccccCCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccC
Q 002189 171 NKLEGEIPVSDGNSPGLDMLVRAKHFHFGKNQLSGSIPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRN 250 (955)
Q Consensus 171 N~l~g~ip~~~~~~~~l~~L~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 250 (955)
|.++..-...+ ...+...++|++|++++|.++..-...+. ..+..+. ........+.|+.|++++|
T Consensus 103 n~i~~~~~~~l--~~~l~~~~~L~~L~l~~n~l~~~~~~~l~---~~l~~~~---------~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 103 NAFGPTAQEPL--IDFLSKHTPLEHLYLHNNGLGPQAGAKIA---RALQELA---------VNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp CCCCTTTHHHH--HHHHHHCTTCCEEECCSSCCHHHHHHHHH---HHHHHHH---------HHHHHHTCCCCCEEECCSS
T ss_pred cccccccccch--hhhhcccccchheeccccccccccccccc---ccccccc---------cccccccCcccceeecccc
Confidence 87762100000 01123344555566655555310000000 0000000 0112245678999999999
Q ss_pred CCCCC----ccccccCCCCCCEEEccCCcCccc------CCCCCCCCCCCEEECcCCCCCCC---CCChhhcCCCCCCEE
Q 002189 251 SLSGP----VPSNLNNLTSVNDLYLSNNKLTGA------MPNLTGLSVLSYLDMSNNSFDAS---EVPSWFSSMQSLTTL 317 (955)
Q Consensus 251 ~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~------~~~~~~l~~L~~L~Ls~N~l~~~---~~p~~~~~l~~L~~L 317 (955)
.++.. +...+...+.|+.|+|++|.|... ...+...++|+.|+|++|.++.. .+...+..+++|++|
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L 248 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhh
Confidence 98732 344566788999999999999753 22467789999999999998531 133556789999999
Q ss_pred ECcCCcceecCCcC----CC--CCCCCcEEEeecCcceeee----CCCc--chhhhhhhcccCCcccc
Q 002189 318 MMENTNLKGQIPAD----LF--SIPHLQTVVMKTNELNGTL----DLGT--SYSENLLVNLQNNRISA 373 (955)
Q Consensus 318 ~Ls~N~l~~~~p~~----~~--~l~~L~~L~Ls~N~l~~~~----~~~~--~~~~l~~L~L~~N~l~~ 373 (955)
+|++|.|++..... +. ..+.|++|+|++|+|+..- .... ..+.++.|+|++|++..
T Consensus 249 ~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 99999998643322 22 3467999999999997632 1111 24567789999999864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.24 E-value=8.9e-14 Score=139.50 Aligned_cols=87 Identities=22% Similarity=0.282 Sum_probs=37.9
Q ss_pred cCcCCCCcccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcCCCCCCCCC
Q 002189 82 GDITGLTELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLS 161 (955)
Q Consensus 82 ~~l~~l~~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~ 161 (955)
..+..|++|++|+|++|+ +.. ++ .|..+++|++|+|++|.|+ .+|..+..+++|++|++++|+|+. ++ .+..++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~-I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~ 115 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNN-IEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLV 115 (198)
T ss_dssp HHHHHTTTCCEEECSEEE-ESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHH
T ss_pred hHHhcccccceeECcccC-CCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccc
Confidence 334444455555555443 332 22 2444444444444444444 333333333444444444444442 11 234444
Q ss_pred CcCeeecCCceee
Q 002189 162 NLYWLDLTDNKLE 174 (955)
Q Consensus 162 ~L~~L~L~~N~l~ 174 (955)
+|+.|+|++|+|+
T Consensus 116 ~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 116 NLRVLYMSNNKIT 128 (198)
T ss_dssp HSSEEEESEEECC
T ss_pred cccccccccchhc
Confidence 4444444444443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=1.6e-11 Score=117.73 Aligned_cols=111 Identities=20% Similarity=0.244 Sum_probs=86.5
Q ss_pred CCCCcEEEcccCCCCCCccccccCCCCCCEEEccCC-cCcccCC-CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCE
Q 002189 239 VKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNN-KLTGAMP-NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTT 316 (955)
Q Consensus 239 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~ 316 (955)
+...+.++++++.+. ..|..+..+++|++|+|++| .|+.+.+ .|.++++|+.|+|++|+|+. ..+..|..+++|++
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSR 84 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC-cccccccccccccc
Confidence 344566778888777 56777888888888888765 4877766 47888888888888888875 56778889999999
Q ss_pred EECcCCcceecCCcCCCCCCCCcEEEeecCcceeee
Q 002189 317 LMMENTNLKGQIPADLFSIPHLQTVVMKTNELNGTL 352 (955)
Q Consensus 317 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 352 (955)
|+|++|+|+ .+|.......+|+.|+|++|++....
T Consensus 85 L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp EECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred eeccCCCCc-ccChhhhccccccccccCCCcccCCc
Confidence 999999998 55555555557999999999997544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=1.4e-13 Score=137.99 Aligned_cols=116 Identities=20% Similarity=0.331 Sum_probs=72.6
Q ss_pred CCCCccccCCCCcEEEccCCCCcCcCCCCCCCCCCcCeeecCCceeeeccCCCCCCCCch-hhhhccccccccCCccccc
Q 002189 128 PIPDSIGSLQELVLLSLNSNGFSGRVPPSIGNLSNLYWLDLTDNKLEGEIPVSDGNSPGL-DMLVRAKHFHFGKNQLSGS 206 (955)
Q Consensus 128 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~g~ip~~~~~~~~l-~~L~~L~~L~L~~N~l~g~ 206 (955)
.++..+..|++|++|+|++|+|+ .++ .+.++++|+.|+|++|+|+ .+| .+ ..+.+|+.|++++
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~-------~~~~~~~~L~~L~l~~------ 102 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIE-------NLDAVADTLEELWISY------ 102 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCS-------SHHHHHHHCCEEECSE------
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccc-------cccccccccccccccc------
Confidence 34455777777777777777777 343 4677777777777777776 222 11 1223344444444
Q ss_pred CCccccCCccceeeeeccCCCccccCCcccCCCCCCcEEEcccCCCCCCcc--ccccCCCCCCEEEccCCcCcccCC
Q 002189 207 IPEKLFRPDMVLIHVLFDSNNLTGELPATLGLVKSLEVVRFDRNSLSGPVP--SNLNNLTSVNDLYLSNNKLTGAMP 281 (955)
Q Consensus 207 ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~~ 281 (955)
|+++.. ..+..+++|+.|++++|+|+. ++ ..+..+++|+.|+|++|++....+
T Consensus 103 -------------------N~i~~l--~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 103 -------------------NQIASL--SGIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp -------------------EECCCH--HHHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred -------------------cccccc--ccccccccccccccccchhcc-ccccccccCCCccceeecCCCccccCcc
Confidence 444421 235667778888888888873 33 457778888888888888776554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=2.5e-11 Score=116.28 Aligned_cols=138 Identities=15% Similarity=0.093 Sum_probs=87.9
Q ss_pred cccCCcccccCCccccCCccceeeeeccCCC-ccccCCcccCCCCCCcEEEcccCCCCCCccccccCCCCCCEEEccCCc
Q 002189 197 HFGKNQLSGSIPEKLFRPDMVLIHVLFDSNN-LTGELPATLGLVKSLEVVRFDRNSLSGPVPSNLNNLTSVNDLYLSNNK 275 (955)
Q Consensus 197 ~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 275 (955)
+++++.+. .+|..+ ....+|++|++++|+ |+...+..|..+++|+.|+|++|+|+...+..|..+++|++|+|++|+
T Consensus 14 ~c~~~~~~-~~p~~l-~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 14 RCTRDGAL-DSLHHL-PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp ECCSSCCC-TTTTTS-CSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EecCCCCc-cCcccc-cCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 33444443 344332 224456677776553 665666678888888888888888886667788888888888888888
Q ss_pred CcccCCCCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcCCCCCC
Q 002189 276 LTGAMPNLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPADLFSIP 336 (955)
Q Consensus 276 l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 336 (955)
|+.+++......+|+.|+|++|++...-...|+..+.......+..++++...|..+..+|
T Consensus 92 l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~p 152 (156)
T d2ifga3 92 LESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMP 152 (156)
T ss_dssp CSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCCC
T ss_pred CcccChhhhccccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcCC
Confidence 8887776655567888888888885422233333332233334445556555555555554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=7.4e-07 Score=92.08 Aligned_cols=149 Identities=17% Similarity=0.168 Sum_probs=101.5
Q ss_pred HHHHHHhcCCCccCeeeccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhcc-CCCcceEEEEEEeCCeE
Q 002189 621 EEVKKYTNNFSDANDVGSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVH-HKNLVSLLGFCFDRGEQ 699 (955)
Q Consensus 621 ~el~~~~~~f~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 699 (955)
.|+++..+.|+..+..+-++-+.||+... +++.++||+...........+.+|...++.+. +--+-+++++..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46777777777666544444568999875 45677888876544444456788999988874 43356788888888899
Q ss_pred EEEEEecCCCCcccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhhcc---------------------------------
Q 002189 700 MLIYEFVPNGSLGDSLSGKNGIRLDWIRRLKIALGAARGLSYLHELA--------------------------------- 746 (955)
Q Consensus 700 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 746 (955)
++||+++++.++.+...... . ...++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999877754332211 1 1223444445555555321
Q ss_pred -----------------------CCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 747 -----------------------NPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 747 -----------------------~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1227899999999999987767799998765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.24 E-value=3.9e-08 Score=94.19 Aligned_cols=80 Identities=19% Similarity=0.141 Sum_probs=48.6
Q ss_pred cccEEecCCCCCCccCCCCCcccccccccccccccccCCCCCCccccCCCCcEEEccCCCCcCcC--CCCCCCCCCcCee
Q 002189 89 ELHTLDLSNNKDLRGPLPTTIGNLKKLSNLMLVGCSFSGPIPDSIGSLQELVLLSLNSNGFSGRV--PPSIGNLSNLYWL 166 (955)
Q Consensus 89 ~L~~L~Ls~N~~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~L~~L~~L 166 (955)
..+.|+++++. . ...+..+..+..|++.++... .++..+..+++|++|+|++|+|+..- +..+..+++|+.|
T Consensus 23 ~~~~Ldls~l~-~----~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 23 SQQALDLKGLR-S----DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSCCBCCCCCS-S----CTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred hhCeeecccCC-C----CchhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccc
Confidence 34556666554 1 123444555555666555544 44445566778888888888887432 3445667777777
Q ss_pred ecCCceee
Q 002189 167 DLTDNKLE 174 (955)
Q Consensus 167 ~L~~N~l~ 174 (955)
+|++|+|+
T Consensus 97 ~Ls~N~i~ 104 (162)
T d1koha1 97 NLSGNELK 104 (162)
T ss_dssp CCTTSCCC
T ss_pred ccccCccc
Confidence 77777776
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=2.5e-08 Score=95.54 Aligned_cols=86 Identities=19% Similarity=0.145 Sum_probs=48.5
Q ss_pred ccccccCCCCCCEEEccCCcCcccCC---CCCCCCCCCEEECcCCCCCCCCCChhhcCCCCCCEEECcCCcceecCCcC-
Q 002189 256 VPSNLNNLTSVNDLYLSNNKLTGAMP---NLTGLSVLSYLDMSNNSFDASEVPSWFSSMQSLTTLMMENTNLKGQIPAD- 331 (955)
Q Consensus 256 ~p~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~- 331 (955)
++..+..+++|+.|+|++|+|+.+.+ .+..+++|+.|+|++|.|+.. .+-.+....+|+.|++++|+++......
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l-~~l~~l~~~~L~~L~L~~Npl~~~~~~~~ 135 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLSDTFRDQS 135 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCG-GGHHHHTTCCCSSCCCTTSTTSSSSSSHH
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccc-hhhhhhhccccceeecCCCCcCcCcccch
Confidence 34444456666666666666665432 234566666777777766541 1223334445777777777776443322
Q ss_pred ------CCCCCCCcEEE
Q 002189 332 ------LFSIPHLQTVV 342 (955)
Q Consensus 332 ------~~~l~~L~~L~ 342 (955)
+..+|+|+.||
T Consensus 136 ~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 136 TYISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHHHTTSTTCCEET
T ss_pred hHHHHHHHHCCCCCEEC
Confidence 44567777664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=1.8e-05 Score=80.87 Aligned_cols=130 Identities=18% Similarity=0.163 Sum_probs=87.3
Q ss_pred eeeccCc-eEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccC--CCcceEEEEEEeCCeEEEEEEecCCCCc
Q 002189 635 DVGSGGY-GKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHH--KNLVSLLGFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 635 ~lG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL 711 (955)
.+..|.. +.||+....++..+++|...... ..++..|.+.++.+.. --+.++++++.+++..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 58999998888889999876543 2357788888887753 3356788888888899999999988766
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------------
Q 002189 712 GDSLSGKNGIRLDWIRRLKIALGAARGLSYLHE----------------------------------------------- 744 (955)
Q Consensus 712 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~----------------------------------------------- 744 (955)
.+... .. ...+.++++.|+-||+
T Consensus 94 ~~~~~-------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSHL-------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSCC-------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc-------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 54221 00 1111222222333331
Q ss_pred ----c----cCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 745 ----L----ANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 745 ----~----~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
. ..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11237999999999999988777899998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.41 E-value=4.6e-05 Score=72.44 Aligned_cols=66 Identities=14% Similarity=0.081 Sum_probs=34.7
Q ss_pred cccCCCCCCcEEEcccCCCCC----CccccccCCCCCCEEEccCCcCcccCC-----CCCCCCCCCEEECcCCCC
Q 002189 234 ATLGLVKSLEVVRFDRNSLSG----PVPSNLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLSYLDMSNNSF 299 (955)
Q Consensus 234 ~~l~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l 299 (955)
..+...++|+.|+|++|.+.. .+...+...+.|+.|+|++|.|+.... .+...++|++|+|++|.+
T Consensus 38 ~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 38 EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred HHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence 345555666666666666652 223334445566666666666654221 244445555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00025 Score=77.12 Aligned_cols=76 Identities=17% Similarity=0.135 Sum_probs=48.7
Q ss_pred cCeeeccCceEEEEEEeCC-CcEEEEEEcccC------C-cchhHHHHHHHHHHHhcc-C-C-CcceEEEEEEeCCeEEE
Q 002189 633 ANDVGSGGYGKVYKGTLPN-GQLIAIKRAQQG------S-MQGGQEFKMEIELLSRVH-H-K-NLVSLLGFCFDRGEQML 701 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-H-~-niv~l~~~~~~~~~~~l 701 (955)
.+.||.|....||+....+ ++.|+||.-... . .....+...|.+.|+.+. + | .+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998654 678999964321 1 112234566888888763 2 3 34455543 5566789
Q ss_pred EEEecCCCC
Q 002189 702 IYEFVPNGS 710 (955)
Q Consensus 702 V~e~~~~gs 710 (955)
||||+++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.20 E-value=2.3e-05 Score=74.57 Aligned_cols=112 Identities=13% Similarity=0.084 Sum_probs=72.5
Q ss_pred CCCCCCcEEEcccC-CCCCC----ccccccCCCCCCEEEccCCcCcccCC-----CCCCCCCCCEEECcCCCCCCCC---
Q 002189 237 GLVKSLEVVRFDRN-SLSGP----VPSNLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLSYLDMSNNSFDASE--- 303 (955)
Q Consensus 237 ~~l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~--- 303 (955)
.+.++|+.|+|+++ .++.. +-..+...++|+.|+|++|.+..... .+...+.|+.|+|++|.|+...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34577888888864 46522 34456778889999999998875322 2445678888888888885411
Q ss_pred CChhhcCCCCCCEEECcCCccee-------cCCcCCCCCCCCcEEEeecCcc
Q 002189 304 VPSWFSSMQSLTTLMMENTNLKG-------QIPADLFSIPHLQTVVMKTNEL 348 (955)
Q Consensus 304 ~p~~~~~l~~L~~L~Ls~N~l~~-------~~p~~~~~l~~L~~L~Ls~N~l 348 (955)
+...+...+.|++|+|++|.+.. .+...+...+.|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 12234555678888888776542 1334444567777887776654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.002 Score=67.74 Aligned_cols=69 Identities=9% Similarity=0.113 Sum_probs=48.2
Q ss_pred eEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc--ceEE-----EEEEeCCeEEEEEEecCCCCc
Q 002189 642 GKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL--VSLL-----GFCFDRGEQMLIYEFVPNGSL 711 (955)
Q Consensus 642 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----~~~~~~~~~~lV~e~~~~gsL 711 (955)
-.||+++..+|+.|++|+.+.+.. ..+++..|.+.+..|....+ +..+ ......+..+.+++|++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 489999999999999999876533 34678889999988853222 1111 122345678899999976544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.50 E-value=5.5e-05 Score=71.75 Aligned_cols=111 Identities=17% Similarity=0.137 Sum_probs=53.6
Q ss_pred CCCCCcEEEccc-CCCCC----CccccccCCCCCCEEEccCCcCcccCC-----CCCCCCCCCEEECcCCCCCCCC---C
Q 002189 238 LVKSLEVVRFDR-NSLSG----PVPSNLNNLTSVNDLYLSNNKLTGAMP-----NLTGLSVLSYLDMSNNSFDASE---V 304 (955)
Q Consensus 238 ~l~~L~~L~Ls~-N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~---~ 304 (955)
+.++|++|+|++ +.++. .+-..+...++|++|+|++|.++.... .+...+.|+.|++++|.++... +
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 345555555554 33431 122333445555555555555543211 1333455666666666553211 1
Q ss_pred ChhhcCCCCCCEEEC--cCCccee----cCCcCCCCCCCCcEEEeecCcc
Q 002189 305 PSWFSSMQSLTTLMM--ENTNLKG----QIPADLFSIPHLQTVVMKTNEL 348 (955)
Q Consensus 305 p~~~~~l~~L~~L~L--s~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 348 (955)
...+...++|+.++| ++|.+.. .+...+...+.|+.|+|+.|..
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 133445556665444 3455542 2333444566777777766654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.26 E-value=0.00035 Score=65.96 Aligned_cols=111 Identities=14% Similarity=0.139 Sum_probs=76.8
Q ss_pred ccceeeeeccC-CCcccc----CCcccCCCCCCcEEEcccCCCCCC----ccccccCCCCCCEEEccCCcCcccC-----
Q 002189 215 DMVLIHVLFDS-NNLTGE----LPATLGLVKSLEVVRFDRNSLSGP----VPSNLNNLTSVNDLYLSNNKLTGAM----- 280 (955)
Q Consensus 215 ~~~L~~L~L~~-N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----- 280 (955)
.+.|++|+|++ +.++.. +-.++...++|++|+|++|.++.. +...+...++|+.|++++|.+....
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 34567777765 345432 345667888999999999998733 3345667789999999999886533
Q ss_pred CCCCCCCCCCEEEC--cCCCCCC---CCCChhhcCCCCCCEEECcCCcce
Q 002189 281 PNLTGLSVLSYLDM--SNNSFDA---SEVPSWFSSMQSLTTLMMENTNLK 325 (955)
Q Consensus 281 ~~~~~l~~L~~L~L--s~N~l~~---~~~p~~~~~l~~L~~L~Ls~N~l~ 325 (955)
..+...++|+.++| ++|.+.. ..+...+...+.|+.|+++.+...
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 24667788987655 4666642 123344567899999999887654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.11 E-value=0.0088 Score=64.47 Aligned_cols=74 Identities=12% Similarity=0.190 Sum_probs=49.4
Q ss_pred cCeeeccCceEEEEEEeCCC--------cEEEEEEcccCCcchhHHHHHHHHHHHhccCCCcc-eEEEEEEeCCeEEEEE
Q 002189 633 ANDVGSGGYGKVYKGTLPNG--------QLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNLV-SLLGFCFDRGEQMLIY 703 (955)
Q Consensus 633 ~~~lG~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~ 703 (955)
++.|+.|---.+|++...++ +.|.+++.-. .....+..+|..+++.+.-.+++ ++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35677788889999986543 4566666542 22334567899999988534554 77776632 6899
Q ss_pred EecCCCCcc
Q 002189 704 EFVPNGSLG 712 (955)
Q Consensus 704 e~~~~gsL~ 712 (955)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.76 E-value=0.014 Score=60.63 Aligned_cols=157 Identities=11% Similarity=0.071 Sum_probs=86.1
Q ss_pred cCHHHHHHHhcCCCccCee-----eccCceEEEEEEeCCCcEEEEEEcccCCcchhHHHHHHHHHHHhccCCCc--ceEE
Q 002189 618 FSFEEVKKYTNNFSDANDV-----GSGGYGKVYKGTLPNGQLIAIKRAQQGSMQGGQEFKMEIELLSRVHHKNL--VSLL 690 (955)
Q Consensus 618 ~~~~el~~~~~~f~~~~~l-----G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~ 690 (955)
++.+|++....+|...+.. ..|---+.|+.+..+|+ +++|+..... ..+++..|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 5678889999999775543 34555788999887654 8999886532 23456667888888753322 1111
Q ss_pred E------EEEeCCeEEEEEEecCCCCcccccCC----------------------CCCCCC-CHHH--------------
Q 002189 691 G------FCFDRGEQMLIYEFVPNGSLGDSLSG----------------------KNGIRL-DWIR-------------- 727 (955)
Q Consensus 691 ~------~~~~~~~~~lV~e~~~~gsL~~~l~~----------------------~~~~~l-~~~~-------------- 727 (955)
. +....+....++.++.+......-.. ...... .+..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 0 12224556777777766444321100 000000 0000
Q ss_pred --HHHHHHHHHHHHHHhhh-ccCCCeeccCCCCccEEEcCCCceEEeeccccc
Q 002189 728 --RLKIALGAARGLSYLHE-LANPPIIHRDIKSSNILLDERLNAKVADFGLSK 777 (955)
Q Consensus 728 --~~~i~~~ia~gL~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGla~ 777 (955)
....+......+.-.+. .-+..+||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01111111112222211 112349999999999999998777899999765
|